Citrus Sinensis ID: 003278
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 834 | 2.2.26 [Sep-21-2011] | |||||||
| O48837 | 851 | Receptor like protein kin | yes | no | 0.985 | 0.965 | 0.610 | 0.0 | |
| Q9M345 | 677 | L-type lectin-domain cont | no | no | 0.365 | 0.450 | 0.431 | 6e-70 | |
| Q9LFH9 | 715 | L-type lectin-domain cont | no | no | 0.366 | 0.427 | 0.428 | 6e-68 | |
| Q9FHG4 | 681 | Probable L-type lectin-do | no | no | 0.345 | 0.422 | 0.451 | 4e-67 | |
| Q9FIF1 | 674 | Probable L-type lectin-do | no | no | 0.393 | 0.486 | 0.398 | 2e-66 | |
| Q9FIF0 | 694 | Putative L-type lectin-do | no | no | 0.395 | 0.475 | 0.403 | 3e-66 | |
| Q9M9E0 | 656 | L-type lectin-domain cont | no | no | 0.345 | 0.439 | 0.421 | 4e-65 | |
| O81291 | 669 | L-type lectin-domain cont | no | no | 0.347 | 0.433 | 0.415 | 6e-65 | |
| O81292 | 674 | L-type lectin-domain cont | no | no | 0.347 | 0.430 | 0.419 | 7e-65 | |
| Q9M2S4 | 684 | L-type lectin-domain cont | no | no | 0.341 | 0.416 | 0.428 | 9e-65 |
| >sp|O48837|LRKS2_ARATH Receptor like protein kinase S.2 OS=Arabidopsis thaliana GN=LECRKS2 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 1012 bits (2617), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 522/855 (61%), Positives = 657/855 (76%), Gaps = 33/855 (3%)
Query: 4 LNRLCFILPADVDEIGPYEKSRVHNVVSRKQEVKEQHGRGCGRRILSFIADKLQRLYEAK 63
++ LCF+LP + E+ P V +E +E+ R CGR+++S I D +RL+ +K
Sbjct: 6 MDHLCFVLPTESGELKPPVM-----VEETTEEEEEKKSRDCGRQVVSLIGDLFRRLHGSK 60
Query: 64 WV---CFCHHNTPRK----EHSGLFHDMEGVQMSEKVGGDNPRIFSYAELYIGSNGFDED 116
V C N + E + F DMEGVQ+S KVG +NPRIF Y+ELYIG+NGF ++
Sbjct: 61 LVKSLNLCSINESKDSISMEINKSFTDMEGVQLSSKVGCENPRIFGYSELYIGTNGFSDE 120
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNLVRLRG 175
+LGSGGFG+VY+A+LPSDGT VAVKCLAEK GE+FEKTFAAELVAVA LRHRNLV+LRG
Sbjct: 121 LILGSGGFGRVYKALLPSDGTTVAVKCLAEKKGEQFEKTFAAELVAVAQLRHRNLVKLRG 180
Query: 176 WCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQL 235
WC+HED+LLLVYDYMPNRSLDRVLFRRPE PL+W++R KI++GLAAAL YLHEQL
Sbjct: 181 WCLHEDELLLVYDYMPNRSLDRVLFRRPEVNSDFKPLDWDRRGKIVKGLAAALFYLHEQL 240
Query: 236 ETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMR------TSSARNHQFHLA 289
ETQIIHRDVKTSNVMLDS++NA+LGDFGLARWLEH++ SS RNHQF +A
Sbjct: 241 ETQIIHRDVKTSNVMLDSEFNAKLGDFGLARWLEHKIDETEHDSSYDSVSSFRNHQFRVA 300
Query: 290 ETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDW 349
++TRIGGTIGYLPPESF+K +VATAK+DVFSFG+VVLEVVSGRRAVDL++ +D+IILLDW
Sbjct: 301 DSTRIGGTIGYLPPESFRKKTVATAKTDVFSFGVVVLEVVSGRRAVDLSFSEDKIILLDW 360
Query: 350 IRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGSY 409
+RRLSD K+L AGD+RL+ GSY L DM+ + HLALLC+L+NP RP+MKWVI A+SG +
Sbjct: 361 VRRLSDNRKLLDAGDSRLAKGSYDLSDMKRMIHLALLCSLNNPTHRPNMKWVIGALSGEF 420
Query: 410 SGKLPALPSFQSHPLYISLSSPTNTSTSNTETTRSTNTTA-------SNTTIASPSSNYV 462
SG LPALPSF+SHPLYI LSS +TSTS T TT T T + ++ ++PSSNYV
Sbjct: 421 SGNLPALPSFKSHPLYIPLSSLKSTSTSATTTTTRTTMTTTTSTTSFNASSESTPSSNYV 480
Query: 463 TAAGETIYATAECGGNTESKSNNSRSQRRNSFFMVETPREISFKEIISATNNFSESQRVA 522
TA ++IY TAE G N N+ R S F+++TPREIS+ +++ AT+NFS+++RVA
Sbjct: 481 TALEDSIYQTAETGENPYFNYNSRRVMSSKS-FVLDTPREISYNDLVLATDNFSDARRVA 539
Query: 523 EMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQ 582
E+DFGTAY G L+ Q+++VKRLGM+KCPAL TRFS EL NL RLRHRNLV L GWCTE
Sbjct: 540 EVDFGTAYYGLLNGDQHIVVKRLGMTKCPALVTRFSTELLNLGRLRHRNLVMLRGWCTEH 599
Query: 583 GEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIH 642
GEMLV+YDYSA R LSHLLFH NH G+S+L+W RYN+IKSLA A+ YLHEEW+EQVIH
Sbjct: 600 GEMLVVYDYSANRKLSHLLFH-NHIPGNSVLRWKSRYNVIKSLACAVRYLHEEWDEQVIH 658
Query: 643 RNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGE 702
RNITSS I LD DMNPRL FALAEFL+RND H+ A S +GIFGYM+PEY+ESGE
Sbjct: 659 RNITSSTIFLDRDMNPRLCGFALAEFLSRNDKAHQAAKKKG-SAQGIFGYMAPEYMESGE 717
Query: 703 ATSMADVYSFGVVVLEVVTGQMAVDFRLP--EGLLVKRVHEFEA-RKRPLAELVDLSLNG 759
AT+MADVYSFGVVVLE+VTGQ AVD++ + L+V R+ E RK+ L E+ D+ L+
Sbjct: 718 ATTMADVYSFGVVVLEMVTGQPAVDYKRKKEDALMVLRIREVVGNRKKLLEEIADIHLDD 777
Query: 760 EYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDKRFMEDGQMTENLEEWKQRNE 819
EY ++EL RL++LG+ CT ++P+LRPS+ Q++SILDG+++ F E+G ++ KQ +
Sbjct: 778 EYENRELARLLRLGLVCTRTDPKLRPSISQVVSILDGSERFFEEEGGKEGDVSR-KQMYD 836
Query: 820 CSLSLIKRIQALGIQ 834
S+ +I+++QALGI
Sbjct: 837 SSMLMIRQMQALGIH 851
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9M345|LRK42_ARATH L-type lectin-domain containing receptor kinase IV.2 OS=Arabidopsis thaliana GN=LECRK42 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 266 bits (679), Expect = 6e-70, Method: Compositional matrix adjust.
Identities = 144/334 (43%), Positives = 202/334 (60%), Gaps = 29/334 (8%)
Query: 101 FSYAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELV 160
F + ELY + GF E ++LGSGGFG+VYR +LP+ VAVK ++ ++ K F AE+V
Sbjct: 335 FRFKELYHATKGFKEKDLLGSGGFGRVYRGILPTTKLEVAVKRVSHDSKQGMKEFVAEIV 394
Query: 161 AVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKI 220
++ + HRNLV L G+C +LLLVYDYMPN SLD+ L+ PE L+W+QR I
Sbjct: 395 SIGRMSHRNLVPLLGYCRRRGELLLVYDYMPNGSLDKYLYNNPE-----TTLDWKQRSTI 449
Query: 221 IRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSS 280
I+G+A+ L YLHE+ E +IHRDVK SNV+LD+ +N RLGDFGLAR +H Q
Sbjct: 450 IKGVASGLFYLHEEWEQVVIHRDVKASNVLLDADFNGRLGDFGLARLYDHGSDPQ----- 504
Query: 281 ARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDL-TY 339
TT + GT+GYL PE + G AT +DV++FG +LEVVSGRR ++ +
Sbjct: 505 ----------TTHVVGTLGYLAPEHSRTGR-ATTTTDVYAFGAFLLEVVSGRRPIEFHSA 553
Query: 340 PDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMK 399
DD +L++W+ L G +++A D +L Y L ++E + L LLC+ +P RPSM+
Sbjct: 554 SDDTFLLVEWVFSLWLRGNIMEAKDPKLGSSGYDLEEVEMVLKLGLLCSHSDPRARPSMR 613
Query: 400 WVIEAVSGSYSGKLPALPSFQSHPLYISLSSPTN 433
V++ + G ALP PL +S S N
Sbjct: 614 QVLQYLRGDM-----ALPELT--PLDLSAGSVMN 640
|
Required during pollen development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFH9|LRK81_ARATH L-type lectin-domain containing receptor kinase VIII.1 OS=Arabidopsis thaliana GN=LECRK81 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 259 bits (662), Expect = 6e-68, Method: Compositional matrix adjust.
Identities = 147/343 (42%), Positives = 203/343 (59%), Gaps = 37/343 (10%)
Query: 98 PRIFSYAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAA 157
P+ FSY EL G+ F+E ++G G FG VYR +LP G +VAVK + + + F +
Sbjct: 361 PKEFSYKELKAGTKNFNESRIIGHGAFGVVYRGILPETGDIVAVKRCSHSSQDKKNEFLS 420
Query: 158 ELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQR 217
EL + LRHRNLVRL+GWC + ++LLVYD MPN SLD+ LF E+ L W+ R
Sbjct: 421 ELSIIGSLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALF------ESRFTLPWDHR 474
Query: 218 KKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMR 277
KKI+ G+A+AL YLH + E Q+IHRDVK+SN+MLD +NA+LGDFGLAR +EH+
Sbjct: 475 KKILLGVASALAYLHRECENQVIHRDVKSSNIMLDESFNAKLGDFGLARQIEHDKS---- 530
Query: 278 TSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAV-- 335
E T GT+GYL PE G A+ K+DVFS+G VVLEVVSGRR +
Sbjct: 531 -----------PEATVAAGTMGYLAPEYLLTGR-ASEKTDVFSYGAVVLEVVSGRRPIEK 578
Query: 336 DLTYPDDQI----ILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHN 391
DL + L++W+ L EGKV A D+RL +G + +M + + L C+ +
Sbjct: 579 DLNVQRHNVGVNPNLVEWVWGLYKEGKVSAAADSRL-EGKFDEGEMWRVLVVGLACSHPD 637
Query: 392 PHLRPSMKWVIEAVSGSYSGKLPALP------SFQSHPLYISL 428
P RP+M+ V++ + G +P +P SF + L +SL
Sbjct: 638 PAFRPTMRSVVQMLIG--EADVPVVPKSRPTMSFSTSHLLLSL 678
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FHG4|LRKS7_ARATH Probable L-type lectin-domain containing receptor kinase S.7 OS=Arabidopsis thaliana GN=LECRKS7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 256 bits (655), Expect = 4e-67, Method: Compositional matrix adjust.
Identities = 140/310 (45%), Positives = 191/310 (61%), Gaps = 22/310 (7%)
Query: 99 RIFSYAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAE 158
R FSY ELY + GF V+G G FG VYRA+ S GT+ AVK + F AE
Sbjct: 351 REFSYKELYTATKGFHSSRVIGRGAFGNVYRAMFVSSGTISAVKRSRHNSTEGKTEFLAE 410
Query: 159 LVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRK 218
L +A LRH+NLV+L+GWC + +LLLVY++MPN SLD++L++ E+ A L+W R
Sbjct: 411 LSIIACLRHKNLVQLQGWCNEKGELLLVYEFMPNGSLDKILYQ--ESQTGAVALDWSHRL 468
Query: 219 KIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRT 278
I GLA+AL YLH + E Q++HRD+KTSN+MLD +NARLGDFGLAR EH+
Sbjct: 469 NIAIGLASALSYLHHECEQQVVHRDIKTSNIMLDINFNARLGDFGLARLTEHDKS----- 523
Query: 279 SSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLT 338
+T GT+GYL PE Q G+ AT K+D FS+G+V+LEV GRR +D
Sbjct: 524 ----------PVSTLTAGTMGYLAPEYLQYGT-ATEKTDAFSYGVVILEVACGRRPID-K 571
Query: 339 YPDDQ--IILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRP 396
P+ Q + L+DW+ RL EG+VL+A D RL G + M+ L + L C + + RP
Sbjct: 572 EPESQKTVNLVDWVWRLHSEGRVLEAVDERLK-GEFDEEMMKKLLLVGLKCAHPDSNERP 630
Query: 397 SMKWVIEAVS 406
SM+ V++ ++
Sbjct: 631 SMRRVLQILN 640
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIF1|LRK21_ARATH Probable L-type lectin-domain containing receptor kinase II.1 OS=Arabidopsis thaliana GN=LECRK21 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 254 bits (648), Expect = 2e-66, Method: Compositional matrix adjust.
Identities = 144/361 (39%), Positives = 215/361 (59%), Gaps = 33/361 (9%)
Query: 97 NPRIFSYAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFA 156
+P+ +S+ LY + GF E+++LG+GGFGKVY+ +LPS GT +AVK + E+ K +
Sbjct: 339 SPQRYSFRILYKATKGFRENQLLGAGGFGKVYKGILPS-GTQIAVKRVYHDAEQGMKQYV 397
Query: 157 AELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQ 216
AE+ ++ LRH+NLV L G+C + +LLLVYDYMPN SLD LF + L W Q
Sbjct: 398 AEIASMGRLRHKNLVHLLGYCRRKGELLLVYDYMPNGSLDDYLFHK----NKLKDLTWSQ 453
Query: 217 RKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQM 276
R II+G+A+AL YLHE+ E ++HRD+K SN++LD+ N +LGDFGLAR+ + +
Sbjct: 454 RVNIIKGVASALLYLHEEWEQVVLHRDIKASNILLDADLNGKLGDFGLARFHDRGVNL-- 511
Query: 277 RTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVD 336
E TR+ GTIGY+ PE G V T +DV++FG +LEVV GRR VD
Sbjct: 512 -------------EATRVVGTIGYMAPELTAMG-VTTTCTDVYAFGAFILEVVCGRRPVD 557
Query: 337 LTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRP 396
P +Q+IL+ W+ + D++L D +K+ + + L L +LC+ NP RP
Sbjct: 558 PDAPREQVILVKWVASCGKRDALTDTVDSKLID--FKVEEAKLLLKLGMLCSQINPENRP 615
Query: 397 SMKWVIEAVSGSYSGKLPALPSFQSHPLYISLSSPT---NTSTSNTETTRSTNTTASNTT 453
SM+ +++ + G+ S +PA+ SF + ++L P T T T T+ S N + + T
Sbjct: 616 SMRQILQYLEGNVS--VPAI-SFGT----VALGIPNISHETVTQMTTTSSSANFSFEDVT 668
Query: 454 I 454
+
Sbjct: 669 V 669
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIF0|LRK22_ARATH Putative L-type lectin-domain containing receptor kinase II.2 OS=Arabidopsis thaliana GN=LECRK22 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 254 bits (648), Expect = 3e-66, Method: Compositional matrix adjust.
Identities = 145/359 (40%), Positives = 210/359 (58%), Gaps = 29/359 (8%)
Query: 97 NPRIFSYAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFA 156
+P+ +S+ LY GF E+ +LG+GGFGKVY+ LPS GT +AVK + E+ K +A
Sbjct: 359 SPQRYSFRNLYKAIRGFRENRLLGAGGFGKVYKGELPS-GTQIAVKRVYHNAEQGMKQYA 417
Query: 157 AELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQ 216
AE+ ++ LRH+NLV+L G+C + +LLLVYDYMPN SLD LF N L W Q
Sbjct: 418 AEIASMGRLRHKNLVQLLGYCRRKGELLLVYDYMPNGSLDDYLF----NKNKLKDLTWSQ 473
Query: 217 RKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQM 276
R II+G+A+AL YLHE+ E ++HRD+K SN++LD+ N RLGDFGLAR+ + Q
Sbjct: 474 RVNIIKGVASALLYLHEEWEQVVLHRDIKASNILLDADLNGRLGDFGLARFHDRGENLQ- 532
Query: 277 RTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVD 336
TR+ GTIGY+ PE G VAT K+D+++FG +LEVV GRR V+
Sbjct: 533 --------------ATRVVGTIGYMAPELTAMG-VATTKTDIYAFGSFILEVVCGRRPVE 577
Query: 337 LTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRP 396
P +Q+ LL W+ ++ D++L D +K + + L L +LC+ NP RP
Sbjct: 578 PDRPPEQMHLLKWVATCGKRDTLMDVVDSKLGD--FKAKEAKLLLKLGMLCSQSNPESRP 635
Query: 397 SMKWVIEAVSGSYSGKLPALPSFQSHPLYISLSSPTN-TSTSNTETTRSTNTTASNTTI 454
SM+ +I+ + G+ + +PS + + +N T T T T+ S N + + TI
Sbjct: 636 SMRHIIQYLEGNAT-----IPSISFDTAGFGIPNISNETITQMTATSSSANFSFEDVTI 689
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M9E0|LRKS1_ARATH L-type lectin-domain containing receptor kinase S.1 OS=Arabidopsis thaliana GN=LECRKS1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 250 bits (638), Expect = 4e-65, Method: Compositional matrix adjust.
Identities = 131/311 (42%), Positives = 194/311 (62%), Gaps = 23/311 (7%)
Query: 98 PRIFSYAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAA 157
P FSY EL + F D +LGSGGFGKVYR +L S+ + +AVKC+ ++ + F A
Sbjct: 346 PHRFSYEELAAATEVFSNDRLLGSGGFGKVYRGIL-SNNSEIAVKCVNHDSKQGLREFMA 404
Query: 158 ELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQR 217
E+ ++ L+H+NLV++RGWC +++L+LVYDYMPN SL++ +F P+ P+ W +R
Sbjct: 405 EISSMGRLQHKNLVQMRGWCRRKNELMLVYDYMPNGSLNQWIFDNPKE-----PMPWRRR 459
Query: 218 KKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMR 277
+++I +A L+YLH + +IHRD+K+SN++LDS+ RLGDFGLA+ EH
Sbjct: 460 RQVINDVAEGLNYLHHGWDQVVIHRDIKSSNILLDSEMRGRLGDFGLAKLYEH------- 512
Query: 278 TSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDL 337
A N TTR+ GT+GYL PE S T SDV+SFG+VVLEVVSGRR ++
Sbjct: 513 -GGAPN-------TTRVVGTLGYLAPE-LASASAPTEASDVYSFGVVVLEVVSGRRPIEY 563
Query: 338 TYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPS 397
+D ++L+DW+R L G+V+ A D R+ + ++E L L L C +P RP+
Sbjct: 564 AEEED-MVLVDWVRDLYGGGRVVDAADERVRSECETMEEVELLLKLGLACCHPDPAKRPN 622
Query: 398 MKWVIEAVSGS 408
M+ ++ + GS
Sbjct: 623 MREIVSLLLGS 633
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81291|LRK44_ARATH L-type lectin-domain containing receptor kinase IV.4 OS=Arabidopsis thaliana GN=LECRK44 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 249 bits (636), Expect = 6e-65, Method: Compositional matrix adjust.
Identities = 131/315 (41%), Positives = 192/315 (60%), Gaps = 25/315 (7%)
Query: 103 YAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAV 162
+ +LY + GF + +LGSGGFG VY+ ++P +AVK ++ + + K F AE+V++
Sbjct: 340 FKDLYYATKGFKDKNILGSGGFGSVYKGIMPKTKKEIAVKRVSNESRQGLKEFVAEIVSI 399
Query: 163 AHLRHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIR 222
+ HRNLV L G+C D+LLLVYDYMPN SLD+ L+ PE L+W+QR K+I
Sbjct: 400 GQMSHRNLVPLVGYCRRRDELLLVYDYMPNGSLDKYLYNSPE-----VTLDWKQRFKVIN 454
Query: 223 GLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSAR 282
G+A+AL YLHE+ E +IHRDVK SNV+LD++ N RLGDFGLA+ +H Q
Sbjct: 455 GVASALFYLHEEWEQVVIHRDVKASNVLLDAELNGRLGDFGLAQLCDHGSDPQ------- 507
Query: 283 NHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDL-TYPD 341
TTR+ GT GYL P+ + G AT +DVF+FG+++LEV GRR +++
Sbjct: 508 --------TTRVVGTWGYLAPDHIRTGR-ATTTTDVFAFGVLLLEVACGRRPIEINNQSG 558
Query: 342 DQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWV 401
++++L+DW+ R E +L A D L Y ++E + L LLC+ +P RP+M+ V
Sbjct: 559 ERVVLVDWVFRFWMEANILDAKDPNLGS-EYDQKEVEMVLKLGLLCSHSDPLARPTMRQV 617
Query: 402 IEAVSGSYSGKLPAL 416
++ + G LP L
Sbjct: 618 LQYLRG--DAMLPDL 630
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81292|LRK43_ARATH L-type lectin-domain containing receptor kinase IV.3 OS=Arabidopsis thaliana GN=LECRK43 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 249 bits (636), Expect = 7e-65, Method: Compositional matrix adjust.
Identities = 132/315 (41%), Positives = 194/315 (61%), Gaps = 25/315 (7%)
Query: 103 YAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAV 162
+ +LY + GF + ++LGSGGFG+VYR V+P+ +AVK ++ + + K F AE+V++
Sbjct: 345 FKDLYYATKGFKDKDLLGSGGFGRVYRGVMPTTKKEIAVKRVSNESRQGLKEFVAEIVSI 404
Query: 163 AHLRHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIR 222
+ HRNLV L G+C D+LLLVYDYMPN SLD+ L+ PE L+W+QR +I
Sbjct: 405 GRMSHRNLVPLLGYCRRRDELLLVYDYMPNGSLDKYLYDCPE-----VTLDWKQRFNVII 459
Query: 223 GLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSAR 282
G+A+ L YLHE+ E +IHRD+K SNV+LD++YN RLGDFGLAR +H Q
Sbjct: 460 GVASGLFYLHEEWEQVVIHRDIKASNVLLDAEYNGRLGDFGLARLCDHGSDPQ------- 512
Query: 283 NHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTY-PD 341
TTR+ GT GYL P+ + G TA +DVF+FG+++LEV GRR +++ D
Sbjct: 513 --------TTRVVGTWGYLAPDHVRTGRATTA-TDVFAFGVLLLEVACGRRPIEIEIESD 563
Query: 342 DQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWV 401
+ ++L+D + EG +L A D L Y ++E + L LLC+ +P +RP+M+ V
Sbjct: 564 ESVLLVDSVFGFWIEGNILDATDPNLG-SVYDQREVETVLKLGLLCSHSDPQVRPTMRQV 622
Query: 402 IEAVSGSYSGKLPAL 416
++ + G LP L
Sbjct: 623 LQYLRG--DATLPDL 635
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M2S4|LRKS4_ARATH L-type lectin-domain containing receptor kinase S.4 OS=Arabidopsis thaliana GN=LECRKS4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 249 bits (635), Expect = 9e-65, Method: Compositional matrix adjust.
Identities = 131/306 (42%), Positives = 188/306 (61%), Gaps = 21/306 (6%)
Query: 97 NPRIFSYAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFA 156
P FSY EL +NGF + E+LGSGGFGKVY+ LP VAVK ++ + + + F
Sbjct: 330 GPHRFSYRELKKATNGFGDKELLGSGGFGKVYKGKLPGSDEFVAVKRISHESRQGVREFM 389
Query: 157 AELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQ 216
+E+ ++ HLRHRNLV+L GWC D LLLVYD+MPN SLD LF EN E L W+Q
Sbjct: 390 SEVSSIGHLRHRNLVQLLGWCRRRDDLLLVYDFMPNGSLDMYLFD--ENPEVI--LTWKQ 445
Query: 217 RKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQM 276
R KII+G+A+ L YLHE E +IHRD+K +NV+LDS+ N R+GDFGLA+ EH
Sbjct: 446 RFKIIKGVASGLLYLHEGWEQTVIHRDIKAANVLLDSEMNGRVGDFGLAKLYEHGSD--- 502
Query: 277 RTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVD 336
TR+ GT GYL PE + G + T+ +DV++FG V+LEV GRR ++
Sbjct: 503 ------------PGATRVVGTFGYLAPELTKSGKLTTS-TDVYAFGAVLLEVACGRRPIE 549
Query: 337 LTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRP 396
+ ++++++DW+ G + D RL +G + ++ + L LLC+ ++P +RP
Sbjct: 550 TSALPEELVMVDWVWSRWQSGDIRDVVDRRL-NGEFDEEEVVMVIKLGLLCSNNSPEVRP 608
Query: 397 SMKWVI 402
+M+ V+
Sbjct: 609 TMRQVV 614
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 834 | ||||||
| 255554124 | 836 | conserved hypothetical protein [Ricinus | 0.995 | 0.992 | 0.766 | 0.0 | |
| 224055897 | 834 | predicted protein [Populus trichocarpa] | 0.992 | 0.992 | 0.744 | 0.0 | |
| 224141241 | 831 | predicted protein [Populus trichocarpa] | 0.992 | 0.996 | 0.733 | 0.0 | |
| 225433536 | 827 | PREDICTED: receptor like protein kinase | 0.989 | 0.997 | 0.738 | 0.0 | |
| 449442471 | 826 | PREDICTED: receptor like protein kinase | 0.985 | 0.995 | 0.707 | 0.0 | |
| 356527258 | 846 | PREDICTED: receptor like protein kinase | 0.989 | 0.975 | 0.688 | 0.0 | |
| 147767429 | 816 | hypothetical protein VITISV_027097 [Viti | 0.974 | 0.996 | 0.708 | 0.0 | |
| 356522982 | 836 | PREDICTED: receptor like protein kinase | 0.978 | 0.976 | 0.663 | 0.0 | |
| 356503214 | 761 | PREDICTED: receptor like protein kinase | 0.892 | 0.977 | 0.701 | 0.0 | |
| 297823071 | 856 | hypothetical protein ARALYDRAFT_902344 [ | 0.989 | 0.963 | 0.617 | 0.0 |
| >gi|255554124|ref|XP_002518102.1| conserved hypothetical protein [Ricinus communis] gi|223542698|gb|EEF44235.1| conserved hypothetical protein [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1281 bits (3315), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 644/840 (76%), Positives = 724/840 (86%), Gaps = 10/840 (1%)
Query: 1 MQQLNRLCFILPADVDEIGPYEKSRVHNV----VSRKQEVKEQHGRGCGRRILSFIADKL 56
M+QLNRLC ILP ++DE+ Y+ R H + + +K RGCG R+L+F+ D L
Sbjct: 1 MKQLNRLCIILP-ELDELATYDH-RQHKLKLPPSPLTEAMKTHPNRGCGTRVLAFVGDSL 58
Query: 57 QRLYEAKWVCFCHHNTPRKEHSG-LFHDMEGVQMSEKVGGDNPRIFSYAELYIGSNGFDE 115
+RLY+++WV HH PRK+ S +F D+EG+QMSEKVGGDNPRIFSYAELYIGSNGF E
Sbjct: 59 RRLYDSRWVSCYHHRRPRKQQSSNVFQDLEGIQMSEKVGGDNPRIFSYAELYIGSNGFSE 118
Query: 116 DEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRG 175
DEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGE+FEKTF AEL+AVA+LRHRNLVRLRG
Sbjct: 119 DEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGEQFEKTFEAELLAVANLRHRNLVRLRG 178
Query: 176 WCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQL 235
WCVHEDQLLLVYDYMPNRSLDRVLFRRPENL A A LNWE+RK+II GLAAALHYLHEQL
Sbjct: 179 WCVHEDQLLLVYDYMPNRSLDRVLFRRPENLTADA-LNWERRKRIIGGLAAALHYLHEQL 237
Query: 236 ETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIG 295
ETQIIHRDVKTSNVMLDS YNARLGDFGLARWLEHEL+YQ RT S NHQF LA++TRIG
Sbjct: 238 ETQIIHRDVKTSNVMLDSHYNARLGDFGLARWLEHELEYQTRTPSIINHQFRLADSTRIG 297
Query: 296 GTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIRRLSD 355
GTIGYLPPESFQK SVATAKSDVFSFGIVVLEVVSGRRAVDLT PDDQIILLDWIRRLSD
Sbjct: 298 GTIGYLPPESFQKRSVATAKSDVFSFGIVVLEVVSGRRAVDLTCPDDQIILLDWIRRLSD 357
Query: 356 EGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGSYSGKLPA 415
+GK+LQAGDNRL DGSY L DME L HL LLCT++NP RPSMKW+++ + G+ SGKLP
Sbjct: 358 DGKLLQAGDNRLQDGSYALSDMERLIHLGLLCTVNNPQFRPSMKWIVQTLPGNISGKLPP 417
Query: 416 LPSFQSHPLYISLSSPTNTSTSNTETTRSTNTTASNTTIASPSSN-YVTAAGETIYATAE 474
LPSFQSHP YISLSS +NTSTSNT + ++ +++ TT + SS+ +VTA GETIYATAE
Sbjct: 418 LPSFQSHPRYISLSSSSNTSTSNTSRSTTSTPSSNTTTTSITSSSIFVTAIGETIYATAE 477
Query: 475 CGGNTESKSNNSRSQRRNSFFMVETPREISFKEIISATNNFSESQRVAEMDFGTAYQGFL 534
G N S SNN RS RRN++ MVETPREISFKEIISATNNFS+S RVAE+DFGTAY G L
Sbjct: 478 FGNNDLSSSNN-RSHRRNTYLMVETPREISFKEIISATNNFSDSHRVAEVDFGTAYYGIL 536
Query: 535 DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSAT 594
++ VLVKRLGM+KCPA+RTRFS+ELQNLARLRHRNLVQL GWCTEQGEMLVIYDYSA+
Sbjct: 537 EDGHQVLVKRLGMTKCPAIRTRFSSELQNLARLRHRNLVQLRGWCTEQGEMLVIYDYSAS 596
Query: 595 RILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDP 654
R+LSHLLFH++ RIGHSILQW HRYNIIKSLASAILYLHEEW EQVIHRNITSS++ LD
Sbjct: 597 RLLSHLLFHHDKRIGHSILQWRHRYNIIKSLASAILYLHEEWEEQVIHRNITSSSVILDT 656
Query: 655 DMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGV 714
DMNPRLG+FALAEFLTRND H+ A GN+SVRGIFGYMSPEYIE+GEAT MADVYSFGV
Sbjct: 657 DMNPRLGNFALAEFLTRNDQAHKAANKGNKSVRGIFGYMSPEYIENGEATPMADVYSFGV 716
Query: 715 VVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGI 774
V+LEVVTGQMAVDFR PE LLV R+HEFE +KRPL +LVD+ L+ EY+HKEL+RL+KLGI
Sbjct: 717 VLLEVVTGQMAVDFRRPEVLLVNRIHEFETQKRPLEDLVDIRLDCEYDHKELLRLLKLGI 776
Query: 775 ACTLSNPELRPSMRQILSILDGNDKRFMEDGQMTENLEEWKQRNECSLSLIKRIQALGIQ 834
ACT SNPELRP+MRQ +SILDGND+ FM+ Q E+ EEWK +N SLSLIKRIQALGIQ
Sbjct: 777 ACTRSNPELRPNMRQTVSILDGNDQFFMKAEQQKESREEWKHKNASSLSLIKRIQALGIQ 836
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224055897|ref|XP_002298697.1| predicted protein [Populus trichocarpa] gi|222845955|gb|EEE83502.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1273 bits (3294), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 623/837 (74%), Positives = 719/837 (85%), Gaps = 9/837 (1%)
Query: 3 QLNRLCFILPADVDEIGPYEKSRVHNVVSRKQEVKEQHGRGCGRRILSFIADKLQRLYEA 62
QLNRLC ILPAD++EI P+E ++ + + V++ RGCG +IL F+ D L+RL ++
Sbjct: 2 QLNRLCIILPADLEEIKPFEDPKIPQPM--QDGVRKDRHRGCGSQILHFLGDSLRRLQDS 59
Query: 63 KWV-CFCHHNTPRKE-HSGLFHDMEGVQMSEKVGGDNPRIFSYAELYIGSNGFDEDEVLG 120
KW+ CF H +++ GLF+D+EG+Q+SEKVGG NPRIFSYAELYIGS GF EDEVLG
Sbjct: 60 KWIGCFLHDKPSKQQPQPGLFYDLEGIQLSEKVGGANPRIFSYAELYIGSKGFCEDEVLG 119
Query: 121 SGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHE 180
SGG+GKVYRAVLPSDGTVVAVKCLAE+GE+FEKTFAAELVAVAHLRHRNLVRLRGWCVHE
Sbjct: 120 SGGYGKVYRAVLPSDGTVVAVKCLAERGEQFEKTFAAELVAVAHLRHRNLVRLRGWCVHE 179
Query: 181 DQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQII 240
+QLLLVYDYMPNRSLDRVLFRRPENL+AA PL+WE+R+KI+ GLAAALHYLHE LETQII
Sbjct: 180 EQLLLVYDYMPNRSLDRVLFRRPENLKAA-PLSWERRRKIVGGLAAALHYLHENLETQII 238
Query: 241 HRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGY 300
HRDVKTSNVMLDS YNARLGDFGLARWLEHEL+YQ+RT S +NHQFHL E+T+IGGTIGY
Sbjct: 239 HRDVKTSNVMLDSHYNARLGDFGLARWLEHELEYQIRTPSMKNHQFHLTESTKIGGTIGY 298
Query: 301 LPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIRRLSDEGKVL 360
LPPESFQK SVATAKSDVFSFGIVVLEVVSGRRAVDL YPDDQI+LLDWIR LS EGK+L
Sbjct: 299 LPPESFQKRSVATAKSDVFSFGIVVLEVVSGRRAVDLAYPDDQIVLLDWIRVLSGEGKLL 358
Query: 361 QAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGSYSGKLPALPSFQ 420
QAGDNRL DGS+ L DME L HL LLCTLHNP LRP+MKWV+EA+SG+ GKLP LPSFQ
Sbjct: 359 QAGDNRLPDGSFGLSDMERLIHLGLLCTLHNPQLRPNMKWVVEALSGNILGKLPPLPSFQ 418
Query: 421 SHPLYISLSSPTNTSTSNTETTRSTNTTASNTTIASPSSNYVTAAGETIYATAE---CGG 477
SHP YI++SS +NTS S T TT +T +S+ TI+ SS YVTA ETIY TAE
Sbjct: 419 SHPRYIAISSASNTSISKTNTTTTTTVPSSDMTISFTSSAYVTAMEETIYETAEFENINK 478
Query: 478 NTESKSNNSRSQRRNSFFMVETPREISFKEIISATNNFSESQRVAEMDFGTAYQGFLDNH 537
+ SKSNN RS R+N+ FMVETPREIS+KEIISATNNFS+SQRVAE+DFGTAY G L++
Sbjct: 479 LSSSKSNN-RSHRQNALFMVETPREISYKEIISATNNFSDSQRVAEVDFGTAYYGILEDG 537
Query: 538 QYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRIL 597
VLVKRLGM++CPA+R RFS EL NL RLRHRNL+QL GWCTE GEMLV+YDYSA+R +
Sbjct: 538 HQVLVKRLGMTQCPAIRVRFSTELLNLGRLRHRNLIQLRGWCTELGEMLVVYDYSASRHM 597
Query: 598 SHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMN 657
SHLLFH+++RIGHSIL W HRYNIIKSLASA+LYLHEEW+EQVIHRNIT+S+I LDPDMN
Sbjct: 598 SHLLFHHDNRIGHSILLWRHRYNIIKSLASAVLYLHEEWDEQVIHRNITNSSIILDPDMN 657
Query: 658 PRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVL 717
PRLG+FALAEFL RNDH H+ N SVRGIFGYMSPEYIE GEAT MADVYS+GVVVL
Sbjct: 658 PRLGNFALAEFLARNDHAHKADAKENNSVRGIFGYMSPEYIEHGEATPMADVYSYGVVVL 717
Query: 718 EVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACT 777
EVV+GQMAVDFR PE LL++RVHEFEA+KRPL +L D+ LNGEY+ +EL+R++KLGIACT
Sbjct: 718 EVVSGQMAVDFRRPEVLLIRRVHEFEAQKRPLEDLADIRLNGEYDLEELIRVVKLGIACT 777
Query: 778 LSNPELRPSMRQILSILDGNDKRFMEDGQMTENLEEWKQRNECSLSLIKRIQALGIQ 834
SNPELRP+MRQI+ ILDGND+ F E GQ TE+ EEW+Q+N CS+S+I+R+QALGIQ
Sbjct: 778 RSNPELRPTMRQIVRILDGNDQWFTERGQNTESREEWRQKNACSMSMIRRVQALGIQ 834
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224141241|ref|XP_002323983.1| predicted protein [Populus trichocarpa] gi|222866985|gb|EEF04116.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1265 bits (3274), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 612/834 (73%), Positives = 709/834 (85%), Gaps = 6/834 (0%)
Query: 3 QLNRLCFILPADVDEIGPYEKSRVHNVVSRKQEVKEQHGRGCGRRILSFIADKLQRLYEA 62
+LN C ILP D +EI P+++ ++ V +VK++ GCGR+IL + D L+RL+E+
Sbjct: 2 KLNCFCIILPEDFEEIKPFDQPQIRPPV--HDDVKKRQHCGCGRQILHVLGDSLRRLHES 59
Query: 63 KWVCFCHHNTPRKEHSGLFHDMEGVQMSEKVGGDNPRIFSYAELYIGSNGFDEDEVLGSG 122
KW+ + P K+ SG FHD+EG+Q+SEKVGGDNPRIFSYAELYIGS GF E+EVLGSG
Sbjct: 60 KWIGCFQDDKPSKQQSGPFHDLEGIQISEKVGGDNPRIFSYAELYIGSKGFCENEVLGSG 119
Query: 123 GFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQ 182
GFGKVYRAVLPSDGTVVAVKCLAE+GE+FEKTF AELVAVA LRHRNLVRLRGWC HEDQ
Sbjct: 120 GFGKVYRAVLPSDGTVVAVKCLAERGEQFEKTFEAELVAVAQLRHRNLVRLRGWCAHEDQ 179
Query: 183 LLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHR 242
L LVYDYMPNRSLDRVLFRRPENL+A PL WE+R+KI+ GLAAALHYLHEQLETQIIHR
Sbjct: 180 LFLVYDYMPNRSLDRVLFRRPENLKAE-PLAWERRRKIVSGLAAALHYLHEQLETQIIHR 238
Query: 243 DVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLP 302
DVKTSNVMLDS YNARLGDFGLARWLEHEL+YQ+RT S +NHQF LAE+TRIGGTIGYL
Sbjct: 239 DVKTSNVMLDSHYNARLGDFGLARWLEHELEYQIRTPSMKNHQFRLAESTRIGGTIGYLS 298
Query: 303 PESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIRRLSDEGKVLQA 362
PESFQK SVATAKSDVFSFGIVVLEV S RRAVDLTYPDD+IILLDWIR LSDEGK+LQA
Sbjct: 299 PESFQKRSVATAKSDVFSFGIVVLEVASRRRAVDLTYPDDRIILLDWIRGLSDEGKLLQA 358
Query: 363 GDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGSYSGKLPALPSFQSH 422
DNRL DGS+ L D+E L HL LLCTLHNP LRP+MKWV+EA+SG+ GKLP LPSF+SH
Sbjct: 359 ADNRLPDGSFGLSDIERLIHLGLLCTLHNPQLRPNMKWVVEALSGNILGKLPPLPSFRSH 418
Query: 423 PLYISLSSPTNTSTSNTETTRSTNTTASNTTIASPSSNYVTAAGETIYATAE--CGGNTE 480
P YI++S P +TS S T TT +T+ +S+ TI+ SS YVTA ET+YATAE
Sbjct: 419 PRYIAIS-PASTSISKTNTTATTSVPSSDMTISFTSSAYVTATEETMYATAEFESSNKLS 477
Query: 481 SKSNNSRSQRRNSFFMVETPREISFKEIISATNNFSESQRVAEMDFGTAYQGFLDNHQYV 540
S +N+RS R+N+FFMVETPREIS+KEIISATNNFS+SQRVAE+DFGTAY G L++ V
Sbjct: 478 SSKSNNRSHRQNAFFMVETPREISYKEIISATNNFSDSQRVAEVDFGTAYYGILEDGHQV 537
Query: 541 LVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRILSHL 600
LVKRLGM++CPA+R RFS EL NL RLRHRNL+QL GWCTE GEMLV+YDYSA+R++SHL
Sbjct: 538 LVKRLGMTQCPAIRVRFSTELLNLGRLRHRNLIQLRGWCTEHGEMLVVYDYSASRLMSHL 597
Query: 601 LFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRL 660
LFH+++RIGHSIL W HRYNIIKSLA+AILYLHEEW+EQVIHRNIT+S+I LDPDMNPRL
Sbjct: 598 LFHHDNRIGHSILHWRHRYNIIKSLAAAILYLHEEWDEQVIHRNITTSSIILDPDMNPRL 657
Query: 661 GSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVV 720
G+FALAEFL RNDH H+ A N+SVRGIFGYMSPEY+ESGEAT MADVYS+GVVVLEVV
Sbjct: 658 GNFALAEFLARNDHAHKAAAKENKSVRGIFGYMSPEYMESGEATPMADVYSYGVVVLEVV 717
Query: 721 TGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSN 780
+GQMAVDFR PE LLV RVHEFE +KRP+ +L D+ LN EY+H+EL+R++KLGIACT SN
Sbjct: 718 SGQMAVDFRRPEVLLVLRVHEFETQKRPMEDLADIRLNREYDHEELIRIVKLGIACTRSN 777
Query: 781 PELRPSMRQILSILDGNDKRFMEDGQMTENLEEWKQRNECSLSLIKRIQALGIQ 834
PELRPS+RQI+ ILDGND+ FME G+ E+ EEW+Q N SLSLI+RIQALGI+
Sbjct: 778 PELRPSIRQIVRILDGNDQWFMEGGKRKESREEWRQNNASSLSLIRRIQALGIK 831
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225433536|ref|XP_002266619.1| PREDICTED: receptor like protein kinase S.2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1222 bits (3163), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 617/836 (73%), Positives = 701/836 (83%), Gaps = 11/836 (1%)
Query: 1 MQQLNRLCFILPADVDEIGPYEKSRVHNVVSRKQEVKEQHGRGCGRRILSFIADKLQRLY 60
MQ LNR+CFILP ++++I P + H+V + KQ GRGCG ++L+ + L R +
Sbjct: 1 MQCLNRICFILPPELNDIHPLD----HHVSTEKQNPNRGRGRGCGTQVLAILQHFLSRFH 56
Query: 61 EAKWVCFCHHNTPRKEHSGLFHDMEGVQMSEKV-GGDNPRIFSYAELYIGSNGFDEDEVL 119
+ KW FCH + K+ S +FHDMEGV +S+KV G+NPRIFS++ELYIGSNGF EDEVL
Sbjct: 57 DLKWTSFCHCHPLTKQASEVFHDMEGVHVSDKVVAGNNPRIFSFSELYIGSNGFCEDEVL 116
Query: 120 GSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVH 179
GSGGFGKV+RAVLPSDGTVVAVKC+AEKGE FEKTF AELVAVA LRHRNLVRLRGWCVH
Sbjct: 117 GSGGFGKVFRAVLPSDGTVVAVKCVAEKGEPFEKTFVAELVAVAQLRHRNLVRLRGWCVH 176
Query: 180 EDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQI 239
E+QLLLVYDYMPNRSLDR+LFRRPEN + L WE+R++I+ GLAAAL+YLHEQLETQI
Sbjct: 177 EEQLLLVYDYMPNRSLDRILFRRPEN---SLLLGWERRRRIVGGLAAALYYLHEQLETQI 233
Query: 240 IHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIG 299
IHRDVKTSNVMLDS YNARLGDFGLARWLEHE++ + +T+S R+HQF LAETTRIGGTIG
Sbjct: 234 IHRDVKTSNVMLDSHYNARLGDFGLARWLEHEIEIETKTNSIRHHQFRLAETTRIGGTIG 293
Query: 300 YLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIRRLSDEGKV 359
YLPPESFQK S+ TAKSDVFSFGIVVLEVV+GRRAVDLTYPDDQIILLDWIRRLSDEGK+
Sbjct: 294 YLPPESFQKRSMTTAKSDVFSFGIVVLEVVTGRRAVDLTYPDDQIILLDWIRRLSDEGKL 353
Query: 360 LQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGSYSGKLPALPSF 419
LQ GDNRL DGSY+L DME L HL LLCTLHNPH RP+MKW++E +S S +LPALPSF
Sbjct: 354 LQVGDNRLPDGSYRLSDMERLIHLGLLCTLHNPHSRPNMKWIVETLSSQSSTRLPALPSF 413
Query: 420 QSHPLYISLSSPTNTSTSNTETTRSTNTTASNTTIASPSSNYVTAAGETIYATAECGGNT 479
QSHPLYISLSSP+ T T T TT +T TT +NTT +S S YVTA GETIYATAE G T
Sbjct: 414 QSHPLYISLSSPSETGTDTTTTTTTTTTTTTNTTFSS--SIYVTATGETIYATAENGRIT 471
Query: 480 ESKSNNSRSQRRNSFF-MVETPREISFKEIISATNNFSESQRVAEMDFGTAYQGFLDNHQ 538
E+ S+NS ++++S F MV+TP+EIS+KEI SATNNFSESQR AE+DFGTAY GFLDN
Sbjct: 472 ETNSSNSSRRQQSSIFPMVQTPQEISYKEIASATNNFSESQRAAELDFGTAYHGFLDNGH 531
Query: 539 YVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRILS 598
+VLVKRLGM CPALR RFSNELQNL RLRHRNLVQL GWCTEQGEMLV+YDY + R+LS
Sbjct: 532 HVLVKRLGMKTCPALRARFSNELQNLGRLRHRNLVQLHGWCTEQGEMLVVYDYLSNRLLS 591
Query: 599 HLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNP 658
HLLFH +++ HS L W HRYNIIKSLASAILYLHEEW+EQVIHRNITSSAI +D DMNP
Sbjct: 592 HLLFHLDNKKVHSTLHWRHRYNIIKSLASAILYLHEEWDEQVIHRNITSSAIIIDADMNP 651
Query: 659 RLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLE 718
RL SFALAEFLTRN+HGH + T RSVRGIFGYMSPEY+ESGEAT MADVYSFG+VVLE
Sbjct: 652 RLSSFALAEFLTRNEHGHHQVTDPTRSVRGIFGYMSPEYMESGEATPMADVYSFGMVVLE 711
Query: 719 VVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTL 778
VVTGQMAVDFR P LLVKRV E RK+PL E+ D L+GE++ +EL+RLIKLG+ACT
Sbjct: 712 VVTGQMAVDFRWPGVLLVKRVRELAERKKPLEEMADWRLDGEHDQEELVRLIKLGMACTR 771
Query: 779 SNPELRPSMRQILSILDGNDKRFMEDGQMTENLEEWKQRNECSLSLIKRIQALGIQ 834
S PELRPSM QI+SILDGNDK FME+ Q E EEWKQRN CSLSLIKRIQALGIQ
Sbjct: 772 SKPELRPSMGQIVSILDGNDKFFMEERQNKERREEWKQRNACSLSLIKRIQALGIQ 827
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449442471|ref|XP_004139005.1| PREDICTED: receptor like protein kinase S.2-like [Cucumis sativus] gi|449522682|ref|XP_004168355.1| PREDICTED: receptor like protein kinase S.2-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1176 bits (3042), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 591/835 (70%), Positives = 676/835 (80%), Gaps = 13/835 (1%)
Query: 3 QLNRLCFILPADVDEIGPYEKSRVHNVVSRKQEVKEQHGRGCGRRILSFIADKLQRLYEA 62
LNRLC +LPAD DE+ P + R ++ Q + H C +I +F+ D L +
Sbjct: 2 HLNRLCLLLPADFDEVQPLD--REDHLQKPNQNTNKHHTPDCWSQIHTFLRDSLFKFQTL 59
Query: 63 KWV-CFCHHNTPRKEHSGLFHDMEGVQMSEKVGGDNPRIFSYAELYIGSNGFDEDEVLGS 121
KWV C+ PRK FHD +GVQ+SEKVGGDNPRIFS+AELYIG+ GF +E+LGS
Sbjct: 60 KWVHSCCYGRRPRKPPPFDFHDTDGVQLSEKVGGDNPRIFSFAELYIGTKGFSAEEILGS 119
Query: 122 GGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHED 181
GGFGKVYRA LPSDGTVVAVKCLAEKGE+FEKTF AELVAVAHLRHRNLVRLRGWCVHED
Sbjct: 120 GGFGKVYRAYLPSDGTVVAVKCLAEKGEKFEKTFVAELVAVAHLRHRNLVRLRGWCVHED 179
Query: 182 QLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIH 241
QLLLVYDYMPNRSLDR LFRR EN L+W+QR KI+ GLAAAL YLHEQLETQIIH
Sbjct: 180 QLLLVYDYMPNRSLDRALFRRIEN--GGTDLSWKQRMKILSGLAAALFYLHEQLETQIIH 237
Query: 242 RDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYL 301
RDVKTSNVMLDS YNARLGDFGLARWLEHEL+YQ R S +HQF L ETT+IGGTIGYL
Sbjct: 238 RDVKTSNVMLDSNYNARLGDFGLARWLEHELEYQNRVPSMGHHQFRLVETTKIGGTIGYL 297
Query: 302 PPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIRRLSDEGKVLQ 361
PPESFQ+ S+ATAKSDVFSFGIVVLEVVSGRRAVDLT PDDQI+LLDWIR+LSD+G +L
Sbjct: 298 PPESFQRRSIATAKSDVFSFGIVVLEVVSGRRAVDLTCPDDQIVLLDWIRKLSDDGTLLL 357
Query: 362 AGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGSYSGKLPALPSFQS 421
+GDNRL DGSY L +ME L HL LLCTL +P RPSMKWV+EA+SG G LPALPSFQS
Sbjct: 358 SGDNRLPDGSYNLIEMERLIHLGLLCTLQSPQYRPSMKWVVEALSGGMMGSLPALPSFQS 417
Query: 422 HPLYISLSSPTNTSTSNTETTRSTNTTASNTTIAS-PSSNYVTAAGETIYATAECGGNTE 480
HP YISLSSPT+ +T+ + ++ T TT S+ T S SS++V+A GETIY TAE GN
Sbjct: 418 HPQYISLSSPTDGNTTRSTSSSRTTTTRSDATTTSVSSSDFVSANGETIYMTAE-NGNNY 476
Query: 481 SKSNNSRSQRRNSFFMVETPREISFKEIISATNNFSESQRVAEMDFGTAYQGFLDNHQYV 540
+ S++ R + M+ETPR ISFKEIISATNNFS+SQRVAE+DFGTAY GFLD+ +V
Sbjct: 477 TNSSDRFLDRSKTIQMIETPRVISFKEIISATNNFSDSQRVAELDFGTAYHGFLDSSHHV 536
Query: 541 LVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRILSHL 600
LVKRLGM CPALR RFSNEL NL RLRHRNL+QL GWCTEQGEMLV+YDYSA R+LSHL
Sbjct: 537 LVKRLGMKTCPALRERFSNELLNLGRLRHRNLIQLRGWCTEQGEMLVVYDYSADRLLSHL 596
Query: 601 LFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRL 660
LFH ++R LQW HRYNIIKSLASA+LYLHEEW+EQVIHRNITSSA+ LD D+NPRL
Sbjct: 597 LFHQDNR----ALQWCHRYNIIKSLASAVLYLHEEWDEQVIHRNITSSAVILDLDLNPRL 652
Query: 661 GSFALAEFLTRNDHG-HRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEV 719
SFALAEFLTRN+HG H N+SVRGIFGYMSPEY++SG+A + AD+YSFGVVVLEV
Sbjct: 653 SSFALAEFLTRNEHGNHHVTIDKNKSVRGIFGYMSPEYLDSGDAVATADIYSFGVVVLEV 712
Query: 720 VTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLS 779
+TGQMAVDFR PE LLV++VHEF ARKRPL EL D+ +NGEYNHKELMRL++LGIACT S
Sbjct: 713 ITGQMAVDFRRPEVLLVRKVHEFLARKRPLEELADIRMNGEYNHKELMRLLRLGIACTHS 772
Query: 780 NPELRPSMRQILSILDGNDKRFMEDGQMTENLEEWKQRNECSLSLIKRIQALGIQ 834
NP+ RP MRQI+ ILDG+D+ F + +M E+LE WKQRN SLSL+KRIQALGIQ
Sbjct: 773 NPDSRPKMRQIVKILDGSDECFTMEEKM-ESLEGWKQRNATSLSLVKRIQALGIQ 826
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356527258|ref|XP_003532229.1| PREDICTED: receptor like protein kinase S.2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1165 bits (3014), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 585/850 (68%), Positives = 695/850 (81%), Gaps = 25/850 (2%)
Query: 4 LNRLCFILPADVDE-IGPYEKSRVHN---VVSRKQEV--KEQHGRGCGRRILSFIADKLQ 57
NRLC +LP + E + P EK + +KQ+V K+ H R CG ++L + D
Sbjct: 3 FNRLCIVLPPNSGEMVVPLEKGVLQEEPFQTPKKQQVEAKKPH-RACGGQVLDLLRDSFT 61
Query: 58 RLYEAKWVCFCHHNTPR-KEHSGLF-HDMEGVQMSEKVGGDNPRIFSYAELYIGSNGFDE 115
+LY+++W C H + K +SG+F HDM+GVQ+S +G DNPRIFSYAEL+IGSNGF E
Sbjct: 62 KLYDSRWWRICQHGEHKEKNNSGVFFHDMDGVQVSVNIGRDNPRIFSYAELFIGSNGFSE 121
Query: 116 DEVLGSGGFGKVYRAVLPSDGTVVAVKC-LAEKGERFEKTFAAELVAVAHLRHRNLVRLR 174
D+VLGSGGFG+VY+AVLPSDGT VAVKC LAEKG++FEK+FAAEL AVA LRH+NLVRLR
Sbjct: 122 DQVLGSGGFGRVYKAVLPSDGTEVAVKCCLAEKGKQFEKSFAAELTAVADLRHKNLVRLR 181
Query: 175 GWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQ 234
GWCV+EDQL LVYDYMPNRSLDRVLFRR EN A PL W QR KI++GLAAAL+YLHEQ
Sbjct: 182 GWCVNEDQLHLVYDYMPNRSLDRVLFRRHEN-SKAEPLQWGQRGKILKGLAAALYYLHEQ 240
Query: 235 LETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMR-----TSSARNHQFHLA 289
LETQIIHRDVKTSNVMLDS YNARLGDFG+ARWLEHEL+Y+ + T + ++ F L
Sbjct: 241 LETQIIHRDVKTSNVMLDSHYNARLGDFGMARWLEHELEYEYKYNNRKTIATKSGHFRLG 300
Query: 290 ETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDW 349
ET+RIGGTIGYLPPES QK S AT+KSDVFSFGIVVLEVVSGRRA+DLT+PD+QIILLDW
Sbjct: 301 ETSRIGGTIGYLPPESLQKPSNATSKSDVFSFGIVVLEVVSGRRAIDLTHPDEQIILLDW 360
Query: 350 IRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGSY 409
IRRLSDEGK+L+A D+RL DGSYKL +M+H H+ LLCTLH+P LRPSMKWV+EA+S
Sbjct: 361 IRRLSDEGKLLEAADSRLLDGSYKLSEMQHFIHIGLLCTLHDPQLRPSMKWVVEALS-DI 419
Query: 410 SGKLPALPSFQSHPLYISLSSPTNTSTSNTETTRSTNT---TASNTTIASPSSNYVTAAG 466
S KLP+LPSF SHPLYISLSSP+NT+ S + T+ ++++ AS+ SSNYVTAAG
Sbjct: 420 SFKLPSLPSFLSHPLYISLSSPSNTNNSPSSTSVTSSSTTDNASSIITNHTSSNYVTAAG 479
Query: 467 ETIYATAECGGNTESKSNNSRSQRRNSFFMVETPREISFKEIISATNNFSESQRVAEMDF 526
ET+Y TAE N+E S+ S S + F +VETPREISFKEI+SAT+NFS+S+RVAE+DF
Sbjct: 480 ETVYVTAEYK-NSEIISSKSMSHHQQPFPVVETPREISFKEIVSATDNFSDSRRVAELDF 538
Query: 527 GTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEML 586
GTAY G LD+ +VLVKRLG+ CPALR RFSNEL+NL RLRHRNLVQL GWCTEQGEML
Sbjct: 539 GTAYHGILDDKCHVLVKRLGLKTCPALRDRFSNELRNLGRLRHRNLVQLRGWCTEQGEML 598
Query: 587 VIYDYSATRILSHLLFH--NNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRN 644
V+YDYSA+RILS L H N R G S+LQWHHRYNI+K+LASA+LYLHEEW+EQVIHRN
Sbjct: 599 VLYDYSASRILSQRLQHHSNGSRRGSSVLQWHHRYNIVKALASAVLYLHEEWDEQVIHRN 658
Query: 645 ITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEAT 704
ITSSA+ L+PDMNPRL SFALAEFL+RN++GH +SVRGIFGYM+PEY+ESGEAT
Sbjct: 659 ITSSAVILEPDMNPRLTSFALAEFLSRNENGHHVVIDTKKSVRGIFGYMAPEYVESGEAT 718
Query: 705 SMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHK 764
+ ADVYSFGVVVLEVV+GQMAVDFR PE LLVK+VHEFE RKRPL EL D+ LNGEYN +
Sbjct: 719 TEADVYSFGVVVLEVVSGQMAVDFRQPEVLLVKKVHEFEMRKRPLKELADIRLNGEYNDQ 778
Query: 765 ELMRLIKLGIACTLSNPELRPSMRQILSILDGNDKRFMEDGQMTENLEEWKQRNECSLSL 824
ELMRL++LGIACT NP+LRPSMRQI+SILDGNDK +++ + E+ EEW++RN+CSLS+
Sbjct: 779 ELMRLVRLGIACTRCNPQLRPSMRQIVSILDGNDKLLIQNNK--ESREEWRERNDCSLSM 836
Query: 825 IKRIQALGIQ 834
IKRIQALGIQ
Sbjct: 837 IKRIQALGIQ 846
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147767429|emb|CAN66719.1| hypothetical protein VITISV_027097 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1147 bits (2966), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 593/837 (70%), Positives = 678/837 (81%), Gaps = 24/837 (2%)
Query: 1 MQQLNRLCFILPADVDEIGPYEKSRVHNVVSRKQEVKEQHGRGCGRRILSFIADKLQRLY 60
MQ LNR+CFILP ++++I P + H+V + KQ GRGCG ++L+ + L R +
Sbjct: 1 MQCLNRICFILPPELNDIHPLD----HHVSTEKQNPNRGRGRGCGTQVLAILQHFLSRFH 56
Query: 61 EAKWVCFCHHNTPRKEHSGLFHDMEGVQMSEKV-GGDNPRIFSYAELYIGSNGFDEDEVL 119
+ KW FCH + K+ S +FHDMEGV +S+KV G+NPRIFS++ELYIGSNGF EDEVL
Sbjct: 57 DLKWTSFCHCHPLTKQASEVFHDMEGVHVSDKVVAGNNPRIFSFSELYIGSNGFCEDEVL 116
Query: 120 GSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVH 179
GSGGFGKV+RAVLPSDGTVVAVKC+AEKGE FEKTF AELVAVA LRHRNLVRLRGWCVH
Sbjct: 117 GSGGFGKVFRAVLPSDGTVVAVKCVAEKGEPFEKTFVAELVAVAQLRHRNLVRLRGWCVH 176
Query: 180 EDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQI 239
E+QLLLVYDYMPNRSLDR+LFRRPEN + L WE+R++I+ GLAAAL+YLHEQLETQI
Sbjct: 177 EEQLLLVYDYMPNRSLDRILFRRPEN---SLLLGWERRRRIVGGLAAALYYLHEQLETQI 233
Query: 240 IHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIG 299
IHRDVKTSNVMLDS YNARLGDFGLARWLEHE++ + +T+S R+HQF LAETTRIGGTIG
Sbjct: 234 IHRDVKTSNVMLDSHYNARLGDFGLARWLEHEIEIETKTNSIRHHQFRLAETTRIGGTIG 293
Query: 300 YLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIRRLSDEGKV 359
YLPPESFQK S+ TAKSDVFSFGIVVLEVV+GRRAVDL P Q+I +
Sbjct: 294 YLPPESFQKRSMTTAKSDVFSFGIVVLEVVTGRRAVDL--PHIQMI----------KSFC 341
Query: 360 LQAGDNRLSDGS-YKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGSYSGKLPALPS 418
L D GS Y+L DME L HL LLCTLHNPH RP+MKW++E +S S +LPALPS
Sbjct: 342 LIGSDGCPMRGSFYRLSDMERLIHLGLLCTLHNPHSRPNMKWIVETLSSQSSTRLPALPS 401
Query: 419 FQSHPLYISLSSPTNTSTSNTETTRSTNTTASNTTIASPSSNYVTAAGETIYATAECGGN 478
FQSHPLYISLSSP+ T T T TT +T TT +NTT +S S YVTA GETIYATAE G
Sbjct: 402 FQSHPLYISLSSPSETGTDTTTTTTTTTTTTTNTTFSS--SIYVTATGETIYATAENGRI 459
Query: 479 TESKSNNSRSQRRNSFF-MVETPREISFKEIISATNNFSESQRVAEMDFGTAYQGFLDNH 537
TE+ S+NS ++++S F MV+TP+EIS+KEI SATNNFSESQR AE+DFGTAY GFLDN
Sbjct: 460 TETNSSNSSRRQQSSIFPMVQTPQEISYKEIASATNNFSESQRAAELDFGTAYHGFLDNG 519
Query: 538 QYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRIL 597
+VLVKRLGM CPALR RFSNELQNL RLRHRNLVQL GWCTEQGEMLV+YDY + R+L
Sbjct: 520 HHVLVKRLGMKTCPALRARFSNELQNLGRLRHRNLVQLHGWCTEQGEMLVVYDYLSNRLL 579
Query: 598 SHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMN 657
SHLLFH +++ HS L W HRYNIIKSLASAILYLHEEW+EQVIHRNITSSAI +D DMN
Sbjct: 580 SHLLFHLDNKKVHSTLHWRHRYNIIKSLASAILYLHEEWDEQVIHRNITSSAIIIDADMN 639
Query: 658 PRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVL 717
PRL SFALAEFLTRN+HGH + T RSVRGIFGYMSPEY+ESGEAT MADVYSFG+VVL
Sbjct: 640 PRLSSFALAEFLTRNEHGHHQVTDPTRSVRGIFGYMSPEYMESGEATPMADVYSFGMVVL 699
Query: 718 EVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACT 777
EVVTGQMAVDFR P LLVKRV E RK+PL E+ D L+GE++ +EL+RLIKLG+ACT
Sbjct: 700 EVVTGQMAVDFRWPGVLLVKRVRELAERKKPLEEMADWRLDGEHDQEELVRLIKLGMACT 759
Query: 778 LSNPELRPSMRQILSILDGNDKRFMEDGQMTENLEEWKQRNECSLSLIKRIQALGIQ 834
S PELRPSM QI+SILDGNDK FME+ Q E EEWKQRN CSLSLIKRIQALGIQ
Sbjct: 760 RSKPELRPSMGQIVSILDGNDKFFMEERQNKERREEWKQRNACSLSLIKRIQALGIQ 816
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356522982|ref|XP_003530121.1| PREDICTED: receptor like protein kinase S.2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1075 bits (2779), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 560/844 (66%), Positives = 674/844 (79%), Gaps = 28/844 (3%)
Query: 11 LPADVDEIGPYEKSRVHNVVSRKQEVK-EQHGRGC-GRRILSFIADKLQRLYEAKWVCFC 68
+P+D D++ P + N+ +++ K ++H +G G +++ + L RL + KW C
Sbjct: 1 MPSDYDKLDPLHATPQTNIKGAQKKAKSKKHPQGARGGHVVATLHGSLTRLCDTKWWNLC 60
Query: 69 HH----NTPRKEHSGLFHDMEGVQMSEKVGGD---NPRIFSYAELYIGSNGFDEDEVLGS 121
H T + + S +FHDMEGVQ+S K+G D NPRIFSYAELYIGS GF E+EVLGS
Sbjct: 61 QHGARIKTKQIKSSCVFHDMEGVQLSSKIGRDSNINPRIFSYAELYIGSRGFSEEEVLGS 120
Query: 122 GGFGKVYRAVLPSDGTVVAVKC-LAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHE 180
GGFGKVY+AV+PSD TVVAVKC LA KG +FEKTFAAEL AVAHLRH+NLV LRGWCV E
Sbjct: 121 GGFGKVYKAVMPSDETVVAVKCCLAGKGGQFEKTFAAELAAVAHLRHKNLVPLRGWCVFE 180
Query: 181 DQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQII 240
DQL LVYDYMPN SLDRVLFR+ NL+ PL W +R KI++GLA+ALHYLHEQLETQII
Sbjct: 181 DQLYLVYDYMPNSSLDRVLFRK--NLKEE-PLGWVRRGKIVKGLASALHYLHEQLETQII 237
Query: 241 HRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRT----SSARNHQFHLAETTRIGG 296
HRDVKTSNVMLDS YNARLGDFGLARWLEHEL+Y+ T +S++ F L+ETTRIGG
Sbjct: 238 HRDVKTSNVMLDSHYNARLGDFGLARWLEHELEYEYETRKASTSSKFEHFRLSETTRIGG 297
Query: 297 TIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIRRLSDE 356
TIGYLPPESFQ+ +AT+KSDVFSFGIVVLEVVSGRRA+DLTYPD++IILLDW+RRLSDE
Sbjct: 298 TIGYLPPESFQRRKIATSKSDVFSFGIVVLEVVSGRRAIDLTYPDEKIILLDWVRRLSDE 357
Query: 357 GKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGSYSGKLPAL 416
+++ A D RL DGSYK+ +ME+L H++LLCTLH+P LRPSMKW+ EA+S S KLP L
Sbjct: 358 RRLVAAVDTRLKDGSYKVFEMENLIHISLLCTLHDPQLRPSMKWIAEALS-DMSNKLPTL 416
Query: 417 PSFQSHPLYISLSSPTNTSTSNTETTRSTNTTASNTTIASPSSNYVTAAGETIYATAECG 476
PSF SHP+YISLSS + TS ++T+ T +++ T S++ S +S YVTA GETIY TAE
Sbjct: 417 PSFHSHPMYISLSSSSETSPNSTKGTGTSSGTESSSNHTSSNSKYVTAIGETIYVTAEAE 476
Query: 477 GNTESKSNNSRSQR----RNSFFMVETPREISFKEIISATNNFSESQRVAEMDFGTAYQG 532
S+ S+R + SF VETPR I +KEI+SAT+NFSES+RVAE+DFGTAY G
Sbjct: 477 NRNSGTSSTKSSKRVMHQQPSF--VETPRVIPYKEIVSATDNFSESKRVAELDFGTAYHG 534
Query: 533 FLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYS 592
LD H +V+VKRLG+ CPALR RFSNEL+NLA+LRHRNLVQL GWCTEQGEMLV+YDYS
Sbjct: 535 ILDGHYHVMVKRLGLKTCPALRQRFSNELRNLAKLRHRNLVQLRGWCTEQGEMLVVYDYS 594
Query: 593 ATRILSHLLFH--NNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAI 650
A R LSH L H N + +S+L+WHHRYNI+KSLASA+LYLHEEW+EQVIHRNITSSA+
Sbjct: 595 ARRFLSHQLHHHKNGTKNSNSVLKWHHRYNIVKSLASALLYLHEEWDEQVIHRNITSSAV 654
Query: 651 TLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVY 710
TL+PDM PRLGSFALAEFL+RN+HGH ++ ++SV GIFGYMSPEY+ESGEAT+ ADVY
Sbjct: 655 TLEPDMTPRLGSFALAEFLSRNEHGHHVISNRSKSVCGIFGYMSPEYVESGEATAAADVY 714
Query: 711 SFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLI 770
SFGVVVLE+V+G AVDFR PE LLVK+VHEFE RKRPL L D+ LNGEYN KELMRL+
Sbjct: 715 SFGVVVLEIVSGLKAVDFRQPEVLLVKKVHEFEVRKRPLVALADIGLNGEYNFKELMRLV 774
Query: 771 KLGIACTLSNPELRPSMRQILSILDGNDKRFMEDGQMTENLEEWKQRNECSLSLIKRIQA 830
LG+ACT S+P+LRPS RQI+SILDGNDK M G+ E+ E+W++RN CSLSL+KRIQA
Sbjct: 775 SLGVACTRSDPKLRPSTRQIVSILDGNDKLIM--GENMESREDWRERNACSLSLVKRIQA 832
Query: 831 LGIQ 834
LGIQ
Sbjct: 833 LGIQ 836
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356503214|ref|XP_003520406.1| PREDICTED: receptor like protein kinase S.2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1060 bits (2741), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 539/768 (70%), Positives = 629/768 (81%), Gaps = 24/768 (3%)
Query: 84 MEGVQMSEKVGGDN----PRIFSYAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVV 139
MEGVQ+S +G D+ PRIFSYAELYIGS GF E+EVLGSGGFGKVY+AV+PSDGTVV
Sbjct: 1 MEGVQLSSMIGKDSNINHPRIFSYAELYIGSRGFSEEEVLGSGGFGKVYKAVMPSDGTVV 60
Query: 140 AVKC-LAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRV 198
AVKC LA KG +FEKTFAAEL AVAHLRH+NLV LRGWCV EDQL LVYDYMPN SLDRV
Sbjct: 61 AVKCCLAGKGGQFEKTFAAELAAVAHLRHKNLVPLRGWCVFEDQLYLVYDYMPNLSLDRV 120
Query: 199 LFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNAR 258
LFR+ E PL W +R KI++GLA ALHYLHEQLETQIIHRDVKTSNVMLDS YNAR
Sbjct: 121 LFRKNMKEE---PLGWVRRGKIVKGLACALHYLHEQLETQIIHRDVKTSNVMLDSHYNAR 177
Query: 259 LGDFGLARWLEHELQYQMRT----SSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATA 314
LGDFGLARWLEHEL+Y+ T +S + F L+ETTRIGGTIGYLPPESFQ+ S+AT+
Sbjct: 178 LGDFGLARWLEHELEYEYETRKESTSRKFEHFRLSETTRIGGTIGYLPPESFQRRSIATS 237
Query: 315 KSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKL 374
KSDVFSFGIVVLEVVSGRRA+DLTY D++IILLDWIRRLSDEG+++ A D R++DGSYK+
Sbjct: 238 KSDVFSFGIVVLEVVSGRRAIDLTYSDEKIILLDWIRRLSDEGRLVAAVDTRVTDGSYKV 297
Query: 375 CDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGSYSGKLPALPSFQSHPLYISLSSPTNT 434
+MEHL H++LLCTLH+P LRPSMKW++EA+S S KLP LPSF HP+YISLSS + T
Sbjct: 298 FEMEHLIHISLLCTLHDPQLRPSMKWIVEALS-DVSNKLPTLPSFHCHPMYISLSSSSET 356
Query: 435 S---TSNTETTRSTNTTASNTTIASPSSNYVTAAGETIYATAEC---GGNTESKSNNSRS 488
S T T T+ T S + + +S +VTA GETIY TAE T S ++ R
Sbjct: 357 SPNSTKGTGTSSGTEIATSTSNHTNSNSKFVTATGETIYVTAEAEHRNSGTSSSKSSKRV 416
Query: 489 QRRNSFFMVETPREISFKEIISATNNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMS 548
F VE PREI +KEI+SAT NFSESQRVAE+DFGTAY G LD H +V+VKRLG+
Sbjct: 417 MHHQPSF-VEAPREIPYKEIVSATGNFSESQRVAELDFGTAYHGILDGHYHVMVKRLGLK 475
Query: 549 KCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRILSHLLFHNNH-- 606
CPALR RFSNEL+NLA+LRHRNLVQL GWCTEQGEMLV+YDYSA+R LSH L H+N+
Sbjct: 476 TCPALRQRFSNELRNLAKLRHRNLVQLRGWCTEQGEMLVVYDYSASRFLSHQLHHHNNAT 535
Query: 607 RIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALA 666
+ G+S+L+WHHRYNI+KSLASA+LYLHEEW+EQVIHRNITSSA+TL+PDM PRLGSFALA
Sbjct: 536 KNGNSVLKWHHRYNIVKSLASALLYLHEEWDEQVIHRNITSSAVTLEPDMTPRLGSFALA 595
Query: 667 EFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAV 726
EFL+RN+HGH T+ ++SV GIFGYMSPEY+ESGEAT+ ADVYSFGVVVLE+V+G AV
Sbjct: 596 EFLSRNEHGHHVITTRSKSVCGIFGYMSPEYVESGEATTAADVYSFGVVVLEIVSGLKAV 655
Query: 727 DFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPS 786
DFR PE LLVK+VHEFE RKRPL EL D+ LNGEYN+KELMRL+ LG+ACT S+P+LRPS
Sbjct: 656 DFRQPEVLLVKKVHEFEMRKRPLEELADIGLNGEYNYKELMRLVSLGVACTSSDPKLRPS 715
Query: 787 MRQILSILDGNDKRFMEDGQMTENLEEWKQRNECSLSLIKRIQALGIQ 834
R+I+SILDGNDK M G+ E+ E+W++RN CSLSL+KRIQALGIQ
Sbjct: 716 TRKIVSILDGNDKLIM--GENMESREDWRERNACSLSLVKRIQALGIQ 761
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297823071|ref|XP_002879418.1| hypothetical protein ARALYDRAFT_902344 [Arabidopsis lyrata subsp. lyrata] gi|297325257|gb|EFH55677.1| hypothetical protein ARALYDRAFT_902344 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1019 bits (2636), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 529/857 (61%), Positives = 658/857 (76%), Gaps = 32/857 (3%)
Query: 4 LNRLCFILPADVDEIGPYEKSRVHNVVSRKQEVKEQHGRGCGRRILSFIADKLQRLYEAK 63
++RLCF+LP + E+ P V K+E +E+ R CGR+++S I D +RL+ +K
Sbjct: 6 MDRLCFVLPTESGELKPPSLKSPAMVEKTKEEEEEKKSRDCGRQVVSLIGDLFRRLHGSK 65
Query: 64 WV---CFCHHNTPRK----EHSGLFHDMEGVQMSEKVGGDNPRIFSYAELYIGSNGFDED 116
V C N + E + F DMEGVQ+S KVG +NPRIF Y+ELYIG+NGF ++
Sbjct: 66 IVKSLYLCSINECKDSISMETNKSFTDMEGVQLSSKVGCENPRIFGYSELYIGTNGFSDE 125
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNLVRLRG 175
+LGSGGFG+VY+AVLPSDGT VAVKCLAEK GE+FEKTFAAELVAVA LRHRNLV+LRG
Sbjct: 126 LILGSGGFGRVYKAVLPSDGTTVAVKCLAEKKGEQFEKTFAAELVAVAQLRHRNLVKLRG 185
Query: 176 WCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQL 235
WC+HED+LLLVYDYMPNRSLDRVLFRRPE PL+W++R KI++GLAAAL YLHEQL
Sbjct: 186 WCLHEDELLLVYDYMPNRSLDRVLFRRPEANSDFKPLDWDRRGKIVKGLAAALFYLHEQL 245
Query: 236 ETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQM------RTSSARNHQFHLA 289
ETQIIHRDVKTSNVMLDS++NA+LGDFGLARWLEH++ SS RNHQF +A
Sbjct: 246 ETQIIHRDVKTSNVMLDSEFNAKLGDFGLARWLEHKIDETEPDSSYDSVSSFRNHQFRVA 305
Query: 290 ETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDW 349
++TRIGGTIGYLPPESF+K +VATAK+DVFSFG+VVLEVVSGRRAVDL++ +D+IILLDW
Sbjct: 306 DSTRIGGTIGYLPPESFRKKTVATAKTDVFSFGVVVLEVVSGRRAVDLSFSEDKIILLDW 365
Query: 350 IRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGSY 409
+RRLSD K+L AGD RL GSY+ DM+ + HLALLC+L+NP RP+MKWVI A+SG +
Sbjct: 366 VRRLSDNRKLLDAGDFRLPKGSYENSDMKRMIHLALLCSLNNPTHRPNMKWVIGALSGEF 425
Query: 410 SGKLPALPSFQSHPLYISLSSPTNTSTSNTETTRSTNT---------TASNTTIASPSSN 460
SG LPALPSF+SHPLYI LSS +TSTS T TT T T AS+ +I PSSN
Sbjct: 426 SGNLPALPSFKSHPLYIPLSSLKSTSTSATTTTTRTTTTTTTSTTSFNASSESI--PSSN 483
Query: 461 YVTAAGETIYATAECGGNTESKSNNSRSQRRNSFFMVETPREISFKEIISATNNFSESQR 520
YVTA ++IY TAE G N N+ R S F+++TPREIS+ +++ AT+NFS+++R
Sbjct: 484 YVTALEDSIYQTAETGENRYFNYNSRRVTSSKS-FVLDTPREISYNDLVLATDNFSDARR 542
Query: 521 VAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCT 580
VAE+DFGTAY G L+ Q+++VKRLGM+KCPAL TRFS EL NL RLRHRNLV L GWCT
Sbjct: 543 VAEVDFGTAYYGLLNGDQHIVVKRLGMTKCPALVTRFSTELLNLGRLRHRNLVMLRGWCT 602
Query: 581 EQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQV 640
E GEMLV+YDYSA R LSHLLFH NH G+S+L+W RYN+IKSLA A+ YLHEEW+EQV
Sbjct: 603 EHGEMLVVYDYSANRKLSHLLFH-NHIPGNSVLRWKSRYNVIKSLACAVRYLHEEWDEQV 661
Query: 641 IHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIES 700
IHRNITSS I LD DMNPRL FALAEFL+RND H +AT S +GIFGYM+PEY+ES
Sbjct: 662 IHRNITSSTIFLDRDMNPRLCGFALAEFLSRNDKAH-QATKKKGSAQGIFGYMAPEYMES 720
Query: 701 GEATSMADVYSFGVVVLEVVTGQMAVDFRLP--EGLLVKRVHEFEA-RKRPLAELVDLSL 757
GEAT+MADVYSFGVVVLE+VTGQ AVD++ + LLV R+ E RK+ L E+ D+ L
Sbjct: 721 GEATTMADVYSFGVVVLEMVTGQPAVDYKRKKEDALLVLRIREIVGNRKKILEEIADIHL 780
Query: 758 NGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDKRFMEDGQMTENLEEWKQR 817
+ EY ++EL RL++LG+ CT ++P+LRPS+ Q++SILDG+++ F E+G ++ KQ
Sbjct: 781 DDEYENRELARLLRLGLVCTRTDPKLRPSISQVVSILDGSERFFEEEGGKEGDVSR-KQM 839
Query: 818 NECSLSLIKRIQALGIQ 834
+ S+ +I+++QALGI
Sbjct: 840 YDSSMLMIRQMQALGIH 856
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 834 | ||||||
| TAIR|locus:2046457 | 851 | AP4.3A [Arabidopsis thaliana ( | 0.984 | 0.964 | 0.581 | 3.2e-255 | |
| TAIR|locus:2143528 | 711 | AT5G03140 [Arabidopsis thalian | 0.352 | 0.413 | 0.397 | 4.2e-57 | |
| TAIR|locus:2168509 | 674 | AT5G59260 [Arabidopsis thalian | 0.302 | 0.373 | 0.439 | 5.5e-54 | |
| TAIR|locus:2099941 | 684 | AT3G55550 [Arabidopsis thalian | 0.342 | 0.418 | 0.382 | 1.9e-53 | |
| TAIR|locus:2170224 | 652 | AT5G06740 [Arabidopsis thalian | 0.366 | 0.469 | 0.386 | 8e-53 | |
| TAIR|locus:2149780 | 682 | LECRKA4.1 "lectin receptor kin | 0.266 | 0.325 | 0.443 | 1.2e-51 | |
| TAIR|locus:2155685 | 675 | AT5G65600 [Arabidopsis thalian | 0.341 | 0.422 | 0.375 | 1.9e-50 | |
| TAIR|locus:2085587 | 669 | AT3G45440 [Arabidopsis thalian | 0.223 | 0.278 | 0.444 | 2.6e-49 | |
| TAIR|locus:2036636 | 632 | NIK3 "NSP-interacting kinase 3 | 0.372 | 0.492 | 0.367 | 4.5e-49 | |
| TAIR|locus:2095517 | 453 | AT3G28690 [Arabidopsis thalian | 0.341 | 0.629 | 0.381 | 9e-49 |
| TAIR|locus:2046457 AP4.3A [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2457 (870.0 bits), Expect = 3.2e-255, P = 3.2e-255
Identities = 497/854 (58%), Positives = 622/854 (72%)
Query: 4 LNRLCFILPADVDEIGPYEKSRVHNVVSRKQEVKEQHGRGCGRRILSFIADKLQRLYEAK 63
++ LCF+LP + E+ P V +E +E+ R CGR+++S I D +RL+ +K
Sbjct: 6 MDHLCFVLPTESGELKPPVM-----VEETTEEEEEKKSRDCGRQVVSLIGDLFRRLHGSK 60
Query: 64 WVC---FCHHNTPRK----EHSGLFHDMEGVQMSEKVGGDNPRIFSYAELYIGSNGFDED 116
V C N + E + F DMEGVQ+S KVG +NPRIF Y+ELYIG+NGF ++
Sbjct: 61 LVKSLNLCSINESKDSISMEINKSFTDMEGVQLSSKVGCENPRIFGYSELYIGTNGFSDE 120
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNLVRLRG 175
+LGSGGFG+VY+A+LPSDGT VAVKCLAEK GE+FEKTFAAELVAVA LRHRNLV+LRG
Sbjct: 121 LILGSGGFGRVYKALLPSDGTTVAVKCLAEKKGEQFEKTFAAELVAVAQLRHRNLVKLRG 180
Query: 176 WCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQL 235
WC+HED+LLLVYDYMPNRSLDRVLFRRPE PL+W++R KI++GLAAAL YLHEQL
Sbjct: 181 WCLHEDELLLVYDYMPNRSLDRVLFRRPEVNSDFKPLDWDRRGKIVKGLAAALFYLHEQL 240
Query: 236 ETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEH---ELQYQMR---TSSARNHQFHLA 289
ETQIIHRDVKTSNVMLDS++NA+LGDFGLARWLEH E ++ SS RNHQF +A
Sbjct: 241 ETQIIHRDVKTSNVMLDSEFNAKLGDFGLARWLEHKIDETEHDSSYDSVSSFRNHQFRVA 300
Query: 290 ETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDW 349
++TRIGGTIGYLPPESF+K +VATAK+DVFSFG+VVLEVVSGRRAVDL++ +D+IILLDW
Sbjct: 301 DSTRIGGTIGYLPPESFRKKTVATAKTDVFSFGVVVLEVVSGRRAVDLSFSEDKIILLDW 360
Query: 350 IRRLSDEGKVLQAGDNRLSDGSYKLCDMEXXXXXXXXXXXXNPHLRPSMKWVIEAVSGSY 409
+RRLSD K+L AGD+RL+ GSY L DM+ NP RP+MKWVI A+SG +
Sbjct: 361 VRRLSDNRKLLDAGDSRLAKGSYDLSDMKRMIHLALLCSLNNPTHRPNMKWVIGALSGEF 420
Query: 410 SGKLPALPSFQSHPLYI-------XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXYV 462
SG LPALPSF+SHPLYI YV
Sbjct: 421 SGNLPALPSFKSHPLYIPLSSLKSTSTSATTTTTRTTMTTTTSTTSFNASSESTPSSNYV 480
Query: 463 TAAGETIYATAECGGNTEXXXXXXXXXXXXXFFMVETPREISFKEIISATNNFSESQRVA 522
TA ++IY TAE G N F +++TPREIS+ +++ AT+NFS+++RVA
Sbjct: 481 TALEDSIYQTAETGENPYFNYNSRRVMSSKSF-VLDTPREISYNDLVLATDNFSDARRVA 539
Query: 523 EMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQ 582
E+DFGTAY G L+ Q+++VKRLGM+KCPAL TRFS EL NL RLRHRNLV L GWCTE
Sbjct: 540 EVDFGTAYYGLLNGDQHIVVKRLGMTKCPALVTRFSTELLNLGRLRHRNLVMLRGWCTEH 599
Query: 583 GEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIH 642
GEMLV+YDYSA R LSHLLFHN H G+S+L+W RYN+IKSLA A+ YLHEEW+EQVIH
Sbjct: 600 GEMLVVYDYSANRKLSHLLFHN-HIPGNSVLRWKSRYNVIKSLACAVRYLHEEWDEQVIH 658
Query: 643 RNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGE 702
RNITSS I LD DMNPRL FALAEFL+RND H+ A S +GIFGYM+PEY+ESGE
Sbjct: 659 RNITSSTIFLDRDMNPRLCGFALAEFLSRNDKAHQAAKKKG-SAQGIFGYMAPEYMESGE 717
Query: 703 ATSMADVYSFGVVVLEVVTGQMAVDFRLP--EGLLVKRVHEFEA-RKRPLAELVDLSLNG 759
AT+MADVYSFGVVVLE+VTGQ AVD++ + L+V R+ E RK+ L E+ D+ L+
Sbjct: 718 ATTMADVYSFGVVVLEMVTGQPAVDYKRKKEDALMVLRIREVVGNRKKLLEEIADIHLDD 777
Query: 760 EYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDKRFMEDGQMTENLEEWKQRNE 819
EY ++EL RL++LG+ CT ++P+LRPS+ Q++SILDG+++ F E+G ++ KQ +
Sbjct: 778 EYENRELARLLRLGLVCTRTDPKLRPSISQVVSILDGSERFFEEEGGKEGDVSR-KQMYD 836
Query: 820 CSLSLIKRIQALGI 833
S+ +I+++QALGI
Sbjct: 837 SSMLMIRQMQALGI 850
|
|
| TAIR|locus:2143528 AT5G03140 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 564 (203.6 bits), Expect = 4.2e-57, Sum P(2) = 4.2e-57
Identities = 130/327 (39%), Positives = 189/327 (57%)
Query: 97 NPRIFSYAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFA 156
+PR F+Y EL + ++ F V+G+G FG VY+ +L G ++A+K + + F
Sbjct: 358 SPREFTYKELKLATDCFSSSRVIGNGAFGTVYKGILQDSGEIIAIKRCSHISQG-NTEFL 416
Query: 157 AELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQ 216
+EL + LRHRNL+RL+G+C + ++LL+YD MPN SLD+ L+ P L P W
Sbjct: 417 SELSLIGTLRHRNLLRLQGYCREKGEILLIYDLMPNGSLDKALYESPTTL----P--WPH 470
Query: 217 RKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQM 276
R+KI+ G+A+AL YLH++ E QIIHRDVKTSN+MLD+ +N +LGDFGLAR EH+
Sbjct: 471 RRKILLGVASALAYLHQECENQIIHRDVKTSNIMLDANFNPKLGDFGLARQTEHDKS--- 527
Query: 277 RTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVD 336
+ T GT+GYL PE G AT K+DVFS+G VVLEV +GRR +
Sbjct: 528 ------------PDATAAAGTMGYLAPEYLLTGR-ATEKTDVFSYGAVVLEVCTGRRPIT 574
Query: 337 LTYPDDQI------ILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEXXXXXXXXXXXX 390
P+ + L+DW+ L EGK+L A D RLS+ + + +M
Sbjct: 575 RPEPEPGLRPGLRSSLVDWVWGLYREGKLLTAVDERLSEFNPE--EMSRVMMVGLACSQP 632
Query: 391 NPHLRPSMKWVIEAVSGSYSGKLPALP 417
+P RP+M+ V++ + G +P +P
Sbjct: 633 DPVTRPTMRSVVQILVGE--ADVPEVP 657
|
|
| TAIR|locus:2168509 AT5G59260 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 558 (201.5 bits), Expect = 5.5e-54, P = 5.5e-54
Identities = 120/273 (43%), Positives = 171/273 (62%)
Query: 97 NPRIFSYAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFA 156
+P+ +S+ LY + GF E+++LG+GGFGKVY+ +LPS GT +AVK + E+ K +
Sbjct: 339 SPQRYSFRILYKATKGFRENQLLGAGGFGKVYKGILPS-GTQIAVKRVYHDAEQGMKQYV 397
Query: 157 AELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQ 216
AE+ ++ LRH+NLV L G+C + +LLLVYDYMPN SLD LF + L+ L W Q
Sbjct: 398 AEIASMGRLRHKNLVHLLGYCRRKGELLLVYDYMPNGSLDDYLFHK-NKLK---DLTWSQ 453
Query: 217 RKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQM 276
R II+G+A+AL YLHE+ E ++HRD+K SN++LD+ N +LGDFGLAR+ H+ +
Sbjct: 454 RVNIIKGVASALLYLHEEWEQVVLHRDIKASNILLDADLNGKLGDFGLARF--HDRGVNL 511
Query: 277 RTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVD 336
E TR+ GTIGY+ PE G V T +DV++FG +LEVV GRR VD
Sbjct: 512 -------------EATRVVGTIGYMAPELTAMG-VTTTCTDVYAFGAFILEVVCGRRPVD 557
Query: 337 LTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSD 369
P +Q+IL+ W+ + D++L D
Sbjct: 558 PDAPREQVILVKWVASCGKRDALTDTVDSKLID 590
|
|
| TAIR|locus:2099941 AT3G55550 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 553 (199.7 bits), Expect = 1.9e-53, P = 1.9e-53
Identities = 114/298 (38%), Positives = 181/298 (60%)
Query: 500 PREISFKEIISATNNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKCPALRTRFS 558
P S++E+ ATN F + + + FG Y+G L + ++V VKR+ +R F
Sbjct: 331 PHRFSYRELKKATNGFGDKELLGSGGFGKVYKGKLPGSDEFVAVKRISHESRQGVR-EFM 389
Query: 559 NELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHR 618
+E+ ++ LRHRNLVQL GWC + ++L++YD+ L LF N + IL W R
Sbjct: 390 SEVSSIGHLRHRNLVQLLGWCRRRDDLLLVYDFMPNGSLDMYLFDENPEV---ILTWKQR 446
Query: 619 YNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRK 678
+ IIK +AS +LYLHE W + VIHR+I ++ + LD +MN R+G F LA+ +HG
Sbjct: 447 FKIIKGVASGLLYLHEGWEQTVIHRDIKAANVLLDSEMNGRVGDFGLAKLY---EHG--- 500
Query: 679 ATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFR-LPEGLLVK 737
+ G V G FGY++PE +SG+ T+ DVY+FG V+LEV G+ ++ LPE L++
Sbjct: 501 SDPGATRVVGTFGYLAPELTKSGKLTTSTDVYAFGAVLLEVACGRRPIETSALPEELVMV 560
Query: 738 RVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795
+ + ++VD LNGE++ +E++ +IKLG+ C+ ++PE+RP+MRQ++ L+
Sbjct: 561 DWVWSRWQSGDIRDVVDRRLNGEFDEEEVVMVIKLGLLCSNNSPEVRPTMRQVVMYLE 618
|
|
| TAIR|locus:2170224 AT5G06740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 547 (197.6 bits), Expect = 8.0e-53, P = 8.0e-53
Identities = 129/334 (38%), Positives = 191/334 (57%)
Query: 97 NPRIFSYAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFA 156
NP+ F EL + F + LG GGFG V++ G +AVK ++EK + ++ F
Sbjct: 314 NPQKFKLRELKRATGNFGAENKLGQGGFGMVFKGKW--QGRDIAVKRVSEKSHQGKQEFI 371
Query: 157 AELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQ 216
AE+ + +L HRNLV+L GWC + LLVY+YMPN SLD+ LF ++ + L WE
Sbjct: 372 AEITTIGNLNHRNLVKLLGWCYERKEYLLVYEYMPNGSLDKYLFLEDKS---RSNLTWET 428
Query: 217 RKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQM 276
RK II GL+ AL YLH E +I+HRD+K SNVMLDS +NA+LGDFGLAR ++ Q +M
Sbjct: 429 RKNIITGLSQALEYLHNGCEKRILHRDIKASNVMLDSDFNAKLGDFGLARMIQ---QSEM 485
Query: 277 RTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVD 336
H H T I GT GY+ PE+F G AT ++DV++FG+++LEVVSG++
Sbjct: 486 ------TH--H--STKEIAGTPGYMAPETFLNGR-ATVETDVYAFGVLMLEVVSGKKPSY 534
Query: 337 LTYPDDQI----ILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEXXXXXXXXXXXXNP 392
+ D+Q +++W+ L G + A D + + + +M+ NP
Sbjct: 535 VLVKDNQNNYNNSIVNWLWELYRNGTITDAADPGMGN-LFDKEEMKSVLLLGLACCHPNP 593
Query: 393 HLRPSMKWVIEAVSGSYSGKLPALPSFQSHPLYI 426
+ RPSMK V++ ++G S P +P+ P ++
Sbjct: 594 NQRPSMKTVLKVLTGETSP--PDVPT--ERPAFV 623
|
|
| TAIR|locus:2149780 LECRKA4.1 "lectin receptor kinase a4.1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 521 (188.5 bits), Expect = 1.2e-51, Sum P(2) = 1.2e-51
Identities = 107/241 (44%), Positives = 159/241 (65%)
Query: 96 DNPRIFSYAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTF 155
D+PR Y +LY+ ++GF + ++G+GGFG V++ LP+ + AVK + + + F
Sbjct: 350 DHPRRLRYRDLYVATDGFKKTGIIGTGGFGTVFKGKLPNSDPI-AVKKIIPSSRQGVREF 408
Query: 156 AAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWE 215
AE+ ++ LRH+NLV L+GWC H++ LLL+YDY+PN SLD +L+ P + A L+W
Sbjct: 409 VAEIESLGKLRHKNLVNLQGWCKHKNDLLLIYDYIPNGSLDSLLYTVPRR--SGAVLSWN 466
Query: 216 QRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQ 275
R +I +G+A+ L YLHE+ E +IHRDVK SNV++DS+ N RLGDFGLAR Y+
Sbjct: 467 ARFQIAKGIASGLLYLHEEWEKIVIHRDVKPSNVLIDSKMNPRLGDFGLARL------YE 520
Query: 276 MRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAV 335
T L+ETT + GTIGY+ PE + G+ ++A SDVF+FG+++LE+V GR+
Sbjct: 521 RGT---------LSETTALVGTIGYMAPELSRNGNPSSA-SDVFAFGVLLLEIVCGRKPT 570
Query: 336 D 336
D
Sbjct: 571 D 571
|
|
| TAIR|locus:2155685 AT5G65600 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 512 (185.3 bits), Expect = 1.9e-50, Sum P(2) = 1.9e-50
Identities = 115/306 (37%), Positives = 178/306 (58%)
Query: 500 PREISFKEIISATNNFSESQRVAEMDFGTAYQGFLDN-HQYVLVKRLGMSKCPALRTRFS 558
PR+ S+K+++SATN FS +++ E FG Y+G L + V VK+L + F
Sbjct: 335 PRKFSYKDLVSATNRFSSHRKLGEGGFGAVYEGNLKEINTMVAVKKLSGDSRQG-KNEFL 393
Query: 559 NELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHR 618
NE++ +++LRHRNLVQL GWC E+ E L+IY+ L+ LF ++L W R
Sbjct: 394 NEVKIISKLRHRNLVQLIGWCNEKNEFLLIYELVPNGSLNSHLFGKRP----NLLSWDIR 449
Query: 619 YNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRK 678
Y I LASA+LYLHEEW++ V+HR+I +S I LD + N +LG F LA + H
Sbjct: 450 YKIGLGLASALLYLHEEWDQCVLHRDIKASNIMLDSEFNVKLGDFGLARLMNHELGSH-- 507
Query: 679 ATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLP------- 731
T+G + G FGYM+PEY+ G A+ +D+YSFG+V+LE+VTG+ +++
Sbjct: 508 -TTG---LAGTFGYMAPEYVMKGSASKESDIYSFGIVLLEIVTGRKSLERTQEDNSDTES 563
Query: 732 --EGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQ 789
E LV++V E ++ + VD L +++ KE L+ LG+ C + RPS++Q
Sbjct: 564 DDEKSLVEKVWELYGKQELITSCVDDKLGEDFDKKEAECLLVLGLWCAHPDKNSRPSIKQ 623
Query: 790 ILSILD 795
+ +++
Sbjct: 624 GIQVMN 629
|
|
| TAIR|locus:2085587 AT3G45440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 438 (159.2 bits), Expect = 2.6e-49, Sum P(3) = 2.6e-49
Identities = 92/207 (44%), Positives = 130/207 (62%)
Query: 98 PRIFSYAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAA 157
P FSY +LYI +NGF++D +LG GGFGKVY+ LPS G + AVK ++ E K F A
Sbjct: 327 PHRFSYKDLYIATNGFNKDGLLGKGGFGKVYKGTLPSKGQI-AVKRVSHDAEEGMKQFVA 385
Query: 158 ELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQR 217
E+V++ +L+H+N+V L G+C + +LLLV +YMPN SLD+ LF + P +W +R
Sbjct: 386 EIVSMGNLKHKNMVPLLGYCRRKGELLLVSEYMPNGSLDQYLFN-----DEKPPFSWRRR 440
Query: 218 KKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMR 277
II+ +A AL+Y+H ++HRD+K SNVMLD+++N RLGDFG+AR+ +H
Sbjct: 441 LLIIKDIATALNYMHTGAPQVVLHRDIKASNVMLDTEFNGRLGDFGMARFHDHGKD---- 496
Query: 278 TSSARNHQFHLAETTRIGGTIGYLPPE 304
TT GTIGY+ PE
Sbjct: 497 -----------PATTAAVGTIGYMAPE 512
|
|
| TAIR|locus:2036636 NIK3 "NSP-interacting kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 515 (186.3 bits), Expect = 4.5e-49, P = 4.5e-49
Identities = 123/335 (36%), Positives = 190/335 (56%)
Query: 75 KEHSGLFHDMEGVQMSEKVGGDNPRIFSYAELYIGSNGFDEDEVLGSGGFGKVYRAVLPS 134
+ + +F D+ Q +V + + +++ EL +N F+ +LG GG+G VY+ L +
Sbjct: 264 RRNKQIFFDVNE-QYDPEVSLGHLKRYTFKELRSATNHFNSKNILGRGGYGIVYKGHL-N 321
Query: 135 DGTVVAVKCLAEKG-ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNR 193
DGT+VAVK L + E F E+ ++ HRNL+RLRG+C + +LVY YMPN
Sbjct: 322 DGTLVAVKRLKDCNIAGGEVQFQTEVETISLALHRNLLRLRGFCSSNQERILVYPYMPNG 381
Query: 194 SLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDS 253
S V R +N+ L+W +RKKI G A L YLHEQ + +IIHRDVK +N++LD
Sbjct: 382 S---VASRLKDNIRGEPALDWSRRKKIAVGTARGLVYLHEQCDPKIIHRDVKAANILLDE 438
Query: 254 QYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVAT 313
+ A +GDFGLA+ L+H R S H+ TT + GT+G++ PE G ++
Sbjct: 439 DFEAVVGDFGLAKLLDH------RDS-------HV--TTAVRGTVGHIAPEYLSTGQ-SS 482
Query: 314 AKSDVFSFGIVVLEVVSGRRAVDLTYPDDQI-ILLDWIRRLSDEGKVLQAGDNRLSDGSY 372
K+DVF FGI++LE+++G++A+D Q ++LDW+++L EGK+ Q D L+D +
Sbjct: 483 EKTDVFGFGILLLELITGQKALDFGRSAHQKGVMLDWVKKLHQEGKLKQLIDKDLND-KF 541
Query: 373 KLCDMEXXXXXXXXXXXXNPHLRPSMKWVIEAVSG 407
++E NP RP M V++ + G
Sbjct: 542 DRVELEEIVQVALLCTQFNPSHRPKMSEVMKMLEG 576
|
|
| TAIR|locus:2095517 AT3G28690 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 496 (179.7 bits), Expect = 9.0e-49, Sum P(2) = 9.0e-49
Identities = 121/317 (38%), Positives = 177/317 (55%)
Query: 99 RIFSYAELYIGSNGFDEDEVLGSGGFGKVYRA---------VLPSDGTVVAVKCLAEKGE 149
RIF + +L + + F + +LG GGFG V++ V P G VAVK L G
Sbjct: 89 RIFMFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNPDGL 148
Query: 150 RFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAA 209
+ K + AE+ + +L H +LV+L G+C+ EDQ LLVY++MP SL+ LFRR
Sbjct: 149 QGHKEWLAEINFLGNLVHPSLVKLVGYCMEEDQRLLVYEFMPRGSLENHLFRR------T 202
Query: 210 APLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLE 269
PL W R KI G A L +LHE+ E +I+RD KTSN++LD +YNA+L DFGLA+
Sbjct: 203 LPLPWSVRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAP 262
Query: 270 HELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVV 329
E ++H +TR+ GT GY PE G + T KSDV+SFG+V+LE++
Sbjct: 263 DE---------KKSHV-----STRVMGTYGYAAPEYVMTGHLTT-KSDVYSFGVVLLEIL 307
Query: 330 SGRRAVDLTYPDDQIILLDWIR-RLSDEGKVLQAGDNRLSDGSYKLCDMEXXXXXXXXXX 388
+GRR+VD + P+ + L++W+R L D+ + + D RL +G Y + +
Sbjct: 308 TGRRSVDKSRPNGEQNLVEWVRPHLLDKKRFYRLLDPRL-EGHYSIKGAQKATQVAAQCL 366
Query: 389 XXNPHLRPSMKWVIEAV 405
+ RP M V+EA+
Sbjct: 367 NRDSKARPKMSEVVEAL 383
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| O48837 | LRKS2_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6105 | 0.9856 | 0.9659 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | eugene3.00012267 | hypothetical protein (834 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 834 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-48 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-46 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-44 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-42 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-41 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-40 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-40 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-29 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-29 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-28 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-26 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-26 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-26 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-25 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-25 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-25 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-24 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-24 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-23 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-23 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-23 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-22 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-21 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-21 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-21 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-21 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-21 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-20 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-20 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-20 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-20 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-20 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-19 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-19 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-19 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-19 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-19 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-19 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-19 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 7e-19 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-19 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-19 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-18 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-18 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-18 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-18 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-18 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-18 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-18 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-18 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 8e-18 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-18 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-17 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-17 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-17 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-17 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-17 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-17 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-17 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 9e-17 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 9e-17 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-16 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-16 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-16 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-16 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-16 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-16 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-16 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 8e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 9e-16 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-15 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-15 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-15 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-15 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-15 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-15 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-15 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-15 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-15 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 7e-15 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 8e-15 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 8e-15 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 9e-15 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-14 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-14 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-14 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-14 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-14 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-14 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 9e-14 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 9e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-13 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-13 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-13 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-13 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-13 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-13 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-13 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-13 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 6e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-13 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 7e-13 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 7e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 8e-13 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-12 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-12 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-12 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-12 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-12 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-12 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-12 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-12 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-12 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-12 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-12 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-12 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-12 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-12 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 8e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 8e-12 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-11 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-11 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-11 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-11 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-11 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-11 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-11 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-11 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-11 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-11 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-11 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 7e-11 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 8e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 9e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 9e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 9e-11 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-10 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-10 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-10 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-10 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-10 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-10 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-10 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-10 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-10 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-10 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-10 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-10 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-10 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-10 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-10 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-10 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-10 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 6e-10 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 6e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-10 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-10 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 7e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 8e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 9e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 9e-10 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-09 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-09 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-09 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-09 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-09 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-09 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-09 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-09 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-09 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-09 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-09 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-09 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 7e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 7e-09 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 7e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 7e-09 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 8e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 8e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 9e-09 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 9e-09 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-08 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-08 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-08 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-08 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-08 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-08 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-08 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-08 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-08 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 7e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-08 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 7e-08 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 7e-08 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 8e-08 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 9e-08 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 9e-08 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-07 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-07 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-07 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-07 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-07 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-07 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-07 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-07 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-07 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-07 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-07 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-07 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-07 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-07 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-07 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-07 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-07 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-07 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-07 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-07 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-07 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-07 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 5e-07 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-07 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 6e-07 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 7e-07 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-07 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 9e-07 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 9e-07 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-06 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-06 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-06 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-06 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-06 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-06 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-06 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-06 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-06 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-06 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-06 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-06 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-06 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-06 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-06 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-06 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-06 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-06 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-06 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-06 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-06 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-06 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-06 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-06 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 6e-06 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-06 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-06 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 9e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 9e-06 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-05 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-05 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-05 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-05 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-05 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-05 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-05 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-05 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-05 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-05 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-05 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-05 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-05 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-05 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-05 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-05 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-05 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-05 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-05 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-05 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 7e-05 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-05 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 8e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 8e-05 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 9e-05 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 9e-05 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 9e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 9e-05 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-04 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-04 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-04 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-04 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-04 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-04 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-04 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-04 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-04 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-04 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-04 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-04 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-04 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-04 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-04 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-04 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-04 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-04 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 5e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 6e-04 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 8e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 9e-04 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 0.001 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 0.001 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 0.001 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 0.001 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 0.001 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 0.001 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 0.001 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.001 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 0.002 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 0.002 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 0.002 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 0.002 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 0.002 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 0.002 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 0.002 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.002 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 0.002 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 0.002 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 0.002 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.002 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.002 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 0.003 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 0.003 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 0.003 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 0.003 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 0.003 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 0.004 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 0.004 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 0.004 | |
| pfam01636 | 238 | pfam01636, APH, Phosphotransferase enzyme family | 0.004 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 170 bits (434), Expect = 5e-48
Identities = 71/222 (31%), Positives = 105/222 (47%), Gaps = 28/222 (12%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLA--EKGERFEKTFAAELVAVAHLRHRNL 170
++ LGSG FG VY+A G +VAVK L + + ++T E+ + L H N+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 171 VRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHY 230
VRL +D L LV +Y L L R PL+ ++ KKI + L Y
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG-------PLSEDEAKKIALQILRGLEY 113
Query: 231 LHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAE 290
LH IIHRD+K N++LD ++ DFGLA+ L SS+ F
Sbjct: 114 LHSN---GIIHRDLKPENILLDENGVVKIADFGLAKKLL--------KSSSSLTTF---- 158
Query: 291 TTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
GT Y+ PE G+ K DV+S G+++ E+++G+
Sbjct: 159 ----VGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 2e-46
Identities = 63/211 (29%), Positives = 93/211 (44%), Gaps = 27/211 (12%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVKCL-AEKGERFEKTFAAELVAVAHLRHRNLVRLRGWC 177
LG GGFG VY A G VA+K + E + E+ + L H N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 178 VHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLET 237
E+ L LV +Y SL +L L+ ++ +I+ + L YLH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEG------KLSEDEILRILLQILEGLEYLHSN--- 111
Query: 238 QIIHRDVKTSNVMLDS-QYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGG 296
IIHRD+K N++LDS +L DFGL++ L + I G
Sbjct: 112 GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTS----------------DKSLLKTIVG 155
Query: 297 TIGYLPPESFQKGSVATAKSDVFSFGIVVLE 327
T Y+ PE + KSD++S G+++ E
Sbjct: 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 2e-44
Identities = 80/298 (26%), Positives = 127/298 (42%), Gaps = 58/298 (19%)
Query: 117 EVLGSGGFGKVYRAVL---PSDGTVVAVKCL---AEKGERFEKTFAAELVAVAHLRHRNL 170
+ LG G FG+VY+ L T VAVK L A + ER K F E + L H N+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEER--KDFLKEARVMKKLGHPNV 58
Query: 171 VRLRGWCVHEDQLLLVYDYMPNRSLDRVL--FRRPENLEAAAPLNWEQRKKIIRGLAAAL 228
VRL G C E+ L LV +YM L L R + L+ + +A +
Sbjct: 59 VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 229 HYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHL 288
YL + + +HRD+ N ++ ++ DFGL+R + + Y+ +T +
Sbjct: 119 EYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKT----GGKLP- 170
Query: 289 AETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-------GRRAVDLTYPD 341
I ++ PES + G + T+KSDV+SFG+++ E+ + G +
Sbjct: 171 ---------IRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE----- 215
Query: 342 DQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMK 399
+L+++R+ RL Y C + L L L C +P RP+
Sbjct: 216 ----VLEYLRK-----------GYRLPKPEY--CP-DELYELMLSCWQLDPEDRPTFS 255
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 154 bits (393), Expect = 2e-42
Identities = 66/221 (29%), Positives = 110/221 (49%), Gaps = 29/221 (13%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCL-AEKGERFEKTFAAELVAVAHLRHRNLV 171
++ E LG G FGKVY A G +VA+K + +K ++ + E+ + L+H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 172 RLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYL 231
RL ED+L LV +Y L +L +R L+ ++ + +R + +AL YL
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRG-------RLSEDEARFYLRQILSALEYL 113
Query: 232 HEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAET 291
H + I+HRD+K N++LD + +L DFGLAR +L + T
Sbjct: 114 HSK---GIVHRDLKPENILLDEDGHVKLADFGLAR----QLDPGEKL------------T 154
Query: 292 TRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
T + GT Y+ PE D++S G+++ E+++G+
Sbjct: 155 TFV-GTPEYMAPEVLLGKGY-GKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 3e-41
Identities = 78/289 (26%), Positives = 124/289 (42%), Gaps = 45/289 (15%)
Query: 116 DEVLGSGGFGKVYRAVL----PSDGTVVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNL 170
+ LG G FG+VY+ L T VAVK L E E + F E + L H N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNI 63
Query: 171 VRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHY 230
VRL G C + L +V +YMP L L + E L + ++ +A + Y
Sbjct: 64 VRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE------KLTLKDLLQMALQIAKGMEY 117
Query: 231 LHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAE 290
L + +HRD+ N ++ ++ DFGL+R + + Y+ R
Sbjct: 118 LESK---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLP------- 167
Query: 291 TTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWI 350
I ++ PES + G T+KSDV+SFG+++ E+ + + YP + + +
Sbjct: 168 -------IKWMAPESLKDG-KFTSKSDVWSFGVLLWEIFTL---GEQPYPG--MSNEEVL 214
Query: 351 RRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMK 399
L ++G L +N C E L L L C ++P RP+
Sbjct: 215 ELL-EDGYRLPRPEN---------CPDE-LYELMLQCWAYDPEDRPTFS 252
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 1e-40
Identities = 78/293 (26%), Positives = 123/293 (41%), Gaps = 53/293 (18%)
Query: 116 DEVLGSGGFGKVYRAVL----PSDGTVVAVKCL-AEKGERFEKTFAAELVAVAHLRHRNL 170
+ LG G FG+VY+ L VAVK L + E+ + F E + L H N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 171 VRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHY 230
V+L G C E+ L++V +YMP L L R+ L+ +A + Y
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYL-RKNRP----KELSLSDLLSFALQIARGMEY 118
Query: 231 LHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAE 290
L + IHRD+ N ++ ++ DFGL+R L + Y + +
Sbjct: 119 LESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY--KVKGGK-------- 165
Query: 291 TTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPD---DQIIL 346
I ++ PES ++G T+KSDV+SFG+++ E+ + G YP +++
Sbjct: 166 -----LPIRWMAPESLKEG-KFTSKSDVWSFGVLLWEIFTLGEEP----YPGMSNAEVL- 214
Query: 347 LDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMK 399
+ L+ G RL C E L L L C +P RP+
Sbjct: 215 -----------EYLKKG-YRLP--KPPNCPPE-LYKLMLQCWAEDPEDRPTFS 252
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 6e-40
Identities = 76/297 (25%), Positives = 120/297 (40%), Gaps = 62/297 (20%)
Query: 116 DEVLGSGGFGKVYRAVL----PSDGTVVAVKCL-AEKGERFEKTFAAELVAVAHLRHRNL 170
+ LG G FG+VY+ L VAVK L + E+ + F E + L H N+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 171 VRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHY 230
V+L G C E+ L +V +YM L L R+ L+ +A + Y
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYL-RKNRP-----KLSLSDLLSFALQIARGMEY 117
Query: 231 LHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAE 290
L + IHRD+ N ++ ++ DFGL+R L + Y R +
Sbjct: 118 LESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD-DY-YRKRGGK-------- 164
Query: 291 TTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTY--------PDD 342
I ++ PES ++G T+KSDV+SFG+++ E+ T ++
Sbjct: 165 -----LPIRWMAPESLKEG-KFTSKSDVWSFGVLLWEI--------FTLGEQPYPGMSNE 210
Query: 343 QIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMK 399
+++ + L+ G RL C E L L L C +P RP+
Sbjct: 211 EVL------------EYLKNG-YRLP--QPPNCPPE-LYDLMLQCWAEDPEDRPTFS 251
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 65/231 (28%), Positives = 108/231 (46%), Gaps = 49/231 (21%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVA-------HLRHRN 169
E+LG G FG VY A+ G ++AVK + EL A+ L+H N
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSV-----ELSGDSEEELEALEREIRILSSLQHPN 60
Query: 170 LVRLRGWCVHEDQ--LLLVYDYMPNRSLDRVL--FRR-PENLEAAAPLNWEQR--KKIIR 222
+VR G E++ L + +Y+ SL +L F + PE + ++ ++I+
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVI--------RKYTRQILE 112
Query: 223 GLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSAR 282
GLA YLH I+HRD+K +N+++DS +L DFG A+ L +++ T S
Sbjct: 113 GLA----YLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRL-GDIETGEGTGS-- 162
Query: 283 NHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRR 333
+ GT ++ PE +G +D++S G V+E+ +G+
Sbjct: 163 -----------VRGTPYWMAPEVI-RGEEYGRAADIWSLGCTVIEMATGKP 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 121 bits (303), Expect = 1e-29
Identities = 90/417 (21%), Positives = 156/417 (37%), Gaps = 47/417 (11%)
Query: 112 GFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGER---FEKTFAAELVAVAHLRH- 167
+ LG G FG+VY A D +VA+K LA+K E + F E+ +A L H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR---DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 168 RNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAA 227
N+V+L + E L LV +Y+ SL+ +L + + PL+ + I+ + +A
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLL----KKIGRKGPLSESEALFILAQILSA 113
Query: 228 LHYLHEQLETQIIHRDVKTSNVMLDSQYN-ARLGDFGLARWLEHELQYQMRTSSARNHQF 286
L YLH + IIHRD+K N++LD +L DFGLA+ L +
Sbjct: 114 LEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP----------GSTSS 160
Query: 287 HLAETTRIGGTIGYLPPESF--QKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQI 344
A + GT GY+ PE + A++ SD++S GI + E+++G +
Sbjct: 161 IPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSAT 220
Query: 345 -ILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403
L I L + S D L +P R S +
Sbjct: 221 SQTLKIILELPTPSLASPLSPSNPELISKAASD------LLKKLLAKDPKNRLSSSSDL- 273
Query: 404 AVSGSYSGKLPALPSFQSHPLYISLSSPTNTSTSNTETTRSTNTTASNTTIASPSSNYVT 463
+H ++ R + + I+S +S ++
Sbjct: 274 ------------SHDLLAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSLNSLAIS 321
Query: 464 AAGETIYATAECGGNTESKSNNSRSQRRNSFFMVETPREISFKEIISATNNFSESQR 520
+ + + + ++S + + + S +I + ++ S S
Sbjct: 322 GSDLKLDDSNFSKELAPNGVSSSPHNSSSLLLSTASSKRSSLPKISARSSPSSLSSS 378
|
Length = 384 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 7e-29
Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 27/216 (12%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGW 176
E +G GGFG+VY+A G VA+K + + + ++ E+ + +H N+V+ G
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65
Query: 177 CVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLE 236
+ +D+L +V ++ SL +L + L Q + + L L YLH
Sbjct: 66 YLKKDELWIVMEFCSGGSLKDLLKSTNQ------TLTESQIAYVCKELLKGLEYLHSN-- 117
Query: 237 TQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGG 296
IIHRD+K +N++L S +L DFGL+ Q+ + ARN + G
Sbjct: 118 -GIIHRDIKAANILLTSDGEVKLIDFGLSA--------QLSDTKARNT---------MVG 159
Query: 297 TIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
T ++ PE K+D++S GI +E+ G+
Sbjct: 160 TPYWMAPEVINGKPY-DYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 61/225 (27%), Positives = 101/225 (44%), Gaps = 27/225 (12%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKC--LAEKGERFEKTFA-AELVAVAHLRHRN 169
++ + +G G FGKVY SDG + +K L+ E+ E+ A E+ + L H N
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEK-EREDALNEVKILKKLNHPN 60
Query: 170 LVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALH 229
+++ + +L +V +Y L + + ++ + P EQ L AL
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQ---KKEGKPFPEEQILDWFVQLCLALK 117
Query: 230 YLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLA 289
YLH + +I+HRD+K N+ L S +LGDFG+++ L +
Sbjct: 118 YLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA-------------- 160
Query: 290 ETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRA 334
T + GT YL PE Q KSD++S G V+ E+ + +
Sbjct: 161 -KTVV-GTPYYLSPELCQNKPY-NYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 72/280 (25%), Positives = 122/280 (43%), Gaps = 35/280 (12%)
Query: 526 FGTAYQGFLDNHQY----VLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTE 581
FG Y+G L V VK L R F E + + +L H N+V+L G CTE
Sbjct: 8 FGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE 67
Query: 582 QGEMLVIYDY-SATRILSHLLFHNNHRIGH--SILQWHHRYNIIKSLASAILYLHEEWNE 638
+ + ++ +Y +L +L S L + +A + YL +
Sbjct: 68 EEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---K 124
Query: 639 QVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYI 698
+ +HR++ + + D+ ++ F L+ + +D+ +RK T G +R +M+PE +
Sbjct: 125 KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY-YRKKTGGKLPIR----WMAPESL 179
Query: 699 ESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLP-EGLLVKRVHEF-EARKRPLAELVDL 755
+ G TS +DV+SFGV++ E+ T G P GL + V E+ R
Sbjct: 180 KDGIFTSKSDVWSFGVLLWEIFTLGAT------PYPGLSNEEVLEYLRKGYRLPK----- 228
Query: 756 SLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795
EY EL L+ C +PE RP+ +++ L+
Sbjct: 229 ---PEYCPDELYELMLS---CWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 56/230 (24%), Positives = 101/230 (43%), Gaps = 30/230 (13%)
Query: 526 FGTAYQGF-LDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGE 584
FGT Y + V +K + +L E++ L +L H N+V+L G ++
Sbjct: 6 FGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENH 65
Query: 585 MLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRN 644
+ ++ +Y L LL N + L I+ + + YLH +IHR+
Sbjct: 66 LYLVMEYCEGGSLKDLLKENEGK-----LSEDEILRILLQILEGLEYLHS---NGIIHRD 117
Query: 645 ITSSAITLD-PDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIES-GE 702
+ I LD + +L F L++ LT + S +++ G YM+PE + G
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDK-------SLLKTIVGTPAYMAPEVLLGKGY 170
Query: 703 ATSMADVYSFGVVVLEVVTGQMAVDFRLPEGL-LVKRVHEFEARKRPLAE 751
+ +D++S GV++ E LPE L++++ + + KRP A+
Sbjct: 171 YSEKSDIWSLGVILYE-----------LPELKDLIRKMLQKDPEKRPSAK 209
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 60/221 (27%), Positives = 104/221 (47%), Gaps = 35/221 (15%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKC--LAEKGERFEKTFAAELVAVAHLRHRNLVRLR 174
+++G G FG VY+ + G VA+K L + E K+ E+ + +L+H N+V+
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 175 GWCVHEDQLLLVYDYMPNRSLDRVLFRR---PENLEAAAPLNWEQRKKIIRGLAAALHYL 231
G D L ++ +Y N SL +++ + PE+L A + + L YL
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVA----------VYVYQVLQGLAYL 115
Query: 232 HEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAET 291
HEQ +IHRD+K +N++ +L DFG+A T + +
Sbjct: 116 HEQ---GVIHRDIKAANILTTKDGVVKLADFGVA------------TKLNDVSK----DD 156
Query: 292 TRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
+ GT ++ PE + S A+ SD++S G V+E+++G
Sbjct: 157 ASVVGTPYWMAPEVIE-MSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 62/231 (26%), Positives = 100/231 (43%), Gaps = 39/231 (16%)
Query: 117 EVLGSGGFGKVYRAVLPS-----DGTVVAVKCLAEKGERF-EKTFAAELVAVAHLRHRNL 170
LG G FGKV+ D +VAVK L E K F E + + +H N+
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70
Query: 171 VRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAA-------PLNWEQRKKIIRG 223
V+ G C D ++V++YM + L++ L + L Q +I
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 224 LAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARN 283
+A+ + YL Q +HRD+ T N ++ ++GDFG++R
Sbjct: 131 IASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSR----------------- 170
Query: 284 HQFHLAETTRIGGT----IGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS 330
+ + R+GG I ++PPES T +SDV+SFG+V+ E+ +
Sbjct: 171 -DVYTTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 67/277 (24%), Positives = 120/277 (43%), Gaps = 38/277 (13%)
Query: 526 FGTAYQGFLDN-----HQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCT 580
FG Y+G L V VK L F E + + +L H N+V+L G CT
Sbjct: 12 FGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLLGVCT 71
Query: 581 EQGEMLVIYDY-SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQ 639
E+ ++++ +Y +L +L + + S L + +A + YL +
Sbjct: 72 EEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDL-----LSFALQIARGMEYLES---KN 123
Query: 640 VIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIE 699
IHR++ + + ++ ++ F L+ L +D+ K G +R +M+PE ++
Sbjct: 124 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY--KVKGGKLPIR----WMAPESLK 177
Query: 700 SGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEF-EARKRPLAELVDLSL 757
G+ TS +DV+SFGV++ E+ T G+ G+ V E+ + R
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFTLGEE-----PYPGMSNAEVLEYLKKGYRLPKP------ 226
Query: 758 NGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSIL 794
EL +L+ C +PE RP+ +++ IL
Sbjct: 227 --PNCPPELYKLML---QCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 62/222 (27%), Positives = 105/222 (47%), Gaps = 37/222 (16%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVKCLAEKGER--FEKTFAAELVAVAHLRHRNLVRLRGW 176
+G G +G+VY+A G +VA+K + + E+ F T E+ + LRH N+VRL+
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66
Query: 177 CVHEDQ--LLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQ 234
+ + + +V++YM + L +L PE + Q K ++ L L YLH
Sbjct: 67 VTSKGKGSIYMVFEYMDH-DLTGLL-DSPEVKFTES-----QIKCYMKQLLEGLQYLHSN 119
Query: 235 LETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRI 294
I+HRD+K SN+++++ +L DFGLAR T R+
Sbjct: 120 ---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY--------------TNRV 162
Query: 295 GGTIGYLPPE----SFQKGSVATAKSDVFSFGIVVLEVVSGR 332
T+ Y PPE + + G + D++S G ++ E+ G+
Sbjct: 163 -ITLWYRPPELLLGATRYGP----EVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 64/220 (29%), Positives = 105/220 (47%), Gaps = 35/220 (15%)
Query: 118 VLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG-ERFEKTFAAELVAVAHLRHRNLVRLRGW 176
VLG G G VY+ G + A+K + G E F K EL + +V+ G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 177 CVHEDQLLLVYDYMPNRSLDRVLFRR---PEN-LEAAAPLNWEQRKKIIRGLAAALHYLH 232
E ++ +V +YM SL +L + PE L A ++I++GL YLH
Sbjct: 68 FYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIA-------RQILKGLD----YLH 116
Query: 233 EQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETT 292
+ IIHRD+K SN++++S+ ++ DFG+++ LE + + + F
Sbjct: 117 TKR--HIIHRDIKPSNLLINSKGEVKIADFGISKVLE--------NTLDQCNTFV----- 161
Query: 293 RIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
GT+ Y+ PE Q S + A +D++S G+ +LE G+
Sbjct: 162 ---GTVTYMSPERIQGESYSYA-ADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 102 bits (258), Expect = 2e-24
Identities = 67/276 (24%), Positives = 118/276 (42%), Gaps = 37/276 (13%)
Query: 526 FGTAYQGFL-----DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCT 580
FG Y+G L V VK L F E + + +L H N+V+L G CT
Sbjct: 12 FGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLLGVCT 71
Query: 581 EQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQV 640
E+ + ++ +Y L L N ++ S L + +A + YL +
Sbjct: 72 EEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDL-----LSFALQIARGMEYLES---KNF 123
Query: 641 IHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIES 700
IHR++ + + ++ ++ F L+ L +D+ + G +R +M+PE ++
Sbjct: 124 IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY--RKRGGKLPIR----WMAPESLKE 177
Query: 701 GEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEF-EARKRPLAELVDLSLN 758
G+ TS +DV+SFGV++ E+ T G+ G+ + V E+ + R
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQ-----PYPGMSNEEVLEYLKNGYRLPQP------- 225
Query: 759 GEYNHKELMRLIKLGIACTLSNPELRPSMRQILSIL 794
EL L+ C +PE RP+ +++ IL
Sbjct: 226 -PNCPPELYDLML---QCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 67/278 (24%), Positives = 117/278 (42%), Gaps = 40/278 (14%)
Query: 526 FGTAYQGFL-----DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCT 580
FG Y+G L V VK L R F E + +L H N+V+L G CT
Sbjct: 12 FGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLLGVCT 71
Query: 581 EQGEMLVIYDYSATR-ILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQ 639
+ + ++ +Y +L L H L + +A + YL +
Sbjct: 72 QGEPLYIVTEYMPGGDLLDFLRKHGEK------LTLKDLLQMALQIAKGMEYLES---KN 122
Query: 640 VIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIE 699
+HR++ + + ++ ++ F L+ + +D+ +RK G ++ +M+PE ++
Sbjct: 123 FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDY-YRKRGGGKLPIK----WMAPESLK 177
Query: 700 SGEATSMADVYSFGVVVLEVVT-GQMAVDFRLP-EGLLVKRVHEF-EARKRPLAELVDLS 756
G+ TS +DV+SFGV++ E+ T G+ P G+ + V E E R
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQ------PYPGMSNEEVLELLEDGYRLPRP----- 226
Query: 757 LNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSIL 794
E EL L+ C +PE RP+ +++ L
Sbjct: 227 ---ENCPDELYELMLQ---CWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 76/283 (26%), Positives = 120/283 (42%), Gaps = 39/283 (13%)
Query: 118 VLGSGGFGKVYRAVLPSDGTVVAVK-CLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGW 176
LG+G G V + + G ++AVK E E +K EL + +V G
Sbjct: 8 ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 177 CVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLE 236
+ + + +YM SLD++L E + KI + L YLHE+
Sbjct: 68 FYNNGDISICMEYMDGGSLDKIL------KEVQGRIPERILGKIAVAVLKGLTYLHEKH- 120
Query: 237 TQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGG 296
+IIHRDVK SN++++S+ +L DFG++ L +S LA+T G
Sbjct: 121 -KIIHRDVKPSNILVNSRGQIKLCDFGVSGQL---------VNS-------LAKT--FVG 161
Query: 297 TIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIRRLSDE 356
T Y+ PE Q G+ + KSD++S G+ ++E+ +GR YP +
Sbjct: 162 TSSYMAPERIQ-GNDYSVKSDIWSLGLSLIELATGR----FPYPPEND---PPDGIFELL 213
Query: 357 GKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMK 399
++ RL G + LC + +P RPS K
Sbjct: 214 QYIVNEPPPRLPSGKFS----PDFQDFVNLCLIKDPRERPSYK 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 99.2 bits (248), Expect = 4e-23
Identities = 61/273 (22%), Positives = 102/273 (37%), Gaps = 36/273 (13%)
Query: 526 FGTAYQGFL--DNHQY---VLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCT 580
FGT Y+ +L KR SK R E++ L RL H N+V+L
Sbjct: 12 FGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARR---EIRILRRLSHPNIVRLIDAFE 68
Query: 581 EQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQV 640
++ + ++ +Y L L L I + + YLH +
Sbjct: 69 DKDHLYLVMEYCEGGDLFDYLSRGG------PLSEDEAKKIALQILRGLEYLHSNG---I 119
Query: 641 IHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIES 700
IHR++ I LD + ++ F LA+ L ++ S + G YM+PE +
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSS-------SSLTTFVGTPWYMAPEVLLG 172
Query: 701 G-EATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNG 759
G DV+S GV++ E++TG+ ++ ++ P L +
Sbjct: 173 GNGYGPKVDVWSLGVILYELLTGK----PPFSGENILDQLQLIRRILGP-----PLEFDE 223
Query: 760 EYNHKELMRLIKLGIACTLS-NPELRPSMRQIL 791
L I L+ +P RP+ +IL
Sbjct: 224 PKWSSGSEEAKDL-IKKCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 6e-23
Identities = 67/238 (28%), Positives = 99/238 (41%), Gaps = 44/238 (18%)
Query: 108 IGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRH 167
I S +G G FG V G VAVKCL + + F AE + LRH
Sbjct: 3 INSKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQA-FLAEASVMTTLRH 59
Query: 168 RNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAA 227
NLV+L G + + L +V +YM SL L R A + Q+ +
Sbjct: 60 PNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSR-----GRAVITLAQQLGFALDVCEG 114
Query: 228 LHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFH 287
+ YL E+ +HRD+ NV++ A++ DFGLA+ +++
Sbjct: 115 MEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAK------------EASQGQ--- 156
Query: 288 LAETTRIGGTIGYLP-----PESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYP 340
G LP PE+ ++ + KSDV+SFGI++ E+ S R YP
Sbjct: 157 ---------DSGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRV---PYP 201
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 1e-22
Identities = 68/241 (28%), Positives = 115/241 (47%), Gaps = 38/241 (15%)
Query: 99 RIFSYAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDG----TVVAVKCLAEK-GERFEK 153
RI EL +VLGSG FG VY+ V +G VA+K L E+ + K
Sbjct: 2 RILKETELEKI-------KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANK 54
Query: 154 TFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLN 213
E +A + H ++VRL G C+ Q+ L+ MP L + +N+ + LN
Sbjct: 55 EILDEAYVMASVDHPHVVRLLGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLN 113
Query: 214 WEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQ 273
W +A + YL E+ +++HRD+ NV++ + + ++ DFGLA+ L+
Sbjct: 114 WC------VQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLD---- 160
Query: 274 YQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GR 332
+ + + AE ++ I ++ ES + T KSDV+S+G+ V E+++ G
Sbjct: 161 --------VDEKEYHAEGGKV--PIKWMALESILHR-IYTHKSDVWSYGVTVWELMTFGA 209
Query: 333 R 333
+
Sbjct: 210 K 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 3e-21
Identities = 77/295 (26%), Positives = 120/295 (40%), Gaps = 50/295 (16%)
Query: 119 LGSGGFGKVYRAVL--PSDGT--VVAVKCL-AEKGERFEKTFAAELVAVAHLRHRNLVRL 173
LG G FGKV D T VAVK L E+ F E+ + L H N+V+
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 174 RGWC--VHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYL 231
+G C L L+ +Y+P+ SL L R + + L + +I +G+ YL
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSS--QICKGMD----YL 125
Query: 232 HEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAET 291
Q + IHRD+ N++++S+ ++ DFGLA+ L + Y + F A
Sbjct: 126 GSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYA-- 180
Query: 292 TRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS---------GRRAVDLTYPDD 342
PE + S ++ SDV+SFG+ + E+ + +
Sbjct: 181 -----------PECL-RTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQG 228
Query: 343 QIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPS 397
Q+I+ + L EG+ L + C E + L LC P RPS
Sbjct: 229 QMIVTRLLELLK-EGERLPRPPS---------CPDE-VYDLMKLCWEAEPQDRPS 272
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 3e-21
Identities = 70/233 (30%), Positives = 116/233 (49%), Gaps = 32/233 (13%)
Query: 108 IGSNGFDEDEVLGSGGFGKVYRAVLPSDG---TVVAVKCL-AEKGERFEKTFAAELVAVA 163
I + + +V+G+G FG+V+R +L G VA+K L E+ + F +E +
Sbjct: 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMG 61
Query: 164 HLRHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRG 223
H N++RL G +++ +YM N +LD+ L R + E ++ Q ++RG
Sbjct: 62 QFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYL--RDHDGEFSS----YQLVGMLRG 115
Query: 224 LAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARN 283
+AA + YL + +HRD+ N++++S ++ DFGL+R LE + + TS
Sbjct: 116 IAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTS---- 168
Query: 284 HQFHLAETTRIGGTIG--YLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRR 333
GG I + PE+ +A SDV+SFGIV+ EV+S G R
Sbjct: 169 -----------GGKIPIRWTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSFGER 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (235), Expect = 4e-21
Identities = 63/223 (28%), Positives = 99/223 (44%), Gaps = 38/223 (17%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKC--LAEKGERFEKTFAAELVAVAHLRHRNLVRLR 174
E LG G +G VY+A G +VA+K L + E T E+ + L+H N+V+L
Sbjct: 5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLL 64
Query: 175 GWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQ 234
E +L LV++Y + L + L +RP L K I+ L L Y H
Sbjct: 65 DVIHTERKLYLVFEYC-DMDLKKYLDKRPGPLSPN------LIKSIMYQLLRGLAYCHSH 117
Query: 235 LETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRI 294
+I+HRD+K N++++ +L DFGLAR +RT T +
Sbjct: 118 ---RILHRDLKPQNILINRDGVLKLADFGLAR----AFGIPLRTY-----------THEV 159
Query: 295 GGTIGYLPPE-----SFQKGSVATAKSDVFSFGIVVLEVVSGR 332
T+ Y PE +V D++S G + E+++G+
Sbjct: 160 -VTLWYRAPEILLGSKHYSTAV-----DIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 6e-21
Identities = 59/267 (22%), Positives = 109/267 (40%), Gaps = 30/267 (11%)
Query: 526 FGTAYQG-FLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGE 584
FG Y + V +K + K R R E++ L +L+H N+V+L ++ +
Sbjct: 12 FGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDK 71
Query: 585 MLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRN 644
+ ++ +Y L LL R+ + ++ + SA+ YLH + ++HR+
Sbjct: 72 LYLVMEYCEGGDLFDLL-KKRGRLSEDEAR-----FYLRQILSALEYLHSKG---IVHRD 122
Query: 645 ITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEAT 704
+ I LD D + +L F LA L + + G YM+PE +
Sbjct: 123 LKPENILLDEDGHVKLADFGLARQLDPGEK--------LTTFVGTPEYMAPEVLLGKGYG 174
Query: 705 SMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHK 764
D++S GV++ E++TG+ L K++ + + D+S
Sbjct: 175 KAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIG--KPKPPFPPPEWDIS-------P 225
Query: 765 ELMRLIKLGIACTLSNPELRPSMRQIL 791
E LI+ + +PE R + + L
Sbjct: 226 EAKDLIR---KLLVKDPEKRLTAEEAL 249
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 6e-21
Identities = 67/221 (30%), Positives = 105/221 (47%), Gaps = 30/221 (13%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVKCLA-EKGER-FEKTFAAELVAVAHLRHRNLVRLRGW 176
+G G FGKVY AV G ++AVK + + + K A E+ + L+H NLV+ G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 177 CVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQR--KKIIRGLAAALHYLHEQ 234
VH +++ + +Y +L+ +L + + +++ GLA YLH
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELL-----EHGRILDEHVIRVYTLQLLEGLA----YLHSH 118
Query: 235 LETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRI 294
I+HRD+K +N+ LD +LGDFG A L + T++ LA
Sbjct: 119 ---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKL------KNNTTTMGEEVQSLA----- 164
Query: 295 GGTIGYLPPESF--QKGSVATAKSDVFSFGIVVLEVVSGRR 333
GT Y+ PE KG +D++S G VVLE+ +G+R
Sbjct: 165 -GTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 1e-20
Identities = 82/298 (27%), Positives = 137/298 (45%), Gaps = 53/298 (17%)
Query: 119 LGSGGFGKVYRA----VLP-SDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRL 173
LG G FGKV+ A + P D +VAVK L + + K F E + +L+H ++V+
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 174 RGWCVHEDQLLLVYDYMPNRSLDRVLFRR-PENL---EAAAP--LNWEQRKKIIRGLAAA 227
G CV D L++V++YM + L++ L P+ + E P L Q I + +AA
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 228 LHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFH 287
+ YL Q +HRD+ T N ++ ++GDFG++R +
Sbjct: 133 MVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSR------------------DVY 171
Query: 288 LAETTRIGG----TIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQ 343
+ R+GG I ++PPES T +SDV+S G+V+ E+ + + +++
Sbjct: 172 STDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSLGVVLWEIFTYGKQPWYQLSNNE 230
Query: 344 IILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWV 401
+I +G+VLQ + C E + L L C PH+R ++K +
Sbjct: 231 VI------ECITQGRVLQRP---------RTCPKE-VYDLMLGCWQREPHMRLNIKEI 272
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 2e-20
Identities = 68/227 (29%), Positives = 113/227 (49%), Gaps = 34/227 (14%)
Query: 116 DEVLGSGGFGKVYRAVLPSDG---TVVAVKCL-AEKGERFEKTFAAELVAVAHLRHRNLV 171
+EV+G+G FG+V R L G VA+K L + E+ + F +E + H N++
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 172 RLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYL 231
L G ++++ ++M N +LD L + Q ++RG+AA + YL
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVI------QLVGMLRGIAAGMKYL 122
Query: 232 HEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAET 291
E +HRD+ N++++S ++ DFGL+R+LE + TSS
Sbjct: 123 SEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSS----------- 168
Query: 292 TRIGGTIG--YLPPE--SFQKGSVATAKSDVFSFGIVVLEVVS-GRR 333
+GG I + PE +++K T+ SDV+S+GIV+ EV+S G R
Sbjct: 169 --LGGKIPIRWTAPEAIAYRK---FTSASDVWSYGIVMWEVMSYGER 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 57/227 (25%), Positives = 99/227 (43%), Gaps = 28/227 (12%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVK--CLAEKGERFEKTFAAELVAVAHLRHRNL 170
++ E +G G FG V + SDG ++ K E+ ++ +E+ + L+H N+
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI 61
Query: 171 VRLRGWCVHEDQ--LLLVYDYMPNRSLDRVLFR-RPENLEAAAPLNWEQRKKIIRGLAAA 227
VR + L +V +Y L +++ + + E W +I+ L A
Sbjct: 62 VRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIW----RILTQLLLA 117
Query: 228 LHYLH--EQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQ 285
L+ H ++HRD+K +N+ LD+ N +LGDFGLA+ L H+ +
Sbjct: 118 LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF----------- 166
Query: 286 FHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
GT Y+ PE S KSD++S G ++ E+ +
Sbjct: 167 -----AKTYVGTPYYMSPEQLNHMSY-DEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 4e-20
Identities = 68/229 (29%), Positives = 106/229 (46%), Gaps = 39/229 (17%)
Query: 119 LGSGGFGKVYRA----VLP-SDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRL 173
LG G FGKV+ A +LP D +VAVK L E E + F E + L+H+++VR
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 174 RGWCVHEDQLLLVYDYMPNRSLDRVLFRR-PE-------NLEAAAPLNWEQRKKIIRGLA 225
G C LL+V++YM + L+R L P+ A L Q I +A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 226 AALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQ 285
+ + YL +HRD+ T N ++ ++GDFG++R
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR------------------D 171
Query: 286 FHLAETTRIGG----TIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS 330
+ + R+GG I ++PPES T +SD++SFG+V+ E+ +
Sbjct: 172 IYSTDYYRVGGRTMLPIRWMPPESILYRKF-TTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 4e-20
Identities = 68/223 (30%), Positives = 107/223 (47%), Gaps = 36/223 (16%)
Query: 116 DEVLGSGGFGKVYRAVL--PSDGTV-VAVKCL---AEKGERFEKTFAAELVAVAHLRHRN 169
++V+G G FG+V R L P + VA+K L + +R + F E + H N
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD--FLTEASIMGQFDHPN 66
Query: 170 LVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALH 229
++RL G ++++ +YM N SLD+ L Q ++RG+A+ +
Sbjct: 67 IIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKF------TVGQLVGMLRGIASGMK 120
Query: 230 YLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLA 289
YL E +HRD+ N++++S ++ DFGL+R LE S A
Sbjct: 121 YLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLE--------DSEA-------T 162
Query: 290 ETTRIGGTIG--YLPPESFQKGSVATAKSDVFSFGIVVLEVVS 330
TT+ GG I + PE+ +A SDV+SFGIV+ EV+S
Sbjct: 163 YTTK-GGKIPIRWTAPEAIAYRKFTSA-SDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 5e-20
Identities = 61/238 (25%), Positives = 103/238 (43%), Gaps = 33/238 (13%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCL-AEKGERFEKTFAAELVAVAHLRHRNLVRLRG 175
EV+G G VY A+ + VA+K + EK + E+ A++ H N+V+
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 176 WCVHEDQLLLVYDYMPNRSLDRVLFRR------PENLEAAAPLNWEQRKKIIRGLAAALH 229
V D+L LV Y+ SL ++ E + A +++ + L
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIAT----------VLKEVLKGLE 116
Query: 230 YLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLA 289
YLH IHRD+K N++L + ++ DFG++ L RT R
Sbjct: 117 YLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLA---DGGDRTRKVRK------ 164
Query: 290 ETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILL 347
GT ++ PE ++ K+D++SFGI +E+ +G A YP ++++L
Sbjct: 165 ---TFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATG-AAPYSKYPPMKVLML 218
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 7e-20
Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 31/219 (14%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVK-CLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWC 177
LG G FGKVY+A G A K E E E F E+ ++ +H N+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELED-FMVEIDILSECKHPNIVGLYEAY 71
Query: 178 VHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLET 237
+E++L ++ ++ +LD ++ LE L Q + + R + AL++LH
Sbjct: 72 FYENKLWILIEFCDGGALDSIM------LELERGLTEPQIRYVCRQMLEALNFLHSHK-- 123
Query: 238 QIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGT 297
+IHRD+K N++L + +L DFG++ + LQ + F GT
Sbjct: 124 -VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ--------KRDTFI--------GT 166
Query: 298 IGYLPPESFQ----KGSVATAKSDVFSFGIVVLEVVSGR 332
++ PE K + K+D++S GI ++E+
Sbjct: 167 PYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 61/229 (26%), Positives = 105/229 (45%), Gaps = 33/229 (14%)
Query: 117 EVLGSGGFGKVYRA--VLPSDG---TVVAVKCLAEKGE-RFEKTFAAELVAVAHLRHRNL 170
E LG G FGKVY+ P++ T VA+K L E E + ++ F E ++ L+H N+
Sbjct: 11 EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNI 70
Query: 171 VRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRR---------PENLEAAAPLNWEQRKKII 221
V L G C E ++++Y+ + L L R + + L+ I
Sbjct: 71 VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 222 RGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSA 281
+AA + YL +HRD+ N ++ ++ DFGL+R + Y++++ S
Sbjct: 131 IQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSL 187
Query: 282 RNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS 330
+ ++PPE+ G T +SD++SFG+V+ E+ S
Sbjct: 188 L--------------PVRWMPPEAILYGKF-TTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 71/249 (28%), Positives = 99/249 (39%), Gaps = 41/249 (16%)
Query: 118 VLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAA----ELVAVAHLRHRNLVRL 173
V+G G FGKV + A+K + K + EK E + L H LV L
Sbjct: 7 VIGKGAFGKVCIVQKRDTKKMFAMKYM-NKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65
Query: 174 RGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHE 233
E+ + LV D + L R +L + EQ K I + AL YLH
Sbjct: 66 WYSFQDEENMYLVVDLLLGGDL-RY------HLSQKVKFSEEQVKFWICEIVLALEYLHS 118
Query: 234 QLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTR 293
+ IIHRD+K N++LD Q + + DF +A + + TT
Sbjct: 119 KG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL-----------------TTS 158
Query: 294 IGGTIGYLPPESF--QKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIR 351
GT GY+ PE Q SVA D +S G+ E + G+R Y + D IR
Sbjct: 159 TSGTPGYMAPEVLCRQGYSVA---VDWWSLGVTAYECLRGKRP----YRGHSRTIRDQIR 211
Query: 352 RLSDEGKVL 360
+ VL
Sbjct: 212 AKQETADVL 220
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 2e-19
Identities = 65/226 (28%), Positives = 96/226 (42%), Gaps = 35/226 (15%)
Query: 118 VLGSGGFGKVYRAV---LPSDGT--VVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNLV 171
LG G FG+VY + D VAVK L E E+ E F E + ++ H+N+V
Sbjct: 13 ALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIV 72
Query: 172 RLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYL 231
RL G ++ + M L L E + L + R +A YL
Sbjct: 73 RLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYL 132
Query: 232 HEQLETQIIHRDVKTSNVMLDS---QYNARLGDFGLARWLEHELQYQMRTSSARNHQFHL 288
E IHRD+ N +L A++ DFG+AR +
Sbjct: 133 EEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR------------------DIYR 171
Query: 289 AETTRIGGT----IGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS 330
A R GG I ++PPE+F G + T+K+DV+SFG+++ E+ S
Sbjct: 172 ASYYRKGGRAMLPIKWMPPEAFLDG-IFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 3e-19
Identities = 64/230 (27%), Positives = 108/230 (46%), Gaps = 40/230 (17%)
Query: 119 LGSGGFGKVYRA----VLPS-DGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRL 173
LG G FGKV+ A + P+ D +VAVK L + K F E + +L+H ++V+
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 174 RGWCVHEDQLLLVYDYMPNRSL---------DRVLFRRPENLEAAAPLNWEQRKKIIRGL 224
G C D L++V++YM + L D ++ + +A L Q I +
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 225 AAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNH 284
A+ + YL Q +HRD+ T N ++ + ++GDFG++R
Sbjct: 133 ASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSR------------------ 171
Query: 285 QFHLAETTRIGG----TIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS 330
+ + R+GG I ++PPES T +SDV+SFG+++ E+ +
Sbjct: 172 DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTT-ESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 3e-19
Identities = 58/228 (25%), Positives = 111/228 (48%), Gaps = 35/228 (15%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCL----------AEKGERFEKTFAAELVAVAHLR 166
E++G G +G+VY A+ + G ++AVK + + + K +E+ + L
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 167 HRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAA 226
H N+V+ G+ E+ L + +Y+P S+ L R E L ++++ GLA
Sbjct: 67 HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL-RTYGRFEE--QLVRFFTEQVLEGLA- 122
Query: 227 ALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQF 286
YLH + I+HRD+K N+++D+ ++ DFG+++ ++ ++
Sbjct: 123 ---YLHSK---GILHRDLKADNLLVDADGICKISDFGISK----------KSDDIYDN-- 164
Query: 287 HLAETTRIGGTIGYLPPESFQ-KGSVATAKSDVFSFGIVVLEVVSGRR 333
+ + G++ ++ PE +AK D++S G VVLE+ +GRR
Sbjct: 165 --DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 66/233 (28%), Positives = 103/233 (44%), Gaps = 40/233 (17%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHL-RHRNLV 171
F+ EV+G G +GKVY+A G +VA+K + + E+ E + H N+
Sbjct: 8 FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSNHPNIA 66
Query: 172 R------LRGWCVHEDQLLLVYDYMPNRS---LDRVLFRRPENLEAAAPLNWEQRKKIIR 222
+ ++DQL LV + S L + L ++ + L+ E I+R
Sbjct: 67 TFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKE------EWIAYILR 120
Query: 223 GLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSAR 282
L YLHE ++IHRD+K N++L +L DFG++ L+ T R
Sbjct: 121 ETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLD-------STLGRR 170
Query: 283 NHQFHLAETTRIGGTIGYLPPE----SFQKGSVATAKSDVFSFGIVVLEVVSG 331
N T I GT ++ PE Q + A+SDV+S GI +E+ G
Sbjct: 171 N--------TFI-GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 5e-19
Identities = 62/220 (28%), Positives = 106/220 (48%), Gaps = 30/220 (13%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVR 172
F + LGSG FG+V+ L + VA+K L ++ F E+ A+ LRH++L+
Sbjct: 8 FTLERKLGSGYFGEVWEG-LWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLIS 66
Query: 173 LRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPE--NLEAAAPLNWEQRKKIIRGLAAALHY 230
L C + + ++ + M SL L R PE L A+ ++ + +A + Y
Sbjct: 67 LFAVCSVGEPVYIITELMEKGSLLAFL-RSPEGQVLPVASLID------MACQVAEGMAY 119
Query: 231 LHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAE 290
L EQ IHRD+ N+++ ++ DFGLAR ++ + +L+
Sbjct: 120 LEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKED--------------VYLSS 162
Query: 291 TTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS 330
+I + PE+ G+ +T KSDV+SFGI++ E+ +
Sbjct: 163 DKKI--PYKWTAPEAASHGTFST-KSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 6e-19
Identities = 67/222 (30%), Positives = 101/222 (45%), Gaps = 35/222 (15%)
Query: 117 EVLGSGGFGKVYRAV-LPSDGTV--VAVKCLAEKGERFEKT---FAAELVAVAHLRHRNL 170
+ LG G FG V R S G V VAVKCL K ++ F E + L H NL
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCL--KSDKLSDIMDDFLKEAAIMHSLDHENL 58
Query: 171 VRLRGWCVHEDQLLLVYDYMPNRSL-DRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALH 229
+RL G V L++V + P SL DR+ R+ + +I A +
Sbjct: 59 IRLYG-VVLTHPLMMVTELAPLGSLLDRL--RKDALGHFLISTLCDYAVQI----ANGMR 111
Query: 230 YLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWL-EHELQYQMRTSSARNHQFHL 288
YL + + IHRD+ N++L S ++GDFGL R L ++E Y M + HL
Sbjct: 112 YLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM--------EEHL 160
Query: 289 AETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS 330
++ + PES + + + SDV+ FG+ + E+ +
Sbjct: 161 ----KV--PFAWCAPESLRTRTF-SHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 7e-19
Identities = 67/242 (27%), Positives = 114/242 (47%), Gaps = 30/242 (12%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCL-AEKGERFEKTFAA-ELVAVAHLRHRNL 170
F+ +G G FG V++ V +D V A+K + K R E+ A E +A L +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 171 VRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHY 230
+R + + +L +V +Y N L ++L ++ PL +Q + + L +
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLL-----KMQRGRPLPEDQVWRFFIQILLGLAH 116
Query: 231 LHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAE 290
LH + +I+HRD+K+ N+ LD+ N ++GD G+A+ L + + A
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLL--------------SDNTNFAN 159
Query: 291 TTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWI 350
T I GT YL PE + KSDV++ G+V+ E +G+ D ++Q L+ I
Sbjct: 160 T--IVGTPYYLSPELCEDKPY-NEKSDVWALGVVLYECCTGKHPFDA---NNQGALILKI 213
Query: 351 RR 352
R
Sbjct: 214 IR 215
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 7e-19
Identities = 57/221 (25%), Positives = 94/221 (42%), Gaps = 30/221 (13%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVR 172
FD E LG G +G VY+A+ G VVA+K + + + E E+ + +V+
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQE--IIKEISILKQCDSPYIVK 62
Query: 173 LRGWCVHEDQLLLVYDYMPNRS-LDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYL 231
G L +V +Y S D + L E+ I+ L YL
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIMKITN-------KTLTEEEIAAILYQTLKGLEYL 115
Query: 232 HEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAET 291
H + IHRD+K N++L+ + A+L DFG++ L +A+
Sbjct: 116 HSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT----------------MAKR 156
Query: 292 TRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
+ GT ++ PE Q+ K+D++S GI +E+ G+
Sbjct: 157 NTVIGTPFWMAPEVIQE-IGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 8e-19
Identities = 60/218 (27%), Positives = 96/218 (44%), Gaps = 27/218 (12%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCL--AEKGERFEKTFAAELVAVAHLRHRNLVRLR 174
V+G G +G V + + G +VA+K +E E +KT E+ + LRH N+V L+
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 175 GWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQ 234
+ +L LV++Y+ L+ +L P L A + I L A+ Y H
Sbjct: 67 EAFRRKGRLYLVFEYVERTLLE-LLEASPGGLPPDAV------RSYIWQLLQAIAYCHSH 119
Query: 235 LETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRI 294
IIHRD+K N+++ +L DFG AR +R A ++A TR
Sbjct: 120 ---NIIHRDIKPENILVSESGVLKLCDFGFAR--------ALRARPASPLTDYVA--TR- 165
Query: 295 GGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
Y PE + DV++ G ++ E++ G
Sbjct: 166 ----WYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-18
Identities = 72/233 (30%), Positives = 109/233 (46%), Gaps = 44/233 (18%)
Query: 116 DEVLGSGGFGKVYRAVLPSDGTVV--AVKCLAE-KGERFEKTFAAELVAVAHL-RHRNLV 171
++V+G G FG+V RA++ DG + A+K L E E + FA EL + L H N++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 172 RLRGWCVHEDQLLLVYDYMPNRSL------DRVLFRRP---ENLEAAAPLNWEQRKKIIR 222
L G C + L + +Y P +L RVL P + A+ L +Q +
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 223 GLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSAR 282
+A + YL E+ Q IHRD+ NV++ +++ DFGL+R
Sbjct: 127 DVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR---------------- 167
Query: 283 NHQFHLAETTRIGGTIGYLPP-----ESFQKGSVATAKSDVFSFGIVVLEVVS 330
E + T+G LP ES SV T KSDV+SFG+++ E+VS
Sbjct: 168 ------GEEVYVKKTMGRLPVRWMAIESLNY-SVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 3e-18
Identities = 67/221 (30%), Positives = 109/221 (49%), Gaps = 31/221 (14%)
Query: 116 DEVLGSGGFGKVY--RAVLPSDGTV-VAVKCL-AEKGERFEKTFAAELVAVAHLRHRNLV 171
++V+G+G FG+V R LP + VA+K L A E+ + F +E + H N++
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 172 RLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYL 231
L G +++V +YM N SLD L + Q ++RG+A+ + YL
Sbjct: 69 HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVI------QLVGMLRGIASGMKYL 122
Query: 232 HEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAET 291
+ +HRD+ N++++S ++ DFGL+R LE + + A T
Sbjct: 123 SDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE--------------AAYT 165
Query: 292 TRIGGTIG--YLPPESFQKGSVATAKSDVFSFGIVVLEVVS 330
TR GG I + PE+ +A SDV+S+GIV+ EV+S
Sbjct: 166 TR-GGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 3e-18
Identities = 62/214 (28%), Positives = 100/214 (46%), Gaps = 29/214 (13%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCV 178
LG G FGKVY+A G + A K + K E + + E+ +A H +V+L G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 179 HEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQ 238
+ +L ++ ++ P ++D ++ LE L Q + I R + AL YLH +
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIM------LELDRGLTEPQIQVICRQMLEALQYLHSM---K 130
Query: 239 IIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTI 298
IIHRD+K NV+L + +L DFG+ SA+N + L GT
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGV---------------SAKNVK-TLQRRDSFIGTP 174
Query: 299 GYLPPE----SFQKGSVATAKSDVFSFGIVVLEV 328
++ PE K + K+D++S GI ++E+
Sbjct: 175 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 3e-18
Identities = 81/302 (26%), Positives = 136/302 (45%), Gaps = 59/302 (19%)
Query: 119 LGSGGFGKVYRA----VLP-SDGTVVAVKCLAEKGE-RFEKTFAAELVAVAHLRHRNLVR 172
+G G FG+V++A +LP T+VAVK L E+ + F E +A H N+V+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 173 LRGWCVHEDQLLLVYDYMPNRSLDRVLFRR-PENLEAAA--------------PLNWEQR 217
L G C + L+++YM L+ L R P + + PL+ ++
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 218 KKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMR 277
I + +AA + YL E+ + +HRD+ T N ++ ++ DFGL+R + Y+
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 278 TSSARNHQFHLAETTRIGGTIGYLPPES--FQKGSVATAKSDVFSFGIVVLEVVSGRRAV 335
+ A I ++PPES + + T +SDV+++G+V+ E+ S
Sbjct: 190 ENDAI--------------PIRWMPPESIFYNR---YTTESDVWAYGVVLWEIFSYGMQP 232
Query: 336 DLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLR 395
+++I ++R +G VL DN C +E L +L LC P R
Sbjct: 233 YYGMAHEEVIY--YVR----DGNVLSCPDN---------CPLE-LYNLMRLCWSKLPSDR 276
Query: 396 PS 397
PS
Sbjct: 277 PS 278
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 3e-18
Identities = 57/221 (25%), Positives = 99/221 (44%), Gaps = 32/221 (14%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVK--CLAEKGERFE---KTFAAELVAVAHLRHRNLV 171
E+LGSG FG VY + DG AVK LA+ G+ + K E+ ++ L+H N+V
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 172 RLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYL 231
+ G ED L + + +P SL ++L + + R + L YL
Sbjct: 66 QYLGTEREEDNLYIFLELVPGGSLAKLLKK-------YGSFPEPVIRLYTRQILLGLEYL 118
Query: 232 HEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAET 291
H++ +HRD+K +N+++D+ +L DFG+A+ +
Sbjct: 119 HDR---NTVHRDIKGANILVDTNGVVKLADFGMAK-----------------QVVEFSFA 158
Query: 292 TRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
G+ ++ PE + +D++S G VLE+ +G+
Sbjct: 159 KSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 4e-18
Identities = 71/223 (31%), Positives = 106/223 (47%), Gaps = 43/223 (19%)
Query: 119 LGSGGFGKVYRAVLPSDGTV-VAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWC 177
LG+G FG+V+ +GT VAVK L G + F E + LRH LV+L C
Sbjct: 14 LGAGQFGEVWMGTW--NGTTKVAVKTLKP-GTMSPEAFLQEAQIMKKLRHDKLVQLYAVC 70
Query: 178 VHEDQLLLVYDYMPNRSLDRVL-------FRRPENLEAAAPLNWEQRKKIIRGLAAALHY 230
E+ + +V +YM SL L R P+ ++ AA +I G+A Y
Sbjct: 71 SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAA--------QIAEGMA----Y 118
Query: 231 LHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAE 290
L + IHRD+ N+++ ++ DFGLAR +E + +Y R + +F
Sbjct: 119 LESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDD-EYTAREGA----KF---- 166
Query: 291 TTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GR 332
I + PE+ G T KSDV+SFGI++ E+V+ GR
Sbjct: 167 ------PIKWTAPEAANYGRF-TIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 4e-18
Identities = 74/224 (33%), Positives = 111/224 (49%), Gaps = 38/224 (16%)
Query: 117 EVLGSGGFGKV--YRAVLPSDGT--VVAVKCL-AEKGERFEKTFAAELVAVAHLRHRNLV 171
VLG G FGKV Y +DGT +VAVK L E G++ + E+ + L H N+V
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 172 RLRGWCVHEDQ----LLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAA 227
+ +G C +Q L L+ +Y+P SL L + NL A L + Q +I G+A
Sbjct: 70 KYKGCC--SEQGGKGLQLIMEYVPLGSLRDYLPKHKLNL--AQLLLFAQ--QICEGMA-- 121
Query: 228 LHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWL-EHELQYQMRTSSARNHQF 286
YLH Q IHRD+ NV+LD+ ++GDFGLA+ + E Y++R + F
Sbjct: 122 --YLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVR-EDGDSPVF 175
Query: 287 HLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS 330
A E ++ + A SDV+SFG+ + E+++
Sbjct: 176 WYA-------------VECLKENKFSYA-SDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 5e-18
Identities = 59/219 (26%), Positives = 98/219 (44%), Gaps = 27/219 (12%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVR 172
+ E +G G G+VY+A + G VA+K + + + E E++ + +H N+V
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN-EILIMKDCKHPNIVD 79
Query: 173 LRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLH 232
+ D+L +V +YM SL ++ + +N Q + R + L YLH
Sbjct: 80 YYDSYLVGDELWVVMEYMDGGSLTDIITQNF------VRMNEPQIAYVCREVLQGLEYLH 133
Query: 233 EQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETT 292
Q +IHRD+K+ N++L + +L DFG A L E R S
Sbjct: 134 SQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE--KSKRNS------------- 175
Query: 293 RIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSG 331
+ GT ++ PE K K D++S GI+ +E+ G
Sbjct: 176 -VVGTPYWMAPEVI-KRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 5e-18
Identities = 44/150 (29%), Positives = 67/150 (44%), Gaps = 12/150 (8%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVK--CLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGW 176
+G G G V++A G VA+K L E+ A+ +H +V+L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 177 CVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLE 236
H +LV +YMP L VL PL Q K +R L + Y+H
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLRDEE------RPLPEAQVKSYMRMLLKGVAYMHAN-- 118
Query: 237 TQIIHRDVKTSNVMLDSQYNARLGDFGLAR 266
I+HRD+K +N+++ + ++ DFGLAR
Sbjct: 119 -GIMHRDLKPANLLISADGVLKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 7e-18
Identities = 60/221 (27%), Positives = 99/221 (44%), Gaps = 34/221 (15%)
Query: 116 DEVLGSGGFGKVYRAV---LPSDGTVVAVK-CLAEKGERFEKTFAAELVAVAHLRHRNLV 171
+G G FG VY+ V ++ VAVK C + F E + H ++V
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 172 RLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYL 231
+L G E+ + +V + P L L +L+ A+ + L+ AL YL
Sbjct: 71 KLIGVIT-ENPVWIVMELAPLGELRSYLQVNKYSLDLASLI------LYSYQLSTALAYL 123
Query: 232 HEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAET 291
+ +HRD+ NV++ S +LGDFGL+R+LE E Y+ A
Sbjct: 124 ES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYK-------------ASK 167
Query: 292 TRIGGTIGYLPPES--FQKGSVATAKSDVFSFGIVVLEVVS 330
++ I ++ PES F++ + A SDV+ FG+ + E++
Sbjct: 168 GKL--PIKWMAPESINFRRFTSA---SDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 8e-18
Identities = 70/225 (31%), Positives = 109/225 (48%), Gaps = 35/225 (15%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCV 178
LG+G FG+V+ + ++ T VAVK L + G K F AE + LRH L++L C
Sbjct: 14 LGAGQFGEVWEGLW-NNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 179 HEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQ 238
E+ + +V + M SL L A L Q + +A+ + YL Q
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQG-----GAGRALKLPQLIDMAAQVASGMAYLEAQ---N 123
Query: 239 IIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTI 298
IHRD+ NV++ ++ DFGLAR ++ E Y+ R + +F I
Sbjct: 124 YIHRDLAARNVLVGENNICKVADFGLARVIK-EDIYEAREGA----KF----------PI 168
Query: 299 GYLPPES--FQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYP 340
+ PE+ + + S+ KSDV+SFGI++ E+V+ GR + YP
Sbjct: 169 KWTAPEAALYNRFSI---KSDVWSFGILLTEIVTYGR----MPYP 206
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (207), Expect = 9e-18
Identities = 61/226 (26%), Positives = 92/226 (40%), Gaps = 48/226 (21%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAH----------LRHR 168
LG G FGKV G + A+K L +K + V H + H
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVL-------KKKKIIKRKEVEHTLTERNILSRINHP 53
Query: 169 NLVRLRGWCVHEDQ--LLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAA 226
+V+L + + L LV +Y P L L + E A + +
Sbjct: 54 FIVKL--HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERA-------RFYAAEIVL 104
Query: 227 ALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQF 286
AL YLH II+RD+K N++LD+ + +L DFGLA+ L E +R + F
Sbjct: 105 ALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSE--------GSRTNTF 153
Query: 287 HLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
GT YL PE A D +S G+++ E+++G+
Sbjct: 154 --------CGTPEYLAPEVLLGKGYGKA-VDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 33/218 (15%)
Query: 119 LGSGGFGKVYRAV-LPSDGTV--VAVKCL-AEKGERFEKTFAAELVAVAHLRHRNLVRLR 174
LG G FG V + V L G VAVK L E +K F E +A L H +VRL
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 175 GWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQ 234
G C + L+LV + P L + L +R E + + + +A + YL +
Sbjct: 63 GVCK-GEPLMLVMELAPLGPLLKYLKKRRE-IPVSDLKELAHQ------VAMGMAYLESK 114
Query: 235 LETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRI 294
+HRD+ NV+L +++ A++ DFG++R + S ++ A T
Sbjct: 115 ---HFVHRDLAARNVLLVNRHQAKISDFGMSR--------ALGAGS----DYYRATT--- 156
Query: 295 GGT--IGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS 330
G + + PE G ++ KSDV+S+G+ + E S
Sbjct: 157 AGRWPLKWYAPECINYGKFSS-KSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 61/234 (26%), Positives = 107/234 (45%), Gaps = 40/234 (17%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAV-AHLRH---RNLVR 172
E++G G +G VYR G VVA+K + + + VA+ + LR N+ +
Sbjct: 7 ELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITK 66
Query: 173 LRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLH 232
G + +L ++ +Y S+ R L + A P+ + IIR + AL Y+H
Sbjct: 67 YYGSYLKGPRLWIIMEYAEGGSV-RTLMK-------AGPIAEKYISVIIREVLVALKYIH 118
Query: 233 EQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETT 292
+ +IHRD+K +N+++ + N +L DFG+A + +S++ F
Sbjct: 119 K---VGVIHRDIKAANILVTNTGNVKLCDFGVAA--------LLNQNSSKRSTF------ 161
Query: 293 RIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR---------RAVDL 337
GT ++ PE +G K+D++S GI + E+ +G RA+ L
Sbjct: 162 --VGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML 213
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 79/305 (25%), Positives = 126/305 (41%), Gaps = 66/305 (21%)
Query: 119 LGSGGFGKV----YRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLR 174
LG G FG V Y + + G VVAVK L + F E+ + L+H N+V+ +
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 175 GWCVH--EDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLH 232
G C L LV +Y+P SL L + E L+ L + +I +G+ YL
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYAS--QICKGM----EYLG 125
Query: 233 EQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETT 292
+ + +HRD+ T N++++S+ ++GDFGL + L + +Y + F A
Sbjct: 126 SK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYA--- 179
Query: 293 RIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPD----------- 341
PES + S + SDV+SFG+V+ E+ TY D
Sbjct: 180 ----------PESLTE-SKFSVASDVWSFGVVLYEL--------FTYSDKSCSPPAEFMR 220
Query: 342 -------DQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHL 394
Q+I+ I L + G++ C E + + C ++P
Sbjct: 221 MMGNDKQGQMIVYHLIELLKNNGRLPAPPG----------CPAE-IYAIMKECWNNDPSQ 269
Query: 395 RPSMK 399
RPS
Sbjct: 270 RPSFS 274
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 58/226 (25%), Positives = 98/226 (43%), Gaps = 33/226 (14%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCV 178
LG G +G+VY V VAVK L E E+ F E + ++H NLV+L G C
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 179 HEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQ 238
E ++ ++M +L L A L + + +++A+ YL ++
Sbjct: 73 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQ-----ISSAMEYLEKK---N 124
Query: 239 IIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGT- 297
IHRD+ N ++ + ++ DFGL+R + + T G
Sbjct: 125 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-----------------TAHAGAKF 167
Query: 298 -IGYLPPESFQKGSVATAKSDVFSFGIVVLEV----VSGRRAVDLT 338
I + PES + KSDV++FG+++ E+ +S +DL+
Sbjct: 168 PIKWTAPESLAYNKFSI-KSDVWAFGVLLWEIATYGMSPYPGIDLS 212
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 3e-17
Identities = 76/285 (26%), Positives = 124/285 (43%), Gaps = 44/285 (15%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVKC-LAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWC 177
LG+G G V + GTV+A K K EL + R +V G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 178 VHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLET 237
++E+ + + ++M SLDR+ + P+ E KI + L YL+
Sbjct: 73 LNENNICMCMEFMDCGSLDRIY-------KKGGPIPVEILGKIAVAVVEGLTYLYNVH-- 123
Query: 238 QIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGT 297
+I+HRD+K SN++++S+ +L DFG++ L + +A+T GT
Sbjct: 124 RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS----------------IADT--FVGT 165
Query: 298 IGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR-----RAVDLTYPDDQIILLDWIRR 352
Y+ PE Q G T KSDV+S GI ++E+ G+ +D DD + +LD +++
Sbjct: 166 STYMSPERIQGGKY-TVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQ 224
Query: 353 LSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPS 397
++Q RL + E L C L +P RP+
Sbjct: 225 ------IVQEPPPRLPSSDFP----EDLRDFVDACLLKDPTERPT 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 4e-17
Identities = 59/245 (24%), Positives = 96/245 (39%), Gaps = 53/245 (21%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCL------AEKGERF---EKTFAAELVAVA 163
F +++G G F V A A+K L EK ++ EK +
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKE------VLT 56
Query: 164 HL-RHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKI-- 220
L H +++L E+ L V +Y PN L + +K
Sbjct: 57 RLNGHPGIIKLYYTFQDEENLYFVLEYAPNGEL------------------LQYIRKYGS 98
Query: 221 -----IRGLAA----ALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHE 271
R AA AL YLH + IIHRD+K N++LD + ++ DFG A+ L+
Sbjct: 99 LDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155
Query: 272 LQYQMRTSSARNHQFHLAETTR----IGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLE 327
+ A N + + R GT Y+ PE A SD+++ G ++ +
Sbjct: 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELL-NEKPAGKSSDLWALGCIIYQ 214
Query: 328 VVSGR 332
+++G+
Sbjct: 215 MLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 5e-17
Identities = 66/216 (30%), Positives = 94/216 (43%), Gaps = 33/216 (15%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCV 178
LGSG FG V+ VA+K + E G E F E + L H NLV+L G C
Sbjct: 12 LGSGQFGVVHLGKWRGK-IDVAIKMIRE-GAMSEDDFIEEAKVMMKLSHPNLVQLYGVCT 69
Query: 179 HEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQ 238
+ + +V +YM N L L R L L + + + YL
Sbjct: 70 KQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLL--DMCSDVCEAME----YLESN---G 120
Query: 239 IIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGT- 297
IHRD+ N ++ ++ DFGLAR++ + QY TSS GT
Sbjct: 121 FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD-QY---TSS--------------QGTK 162
Query: 298 --IGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSG 331
+ + PPE F ++KSDV+SFG+++ EV S
Sbjct: 163 FPVKWAPPEVFDYSRF-SSKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 5e-17
Identities = 53/216 (24%), Positives = 100/216 (46%), Gaps = 29/216 (13%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCL-AEKGERFEKTFAAELVAVAHLRHRNLVRLRG 175
E +G G FG+VY+A+ VVA+K + E+ E + E+ ++ R + + G
Sbjct: 7 ECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYG 66
Query: 176 WCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQL 235
+ +L ++ +Y S +L + A I+R + L YLHE+
Sbjct: 67 SFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIA--------FILREVLLGLEYLHEE- 117
Query: 236 ETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIG 295
IHRD+K +N++L + + +L DFG++ Q+ ++ ++ + F
Sbjct: 118 --GKIHRDIKAANILLSEEGDVKLADFGVSG--------QLTSTMSKRNTF--------V 159
Query: 296 GTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSG 331
GT ++ PE ++ K+D++S GI +E+ G
Sbjct: 160 GTPFWMAPEVIKQSGYDE-KADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 83.6 bits (205), Expect = 6e-17
Identities = 67/274 (24%), Positives = 107/274 (39%), Gaps = 19/274 (6%)
Query: 526 FGTAYQGFLDNHQYVLVKRL--GMSKCPALRTRFSNELQNLARLRH-RNLVQLCGWCTEQ 582
FG Y + + V +K L + RF E+Q LA L H N+V+L + ++
Sbjct: 13 FGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDE 70
Query: 583 GEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIH 642
G + ++ +Y L LL L I+ + SA+ YLH + +IH
Sbjct: 71 GSLYLVMEYVDGGSLEDLL---KKIGRKGPLSESEALFILAQILSALEYLHSK---GIIH 124
Query: 643 RNITSSAITLDPDMN-PRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIES- 700
R+I I LD D +L F LA+ L + + G GYM+PE +
Sbjct: 125 RDIKPENILLDRDGRVVKLIDFGLAKLLPDPG-STSSIPALPSTSVGTPGYMAPEVLLGL 183
Query: 701 --GEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLN 758
A+S +D++S G+ + E++TG + + + P N
Sbjct: 184 SLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSN 243
Query: 759 GEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792
E K L+K +P+ R S LS
Sbjct: 244 PELISKAASDLLK---KLLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 6e-17
Identities = 63/223 (28%), Positives = 104/223 (46%), Gaps = 30/223 (13%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVK----CLAEKGERFE--KTFAAELVAVAHLRHRNL 170
+ LG+G F Y+A GT++AVK E+ E + E+ +A L H ++
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 171 VRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHY 230
+R+ G + L ++M S+ +L + EA EQ ++RGL+ Y
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQ---LLRGLS----Y 118
Query: 231 LHEQLETQIIHRDVKTSNVMLDSQ-YNARLGDFGLARWLEHELQYQMRTSSARNHQFHLA 289
LHE QIIHRDVK +N+++DS R+ DFG A ++ +F
Sbjct: 119 LHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAA--------ARLAAKGTGAGEFQ-- 165
Query: 290 ETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
++ GTI ++ PE +G DV+S G V++E+ + +
Sbjct: 166 --GQLLGTIAFMAPEVL-RGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 9e-17
Identities = 64/220 (29%), Positives = 100/220 (45%), Gaps = 30/220 (13%)
Query: 118 VLGSGGFGKVYRAV---LPSDGTV--VAVKCLAEKGERFEK-TFAAELVAVAHL-RHRNL 170
LG+G FGKV A L V VAVK L E+ +EL ++HL H N+
Sbjct: 42 TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENI 101
Query: 171 VRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHY 230
V L G C +L++ +Y L L R+ E+ L E +A + +
Sbjct: 102 VNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESF-----LTLEDLLSFSYQVAKGMAF 156
Query: 231 LHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAE 290
L + IHRD+ NV+L ++ DFGLAR + ++ Y ++ +
Sbjct: 157 LASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGN----------- 202
Query: 291 TTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS 330
R+ + ++ PES V T +SDV+S+GI++ E+ S
Sbjct: 203 -ARL--PVKWMAPESIFNC-VYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 9e-17
Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 26/216 (12%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVK-CLAEKGERFEKTFAAELVAVAHLRHRNLVRLRG 175
E +G G FG VY+ VL T VAVK C + ++ F E + H N+V+L G
Sbjct: 1 EKIGKGNFGDVYKGVL-KGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIG 59
Query: 176 WCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQL 235
CV + + +V + +P SL L R+ +N L ++ ++ AA + YL +
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFL-RKKKN-----RLTVKKLLQMSLDAAAGMEYLESK- 112
Query: 236 ETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIG 295
IHRD+ N ++ ++ DFG++R E Y T S Q
Sbjct: 113 --NCIHRDLAARNCLVGENNVLKISDFGMSRE-EEGGIY---TVSDGLKQI--------- 157
Query: 296 GTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSG 331
I + PE+ G T++SDV+S+GI++ E S
Sbjct: 158 -PIKWTAPEALNYGRY-TSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 81/306 (26%), Positives = 125/306 (40%), Gaps = 67/306 (21%)
Query: 119 LGSGGFGKVYRAVL-----PSDGTVVAVKCLAEK---GERFEKTFAAELVAVAHLRHRNL 170
LG G FG VY + T VA+K + E ER E F E + ++
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIE--FLNEASVMKEFNCHHV 71
Query: 171 VRLRGWCVHEDQLLLVYDYMPNRSL-DRVLFRRPENLEAAAPLNWEQRKKIIR---GLAA 226
VRL G L+V + M L + RRPE E L +K I+ +A
Sbjct: 72 VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEA-ENNPGLGPPTLQKFIQMAAEIAD 130
Query: 227 ALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWL-EHELQYQMRTSSARNHQ 285
+ YL + +HRD+ N M+ ++GDFG+ R + E + Y
Sbjct: 131 GMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDY-Y----------- 175
Query: 286 FHLAETTRIGGTIGYLP-----PESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYP 340
R GG G LP PES + G V T KSDV+SFG+V+ E+ + + Y
Sbjct: 176 -------RKGGK-GLLPVRWMAPESLKDG-VFTTKSDVWSFGVVLWEMAT---LAEQPYQ 223
Query: 341 ---DDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPS 397
+++++ + +G L +N C + L L +C +NP +RP+
Sbjct: 224 GLSNEEVL------KFVIDGGHLDLPEN---------CP-DKLLELMRMCWQYNPKMRPT 267
Query: 398 MKWVIE 403
++
Sbjct: 268 FLEIVS 273
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-16
Identities = 68/227 (29%), Positives = 109/227 (48%), Gaps = 34/227 (14%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVV--AVKCLAEKGERFE-KTFAAELVAVAHL-RHRNLVR 172
+V+G G FG+V +A + DG + A+K + E + + + FA EL + L H N++
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 173 LRGWCVHEDQLLLVYDYMPNRSL------DRVLFRRPENLEA---AAPLNWEQRKKIIRG 223
L G C H L L +Y P+ +L RVL P A A+ L+ +Q
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 224 LAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARN 283
+A + YL ++ Q IHRD+ N+++ Y A++ DFGL+R E ++ M R
Sbjct: 133 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR- 188
Query: 284 HQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS 330
++ ES SV T SDV+S+G+++ E+VS
Sbjct: 189 ----------------WMAIESLNY-SVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 68/232 (29%), Positives = 107/232 (46%), Gaps = 44/232 (18%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVV--AVKCLAE-KGERFEKTFAAELVAVAHL-RHRNLVR 172
+V+G G FG+V +A + DG + A+K + E + + FA EL + L H N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 173 LRGWCVHEDQLLLVYDYMPNRSL------DRVLFRRP---ENLEAAAPLNWEQRKKIIRG 223
L G C H L L +Y P+ +L RVL P A+ L+ +Q
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 224 LAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARN 283
+A + YL ++ Q IHRD+ N+++ Y A++ DFGL+R
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR----------------- 160
Query: 284 HQFHLAETTRIGGTIGYLPP-----ESFQKGSVATAKSDVFSFGIVVLEVVS 330
+ + T+G LP ES SV T SDV+S+G+++ E+VS
Sbjct: 161 -----GQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 1e-16
Identities = 61/218 (27%), Positives = 105/218 (48%), Gaps = 27/218 (12%)
Query: 118 VLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWC 177
VLG G +G VY A S +A+K + E+ R+ + E+ ++L+HRN+V+ G
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 178 VHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLET 237
+ + +P SL +L + L+ K+I+ G L YLH+
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEG----LKYLHDN--- 127
Query: 238 QIIHRDVKTSNVMLDSQYNA--RLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIG 295
QI+HRD+K NV++++ Y+ ++ DFG ++ L A + ET
Sbjct: 128 QIVHRDIKGDNVLVNT-YSGVVKISDFGTSKRL------------AGINP--CTET--FT 170
Query: 296 GTIGYLPPESFQKGSVA-TAKSDVFSFGIVVLEVVSGR 332
GT+ Y+ PE KG A +D++S G ++E+ +G+
Sbjct: 171 GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 52/211 (24%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 518 SQRVAEMDFGTAYQGFLDNHQ-----YVLVKRLGMSKCPALRTRFSNELQNLARLRHRNL 572
+++ E FG D V VK L S R+ F E++ L L H N+
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 573 VQLCGWCTEQGE--MLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAIL 630
V+ G C + G + +I +Y + L L + +I L ++ + +
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLL---LFSS--QICKGMD 123
Query: 631 YLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIF 690
YL +++ IHR++ + I ++ + ++ F LA+ L D + S IF
Sbjct: 124 YLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE-DKDYYYVKEPGES--PIF 177
Query: 691 GYMSPEYIESGEATSMADVYSFGVVVLEVVT 721
Y +PE + + + +S +DV+SFGV + E+ T
Sbjct: 178 WY-APECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 59/225 (26%), Positives = 93/225 (41%), Gaps = 28/225 (12%)
Query: 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKC-LAEKGERFEKTFAAELVAVAHLRHRN 169
E LG G G V + L + G + A+K + +K EL +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 170 LVRLRGWCV--HEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAA 227
+V+ G + + + +Y SLD + + + + + KI +
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIY---KKVKKRGGRIGEKVLGKIAESVLKG 117
Query: 228 LHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFH 287
L YLH + +IIHRD+K SN++L + +L DFG++ EL +S
Sbjct: 118 LSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS----GEL-----VNS------- 158
Query: 288 LAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
LA T GT Y+ PE Q + SDV+S G+ +LEV R
Sbjct: 159 LAGT--FTGTSFYMAPERIQGKPY-SITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 5e-16
Identities = 67/221 (30%), Positives = 109/221 (49%), Gaps = 34/221 (15%)
Query: 117 EVLGSGGFGKVYRAV-LPSDGTV---VAVKCLAEK-GERFEKTFAAELVAVAHLRHRNLV 171
+VLGSG FG VY+ + +P TV VA+K L E G + F E + +A + H +LV
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 172 RLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYL 231
RL G C+ + LV MP+ L + +N+ + LNW + +A + YL
Sbjct: 73 RLLGVCL-SPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYL 125
Query: 232 HEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAET 291
E+ +++HRD+ NV++ S + ++ DFGLAR LE + + E
Sbjct: 126 EER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK----------------EY 166
Query: 292 TRIGGT--IGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS 330
GG I ++ E T +SDV+S+G+ + E+++
Sbjct: 167 NADGGKMPIKWMALECIHYRKF-THQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 5e-16
Identities = 71/307 (23%), Positives = 140/307 (45%), Gaps = 36/307 (11%)
Query: 494 FFMVETPREISFKEIISATNNFSESQRVAEMDFGTAYQGFLDNH--QYVLVKRLGMSKCP 551
FF + + I+ +I+S+ E ++ G +Y+G + Q+V+ + ++ P
Sbjct: 674 FFDSKVSKSITINDILSSLK---EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP 730
Query: 552 ALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHS 611
S+E+ ++ +L+H N+V+L G C + +I++Y + LS +L
Sbjct: 731 ------SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL---------R 775
Query: 612 ILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTR 671
L W R I +A A+ +LH + V+ N++ I +D P L +L L
Sbjct: 776 NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL-RLSLPGLLCT 834
Query: 672 NDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLP 731
+ + Y++PE E+ + T +D+Y FG++++E++TG+ D
Sbjct: 835 DTKCFISS-----------AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG 883
Query: 732 -EGLLVKRVHEFEARKRPLAELVDLSLNGE--YNHKELMRLIKLGIACTLSNPELRPSMR 788
G +V+ + L +D S+ G+ N E++ ++ L + CT ++P RP
Sbjct: 884 VHGSIVEWA-RYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCAN 942
Query: 789 QILSILD 795
+L L+
Sbjct: 943 DVLKTLE 949
|
Length = 968 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 6e-16
Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 29/214 (13%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCV 178
LG G FGKVY+A G + A K + K E + + E+ +A H N+V+L
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 179 HEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQ 238
+E+ L ++ ++ ++D V+ LE PL Q + + + AL+YLH E +
Sbjct: 73 YENNLWILIEFCAGGAVDAVM------LELERPLTEPQIRVVCKQTLEALNYLH---ENK 123
Query: 239 IIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTI 298
IIHRD+K N++ + +L DFG+ SA+N + + GT
Sbjct: 124 IIHRDLKAGNILFTLDGDIKLADFGV---------------SAKNTR-TIQRRDSFIGTP 167
Query: 299 GYLPPE----SFQKGSVATAKSDVFSFGIVVLEV 328
++ PE K K+DV+S GI ++E+
Sbjct: 168 YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 7e-16
Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 29/218 (13%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLA-EKGERFEKTFAAELVAVAHLRHRNLV 171
++ + +GSG +G VY+A + G +VA+K + E G+ FE E+ + RH N+V
Sbjct: 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFE-IIQQEISMLKECRHPNIV 63
Query: 172 RLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYL 231
G + D+L +V +Y SL + PL+ Q + R L YL
Sbjct: 64 AYFGSYLRRDKLWIVMEYCGGGSLQDIY------QVTRGPLSELQIAYVCRETLKGLAYL 117
Query: 232 HEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAET 291
HE IHRD+K +N++L + +L DFG++ L T + R
Sbjct: 118 HET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTA-------TIAKRK-------- 159
Query: 292 TRIGGTIGYLPPESFQ--KGSVATAKSDVFSFGIVVLE 327
+ I GT ++ PE + K D+++ GI +E
Sbjct: 160 SFI-GTPYWMAPEVAAVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 8e-16
Identities = 80/285 (28%), Positives = 135/285 (47%), Gaps = 43/285 (15%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGW 176
+ LG+G FG+V+ + T VA+K L + G + F AE + L+H LVRL
Sbjct: 12 KKLGAGQFGEVWMG-YYNGHTKVAIKSLKQ-GSMSPEAFLAEANLMKQLQHPRLVRLYA- 68
Query: 177 CVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLE 236
V ++ + ++ +YM N SL L + PE ++ + +I G+A ++ +
Sbjct: 69 VVTQEPIYIITEYMENGSLVDFL-KTPEGIKLTINKLIDMAAQIAEGMA----FIERK-- 121
Query: 237 TQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGG 296
IHRD++ +N+++ ++ DFGLAR +E +Y R + +F
Sbjct: 122 -NYIHRDLRAANILVSETLCCKIADFGLARLIEDN-EYTAREGA----KF---------- 165
Query: 297 TIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIRRLSDE 356
I + PE+ G+ T KSDV+SFGI++ E+V+ R + YP + + I+ L +
Sbjct: 166 PIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTYGR---IPYPG--MTNPEVIQNL-ER 218
Query: 357 GKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWV 401
G + DN C E L L LC P RP+ +++
Sbjct: 219 GYRMPRPDN---------CPEE-LYELMRLCWKEKPEERPTFEYL 253
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 9e-16
Identities = 69/245 (28%), Positives = 106/245 (43%), Gaps = 51/245 (20%)
Query: 101 FSYAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCL-AEKGERFEKTFAAEL 159
F+ +L D E +G G FG V + + GT++AVK + + E+ +K +L
Sbjct: 1 FTAEDLK------DLGE-IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDL 53
Query: 160 VAVAHLRH-RNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRR---------PENLEAA 209
V +V+ G E + + M + SLD+ ++ PE +
Sbjct: 54 DVVMRSSDCPYIVKFYGALFREGDCWICMELM-DISLDK-FYKYVYEVLKSVIPEEILG- 110
Query: 210 APLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLE 269
KI AL+YL E+L +IIHRDVK SN++LD N +L DFG++ L
Sbjct: 111 ---------KIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159
Query: 270 HELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVA--TAKSDVFSFGIVVLE 327
S A+ TR G Y+ PE + +SDV+S GI + E
Sbjct: 160 D--------SIAK---------TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYE 202
Query: 328 VVSGR 332
V +G+
Sbjct: 203 VATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 1e-15
Identities = 61/236 (25%), Positives = 117/236 (49%), Gaps = 40/236 (16%)
Query: 118 VLGSGGFGKVYRAVLPSDGTVVAVK-----CLAEKGERFEKT----FAAELVAVAHLRHR 168
++GSG FG VY + S G ++AVK ++ + +++ A E+ + L+H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 169 NLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRR---PENLEAAAPLNWEQRKKIIRGLA 225
N+V+ G + D L + +Y+P S+ +L E L + +R +
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLV----------RNFVRQIL 116
Query: 226 AALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQ 285
L+YLH + IIHRD+K +N+++D++ ++ DFG+++ LE S+ N
Sbjct: 117 KGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANS-----LSTKTNGA 168
Query: 286 FHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPD 341
+ G++ ++ PE K + T K+D++S G +V+E+++G+ +PD
Sbjct: 169 -----RPSLQGSVFWMAPEVV-KQTSYTRKADIWSLGCLVVEMLTGKHP----FPD 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 76/299 (25%), Positives = 125/299 (41%), Gaps = 46/299 (15%)
Query: 118 VLGSGGFGKVYRAVLP-----SDGTVVAVKCLAE-KGERFEKTFAAELVAVAHLRHRNLV 171
LG G FG+V+ A T+V VK L + K E + F EL L H+N+V
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 172 RLRGWCVHEDQLLLVYDYMPNRSLDRVLF--RRPENLEAAAPLNWEQRKKIIRGLAAALH 229
RL G C + ++ +Y L + L + + PL+ +Q+ + +A +
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 230 YLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLA 289
+L + +HRD+ N ++ SQ ++ L++ N +++
Sbjct: 132 HLSN---ARFVHRDLAARNCLVSSQREVKVSLLSLSK-------------DVYNSEYYKL 175
Query: 290 ETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDW 349
I + +L PE+ Q+ +T KSDV+SFG+++ EV + +L +
Sbjct: 176 RNALI--PLRWLAPEAVQEDDFST-KSDVWSFGVLMWEVFT---QGELPFYG-------- 221
Query: 350 IRRLSDEGKV--LQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVS 406
LSDE + LQAG L C L L C NP RPS ++ A+
Sbjct: 222 ---LSDEEVLNRLQAGKLELPVPEG--CP-SRLYKLMTRCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 65/212 (30%), Positives = 104/212 (49%), Gaps = 26/212 (12%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCV 178
LG+G FG+V+ ++ T VAVK L + G + F E + L+H LVRL
Sbjct: 14 LGAGQFGEVWMGYY-NNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 179 HEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQ 238
E+ + ++ +YM SL L + E + P + +I G+A Y+ +
Sbjct: 72 KEEPIYIITEYMAKGSLLDFL-KSDEGGKVLLPKLIDFSAQIAEGMA----YIERK---N 123
Query: 239 IIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTI 298
IHRD++ +NV++ ++ DFGLAR +E +Y R + +F I
Sbjct: 124 YIHRDLRAANVLVSESLMCKIADFGLARVIEDN-EYTAREGA----KF----------PI 168
Query: 299 GYLPPESFQKGSVATAKSDVFSFGIVVLEVVS 330
+ PE+ GS T KSDV+SFGI++ E+V+
Sbjct: 169 KWTAPEAINFGSF-TIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 69/294 (23%), Positives = 123/294 (41%), Gaps = 68/294 (23%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVK----CLAEKGERFEKTFAAELVAVAHLRHRNLVRLR 174
LG G +G VY+ SD A+K + ER + E+ +A + H N++ +
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAV--NEIRILASVNHPNIISYK 65
Query: 175 GWCVHEDQLLLVYDYMPNRSLDRVLFRR-------PENLEAAAPLNWEQRKKIIRGLAAA 227
+ ++L +V +Y P L + + +R PE W +++RGL A
Sbjct: 66 EAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEI------WRIFIQLLRGLQA- 118
Query: 228 LHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFH 287
LHEQ +I+HRD+K++N++L + ++GD G+++ L+ +
Sbjct: 119 ---LHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK------------- 159
Query: 288 LAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILL 347
T+IG T Y+ PE + KG + KSD++S G ++ E+ + P
Sbjct: 160 ----TQIG-TPHYMAPEVW-KGRPYSYKSDIWSLGCLLYEMATFA------PPF------ 201
Query: 348 DWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEH---LTHLALLCTLHNPHLRPSM 398
E + +Q ++ G Y + L + P LRP+
Sbjct: 202 --------EARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNC 247
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 63/235 (26%), Positives = 114/235 (48%), Gaps = 42/235 (17%)
Query: 116 DEVLGSGGFGKVYRAVL-----PSDGTVVAVKCLAEKGERFEKTFAAELVAVAHL----- 165
+ LG G FG+V +A P++ + VAVK L K + EK + +LV+ +
Sbjct: 17 GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKML--KDDATEKDLS-DLVSEMEMMKMIG 73
Query: 166 RHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVL-FRRPENLEAAAPLNWEQRKKIIR-- 222
+H+N++ L G C E L +V +Y + +L L RRP A+ + + +
Sbjct: 74 KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD 133
Query: 223 ------GLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQM 276
+A + +L + + IHRD+ NV++ + ++ DFGLAR + H + Y
Sbjct: 134 LVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDI-HHIDYYR 189
Query: 277 RTSSARNHQFHLAETTRIGGTIGYLPPES-FQKGSVATAKSDVFSFGIVVLEVVS 330
+T++ R + ++ PE+ F + V T +SDV+SFG+++ E+ +
Sbjct: 190 KTTNGRL-------------PVKWMAPEALFDR--VYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 63/222 (28%), Positives = 105/222 (47%), Gaps = 28/222 (12%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLA------EKGERFEKTFAAELVAVAHLRHRNL 170
EVLG G +G VY L + G ++AVK + E+ + E+ + L+H N+
Sbjct: 6 EVLGKGAYGTVYCG-LTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 171 VRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHY 230
V+ G C+ ++ + + +++P S+ +L R E P+ + K+I+ G+A Y
Sbjct: 65 VQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPE---PVFCKYTKQILDGVA----Y 117
Query: 231 LHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAE 290
LH ++HRD+K +NVML +L DFG AR R + H H
Sbjct: 118 LHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCAR----------RLAWVGLHGTHSNM 164
Query: 291 TTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
+ GT ++ PE + KSD++S G V E+ +G+
Sbjct: 165 LKSMHGTPYWMAPEVINESGYGR-KSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 56/216 (25%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFA---AELVAVAHLRHRNLVRLRG 175
+ G +G+V+ A S G + A+K + + + E ++ + +V+L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 176 WCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQL 235
+ L LV +Y+P L +L EN+ + L+ + + I + AL YLH
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLL----ENVGS---LDEDVARIYIAEIVLALEYLHSN- 112
Query: 236 ETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIG 295
IIHRD+K N+++DS + +L DFGL+ + L + + E RI
Sbjct: 113 --GIIHRDLKPDNILIDSNGHLKLTDFGLS---KVGLVRRQINLNDDE-----KEDKRIV 162
Query: 296 GTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSG 331
GT Y+ PE G + D +S G ++ E + G
Sbjct: 163 GTPDYIAPEVI-LGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (188), Expect = 3e-15
Identities = 68/286 (23%), Positives = 115/286 (40%), Gaps = 61/286 (21%)
Query: 526 FGTAY--QGFLDNHQYVLVKRLGMSKCPALRTRFS-NELQNLARLRHRNLVQLCGWCTEQ 582
FG Y + D YVL K + +S + NE++ L +L H N+++ E+
Sbjct: 13 FGKVYLVRRKSDGKLYVL-KEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK 71
Query: 583 GEMLVIYDY-----SATRILSHLLFHNN---HRIGHSILQWHHRYNIIKSLASAILYLHE 634
G++ ++ +Y + +I +I +Q L A+ YLH
Sbjct: 72 GKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ----------LCLALKYLHS 121
Query: 635 EWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMS 694
+++HR+I I L + +LG F +++ L+ ++V G Y+S
Sbjct: 122 R---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST-------VDLAKTVVGTPYYLS 171
Query: 695 PEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVD 754
PE ++ +D++S G V+ E+ T + H FE L EL
Sbjct: 172 PELCQNKPYNYKSDIWSLGCVLYELCTLK----------------HPFEGEN--LLELAL 213
Query: 755 LSLNGEY----NH--KELMRLIKLGIACTLS-NPELRPSMRQILSI 793
L G+Y + EL L+ L +PE RPS+ QIL
Sbjct: 214 KILKGQYPPIPSQYSSELRNLVSS----LLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 4e-15
Identities = 60/218 (27%), Positives = 100/218 (45%), Gaps = 31/218 (14%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVK----CLAEKGERFE-KTFAAELVAVAHLRHRNLVRL 173
LG G FG+VY G +AVK + E E+ + +L+H +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 174 RGWCVHEDQLLLVY-DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLH 232
G C+ +D+ L ++ +YMP S+ + L+A L +K R + + YLH
Sbjct: 70 YG-CLRDDETLSIFMEYMPGGSVK-------DQLKAYGALTETVTRKYTRQILEGVEYLH 121
Query: 233 EQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETT 292
I+HRD+K +N++ DS N +LGDFG ++ R + + + T
Sbjct: 122 SN---MIVHRDIKGANILRDSAGNVKLGDFGASK----------RLQTICSSGTGMKSVT 168
Query: 293 RIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS 330
GT ++ PE G K+DV+S G V+E+++
Sbjct: 169 ---GTPYWMSPEVIS-GEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 5e-15
Identities = 56/229 (24%), Positives = 101/229 (44%), Gaps = 26/229 (11%)
Query: 507 EIISATNNFSESQRVAEMDFGTAYQGFL------DNHQYVLVKRLGMSKCPALRTRFSNE 560
EI + F E + E FG Y+G L + V +K L + P ++ F E
Sbjct: 1 EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58
Query: 561 LQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRILSHLLFHN----------NHRIGH 610
+ ++ L+H N+V L G CT++ ++++Y A L L N
Sbjct: 59 AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118
Query: 611 SILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLT 670
S L +I +A+ + YL + +HR++ + + + ++ F L+ +
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIY 175
Query: 671 RNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEV 719
D+ +R + VR +M PE I G+ T+ +D++SFGVV+ E+
Sbjct: 176 SADY-YRVQSKSLLPVR----WMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 7e-15
Identities = 64/239 (26%), Positives = 111/239 (46%), Gaps = 41/239 (17%)
Query: 99 RIFSYAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTV----VAVKCLAEKGERFEKT 154
RI EL ++LGSG FG V++ + +G VA+K + ++ R +T
Sbjct: 2 RILKETELRKL-------KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGR--QT 52
Query: 155 FAA---ELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAP 211
F ++A+ L H +VRL G C L LV P SL + + ++L+
Sbjct: 53 FQEITDHMLAMGSLDHAYIVRLLGICPGA-SLQLVTQLSPLGSLLDHVRQHRDSLDPQRL 111
Query: 212 LNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHE 271
LNW + +A ++YL E +++HR++ N++L S ++ DFG+A L +
Sbjct: 112 LNWCVQ------IAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162
Query: 272 LQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS 330
+ ++ +E I ++ ES G T +SDV+S+G+ V E++S
Sbjct: 163 -----------DKKYFYSE---HKTPIKWMALESILFGRY-THQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 8e-15
Identities = 54/215 (25%), Positives = 104/215 (48%), Gaps = 30/215 (13%)
Query: 122 GGFGKVYRAVLPSDGTVVAVKCLA--EKGERFEKTFAAELVAVAHLRHRNLVRLRGWCV- 178
G +G VYRA G +VA+K L ++ E F T E+ + L+H N+V ++ V
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVG 75
Query: 179 -HEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLET 237
+ D++ +V +Y+ + L ++ + + + K ++ L + + +LH+
Sbjct: 76 SNLDKIYMVMEYVEH-DLKSLMETMKQPFLQS------EVKCLMLQLLSGVAHLHDNW-- 126
Query: 238 QIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGT 297
I+HRD+KTSN++L+++ ++ DFGLAR +Y L T++ T
Sbjct: 127 -ILHRDLKTSNLLLNNRGILKICDFGLAR------EY----------GSPLKPYTQLVVT 169
Query: 298 IGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
+ Y PE + D++S G + E+++ +
Sbjct: 170 LWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 8e-15
Identities = 51/163 (31%), Positives = 77/163 (47%), Gaps = 18/163 (11%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGER--FEKTFAAELVAVAHLRHRNL 170
++ LG G FG+VY+A G VVA+K + E+ F T E+ + L+H N+
Sbjct: 10 YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNV 69
Query: 171 VRLRGWCV-----HEDQLLLVYDYMPNRSLDRV-LFRRPE-NLEAAAPLNWEQRKKIIRG 223
V L V + + VY P D L P L + Q K +
Sbjct: 70 VPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTES------QIKCYMLQ 123
Query: 224 LAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLAR 266
L ++YLHE I+HRD+K +N+++D+Q ++ DFGLAR
Sbjct: 124 LLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLAR 163
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 9e-15
Identities = 58/207 (28%), Positives = 91/207 (43%), Gaps = 28/207 (13%)
Query: 526 FGTAYQGF-LDNHQYVLVKRLGMSKC-PALRTRFSNELQNLARLRHRNLVQLCGWC--TE 581
FG+ Y D + + VK + +S E++ L+ L+H N+V+ E
Sbjct: 13 FGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVR-YYGSERDE 71
Query: 582 QGEMLVIY-DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAIL----YLHEEW 636
+ L I+ +Y + LS LL + G L +I+ IL YLH
Sbjct: 72 EKNTLNIFLEYVSGGSLSSLL----KKFGK--LP----EPVIRKYTRQILEGLAYLHSN- 120
Query: 637 NEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPE 696
++HR+I + I +D D +L F A+ L + G G SVRG +M+PE
Sbjct: 121 --GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE-----GTGSVRGTPYWMAPE 173
Query: 697 YIESGEATSMADVYSFGVVVLEVVTGQ 723
I E AD++S G V+E+ TG+
Sbjct: 174 VIRGEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 83/306 (27%), Positives = 129/306 (42%), Gaps = 63/306 (20%)
Query: 119 LGSGGFGKVYRAVLPSDGTV-------VAVKCLAEKG---ERFEKTFAAELVAVAHLRHR 168
LG G FG VY + + G V VA+K + E ER E F E +
Sbjct: 14 LGQGSFGMVYEGI--AKGVVKDEPETRVAIKTVNEAASMRERIE--FLNEASVMKEFNCH 69
Query: 169 NLVRLRGWCVHEDQLLLVYDYMPN---RSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLA 225
++VRL G L++ + M +S R L EN AP + ++ ++ +A
Sbjct: 70 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIA 129
Query: 226 AALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQ 285
+ YL+ + +HRD+ N M+ + ++GDFG+ R
Sbjct: 130 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR------------------D 168
Query: 286 FHLAETTRIGGTIGYLP-----PESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYP 340
+ + R GG G LP PES + G V T SDV+SFG+V+ E+ +
Sbjct: 169 IYETDYYRKGGK-GLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGMS 226
Query: 341 DDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLC-DMEHLTHLALLCTLHNPHLRPSMK 399
++Q++ R EG +L DN C DM L L +C +NP +RPS
Sbjct: 227 NEQVL------RFVMEGGLLDKPDN---------CPDM--LFELMRMCWQYNPKMRPSFL 269
Query: 400 WVIEAV 405
+I ++
Sbjct: 270 EIISSI 275
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 70/229 (30%), Positives = 105/229 (45%), Gaps = 44/229 (19%)
Query: 117 EVLGSGGFGKV----YRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVR 172
+ +G G FG V YR G VAVKC+ K + + F AE + LRH NLV+
Sbjct: 12 QTIGKGEFGDVMLGDYR------GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQ 63
Query: 173 LRGWCVHED-QLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYL 231
L G V E L +V +YM SL L R ++ L + K + A+ YL
Sbjct: 64 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-----LGGDCLLKFSLDVCEAMEYL 118
Query: 232 HEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAET 291
+HRD+ NV++ A++ DFGL T A + Q +T
Sbjct: 119 EAN---NFVHRDLAARNVLVSEDNVAKVSDFGL-------------TKEASSTQ----DT 158
Query: 292 TRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYP 340
++ + + PE+ ++ +T KSDV+SFGI++ E+ S R + YP
Sbjct: 159 GKL--PVKWTAPEALREKKFST-KSDVWSFGILLWEIYSFGR---VPYP 201
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 2e-14
Identities = 60/209 (28%), Positives = 93/209 (44%), Gaps = 31/209 (14%)
Query: 136 GTVVAVKCL---AEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLL-VYDYMP 191
G VA+K L A + E F E A L H N+V L LL V++Y+P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 192 NRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVML 251
R+L VL A L + +++ + AL H Q I+HRD+K N+M+
Sbjct: 63 GRTLREVL-------AADGALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMV 112
Query: 252 ---DSQYNARLGDFGLARWLE--HELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESF 306
+ +A++ DFG+ L + T TT + GT Y PE
Sbjct: 113 SQTGVRPHAKVLDFGIGTLLPGVRDADVATLTR-----------TTEVLGTPTYCAPEQL 161
Query: 307 QKGSVATAKSDVFSFGIVVLEVVSGRRAV 335
+G T SD++++G++ LE ++G+R V
Sbjct: 162 -RGEPVTPNSDLYAWGLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 2e-14
Identities = 46/161 (28%), Positives = 77/161 (47%), Gaps = 19/161 (11%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKT----FAA--ELVAVAHLR 166
+++ + LG G + VY+A G +VA+K + + GER E F A E+ + L+
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKI-KLGERKEAKDGINFTALREIKLLQELK 60
Query: 167 HRNLVRLRGWCVHEDQLLLVYDYMPNRSLD-RVLFRRPENLEAAAPLNWEQRKKIIRGLA 225
H N++ L H+ + LV+++M D + + + A K +
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMET---DLEKVIKDKSIVLTPA-----DIKSYMLMTL 112
Query: 226 AALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLAR 266
L YLH I+HRD+K +N+++ S +L DFGLAR
Sbjct: 113 RGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLAR 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 54/162 (33%), Positives = 83/162 (51%), Gaps = 14/162 (8%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGER--FEKTFAAELVAVAHLRHRNL 170
F++ +G G +G VYRA + G +VA+K + ER + E+ + +LRH N+
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI 68
Query: 171 VRLRGWCV--HEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAAL 228
V L+ V H D + LV +Y + L +L +N+ P + Q K ++ L L
Sbjct: 69 VELKEVVVGKHLDSIFLVMEYC-EQDLASLL----DNMPT--PFSESQVKCLMLQLLRGL 121
Query: 229 HYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEH 270
YLHE IIHRD+K SN++L + ++ DFGLAR
Sbjct: 122 QYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (182), Expect = 3e-14
Identities = 45/154 (29%), Positives = 74/154 (48%), Gaps = 15/154 (9%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLR----HRNLVR 172
+ LG G FG VY A G +VA+K + +K +E+ L V LR H N+V+
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEE--CMNLREVKSLRKLNEHPNIVK 62
Query: 173 LRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLH 232
L+ D+L V++YM +L +++ R P + + II + L ++H
Sbjct: 63 LKEVFRENDELYFVFEYM-EGNLYQLMKDR-----KGKPFSESVIRSIIYQILQGLAHIH 116
Query: 233 EQLETQIIHRDVKTSNVMLDSQYNARLGDFGLAR 266
+ HRD+K N+++ ++ DFGLAR
Sbjct: 117 KH---GFFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 55/203 (27%), Positives = 96/203 (47%), Gaps = 24/203 (11%)
Query: 526 FGTAYQGF-LDNHQYVLVKRLGMSKCP--ALRTRFSNELQNLARLRHRNLVQLCGWCTEQ 582
FG Y+G L+ +V +K++ + K AL++ E+ L L+H N+V+ G
Sbjct: 13 FGVVYKGLNLETGDFVAIKQISLEKIKEEALKS-IMQEIDLLKNLKHPNIVKYIGSIETS 71
Query: 583 GEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRY--NIIKSLASAILYLHEEWNEQV 640
+ +I +Y+ L ++ S++ Y +++ LA YLHE+ V
Sbjct: 72 DSLYIILEYAENGSLRQII-KKFGPFPESLVA---VYVYQVLQGLA----YLHEQ---GV 120
Query: 641 IHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIES 700
IHR+I ++ I D +L F +A L + SV G +M+PE IE
Sbjct: 121 IHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-------DASVVGTPYWMAPEVIEM 173
Query: 701 GEATSMADVYSFGVVVLEVVTGQ 723
A++ +D++S G V+E++TG
Sbjct: 174 SGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 4e-14
Identities = 73/318 (22%), Positives = 134/318 (42%), Gaps = 45/318 (14%)
Query: 115 EDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLR 174
E+ V+ G G Y+ +G VK + + A++ L+H N+V+L
Sbjct: 694 EENVISRGKKGASYKGKSIKNGMQFVVKEI-NDVNSIPSSEIADM---GKLQHPNIVKLI 749
Query: 175 GWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQ 234
G C E L+++Y+ ++L VL L+WE+R+KI G+A AL +LH +
Sbjct: 750 GLCRSEKGAYLIHEYIEGKNLSEVL----------RNLSWERRRKIAIGIAKALRFLHCR 799
Query: 235 LETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRI 294
++ ++ +++D + L L L + SSA
Sbjct: 800 CSPAVVVGNLSPEKIIIDGKDEPHL-RLSLPGLL--CTDTKCFISSA------------- 843
Query: 295 GGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIRRLS 354
Y+ PE+ + + T KSD++ FG++++E+++G+ D + I ++W R
Sbjct: 844 -----YVAPETRETKDI-TEKSDIYGFGLILIELLTGKSPADAEFGVHGSI-VEWARYCY 896
Query: 355 DEGKVLQAGDNRLS-DGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGSYSGKL 413
+ + D + D S ++ + +LAL CT +P RP V++ +
Sbjct: 897 SDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLES------ 950
Query: 414 PALPSFQSHPLYISLSSP 431
A S S + SS
Sbjct: 951 -ASRSSSSCVTGLKFSSL 967
|
Length = 968 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 4e-14
Identities = 78/298 (26%), Positives = 125/298 (41%), Gaps = 60/298 (20%)
Query: 119 LGSGGFGKVYRAVL-----PSDGTV-VAVKCLAEKGERFEKTFAAELVAVAHL----RHR 168
LGSG FG+VY P G + VAVK L + EK E + AHL H
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK---KEFLKEAHLMSNFNHP 59
Query: 169 NLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAP--LNWEQRKKIIRGLAA 226
N+V+L G C+ + ++ + M L + + R +E P L ++ I +A
Sbjct: 60 NIVKLLGVCLLNEPQYIIMELMEGGDL--LSYLRDARVERFGPPLLTLKELLDICLDVAK 117
Query: 227 ALHYLHEQLETQIIHRDVKTSNVML-DSQYNAR----LGDFGLARWLEHELQYQMRTSSA 281
YL + IHRD+ N ++ + Y+A +GDFGLAR + Y+
Sbjct: 118 GCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGL 174
Query: 282 RNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYP 340
+ ++ PES G T +SDV+SFG+++ E+++ G++ YP
Sbjct: 175 LP--------------VRWMAPESLLDG-KFTTQSDVWSFGVLMWEILTLGQQP----YP 215
Query: 341 D-DQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPS 397
+ +L + G LQ +N C + + L C +P RP+
Sbjct: 216 ALNNQEVLQHVT----AGGRLQKPEN---------CP-DKIYQLMTNCWAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 5e-14
Identities = 61/223 (27%), Positives = 110/223 (49%), Gaps = 30/223 (13%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDG----TVVAVKCLAE-KGERFEKTFAAELVAVAHLRH 167
F + +VLGSG FG VY+ + +G VA+K L E + K E +A + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 168 RNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAA 227
++ RL G C+ + L+ MP L + +N+ + LNW + +A
Sbjct: 69 PHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 121
Query: 228 LHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFH 287
++YL E+ +++HRD+ NV++ + + ++ DFGLA+ L A ++H
Sbjct: 122 MNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL-----------GADEKEYH 167
Query: 288 LAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS 330
AE ++ I ++ ES + T +SDV+S+G+ V E+++
Sbjct: 168 -AEGGKV--PIKWMALESILH-RIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (181), Expect = 6e-14
Identities = 57/234 (24%), Positives = 99/234 (42%), Gaps = 55/234 (23%)
Query: 118 VLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAA---------ELVAVAHLRHR 168
+GSG +G V AV G VA+K + F E+ + HLRH
Sbjct: 7 PIGSGAYGVVCSAVDKRTGRKVAIK-------KISNVFDDLIDAKRILREIKLLRHLRHE 59
Query: 169 NLVRLRGWCVHEDQ-----LLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRG 223
N++ L + +V + M L +V+ + P+ PL + + +
Sbjct: 60 NIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVI-KSPQ------PLTDDHIQYFLYQ 111
Query: 224 LAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARN 283
+ L YLH +IHRD+K SN++++S + ++ DFGLAR ++ + +
Sbjct: 112 ILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE----------D 158
Query: 284 HQFHLAE--TTRIGGTIGYLPPE---SFQKGSVATAKSDVFSFGIVVLEVVSGR 332
+ L E TR Y PE S + + A D++S G + E+++ +
Sbjct: 159 EKGFLTEYVVTRW-----YRAPELLLSSSRYTKAI---DIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 9e-14
Identities = 62/226 (27%), Positives = 105/226 (46%), Gaps = 45/226 (19%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHR--NLVRLRGW 176
+GSG G+VY+ G V+AVK + G + E + V H +V+ G+
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGY 82
Query: 177 CVHEDQLLLVYDYMPNRSLDRVLFRR----PENLEAAAPLNWEQRKKIIRGLAAALHYLH 232
+ + + + + M + LD++L R PE++ K+ + ALHYL
Sbjct: 83 FITDSDVFICMELM-STCLDKLLKRIQGPIPEDILG----------KMTVAIVKALHYLK 131
Query: 233 EQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETT 292
E + +IHRDVK SN++LD+ N +L DFG++ ++ S A+ T
Sbjct: 132 E--KHGVIHRDVKPSNILLDASGNVKLCDFGISG--------RLVDSKAK---------T 172
Query: 293 RIGGTIGYLPPE------SFQKGSVATAKSDVFSFGIVVLEVVSGR 332
R G Y+ PE K + ++DV+S GI ++E+ +G+
Sbjct: 173 RSAGCAAYMAPERIDPPDPNPKYDI---RADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 9e-14
Identities = 55/218 (25%), Positives = 93/218 (42%), Gaps = 32/218 (14%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVKCLAEKGER--FEKTFAAELVAVAHLRHRNLVRLRGW 176
+G G +G VY+A G +VA+K + + E KT E+ + L H N+++L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 177 CVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLE 236
H+ L LV+++M + L +++ R L K + L L + H
Sbjct: 67 FRHKGDLYLVFEFM-DTDLYKLIKDR------QRGLPESLIKSYLYQLLQGLAFCHSH-- 117
Query: 237 TQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAE--TTRI 294
I+HRD+K N++++++ +L DFGLAR S + TR
Sbjct: 118 -GILHRDLKPENLLINTEGVLKLADFGLAR-------------SFGSPVRPYTHYVVTRW 163
Query: 295 GGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
Y PE + D++S G + E++S R
Sbjct: 164 -----YRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-13
Identities = 65/234 (27%), Positives = 108/234 (46%), Gaps = 44/234 (18%)
Query: 119 LGSGGFGKVYRAVL-------PSDGTVVAVKCLAEKGERFEKTFAAELVAVAHL-----R 166
LG G FG+V RA P VAVK L + +K A +L++ L +
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT--DKDLA-DLISEMELMKLIGK 76
Query: 167 HRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVL-FRRPENLEAA--------APLNWEQR 217
H+N++ L G C E L ++ +Y +L L RRP + L+++
Sbjct: 77 HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136
Query: 218 KKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMR 277
+A + YL + + IHRD+ NV++ ++ DFGLAR + H++ Y +
Sbjct: 137 VSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGV-HDIDYYKK 192
Query: 278 TSSARNHQFHLAETTRIGGTIGYLPPES-FQKGSVATAKSDVFSFGIVVLEVVS 330
TS+ R + ++ PE+ F + V T +SDV+SFGI++ E+ +
Sbjct: 193 TSNGRL-------------PVKWMAPEALFDR--VYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 83/318 (26%), Positives = 128/318 (40%), Gaps = 63/318 (19%)
Query: 119 LGSGGFGKVYRAVLP-----SDGTVVAVKCLAEKG---ERFEKTFAAELVAVAHLRHRNL 170
LG G FG VY T VAVK + E ER E F E + ++
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--FLNEASVMKGFTCHHV 71
Query: 171 VRLRGWCVHEDQLLLVYDYMPN---RSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAA 227
VRL G L+V + M + +S R L EN P ++ ++ +A
Sbjct: 72 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131
Query: 228 LHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFH 287
+ YL+ + + +HRD+ N M+ + ++GDFG+ R + +E Y
Sbjct: 132 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDI-YETDYY------------ 175
Query: 288 LAETTRIGGTIGYLP-----PESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDD 342
R GG G LP PES + G T SD++SFG+V+ E+ S ++
Sbjct: 176 -----RKGGK-GLLPVRWMAPESLKDGVF-TTSSDMWSFGVVLWEITSLAEQPYQGLSNE 228
Query: 343 QIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVI 402
Q++ + +G L DN C E +T L +C NP +RP+ ++
Sbjct: 229 QVL------KFVMDGGYLDQPDN---------CP-ERVTDLMRMCWQFNPKMRPTFLEIV 272
Query: 403 EAVSGSYSGKLPALPSFQ 420
+ K PSF
Sbjct: 273 NLL------KDDLHPSFP 284
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 58/228 (25%), Positives = 98/228 (42%), Gaps = 39/228 (17%)
Query: 117 EVLGSGGFGKVYRAVLPSDG-TVVAVK-----------CLAEKGERFEKTFAAELVAVAH 164
E LGSG FG VY+ ++G ++A+K E+ + + +
Sbjct: 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65
Query: 165 LRHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRK--KIIR 222
LRH N+VR + D+L +V D + L E + + + + I
Sbjct: 66 LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQ-----RFTEERIWNIFV 120
Query: 223 GLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSAR 282
+ AL YLH+ E +I+HRD+ +N+ML + DFGLA+ + E
Sbjct: 121 QMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPE----------- 167
Query: 283 NHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS 330
++ T + GTI Y PE K K+DV++FG ++ ++ +
Sbjct: 168 ------SKLTSVVGTILYSCPE-IVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 64/223 (28%), Positives = 106/223 (47%), Gaps = 30/223 (13%)
Query: 116 DEVLGSGGFGKVYRAVL--PSDGTV-VAVKCL-AEKGERFEKTFAAELVAVAHLRHRNLV 171
+ +LG+G FG++ R L PS + VA+ L A ++ + F AE + + H N+V
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIV 69
Query: 172 RLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYL 231
RL G + +++V +YM N +LD L + L A Q ++ GLA+ + YL
Sbjct: 70 RLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAG------QLMGMLPGLASGMKYL 123
Query: 232 HEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAET 291
E +H+ + V+++S ++ F R E + + T S ++ A
Sbjct: 124 SEM---GYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAA-- 176
Query: 292 TRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRR 333
PE+ Q ++A SDV+SFGIV+ EV+S G R
Sbjct: 177 -----------PEAIQYHHFSSA-SDVWSFGIVMWEVMSYGER 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 56/226 (24%), Positives = 93/226 (41%), Gaps = 32/226 (14%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTV---VAVKCLAEKG--ERFEKTFAAELVAVAHLRHRNLV 171
++LG G FG V L D VAVK + + F +E + H N++
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 172 RLRGWCVHEDQL------LLVYDYMPNRSLDRVLFR-RPENLEAAAPLNWEQRKKIIRGL 224
+L G C L +++ +M + L L R L PL + K + +
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPL--QTLLKFMVDI 122
Query: 225 AAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNH 284
A + YL + IHRD+ N ML + DFGL++ + Y+
Sbjct: 123 ALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYR--------- 170
Query: 285 QFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS 330
Q +A+ + ++ ES V T+KSDV++FG+ + E+ +
Sbjct: 171 QGRIAKM-----PVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 62/234 (26%), Positives = 109/234 (46%), Gaps = 44/234 (18%)
Query: 119 LGSGGFGKVYRAVL-------PSDGTVVAVKCLAEKGERFEKTFAAELVAVAHL-----R 166
LG G FG+V A P + VAVK L K + EK + +LV+ + +
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKML--KDDATEKDLS-DLVSEMEMMKMIGK 79
Query: 167 HRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVL-FRRPENLEAA--------APLNWEQR 217
H+N++ L G C + L ++ +Y +L L RRP +E + + ++
Sbjct: 80 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDL 139
Query: 218 KKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMR 277
+A + YL Q + IHRD+ NV++ ++ DFGLAR + + + Y +
Sbjct: 140 VSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDV-NNIDYYKK 195
Query: 278 TSSARNHQFHLAETTRIGGTIGYLPPES-FQKGSVATAKSDVFSFGIVVLEVVS 330
T++ R + ++ PE+ F + V T +SDV+SFG+++ E+ +
Sbjct: 196 TTNGRL-------------PVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 74/296 (25%), Positives = 124/296 (41%), Gaps = 63/296 (21%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCL-AEKGERFEKTFAAEL-VAVAHLRHRNLVRLR 174
E LG G +G V + GT++AVK + A + +K +L +++ + V
Sbjct: 7 EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFY 66
Query: 175 GWCVHEDQLLLVYDYMPNRSLDRVLFRR--------PENLEAAAPLNWEQRKKIIRGLAA 226
G E + + + M + SLD+ +++ PE++ KI +
Sbjct: 67 GALFREGDVWICMEVM-DTSLDK-FYKKVYDKGLTIPEDILG----------KIAVSIVK 114
Query: 227 ALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQF 286
AL YLH +L +IHRDVK SNV+++ +L DFG++ +L S
Sbjct: 115 ALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYL---------VDS------ 157
Query: 287 HLAETTRIGGTIGYLPPESF-----QKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPD 341
+A+T G Y+ PE QKG KSDV+S GI ++E+ +GR +P
Sbjct: 158 -VAKTIDAGCK-PYMAPERINPELNQKGY--DVKSDVWSLGITMIELATGR------FPY 207
Query: 342 DQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPS 397
D W +V++ +L + + + + C N RP+
Sbjct: 208 DS-----WKTPFQQLKQVVEEPSPQLPAEKFSP-EFQDFVN---KCLKKNYKERPN 254
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 46/153 (30%), Positives = 75/153 (49%), Gaps = 13/153 (8%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKC--LAEKGERFEKTFAAELVAVAHLRHRNLVRLR 174
E +G G +G VY+A G +VA+K L + E T E+ + L H N+VRL
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLL 64
Query: 175 GWCVHEDQ-LLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHE 233
VH + L LV++++ + L + + P L+ K + L + Y H
Sbjct: 65 D-VVHSENKLYLVFEFL-DLDLKKYMDSSPLT-----GLDPPLIKSYLYQLLQGIAYCHS 117
Query: 234 QLETQIIHRDVKTSNVMLDSQYNARLGDFGLAR 266
+++HRD+K N+++D + +L DFGLAR
Sbjct: 118 H---RVLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 3e-13
Identities = 62/269 (23%), Positives = 111/269 (41%), Gaps = 33/269 (12%)
Query: 526 FGTAYQGF-LDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGE 584
FG Y+ + V +K + + + + NE+Q L + +H N+V+ G ++ E
Sbjct: 13 FGEVYKARHKRTGKEVAIKVIKLESKEK-KEKIINEIQILKKCKHPNIVKYYGSYLKKDE 71
Query: 585 MLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRN 644
+ ++ ++ + L LL N + S + + + K L + YLH + +IHR+
Sbjct: 72 LWIVMEFCSGGSLKDLLKSTNQTLTESQIAY-----VCKELLKGLEYLH---SNGIIHRD 123
Query: 645 ITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEAT 704
I ++ I L D +L F L+ L+ T ++ G +M+PE I
Sbjct: 124 IKAANILLTSDGEVKLIDFGLSAQLSD--------TKARNTMVGTPYWMAPEVINGKPYD 175
Query: 705 SMADVYSFGVVVLEVVTGQMA-VDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYNH 763
AD++S G+ +E+ G+ + + L F+ L N E
Sbjct: 176 YKADIWSLGITAIELAEGKPPYSELPPMKAL-------FKIATNGPPGL----RNPEKWS 224
Query: 764 KELMRLIKLGIACTLSNPELRPSMRQILS 792
E +K C NPE RP+ Q+L
Sbjct: 225 DEFKDFLKK---CLQKNPEKRPTAEQLLK 250
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 62/227 (27%), Positives = 108/227 (47%), Gaps = 31/227 (13%)
Query: 118 VLGSGGFGK--VYRAVLPSDGTVVAVK--CLAEKGERFEKTFAAELVAVAHLRHRNLVRL 173
VLG G FG+ +YR D ++V K L E+ + E+V ++ L+H N++
Sbjct: 7 VLGKGAFGEATLYRRT--EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAY 64
Query: 174 RGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHE 233
+ ++ LL+ +Y +L + R+ L E + + +A+ Y+H+
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQL-----FEEEMVLWYLFQIVSAVSYIHK 119
Query: 234 QLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTR 293
I+HRD+KT N+ L +LGDFG+++ L ++ +AET
Sbjct: 120 A---GILHRDIKTLNIFLTKAGLIKLGDFGISKIL--------------GSEYSMAET-- 160
Query: 294 IGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYP 340
+ GT Y+ PE Q G KSD+++ G V+ E+++ +R D T P
Sbjct: 161 VVGTPYYMSPELCQ-GVKYNFKSDIWALGCVLYELLTLKRTFDATNP 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-13
Identities = 61/224 (27%), Positives = 104/224 (46%), Gaps = 33/224 (14%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKT-----FAAELVAVAHLRHRNLV 171
++LG G FG+VY G +A K + E E + E+ + +L+H +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 172 RLRGWCVH---EDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAAL 228
+ G C+ E L + +YMP S+ + L+A L +K R + +
Sbjct: 68 QYYG-CLRDRAEKTLTIFMEYMPGGSVK-------DQLKAYGALTESVTRKYTRQILEGM 119
Query: 229 HYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHL 288
YLH + I+HRD+K +N++ DS N +LGDFG ++ L+ M + R+
Sbjct: 120 SYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ---TICMSGTGIRS----- 168
Query: 289 AETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
+ GT ++ PE G K+DV+S G V+E+++ +
Sbjct: 169 -----VTGTPYWMSPEVIS-GEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 5e-13
Identities = 65/225 (28%), Positives = 115/225 (51%), Gaps = 30/225 (13%)
Query: 116 DEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRG 175
++ LG+G FG+V+ A + T VAVK + + G + F AE + L+H LV+L
Sbjct: 11 EKKLGAGQFGEVWMATY-NKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHA 68
Query: 176 WCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQL 235
V ++ + ++ ++M SL L + E + P + +I G+A ++ ++
Sbjct: 69 -VVTKEPIYIITEFMAKGSLLDFL-KSDEGSKQPLPKLIDFSAQIAEGMA----FIEQR- 121
Query: 236 ETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIG 295
IHRD++ +N+++ + ++ DFGLAR +E +Y R + +F
Sbjct: 122 --NYIHRDLRAANILVSASLVCKIADFGLARVIEDN-EYTAREGA----KF--------- 165
Query: 296 GTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYP 340
I + PE+ GS T KSDV+SFGI+++E+V+ R + YP
Sbjct: 166 -PIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGR---IPYP 205
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 5e-13
Identities = 48/165 (29%), Positives = 80/165 (48%), Gaps = 21/165 (12%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLR------ 166
++E +G G +G VY+A + G VA+K + E + L +A L+
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSE-EGIPLSTLREIALLKQLESFE 59
Query: 167 HRNLVRLRGWCV-----HEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKII 221
H N+VRL C E +L LV++++ ++ L L + P+ L E K ++
Sbjct: 60 HPNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPK-----PGLPPETIKDLM 113
Query: 222 RGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLAR 266
R L + +LH I+HRD+K N+++ S ++ DFGLAR
Sbjct: 114 RQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 6e-13
Identities = 66/257 (25%), Positives = 109/257 (42%), Gaps = 52/257 (20%)
Query: 117 EVLGSGGFGKVY---------------RAVLPSDGTV-VAVKCL---AEKGERFEKTFAA 157
E LG G FG+V+ +D V VAVK L A R + F
Sbjct: 11 EKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAR--EDFLK 68
Query: 158 ELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRR----PENLEAAAPLN 213
E+ ++ L N+ RL G C + L ++ +YM N L++ L + + L+
Sbjct: 69 EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLS 128
Query: 214 WEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQ 273
+ + +A+ + YL E L +HRD+ T N ++ Y ++ DFG++R L
Sbjct: 129 FSTLLYMATQIASGMRYL-ESL--NFVHRDLATRNCLVGKNYTIKIADFGMSRNL----- 180
Query: 274 YQMRTSSARNHQFHLAETTRIGGT----IGYLPPESFQKGSVATAKSDVFSFGIVVLEVV 329
Y ++ R+ G I ++ ES G T KSDV++FG+ + E++
Sbjct: 181 YS-------------SDYYRVQGRAPLPIRWMAWESVLLGKF-TTKSDVWAFGVTLWEIL 226
Query: 330 S-GRRAVDLTYPDDQII 345
+ R D Q+I
Sbjct: 227 TLCREQPYEHLTDQQVI 243
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 6e-13
Identities = 58/221 (26%), Positives = 102/221 (46%), Gaps = 31/221 (14%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCL-AEKGERFEKTFAAELVAVAHLRHRNLV 171
F + E +G G FG+V++ + VVA+K + E+ E + E+ ++ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 172 RLRGWCVHEDQLLLVYDYMPNRS-LDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHY 230
+ G + + +L ++ +Y+ S LD L PL+ Q I+R + L Y
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALD---------LLEPGPLDETQIATILREILKGLDY 116
Query: 231 LHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAE 290
LH + + IHRD+K +NV+L +L DFG+A Q+ + + + F
Sbjct: 117 LHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAG--------QLTDTQIKRNTFV--- 162
Query: 291 TTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSG 331
GT ++ PE K S +K+D++S GI +E+ G
Sbjct: 163 -----GTPFWMAPEVI-KQSAYDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 6e-13
Identities = 66/247 (26%), Positives = 106/247 (42%), Gaps = 37/247 (14%)
Query: 97 NPRIFSYAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFA 156
N + L ++ ++ E +G G +GKVY+ DG++ AVK L + E+ A
Sbjct: 8 NSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEA 67
Query: 157 AELVAVAHLRHRNLVRLRGWCVHED-----QLLLVYDYMPNRSLDRV---LFRRPENLEA 208
+ + H N+V+ G D QL LV + S+ + L + L+
Sbjct: 68 EYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDE 127
Query: 209 AAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWL 268
A I+ G L +LH +IIHRDVK +N++L ++ +L DFG++ L
Sbjct: 128 AMI------SYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQL 178
Query: 269 EHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESF----QKGSVATAKSDVFSFGIV 324
+S R L T + GT ++ PE Q A+ DV+S GI
Sbjct: 179 ----------TSTR-----LRRNTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGIT 222
Query: 325 VLEVVSG 331
+E+ G
Sbjct: 223 AIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 6e-13
Identities = 68/219 (31%), Positives = 94/219 (42%), Gaps = 33/219 (15%)
Query: 118 VLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEK----TFAAELVAVAHLRHRNLVRL 173
V+G G FGKV A +DG AVK L +K +K A V + +++H LV L
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 174 RGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHE 233
D+L V DY+ L L R E A + +A+AL YLH
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAE-------IASALGYLHS 114
Query: 234 QLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW-LEHELQYQMRTSSARNHQFHLAETT 292
II+RD+K N++LDSQ + L DFGL + +EH T+
Sbjct: 115 ---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-----------------KTTS 154
Query: 293 RIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSG 331
GT YL PE +K D + G V+ E++ G
Sbjct: 155 TFCGTPEYLAPEVLRKQPYDRT-VDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 7e-13
Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCV 178
+GSG FG V+ VA+K + E G E+ F E + L H LV+L G C
Sbjct: 12 IGSGQFGLVWLGYWLEK-RKVAIKTIRE-GAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 179 HEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQ 238
+ LV+++M + L L + L + G+A YL +
Sbjct: 70 ERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLL--GMCLDVCEGMA----YLE---SSN 120
Query: 239 IIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTI 298
+IHRD+ N ++ ++ DFG+ R++ + QY +S+ +F +
Sbjct: 121 VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD-QY----TSSTGTKF----------PV 165
Query: 299 GYLPPESFQKGSVATAKSDVFSFGIVVLEVVS 330
+ PE F ++ KSDV+SFG+++ EV S
Sbjct: 166 KWSSPEVFSFSKYSS-KSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 7e-13
Identities = 60/229 (26%), Positives = 104/229 (45%), Gaps = 33/229 (14%)
Query: 117 EVLGSGGFGKVYRAVL----PSDGT-VVAVKCLAEKGE-RFEKTFAAELVAVAHLRHRNL 170
E LG FGKVY+ L P + T VA+K L +K E + F E + + L+H N+
Sbjct: 11 EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNI 70
Query: 171 VRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKK---------II 221
V L G E L +++ Y + L L R + + + + + K I+
Sbjct: 71 VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130
Query: 222 RGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSA 281
+AA + +L ++H+D+ T NV++ + N ++ D GL R + Y++ +S
Sbjct: 131 TQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSL 187
Query: 282 RNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS 330
I ++ PE+ G + SD++S+G+V+ EV S
Sbjct: 188 L--------------PIRWMSPEAIMYGKFSI-DSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 7e-13
Identities = 61/219 (27%), Positives = 103/219 (47%), Gaps = 30/219 (13%)
Query: 119 LGSGGFGKV----YRAVLPSDGTVVAVKCLA-EKGERFEKTFAAELVAVAHLRHRNLVRL 173
LG G FGKV Y + G VAVK L E G E+ + +L H N+V+
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 174 RGWCVHE--DQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYL 231
+G C + + + L+ +++P+ SL L P N +N +Q+ K + + YL
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYL---PRN---KNKINLKQQLKYAVQICKGMDYL 125
Query: 232 HEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAET 291
+ Q +HRD+ NV+++S++ ++GDFGL + +E + +Y + F A
Sbjct: 126 GSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYA-- 180
Query: 292 TRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS 330
PE + A SDV+SFG+ + E+++
Sbjct: 181 -----------PECLIQSKFYIA-SDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 8e-13
Identities = 60/221 (27%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCL-AEKGERFEKTFAAELVAVAHLRHRNLV 171
F + E +G G FG+VY+ + VVA+K + E+ E + E+ ++ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 172 RLRGWCVHEDQLLLVYDYMPNRS-LDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHY 230
R G + +L ++ +Y+ S LD L PL I+R + L Y
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALD---------LLKPGPLEETYIATILREILKGLDY 116
Query: 231 LHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAE 290
LH + + IHRD+K +NV+L Q + +L DFG+A Q+ + + + F
Sbjct: 117 LHSERK---IHRDIKAANVLLSEQGDVKLADFGVAG--------QLTDTQIKRNTFV--- 162
Query: 291 TTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSG 331
GT ++ PE K S K+D++S GI +E+ G
Sbjct: 163 -----GTPFWMAPEVI-KQSAYDFKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 1e-12
Identities = 66/237 (27%), Positives = 97/237 (40%), Gaps = 63/237 (26%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAH-------- 164
F+ + LG+G FG+V G A+K L K +L V H
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKIL-------SKAKIVKLKQVEHVLNEKRIL 55
Query: 165 --LRHRNLVRLRGWCVHEDQLLLVYDYMPNR---SLDRVLFRRPENLEAAAPLNWEQRKK 219
+RH LV L G + L LV +Y+P S R R PE
Sbjct: 56 QSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEP-------------- 101
Query: 220 IIRGLAA----ALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQ 275
+ R AA AL YLH I++RD+K N++LDS ++ DFG A+ ++
Sbjct: 102 VARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG----- 153
Query: 276 MRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKS-DVFSFGIVVLEVVSG 331
RT + + GT YL PE S K+ D ++ GI++ E+++G
Sbjct: 154 -RTYT-------------LCGTPEYLAPEIIL--SKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 58/221 (26%), Positives = 105/221 (47%), Gaps = 31/221 (14%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCL-AEKGERFEKTFAAELVAVAHLRHRNLV 171
F + E +G G FG+V++ + VVA+K + E+ E + E+ ++ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 172 RLRGWCVHEDQLLLVYDYMPNRS-LDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHY 230
+ G + +L ++ +Y+ S LD L R A P + Q +++ + L Y
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALD--LLR-------AGPFDEFQIATMLKEILKGLDY 116
Query: 231 LHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAE 290
LH + + IHRD+K +NV+L Q + +L DFG+A Q+ + + + F
Sbjct: 117 LHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAG--------QLTDTQIKRNTFV--- 162
Query: 291 TTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSG 331
GT ++ PE Q+ S +K+D++S GI +E+ G
Sbjct: 163 -----GTPFWMAPEVIQQ-SAYDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 59/218 (27%), Positives = 96/218 (44%), Gaps = 21/218 (9%)
Query: 518 SQRVAEMDFGTAYQGFL-----DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNL 572
S + E FG + G L + V VK + T E L L H+N+
Sbjct: 11 SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNI 70
Query: 573 VQLCGWCTEQGEM-LVIYDYSATRILSHLLFHNNHRIG----HSILQWHHRYNIIKSLAS 627
+ + C E GE V+Y Y L LF R+G L ++ +A
Sbjct: 71 LPILHVCIEDGEPPFVLYPYMNWGNLK--LFLQQCRLGEANNPQALSTQQLVHMAIQIAC 128
Query: 628 AILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVR 687
+ YLH VIH++I + +D ++ ++ AL+ L D+ H + NR V+
Sbjct: 129 GMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDY-HCLGDNENRPVK 184
Query: 688 GIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQM 724
+M+ E + + E +S +DV+SFGV++ E++T GQ
Sbjct: 185 ----WMALESLVNKEYSSASDVWSFGVLLWELMTLGQT 218
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 27/212 (12%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCV 178
LG+G FG V V A+K + E G E F E + L H LV+L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDV-AIKMIKE-GSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 179 HEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQ 238
+ + +V +YM N L L + + + L E K + G+A YL + Q
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLL--EMCKDVCEGMA----YLESK---Q 120
Query: 239 IIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTI 298
IHRD+ N ++D Q ++ DFGL+R++ + +Y +S+ +F +
Sbjct: 121 FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD-EY----TSSVGSKF----------PV 165
Query: 299 GYLPPESFQKGSVATAKSDVFSFGIVVLEVVS 330
+ PPE S ++KSDV++FG+++ EV S
Sbjct: 166 RWSPPEVLLY-SKFSSKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 27/215 (12%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVK-CLAEKGERFEKTFAAELVAVAHLRHRNLVRLRG 175
E+LG G FG+V++ L D T VAVK C + + + F +E + H N+V+L G
Sbjct: 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIG 59
Query: 176 WCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQL 235
C + +V + +P L ++ + L+ +Q K AA + YL +
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFLRKKKDELKT------KQLVKFALDAAAGMAYLESK- 112
Query: 236 ETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIG 295
IHRD+ N ++ ++ DFG++R E + Y SS+ Q
Sbjct: 113 --NCIHRDLAARNCLVGENNVLKISDFGMSRQ-EDDGIY----SSSGLKQI--------- 156
Query: 296 GTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS 330
I + PE+ G +++SDV+S+GI++ E S
Sbjct: 157 -PIKWTAPEALNYGRY-SSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 2e-12
Identities = 69/220 (31%), Positives = 99/220 (45%), Gaps = 33/220 (15%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAEL-VAVAHLRHRNLVR 172
+V+G G FGKV A SDG+ AVK L +K ++ + AE V + +L+H LV
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 173 LRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLH 232
L ++L V DY+ L L R LE A + +A+A+ YLH
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAE-------VASAIGYLH 113
Query: 233 EQLETQIIHRDVKTSNVMLDSQYNARLGDFGLAR-WLEHELQYQMRTSSARNHQFHLAET 291
II+RD+K N++LDSQ + L DFGL + +E E T
Sbjct: 114 SL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-----------------ETT 153
Query: 292 TRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSG 331
+ GT YL PE +K D + G V+ E++ G
Sbjct: 154 STFCGTPEYLAPEVLRKEPYDRT-VDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 67/229 (29%), Positives = 108/229 (47%), Gaps = 44/229 (19%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCV 178
LG+G FG+V+ + T VAVK L + G ++F E + LRH LV+L V
Sbjct: 14 LGNGQFGEVWMGTW-NGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQLYA-VV 70
Query: 179 HEDQLLLVYDYMPNRSL-------DRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYL 231
E+ + +V +YM SL + + P ++ AA + AA + Y+
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQV------------AAGMAYI 118
Query: 232 HEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAET 291
IHRD++++N+++ ++ DFGLAR +E +Y R + +F
Sbjct: 119 ERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDN-EYTARQGA----KF----- 165
Query: 292 TRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYP 340
I + PE+ G T KSDV+SFGI++ E+V+ R + YP
Sbjct: 166 -----PIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGR---VPYP 205
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 63/246 (25%), Positives = 104/246 (42%), Gaps = 32/246 (13%)
Query: 101 FSYAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVA---VKCLAEKGERFEK---- 153
FS +E YI LG G +GKV +A G +VA VK + + +
Sbjct: 4 FSISERYIQKGAH-----LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLV 58
Query: 154 -------TFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENL 206
T EL + ++H N++ L V D + LV D M L +V+ R+
Sbjct: 59 GMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIR-- 115
Query: 207 EAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLAR 266
L Q K I+ + L+ LH+ +HRD+ +N+ ++S+ ++ DFGLAR
Sbjct: 116 -----LTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGLAR 167
Query: 267 WLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVL 326
+ Y S Q T+++ T+ Y PE D++S G +
Sbjct: 168 RYGYPP-YSDTLSKDETMQRREEMTSKV-VTLWYRAPELLMGAEKYHFAVDMWSVGCIFA 225
Query: 327 EVVSGR 332
E+++G+
Sbjct: 226 ELLTGK 231
|
Length = 335 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 72/233 (30%), Positives = 105/233 (45%), Gaps = 36/233 (15%)
Query: 117 EVLGSGGFGKVYRA-VLPSDG--TVVAVKCLA--EKGERFEKTFAAELVAVAHLRHRNLV 171
V+G G FG VY ++ SDG AVK L E E+ F E + + H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQ-FLKEGIIMKDFSHPNVL 59
Query: 172 RLRGWCVHEDQL-LLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAA--L 228
L G C+ + L+V YM + L R R + N + I GL A +
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGDL-RNFIRSETH-------NPTVKDLIGFGLQVAKGM 111
Query: 229 HYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHL 288
YL + + +HRD+ N MLD + ++ DFGLAR + Y S NH
Sbjct: 112 EYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDI-----YDKEYYSVHNH---- 159
Query: 289 AETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPD 341
T + ++ ES Q T KSDV+SFG+++ E+++ R A YPD
Sbjct: 160 ---TGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMT-RGAP--PYPD 205
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 37/226 (16%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKT-----FAAELVAVAHLRHRNLV 171
++LG G FG+VY G +AVK + E E + E+ + +L H +V
Sbjct: 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67
Query: 172 RLRGWCVH---EDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAAL 228
+ G C+ E L + ++MP S+ + L++ L +K R + +
Sbjct: 68 QYYG-CLRDPMERTLSIFMEHMPGGSIK-------DQLKSYGALTENVTRKYTRQILEGV 119
Query: 229 HYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHL 288
YLH + I+HRD+K +N++ DS N +LGDFG +S R L
Sbjct: 120 SYLHSNM---IVHRDIKGANILRDSVGNVKLGDFG---------------ASKRLQTICL 161
Query: 289 AET--TRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
+ T + GT ++ PE G K+D++S G V+E+++ +
Sbjct: 162 SGTGMKSVTGTPYWMSPEVIS-GEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 71/306 (23%), Positives = 129/306 (42%), Gaps = 60/306 (19%)
Query: 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAA-------ELVAVA 163
F ++ +G G F VY+A+ DG VVA+K K + FE A E+ +
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALK----KVQIFEMMDAKARQDCLKEIDLLK 57
Query: 164 HLRHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVL--FRRPENLEAAAPLNWEQRKKII 221
L H N+++ + ++L +V + L R++ F++ + L W K
Sbjct: 58 QLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRL-IPERTIW----KYF 112
Query: 222 RGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSA 281
L +AL ++H + +I+HRD+K +NV + + +LGD GL R+ + T++A
Sbjct: 113 VQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK------TTAA 163
Query: 282 RNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPD 341
+ + GT Y+ PE + KSD++S G ++ E+ A+ +
Sbjct: 164 HS----------LVGTPYYMSPERIH-ENGYNFKSDIWSLGCLLYEMA----ALQSPFYG 208
Query: 342 DQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEH----LTHLALLCTLHNPHLRPS 397
D++ L ++ Y +H L L C +P RP
Sbjct: 209 DKMNLYSLC--------------KKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPD 254
Query: 398 MKWVIE 403
+ +V++
Sbjct: 255 ISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 60/224 (26%), Positives = 103/224 (45%), Gaps = 36/224 (16%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGW 176
E++G G FG V + G VAVK + K + + F E + L H+NLVRL G
Sbjct: 12 EIIGEGEFGAVLQG--EYTGQKVAVKNI--KCDVTAQAFLEETAVMTKLHHKNLVRLLGV 67
Query: 177 CVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLE 236
+H L +V + M +L L R A ++ Q + +A + YL +
Sbjct: 68 ILHNG-LYIVMELMSKGNLVNFLRTR-----GRALVSVIQLLQFSLDVAEGMEYLESK-- 119
Query: 237 TQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGG 296
+++HRD+ N+++ A++ DFGLAR + + +++
Sbjct: 120 -KLVHRDLAARNILVSEDGVAKVSDFGLAR------------VGSMG-----VDNSKL-- 159
Query: 297 TIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYP 340
+ + PE+ + ++ KSDV+S+G+++ EV S RA YP
Sbjct: 160 PVKWTAPEALKHKKFSS-KSDVWSYGVLLWEVFSYGRA---PYP 199
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 59/241 (24%), Positives = 114/241 (47%), Gaps = 35/241 (14%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCL---AEKGERFEKTFAAELVAVAHLRHRN 169
F + E LG G + VY+ + G +VA+K + AE+G T E+ + L+H N
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGT--PSTAIREISLMKELKHEN 59
Query: 170 LVRLRGWCVHEDQLLLVYDYMPN---RSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAA 226
+VRL E++L+LV++YM + +D R + ++ +++G+A
Sbjct: 60 IVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQ----LLKGIA- 114
Query: 227 ALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQF 286
+ HE +++HRD+K N++++ + +L DFGLAR + + ++ N
Sbjct: 115 ---FCHEN---RVLHRDLKPQNLLINKRGELKLADFGLAR------AFGIPVNTFSNEVV 162
Query: 287 HLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIIL 346
T+ Y P+ + D++S G ++ E+++GR T +DQ++
Sbjct: 163 ----------TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLK 212
Query: 347 L 347
+
Sbjct: 213 I 213
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 59/220 (26%), Positives = 104/220 (47%), Gaps = 33/220 (15%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCL---AEKGERFEKTFAAELVAVAHLRHRNLVRL 173
E LG G + VY+ + +G +VA+K + E+G F A L+ L+H N+V L
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLK--GLKHANIVLL 68
Query: 174 RGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRK-KIIRGLAAALHYLH 232
++ L V++YM + L + + + P L P N +++RGLA Y+H
Sbjct: 69 HDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLH---PYNVRLFMFQLLRGLA----YIH 120
Query: 233 EQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETT 292
Q I+HRD+K N+++ +L DFGLAR + + Q + +E
Sbjct: 121 GQ---HILHRDLKPQNLLISYLGELKLADFGLAR------------AKSIPSQTYSSEVV 165
Query: 293 RIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
T+ Y PP+ + ++ D++ G + +E++ G+
Sbjct: 166 ----TLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 62/232 (26%), Positives = 103/232 (44%), Gaps = 37/232 (15%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGER--FEKTFAAELVAVAHLRHRNL 170
FD +G G +G+VY+A G +VA+K + E+ F T E+ + L HRN+
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68
Query: 171 VRLRGWCVHEDQLL----------LVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKI 220
V L+ + L LV++YM D L E+ + + K
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYM-----DHDLMGLLES--GLVHFSEDHIKSF 121
Query: 221 IRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSS 280
++ L L+Y H+ +HRD+K SN++L+++ +L DFGLAR E
Sbjct: 122 MKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSE--------E 170
Query: 281 ARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
+R + T ++ T+ Y PPE DV+S G ++ E+ + +
Sbjct: 171 SRPY------TNKV-ITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 59/224 (26%), Positives = 105/224 (46%), Gaps = 37/224 (16%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCL-----AEKGERFEKTFAAELVAVAHLRHRNLV 171
++LG G FG+VY G +AVK + +++ + E+ + +LRH +V
Sbjct: 8 KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67
Query: 172 RLRGWCV--HEDQLLLVY-DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAAL 228
+ G C+ E++ L ++ +YMP S+ + L+A L ++ R + +
Sbjct: 68 QYYG-CLRDPEEKKLSIFVEYMPGGSIK-------DQLKAYGALTENVTRRYTRQILQGV 119
Query: 229 HYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHL 288
YLH + I+HRD+K +N++ DS N +LGDFG +S R +
Sbjct: 120 SYLHSNM---IVHRDIKGANILRDSAGNVKLGDFG---------------ASKRIQTICM 161
Query: 289 AET--TRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS 330
+ T + GT ++ PE G K+DV+S V+E+++
Sbjct: 162 SGTGIKSVTGTPYWMSPEVIS-GEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 64/222 (28%), Positives = 102/222 (45%), Gaps = 30/222 (13%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCV 178
LG G FG+V+ + T VA+K L + G + F E + LRH LV+L V
Sbjct: 14 LGQGCFGEVWMGTW-NGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VV 70
Query: 179 HEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQ 238
E+ + +V +YM SL L E L Q + +A+ + Y+
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFL-----KGEMGKYLRLPQLVDMAAQIASGMAYVERM---N 122
Query: 239 IIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTI 298
+HRD++ +N+++ ++ DFGLAR +E +Y R + +F I
Sbjct: 123 YVHRDLRAANILVGENLVCKVADFGLARLIEDN-EYTARQGA----KF----------PI 167
Query: 299 GYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYP 340
+ PE+ G T KSDV+SFGI++ E+ + R + YP
Sbjct: 168 KWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGR---VPYP 205
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 57/229 (24%), Positives = 100/229 (43%), Gaps = 33/229 (14%)
Query: 117 EVLGSGGFGKVYRAVLPSDGT----VVAVKCLAEKGERFEKT-FAAELVAVAHLRHRNLV 171
E LG FGK+Y+ L G +VA+K L + + F E +A L H N+V
Sbjct: 11 EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIV 70
Query: 172 RLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRP----------ENLEAAAPLNWEQRKKII 221
L G E + ++++Y+ L L R E+ + L+ I
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 222 RGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSA 281
+AA + YL +H+D+ N+++ Q + ++ D GL+R + Y+++ S
Sbjct: 131 IQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187
Query: 282 RNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS 330
I ++PPE+ G ++ SD++SFG+V+ E+ S
Sbjct: 188 L--------------PIRWMPPEAIMYGKFSS-DSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 5e-12
Identities = 59/236 (25%), Positives = 108/236 (45%), Gaps = 42/236 (17%)
Query: 117 EVLGSGGFGKVYRAVLPSDG----------------TVVAVKCL-AEKGERFEKTFAAEL 159
E LG G FG+V+ + ++G +VAVK L A+ + F E+
Sbjct: 11 EKLGEGQFGEVH--LCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68
Query: 160 VAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRP--ENLEAAAPLNWEQR 217
++ L++ N++RL G CV +D L ++ +YM N L++ L +R A +
Sbjct: 69 KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128
Query: 218 KKIIR---GLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQY 274
++ +A+ + YL +HRD+ T N ++ + Y ++ DFG++R L Y
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185
Query: 275 QMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS 330
+++ + I ++ ES G TA SDV++FG+ + E+ +
Sbjct: 186 RIQGRAVL--------------PIRWMAWESILLGKFTTA-SDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 5e-12
Identities = 54/218 (24%), Positives = 94/218 (43%), Gaps = 33/218 (15%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVKCLAEK---GERFEKTFAAELVAVAHLRHRNLVRLRG 175
LG GGFG+V + S A+KC+ ++ ++ +E + H +V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 176 WCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQL 235
+ + ++ +Y L +L R + + I + A YLH +
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDR-------GLFDEYTARFYIACVVLAFEYLHNR- 112
Query: 236 ETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIG 295
II+RD+K N++LDS +L DFG A+ +L+ +T +
Sbjct: 113 --GIIYRDLKPENLLLDSNGYVKLVDFGFAK----KLKSGQKTWT-------------FC 153
Query: 296 GTIGYLPPESFQ-KGSVATAKSDVFSFGIVVLEVVSGR 332
GT Y+ PE KG + D +S GI++ E+++GR
Sbjct: 154 GTPEYVAPEIILNKGYDFSV--DYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 6e-12
Identities = 60/239 (25%), Positives = 103/239 (43%), Gaps = 47/239 (19%)
Query: 117 EVLGSGGFGKVY----------------RAVLPSDGTVVAVKCLAEKGERFEKT-FAAEL 159
E LG G FG+V+ V + +VAVK L E + + F E+
Sbjct: 11 EKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEI 70
Query: 160 VAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFR-RPEN---LEAAAPLNWE 215
++ L+ N++RL C+ D L ++ +YM N L++ L R P+ +++
Sbjct: 71 KIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYS 130
Query: 216 QRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQ 275
+ +A+ + YL +HRD+ T N ++ Y ++ DFG++R L Y
Sbjct: 131 TLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYY- 186
Query: 276 MRTSSARNHQFHLAETTRIGG----TIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS 330
RI G I ++ ES G TA SDV++FG+ + E+++
Sbjct: 187 -----------------RIQGRAVLPIRWMSWESILLGKFTTA-SDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 7e-12
Identities = 62/244 (25%), Positives = 102/244 (41%), Gaps = 53/244 (21%)
Query: 116 DEVLGSGGFGKVYRAV------LPSDGTVVAVKCLAEKGERFE-KTFAAELVAVAHLRHR 168
+ LG G FGKV +A T VAVK L E E + +E + + H
Sbjct: 5 GKTLGEGEFGKVVKATAFRLKGRAGY-TTVAVKMLKENASSSELRDLLSEFNLLKQVNHP 63
Query: 169 NLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRK---------- 218
++++L G C + LLL+ +Y SL R R + + + R
Sbjct: 64 HVIKLYGACSQDGPLLLIVEYAKYGSL-RSFLRESRKVGPSYLGSDGNRNSSYLDNPDER 122
Query: 219 ------------KIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLAR 266
+I RG+ YL E +++HRD+ NV++ ++ DFGL+R
Sbjct: 123 ALTMGDLISFAWQISRGMQ----YLA---EMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175
Query: 267 WLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVL 326
+ E Y R+ RI + ++ ES + T +SDV+SFG+++
Sbjct: 176 DVYEEDSYVKRSKG------------RI--PVKWMAIESLFD-HIYTTQSDVWSFGVLLW 220
Query: 327 EVVS 330
E+V+
Sbjct: 221 EIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 7e-12
Identities = 65/220 (29%), Positives = 98/220 (44%), Gaps = 28/220 (12%)
Query: 118 VLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVA--VAHLRHRNLVRLR- 174
V+G G +G+V +DG +K L + + AAE A ++ L+H N+V R
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66
Query: 175 GWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQ 234
W + L +V + L L + L L Q + +A AL YLHE+
Sbjct: 67 SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKL-----LPENQVVEWFVQIAMALQYLHEK 121
Query: 235 LETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRI 294
I+HRD+KT NV L ++GD G+AR LE+ Q M ++ +
Sbjct: 122 ---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN--QCDMAST--------------L 162
Query: 295 GGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRA 334
GT Y+ PE F KSDV++ G V E+ + + A
Sbjct: 163 IGTPYYMSPELFSNKPY-NYKSDVWALGCCVYEMATLKHA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 8e-12
Identities = 47/196 (23%), Positives = 86/196 (43%), Gaps = 22/196 (11%)
Query: 534 LDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSA 593
L N++ V +KR+ + KC E+Q +++ H N+V+ E+ ++ Y +
Sbjct: 23 LPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS 82
Query: 594 TRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLD 653
L ++ L ++K + + YLH N Q IHR+I + I L
Sbjct: 83 GGSLLDIM---KSSYPRGGLDEAIIATVLKEVLKGLEYLHS--NGQ-IHRDIKAGNILLG 136
Query: 654 PDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVR------GIFGYMSPEYIESGEA-TSM 706
D + ++ F ++ L A G+R+ + G +M+PE +E
Sbjct: 137 EDGSVKIADFGVSASL---------ADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFK 187
Query: 707 ADVYSFGVVVLEVVTG 722
AD++SFG+ +E+ TG
Sbjct: 188 ADIWSFGITAIELATG 203
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 8e-12
Identities = 55/219 (25%), Positives = 98/219 (44%), Gaps = 35/219 (15%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVKCL-AEKGERFEKTFAAELVAVAHLRHRNLVRLRGWC 177
+GSG G VY+ + G + A+K + + + E+ + + H N+V+
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF 141
Query: 178 VHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLET 237
H ++ ++ ++M SL+ + L A ++I+ G+A YLH +
Sbjct: 142 DHNGEIQVLLEFMDGGSLEGTHIADEQFLADVA-------RQILSGIA----YLHRR--- 187
Query: 238 QIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGT 297
I+HRD+K SN++++S N ++ DFG++R L +T N GT
Sbjct: 188 HIVHRDIKPSNLLINSAKNVKIADFGVSRILA-------QTMDPCNSSV---------GT 231
Query: 298 IGYLPPE----SFQKGSVATAKSDVFSFGIVVLEVVSGR 332
I Y+ PE G+ D++S G+ +LE GR
Sbjct: 232 IAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 68/285 (23%), Positives = 120/285 (42%), Gaps = 63/285 (22%)
Query: 526 FGTAYQGF-LDNHQYVLVKRL-----GMSKCPALRTRFSNELQNLARLRHRNLVQLCGWC 579
FG+ Y+G LD+ + VK + G + A++ + E+ L++L+H N+VQ G
Sbjct: 13 FGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVK-QLEQEIALLSKLQHPNIVQYLGTE 71
Query: 580 TEQGEMLVIYDYSATRILSHLLFHNNHRIG---HSILQWHHRYNIIKSLASAILYLHEEW 636
E+ + + + L+ LL + G +++ + R I+ L YLH
Sbjct: 72 REEDNLYIFLELVPGGSLAKLL----KKYGSFPEPVIRLYTR-QILLGLE----YLH--- 119
Query: 637 NEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPE 696
+ +HR+I + I +D + +L F +A+ S +S +G +M+PE
Sbjct: 120 DRNTVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAKSFKGSPYWMAPE 171
Query: 697 YIES-GEATSMADVYSFGVVVLEVVTG--------QMAVDFRLPEGLLVKRVHEFEARKR 747
I G AD++S G VLE+ TG +A F++ R +
Sbjct: 172 VIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKI-------------GRSK 218
Query: 748 PLAELVD-LSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQIL 791
L + D LS K+ + C +P LRP+ ++L
Sbjct: 219 ELPPIPDHLSDEA----KDFILK------CLQRDPSLRPTAAELL 253
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 1e-11
Identities = 55/215 (25%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGW 176
E +G G G VY A+ + G VA+K + + + ++ E++ + +H N+V
Sbjct: 25 EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDS 84
Query: 177 CVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLE 236
+ D+L +V +Y+ SL V+ ++ Q + R AL +LH
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVV--------TETCMDEGQIAAVCRECLQALEFLHSN-- 134
Query: 237 TQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGG 296
Q+IHRD+K+ N++L + +L DFG + E S R + + G
Sbjct: 135 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-------QSKR---------STMVG 177
Query: 297 TIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSG 331
T ++ PE + + K D++S GI+ +E+V G
Sbjct: 178 TPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 61/222 (27%), Positives = 101/222 (45%), Gaps = 30/222 (13%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLA-EKGERFEKTFAA-ELVAVAHLRHRNL 170
++ + +G G FGK+Y A SD +K + K EK + E++ +A ++H N+
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61
Query: 171 VRLRGWCVHEDQLLLVYDYMPNRSL-DRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALH 229
V +L +V +Y L R+ +R L+W + ++ L
Sbjct: 62 VTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQ------ISLGLK 115
Query: 230 YLHEQLETQIIHRDVKTSNVMLDSQ-YNARLGDFGLARWLEHELQYQMRTSSARNHQFHL 288
++H++ +I+HRD+K+ N+ L A+LGDFG+AR L N L
Sbjct: 116 HIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL--------------NDSMEL 158
Query: 289 AETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS 330
A T GT YL PE Q K+D++S G V+ E+ +
Sbjct: 159 AYTC--VGTPYYLSPEICQNRPY-NNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 1e-11
Identities = 39/166 (23%), Positives = 75/166 (45%), Gaps = 17/166 (10%)
Query: 112 GFDEDEVLGSGGFGKVYRAVL--PSDGTVVAVKCL---AEKGERFEKTFAAELVAVAHLR 166
++ + +G G +G+VY+A DG A+K E+ ++ E+ + L+
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 167 HRNLVRLRGWCVH--EDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGL 224
H N+V L + + + L++DY + + F R + K ++ +
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAK---RVSIPPSMVKSLLWQI 117
Query: 225 AAALHYLHEQLETQIIHRDVKTSNVMLDSQYNAR----LGDFGLAR 266
+HYLH ++HRD+K +N+++ + R +GD GLAR
Sbjct: 118 LNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 60/227 (26%), Positives = 110/227 (48%), Gaps = 29/227 (12%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAA--ELVAVAHLRHRNL 170
+++ V+G G FG V+ +D +V +K + + ++ AA E + L H N+
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61
Query: 171 VRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHY 230
+ + + L++V +Y P +L + +R +L L+ + + ALH+
Sbjct: 62 IEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSL-----LDEDTILHFFVQILLALHH 116
Query: 231 LHEQLETQIIHRDVKTSNVMLDSQYN-ARLGDFGLARWLEHELQYQMRTSSARNHQFHLA 289
+H +L I+HRD+KT N++LD ++GDFG+++ L + S A
Sbjct: 117 VHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILS--------SKSK-------A 158
Query: 290 ETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVD 336
T + GT Y+ PE +G KSD+++ G V+ E+ S +RA +
Sbjct: 159 YT--VVGTPCYISPE-LCEGKPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 35/216 (16%)
Query: 119 LGSGGFGKV----YRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLR 174
LGSG FG V +RA + VA+K + E G E+ F E + L H LV+L
Sbjct: 12 LGSGQFGVVHLGKWRAQIK-----VAIKAINE-GAMSEEDFIEEAKVMMKLSHPKLVQLY 65
Query: 175 GWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQ 234
G C + L +V ++M N L L +R L L+ + + + + YL
Sbjct: 66 GVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLS------MCQDVCEGMEYLE-- 117
Query: 235 LETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRI 294
IHRD+ N ++ S ++ DFG+ R++ + +Y +S+ +F
Sbjct: 118 -RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD-EY----TSSSGAKF-------- 163
Query: 295 GGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS 330
+ + PPE F S ++KSDV+SFG+++ EV +
Sbjct: 164 --PVKWSPPEVFNF-SKYSSKSDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 25/215 (11%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVK-CLAEKGERFEKTFAAELVAVAHLRHRNLVRLRG 175
E +G G FG+V+ L +D T VAVK C + F E + H N+VRL G
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 176 WCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQL 235
C + + +V + + + D + F R E L ++ +++ AA + YL +
Sbjct: 61 VCTQKQPIYIVMELV--QGGDFLTFLRTE----GPRLKVKELIQMVENAAAGMEYLESK- 113
Query: 236 ETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIG 295
IHRD+ N ++ + ++ DFG++R E + + S+ Q
Sbjct: 114 --HCIHRDLAARNCLVTEKNVLKISDFGMSR----EEEDGVYASTGGMKQI--------- 158
Query: 296 GTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS 330
+ + PE+ G +++SDV+SFGI++ E S
Sbjct: 159 -PVKWTAPEALNYGRY-SSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 1e-11
Identities = 55/215 (25%), Positives = 100/215 (46%), Gaps = 28/215 (13%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGW 176
E +G G G V+ A+ + G VA+K + + + ++ E++ + L++ N+V
Sbjct: 25 EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDS 84
Query: 177 CVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLE 236
+ D+L +V +Y+ SL V+ ++ Q + R AL +LH
Sbjct: 85 FLVGDELFVVMEYLAGGSLTDVV--------TETCMDEAQIAAVCRECLQALEFLHAN-- 134
Query: 237 TQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGG 296
Q+IHRD+K+ NV+L + +L DFG + E Q + S+ + G
Sbjct: 135 -QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE---QSKRST-------------MVG 177
Query: 297 TIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSG 331
T ++ PE + + K D++S GI+ +E+V G
Sbjct: 178 TPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 72/298 (24%), Positives = 132/298 (44%), Gaps = 52/298 (17%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAA-------ELVAVAHL 165
F ++ +G G F +VYRA DG VA+K K + F+ A E+ + L
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALK----KVQIFDLMDAKARADCIKEIDLLKQL 59
Query: 166 RHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVL--FRRPENLEAAAPLNWEQRKKIIRG 223
H N+++ + +++L +V + L R++ F++ + L + W K
Sbjct: 60 NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTV-W----KYFVQ 114
Query: 224 LAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARN 283
L +AL ++H + +++HRD+K +NV + + +LGD GL R+ + +T++A +
Sbjct: 115 LCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRF------FSSKTTAAHS 165
Query: 284 HQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQ 343
+ GT Y+ PE + KSD++S G ++ E+ A+ + D+
Sbjct: 166 ----------LVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMA----ALQSPFYGDK 210
Query: 344 IILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWV 401
+ L + K+ Q L Y E L L +C +P RP + +V
Sbjct: 211 MNLYSLCK------KIEQCDYPPLPSDHYS----EELRQLVNMCINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 64/220 (29%), Positives = 101/220 (45%), Gaps = 32/220 (14%)
Query: 117 EVLGSGGFGKVY--RAVLPSD-GTVVAVKCL--AEKGERFEKTFAAELVAVAHLRHRNLV 171
+VLG G FGKV+ R + D G + A+K L A R E +A + H +V
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 172 RLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYL 231
+L E +L L+ D++ R D LF R L E K + LA AL +L
Sbjct: 62 KLHYAFQTEGKLYLILDFL--RGGD--LFTR---LSKEVMFTEEDVKFYLAELALALDHL 114
Query: 232 HEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAET 291
H II+RD+K N++LD + + +L DFGL++ H +
Sbjct: 115 HS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESID----------------HEKKA 155
Query: 292 TRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSG 331
GT+ Y+ PE + + +D +SFG+++ E+++G
Sbjct: 156 YSFCGTVEYMAPEVVNRRGHTQS-ADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 45/152 (29%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVKCLAEKGE--RFEKTFAAELVAVAHLRHRNLVRLRGW 176
+G G +G V++ G +VA+K E + +K E+ + L+H NLV L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 177 CVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLE 236
+ +L LV++Y + L+ L + P + KKII A+++ H+
Sbjct: 69 FRRKRKLHLVFEYCDHTVLN-ELEKNPRGV------PEHLIKKIIWQTLQAVNFCHKH-- 119
Query: 237 TQIIHRDVKTSNVMLDSQYNARLGDFGLARWL 268
IHRDVK N+++ Q +L DFG AR L
Sbjct: 120 -NCIHRDVKPENILITKQGQIKLCDFGFARIL 150
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 32/215 (14%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVKCL-AEKGERFEKTFAAELVAVAHLRHRNLVRLRGWC 177
+G G G V A S G VAVK + K +R E F E+V + +H N+V +
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFN-EVVIMRDYQHPNIVEMYSSY 85
Query: 178 VHEDQLLLVYDYMPNRSL-DRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLE 236
+ D+L +V +++ +L D V R +N EQ + + AL +LH Q
Sbjct: 86 LVGDELWVVMEFLEGGALTDIVTHTR---------MNEEQIATVCLAVLKALSFLHAQ-- 134
Query: 237 TQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGG 296
+IHRD+K+ +++L S +L DFG + E+ R S + G
Sbjct: 135 -GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV--PRRKS--------------LVG 177
Query: 297 TIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSG 331
T ++ PE + T + D++S GI+V+E+V G
Sbjct: 178 TPYWMAPEVISRLPYGT-EVDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 61/235 (25%), Positives = 109/235 (46%), Gaps = 31/235 (13%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKC--LAEKGERFEKTFAAELVAVAHLRHRNL 170
F + E +G G +G VY+A G VVA+K L + E T E+ + L H N+
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 171 VRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHY 230
V+L E++L LV++++ ++ L + + + + + K + L L +
Sbjct: 62 VKLLDVIHTENKLYLVFEFL-HQDLKKFM-----DASPLSGIPLPLIKSYLFQLLQGLAF 115
Query: 231 LHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAE 290
H +++HRD+K N++++++ +L DFGLAR +RT + H+
Sbjct: 116 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR----AFGVPVRTYT---HEVV--- 162
Query: 291 TTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQII 345
T+ Y PE + D++S G + E+V+ RRA+ +P D I
Sbjct: 163 ------TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL---FPGDSEI 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 63/234 (26%), Positives = 110/234 (47%), Gaps = 44/234 (18%)
Query: 119 LGSGGFGKVYRAVL-------PSDGTVVAVKCLAEKGERFEKTFAAELVAVAHL-----R 166
LG G FG+V A P+ T VAVK L K + EK + +L++ + +
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKML--KSDATEKDLS-DLISEMEMMKMIGK 82
Query: 167 HRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVL-FRRPENLE-----AAAPLNWEQRKKI 220
H+N++ L G C + L ++ +Y +L L RRP +E P K +
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 221 IR---GLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMR 277
+ +A + YL + + IHRD+ NV++ ++ DFGLAR + H + Y +
Sbjct: 143 VSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDI-HHIDYYKK 198
Query: 278 TSSARNHQFHLAETTRIGGTIGYLPPES-FQKGSVATAKSDVFSFGIVVLEVVS 330
T++ R + ++ PE+ F + + T +SDV+SFG+++ E+ +
Sbjct: 199 TTNGRL-------------PVKWMAPEALFDR--IYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-11
Identities = 83/356 (23%), Positives = 151/356 (42%), Gaps = 62/356 (17%)
Query: 119 LGSGGFGKVYRAVL-------PSDGTVVAVKCLAEKG-ERFEKTFAAELVAVAHL-RHRN 169
LG G FG+V A P+ VAVK L + ++ +E+ + + +H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 170 LVRLRGWCVHEDQLLLVYDYMPNRSLDRVL-FRRPENLEAA--------APLNWEQRKKI 220
++ L G C + L ++ +Y +L L RRP ++ + L ++
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 221 IRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSS 280
+A + YL Q + IHRD+ NV++ ++ DFGLAR + H + Y +T++
Sbjct: 140 AYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDV-HNIDYYKKTTN 195
Query: 281 ARNHQFHLAETTRIGGTIGYLPPES-FQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTY 339
R + ++ PE+ F + V T +SDV+SFG+++ E+ + + Y
Sbjct: 196 GRL-------------PVKWMAPEALFDR--VYTHQSDVWSFGVLLWEIFTLGGS---PY 237
Query: 340 PDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMK 399
P I ++ + +L EG + N C E L + C P RP+ K
Sbjct: 238 PG---IPVEELFKLLKEGHRMDKPAN---------CTHE-LYMIMRECWHAVPSQRPTFK 284
Query: 400 WVIEAVSGSYSGKLPALPSFQSHPLYISLSSPTNTSTSNTETTRSTNTTASNTTIA 455
++E L + + S Y+ LS P + + S+ ++ ++ A
Sbjct: 285 QLVE--------DLDRVLTVTSTDEYLDLSVPFEQYSPGCPDSPSSCSSGDDSVFA 332
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 53/219 (24%), Positives = 100/219 (45%), Gaps = 30/219 (13%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLA-EKGERFEKTFAAELVAVAHLRHRNLV 171
F+ + +GSG +G VY+A + G + A+K + E GE F E++ + +H N+V
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFA-VVQQEIIMMKDCKHSNIV 69
Query: 172 RLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYL 231
G + D+L + ++ SL + PL+ Q + R L+YL
Sbjct: 70 AYFGSYLRRDKLWICMEFCGGGSLQDIY-------HVTGPLSESQIAYVSRETLQGLYYL 122
Query: 232 HEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAET 291
H + + +HRD+K +N++L + +L DFG++ Q+ + A+ F
Sbjct: 123 HSKGK---MHRDIKGANILLTDNGHVKLADFGVSA--------QITATIAKRKSFI---- 167
Query: 292 TRIGGTIGYLPPE--SFQKGSVATAKSDVFSFGIVVLEV 328
GT ++ PE + ++ D+++ GI +E+
Sbjct: 168 ----GTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 42/152 (27%), Positives = 81/152 (53%), Gaps = 10/152 (6%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKC--LAEKGERFEKTFAAELVAVAHLRHRNLVRLR 174
E +G G +G VY+ G +VA+K L + E T E+ + L+H N+V L+
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQ 65
Query: 175 GWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQ 234
+ E +L L+++++ S+D L + ++L ++ E K + + + + H +
Sbjct: 66 DVLMQESRLYLIFEFL---SMD--LKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120
Query: 235 LETQIIHRDVKTSNVMLDSQYNARLGDFGLAR 266
+++HRD+K N+++D++ +L DFGLAR
Sbjct: 121 ---RVLHRDLKPQNLLIDNKGVIKLADFGLAR 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 5e-11
Identities = 60/286 (20%), Positives = 116/286 (40%), Gaps = 39/286 (13%)
Query: 515 FSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQ 574
F+ +++ FG ++G N V +K L + F E+Q L RLRH++L+
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQD-FQKEVQALKRLRHKHLIS 66
Query: 575 LCGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHE 634
L C+ + +I + L L + +L ++ +A + YL E
Sbjct: 67 LFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQ----VLPVASLIDMACQVAEGMAYLEE 122
Query: 635 EWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMS 694
+ IHR++ + I + D+ ++ F LA + + + ++ + + +
Sbjct: 123 ---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY---LSSDKKIPYK----WTA 172
Query: 695 PEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEAR----KRPL 749
PE G ++ +DV+SFG+++ E+ T GQ+ G+ V++ P
Sbjct: 173 PEAASHGTFSTKSDVWSFGILLYEMFTYGQVPY-----PGMNNHEVYDQITAGYRMPCPA 227
Query: 750 AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795
++ Y +M C + PE RPS + + LD
Sbjct: 228 KCPQEI-----YK---IML------ECWAAEPEDRPSFKALREELD 259
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 61/224 (27%), Positives = 103/224 (45%), Gaps = 35/224 (15%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCL-AEKGERFEKTFAAELVAVAHLRHRNLV 171
F++ LG+G G V + + G ++A K + E EL + +V
Sbjct: 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIV 62
Query: 172 RLRGWCVHEDQLLLVYDYMPNRSLDRVLF---RRPENLEAAAPLNWEQRKKIIRGLAAAL 228
G + ++ + ++M SLD+VL R PEN+ + ++RGL
Sbjct: 63 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILG------KISIAVLRGLT--- 113
Query: 229 HYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHL 288
YL E+ +I+HRDVK SN++++S+ +L DFG++ +L M S
Sbjct: 114 -YLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFV------- 159
Query: 289 AETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
GT Y+ PE Q G+ T +SD++S G+ ++E+ GR
Sbjct: 160 -------GTRSYMSPERLQ-GTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 64/230 (27%), Positives = 107/230 (46%), Gaps = 36/230 (15%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVA-HLRHRNLV 171
F+ EV+G+G +G+VY+ G + A+K + + E E+ E+ + + HRN+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTEDEEEEIKLEINMLKKYSHHRNIA 76
Query: 172 RLRGWCV------HEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLA 225
G + H+DQL LV ++ S+ ++ N + + R+ I+RGLA
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICRE-ILRGLA 135
Query: 226 AALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQ 285
+LH ++IHRD+K NV+L +L DFG++ L+ RT RN
Sbjct: 136 ----HLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD-------RTVGRRN-- 179
Query: 286 FHLAETTRIGGTIGYLPPESF----QKGSVATAKSDVFSFGIVVLEVVSG 331
T I GT ++ PE + +SD++S GI +E+ G
Sbjct: 180 ------TFI-GTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 5e-11
Identities = 62/227 (27%), Positives = 90/227 (39%), Gaps = 49/227 (21%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVA---VAHLRHRNLVRLRG 175
LG GGFG+V + + G + A K L +K + K L + + R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 176 WCVHEDQLLLVYDYMPNRSL-------DRVLFRRPENLEAAAPLNWEQRKKIIRGLAAAL 228
+D L LV M L F + AA +II G L
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAA--------QIICG----L 108
Query: 229 HYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHL 288
+LH++ +I++RD+K NV+LD N R+ D GLA L
Sbjct: 109 EHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLA--------------------VEL 145
Query: 289 AETTRI---GGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
+I GT GY+ PE Q V D F+ G + E+++GR
Sbjct: 146 KGGKKIKGRAGTPGYMAPEVLQGE-VYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 6e-11
Identities = 47/221 (21%), Positives = 87/221 (39%), Gaps = 34/221 (15%)
Query: 500 PREISFKEIISATNNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKC-PALRTRFS 558
+E+ I FG G Q V VK K F
Sbjct: 5 SKELKLGATIGKGE------------FGDVMLGDYRG-QKVAVK---CLKDDSTAAQAFL 48
Query: 559 NELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHR 618
E + LRH NLVQL G + + ++ +Y A L L R G +++ +
Sbjct: 49 AEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYL---RSR-GRAVITLAQQ 104
Query: 619 YNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRK 678
+ + YL E+ +HR++ + + + D+ ++ F LA ++
Sbjct: 105 LGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLA----------KE 151
Query: 679 ATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEV 719
A+ G S + + +PE + + ++ +DV+SFG+++ E+
Sbjct: 152 ASQGQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 7e-11
Identities = 57/217 (26%), Positives = 97/217 (44%), Gaps = 34/217 (15%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLA-EKGERFEKTFAAELVAVAHLRHRNLVRLRG 175
E+LG G G VY+A ++AVK + + +K +EL + ++ G
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYG 66
Query: 176 WCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQL 235
E+++ + ++M SLD V + PE++ +I + L YL
Sbjct: 67 AFFVENRISICTEFMDGGSLD-VYRKIPEHVLG----------RIAVAVVKGLTYL---W 112
Query: 236 ETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIG 295
+I+HRDVK SN++++++ +L DFG++ Q+ S A+ +
Sbjct: 113 SLKILHRDVKPSNMLVNTRGQVKLCDFGVST--------QLVNSIAKTYV---------- 154
Query: 296 GTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
GT Y+ PE G SDV+S GI +E+ GR
Sbjct: 155 GTNAYMAPERIS-GEQYGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 8e-11
Identities = 56/246 (22%), Positives = 94/246 (38%), Gaps = 46/246 (18%)
Query: 559 NELQNLARLRHRNLVQLCGW-CTEQGEMLVIY-DYSATRILSHLLFH---NNHRIGHSIL 613
+E+ L L+H N+V+ + L I +Y L+ L+ I +
Sbjct: 48 SEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFI 107
Query: 614 QWHHRYNIIKSLASAILYLH--EEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTR 671
W I+ L A+ H + V+HR++ + I LD + N +LG F LA+ L
Sbjct: 108 -W----RILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL-- 160
Query: 672 NDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLP 731
H A + G YMSPE + +D++S G ++ E+
Sbjct: 161 -GHDSSFAK----TYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS-------- 207
Query: 732 EGLLVKRVHEFEARKRPLAELVDLSLNGEYN------HKELMRLIKLGIACTLSNPELRP 785
F AR + +L G++ EL +IK + +P+ RP
Sbjct: 208 --------PPFTARNQ--LQLASKIKEGKFRRIPYRYSSELNEVIK---SMLNVDPDKRP 254
Query: 786 SMRQIL 791
S ++L
Sbjct: 255 STEELL 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 9e-11
Identities = 70/220 (31%), Positives = 99/220 (45%), Gaps = 33/220 (15%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK---GERFEKTFAAEL-VAVAHLRHRNLVR 172
+V+G G FGKV A DG AVK L +K + +K AE V + +++H LV
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 173 LRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKI-IRGLAAALHYL 231
L ++L V D++ L L R E + P E R + +A+AL YL
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQR-----ERSFP---EPRARFYAAEIASALGYL 112
Query: 232 HEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAET 291
H I++RD+K N++LDSQ + L DFGL + E Q T T
Sbjct: 113 HS---INIVYRDLKPENILLDSQGHVVLTDFGLCK----EGIAQSDT------------T 153
Query: 292 TRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSG 331
T GT YL PE +K D + G V+ E++ G
Sbjct: 154 TTFCGTPEYLAPEVIRKQPYDNT-VDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 9e-11
Identities = 63/234 (26%), Positives = 96/234 (41%), Gaps = 45/234 (19%)
Query: 114 DEDEV---LGSGGFGKVYRAVLPSDGTVVAVKCLA-EKGERFEKTFAAELVAVAHLRHRN 169
DE EV LG G +G VY+ + G +A+K + E E EL +
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPY 60
Query: 170 LVRLRGWCVHEDQLLLVYDYMPNRSLDRV------LFRRPENLEAAAPLNWEQRKKIIRG 223
+V G E + + +YM SLD++ PE+ ++I
Sbjct: 61 IVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPED----------VLRRITYA 110
Query: 224 LAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARN 283
+ L +L E+ IIHRDVK +NV+++ +L DFG++ L L
Sbjct: 111 VVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA---------- 158
Query: 284 HQFHLAETTRIGGTIGYLPPESFQKGSVA-----TAKSDVFSFGIVVLEVVSGR 332
T IG Y+ PE + G T +SDV+S G+ +LE+ GR
Sbjct: 159 -------KTNIGCQ-SYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 9e-11
Identities = 64/260 (24%), Positives = 109/260 (41%), Gaps = 62/260 (23%)
Query: 112 GFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLV 171
G+ + L G G+V+ A P V +K + +KG T E + + ++ H +++
Sbjct: 67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLK-IGQKG-----TTLIEAMLLQNVNHPSVI 120
Query: 172 RLRGWCVHEDQLLLV--------YDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRG 223
R++ V +V Y Y+ RS RP ++ A + K+I+ G
Sbjct: 121 RMKDTLVSGAITCMVLPHYSSDLYTYLTKRS-------RPLPIDQALII----EKQILEG 169
Query: 224 LAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARN 283
L YLH Q +IIHRDVKT N+ ++ +GD G A
Sbjct: 170 LR----YLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAA------------------ 204
Query: 284 HQFHLAETTRIG--GTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAV---DLT 338
QF + +G GT+ PE + + K+D++S GIV+ E+++ + +
Sbjct: 205 -QFPVVAPAFLGLAGTVETNAPEVLARDKYNS-KADIWSAGIVLFEMLAYPSTIFEDPPS 262
Query: 339 YPDDQII-----LLDWIRRL 353
P++ + LL I L
Sbjct: 263 TPEEYVKSCHSHLLKIISTL 282
|
Length = 357 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 59/205 (28%), Positives = 91/205 (44%), Gaps = 23/205 (11%)
Query: 526 FGTAYQGF-LDNHQYVLVK--RLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQ 582
FG Y LD + + VK R+ + ++ ++E++ L L+H NLV+ G +
Sbjct: 13 FGKVYTAVNLDTGELMAVKEIRIQDNDPKTIK-EIADEMKVLELLKHPNLVKYYGVEVHR 71
Query: 583 GEMLVIYDYSATRILSHLLFHNNHRIGHSILQWH--HRYNIIKSLASAILYLHEEWNEQV 640
++ + +Y + L LL H IL H Y L + YLH +
Sbjct: 72 EKVYIFMEYCSGGTLEELLEHGR------ILDEHVIRVY--TLQLLEGLAYLHSH---GI 120
Query: 641 IHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIES 700
+HR+I + I LD + +LG F A L N +S+ G YM+PE I
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT---TTMGEEVQSLAGTPAYMAPEVITG 177
Query: 701 GEATS---MADVYSFGVVVLEVVTG 722
G+ AD++S G VVLE+ TG
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATG 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 57/240 (23%), Positives = 105/240 (43%), Gaps = 32/240 (13%)
Query: 557 FSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWH 616
F E + + +L H NLVQL G CT+Q + ++ +Y A L + L ++G L
Sbjct: 46 FIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWL--- 102
Query: 617 HRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGH 676
++ + A+ YL IHR++ + + D ++ F LA ++ + +
Sbjct: 103 --LDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-- 155
Query: 677 RKATSGNR-SVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGL 734
++ G + V+ + PE + +S +DV+SFGV++ EV + G+M + R
Sbjct: 156 -TSSQGTKFPVK----WAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYE-RFSNSE 209
Query: 735 LVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSIL 794
+V+ V RP + + +C PE RP+ +++LS L
Sbjct: 210 VVESVSAGYRLYRP--------------KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 54/214 (25%), Positives = 97/214 (45%), Gaps = 30/214 (14%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCV 178
+G G G V A + S G +VAVK + + ++ + E+V + +H N+V + +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 179 HEDQLLLVYDYMPNRSL-DRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLET 237
D+L +V +++ +L D V R +N EQ + + AL LH Q
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTR---------MNEEQIAAVCLAVLKALSVLHAQ--- 135
Query: 238 QIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGT 297
+IHRD+K+ +++L +L DFG + E+ + + GT
Sbjct: 136 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR----------------KSLVGT 179
Query: 298 IGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSG 331
++ PE + + D++S GI+V+E+V G
Sbjct: 180 PYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 48/163 (29%), Positives = 85/163 (52%), Gaps = 24/163 (14%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKC--LAEKGERFEKTFAAELVAVAHLRHRNL 170
+++ E +G G +G VY+A +A+K L ++ E T E+ + ++H N+
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
Query: 171 VRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQR------KKIIRGL 224
VRL+ E +L LV++Y LD L ++++++ R +I+RG+
Sbjct: 64 VRLQDVVHSEKRLYLVFEY-----LDLDL---KKHMDSSPDFAKNPRLIKTYLYQILRGI 115
Query: 225 AAALHYLHEQLETQIIHRDVKTSNVMLDSQYNA-RLGDFGLAR 266
A Y H +++HRD+K N+++D + NA +L DFGLAR
Sbjct: 116 A----YCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLAR 151
|
Length = 294 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 1e-10
Identities = 67/229 (29%), Positives = 106/229 (46%), Gaps = 44/229 (19%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCV 178
LG G FG+V+ + T VA+K L + G + F E + LRH LV L V
Sbjct: 14 LGQGCFGEVWMGTW-NGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLVPLYA-VV 70
Query: 179 HEDQLLLVYDYMPNRSL-------DRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYL 231
E+ + +V ++M SL D + P+ ++ AA +I G+A Y+
Sbjct: 71 SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAA--------QIADGMA----YI 118
Query: 232 HEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAET 291
IHRD++ +N+++ ++ DFGLAR +E +Y R + +F
Sbjct: 119 ERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDN-EYTARQGA----KF----- 165
Query: 292 TRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYP 340
I + PE+ G T KSDV+SFGI++ E+V+ R + YP
Sbjct: 166 -----PIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGR---VPYP 205
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 1e-10
Identities = 52/166 (31%), Positives = 78/166 (46%), Gaps = 43/166 (25%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAA------------ELVAVAHLR 166
LG G +G V++A+ VVA+K K F A E++ + L
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALK----------KIFDAFRNATDAQRTFREIMFLQELG 64
Query: 167 -HRNLVRLRGWCVHEDQ----LLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKK-I 220
H N+V+L V + + + LV++YM L V+ R LE + K+ I
Sbjct: 65 DHPNIVKLLN--VIKAENDKDIYLVFEYM-ETDLHAVI--RANILE-------DVHKRYI 112
Query: 221 IRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLAR 266
+ L AL Y+H +IHRD+K SN++L+S +L DFGLAR
Sbjct: 113 MYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR 155
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 58/222 (26%), Positives = 102/222 (45%), Gaps = 41/222 (18%)
Query: 119 LGSGGFGKVYRAV--LPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHR----NLVR 172
LGSG FG V + V + VA+K L + E K+ E++ A + H+ +VR
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE---KSVRDEMMREAEIMHQLDNPYIVR 59
Query: 173 LRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLH 232
+ G C E L+LV + L++ L + + + +++ ++ + YL
Sbjct: 60 MIGVCEAEA-LMLVMEMASGGPLNKFLSGKKDEITV------SNVVELMHQVSMGMKYLE 112
Query: 233 EQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETT 292
+ +HRD+ NV+L +Q+ A++ DFGL++ L + Y
Sbjct: 113 GK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY---------------KA 154
Query: 293 RIGGT--IGYLPPE--SFQKGSVATAKSDVFSFGIVVLEVVS 330
R G + + PE +F+K S ++SDV+S+GI + E S
Sbjct: 155 RSAGKWPLKWYAPECINFRKFS---SRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 56/258 (21%), Positives = 111/258 (43%), Gaps = 33/258 (12%)
Query: 538 QYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRIL 597
+ + VK + + A++ + EL L + +V G G++ + +Y L
Sbjct: 27 KIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSL 86
Query: 598 SHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMN 657
+L RI IL I ++ + YLHE ++IHR++ S I ++
Sbjct: 87 DKILKEVQGRIPERILG-----KIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQ 139
Query: 658 PRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVL 717
+L F ++ L N K G S YM+PE I+ + + +D++S G+ ++
Sbjct: 140 IKLCDFGVSGQLV-NSLA--KTFVGTSS------YMAPERIQGNDYSVKSDIWSLGLSLI 190
Query: 718 EVVTGQMAVDF--RLPEGL--LVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLG 773
E+ TG+ P+G+ L++ + + P +G+++ + + L
Sbjct: 191 ELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLP---------SGKFS-PDFQDFVNL- 239
Query: 774 IACTLSNPELRPSMRQIL 791
C + +P RPS +++L
Sbjct: 240 --CLIKDPRERPSYKELL 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 54/204 (26%), Positives = 92/204 (45%), Gaps = 17/204 (8%)
Query: 526 FGTAYQGFLDNHQYVLVKRLGMSKCPALRT-----RFSNELQNLARLRHRNLVQLCGWCT 580
+GT Y G + Q + VK++ + L + E+ L L+H N+VQ G C
Sbjct: 13 YGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCL 72
Query: 581 EQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQV 640
+ + + ++ +S +L +R G +Y K + + YLH N V
Sbjct: 73 DDNTISIFMEFVPGGSISSIL----NRFGPLPEPVFCKYT--KQILDGVAYLH---NNCV 123
Query: 641 IHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYI-E 699
+HR+I + + L P+ +L F A L H ++ +S+ G +M+PE I E
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG-LHGTHSNMLKSMHGTPYWMAPEVINE 182
Query: 700 SGEATSMADVYSFGVVVLEVVTGQ 723
SG +D++S G V E+ TG+
Sbjct: 183 SGYGRK-SDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 62/219 (28%), Positives = 101/219 (46%), Gaps = 32/219 (14%)
Query: 118 VLGSGGFGKVYRAVLPSDG----TVVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNLVR 172
VLGSG FG VY+ + DG VA+K L E + K E +A + + R
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 173 LRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLH 232
L G C+ + LV MP L + + + + LNW + +A + YL
Sbjct: 74 LLGICL-TSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLE 126
Query: 233 EQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLE-HELQYQMRTSSARNHQFHLAET 291
E +++HRD+ NV++ S + ++ DFGLAR L+ E +Y A+
Sbjct: 127 E---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYH-------------ADG 170
Query: 292 TRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS 330
++ I ++ ES T +SDV+S+G+ V E+++
Sbjct: 171 GKV--PIKWMALESILHRRF-THQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 62/229 (27%), Positives = 101/229 (44%), Gaps = 34/229 (14%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVR 172
F+ E++G+G +G+VY+ G + A+K + G+ E+ + + HRN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 173 LRGWCVH------EDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAA 226
G + +DQL LV ++ S+ ++ N L E I R +
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN-----TLKEEWIAYICREILR 122
Query: 227 ALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQF 286
L +LH+ ++IHRD+K NV+L +L DFG++ L+ RT RN
Sbjct: 123 GLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD-------RTVGRRN--- 169
Query: 287 HLAETTRIGGTIGYLPPESFQKGSVATA----KSDVFSFGIVVLEVVSG 331
T I GT ++ PE A KSD++S GI +E+ G
Sbjct: 170 -----TFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 60/228 (26%), Positives = 89/228 (39%), Gaps = 43/228 (18%)
Query: 122 GGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHR-----NLVRLRGW 176
G FG VY A S G A+K L +K + K + A + + +L
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVL-KKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65
Query: 177 CVHEDQLLLVYDYMPN---RSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHE 233
+D L LV +Y+ SL + L P +W K+ I + + LH+
Sbjct: 66 FQSKDYLYLVMEYLNGGDCASLIKTL--------GGLPEDWA--KQYIAEVVLGVEDLHQ 115
Query: 234 QLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTR 293
+ IIHRD+K N+++D + +L DFGL+R E +
Sbjct: 116 R---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGL--------------------ENKK 152
Query: 294 IGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPD 341
GT YL PE+ G SD +S G V+ E + G PD
Sbjct: 153 FVGTPDYLAPETIL-GVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD 199
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 67/220 (30%), Positives = 97/220 (44%), Gaps = 33/220 (15%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAEL-VAVAHLRHRNLVR 172
+V+G G FGKV A ++ AVK L +K ++ EK +E V + +++H LV
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 173 LRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLH 232
L D+L V DY+ L L R LE A + +A+AL YLH
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAE-------IASALGYLH 113
Query: 233 EQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW-LEHELQYQMRTSSARNHQFHLAET 291
I++RD+K N++LDSQ + L DFGL + +EH T
Sbjct: 114 S---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-----------------GTT 153
Query: 292 TRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSG 331
+ GT YL PE K D + G V+ E++ G
Sbjct: 154 STFCGTPEYLAPEVLHKQPYDRT-VDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-10
Identities = 70/277 (25%), Positives = 112/277 (40%), Gaps = 56/277 (20%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFA---AELVAVAHLRHRN 169
F + + LG G FG+V A + A+K L +K A AE +A +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 170 LVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRR---PENLEAAAPLNWEQRKKIIRGLAA 226
+VRL +D L V DY+P + +L R PE+L + I L
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLA----------RFYIAELTC 112
Query: 227 ALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLA---RWLEHELQYQ-------- 275
A+ +H+ IHRD+K N+++D + +L DFGL RW YQ
Sbjct: 113 AVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQD 169
Query: 276 ----------------------MRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVAT 313
+ +AR HQ LA + + GT Y+ PE + T
Sbjct: 170 SMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHS--LVGTPNYIAPEVLLRTGY-T 226
Query: 314 AKSDVFSFGIVVLEVVSGRRAVDLTYP-DDQIILLDW 349
D +S G+++ E++ G+ P + Q+ +++W
Sbjct: 227 QLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 69/223 (30%), Positives = 105/223 (47%), Gaps = 34/223 (15%)
Query: 118 VLGSGGFGKVY--RAVLPSD-GTVVAVKCL-----AEKGERFEKTFAAELVAVAHLRHRN 169
VLG+G +GKV+ R V D G + A+K L +K + E T V A R
Sbjct: 7 VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPF 66
Query: 170 LVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALH 229
LV L + +L L+ DY+ L L++R E+ + I + AL
Sbjct: 67 LVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRV-------YIAEIVLALD 119
Query: 230 YLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLA 289
+LH QL II+RD+K N++LDS+ + L DFGL++ E + R + F
Sbjct: 120 HLH-QL--GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-------RAYSF--- 166
Query: 290 ETTRIGGTIGYLPPESFQKGSVATAKS-DVFSFGIVVLEVVSG 331
GTI Y+ PE + GS K+ D +S G++ E+++G
Sbjct: 167 -----CGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 57/220 (25%), Positives = 98/220 (44%), Gaps = 38/220 (17%)
Query: 118 VLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAA------ELVAVAHLRHRNLV 171
V+G G FG RA+L V + + A K R K+ +A E V +A ++H N+V
Sbjct: 7 VVGEGSFG---RALLVQH--VNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIV 61
Query: 172 RLRGWCVHEDQLLLVYDYMPNRSL-DRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHY 230
+ + L +V +Y L ++ +R + L W + + + +
Sbjct: 62 AFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQ------MCLGVQH 115
Query: 231 LHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAE 290
+HE+ +++HRD+K+ N+ L +LGDFG AR L Y
Sbjct: 116 IHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYA--------------- 157
Query: 291 TTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS 330
T + GT Y+PPE ++ KSD++S G ++ E+ +
Sbjct: 158 CTYV-GTPYYVPPEIWENMPY-NNKSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 64/226 (28%), Positives = 104/226 (46%), Gaps = 40/226 (17%)
Query: 119 LGSGGFGKVYRAV-LPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLR------HRNLV 171
+G G +GKV++A L + G VA+K + + E + + VA LR H N+V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 172 RLRGWCV-----HEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAA 226
RL C E +L LV++++ ++ L L + PE P E K ++ L
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPE---PGVPT--ETIKDMMFQLLR 121
Query: 227 ALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQF 286
L +LH +++HRD+K N+++ S +L DFGLAR +QM +S
Sbjct: 122 GLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI----YSFQMALTS------ 168
Query: 287 HLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
+ T+ Y PE + S AT D++S G + E+ +
Sbjct: 169 -------VVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 3e-10
Identities = 70/306 (22%), Positives = 116/306 (37%), Gaps = 77/306 (25%)
Query: 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNL 170
+ F+ +V+G G FG+V+ G V A+K K+ + +AH+R
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMK-------VLRKSDMIKRNQIAHVRAERD 53
Query: 171 VRLRG---WCVH-------EDQLLLVYDYMPNRSLDRVLFRR---PENLEAAAPLNWEQR 217
+ W V E+ L LV +YMP L +L R+ PE
Sbjct: 54 ILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETA---------- 103
Query: 218 KKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLA---RWLEHELQY 274
+ I L AL +H+ IHRD+K N+++D+ + +L DFGL + Y
Sbjct: 104 RFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160
Query: 275 QMRTSS------------ARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFG 322
+ + + A +T GT Y+ PE +G+ + D +S G
Sbjct: 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTV--GTPDYIAPEVL-RGTPYGLECDWWSLG 217
Query: 323 IVVLEVVSG-----------------RRAVDLTYPDDQII---LLDWIRRLSDEGKVLQA 362
+++ E++ G L +P D + +D I RL L
Sbjct: 218 VILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRL------LCD 271
Query: 363 GDNRLS 368
++RL
Sbjct: 272 PEDRLG 277
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 61.7 bits (149), Expect = 3e-10
Identities = 54/215 (25%), Positives = 99/215 (46%), Gaps = 28/215 (13%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGW 176
E +G G G VY A+ + G VA+K + + + ++ E++ + ++ N+V
Sbjct: 25 EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 84
Query: 177 CVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLE 236
+ D+L +V +Y+ SL V+ ++ Q + R AL +LH
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVV--------TETCMDEGQIAAVCRECLQALDFLHSN-- 134
Query: 237 TQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGG 296
Q+IHRD+K+ N++L + +L DFG + E Q + S+ + G
Sbjct: 135 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---QSKRST-------------MVG 177
Query: 297 TIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSG 331
T ++ PE + + K D++S GI+ +E+V G
Sbjct: 178 TPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 55/231 (23%), Positives = 106/231 (45%), Gaps = 26/231 (11%)
Query: 507 EIISATNNFSESQRVAEMDFGTAYQGFL------DNHQYVLVKRLGMSKCPALRTRFSNE 560
EI +T F E + E FG Y+G L + Q V +K L LR F +E
Sbjct: 1 EINLSTVRFME--ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 561 LQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRILSHLLFH----------NNHRIGH 610
+RL+H N+V L G T++ + +I+ Y + L L ++ +
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 611 SILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLT 670
S L+ +I+ +A+ + +L + V+H+++ + + + +N ++ L +
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175
Query: 671 RNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT 721
D+ ++ + +R +MSPE I G+ + +D++S+GVV+ EV +
Sbjct: 176 AADY-YKLMGNSLLPIR----WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 4e-10
Identities = 66/249 (26%), Positives = 105/249 (42%), Gaps = 59/249 (23%)
Query: 117 EVLGSGGFGKVY--RAVLPSD--------------GTVVAVKCL---AEKGERFEKTFAA 157
E LG G FG+V+ V P D +VAVK L A K R F
Sbjct: 11 EKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNAR--NDFLK 68
Query: 158 ELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNRSLD-----RVLFRRPENLEAAAP- 211
E+ ++ L+ N++RL G CV ED L ++ +YM N L+ L + EN A P
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 212 ------LNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLA 265
+++ + +A+ + YL +HRD+ T N ++ ++ DFG++
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYLS---SLNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 266 RWLEHELQYQMRTSSARNHQFHLAETTRIGG----TIGYLPPESFQKGSVATAKSDVFSF 321
R L + + RI G I ++ E G TA SDV++F
Sbjct: 186 RNL------------------YAGDYYRIQGRAVLPIRWMAWECILMGKFTTA-SDVWAF 226
Query: 322 GIVVLEVVS 330
G+ + E++
Sbjct: 227 GVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 4e-10
Identities = 57/220 (25%), Positives = 94/220 (42%), Gaps = 31/220 (14%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVK----CLAEKGERFEKTFAAELVAVAHLRHRNLVRLR 174
+G G FGK DG +K ER E E+ +++++H N+V+ +
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESR--KEVAVLSNMKHPNIVQYQ 65
Query: 175 GWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQ 234
L +V DY L +++ N + +Q + AL ++H++
Sbjct: 66 ESFEENGNLYIVMDYCEGGDL----YKKI-NAQRGVLFPEDQILDWFVQICLALKHVHDR 120
Query: 235 LETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRI 294
+I+HRD+K+ N+ L +LGDFG+AR L N LA T
Sbjct: 121 ---KILHRDIKSQNIFLTKDGTIKLGDFGIARVL--------------NSTVELARTCI- 162
Query: 295 GGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRA 334
GT YL PE + KSD+++ G V+ E+ + + A
Sbjct: 163 -GTPYYLSPEICENRPY-NNKSDIWALGCVLYEMCTLKHA 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 70/233 (30%), Positives = 110/233 (47%), Gaps = 44/233 (18%)
Query: 113 FDEDEVLGSGGFGKVY--RAVLPSD-GTVVAVKCL-----AEKGERFEKTFAAELVAVAH 164
F+ +VLG+G +GKV+ R V D G + A+K L +K + E T E + H
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHT-RTERQVLEH 60
Query: 165 LRHRN-LVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRG 223
+R LV L + +L L+ DY+ L L +R E + EQ +I G
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQR-ERFK-------EQEVQIYSG 112
Query: 224 -LAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSAR 282
+ AL +LH+ II+RD+K N++LDS + L DFGL++
Sbjct: 113 EIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSK---------------- 153
Query: 283 NHQFHLAETTR---IGGTIGYLPPESFQKGSVATAKS-DVFSFGIVVLEVVSG 331
+FH E R GTI Y+ P+ + G K+ D +S G+++ E+++G
Sbjct: 154 --EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 55/214 (25%), Positives = 96/214 (44%), Gaps = 30/214 (14%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCV 178
+G G G V A G VAVK + + ++ + E+V + H N+V + +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 179 HEDQLLLVYDYMPNRSL-DRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLET 237
D+L +V +++ +L D V R +N EQ + + AL YLH Q
Sbjct: 90 VGDELWVVMEFLEGGALTDIVTHTR---------MNEEQIATVCLSVLRALSYLHNQ--- 137
Query: 238 QIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGT 297
+IHRD+K+ +++L S +L DFG + E + + + GT
Sbjct: 138 GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE----------------VPKRKSLVGT 181
Query: 298 IGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSG 331
++ PE + T + D++S GI+V+E++ G
Sbjct: 182 PYWMAPEVISRLPYGT-EVDIWSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 57/228 (25%), Positives = 103/228 (45%), Gaps = 31/228 (13%)
Query: 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCL---AEKGERFEKTFAAELVAVAHLR 166
++ +++ E LG G + VY+ +G +VA+K + E+G F A L+ L+
Sbjct: 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLK--GLK 61
Query: 167 HRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAA 226
H N+V L ++ L LV++Y+ + L + + + P L E K + L
Sbjct: 62 HANIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHP------ENVKLFLFQLLR 114
Query: 227 ALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQF 286
L Y+H++ I+HRD+K N+++ +L DFGLA R S +H +
Sbjct: 115 GLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLA-----------RAKSVPSHTY 160
Query: 287 HLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRA 334
T+ Y PP+ + + D++ G + +E++ G A
Sbjct: 161 SNEVV-----TLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 5e-10
Identities = 64/281 (22%), Positives = 123/281 (43%), Gaps = 33/281 (11%)
Query: 514 NFSESQRVAEMDFGTAYQGF--LDNHQYVLVKRLGMSKCPAL-RTRFSNELQNLARLRHR 570
+F ++ + FG ++ D Y + K++ +SK R +E + LA+L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAM-KQIDLSKMNRREREEAIDEARVLAKLDSS 59
Query: 571 NLVQLCGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAIL 630
+++ ++G++ ++ +Y+ L LL R W I+ LA
Sbjct: 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA---- 115
Query: 631 YLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIF 690
+LH +++++HR+I S + LD N ++G +A+ L+ N T+ ++ G
Sbjct: 116 HLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN-------TNFANTIVGTP 165
Query: 691 GYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLA 750
Y+SPE E +DV++ GVV+ E TG+ D +G L+ ++ P++
Sbjct: 166 YYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDAN-NQGALILKI--IRGVFPPVS 222
Query: 751 ELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQIL 791
Y+ ++L +LI C + RP Q+L
Sbjct: 223 --------QMYS-QQLAQLIDQ---CLTKDYRQRPDTFQLL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 6e-10
Identities = 47/189 (24%), Positives = 85/189 (44%), Gaps = 16/189 (8%)
Query: 535 DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGE--MLVIYDYS 592
+ V VK L + + E+ L L H N+V+ G C+EQG + +I +Y
Sbjct: 31 GTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYV 90
Query: 593 ATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITL 652
L L + + +L + + + YLH ++ IHR++ + + L
Sbjct: 91 PLGSLRDYLPKHKLNLAQLLL-------FAQQICEGMAYLH---SQHYIHRDLAARNVLL 140
Query: 653 DPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSF 712
D D ++G F LA+ + +R G+ V F Y + E ++ + + +DV+SF
Sbjct: 141 DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV---FWY-AVECLKENKFSYASDVWSF 196
Query: 713 GVVVLEVVT 721
GV + E++T
Sbjct: 197 GVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 70/293 (23%), Positives = 127/293 (43%), Gaps = 34/293 (11%)
Query: 511 ATNNFSESQRVAEMDFGTAYQGFL------DNHQYVLVKRLGMSKCPALRTRFSNELQNL 564
A + S+ + + FG Y+G + V +K + + R F NE +
Sbjct: 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63
Query: 565 ARLRHRNLVQLCGWCTEQGEMLVIYDYSATR--ILSHLLFHNNHRIGHSILQWHHRYNII 622
++V+L G ++ LVI + TR + S+L + + +I
Sbjct: 64 KEFNCHHVVRLLGVVSQGQPTLVIMEL-MTRGDLKSYLRSLRPEMENNPVQAPPSLKKMI 122
Query: 623 K---SLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKA 679
+ +A + YL+ + +HR++ + + D ++G F + + D+ +RK
Sbjct: 123 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY-YRKG 178
Query: 680 TSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRV 739
G VR +MSPE ++ G T+ +DV+SFGVV+ E+ T + + +G+ ++V
Sbjct: 179 GKGLLPVR----WMSPESLKDGVFTTYSDVWSFGVVLWEIAT----LAEQPYQGMSNEQV 230
Query: 740 HEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792
F L+D N ELMR+ C NP++RPS +I+S
Sbjct: 231 LRFVME----GGLLDKPDNCPDMLFELMRM------CWQYNPKMRPSFLEIIS 273
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 6e-10
Identities = 60/275 (21%), Positives = 114/275 (41%), Gaps = 45/275 (16%)
Query: 526 FGTA--YQGFLDNHQYVLVKRLGMSKC-PALRTRFSNELQNLARLRHRNLVQLCGWCTEQ 582
FG A Y+ D+ V+ K + +++ R NE+ L+ L+H N++ +
Sbjct: 13 FGEATLYRRTEDDSL-VVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD 71
Query: 583 GEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIH 642
+L+ +Y+ L + + G + + + + SA+ Y+H+ ++H
Sbjct: 72 NTLLIEMEYANGGTLYDKI---VRQKG-QLFEEEMVLWYLFQIVSAVSYIHKA---GILH 124
Query: 643 RNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGE 702
R+I + I L +LG F +++ L S +V G YMSPE + +
Sbjct: 125 RDIKTLNIFLTKAGLIKLGDFGISKILGSE-------YSMAETVVGTPYYMSPELCQGVK 177
Query: 703 ATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYN 762
+D+++ G V+ E++T +KR F+A LV + G Y
Sbjct: 178 YNFKSDIWALGCVLYELLT--------------LKRT--FDATNPL--NLVVKIVQGNYT 219
Query: 763 ------HKELMRLIKLGIACTLSNPELRPSMRQIL 791
EL+ L+ + +PE RP+ ++L
Sbjct: 220 PVVSVYSSELISLVH---SLLQQDPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 60/218 (27%), Positives = 95/218 (43%), Gaps = 41/218 (18%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFA---AELVAVAHLRHRNLVRLRG 175
+G G FG VY A + VVA+K ++ G++ + + E+ + LRH N ++ RG
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 176 WCVHEDQLLLVYDYMPNRSLDRV-LFRRP-ENLEAAAPLNWEQRKKIIRGLAAALHYLHE 233
+ E LV +Y + D + + ++P + +E AA + G L YLH
Sbjct: 83 CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA---------VTHGALQGLAYLHS 133
Query: 234 QLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTR 293
+IHRDVK N++L +LGDFG A +A
Sbjct: 134 H---NMIHRDVKAGNILLSEPGLVKLGDFGSASI--------------------MAPANX 170
Query: 294 IGGTIGYLPPE---SFQKGSVATAKSDVFSFGIVVLEV 328
GT ++ PE + +G K DV+S GI +E+
Sbjct: 171 FVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 6e-10
Identities = 59/220 (26%), Positives = 95/220 (43%), Gaps = 37/220 (16%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVKCL----AEKGERFEKTFAAELVA-VAHLRHRNLVRL 173
+G G +G VY+A P G VA+K + E G L+ + H N+VRL
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 174 RGWCV-----HEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAAL 228
C E ++ LV++++ ++ L L + P L E K ++R L
Sbjct: 68 MDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVP-----PPGLPAETIKDLMRQFLRGL 121
Query: 229 HYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHL 288
+LH I+HRD+K N+++ S +L DFGLAR + +
Sbjct: 122 DFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARI----------------YSCQM 162
Query: 289 AETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEV 328
A T + T+ Y PE + + AT D++S G + E+
Sbjct: 163 ALTPVV-VTLWYRAPEVLLQSTYATP-VDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 6e-10
Identities = 41/128 (32%), Positives = 58/128 (45%), Gaps = 18/128 (14%)
Query: 206 LEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLA 265
++ + PL EQ I R L AL YLH + IIHRDVKT N+ LD NA LGDFG A
Sbjct: 176 VDRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAA 232
Query: 266 RWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVV 325
+ + + + + GT+ PE K+D++S G+V+
Sbjct: 233 ------CKLDAHPDTPQCYGW--------SGTLETNSPELLALDPYCA-KTDIWSAGLVL 277
Query: 326 LEVVSGRR 333
E+
Sbjct: 278 FEMSVKNV 285
|
Length = 392 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 7e-10
Identities = 48/202 (23%), Positives = 88/202 (43%), Gaps = 21/202 (10%)
Query: 526 FGTAYQGF----LDNHQY-VLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCT 580
FGT Y+G + + V +K L P +E +A + H ++V+L G C
Sbjct: 20 FGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICL 79
Query: 581 EQGEMLVIYDYSATRILSHLLFHNNHRIG-HSILQWHHRYNIIKSLASAILYLHEEWNEQ 639
L+ +L ++ H + IG +L W +A + YL E+ +
Sbjct: 80 SSQVQLITQLMPLGCLLDYVRNHKD-NIGSQYLLNWC------VQIAKGMSYLEEK---R 129
Query: 640 VIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIE 699
++HR++ + + + + ++ F LA+ L D A G ++ +M+ E I
Sbjct: 130 LVHRDLAARNVLVKTPQHVKITDFGLAKLLDV-DEKEYHAEGGKVPIK----WMALESIL 184
Query: 700 SGEATSMADVYSFGVVVLEVVT 721
T +DV+S+GV V E++T
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 7e-10
Identities = 48/204 (23%), Positives = 89/204 (43%), Gaps = 24/204 (11%)
Query: 526 FGTAYQGFLDNHQYVLVKRL---GMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQ 582
FG ++G +N V VK L M F E Q + +LRH L+QL CT +
Sbjct: 19 FGEVWEGLWNNTTPVAVKTLKPGTMDP-----KDFLAEAQIMKKLRHPKLIQLYAVCTLE 73
Query: 583 GEMLVIYDYSATRILSH-LLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVI 641
+ ++ T ++ + L L+ ++ +AS + YL E N I
Sbjct: 74 EPIYIV-----TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL-EAQN--YI 125
Query: 642 HRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESG 701
HR++ + + + + ++ F LA + + + R+ + + +PE
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGA------KFPIKWTAPEAALYN 179
Query: 702 EATSMADVYSFGVVVLEVVT-GQM 724
+ +DV+SFG+++ E+VT G+M
Sbjct: 180 RFSIKSDVWSFGILLTEIVTYGRM 203
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 7e-10
Identities = 50/215 (23%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGW 176
E +G G G VY A+ + G VA++ + + + ++ E++ + ++ N+V
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 177 CVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLE 236
+ D+L +V +Y+ SL V+ ++ Q + R AL +LH
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVV--------TETCMDEGQIAAVCRECLQALEFLHSN-- 135
Query: 237 TQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGG 296
Q+IHRD+K+ N++L + +L DFG + E ++ + + G
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE----------------QSKRSTMVG 178
Query: 297 TIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSG 331
T ++ PE + + K D++S GI+ +E++ G
Sbjct: 179 TPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 50/213 (23%), Positives = 97/213 (45%), Gaps = 28/213 (13%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCV 178
+G G G V A G VAVK + + ++ + E+V + +H+N+V + +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 179 HEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQ 238
++L ++ +++ +L ++ + LN EQ + + AL YLH Q
Sbjct: 89 VGEELWVLMEFLQGGAL--------TDIVSQTRLNEEQIATVCESVLQALCYLHSQ---G 137
Query: 239 IIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTI 298
+IHRD+K+ +++L +L DFG + + + + + GT
Sbjct: 138 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD----------------VPKRKSLVGTP 181
Query: 299 GYLPPESFQKGSVATAKSDVFSFGIVVLEVVSG 331
++ PE + T + D++S GI+V+E+V G
Sbjct: 182 YWMAPEVISRTPYGT-EVDIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 8e-10
Identities = 41/164 (25%), Positives = 70/164 (42%), Gaps = 20/164 (12%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGER--FEKTFAAELVAVAHLRHRNLVRLR 174
+GSG +G+V A G VA+K L+ + K EL + H+ H N++ L
Sbjct: 21 SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLL 80
Query: 175 GWCVHEDQLLL----VYDYMP--NRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAAL 228
L VY L+ ++ + L+ + + ++ + L
Sbjct: 81 D-VFTPASSLEDFQDVYLVTHLMGADLNNIVKCQ--------KLSDDHIQFLVYQILRGL 131
Query: 229 HYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHEL 272
Y+H IIHRD+K SN+ ++ ++ DFGLAR + E+
Sbjct: 132 KYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEM 172
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 9e-10
Identities = 54/213 (25%), Positives = 94/213 (44%), Gaps = 30/213 (14%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVKCLA-EKGERFEKTFAAELVAVAHLRHRNLVRLRGWC 177
+GSG +G VY+A G + AVK + E G+ F E+ V +H N+V G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFS-LIQQEIFMVKECKHCNIVAYFGSY 75
Query: 178 VHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLET 237
+ ++L + +Y SL + PL+ Q + R L YLH + +
Sbjct: 76 LSREKLWICMEYCGGGSLQDIY-------HVTGPLSELQIAYVCRETLQGLAYLHSKGK- 127
Query: 238 QIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGT 297
+HRD+K +N++L + +L DFG+A ++ + A+ F GT
Sbjct: 128 --MHRDIKGANILLTDNGDVKLADFGVAA--------KITATIAKRKSFI--------GT 169
Query: 298 IGYLPPE--SFQKGSVATAKSDVFSFGIVVLEV 328
++ PE + +K D+++ GI +E+
Sbjct: 170 PYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 9e-10
Identities = 53/197 (26%), Positives = 87/197 (44%), Gaps = 34/197 (17%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVK---CLAEKGERFEKTFAAELVAVAHLRHRNLVRLRG 175
+G G FG+V++A +VA+K EK E F T E+ + L+H N+V L
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIE 78
Query: 176 WCVHE--------DQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAA 227
C + LV+++ + L N + KK+++ L
Sbjct: 79 ICRTKATPYNRYKGSFYLVFEF-----CEHDLAGLLSN--KNVKFTLSEIKKVMKMLLNG 131
Query: 228 LHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFH 287
L+Y+H +I+HRD+K +N+++ +L DFGLAR + + +S N
Sbjct: 132 LYYIHR---NKILHRDMKAANILITKDGILKLADFGLAR------AFSLSKNSKPNRY-- 180
Query: 288 LAETTRIGGTIGYLPPE 304
T R+ T+ Y PPE
Sbjct: 181 ---TNRV-VTLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 51/217 (23%), Positives = 95/217 (43%), Gaps = 22/217 (10%)
Query: 519 QRVAEMDFGTAYQGFL------DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNL 572
+ + E FG + G ++ + V VK L + R F E + L +H N+
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70
Query: 573 VQLCGWCTEQGEMLVIYDYSATRILSHLL--------FHNNHRIGHSILQWHHRYNIIKS 624
V+ G CTE +++++Y L+ L F + L I
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 625 LASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNR 684
+AS ++YL ++ +HR++ + + D+ ++G F ++ + D+ +R
Sbjct: 131 IASGMVYLA---SQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDY-YRVGGHTML 186
Query: 685 SVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT 721
+R +M PE I + T+ +DV+SFGVV+ E+ T
Sbjct: 187 PIR----WMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 1e-09
Identities = 64/230 (27%), Positives = 105/230 (45%), Gaps = 39/230 (16%)
Query: 113 FDEDEVLGSGGFGKVY---RAVLPSDGTVVAVKCL-----AEKGERFEKTFAAELVAVAH 164
F+ +VLG+G +GKV+ + G + A+K L +K + E T E + H
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHT-RTERNVLEH 60
Query: 165 LRHRN-LVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRG 223
+R LV L E +L L+ DY+ + L++R E + G
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEV--------RFYSG 112
Query: 224 -LAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLAR-WLEHELQYQMRTSSA 281
+ AL +LH+ I++RD+K N++LDS+ + L DFGL++ +L E + RT S
Sbjct: 113 EIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE---KERTYS- 165
Query: 282 RNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSG 331
GTI Y+ PE + D +S GI++ E+++G
Sbjct: 166 ------------FCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 70/300 (23%), Positives = 132/300 (44%), Gaps = 52/300 (17%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAA-------ELVAVAHL 165
F ++ +G G F +VYRA D VA+K K + FE A E+ + L
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALK----KVQIFEMMDAKARQDCVKEIDLLKQL 59
Query: 166 RHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVL--FRRPENLEAAAPLNWEQRKKIIRG 223
H N+++ + +++L +V + L +++ F++ + L + W K
Sbjct: 60 NHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTV-W----KYFVQ 114
Query: 224 LAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARN 283
L +A+ ++H + +++HRD+K +NV + + +LGD GL R+ + +T++A +
Sbjct: 115 LCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRF------FSSKTTAAHS 165
Query: 284 HQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQ 343
+ GT Y+ PE + KSD++S G ++ E+ A+ + D+
Sbjct: 166 ----------LVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMA----ALQSPFYGDK 210
Query: 344 IILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403
+ L + K+ Q L Y E L L +C +P RP + +V +
Sbjct: 211 MNLFSLCQ------KIEQCDYPPLPTEHYS----EKLRELVSMCIYPDPDQRPDIGYVHQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 70/304 (23%), Positives = 126/304 (41%), Gaps = 68/304 (22%)
Query: 117 EVLGSGGFGKVYRAVLPSDG-------TVVAVKCLAEKGERFEKTFAAELVAVAHLRHRN 169
E LG G F K+++ + G T V +K L + + ++F ++ L H++
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60
Query: 170 LVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALH 229
LV G CV D+ ++V +Y+ SLD L + + ++W + ++ + LA ALH
Sbjct: 61 LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKN----KNLINISW--KLEVAKQLAWALH 114
Query: 230 YLHEQLETQIIHRDVKTSNVMLDSQYNA--------RLGDFGLARWLEHELQYQMRTSSA 281
+L ++ + H +V NV+L + + +L D G++ + + R
Sbjct: 115 FLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLER---- 167
Query: 282 RNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPD 341
I ++PPE + + +D +SFG + E+ SG D
Sbjct: 168 ----------------IPWVPPECIENPQNLSLAADKWSFGTTLWEIFSG--------GD 203
Query: 342 DQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALL---CTLHNPHLRPSM 398
+ LD ++ LQ ++R + K T LA L C + P RPS
Sbjct: 204 KPLSALDSQKK-------LQFYEDRHQLPAPK------WTELANLINQCMDYEPDFRPSF 250
Query: 399 KWVI 402
+ +I
Sbjct: 251 RAII 254
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 45/152 (29%), Positives = 71/152 (46%), Gaps = 17/152 (11%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFA---AELVAVAHLRHRNLVRLRG 175
+G G FG VY A VVA+K ++ G++ + + E+ + LRH N + +G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 176 WCVHEDQLLLVYDYMPNRSLDRV-LFRRP-ENLEAAAPLNWEQRKKIIRGLAAALHYLHE 233
+ E LV +Y + D + + ++P + +E AA I G L YLH
Sbjct: 83 CYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAA---------ICHGALQGLAYLHS 133
Query: 234 QLETQIIHRDVKTSNVMLDSQYNARLGDFGLA 265
+ IHRD+K N++L +L DFG A
Sbjct: 134 H---ERIHRDIKAGNILLTEPGTVKLADFGSA 162
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 42/155 (27%), Positives = 72/155 (46%), Gaps = 14/155 (9%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGE--RFEKTFAAELVAVAHLRHRNLVRLR 174
++G G +G V + G +VA+K E + +K E+ + LRH NLV L
Sbjct: 7 GLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLI 66
Query: 175 GWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAP-LNWEQRKKIIRGLAAALHYLHE 233
+ +L LV++++ + LD +LE L+ + +K + + + + H
Sbjct: 67 EVFRRKKRLYLVFEFVDHTVLD--------DLEKYPNGLDESRVRKYLFQILRGIEFCHS 118
Query: 234 QLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWL 268
IIHRD+K N+++ +L DFG AR L
Sbjct: 119 H---NIIHRDIKPENILVSQSGVVKLCDFGFARTL 150
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 47/201 (23%), Positives = 92/201 (45%), Gaps = 16/201 (7%)
Query: 525 DFGTAYQGFLD----NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCT 580
+FG ++G L V +K L R F +E + + H N+++L G T
Sbjct: 17 EFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVT 76
Query: 581 EQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQV 640
+ ++I +Y L L +H S Q +++ +A+ + YL +
Sbjct: 77 KFKPAMIITEYMENGALDKYL--RDHDGEFSSYQL---VGMLRGIAAGMKYLS---DMNY 128
Query: 641 IHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIES 700
+HR++ + I ++ ++ ++ F L+ L + G + G +R + +PE I
Sbjct: 129 VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIR----WTAPEAIAY 184
Query: 701 GEATSMADVYSFGVVVLEVVT 721
+ TS +DV+SFG+V+ EV++
Sbjct: 185 RKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 51/198 (25%), Positives = 93/198 (46%), Gaps = 19/198 (9%)
Query: 526 FGTAYQGFLDNHQ----YVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTE 581
FG YQG + + V VK P++R +F E + + H ++V+L G TE
Sbjct: 19 FGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE 78
Query: 582 QGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVI 641
+ ++ + + L L N + + + L + Y + +LA YL +++ +
Sbjct: 79 N-PVWIVMELAPLGELRSYLQVNKYSLDLASLILY-SYQLSTALA----YLE---SKRFV 129
Query: 642 HRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESG 701
HR+I + + + +LG F L+ +L D + KA+ G ++ +M+PE I
Sbjct: 130 HRDIAARNVLVSSPDCVKLGDFGLSRYL--EDESYYKASKGKLPIK----WMAPESINFR 183
Query: 702 EATSMADVYSFGVVVLEV 719
TS +DV+ FGV + E+
Sbjct: 184 RFTSASDVWMFGVCMWEI 201
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 47/206 (22%), Positives = 94/206 (45%), Gaps = 17/206 (8%)
Query: 519 QRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGW 578
+++ + +FG Y+G L + V VK + P L+ +F E + L + H N+V+L G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 579 CTEQGEMLVIYDY-SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWN 637
C ++ + ++ + +L+ L N +LQ + A+ + YL E N
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQ------MSLDAAAGMEYL-ESKN 113
Query: 638 EQVIHRNITSSAITLDPDMNPRLGSFALAEF-LTRNDHGHRKATSGNRSVRGIFGYMSPE 696
IHR++ + + + +++F ++R + G S I + +PE
Sbjct: 114 --CIHRDLAARNCLVGEN-----NVLKISDFGMSREEEGGIYTVSDGLKQIPI-KWTAPE 165
Query: 697 YIESGEATSMADVYSFGVVVLEVVTG 722
+ G TS +DV+S+G+++ E +
Sbjct: 166 ALNYGRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-09
Identities = 60/218 (27%), Positives = 100/218 (45%), Gaps = 35/218 (16%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVKCL-AEKGERFEKTFAAELVAVAHLRHRNLVRLRGWC 177
LG+G G V + G ++A K + E EL + +V G
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 178 VHEDQLLLVYDYMPNRSLDRVL---FRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQ 234
+ ++ + ++M SLD+VL R PE + + ++RGLA YL E+
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSI------AVLRGLA----YLREK 122
Query: 235 LETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRI 294
QI+HRDVK SN++++S+ +L DFG++ Q+ S A +
Sbjct: 123 --HQIMHRDVKPSNILVNSRGEIKLCDFGVSG--------QLIDSMANS----------F 162
Query: 295 GGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
GT Y+ PE Q G+ + +SD++S G+ ++E+ GR
Sbjct: 163 VGTRSYMSPERLQ-GTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 40/158 (25%), Positives = 78/158 (49%), Gaps = 16/158 (10%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVK--CLAEKGERFEKTFAAELVAVAHLRHRNL 170
+++ E +G G +G V++A +VA+K L + E + E+ + L+H+N+
Sbjct: 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 61
Query: 171 VRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQR--KKIIRGLAAAL 228
VRL + +L LV++Y D+ L + ++ + ++++GLA
Sbjct: 62 VRLYDVLHSDKKLTLVFEY-----CDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLA--- 113
Query: 229 HYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLAR 266
+ H ++HRD+K N++++ +L DFGLAR
Sbjct: 114 -FCHSH---NVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 45/160 (28%), Positives = 77/160 (48%), Gaps = 12/160 (7%)
Query: 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCL--AEKGERFEKTFAAELVAVAHLRHR 168
N F+ V+G G +G V + +VA+K +E+ E ++T EL + L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 169 NLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAAL 228
N+V L+ +L LV++Y+ L+ + E + P E+ + I L A+
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELL-----EEMPNGVPP--EKVRSYIYQLIKAI 113
Query: 229 HYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWL 268
H+ H+ I+HRD+K N+++ +L DFG AR L
Sbjct: 114 HWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNL 150
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 61/229 (26%), Positives = 102/229 (44%), Gaps = 55/229 (24%)
Query: 119 LGSGGFGKVYRAVLPSDGT--VVAVKCLAEKGERFEKTFAAELVAVAH----LRHRNLVR 172
LGSG FG V + + + VAVK L K + + EL+ A+ L + +VR
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKIL--KNDNNDPALKDELLREANVMQQLDNPYIVR 60
Query: 173 LRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLN-WEQRKK---------IIR 222
+ G C E +L++ L PLN + Q+ K ++
Sbjct: 61 MIGICEAESWMLVM------------------ELAELGPLNKFLQKNKHVTEKNITELVH 102
Query: 223 GLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWL-EHELQYQMRTSSA 281
++ + YL E T +HRD+ NV+L +Q+ A++ DFGL++ L E Y+ +T
Sbjct: 103 QVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK 159
Query: 282 RNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS 330
+++ E ++ K S +KSDV+SFG+++ E S
Sbjct: 160 WPVKWYAPECM------------NYYKFS---SKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 63/222 (28%), Positives = 98/222 (44%), Gaps = 36/222 (16%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVA---VAHLRHRNLVRLRG 175
LG GGFG+V + + G + A K L +K + K + +V +A + R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 176 WCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRK-----KIIRGLAAALHY 230
+ L LV M L ++ N++ P E R +II GL +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIY----NVDEENPGFPEPRACFYTAQIISGL----EH 112
Query: 231 LHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAE 290
LH++ +II+RD+K NV+LD+ N R+ D GLA L Q +T
Sbjct: 113 LHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVEL---KDGQSKTKG---------- 156
Query: 291 TTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
GT G++ PE Q G D F+ G+ + E+++ R
Sbjct: 157 ---YAGTPGFMAPELLQ-GEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 526 FGTAYQGFL-------DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGW 578
FG Y+G V VK L + F E ++ H N+V+L G
Sbjct: 8 FGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGV 67
Query: 579 CTEQGEMLVIYDY-SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWN 637
C +I + +LS+L R G +L +I +A +YL +
Sbjct: 68 CLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM-- 125
Query: 638 EQVIHRNITS-----SAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGY 692
IHR++ + S D D ++G F LA + ++D+ +RK G VR +
Sbjct: 126 -HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDY-YRKEGEGLLPVR----W 179
Query: 693 MSPEYIESGEATSMADVYSFGVVVLEVVT 721
M+PE + G+ T+ +DV+SFGV++ E++T
Sbjct: 180 MAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 55/215 (25%), Positives = 95/215 (44%), Gaps = 28/215 (13%)
Query: 515 FSESQRVAEMDFGTAY--QGFLDNHQYVLVKRLGMSKC-PALRTRFSNELQNLARLRHRN 571
+ + +++ E FG A + D QYV +K + +SK P R E+ L+ ++H N
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYV-IKEINISKMSPKEREESRKEVAVLSNMKHPN 60
Query: 572 LVQLCGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIG-----HSILQWHHRYNIIKSLA 626
+VQ E G + ++ DY L + N + G IL W +
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGGDLYKKI---NAQRGVLFPEDQILDW------FVQIC 111
Query: 627 SAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSV 686
A+ ++H+ +++HR+I S I L D +LG F +A L R+
Sbjct: 112 LALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLN-------STVELARTC 161
Query: 687 RGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT 721
G Y+SPE E+ + +D+++ G V+ E+ T
Sbjct: 162 IGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 4e-09
Identities = 49/184 (26%), Positives = 87/184 (47%), Gaps = 15/184 (8%)
Query: 540 VLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQG--EMLVIYDYSATRIL 597
V VK+L S LR F E++ L L+H N+V+ G C G + ++ +Y L
Sbjct: 36 VAVKKLQHSTAEHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSL 94
Query: 598 SHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMN 657
L + R+ H L + I K + YL + + +HR++ + I ++ +
Sbjct: 95 RDYLQKHRERLDHRKL-LLYASQICKGME----YLGSK---RYVHRDLATRNILVESENR 146
Query: 658 PRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVL 717
++G F L + L ++ ++ G IF Y +PE + + + +DV+SFGVV+
Sbjct: 147 VKIGDFGLTKVLPQDKEYYKVREPGESP---IFWY-APESLTESKFSVASDVWSFGVVLY 202
Query: 718 EVVT 721
E+ T
Sbjct: 203 ELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 4e-09
Identities = 46/173 (26%), Positives = 74/173 (42%), Gaps = 28/173 (16%)
Query: 624 SLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGN 683
++ A+ YL E VIHR++ S I LD N +L F ++ L + R A
Sbjct: 122 AIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSA---- 175
Query: 684 RSVRGIFGYMSPEYIESGEATS----MADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRV 739
G YM+PE I+ + ADV+S G+ ++E+ TGQ ++ +
Sbjct: 176 ----GCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP--YKNCKT------ 223
Query: 740 HEFEARKRPLAE-LVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQIL 791
EFE + L E L N ++ + + L C + RP R++L
Sbjct: 224 -EFEVLTKILQEEPPSLPPNEGFSP-DFCSFVDL---CLTKDHRKRPKYRELL 271
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 54/238 (22%), Positives = 107/238 (44%), Gaps = 32/238 (13%)
Query: 568 RHRNLVQLCGWCTEQGEMLVIYDYSATRILSHLL----------FHNNHRIGHSILQWHH 617
+H+N++ L G CT+ G + V+ +Y++ L L + ++ L +
Sbjct: 76 KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135
Query: 618 RYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHR 677
+ +A + YL +++ IHR++ + + + D ++ F LA + D+ ++
Sbjct: 136 LVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDY-YK 191
Query: 678 KATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVK 737
K T+G V+ +M+PE + T +DV+SFGV++ E+ T + +P L K
Sbjct: 192 KTTNGRLPVK----WMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 247
Query: 738 RVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795
+ E +P +L + +MR C + P RP+ +Q++ LD
Sbjct: 248 LLKEGHRMDKPANCTHELYM--------IMR------ECWHAVPSQRPTFKQLVEDLD 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 5e-09
Identities = 60/220 (27%), Positives = 97/220 (44%), Gaps = 39/220 (17%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVA---VKCLAE-------KGERFEKTFAAELVAVAHLRHR 168
LG G FG VY L D VA +K L E E + A+L++ L H
Sbjct: 8 LGKGSFGTVY---LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLS--KLDHP 62
Query: 169 NLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAAL 228
+V+ + D ++ +Y R LD + E L+ Q + L +
Sbjct: 63 AIVKFHASFLERDAFCIITEYCEGRDLD---CKLEELKHTGKTLSENQVCEWFIQLLLGV 119
Query: 229 HYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHL 288
HY+H++ +I+HRD+K N+ L + ++GDFG++R L M + L
Sbjct: 120 HYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLL-------MGSCD-------L 161
Query: 289 AETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEV 328
A T GT Y+ PE+ + + KSD++S G ++ E+
Sbjct: 162 ATT--FTGTPYYMSPEALKHQGYDS-KSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 5e-09
Identities = 61/236 (25%), Positives = 104/236 (44%), Gaps = 41/236 (17%)
Query: 116 DEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG--ERFEKTFAAELVAVAHLRHRNLVRL 173
VLGSG G V A SDG AVK + +G E + AE+ + + ++V+
Sbjct: 37 SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVK- 95
Query: 174 RGWCVHED-------------QLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKI 220
C HED + LV DY L + + R + + +
Sbjct: 96 ---C-HEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAK---TNRTFREHEAGLL 148
Query: 221 IRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSS 280
+ A+H++H + +IHRD+K++N++L S +LGDFG ++ Y S
Sbjct: 149 FIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFGFSK------MYAATVSD 199
Query: 281 ARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVD 336
F GT Y+ PE +++ + K+D+FS G+++ E+++ +R D
Sbjct: 200 DVGRTF--------CGTPYYVAPEIWRRKPY-SKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 7e-09
Identities = 59/224 (26%), Positives = 103/224 (45%), Gaps = 35/224 (15%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCL-AEKGERFEKTFAAELVAVAHLRHRNLV 171
F++ LG+G G V++ G ++A K + E EL + +V
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 172 RLRGWCVHEDQLLLVYDYMPNRSLDRVLF---RRPENLEAAAPLNWEQRKKIIRGLAAAL 228
G + ++ + ++M SLD+VL R PE + + +I+GL
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI------AVIKGLT--- 117
Query: 229 HYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHL 288
YL E+ +I+HRDVK SN++++S+ +L DFG++ Q+ S A +
Sbjct: 118 -YLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSG--------QLIDSMANS----- 161
Query: 289 AETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
GT Y+ PE Q G+ + +SD++S G+ ++E+ GR
Sbjct: 162 -----FVGTRSYMSPERLQ-GTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 7e-09
Identities = 56/232 (24%), Positives = 96/232 (41%), Gaps = 51/232 (21%)
Query: 119 LGSGGFGKVYRAVL----------PSDGTVVAVKCLAEKGERFEKTFAAELVAV-AHLRH 167
LG G F +Y+ VL P V +K L F E ++ + L H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFF--ETASLMSQLSH 60
Query: 168 RNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAA 227
++LV+L G CV D+ ++V +Y+ LD L R N+ L+ + + LA+A
Sbjct: 61 KHLVKLYGVCV-RDENIMVEEYVKFGPLDVFLHREKNNVSLHWKLD------VAKQLASA 113
Query: 228 LHYLHEQLETQIIHRDVKTSNVML-------DSQYNARLGDFGLARWLEHELQYQMRTSS 280
LHYL ++ +++H +V N+++ +L D G+ + + R
Sbjct: 114 LHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVER--- 167
Query: 281 ARNHQFHLAETTRIGGTIGYLPPESFQKGSVA-TAKSDVFSFGIVVLEVVSG 331
I ++ PE + G + T +D +SFG +LE+ S
Sbjct: 168 -----------------IPWIAPECIRNGQASLTIAADKWSFGTTLLEICSN 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 7e-09
Identities = 52/223 (23%), Positives = 95/223 (42%), Gaps = 40/223 (17%)
Query: 118 VLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRL---- 173
++G GGFG+VY G + A+KCL +K + ++ E +A+ +LV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ---GETLALNERIMLSLVSTGDCP 57
Query: 174 ----RGWCVHE-DQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAAL 228
+ H D+L + D M L +L + ++ + + L
Sbjct: 58 FIVCMTYAFHTPDKLCFILDLMNGGDLHY-------HLSQHGVFSEKEMRFYATEIILGL 110
Query: 229 HYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHL 288
++H + +++RD+K +N++LD + R+ D GLA F
Sbjct: 111 EHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA------------------CDFSK 149
Query: 289 AETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSG 331
+ GT GY+ PE QKG+ + +D FS G ++ +++ G
Sbjct: 150 KKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 65/234 (27%), Positives = 101/234 (43%), Gaps = 37/234 (15%)
Query: 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRN 169
S+ ++ E +G G +GKV++ + +G+ AVK L + E+ A + A H N
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPN 76
Query: 170 LVRLRGW-----CVHEDQLLLVYDYMPNRS---LDRVLFRRPENLEAAAPLNWEQRKKII 221
+V+ G + DQL LV + S L + +R E +E P+ I
Sbjct: 77 VVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEE--PI-------IA 127
Query: 222 RGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSA 281
L AL L + IHRDVK +N++L ++ +L DFG++ L T
Sbjct: 128 YILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS-------TRLR 180
Query: 282 RNHQFHLAETTRIGGTIGYLPPESF----QKGSVATAKSDVFSFGIVVLEVVSG 331
RN GT ++ PE Q S A+ DV+S GI +E+ G
Sbjct: 181 RNTSV---------GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 8e-09
Identities = 53/221 (23%), Positives = 94/221 (42%), Gaps = 26/221 (11%)
Query: 516 SESQRVAEM---DFGTAYQGFLDNHQYVLVKRL---GMSKCPALRTRFSNELQNLARLRH 569
SE V E+ FG + G+ + V +K + MS+ F E Q + +L H
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE-----EDFIEEAQVMMKLSH 58
Query: 570 RNLVQLCGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAI 629
LVQL G CTE+ + +++++ LS L R + + +
Sbjct: 59 PKLVQLYGVCTERSPICLVFEFMEHGCLSDYL-----RAQRGKFSQETLLGMCLDVCEGM 113
Query: 630 LYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGI 689
YL VIHR++ + + + ++ F + F+ D + +T V+
Sbjct: 114 AYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVL--DDQYTSSTGTKFPVK-- 166
Query: 690 FGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFR 729
+ SPE + +S +DV+SFGV++ EV + G+ + R
Sbjct: 167 --WSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENR 205
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 8e-09
Identities = 63/242 (26%), Positives = 102/242 (42%), Gaps = 62/242 (25%)
Query: 116 DEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAA---------ELVAVAHLR 166
E +GSG +G V A+ G VA+K + F EL + H +
Sbjct: 10 IENIGSGAYGVVCSAIDTRSGKKVAIKKIP-------HAFDVPTLAKRTLRELKILRHFK 62
Query: 167 HRNLVRLRGWCVHEDQLL----LVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRK---- 218
H N++ +R +V D M + L ++ PL E +
Sbjct: 63 HDNIIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSD-------QPLTEEHIRYFLY 114
Query: 219 KIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRT 278
+++RGL Y+H +IHRD+K SN++++ R+GDFG+AR L +
Sbjct: 115 QLLRGL----KYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGL---------S 158
Query: 279 SSARNHQFHLAE--TTRIGGTIGYLPPE---SFQKGSVATAKSDVFSFGIVVLEVVSGRR 333
SS H++ + E TR Y PE S + + A D++S G + E++ GRR
Sbjct: 159 SSPTEHKYFMTEYVATR-----WYRAPELLLSLPEYTTAI---DMWSVGCIFAEML-GRR 209
Query: 334 AV 335
+
Sbjct: 210 QL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 9e-09
Identities = 54/238 (22%), Positives = 108/238 (45%), Gaps = 32/238 (13%)
Query: 568 RHRNLVQLCGWCTEQGEMLVIYDYSATRILSHLL----------FHNNHRIGHSILQWHH 617
+H+N++ L G CT+ G + VI +Y++ L L ++ R+ + +
Sbjct: 79 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKD 138
Query: 618 RYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHR 677
+ +A + YL +++ IHR++ + + + + ++ F LA + D+ ++
Sbjct: 139 LVSCTYQVARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDY-YK 194
Query: 678 KATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVK 737
K T+G V+ +M+PE + T +DV+SFGV++ E+ T + +P L K
Sbjct: 195 KTTNGRLPVK----WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 250
Query: 738 RVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795
+ E +P +L + +MR C + P RP+ +Q++ LD
Sbjct: 251 LLKEGHRMDKPANCTNELYM--------MMR------DCWHAIPSHRPTFKQLVEDLD 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 9e-09
Identities = 45/152 (29%), Positives = 71/152 (46%), Gaps = 17/152 (11%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFA---AELVAVAHLRHRNLVRLRG 175
+G G FG VY A VVAVK ++ G++ + + E+ + L+H N + +G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 176 WCVHEDQLLLVYDYMPNRSLDRV-LFRRP-ENLEAAAPLNWEQRKKIIRGLAAALHYLHE 233
+ E LV +Y + D + + ++P + +E AA I G L YLH
Sbjct: 89 CYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA---------ITHGALQGLAYLHS 139
Query: 234 QLETQIIHRDVKTSNVMLDSQYNARLGDFGLA 265
+IHRD+K N++L +L DFG A
Sbjct: 140 H---NMIHRDIKAGNILLTEPGQVKLADFGSA 168
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 51/228 (22%), Positives = 102/228 (44%), Gaps = 33/228 (14%)
Query: 525 DFGTAYQGFLD----NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCT 580
+FG +G L +V +K L R F +E + + H N++ L G T
Sbjct: 16 EFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT 75
Query: 581 EQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQV 640
+ +++I ++ L L N+ + +++Q +++ +A+ + YL E
Sbjct: 76 KSRPVMIITEFMENGALDSFLRQNDGQF--TVIQL---VGMLRGIAAGMKYLSEM---NY 127
Query: 641 IHRNITSSAITLDPDMNPRLGSFALAEFLTRN--DHGHRKATSGNRSVRGIFGYMSPEYI 698
+HR++ + I ++ ++ ++ F L+ FL + D + + G +R + +PE I
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIR----WTAPEAI 183
Query: 699 ESGEATSMADVYSFGVVVLEV---------------VTGQMAVDFRLP 731
+ TS +DV+S+G+V+ EV V + D+RLP
Sbjct: 184 AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLP 231
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 56/218 (25%), Positives = 94/218 (43%), Gaps = 40/218 (18%)
Query: 559 NELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY-SATRILSHLLFHNNHRIGHSILQWHH 617
E+Q L L+H +VQ G + + + +Y + L + + ++ + +
Sbjct: 53 CEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGA--LTETVTRKYT 110
Query: 618 RYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHR 677
R + + YLH + ++HR+I + I D N +LG F ++ L
Sbjct: 111 R-----QILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRL----QTIC 158
Query: 678 KATSGNRSVRGIFGYMSPEYIESGEATS-MADVYSFGVVVLEVVTGQ--------MAVDF 728
+ +G +SV G +MSPE I SGE ADV+S G V+E++T + MA F
Sbjct: 159 SSGTGMKSVTGTPYWMSPEVI-SGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIF 217
Query: 729 R---------LPEGL------LVKRVHEFEARKRPLAE 751
+ LP + ++R A+KRP AE
Sbjct: 218 KIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAE 255
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 56/238 (23%), Positives = 108/238 (45%), Gaps = 32/238 (13%)
Query: 568 RHRNLVQLCGWCTEQGEMLVIYDYSATRILSHLL----------FHNNHRIGHSILQWHH 617
+H+N++ L G CT+ G + VI +Y++ L L +N ++ L +
Sbjct: 82 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141
Query: 618 RYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHR 677
+ +A + YL +++ IHR++ + + + D ++ F LA + D+ ++
Sbjct: 142 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY-YK 197
Query: 678 KATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVK 737
K T+G V+ +M+PE + T +DV+SFGV++ E+ T + +P L K
Sbjct: 198 KTTNGRLPVK----WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 253
Query: 738 RVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795
+ E +P +L + +MR C + P RP+ +Q++ LD
Sbjct: 254 LLKEGHRMDKPSNCTNELYM--------MMR------DCWHAVPSQRPTFKQLVEDLD 297
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 46/155 (29%), Positives = 77/155 (49%), Gaps = 19/155 (12%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCL---AEKGERFEKTFAAELVAVAHLRHRNLVRL 173
+ LG G + VY+ G +VA+K + E+G F T E + L+H N+V L
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPF--TAIREASLLKDLKHANIVTL 68
Query: 174 RGWCVHEDQLL-LVYDYMPNRSLDRVLFRRPENLEAA-APLNWEQRKKIIRGLAAALHYL 231
+H + L LV++Y+ + L + + L L Q ++RGLA Y
Sbjct: 69 HD-IIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQ---LLRGLA----YC 119
Query: 232 HEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLAR 266
H++ +++HRD+K N+++ + +L DFGLAR
Sbjct: 120 HQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 61/246 (24%), Positives = 94/246 (38%), Gaps = 37/246 (15%)
Query: 119 LGSGGFGKVYRAVLPS--DGTVVAVKCLAEKGERFEK-TFAAELVAVAHLRHRNLVRLRG 175
+G+G FGKV V VK L E+ F E+ L H N+++ G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 176 WCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRK--KIIRGLAAALHYLHE 233
C+ LLV ++ P L L + A + QR ++ GL LH
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGL-LWLHQAD- 120
Query: 234 QLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTR 293
IH D+ N L + + ++GD+GLA E + + H L
Sbjct: 121 -----FIHSDLALRNCQLTADLSVKIGDYGLA----LEQYPEDYYITKDCHAVPLR---- 167
Query: 294 IGGTIGYLPPE---SFQ---KGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPD--DQII 345
+L PE T KS+++S G+ + E+ + A D YPD D+ +
Sbjct: 168 ------WLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT---AADQPYPDLSDEQV 218
Query: 346 LLDWIR 351
L +R
Sbjct: 219 LKQVVR 224
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 55/237 (23%), Positives = 104/237 (43%), Gaps = 30/237 (12%)
Query: 557 FSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWH 616
F E + + +L H LVQL G CT+Q + ++ +Y + L + L + R Q
Sbjct: 46 FIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKR-----FQPS 100
Query: 617 HRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGH 676
+ K + + YL ++Q IHR++ + +D ++ F L+ ++ D +
Sbjct: 101 QLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVL--DDEY 155
Query: 677 RKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLL 735
+ VR + PE + + +S +DV++FGV++ EV + G+M + R
Sbjct: 156 TSSVGSKFPVR----WSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYE-RFNNSET 210
Query: 736 VKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792
V++V + RP H ++ + +C E RP+ +Q+LS
Sbjct: 211 VEKVSQGLRLYRP--------------HLASEKVYAIMYSCWHEKAEERPTFQQLLS 253
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 2e-08
Identities = 54/219 (24%), Positives = 89/219 (40%), Gaps = 34/219 (15%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVKCLAE--KGERFEKTFAAELVAVAHLRHRNLVRLRGW 176
+GSG +G V A+ G VA+K L+ + E F K EL + H++H N++ L
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 177 CVHEDQLLLVYDY---MPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHE 233
D+ MP D PL+ ++ + ++ + L Y+H
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQTDLQKIM-------GHPLSEDKVQYLVYQMLCGLKYIHS 135
Query: 234 QLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTR 293
IIHRD+K N+ ++ ++ DFGLAR + AE T
Sbjct: 136 ---AGIIHRDLKPGNLAVNEDCELKILDFGLARHAD-------------------AEMTG 173
Query: 294 IGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
T Y PE D++S G ++ E+++G+
Sbjct: 174 YVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 59/229 (25%), Positives = 100/229 (43%), Gaps = 39/229 (17%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTV--VAVKCLA-EKGERFE-KTFAAELVAVAHLRHRNLVR 172
+ LG G FG V L D ++ VAVK + R E + F +E V + H N++R
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 173 LRGWCVHEDQL------LLVYDYMPNRSLDR-VLFRRPENLEAAAPLNWEQRKKIIRGLA 225
L G C+ + +++ +M + L +L+ R + P + K + +A
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPT--QMLVKFMTDIA 122
Query: 226 AALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQ 285
+ + YL + IHRD+ N ML+ N + DFGL++ + + Y+
Sbjct: 123 SGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQ--------- 170
Query: 286 FHLAETTRIGGTIGYLPPESFQKGSVA----TAKSDVFSFGIVVLEVVS 330
G I +P + S+A T KSDV+SFG+ + E+ +
Sbjct: 171 ----------GRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 56/204 (27%), Positives = 85/204 (41%), Gaps = 18/204 (8%)
Query: 526 FGTAYQGFL-----DN-HQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWC 579
FG Y+G D V VK L S + F E +++ H+N+V+L G
Sbjct: 19 FGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVS 78
Query: 580 TEQGEMLVIYDYSATRILSHLLFHNNHRIGH-SILQWHHRYNIIKSLASAILYLHEEWNE 638
E+ ++ + A L L N R S L + +A YL E
Sbjct: 79 FERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN--- 135
Query: 639 QVIHRNITSSAITLD---PDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSP 695
IHR+I + L P ++ F +A + R + +RK G R++ I +M P
Sbjct: 136 HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASY-YRK---GGRAMLPI-KWMPP 190
Query: 696 EYIESGEATSMADVYSFGVVVLEV 719
E G TS DV+SFGV++ E+
Sbjct: 191 EAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (134), Expect = 3e-08
Identities = 41/165 (24%), Positives = 75/165 (45%), Gaps = 15/165 (9%)
Query: 559 NELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHR 618
NE+ + +H N+V E+ V+ +Y L+ ++ N R+ + +
Sbjct: 64 NEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAY--- 120
Query: 619 YNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRK 678
+ + + + YLH ++ VIHR+I S I L D + +L F A LT+ R
Sbjct: 121 --VCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE-KSKRN 174
Query: 679 ATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQ 723
SV G +M+PE I+ + D++S G++ +E+ G+
Sbjct: 175 ------SVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 70/284 (24%), Positives = 122/284 (42%), Gaps = 40/284 (14%)
Query: 526 FGTAYQGFLDN------HQYVLVKRLGMSKCPALRTR--FSNELQNLARLRHRNLVQLCG 577
FG Y+G V +K + ++ ++R R F NE + ++V+L G
Sbjct: 19 FGMVYEGLAKGVVKGEPETRVAIKTV--NENASMRERIEFLNEASVMKEFNCHHVVRLLG 76
Query: 578 WCTEQGEMLVIYDYSATRIL-SHLLFH---NNHRIGHSILQWHHRYNIIKSLASAILYLH 633
+ LV+ + A L S+L + G + +A + YL
Sbjct: 77 VVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA 136
Query: 634 EEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYM 693
+ + +HR++ + + D+ ++G F + + D+ +RK G VR +M
Sbjct: 137 AK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDY-YRKGGKGLLPVR----WM 188
Query: 694 SPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLP-EGLLVKRVHEFEARKRPLAE 751
+PE ++ G T+ +DV+SFGVV+ E+ T + P +GL + V +F L
Sbjct: 189 APESLKDGVFTTKSDVWSFGVVLWEMATLAE------QPYQGLSNEEVLKFVIDGGHL-- 240
Query: 752 LVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795
DL N ELMR+ C NP++RP+ +I+S L
Sbjct: 241 --DLPENCPDKLLELMRM------CWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 53/215 (24%), Positives = 95/215 (44%), Gaps = 27/215 (12%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVKCLA-EKGERFEKTFAAELVAVAHLRHRNLVRLRGWC 177
LG G + VY+ +VA+K + E E T E+ + L+H N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 178 VHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLET 237
E L LV++Y+ ++ L + L + +N K + L L+Y H +
Sbjct: 74 HTEKSLTLVFEYL-DKDLKQYLD------DCGNSINMHNVKLFLFQLLRGLNYCHRR--- 123
Query: 238 QIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGT 297
+++HRD+K N++++ + +L DFGLAR + T + N T
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLAR------AKSIPTKTYSNEVV----------T 167
Query: 298 IGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
+ Y PP+ + + + D++ G + E+ +GR
Sbjct: 168 LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 64/272 (23%), Positives = 112/272 (41%), Gaps = 38/272 (13%)
Query: 540 VLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRILSH 599
V VK L ++ F E +A H N+V+L G C M ++++Y A L+
Sbjct: 38 VAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNE 97
Query: 600 LLFHNNHRIGHSILQWH----------------HRYNIIKSLASAILYLHEEWNEQVIHR 643
L H + R S+ + I K +A+ + YL E + +HR
Sbjct: 98 FLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHR 154
Query: 644 NITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEA 703
++ + + +M ++ F L+ + D+ ++ + + +R +M PE I
Sbjct: 155 DLATRNCLVGENMVVKIADFGLSRNIYSADY-YKASENDAIPIR----WMPPESIFYNRY 209
Query: 704 TSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYNH 763
T+ +DV+++GVV+ E+ + M + + ++ V + P + L L YN
Sbjct: 210 TTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVLSCP--DNCPLEL---YN- 263
Query: 764 KELMRLIKLGIACTLSNPELRPSMRQILSILD 795
LMRL C P RPS I IL
Sbjct: 264 --LMRL------CWSKLPSDRPSFASINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 59/268 (22%), Positives = 109/268 (40%), Gaps = 45/268 (16%)
Query: 540 VLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRILSH 599
VLVK L +K L++ F EL +L H+N+V+L G C E +I +Y+ L
Sbjct: 38 VLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQ 97
Query: 600 LLFHNNHRIGHSI---LQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDM 656
L + L + + +A + +L N + +HR++ + +
Sbjct: 98 FLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQR 154
Query: 657 NPRLGSFALAEFLTRND-HGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVV 715
++ +L++ + ++ + R A R +++PE ++ + ++ +DV+SFGV+
Sbjct: 155 EVKVSLLSLSKDVYNSEYYKLRNALIPLR-------WLAPEAVQEDDFSTKSDVWSFGVL 207
Query: 716 VLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELM-------- 767
+ EV F + P L D + +L
Sbjct: 208 MWEV----------------------FTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCP 245
Query: 768 -RLIKLGIACTLSNPELRPSMRQILSIL 794
RL KL C NP+ RPS +++S L
Sbjct: 246 SRLYKLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 59/220 (26%), Positives = 102/220 (46%), Gaps = 33/220 (15%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLA-EKGERFEKTFAAELVAVAHLRHRNLVRLRG 175
E LG G + V++ +VA+K + E E T E+ + L+H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 176 WCVHEDQ-LLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQ--RKKIIRGLAAALHYLH 232
VH D+ L LV++Y LD+ L + ++ ++ + +I+RGLA Y H
Sbjct: 72 -IVHTDKSLTLVFEY-----LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLA----YCH 121
Query: 233 EQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETT 292
+ +++HRD+K N++++ + +L DFGLAR + T + N
Sbjct: 122 RR---KVLHRDLKPQNLLINERGELKLADFGLAR------AKSVPTKTYSNEVV------ 166
Query: 293 RIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
T+ Y PP+ S + + D++ G + E+ SGR
Sbjct: 167 ----TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 5e-08
Identities = 65/221 (29%), Positives = 103/221 (46%), Gaps = 34/221 (15%)
Query: 118 VLGSGGFGKVY--RAVLPSD-GTVVAVKCLAE-KGERFEKTFA---AELVAVAHLRHRNL 170
VLG GG+GKV+ R V +D G + A+K L + R +K A AE + ++H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 171 VRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHY 230
V L +L L+ +Y+ L L R +E A + ++ AL +
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSE-------ISLALEH 115
Query: 231 LHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAE 290
LH+Q II+RD+K N++LD+Q + +L DFGL + HE H F
Sbjct: 116 LHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE--------GTVTHTF---- 160
Query: 291 TTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSG 331
GTI Y+ PE + A D +S G ++ ++++G
Sbjct: 161 ----CGTIEYMAPEILMRSGHGKA-VDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 6e-08
Identities = 45/201 (22%), Positives = 87/201 (43%), Gaps = 18/201 (8%)
Query: 525 DFGTAYQGFL---DNHQY-VLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCT 580
+FG+ +G + V VK L A + F E +A+L H +V+L G C
Sbjct: 7 NFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK 66
Query: 581 EQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQV 640
+ MLV+ +L +L + + + H+ +A + YL +
Sbjct: 67 GEPLMLVMELAPLGPLLKYLKKRREIPV-SDLKELAHQ------VAMGMAYLES---KHF 116
Query: 641 IHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIES 700
+HR++ + + L ++ F ++ L +R T+G ++ + +PE I
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLK----WYAPECINY 172
Query: 701 GEATSMADVYSFGVVVLEVVT 721
G+ +S +DV+S+GV + E +
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 6e-08
Identities = 55/226 (24%), Positives = 89/226 (39%), Gaps = 52/226 (23%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEK-TFAAELVAVAHLR-HRNLVRLRGW 176
+G G F +V +A G A+KC+ + + E+ E+ A+ L H N++RL
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIE- 65
Query: 177 CVHEDQ----LLLV--------YDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGL 224
V D+ L LV Y+ + R +RP L ++ K + L
Sbjct: 66 -VLFDRKTGRLALVFELMDMNLYELIKGR-------KRP--------LPEKRVKSYMYQL 109
Query: 225 AAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNH 284
+L ++H I HRD+K N+++ +L DFG R + + Y S
Sbjct: 110 LKSLDHMHRN---GIFHRDIKPENILIK-DDILKLADFGSCRGIYSKPPYTEYIS----- 160
Query: 285 QFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS 330
TR Y PE K D+++ G V E++S
Sbjct: 161 -------TR-----WYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 6e-08
Identities = 73/263 (27%), Positives = 108/263 (41%), Gaps = 51/263 (19%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVA--------VAHLRHR 168
++LG G FGKV + G A+K L R E A + VA + + RH
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKIL-----RKEVIIAKDEVAHTVTESRVLQNTRHP 55
Query: 169 NLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAAL 228
L L+ D+L V +Y L L R E A + + +AL
Sbjct: 56 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE-------IVSAL 108
Query: 229 HYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHL 288
YLH + +++RD+K N+MLD + ++ DFGL + + + A F
Sbjct: 109 EYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK--------EGISDGATMKTF-- 155
Query: 289 AETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDD-----Q 343
GT YL PE + A D + G+V+ E++ GR Y D +
Sbjct: 156 ------CGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPF---YNQDHERLFE 205
Query: 344 IILLDWI---RRLSDEGKVLQAG 363
+IL++ I R LS E K L AG
Sbjct: 206 LILMEEIRFPRTLSPEAKSLLAG 228
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 61/231 (26%), Positives = 98/231 (42%), Gaps = 56/231 (24%)
Query: 118 VLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRL--RG 175
++G GGFG+VY G + A+KCL +K + ++ E +A L R ++ L G
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ---GETLA---LNERIMLSLVSTG 54
Query: 176 WCVH----------EDQLLLVYDYMPNRSLDRVL-----FRRPENLEAAAPLNWEQRKKI 220
C D+L + D M L L F E AA +I
Sbjct: 55 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAA--------EI 106
Query: 221 IRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSS 280
I GL ++H + +++RD+K +N++LD + R+ D GLA + +
Sbjct: 107 ILGL----EHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA------CDFSKKKPH 153
Query: 281 ARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSG 331
A GT GY+ PE QKG + +D FS G ++ +++ G
Sbjct: 154 ASV------------GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 7e-08
Identities = 47/186 (25%), Positives = 80/186 (43%), Gaps = 28/186 (15%)
Query: 148 GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVL--FRRPEN 205
G R E++A+ L H N++++ E YM + D L F E
Sbjct: 203 GSRAAIQLENEILALGRLNHENILKIEEILRSEA-----NTYMITQKYDFDLYSFMYDEA 257
Query: 206 LE-AAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGL 264
+ PL + R I++ L A+ Y+H++ +IHRD+K N+ L+ LGDFG
Sbjct: 258 FDWKDRPLLKQTRA-IMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCDGKIVLGDFGT 313
Query: 265 ARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIV 324
A E E A ++ + GT+ PE +D++S G++
Sbjct: 314 AMPFEKE-------REAFDYGWV--------GTVATNSPEILAGDGYCEI-TDIWSCGLI 357
Query: 325 VLEVVS 330
+L+++S
Sbjct: 358 LLDMLS 363
|
Length = 501 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 7e-08
Identities = 57/230 (24%), Positives = 98/230 (42%), Gaps = 45/230 (19%)
Query: 118 VLGSGGFGKVYRAVLPSDGTVVAVKCLAE----KGERFEKTFAAELVAVAHLRHRNLVRL 173
VLG G FGKV A + A+K L + + + E T + V + L +L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66
Query: 174 RGWCVHEDQLLLVYDYMPNRSL----DRV-LFRRPENLEAAAPLNWEQRKKIIRGLAAAL 228
D+L V +Y+ L +V F+ P+ + AA + + L
Sbjct: 67 HSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEI------------SVGL 114
Query: 229 HYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHL 288
+LH + II+RD+K NVMLDS+ + ++ DFG+ + H
Sbjct: 115 FFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGM----------------CKEHMVDG 155
Query: 289 AETTRIGGTIGYLPPE--SFQKGSVATAKSDVFSFGIVVLEVVSGRRAVD 336
T GT Y+ PE ++Q + D +++G+++ E+++G+ D
Sbjct: 156 VTTRTFCGTPDYIAPEIIAYQPYGKSV---DWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 7e-08
Identities = 69/278 (24%), Positives = 113/278 (40%), Gaps = 58/278 (20%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFA---AELVAVAHLRHRN 169
F + + LG G FG+V A + A+K L +K A AE +A +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 170 LVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRR---PENLEAAAPLNWEQRKKIIRGLAA 226
+V+L +D L V DY+P + +L R PE L + I L
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLA----------RFYIAELTL 112
Query: 227 ALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLA---RWLEHELQYQ-------- 275
A+ +H+ IHRD+K N+++D + +L DFGL RW + YQ
Sbjct: 113 AIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQD 169
Query: 276 ----------------------MRTSSARNHQFHLAETTRIGGTIGYLPPES-FQKGSVA 312
+ + + HQ LA + + GT Y+ PE +KG
Sbjct: 170 SMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHS--LVGTPNYIAPEVLLRKGY-- 225
Query: 313 TAKSDVFSFGIVVLEVVSGRRAVDLTYP-DDQIILLDW 349
T D +S G+++ E++ G+ P + Q+ +++W
Sbjct: 226 TQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 7e-08
Identities = 63/250 (25%), Positives = 101/250 (40%), Gaps = 53/250 (21%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVA----VAHLRHRNLVRLR 174
+G G FG+V + A+K L K + + AA + A +A + +V+L
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTL-RKADVLMRNQAAHVKAERDILAEADNEWVVKLY 67
Query: 175 GWCVHEDQLLLVYDYMPNRSLDRVLFRR---PENLEAAAPLNWEQRKKIIRGLAAALHYL 231
+D L V DY+P + +L R E+L + I L A+ +
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLA----------RFYIAELTCAIESV 117
Query: 232 HEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLA---RWLEHELQYQ----MRTSS---- 280
H+ IHRD+K N+++D + +L DFGL RW YQ R S
Sbjct: 118 HK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPS 174
Query: 281 ------------------ARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFG 322
R HQ LA + + GT Y+ PE + + T D +S G
Sbjct: 175 EEWSEIDRCRLKPLERRRKRQHQRCLAHS--LVGTPNYIAPEVLLR-TGYTQLCDWWSVG 231
Query: 323 IVVLEVVSGR 332
+++ E++ G+
Sbjct: 232 VILYEMLVGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 8e-08
Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 36/218 (16%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVKCLAE--KGERFEKTFAAELVAVAHLRHRNLVRLRGW 176
+G G FG V A G VA+K + + K EL + HLRH N++ L
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDI 77
Query: 177 CVH--EDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQ 234
+ ED + V + + L R+L RP + ++ I+RGL Y+H
Sbjct: 78 FISPLED-IYFVTELL-GTDLHRLLTSRPLEKQFIQYFLYQ----ILRGL----KYVHS- 126
Query: 235 LETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRI 294
++HRD+K SN++++ + ++ DFGLAR + ++ + T R + L
Sbjct: 127 --AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRYYRAPEIML------ 178
Query: 295 GGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
++QK V D++S G + E++ G+
Sbjct: 179 ----------TWQKYDVEV---DIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 9e-08
Identities = 48/201 (23%), Positives = 87/201 (43%), Gaps = 19/201 (9%)
Query: 526 FGTAYQGFLDNHQY-----VLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCT 580
FGT Y+G V +K L + P F +E +A + H +LV+L G C
Sbjct: 20 FGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCL 79
Query: 581 EQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQV 640
LV +L ++ H ++ +L W +A ++YL E ++
Sbjct: 80 SPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYLEE---RRL 130
Query: 641 IHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIES 700
+HR++ + + + + ++ F LA L D A G ++ +M+ E I
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLARLL-EGDEKEYNADGGKMPIK----WMALECIHY 185
Query: 701 GEATSMADVYSFGVVVLEVVT 721
+ T +DV+S+GV + E++T
Sbjct: 186 RKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 9e-08
Identities = 55/238 (23%), Positives = 106/238 (44%), Gaps = 32/238 (13%)
Query: 568 RHRNLVQLCGWCTEQGEMLVIYDYSATRILSHLL----------FHNNHRIGHSILQWHH 617
+H+N++ L G CT++G + VI +Y+A L L + ++ L +
Sbjct: 76 KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135
Query: 618 RYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHR 677
+ +A + YL + + IHR++ + + + D ++ F LA + D+ ++
Sbjct: 136 LVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDY-YK 191
Query: 678 KATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVK 737
K ++G V+ +M+PE + T +DV+SFG+++ E+ T + +P L K
Sbjct: 192 KTSNGRLPVK----WMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK 247
Query: 738 RVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795
+ E +P N + LMR C + P RP+ +Q++ LD
Sbjct: 248 LLREGHRMDKP--------SNCTHELYMLMR------ECWHAVPTQRPTFKQLVEALD 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.3 bits (129), Expect = 1e-07
Identities = 42/187 (22%), Positives = 77/187 (41%), Gaps = 24/187 (12%)
Query: 540 VLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGE--MLVIYDYSATRIL 597
VL K+ + + T E L+R+ H +V+L Q E + ++ +Y+
Sbjct: 25 VLKKKKIIKRKEVEHTL--TERNILSRINHPFIVKL--HYAFQTEEKLYLVLEYAPG--- 77
Query: 598 SHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMN 657
L H + + R+ + A+ YLH + +I+R++ I LD D +
Sbjct: 78 GELFSHLSKE--GRFSEERARF-YAAEIVLALEYLH---SLGIIYRDLKPENILLDADGH 131
Query: 658 PRLGSFALA-EFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVV 716
+L F LA E + + G Y++PE + D +S GV++
Sbjct: 132 IKLTDFGLAKELSSEGSR--------TNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLL 183
Query: 717 LEVVTGQ 723
E++TG+
Sbjct: 184 YEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 61/249 (24%), Positives = 107/249 (42%), Gaps = 42/249 (16%)
Query: 557 FSNELQNLARL-RHRNLVQLCGWCTEQGEMLVIYDYS----------ATRIL-SHLLFHN 604
F+ EL+ L +L H N++ L G C +G + + +Y+ +R+L + F
Sbjct: 54 FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 113
Query: 605 NHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFA 664
+ S L + +A + YL ++ Q IHR++ + I + + ++ F
Sbjct: 114 ANSTA-STLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 169
Query: 665 LAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT--G 722
L +R + K T G VR +M+ E + T+ +DV+S+GV++ E+V+ G
Sbjct: 170 L----SRGQEVYVKKTMGRLPVR----WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 221
Query: 723 QMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPE 782
G+ ++E K P ++ LN + +LMR C P
Sbjct: 222 TPYC------GMTCAELYE----KLPQGYRLEKPLNCDDEVYDLMR------QCWREKPY 265
Query: 783 LRPSMRQIL 791
RPS QIL
Sbjct: 266 ERPSFAQIL 274
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 65/278 (23%), Positives = 124/278 (44%), Gaps = 40/278 (14%)
Query: 534 LDNHQY---VLVKRLGMSKCPALRTRFSNELQNLARL-RHRNLVQLCGWCTEQGEMLVIY 589
LDN V VK L + +E++ + + +H+N++ L G CT++G + V+
Sbjct: 36 LDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVV 95
Query: 590 DYSATRILSHLL-------FHNNHRIGHSILQWHHRYNIIK---SLASAILYLHEEWNEQ 639
+Y+A L L + + + + +++ +A + +L +++
Sbjct: 96 EYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKK 152
Query: 640 VIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIE 699
IHR++ + + + D ++ F LA + D+ +RK T+G V+ +M+PE +
Sbjct: 153 CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDY-YRKTTNGRLPVK----WMAPEALF 207
Query: 700 SGEATSMADVYSFGVVVLEVVT--GQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSL 757
T +DV+SFGV++ E+ T G + E L K + E ++P +L
Sbjct: 208 DRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--LFKLLKEGYRMEKPQNCTQEL-- 263
Query: 758 NGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795
Y+ LMR C P RP+ +Q++ LD
Sbjct: 264 ---YH---LMR------DCWHEVPSQRPTFKQLVEDLD 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 62/250 (24%), Positives = 107/250 (42%), Gaps = 51/250 (20%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRN--L 170
F+ +V+G G FG+V G + A+K L K + EK VAH+R L
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKIL-RKADMLEKE------QVAHIRAERDIL 55
Query: 171 VRLRG-WCVH-------EDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIR 222
V G W V + L L+ +++P + +L ++ L+ E + I
Sbjct: 56 VEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDT-------LSEEATQFYIA 108
Query: 223 GLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLA------------RWLEH 270
A+ +H+ IHRD+K N++LD++ + +L DFGL R L H
Sbjct: 109 ETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTH 165
Query: 271 ---------ELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSF 321
+ + + + + ++ LA +T GT Y+ PE F + D +S
Sbjct: 166 NPPSDFSFQNMNSKRKAETWKKNRRQLAYSTV--GTPDYIAPEVFMQTGY-NKLCDWWSL 222
Query: 322 GIVVLEVVSG 331
G+++ E++ G
Sbjct: 223 GVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 60/242 (24%), Positives = 109/242 (45%), Gaps = 37/242 (15%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAE----KGERFEKTFAAELVAVAHLRHRNLVR 172
VLG G FGKV A L G + AVK L + + + E T + + H L +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 173 LRGWCVHE--DQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHY 230
L +C + D+L V +++ L +F +++ + + + + + +AL +
Sbjct: 61 L--YCCFQTPDRLFFVMEFVNGGDL---MF----HIQKSRRFDEARARFYAAEITSALMF 111
Query: 231 LHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAE 290
LH++ II+RD+K NV+LD + + +L DFG+ + F+
Sbjct: 112 LHDK---GIIYRDLKLDNVLLDHEGHCKLADFGM----------------CKEGIFNGKT 152
Query: 291 TTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDD--QIILLD 348
T+ GT Y+ PE Q+ + D ++ G+++ E++ G + DD + IL D
Sbjct: 153 TSTFCGTPDYIAPEILQEMLYGPS-VDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND 211
Query: 349 WI 350
+
Sbjct: 212 EV 213
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 44/158 (27%), Positives = 73/158 (46%), Gaps = 17/158 (10%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFA---AELVAVAHLRHRN 169
F + +G G FG VY A VVA+K ++ G++ + + E+ + ++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 170 LVRLRGWCVHEDQLLLVYDYMPNRSLDRV-LFRRP-ENLEAAAPLNWEQRKKIIRGLAAA 227
+ +G + E LV +Y + D + + ++P + +E AA I G
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA---------ITHGALQG 137
Query: 228 LHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLA 265
L YLH +IHRD+K N++L +L DFG A
Sbjct: 138 LAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSA 172
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 58/223 (26%), Positives = 98/223 (43%), Gaps = 35/223 (15%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGE--RFEKT--FAAELVAVAHLRHR 168
F+ E LG+G FG+V A G A+KCL +K E + ++ A E + L H
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCL-KKREILKMKQVQHVAQEKSILMELSHP 78
Query: 169 NLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAAL 228
+V + E+++ + +++ + LF +L A + K L A
Sbjct: 79 FIVNMMCSFQDENRVYFLLEFV----VGGELF---THLRKAGRFPNDVAKFYHAELVLAF 131
Query: 229 HYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHL 288
YLH + II+RD+K N++LD++ + ++ DFG A+ + F L
Sbjct: 132 EYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAK-------------KVPDRTFTL 175
Query: 289 AETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSG 331
GT YL PE Q A D ++ G+++ E ++G
Sbjct: 176 C------GTPEYLAPEVIQSKGHGKA-VDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 69/275 (25%), Positives = 100/275 (36%), Gaps = 75/275 (27%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVA--------VAHLRHR 168
++LG G FGKV + G A+K L + E A + VA + + RH
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKIL-----KKEVIIAKDEVAHTLTESRVLQNTRHP 55
Query: 169 NLVRLRGWCVHEDQLLLVYDYMPNRSL------------DRVLFRRPENLEAAAPLNWEQ 216
L L+ D+L V +Y L DR F E
Sbjct: 56 FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE------------ 103
Query: 217 RKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQM 276
+ +AL YLH +++RD+K N+MLD + ++ DFGL + +
Sbjct: 104 -------IVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGA 150
Query: 277 RTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVD 336
+ GT YL PE + A D + G+V+ E++ GR
Sbjct: 151 TMKT-------------FCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPF- 195
Query: 337 LTYPDDQIILLDWI--------RRLSDEGKVLQAG 363
Y D L + I R LS E K L AG
Sbjct: 196 --YNQDHEKLFELILMEEIRFPRTLSPEAKSLLAG 228
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 2e-07
Identities = 43/188 (22%), Positives = 84/188 (44%), Gaps = 17/188 (9%)
Query: 537 HQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRI 596
+ +K++ + R + EL+ L +V+ G ++GE+ ++ +Y
Sbjct: 26 GKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGS 85
Query: 597 LSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDM 656
L+ LL I +L + I + + + YLH + + +IHR+I S + ++
Sbjct: 86 LADLLKKVGK-IPEPVLAY-----IARQILKGLDYLHTKRH--IIHRDIKPSNLLINSKG 137
Query: 657 NPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSM-ADVYSFGVV 715
++ F +++ L + G YMSPE I+ GE+ S AD++S G+
Sbjct: 138 EVKIADFGISKVLENTLDQCN-------TFVGTVTYMSPERIQ-GESYSYAADIWSLGLT 189
Query: 716 VLEVVTGQ 723
+LE G+
Sbjct: 190 LLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 50/221 (22%), Positives = 100/221 (45%), Gaps = 23/221 (10%)
Query: 540 VLVKRLGMSKCPALRTR--FSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRIL 597
V VK L K P L R F E + L L+H ++V+ G C + ++++++Y L
Sbjct: 38 VAVKAL---KDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDL 94
Query: 598 SH----------LLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITS 647
+ +L R L +I +AS ++YL ++ +HR++ +
Sbjct: 95 NKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLAT 151
Query: 648 SAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMA 707
+ ++ ++G F ++ + D+ +R +R +M PE I + T+ +
Sbjct: 152 RNCLVGANLLVKIGDFGMSRDVYSTDY-YRVGGHTMLPIR----WMPPESIMYRKFTTES 206
Query: 708 DVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRP 748
DV+SFGV++ E+ T F+L +++ + + +RP
Sbjct: 207 DVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERP 247
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 45/177 (25%), Positives = 84/177 (47%), Gaps = 24/177 (13%)
Query: 557 FSNELQNLARL-RHRNLVQLCGWCTEQGEMLVIYDYS----------ATRIL-SHLLFHN 604
F+ EL+ L +L H N++ L G C +G + + +Y+ +R+L + F
Sbjct: 49 FAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAK 108
Query: 605 NHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFA 664
H S L +A+ + YL E+ Q IHR++ + + + ++ ++ F
Sbjct: 109 EHGTA-STLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFG 164
Query: 665 LAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT 721
L +R + + K T G VR +M+ E + T+ +DV+SFGV++ E+V+
Sbjct: 165 L----SRGEEVYVKKTMGRLPVR----WMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 2e-07
Identities = 43/177 (24%), Positives = 82/177 (46%), Gaps = 24/177 (13%)
Query: 557 FSNELQNLARL-RHRNLVQLCGWCTEQGEMLVIYDYS----------ATRIL-SHLLFHN 604
F+ EL+ L +L H N++ L G C +G + + +Y+ +R+L + F
Sbjct: 42 FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 101
Query: 605 NHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFA 664
+ S L + +A + YL ++ Q IHR++ + I + + ++ F
Sbjct: 102 ANSTA-STLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157
Query: 665 LAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT 721
L +R + K T G VR +M+ E + T+ +DV+S+GV++ E+V+
Sbjct: 158 L----SRGQEVYVKKTMGRLPVR----WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 70/283 (24%), Positives = 125/283 (44%), Gaps = 42/283 (14%)
Query: 519 QRVAEMDFGTAYQGFLDNHQYVLVKRLG---MSKCPALRTRFSNELQNLARLRHRNLVQL 575
+++ FG + G + + V VK L MS F E Q + +LRH LVQL
Sbjct: 12 KKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP-----ESFLEEAQIMKKLRHDKLVQL 66
Query: 576 CGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEE 635
+E+ + ++ +Y + L L R L+ + ++ +A+ + Y+ E
Sbjct: 67 YAVVSEE-PIYIVTEYMSKGSLLDFLKDGEGRA----LKLPNLVDMAAQVAAGMAYI-ER 120
Query: 636 WNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSP 695
N IHR++ S+ I + + ++ F LA + N++ R+ + + +P
Sbjct: 121 MN--YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGA------KFPIKWTAP 172
Query: 696 EYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLP-EGLLVKRVHEFEAR--KRPLAEL 752
E G T +DV+SFG+++ E+VT R+P G+ + V E R + P +
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELVTKG-----RVPYPGMNNREVLEQVERGYRMPCPQD 227
Query: 753 VDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795
+SL+ ELM + C +PE RP+ + S L+
Sbjct: 228 CPISLH------ELM------LQCWKKDPEERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 60/253 (23%), Positives = 111/253 (43%), Gaps = 45/253 (17%)
Query: 519 QRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGW 578
+ + E +FG QG Q V VK + KC F E + +L H+NLV+L G
Sbjct: 12 EIIGEGEFGAVLQGEYTG-QKVAVKNI---KCDVTAQAFLEETAVMTKLHHKNLVRLLGV 67
Query: 579 CTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNE 638
G +V+ S +++ L R S++Q ++++ +A + YL ++
Sbjct: 68 ILHNGLYIVMELMSKGNLVNFL--RTRGRALVSVIQLL-QFSL--DVAEGMEYLE---SK 119
Query: 639 QVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYI 698
+++HR++ + I + D ++ F LA G + V+ + +PE +
Sbjct: 120 KLVHRDLAARNILVSEDGVAKVSDFGLARV------GSMGVDNSKLPVK----WTAPEAL 169
Query: 699 ESGEATSMADVYSFGVVVLEV---------------VTGQMAVDFRL--PEG------LL 735
+ + +S +DV+S+GV++ EV V + +R+ PEG +L
Sbjct: 170 KHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVL 229
Query: 736 VKRVHEFEARKRP 748
+ E E +KRP
Sbjct: 230 MTSCWETEPKKRP 242
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 52/219 (23%), Positives = 98/219 (44%), Gaps = 24/219 (10%)
Query: 519 QRVAEMDFGTAYQGFL-----DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLV 573
+ + E FG Y+G L D+ Q V +K L P F E +A L H N+V
Sbjct: 11 EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIV 70
Query: 574 QLCGWCTEQGEMLVIYDYSATRILSH-LLFHNNHR-IG---------HSILQWHHRYNII 622
L G T++ + ++++Y L L+ + H +G S L +I
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 623 KSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSG 682
+A+ + YL + +H+++ + I + ++ ++ L+ + D+ +R
Sbjct: 131 IQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADY-YRVQPKS 186
Query: 683 NRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT 721
+R +M PE I G+ +S +D++SFGVV+ E+ +
Sbjct: 187 LLPIR----WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 65/230 (28%), Positives = 94/230 (40%), Gaps = 54/230 (23%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVA---VAH-LRHRN----- 169
+G G FG+VY+ + A+K L++K E+VA VAH + RN
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKK----------EIVAKKEVAHTIGERNILVRT 50
Query: 170 -------LVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKI-I 221
+V L+ + L LV DYM L L + E E R K I
Sbjct: 51 LLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQK-----EGRFS---EDRAKFYI 102
Query: 222 RGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSA 281
L AL +LH+ I++RD+K N++LD+ + L DFGL+ + +
Sbjct: 103 AELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLS-----------KANLT 148
Query: 282 RNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSG 331
N T GT YL PE T D +S G++V E+ G
Sbjct: 149 DN-----KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 68/257 (26%), Positives = 106/257 (41%), Gaps = 50/257 (19%)
Query: 118 VLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG-----ERFEKTFAAELVAVAHLRHRNLVR 172
VLG G FGKV A L + AVK L +K + E T + V +H L +
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVL-KKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 173 LRGWCVHEDQLLLVYDYMPNRSL------DRVLFRRPENLEAAAPLNWEQRKKIIRGLAA 226
L +D+L V +Y+ L F P AA +
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGR-FDEPRARFYAAEI------------VL 107
Query: 227 ALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQF 286
L +LHE+ II+RD+K NV+LDS+ + ++ DFG+ + + + TS+
Sbjct: 108 GLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCK---EGILGGVTTST------ 155
Query: 287 HLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDD--QI 344
GT Y+ PE D ++ G+++ E+++G+ + D+ Q
Sbjct: 156 -------FCGTPDYIAPEILS-YQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQS 207
Query: 345 ILLDWI---RRLSDEGK 358
IL D + R LS E K
Sbjct: 208 ILEDEVRYPRWLSKEAK 224
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 54/219 (24%), Positives = 92/219 (42%), Gaps = 33/219 (15%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVKCLAE--KGERFEKTFAAELVAVAHLRHRNLVRLRGW 176
+GSG +G V A+ G VA+K L + E F K EL + H++H N++ L
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 177 CVHEDQLLLVYDY---MPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHE 233
+ L +D+ MP D + E L ++ + ++ + L Y+H
Sbjct: 83 FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSE------DRIQFLVYQMLKGLKYIHA 136
Query: 234 QLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTR 293
IIHRD+K N+ ++ ++ DFGLAR + E+ + T
Sbjct: 137 ---AGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-------------- 179
Query: 294 IGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
Y PE T D++S G ++ E+++G+
Sbjct: 180 -----WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 53/224 (23%), Positives = 93/224 (41%), Gaps = 37/224 (16%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK---GERFEKTFAAELVAVAHLRHRN 169
+ + +G+G FG+V+ A+K +A + E+ E + + H
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62
Query: 170 LVRLRGWCVHEDQ--LLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAA 227
++RL + DQ L ++ +Y+P L F L + + + A
Sbjct: 63 IIRL--FWTEHDQRFLYMLMEYVPGGEL----F---SYLRNSGRFSNSTGLFYASEIVCA 113
Query: 228 LHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFH 287
L YLH + +I++RD+K N++LD + + +L DFG A+ L
Sbjct: 114 LEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD----------------- 153
Query: 288 LAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSG 331
T + GT YL PE Q A D ++ GI++ E++ G
Sbjct: 154 --RTWTLCGTPEYLAPEVIQSKGHNKA-VDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-07
Identities = 53/232 (22%), Positives = 97/232 (41%), Gaps = 35/232 (15%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVKCLAE---KGERFEKTFAAELVAVAHLRHRNLVRLRG 175
+G GG G+VY A P VA+K + E + +K F E A L H +V +
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69
Query: 176 WCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRK---------------KI 220
C D VY MP + L++ W++ I
Sbjct: 70 ICSDGD---PVYYTMP--------YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSI 118
Query: 221 IRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTS- 279
+ A + Y+H + ++HRD+K N++L + D+G A + + E + +
Sbjct: 119 FHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDV 175
Query: 280 SARNHQFH-LAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS 330
RN + + +I GT Y+ PE G A+ +D+++ G+++ ++++
Sbjct: 176 DERNICYSSMTIPGKIVGTPDYMAPERL-LGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 62/250 (24%), Positives = 107/250 (42%), Gaps = 51/250 (20%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVR 172
F+ +V+G G FG+V G V A+K L K + EK V H+R +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKIL-RKADMLEKE------QVGHIRAERDIL 55
Query: 173 LRG---WCVH-----EDQ--LLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIR 222
+ W V +D+ L L+ +++P + +L ++ L E+ + I
Sbjct: 56 VEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDT-------LTEEETQFYIA 108
Query: 223 GLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLA------------RWLEH 270
A+ +H+ IHRD+K N++LDS+ + +L DFGL R L H
Sbjct: 109 ETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNH 165
Query: 271 EL---------QYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSF 321
L + + + + ++ LA +T GT Y+ PE F + D +S
Sbjct: 166 SLPSDFTFQNMNSKRKAETWKRNRRQLAFSTV--GTPDYIAPEVFMQTGY-NKLCDWWSL 222
Query: 322 GIVVLEVVSG 331
G+++ E++ G
Sbjct: 223 GVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 60/225 (26%), Positives = 92/225 (40%), Gaps = 44/225 (19%)
Query: 118 VLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAEL-------VAVAHLRHRNL 170
VLG G FGKV A G + A+K L +KG+ + L RH L
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKAL-KKGDIIARDEVESLMCEKRIFETANSERHPFL 64
Query: 171 VRLRGWCVHEDQLLLVYDYMPNRSL----DRVLFRRPENLEAAAPLNWEQRKKIIRGLAA 226
V L ED + V +Y L +F P + AA +
Sbjct: 65 VNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAAC------------VVL 112
Query: 227 ALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQF 286
L YLHE +I++RD+K N++LD++ ++ DFGL + + + RTS+
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK---EGMGFGDRTST------ 160
Query: 287 HLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSG 331
GT +L PE + S A D + G+++ E++ G
Sbjct: 161 -------FCGTPEFLAPEVLTETSYTRA-VDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 65/267 (24%), Positives = 110/267 (41%), Gaps = 62/267 (23%)
Query: 543 KRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRILSHLLF 602
++ M K ALR +E++ L L H N+VQ G E L I+ L +
Sbjct: 47 RQKDMVK--ALR----SEIETLKDLDHLNIVQYLG-FETTEEYLSIF----------LEY 89
Query: 603 HNNHRIGHSILQWHHRY--NIIKSLASAIL----YLHEEWNEQVIHRNITSSAITLDPDM 656
IG S L+ + R+ +++ +L YLH ++ ++HR++ + + +D D
Sbjct: 90 VPGGSIG-SCLRTYGRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDAD- 144
Query: 657 NPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMA--DVYSFGV 714
G +++F N S++G +M+PE I S A D++S G
Sbjct: 145 ----GICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGC 200
Query: 715 VVLEVVTG--------QMAVDFRLPEGLLVKRVHEFEARKR-PLAELVDLSLNGEYNHKE 765
VVLE+ G +A F+L R P+ D+S+N +
Sbjct: 201 VVLEMFAGRRPWSDEEAIAAMFKL-----------GNKRSAPPIPP--DVSMNLSPVALD 247
Query: 766 LMRLIKLGIACTLSNPELRPSMRQILS 792
+ AC NP+ RP+ R++L
Sbjct: 248 FLN------ACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 61/262 (23%), Positives = 115/262 (43%), Gaps = 38/262 (14%)
Query: 535 DNHQYVLVKRLGMSKCPALRTRFS-NELQNLARLRHRNLVQLC-GWCTEQGEMLVIYDYS 592
D QYV +K+L + + + E Q L++L+H N+V W E G + ++ +
Sbjct: 24 DGKQYV-IKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFC 82
Query: 593 ATRILSHLLFHNNHRI--GHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAI 650
L H L ++ + +++W +A A+ YLHE+ ++HR++ + +
Sbjct: 83 EGGDLYHKLKEQKGKLLPENQVVEW------FVQIAMALQYLHEK---HILHRDLKTQNV 133
Query: 651 TLDPDMNPRLGSFALAEFL-TRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADV 709
L ++G +A L + D ++ G YMSPE + +DV
Sbjct: 134 FLTRTNIIKVGDLGIARVLENQCDMA--------STLIGTPYYMSPELFSNKPYNYKSDV 185
Query: 710 YSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRL 769
++ G V E+ T + A + + L+ + + E + P+ + +Y+ EL L
Sbjct: 186 WALGCCVYEMATLKHAFNAKDMNSLVYRII---EGKLPPMPK--------DYS-PELGEL 233
Query: 770 IKLGIACTLSNPELRPSMRQIL 791
I ++ PE RPS++ IL
Sbjct: 234 IATMLS---KRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 52/219 (23%), Positives = 96/219 (43%), Gaps = 33/219 (15%)
Query: 514 NFSESQRVAEMDFGTAY--QGFLDNHQYVLVKRLGMSKCPALRTRFS-NELQNLARLRHR 570
+ +++ E FG Y + D+ V +K + ++K P S E+ LA+++H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCV-IKEIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 571 NLVQLCGWCTEQGEMLVIYDYS-----ATRILSH--LLFHNNHRIGHSILQWHHRYNIIK 623
N+V E G + ++ +Y RI +LF + IL W
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQ-----ILSW------FV 108
Query: 624 SLASAILYLHEEWNEQVIHRNITSSAITLDPD-MNPRLGSFALAEFLTRNDHGHRKATSG 682
++ + ++H+ +++HR+I S I L + M +LG F +A L ND +
Sbjct: 109 QISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL--ND-----SMEL 158
Query: 683 NRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT 721
+ G Y+SPE ++ + D++S G V+ E+ T
Sbjct: 159 AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 32/109 (29%), Positives = 51/109 (46%), Gaps = 21/109 (19%)
Query: 224 LAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARN 283
+ + +LH I++RD+K NV+LD Q N RL D GLA +++
Sbjct: 104 ITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLA--------VELKDGKT-- 150
Query: 284 HQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
T+ GT GY+ PE ++ + D F+ G + E+V+GR
Sbjct: 151 -------ITQRAGTNGYMAPEILKEEPYSYP-VDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 3e-07
Identities = 37/119 (31%), Positives = 55/119 (46%), Gaps = 18/119 (15%)
Query: 209 AAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWL 268
PL Q + R L +A+ Y+H + IIHRD+KT NV+++ + LGDFG A +
Sbjct: 254 LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFA 310
Query: 269 EHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLE 327
+ + FH I GT+ PE G T D++S G+V+ E
Sbjct: 311 R----------GSWSTPFHYG----IAGTVDTNAPEVL-AGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 50/226 (22%), Positives = 95/226 (42%), Gaps = 32/226 (14%)
Query: 525 DFGTAYQGFLD--NHQYVLV--KRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCT 580
+FG +G L + + V K L R F E + + H N+++L G T
Sbjct: 16 EFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVT 75
Query: 581 EQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQV 640
+ +++I +Y L L N+ + +++ +AS + YL E
Sbjct: 76 KSRPVMIITEYMENGSLDKFLRENDGK-----FTVGQLVGMLRGIASGMKYLSEM---NY 127
Query: 641 IHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIES 700
+HR++ + I ++ ++ ++ F L+ L + G +R + +PE I
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRRL-EDSEATYTTKGGKIPIR----WTAPEAIAY 182
Query: 701 GEATSMADVYSFGVVVLEVV----------TGQMAVD-----FRLP 731
+ TS +DV+SFG+V+ EV+ + Q + +RLP
Sbjct: 183 RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLP 228
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 4e-07
Identities = 62/239 (25%), Positives = 103/239 (43%), Gaps = 42/239 (17%)
Query: 104 AELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKT----FAAEL 159
+L + + FD +V+G G FG+V S V A+K L+ K E +++ F E
Sbjct: 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLS-KFEMIKRSDSAFFWEER 94
Query: 160 VAVAHLRHRNLVRLRGWCVHEDQ--LLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQ- 216
+AH +V+L +D L +V +YMP L ++ N + P W +
Sbjct: 95 DIMAHANSEWIVQLH--YAFQDDKYLYMVMEYMPGGDLVNLM----SNYDI--PEKWARF 146
Query: 217 -RKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQ 275
+++ L A +H + IHRDVK N++LD + +L DFG ++
Sbjct: 147 YTAEVVLALDA-IHSM------GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN--GM 197
Query: 276 MRTSSARNHQFHLAETTRIGGTIGYLPPESF--QKGSVATAKS-DVFSFGIVVLEVVSG 331
+R +A GT Y+ PE Q G + D +S G+ + E++ G
Sbjct: 198 VRCDTAV-------------GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 4e-07
Identities = 71/259 (27%), Positives = 113/259 (43%), Gaps = 43/259 (16%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELV---AVAHLRHRNLVRL 173
++LG G FGKV + G A+K L ++ + A L + + RH L L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 174 RGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRG-LAAALHYLH 232
+ +D+L V +Y+ L L R E + + E R + + +AL YLH
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSR--ERVFS------EDRTRFYGAEIVSALDYLH 112
Query: 233 EQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETT 292
+I++RD+K N+MLD + ++ DFGL + + T +A F
Sbjct: 113 S---GKIVYRDLKLENLMLDKDGHIKITDFGLCK--------EGITDAATMKTF------ 155
Query: 293 RIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDD-----QIILL 347
GT YL PE + A D + G+V+ E++ GR Y D ++IL+
Sbjct: 156 --CGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPF---YNQDHEKLFELILM 209
Query: 348 DWI---RRLSDEGKVLQAG 363
+ I R LS + K L +G
Sbjct: 210 EDIKFPRTLSADAKSLLSG 228
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 5e-07
Identities = 63/267 (23%), Positives = 100/267 (37%), Gaps = 70/267 (26%)
Query: 526 FGTAYQGF-LDNHQYVLVKRLGMSKCPALRTRFSNELQNL-------ARLRHRNLVQLCG 577
+G Y L + +K + R S +Q L + L+HRN+VQ G
Sbjct: 21 YGIVYAARDLSTQVRIAIKEI--------PERDSRYVQPLHEEIALHSYLKHRNIVQYLG 72
Query: 578 WCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAIL----YLH 633
+E G + + LS LL R L+ + I IL YLH
Sbjct: 73 SDSENGFFKIFMEQVPGGSLSALL-----RSKWGPLKDNE--QTIIFYTKQILEGLKYLH 125
Query: 634 EEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSG----NRSVRGI 689
+ Q++HR+I + + N G +++F G K +G + G
Sbjct: 126 D---NQIVHRDIKGDNVLV----NTYSGVVKISDF------GTSKRLAGINPCTETFTGT 172
Query: 690 FGYMSPEYIESGEA--TSMADVYSFGVVVLEVVTGQ---------MAVDFR--------- 729
YM+PE I+ G + AD++S G ++E+ TG+ A F+
Sbjct: 173 LQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPE 232
Query: 730 LPEGL------LVKRVHEFEARKRPLA 750
+PE L + R E + KR A
Sbjct: 233 IPESLSAEAKNFILRCFEPDPDKRASA 259
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 5e-07
Identities = 46/205 (22%), Positives = 89/205 (43%), Gaps = 19/205 (9%)
Query: 519 QRVAEMDFGTAYQGFLDNHQYVLVKRL--GMSKCPALRTRFSNELQNLARLRHRNLVQLC 576
+++ FG + G+ +N V VK L G A F E + L+H LV+L
Sbjct: 12 KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA----FLEEANLMKTLQHDKLVRLY 67
Query: 577 GWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEW 636
T++ + +I +Y A L L + + + +A + Y+ +
Sbjct: 68 AVVTKEEPIYIITEYMAKGSLLDFLKSDEG----GKVLLPKLIDFSAQIAEGMAYIERK- 122
Query: 637 NEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPE 696
IHR++ ++ + + + ++ F LA + N++ R+ + + +PE
Sbjct: 123 --NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGA------KFPIKWTAPE 174
Query: 697 YIESGEATSMADVYSFGVVVLEVVT 721
I G T +DV+SFG+++ E+VT
Sbjct: 175 AINFGSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 5e-07
Identities = 56/229 (24%), Positives = 98/229 (42%), Gaps = 40/229 (17%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRL----- 173
LG G G V+ AV VAVK + + K E+ + L H N+V++
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 174 ---------RGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGL 224
G + + +V +YM L VL + P + E A ++ ++RG
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLSEEHARLFMYQ----LLRG- 126
Query: 225 AAALHYLHEQLETQIIHRDVKTSNVMLDS-QYNARLGDFGLARWLEHELQYQMRTSSARN 283
L Y+H ++HRD+K +NV +++ ++GDFGLAR ++
Sbjct: 127 ---LKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYS---------- 170
Query: 284 HQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
H+ +L+E T Y P + T D+++ G + E+++G+
Sbjct: 171 HKGYLSEGLV---TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 5e-07
Identities = 64/302 (21%), Positives = 109/302 (36%), Gaps = 46/302 (15%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVK--CLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGW 176
+ + T+VAVK L + K E++ L+H N++
Sbjct: 10 FEDLMIVHLAKHK--PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTS 67
Query: 177 CVHEDQLLLVYDYMPNRSLDRVLFRR--PENL-EAAAPLNWEQRKKIIRGLAAALHYLHE 233
+ + +L +V M S L + PE L E A I++ + AL Y+H
Sbjct: 68 FIVDSELYVVSPLMAYGSC-EDLLKTHFPEGLPELAIAF-------ILKDVLNALDYIHS 119
Query: 234 QLETQIIHRDVKTSNVMLDSQYNARLGDFGLAR-WLEHELQYQMRTSSARNHQFHLAETT 292
+ IHR VK S+++L L + ++H + ++ ++ +L
Sbjct: 120 K---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP--- 173
Query: 293 RIGGTIGYLPPESFQKG-SVATAKSDVFSFGIVVLEVVSGR---RAVDLTY--------- 339
+L PE Q+ KSD++S GI E+ +G + + T
Sbjct: 174 -------WLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGT 226
Query: 340 ---PDDQIILLDWIRRLSDEGKVLQAGDNRLS-DGSYKLCDMEHLTHLALLCTLHNPHLR 395
D+ + +S + +NR S D Y EH LC +P R
Sbjct: 227 VPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESR 286
Query: 396 PS 397
PS
Sbjct: 287 PS 288
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 6e-07
Identities = 49/211 (23%), Positives = 88/211 (41%), Gaps = 17/211 (8%)
Query: 519 QRVAEMDFGTAYQGFLDN----HQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQ 574
+++ + FG +G V VK L K + F E + L H NL++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 575 LCGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHE 634
L G M+V +L L +GH ++ Y + +A+ + YL
Sbjct: 61 LYGVVLTHPLMMVTELAPLGSLLDRL---RKDALGHFLISTLCDYAV--QIANGMRYLES 115
Query: 635 EWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMS 694
+ + IHR++ + I L D ++G F L L +N+ + + V F + +
Sbjct: 116 K---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV--MEEHLKVP--FAWCA 168
Query: 695 PEYIESGEATSMADVYSFGVVVLEVVT-GQM 724
PE + + + +DV+ FGV + E+ T G+
Sbjct: 169 PESLRTRTFSHASDVWMFGVTLWEMFTYGEE 199
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 6e-07
Identities = 68/311 (21%), Positives = 131/311 (42%), Gaps = 49/311 (15%)
Query: 515 FSESQRVAEMDFGTAYQGFLDN--HQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNL 572
F++ +R+ + FG ++G +DN Q V +K + + + E+ L++ +
Sbjct: 6 FTKLERIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 64
Query: 573 VQLCGWCTEQGEMLVIYDY----SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASA 628
+ G + ++ +I +Y SA +L F + +I ++K +
Sbjct: 65 TKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPF-DEFQIA----------TMLKEILKG 113
Query: 629 ILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRG 688
+ YLH +E+ IHR+I ++ + L + +L F +A LT D ++ T G
Sbjct: 114 LDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNT-----FVG 163
Query: 689 IFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRP 748
+M+PE I+ S AD++S G+ +E+ G+ P +L F K
Sbjct: 164 TPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL------FLIPKNN 217
Query: 749 LAELVDLSLNGEY--NHKELMRLIKLGIACTLSNPELRPSMRQIL--SILDGNDKRFMED 804
L GE+ KE + AC +P RP+ +++L + N K+
Sbjct: 218 PPTLT-----GEFSKPFKEFID------ACLNKDPSFRPTAKELLKHKFIVKNAKKTSYL 266
Query: 805 GQMTENLEEWK 815
++ + + WK
Sbjct: 267 TELIDRFKRWK 277
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 6e-07
Identities = 70/257 (27%), Positives = 114/257 (44%), Gaps = 58/257 (22%)
Query: 111 NGFDEDEVLGSGGFGKVYRAVLPSD-GTVVAVKCLAEKGERFEKTFAAELVAVAHLR-HR 168
+ F+ +V+G G FG+V R V D G + A+K L K E EK VAH+R R
Sbjct: 1 DDFESIKVIGRGAFGEV-RLVQKKDTGHIYAMKKL-RKSEMLEKE------QVAHVRAER 52
Query: 169 N-LVRLRG-WCVH-------EDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKK 219
+ L W V E+ L L+ +Y+P + +L ++ E E+ +
Sbjct: 53 DILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTE-------EETRF 105
Query: 220 IIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLE--HELQY--- 274
I A+ +H +L IHRD+K N++LD++ + +L DFGL L+ H ++
Sbjct: 106 YIAETILAIDSIH-KL--GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRI 162
Query: 275 --------------QMRTSSARNHQFH-----LAETTRIGGTIGYLPPESF-QKGSVATA 314
+ +S + + LA +T GT Y+ PE F Q G
Sbjct: 163 LSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTV--GTPDYIAPEVFLQTGYNKEC 220
Query: 315 KSDVFSFGIVVLEVVSG 331
D +S G+++ E++ G
Sbjct: 221 --DWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 6e-07
Identities = 65/241 (26%), Positives = 102/241 (42%), Gaps = 35/241 (14%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFE----KTFAAELVAVAHLRHR 168
F + ++LG G G+V+ L G + A+K L +K E + K E +A L H
Sbjct: 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVL-DKKEMIKRNKVKRVLTEQEILATLDHP 61
Query: 169 NLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAA-- 226
L L E L LV DY P L R+L R+P +++ R AA
Sbjct: 62 FLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKC---------LSEEVARFYAAEV 112
Query: 227 --ALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLE---HELQYQMRTSSA 281
AL YLH I++RD+K N++L + L DF L++ + + +R S
Sbjct: 113 LLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSR 169
Query: 282 RN------HQFHLAETTRIG----GTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSG 331
R+ + E + GT Y+ PE G + D ++ GI++ E++ G
Sbjct: 170 RSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVI-SGDGHGSAVDWWTLGILLYEMLYG 228
Query: 332 R 332
Sbjct: 229 T 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 6e-07
Identities = 57/229 (24%), Positives = 97/229 (42%), Gaps = 31/229 (13%)
Query: 118 VLGSGGFGKVYRAVLPSDGTVVAVKC----LAEKGERFEKTFAAELVAVAHLRHRNLVRL 173
V+G G + KV L + A+K L E + + V H LV L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 174 RGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHE 233
E +L V +Y+ L +F +++ L E + ++ AL+YLHE
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDL---MF----HMQRQRKLPEEHARFYSAEISLALNYLHE 114
Query: 234 QLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTR 293
+ II+RD+K NV+LDS+ + +L D+G+ + +R T+
Sbjct: 115 R---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-------EGLRPGDT---------TST 155
Query: 294 IGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDD 342
GT Y+ PE +G D ++ G+++ E+++GR D+ D
Sbjct: 156 FCGTPNYIAPEIL-RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 203
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 7e-07
Identities = 54/215 (25%), Positives = 95/215 (44%), Gaps = 27/215 (12%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVKCLA-EKGERFEKTFAAELVAVAHLRHRNLVRLRGWC 177
LG G + V++ +VA+K + E E T E+ + +L+H N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 178 VHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLET 237
E L LV++Y LD L + +N ++ K + L L Y H++
Sbjct: 73 HTERCLTLVFEY-----LDSDLKQYLDN--CGNLMSMHNVKIFMFQLLRGLSYCHKR--- 122
Query: 238 QIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGT 297
+I+HRD+K N++++ + +L DFGLAR + T + N T
Sbjct: 123 KILHRDLKPQNLLINEKGELKLADFGLAR------AKSVPTKTYSNEVV----------T 166
Query: 298 IGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
+ Y PP+ + + D++ G ++ E+ +GR
Sbjct: 167 LWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 7e-07
Identities = 59/231 (25%), Positives = 98/231 (42%), Gaps = 47/231 (20%)
Query: 118 VLGSGGFGKVYRAVLPSDGTVVAVKCLAE----KGERFEKTFAAELVAVAHLRHRNLVRL 173
VLG G FGKV A + A+K L + + + E T + V + L +L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66
Query: 174 RGWCVHEDQLLLVYDYMPNRSLDRVL-----FRRPENLEAAAPLNWEQRKKIIRGLAAAL 228
D+L V +Y+ L + F+ P + AA +A L
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAE------------IAIGL 114
Query: 229 HYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHL 288
+LH + II+RD+K NVMLD++ + ++ DFG+ + + F
Sbjct: 115 FFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGM----------------CKENIFGG 155
Query: 289 AETTRIGGTIGYLPPE--SFQKGSVATAKS-DVFSFGIVVLEVVSGRRAVD 336
T GT Y+ PE ++Q KS D ++FG+++ E+++G+ D
Sbjct: 156 KTTRTFCGTPDYIAPEIIAYQ----PYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 7e-07
Identities = 59/226 (26%), Positives = 94/226 (41%), Gaps = 45/226 (19%)
Query: 118 VLGSGGFGKVYRAVLPSDGTVVAVKCLAE----KGERFEKTFAAELVAVAHLRHRNLVRL 173
VLG G FGKV A L A+K L + + + E T V H L L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 174 RGWCVH--EDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKK-----IIRGLAA 226
+C ++ L V +Y+ L +F + E R + II GL
Sbjct: 62 --FCTFQTKEHLFFVMEYLNGGDL---MFHIQSSGRFD-----EARARFYAAEIICGL-- 109
Query: 227 ALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQF 286
+LH++ II+RD+K NV+LD + ++ DFG+ + + + + S+
Sbjct: 110 --QFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCK---ENMNGEGKAST------ 155
Query: 287 HLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
GT Y+ PE KG D +SFG+++ E++ G+
Sbjct: 156 -------FCGTPDYIAPEIL-KGQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 9e-07
Identities = 65/244 (26%), Positives = 100/244 (40%), Gaps = 44/244 (18%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK----GERFEKTFAAELVAVAHLRHRNLVR 172
+VLG G FGKV A L G AVK L + + E T + V + L
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 173 LRGWCVHEDQLLLVYDYMPNRSL-----DRVLFRRPENLEAAAPLNWEQRKKIIRGLAAA 227
L ++ L V +++ L D+ F AA +I+ GL
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAA--------EIVCGL--- 109
Query: 228 LHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFH 287
+LH + II+RD+K NVMLD + ++ DFG+ + + F
Sbjct: 110 -QFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGM----------------CKENVFG 149
Query: 288 LAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILL 347
+ GT Y+ PE Q G T D +SFG+++ E++ G+ + DD+ L
Sbjct: 150 DNRASTFCGTPDYIAPEILQ-GLKYTFSVDWWSFGVLLYEMLIGQSPF---HGDDEDELF 205
Query: 348 DWIR 351
+ IR
Sbjct: 206 ESIR 209
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 9e-07
Identities = 57/228 (25%), Positives = 97/228 (42%), Gaps = 39/228 (17%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAEL---VAVAHLRHRN 169
F + VLG GGFG+V + + G + A K L +K + K + L + + R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 170 LVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRG--LAAA 227
+V L +D L LV M L ++ E +E+ + + +
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGE-------AGFEEGRAVFYAAEICCG 114
Query: 228 LHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFH 287
L LH++ +I++RD+K N++LD + R+ D GLA H
Sbjct: 115 LEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLA--------------------VH 151
Query: 288 LAETTRIG---GTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
+ E I GT+GY+ PE K T D ++ G ++ E+++G+
Sbjct: 152 VPEGQTIKGRVGTVGYMAPEVV-KNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 45/177 (25%), Positives = 85/177 (48%), Gaps = 17/177 (9%)
Query: 554 RTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY----SATRIL-SH----LLFHN 604
R F E + L L+H+++V+ G CTE +L++++Y R L SH +
Sbjct: 51 RQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAG 110
Query: 605 NHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFA 664
+ L I +AS ++YL + +HR++ + + + ++G F
Sbjct: 111 GEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVVKIGDFG 167
Query: 665 LAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT 721
++ + D+ +R G R++ I +M PE I + T+ +D++SFGVV+ E+ T
Sbjct: 168 MSRDIYSTDY-YR---VGGRTMLPI-RWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 39/183 (21%), Positives = 86/183 (46%), Gaps = 12/183 (6%)
Query: 539 YVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRILS 598
V +K L R F +E + + H N++ L G T+ ++++ +Y L
Sbjct: 34 PVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLD 93
Query: 599 HLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNP 658
L ++ + +++Q +++ +AS + YL + +HR++ + I ++ ++
Sbjct: 94 AFLRKHDGQF--TVIQL---VGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVC 145
Query: 659 RLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLE 718
++ F L+ L + G +R + +PE I + TS +DV+S+G+V+ E
Sbjct: 146 KVSDFGLSRVLEDDPEAAYTTRGGKIPIR----WTAPEAIAYRKFTSASDVWSYGIVMWE 201
Query: 719 VVT 721
V++
Sbjct: 202 VMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 49/203 (24%), Positives = 89/203 (43%), Gaps = 22/203 (10%)
Query: 526 FGTAYQGFLDNHQYVLVKRL---GMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQ 582
FG + G + V VK L MS F E Q + +LRH LVQL C+E+
Sbjct: 19 FGEVWMGTWNGTTKVAVKTLKPGTMSP-----EAFLQEAQIMKKLRHDKLVQLYAVCSEE 73
Query: 583 GEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIH 642
+ ++ +Y + L L L+ ++ +A + YL IH
Sbjct: 74 EPIYIVTEYMSKGSLLDFL----KSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIH 126
Query: 643 RNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGE 702
R++ + I + ++ ++ F LA + +++ R+ + + +PE G
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGA------KFPIKWTAPEAANYGR 180
Query: 703 ATSMADVYSFGVVVLEVVT-GQM 724
T +DV+SFG+++ E+VT G++
Sbjct: 181 FTIKSDVWSFGILLTEIVTYGRV 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 42/179 (23%), Positives = 72/179 (40%), Gaps = 26/179 (14%)
Query: 551 PALRTRFSNELQNLARLRHRNLVQLCGWCTE--QGEMLVIYDY----SATRILSHLLFHN 604
P L+ + EL+ + +V+ G + + + +Y S I +
Sbjct: 40 PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVK-KR 98
Query: 605 NHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFA 664
RIG +L I +S+ + YLH ++IHR+I S I L +L F
Sbjct: 99 GGRIGEKVLG-----KIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFG 150
Query: 665 LA-EFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTG 722
++ E + S + G YM+PE I+ + +DV+S G+ +LEV
Sbjct: 151 VSGELVN----------SLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQN 199
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 53/215 (24%), Positives = 100/215 (46%), Gaps = 36/215 (16%)
Query: 560 ELQNLARLRHRNLVQLCGWCTEQGEMLVIY-DYSATRILSHLLFHNNHRIGHSILQWHHR 618
E+ L L+H N+VQ G + + L I+ +Y ++ LL +N ++++
Sbjct: 56 EIALLKELQHENIVQYLG-SSLDADHLNIFLEYVPGGSVAALL-NNYGAFEETLVR---- 109
Query: 619 YNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRK 678
N ++ + + YLH N +IHR+I + I +D ++ F +++ L N
Sbjct: 110 -NFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLS--T 163
Query: 679 ATSGNR-SVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTG--------QMAVDFR 729
T+G R S++G +M+PE ++ T AD++S G +V+E++TG Q+ F+
Sbjct: 164 KTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFK 223
Query: 730 L--------PEGLLVKRVH------EFEARKRPLA 750
+ P + + + E + KRP A
Sbjct: 224 IGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTA 258
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 1e-06
Identities = 48/185 (25%), Positives = 77/185 (41%), Gaps = 27/185 (14%)
Query: 553 LRTRFSNELQNLARLRHRNLVQLC--GWCTEQGEMLVIYDYSATRILSHLLFHNN----H 606
R RF E ARL H N+V L G G + +++Y R L +L +
Sbjct: 21 QRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYVPGRTLREVLAADGALPAG 79
Query: 607 RIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHR-----NITSSAITLDPDMNPRLG 661
G +LQ ++ +LA A H N+ ++HR NI S + P + ++
Sbjct: 80 ETGRLMLQ------VLDALACA----H---NQGIVHRDLKPQNIMVSQTGVRP--HAKVL 124
Query: 662 SFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT 721
F + L + V G Y +PE + T +D+Y++G++ LE +T
Sbjct: 125 DFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLT 184
Query: 722 GQMAV 726
GQ V
Sbjct: 185 GQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 48/233 (20%), Positives = 104/233 (44%), Gaps = 27/233 (11%)
Query: 106 LYIGSNGFDEDEVLGSGGFGKVYRAVL----PSDGTVVAVKCLAEKGERFEKT-FAAELV 160
+ I + ++L G FG+++ +L P V VK + + + T E
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60
Query: 161 AVAHLRHRNLVRLRGWCVHE-DQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKK 219
+ L H+N++ + C+ + + ++Y YM +L L ++ EA P ++
Sbjct: 61 LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFL-QQCRLGEANNPQALSTQQL 119
Query: 220 IIRGL--AAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMR 277
+ + A + YLH++ +IH+D+ N ++D + ++ D L+R L + M
Sbjct: 120 VHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDL-----FPMD 171
Query: 278 TSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS 330
+++ + ++ ES ++A SDV+SFG+++ E+++
Sbjct: 172 YHCLGDNENR---------PVKWMALESLVNKEYSSA-SDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 59/285 (20%), Positives = 115/285 (40%), Gaps = 31/285 (10%)
Query: 514 NFSESQRVAEMDFGTAYQG-FLDNHQYVLVKRLGMSKCPALRTRFS--NELQNLARLRHR 570
NF +++ F Y+ L + V +K++ + + R E+ L +L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 571 NLVQLCGWCTEQGEMLVIYDYSATRILSHLL--FHNNHRIGHSILQWHHRYNIIKSLASA 628
N+++ E E+ ++ + + LS ++ F R+ W + L SA
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKY----FVQLCSA 118
Query: 629 ILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRG 688
+ ++H + +V+HR+I + + + +LG L F + T+ S+ G
Sbjct: 119 LEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-------TTAAHSLVG 168
Query: 689 IFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRP 748
YMSPE I +D++S G ++ E+ Q F + L + E P
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP--FYGDKMNLYSLCKKIEQCDYP 226
Query: 749 LAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSI 793
L ++ +EL +L+ + C +PE RP + + +
Sbjct: 227 -------PLPSDHYSEELRQLVNM---CINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 46/188 (24%), Positives = 87/188 (46%), Gaps = 26/188 (13%)
Query: 540 VLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY----SATR 595
V VK + + K R NE+ + +H+N+V++ E+ V+ ++ + T
Sbjct: 49 VAVKMMDLRK-QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTD 107
Query: 596 ILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPD 655
I+S N +I + +S+ A+ YLH ++ VIHR+I S +I L D
Sbjct: 108 IVSQTRL-NEEQIA----------TVCESVLQALCYLH---SQGVIHRDIKSDSILLTLD 153
Query: 656 MNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVV 715
+L F ++++ +S+ G +M+PE I + D++S G++
Sbjct: 154 GRVKLSDFGFCAQISKD-------VPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIM 206
Query: 716 VLEVVTGQ 723
V+E+V G+
Sbjct: 207 VIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 1e-06
Identities = 56/225 (24%), Positives = 98/225 (43%), Gaps = 41/225 (18%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAA-----ELVAVAHLRHRNLVRL 173
+G G +G V A VA+K +A F+ A E+ + HL H N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANA---FDNRIDAKRTLREIKLLRHLDHENVIAI 69
Query: 174 RGWC--VHEDQ---LLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAAL 228
+ H + + +VY+ M + L +++ ++ L+ + + + L L
Sbjct: 70 KDIMPPPHREAFNDVYIVYELM-DTDLHQII-------RSSQTLSDDHCQYFLYQLLRGL 121
Query: 229 HYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHL 288
Y+H ++HRD+K SN++L++ + ++ DFGLA RT+S F
Sbjct: 122 KYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLA-----------RTTSE-KGDF-- 164
Query: 289 AETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRR 333
T T Y PE S T DV+S G + E++ GR+
Sbjct: 165 --MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 56/230 (24%), Positives = 97/230 (42%), Gaps = 42/230 (18%)
Query: 118 VLGSGGFGKVYRAVLPSD---GTVVAVKCLAEKGERFEKT----FAAELVAVAHLRHRNL 170
+LG G FG V A L S+ VAVK L K + F + F E + H N+
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKML--KADIFSSSDIEEFLREAACMKEFDHPNV 63
Query: 171 VRLRGWCVH---EDQL---LLVYDYMPNRSLDRVLF--RRPENLEAAAPLNWEQRK--KI 220
++L G + + +L +++ +M + L L R E P + +
Sbjct: 64 IKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEE-----PFTLPLQTLVRF 118
Query: 221 IRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSS 280
+ +A+ + YL + IHRD+ N ML+ + DFGL++ + Y+ +S
Sbjct: 119 MIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCAS 175
Query: 281 ARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS 330
+ +L ES +V T SDV++FG+ + E+++
Sbjct: 176 KL--------------PVKWLALESLAD-NVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 54/237 (22%), Positives = 110/237 (46%), Gaps = 19/237 (8%)
Query: 554 RTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRILSHLL-FHNNHRI---- 608
R F E + L L+H ++V+ G C E ++++++Y L+ L H +
Sbjct: 51 RKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAE 110
Query: 609 GH--SILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALA 666
G+ + L +I + +A+ ++YL ++ +HR++ + + ++ ++G F ++
Sbjct: 111 GNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKIGDFGMS 167
Query: 667 EFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAV 726
+ D+ +R +R +M PE I + T+ +DV+S GVV+ E+ T
Sbjct: 168 RDVYSTDY-YRVGGHTMLPIR----WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
Query: 727 DFRLPEGLLVKRVHEFEARKRPLA---ELVDLSLNGEYNHKELMRLIKLGIACTLSN 780
++L +++ + + +RP E+ DL L G + + MRL I L N
Sbjct: 223 WYQLSNNEVIECITQGRVLQRPRTCPKEVYDLML-GCWQREPHMRLNIKEIHSLLQN 278
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 45/166 (27%), Positives = 67/166 (40%), Gaps = 21/166 (12%)
Query: 559 NELQNLARLRHRNLVQLCGWCTEQGE--MLVIYDYSATRILSHLLFHNNHRIGHSILQWH 616
NE + L L H LV L W + Q E M ++ D L + L + W
Sbjct: 49 NERRILQELNHPFLVNL--WYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFW- 105
Query: 617 HRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGH 676
I + A+ YLH + +IHR+I I LD + + F +A +T +
Sbjct: 106 -----ICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD---- 153
Query: 677 RKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTG 722
TS + G GYM+PE + + D +S GV E + G
Sbjct: 154 TLTTSTS----GTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRG 195
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 44/205 (21%), Positives = 93/205 (45%), Gaps = 20/205 (9%)
Query: 519 QRVAEMDFGTAYQGFLDNHQYVLVKRLGM-SKCPALRTRFSNELQNLARLRHRNLVQLCG 577
+++ FG + G+ + H V +K L S P F E + +L+H LV+L
Sbjct: 12 KKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPE---AFLAEANLMKQLQHPRLVRLYA 68
Query: 578 WCTEQGEMLVIYDYSAT-RILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEW 636
T++ + +I +Y ++ L ++ + L ++ +A + ++ +
Sbjct: 69 VVTQE-PIYIITEYMENGSLVDFLKTPEGIKLTINKL-----IDMAAQIAEGMAFIERK- 121
Query: 637 NEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPE 696
IHR++ ++ I + + ++ F LA + N++ R+ + + +PE
Sbjct: 122 --NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGA------KFPIKWTAPE 173
Query: 697 YIESGEATSMADVYSFGVVVLEVVT 721
I G T +DV+SFG+++ E+VT
Sbjct: 174 AINYGTFTIKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 64/279 (22%), Positives = 118/279 (42%), Gaps = 32/279 (11%)
Query: 526 FGTAYQGFL------DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWC 579
FG Y+G + V VK + S R F NE + ++V+L G
Sbjct: 19 FGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVV 78
Query: 580 TEQGEMLVIYDYSA----TRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEE 635
++ LV+ + A L L + G + +A + YL+ +
Sbjct: 79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK 138
Query: 636 WNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSP 695
+ +HR++ + + D ++G F + + D+ +RK G VR M+P
Sbjct: 139 ---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDY-YRKGGKGLLPVRW----MAP 190
Query: 696 EYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDL 755
E ++ G T+ +D++SFGVV+ E+ + + + +GL ++V +F L D
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWEITS----LAEQPYQGLSNEQVLKFVMDGGYL----DQ 242
Query: 756 SLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSIL 794
N +LMR+ C NP++RP+ +I+++L
Sbjct: 243 PDNCPERVTDLMRM------CWQFNPKMRPTFLEIVNLL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 62/291 (21%), Positives = 123/291 (42%), Gaps = 59/291 (20%)
Query: 515 FSESQRVAEMDFGTAYQGFLDNH--QYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNL 572
F++ +R+ + FG Y+G +DN + V +K + + + E+ L++ +
Sbjct: 6 FTKLERIGKGSFGEVYKG-IDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYI 64
Query: 573 VQLCGWCTEQGEMLVIYDY----SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASA 628
+ G + ++ +I +Y SA +L L+ + I++ +
Sbjct: 65 TRYYGSYLKGTKLWIIMEYLGGGSALDLLKP-----------GPLEETYIATILREILKG 113
Query: 629 ILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRG 688
+ YLH +E+ IHR+I ++ + L + +L F +A LT D ++ T G
Sbjct: 114 LDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNT-----FVG 163
Query: 689 IFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQ--------MAVDFRLPEGLLVKRVH 740
+M+PE I+ AD++S G+ +E+ G+ M V F +P
Sbjct: 164 TPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP--------- 214
Query: 741 EFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQIL 791
+ P +L G+Y+ K ++ AC +P RP+ +++L
Sbjct: 215 ----KNSP------PTLEGQYS-KPFKEFVE---ACLNKDPRFRPTAKELL 251
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 42/198 (21%), Positives = 89/198 (44%), Gaps = 16/198 (8%)
Query: 525 DFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGE 584
+FG ++G L + V VK L+ +F +E + L + H N+V+L G CT++
Sbjct: 7 NFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQP 66
Query: 585 MLVIYDY-SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHR 643
+ ++ + LS L R L+ A+ + YL ++ IHR
Sbjct: 67 IYIVMELVPGGDFLSFL------RKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHR 117
Query: 644 NITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEA 703
++ + + + ++ F ++R + ++SG + + + +PE + G
Sbjct: 118 DLAARNCLVGENNVLKISDFG----MSRQEDDGIYSSSGLKQIP--IKWTAPEALNYGRY 171
Query: 704 TSMADVYSFGVVVLEVVT 721
+S +DV+S+G+++ E +
Sbjct: 172 SSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 66/283 (23%), Positives = 124/283 (43%), Gaps = 38/283 (13%)
Query: 521 VAEMDFGTAYQGFLDNHQYVL---VKRLGMSKCPALRTR-FSNELQNLARLRHRNLVQLC 576
+ E +FG+ +G L+ +L VK + ++ C F +E + H N+++L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 577 GWCTEQGEM------LVIYDYSATRILSHLLFHNNHRIGHS--ILQWHHRYNIIKSLASA 628
G C + E +VI + L L ++ R+G L + +AS
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYS--RLGDCPQYLPTQMLVKFMTDIASG 124
Query: 629 ILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRG 688
+ YL ++ IHR++ + L+ +MN + F L++ + D+ +R+ V+
Sbjct: 125 MEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDY-YRQGRIAKMPVK- 179
Query: 689 IFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKR 747
+++ E + T+ +DV+SFGV + E+ T GQ G+ ++++ +
Sbjct: 180 ---WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPY-----PGVENSEIYDYLRQGN 231
Query: 748 PLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQI 790
L + D L+G Y LM +C L NP+ RPS +
Sbjct: 232 RLKQPPD-CLDGLY---SLMS------SCWLLNPKDRPSFETL 264
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 2e-06
Identities = 56/234 (23%), Positives = 97/234 (41%), Gaps = 55/234 (23%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEK-TFAA----ELVAVAHLRHRNLV 171
+G G +G V A G VA+K K FE TF E+ + +H N++
Sbjct: 11 SYIGEGAYGMVCSATHKPTGVKVAIK----KISPFEHQTFCQRTLREIKILRRFKHENII 66
Query: 172 ------RLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRK----KII 221
R + D + +V + M L +++ L+ + + +I+
Sbjct: 67 GILDIIRPPSFESFND-VYIVQELMET-DLYKLI--------KTQHLSNDHIQYFLYQIL 116
Query: 222 RGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSA 281
RGL Y+H ++HRD+K SN++L++ + ++ DFGLAR +
Sbjct: 117 RGL----KYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLAR------------IAD 157
Query: 282 RNHQFHLAETTRIGGTIGYLPPE---SFQKGSVATAKSDVFSFGIVVLEVVSGR 332
H H T T Y PE + + + A D++S G ++ E++S R
Sbjct: 158 PEHD-HTGFLTEYVATRWYRAPEIMLNSKGYTKAI---DIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 31/91 (34%), Positives = 49/91 (53%), Gaps = 15/91 (16%)
Query: 240 IHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIG 299
IHRDV NV+L A++ DFGLAR + ++ Y ++ +AR +
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK-GNARL-------------PVK 279
Query: 300 YLPPESFQKGSVATAKSDVFSFGIVVLEVVS 330
++ PES V T +SDV+S+GI++ E+ S
Sbjct: 280 WMAPESIFD-CVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 55/230 (23%), Positives = 101/230 (43%), Gaps = 31/230 (13%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAE----KGERFEKTFAAELVAVAHLRHRNLVR 172
+VLG G FGKV A L V A+K L + + + + T + + +H L
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 173 LRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLH 232
L +D+L V +Y+ L +F+ ++ + + + + + AL +LH
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDL---MFQ----IQRSRKFDEPRSRFYAAEVTLALMFLH 113
Query: 233 EQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETT 292
+I+RD+K N++LD++ + +L DFG+ + E L TT
Sbjct: 114 RH---GVIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVT--------------TT 154
Query: 293 RIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDD 342
GT Y+ PE Q+ D ++ G+++ E+++G+ + DD
Sbjct: 155 TFCGTPDYIAPEILQELEYG-PSVDWWALGVLMYEMMAGQPPFEADNEDD 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 64/279 (22%), Positives = 122/279 (43%), Gaps = 36/279 (12%)
Query: 520 RVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWC 579
++ + FG + G + V +K L + F E Q + +LRH LV L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTL--KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV 70
Query: 580 TEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQ 639
+E+ + ++ ++ L L + + L+ ++ +A + Y+ E N
Sbjct: 71 SEE-PIYIVTEFMGKGSLLDFLKEGDGKY----LKLPQLVDMAAQIADGMAYI-ERMN-- 122
Query: 640 VIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIE 699
IHR++ ++ I + ++ ++ F LA + N++ R+ + + +PE
Sbjct: 123 YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGA------KFPIKWTAPEAAL 176
Query: 700 SGEATSMADVYSFGVVVLEVVTGQMAVDFRLP-EGLLVKRVHEFEAR--KRPLAELVDLS 756
G T +DV+SFG+++ E+VT R+P G++ + V E R + P + S
Sbjct: 177 YGRFTIKSDVWSFGILLTELVTKG-----RVPYPGMVNREVLEQVERGYRMPCPQGCPES 231
Query: 757 LNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795
L+ ELM+L C +P+ RP+ I S L+
Sbjct: 232 LH------ELMKL------CWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 3e-06
Identities = 47/187 (25%), Positives = 83/187 (44%), Gaps = 24/187 (12%)
Query: 540 VLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRILSH 599
V VK++ + K R NE+ + H N+V + E+ V+ ++ L+
Sbjct: 50 VAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTD 108
Query: 600 LLFH---NNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDM 656
++ H N +I L S+ A+ YLH N+ VIHR+I S +I L D
Sbjct: 109 IVTHTRMNEEQIATVCL----------SVLRALSYLH---NQGVIHRDIKSDSILLTSDG 155
Query: 657 NPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVV 716
+L F ++ K +S+ G +M+PE I + D++S G++V
Sbjct: 156 RIKLSDFGFCAQVS-------KEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMV 208
Query: 717 LEVVTGQ 723
+E++ G+
Sbjct: 209 IEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 62/286 (21%), Positives = 112/286 (39%), Gaps = 33/286 (11%)
Query: 514 NFSESQRVAEMDFGTAYQG--FLDNHQYVL--VKRLGMSKCPALRTRFSNELQNLARLRH 569
NF +++ F Y+ LD L V+ M A R E+ L +L H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKA-RQDCVKEIDLLKQLNH 61
Query: 570 RNLVQLCGWCTEQGEMLVIYDYSATRILSHLL--FHNNHRIGHSILQWHHRYNIIKSLAS 627
N+++ E E+ ++ + + LS ++ F R+ W + L S
Sbjct: 62 PNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKY----FVQLCS 117
Query: 628 AILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVR 687
A+ ++H + +V+HR+I + + + +LG L F + T+ S+
Sbjct: 118 AVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-------TTAAHSLV 167
Query: 688 GIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKR 747
G YMSPE I +D++S G ++ E+ Q F + L + E
Sbjct: 168 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP--FYGDKMNLFSLCQKIEQCDY 225
Query: 748 PLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSI 793
P L E+ ++L L+ + C +P+ RP + + I
Sbjct: 226 P-------PLPTEHYSEKLRELVSM---CIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 51/173 (29%), Positives = 81/173 (46%), Gaps = 42/173 (24%)
Query: 240 IHRDVKTSNVMLDSQYN-ARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTI 298
IHRD+ N++L S+ N ++ DFGLAR + + Y +R AR +
Sbjct: 195 IHRDLAARNILL-SENNVVKICDFGLARDIYKDPDY-VRKGDARL-------------PL 239
Query: 299 GYLPPES-FQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIRRLSDEG 357
++ PES F K V T +SDV+SFG+++ E+ S + YP QI DE
Sbjct: 240 KWMAPESIFDK--VYTTQSDVWSFGVLLWEIFSLGAS---PYPGVQI----------DEE 284
Query: 358 KVLQAGDNRLSDGSYKLCDMEHLT----HLALLCTLHNPHLRPSMKWVIEAVS 406
RL +G+ ++ E+ T + L C +NP RP+ ++E +
Sbjct: 285 FC-----RRLKEGT-RMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILG 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (118), Expect = 3e-06
Identities = 38/119 (31%), Positives = 57/119 (47%), Gaps = 15/119 (12%)
Query: 152 EKTFAAELVAVAHL--RHRNLVRLRGWCVH-EDQLLLVYDYMPNRSLDRVLFRRPENLEA 208
K F A V L + N ++L + V +L+ DY+ D LF + L+
Sbjct: 51 AKNFNAIEPMVHQLMKDNPNFIKLY-YSVTTLKGHVLIMDYIK----DGDLF---DLLKK 102
Query: 209 AAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLD-SQYNARLGDFGLAR 266
L+ + KKIIR L AL+ LH+ IIH D+K NV+ D ++ L D+GL +
Sbjct: 103 EGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCK 158
|
Length = 267 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 4e-06
Identities = 42/186 (22%), Positives = 84/186 (45%), Gaps = 18/186 (9%)
Query: 538 QYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRIL 597
+ V VK++ + K R NE+ + +H N+V++ E+ V+ ++ L
Sbjct: 45 RQVAVKKMDLRK-QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103
Query: 598 SHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMN 657
+ + + H+ + + ++ A+ +LH + VIHR+I S +I L D
Sbjct: 104 TDI-------VTHTRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGR 153
Query: 658 PRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVL 717
+L F ++ K +S+ G +M+PE I + D++S G++V+
Sbjct: 154 VKLSDFGFCAQVS-------KEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVI 206
Query: 718 EVVTGQ 723
E+V G+
Sbjct: 207 EMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 4e-06
Identities = 53/236 (22%), Positives = 93/236 (39%), Gaps = 44/236 (18%)
Query: 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNL 170
FD ++G G FG+V + G + A+K + + A E V+ R++
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKK-----SVLLAQETVSFFE-EERDI 54
Query: 171 VRLRG--WCVH-------EDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKII 221
+ + W +D L LV +Y P L +L R + + + + +
Sbjct: 55 LSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYED------QFDEDMAQFYL 108
Query: 222 RGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSA 281
L A+H +H+ +HRD+K NV++D + +L DFG S+A
Sbjct: 109 AELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFG---------------SAA 150
Query: 282 RNHQFHLAETTRIGGTIGYLPPESFQ-----KGSVATAKSDVFSFGIVVLEVVSGR 332
R + + GT Y+ PE + D +S G++ E++ GR
Sbjct: 151 RLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 59/233 (25%), Positives = 95/233 (40%), Gaps = 45/233 (19%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVR 172
F+ +V+G G FG+V + + A+K L ++E AE A R V
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKIL----NKWEMLKRAE---TACFREERNVL 55
Query: 173 LRGWC-----VH-----EDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIR 222
+ G C +H E+ L LV DY L +L + + L + + I
Sbjct: 56 VNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPE------DMARFYIA 109
Query: 223 GLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSAR 282
+ A+H +H+ +HRD+K NV+LD + RL DFG S +
Sbjct: 110 EMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFG---------------SCLK 151
Query: 283 NHQFHLAETTRIGGTIGYLPPESFQKGSVATAK----SDVFSFGIVVLEVVSG 331
+Q +++ GT Y+ PE Q K D +S G+ + E++ G
Sbjct: 152 MNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 5e-06
Identities = 43/179 (24%), Positives = 74/179 (41%), Gaps = 40/179 (22%)
Query: 621 IIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKAT 680
I++ + + YLHEE IHR+I ++ I L + + +L F ++ LT
Sbjct: 103 ILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTST-------M 152
Query: 681 SGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQ--------MAVDFRLPE 732
S + G +M+PE I+ AD++S G+ +E+ G+ M V F +P+
Sbjct: 153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK 212
Query: 733 GLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQIL 791
P E S K+ + L C +P+ RPS +++L
Sbjct: 213 ------------NNPPSLEGNKFSKPF----KDFVSL------CLNKDPKERPSAKELL 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 5e-06
Identities = 54/256 (21%), Positives = 113/256 (44%), Gaps = 41/256 (16%)
Query: 519 QRVAEMDFGTAYQGFL--DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLC 576
+R+ +FG + G L DN V VK + P L+ +F E + L + H N+V+L
Sbjct: 1 ERIGRGNFGEVFSGRLRADN-TPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 59
Query: 577 GWCTEQGEMLVIYDY-SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEE 635
G CT++ + ++ + L+ L ++Q ++++ A+ + YL
Sbjct: 60 GVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQ------MVENAAAGMEYLE-- 111
Query: 636 WNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSP 695
++ IHR++ + + ++ F ++ + G +T G + + + +P
Sbjct: 112 -SKHCIHRDLAARNCLVTEKNVLKISDFGMSR---EEEDGVYASTGGMKQIP--VKWTAP 165
Query: 696 EYIESGEATSMADVYSFGVVVLEV----------VTGQMAVDF-----RL------PEGL 734
E + G +S +DV+SFG+++ E ++ Q + RL P+ +
Sbjct: 166 EALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAV 225
Query: 735 --LVKRVHEFEARKRP 748
L++R E++ +RP
Sbjct: 226 YRLMERCWEYDPGQRP 241
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 6e-06
Identities = 37/215 (17%), Positives = 91/215 (42%), Gaps = 35/215 (16%)
Query: 520 RVAEMDFGTAYQGF-LDNHQYVLVKRLGMS------KCPALRTRFSNELQNLARLRHRNL 572
++ E +G Y+ + V +K++ + ALR E++ L L H N+
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR-----EIKLLKELNHPNI 60
Query: 573 VQLCGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYL 632
++L +G++ +++++ T + L+ + S+++ + Y +++ LA +
Sbjct: 61 IKLLDVFRHKGDLYLVFEFMDTDLY-KLIKDRQRGLPESLIK-SYLYQLLQGLA----FC 114
Query: 633 HEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHG---HRKATSGNRSVRGI 689
H ++HR++ + ++ + +L F LA + H T
Sbjct: 115 HSHG---ILHRDLKPENLLINTEGVLKLADFGLARSF-GSPVRPYTHYVVTR-------- 162
Query: 690 FGYMSPEYI-ESGEATSMADVYSFGVVVLEVVTGQ 723
Y +PE + ++ D++S G + E+++ +
Sbjct: 163 -WYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 6e-06
Identities = 47/198 (23%), Positives = 94/198 (47%), Gaps = 18/198 (9%)
Query: 525 DFGTAYQGFLD---NHQYVLVKRL-GMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCT 580
+FGT +G + + V VK L + PAL+ E + +L + +V++ G C
Sbjct: 7 NFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE 66
Query: 581 EQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQV 640
+ MLV+ + + L+ L N H +I + H+ ++ + YL E
Sbjct: 67 AESWMLVM-ELAELGPLNKFLQKNKHVTEKNITELVHQVSM------GMKYLEET---NF 116
Query: 641 IHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIES 700
+HR++ + + L ++ F L++ L +++ ++ T G V+ + +PE +
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVK----WYAPECMNY 172
Query: 701 GEATSMADVYSFGVVVLE 718
+ +S +DV+SFGV++ E
Sbjct: 173 YKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 6e-06
Identities = 48/165 (29%), Positives = 79/165 (47%), Gaps = 32/165 (19%)
Query: 240 IHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIG 299
IHRD+ N++L ++ DFGLAR + + Y +R SAR +
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKGSARL-------------PLK 241
Query: 300 YLPPES-FQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIRRLSDEGK 358
++ PES F K V T +SDV+SFG+++ E+ S + YP QI ++ +RL D G
Sbjct: 242 WMAPESIFDK--VYTTQSDVWSFGVLLWEIFSLGAS---PYPGVQIN-EEFCQRLKD-GT 294
Query: 359 VLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403
++A +N + + + L C +P RP+ ++E
Sbjct: 295 RMRAPENATPE----------IYRIMLACWQGDPKERPTFSALVE 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 6e-06
Identities = 69/264 (26%), Positives = 105/264 (39%), Gaps = 52/264 (19%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELV---AVAHLRHRNLVRL 173
++LG G FGKV + G A+K L ++ + A L + + RH L L
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 174 RGWCVHEDQLLLVYDYMPNRSL------DRVLFRRPENLEAAAPLNWEQRKKIIRGLAAA 227
+ D+L V +Y L +RV A + +A
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE-------------IVSA 107
Query: 228 LHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFH 287
L YLH E +++RD+K N+MLD + ++ DFGL + + A F
Sbjct: 108 LDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK--------EGIKDGATMKTF- 156
Query: 288 LAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDD----- 342
GT YL PE + A D + G+V+ E++ GR Y D
Sbjct: 157 -------CGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPF---YNQDHEKLF 205
Query: 343 QIILLDWI---RRLSDEGKVLQAG 363
++IL++ I R LS E K L +G
Sbjct: 206 ELILMEEIRFPRTLSPEAKSLLSG 229
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 7e-06
Identities = 46/181 (25%), Positives = 75/181 (41%), Gaps = 41/181 (22%)
Query: 619 YNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRK 678
Y +K L YLH + + IHR+I + I L+ + +L F ++ LT K
Sbjct: 106 YQTLKGLE----YLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLT---DTMAK 155
Query: 679 ATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKR 738
+V G +M+PE I+ + AD++S G+ +E MA + + P
Sbjct: 156 R----NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIE-----MA-EGKPPYS----D 201
Query: 739 VHE----FEARKRP---LAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQIL 791
+H F +P L++ S E +K C + +PE RPS Q+L
Sbjct: 202 IHPMRAIFMIPNKPPPTLSDPEKWS-------PEFNDFVKK---CLVKDPEERPSAIQLL 251
Query: 792 S 792
Sbjct: 252 Q 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 7e-06
Identities = 57/217 (26%), Positives = 94/217 (43%), Gaps = 39/217 (17%)
Query: 560 ELQNLARLRHRNLVQLCGWCTEQGE--MLVIYDYSATRILSHLLFHNNHRIGHSILQWHH 617
E+Q L L+H +VQ G ++ E + + +Y + L + S+ + +
Sbjct: 54 EIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL-KAYGALTESVTRKYT 112
Query: 618 RYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHR 677
R I++ ++ YLH + ++HR+I + I D N +LG F ++ L
Sbjct: 113 R-QILEGMS----YLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRL----QTIC 160
Query: 678 KATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQ--------MAVDFR 729
+ +G RSV G +MSPE I ADV+S G V+E++T + MA F+
Sbjct: 161 MSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFK 220
Query: 730 ---------LPEGL------LVKRVHEFEARKRPLAE 751
LP + + + EAR RP AE
Sbjct: 221 IATQPTNPQLPSHISEHARDFLGCIF-VEARHRPSAE 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 9e-06
Identities = 43/157 (27%), Positives = 71/157 (45%), Gaps = 31/157 (19%)
Query: 122 GGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRG--WCVH 179
G FGKVY ++ + AVK + +K + K ++ A R+ + L + VH
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVV-KKADMINKNMVHQVQA-----ERDALALSKSPFIVH 68
Query: 180 -------EDQLLLVYDYMPN---RSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALH 229
+ + LV +Y+ +SL L + E K I +A AL
Sbjct: 69 LYYSLQSANNVYLVMEYLIGGDVKSL----------LHIYGYFDEEMAVKYISEVALALD 118
Query: 230 YLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLAR 266
YLH IIHRD+K N+++ ++ + +L DFGL++
Sbjct: 119 YLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 9e-06
Identities = 58/227 (25%), Positives = 97/227 (42%), Gaps = 47/227 (20%)
Query: 118 VLGSGGFGKVYRAVLPSDGTVVAVKCLAE----KGERFEKTFAAELVAVAHLRHRNLVRL 173
VLG G FGKV A + A+K L + + + E T + V + L +L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66
Query: 174 RGWCVHEDQLLLVYDYMPNRSLDRVL-----FRRPENLEAAAPLNWEQRKKIIRGLAAAL 228
D+L V +Y+ L + F+ P + AA + A L
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEI------------AIGL 114
Query: 229 HYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHL 288
+LH + II+RD+K NVMLDS+ + ++ DFG+ + + +
Sbjct: 115 FFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGM----------------CKENMWDG 155
Query: 289 AETTRIGGTIGYLPPE--SFQKGSVATAKS-DVFSFGIVVLEVVSGR 332
T GT Y+ PE ++Q KS D ++FG+++ E+++G+
Sbjct: 156 VTTKTFCGTPDYIAPEIIAYQ----PYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (115), Expect = 1e-05
Identities = 31/114 (27%), Positives = 54/114 (47%), Gaps = 11/114 (9%)
Query: 560 ELQNLARLRHRNLVQLCGWCTE--QGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHH 617
E++ L +LRH N+V+L T +G + ++++Y L+ LL + S
Sbjct: 48 EIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHD-LTGLLDSPEVKFTES-----Q 101
Query: 618 RYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTR 671
+K L + YLH + ++HR+I S I ++ D +L F LA T+
Sbjct: 102 IKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTK 152
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 33/104 (31%), Positives = 54/104 (51%), Gaps = 13/104 (12%)
Query: 621 IIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKAT 680
II+ + A+ Y+H+ VIHR+I ++ I + N +L F +A L +N
Sbjct: 106 IIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN-------- 154
Query: 681 SGNRSV-RGIFGYMSPEYIESGEA-TSMADVYSFGVVVLEVVTG 722
S RS G +M+PE I G+ + AD++S G+ + E+ TG
Sbjct: 155 SSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 40/165 (24%), Positives = 74/165 (44%), Gaps = 13/165 (7%)
Query: 560 ELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRY 619
E++ +ARL H +++++ G E + ++ A +SHLL +++
Sbjct: 53 EIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLL-SKYGAFKEAVI-----I 106
Query: 620 NIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPD-MNPRLGSFALAEFLTRNDHGHRK 678
N + L + YLHE Q+IHR++ + + +D R+ F A L G
Sbjct: 107 NYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG--- 160
Query: 679 ATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQ 723
A + G +M+PE + + DV+S G V++E+ T +
Sbjct: 161 AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 48/206 (23%), Positives = 83/206 (40%), Gaps = 45/206 (21%)
Query: 621 IIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKAT 680
I++ + + YLH +E+ IHR+I ++ + L +L F +A LT
Sbjct: 106 ILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ------I 156
Query: 681 SGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQ--------MAVDFRLPE 732
N V F +M+PE I+ S AD++S G+ +E+ G+ M V F +P+
Sbjct: 157 KRNTFVGTPF-WMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPK 215
Query: 733 GLLVKRVHEFEAR-KRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQIL 791
E +PL E V+ LN E P RP+ +++L
Sbjct: 216 ----NNPPTLEGNYSKPLKEFVEACLNKE--------------------PSFRPTAKELL 251
Query: 792 --SILDGNDKRFMEDGQMTENLEEWK 815
+ K+ ++ + + WK
Sbjct: 252 KHKFIVRFAKKTSYLTELIDRYKRWK 277
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 48/198 (24%), Positives = 86/198 (43%), Gaps = 20/198 (10%)
Query: 526 FGTAYQGFLDNHQYVLVKRL--GMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQG 583
FG + G + V +K L G A F E Q + +LRH LVQL +E+
Sbjct: 19 FGEVWMGTWNGTTRVAIKTLKPGTMSPEA----FLQEAQVMKKLRHEKLVQLYAVVSEEP 74
Query: 584 EMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHR 643
+V S +L L L+ ++ +AS + Y+ E N +HR
Sbjct: 75 IYIVTEYMSKGSLLDFLKGEMG-----KYLRLPQLVDMAAQIASGMAYV-ERMN--YVHR 126
Query: 644 NITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEA 703
++ ++ I + ++ ++ F LA + N++ R+ + + +PE G
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA------KFPIKWTAPEAALYGRF 180
Query: 704 TSMADVYSFGVVVLEVVT 721
T +DV+SFG+++ E+ T
Sbjct: 181 TIKSDVWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 64/246 (26%), Positives = 98/246 (39%), Gaps = 48/246 (19%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERF--EKTFAAELVAVAHLRHRNLVRLRGW 176
+GSG +G V A G VAVK L+ + K EL + H++H N++
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 79
Query: 177 CVHEDQLLLVYDYMPNRSLDR---------VLFRRPENLEAAAPLNWEQRKKIIRGLAAA 227
LL V+ P RSL+ ++ N+ L + + +I +
Sbjct: 80 -----GLLDVFT--PARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 132
Query: 228 LHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFH 287
L Y+H IIHRD+K SN+ ++ ++ DFGLAR + E+
Sbjct: 133 LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--------------- 174
Query: 288 LAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILL 347
T T Y PE D++S G ++ E+++GR T D I L
Sbjct: 175 ----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT---DHIDQL 227
Query: 348 DWIRRL 353
I RL
Sbjct: 228 KLILRL 233
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 41/190 (21%), Positives = 70/190 (36%), Gaps = 54/190 (28%)
Query: 621 IIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRK-- 678
I ++ + YL+ +++HR+I S I + N G K
Sbjct: 108 IAVAVVEGLTYLYNV--HRIMHRDIKPSNILV-------------------NSRGQIKLC 146
Query: 679 --ATSGN--RSVRGIF----GYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRL 730
SG S+ F YMSPE I+ G+ T +DV+S G+ ++E+ G+ F
Sbjct: 147 DFGVSGELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAF-- 204
Query: 731 PEGLLVKRVHEFEARKRPLAELVDL----------SLNGEYNHKELMRLIKLGIACTLSN 780
+ ++DL L ++L + AC L +
Sbjct: 205 SNIDDDGQDDP--------MGILDLLQQIVQEPPPRLPSSDFPEDLRDFVD---ACLLKD 253
Query: 781 PELRPSMRQI 790
P RP+ +Q+
Sbjct: 254 PTERPTPQQL 263
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 2e-05
Identities = 29/112 (25%), Positives = 52/112 (46%), Gaps = 16/112 (14%)
Query: 625 LASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHG--------- 675
+ A+ YLH ++ +IHR++ I LD DM+ ++ F A+ L N
Sbjct: 111 ILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATN 167
Query: 676 HRKATSGNRSVRGIF-G---YMSPEYIESGEATSMADVYSFGVVVLEVVTGQ 723
NR F G Y+SPE + A +D+++ G ++ +++TG+
Sbjct: 168 IDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 44/187 (23%), Positives = 78/187 (41%), Gaps = 18/187 (9%)
Query: 555 TRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQ 614
++ + + L H +V+L G C LV +L H+ H + +L
Sbjct: 54 QEITDHMLAMGSLDHAYIVRLLGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLN 113
Query: 615 WHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDH 674
W +A + YL E +++HRN+ + I L D ++ F +A+ L +D
Sbjct: 114 W------CVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK 164
Query: 675 GHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT--GQMAVDFRLPE 732
+ + + +M+ E I G T +DV+S+GV V E+++ + R E
Sbjct: 165 KYFYS-----EHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE 219
Query: 733 --GLLVK 737
LL K
Sbjct: 220 VPDLLEK 226
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 52/239 (21%), Positives = 97/239 (40%), Gaps = 24/239 (10%)
Query: 491 RNSFFMVETPREISFKEIISATNNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKC 550
R + E E F E+ + E++ +AE G F V VK L
Sbjct: 4 RQQLRLKEKLGEGQFGEV-----HLCEAEGLAEF-LGEGAPEFDGQPVLVAVKMLRADVT 57
Query: 551 PALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGH 610
R F E++ ++RL++ N+++L G C + +I +Y L+ L
Sbjct: 58 KTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIES-- 115
Query: 611 SILQWHHRYNIIKSLASAILYLHEEWNE--------QVIHRNITSSAITLDPDMNPRLGS 662
+ H NI + +LY+ + +HR++ + + ++
Sbjct: 116 ---TFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIAD 172
Query: 663 FALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT 721
F ++ L D+ + R+V I +M+ E I G+ T+ +DV++FGV + E+ T
Sbjct: 173 FGMSRNLYSGDYYRIQG----RAVLPI-RWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 44/198 (22%), Positives = 90/198 (45%), Gaps = 21/198 (10%)
Query: 534 LDNHQYVLVKRL---GMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYD 590
+ + V++K++ M+K R NE Q L L H N+++ E ++++ +
Sbjct: 22 KADQKLVIIKQIPVEQMTK--DERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79
Query: 591 YSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAI 650
Y+ L+ + R +S+L I+ +L LH + ++HR++ + I
Sbjct: 80 YAPGGTLAEYI---QKR-CNSLLD---EDTILHFFVQILLALHHVHTKLILHRDLKTQNI 132
Query: 651 TLDP-DMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADV 709
LD M ++G F +++ L+ + S +V G Y+SPE E +D+
Sbjct: 133 LLDKHKMVVKIGDFGISKILS--------SKSKAYTVVGTPCYISPELCEGKPYNQKSDI 184
Query: 710 YSFGVVVLEVVTGQMAVD 727
++ G V+ E+ + + A +
Sbjct: 185 WALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-05
Identities = 44/177 (24%), Positives = 86/177 (48%), Gaps = 21/177 (11%)
Query: 157 AELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQ 216
+EL +A H +V+ +D+LLL+ +Y L++ + +R L+ P +
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQR---LKEHLPFQEYE 170
Query: 217 RKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQM 276
+ + AL +H + +++HRD+K++N+ L +LGDFG ++ QY
Sbjct: 171 VGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSK------QYSD 221
Query: 277 RTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRR 333
S L + GT YL PE +++ + K+D++S G+++ E+++ R
Sbjct: 222 SVS--------LDVASSFCGTPYYLAPELWERKRY-SKKADMWSLGVILYELLTLHR 269
|
Length = 478 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 42/152 (27%), Positives = 65/152 (42%), Gaps = 12/152 (7%)
Query: 119 LGSGGFGKVYRAVLPSD--GTVVAVKCL-AEKGERFEKTFAAELVAVAHLRHRNLVRLRG 175
+G+G FGKV + S V VK L + + F E L+H NL++ G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 176 WCVHEDQLLLVYDYMPNRSLDRVL--FRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHE 233
C LLV ++ P L L R+ E + P ++ I A L +LH+
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELM-TPDPTTLQRMACEI---ALGLLHLHK 118
Query: 234 QLETQIIHRDVKTSNVMLDSQYNARLGDFGLA 265
IH D+ N +L + ++GD+GL+
Sbjct: 119 N---NFIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 55/222 (24%), Positives = 93/222 (41%), Gaps = 35/222 (15%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK----GERFEKTFAAELVAVAHLRHRNLVR 172
++LG G FGKV+ A L A+K L + + E T + V H L
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 173 LRGWCVHE--DQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHY 230
L +C + + L V +Y+ L +F + P +II G L +
Sbjct: 61 L--YCTFQTKENLFFVMEYLNGGDL---MFHIQSCHKFDLPRATFYAAEIICG----LQF 111
Query: 231 LHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAE 290
LH + I++RD+K N++LD+ + ++ DFG+ + + A+
Sbjct: 112 LHSK---GIVYRDLKLDNILLDTDGHIKIADFGM----------------CKENMLGDAK 152
Query: 291 TTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
T GT Y+ PE G D +SFG+++ E++ G+
Sbjct: 153 TCTFCGTPDYIAPEILL-GQKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 26/156 (16%), Positives = 58/156 (37%), Gaps = 20/156 (12%)
Query: 114 DEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLV-- 171
++L G +VY L + +K + E+ E+ + L + L
Sbjct: 1 SSIKLLKGGLTNRVYL--LGTKDEDYVLK-INPSREK-GADREREVAILQLLARKGLPVP 56
Query: 172 RLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYL 231
++ + L+ +++ +LD ++ E+++ I LA L L
Sbjct: 57 KVLASGESDGWSYLLMEWIEGETLD--------------EVSEEEKEDIAEQLAELLAKL 102
Query: 232 HEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267
H+ + H D+ N+++D + D+ A +
Sbjct: 103 HQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 38/136 (27%), Positives = 65/136 (47%), Gaps = 31/136 (22%)
Query: 227 ALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQF 286
AL++LHE+ II+RD+K NV+LD++ + +L D+G+ + +R
Sbjct: 108 ALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK-------EGIRPGDT----- 152
Query: 287 HLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLT----YPDD 342
T+ GT Y+ PE +G D ++ G+++ E+++GR D+ PD
Sbjct: 153 ----TSTFCGTPNYIAPEIL-RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQ 207
Query: 343 -------QIILLDWIR 351
Q+IL IR
Sbjct: 208 NTEDYLFQVILEKQIR 223
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 57/234 (24%), Positives = 106/234 (45%), Gaps = 43/234 (18%)
Query: 118 VLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGW- 176
++G+G FG VY A+ VA+K + + + + EL+ + +L H N++ L+ +
Sbjct: 73 IIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR----ELLIMKNLNHINIIFLKDYY 128
Query: 177 ---CVHEDQ----LLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALH 229
C +++ L +V +++P +++ + + N A K L AL
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLF---LVKLYSYQLCRALA 184
Query: 230 YLHEQLETQIIHRDVKTSNVMLDSQ-YNARLGDFGLARWLEHELQYQMRTSSARNHQFHL 288
Y+H + I HRD+K N+++D + +L DFG A+ L R+ S +F+
Sbjct: 185 YIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAK----NLLAGQRSVSYICSRFYR 237
Query: 289 AETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVV------SGRRAVD 336
A +G T Y T D++S G ++ E++ SG+ +VD
Sbjct: 238 APELMLGAT-NY------------TTHIDLWSLGCIIAEMILGYPIFSGQSSVD 278
|
Length = 440 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 62/226 (27%), Positives = 93/226 (41%), Gaps = 35/226 (15%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAEL---VAVAHLRHRN 169
F VLG GGFG+V + + G + A K L +K + K A L + + R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 170 LVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRG-LAAAL 228
+V L +D L LV M L ++ N+ P EQR L L
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIY----NM--GNPGFDEQRAIFYAAELCCGL 115
Query: 229 HYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHL 288
L + +I++RD+K N++LD + + R+ D GLA Q
Sbjct: 116 EDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAV------------------QIPE 154
Query: 289 AETTRIG--GTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
ET R G GT+GY+ PE T D + G ++ E++ G+
Sbjct: 155 GETVR-GRVGTVGYMAPEVINNEKY-TFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 45/189 (23%), Positives = 83/189 (43%), Gaps = 24/189 (12%)
Query: 538 QYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRIL 597
+ V VK++ + K R NE+ + +H N+V++ E+ V+ ++ L
Sbjct: 46 KLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104
Query: 598 SHLLFH---NNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDP 654
+ ++ H N +I L ++ A+ LH + VIHR+I S +I L
Sbjct: 105 TDIVTHTRMNEEQIAAVCL----------AVLKALSVLHAQ---GVIHRDIKSDSILLTH 151
Query: 655 DMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGV 714
D +L F ++ K +S+ G +M+PE I D++S G+
Sbjct: 152 DGRVKLSDFGFCAQVS-------KEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGI 204
Query: 715 VVLEVVTGQ 723
+V+E+V G+
Sbjct: 205 MVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 32/116 (27%), Positives = 55/116 (47%), Gaps = 19/116 (16%)
Query: 220 IIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTS 279
I R + A+ YLHE +IIHRD+K N+ ++ + LGDFG A + + +
Sbjct: 187 IERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA-------CFPVDIN 236
Query: 280 SARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAV 335
+ + + + GTI PE + A D++S GIV+ E+ + ++
Sbjct: 237 ANKYYGW--------AGTIATNAPELLARDPYGPA-VDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 59/233 (25%), Positives = 98/233 (42%), Gaps = 34/233 (14%)
Query: 106 LYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLA--EKGERFEKTFAAELVAVA 163
L + + +D +V+G G FG+V S V A+K L+ E +R + F E +
Sbjct: 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIM 97
Query: 164 HLRHRNLVRLRGWCVHEDQ--LLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKII 221
+ V ++ +C +D L +V +YMP L ++ N + P W K
Sbjct: 98 AFANSPWV-VQLFCAFQDDKYLYMVMEYMPGGDLVNLM----SNYDV--PEKWA--KFYT 148
Query: 222 RGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSA 281
+ AL +H +IHRDVK N++LD + +L DFG ++ + T+
Sbjct: 149 AEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV- 204
Query: 282 RNHQFHLAETTRIGGTIGYLPPESF--QKGSVATAKS-DVFSFGIVVLEVVSG 331
GT Y+ PE Q G + D +S G+ + E++ G
Sbjct: 205 --------------GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 4e-05
Identities = 49/187 (26%), Positives = 85/187 (45%), Gaps = 21/187 (11%)
Query: 540 VLVKRLGMSKCPALRTRFSNELQNLARL-RHRNLVQLCGWCTEQGEMLVIYDYSATRILS 598
V VK L + + R +EL+ ++ L H N+V L G CT G +LVI +Y L
Sbjct: 68 VAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLL 127
Query: 599 HLLFHNNHRIGHSILQW----HHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDP 654
+ L R S L Y + K +A +L ++ IHR++ + + L
Sbjct: 128 NFL----RRKRESFLTLEDLLSFSYQVAKGMA----FLA---SKNCIHRDLAARNVLLTH 176
Query: 655 DMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGV 714
++ F LA + ND + + V+ +M+PE I + T +DV+S+G+
Sbjct: 177 GKIVKICDFGLARDI-MNDSNYVVKGNARLPVK----WMAPESIFNCVYTFESDVWSYGI 231
Query: 715 VVLEVVT 721
++ E+ +
Sbjct: 232 LLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 56/218 (25%), Positives = 92/218 (42%), Gaps = 41/218 (18%)
Query: 560 ELQNLARLRHRNLVQLCGWCT---EQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWH 616
E+Q L LRH +VQ G C E+ ++ + +Y + L G
Sbjct: 54 EIQLLKNLRHDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQL----KAYGALTENVT 108
Query: 617 HRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGH 676
RY + + + YLH + ++HR+I + I D N +LG F ++ +
Sbjct: 109 RRYT--RQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRI----QTI 159
Query: 677 RKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQ--------MAVDF 728
+ +G +SV G +MSPE I ADV+S V+E++T + MA F
Sbjct: 160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIF 219
Query: 729 ---------RLPEGL------LVKRVHEFEARKRPLAE 751
LP+G+ +K++ E ++RP AE
Sbjct: 220 KIATQPTKPMLPDGVSDACRDFLKQIF-VEEKRRPTAE 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 5e-05
Identities = 45/188 (23%), Positives = 76/188 (40%), Gaps = 31/188 (16%)
Query: 552 ALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHS 611
+R + E++ L + H N+V+ GE+ V+ ++ L I
Sbjct: 114 TVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL------EGTHIADE 167
Query: 612 ILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTR 671
++ + + S I YLH ++HR+I S + ++ N ++ F ++ L +
Sbjct: 168 ----QFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220
Query: 672 NDHGHRKATSGNRSVRGIFGYMSPEYIES----GEATSMA-DVYSFGVVVLEVVTGQMAV 726
N SV G YMSPE I + G A D++S GV +LE G
Sbjct: 221 T------MDPCNSSV-GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLG---- 269
Query: 727 DFRLPEGL 734
R P G+
Sbjct: 270 --RFPFGV 275
|
Length = 353 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 6e-05
Identities = 38/170 (22%), Positives = 80/170 (47%), Gaps = 17/170 (10%)
Query: 557 FSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWH 616
F E + + +L H LVQL G CT+Q + ++ ++ L + L ++ +L
Sbjct: 46 FIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDML--- 102
Query: 617 HRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGH 676
++ + + + YL IHR++ + + ++ F + ++ +++
Sbjct: 103 --LSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-- 155
Query: 677 RKATSGNR-SVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQM 724
++SG + V+ + PE + +S +DV+SFGV++ EV T G+M
Sbjct: 156 -TSSSGAKFPVK----WSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKM 200
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 7e-05
Identities = 41/182 (22%), Positives = 78/182 (42%), Gaps = 14/182 (7%)
Query: 540 VLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRILSH 599
V + L R F E L + H N+V+L G T M+++ +Y + L
Sbjct: 36 VAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDS 95
Query: 600 LLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPR 659
L + ++ L ++ LAS + YL E +H+ + + + ++ D+ +
Sbjct: 96 FLRKHEGQLVAGQLM-----GMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCK 147
Query: 660 LGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEV 719
+ F R +A S + + +PE I+ +S +DV+SFG+V+ EV
Sbjct: 148 ISGFR------RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEV 201
Query: 720 VT 721
++
Sbjct: 202 MS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 7e-05
Identities = 64/303 (21%), Positives = 122/303 (40%), Gaps = 54/303 (17%)
Query: 521 VAEMDFGTAYQGF------LDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQ 574
+ E +FG + + V VK L + + +E L ++ H ++++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 575 LCGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIK----------- 623
L G C++ G +L+I +Y+ L L + ++G S L N
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFL-RESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 624 --------SLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHG 675
++ + YL E +++HR++ + + + ++ F L+ + D
Sbjct: 127 GDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEED-S 182
Query: 676 HRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGL 734
+ K + G V+ +M+ E + T+ +DV+SFGV++ E+VT G PE L
Sbjct: 183 YVKRSKGRIPVK----WMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERL 238
Query: 735 --LVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792
L+K + E RP E +E+ L+ + C P+ RP+ I
Sbjct: 239 FNLLKTGYRME---RP-----------ENCSEEMYNLM---LTCWKQEPDKRPTFADISK 281
Query: 793 ILD 795
L+
Sbjct: 282 ELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 7e-05
Identities = 43/158 (27%), Positives = 73/158 (46%), Gaps = 25/158 (15%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVKCLAE--KGERFEKTFAAELVAVAHLRHRNLVRLRGW 176
+GSG G V A G VAVK L+ + + K ELV + + H+N++ L
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISL--- 85
Query: 177 CVHEDQLLLVYDYMPNRSLDRV--LFRRPENLEAA------APLNWEQRKKIIRGLAAAL 228
+ + P +SL+ ++ E ++A L+ E+ ++ + +
Sbjct: 86 ---------LNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGI 136
Query: 229 HYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLAR 266
+LH IIHRD+K SN+++ S ++ DFGLAR
Sbjct: 137 KHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 8e-05
Identities = 43/201 (21%), Positives = 88/201 (43%), Gaps = 19/201 (9%)
Query: 526 FGTAYQGFL----DNHQY-VLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCT 580
FGT Y+G + + V +K L + P +E +A + + ++ +L G C
Sbjct: 20 FGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL 79
Query: 581 EQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQV 640
L+ +L ++ H ++ +L W +A + YL E ++
Sbjct: 80 TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEER---RL 130
Query: 641 IHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIES 700
+HR++ + + + + ++ F LA+ L ++ + A G ++ +M+ E I
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYH-AEGGKVPIK----WMALESILH 185
Query: 701 GEATSMADVYSFGVVVLEVVT 721
T +DV+S+GV V E++T
Sbjct: 186 RIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 8e-05
Identities = 45/154 (29%), Positives = 70/154 (45%), Gaps = 12/154 (7%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLA--EKGERFEKT-FAAELVAVAHLRHRN 169
F+ +V+G G FG+V + + G V A+K L E +R E F E + + R
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRW 62
Query: 170 LVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALH 229
+ L E+ L LV DY L +L + + L + + + + A+
Sbjct: 63 ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPE------DMARFYLAEMVLAID 116
Query: 230 YLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFG 263
+H QL +HRD+K NV+LD + RL DFG
Sbjct: 117 SVH-QL--GYVHRDIKPDNVLLDKNGHIRLADFG 147
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 9e-05
Identities = 45/184 (24%), Positives = 83/184 (45%), Gaps = 18/184 (9%)
Query: 557 FSNELQNLARLRHRNLVQLCGWCTEQ-GEMLVIYDYSATRILSHLLFHNNHRIGHSILQW 615
F E + +LRH NLVQL G E+ G + ++ +Y A L L G S+L
Sbjct: 46 FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL----RSRGRSVLGG 101
Query: 616 HHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHG 675
+ A+ YL E N +HR++ + + + D ++ F L
Sbjct: 102 DCLLKFSLDVCEAMEYL--EAN-NFVHRDLAARNVLVSEDNVAKVSDFGLT--------- 149
Query: 676 HRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLL 735
++A+S + + + +PE + + ++ +DV+SFG+++ E+ + R+P +
Sbjct: 150 -KEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV 208
Query: 736 VKRV 739
V RV
Sbjct: 209 VPRV 212
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 9e-05
Identities = 41/186 (22%), Positives = 80/186 (43%), Gaps = 18/186 (9%)
Query: 538 QYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRIL 597
Q V +K++ + K P + NE+ + L++ N+V E+ V+ +Y A L
Sbjct: 45 QEVAIKQINLQKQPK-KELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSL 103
Query: 598 SHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMN 657
+ + + + + + + A+ +LH QVIHR+I S + L D +
Sbjct: 104 TDV-------VTETCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGS 153
Query: 658 PRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVL 717
+L F +T S ++ G +M+PE + D++S G++ +
Sbjct: 154 VKLTDFGFCAQIT-------PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAI 206
Query: 718 EVVTGQ 723
E+V G+
Sbjct: 207 EMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 9e-05
Identities = 21/99 (21%), Positives = 42/99 (42%), Gaps = 11/99 (11%)
Query: 625 LASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNR 684
+ + +LH ++++R++ + LD N R+ LA L +A
Sbjct: 104 IICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA----- 155
Query: 685 SVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQ 723
G GYM+PE ++ D ++ G + E++ G+
Sbjct: 156 ---GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 9e-05
Identities = 55/272 (20%), Positives = 108/272 (39%), Gaps = 45/272 (16%)
Query: 530 YQGFLDNHQYVLVKRLGMSK--CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEML- 586
Y+G +N + V+++ L NE++NL R+ N++++ G+ + + L
Sbjct: 37 YKGIFNNKE-VIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95
Query: 587 ---VIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHR 643
+I +Y L +L L + + ++ + L++ N+ ++
Sbjct: 96 RLSLILEYCTRGYLREVLDKEKD------LSFKTKLDMAIDCCKGLYNLYKYTNKP--YK 147
Query: 644 NITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVR-GIFGYMSPEYIES-- 700
N+TS + + + ++ HG K S Y S + +
Sbjct: 148 NLTSVSFLVTENYKLKIIC-----------HGLEKILSSPPFKNVNFMVYFSYKMLNDIF 196
Query: 701 GEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGE 760
E T D+YS GVV+ E+ TG+ + F E L K ++ +L+ N
Sbjct: 197 SEYTIKDDIYSLGVVLWEIFTGK--IPF---ENLTTKEIY----------DLIINKNNSL 241
Query: 761 YNHKELMRLIK-LGIACTLSNPELRPSMRQIL 791
+ IK + ACT + RP++++IL
Sbjct: 242 KLPLDCPLEIKCIVEACTSHDSIKRPNIKEIL 273
|
Length = 283 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 38/166 (22%), Positives = 73/166 (43%), Gaps = 39/166 (23%)
Query: 632 LHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFG 691
LHE+ +++HR++ S+ I L + ++G +++ L +N ++ G
Sbjct: 119 LHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN---------MAKTQIGTPH 166
Query: 692 YMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAE 751
YM+PE + + +D++S G ++ E+ T F P FEAR + +
Sbjct: 167 YMAPEVWKGRPYSYKSDIWSLGCLLYEMAT------FAPP----------FEARS--MQD 208
Query: 752 LVDLSLNGEY------NHKELMRLIKLGIACTLSNPELRPSMRQIL 791
L G+Y ++L I+ + P+LRP+ +IL
Sbjct: 209 LRYKVQRGKYPPIPPIYSQDLQNFIR---SMLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 47/176 (26%), Positives = 79/176 (44%), Gaps = 24/176 (13%)
Query: 619 YNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRK 678
+NI + A+ YLH+E ++++HR++T + I L D + F LA+ K
Sbjct: 116 WNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES----K 169
Query: 679 ATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKR 738
TS V G Y PE +++ ADV++FG ++ ++ T Q L K
Sbjct: 170 LTS----VVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKI 225
Query: 739 VHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSIL 794
V EA PL E G Y+ + +I +C + E RP + Q+ +++
Sbjct: 226 V---EAVYEPLPE-------GMYSED-VTDVIT---SCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 54/237 (22%), Positives = 86/237 (36%), Gaps = 57/237 (24%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK---GERFEKTFAAELVAVAHLRHRN 169
F + VLG GGFG+V + + G + A K L +K + E E + + +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 170 LVRLRGWCVHEDQLLLVYDYM--------------PNRSLDRVLFRRPENLEAAAPLNWE 215
+V L +D L LV M P +R LF E
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAE----------- 110
Query: 216 QRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQ 275
+ L LH + ++RD+K N++LD + R+ D GLA + +
Sbjct: 111 --------ILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIR 159
Query: 276 MRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
R GT+GY+ PE T D + G ++ E++ G+
Sbjct: 160 GRV-----------------GTVGYMAPEVL-NNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 52/224 (23%), Positives = 94/224 (41%), Gaps = 31/224 (13%)
Query: 118 VLGSGGFGKVYRAVLPSDGTVVAVKC----LAEKGERFEKTFAAELVAVAHLRHRNLVRL 173
V+G G + KV L + + A+K L E + + V + LV L
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 174 RGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHE 233
+L LV +Y+ L +F +++ L E + + AL++LHE
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDL---MF----HMQRQRKLPEEHARFYAAEICIALNFLHE 114
Query: 234 QLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTR 293
+ II+RD+K NV+LD+ + +L D+G+ + + T+
Sbjct: 115 R---GIIYRDLKLDNVLLDADGHIKLTDYGMCK-------EGLGPGDT---------TST 155
Query: 294 IGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDL 337
GT Y+ PE +G D ++ G+++ E+++GR D+
Sbjct: 156 FCGTPNYIAPEIL-RGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 45/202 (22%), Positives = 92/202 (45%), Gaps = 18/202 (8%)
Query: 526 FGTAYQGFLDNHQ-YVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGE 584
+G Y+G + V VK L F E + ++H NLVQL G CT +
Sbjct: 19 YGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGVCTREPP 76
Query: 585 MLVIYDY-SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHR 643
+I ++ + +L +L N + +L + + ++SA+ YL + + IHR
Sbjct: 77 FYIITEFMTYGNLLDYLRECNRQEVNAVVLLY-----MATQISSAMEYLEK---KNFIHR 128
Query: 644 NITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEA 703
++ + + + ++ F L+ +T + + A +G + + +PE + +
Sbjct: 129 DLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAG---AKFPIKWTAPESLAYNKF 182
Query: 704 TSMADVYSFGVVVLEVVTGQMA 725
+ +DV++FGV++ E+ T M+
Sbjct: 183 SIKSDVWAFGVLLWEIATYGMS 204
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 2e-04
Identities = 25/104 (24%), Positives = 47/104 (45%), Gaps = 4/104 (3%)
Query: 620 NIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEF-LTRNDHGHRK 678
I + A+ YLH + +IHR++ I +D + + +L F L++ L R
Sbjct: 97 IYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153
Query: 679 ATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTG 722
++ + G Y++PE I + D +S G ++ E + G
Sbjct: 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 61/225 (27%), Positives = 93/225 (41%), Gaps = 55/225 (24%)
Query: 560 ELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRY 619
E+Q L L H +VQ G + E R LS + H G SI Y
Sbjct: 54 EIQLLKNLLHERIVQYYGCLRDPME----------RTLSIFM---EHMPGGSIKDQLKSY 100
Query: 620 NII---------KSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLT 670
+ + + + YLH + ++HR+I + I D N +LG F ++ L
Sbjct: 101 GALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRL- 156
Query: 671 RNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATS-MADVYSFGVVVLEVVTGQ------ 723
+ +G +SV G +MSPE I SGE AD++S G V+E++T +
Sbjct: 157 ---QTICLSGTGMKSVTGTPYWMSPEVI-SGEGYGRKADIWSVGCTVVEMLTEKPPWAEF 212
Query: 724 --MAVDFR---------LPEGL------LVKRVHEFEARKRPLAE 751
MA F+ LP + +KR+ EA+ RP A+
Sbjct: 213 EAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRIF-VEAKLRPSAD 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 43/210 (20%), Positives = 90/210 (42%), Gaps = 19/210 (9%)
Query: 515 FSESQRVAEMDFGTAYQGF-LDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLV 573
++ +++ + GT Y + Q V +K++ + + P + NE+ + ++ N+V
Sbjct: 21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK-KELIINEILVMRENKNPNIV 79
Query: 574 QLCGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLH 633
E+ V+ +Y A L+ + + + + + + A+ +LH
Sbjct: 80 NYLDSYLVGDELWVVMEYLAGGSLTDV-------VTETCMDEGQIAAVCRECLQALDFLH 132
Query: 634 EEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYM 693
+ QVIHR+I S I L D + +L F +T S ++ G +M
Sbjct: 133 ---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT-------PEQSKRSTMVGTPYWM 182
Query: 694 SPEYIESGEATSMADVYSFGVVVLEVVTGQ 723
+PE + D++S G++ +E+V G+
Sbjct: 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 2e-04
Identities = 42/160 (26%), Positives = 72/160 (45%), Gaps = 33/160 (20%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHL----------RHR 168
+G GG+G+V+ A G +VA+K R +K+ +L V H+ +
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALK-------RMKKSLLFKLNEVRHVLTERDILTTTKSE 61
Query: 169 NLVRLRGWCVHEDQLLLVYDYMPN---RSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLA 225
LV+L ++ L L +Y+P R+L L L+ + + + +
Sbjct: 62 WLVKLLYAFQDDEYLYLAMEYVPGGDFRTL----------LNNLGVLSEDHARFYMAEMF 111
Query: 226 AALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLA 265
A+ LHE IHRD+K N ++D+ + +L DFGL+
Sbjct: 112 EAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLS 148
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 46/163 (28%), Positives = 74/163 (45%), Gaps = 22/163 (13%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERF---EKTFAAELVAVAHLRHRNLVRLRG 175
+GSG +G V A VAVK L+ + +T+ EL + H++H N++ L
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYR-ELRLLKHMKHENVIGLLD 81
Query: 176 WCVHE------DQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALH 229
+++ LV + M + V ++ L+ E + +I L L
Sbjct: 82 VFTPATSIENFNEVYLVTNLMGADLNNIVKCQK---------LSDEHVQFLIYQLLRGLK 132
Query: 230 YLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHEL 272
Y+H IIHRD+K SNV ++ R+ DFGLAR + E+
Sbjct: 133 YIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEM 172
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 43/160 (26%), Positives = 70/160 (43%), Gaps = 17/160 (10%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVK--CLAEKGERFEKTFAAELVAVAHLRHRN-LVRL 173
E +G G +GKVY+A + G +VA+K L E T E+ + L +VRL
Sbjct: 7 EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRL 66
Query: 174 RGWCVHEDQ------LLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAA 227
H ++ L LV++Y+ D F PL + K + L
Sbjct: 67 LD-VEHVEEKNGKPSLYLVFEYL---DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122
Query: 228 LHYLHEQLETQIIHRDVKTSNVMLDSQYNA-RLGDFGLAR 266
+ + H+ ++HRD+K N+++D Q ++ D GL R
Sbjct: 123 VAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 40/203 (19%), Positives = 83/203 (40%), Gaps = 16/203 (7%)
Query: 519 QRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGW 578
+++ FG + + H V VK M F E + L+H LV+L
Sbjct: 12 KKLGAGQFGEVWMATYNKHTKVAVKT--MKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 69
Query: 579 CTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNE 638
T++ ++ + +L L + + +A + ++ +
Sbjct: 70 VTKEPIYIITEFMAKGSLLDFLKSDEGSKQ-----PLPKLIDFSAQIAEGMAFIEQR--- 121
Query: 639 QVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYI 698
IHR++ ++ I + + ++ F LA + N++ R+ + + +PE I
Sbjct: 122 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGA------KFPIKWTAPEAI 175
Query: 699 ESGEATSMADVYSFGVVVLEVVT 721
G T +DV+SFG++++E+VT
Sbjct: 176 NFGSFTIKSDVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 40/164 (24%), Positives = 79/164 (48%), Gaps = 14/164 (8%)
Query: 560 ELQNLARLRHRNLVQLCGWCTEQGE--MLVIYDYSATRILSHLLFHNNHRIGHSILQWHH 617
E++ L L H N+V+ G CTE G + +I ++ + L L N ++I L+
Sbjct: 56 EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKIN---LKQQL 112
Query: 618 RYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHR 677
+Y + + + YL + Q +HR++ + + ++ + ++G F L + + D +
Sbjct: 113 KYAV--QICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEYY 166
Query: 678 KATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT 721
S +F Y +PE + + +DV+SFGV + E++T
Sbjct: 167 TVKDDLDS--PVFWY-APECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 26/110 (23%), Positives = 44/110 (40%), Gaps = 16/110 (14%)
Query: 613 LQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRN 672
W +Y I + + LH+ +IHR+I + +D + +L F L+
Sbjct: 96 EDWAKQY--IAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSR----- 145
Query: 673 DHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTG 722
N+ G Y++PE I M+D +S G V+ E + G
Sbjct: 146 ------NGLENKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 3e-04
Identities = 57/233 (24%), Positives = 93/233 (39%), Gaps = 51/233 (21%)
Query: 116 DEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAA-----ELVAVAHLRHRNL 170
D +G G FG V+ P DG VA+K + F+ + EL + +H N+
Sbjct: 5 DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNV---FQNLVSCKRVFRELKMLCFFKHDNV 61
Query: 171 VRL-------RGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRK----K 219
+ E + +V + M L +++ PL+ + K +
Sbjct: 62 LSALDILQPPHIDPFEE--IYVVTELM-QSDLHKIIVSPQ-------PLSSDHVKVFLYQ 111
Query: 220 IIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTS 279
I+RGL YLH I+HRD+K N++++S ++ DFGLAR E + M
Sbjct: 112 ILRGL----KYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHM--- 161
Query: 280 SARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
T+ T Y PE T+ D++S G + E++ R
Sbjct: 162 ------------TQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 3e-04
Identities = 59/226 (26%), Positives = 88/226 (38%), Gaps = 38/226 (16%)
Query: 119 LGSGGFGKVYRA--VLPSDGTVVAVKCLAEKGERFEKTFAA-----ELVAVAHLR-HRNL 170
LG G +G V A S+ VA+K + F K A EL + H R H+N+
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNV---FSKKILAKRALRELKLLRHFRGHKNI 64
Query: 171 VRLRGW-CVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALH 229
L V +Y Y D R PL + I + L
Sbjct: 65 TCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQ-----PLTDAHFQSFIYQILCGLK 119
Query: 230 YLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLA 289
Y+H ++HRD+K N+++++ ++ DFGLAR E + N F
Sbjct: 120 YIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGF-SENPGE-------NAGF--- 165
Query: 290 ETTRIGGTIGYLPPE---SFQKGSVATAKSDVFSFGIVVLEVVSGR 332
T T Y PE SFQ + A DV+S G ++ E++ +
Sbjct: 166 -MTEYVATRWYRAPEIMLSFQSYTKAI---DVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 3e-04
Identities = 67/279 (24%), Positives = 109/279 (39%), Gaps = 84/279 (30%)
Query: 119 LGSGGFGKVYRA-VLPSDGT----VVAVKCLAEKGERFE-KTFAAELVAVAHL-RHRNLV 171
LG G FG+V A D T VAVK L E E + +EL + H+ H N+V
Sbjct: 15 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 74
Query: 172 RLRGWCVHEDQLLLVY------------------DYMPNRSLDRVLFRRPENLEAAAPLN 213
L G C L+V +++P ++ D FR+ ++ +
Sbjct: 75 NLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKD-ARFRQGKSGYGDISED 133
Query: 214 WEQRKKII--RGLAAALHYLHEQ---------------------LETQI----------- 239
++R I +A+ ++ E+ LE I
Sbjct: 134 LKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGME 193
Query: 240 -------IHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETT 292
IHRD+ N++L ++ DFGLAR + + Y +R AR
Sbjct: 194 FLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKGDARL--------- 243
Query: 293 RIGGTIGYLPPES-FQKGSVATAKSDVFSFGIVVLEVVS 330
+ ++ PE+ F + V T +SDV+SFG+++ E+ S
Sbjct: 244 ----PLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 4e-04
Identities = 57/228 (25%), Positives = 92/228 (40%), Gaps = 39/228 (17%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRN--- 169
F VLG GGFG+V + + G + A K L +K + K A L L N
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 170 LVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRG--LAAA 227
+V L +D L LV M L ++ N+ +++ + + +
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIY----NM---GNPGFDEERAVFYAAEITCG 114
Query: 228 LHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFH 287
L LH + +I++RD+K N++LD + R+ D GLA
Sbjct: 115 LEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLA--------------------VE 151
Query: 288 LAETTRIG---GTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
+ E I GT+GY+ PE K T D + G ++ E++ G+
Sbjct: 152 IPEGETIRGRVGTVGYMAPEVV-KNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 49/220 (22%), Positives = 92/220 (41%), Gaps = 25/220 (11%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVKCLAE-KGERFEKTFAAELVAVAHLRHRNLVRLRG-W 176
+G G +G VY+A DG L + +G + E+ + L+H N++ L+ +
Sbjct: 9 VGRGTYGHVYKA-KRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 177 CVHED-QLLLVYDYMPNRSLDRVLFRRPENL-EAAAPLNWEQRKKIIRGLAAALHYLHEQ 234
H D ++ L++DY + + F R + L K ++ + +HYLH
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 235 LETQIIHRDVKTSNVMLDSQYNAR----LGDFGLARWLEHELQYQMRTSSARNHQFHLAE 290
++HRD+K +N+++ + R + D G AR L+ LA+
Sbjct: 128 W---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK-------------PLAD 171
Query: 291 TTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS 330
+ T Y PE T D+++ G + E+++
Sbjct: 172 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 5e-04
Identities = 54/249 (21%), Positives = 104/249 (41%), Gaps = 47/249 (18%)
Query: 498 ETPRE-ISFKEIISATNNFSESQRVAEMDFGTAY-------QGFLDNH----------QY 539
E PR+ ++FKE ++ E FG + + F+D
Sbjct: 1 EFPRKRLTFKE------------KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVL 48
Query: 540 VLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRILSH 599
V VK L R F E++ ++RL+ N+++L C + +I +Y L+
Sbjct: 49 VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108
Query: 600 LLFHNNHRIGHSILQWHHR---YNIIKSLASAIL----YLHEEWNEQVIHRNITSSAITL 652
L + H + + Y+ + +A+ I YL + +HR++ + +
Sbjct: 109 FL--SRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLV 163
Query: 653 DPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSF 712
+ ++ F ++ L D+ + R+V I +MS E I G+ T+ +DV++F
Sbjct: 164 GKNYTIKIADFGMSRNLYSGDYYRIQG----RAVLPI-RWMSWESILLGKFTTASDVWAF 218
Query: 713 GVVVLEVVT 721
GV + E++T
Sbjct: 219 GVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 48/209 (22%), Positives = 85/209 (40%), Gaps = 28/209 (13%)
Query: 551 PALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGH 610
PA+R + ELQ L +V G GE+ + ++ L +L RI
Sbjct: 44 PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KEAKRIPE 102
Query: 611 SILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLT 670
IL + ++ + YL E+ Q++HR++ S I ++ +L F ++ L
Sbjct: 103 EILG-----KVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155
Query: 671 RNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAV---D 727
S S G YMSPE ++ + +D++S G+ ++E+ G+ + D
Sbjct: 156 ---------DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD 206
Query: 728 FRLPEGLLVKRV--------HEFEARKRP 748
+ E + + V H R RP
Sbjct: 207 AKELEAIFGRPVVDGEEGEPHSISPRPRP 235
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 5e-04
Identities = 40/167 (23%), Positives = 78/167 (46%), Gaps = 22/167 (13%)
Query: 162 VAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKII 221
++ + H +L + G CV + ++V +++ + LD V R+ + P+ W + +
Sbjct: 70 MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLD-VCLRKE---KGRVPVAW--KITVA 123
Query: 222 RGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSA 281
+ LA+AL YL ++ ++H +V N++L ARLG L ++ S
Sbjct: 124 QQLASALSYLEDK---NLVHGNVCAKNILL-----ARLG-------LAEGTSPFIKLSDP 168
Query: 282 RNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEV 328
L+ R+ I ++ PE G+ + +D +SFG +LE+
Sbjct: 169 GVSFTALSREERV-ERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 6e-04
Identities = 32/97 (32%), Positives = 48/97 (49%), Gaps = 7/97 (7%)
Query: 117 EVLGSGGFGKVYRAV---LPSDGTV--VAVKCLAEKGERFEK-TFAAELVAVAHL-RHRN 169
+ LG+G FGKV A L + V VAVK L E+ +EL ++HL +H+N
Sbjct: 44 KTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKN 103
Query: 170 LVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENL 206
+V L G C H +L++ +Y L L ++ E
Sbjct: 104 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETF 140
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 6e-04
Identities = 49/221 (22%), Positives = 93/221 (42%), Gaps = 27/221 (12%)
Query: 119 LGSGGFGKVYRAVLP--SDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRG- 175
+G G +G VY+A D A+K + +G + E+ + L+H N++ L+
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQI--EGTGISMSACREIALLRELKHPNVISLQKV 66
Query: 176 WCVHED-QLLLVYDYMPNRSLDRVLFRRPENL-EAAAPLNWEQRKKIIRGLAAALHYLHE 233
+ H D ++ L++DY + + F R + L K ++ + +HYLH
Sbjct: 67 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 126
Query: 234 QLETQIIHRDVKTSNVMLDSQYNAR----LGDFGLARWLEHELQYQMRTSSARNHQFHLA 289
++HRD+K +N+++ + R + D G AR L+ LA
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK-------------PLA 170
Query: 290 ETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS 330
+ + T Y PE T D+++ G + E+++
Sbjct: 171 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 7e-04
Identities = 37/134 (27%), Positives = 58/134 (43%), Gaps = 29/134 (21%)
Query: 602 FHNNHRIGHSILQWHHRYNIIKSLASAIL----YLHEEWNEQVIHRNITSSAITLDPDMN 657
++ + +L+ I+ +A A + YL EE +IHR++ S I LD + N
Sbjct: 89 LDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGN 146
Query: 658 PRLGSFALAEFL------TRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSM---AD 708
+L F ++ L TR D G R YM+PE I+ +D
Sbjct: 147 IKLCDFGISGQLVDSIAKTR-DAGCRP-------------YMAPERIDPSARDGYDVRSD 192
Query: 709 VYSFGVVVLEVVTG 722
V+S G+ + EV TG
Sbjct: 193 VWSLGITLYEVATG 206
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 8e-04
Identities = 38/149 (25%), Positives = 69/149 (46%), Gaps = 9/149 (6%)
Query: 119 LGSGGFGKVYRAVLPSDGTV--VAVKCL-AEKGERFEKTFAAELVAVAHLRHRNLVRLRG 175
+G+G FGKV + + +D V V VK L A + + F + L+H N+++ G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 176 WCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQL 235
CV LLV++Y L L + + + L +++ +AA + ++H+
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLL---LLQRMACEIAAGVTHMHKH- 118
Query: 236 ETQIIHRDVKTSNVMLDSQYNARLGDFGL 264
+H D+ N L S ++GD+G+
Sbjct: 119 --NFLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 9e-04
Identities = 27/91 (29%), Positives = 46/91 (50%), Gaps = 15/91 (16%)
Query: 240 IHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIG 299
+HRD+ NV+L ++ DFGLAR + H+ Y + S+ +
Sbjct: 259 VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL--------------PVK 304
Query: 300 YLPPESFQKGSVATAKSDVFSFGIVVLEVVS 330
++ PES ++ T SDV+S+GI++ E+ S
Sbjct: 305 WMAPESIFD-NLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 0.001
Identities = 43/209 (20%), Positives = 77/209 (36%), Gaps = 53/209 (25%)
Query: 529 AYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVI 588
A + F ++ VK+ ALR E++ L +LRH N+V L +G + ++
Sbjct: 30 AIKKFKESEDDEDVKKT------ALR-----EVKVLRQLRHENIVNLKEAFRRKGRLYLV 78
Query: 589 YDYSATRILSHLLFHNNHRIGHSILQWHHRY------NIIKS----LASAILYLHEEWNE 638
++Y + ++L+ + ++S L AI Y H
Sbjct: 79 FEY----------------VERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHS---H 119
Query: 639 QVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPE-- 696
+IHR+I I + +L F A L R Y +PE
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATR------WYRAPELL 173
Query: 697 --YIESGEATSMADVYSFGVVVLEVVTGQ 723
G+ DV++ G ++ E++ G+
Sbjct: 174 VGDTNYGKP---VDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 32/101 (31%), Positives = 51/101 (50%), Gaps = 12/101 (11%)
Query: 625 LASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEF-LTRNDHGHRKATSGN 683
LA A+ +LH + +I+R++ I LD + G L +F L++ H K
Sbjct: 107 LALALDHLH---SLGIIYRDLKPENILLDEE-----GHIKLTDFGLSKESIDHEKKAY-- 156
Query: 684 RSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQM 724
S G YM+PE + T AD +SFGV++ E++TG +
Sbjct: 157 -SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSL 196
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 68/282 (24%), Positives = 113/282 (40%), Gaps = 48/282 (17%)
Query: 521 VAEMDFGTAY--QGFLDNHQYVLVK-RLGMSKCPALRTRFSNELQNLARLRHRNLVQLCG 577
V E FG A Q + +Y + + RL S +R E LA+++H N+V
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSR--KEAVLLAKMKHPNIVAFKE 65
Query: 578 WCTEQGEMLVIYDYSATRILSHLLFHNNHRI--GHSILQWHHRYNIIKSLASAILYLHEE 635
G + ++ +Y L + ++ +ILQW + + ++HE+
Sbjct: 66 SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW------FVQMCLGVQHIHEK 119
Query: 636 WNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSP 695
+V+HR+I S I L + +LG F A LT + + G Y+ P
Sbjct: 120 ---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLT-------SPGAYACTYVGTPYYVPP 169
Query: 696 EYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEAR--KRPLAELV 753
E E+ + +D++S G ++ E+ T + H F+A K + ++
Sbjct: 170 EIWENMPYNNKSDIWSLGCILYELCTLK----------------HPFQANSWKNLILKVC 213
Query: 754 DLSLN---GEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792
S Y++ EL LIK NP RPS ILS
Sbjct: 214 QGSYKPLPSHYSY-ELRSLIKQMFK---RNPRSRPSATTILS 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 41/210 (19%), Positives = 90/210 (42%), Gaps = 19/210 (9%)
Query: 515 FSESQRVAEMDFGTAYQGF-LDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLV 573
++ +++ + GT Y + Q V ++++ + + P + NE+ + ++ N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNPNIV 80
Query: 574 QLCGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLH 633
E+ V+ +Y A L+ + + + + + + A+ +LH
Sbjct: 81 NYLDSYLVGDELWVVMEYLAGGSLTDV-------VTETCMDEGQIAAVCRECLQALEFLH 133
Query: 634 EEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYM 693
+ QVIHR+I S I L D + +L F +T S ++ G +M
Sbjct: 134 ---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT-------PEQSKRSTMVGTPYWM 183
Query: 694 SPEYIESGEATSMADVYSFGVVVLEVVTGQ 723
+PE + D++S G++ +E++ G+
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 63/235 (26%), Positives = 100/235 (42%), Gaps = 41/235 (17%)
Query: 564 LARLRHRNLVQLCGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIK 623
++++ H +L + G C E +++ ++ L L G + W + + +
Sbjct: 70 MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK---GRVPVAW--KITVAQ 124
Query: 624 SLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAE----FLTRNDHG-HRK 678
LASA+ YL ++ ++H N+ + I L RLG LAE F+ +D G
Sbjct: 125 QLASALSYLE---DKNLVHGNVCAKNILL-----ARLG---LAEGTSPFIKLSDPGVSFT 173
Query: 679 ATSGNRSVRGIFGYMSPEYIESGEATSMA-DVYSFGVVVLEVV-TGQMAVDFRLPEGLLV 736
A S V I +++PE + G + S A D +SFG +LE+ G++ + R P
Sbjct: 174 ALSREERVERI-PWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP----- 227
Query: 737 KRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQIL 791
F +K L E + KEL LI C P RPS R IL
Sbjct: 228 SEKERFYEKKHRLPEP---------SCKELATLIS---QCLTYEPTQRPSFRTIL 270
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 44/154 (28%), Positives = 73/154 (47%), Gaps = 17/154 (11%)
Query: 119 LGSGGFGKV---YRAVLPSDGTVVAVKCLAE--KGERFEKTFAAELVAVAHLRHRNLVRL 173
+GSG G V Y AVL + VA+K L+ + + K ELV + + H+N++ L
Sbjct: 25 IGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 81
Query: 174 RGWCVHEDQLLLVYD-YMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLH 232
+ L D Y+ +D L + + L+ E+ ++ + + +LH
Sbjct: 82 LNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLH 136
Query: 233 EQLETQIIHRDVKTSNVMLDSQYNARLGDFGLAR 266
IIHRD+K SN+++ S ++ DFGLAR
Sbjct: 137 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 63/264 (23%), Positives = 103/264 (39%), Gaps = 49/264 (18%)
Query: 105 ELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLA--EKGERFEKTFAAELVAV 162
+L + + ++ +V+G G FG+V S V A+K L+ E +R + F E +
Sbjct: 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 96
Query: 163 AHLRHRNLVRLRGWCVHEDQLL-LVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKII 221
+ V + +D+ L +V +YMP L ++ N + P W +
Sbjct: 97 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM----SNYDV--PEKWA--RFYT 148
Query: 222 RGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSA 281
+ AL +H IHRDVK N++LD + +L DFG + E + T+
Sbjct: 149 AEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV- 204
Query: 282 RNHQFHLAETTRIGGTIGYLPPESF--QKGSVATAKS-DVFSFGIVVLEVVSG------- 331
GT Y+ PE Q G + D +S G+ + E++ G
Sbjct: 205 --------------GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250
Query: 332 ----------RRAVDLTYPDDQII 345
LT+PDD I
Sbjct: 251 SLVGTYSKIMNHKNSLTFPDDNDI 274
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 28/91 (30%), Positives = 48/91 (52%), Gaps = 15/91 (16%)
Query: 240 IHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIG 299
IHRD+ N++L ++ DFGLAR + ++ Y ++ +AR +
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVK-GNARL-------------PVK 281
Query: 300 YLPPESFQKGSVATAKSDVFSFGIVVLEVVS 330
++ PES V T +SDV+S+GI++ E+ S
Sbjct: 282 WMAPESIFN-CVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.002
Identities = 44/187 (23%), Positives = 82/187 (43%), Gaps = 13/187 (6%)
Query: 540 VLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRILSH 599
V VK L R F E++ L+RL N+ +L G CT + +I +Y L+
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108
Query: 600 LL-----FHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDP 654
L + L + + +AS + YL E N +HR++ + +
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL-ESLN--FVHRDLATRNCLVGK 165
Query: 655 DMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGV 714
+ ++ F ++ L +D+ R+ I +M+ E + G+ T+ +DV++FGV
Sbjct: 166 NYTIKIADFGMSRNLYSSDY----YRVQGRAPLPI-RWMAWESVLLGKFTTKSDVWAFGV 220
Query: 715 VVLEVVT 721
+ E++T
Sbjct: 221 TLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 41/186 (22%), Positives = 80/186 (43%), Gaps = 18/186 (9%)
Query: 538 QYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRIL 597
Q V +K++ + + P + NE+ + +H N+V E+ V+ +Y A L
Sbjct: 45 QEVAIKQMNLQQQPK-KELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSL 103
Query: 598 SHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMN 657
+ + + + + + + A+ +LH + QVIHR+I S I L D +
Sbjct: 104 TDV-------VTETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGS 153
Query: 658 PRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVL 717
+L F +T S ++ G +M+PE + D++S G++ +
Sbjct: 154 VKLTDFGFCAQIT-------PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAI 206
Query: 718 EVVTGQ 723
E+V G+
Sbjct: 207 EMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 0.002
Identities = 39/144 (27%), Positives = 59/144 (40%), Gaps = 30/144 (20%)
Query: 535 DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLV--IYDYS 592
D QY G+S+ A R E+ L L+H N+V L E + V ++DY
Sbjct: 38 DKEQYT-----GISQ-SACR-----EIALLRELKHENVVSLVEVFLEHADKSVYLLFDY- 85
Query: 593 ATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAIL----YLHEEWNEQVIHRNITSS 648
A L ++ + SI ++KSL IL YLH W V+HR++ +
Sbjct: 86 AEHDLWQIIKFHRQAKRVSI----PPS-MVKSLLWQILNGVHYLHSNW---VLHRDLKPA 137
Query: 649 AITLDPDMNPR----LGSFALAEF 668
I + + R +G LA
Sbjct: 138 NILVMGEGPERGVVKIGDLGLARL 161
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 42/194 (21%), Positives = 89/194 (45%), Gaps = 21/194 (10%)
Query: 540 VLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRILSH 599
V VK L R F E++ L+RL+ N+++L G C ++ + +I +Y L+
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 600 LLFHN---------NHRIGHS----ILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNIT 646
L + N + + + + ++ +AS + YL + +HR++
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVHRDLA 165
Query: 647 SSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSM 706
+ + ++ ++ F ++ L D+ + R+V I +M+ E I G+ T+
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQG----RAVLPI-RWMAWECILMGKFTTA 220
Query: 707 ADVYSFGVVVLEVV 720
+DV++FGV + E++
Sbjct: 221 SDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 63/245 (25%), Positives = 100/245 (40%), Gaps = 41/245 (16%)
Query: 557 FSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSI-LQW 615
F +++L H++LV+L G C ++V +Y L L HR +++ L W
Sbjct: 48 FFETASLMSQLSHKHLVKLYGVCVRDENIMVE-EYVKFGPLDVFL----HREKNNVSLHW 102
Query: 616 HHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITL---DPDMNPRLGSFALAEFLTRN 672
+ ++ K LASA+ YL ++ +++H N+ I + + F+ +
Sbjct: 103 --KLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVP-------FIKLS 150
Query: 673 DHGHRKATSGNRSVRGI-FGYMSPEYIESGEA--TSMADVYSFGVVVLEVVTGQMAVDFR 729
D G T +R R +++PE I +G+A T AD +SFG +LE+
Sbjct: 151 DPGIPI-TVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEIC-------SN 202
Query: 730 LPEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQ 789
E L E E + L EL LI C +P RPS R
Sbjct: 203 GEEPLSTLSSSEKERFYQDQHRLPMPDC------AELANLIN---QCWTYDPTKRPSFRA 253
Query: 790 ILSIL 794
IL L
Sbjct: 254 ILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 45/190 (23%), Positives = 81/190 (42%), Gaps = 18/190 (9%)
Query: 540 VLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRILSH 599
V+VK L S P + F E+Q L H N++Q G C E L++ ++ L +
Sbjct: 25 VVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKN 84
Query: 600 LLFHNN-HRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNP 658
L N + R + +AS +L+LH+ IH ++ L D++
Sbjct: 85 YLRSNRGMVAQMAQKDVLQR--MACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSV 139
Query: 659 RLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIES-------GEATSMADVYS 711
++G + LA D+ T +V +++PE +E + T ++++S
Sbjct: 140 KIGDYGLALEQYPEDY---YITKDCHAVP--LRWLAPELVEIRGQDLLPKDQTKKSNIWS 194
Query: 712 FGVVVLEVVT 721
GV + E+ T
Sbjct: 195 LGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 31/100 (31%), Positives = 49/100 (49%), Gaps = 12/100 (12%)
Query: 626 ASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALA-EFLTRNDHGHRKATSGNR 684
A IL L N V++R++ + I LD + R+ LA +F + H
Sbjct: 104 AEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA--------- 154
Query: 685 SVRGIFGYMSPEYIESGEA-TSMADVYSFGVVVLEVVTGQ 723
SV G GYM+PE ++ G A S AD +S G ++ +++ G
Sbjct: 155 SV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.002
Identities = 49/187 (26%), Positives = 73/187 (39%), Gaps = 43/187 (22%)
Query: 119 LGSGGFGKVYRAVLPSD-----GTVVAVKCLAEKG-------ERFEKTFAAELVAVAHLR 166
LG G FG VY+A L + G V K E G ER + + A
Sbjct: 140 LGEGAFGVVYKASLVNKQSKKEGKYVLKKA-TEYGAVEIWMNERVRRACPN---SCADFV 195
Query: 167 HRNLVRLRGWCVHEDQLLLV---------YDYMPNR----SLDRVLFRRPENLEAAAPLN 213
+ L + ED+ LV D M ++ +++ L + ++L P
Sbjct: 196 YGFLEPVSS--KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDL----PKG 249
Query: 214 WEQRKKII----RGLAAALHYLHEQLETQIIHRDVKTSNVMLD-SQYNARLGDFGLARWL 268
E+ KII R + AL LH T I+HRDVK N++ + ++ D G A L
Sbjct: 250 LERENKIIQTIMRQILFALDGLHS---TGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADL 306
Query: 269 EHELQYQ 275
+ Y
Sbjct: 307 RVGINYI 313
|
Length = 566 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 42/160 (26%), Positives = 75/160 (46%), Gaps = 24/160 (15%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAA-----ELVAVAHLRHRNLV 171
EV+G G +G V A+ G VA+K + + FE A E+ + LRH ++V
Sbjct: 6 EVIGKGSYGVVCSAIDTHTGEKVAIKKINDV---FEHVSDATRILREIKLLRLLRHPDIV 62
Query: 172 RLRGWCVHEDQ-----LLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAA 226
++ + + + +V++ M + L +V+ +A L E + + L
Sbjct: 63 EIKHIMLPPSRREFKDIYVVFELMES-DLHQVI-------KANDDLTPEHHQFFLYQLLR 114
Query: 227 ALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLAR 266
AL Y+H + HRD+K N++ ++ ++ DFGLAR
Sbjct: 115 ALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLAR 151
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 55/216 (25%), Positives = 91/216 (42%), Gaps = 30/216 (13%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVKCL--AEKGERFEKTFA-AELVAVAHLRHRNLVRLRG 175
+G G FGKV + + A+K + A R E T AE +A + +V L+
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 176 WCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQL 235
++L LV ++ L F +L+ + + + L AL LH+
Sbjct: 61 SFQSPEKLYLVLAFINGGEL----F---HHLQREGRFDLSRARFYTAELLCALENLHK-- 111
Query: 236 ETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIG 295
+I+RD+K N++LD Q + L DFGL + M+ +T
Sbjct: 112 -FNVIYRDLKPENILLDYQGHIALCDFGLCK-------LNMKDDD---------KTNTFC 154
Query: 296 GTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSG 331
GT YL PE G T D ++ G+++ E+++G
Sbjct: 155 GTPEYLAPE-LLLGHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 43/161 (26%), Positives = 76/161 (47%), Gaps = 31/161 (19%)
Query: 119 LGSGGFGKV---YRAVLPSDGTVVAVKCLAE--KGERFEKTFAAELVAVAHLRHRNLVRL 173
+GSG G V Y A+L + VA+K L+ + + K ELV + + H+N++ L
Sbjct: 32 IGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 174 RGWCVHEDQLLLVYDYMPNRSLDRV--LFRRPENLEA------AAPLNWEQRKKIIRGLA 225
+ + P +SL+ ++ E ++A L+ E+ ++ +
Sbjct: 89 ------------LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQML 136
Query: 226 AALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLAR 266
+ +LH IIHRD+K SN+++ S ++ DFGLAR
Sbjct: 137 CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 37/167 (22%), Positives = 68/167 (40%), Gaps = 27/167 (16%)
Query: 116 DEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFE-KTFAAELVAVAHLRHRNLVRLR 174
D+++G GGFG VY SD + K E E +T E + ++ + ++
Sbjct: 17 DKLIGCGGFGCVYETQCASDHCIN--NQAVAKIENLENETIVMETLVYNNIYDID--KIA 72
Query: 175 GW----------------CVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRK 218
W C + + Y ++ L++++ E + N + K
Sbjct: 73 LWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFI---LLEKLVENTKEIFKRIKCKNKKLIK 129
Query: 219 KIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLA 265
I++ + L Y+HE I H D+K N+M+D + D+G+A
Sbjct: 130 NIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIA 173
|
Length = 294 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 74/328 (22%), Positives = 125/328 (38%), Gaps = 97/328 (29%)
Query: 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNL 170
F +V+G G FG+V G + A+K L K E F+K +AH++
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLL-KSEMFKKD------QLAHVKAERD 53
Query: 171 VRLRG---WCVH-----EDQ--LLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQ-RKK 219
V W V +D L L+ +++P L +L + ++ +
Sbjct: 54 VLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTML------------IKYDTFSED 101
Query: 220 IIRGLAA----ALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWL--EHELQ 273
+ R A A+ +H+ IHRD+K N+++D + +L DFGL+ +H+
Sbjct: 102 VTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158
Query: 274 YQMR---------TSSARNHQ------FHLAETTRIG--------------GTIGYLPPE 304
Y + RN ++ +I GT Y+ PE
Sbjct: 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPE 218
Query: 305 SF-QKGSVATAKSDVFSFGIVVLEVVSG-------------RRAVD----LTYPDDQIIL 346
F Q+G + D +S G ++ E + G R+ ++ L +PDD +
Sbjct: 219 IFLQQGY--GQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLS 276
Query: 347 L---DWIRRLSDEGKVLQAGDNRLSDGS 371
+ D IRRL + +NRL G
Sbjct: 277 VEAEDLIRRL------ITNAENRLGRGG 298
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.003
Identities = 31/105 (29%), Positives = 48/105 (45%), Gaps = 15/105 (14%)
Query: 622 IKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALA-EFLTRN-DHGHRKA 679
I + A+ +LH+ +I+R+I I LD + + L F L+ EFL + +
Sbjct: 111 IAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY--- 164
Query: 680 TSGNRSVRGIFGYMSPEYIESGEA--TSMADVYSFGVVVLEVVTG 722
S G YM+PE I G D +S GV+ E++TG
Sbjct: 165 -----SFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 30/100 (30%), Positives = 48/100 (48%), Gaps = 12/100 (12%)
Query: 626 ASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALA-EFLTRNDHGHRKATSGNR 684
IL L N V++R++ + I LD + R+ LA +F + H
Sbjct: 104 TEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA--------- 154
Query: 685 SVRGIFGYMSPEYIESGEA-TSMADVYSFGVVVLEVVTGQ 723
SV G GYM+PE ++ G A S AD +S G ++ +++ G
Sbjct: 155 SV-GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGH 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.003
Identities = 24/97 (24%), Positives = 51/97 (52%), Gaps = 10/97 (10%)
Query: 627 SAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSV 686
+ +LH++ +I+R++ + LD D + ++ F + + N +G KA++
Sbjct: 107 CGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCK---ENMNGEGKAST----F 156
Query: 687 RGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQ 723
G Y++PE ++ + D +SFGV++ E++ GQ
Sbjct: 157 CGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.003
Identities = 24/93 (25%), Positives = 49/93 (52%), Gaps = 10/93 (10%)
Query: 631 YLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIF 690
+LH + +I+R++ + LD D + ++ F + + N G +A++ G
Sbjct: 111 FLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCK---ENVFGDNRAST----FCGTP 160
Query: 691 GYMSPEYIESGEATSMADVYSFGVVVLEVVTGQ 723
Y++PE ++ + T D +SFGV++ E++ GQ
Sbjct: 161 DYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 56/228 (24%), Positives = 89/228 (39%), Gaps = 35/228 (15%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKT----FAAELVAVAHLRHR 168
F+ +V+G G FG+V L + V A+K L K E ++ F E + + ++
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKIL-NKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 169 NLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAAL 228
+ L E+ L LV DY L +L + + L + I L
Sbjct: 62 WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL 121
Query: 229 HYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHL 288
HY +HRD+K N+++D + RL DFG L + Q +
Sbjct: 122 HY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-------- 164
Query: 289 AETTRIGGTIGYLPPESFQ-----KGSVATAKSDVFSFGIVVLEVVSG 331
GT Y+ PE Q KG + D +S G+ + E++ G
Sbjct: 165 -------GTPDYISPEILQAMEDGKGKYG-PECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.004
Identities = 40/179 (22%), Positives = 70/179 (39%), Gaps = 41/179 (22%)
Query: 509 ISATNNFSESQRVAEMDFGTAYQGF-LDNHQYVLVKRLGMSK------CPALRTRFSNEL 561
S ++ ++ E FG Y+ + + V +K++ M ALR E+
Sbjct: 4 CSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-----EI 58
Query: 562 QNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRI--------------LSHLLFHNNHR 607
+ L +L+H N+V L +M V + R LS LL + + +
Sbjct: 59 KILKKLKHPNVVPLI-------DMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK 111
Query: 608 IGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALA 666
+ S + L I YLHE ++HR+I ++ I +D ++ F LA
Sbjct: 112 LTES-----QIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLA 162
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.004
Identities = 28/108 (25%), Positives = 53/108 (49%), Gaps = 18/108 (16%)
Query: 621 IIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKAT 680
I S+ A+ YLH + + VIHR++ S + ++ + +L F ++ +L D +
Sbjct: 108 IAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLV--DSVAKTID 163
Query: 681 SGNRSVRGIFGYMSPEYIESGEATSM------ADVYSFGVVVLEVVTG 722
+G + YM+PE I + +DV+S G+ ++E+ TG
Sbjct: 164 AGCKP------YMAPERINP--ELNQKGYDVKSDVWSLGITMIELATG 203
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.004
Identities = 54/234 (23%), Positives = 99/234 (42%), Gaps = 30/234 (12%)
Query: 564 LARLRHRNLVQLCGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIK 623
+++L H++LV G C E +++ +Y L L N + I S W + + K
Sbjct: 53 MSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINIS---W--KLEVAK 107
Query: 624 SLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGN 683
LA A+ +L + + + H N+ + + L + + + G+ F+ +D G
Sbjct: 108 QLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGN---PPFIKLSDPGISITVLPK 161
Query: 684 RSVRGIFGYMSPEYIESGEATSM-ADVYSFGVVVLEVVTG-QMAVDFRLPEGLLVKRVHE 741
+ ++ PE IE+ + S+ AD +SFG + E+ +G + + K++
Sbjct: 162 EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ----KKLQF 217
Query: 742 FEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795
+E R + A EL LI C P+ RPS R I+ L+
Sbjct: 218 YEDRHQLPAP----------KWTELANLIN---QCMDYEPDFRPSFRAIIRDLN 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|216618 pfam01636, APH, Phosphotransferase enzyme family | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.004
Identities = 22/104 (21%), Positives = 34/104 (32%), Gaps = 9/104 (8%)
Query: 167 HRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAA 226
R L RL L R L + A ++ ++ L A
Sbjct: 99 ARLLARLHSV----PPEALPLARRLRRRLKLLRQLAAALRRLVAAELLDRLAELWERLLA 154
Query: 227 ALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLG---DFGLARW 267
AL L L ++H D+ N+++D R+ DF A
Sbjct: 155 ALLALLPALPLVLVHGDLHPGNLLVDP--GGRVTGVIDFEDAGL 196
|
This family consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include: aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation. This family also includes homoserine kinase. This family is related to fructosamine kinase pfam03881. Length = 238 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 834 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-61 Score=528.17 Aligned_cols=288 Identities=45% Similarity=0.778 Sum_probs=255.6
Q ss_pred CCccccHHHHHhhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeee
Q 003278 97 NPRIFSYAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGW 176 (834)
Q Consensus 97 ~~~~f~~~el~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~ 176 (834)
..+.|+|.||..||++|+..++||+||||.||+|.+ .+|+.||||++........++|.+|+.+|++++|||||+|+||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence 567899999999999999999999999999999999 5679999998876543214569999999999999999999999
Q ss_pred EEeCC-EEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCC
Q 003278 177 CVHED-QLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQY 255 (834)
Q Consensus 177 ~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~ 255 (834)
|.+.+ +.+||||||+||+|+++|+.... . +|+|.+|++||.++|+||+|||+.+.++||||||||+|||||+++
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~----~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~ 214 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKG----E-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDF 214 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCC----C-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCC
Confidence 99999 59999999999999999987542 1 799999999999999999999999989999999999999999999
Q ss_pred ceEEeeccchhhhhh-hhhhhhhcccccccccccccceee-eccccCCCccccccCCCCCcccceeehhhHHHHHHhCCc
Q 003278 256 NARLGDFGLARWLEH-ELQYQMRTSSARNHQFHLAETTRI-GGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRR 333 (834)
Q Consensus 256 ~~kl~DFGla~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~-~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~ 333 (834)
++||+|||+|+.... .. ...+. .||.+|+||||+..+ ..|.|+|||||||+|+||+||++
T Consensus 215 ~aKlsDFGLa~~~~~~~~-----------------~~~~~~~gt~gY~~PEy~~~g-~lt~KsDVySFGVvllElitgr~ 276 (361)
T KOG1187|consen 215 NAKLSDFGLAKLGPEGDT-----------------SVSTTVMGTFGYLAPEYASTG-KLTEKSDVYSFGVVLLELITGRK 276 (361)
T ss_pred CEEccCccCcccCCcccc-----------------ceeeecCCCCccCChhhhccC-CcCcccccccchHHHHHHHhCCc
Confidence 999999999976432 10 01111 799999999999876 67999999999999999999999
Q ss_pred cCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCH-HHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 334 AVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKL-CDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 334 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~-~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
|.+...+.....++.|+++...++++.+++|+++..+.+.. +++.++..+|+.|++.+|..||+|.+|+++|...
T Consensus 277 ~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 277 AVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred ccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 99977666667799999999999999999999997556664 7889999999999999999999999999999543
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-60 Score=517.33 Aligned_cols=287 Identities=40% Similarity=0.667 Sum_probs=247.6
Q ss_pred CCccccHHHHHHHhhCcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEE
Q 003278 499 TPREISFKEIISATNNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGW 578 (834)
Q Consensus 499 ~~~~~~~~el~~at~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~ 578 (834)
..+.|++.||.+||++|+..++||+||||.||+|.++++..||||++....... ..+|.+|+.+|++++|||||+|+||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEE
Confidence 457799999999999999999999999999999999999999999887655432 4569999999999999999999999
Q ss_pred EeeCC-eEEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCC
Q 003278 579 CTEQG-EMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMN 657 (834)
Q Consensus 579 ~~~~~-~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~ 657 (834)
|.+.+ +.+||||||++|+|.++|+..... +|+|.+|++||.++|+||+|||+.+.++||||||||+|||||++++
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~----~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~ 215 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGE----PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN 215 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCC----CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC
Confidence 99998 599999999999999999875431 6899999999999999999999988889999999999999999999
Q ss_pred ceEeeeeecccccc-CCCCCcccccCcccc-ccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCch--
Q 003278 658 PRLGSFALAEFLTR-NDHGHRKATSGNRSV-RGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEG-- 733 (834)
Q Consensus 658 ~ki~DfGla~~~~~-~~~~~~~~~~~~~~~-~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~-- 733 (834)
+||+|||+|+..+. ... ..+. .||.+|+||||+..+..|.|+|||||||+|+||+||+.|.+...+.+
T Consensus 216 aKlsDFGLa~~~~~~~~~--------~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~ 287 (361)
T KOG1187|consen 216 AKLSDFGLAKLGPEGDTS--------VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGEL 287 (361)
T ss_pred EEccCccCcccCCccccc--------eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccc
Confidence 99999999976543 211 1112 79999999999999999999999999999999999999988654322
Q ss_pred hHHHHHHHHHhhcCccccccccccC-CCCCH-HHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCc
Q 003278 734 LLVKRVHEFEARKRPLAELVDLSLN-GEYNH-KELMRLIKLGIACTLSNPELRPSMRQILSILDGNDK 799 (834)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~d~~l~-~~~~~-~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~ 799 (834)
.+..|..... ....+.+++|+.+. +.+.. +++.++.++|++|++.+|.+||+|.+|+++|+.+.+
T Consensus 288 ~l~~w~~~~~-~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 288 SLVEWAKPLL-EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred cHHHHHHHHH-HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 2444443332 23478899999987 66665 789999999999999999999999999999965543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-52 Score=459.99 Aligned_cols=546 Identities=22% Similarity=0.242 Sum_probs=351.8
Q ss_pred eeeccCCeEEEEEE---ECCCCeEEEEEEecccChh--hHHHHHHHHHHHHhCC-CCceeeEeeeEEeCCEEEEEEEccC
Q 003278 118 VLGSGGFGKVYRAV---LPSDGTVVAVKCLAEKGER--FEKTFAAELVAVAHLR-HRNLVRLRGWCVHEDQLLLVYDYMP 191 (834)
Q Consensus 118 ~LG~G~fG~Vy~~~---~~~~g~~vAvK~l~~~~~~--~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~ 191 (834)
++|+|+||.|+.+. -...|..+|+|.+.+.... .......|..++..++ ||.+|++.-.+..+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 47999999999653 2346788999988654211 1124556778888887 9999999999999999999999999
Q ss_pred CCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhhh
Q 003278 192 NRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHE 271 (834)
Q Consensus 192 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~~ 271 (834)
+|.|...+... ..++......+...+|-|++++|.. +|+|||+|++||+++.+|++|+.|||+++.....
T Consensus 81 gg~lft~l~~~-------~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~ 150 (612)
T KOG0603|consen 81 GGDLFTRLSKE-------VMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE 150 (612)
T ss_pred cchhhhccccC-------CchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhh
Confidence 99998887543 3356667777888999999999985 9999999999999999999999999999865332
Q ss_pred hhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHHHH
Q 003278 272 LQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIR 351 (834)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~ 351 (834)
...+||.-|||||.+. + ....+|+||||++.+||+||--||.. +-..
T Consensus 151 --------------------~~~cgt~eymApEI~~-g--h~~a~D~ws~gvl~felltg~~pf~~----------~~~~ 197 (612)
T KOG0603|consen 151 --------------------KIACGTYEYRAPEIIN-G--HLSAADWWSFGVLAFELLTGTLPFGG----------DTMK 197 (612)
T ss_pred --------------------hhcccchhhhhhHhhh-c--cCCcccchhhhhhHHHHhhCCCCCch----------HHHH
Confidence 1127999999999885 3 46779999999999999999988853 1111
Q ss_pred HHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchh-hHHHHhhcCCCCCCCCCCCccCCCcc---c-
Q 003278 352 RLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMK-WVIEAVSGSYSGKLPALPSFQSHPLY---I- 426 (834)
Q Consensus 352 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~-~V~~~l~~~~~~~~p~~ps~~s~p~~---~- 426 (834)
.+.... . ..+..-......+...-...+|..|--.. +++..+... +.+..+.+. .
T Consensus 198 ~Il~~~----~--------~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h--------~f~~~i~~~~l~~r 257 (612)
T KOG0603|consen 198 RILKAE----L--------EMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQH--------EFFQSIDWNELEAR 257 (612)
T ss_pred HHhhhc----c--------CCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhcc--------chheeeeHhhHhhc
Confidence 111100 0 00000011122233333445566665432 233322210 011111110 0
Q ss_pred ccCCCCCCCCCCCcccc-ccCccc-CCCcccCCCCCcccccccccccccccCCCcCCCCCCccccccCcccccCCCcccc
Q 003278 427 SLSSPTNTSTSNTETTR-STNTTA-SNTTIASPSSNYVTAAGETIYATAECGGNTESKSNNSRSQRRNSFFMVETPREIS 504 (834)
Q Consensus 427 s~ssp~~~s~s~~~~s~-ss~ss~-s~~~~~spssn~v~a~~~~~~a~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 504 (834)
...++ ..+........ .-.... +.++..+|....... ...+.. +. ....+...+.....
T Consensus 258 ~~~~~-fkp~~~~e~~~~~fd~eft~~~P~dsp~~~~~~s-~~~if~-----g~-----------sfva~~il~~~~~~- 318 (612)
T KOG0603|consen 258 SRPPP-FKPGSITERDVAQFDPEFTSQVPADSPLLSASGS-DHTIFS-----GP-----------SFVAPGVLEDAVTA- 318 (612)
T ss_pred CCCCC-CCCcccchhhhhhcCchhccCCcccCCCCCCCcc-ccchhc-----CC-----------CccChHHhhccccC-
Confidence 00000 00000000000 000000 000000000000000 000000 00 00000000000000
Q ss_pred HHHHHHHhhCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhc-cCCCceeEEEEEeeC
Q 003278 505 FKEIISATNNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARL-RHRNLVQLCGWCTEQ 582 (834)
Q Consensus 505 ~~el~~at~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l-~HpNiv~l~g~~~~~ 582 (834)
..++.|.-...+|.|+|+.|-++.. ...+..+||++..... .-.+|+.++.+. +||||+++.+.|.+.
T Consensus 319 -----~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-----~~~~e~~~~~~~~~h~niv~~~~v~~~~ 388 (612)
T KOG0603|consen 319 -----PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-----DNQDEIPISLLVRDHPNIVKSHDVYEDG 388 (612)
T ss_pred -----CcchhhccccccCCCCccceeeeeccccccchhheecccccc-----ccccccchhhhhcCCCcceeecceecCC
Confidence 0233444455699999999998884 5577889999875421 223467666555 799999999999999
Q ss_pred CeEEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceee-cCCCCceEe
Q 003278 583 GEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITL-DPDMNPRLG 661 (834)
Q Consensus 583 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILl-d~~~~~ki~ 661 (834)
.+.++|||++.+|-+.+-+..... .. ..+..|+.+++.|+.|||+ ++||||||||+|||+ ++.++++|+
T Consensus 389 ~~~~~v~e~l~g~ell~ri~~~~~------~~-~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrlt 458 (612)
T KOG0603|consen 389 KEIYLVMELLDGGELLRRIRSKPE------FC-SEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLT 458 (612)
T ss_pred ceeeeeehhccccHHHHHHHhcch------hH-HHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEE
Confidence 999999999999877766654321 22 5667799999999999996 799999999999999 588999999
Q ss_pred eeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHH
Q 003278 662 SFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHE 741 (834)
Q Consensus 662 DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~ 741 (834)
|||.++.+... ..+.+=|..|.|||++....||+.+|+|||||+||||+||+.|+........+..++.
T Consensus 459 yFG~a~~~~~~----------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~- 527 (612)
T KOG0603|consen 459 YFGFWSELERS----------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQ- 527 (612)
T ss_pred EechhhhCchh----------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhc-
Confidence 99999876543 1233567889999999999999999999999999999999999874433212222111
Q ss_pred HHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 742 FEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 742 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
..++. ..-.+++..|+. .|++.||.+||+|.++..
T Consensus 528 ----~~~~s---------~~vS~~AKdLl~---~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 528 ----MPKFS---------ECVSDEAKDLLQ---QLLQVDPALRLGADEIGA 562 (612)
T ss_pred ----CCccc---------cccCHHHHHHHH---HhccCChhhCcChhhhcc
Confidence 11111 111244555554 799999999999999864
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-50 Score=435.08 Aligned_cols=260 Identities=30% Similarity=0.442 Sum_probs=210.0
Q ss_pred CcccccCCcEEEEEEECCCcEEEEEEecCCC-ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCC-eEEEEEeccCCCc
Q 003278 519 QRVAEMDFGTAYQGFLDNHQYVLVKRLGMSK-CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQG-EMLVIYDYSATRI 596 (834)
Q Consensus 519 ~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~-~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~-~~~lv~Ey~~~g~ 596 (834)
+.+|+|+||+||+|.+++...||||++.... .....+.|.+|+.+|++++|||||+|+|+|.+.. ..+|||||+++|+
T Consensus 47 ~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~Gs 126 (362)
T KOG0192|consen 47 EVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGS 126 (362)
T ss_pred hhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCc
Confidence 4499999999999999877779999987543 2333678999999999999999999999999987 7999999999999
Q ss_pred hhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCc-eeecccccCceeecCCC-CceEeeeeeccccccCCC
Q 003278 597 LSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQ-VIHRNITSSAITLDPDM-NPRLGSFALAEFLTRNDH 674 (834)
Q Consensus 597 L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~-iiHrDlK~~NILld~~~-~~ki~DfGla~~~~~~~~ 674 (834)
|.++|+.. ....++|..++++|.|||+||.|||+. . ||||||||+||||+.++ ++||+|||+++......
T Consensus 127 L~~~l~~~----~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~- 198 (362)
T KOG0192|consen 127 LSVLLHKK----RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK- 198 (362)
T ss_pred HHHHHhhc----ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence 99999874 123599999999999999999999974 4 99999999999999997 99999999998754321
Q ss_pred CCcccccCccccccccCccchhccc--cCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCccccc
Q 003278 675 GHRKATSGNRSVRGIFGYMSPEYIE--SGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAEL 752 (834)
Q Consensus 675 ~~~~~~~~~~~~~Gt~~Y~aPE~~~--~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (834)
...+...||+.|||||+++ ...|+.|+|||||||+||||+||+.||....+ ..+...+.. ...++
T Consensus 199 ------~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~~v~~--~~~Rp---- 265 (362)
T KOG0192|consen 199 ------TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVASAVVV--GGLRP---- 265 (362)
T ss_pred ------ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHh--cCCCC----
Confidence 1122368999999999999 56899999999999999999999999986655 333332221 11222
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCccccccCc
Q 003278 753 VDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDKRFMEDGQ 806 (834)
Q Consensus 753 ~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~~~~~~~~ 806 (834)
.++.. ++.. +..++.+||+.||+.||+|.+|+..|+.+...+...+.
T Consensus 266 ---~~p~~-~~~~---l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~~~ 312 (362)
T KOG0192|consen 266 ---PIPKE-CPPH---LSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSAGP 312 (362)
T ss_pred ---CCCcc-CCHH---HHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcccCc
Confidence 11111 2333 44555579999999999999999999988776665544
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-47 Score=413.07 Aligned_cols=255 Identities=33% Similarity=0.502 Sum_probs=205.7
Q ss_pred CCCCCCeeeccCCeEEEEEEECCCCeE-EEEEEecccC--hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCC-EEEEEE
Q 003278 112 GFDEDEVLGSGGFGKVYRAVLPSDGTV-VAVKCLAEKG--ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHED-QLLLVY 187 (834)
Q Consensus 112 ~f~~~~~LG~G~fG~Vy~~~~~~~g~~-vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-~~~lV~ 187 (834)
.+...+.||+|+||+||+|.+. |+. ||||++.... ....+.|.+|+.+|++++|||||+|+|+|.+.. .+++||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVt 119 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVT 119 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEE
Confidence 3445567999999999999994 566 9999987542 222678999999999999999999999999988 799999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCC-eecCCCCCCceEECCCC-ceEEeeccch
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQ-IIHRDVKTSNVMLDSQY-NARLGDFGLA 265 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-iiHrDlKp~NILld~~~-~~kl~DFGla 265 (834)
|||++|+|.++|+.. ....++|..+++|+.|||+||.|||++ + ||||||||+|||++.++ ++||||||++
T Consensus 120 Ey~~~GsL~~~l~~~-----~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGls 191 (362)
T KOG0192|consen 120 EYMPGGSLSVLLHKK-----RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLS 191 (362)
T ss_pred EeCCCCcHHHHHhhc-----ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccc
Confidence 999999999999874 135799999999999999999999997 4 99999999999999997 9999999999
Q ss_pred hhhhhhhhhhhhcccccccccccccceeeeccccCCCcccccc-CCCCCcccceeehhhHHHHHHhCCccCCCCCCCccc
Q 003278 266 RWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQK-GSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQI 344 (834)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~ 344 (834)
+...... ...+...||+.|||||.+.. ...++.|+|||||||+||||+||+.||..... .+
T Consensus 192 r~~~~~~----------------~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~- 253 (362)
T KOG0192|consen 192 REKVISK----------------TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQ- 253 (362)
T ss_pred eeecccc----------------ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HH-
Confidence 8643210 11344679999999999974 35789999999999999999999999975433 11
Q ss_pred hHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 345 ILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 345 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
-+..+...+....+. .+....+..|+..||+.||..||++.+++..|...
T Consensus 254 ----~~~~v~~~~~Rp~~p----------~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~ 303 (362)
T KOG0192|consen 254 ----VASAVVVGGLRPPIP----------KECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI 303 (362)
T ss_pred ----HHHHHHhcCCCCCCC----------ccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence 111222222222211 11335688899999999999999999999998764
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-46 Score=385.83 Aligned_cols=253 Identities=27% Similarity=0.456 Sum_probs=208.3
Q ss_pred CCCCCeeeccCCeEEEEEEECCCCeEEEEEEecc-cChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCC-EEEEEEEcc
Q 003278 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAE-KGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHED-QLLLVYDYM 190 (834)
Q Consensus 113 f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-~~~lV~Ey~ 190 (834)
++..+.||+|..|+|||++++.+++.+|+|.+.. ......++..+|++++...+||+||++||.|..++ +..++||||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM 160 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM 160 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence 4456789999999999999999999999999843 34567788999999999999999999999999999 599999999
Q ss_pred CCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhh
Q 003278 191 PNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEH 270 (834)
Q Consensus 191 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~ 270 (834)
.+|||+.++... +.+++...-+|+.+|++||.|||+. .+||||||||+|||++..|++||||||.++.+.+
T Consensus 161 DgGSLd~~~k~~-------g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn 231 (364)
T KOG0581|consen 161 DGGSLDDILKRV-------GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN 231 (364)
T ss_pred CCCCHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence 999999998643 4688999999999999999999974 5999999999999999999999999999997654
Q ss_pred hhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHHH
Q 003278 271 ELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWI 350 (834)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~ 350 (834)
.. ..++.||..|||||.++.. .|+.++||||||++++|+++|+-|+..+.+. .....+..
T Consensus 232 S~------------------a~tfvGT~~YMsPERi~g~-~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~-~~~~~~Ll 291 (364)
T KOG0581|consen 232 SI------------------ANTFVGTSAYMSPERISGE-SYSVKSDIWSLGLSLLELAIGRFPYPPPNPP-YLDIFELL 291 (364)
T ss_pred hh------------------cccccccccccChhhhcCC-cCCcccceecccHHHHHHhhCCCCCCCcCCC-CCCHHHHH
Confidence 31 4567899999999999755 7899999999999999999999998654111 11122211
Q ss_pred HHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 351 RRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 351 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
.. +....-|++..+.+. ..+..+.-.||+.||.+||+..|+++.
T Consensus 292 ~~------Iv~~ppP~lP~~~fS----~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 292 CA------IVDEPPPRLPEGEFS----PEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred HH------HhcCCCCCCCcccCC----HHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 11 122223344433333 357888999999999999999998864
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-46 Score=384.16 Aligned_cols=257 Identities=21% Similarity=0.306 Sum_probs=208.3
Q ss_pred cccHHHHHHHhhCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEe
Q 003278 502 EISFKEIISATNNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCT 580 (834)
Q Consensus 502 ~~~~~el~~at~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~ 580 (834)
.+++.||+. .+.||+|..|+|||+..+ ++..+|.|.+..+..++.+++..+|++++.+.+||+||.+||+|.
T Consensus 75 ~i~~~dle~-------~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~ 147 (364)
T KOG0581|consen 75 GISLSDLER-------LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFY 147 (364)
T ss_pred ccCHHHhhh-------hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEE
Confidence 356666654 467999999999999975 578899999988888888999999999999999999999999999
Q ss_pred eCC-eEEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCce
Q 003278 581 EQG-EMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPR 659 (834)
Q Consensus 581 ~~~-~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~k 659 (834)
.++ .+.|+||||.+|+|+.++...+ .+++...-+|+.+|.+||.|||+. +.||||||||+|||++..|.+|
T Consensus 148 ~~~~~isI~mEYMDgGSLd~~~k~~g------~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVK 219 (364)
T KOG0581|consen 148 SNGEEISICMEYMDGGSLDDILKRVG------RIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVK 219 (364)
T ss_pred eCCceEEeehhhcCCCCHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEE
Confidence 988 5999999999999999987543 267777889999999999999973 7999999999999999999999
Q ss_pred EeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCC-chhHHHH
Q 003278 660 LGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLP-EGLLVKR 738 (834)
Q Consensus 660 i~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~-~~~~~~~ 738 (834)
|||||.++.+... ...+++||..|||||.+.++.|+.++||||||++++|+++|+.|+....+ .......
T Consensus 220 icDFGVS~~lvnS---------~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~L 290 (364)
T KOG0581|consen 220 ICDFGVSGILVNS---------IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFEL 290 (364)
T ss_pred eccccccHHhhhh---------hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHH
Confidence 9999999876542 23468999999999999999999999999999999999999999865311 1111111
Q ss_pred HHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 739 VHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 739 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
+...... . .|.++.....+++..++. .|++.||.+|||..|+++
T Consensus 291 l~~Iv~~-p------pP~lP~~~fS~ef~~FV~---~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 291 LCAIVDE-P------PPRLPEGEFSPEFRSFVS---CCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred HHHHhcC-C------CCCCCcccCCHHHHHHHH---HHhcCCcccCCCHHHHhc
Confidence 1111111 1 123333323345555554 799999999999999985
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-46 Score=404.16 Aligned_cols=250 Identities=24% Similarity=0.404 Sum_probs=202.9
Q ss_pred CcccccCCcEEEEEEECCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEeccCCCchh
Q 003278 519 QRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRILS 598 (834)
Q Consensus 519 ~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~~~g~L~ 598 (834)
++||+|-||.||.|.+++...||||.++..... .+.|.+|+++|.+|+|+|||+|+|+|...+.++||||||+.|+|.
T Consensus 212 ~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~--~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl 289 (468)
T KOG0197|consen 212 RELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS--PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLL 289 (468)
T ss_pred HHhcCCccceEEEEEEcCCCcccceEEeccccC--hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHH
Confidence 579999999999999999989999998764322 367999999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCCCCCcc
Q 003278 599 HLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRK 678 (834)
Q Consensus 599 ~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~~~~~~ 678 (834)
++|+..+. ..+.-.+.+.++.|||+||+||++ +.+|||||.++|||++++..+||+|||||+....+... .
T Consensus 290 ~yLr~~~~----~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~--~ 360 (468)
T KOG0197|consen 290 DYLRTREG----GLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT--A 360 (468)
T ss_pred HHhhhcCC----CccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCCCcee--e
Confidence 99987322 347778889999999999999996 79999999999999999999999999999954433221 1
Q ss_pred cccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCcccccccccc
Q 003278 679 ATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSL 757 (834)
Q Consensus 679 ~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 757 (834)
... -.-...|+|||.+..+.++.|||||||||+||||+| |+.|+. .++...++..+.......+|
T Consensus 361 ~~~----~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~-~msn~ev~~~le~GyRlp~P--------- 426 (468)
T KOG0197|consen 361 SEG----GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYP-GMSNEEVLELLERGYRLPRP--------- 426 (468)
T ss_pred cCC----CCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCC-CCCHHHHHHHHhccCcCCCC---------
Confidence 111 123456999999999999999999999999999999 555544 45555555555444333332
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCC
Q 003278 758 NGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGND 798 (834)
Q Consensus 758 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~ 798 (834)
..++.++ .++|..||..+|++||||+.+...|+.+.
T Consensus 427 --~~CP~~v---Y~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 427 --EGCPDEV---YELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred --CCCCHHH---HHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 2344444 45667899999999999999988887654
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-46 Score=386.96 Aligned_cols=200 Identities=31% Similarity=0.557 Sum_probs=180.3
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYD 188 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 188 (834)
.+|...+.||+|+||+||+|+++.++..||||.+.++ .....+.+..|+.+|+.++|||||+|++++..++.+|||||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 4688888999999999999999999999999999776 55667778999999999999999999999999999999999
Q ss_pred ccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCC------CceEEeec
Q 003278 189 YMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQ------YNARLGDF 262 (834)
Q Consensus 189 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~------~~~kl~DF 262 (834)
||.+|+|..+|+.+ ..+++.+.+.++.|+|.||++||+. +||||||||.||||+.. -.+||+||
T Consensus 90 yC~gGDLs~yi~~~-------~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADF 159 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRR-------GRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADF 159 (429)
T ss_pred eCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEeccc
Confidence 99999999999875 3588999999999999999999995 99999999999999764 45899999
Q ss_pred cchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCC
Q 003278 263 GLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLT 338 (834)
Q Consensus 263 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~ 338 (834)
|+||.+.... ...+.+|+|-|||||++... .|+.|+|+||.|++|||++||+.||+..
T Consensus 160 GfAR~L~~~~-----------------~a~tlcGSplYMAPEV~~~~-~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 160 GFARFLQPGS-----------------MAETLCGSPLYMAPEVIMSQ-QYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred chhhhCCchh-----------------HHHHhhCCccccCHHHHHhc-cccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 9999876432 13567899999999999765 6899999999999999999999999854
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=381.60 Aligned_cols=207 Identities=25% Similarity=0.406 Sum_probs=183.4
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCC-ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEe
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSK-CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYD 590 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~-~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~E 590 (834)
.+|....+||.|+||+||+|+. +++..||||.+.... .+..++-+..|+++|+.++|||||+|++++...+.+++|||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 4677778899999999999996 457899999998765 56667788999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCC------CCceEeeee
Q 003278 591 YSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPD------MNPRLGSFA 664 (834)
Q Consensus 591 y~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~------~~~ki~DfG 664 (834)
||.+|+|.+|++..+ .++......++.|+|.||++||+ ++||||||||.||||+.. -.+||+|||
T Consensus 90 yC~gGDLs~yi~~~~------~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG 160 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRRG------RLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFG 160 (429)
T ss_pred eCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccc
Confidence 999999999998764 37888888899999999999996 799999999999999865 357999999
Q ss_pred eccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHH
Q 003278 665 LAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLV 736 (834)
Q Consensus 665 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~ 736 (834)
+|+.+.... ...++||++.|||||++..+.|+.|+|+||.|++||||+||+.||+...+...+.
T Consensus 161 fAR~L~~~~--------~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~ 224 (429)
T KOG0595|consen 161 FARFLQPGS--------MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLL 224 (429)
T ss_pred hhhhCCchh--------HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHH
Confidence 999876432 2456899999999999999999999999999999999999999998777665543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-46 Score=368.88 Aligned_cols=260 Identities=23% Similarity=0.405 Sum_probs=208.8
Q ss_pred CCCCCCeeeccCCeEEEEEEECCCCeEEEEEEec--ccChhhHHHHHHHHHHHHhCCCCceeeEee-eEEeCCE-EEEEE
Q 003278 112 GFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLA--EKGERFEKTFAAELVAVAHLRHRNLVRLRG-WCVHEDQ-LLLVY 187 (834)
Q Consensus 112 ~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~--~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g-~~~~~~~-~~lV~ 187 (834)
+|.+.++||+|+||+|||+....+|..||.|.+. ..+.+..+....|+.+|++|+|||||++++ .+.+.++ ++|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 4777889999999999999999999999999875 234566778899999999999999999999 4555555 89999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCC-CeecCCCCCCceEECCCCceEEeeccchh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLET-QIIHRDVKTSNVMLDSQYNARLGDFGLAR 266 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~iiHrDlKp~NILld~~~~~kl~DFGla~ 266 (834)
|||..|+|...+..-+. ....+++..+++++.|++.||..+|...+. -|+||||||.||+|+.+|.+||+||||+|
T Consensus 100 E~c~~GDLsqmIk~~K~---qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKK---QKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HhhcccCHHHHHHHHHh---ccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence 99999999999976432 346789999999999999999999985322 29999999999999999999999999999
Q ss_pred hhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchH
Q 003278 267 WLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIIL 346 (834)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l 346 (834)
++.++.++ +++.+|||.||+||.+... .|+.||||||+||++|||+.-++||... ++
T Consensus 177 ~l~s~~tf----------------A~S~VGTPyYMSPE~i~~~-~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~ 233 (375)
T KOG0591|consen 177 FLSSKTTF----------------AHSLVGTPYYMSPERIHES-GYNFKSDIWSLGCLLYEMCALQSPFYGD------NL 233 (375)
T ss_pred HhcchhHH----------------HHhhcCCCcccCHHHHhcC-CCCcchhHHHHHHHHHHHHhcCCCcccc------cH
Confidence 88665332 4667899999999999765 6899999999999999999999999643 33
Q ss_pred HHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhc
Q 003278 347 LDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSG 407 (834)
Q Consensus 347 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~ 407 (834)
......+ ..|... ++.+..| ...+..|+-.|+..||+.||+....+..+..
T Consensus 234 ~~L~~KI-~qgd~~-----~~p~~~Y----S~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 234 LSLCKKI-EQGDYP-----PLPDEHY----STDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred HHHHHHH-HcCCCC-----CCcHHHh----hhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 3322222 223222 2221222 2457889999999999999996655555443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=376.80 Aligned_cols=254 Identities=26% Similarity=0.357 Sum_probs=200.3
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccCh------h-hHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGE------R-FEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQL 183 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~------~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 183 (834)
+.|-..+.||+|+||.|-+|..+.+|+.||||++.+... . ......+|+++|++|+|||||+++++|..++..
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~ 251 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS 251 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence 346677899999999999999999999999999865311 1 122346999999999999999999999999999
Q ss_pred EEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCC---CceEEe
Q 003278 184 LLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQ---YNARLG 260 (834)
Q Consensus 184 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~---~~~kl~ 260 (834)
||||||+.||+|.+.+-.+ ..+.+...+-++.|++.|+.|||++ ||+||||||+||||..+ ..+||+
T Consensus 252 YmVlE~v~GGeLfd~vv~n-------k~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKIt 321 (475)
T KOG0615|consen 252 YMVLEYVEGGELFDKVVAN-------KYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKIT 321 (475)
T ss_pred EEEEEEecCccHHHHHHhc-------cccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEec
Confidence 9999999999999998654 3456667788999999999999997 99999999999999765 779999
Q ss_pred eccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCC--CCCcccceeehhhHHHHHHhCCccCCCC
Q 003278 261 DFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGS--VATAKSDVFSFGIVVLEVVSGRRAVDLT 338 (834)
Q Consensus 261 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~--~~~~ksDV~SfGvvl~ElltG~~p~~~~ 338 (834)
|||+|+..... .-..+.||||.|.|||++.... .+..|+|+||+|||||-++||-+||...
T Consensus 322 DFGlAK~~g~~-----------------sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~ 384 (475)
T KOG0615|consen 322 DFGLAKVSGEG-----------------SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEE 384 (475)
T ss_pred ccchhhccccc-----------------eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccc
Confidence 99999975421 1246789999999999986533 2345899999999999999999999866
Q ss_pred CCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 339 YPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 339 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
+.+. .+.+.+ ..|+.... +.....--++..+|+.+-|..||++||+..|+++.
T Consensus 385 ~~~~--sl~eQI----~~G~y~f~-------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 385 YTDP--SLKEQI----LKGRYAFG-------PLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred cCCc--cHHHHH----hcCccccc-------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 5442 222211 22322211 00111122567789999999999999999998763
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=391.17 Aligned_cols=249 Identities=27% Similarity=0.457 Sum_probs=206.0
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc---ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK---GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 187 (834)
..|...+.||+|||..||+++...+|..||+|++.++ .....+...+||++.+.|+|||||+++++|++.++.|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 3588889999999999999999899999999999763 3455678899999999999999999999999999999999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
|+|++|+|..++.++ .++++..+..++.||+.||.|||+. +|||||||..|++|++++++||+|||||..
T Consensus 98 ELC~~~sL~el~Krr-------k~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~ 167 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR-------KPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQ 167 (592)
T ss_pred EecCCccHHHHHHhc-------CCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeee
Confidence 999999999998754 4789999999999999999999996 999999999999999999999999999987
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHH
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILL 347 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~ 347 (834)
+..+.. ...++||||.|+|||++... .++..+||||+||++|-||+|++||+... +.
T Consensus 168 le~~~E----------------rk~TlCGTPNYIAPEVl~k~-gHsfEvDiWSlGcvmYtLL~G~PPFetk~------vk 224 (592)
T KOG0575|consen 168 LEYDGE----------------RKKTLCGTPNYIAPEVLNKS-GHSFEVDIWSLGCVMYTLLVGRPPFETKT------VK 224 (592)
T ss_pred ecCccc----------------ccceecCCCcccChhHhccC-CCCCchhhhhhhhHHHhhhhCCCCcccch------HH
Confidence 753311 14678999999999999744 57999999999999999999999997532 11
Q ss_pred HHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 348 DWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 348 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
+-...+.. ... .++ ... .....+|+..-|+.||.+|||..+|+..
T Consensus 225 ety~~Ik~-~~Y------~~P-~~l----s~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 225 ETYNKIKL-NEY------SMP-SHL----SAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred HHHHHHHh-cCc------ccc-ccc----CHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 11111111 110 010 011 1234577888899999999999999974
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-45 Score=388.00 Aligned_cols=275 Identities=25% Similarity=0.399 Sum_probs=211.4
Q ss_pred CccccHHHHHHHhhCcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEE
Q 003278 500 PREISFKEIISATNNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWC 579 (834)
Q Consensus 500 ~~~~~~~el~~at~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~ 579 (834)
..++.|++| ++.+-+|.|+-|.||.|.+.+. .||||+++. .=..+|+-|++|+||||+.|.|+|
T Consensus 118 ~WeiPFe~I-------sELeWlGSGaQGAVF~Grl~ne-tVAVKKV~e--------lkETdIKHLRkLkH~NII~FkGVC 181 (904)
T KOG4721|consen 118 LWEIPFEEI-------SELEWLGSGAQGAVFLGRLHNE-TVAVKKVRE--------LKETDIKHLRKLKHPNIITFKGVC 181 (904)
T ss_pred hccCCHHHh-------hhhhhhccCcccceeeeeccCc-eehhHHHhh--------hhhhhHHHHHhccCcceeeEeeee
Confidence 467788776 4457799999999999999875 599998742 123589999999999999999999
Q ss_pred eeCCeEEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCce
Q 003278 580 TEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPR 659 (834)
Q Consensus 580 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~k 659 (834)
+....++||||||+.|-|...|+... .+.-...+++..+||.||.|||. ..|||||||+-||||..+-.+|
T Consensus 182 tqsPcyCIiMEfCa~GqL~~VLka~~------~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VK 252 (904)
T KOG4721|consen 182 TQSPCYCIIMEFCAQGQLYEVLKAGR------PITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVK 252 (904)
T ss_pred cCCceeEEeeeccccccHHHHHhccC------ccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEE
Confidence 99999999999999999999997653 24445567889999999999997 6899999999999999999999
Q ss_pred EeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHH
Q 003278 660 LGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRV 739 (834)
Q Consensus 660 i~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~ 739 (834)
|+|||-++.+... +...+++||..|||||+|++.+.++|+||||||||||||+||..|+..-.... ++
T Consensus 253 IsDFGTS~e~~~~--------STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA-II--- 320 (904)
T KOG4721|consen 253 ISDFGTSKELSDK--------STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA-II--- 320 (904)
T ss_pred eccccchHhhhhh--------hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe-eE---
Confidence 9999999865432 12346899999999999999999999999999999999999999985321110 00
Q ss_pred HHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCccccccCc--cccchHHHhhh
Q 003278 740 HEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDKRFMEDGQ--MTENLEEWKQR 817 (834)
Q Consensus 740 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~~~~~~~~--~~~~~~~~~~~ 817 (834)
|-.+... ..+. . .+.+++-+.-|++ +||...|..||+|++|+.-|+-......+..+ +.+.+.+|++.
T Consensus 321 --wGVGsNs-L~Lp---v-PstcP~GfklL~K---qcw~sKpRNRPSFrqil~HldIa~pell~~tee~yf~sq~swrEe 390 (904)
T KOG4721|consen 321 --WGVGSNS-LHLP---V-PSTCPDGFKLLLK---QCWNSKPRNRPSFRQILLHLDIASPELLSTTEETYFKSQASWREE 390 (904)
T ss_pred --EeccCCc-cccc---C-cccCchHHHHHHH---HHHhcCCCCCccHHHHHHHHhhcCHHHhcccHHHHHHHHHHHHHH
Confidence 0001111 1111 1 2234445554444 79999999999999999998866655443322 44556667765
Q ss_pred chhc
Q 003278 818 NECS 821 (834)
Q Consensus 818 ~~~~ 821 (834)
-.|-
T Consensus 391 vk~h 394 (904)
T KOG4721|consen 391 VKLH 394 (904)
T ss_pred HHHh
Confidence 5543
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=384.09 Aligned_cols=254 Identities=29% Similarity=0.455 Sum_probs=203.9
Q ss_pred CCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEccCC
Q 003278 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPN 192 (834)
Q Consensus 113 f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 192 (834)
+...+.||+|-||+||.|.+ .....||||.++.. ....+.|.+|+.+|.+|+|+|||+|+|+|..++.++||||||++
T Consensus 208 l~l~~~LG~G~FG~V~~g~~-~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~ 285 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKW-NGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK 285 (468)
T ss_pred HHHHHHhcCCccceEEEEEE-cCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence 44567899999999999999 34558999998764 34567899999999999999999999999999999999999999
Q ss_pred CCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhhhh
Q 003278 193 RSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHEL 272 (834)
Q Consensus 193 gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~ 272 (834)
|+|.++|... ....+.-.+.+.++.|||+|++||+++ ++|||||.+.|||++++..+||+||||||.+.++
T Consensus 286 GsLl~yLr~~-----~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~- 356 (468)
T KOG0197|consen 286 GSLLDYLRTR-----EGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDD- 356 (468)
T ss_pred CcHHHHhhhc-----CCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCC-
Confidence 9999999762 235678889999999999999999996 9999999999999999999999999999954333
Q ss_pred hhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccchHHHHHH
Q 003278 273 QYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQIILLDWIR 351 (834)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~ 351 (834)
.|..+ ....-...|.|||.+..+ .++.|||||||||+||||+| |+.|+... ...+.+
T Consensus 357 ~Y~~~--------------~~~kfPIkWtAPEa~~~~-~FS~kSDVWSFGVlL~E~fT~G~~py~~m------sn~ev~- 414 (468)
T KOG0197|consen 357 EYTAS--------------EGGKFPIKWTAPEALNYG-KFSSKSDVWSFGVLLWELFTYGRVPYPGM------SNEEVL- 414 (468)
T ss_pred ceeec--------------CCCCCCceecCHHHHhhC-CcccccceeehhhhHHHHhccCCCCCCCC------CHHHHH-
Confidence 22111 111124679999999877 57999999999999999999 66665432 222222
Q ss_pred HHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcCC
Q 003278 352 RLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGSY 409 (834)
Q Consensus 352 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~~ 409 (834)
....+|..+...+. ....+.+|+..||+.+|++|||+..+...|..++
T Consensus 415 ~~le~GyRlp~P~~----------CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 415 ELLERGYRLPRPEG----------CPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred HHHhccCcCCCCCC----------CCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 33445554433322 2357899999999999999999998888877654
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-45 Score=361.24 Aligned_cols=256 Identities=23% Similarity=0.340 Sum_probs=199.2
Q ss_pred CcCcCCcccccCCcEEEEEE-ECCCcEEEEEEecCCC-ChhHHHHHHHHHHHHHhccCCCceeEEE-EEeeCCe-EEEEE
Q 003278 514 NFSESQRVAEMDFGTAYQGF-LDNHQYVLVKRLGMSK-CPALRTRFSNELQNLARLRHRNLVQLCG-WCTEQGE-MLVIY 589 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~-~~~~~~~f~~E~~~l~~l~HpNiv~l~g-~~~~~~~-~~lv~ 589 (834)
+|...++||.|+||.|||+. +.+|..||.|.+.... +...++....|+.+|++|+|||||++++ -+.+..+ ++|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 34556779999999999998 6789999999987543 3456778899999999999999999999 3444444 89999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCC-ceeecccccCceeecCCCCceEeeeeeccc
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNE-QVIHRNITSSAITLDPDMNPRLGSFALAEF 668 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~-~iiHrDlK~~NILld~~~~~ki~DfGla~~ 668 (834)
|||..|+|.+.+.+... ....+++....+++.|+++||..+|+.+++ .|+||||||.||+||.+|.+|++||||+++
T Consensus 100 E~c~~GDLsqmIk~~K~--qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKK--QKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HhhcccCHHHHHHHHHh--ccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 99999999999876432 223578888899999999999999985533 399999999999999999999999999998
Q ss_pred cccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCc
Q 003278 669 LTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRP 748 (834)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
+... +....+.+|||.||+||.+.+..|+.||||||+||++|||..-+.||.... --.+...+.. ..
T Consensus 178 l~s~-------~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n-~~~L~~KI~q-----gd 244 (375)
T KOG0591|consen 178 LSSK-------TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN-LLSLCKKIEQ-----GD 244 (375)
T ss_pred hcch-------hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc-HHHHHHHHHc-----CC
Confidence 7643 223456899999999999999999999999999999999999999997651 1111111111 11
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 749 LAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 749 ~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
. +.++.+.....+.+++. .|++.||+.||+.-.+++
T Consensus 245 ~-----~~~p~~~YS~~l~~li~---~ci~vd~~~RP~t~~~v~ 280 (375)
T KOG0591|consen 245 Y-----PPLPDEHYSTDLRELIN---MCIAVDPEQRPDTVPYVQ 280 (375)
T ss_pred C-----CCCcHHHhhhHHHHHHH---HHccCCcccCCCcchHHH
Confidence 1 11222333345555554 799999999998444443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=366.13 Aligned_cols=245 Identities=27% Similarity=0.375 Sum_probs=199.1
Q ss_pred hcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEE
Q 003278 109 GSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLL 185 (834)
Q Consensus 109 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 185 (834)
.-++|+..++||+|+||+||.++.+.+++.+|+|+++++. ....+....|..+|.+++||.||+|+-.|.+.+.+||
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 3467999999999999999999999999999999997652 2235667899999999999999999999999999999
Q ss_pred EEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccch
Q 003278 186 VYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLA 265 (834)
Q Consensus 186 V~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla 265 (834)
|+||++||.|..+|.+. ..+++.....++.+|+.||.|||+. +||||||||+|||||.+|+++|+||||+
T Consensus 103 Vld~~~GGeLf~hL~~e-------g~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~ 172 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQRE-------GRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLC 172 (357)
T ss_pred EEeccCCccHHHHHHhc-------CCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccc
Confidence 99999999999999653 4688888999999999999999996 9999999999999999999999999999
Q ss_pred hhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccch
Q 003278 266 RWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQII 345 (834)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~ 345 (834)
+..... ...+.+++||+.|||||++... .++..+|+||+||++|||+||.+||....
T Consensus 173 k~~~~~----------------~~~t~tfcGT~eYmAPEil~~~-gy~~~vDWWsLGillYeML~G~pPF~~~~------ 229 (357)
T KOG0598|consen 173 KEDLKD----------------GDATRTFCGTPEYMAPEILLGK-GYDKAVDWWSLGILLYEMLTGKPPFYAED------ 229 (357)
T ss_pred hhcccC----------------CCccccccCCccccChHHHhcC-CCCcccchHhHHHHHHHHhhCCCCCcCcc------
Confidence 843211 1125668999999999999765 67999999999999999999999997542
Q ss_pred HHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCc
Q 003278 346 LLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPS 397 (834)
Q Consensus 346 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs 397 (834)
...+....... ++.. .+ ...+ ....++...-+..||++|--
T Consensus 230 ~~~~~~~I~~~-k~~~-~p-----~~ls----~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 230 VKKMYDKILKG-KLPL-PP-----GYLS----EEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred HHHHHHHHhcC-cCCC-CC-----ccCC----HHHHHHHHHHhccCHHHhcC
Confidence 22333333322 2110 00 1111 23556677778899999953
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=381.82 Aligned_cols=266 Identities=27% Similarity=0.389 Sum_probs=206.1
Q ss_pred CccccHHHHHHHhhCcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCC-ChhHHHHHHHHHHHHHhccCCCceeEEEE
Q 003278 500 PREISFKEIISATNNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSK-CPALRTRFSNELQNLARLRHRNLVQLCGW 578 (834)
Q Consensus 500 ~~~~~~~el~~at~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~-~~~~~~~f~~E~~~l~~l~HpNiv~l~g~ 578 (834)
..++.++|+. -..+||+|.||+||||.+.+ .||||.++... .++..+.|++|+.++++-||.||+-|+||
T Consensus 386 ~WeIp~~ev~-------l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~ 456 (678)
T KOG0193|consen 386 EWEIPPEEVL-------LGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGA 456 (678)
T ss_pred ccccCHHHhh-------ccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehh
Confidence 3455565554 45789999999999999754 69999998764 45677899999999999999999999999
Q ss_pred EeeCCeEEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCc
Q 003278 579 CTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNP 658 (834)
Q Consensus 579 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ 658 (834)
|...+. .||.-+|++.+|..+|+-.. ..++..+.++||.|||.||.|||. ++|||||||+.||+|.+++.+
T Consensus 457 ~~~p~~-AIiTqwCeGsSLY~hlHv~e-----tkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kV 527 (678)
T KOG0193|consen 457 CMNPPL-AIITQWCEGSSLYTHLHVQE-----TKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKV 527 (678)
T ss_pred hcCCce-eeeehhccCchhhhhccchh-----hhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcE
Confidence 998776 99999999999999997543 347888889999999999999996 799999999999999999999
Q ss_pred eEeeeeeccccccCCCCCcccccCccccccccCccchhcccc---CCCCccCcchhhHHHHHHHHhCCCccCCCCCchhH
Q 003278 659 RLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIES---GEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLL 735 (834)
Q Consensus 659 ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~---~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~ 735 (834)
||+||||+..-.... .........|..-|||||+++. .+|+..+||||||||+|||+||..|+... ..+.+
T Consensus 528 kIgDFGLatvk~~w~-----g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~-~~dqI 601 (678)
T KOG0193|consen 528 KIGDFGLATVKTRWS-----GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ-NRDQI 601 (678)
T ss_pred EEecccceeeeeeec-----cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC-Chhhe
Confidence 999999996533221 1122234468888999999964 57899999999999999999999999733 22222
Q ss_pred HHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCc
Q 003278 736 VKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDK 799 (834)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~ 799 (834)
+..+-+++.. .|.......+++++ .+|+..||..+|++||.|.+|+..|+...+
T Consensus 602 ifmVGrG~l~-------pd~s~~~s~~pk~m---k~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 602 IFMVGRGYLM-------PDLSKIRSNCPKAM---KRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred EEEecccccC-------ccchhhhccCHHHH---HHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 2222111111 12222223344454 455568999999999999999997765433
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=381.97 Aligned_cols=247 Identities=21% Similarity=0.384 Sum_probs=203.1
Q ss_pred CcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCC--CChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEe
Q 003278 514 NFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMS--KCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYD 590 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~--~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~E 590 (834)
.|...+.||+|||..+|++.. +.|+.||+|++... ..+..+++..+||++.+.|+|||||+|+++|.+.+++|||.|
T Consensus 19 ~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLE 98 (592)
T KOG0575|consen 19 RYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLE 98 (592)
T ss_pred eeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEE
Confidence 477788999999999999996 88999999998753 234567889999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccc
Q 003278 591 YSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLT 670 (834)
Q Consensus 591 y~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~ 670 (834)
+|.+|+|.+++... .++++.....+++||+.||.|||+ .+|||||||-.|+||++++++||+|||||..+.
T Consensus 99 LC~~~sL~el~Krr------k~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le 169 (592)
T KOG0575|consen 99 LCHRGSLMELLKRR------KPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLE 169 (592)
T ss_pred ecCCccHHHHHHhc------CCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeec
Confidence 99999999998732 358899999999999999999997 689999999999999999999999999998876
Q ss_pred cCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCccc
Q 003278 671 RNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLA 750 (834)
Q Consensus 671 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (834)
..+. ...+.||||-|+|||++.....+..+||||+|||+|-|++|++||+...-.... ..+.. .
T Consensus 170 ~~~E-------rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety-~~Ik~---~----- 233 (592)
T KOG0575|consen 170 YDGE-------RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETY-NKIKL---N----- 233 (592)
T ss_pred Cccc-------ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHH-HHHHh---c-----
Confidence 4421 234689999999999999888999999999999999999999999754222111 11111 0
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 751 ELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 751 ~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
+-.++. .-..++..|+. +.+++||.+|||+.+|+.
T Consensus 234 ---~Y~~P~-~ls~~A~dLI~---~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 234 ---EYSMPS-HLSAEAKDLIR---KLLRPNPSERPSLDEVLD 268 (592)
T ss_pred ---Cccccc-ccCHHHHHHHH---HHhcCCcccCCCHHHHhc
Confidence 111111 11234455554 678899999999999985
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=401.73 Aligned_cols=257 Identities=24% Similarity=0.351 Sum_probs=207.8
Q ss_pred cCCcccccCCcEEEEEEECC------CcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEe
Q 003278 517 ESQRVAEMDFGTAYQGFLDN------HQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYD 590 (834)
Q Consensus 517 ~~~~ig~g~~g~vy~~~~~~------~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~E 590 (834)
..+.||+|.||.||+|...+ .+.||||.++.....+.+.+|.+|+++|+.++|||||+|+|+|.+++..++|+|
T Consensus 490 ~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFE 569 (774)
T KOG1026|consen 490 FKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFE 569 (774)
T ss_pred ehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEE
Confidence 34669999999999998643 468999999988888788999999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhcCCCCC----C----CcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEee
Q 003278 591 YSATRILSHLLFHNNHRI----G----HSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGS 662 (834)
Q Consensus 591 y~~~g~L~~~l~~~~~~~----~----~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~D 662 (834)
||..|||+++|....... + ..+|+-.+-+.||.|||.||+||-+ ...|||||.++|+|+.+++.+||+|
T Consensus 570 Ym~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~l~VKIsD 646 (774)
T KOG1026|consen 570 YMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGENLVVKISD 646 (774)
T ss_pred ecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CcccccchhhhhceeccceEEEecc
Confidence 999999999998653221 1 2348888999999999999999986 6899999999999999999999999
Q ss_pred eeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHH
Q 003278 663 FALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHE 741 (834)
Q Consensus 663 fGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~ 741 (834)
|||++-+-..++... .... -=.++|||||.|..++||++||||||||||||++| |+.|++ ...+.+++..+..
T Consensus 647 fGLsRdiYssDYYk~-~~~t----~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~-glSn~EVIe~i~~ 720 (774)
T KOG1026|consen 647 FGLSRDIYSSDYYKV-RGNT----LLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYY-GLSNQEVIECIRA 720 (774)
T ss_pred cccchhhhhhhhhcc-cCCc----eeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCccc-ccchHHHHHHHHc
Confidence 999987655543211 0000 11357999999999999999999999999999998 666665 4555555555443
Q ss_pred HHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHcc
Q 003278 742 FEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDG 796 (834)
Q Consensus 742 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~ 796 (834)
.. +.+. .+.++. ++..||+.||+.+|++||+|+||-..|+.
T Consensus 721 g~-----lL~~------Pe~CP~---~vY~LM~~CW~~~P~~RPsF~eI~~~L~~ 761 (774)
T KOG1026|consen 721 GQ-----LLSC------PENCPT---EVYSLMLECWNENPKRRPSFKEIHSRLQA 761 (774)
T ss_pred CC-----cccC------CCCCCH---HHHHHHHHHhhcCcccCCCHHHHHHHHHH
Confidence 21 1111 123343 45667789999999999999999998854
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=351.84 Aligned_cols=265 Identities=25% Similarity=0.325 Sum_probs=205.0
Q ss_pred CCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEc
Q 003278 112 GFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDY 189 (834)
Q Consensus 112 ~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 189 (834)
.|+...++|+|+||+||||+++.+|++||||++.+. +....+-.++|+++|++|+|+|+|.|+..|.....++||+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 466778999999999999999999999999998654 345567789999999999999999999999999999999999
Q ss_pred cCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhh
Q 003278 190 MPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLE 269 (834)
Q Consensus 190 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~ 269 (834)
|...-|+. |.+.+ ..++.....+|+.|+++|+.|+|++ +||||||||+|||++.++.+||||||+||.+.
T Consensus 83 ~dhTvL~e-Le~~p------~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~ 152 (396)
T KOG0593|consen 83 CDHTVLHE-LERYP------NGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLS 152 (396)
T ss_pred cchHHHHH-HHhcc------CCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhc
Confidence 98755544 43332 3477888999999999999999996 89999999999999999999999999999764
Q ss_pred hhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHH
Q 003278 270 HELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDW 349 (834)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~ 349 (834)
... ..-|..+.|.+|.|||.+.....|...+||||.||++.||+||.+-|...++-++..++.-
T Consensus 153 ~pg----------------d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~k 216 (396)
T KOG0593|consen 153 APG----------------DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRK 216 (396)
T ss_pred CCc----------------chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHH
Confidence 211 1135567899999999998767889999999999999999999988876554444332211
Q ss_pred --------HHHHhhcCcc------ccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 350 --------IRRLSDEGKV------LQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 350 --------~~~~~~~~~~------~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
-..+...... .+.-++...+..++. -...+++++..|++.||++|++.++++.
T Consensus 217 tLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~-~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 217 TLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPK-ISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred HHcccCHHHHHHhccCCceeeeecCCCCCccchhhhccc-chHHHHHHHHHHhcCCccccccHHHHhc
Confidence 0111221111 111111111111111 1235789999999999999999999875
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=392.81 Aligned_cols=266 Identities=33% Similarity=0.493 Sum_probs=218.2
Q ss_pred hhcCCCCCCCeeeccCCeEEEEEEEC-----CCCeEEEEEEecccChh-hHHHHHHHHHHHHhCCCCceeeEeeeEEeCC
Q 003278 108 IGSNGFDEDEVLGSGGFGKVYRAVLP-----SDGTVVAVKCLAEKGER-FEKTFAAELVAVAHLRHRNLVRLRGWCVHED 181 (834)
Q Consensus 108 ~~t~~f~~~~~LG~G~fG~Vy~~~~~-----~~g~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~ 181 (834)
..+.+-...+.||+|+||+||+|... .+.+.||||.+++..+. ..++|.+|+++|..++|||||+|+|.|.+++
T Consensus 483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~ 562 (774)
T KOG1026|consen 483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD 562 (774)
T ss_pred echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence 34455666789999999999999864 23568999999887655 7889999999999999999999999999999
Q ss_pred EEEEEEEccCCCCHhHHHhcCCCccc---c----CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCC
Q 003278 182 QLLLVYDYMPNRSLDRVLFRRPENLE---A----AAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQ 254 (834)
Q Consensus 182 ~~~lV~Ey~~~gsL~~~l~~~~~~~~---~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~ 254 (834)
.++||+|||..|||.++|.-+..... . ..+|+-.+.+.||.|||.||+||-++ .+|||||...|+|+.++
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGEN 639 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccc
Confidence 99999999999999999975532211 1 34599999999999999999999996 89999999999999999
Q ss_pred CceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCc
Q 003278 255 YNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRR 333 (834)
Q Consensus 255 ~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~ 333 (834)
..+||+||||+|.+....+|..... + .=.++|||||.+..+ .+|.+||||||||||||++| |+.
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~------------t--~lPIRWMppEsIly~-kFTteSDVWs~GVvLWEIFsyG~Q 704 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGN------------T--LLPIRWMPPESILYG-KFTTESDVWSFGVVLWEIFSYGKQ 704 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCC------------c--eeeeecCCHHHhhcC-cccchhhhhhhhhhhhhhhccccC
Confidence 9999999999998766655543210 0 124789999999988 57999999999999999998 888
Q ss_pred cCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 334 AVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 334 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
|+..-..+ + +-.....|+++...+.. ...+..|++.||+.+|.+||+++||-..|+..
T Consensus 705 Py~glSn~-E------VIe~i~~g~lL~~Pe~C----------P~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~ 762 (774)
T KOG1026|consen 705 PYYGLSNQ-E------VIECIRAGQLLSCPENC----------PTEVYSLMLECWNENPKRRPSFKEIHSRLQAW 762 (774)
T ss_pred cccccchH-H------HHHHHHcCCcccCCCCC----------CHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence 87543222 1 22344567766554433 34799999999999999999999999998764
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=359.94 Aligned_cols=258 Identities=26% Similarity=0.448 Sum_probs=202.0
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCC--EEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHED--QLLLVYD 188 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~--~~~lV~E 188 (834)
.++...+.||+|+||.||++....+|...|||.+...+....+.+.+|+.+|++++|||||+++|.....+ .+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 45677889999999999999998889999999886553333667899999999999999999999855544 6999999
Q ss_pred ccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECC-CCceEEeeccchhh
Q 003278 189 YMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDS-QYNARLGDFGLARW 267 (834)
Q Consensus 189 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~-~~~~kl~DFGla~~ 267 (834)
|+++|||.+++.+.. ..|++..+..+..||++||+|||++ +||||||||+|||++. ++.+||+|||+++.
T Consensus 97 y~~~GsL~~~~~~~g------~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~ 167 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYG------GKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKK 167 (313)
T ss_pred ccCCCcHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccc
Confidence 999999999997542 2689999999999999999999986 9999999999999999 79999999999986
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHH
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILL 347 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~ 347 (834)
..... ........+.||+.|||||++..+.....++|||||||+++||+||++||... ....
T Consensus 168 ~~~~~-------------~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~ 229 (313)
T KOG0198|consen 168 LESKG-------------TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEA 229 (313)
T ss_pred ccccc-------------ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchH
Confidence 54210 00111345679999999999986534445899999999999999999998642 1122
Q ss_pred HHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHh
Q 003278 348 DWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAV 405 (834)
Q Consensus 348 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l 405 (834)
.++.....+.....+.+. + .....++...|++.||..|||+.++++..
T Consensus 230 ~~~~~ig~~~~~P~ip~~-l---------s~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 230 EALLLIGREDSLPEIPDS-L---------SDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred HHHHHHhccCCCCCCCcc-c---------CHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 233333222222211111 1 13456778899999999999999998753
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=360.27 Aligned_cols=259 Identities=23% Similarity=0.313 Sum_probs=204.9
Q ss_pred CCcccccCCcEEEEEEECCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEeccCCCch
Q 003278 518 SQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRIL 597 (834)
Q Consensus 518 ~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~~~g~L 597 (834)
.++||+|-||.|..+..+++..||||.++...+...+.+|.+||++|++|+|||||+|+|+|..++.+++|+|||++|+|
T Consensus 543 ~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDL 622 (807)
T KOG1094|consen 543 KEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDL 622 (807)
T ss_pred hhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcH
Confidence 46899999999999999999999999999888888889999999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCCCCCc
Q 003278 598 SHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHR 677 (834)
Q Consensus 598 ~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~~~~~ 677 (834)
.++|..+..+. ++-..-++|+.|||.||+||.+ -.+|||||.+.|+|+|.++++||+|||+++.+-..++...
T Consensus 623 nqFl~aheapt----~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~v 695 (807)
T KOG1094|consen 623 NQFLSAHELPT----AETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRV 695 (807)
T ss_pred HHHHHhccCcc----cccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccccCCceee
Confidence 99998764321 3344557799999999999986 5899999999999999999999999999997655443211
Q ss_pred ccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh--CCCccCCCCCchhHHHHHHHHHhhcCcccccccc
Q 003278 678 KATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT--GQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDL 755 (834)
Q Consensus 678 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t--G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 755 (834)
....+=...|||||.+..+++|++||||+|||+|||+++ .+.|+.... +.........+...... ...+
T Consensus 696 -----qgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt-~e~vven~~~~~~~~~~-~~~l-- 766 (807)
T KOG1094|consen 696 -----QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT-DEQVVENAGEFFRDQGR-QVVL-- 766 (807)
T ss_pred -----ecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh-HHHHHHhhhhhcCCCCc-ceec--
Confidence 011223467999999999999999999999999999876 567775332 22333333332221111 1111
Q ss_pred ccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHcc
Q 003278 756 SLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDG 796 (834)
Q Consensus 756 ~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~ 796 (834)
. ....++ ..+.+++++||..|-++||||+++...|+.
T Consensus 767 ~-~P~~cp---~~lyelml~Cw~~es~~RPsFe~lh~~lq~ 803 (807)
T KOG1094|consen 767 S-RPPACP---QGLYELMLRCWRRESEQRPSFEQLHLFLQE 803 (807)
T ss_pred c-CCCcCc---HHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence 0 111222 345688899999999999999999988864
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=371.26 Aligned_cols=263 Identities=22% Similarity=0.319 Sum_probs=200.7
Q ss_pred hCcCcCCcccccCCcEEEEEEE------CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhc-cCCCceeEEEEEeeC-Ce
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL------DNHQYVLVKRLGMSKCPALRTRFSNELQNLARL-RHRNLVQLCGWCTEQ-GE 584 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l-~HpNiv~l~g~~~~~-~~ 584 (834)
++|...+.||+|+||.||+|.. .++..||||++...........|.+|+.+|.++ +|||||+++|+|... +.
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGP 86 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCc
Confidence 4677778899999999999974 224679999987554444556799999999999 899999999988764 46
Q ss_pred EEEEEeccCCCchhhhhhcCCCCC--------------------------------------------------------
Q 003278 585 MLVIYDYSATRILSHLLFHNNHRI-------------------------------------------------------- 608 (834)
Q Consensus 585 ~~lv~Ey~~~g~L~~~l~~~~~~~-------------------------------------------------------- 608 (834)
.++||||+++|+|.+++.......
T Consensus 87 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (338)
T cd05102 87 LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDL 166 (338)
T ss_pred eEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccc
Confidence 889999999999999987532100
Q ss_pred CCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCCCCCcccccCcccccc
Q 003278 609 GHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRG 688 (834)
Q Consensus 609 ~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~G 688 (834)
....+++...+.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++.+..... ........|
T Consensus 167 ~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~-----~~~~~~~~~ 238 (338)
T cd05102 167 WKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-----YVRKGSARL 238 (338)
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcc-----hhcccCCCC
Confidence 01247888899999999999999996 6999999999999999999999999999986533211 011223456
Q ss_pred ccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCccccccccccCCCCCHHHHH
Q 003278 689 IFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELM 767 (834)
Q Consensus 689 t~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 767 (834)
|+.|||||++.+..++.++|||||||+||||+| |..||........+...... ... ....... . .
T Consensus 239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~---~~~-------~~~~~~~-~---~ 304 (338)
T cd05102 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD---GTR-------MRAPENA-T---P 304 (338)
T ss_pred CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhc---CCC-------CCCCCCC-C---H
Confidence 788999999999999999999999999999997 99898653332222221111 000 0011111 1 2
Q ss_pred HHHHHHHHhccCCCCCCCChhHHHHHHccC
Q 003278 768 RLIKLGIACTLSNPELRPSMRQILSILDGN 797 (834)
Q Consensus 768 ~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~ 797 (834)
.+.+++.+||+.||++||||.+|++.|+..
T Consensus 305 ~l~~li~~cl~~dp~~RPs~~el~~~l~~~ 334 (338)
T cd05102 305 EIYRIMLACWQGDPKERPTFSALVEILGDL 334 (338)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 455677799999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=355.18 Aligned_cols=250 Identities=22% Similarity=0.299 Sum_probs=190.6
Q ss_pred cCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChh----H--HHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEE
Q 003278 515 FSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPA----L--RTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLV 587 (834)
Q Consensus 515 f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~----~--~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~l 587 (834)
|--.+.+|+|+||.|-+|.- .+|+.||||+++...... . .....+|+++|++|+|||||++++++.+.+..|+
T Consensus 174 yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~Ym 253 (475)
T KOG0615|consen 174 YIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYM 253 (475)
T ss_pred eEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEE
Confidence 34467899999999999984 668999999997543211 1 1224689999999999999999999999999999
Q ss_pred EEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCC---CCceEeeee
Q 003278 588 IYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPD---MNPRLGSFA 664 (834)
Q Consensus 588 v~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~---~~~ki~DfG 664 (834)
||||+.+|.|.+.+..++. +....---++.|++.|+.|||+ .||+||||||+||||..+ ..+||+|||
T Consensus 254 VlE~v~GGeLfd~vv~nk~------l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 254 VLEYVEGGELFDKVVANKY------LREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred EEEEecCccHHHHHHhccc------cccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEecccc
Confidence 9999999999999876543 3333334589999999999997 699999999999999866 778999999
Q ss_pred eccccccCCCCCcccccCccccccccCccchhccccCCC--C-ccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHH
Q 003278 665 LAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEA--T-SMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHE 741 (834)
Q Consensus 665 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~--~-~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~ 741 (834)
+|++... .+...+.|||+.|.|||++.++.+ + .|+|+||+|||||-++||-.||.....+..+.+.+..
T Consensus 325 lAK~~g~--------~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~ 396 (475)
T KOG0615|consen 325 LAKVSGE--------GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILK 396 (475)
T ss_pred hhhcccc--------ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhc
Confidence 9997542 223457899999999999976543 3 4789999999999999999999865544333333322
Q ss_pred HHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 742 FEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 742 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
.... +.... ..+--.+...++-+.+.-||++|||+.|+++
T Consensus 397 G~y~---f~p~~--------w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 397 GRYA---FGPLQ--------WDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred Cccc---ccChh--------hhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 2111 11111 1111123344455889999999999999875
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=395.66 Aligned_cols=261 Identities=25% Similarity=0.348 Sum_probs=205.4
Q ss_pred CCcccccCCcEEEEEEECC--C----cEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 518 SQRVAEMDFGTAYQGFLDN--H----QYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 518 ~~~ig~g~~g~vy~~~~~~--~----~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
.+.||+|.||.||+|.+.+ + ..||||.+......+...+|.+|+.+|++++|||||+++|.|.+....+|++||
T Consensus 697 ~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~ley 776 (1025)
T KOG1095|consen 697 LRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEY 776 (1025)
T ss_pred eeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehh
Confidence 4679999999999999754 3 248999998877778888999999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCC-CCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccc
Q 003278 592 SATRILSHLLFHNN-HRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLT 670 (834)
Q Consensus 592 ~~~g~L~~~l~~~~-~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~ 670 (834)
|.+|+|..+|++.. .......|.-...+.++.|||+|+.||++ +..|||||.++|+||+....+||+|||+|+-+.
T Consensus 777 M~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy 853 (1025)
T KOG1095|consen 777 MEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFGLARDIY 853 (1025)
T ss_pred cccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccchhHhhh
Confidence 99999999998763 22223458888899999999999999996 789999999999999999999999999999654
Q ss_pred cCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCcc
Q 003278 671 RNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRPL 749 (834)
Q Consensus 671 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
..+.. +..... .=...|||||.+..+.+|.|+|||||||+|||++| |..|+... .+..++..+.+. .+
T Consensus 854 ~~~yy-r~~~~a----~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~-~n~~v~~~~~~g---gR-- 922 (1025)
T KOG1095|consen 854 DKDYY-RKHGEA----MLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSR-SNFEVLLDVLEG---GR-- 922 (1025)
T ss_pred hchhe-eccCcc----ccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCc-chHHHHHHHHhC---Cc--
Confidence 44321 111100 11246999999999999999999999999999999 55555433 333332222111 11
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCccc
Q 003278 750 AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDKRF 801 (834)
Q Consensus 750 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~~~ 801 (834)
++ ...++++. +.+||.+||..+|++||+|..|++.+..+...+
T Consensus 923 ---L~---~P~~CP~~---ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 923 ---LD---PPSYCPEK---LYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred ---cC---CCCCCChH---HHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 11 13455544 457778999999999999999999887665533
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=369.31 Aligned_cols=266 Identities=27% Similarity=0.418 Sum_probs=203.1
Q ss_pred hcCCCCCCCeeeccCCeEEEEEEEC-----CCCeEEEEEEecccC-hhhHHHHHHHHHHHHhC-CCCceeeEeeeEEeCC
Q 003278 109 GSNGFDEDEVLGSGGFGKVYRAVLP-----SDGTVVAVKCLAEKG-ERFEKTFAAELVAVAHL-RHRNLVRLRGWCVHED 181 (834)
Q Consensus 109 ~t~~f~~~~~LG~G~fG~Vy~~~~~-----~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~ 181 (834)
..++|...++||+|+||.||+|.+. .+++.||||++.... ....+.+.+|+.++.++ +|||||+++|+|...+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 4567899999999999999999752 345789999986532 33456789999999999 8999999999988654
Q ss_pred -EEEEEEEccCCCCHhHHHhcCCCcc------------------------------------------------------
Q 003278 182 -QLLLVYDYMPNRSLDRVLFRRPENL------------------------------------------------------ 206 (834)
Q Consensus 182 -~~~lV~Ey~~~gsL~~~l~~~~~~~------------------------------------------------------ 206 (834)
.+++||||+++|+|.+++.......
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 5899999999999999987532100
Q ss_pred -ccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhhhhhhhhhcccccccc
Q 003278 207 -EAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQ 285 (834)
Q Consensus 207 -~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~ 285 (834)
....++++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++.+......
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~----------- 230 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY----------- 230 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcch-----------
Confidence 0024588999999999999999999985 9999999999999999999999999999854322110
Q ss_pred cccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccchHHHHHHHHhhcCccccccc
Q 003278 286 FHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGD 364 (834)
Q Consensus 286 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 364 (834)
.......||+.|+|||++... .++.++|||||||+||||+| |+.||....... .+ ... ...+...
T Consensus 231 ---~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~---~~~-~~~~~~~---- 296 (338)
T cd05102 231 ---VRKGSARLPLKWMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EF---CQR-LKDGTRM---- 296 (338)
T ss_pred ---hcccCCCCCccccCcHHhhcC-CCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HH---HHH-HhcCCCC----
Confidence 012233467899999988654 67999999999999999997 999986533221 11 111 1122111
Q ss_pred cccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 365 NRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 365 ~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
+.. .. ....+.+|+..||+.||.+||+|.+|++.|+..
T Consensus 297 -~~~-~~----~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~ 334 (338)
T cd05102 297 -RAP-EN----ATPEIYRIMLACWQGDPKERPTFSALVEILGDL 334 (338)
T ss_pred -CCC-CC----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111 11 124578999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=373.59 Aligned_cols=254 Identities=20% Similarity=0.271 Sum_probs=200.2
Q ss_pred CcccccCCcEEEEEEECC--C---cEEEEEEecC--CCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 519 QRVAEMDFGTAYQGFLDN--H---QYVLVKRLGM--SKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 519 ~~ig~g~~g~vy~~~~~~--~---~~vavK~~~~--~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
++||+|.||.||+|.+.. + ..||||..+. ........+|.+|+++|++++|||||+|||++....+++||||+
T Consensus 163 kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl 242 (474)
T KOG0194|consen 163 KKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMEL 242 (474)
T ss_pred ceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEe
Confidence 789999999999999743 2 2389998875 34456678999999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccccc
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTR 671 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~ 671 (834)
|.||+|.++|..... .++..++++++.++|+||+|||+ +++|||||.++|+|++.++.+||+||||++....
T Consensus 243 ~~gGsL~~~L~k~~~-----~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~ 314 (474)
T KOG0194|consen 243 CNGGSLDDYLKKNKK-----SLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ 314 (474)
T ss_pred cCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccccccCCcc
Confidence 999999999987643 48899999999999999999996 7999999999999999999999999999976431
Q ss_pred CCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHH-HHHHhhcCcc
Q 003278 672 NDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRV-HEFEARKRPL 749 (834)
Q Consensus 672 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~-~~~~~~~~~~ 749 (834)
-. .. .....=...|+|||.+..+.|+.++|||||||++||+.+ |..|+...... .+...+ ........
T Consensus 315 ~~-----~~--~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~-~v~~kI~~~~~r~~~-- 384 (474)
T KOG0194|consen 315 YV-----MK--KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY-EVKAKIVKNGYRMPI-- 384 (474)
T ss_pred ee-----ec--cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH-HHHHHHHhcCccCCC--
Confidence 10 00 001122357999999999999999999999999999998 78877543322 222222 11111100
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCcccc
Q 003278 750 AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDKRFM 802 (834)
Q Consensus 750 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~~~~ 802 (834)
....++++..++ .+||..+|++||||.+|.+.|+.+.+...
T Consensus 385 ---------~~~~p~~~~~~~---~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 385 ---------PSKTPKELAKVM---KQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred ---------CCCCHHHHHHHH---HHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 113345555444 48999999999999999999987766544
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=385.61 Aligned_cols=498 Identities=18% Similarity=0.236 Sum_probs=309.4
Q ss_pred HHHHHHHHHhCCCCceeeEeeeEEeCCEE----EEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHH
Q 003278 155 FAAELVAVAHLRHRNLVRLRGWCVHEDQL----LLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHY 230 (834)
Q Consensus 155 ~~~E~~~l~~l~H~nIv~l~g~~~~~~~~----~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~y 230 (834)
...|...+.++.|+|++.+++|-...... .+..|+++.-++...+.. ...++..+.+.+..++.+||.|
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~-------v~~i~~~~~r~~~~~~~~GL~~ 301 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS-------VGSIPLETLRILHQKLLEGLAY 301 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh-------ccccCHHHHHHHHHHHhhhHHH
Confidence 34577788899999999999987765432 234578888888777753 2467778888999999999999
Q ss_pred HHhccCCCeecCCCCCC---ceEECCCCceEEe--eccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccc
Q 003278 231 LHEQLETQIIHRDVKTS---NVMLDSQYNARLG--DFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPES 305 (834)
Q Consensus 231 LH~~~~~~iiHrDlKp~---NILld~~~~~kl~--DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~ 305 (834)
+|+. ...|.-+-.+ +-..+.++....+ ||+.++.+...... -...-+..|.|||.
T Consensus 302 ~h~~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~-----------------~~~~~~~~~~~~e~ 361 (1351)
T KOG1035|consen 302 LHSL---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS-----------------FSDLLAEIRNADED 361 (1351)
T ss_pred HHHh---ccceeEEecccccccccCccceeecchhhhcccccCCCcccc-----------------hhhcCccccccccc
Confidence 9985 4444444333 3334445555555 78776654322110 01112345677776
Q ss_pred cccCC-CCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHH
Q 003278 306 FQKGS-VATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLA 384 (834)
Q Consensus 306 ~~~~~-~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~ 384 (834)
..... ......|+|.+|..+..+..|..+...... .....+. ... ..+....
T Consensus 362 ~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~------------------~~~~l~~-----~~~----~~~~d~~ 414 (1351)
T KOG1035|consen 362 LKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAV------------------PVSLLDV-----LST----SELLDAL 414 (1351)
T ss_pred cccccchhhhhhHHHHHHHHHhhhhhcCcccccccc------------------hhhhhcc-----ccc----hhhhhhh
Confidence 64331 122336999999999999988654322100 0000000 000 0244556
Q ss_pred HHhcccCCCCCCchhhHHHHhhcCCCCCCCCCCCccCCCcccccCCCCCCCCCCCccccccCcccCCCcccCCCCCcccc
Q 003278 385 LLCTLHNPHLRPSMKWVIEAVSGSYSGKLPALPSFQSHPLYISLSSPTNTSTSNTETTRSTNTTASNTTIASPSSNYVTA 464 (834)
Q Consensus 385 ~~Cl~~~p~~RPsm~~V~~~l~~~~~~~~p~~ps~~s~p~~~s~ssp~~~s~s~~~~s~ss~ss~s~~~~~spssn~v~a 464 (834)
..|+..++++|++..+++...........+..+ + ++. ......+. -.+..+
T Consensus 415 ~~~~~~~~~~Rl~~~~ll~~~f~~~~~~~~~~~-------~----~~~------~~~~~~~~--------~~r~~~---- 465 (1351)
T KOG1035|consen 415 PKCLDEDSEERLSALELLTHPFLRFPTDNESSE-------F----APN------DETSVPQF--------RLRFSG---- 465 (1351)
T ss_pred hhhcchhhhhccchhhhhhchhccccccccccc-------c----cCc------cccccCcc--------CCCCcc----
Confidence 689999999999999888754321110000000 0 000 00000000 000000
Q ss_pred cccccccccccCCCcCCCCCCccccccCcccccCCCccccHHHHHHHhhCcCcCCcccccCCcEEEEEEE-CCCcEEEEE
Q 003278 465 AGETIYATAECGGNTESKSNNSRSQRRNSFFMVETPREISFKEIISATNNFSESQRVAEMDFGTAYQGFL-DNHQYVLVK 543 (834)
Q Consensus 465 ~~~~~~a~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~el~~at~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK 543 (834)
+.....+.+ .+--++|.+...+|+||||.||+++. =||+.+|||
T Consensus 466 ------------------------------~~s~~~r~~-----SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIK 510 (1351)
T KOG1035|consen 466 ------------------------------AMSPLQRQF-----SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIK 510 (1351)
T ss_pred ------------------------------ccCccccch-----hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhh
Confidence 000000001 11224667778899999999999984 478899999
Q ss_pred EecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEee------------------------------------------
Q 003278 544 RLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTE------------------------------------------ 581 (834)
Q Consensus 544 ~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~------------------------------------------ 581 (834)
++........-....+|+.+|++|+|||||+++..+.+
T Consensus 511 KIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~ 590 (1351)
T KOG1035|consen 511 KIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTL 590 (1351)
T ss_pred hccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCc
Confidence 99876544444567889999999999999999865400
Q ss_pred ---------------------------------------------------------------------C--------Ce
Q 003278 582 ---------------------------------------------------------------------Q--------GE 584 (834)
Q Consensus 582 ---------------------------------------------------------------------~--------~~ 584 (834)
. -.
T Consensus 591 ~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~ 670 (1351)
T KOG1035|consen 591 SELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLI 670 (1351)
T ss_pred chhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCcchhhhhhccccCCccccccccccceE
Confidence 0 12
Q ss_pred EEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeee
Q 003278 585 MLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFA 664 (834)
Q Consensus 585 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfG 664 (834)
+||-||||+..+|.+++..+.... .-....+++++|++||+|+|+ .+||||||||.||+||++..+||+|||
T Consensus 671 LYIQMEyCE~~ll~~iI~~N~~~~-----~~d~~wrLFreIlEGLaYIH~---~giIHRDLKP~NIFLd~~~~VKIGDFG 742 (1351)
T KOG1035|consen 671 LYIQMEYCEKTLLRDIIRRNHFNS-----QRDEAWRLFREILEGLAYIHD---QGIIHRDLKPRNIFLDSRNSVKIGDFG 742 (1351)
T ss_pred EEEEHhhhhhhHHHHHHHhcccch-----hhHHHHHHHHHHHHHHHHHHh---CceeeccCCcceeEEcCCCCeeecccc
Confidence 477899999988888876654321 112234689999999999997 689999999999999999999999999
Q ss_pred eccccc----cC-------CCCCcccccCccccccccCccchhccccC---CCCccCcchhhHHHHHHHHhCCCccCCCC
Q 003278 665 LAEFLT----RN-------DHGHRKATSGNRSVRGIFGYMSPEYIESG---EATSMADVYSFGVVVLEVVTGQMAVDFRL 730 (834)
Q Consensus 665 la~~~~----~~-------~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~---~~~~k~DV~SfGvvl~E~~tG~~p~~~~~ 730 (834)
+|+... .. ...........++..||.-|+|||.+.+. .|+.|+|+||+||||+||+- ||...+
T Consensus 743 LAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM 819 (1351)
T KOG1035|consen 743 LATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM 819 (1351)
T ss_pred cchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchH
Confidence 998732 00 00011122234567899999999999654 49999999999999999974 554433
Q ss_pred CchhHHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 731 PEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
.....+..+. ...+..- ..+..++...=.+++.+.++.||.+|||+.|+++
T Consensus 820 ERa~iL~~LR-----~g~iP~~------~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 820 ERASILTNLR-----KGSIPEP------ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHHHHhcc-----cCCCCCC------cccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 2222222111 1111111 1111122222234445778899999999999885
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=363.71 Aligned_cols=265 Identities=23% Similarity=0.338 Sum_probs=209.1
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHH-HHHHHHHHHHhCC-CCceeeEeeeEEeCC-EEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEK-TFAAELVAVAHLR-HRNLVRLRGWCVHED-QLLLVY 187 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~-~~~~E~~~l~~l~-H~nIv~l~g~~~~~~-~~~lV~ 187 (834)
++|...++||.|.||.||+|+...+|..||||+++++.....+ .=++|+..|++|+ |||||+|...+.+.+ .+++||
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf 89 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF 89 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence 5677889999999999999999999999999999876444333 2368999999999 999999999999988 999999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
|||. .+|.+++..+ ..++++..++.|+.||++||+|+|.+ |+.|||+||+|||+..+..+||+||||||.
T Consensus 90 E~Md-~NLYqLmK~R------~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 90 EFMD-CNLYQLMKDR------NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLARE 159 (538)
T ss_pred Hhhh-hhHHHHHhhc------CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccc
Confidence 9995 6999999766 25799999999999999999999996 999999999999999888999999999997
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHH
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILL 347 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~ 347 (834)
+.+... -|..+.|.+|.|||++.....|+.+.|+||+|||++|+.+-++-|....+-++..-+
T Consensus 160 v~SkpP-----------------YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KI 222 (538)
T KOG0661|consen 160 VRSKPP-----------------YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKI 222 (538)
T ss_pred cccCCC-----------------cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHH
Confidence 654322 366778999999999988889999999999999999999999888765444433211
Q ss_pred ----------HHHH--HHhhc--CccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 348 ----------DWIR--RLSDE--GKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 348 ----------~~~~--~~~~~--~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
.|.. .+... -...+.....+.. -.+. .....+.|+..|+..||.+||++.+.++.
T Consensus 223 c~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~-L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 223 CEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKD-LLPN-ASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHhCCCccccchhHHHHHHHhccCCCcCCCCChHH-hCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 1111 00000 0011111111110 0111 23567889999999999999999998875
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=357.11 Aligned_cols=267 Identities=25% Similarity=0.360 Sum_probs=202.9
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeC--CEEEE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHE--DQLLL 185 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~l 185 (834)
.+.|+..++||+|.||.||||+...+|+.||+|++... .+.+.....+||.+|++|+|||||+|.+...+. ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 35688889999999999999999999999999987654 355677788999999999999999999998887 68999
Q ss_pred EEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccch
Q 003278 186 VYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLA 265 (834)
Q Consensus 186 V~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla 265 (834)
|+|||+. +|.-++... ...++..+++.++.|++.||+|||++ +|+|||||.+|||||.+|.+||+|||||
T Consensus 196 VFeYMdh-DL~GLl~~p------~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLA 265 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSP------GVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLA 265 (560)
T ss_pred EEecccc-hhhhhhcCC------CcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccce
Confidence 9999976 777777532 35689999999999999999999996 9999999999999999999999999999
Q ss_pred hhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccch
Q 003278 266 RWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQII 345 (834)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~ 345 (834)
++...+.. ..-|..+-|.+|.|||.+.....|+..+|+||.||||.||++|++.+.....-++
T Consensus 266 r~y~~~~~---------------~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQ-- 328 (560)
T KOG0600|consen 266 RFYTPSGS---------------APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQ-- 328 (560)
T ss_pred eeccCCCC---------------cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHH--
Confidence 97643311 1134455799999999998888899999999999999999999988765432222
Q ss_pred HHHHHHHHhhcCc-----cccccccccC--CCCCCHHH-------HHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 346 LLDWIRRLSDEGK-----VLQAGDNRLS--DGSYKLCD-------MEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 346 l~~~~~~~~~~~~-----~~~~~d~~l~--~~~~~~~~-------~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
+.-+.++..... +......... ...+...- ....+.|...-|..||++|.|+.++++.
T Consensus 329 -l~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 329 -LHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred -HHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 222222221110 0000000000 00111100 1234556666677899999999988753
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=354.16 Aligned_cols=260 Identities=20% Similarity=0.300 Sum_probs=201.0
Q ss_pred CccccHHHHHHHhhCcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCCC--hhHHHHHHHHHHHHHhccCCCceeEEE
Q 003278 500 PREISFKEIISATNNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKC--PALRTRFSNELQNLARLRHRNLVQLCG 577 (834)
Q Consensus 500 ~~~~~~~el~~at~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~--~~~~~~f~~E~~~l~~l~HpNiv~l~g 577 (834)
.+.++.+++ ++.....||+|++|.||+|.+ ++..||||.+..... ....+.|.+|+.+|.+++|||||+++|
T Consensus 12 ~~~i~~~~i-----~~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g 85 (283)
T PHA02988 12 IKCIESDDI-----DKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG 85 (283)
T ss_pred ceecCHHHc-----CCCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEee
Confidence 344566665 333446799999999999998 567899999875432 223467889999999999999999999
Q ss_pred EEee----CCeEEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeec
Q 003278 578 WCTE----QGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLD 653 (834)
Q Consensus 578 ~~~~----~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld 653 (834)
++.+ ....++||||+++|+|.+++.... .++|..+++++.|++.||.|||+. .+++||||||+|||++
T Consensus 86 ~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~------~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~ 157 (283)
T PHA02988 86 FIIDIVDDLPRLSLILEYCTRGYLREVLDKEK------DLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVT 157 (283)
T ss_pred eEEecccCCCceEEEEEeCCCCcHHHHHhhCC------CCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEEC
Confidence 9877 356899999999999999986532 478999999999999999999963 4788999999999999
Q ss_pred CCCCceEeeeeeccccccCCCCCcccccCccccccccCccchhcccc--CCCCccCcchhhHHHHHHHHhCCCccCCCCC
Q 003278 654 PDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIES--GEATSMADVYSFGVVVLEVVTGQMAVDFRLP 731 (834)
Q Consensus 654 ~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~ 731 (834)
+++.+||+|||+++.+... .....||..|||||++.+ ..++.++|||||||++|||+||+.||....+
T Consensus 158 ~~~~~kl~dfg~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~ 227 (283)
T PHA02988 158 ENYKLKIICHGLEKILSSP----------PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT 227 (283)
T ss_pred CCCcEEEcccchHhhhccc----------cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH
Confidence 9999999999999764321 113468899999999976 6899999999999999999999999975433
Q ss_pred chhHHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccC
Q 003278 732 EGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGN 797 (834)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~ 797 (834)
.. +...+.. .... +.++.. .+.+ +.+++.+||+.||++||||.+|++.|+-.
T Consensus 228 ~~-~~~~i~~---~~~~------~~~~~~-~~~~---l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 228 KE-IYDLIIN---KNNS------LKLPLD-CPLE---IKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred HH-HHHHHHh---cCCC------CCCCCc-CcHH---HHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 22 2221111 1010 011111 2233 44556699999999999999999998654
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=357.92 Aligned_cols=266 Identities=23% Similarity=0.348 Sum_probs=208.8
Q ss_pred HhhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHHHHHhC-CCCceeeEeeeEEeCCE
Q 003278 107 YIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVAVAHL-RHRNLVRLRGWCVHEDQ 182 (834)
Q Consensus 107 ~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~ 182 (834)
....++|...+.||+|+|++||+|+.+.+++.||||++.+.. +...+-...|-.+|.+| .||.||+||-.|.+...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 445578999999999999999999999999999999987642 22234456788899999 89999999999999999
Q ss_pred EEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeec
Q 003278 183 LLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDF 262 (834)
Q Consensus 183 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DF 262 (834)
+|+|+||++||+|.++|.+. +.|+......++.+|+.||+|||+. |||||||||+|||||+|+++||+||
T Consensus 149 LYFvLe~A~nGdll~~i~K~-------Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDF 218 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKY-------GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDF 218 (604)
T ss_pred eEEEEEecCCCcHHHHHHHh-------CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeec
Confidence 99999999999999999754 5688888899999999999999996 9999999999999999999999999
Q ss_pred cchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCc
Q 003278 263 GLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDD 342 (834)
Q Consensus 263 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~ 342 (834)
|.|+.+.......-.+... .......++++||..|++||.+..+ ..+..+|+|+|||+||.|+.|++||....+
T Consensus 219 GsAK~l~~~~~~~~~~~~~---~~a~s~~~SFVGTAeYVSPElL~~~-~~~~~sDiWAlGCilyQmlaG~PPFra~Ne-- 292 (604)
T KOG0592|consen 219 GSAKILSPSQKSQENPVDP---NQASSRRSSFVGTAEYVSPELLNDS-PAGPSSDLWALGCILYQMLAGQPPFRAANE-- 292 (604)
T ss_pred cccccCChhhccccCccCc---ccccCcccceeeeecccCHHHhcCC-CCCcccchHHHHHHHHHHhcCCCCCccccH--
Confidence 9999886543211100000 0011113679999999999999765 678999999999999999999999975321
Q ss_pred cchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 343 QIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 343 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
-.+..-+.. +|-... ..++ +.+.+|+..-|..||.+|++..++-+.
T Consensus 293 -yliFqkI~~----------l~y~fp-~~fp----~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 293 -YLIFQKIQA----------LDYEFP-EGFP----EDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred -HHHHHHHHH----------hcccCC-CCCC----HHHHHHHHHHHccCccccccHHHHhhC
Confidence 112221111 111222 1222 346677888889999999999887664
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=353.94 Aligned_cols=253 Identities=25% Similarity=0.419 Sum_probs=194.8
Q ss_pred CcCcCCcccccCCcEEEEEEECC-CcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCC--eEEEEEe
Q 003278 514 NFSESQRVAEMDFGTAYQGFLDN-HQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQG--EMLVIYD 590 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~~~-~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~--~~~lv~E 590 (834)
++...+.||+|+||+||.+...+ |...|||.+.....+. .+.+.+|+.+|++++|||||+++|...... ..+|+||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 45667889999999999999754 8899999987664443 567899999999999999999999755444 6899999
Q ss_pred ccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecC-CCCceEeeeeecccc
Q 003278 591 YSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDP-DMNPRLGSFALAEFL 669 (834)
Q Consensus 591 y~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~-~~~~ki~DfGla~~~ 669 (834)
|+++|+|.+++...+. .|+.....+++.||++||+|||+ ++||||||||+||||+. ++.+||+|||+++..
T Consensus 97 y~~~GsL~~~~~~~g~-----~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~ 168 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG-----KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKL 168 (313)
T ss_pred ccCCCcHHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCcccccc
Confidence 9999999999976542 38888899999999999999996 79999999999999999 799999999999865
Q ss_pred ccCCCCCcccccCccccccccCccchhccccCCCC-ccCcchhhHHHHHHHHhCCCccCCC-CCchhHHHHHHHHHhhcC
Q 003278 670 TRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEAT-SMADVYSFGVVVLEVVTGQMAVDFR-LPEGLLVKRVHEFEARKR 747 (834)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~k~DV~SfGvvl~E~~tG~~p~~~~-~~~~~~~~~~~~~~~~~~ 747 (834)
.... ........+.||+.|||||++..+... .++|||||||+++||+||+.|+... .+...+.. .. ...
T Consensus 169 ~~~~----~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~---ig--~~~ 239 (313)
T KOG0198|consen 169 ESKG----TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLL---IG--RED 239 (313)
T ss_pred cccc----ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHH---Hh--ccC
Confidence 4310 111223457899999999999865443 4899999999999999999998642 11111111 11 111
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHH
Q 003278 748 PLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSI 793 (834)
Q Consensus 748 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~ 793 (834)
... .++.. -..++..++. .|+..||++|||+.++++.
T Consensus 240 ~~P-----~ip~~-ls~~a~~Fl~---~C~~~~p~~Rpta~eLL~h 276 (313)
T KOG0198|consen 240 SLP-----EIPDS-LSDEAKDFLR---KCFKRDPEKRPTAEELLEH 276 (313)
T ss_pred CCC-----CCCcc-cCHHHHHHHH---HHhhcCcccCcCHHHHhhC
Confidence 111 12211 2244454444 7999999999999999874
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=348.16 Aligned_cols=263 Identities=20% Similarity=0.315 Sum_probs=205.7
Q ss_pred CcCcCCcccccCCcEEEEEE-ECCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEecc
Q 003278 514 NFSESQRVAEMDFGTAYQGF-LDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYS 592 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~ 592 (834)
.|.-.+.||.|.-++||+|. ...+.+||||+++.+.+....+.+.+|++.|+.++|||||+++..|.....+++||.||
T Consensus 27 ~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfM 106 (516)
T KOG0582|consen 27 DYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFM 106 (516)
T ss_pred ceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhh
Confidence 44555779999999999998 46679999999998888777888999999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccC
Q 003278 593 ATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRN 672 (834)
Q Consensus 593 ~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~ 672 (834)
.+|++.+++...=. ..+++.....|.+++++||.|||. .|.||||||+.|||||++|.+||+|||.+-.+...
T Consensus 107 a~GS~ldIik~~~~----~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 107 AGGSLLDIIKTYYP----DGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred cCCcHHHHHHHHcc----ccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 99999999976422 127888888999999999999997 69999999999999999999999999998877654
Q ss_pred CCCCcccccCccccccccCccchhccc--cCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCccc
Q 003278 673 DHGHRKATSGNRSVRGIFGYMSPEYIE--SGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLA 750 (834)
Q Consensus 673 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~--~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (834)
. .+..... .+++||+.|||||++. ...|+.|+|||||||+..||++|..||....|...++..+.. ....+..
T Consensus 180 G--~R~~~rf-~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn--~pp~~~t 254 (516)
T KOG0582|consen 180 G--DRQVTRF-NTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQN--DPPTLLT 254 (516)
T ss_pred C--ceeeEee-ccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC--CCCCccc
Confidence 3 2322222 5678999999999954 346999999999999999999999999865554433333221 0001111
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 751 ELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 751 ~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
...|..-...+. + .+-++.-.|++.||++|||++++++
T Consensus 255 ~~~~~d~~k~~~-k---sf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 255 SGLDKDEDKKFS-K---SFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred ccCChHHhhhhc-H---HHHHHHHHHhhcCcccCCCHHHHhc
Confidence 111111111111 2 3344445799999999999999875
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=353.30 Aligned_cols=261 Identities=15% Similarity=0.256 Sum_probs=203.3
Q ss_pred CCccccHHHHHhhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccCh---hhHHHHHHHHHHHHhCCCCceeeE
Q 003278 97 NPRIFSYAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGE---RFEKTFAAELVAVAHLRHRNLVRL 173 (834)
Q Consensus 97 ~~~~f~~~el~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l 173 (834)
+.+.++..++. +.....||+|++|.||+|.+ +|+.||||.+..... ...+.|.+|+.+|.+++|||||++
T Consensus 11 ~~~~i~~~~i~-----~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~ 83 (283)
T PHA02988 11 DIKCIESDDID-----KYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKI 83 (283)
T ss_pred cceecCHHHcC-----CCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEE
Confidence 44556666663 33346899999999999998 689999999865422 235678899999999999999999
Q ss_pred eeeEEe----CCEEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCce
Q 003278 174 RGWCVH----EDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNV 249 (834)
Q Consensus 174 ~g~~~~----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NI 249 (834)
+|++.+ ....++||||+++|+|.+++... ..++|.....++.+++.||.|||+. .+++||||||+||
T Consensus 84 ~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-------~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~ni 154 (283)
T PHA02988 84 YGFIIDIVDDLPRLSLILEYCTRGYLREVLDKE-------KDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSF 154 (283)
T ss_pred eeeEEecccCCCceEEEEEeCCCCcHHHHHhhC-------CCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhE
Confidence 999987 34689999999999999999643 3588999999999999999999974 3788999999999
Q ss_pred EECCCCceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCcccccc-CCCCCcccceeehhhHHHHH
Q 003278 250 MLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQK-GSVATAKSDVFSFGIVVLEV 328 (834)
Q Consensus 250 Lld~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~ksDV~SfGvvl~El 328 (834)
|+++++.+||+|||+++.+... .....||+.|+|||.+.. ...++.++|||||||++|||
T Consensus 155 ll~~~~~~kl~dfg~~~~~~~~-------------------~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el 215 (283)
T PHA02988 155 LVTENYKLKIICHGLEKILSSP-------------------PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEI 215 (283)
T ss_pred EECCCCcEEEcccchHhhhccc-------------------cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHH
Confidence 9999999999999999754211 122358899999999864 24679999999999999999
Q ss_pred HhCCccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 329 VSGRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 329 ltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
+||+.||...... .+.......+... .+. ......+.+++..||+.||++||+|.+|++.|+..
T Consensus 216 ~~g~~Pf~~~~~~------~~~~~i~~~~~~~-----~~~-----~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 216 FTGKIPFENLTTK------EIYDLIINKNNSL-----KLP-----LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred HHCCCCCCCCCHH------HHHHHHHhcCCCC-----CCC-----CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 9999999743211 1111111111111 111 01124688999999999999999999999998754
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=359.12 Aligned_cols=240 Identities=25% Similarity=0.446 Sum_probs=193.8
Q ss_pred CCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEccCCC
Q 003278 114 DEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNR 193 (834)
Q Consensus 114 ~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 193 (834)
.+.+-||+|+-|.||+|++ .++.||||+++.- -..+|+-|++|+|||||.+.|+|.....+|||||||+.|
T Consensus 127 sELeWlGSGaQGAVF~Grl--~netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G 197 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRL--HNETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG 197 (904)
T ss_pred hhhhhhccCcccceeeeec--cCceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence 3457899999999999998 4789999987532 235788899999999999999999999999999999999
Q ss_pred CHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhhhhh
Q 003278 194 SLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQ 273 (834)
Q Consensus 194 sL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~ 273 (834)
-|...|... .+++-.....+..+||.|+.|||.+ .|||||||+-||||..+..+||+|||.++.+....
T Consensus 198 qL~~VLka~-------~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S- 266 (904)
T KOG4721|consen 198 QLYEVLKAG-------RPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKS- 266 (904)
T ss_pred cHHHHHhcc-------CccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhhh-
Confidence 999999653 4577778899999999999999986 99999999999999999999999999998754321
Q ss_pred hhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHHHHHH
Q 003278 274 YQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIRRL 353 (834)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~ 353 (834)
....++||..|||||++.+. ..+.|+|||||||||||||||..|+..... ..+-|
T Consensus 267 ----------------TkMSFaGTVaWMAPEvIrne-PcsEKVDIwSfGVVLWEmLT~EiPYkdVds----sAIIw---- 321 (904)
T KOG4721|consen 267 ----------------TKMSFAGTVAWMAPEVIRNE-PCSEKVDIWSFGVVLWEMLTGEIPYKDVDS----SAIIW---- 321 (904)
T ss_pred ----------------hhhhhhhhHhhhCHHHhhcC-CcccccceehhHHHHHHHHhcCCCccccch----heeEE----
Confidence 13567899999999999765 679999999999999999999988753211 11111
Q ss_pred hhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhh
Q 003278 354 SDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVS 406 (834)
Q Consensus 354 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~ 406 (834)
-+..+.|. -..+....+-+.-|+.+||+..|..||++++++..|.
T Consensus 322 -------GVGsNsL~-LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 322 -------GVGSNSLH-LPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred -------eccCCccc-ccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence 11111111 1112223456778899999999999999999998874
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=354.90 Aligned_cols=264 Identities=23% Similarity=0.347 Sum_probs=202.4
Q ss_pred HhhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEE
Q 003278 107 YIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQL 183 (834)
Q Consensus 107 ~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 183 (834)
....++|+...+||+||||+||+|+-+.+|..+|+|++++.. ....+....|-.+|...++|+||+||..|.+.+.+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 456789999999999999999999999999999999997652 22345678899999999999999999999999999
Q ss_pred EEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeecc
Q 003278 184 LLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFG 263 (834)
Q Consensus 184 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFG 263 (834)
||||||+|||++..+|.+. ..|+......++.+++.|+.-||.. |+|||||||+|+|||..|++||+|||
T Consensus 217 YLiMEylPGGD~mTLL~~~-------~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFG 286 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRK-------DTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFG 286 (550)
T ss_pred EEEEEecCCccHHHHHHhc-------CcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeecccc
Confidence 9999999999999999653 5688889999999999999999986 99999999999999999999999999
Q ss_pred chhhhhhhhhhhh---------hcccccccccc-------c---------------ccceeeeccccCCCccccccCCCC
Q 003278 264 LARWLEHELQYQM---------RTSSARNHQFH-------L---------------AETTRIGGTIGYLPPESFQKGSVA 312 (834)
Q Consensus 264 la~~~~~~~~~~~---------~~~~~~~~~~~-------~---------------~~~~~~~Gt~~Y~aPE~~~~~~~~ 312 (834)
|+.-+........ .........+. . .-.-.++|||.|||||++... .|
T Consensus 287 Ls~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~k-gY 365 (550)
T KOG0605|consen 287 LSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGK-GY 365 (550)
T ss_pred ccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcC-CC
Confidence 9965433111000 00000000000 0 001246799999999999754 57
Q ss_pred CcccceeehhhHHHHHHhCCccCCCCCCCcc-chHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccC
Q 003278 313 TAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQ-IILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHN 391 (834)
Q Consensus 313 ~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~ 391 (834)
+..+|+||+|||+||||.|-+||....+.+. ..++.|-..+. ...+..+ . .+..+|+..|+- |
T Consensus 366 ~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~------fP~~~~~-----s----~eA~DLI~rll~-d 429 (550)
T KOG0605|consen 366 GKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLK------FPEEVDL-----S----DEAKDLITRLLC-D 429 (550)
T ss_pred CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc------CCCcCcc-----c----HHHHHHHHHHhc-C
Confidence 9999999999999999999999986554432 23445543321 1111111 1 345667777776 9
Q ss_pred CCCCCc
Q 003278 392 PHLRPS 397 (834)
Q Consensus 392 p~~RPs 397 (834)
|++|--
T Consensus 430 ~~~RLG 435 (550)
T KOG0605|consen 430 PENRLG 435 (550)
T ss_pred HHHhcC
Confidence 999965
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=354.45 Aligned_cols=266 Identities=20% Similarity=0.272 Sum_probs=199.5
Q ss_pred CcCcCCcccccCCcEEEEEEECC-----------------CcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEE
Q 003278 514 NFSESQRVAEMDFGTAYQGFLDN-----------------HQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLC 576 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~ 576 (834)
.|...++||+|+||.||+|..++ +..||+|.+........+..|.+|+.+|.+++|||||+++
T Consensus 6 ~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 85 (304)
T cd05096 6 HLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLL 85 (304)
T ss_pred hCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEE
Confidence 45566789999999999997533 3369999987655555667899999999999999999999
Q ss_pred EEEeeCCeEEEEEeccCCCchhhhhhcCCCC-------------CCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeec
Q 003278 577 GWCTEQGEMLVIYDYSATRILSHLLFHNNHR-------------IGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHR 643 (834)
Q Consensus 577 g~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~-------------~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHr 643 (834)
|++.+.+..++||||+++|+|.+++...... .....++|...+.++.|++.||+|||+ .+|+||
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH~ 162 (304)
T cd05096 86 GVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHR 162 (304)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCcccc
Confidence 9999999999999999999999988653210 112347888999999999999999997 689999
Q ss_pred ccccCceeecCCCCceEeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhC-
Q 003278 644 NITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTG- 722 (834)
Q Consensus 644 DlK~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG- 722 (834)
||||+|||+++++.+||+|||+++.+..... ........++..|||||++..+.++.++|||||||++|||+++
T Consensus 163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~ 237 (304)
T cd05096 163 DLATRNCLVGENLTIKIADFGMSRNLYAGDY-----YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC 237 (304)
T ss_pred CcchhheEEcCCccEEECCCccceecccCce-----eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence 9999999999999999999999976533211 0111234567899999999989999999999999999999974
Q ss_pred -CCccCCCCCchhHHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHc
Q 003278 723 -QMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795 (834)
Q Consensus 723 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~ 795 (834)
..|+..... ...................... ....+ ..+.+++.+||+.||++||||.+|.+.|+
T Consensus 238 ~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~----~~~~~---~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 238 KEQPYGELTD-EQVIENAGEFFRDQGRQVYLFR----PPPCP---QGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCCCCcCCH-HHHHHHHHHHhhhccccccccC----CCCCC---HHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 455543222 2222222221111100000000 01112 24566777999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=333.23 Aligned_cols=199 Identities=26% Similarity=0.391 Sum_probs=178.9
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 187 (834)
++|+..+.||.|+||+|.+++.+.+|..+|+|++++.. -+..+...+|..+|+.+.||++|+|++.|.+.+.+||||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 46888999999999999999999999999999997642 233456788999999999999999999999999999999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
||++||.|.++|++. .+++....+.++.||+.||+|||+. .||+|||||+|||||.+|.+||+|||+|+.
T Consensus 124 eyv~GGElFS~Lrk~-------~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~ 193 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKS-------GRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKR 193 (355)
T ss_pred eccCCccHHHHHHhc-------CCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEE
Confidence 999999999999753 5688889999999999999999995 999999999999999999999999999986
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCC
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTY 339 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~ 339 (834)
+.. .+.+.||||.|+|||.++.. .+...+|+|||||++|||+.|.+||....
T Consensus 194 v~~-------------------rT~TlCGTPeYLAPEii~sk-~ynkavDWWalGVLIYEMlaG~pPF~~~~ 245 (355)
T KOG0616|consen 194 VSG-------------------RTWTLCGTPEYLAPEIIQSK-GYNKAVDWWALGVLIYEMLAGYPPFYDDN 245 (355)
T ss_pred ecC-------------------cEEEecCCccccChHHhhcC-CCCcchhHHHHHHHHHHHHcCCCCCcCCC
Confidence 432 26789999999999998754 67889999999999999999999997543
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=353.56 Aligned_cols=267 Identities=23% Similarity=0.323 Sum_probs=199.8
Q ss_pred CCCCCCCeeeccCCeEEEEEEECC----------------CCeEEEEEEecccC-hhhHHHHHHHHHHHHhCCCCceeeE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPS----------------DGTVVAVKCLAEKG-ERFEKTFAAELVAVAHLRHRNLVRL 173 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~----------------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l 173 (834)
++|...+.||+|+||.||+|.+.. ++..||||.+.... ......|.+|+.++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 467888999999999999998632 34579999986542 3345679999999999999999999
Q ss_pred eeeEEeCCEEEEEEEccCCCCHhHHHhcCCCc------------cccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeec
Q 003278 174 RGWCVHEDQLLLVYDYMPNRSLDRVLFRRPEN------------LEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIH 241 (834)
Q Consensus 174 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~------------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH 241 (834)
+++|.+.+..++||||+++|+|.+++...... ......++|..+..|+.|++.||.|||+. +|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence 99999999999999999999999998653211 11124589999999999999999999985 9999
Q ss_pred CCCCCCceEECCCCceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeeh
Q 003278 242 RDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSF 321 (834)
Q Consensus 242 rDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~Sf 321 (834)
|||||+|||++.++.+||+|||+++.+..... ........+|+.|||||++..+ .++.++|||||
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~--------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~sl 226 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDY--------------YRIQGRAVLPIRWMAWECILMG-KFTTASDVWAF 226 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCce--------------eEecCcCCCCccccCHHHHhcC-CCCchhhhHHH
Confidence 99999999999999999999999975422110 0012233468899999988655 57999999999
Q ss_pred hhHHHHHHhCC--ccCCCCCCCccchHHHHHHHHhhcC-ccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCch
Q 003278 322 GIVVLEVVSGR--RAVDLTYPDDQIILLDWIRRLSDEG-KVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSM 398 (834)
Q Consensus 322 Gvvl~ElltG~--~p~~~~~~~~~~~l~~~~~~~~~~~-~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm 398 (834)
||++|||+++. .|+... .. .....++....... .......+ . .....+.+++..||+.+|.+||+|
T Consensus 227 G~~l~el~~~~~~~p~~~~--~~-~~~~~~~~~~~~~~~~~~~~~~~----~----~~~~~~~~li~~cl~~~p~~RPs~ 295 (304)
T cd05096 227 GVTLWEILMLCKEQPYGEL--TD-EQVIENAGEFFRDQGRQVYLFRP----P----PCPQGLYELMLQCWSRDCRERPSF 295 (304)
T ss_pred HHHHHHHHHccCCCCCCcC--CH-HHHHHHHHHHhhhccccccccCC----C----CCCHHHHHHHHHHccCCchhCcCH
Confidence 99999999754 444322 11 11222332222111 10100001 0 112468899999999999999999
Q ss_pred hhHHHHhh
Q 003278 399 KWVIEAVS 406 (834)
Q Consensus 399 ~~V~~~l~ 406 (834)
.+|.+.|+
T Consensus 296 ~~i~~~l~ 303 (304)
T cd05096 296 SDIHAFLT 303 (304)
T ss_pred HHHHHHHh
Confidence 99998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=359.77 Aligned_cols=249 Identities=25% Similarity=0.410 Sum_probs=203.7
Q ss_pred hcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc----Ch-hhHHHHHHHHHHHHhCC-CCceeeEeeeEEeCCE
Q 003278 109 GSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK----GE-RFEKTFAAELVAVAHLR-HRNLVRLRGWCVHEDQ 182 (834)
Q Consensus 109 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~----~~-~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~ 182 (834)
..++|...+.||+|+||.||.|....+|..||||.+... .. ...+...+|+.++++++ ||||++++.++...+.
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 346788999999999999999999999999999977653 12 33456678999999999 9999999999999999
Q ss_pred EEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCC-CceEEee
Q 003278 183 LLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQ-YNARLGD 261 (834)
Q Consensus 183 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~-~~~kl~D 261 (834)
+|+||||+.+|+|.+++... .++.+.....++.|++.|++|||+. +|+||||||+|||||.+ +++||+|
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~-------g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~D 164 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNK-------GRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSD 164 (370)
T ss_pred EEEEEEecCCccHHHHHHHc-------CCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEec
Confidence 99999999999999999752 4688889999999999999999996 99999999999999999 9999999
Q ss_pred ccchhhhh-hhhhhhhhcccccccccccccceeeeccccCCCccccccCC-CCCcccceeehhhHHHHHHhCCccCCCCC
Q 003278 262 FGLARWLE-HELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGS-VATAKSDVFSFGIVVLEVVSGRRAVDLTY 339 (834)
Q Consensus 262 FGla~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~ksDV~SfGvvl~ElltG~~p~~~~~ 339 (834)
||++.... .+ ....+.+||+.|+|||++.... +...++||||+||+||.|++|+-||+...
T Consensus 165 FG~s~~~~~~~-----------------~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~ 227 (370)
T KOG0583|consen 165 FGLSAISPGED-----------------GLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN 227 (370)
T ss_pred cccccccCCCC-----------------CcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc
Confidence 99998652 11 1145678999999999998755 55689999999999999999999997521
Q ss_pred CCccchHHHHHHHHhhcCc--cccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 340 PDDQIILLDWIRRLSDEGK--VLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 340 ~~~~~~l~~~~~~~~~~~~--~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
...+ .+.+ ..+. +...++ -..+..|+..|+..||..|+++.++++
T Consensus 228 ---~~~l---~~ki-~~~~~~~p~~~~------------S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 228 ---VPNL---YRKI-RKGEFKIPSYLL------------SPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred ---HHHH---HHHH-hcCCccCCCCcC------------CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 1111 1111 1111 111110 235788999999999999999999984
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=343.83 Aligned_cols=268 Identities=24% Similarity=0.331 Sum_probs=208.0
Q ss_pred hcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC-hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEE
Q 003278 109 GSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG-ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 109 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 187 (834)
..+.|+..++||.|.-++||+|+....+..||||++.-.. ....+.+.+|+..|+.++|||||+++..|..+..+|+||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 3467888999999999999999999999999999986432 233578899999999999999999999999999999999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
.||.+||+.+++...- ...+++..+..|.+++++||.|||.+ |.||||||+.|||||++|.+||+|||.+-.
T Consensus 104 pfMa~GS~ldIik~~~-----~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~ 175 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYY-----PDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSAS 175 (516)
T ss_pred hhhcCCcHHHHHHHHc-----cccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeee
Confidence 9999999999997542 23488899999999999999999996 999999999999999999999999998865
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCccc-cccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchH
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPES-FQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIIL 346 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~-~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l 346 (834)
+-.... .......++.||+.|||||+ .+...-|+.|+||||||++.+||.+|..||.... .-++.+
T Consensus 176 l~~~G~------------R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~p-PmkvLl 242 (516)
T KOG0582|consen 176 LFDSGD------------RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYP-PMKVLL 242 (516)
T ss_pred ecccCc------------eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCC-hHHHHH
Confidence 533210 01111256789999999999 5556678999999999999999999999997532 222221
Q ss_pred HHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 347 LDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 347 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
. .+ .+... ..+....+.+.+..-...+.++...||+.||.+||+..+++..
T Consensus 243 ~----tL--qn~pp-~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 243 L----TL--QNDPP-TLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred H----Hh--cCCCC-CcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 1 11 11111 0110000011111112367788899999999999999998763
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=342.00 Aligned_cols=243 Identities=20% Similarity=0.256 Sum_probs=191.9
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChh--HHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPA--LRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIY 589 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~--~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~ 589 (834)
++|...+.||+|+||+||..+. +.++.+|+|.++....-. ..+....|..+|.+++||.||+|+-.+.+.+.+|+|+
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl 104 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL 104 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence 5788899999999999999985 558899999987543221 2355778999999999999999999999999999999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccc
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFL 669 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~ 669 (834)
||+.||.|..+|.+.+. +++....-++.+|+.||.|||+ .+||||||||+|||||.+|.++|+||||++..
T Consensus 105 d~~~GGeLf~hL~~eg~------F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 105 DYLNGGELFYHLQREGR------FSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred eccCCccHHHHHHhcCC------cchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 99999999999976543 6666556688999999999996 79999999999999999999999999999853
Q ss_pred ccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcc
Q 003278 670 TRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPL 749 (834)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
... ...+.++|||+.|||||++.+..|+..+|.||+||++|||+||..||....... ... .....+.
T Consensus 176 ~~~-------~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~-~~~---~I~~~k~-- 242 (357)
T KOG0598|consen 176 LKD-------GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK-MYD---KILKGKL-- 242 (357)
T ss_pred ccC-------CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH-HHH---HHhcCcC--
Confidence 322 223456899999999999999999999999999999999999999997543221 111 1111110
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCC
Q 003278 750 AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPS 786 (834)
Q Consensus 750 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPt 786 (834)
.....+...+...+++ .-+..||++|--
T Consensus 243 ------~~~p~~ls~~ardll~---~LL~rdp~~RLg 270 (357)
T KOG0598|consen 243 ------PLPPGYLSEEARDLLK---KLLKRDPRQRLG 270 (357)
T ss_pred ------CCCCccCCHHHHHHHH---HHhccCHHHhcC
Confidence 1112223345555554 567789999963
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=363.54 Aligned_cols=262 Identities=24% Similarity=0.308 Sum_probs=201.3
Q ss_pred hCcCcCCcccccCCcEEEEEEE------CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhc-cCCCceeEEEEEeeCCeE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL------DNHQYVLVKRLGMSKCPALRTRFSNELQNLARL-RHRNLVQLCGWCTEQGEM 585 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l-~HpNiv~l~g~~~~~~~~ 585 (834)
++|...+.||+|+||.||+|.. +++..||||+++........+.|.+|+.+|..+ +|||||+++|+|.+.+..
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 3566678899999999999963 235689999987554444557789999999999 899999999999999999
Q ss_pred EEEEeccCCCchhhhhhcCCCC----------------------------------------------------------
Q 003278 586 LVIYDYSATRILSHLLFHNNHR---------------------------------------------------------- 607 (834)
Q Consensus 586 ~lv~Ey~~~g~L~~~l~~~~~~---------------------------------------------------------- 607 (834)
++||||+++|+|.+++......
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 9999999999999998653210
Q ss_pred -----------CCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCCCCC
Q 003278 608 -----------IGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGH 676 (834)
Q Consensus 608 -----------~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~~~~ 676 (834)
.....++|..++.++.|+++||+|||+ .+|+||||||+|||+++++.+||+|||+++........
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~- 270 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY- 270 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCcccc-
Confidence 011247899999999999999999996 69999999999999999999999999999765432110
Q ss_pred cccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCcccccccc
Q 003278 677 RKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDL 755 (834)
Q Consensus 677 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 755 (834)
.......++..|||||++.+..++.++|||||||++|||+| |..|+............+... .+.. .
T Consensus 271 ----~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~---~~~~----~- 338 (375)
T cd05104 271 ----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEG---YRML----S- 338 (375)
T ss_pred ----cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhC---ccCC----C-
Confidence 11122346678999999999999999999999999999998 777775433332222222111 0110 0
Q ss_pred ccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHcc
Q 003278 756 SLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDG 796 (834)
Q Consensus 756 ~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~ 796 (834)
....+. ++.+++.+||+.||++||||.+|++.|+.
T Consensus 339 ---~~~~~~---~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 339 ---PECAPS---EMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred ---CCCCCH---HHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 111223 35566679999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=357.74 Aligned_cols=250 Identities=25% Similarity=0.382 Sum_probs=206.5
Q ss_pred CCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEccC
Q 003278 112 GFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMP 191 (834)
Q Consensus 112 ~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 191 (834)
.|..-.+||+|+.|.||.+....++..||||++........+-..+|+.+|+..+|+|||.++..|...+++|.|||||+
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ 353 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYME 353 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecC
Confidence 46777899999999999999999999999999987766667778999999999999999999999999999999999999
Q ss_pred CCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhhh
Q 003278 192 NRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHE 271 (834)
Q Consensus 192 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~~ 271 (834)
+|+|.+.+.. ..+++.++..|++++++||+|||.+ +|||||||++||||+.++.+||+|||++..+..+
T Consensus 354 ggsLTDvVt~--------~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~ 422 (550)
T KOG0578|consen 354 GGSLTDVVTK--------TRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE 422 (550)
T ss_pred CCchhhhhhc--------ccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence 9999988743 4589999999999999999999996 9999999999999999999999999999866433
Q ss_pred hhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHHHH
Q 003278 272 LQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIR 351 (834)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~ 351 (834)
. ...++.+|||.|||||++... .|..|+||||||++++||+-|.+|+-...+-.. +.
T Consensus 423 ~----------------~KR~TmVGTPYWMAPEVvtrk-~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrA------ly 479 (550)
T KOG0578|consen 423 Q----------------SKRSTMVGTPYWMAPEVVTRK-PYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------LY 479 (550)
T ss_pred c----------------CccccccCCCCccchhhhhhc-ccCccccchhhhhHHHHHhcCCCCccCCChHHH------HH
Confidence 1 125678899999999998654 789999999999999999999999854222111 11
Q ss_pred HHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 352 RLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 352 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
.+...|. +.+... ..--..+.++..+||+.|+.+||++.|+++.
T Consensus 480 LIa~ng~------P~lk~~---~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 480 LIATNGT------PKLKNP---EKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred HHhhcCC------CCcCCc---cccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 1112221 222111 1112357788899999999999999999874
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=372.68 Aligned_cols=267 Identities=22% Similarity=0.356 Sum_probs=216.0
Q ss_pred cccHHHHHHHhhCcCc---------CCcccccCCcEEEEEEECC----CcEEEEEEecCCCChhHHHHHHHHHHHHHhcc
Q 003278 502 EISFKEIISATNNFSE---------SQRVAEMDFGTAYQGFLDN----HQYVLVKRLGMSKCPALRTRFSNELQNLARLR 568 (834)
Q Consensus 502 ~~~~~el~~at~~f~~---------~~~ig~g~~g~vy~~~~~~----~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~ 568 (834)
.++|++--+|-..|.. .+.||.|.||.||+|.|+- ...||||.++....+..+..|+.|+.+|.+..
T Consensus 609 P~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFd 688 (996)
T KOG0196|consen 609 PHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFD 688 (996)
T ss_pred CccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCC
Confidence 3556555555544432 4679999999999999743 35799999998888888899999999999999
Q ss_pred CCCceeEEEEEeeCCeEEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccC
Q 003278 569 HRNLVQLCGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSS 648 (834)
Q Consensus 569 HpNiv~l~g~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~ 648 (834)
||||++|-|+.+....++||.|||+||+|+.+|+.+. ..+.|.+.+-++++||.||.||-+ .+.|||||..+
T Consensus 689 HPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~D-----GqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAAR 760 (996)
T KOG0196|consen 689 HPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQND-----GQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAAR 760 (996)
T ss_pred CCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcC-----CceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhh
Confidence 9999999999999999999999999999999998754 248888899999999999999986 69999999999
Q ss_pred ceeecCCCCceEeeeeeccccccCCCCCcccccCcccccc--ccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCc
Q 003278 649 AITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRG--IFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMA 725 (834)
Q Consensus 649 NILld~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~G--t~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p 725 (834)
|||++.+..+||+||||++.+.++... ..++.-| ...|.|||.|...++|.+|||||||||+||.++ |.+|
T Consensus 761 NILVNsnLvCKVsDFGLSRvledd~~~------~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERP 834 (996)
T KOG0196|consen 761 NILVNSNLVCKVSDFGLSRVLEDDPEA------AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 834 (996)
T ss_pred heeeccceEEEeccccceeecccCCCc------cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCc
Confidence 999999999999999999987654311 1111112 357999999999999999999999999999776 8888
Q ss_pred cCCCCCchhHHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccC
Q 003278 726 VDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGN 797 (834)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~ 797 (834)
+-.. .+..++..+.+......| .++...|-+||+.||+.|..+||+|.+|+..|+..
T Consensus 835 YWdm-SNQdVIkaIe~gyRLPpP--------------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDkl 891 (996)
T KOG0196|consen 835 YWDM-SNQDVIKAIEQGYRLPPP--------------MDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKL 891 (996)
T ss_pred cccc-chHHHHHHHHhccCCCCC--------------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHH
Confidence 7644 444444544433222111 22334677889999999999999999999998743
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=353.34 Aligned_cols=248 Identities=25% Similarity=0.370 Sum_probs=204.0
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYD 188 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 188 (834)
++|...+.||+|+||+||||+.+.+.+.||+|.+.+. .++..+.+.+|+++++.|+|||||.++++|+...++|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 4678888999999999999999999999999999764 34456778999999999999999999999999999999999
Q ss_pred ccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhh
Q 003278 189 YMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWL 268 (834)
Q Consensus 189 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~ 268 (834)
|+.| +|..+|.. ...|+++....|+.+++.||.|||+. +|+|||+||.||||+..+.+|+||||+||.+
T Consensus 82 ~a~g-~L~~il~~-------d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m 150 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ-------DGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAM 150 (808)
T ss_pred hhhh-hHHHHHHh-------ccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhc
Confidence 9987 99999964 35689999999999999999999995 9999999999999999999999999999965
Q ss_pred hhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHH
Q 003278 269 EHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLD 348 (834)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~ 348 (834)
... ....+.+.|||-|||||.+. +..|+..+|.||+||+|||+.+|++||... .+..
T Consensus 151 ~~~----------------t~vltsikGtPlYmAPElv~-e~pyd~~sDlWslGcilYE~~~G~PPF~a~------si~~ 207 (808)
T KOG0597|consen 151 STN----------------TSVLTSIKGTPLYMAPELVE-EQPYDHTSDLWSLGCILYELYVGQPPFYAR------SITQ 207 (808)
T ss_pred ccC----------------ceeeeeccCcccccCHHHHc-CCCccchhhHHHHHHHHHHHhcCCCCchHH------HHHH
Confidence 432 12257788999999999887 557899999999999999999999999532 2333
Q ss_pred HHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 349 WIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 349 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
.++.+..+ +... +...-..+..+..--++.||.+|-+-.+++..
T Consensus 208 Lv~~I~~d--------~v~~----p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 208 LVKSILKD--------PVKP----PSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred HHHHHhcC--------CCCC----cccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 33333221 1111 11122345566667789999999998887753
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=348.68 Aligned_cols=252 Identities=24% Similarity=0.318 Sum_probs=197.3
Q ss_pred CCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEE
Q 003278 112 GFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYD 188 (834)
Q Consensus 112 ~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 188 (834)
+|+..+.||+|+||.||+|....+|+.||||.+.... ......+.+|+.++.+++|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3677889999999999999998899999999986432 2233567899999999999999999999999999999999
Q ss_pred ccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhh
Q 003278 189 YMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWL 268 (834)
Q Consensus 189 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~ 268 (834)
|+++|+|..++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.+
T Consensus 81 ~~~~g~L~~~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~ 152 (285)
T cd05631 81 IMNGGDLKFHIYNMG-----NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQI 152 (285)
T ss_pred ecCCCcHHHHHHhhC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEc
Confidence 999999998875432 23589999999999999999999985 9999999999999999999999999998753
Q ss_pred hhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHH
Q 003278 269 EHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLD 348 (834)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~ 348 (834)
.... ......||+.|+|||++... .++.++|||||||++|||+||+.||......... ..
T Consensus 153 ~~~~-----------------~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~--~~ 212 (285)
T cd05631 153 PEGE-----------------TVRGRVGTVGYMAPEVINNE-KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR--EE 212 (285)
T ss_pred CCCC-----------------eecCCCCCCCccCHhhhcCC-CCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH--HH
Confidence 2110 01234689999999998754 6799999999999999999999999754322111 11
Q ss_pred HHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCc-----hhhHHH
Q 003278 349 WIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPS-----MKWVIE 403 (834)
Q Consensus 349 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----m~~V~~ 403 (834)
.... ..... .... ..+ ...+..|+..||+.||.+||+ +.++++
T Consensus 213 ~~~~-~~~~~------~~~~-~~~----s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 213 VDRR-VKEDQ------EEYS-EKF----SEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred HHHH-hhccc------ccCC-ccC----CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 1111 11100 0000 111 235778999999999999997 666664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=322.95 Aligned_cols=262 Identities=24% Similarity=0.303 Sum_probs=203.7
Q ss_pred CCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEc
Q 003278 112 GFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDY 189 (834)
Q Consensus 112 ~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 189 (834)
.|...++||+|.||.||+|++..+|+.||||+++.. .+.......+|++.|+.++|+|||.|+++|...+.+-||+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 466778999999999999999999999999998643 223456678999999999999999999999999999999999
Q ss_pred cCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhh
Q 003278 190 MPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLE 269 (834)
Q Consensus 190 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~ 269 (834)
|+. +|+..+... ...|+-.+++.++.++.+||+|||+. .|+||||||.|+|+++++.+||+|||+|+.+.
T Consensus 83 m~t-dLe~vIkd~------~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~ 152 (318)
T KOG0659|consen 83 MPT-DLEVVIKDK------NIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFG 152 (318)
T ss_pred ccc-cHHHHhccc------ccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccC
Confidence 974 899888653 35788899999999999999999995 99999999999999999999999999999764
Q ss_pred hhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHH
Q 003278 270 HELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDW 349 (834)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~ 349 (834)
.... ..+.-+-|.+|.|||.+...+.|+..+||||.|||+.||+-|.+-|....+-++. ..
T Consensus 153 ~p~~----------------~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL---~~ 213 (318)
T KOG0659|consen 153 SPNR----------------IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQL---SK 213 (318)
T ss_pred CCCc----------------ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHH---HH
Confidence 3211 0122257999999999988888999999999999999999998766543322221 22
Q ss_pred HHHHhhcCc---------------cccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 350 IRRLSDEGK---------------VLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 350 ~~~~~~~~~---------------~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
+-+.+.... +.+...+.+. .-+.. ......+|...-+..||.+|.+++|.+++
T Consensus 214 If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~-~lf~a-as~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 214 IFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLN-NLFPA-ASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHHcCCCCcccCccccccccHHHHhcCCCCccc-ccccc-ccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 222111110 1111111111 11222 22345888889999999999999998864
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=359.50 Aligned_cols=258 Identities=28% Similarity=0.400 Sum_probs=202.4
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCe---E-EEEEEecc---cChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGT---V-VAVKCLAE---KGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQ 182 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~---~-vAvK~l~~---~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~ 182 (834)
.++-...++||+|+||+||+|.++..+. . ||||..+. ......++|.+|.++|++++|||||+|||++.....
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 3444555899999999999999865422 3 89998875 235567889999999999999999999999999999
Q ss_pred EEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeec
Q 003278 183 LLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDF 262 (834)
Q Consensus 183 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DF 262 (834)
+++|||+|+||+|.++|...+ ..++..+++.++.++|+||+|||+. ++|||||-+.|+|++.++.+||+||
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~------~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDF 306 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNK------KSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDF 306 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCC------CCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCcc
Confidence 999999999999999997653 2588999999999999999999996 9999999999999999999999999
Q ss_pred cchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCC
Q 003278 263 GLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPD 341 (834)
Q Consensus 263 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~ 341 (834)
|+++.-. .+.+. .....-...|+|||.+..+ .++.|+|||||||++||+.+ |..|+.....
T Consensus 307 GLs~~~~---~~~~~-------------~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~- 368 (474)
T KOG0194|consen 307 GLSRAGS---QYVMK-------------KFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPYPGMKN- 368 (474)
T ss_pred ccccCCc---ceeec-------------cccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCCCCCCH-
Confidence 9998532 11110 0011134789999999888 78999999999999999999 7777653321
Q ss_pred ccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcCC
Q 003278 342 DQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGSY 409 (834)
Q Consensus 342 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~~ 409 (834)
..+..++ ...+...... . .....+..+...||..+|+.||+|.+|.+.+....
T Consensus 369 --~~v~~kI---~~~~~r~~~~-------~---~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~ 421 (474)
T KOG0194|consen 369 --YEVKAKI---VKNGYRMPIP-------S---KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALE 421 (474)
T ss_pred --HHHHHHH---HhcCccCCCC-------C---CCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHH
Confidence 1122222 1222211111 1 22356777888999999999999999999988754
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=361.66 Aligned_cols=262 Identities=23% Similarity=0.323 Sum_probs=201.0
Q ss_pred hCcCcCCcccccCCcEEEEEEE------CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhc-cCCCceeEEEEEeeCCeE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL------DNHQYVLVKRLGMSKCPALRTRFSNELQNLARL-RHRNLVQLCGWCTEQGEM 585 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l-~HpNiv~l~g~~~~~~~~ 585 (834)
++|...+.||+|+||.||+|.. +++..||||.+...........+.+|+++++.+ +|||||+++|+|.+.+..
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 4677788999999999999873 234579999997655555567789999999999 899999999999999999
Q ss_pred EEEEeccCCCchhhhhhcCCCC----------------------------------------------------------
Q 003278 586 LVIYDYSATRILSHLLFHNNHR---------------------------------------------------------- 607 (834)
Q Consensus 586 ~lv~Ey~~~g~L~~~l~~~~~~---------------------------------------------------------- 607 (834)
++||||+++|+|.+++......
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 9999999999999988643210
Q ss_pred ------CCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCCCCCccccc
Q 003278 608 ------IGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATS 681 (834)
Q Consensus 608 ------~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~~~ 681 (834)
.....++|...++|+.|+++||+|||+ .+|+||||||+|||+++++.+||+|||+++.+..... ..
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~-----~~ 269 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN-----YV 269 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc-----ee
Confidence 011247888899999999999999996 6999999999999999999999999999976532211 01
Q ss_pred CccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCccccccccccCCC
Q 003278 682 GNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGE 760 (834)
Q Consensus 682 ~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 760 (834)
......+++.|||||++.++.++.++|||||||++|||+| |+.||............... ...+ ... .
T Consensus 270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~---~~~~-------~~~-~ 338 (374)
T cd05106 270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKR---GYQM-------SRP-D 338 (374)
T ss_pred eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHc---ccCc-------cCC-C
Confidence 1122346678999999999999999999999999999998 99998654332221111110 0000 001 1
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHcc
Q 003278 761 YNHKELMRLIKLGIACTLSNPELRPSMRQILSILDG 796 (834)
Q Consensus 761 ~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~ 796 (834)
..+. .+.+++.+||+.||++|||+.+|++.|+.
T Consensus 339 ~~~~---~l~~li~~cl~~dp~~RPs~~~l~~~l~~ 371 (374)
T cd05106 339 FAPP---EIYSIMKMCWNLEPTERPTFSQISQLIQR 371 (374)
T ss_pred CCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 1123 35556669999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=354.65 Aligned_cols=269 Identities=25% Similarity=0.388 Sum_probs=208.6
Q ss_pred ccHHHHHhhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEE
Q 003278 101 FSYAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCV 178 (834)
Q Consensus 101 f~~~el~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~ 178 (834)
.+..+..+--+.+...+.||+|.||+||+|.|.. .||||.++.. .....+.|.+|+.++++-+|.||+=+.|||.
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~ 458 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACM 458 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhc
Confidence 3445556666667788999999999999999943 4999998754 3446688999999999999999999999999
Q ss_pred eCCEEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceE
Q 003278 179 HEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNAR 258 (834)
Q Consensus 179 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~k 258 (834)
.++. .+|.-+|.|-+|+.+||-.. ..|+..+.+.|+.|||+|+.|||.+ +|||||||+.||+|.+++.+|
T Consensus 459 ~p~~-AIiTqwCeGsSLY~hlHv~e------tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVk 528 (678)
T KOG0193|consen 459 NPPL-AIITQWCEGSSLYTHLHVQE------TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVK 528 (678)
T ss_pred CCce-eeeehhccCchhhhhccchh------hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEE
Confidence 8876 99999999999999998653 4588889999999999999999995 999999999999999999999
Q ss_pred EeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCcccccc--CCCCCcccceeehhhHHHHHHhCCccCC
Q 003278 259 LGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQK--GSVATAKSDVFSFGIVVLEVVSGRRAVD 336 (834)
Q Consensus 259 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~~ksDV~SfGvvl~ElltG~~p~~ 336 (834)
|+||||+..-..- . .........|..-|||||++.. ...++..|||||||||+|||+||.-|+.
T Consensus 529 IgDFGLatvk~~w---------~-----g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys 594 (678)
T KOG0193|consen 529 IGDFGLATVKTRW---------S-----GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS 594 (678)
T ss_pred Eecccceeeeeee---------c-----cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC
Confidence 9999998531100 0 0001123347889999999853 3367999999999999999999999987
Q ss_pred CCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcCC
Q 003278 337 LTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGSY 409 (834)
Q Consensus 337 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~~ 409 (834)
. ...+++.+ +...|.+. .|... ........|.+|...||..+|++||.+.+++..|....
T Consensus 595 i-~~~dqIif------mVGrG~l~--pd~s~----~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~ 654 (678)
T KOG0193|consen 595 I-QNRDQIIF------MVGRGYLM--PDLSK----IRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELL 654 (678)
T ss_pred C-CChhheEE------EecccccC--ccchh----hhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhh
Confidence 3 33333221 11222211 11111 01122356889999999999999999999999887654
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=328.99 Aligned_cols=262 Identities=21% Similarity=0.244 Sum_probs=195.9
Q ss_pred CcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCC-hhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 514 NFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKC-PALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~-~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
.|....++|+|+||+|||++. +.|+.||||++..+.. +..++--.+||++|++|+|||+|.|+.+|.....++||+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 355567899999999999996 4599999999876544 66677778999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccccc
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTR 671 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~ 671 (834)
|...-|+++-+..+ .++......++.|++.|+.|+|+ .+||||||||+||||+.++.+|+||||+|+.+..
T Consensus 83 ~dhTvL~eLe~~p~------G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~ 153 (396)
T KOG0593|consen 83 CDHTVLHELERYPN------GVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSA 153 (396)
T ss_pred cchHHHHHHHhccC------CCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcC
Confidence 99988876644322 26677778899999999999996 6899999999999999999999999999998763
Q ss_pred CCCCCcccccCccccccccCccchhcccc-CCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHH-------
Q 003278 672 NDHGHRKATSGNRSVRGIFGYMSPEYIES-GEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFE------- 743 (834)
Q Consensus 672 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~------- 743 (834)
... ..+-++-|.-|.|||.+.+ -.|+..+||||.||++.||+||+.-|.....-+.+. .+....
T Consensus 154 pgd-------~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy-~I~ktLG~L~prh 225 (396)
T KOG0593|consen 154 PGD-------NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLY-LIRKTLGNLIPRH 225 (396)
T ss_pred Ccc-------hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHH-HHHHHHcccCHHH
Confidence 221 1234567889999999987 678999999999999999999986554333222211 111110
Q ss_pred ----hhcCccccccccccCCCCC-----HHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 744 ----ARKRPLAELVDLSLNGEYN-----HKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 744 ----~~~~~~~~~~d~~l~~~~~-----~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
....-+.-+.=|......+ +.-..-++.++..|++.||++|++-++++.
T Consensus 226 q~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 226 QSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred HHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 0000011110011000000 111224677888999999999999999874
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=349.49 Aligned_cols=249 Identities=25% Similarity=0.427 Sum_probs=204.7
Q ss_pred CCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc-ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEcc
Q 003278 112 GFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYM 190 (834)
Q Consensus 112 ~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 190 (834)
-|+..+.||+|+||.||||.+..+++.||+|++.-. .+...+..++|+.+|++++++||.++||.+..+..++++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 467778999999999999999999999999998643 3445677889999999999999999999999999999999999
Q ss_pred CCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhh
Q 003278 191 PNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEH 270 (834)
Q Consensus 191 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~ 270 (834)
.+|++.+.|... ..+++....-|++++..||.|||++ +.||||||+.|||+..+|.+||+|||.+-++..
T Consensus 94 ~gGsv~~lL~~~-------~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~ 163 (467)
T KOG0201|consen 94 GGGSVLDLLKSG-------NILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTN 163 (467)
T ss_pred cCcchhhhhccC-------CCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeec
Confidence 999999988532 3346666777999999999999997 999999999999999999999999999987654
Q ss_pred hhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHHH
Q 003278 271 ELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWI 350 (834)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~ 350 (834)
... ...+++|||.|||||++. +..|+.|+||||||++.+||++|.+|+....+..-..
T Consensus 164 ~~~----------------rr~tfvGTPfwMAPEVI~-~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf----- 221 (467)
T KOG0201|consen 164 TVK----------------RRKTFVGTPFWMAPEVIK-QSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF----- 221 (467)
T ss_pred hhh----------------ccccccccccccchhhhc-cccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE-----
Confidence 321 135678999999999997 5578999999999999999999999987655422111
Q ss_pred HHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 351 RRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 351 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
.+....-|.+. +.+. ..+.+++..||+.||+.||++.+++..
T Consensus 222 -------lIpk~~PP~L~-~~~S----~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 222 -------LIPKSAPPRLD-GDFS----PPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred -------eccCCCCCccc-cccC----HHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 11222223332 2333 357788999999999999999988753
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=377.71 Aligned_cols=265 Identities=29% Similarity=0.456 Sum_probs=208.4
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCC-C----eEEEEEEeccc-ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSD-G----TVVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQL 183 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~-g----~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 183 (834)
..+-+..+.||+|+||+||.|....- | ..||||.+.+. +.+...+|++|..+|++++|||||+|+|.|.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 34556678999999999999987532 3 34999998764 455678899999999999999999999999999999
Q ss_pred EEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeecc
Q 003278 184 LLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFG 263 (834)
Q Consensus 184 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFG 263 (834)
++++|||.+|+|..+|............|+....+.++.|||+|+.||+++ ++|||||...|+||+....+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccc
Confidence 999999999999999987644444456789999999999999999999996 99999999999999999999999999
Q ss_pred chhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCc
Q 003278 264 LARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDD 342 (834)
Q Consensus 264 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~ 342 (834)
+||-+.....+.... ...=...|||||++..+ .+|.|+|||||||+|||++| |..|+.... .
T Consensus 848 lArDiy~~~yyr~~~--------------~a~lPvkWm~PEsl~d~-iFtskSDvWsFGVllWEifslG~~PY~~~~--n 910 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHG--------------EAMLPVKWMPPESLKDG-IFTSKSDVWSFGVLLWEIFSLGATPYPSRS--N 910 (1025)
T ss_pred hhHhhhhchheeccC--------------ccccceecCCHHHHhhc-ccccccchhhhHHHHHHHHhCCCCCCCCcc--h
Confidence 999654443332110 01123689999999886 78999999999999999999 555553221 1
Q ss_pred cchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcCC
Q 003278 343 QIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGSY 409 (834)
Q Consensus 343 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~~ 409 (834)
...+..| ...| ||... ....+.+.+|+..||+.+|++||++..+++.+..+.
T Consensus 911 ~~v~~~~----~~gg--------RL~~P---~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 911 FEVLLDV----LEGG--------RLDPP---SYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred HHHHHHH----HhCC--------ccCCC---CCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence 1112112 2233 22111 123467889999999999999999999999876654
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=352.28 Aligned_cols=200 Identities=27% Similarity=0.395 Sum_probs=175.0
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc-ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYD 188 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 188 (834)
-++|+..+.||+|+||.||+++...+|..||+|.+... .....+.+.+|+.+|.+++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 46799999999999999999999989999999998654 33455679999999999999999999999999999999999
Q ss_pred ccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhh
Q 003278 189 YMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWL 268 (834)
Q Consensus 189 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~ 268 (834)
|+++|+|.+++... ..+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||+++.+
T Consensus 84 ~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 154 (331)
T cd06649 84 HMDGGSLDQVLKEA-------KRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 154 (331)
T ss_pred cCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccc
Confidence 99999999998643 3578899999999999999999984 36999999999999999999999999998754
Q ss_pred hhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCC
Q 003278 269 EHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDL 337 (834)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~ 337 (834)
... ......||+.|+|||++... .++.++|||||||++|||+||+.||..
T Consensus 155 ~~~------------------~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 155 IDS------------------MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred ccc------------------ccccCCCCcCcCCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 211 02334699999999998654 679999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=344.67 Aligned_cols=251 Identities=16% Similarity=0.208 Sum_probs=194.1
Q ss_pred cCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCC--hhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 515 FSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKC--PALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 515 f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~--~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
|...+.||+|+||.||+|.. .++..||||.+..... ......+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 56678899999999999985 5788999998864322 22335678999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccccc
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTR 671 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~ 671 (834)
+++|+|..++..... ..+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||++.....
T Consensus 82 ~~~g~L~~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05631 82 MNGGDLKFHIYNMGN----PGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE 154 (285)
T ss_pred cCCCcHHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence 999999888754321 247889999999999999999996 6999999999999999999999999999976432
Q ss_pred CCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcccc
Q 003278 672 NDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAE 751 (834)
Q Consensus 672 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
.. ......||..|||||++.+..++.++|||||||+||||+||+.||......... ....... . ....
T Consensus 155 ~~--------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~-~~~~~~~-~-~~~~- 222 (285)
T cd05631 155 GE--------TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR-EEVDRRV-K-EDQE- 222 (285)
T ss_pred CC--------eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH-HHHHHHh-h-cccc-
Confidence 21 112357999999999999999999999999999999999999999754332111 1111000 0 0000
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCC-----hhHHHH
Q 003278 752 LVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPS-----MRQILS 792 (834)
Q Consensus 752 ~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPt-----m~~v~~ 792 (834)
.....++ . .+..++.+||..||++||+ ++++++
T Consensus 223 ----~~~~~~s-~---~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 223 ----EYSEKFS-E---DAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred ----cCCccCC-H---HHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 0111122 2 3445566899999999997 677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=361.09 Aligned_cols=264 Identities=26% Similarity=0.378 Sum_probs=202.4
Q ss_pred cCCCCCCCeeeccCCeEEEEEEE-----CCCCeEEEEEEecccC-hhhHHHHHHHHHHHHhC-CCCceeeEeeeEEeCCE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVL-----PSDGTVVAVKCLAEKG-ERFEKTFAAELVAVAHL-RHRNLVRLRGWCVHEDQ 182 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~-----~~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~ 182 (834)
.++|+..+.||+|+||.||+|.+ ..++..||||+++... ....+.+.+|+.++..+ +|||||+++|+|...+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45688899999999999999974 2456789999986432 33456788999999999 89999999999999999
Q ss_pred EEEEEEccCCCCHhHHHhcCCCc---------------------------------------------------------
Q 003278 183 LLLVYDYMPNRSLDRVLFRRPEN--------------------------------------------------------- 205 (834)
Q Consensus 183 ~~lV~Ey~~~gsL~~~l~~~~~~--------------------------------------------------------- 205 (834)
.++|||||++|+|.+++......
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 99999999999999998653210
Q ss_pred -----------cccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhhhhhh
Q 003278 206 -----------LEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQY 274 (834)
Q Consensus 206 -----------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~ 274 (834)
......++|..+..|+.||++||.|||+. +|+||||||+|||++.++.+||+|||+++.+......
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 00123689999999999999999999985 9999999999999999999999999999754322100
Q ss_pred hhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccchHHHHHHHH
Q 003278 275 QMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQIILLDWIRRL 353 (834)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~ 353 (834)
.......++..|+|||.+... .++.++|||||||++|||+| |..|+...... ..+..++
T Consensus 271 --------------~~~~~~~~~~~y~aPE~~~~~-~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~--~~~~~~~--- 330 (375)
T cd05104 271 --------------VVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSSPYPGMPVD--SKFYKMI--- 330 (375)
T ss_pred --------------cccCCCCCCcceeChhHhcCC-CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch--HHHHHHH---
Confidence 001223356789999998654 67999999999999999998 88887543221 1122221
Q ss_pred hhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhc
Q 003278 354 SDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSG 407 (834)
Q Consensus 354 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~ 407 (834)
..+.... .+. . ....+.+|+..||+.||++||+|.+|++.|+.
T Consensus 331 -~~~~~~~--~~~-----~---~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 331 -KEGYRML--SPE-----C---APSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred -HhCccCC--CCC-----C---CCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 1111110 010 0 12457899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=360.15 Aligned_cols=269 Identities=29% Similarity=0.479 Sum_probs=215.1
Q ss_pred ccccHHHHHhhcCC---------CCCCCeeeccCCeEEEEEEECCCC---eEEEEEEeccc-ChhhHHHHHHHHHHHHhC
Q 003278 99 RIFSYAELYIGSNG---------FDEDEVLGSGGFGKVYRAVLPSDG---TVVAVKCLAEK-GERFEKTFAAELVAVAHL 165 (834)
Q Consensus 99 ~~f~~~el~~~t~~---------f~~~~~LG~G~fG~Vy~~~~~~~g---~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l 165 (834)
..++|++=-.|... -.+.++||.|.||+||+|+++..| ..||||.++.- .++.+.+|+.|..+|.+.
T Consensus 608 DP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF 687 (996)
T KOG0196|consen 608 DPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF 687 (996)
T ss_pred CCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC
Confidence 34666664444433 355689999999999999998666 46999999753 456678899999999999
Q ss_pred CCCceeeEeeeEEeCCEEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCC
Q 003278 166 RHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVK 245 (834)
Q Consensus 166 ~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlK 245 (834)
+||||++|.|.........+|.|||+||+|+.+|..+. +.++|.+...++++||.|+.||-++ ++|||||.
T Consensus 688 dHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~D------GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLA 758 (996)
T KOG0196|consen 688 DHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQND------GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLA 758 (996)
T ss_pred CCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcC------CceEeehHHHHHHHHHHHhHHHhhc---Cchhhhhh
Confidence 99999999999999999999999999999999997653 4588999999999999999999996 99999999
Q ss_pred CCceEECCCCceEEeeccchhhhhhhhhhhhhcccccccccccccceeeec--cccCCCccccccCCCCCcccceeehhh
Q 003278 246 TSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGG--TIGYLPPESFQKGSVATAKSDVFSFGI 323 (834)
Q Consensus 246 p~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G--t~~Y~aPE~~~~~~~~~~ksDV~SfGv 323 (834)
..|||++.+..+||+||||+|.++++.. ...++..| ...|.|||.+... .+|..||||||||
T Consensus 759 ARNILVNsnLvCKVsDFGLSRvledd~~---------------~~ytt~GGKIPiRWTAPEAIa~R-KFTsASDVWSyGI 822 (996)
T KOG0196|consen 759 ARNILVNSNLVCKVSDFGLSRVLEDDPE---------------AAYTTLGGKIPIRWTAPEAIAYR-KFTSASDVWSYGI 822 (996)
T ss_pred hhheeeccceEEEeccccceeecccCCC---------------ccccccCCccceeecChhHhhhc-ccCchhhccccce
Confidence 9999999999999999999998765531 11223333 3789999999766 6799999999999
Q ss_pred HHHHHHh-CCccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHH
Q 003278 324 VVLEVVS-GRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVI 402 (834)
Q Consensus 324 vl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~ 402 (834)
|+||.++ |.+|+-.....+ -+..+ .+|- ||+ .++.....|.+|++.||+.|...||.+.+++
T Consensus 823 VmWEVmSyGERPYWdmSNQd------VIkaI-e~gy-------RLP---pPmDCP~aL~qLMldCWqkdR~~RP~F~qiV 885 (996)
T KOG0196|consen 823 VMWEVMSYGERPYWDMSNQD------VIKAI-EQGY-------RLP---PPMDCPAALYQLMLDCWQKDRNRRPKFAQIV 885 (996)
T ss_pred EEEEecccCCCcccccchHH------HHHHH-Hhcc-------CCC---CCCCCcHHHHHHHHHHHHHHhhcCCCHHHHH
Confidence 9999876 888864332221 12211 2221 221 1233446799999999999999999999999
Q ss_pred HHhhcCC
Q 003278 403 EAVSGSY 409 (834)
Q Consensus 403 ~~l~~~~ 409 (834)
..|.+..
T Consensus 886 ~~lDklI 892 (996)
T KOG0196|consen 886 STLDKLI 892 (996)
T ss_pred HHHHHHh
Confidence 9998754
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=344.53 Aligned_cols=249 Identities=30% Similarity=0.502 Sum_probs=189.5
Q ss_pred CcccccCCcEEEEEEEC-----CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEeccC
Q 003278 519 QRVAEMDFGTAYQGFLD-----NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSA 593 (834)
Q Consensus 519 ~~ig~g~~g~vy~~~~~-----~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~~ 593 (834)
+.||+|.||.||+|.+. .+..|+||.++........+.|.+|++.+++++||||++++|+|...+..++||||++
T Consensus 5 ~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~ 84 (259)
T PF07714_consen 5 KQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCP 84 (259)
T ss_dssp EEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--T
T ss_pred eEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccccc
Confidence 56999999999999986 2567999999766566667889999999999999999999999998888999999999
Q ss_pred CCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCC
Q 003278 594 TRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRND 673 (834)
Q Consensus 594 ~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~ 673 (834)
+|+|.++|.... ...++|..+..|+.|||+||+|||+ .+|+|+||+++|||+++++.+||+|||++.......
T Consensus 85 ~g~L~~~L~~~~----~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 85 GGSLDDYLKSKN----KEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp TEBHHHHHHHTC----TTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred cccccccccccc----ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 999999998762 1348999999999999999999997 589999999999999999999999999997652221
Q ss_pred CCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCccccc
Q 003278 674 HGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRPLAEL 752 (834)
Q Consensus 674 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (834)
.. .......+...|+|||.+....++.++||||||+++|||+| |+.|+... ....+...+.. ..+. .
T Consensus 158 ~~-----~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~-~~~~~~~~~~~---~~~~--~- 225 (259)
T PF07714_consen 158 KY-----KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY-DNEEIIEKLKQ---GQRL--P- 225 (259)
T ss_dssp SE-----EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS-CHHHHHHHHHT---TEET--T-
T ss_pred cc-----cccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccc---cccc--e-
Confidence 11 11122346778999999999999999999999999999999 66776543 22222222211 1110 0
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHH
Q 003278 753 VDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSIL 794 (834)
Q Consensus 753 ~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L 794 (834)
.. ...+.. +.+++.+||+.||++||||.+|++.|
T Consensus 226 ----~~-~~~~~~---~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 ----IP-DNCPKD---IYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ----SB-TTSBHH---HHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ----ec-cchhHH---HHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 00 111233 44566699999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=320.04 Aligned_cols=249 Identities=26% Similarity=0.401 Sum_probs=204.4
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 187 (834)
++|+..+.||+|-||.||.|+.+.++-+||+|++.+.. .....++.+|+++-+.|+||||+++||||.+....||++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 56999999999999999999999999999999986542 345678999999999999999999999999999999999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
||.++|+|...|...+ ...++......++.|+|.||.|+|. ++||||||||+|+|++.++.+|++|||-+-.
T Consensus 102 Eya~~gel~k~L~~~~-----~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~ 173 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGR-----MKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVH 173 (281)
T ss_pred EecCCchHHHHHHhcc-----cccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceee
Confidence 9999999999997543 2456666777899999999999998 4999999999999999999999999998753
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHH
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILL 347 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~ 347 (834)
-. .....+.+||..|.|||.... ..++.++|+|++||+.||++.|.+||+....+ ...
T Consensus 174 ~p------------------~~kR~tlcgt~dyl~pEmv~~-~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~---etY 231 (281)
T KOG0580|consen 174 AP------------------SNKRKTLCGTLDYLPPEMVEG-RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS---ETY 231 (281)
T ss_pred cC------------------CCCceeeecccccCCHhhcCC-CCccchhhHHHHHHHHHHHHhcCCchhhhhhH---HHH
Confidence 21 112577899999999998864 46799999999999999999999999754311 122
Q ss_pred HHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 348 DWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 348 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
.-++. .+..+|.. . .....+++..|+..+|.+|.+..||++.
T Consensus 232 krI~k-------~~~~~p~~----i----s~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 232 KRIRK-------VDLKFPST----I----SGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred HHHHH-------ccccCCcc----c----ChhHHHHHHHHhccCccccccHHHHhhh
Confidence 21211 11112211 1 1346789999999999999999999874
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=340.60 Aligned_cols=255 Identities=23% Similarity=0.304 Sum_probs=199.4
Q ss_pred hCcCcCCcccccCCcEEEEEEEC----CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD----NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVI 588 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~----~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv 588 (834)
++|...+.||+|+||.||+|.+. .+..||+|.++..........|.+|+.++.+++|||||+++|++...+..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 35666788999999999999863 35689999988665555557899999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccc
Q 003278 589 YDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEF 668 (834)
Q Consensus 589 ~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~ 668 (834)
|||+++|+|.+++.... ..++|..++.++.|++.||+|||+ .+++||||||+|||++.++.+|++|||++..
T Consensus 85 ~e~~~~~~L~~~l~~~~-----~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~ 156 (266)
T cd05064 85 TEYMSNGALDSFLRKHE-----GQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQE 156 (266)
T ss_pred EEeCCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCccccc
Confidence 99999999999986532 247899999999999999999996 6899999999999999999999999998764
Q ss_pred cccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcC
Q 003278 669 LTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKR 747 (834)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
..... ........+|..|+|||++.++.++.++|||||||++||+++ |+.|+....... +..... ....
T Consensus 157 ~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~-~~~~~~---~~~~ 226 (266)
T cd05064 157 DKSEA------IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD-VIKAVE---DGFR 226 (266)
T ss_pred ccccc------hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-HHHHHH---CCCC
Confidence 32111 011112345678999999999999999999999999999775 999986443322 222111 1100
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHcc
Q 003278 748 PLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDG 796 (834)
Q Consensus 748 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~ 796 (834)
....... + ..+.+++.+||+.+|++|||+.+|.+.|+.
T Consensus 227 -------~~~~~~~-~---~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 227 -------LPAPRNC-P---NLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred -------CCCCCCC-C---HHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 0111111 2 245566679999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=352.09 Aligned_cols=249 Identities=22% Similarity=0.361 Sum_probs=199.1
Q ss_pred hCcCcCCcccccCCcEEEEEE-ECCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 513 NNFSESQRVAEMDFGTAYQGF-LDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
..|..-.+||+|+-|.||.+. ..+++.||||++.....+. ++-..+|+.+|+..+|+|||+++..|...+++++||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~-keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK-KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc-hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 345556789999999999998 5668899999987654332 35578999999999999999999998888999999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccccc
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTR 671 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~ 671 (834)
|.+|+|.+.+.+. .+++.+...|.++++.||+|||. .+|||||||++||||+.++.+||+|||++..+..
T Consensus 352 m~ggsLTDvVt~~-------~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~ 421 (550)
T KOG0578|consen 352 MEGGSLTDVVTKT-------RMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE 421 (550)
T ss_pred cCCCchhhhhhcc-------cccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence 9999999887542 48888889999999999999996 7999999999999999999999999999987654
Q ss_pred CCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcccc
Q 003278 672 NDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAE 751 (834)
Q Consensus 672 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
.. ....+.+||+.|||||++....|+.|+||||||++++||+-|+.||-.+.|-..+.. + .....+ +
T Consensus 422 ~~-------~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyL-I---a~ng~P--~ 488 (550)
T KOG0578|consen 422 EQ-------SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-I---ATNGTP--K 488 (550)
T ss_pred cc-------CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHH-H---hhcCCC--C
Confidence 32 234568999999999999999999999999999999999999999876544322111 1 111111 1
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 752 LVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 752 ~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
+-.+ +--..++.+++ .+|++.||++||++.|+++
T Consensus 489 lk~~----~klS~~~kdFL---~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 489 LKNP----EKLSPELKDFL---DRCLVVDVEQRASAKELLE 522 (550)
T ss_pred cCCc----cccCHHHHHHH---HHHhhcchhcCCCHHHHhc
Confidence 1111 01123444444 4899999999999999985
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=353.29 Aligned_cols=254 Identities=21% Similarity=0.275 Sum_probs=200.9
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 187 (834)
++|+..+.||+|+||.||+|++..+|+.||||++.... ....+.+.+|+.++.+++||||+++++++...+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999998889999999986532 233466889999999999999999999999999999999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
||+++|+|.+++... ..+++.....++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 e~~~g~~L~~~l~~~-------~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~ 150 (333)
T cd05600 81 EYVPGGDFRTLLNNL-------GVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKG 150 (333)
T ss_pred eCCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCcc
Confidence 999999999998643 3588899999999999999999985 999999999999999999999999999975
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHH
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILL 347 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~ 347 (834)
... ......||+.|+|||++... .++.++|||||||++|||+||+.||......+ ..
T Consensus 151 ~~~-------------------~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---~~ 207 (333)
T cd05600 151 IVT-------------------YANSVVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE---TW 207 (333)
T ss_pred ccc-------------------ccCCcccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCHHH---HH
Confidence 321 12345699999999998655 67999999999999999999999986532211 11
Q ss_pred HHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 348 DWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 348 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
. .+......... +...+.. ......+.++...||..+|.+||++.++++.
T Consensus 208 ~---~i~~~~~~~~~--~~~~~~~--~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 208 E---NLKYWKETLQR--PVYDDPR--FNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred H---HHHhccccccC--CCCCccc--cccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 1 11110111110 0000000 0112356788899999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=396.93 Aligned_cols=269 Identities=24% Similarity=0.455 Sum_probs=219.0
Q ss_pred cccHHHHHhhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEe
Q 003278 100 IFSYAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVH 179 (834)
Q Consensus 100 ~f~~~el~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~ 179 (834)
.+++.++. ..|...++||+|+||.||+|....+|..||||.+...... ...|+..+++++|||||+++|+|.+
T Consensus 682 ~~~~~~~~---~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~ 754 (968)
T PLN00113 682 SITINDIL---SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRS 754 (968)
T ss_pred hhhHHHHH---hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEc
Confidence 45666654 4577889999999999999999889999999998654321 2346889999999999999999999
Q ss_pred CCEEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEE
Q 003278 180 EDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARL 259 (834)
Q Consensus 180 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl 259 (834)
.+..++||||+++|+|.++++ .++|..+.+|+.|+|+||+|||..+.++|+||||||+|||++.++.+++
T Consensus 755 ~~~~~lv~Ey~~~g~L~~~l~----------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~ 824 (968)
T PLN00113 755 EKGAYLIHEYIEGKNLSEVLR----------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL 824 (968)
T ss_pred CCCCEEEEeCCCCCcHHHHHh----------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEE
Confidence 999999999999999999984 2789999999999999999999877789999999999999999988887
Q ss_pred eeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCC
Q 003278 260 GDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTY 339 (834)
Q Consensus 260 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~ 339 (834)
. ||.+..... .+...||++|||||++... .++.|+|||||||++|||+||+.|++...
T Consensus 825 ~-~~~~~~~~~--------------------~~~~~~t~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~el~tg~~p~~~~~ 882 (968)
T PLN00113 825 R-LSLPGLLCT--------------------DTKCFISSAYVAPETRETK-DITEKSDIYGFGLILIELLTGKSPADAEF 882 (968)
T ss_pred E-ecccccccc--------------------CCCccccccccCcccccCC-CCCcccchhhHHHHHHHHHhCCCCCCccc
Confidence 6 665542110 1223589999999998654 67999999999999999999999986543
Q ss_pred CCccchHHHHHHHHhhcCccccccccccCCC-CCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 340 PDDQIILLDWIRRLSDEGKVLQAGDNRLSDG-SYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 340 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
. ....+..|++...........+|+.+... .....++..+.+++.+||+.+|++||+|.+|+++|+..
T Consensus 883 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 951 (968)
T PLN00113 883 G-VHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA 951 (968)
T ss_pred C-CCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence 3 23457788876665555555666665422 23456677888999999999999999999999999864
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=359.92 Aligned_cols=265 Identities=26% Similarity=0.434 Sum_probs=202.0
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECC-----CCeEEEEEEecccC-hhhHHHHHHHHHHHHhC-CCCceeeEeeeEEeCCE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPS-----DGTVVAVKCLAEKG-ERFEKTFAAELVAVAHL-RHRNLVRLRGWCVHEDQ 182 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~-----~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~ 182 (834)
.++|+..+.||+|+||.||+|+... ++..||||++.... ....+.+.+|+.+++.+ +|||||+++|+|...+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 3568889999999999999998643 33579999987542 33456788999999999 89999999999999999
Q ss_pred EEEEEEccCCCCHhHHHhcCCCc---------------------------------------------------------
Q 003278 183 LLLVYDYMPNRSLDRVLFRRPEN--------------------------------------------------------- 205 (834)
Q Consensus 183 ~~lV~Ey~~~gsL~~~l~~~~~~--------------------------------------------------------- 205 (834)
.++||||+++|+|.+++......
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 99999999999999998643210
Q ss_pred ------cccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhhhhhhhhhcc
Q 003278 206 ------LEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTS 279 (834)
Q Consensus 206 ------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~ 279 (834)
.....+++|....+|+.|+++||.|||+. +|+||||||+|||+++++.+||+|||+++.+......
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~----- 268 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY----- 268 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce-----
Confidence 01123589999999999999999999985 9999999999999999999999999999754321100
Q ss_pred cccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccchHHHHHHHHhhcCc
Q 003278 280 SARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQIILLDWIRRLSDEGK 358 (834)
Q Consensus 280 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 358 (834)
.......+++.|||||++..+ .++.++|||||||++|||+| |+.||....... .+. .....+.
T Consensus 269 ---------~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~~----~~~~~~~ 332 (374)
T cd05106 269 ---------VVKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KFY----KMVKRGY 332 (374)
T ss_pred ---------eeccCCCCccceeCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccH--HHH----HHHHccc
Confidence 001223356789999998654 67999999999999999997 999986432221 111 1111111
Q ss_pred cccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 359 VLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 359 ~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
....+ .. ....+.+++..||+.||.+||++.+|++.|+..
T Consensus 333 --~~~~~-----~~---~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 333 --QMSRP-----DF---APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred --CccCC-----CC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 00000 00 124578899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=339.77 Aligned_cols=256 Identities=25% Similarity=0.384 Sum_probs=200.2
Q ss_pred cCCCCCCCeeeccCCeEEEEEEEC---CCCeEEEEEEecccC-hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLP---SDGTVVAVKCLAEKG-ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLL 185 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~---~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 185 (834)
.++|+..+.||+|+||.||+|.+. ..+..||+|.++... ......|.+|+.++.+++||||++++|++...+..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356888899999999999999874 346789999987542 3345679999999999999999999999999999999
Q ss_pred EEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccch
Q 003278 186 VYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLA 265 (834)
Q Consensus 186 V~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla 265 (834)
||||+++|+|.+++... ...++|..++.++.|++.||+|||+. +++||||||+|||++.++.+|++|||++
T Consensus 84 v~e~~~~~~L~~~l~~~------~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~ 154 (266)
T cd05064 84 VTEYMSNGALDSFLRKH------EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRL 154 (266)
T ss_pred EEEeCCCCcHHHHHHhC------CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccc
Confidence 99999999999998653 23689999999999999999999985 9999999999999999999999999987
Q ss_pred hhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccc
Q 003278 266 RWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQI 344 (834)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~ 344 (834)
........ .......+|..|+|||.+..+ .++.++|||||||++||+++ |+.||......
T Consensus 155 ~~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--- 215 (266)
T cd05064 155 QEDKSEAI---------------YTTMSGKSPVLWAAPEAIQYH-HFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--- 215 (266)
T ss_pred ccccccch---------------hcccCCCCceeecCHHHHhhC-CccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---
Confidence 64321100 001122356889999988654 67899999999999999775 99998643211
Q ss_pred hHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhc
Q 003278 345 ILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSG 407 (834)
Q Consensus 345 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~ 407 (834)
.+.. .+ .++.... .. .. ....+.+++..||+.+|.+||++.++.+.|..
T Consensus 216 ~~~~---~~-~~~~~~~-----~~-~~----~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 216 DVIK---AV-EDGFRLP-----AP-RN----CPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred HHHH---HH-HCCCCCC-----CC-CC----CCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 1111 11 1221111 10 11 12457889999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=350.46 Aligned_cols=239 Identities=23% Similarity=0.362 Sum_probs=193.7
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 187 (834)
++|+..+.||+|+||.||+|++..+|+.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56888899999999999999998899999999986431 233456889999999999999999999999999999999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
||+++|+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 98 e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 167 (329)
T PTZ00263 98 EFVVGGELFTHLRKA-------GRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKK 167 (329)
T ss_pred cCCCCChHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceE
Confidence 999999999998643 3578888999999999999999986 999999999999999999999999999975
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHH
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILL 347 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~ 347 (834)
+... .....||+.|+|||.+... .++.++|||||||++|||+||+.||..... .
T Consensus 168 ~~~~-------------------~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~---~--- 221 (329)
T PTZ00263 168 VPDR-------------------TFTLCGTPEYLAPEVIQSK-GHGKAVDWWTMGVLLYEFIAGYPPFFDDTP---F--- 221 (329)
T ss_pred cCCC-------------------cceecCChhhcCHHHHcCC-CCCCcceeechHHHHHHHHcCCCCCCCCCH---H---
Confidence 4211 2335699999999998654 568999999999999999999999853211 1
Q ss_pred HHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCc
Q 003278 348 DWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPS 397 (834)
Q Consensus 348 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs 397 (834)
...... .++.. .+. ...+ ..+.+++..||+.||.+||+
T Consensus 222 ~~~~~i-~~~~~------~~p-~~~~----~~~~~li~~~L~~dP~~R~~ 259 (329)
T PTZ00263 222 RIYEKI-LAGRL------KFP-NWFD----GRARDLVKGLLQTDHTKRLG 259 (329)
T ss_pred HHHHHH-hcCCc------CCC-CCCC----HHHHHHHHHHhhcCHHHcCC
Confidence 111111 11211 010 1111 35678999999999999997
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=348.20 Aligned_cols=202 Identities=25% Similarity=0.413 Sum_probs=175.3
Q ss_pred hcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc-ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEE
Q 003278 109 GSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 109 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 187 (834)
..++|+..+.||+|+||.||+|.+..+|..+|+|.+... .......+.+|+.++.+++|||||+++++|.+.+..++||
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 347899999999999999999999889999999988654 3344567899999999999999999999999999999999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
||+++|+|.+++... ..+++.....++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||+++.
T Consensus 83 e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~ 153 (333)
T cd06650 83 EHMDGGSLDQVLKKA-------GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 153 (333)
T ss_pred ecCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchh
Confidence 999999999998643 3578889999999999999999974 3799999999999999999999999999875
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCC
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLT 338 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~ 338 (834)
+.... .....||+.|+|||.+... .++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~------------------~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 154 LIDSM------------------ANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred hhhhc------------------cccCCCCccccCHHHhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 42210 1234689999999988644 6789999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=358.13 Aligned_cols=263 Identities=21% Similarity=0.306 Sum_probs=202.4
Q ss_pred hCcCcCCcccccCCcEEEEEEECC------CcEEEEEEecCCCChhHHHHHHHHHHHHHhcc-CCCceeEEEEEeeCCeE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDN------HQYVLVKRLGMSKCPALRTRFSNELQNLARLR-HRNLVQLCGWCTEQGEM 585 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~------~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~-HpNiv~l~g~~~~~~~~ 585 (834)
+.|...++||+|+||.||+|.... +..||||++.........+.|.+|+++|+++. |||||+++|+|.+.+..
T Consensus 37 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (400)
T cd05105 37 DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPI 116 (400)
T ss_pred cceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCce
Confidence 456667889999999999998522 24699999976555555678999999999996 99999999999999999
Q ss_pred EEEEeccCCCchhhhhhcCCCC----------------------------------------------------------
Q 003278 586 LVIYDYSATRILSHLLFHNNHR---------------------------------------------------------- 607 (834)
Q Consensus 586 ~lv~Ey~~~g~L~~~l~~~~~~---------------------------------------------------------- 607 (834)
+|||||+++|+|.++|......
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (400)
T cd05105 117 YIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKE 196 (400)
T ss_pred EEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhh
Confidence 9999999999999988653210
Q ss_pred --------------------------------CCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCC
Q 003278 608 --------------------------------IGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPD 655 (834)
Q Consensus 608 --------------------------------~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~ 655 (834)
.....++|..++.++.|+++||+|||+ .+|+||||||+|||++++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~~~ 273 (400)
T cd05105 197 ASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLAQG 273 (400)
T ss_pred hhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEeCC
Confidence 001247888899999999999999996 689999999999999999
Q ss_pred CCceEeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchh
Q 003278 656 MNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGL 734 (834)
Q Consensus 656 ~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~ 734 (834)
+.+||+|||+++.+..... ........|++.|||||++.+..++.++|||||||++|||+| |..|+........
T Consensus 274 ~~~kL~DfGla~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~ 348 (400)
T cd05105 274 KIVKICDFGLARDIMHDSN-----YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST 348 (400)
T ss_pred CEEEEEeCCcceecccccc-----ccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH
Confidence 9999999999976533211 011223457788999999999999999999999999999997 8888764433322
Q ss_pred HHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccC
Q 003278 735 LVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGN 797 (834)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~ 797 (834)
....... ...+ ...... ...+.+++.+||+.||++||||.+|.++|+..
T Consensus 349 ~~~~~~~---~~~~-------~~~~~~----~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 349 FYNKIKS---GYRM-------AKPDHA----TQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred HHHHHhc---CCCC-------CCCccC----CHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 2211111 0000 011111 12456677799999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=348.49 Aligned_cols=249 Identities=20% Similarity=0.301 Sum_probs=196.4
Q ss_pred hhCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCC---h-hHHHHHHHHHHHHHhcc-CCCceeEEEEEeeCCeE
Q 003278 512 TNNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKC---P-ALRTRFSNELQNLARLR-HRNLVQLCGWCTEQGEM 585 (834)
Q Consensus 512 t~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~---~-~~~~~f~~E~~~l~~l~-HpNiv~l~g~~~~~~~~ 585 (834)
.+.|...+.||+|+||+||.|.. ..+..||||.++.... . ...+...+|+.++++++ ||||++++.++.....+
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~ 95 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI 95 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence 35667778899999999999974 5679999997765411 1 23455678999999999 99999999999999999
Q ss_pred EEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCC-CCceEeeee
Q 003278 586 LVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPD-MNPRLGSFA 664 (834)
Q Consensus 586 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~-~~~ki~DfG 664 (834)
++||||+.+|+|.+++...+ .+.+....+++.|++.|++|||+ .+|+||||||+|||||.+ +++||+|||
T Consensus 96 ~ivmEy~~gGdL~~~i~~~g------~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 96 YIVMEYCSGGDLFDYIVNKG------RLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred EEEEEecCCccHHHHHHHcC------CCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEeccc
Confidence 99999999999999998733 26667778899999999999996 799999999999999999 999999999
Q ss_pred eccccccCCCCCcccccCccccccccCccchhccccCC-CC-ccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHH
Q 003278 665 LAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGE-AT-SMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEF 742 (834)
Q Consensus 665 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~-~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~ 742 (834)
++...... .....+.+||+.|+|||++.+.. |+ .++||||+||+||-|++|..||+.......... .
T Consensus 167 ~s~~~~~~-------~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~k----i 235 (370)
T KOG0583|consen 167 LSAISPGE-------DGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRK----I 235 (370)
T ss_pred cccccCCC-------CCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHH----H
Confidence 99876311 11234679999999999999877 87 569999999999999999999986433222211 1
Q ss_pred HhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHH
Q 003278 743 EARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQIL 791 (834)
Q Consensus 743 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~ 791 (834)
....-.+...++ .. .+..+..+|+..||..|+|+.+|+
T Consensus 236 ~~~~~~~p~~~~--------S~---~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 236 RKGEFKIPSYLL--------SP---EARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred hcCCccCCCCcC--------CH---HHHHHHHHHcCCCcccCCCHHHHh
Confidence 111111111110 22 344455589999999999999998
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=347.94 Aligned_cols=245 Identities=22% Similarity=0.283 Sum_probs=196.9
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 187 (834)
++|+..+.||+|+||.||+|....+|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46888899999999999999998899999999986432 234566889999999999999999999999999999999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
||+++|+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~ 150 (291)
T cd05612 81 EYVPGGELFSYLRNS-------GRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKK 150 (291)
T ss_pred eCCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchh
Confidence 999999999998643 3588899999999999999999985 999999999999999999999999999875
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHH
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILL 347 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~ 347 (834)
+... .....||+.|+|||.+... .++.++|||||||++|||+||+.||......
T Consensus 151 ~~~~-------------------~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~------ 204 (291)
T cd05612 151 LRDR-------------------TWTLCGTPEYLAPEVIQSK-GHNKAVDWWALGILIYEMLVGYPPFFDDNPF------ 204 (291)
T ss_pred ccCC-------------------cccccCChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------
Confidence 4211 2234699999999988654 5789999999999999999999998643211
Q ss_pred HHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCc-----hhhHHH
Q 003278 348 DWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPS-----MKWVIE 403 (834)
Q Consensus 348 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----m~~V~~ 403 (834)
....... .+.. .+. ... ...+.++...||+.||.+||+ +.++++
T Consensus 205 ~~~~~i~-~~~~------~~~-~~~----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 205 GIYEKIL-AGKL------EFP-RHL----DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred HHHHHHH-hCCc------CCC-ccC----CHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 1111111 1111 011 111 135778999999999999995 555553
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=345.79 Aligned_cols=242 Identities=23% Similarity=0.302 Sum_probs=192.5
Q ss_pred eeccCCeEEEEEEECCCCeEEEEEEeccc---ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEccCCCCH
Q 003278 119 LGSGGFGKVYRAVLPSDGTVVAVKCLAEK---GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNRSL 195 (834)
Q Consensus 119 LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 195 (834)
||+|+||.||+|....+++.||+|++... .......+.+|+.++.+++||||++++++|...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999889999999998643 233446688999999999999999999999999999999999999999
Q ss_pred hHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhhhhhhh
Q 003278 196 DRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQ 275 (834)
Q Consensus 196 ~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 275 (834)
.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--- 147 (312)
T cd05585 81 FHHLQRE-------GRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--- 147 (312)
T ss_pred HHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC---
Confidence 9998643 3588999999999999999999985 99999999999999999999999999987432110
Q ss_pred hhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHHHHHHhh
Q 003278 276 MRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIRRLSD 355 (834)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~ 355 (834)
.......||+.|+|||.+... .++.++|||||||++|||+||+.||.... ..........
T Consensus 148 -------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~------~~~~~~~~~~ 207 (312)
T cd05585 148 -------------DKTNTFCGTPEYLAPELLLGH-GYTKAVDWWTLGVLLYEMLTGLPPFYDEN------VNEMYRKILQ 207 (312)
T ss_pred -------------CccccccCCcccCCHHHHcCC-CCCCccceechhHHHHHHHhCCCCcCCCC------HHHHHHHHHc
Confidence 112345799999999988654 67999999999999999999999986421 1122222211
Q ss_pred cCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHh
Q 003278 356 EGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAV 405 (834)
Q Consensus 356 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l 405 (834)
. .. .+. ... ...+.+++..||+.||.+||+...+.+.|
T Consensus 208 ~-~~------~~~-~~~----~~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 208 E-PL------RFP-DGF----DRDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred C-CC------CCC-CcC----CHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 1 10 111 111 13577899999999999999765555544
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=349.83 Aligned_cols=242 Identities=25% Similarity=0.292 Sum_probs=192.9
Q ss_pred CeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEccCCC
Q 003278 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNR 193 (834)
Q Consensus 117 ~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 193 (834)
+.||+|+||.||+|....+|+.||||++.... ......+.+|+.++.+++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999998999999999986532 233456788999999999999999999999999999999999999
Q ss_pred CHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhhhhh
Q 003278 194 SLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQ 273 (834)
Q Consensus 194 sL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~ 273 (834)
+|..++... ..+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~-------~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 148 (323)
T cd05571 81 ELFFHLSRE-------RVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-- 148 (323)
T ss_pred cHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--
Confidence 999888643 3688999999999999999999985 9999999999999999999999999998742110
Q ss_pred hhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHHHHHH
Q 003278 274 YQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIRRL 353 (834)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~ 353 (834)
........||+.|+|||.+... .++.++|||||||++|||+||+.||.... ...+...+
T Consensus 149 --------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~---~~~~~~~~--- 207 (323)
T cd05571 149 --------------GATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HEKLFELI--- 207 (323)
T ss_pred --------------CCcccceecCccccChhhhcCC-CCCccccCcccchhhhhhhcCCCCCCCCC---HHHHHHHH---
Confidence 0112346799999999988644 67999999999999999999999985421 11111111
Q ss_pred hhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----chhhHHH
Q 003278 354 SDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRP-----SMKWVIE 403 (834)
Q Consensus 354 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~~V~~ 403 (834)
. .+. ..+. ... ...+.++...||+.||++|| +..++++
T Consensus 208 ~-~~~------~~~p-~~~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 208 L-MEE------IRFP-RTL----SPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred H-cCC------CCCC-CCC----CHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 1 111 1111 111 23577899999999999999 6777765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=340.22 Aligned_cols=260 Identities=23% Similarity=0.352 Sum_probs=202.7
Q ss_pred CcCcCCcccccCCcEEEEEEECCC------cEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEE
Q 003278 514 NFSESQRVAEMDFGTAYQGFLDNH------QYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLV 587 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~~~~------~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~l 587 (834)
+|...+.||+|+||.||+|..... ..||+|.+..........+|.+|+.++.+++||||+++++++.+.+..++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 566678899999999999986432 57999998766556666789999999999999999999999999899999
Q ss_pred EEeccCCCchhhhhhcCCCCC----------CCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCC
Q 003278 588 IYDYSATRILSHLLFHNNHRI----------GHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMN 657 (834)
Q Consensus 588 v~Ey~~~g~L~~~l~~~~~~~----------~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~ 657 (834)
+|||+++|+|.+++....... ....+++...+.++.|++.||+|||+ .+|+||||||+|||+++++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCCc
Confidence 999999999999987542111 11357888999999999999999997 68999999999999999999
Q ss_pred ceEeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHH
Q 003278 658 PRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLV 736 (834)
Q Consensus 658 ~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~ 736 (834)
+||+|||+++........ .......+|+.|||||++.++.++.++|||||||++|||+| |..|+....+.. ..
T Consensus 163 ~~L~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~-~~ 236 (283)
T cd05048 163 VKISDFGLSRDIYSADYY-----RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE-VI 236 (283)
T ss_pred EEECCCcceeeccccccc-----cccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH-HH
Confidence 999999999764322110 01122356888999999998999999999999999999998 988886543322 21
Q ss_pred HHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHcc
Q 003278 737 KRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDG 796 (834)
Q Consensus 737 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~ 796 (834)
..+. ...... .... .+ .++.+++.+||+.||.+|||+.+|++.|++
T Consensus 237 ~~i~-----~~~~~~-----~~~~-~~---~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 237 EMIR-----SRQLLP-----CPED-CP---ARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHH-----cCCcCC-----Cccc-CC---HHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1111 111111 1111 12 345566679999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=343.64 Aligned_cols=248 Identities=23% Similarity=0.398 Sum_probs=204.1
Q ss_pred CcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEecc
Q 003278 514 NFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYS 592 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~ 592 (834)
-|....+||.|.||.||||.. ..+..||+|.++.+......+...+|+.+|+.++||||.++||.+.....++++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 456668899999999999995 4578899999998877776778899999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccC
Q 003278 593 ATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRN 672 (834)
Q Consensus 593 ~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~ 672 (834)
.+|++.++|.... .++.....-|++++..||.|||+ .+.||||||+.|||+..+|.+|++|||++..++..
T Consensus 94 ~gGsv~~lL~~~~------~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~ 164 (467)
T KOG0201|consen 94 GGGSVLDLLKSGN------ILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNT 164 (467)
T ss_pred cCcchhhhhccCC------CCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeech
Confidence 9999999986543 23444445589999999999997 68999999999999999999999999999887654
Q ss_pred CCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCccccc
Q 003278 673 DHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAEL 752 (834)
Q Consensus 673 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (834)
. ....+++||+.|||||++....|+.|+||||+||+.+||++|..|+....|...+.. +.+-
T Consensus 165 ~-------~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl-----------Ipk~ 226 (467)
T KOG0201|consen 165 V-------KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL-----------IPKS 226 (467)
T ss_pred h-------hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe-----------ccCC
Confidence 2 123468999999999999988999999999999999999999999876666432211 1111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 753 VDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 753 ~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
..|.+.+.+. +.+.+++. .|++.||+.|||+.++++
T Consensus 227 ~PP~L~~~~S-~~~kEFV~---~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 227 APPRLDGDFS-PPFKEFVE---ACLDKNPEFRPSAKELLK 262 (467)
T ss_pred CCCccccccC-HHHHHHHH---HHhhcCcccCcCHHHHhh
Confidence 2344555333 34455554 799999999999999985
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=346.86 Aligned_cols=199 Identities=20% Similarity=0.289 Sum_probs=174.7
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
++|...+.||+|+||.||++... ++..+|+|.+.....+...++|.+|+++|++++|||||++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence 57888889999999999999965 57889999987665556667899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccccc
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTR 671 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~ 671 (834)
+++|+|.+++.... .+++.....++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||++..+..
T Consensus 85 ~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 85 MDGGSLDQVLKEAK------RIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred CCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence 99999999986532 377888889999999999999973 4699999999999999999999999999875432
Q ss_pred CCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCC
Q 003278 672 NDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDF 728 (834)
Q Consensus 672 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~ 728 (834)
. ......||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 157 ~---------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 157 S---------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred c---------ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 1 12245799999999999998999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=348.40 Aligned_cols=258 Identities=19% Similarity=0.303 Sum_probs=199.3
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCc----EEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQ----YVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLV 587 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~----~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~l 587 (834)
.+|...+.||+|+||.||+|.+. ++. .||||.+.........++|.+|+.+++.++||||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46888899999999999999853 333 38999987655555567899999999999999999999999874 5679
Q ss_pred EEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecc
Q 003278 588 IYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAE 667 (834)
Q Consensus 588 v~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~ 667 (834)
++||+++|+|.+++..... .+++...+.++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++
T Consensus 86 v~e~~~~g~l~~~l~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~ 157 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (316)
T ss_pred eeecCCCCCHHHHHHhccc-----cCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccc
Confidence 9999999999999875432 37888899999999999999996 689999999999999999999999999998
Q ss_pred ccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhc
Q 003278 668 FLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARK 746 (834)
Q Consensus 668 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~ 746 (834)
.+...... .......++..|||||++.+..++.++|||||||++|||+| |+.|+...... ...... ....
T Consensus 158 ~~~~~~~~-----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~-~~~~~~---~~~~ 228 (316)
T cd05108 158 LLGADEKE-----YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-EISSIL---EKGE 228 (316)
T ss_pred cccCCCcc-----eeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHH---hCCC
Confidence 75432210 01112235678999999999999999999999999999998 88888643221 111111 1110
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCc
Q 003278 747 RPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDK 799 (834)
Q Consensus 747 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~ 799 (834)
. ... ..... ..+.+++.+||..+|++||||.+|+..|....+
T Consensus 229 ~----~~~---~~~~~----~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 229 R----LPQ---PPICT----IDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred C----CCC---CCCCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 0 000 01111 245567779999999999999999998875544
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=372.29 Aligned_cols=188 Identities=25% Similarity=0.307 Sum_probs=159.0
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc---ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK---GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 187 (834)
++|.+.+.||+|+||.||+|.+..+++.||||++... .......+..|+.++..++||||+++++++...+.+||||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 5788899999999999999999889999999998643 2334567889999999999999999999999999999999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
||+++++|..++... ..+++...+.|+.||+.||.|||.. +||||||||+|||++.++.+||+|||+++.
T Consensus 84 Ey~~g~~L~~li~~~-------~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~~ 153 (669)
T cd05610 84 EYLIGGDVKSLLHIY-------GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153 (669)
T ss_pred eCCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCcc
Confidence 999999999998643 3578889999999999999999985 999999999999999999999999999986
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhH
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIV 324 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvv 324 (834)
..... .......||+.|++||...........+++||+|.-
T Consensus 154 ~~~~~----------------~~~~~~~~t~~~~~pe~~~~~~~~~~~s~~~s~g~~ 194 (669)
T cd05610 154 TLNRE----------------LNMMDILTTPSMAKPKNDYSRTPGQVLSLISSLGFN 194 (669)
T ss_pred ccCCc----------------ccccccccCccccCccccccCCCCceeeeeeecCcC
Confidence 42211 012345689999999976544445567889999953
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=342.00 Aligned_cols=267 Identities=23% Similarity=0.285 Sum_probs=199.1
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYD 188 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 188 (834)
++|+..+.||+|+||.||+|+++.+++.||||++... .....+.+.+|+.++++++||||++++++|...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 4688899999999999999999889999999998643 23345678899999999999999999999999999999999
Q ss_pred ccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhh
Q 003278 189 YMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWL 268 (834)
Q Consensus 189 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~ 268 (834)
|++++++..+... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+
T Consensus 81 ~~~~~~l~~~~~~-------~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 150 (287)
T cd07848 81 YVEKNMLELLEEM-------PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNL 150 (287)
T ss_pred cCCCCHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccc
Confidence 9999887655422 23588999999999999999999985 9999999999999999999999999999764
Q ss_pred hhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHH
Q 003278 269 EHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLD 348 (834)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~ 348 (834)
..... .......||+.|+|||++... .++.++|||||||++|||++|+.||......+......
T Consensus 151 ~~~~~---------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~ 214 (287)
T cd07848 151 SEGSN---------------ANYTEYVATRWYRSPELLLGA-PYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQ 214 (287)
T ss_pred ccccc---------------ccccccccccccCCcHHHcCC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 32100 012345689999999998654 57899999999999999999999986532211111000
Q ss_pred ---------HHHHHhhcCccccccccccCCCC-----CCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 349 ---------WIRRLSDEGKVLQAGDNRLSDGS-----YKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 349 ---------~~~~~~~~~~~~~~~d~~l~~~~-----~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
+...............+...... +.......+.++...||+.||++||++.++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 215 KVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred HhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000000000000000000 00001235789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=321.90 Aligned_cols=263 Identities=25% Similarity=0.295 Sum_probs=201.2
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC--hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeC--CEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG--ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHE--DQLLLV 186 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lV 186 (834)
++|+..+.|++|.||.||+|+++.++++||+|+++... +.+.-.-++||.+|.+++|||||.+....... +.+|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 45888899999999999999999999999999987542 33445568999999999999999998877643 579999
Q ss_pred EEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchh
Q 003278 187 YDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLAR 266 (834)
Q Consensus 187 ~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~ 266 (834)
||||.. +|..++...+ .++...+.+.++.|+++||+|||.. .|+||||||||+|+.+.|.+||+||||||
T Consensus 156 Me~~Eh-DLksl~d~m~------q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR 225 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK------QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAR 225 (419)
T ss_pred HHHHHh-hHHHHHHhcc------CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhh
Confidence 999975 8988887653 4688889999999999999999985 89999999999999999999999999999
Q ss_pred hhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchH
Q 003278 267 WLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIIL 346 (834)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l 346 (834)
.+.+.. ...|..+-|.+|.|||.+.....|+...|+||+|||+.||+++++-|.....-++.
T Consensus 226 ~ygsp~----------------k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl-- 287 (419)
T KOG0663|consen 226 EYGSPL----------------KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQL-- 287 (419)
T ss_pred hhcCCc----------------ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHH--
Confidence 764321 12466778999999999998889999999999999999999999888654433332
Q ss_pred HHHHHHHhhcCcccccccccc-----------CC-------CCCCHH-HHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 347 LDWIRRLSDEGKVLQAGDNRL-----------SD-------GSYKLC-DMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 347 ~~~~~~~~~~~~~~~~~d~~l-----------~~-------~~~~~~-~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
+-+-.++.- -.+.+-|.. .. ..+... -.+.-.+|.-.-+..||.+|-|+.+-++.
T Consensus 288 -~~If~llGt--Pte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 288 -DKIFKLLGT--PSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred -HHHHHHhCC--CccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 222222211 011111100 00 111111 01233456666678899999999987653
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=344.05 Aligned_cols=246 Identities=20% Similarity=0.309 Sum_probs=187.7
Q ss_pred cCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEeccC
Q 003278 515 FSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSA 593 (834)
Q Consensus 515 f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~~ 593 (834)
|...+.||+|+||.||+|... +++.||||.+...........|.+|++++++++|||||++++++.+.+..++||||+.
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 155 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD 155 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence 344578999999999999864 6889999998765555566789999999999999999999999999999999999999
Q ss_pred CCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCC
Q 003278 594 TRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRND 673 (834)
Q Consensus 594 ~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~ 673 (834)
+|+|.... .+.+.....++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++.+....
T Consensus 156 ~~~L~~~~----------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 156 GGSLEGTH----------IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred CCcccccc----------cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 99986432 24556677899999999999996 699999999999999999999999999998653221
Q ss_pred CCCcccccCccccccccCccchhccccC-----CCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCc
Q 003278 674 HGHRKATSGNRSVRGIFGYMSPEYIESG-----EATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRP 748 (834)
Q Consensus 674 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-----~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
.......||..|+|||++... ..+.++|||||||++|||++|+.||....... .............
T Consensus 223 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~- 293 (353)
T PLN00034 223 -------DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD-WASLMCAICMSQP- 293 (353)
T ss_pred -------ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc-HHHHHHHHhccCC-
Confidence 112235799999999988532 23458999999999999999999986322211 1111111100000
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 749 LAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 749 ~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
+...... .. .+.+++.+||+.||++|||+.||++
T Consensus 294 ------~~~~~~~-~~---~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 294 ------PEAPATA-SR---EFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred ------CCCCCcc-CH---HHHHHHHHHccCChhhCcCHHHHhc
Confidence 0011111 22 3455666899999999999999986
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=342.50 Aligned_cols=264 Identities=21% Similarity=0.261 Sum_probs=198.0
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC-hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEc
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG-ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDY 189 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 189 (834)
++|...+.||+|+||.||+|....++..||+|.+.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46888899999999999999998899999999986432 23345678999999999999999999999999999999999
Q ss_pred cCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhh
Q 003278 190 MPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLE 269 (834)
Q Consensus 190 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~ 269 (834)
+++ +|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 85 ~~~-~l~~~l~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~ 154 (288)
T cd07871 85 LDS-DLKQYLDNCG------NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKS 154 (288)
T ss_pred CCc-CHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence 984 8988875432 3578899999999999999999985 99999999999999999999999999987432
Q ss_pred hhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHH
Q 003278 270 HELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDW 349 (834)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~ 349 (834)
... .......||+.|+|||.+.....++.++|||||||++|||+||+.||......+.. ..
T Consensus 155 ~~~----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~---~~ 215 (288)
T cd07871 155 VPT----------------KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEEL---HL 215 (288)
T ss_pred CCC----------------ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HH
Confidence 110 00123458999999998876556789999999999999999999998654322111 11
Q ss_pred HHHHhhc------------CccccccccccCCCCC---CHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 350 IRRLSDE------------GKVLQAGDNRLSDGSY---KLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 350 ~~~~~~~------------~~~~~~~d~~l~~~~~---~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
+...... ........+....... .........++...|++.||.+|||+.|+++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 216 IFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred HHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 1111000 0000000000000000 0000134678999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=352.81 Aligned_cols=250 Identities=22% Similarity=0.421 Sum_probs=193.6
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc-ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEc
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDY 189 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 189 (834)
++|+..+.||+|+||.||+|.+..+|+.||||++... .....+.+.+|+.+++.++|+||+++++++...+.+++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 3466778999999999999999889999999998643 334557789999999999999999999999999999999999
Q ss_pred cCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhh
Q 003278 190 MPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLE 269 (834)
Q Consensus 190 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~ 269 (834)
+++|+|.... .+++..+..|+.||+.||.|||+. +|+||||||+|||+++++.+||+|||+++.+.
T Consensus 154 ~~~~~L~~~~-----------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~ 219 (353)
T PLN00034 154 MDGGSLEGTH-----------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILA 219 (353)
T ss_pred CCCCcccccc-----------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecc
Confidence 9999985431 345677889999999999999985 99999999999999999999999999997543
Q ss_pred hhhhhhhhcccccccccccccceeeeccccCCCcccccc----CCCCCcccceeehhhHHHHHHhCCccCCCCCCCccch
Q 003278 270 HELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQK----GSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQII 345 (834)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~----~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~ 345 (834)
... .......||..|+|||.+.. +...+.++|||||||++|||++|+.||......+...
T Consensus 220 ~~~----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~ 283 (353)
T PLN00034 220 QTM----------------DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWAS 283 (353)
T ss_pred ccc----------------ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHH
Confidence 210 01233469999999998743 2334568999999999999999999987332221111
Q ss_pred HHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 346 LLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 346 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
+. ..... ... +... .. ....+.+++..||+.||++||++.|+++.
T Consensus 284 ~~---~~~~~-~~~-----~~~~-~~----~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 284 LM---CAICM-SQP-----PEAP-AT----ASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred HH---HHHhc-cCC-----CCCC-Cc----cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11 11000 000 0000 11 12457889999999999999999999874
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=345.45 Aligned_cols=252 Identities=20% Similarity=0.274 Sum_probs=199.2
Q ss_pred cCCcccccCCcEEEEEEECCC-cEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEeccCCC
Q 003278 517 ESQRVAEMDFGTAYQGFLDNH-QYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATR 595 (834)
Q Consensus 517 ~~~~ig~g~~g~vy~~~~~~~-~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~~~g 595 (834)
-..++|-|.||.||.|.++.. ..||||.++.+..+ .++|+.|+.+|+.++|||+|+|+|+|+....+|||.|||.+|
T Consensus 271 MkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe--veEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yG 348 (1157)
T KOG4278|consen 271 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYG 348 (1157)
T ss_pred eeeccCCCcccceeeeeeeccceeeehhhhhhcchh--HHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCc
Confidence 357899999999999998774 46999999876544 478999999999999999999999999999999999999999
Q ss_pred chhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCCCC
Q 003278 596 ILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHG 675 (834)
Q Consensus 596 ~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~~~ 675 (834)
+|.+||++.++. .++--..+.+|.||+.||+||.. +..|||||..+|+|+.++..+||+||||+++++.+.+.
T Consensus 349 NLLdYLRecnr~----ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT 421 (1157)
T KOG4278|consen 349 NLLDYLRECNRS----EVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT 421 (1157)
T ss_pred cHHHHHHHhchh----hcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhhcCCcee
Confidence 999999987642 35555668899999999999985 78999999999999999999999999999998765321
Q ss_pred CcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcccccccc
Q 003278 676 HRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDL 755 (834)
Q Consensus 676 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 755 (834)
......-.+.|.|||.+....++.|+|||+|||+|||+.|-.+..+....-..+...+......++
T Consensus 422 ------AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~-------- 487 (1157)
T KOG4278|consen 422 ------AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDG-------- 487 (1157)
T ss_pred ------cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccC--------
Confidence 111223356799999999999999999999999999999966544433322211111111111111
Q ss_pred ccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccC
Q 003278 756 SLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGN 797 (834)
Q Consensus 756 ~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~ 797 (834)
.+.|+ ..+.+||..||+-+|.+||+|+||.+.++..
T Consensus 488 ---PeGCP---pkVYeLMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 488 ---PEGCP---PKVYELMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred ---CCCCC---HHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence 12233 3456777899999999999999999988743
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=344.82 Aligned_cols=257 Identities=24% Similarity=0.386 Sum_probs=199.3
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeE----EEEEEeccc-ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTV----VAVKCLAEK-GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLL 185 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~----vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 185 (834)
++|+..+.||+|+||.||+|++..+|.. ||||.+... .....+.|.+|+.+++.++||||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 4689999999999999999998666554 899998654 234567899999999999999999999999865 5789
Q ss_pred EEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccch
Q 003278 186 VYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLA 265 (834)
Q Consensus 186 V~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla 265 (834)
|+||+++|+|.+++.... ..+++...+.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 86 v~e~~~~g~l~~~l~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a 156 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK------DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLA 156 (316)
T ss_pred eeecCCCCCHHHHHHhcc------ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccc
Confidence 999999999999987532 3578999999999999999999985 9999999999999999999999999999
Q ss_pred hhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccc
Q 003278 266 RWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQI 344 (834)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~ 344 (834)
+.+...... .......+|..|+|||++... .++.++|||||||++|||+| |+.|++.....
T Consensus 157 ~~~~~~~~~--------------~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--- 218 (316)
T cd05108 157 KLLGADEKE--------------YHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--- 218 (316)
T ss_pred ccccCCCcc--------------eeccCCccceeecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---
Confidence 865322100 001112346789999998654 67899999999999999998 99988642111
Q ss_pred hHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcCC
Q 003278 345 ILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGSY 409 (834)
Q Consensus 345 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~~ 409 (834)
.+. .....+.... .+ ... ...+..++..||+.+|..||+|.+++..+....
T Consensus 219 ~~~----~~~~~~~~~~--~~----~~~----~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 219 EIS----SILEKGERLP--QP----PIC----TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred HHH----HHHhCCCCCC--CC----CCC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 111 1111111110 01 111 135788999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=337.66 Aligned_cols=262 Identities=26% Similarity=0.432 Sum_probs=204.1
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCC-----eEEEEEEecccC-hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDG-----TVVAVKCLAEKG-ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLL 184 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g-----~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 184 (834)
++|+..+.||+|+||.||+|.....+ ..||+|.+.... ......|.+|+.++.+++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 45888899999999999999875544 689999986543 344567899999999999999999999999999999
Q ss_pred EEEEccCCCCHhHHHhcCCCccc---------cCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCC
Q 003278 185 LVYDYMPNRSLDRVLFRRPENLE---------AAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQY 255 (834)
Q Consensus 185 lV~Ey~~~gsL~~~l~~~~~~~~---------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~ 255 (834)
++|||+++|+|.+++........ ....+++.....++.|++.||.|||+. +|+||||||+|||+++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 99999999999999975422110 114689999999999999999999985 999999999999999999
Q ss_pred ceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCcc
Q 003278 256 NARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRA 334 (834)
Q Consensus 256 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p 334 (834)
.+||+|||+++........ ...+...+|+.|+|||++..+ .++.++|||||||++|||+| |+.|
T Consensus 162 ~~~L~dfg~~~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~slG~il~el~~~g~~p 226 (283)
T cd05048 162 TVKISDFGLSRDIYSADYY--------------RVQSKSLLPVRWMPPEAILYG-KFTTESDIWSFGVVLWEIFSYGLQP 226 (283)
T ss_pred cEEECCCcceeeccccccc--------------cccCCCcccccccCHHHhccC-cCchhhhHHHHHHHHHHHHcCCCCC
Confidence 9999999999754221100 012233478899999988655 57999999999999999998 9999
Q ss_pred CCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhc
Q 003278 335 VDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSG 407 (834)
Q Consensus 335 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~ 407 (834)
|...... .+..++ ..+...... . .....+.+|+..||+.||.+||++.+|++.|+.
T Consensus 227 ~~~~~~~---~~~~~i----~~~~~~~~~------~----~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 227 YYGFSNQ---EVIEMI----RSRQLLPCP------E----DCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred CCCCCHH---HHHHHH----HcCCcCCCc------c----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 8643221 111111 112111110 1 112568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=333.64 Aligned_cols=251 Identities=20% Similarity=0.342 Sum_probs=197.8
Q ss_pred CcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEeccC
Q 003278 514 NFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSA 593 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~~ 593 (834)
+|...+.||+|+||.||++...++..+|+|.+..... ..+.|.+|+.+|++++||||++++++|.+.+..++||||++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM--SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc--cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 4566678999999999999998888899998764322 23578899999999999999999999999999999999999
Q ss_pred CCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCC
Q 003278 594 TRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRND 673 (834)
Q Consensus 594 ~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~ 673 (834)
+|+|.+++.... ..++|..+..++.|++.||+|||+ .+|+||||||+||++++++.+|++|||+++......
T Consensus 83 ~~~L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05114 83 NGCLLNYLRQRQ-----GKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE 154 (256)
T ss_pred CCcHHHHHHhCc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCc
Confidence 999999886432 237899999999999999999996 689999999999999999999999999997643221
Q ss_pred CCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCccccc
Q 003278 674 HGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRPLAEL 752 (834)
Q Consensus 674 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (834)
. .......++..|+|||++.+..++.++|||||||++|||+| |+.|+........ ...+.. ...+
T Consensus 155 ~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~-~~~i~~---~~~~---- 220 (256)
T cd05114 155 Y------TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV-VEMISR---GFRL---- 220 (256)
T ss_pred e------eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHHC---CCCC----
Confidence 1 01112345678999999988889999999999999999999 8888864432221 121111 1111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHc
Q 003278 753 VDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795 (834)
Q Consensus 753 ~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~ 795 (834)
..+. ... ..+.+++.+||+.+|++||||.+|++.|.
T Consensus 221 ~~~~----~~~---~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 221 YRPK----LAS---MTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CCCC----CCC---HHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1111 111 24667778999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=348.12 Aligned_cols=245 Identities=22% Similarity=0.322 Sum_probs=195.4
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCC-eEEEEEEeccc---ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDG-TVVAVKCLAEK---GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLV 186 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g-~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 186 (834)
++|+..+.||+|+||.||+|.+..++ ..||+|++... .....+.+.+|+.++..++|||||++++++.+.+..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 56888999999999999999875554 68999998643 223456788999999999999999999999999999999
Q ss_pred EEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchh
Q 003278 187 YDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLAR 266 (834)
Q Consensus 187 ~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~ 266 (834)
|||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 110 ~Ey~~~g~L~~~i~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~ 179 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRN-------KRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAK 179 (340)
T ss_pred EeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCe
Confidence 9999999999998643 3588999999999999999999985 99999999999999999999999999997
Q ss_pred hhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchH
Q 003278 267 WLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIIL 346 (834)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l 346 (834)
.+... .....||+.|||||++... .++.++|||||||++|||+||+.||....+ ...
T Consensus 180 ~~~~~-------------------~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~---~~~ 236 (340)
T PTZ00426 180 VVDTR-------------------TYTLCGTPEYIAPEILLNV-GHGKAADWWTLGIFIYEILVGCPPFYANEP---LLI 236 (340)
T ss_pred ecCCC-------------------cceecCChhhcCHHHHhCC-CCCccccccchhhHHHHHhcCCCCCCCCCH---HHH
Confidence 53211 2345699999999998654 578999999999999999999999864321 111
Q ss_pred HHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----chhhHHH
Q 003278 347 LDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRP-----SMKWVIE 403 (834)
Q Consensus 347 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~~V~~ 403 (834)
..... .+.. .+. ...+ ..+.+++..|++.+|.+|+ ++.++.+
T Consensus 237 ---~~~i~-~~~~------~~p-~~~~----~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 237 ---YQKIL-EGII------YFP-KFLD----NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred ---HHHHh-cCCC------CCC-CCCC----HHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 11111 1111 011 1111 3467899999999999995 6777664
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=336.03 Aligned_cols=202 Identities=23% Similarity=0.377 Sum_probs=167.9
Q ss_pred hCcCcCCcccccCCcEEEEEE-ECCCcEEEEEEecCCCC-hhHHHHHHHHHHHHHhccCCCceeEEEEEeeC--CeEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGF-LDNHQYVLVKRLGMSKC-PALRTRFSNELQNLARLRHRNLVQLCGWCTEQ--GEMLVI 588 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~-~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~--~~~~lv 588 (834)
+.|....+||+|.||.||||+ +.+|..||+|++..+.. +....-..+||.+|++|+|||||+|.+..++. +.+|+|
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 456667889999999999998 67899999999987653 33334457899999999999999999988876 689999
Q ss_pred EeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccc
Q 003278 589 YDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEF 668 (834)
Q Consensus 589 ~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~ 668 (834)
+|||+. +|..++...+ ..++..+.-.++.|++.||+|||+ .+|+|||||++|||||.+|.+||+|||||++
T Consensus 197 FeYMdh-DL~GLl~~p~-----vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~ 267 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSPG-----VKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARF 267 (560)
T ss_pred Eecccc-hhhhhhcCCC-----cccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceee
Confidence 999987 5656654432 247788888999999999999996 7999999999999999999999999999998
Q ss_pred cccCCCCCcccccCccccccccCccchhccccC-CCCccCcchhhHHHHHHHHhCCCccCCC
Q 003278 669 LTRNDHGHRKATSGNRSVRGIFGYMSPEYIESG-EATSMADVYSFGVVVLEVVTGQMAVDFR 729 (834)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~k~DV~SfGvvl~E~~tG~~p~~~~ 729 (834)
....... ..++.+-|.-|.|||.+.+. .|+.++|+||.||||.||++|+..+...
T Consensus 268 y~~~~~~------~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~ 323 (560)
T KOG0600|consen 268 YTPSGSA------PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGR 323 (560)
T ss_pred ccCCCCc------ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCc
Confidence 6544321 12344568999999998764 6999999999999999999998776543
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=347.52 Aligned_cols=243 Identities=23% Similarity=0.301 Sum_probs=192.9
Q ss_pred CeeeccCCeEEEEEEECCCCeEEEEEEeccc---ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEccCCC
Q 003278 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK---GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNR 193 (834)
Q Consensus 117 ~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 193 (834)
++||+|+||.||++....+|+.||||++... .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4799999999999999889999999998653 2234467889999999999999999999999999999999999999
Q ss_pred CHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhhhhh
Q 003278 194 SLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQ 273 (834)
Q Consensus 194 sL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~ 273 (834)
+|..++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~- 149 (328)
T cd05593 81 ELFFHLSRE-------RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA- 149 (328)
T ss_pred CHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-
Confidence 999888543 3588999999999999999999985 99999999999999999999999999987421110
Q ss_pred hhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHHHHHH
Q 003278 274 YQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIRRL 353 (834)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~ 353 (834)
.......||+.|+|||.+... .++.++|||||||++|||+||+.||...... ......
T Consensus 150 ---------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~Pf~~~~~~------~~~~~~ 207 (328)
T cd05593 150 ---------------ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELI 207 (328)
T ss_pred ---------------cccccccCCcCccChhhhcCC-CCCccCCccccchHHHHHhhCCCCCCCCCHH------HHHHHh
Confidence 012345699999999998654 5789999999999999999999998642211 111111
Q ss_pred hhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----chhhHHHH
Q 003278 354 SDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRP-----SMKWVIEA 404 (834)
Q Consensus 354 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~~V~~~ 404 (834)
.. +. ..+. ... ...+.++...||+.||.+|| ++.++++.
T Consensus 208 ~~-~~------~~~p-~~~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 208 LM-ED------IKFP-RTL----SADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred cc-CC------ccCC-CCC----CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 11 10 1111 111 13567889999999999997 77777653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=343.93 Aligned_cols=244 Identities=24% Similarity=0.333 Sum_probs=190.3
Q ss_pred CeeeccCCeEEEEEEECCCCeEEEEEEeccc---ChhhHHHHHHHHHHHHhC-CCCceeeEeeeEEeCCEEEEEEEccCC
Q 003278 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK---GERFEKTFAAELVAVAHL-RHRNLVRLRGWCVHEDQLLLVYDYMPN 192 (834)
Q Consensus 117 ~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 192 (834)
+.||+|+||.||+|....+++.||+|++... .....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999998753 223345677888888776 899999999999999999999999999
Q ss_pred CCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhhhh
Q 003278 193 RSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHEL 272 (834)
Q Consensus 193 gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~ 272 (834)
|+|..++... ..+++..+..|+.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~~L~~~~~~~-------~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~ 150 (329)
T cd05618 81 GDLMFHMQRQ-------RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 150 (329)
T ss_pred CCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC
Confidence 9998887542 3588999999999999999999985 99999999999999999999999999987421100
Q ss_pred hhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCc--cchHHHHH
Q 003278 273 QYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDD--QIILLDWI 350 (834)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~--~~~l~~~~ 350 (834)
.......||+.|+|||++... .++.++|||||||++|||+||+.||....... ......++
T Consensus 151 ----------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~ 213 (329)
T cd05618 151 ----------------DTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 213 (329)
T ss_pred ----------------CccccccCCccccCHHHHcCC-CCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHH
Confidence 012345799999999998654 67889999999999999999999996322111 11122333
Q ss_pred HHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCch
Q 003278 351 RRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSM 398 (834)
Q Consensus 351 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm 398 (834)
......... .+. ... ...+..++..||+.||.+||+.
T Consensus 214 ~~~i~~~~~------~~p-~~~----~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 214 FQVILEKQI------RIP-RSL----SVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred HHHHhcCCC------CCC-CCC----CHHHHHHHHHHhcCCHHHcCCC
Confidence 332222111 111 111 2357789999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=342.83 Aligned_cols=244 Identities=23% Similarity=0.320 Sum_probs=191.7
Q ss_pred CeeeccCCeEEEEEEECCCCeEEEEEEeccc---ChhhHHHHHHHHHHHHhC-CCCceeeEeeeEEeCCEEEEEEEccCC
Q 003278 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK---GERFEKTFAAELVAVAHL-RHRNLVRLRGWCVHEDQLLLVYDYMPN 192 (834)
Q Consensus 117 ~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 192 (834)
++||+|+||.||+|....++..||||+++.. .....+.+..|..++.++ +||||++++++|...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4799999999999999889999999998753 223345678899999988 799999999999999999999999999
Q ss_pred CCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhhhh
Q 003278 193 RSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHEL 272 (834)
Q Consensus 193 gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~ 272 (834)
|+|..++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 g~L~~~~~~~-------~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~- 149 (329)
T cd05588 81 GDLMFHMQRQ-------RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP- 149 (329)
T ss_pred CCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccC-
Confidence 9998887542 3589999999999999999999985 9999999999999999999999999998632110
Q ss_pred hhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCc--cchHHHHH
Q 003278 273 QYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDD--QIILLDWI 350 (834)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~--~~~l~~~~ 350 (834)
........||+.|+|||++... .++.++|||||||++|||+||+.||+.....+ .....++.
T Consensus 150 ---------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~ 213 (329)
T cd05588 150 ---------------GDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYL 213 (329)
T ss_pred ---------------CCccccccCCccccCHHHHcCC-CCCCccceechHHHHHHHHHCCCCcccccccccccccchHHH
Confidence 0012346799999999998654 67899999999999999999999997432211 11222333
Q ss_pred HHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCch
Q 003278 351 RRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSM 398 (834)
Q Consensus 351 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm 398 (834)
......+.. ++. ... ...+.+++..||+.||.+||+.
T Consensus 214 ~~~~~~~~~------~~p-~~~----~~~~~~li~~~L~~dP~~R~~~ 250 (329)
T cd05588 214 FQVILEKQI------RIP-RSL----SVKASSVLKGFLNKDPKERLGC 250 (329)
T ss_pred HHHHHcCCC------CCC-CCC----CHHHHHHHHHHhccCHHHcCCC
Confidence 332222211 111 111 1357789999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=345.64 Aligned_cols=248 Identities=27% Similarity=0.400 Sum_probs=202.2
Q ss_pred CeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEccCCCCHh
Q 003278 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNRSLD 196 (834)
Q Consensus 117 ~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~ 196 (834)
-+||+|.||+||-|++..+...+|||-+..+..+..+-+..|+.+.++|+|+|||+++|+|.+++.+-+.||-+|||||.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 37999999999999999888999999998888888888999999999999999999999999999999999999999999
Q ss_pred HHHhcCCCccccCCCC--CHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEEC-CCCceEEeeccchhhhhhhhh
Q 003278 197 RVLFRRPENLEAAAPL--NWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLD-SQYNARLGDFGLARWLEHELQ 273 (834)
Q Consensus 197 ~~l~~~~~~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld-~~~~~kl~DFGla~~~~~~~~ 273 (834)
++|... .+|| ++.+.-.+..||++||.|||+. .|||||||-.|||++ -.|.+||+|||.++.+..-.
T Consensus 661 sLLrsk------WGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin- 730 (1226)
T KOG4279|consen 661 SLLRSK------WGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN- 730 (1226)
T ss_pred HHHHhc------cCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCC-
Confidence 999654 4566 7788889999999999999996 999999999999997 47889999999998653211
Q ss_pred hhhhcccccccccccccceeeeccccCCCccccccCC-CCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHHHHH
Q 003278 274 YQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGS-VATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIRR 352 (834)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~ 352 (834)
.-+-++.||..|||||++..|. .|...+|||||||++.||.|||+||-..... +. .
T Consensus 731 ---------------P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp-qA-------A 787 (1226)
T KOG4279|consen 731 ---------------PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP-QA-------A 787 (1226)
T ss_pred ---------------ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh-hH-------h
Confidence 1145678999999999997654 4788999999999999999999998532211 11 1
Q ss_pred HhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 353 LSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 353 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
+..-| +-.+.|.+ +.+--......++.|..++|.+||+++++++.
T Consensus 788 MFkVG--myKvHP~i-----Peelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 788 MFKVG--MYKVHPPI-----PEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred hhhhc--ceecCCCC-----cHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 11111 11122222 22223456678999999999999999998863
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=342.29 Aligned_cols=243 Identities=19% Similarity=0.217 Sum_probs=189.7
Q ss_pred ccccCCcEEEEEEEC-CCcEEEEEEecCCC--ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEeccCCCch
Q 003278 521 VAEMDFGTAYQGFLD-NHQYVLVKRLGMSK--CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRIL 597 (834)
Q Consensus 521 ig~g~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~~~g~L 597 (834)
||+|+||.||+|... ++..||+|.+.... .......+.+|+.+|.+++|||||++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999964 57889999986432 223346788999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCCCCCc
Q 003278 598 SHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHR 677 (834)
Q Consensus 598 ~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~~~~~ 677 (834)
.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---- 147 (312)
T cd05585 81 FHHLQREG------RFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD---- 147 (312)
T ss_pred HHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC----
Confidence 99886532 37888889999999999999996 699999999999999999999999999997532211
Q ss_pred ccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcccccccccc
Q 003278 678 KATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSL 757 (834)
Q Consensus 678 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 757 (834)
......+||+.|||||++.+..++.++|||||||++|||+||+.||........ .. .... .+. .+
T Consensus 148 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~-~~---~~~~--~~~------~~ 212 (312)
T cd05585 148 ---DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM-YR---KILQ--EPL------RF 212 (312)
T ss_pred ---CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHH-HH---HHHc--CCC------CC
Confidence 112346799999999999999999999999999999999999999864322211 11 1111 110 11
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHc
Q 003278 758 NGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795 (834)
Q Consensus 758 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~ 795 (834)
....+ .+ +.+++.+||..||++||++..+.+.|+
T Consensus 213 ~~~~~-~~---~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 213 PDGFD-RD---AKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred CCcCC-HH---HHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 11122 23 445556899999999997665555543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=347.27 Aligned_cols=242 Identities=25% Similarity=0.304 Sum_probs=191.8
Q ss_pred CeeeccCCeEEEEEEECCCCeEEEEEEeccc---ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEccCCC
Q 003278 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK---GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNR 193 (834)
Q Consensus 117 ~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 193 (834)
+.||+|+||.||++....+|..||+|++... .......+.+|+.++++++||||++++++|...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4799999999999999889999999998653 2233456788999999999999999999999999999999999999
Q ss_pred CHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhhhhh
Q 003278 194 SLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQ 273 (834)
Q Consensus 194 sL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~ 273 (834)
+|..++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~- 149 (323)
T cd05595 81 ELFFHLSRE-------RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG- 149 (323)
T ss_pred cHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-
Confidence 998888543 3588999999999999999999985 99999999999999999999999999987421110
Q ss_pred hhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHHHHHH
Q 003278 274 YQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIRRL 353 (834)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~ 353 (834)
.......||+.|+|||.+..+ .++.++|||||||++|||+||+.||...... .+. ...
T Consensus 150 ---------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~---~~~---~~~ 207 (323)
T cd05595 150 ---------------ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLF---ELI 207 (323)
T ss_pred ---------------CccccccCCcCcCCcccccCC-CCCchhchhhhHHHHHHHHhCCCCCCCCCHH---HHH---HHH
Confidence 012335699999999998654 6789999999999999999999998643211 111 111
Q ss_pred hhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----chhhHHH
Q 003278 354 SDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRP-----SMKWVIE 403 (834)
Q Consensus 354 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~~V~~ 403 (834)
.. +. ..+. ... ...+.++...||+.||.+|| ++.++++
T Consensus 208 ~~-~~------~~~p-~~~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 208 LM-EE------IRFP-RTL----SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred hc-CC------CCCC-CCC----CHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 11 11 0111 111 13577899999999999998 6777765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=365.17 Aligned_cols=254 Identities=22% Similarity=0.325 Sum_probs=201.8
Q ss_pred CCCCCeeeccCCeEEEEEEECCC-CeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEccC
Q 003278 113 FDEDEVLGSGGFGKVYRAVLPSD-GTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMP 191 (834)
Q Consensus 113 f~~~~~LG~G~fG~Vy~~~~~~~-g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 191 (834)
|...+.||+|+||.||+|....+ +..||+|.+..........+.+|+.+|+.++|||||+++++|...+..||||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 77889999999999999998777 78899998765555555678889999999999999999999999999999999999
Q ss_pred CCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhhh
Q 003278 192 NRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHE 271 (834)
Q Consensus 192 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~~ 271 (834)
+|+|.++|.... ....++++.....++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 149 gg~L~~~l~~~~---~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 149 GGDLNKQIKQRL---KEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred CCCHHHHHHHHH---hccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 999999886432 1235689999999999999999999985 9999999999999999999999999999864321
Q ss_pred hhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHHHH
Q 003278 272 LQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIR 351 (834)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~ 351 (834)
.. .......+||++|+|||++... .++.++|||||||++|||+||+.||..... .....
T Consensus 223 ~~--------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~------~~~~~ 281 (478)
T PTZ00267 223 VS--------------LDVASSFCGTPYYLAPELWERK-RYSKKADMWSLGVILYELLTLHRPFKGPSQ------REIMQ 281 (478)
T ss_pred cc--------------cccccccCCCccccCHhHhCCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHH
Confidence 10 0113456799999999988654 679999999999999999999999864321 11111
Q ss_pred HHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 352 RLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 352 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
.... +.... .. ... ...+.+++..||+.+|+.||++.+++..
T Consensus 282 ~~~~-~~~~~-----~~-~~~----s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 282 QVLY-GKYDP-----FP-CPV----SSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred HHHh-CCCCC-----CC-ccC----CHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 1111 11110 00 111 1357889999999999999999998753
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=352.86 Aligned_cols=265 Identities=25% Similarity=0.383 Sum_probs=203.1
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECC-----CCeEEEEEEecccC-hhhHHHHHHHHHHHHhCC-CCceeeEeeeEEeCCE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPS-----DGTVVAVKCLAEKG-ERFEKTFAAELVAVAHLR-HRNLVRLRGWCVHEDQ 182 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~-----~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~ 182 (834)
.++|...++||+|+||.||+|.+.. .+..||||++.... ....+.|.+|+.+++++. |||||+++|+|.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 4678889999999999999998643 23579999986542 334567999999999996 9999999999999999
Q ss_pred EEEEEEccCCCCHhHHHhcCCCcc--------------------------------------------------------
Q 003278 183 LLLVYDYMPNRSLDRVLFRRPENL-------------------------------------------------------- 206 (834)
Q Consensus 183 ~~lV~Ey~~~gsL~~~l~~~~~~~-------------------------------------------------------- 206 (834)
.|||||||++|+|.++|+......
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 999999999999999986532100
Q ss_pred ---------------------------------ccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECC
Q 003278 207 ---------------------------------EAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDS 253 (834)
Q Consensus 207 ---------------------------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~ 253 (834)
.....++|..+..++.|+++||.|||+. +|+||||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeC
Confidence 0123588999999999999999999985 9999999999999999
Q ss_pred CCceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CC
Q 003278 254 QYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GR 332 (834)
Q Consensus 254 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~ 332 (834)
++.+||+|||+++.+...... .......|++.|+|||.+... .++.++|||||||++|||++ |.
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlGvil~ellt~g~ 337 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNY--------------VSKGSTFLPVKWMAPESIFDN-LYTTLSDVWSYGILLWEIFSLGG 337 (400)
T ss_pred CCEEEEEeCCcceeccccccc--------------cccCCcCCCcceEChhhhcCC-CCCchhhHHHHHHHHHHHHHCCC
Confidence 999999999999754321100 012233478899999988654 67999999999999999997 88
Q ss_pred ccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 333 RAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 333 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
.|+.....+.. +. .....+.... .. .. ....+.+++..||+.+|++||++.+|++.|...
T Consensus 338 ~P~~~~~~~~~--~~----~~~~~~~~~~-----~~-~~----~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 338 TPYPGMIVDST--FY----NKIKSGYRMA-----KP-DH----ATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred CCCcccchhHH--HH----HHHhcCCCCC-----CC-cc----CCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 88864322211 11 1111111110 00 11 124578899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=350.70 Aligned_cols=246 Identities=23% Similarity=0.303 Sum_probs=197.6
Q ss_pred HhhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHHHHHhC-CCCceeeEeeeEEeCCE
Q 003278 107 YIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVAVAHL-RHRNLVRLRGWCVHEDQ 182 (834)
Q Consensus 107 ~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~ 182 (834)
....++|...++||+|+||+|+++..+.+++.+|||++++.. ....+....|.+++... +||.|+.|+.+|...++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 345678999999999999999999999999999999998652 33455677788877766 59999999999999999
Q ss_pred EEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeec
Q 003278 183 LLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDF 262 (834)
Q Consensus 183 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DF 262 (834)
+|+||||+.||++..+.+ ...++......++.+|+.||.|||+. +||+||||-+|||||.+|++||+||
T Consensus 444 l~fvmey~~Ggdm~~~~~--------~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADF 512 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIH--------TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADF 512 (694)
T ss_pred EEEEEEecCCCcEEEEEe--------cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccc
Confidence 999999999999654443 24688899999999999999999995 9999999999999999999999999
Q ss_pred cchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCc
Q 003278 263 GLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDD 342 (834)
Q Consensus 263 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~ 342 (834)
|+++..- .....+++++|||.|||||++... .|+..+|+|||||+||||+.|..||.....+
T Consensus 513 GlcKe~m----------------~~g~~TsTfCGTpey~aPEil~e~-~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe- 574 (694)
T KOG0694|consen 513 GLCKEGM----------------GQGDRTSTFCGTPEFLAPEVLTEQ-SYTRAVDWWGLGVLLYEMLVGESPFPGDDEE- 574 (694)
T ss_pred ccccccC----------------CCCCccccccCChhhcChhhhccC-cccchhhHHHHHHHHHHHHcCCCCCCCCCHH-
Confidence 9998421 111247889999999999998755 7899999999999999999999999754322
Q ss_pred cchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCch
Q 003278 343 QIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSM 398 (834)
Q Consensus 343 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm 398 (834)
.+.+-+. . .| ..|+..-..+.+.|+..-+..||++|--+
T Consensus 575 --e~FdsI~---~-------d~-----~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 575 --EVFDSIV---N-------DE-----VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred --HHHHHHh---c-------CC-----CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 2222111 1 11 11222222345677778889999999877
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=349.17 Aligned_cols=268 Identities=22% Similarity=0.286 Sum_probs=195.9
Q ss_pred CCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEE
Q 003278 112 GFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYD 188 (834)
Q Consensus 112 ~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 188 (834)
.|+..+.||+|+||+||+|+...++..||||++.... ....+.+.+|+.++.+++|||||++++++.+.+.+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5888899999999999999999999999999986532 2345678899999999999999999999999999999999
Q ss_pred ccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhh
Q 003278 189 YMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWL 268 (834)
Q Consensus 189 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~ 268 (834)
|+++|+|.+++.+. ..+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+
T Consensus 82 ~~~gg~L~~~l~~~-------~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~ 151 (381)
T cd05626 82 YIPGGDMMSLLIRM-------EVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGF 151 (381)
T ss_pred cCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence 99999999998643 3578889999999999999999985 9999999999999999999999999998643
Q ss_pred hhhhhhhh-hc------cc-c-----------------------cccccccccceeeeccccCCCccccccCCCCCcccc
Q 003278 269 EHELQYQM-RT------SS-A-----------------------RNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSD 317 (834)
Q Consensus 269 ~~~~~~~~-~~------~~-~-----------------------~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksD 317 (834)
........ .. .. . ...........+..||+.|+|||.+... .++.++|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~D 230 (381)
T cd05626 152 RWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK-GYTQLCD 230 (381)
T ss_pred ccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC-CCCCccc
Confidence 21100000 00 00 0 0000000012346799999999998654 5789999
Q ss_pred eeehhhHHHHHHhCCccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHH--HhcccCCCCC
Q 003278 318 VFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLAL--LCTLHNPHLR 395 (834)
Q Consensus 318 V~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~--~Cl~~~p~~R 395 (834)
||||||++|||+||+.||........ . ............. +. ...+. .+.++.. .|+..+|..|
T Consensus 231 iwSlG~il~elltG~~Pf~~~~~~~~---~---~~i~~~~~~~~~~-~~---~~~s~----~~~dli~~ll~~~~~~~~R 296 (381)
T cd05626 231 WWSVGVILFEMLVGQPPFLAPTPTET---Q---LKVINWENTLHIP-PQ---VKLSP----EAVDLITKLCCSAEERLGR 296 (381)
T ss_pred eeehhhHHHHHHhCCCCCcCCCHHHH---H---HHHHccccccCCC-CC---CCCCH----HHHHHHHHHccCcccccCC
Confidence 99999999999999999975432211 0 1111100001100 00 11222 2334443 3778888889
Q ss_pred CchhhHHHH
Q 003278 396 PSMKWVIEA 404 (834)
Q Consensus 396 Psm~~V~~~ 404 (834)
|++.+++..
T Consensus 297 ~~~~~~l~h 305 (381)
T cd05626 297 NGADDIKAH 305 (381)
T ss_pred CCHHHHhcC
Confidence 999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=344.85 Aligned_cols=268 Identities=22% Similarity=0.315 Sum_probs=196.7
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 187 (834)
++|+..+.||+|+||.||+|+...+|+.||||++.... ......+.+|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47888999999999999999998899999999986431 233456788999999999999999999999999999999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
||+++|+|.+++... ..+++..+..|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 E~~~~g~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~ 150 (364)
T cd05599 81 EYLPGGDMMTLLMKK-------DTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTG 150 (364)
T ss_pred CCCCCcHHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeeccccee
Confidence 999999999998643 3588999999999999999999985 999999999999999999999999999975
Q ss_pred hhhhhhhhhhccccc-------------------cccc---ccccceeeeccccCCCccccccCCCCCcccceeehhhHH
Q 003278 268 LEHELQYQMRTSSAR-------------------NHQF---HLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVV 325 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~-------------------~~~~---~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl 325 (834)
+.............. .... .........||+.|+|||++... .++.++|||||||++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il 229 (364)
T cd05599 151 LKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT-GYNKECDWWSLGVIM 229 (364)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC-CCCCeeeeecchhHH
Confidence 432110000000000 0000 00001235699999999988654 578999999999999
Q ss_pred HHHHhCCccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCc---hhhHH
Q 003278 326 LEVVSGRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPS---MKWVI 402 (834)
Q Consensus 326 ~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs---m~~V~ 402 (834)
|||++|+.||...... ................+. .... ..+.++...|+. +|.+||+ +.+++
T Consensus 230 ~el~~G~~Pf~~~~~~------~~~~~i~~~~~~~~~~~~----~~~s----~~~~~li~~ll~-~p~~R~~~~~~~~ll 294 (364)
T cd05599 230 YEMLVGYPPFCSDNPQ------ETYRKIINWKETLQFPDE----VPLS----PEAKDLIKRLCC-EAERRLGNNGVNEIK 294 (364)
T ss_pred HHhhcCCCCCCCCCHH------HHHHHHHcCCCccCCCCC----CCCC----HHHHHHHHHHcc-CHhhcCCCCCHHHHh
Confidence 9999999998643211 111111111111111100 0111 245567777775 8999998 77776
Q ss_pred HH
Q 003278 403 EA 404 (834)
Q Consensus 403 ~~ 404 (834)
+.
T Consensus 295 ~h 296 (364)
T cd05599 295 SH 296 (364)
T ss_pred cC
Confidence 53
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=341.79 Aligned_cols=255 Identities=21% Similarity=0.286 Sum_probs=199.9
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 187 (834)
++|+..+.||+|+||.||+|....+|+.||||++.... ....+.+.+|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888999999999999999999999999999987532 234566889999999999999999999999999999999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
||+++|+|.+++.... ..+++.....++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 e~~~~~~L~~~l~~~~------~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~ 151 (330)
T cd05601 81 EYQPGGDLLSLLNRYE------DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAAR 151 (330)
T ss_pred CCCCCCCHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeE
Confidence 9999999999986532 3588999999999999999999985 999999999999999999999999999975
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCcccccc-----CCCCCcccceeehhhHHHHHHhCCccCCCCCCCc
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQK-----GSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDD 342 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-----~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~ 342 (834)
+..... .......||+.|+|||.+.. +..++.++|||||||++|||+||+.||......
T Consensus 152 ~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~- 215 (330)
T cd05601 152 LTANKM---------------VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA- 215 (330)
T ss_pred CCCCCc---------------eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH-
Confidence 432110 01233469999999998863 345688999999999999999999998643211
Q ss_pred cchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 343 QIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 343 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
.....+..........+. ... ...+.+|...|++ +|.+||++.+++..
T Consensus 216 -----~~~~~i~~~~~~~~~~~~----~~~----~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 216 -----KTYNNIMNFQRFLKFPED----PKV----SSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred -----HHHHHHHcCCCccCCCCC----CCC----CHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 112222221111111110 011 1346778888997 99999999988753
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=342.08 Aligned_cols=266 Identities=23% Similarity=0.294 Sum_probs=197.2
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC-hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG-ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYD 188 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 188 (834)
.++|+..+.||+|+||.||+|....+|+.||||++.... ......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467999999999999999999998899999999986432 2223457789999999999999999999999999999999
Q ss_pred ccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhh
Q 003278 189 YMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWL 268 (834)
Q Consensus 189 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~ 268 (834)
|++ ++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 84 ~~~-~~l~~~~~~~------~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 153 (303)
T cd07869 84 YVH-TDLCQYMDKH------PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAK 153 (303)
T ss_pred CCC-cCHHHHHHhC------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceec
Confidence 996 6777777543 23578889999999999999999985 9999999999999999999999999998743
Q ss_pred hhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHH
Q 003278 269 EHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLD 348 (834)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~ 348 (834)
.... .......||+.|+|||.+.....++.++|||||||++|||+||+.||....... ....
T Consensus 154 ~~~~----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~ 215 (303)
T cd07869 154 SVPS----------------HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ--DQLE 215 (303)
T ss_pred cCCC----------------ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHH
Confidence 2110 011234589999999988655567889999999999999999999997432111 1111
Q ss_pred HHHHHhhcCc---cc-----ccccc-ccCC-CCCCHH-------HHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 349 WIRRLSDEGK---VL-----QAGDN-RLSD-GSYKLC-------DMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 349 ~~~~~~~~~~---~~-----~~~d~-~l~~-~~~~~~-------~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
.+........ .. ...++ +... ...... ....+.+++..|++.||.+|||+.++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 216 RIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred HHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 1111110000 00 00000 0000 000000 0134668999999999999999999885
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=341.63 Aligned_cols=200 Identities=19% Similarity=0.298 Sum_probs=174.3
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
++|...++||+|+||.||++... ++..+|+|.+...........|.+|++++++++|||||+++++|.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence 57888899999999999999975 57889999887655555567899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccccc
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTR 671 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~ 671 (834)
+++|+|.+++...+ .+++.....++.|++.||+|||+. .+|+||||||+|||+++++.+||+|||++..+..
T Consensus 85 ~~~~~L~~~l~~~~------~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 85 MDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred CCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 99999999986532 377888889999999999999962 4799999999999999999999999999875432
Q ss_pred CCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCC
Q 003278 672 NDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFR 729 (834)
Q Consensus 672 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~ 729 (834)
. ......||..|+|||++.+..++.++|||||||++|||++|+.|+...
T Consensus 157 ~---------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 157 S---------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred h---------ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 1 122357899999999999888999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=335.54 Aligned_cols=250 Identities=36% Similarity=0.591 Sum_probs=190.5
Q ss_pred CCeeeccCCeEEEEEEEC----CCCeEEEEEEeccc-ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEcc
Q 003278 116 DEVLGSGGFGKVYRAVLP----SDGTVVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYM 190 (834)
Q Consensus 116 ~~~LG~G~fG~Vy~~~~~----~~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 190 (834)
.+.||.|+||.||+|.+. ..+..|+||.++.. .....+.|.+|+..+++++||||++++|+|...+..++||||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 468999999999999996 34678999999653 3345788999999999999999999999999888899999999
Q ss_pred CCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhh
Q 003278 191 PNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEH 270 (834)
Q Consensus 191 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~ 270 (834)
++|+|.++|.... ...++|..+..|+.|||+||.|||+. +|+|+||+++|||+++++.+||+|||+++....
T Consensus 84 ~~g~L~~~L~~~~-----~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 84 PGGSLDDYLKSKN-----KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISE 155 (259)
T ss_dssp TTEBHHHHHHHTC-----TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred ccccccccccccc-----cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc
Confidence 9999999998751 34689999999999999999999995 899999999999999999999999999976421
Q ss_pred hhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccchHHHH
Q 003278 271 ELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQIILLDW 349 (834)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~ 349 (834)
.... .......+...|+|||.+... .++.++||||||+++|||+| |+.|+... . ...+
T Consensus 156 ~~~~--------------~~~~~~~~~~~~~aPE~~~~~-~~~~ksDVysfG~~l~ei~~~~~~p~~~~--~----~~~~ 214 (259)
T PF07714_consen 156 KSKY--------------KNDSSQQLPLRYLAPEVLKDG-EYTKKSDVYSFGMLLYEILTLGKFPFSDY--D----NEEI 214 (259)
T ss_dssp SSSE--------------EESTTSESGGGGS-HHHHHHS-EESHHHHHHHHHHHHHHHHTTSSGTTTTS--C----HHHH
T ss_pred cccc--------------ccccccccccccccccccccc-ccccccccccccccccccccccccccccc--c----cccc
Confidence 1000 011223467899999998765 47999999999999999999 67776432 1 1222
Q ss_pred HHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHh
Q 003278 350 IRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAV 405 (834)
Q Consensus 350 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l 405 (834)
...+ .++......+ . ....+..++..||..+|++||+|.++++.|
T Consensus 215 ~~~~-~~~~~~~~~~-~---------~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 215 IEKL-KQGQRLPIPD-N---------CPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHH-HTTEETTSBT-T---------SBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cccc-cccccceecc-c---------hhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 2232 2232222111 1 124588999999999999999999999875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=348.81 Aligned_cols=258 Identities=22% Similarity=0.262 Sum_probs=199.8
Q ss_pred HhhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc---ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEE
Q 003278 107 YIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK---GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQL 183 (834)
Q Consensus 107 ~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 183 (834)
....++|+..+.||+|+||.||+|....++..||||++... .....+.+.+|+.+++.++||||+++++++.+++..
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 34567899999999999999999999889999999998642 122345578899999999999999999999999999
Q ss_pred EEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeecc
Q 003278 184 LLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFG 263 (834)
Q Consensus 184 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFG 263 (834)
++||||+++|+|.+++... .++......++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~--------~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG 187 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSNY--------DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFG 187 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc--------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEecc
Confidence 9999999999999988542 367778889999999999999985 99999999999999999999999999
Q ss_pred chhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccC---CCCCcccceeehhhHHHHHHhCCccCCCCCC
Q 003278 264 LARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKG---SVATAKSDVFSFGIVVLEVVSGRRAVDLTYP 340 (834)
Q Consensus 264 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~---~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~ 340 (834)
+++.+.... ........||+.|+|||.+... ..++.++|||||||++|||+||+.||.....
T Consensus 188 ~~~~~~~~~---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~ 252 (370)
T cd05596 188 TCMKMDANG---------------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 252 (370)
T ss_pred ceeeccCCC---------------cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH
Confidence 987542210 0012345699999999988542 2468899999999999999999999864321
Q ss_pred CccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCC--CCchhhHHHH
Q 003278 341 DDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHL--RPSMKWVIEA 404 (834)
Q Consensus 341 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPsm~~V~~~ 404 (834)
. .....+..........+. ... ...+.++...|++.+|.+ ||++.++++.
T Consensus 253 ~------~~~~~i~~~~~~~~~~~~----~~~----s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 253 V------GTYSKIMDHKNSLTFPDD----IEI----SKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred H------HHHHHHHcCCCcCCCCCc----CCC----CHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 1 111111111110111110 011 135678899999999987 9999998764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=313.84 Aligned_cols=276 Identities=22% Similarity=0.289 Sum_probs=215.0
Q ss_pred HhhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCC-----
Q 003278 107 YIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHED----- 181 (834)
Q Consensus 107 ~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~----- 181 (834)
.+..++|.+.+.||+|||+-||.+..-.++..+|+|++.....+..+..++|+...++++||||+++++++..+.
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 345567999999999999999999988999999999998877777888999999999999999999999886543
Q ss_pred EEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEee
Q 003278 182 QLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGD 261 (834)
Q Consensus 182 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~D 261 (834)
+.||++.|...|||.+.+...+. +...+++.+.+.|+.++++||.+||+. .+++.||||||.|||+.+++.++|.|
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~---kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D 172 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKI---KGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMD 172 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhh---cCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEe
Confidence 49999999999999999976543 245789999999999999999999985 45799999999999999999999999
Q ss_pred ccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccc--cCCCCCcccceeehhhHHHHHHhCCccCCCCC
Q 003278 262 FGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQ--KGSVATAKSDVFSFGIVVLEVVSGRRAVDLTY 339 (834)
Q Consensus 262 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~--~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~ 339 (834)
||.++...-....+. . .........-..|..|.|||.+. .+...+.++|||||||+||+|+.|..||+..+
T Consensus 173 ~GS~~~a~i~i~~~~------~-a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~ 245 (302)
T KOG2345|consen 173 LGSATQAPIQIEGSR------Q-ALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIY 245 (302)
T ss_pred ccCccccceEeechH------H-HHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHh
Confidence 999876432111000 0 00111123334689999999874 35567899999999999999999999998665
Q ss_pred CCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhc
Q 003278 340 PDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSG 407 (834)
Q Consensus 340 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~ 407 (834)
..+....+. ...+++.-.-++ .+ .+.+.++..+|++.||.+||+..+++..+..
T Consensus 246 ~~GgSlaLA-----v~n~q~s~P~~~-----~y----se~l~~lik~mlqvdP~qRP~i~~ll~~~d~ 299 (302)
T KOG2345|consen 246 QQGGSLALA-----VQNAQISIPNSS-----RY----SEALHQLIKSMLQVDPNQRPTIPELLSKLDD 299 (302)
T ss_pred hcCCeEEEe-----eeccccccCCCC-----Cc----cHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence 543321100 001111111111 12 2578899999999999999999999988764
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=335.73 Aligned_cols=256 Identities=19% Similarity=0.297 Sum_probs=195.8
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCc----EEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQ----YVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLV 587 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~----~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~l 587 (834)
++|...+.||+|+||.||+|... ++. .+++|.+..........++..|+..+++++|||||+++|++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 35667788999999999999863 343 4778877544333444678889999999999999999999864 45778
Q ss_pred EEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecc
Q 003278 588 IYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAE 667 (834)
Q Consensus 588 v~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~ 667 (834)
++||+++|+|.+++.... ..++|.....++.|++.||+|||+ .+++||||||+|||+++++.+|++|||+++
T Consensus 86 i~e~~~~gsL~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~ 157 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR-----DSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVAD 157 (279)
T ss_pred EEEeCCCCcHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccce
Confidence 999999999999986533 248899999999999999999996 689999999999999999999999999998
Q ss_pred ccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhc
Q 003278 668 FLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARK 746 (834)
Q Consensus 668 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~ 746 (834)
.+...... .......|+..|+|||++.++.++.++|||||||++|||+| |+.|+....+.. ....+ ....
T Consensus 158 ~~~~~~~~-----~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-~~~~~---~~~~ 228 (279)
T cd05111 158 LLYPDDKK-----YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE-VPDLL---EKGE 228 (279)
T ss_pred eccCCCcc-----cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHH---HCCC
Confidence 65432210 11223567889999999999999999999999999999998 988886443321 11111 1111
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccC
Q 003278 747 RPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGN 797 (834)
Q Consensus 747 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~ 797 (834)
.+ ..+ .... ..+..++.+||+.||++|||+.++++.|...
T Consensus 229 ~~----~~~----~~~~---~~~~~li~~c~~~~p~~Rps~~el~~~l~~~ 268 (279)
T cd05111 229 RL----AQP----QICT---IDVYMVMVKCWMIDENVRPTFKELANEFTRM 268 (279)
T ss_pred cC----CCC----CCCC---HHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 11 111 1111 2345566799999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=329.88 Aligned_cols=252 Identities=25% Similarity=0.411 Sum_probs=197.9
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEcc
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYM 190 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 190 (834)
++|+..+.||+|+||.||+|.+. ++..+|+|.+... ....+.|.+|+.++++++||||++++++|...+..++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence 45778889999999999999984 5678999987643 233567899999999999999999999999999999999999
Q ss_pred CCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhh
Q 003278 191 PNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEH 270 (834)
Q Consensus 191 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~ 270 (834)
++|+|.+++.... ..++|..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 82 ~~~~L~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~ 152 (256)
T cd05114 82 ENGCLLNYLRQRQ------GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD 152 (256)
T ss_pred CCCcHHHHHHhCc------cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCC
Confidence 9999999986432 3588999999999999999999985 999999999999999999999999999875422
Q ss_pred hhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccchHHHH
Q 003278 271 ELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQIILLDW 349 (834)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~ 349 (834)
... .......++..|+|||.+... .++.++|||||||++|||+| |+.|+..... ......
T Consensus 153 ~~~---------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~---~~~~~~ 213 (256)
T cd05114 153 DEY---------------TSSSGAKFPVKWSPPEVFNFS-KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN---YEVVEM 213 (256)
T ss_pred Cce---------------eccCCCCCchhhCChhhcccC-ccchhhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH
Confidence 100 001222356789999998644 67899999999999999999 8888854321 112222
Q ss_pred HHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhh
Q 003278 350 IRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVS 406 (834)
Q Consensus 350 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~ 406 (834)
+. .+... ..+.. ....+..++.+||+.+|++||+|.++++.|+
T Consensus 214 i~----~~~~~--~~~~~--------~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 214 IS----RGFRL--YRPKL--------ASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred HH----CCCCC--CCCCC--------CCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11 11111 01111 1246789999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=390.27 Aligned_cols=268 Identities=25% Similarity=0.464 Sum_probs=212.2
Q ss_pred cccHHHHHHHhhCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEe
Q 003278 502 EISFKEIISATNNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCT 580 (834)
Q Consensus 502 ~~~~~el~~at~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~ 580 (834)
.++++++. ..|...+.||+|+||.||+|.. .++..||||++..... ....|++.|++++|||||+++|+|.
T Consensus 682 ~~~~~~~~---~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~l~~l~HpnIv~~~~~~~ 753 (968)
T PLN00113 682 SITINDIL---SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-----IPSSEIADMGKLQHPNIVKLIGLCR 753 (968)
T ss_pred hhhHHHHH---hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-----ccHHHHHHHhhCCCCCcceEEEEEE
Confidence 34555544 4577788999999999999996 5788999999864322 1234688999999999999999999
Q ss_pred eCCeEEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceE
Q 003278 581 EQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRL 660 (834)
Q Consensus 581 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki 660 (834)
+.+..++||||+++|+|.+++.. ++|..+.+|+.|+|+||+|||+.+.++|+||||||+||+++.++.+++
T Consensus 754 ~~~~~~lv~Ey~~~g~L~~~l~~---------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~ 824 (968)
T PLN00113 754 SEKGAYLIHEYIEGKNLSEVLRN---------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL 824 (968)
T ss_pred cCCCCEEEEeCCCCCcHHHHHhc---------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEE
Confidence 99999999999999999999842 789999999999999999999766689999999999999999998888
Q ss_pred eeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCch-hHHHHH
Q 003278 661 GSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEG-LLVKRV 739 (834)
Q Consensus 661 ~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~-~~~~~~ 739 (834)
. ||.+..... .....||++|||||++.+..++.++|||||||++|||+||+.|++...... ....+.
T Consensus 825 ~-~~~~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~ 892 (968)
T PLN00113 825 R-LSLPGLLCT-----------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWA 892 (968)
T ss_pred E-ecccccccc-----------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHH
Confidence 6 666543211 112368899999999999999999999999999999999999986443322 222222
Q ss_pred HHHHhhcCccccccccccCC--CCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCc
Q 003278 740 HEFEARKRPLAELVDLSLNG--EYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDK 799 (834)
Q Consensus 740 ~~~~~~~~~~~~~~d~~l~~--~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~ 799 (834)
.. .........++|+.+.. ....++..++++++.+||+.||++||||.||++.|+.+.+
T Consensus 893 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 893 RY-CYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred HH-hcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 22 11122234456665543 2345677788999999999999999999999999987654
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=342.98 Aligned_cols=252 Identities=25% Similarity=0.361 Sum_probs=209.1
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecc--cChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCE-EEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAE--KGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQ-LLLVY 187 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~-~~lV~ 187 (834)
++|...+++|+|+||.++.++.+.+++.+++|.+.- ..+..++...+|+.++++++|||||.+++.|.+++. ++|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 568888999999999999999999999999998753 345556678899999999999999999999999998 99999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
+||+||+|.+.+.+.+ ...++.+.+..++.|++.|+.|||+. .|+|||||++||+++.+..+||.|||+|+.
T Consensus 84 ~Y~eGg~l~~~i~~~k-----~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~ 155 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-----GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKI 155 (426)
T ss_pred eecCCCCHHHHHHHHh-----hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhh
Confidence 9999999999997654 34688999999999999999999974 999999999999999999999999999998
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHH
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILL 347 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~ 347 (834)
+..+.. ...++.||+.||.||.+.+ ..|..|+|||||||++|||++-+++|...... .|
T Consensus 156 l~~~~~----------------~a~tvvGTp~YmcPEil~d-~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~---~L- 214 (426)
T KOG0589|consen 156 LNPEDS----------------LASTVVGTPYYMCPEILSD-IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS---EL- 214 (426)
T ss_pred cCCchh----------------hhheecCCCcccCHHHhCC-CCCCccCcchhhcchHHHHHhcccccCccchH---HH-
Confidence 765421 1456789999999998864 57899999999999999999999999764322 12
Q ss_pred HHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 348 DWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 348 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
+.+... ..-..++ +.+ ...+..|+..|++.+|..||+..+++..
T Consensus 215 --i~ki~~------~~~~Plp-~~y----s~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 215 --ILKINR------GLYSPLP-SMY----SSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred --HHHHhh------ccCCCCC-ccc----cHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 222211 1111121 122 2357889999999999999999999875
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=348.98 Aligned_cols=216 Identities=24% Similarity=0.361 Sum_probs=175.2
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 187 (834)
++|+..+.||+|+||+||+|....+++.||||++.... ......+.+|+.++.+++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47888999999999999999998899999999986532 223456788999999999999999999999999999999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
||+++|+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 E~~~gg~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~ 150 (363)
T cd05628 81 EFLPGGDMMTLLMKK-------DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTG 150 (363)
T ss_pred cCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccc
Confidence 999999999998643 4588999999999999999999985 999999999999999999999999999986
Q ss_pred hhhhhhhhh-h------cc-------cccc-c----ccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHH
Q 003278 268 LEHELQYQM-R------TS-------SARN-H----QFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEV 328 (834)
Q Consensus 268 ~~~~~~~~~-~------~~-------~~~~-~----~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~El 328 (834)
+........ . +. .... . ..........+||+.|+|||.+... .++.++|||||||++|||
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~el 229 (363)
T cd05628 151 LKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEM 229 (363)
T ss_pred ccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC-CCCCchhhhhhHHHHHHH
Confidence 532110000 0 00 0000 0 0000012346799999999998654 678999999999999999
Q ss_pred HhCCccCCC
Q 003278 329 VSGRRAVDL 337 (834)
Q Consensus 329 ltG~~p~~~ 337 (834)
+||+.||..
T Consensus 230 l~G~~Pf~~ 238 (363)
T cd05628 230 LIGYPPFCS 238 (363)
T ss_pred HhCCCCCCC
Confidence 999999964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=334.46 Aligned_cols=264 Identities=25% Similarity=0.425 Sum_probs=202.1
Q ss_pred hhcCCCCCCCeeeccCCeEEEEEEEC-----CCCeEEEEEEecccC-hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCC
Q 003278 108 IGSNGFDEDEVLGSGGFGKVYRAVLP-----SDGTVVAVKCLAEKG-ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHED 181 (834)
Q Consensus 108 ~~t~~f~~~~~LG~G~fG~Vy~~~~~-----~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~ 181 (834)
.++++|+..+.||+|+||.||+|.+. .++..||||.+.... ......|.+|+.+++.++||||+++++++...+
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 35678999999999999999999864 235789999886432 234567899999999999999999999999999
Q ss_pred EEEEEEEccCCCCHhHHHhcCCCccc---cCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceE
Q 003278 182 QLLLVYDYMPNRSLDRVLFRRPENLE---AAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNAR 258 (834)
Q Consensus 182 ~~~lV~Ey~~~gsL~~~l~~~~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~k 258 (834)
..++||||+++|+|.+++........ ....++|..+..++.|+++||.|||+. +++||||||+|||+++++.+|
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEE
Confidence 99999999999999999865322111 124578999999999999999999985 999999999999999999999
Q ss_pred EeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCC
Q 003278 259 LGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDL 337 (834)
Q Consensus 259 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~ 337 (834)
|+|||+++.+...... .......+++.|+|||++..+ .++.++|||||||++|||+| |..|+..
T Consensus 160 l~dfg~~~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~p~~~ 224 (277)
T cd05062 160 IGDFGMTRDIYETDYY--------------RKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQG 224 (277)
T ss_pred ECCCCCccccCCccee--------------ecCCCCccCHhhcChhHhhcC-CcCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 9999998754321110 001123467889999998654 57999999999999999999 6777753
Q ss_pred CCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhh
Q 003278 338 TYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVS 406 (834)
Q Consensus 338 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~ 406 (834)
... .....++ .++..... . . .....+.+++.+|++.+|++||++.++++.|+
T Consensus 225 ~~~---~~~~~~~----~~~~~~~~-----~-~----~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 225 MSN---EQVLRFV----MEGGLLDK-----P-D----NCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred CCH---HHHHHHH----HcCCcCCC-----C-C----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 211 1111111 11111111 0 1 11246889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=337.59 Aligned_cols=256 Identities=20% Similarity=0.304 Sum_probs=199.5
Q ss_pred hhCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCC--hhHHHHHHHHHHHHHhc-cCCCceeEEEEEeeCCeEEE
Q 003278 512 TNNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKC--PALRTRFSNELQNLARL-RHRNLVQLCGWCTEQGEMLV 587 (834)
Q Consensus 512 t~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~--~~~~~~f~~E~~~l~~l-~HpNiv~l~g~~~~~~~~~l 587 (834)
..+|.=.+.||+|+|.+||+|.- +.+..+|||++..... +...+....|=.+|.+| .||-||+|+--|.+...+|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 34566677899999999999984 5688999998864321 11123456788899999 89999999999999999999
Q ss_pred EEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecc
Q 003278 588 IYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAE 667 (834)
Q Consensus 588 v~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~ 667 (834)
|+||+++|+|.+++.+.+ .++.....-+|.+|..||+|||+ .|||||||||+|||||+||.+||+|||-|+
T Consensus 152 vLe~A~nGdll~~i~K~G------sfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK 222 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKKYG------SFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAK 222 (604)
T ss_pred EEEecCCCcHHHHHHHhC------cchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccc
Confidence 999999999999998764 36766667799999999999996 799999999999999999999999999999
Q ss_pred ccccCCCC------CcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHH
Q 003278 668 FLTRNDHG------HRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHE 741 (834)
Q Consensus 668 ~~~~~~~~------~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~ 741 (834)
.+...... ...+.+...+++||..|.+||++..+..+..+|+|+|||+||+|++|+.||...... ...+.+..
T Consensus 223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney-liFqkI~~ 301 (604)
T KOG0592|consen 223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY-LIFQKIQA 301 (604)
T ss_pred cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH-HHHHHHHH
Confidence 87654222 111222236799999999999999999999999999999999999999999754322 22233322
Q ss_pred HHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 742 FEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 742 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
. |..++..++ +.+..|++ +-+..||.+|+|..+|-+
T Consensus 302 l-----------~y~fp~~fp-~~a~dLv~---KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 302 L-----------DYEFPEGFP-EDARDLIK---KLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred h-----------cccCCCCCC-HHHHHHHH---HHHccCccccccHHHHhh
Confidence 2 112222333 44455554 567799999999988765
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=310.29 Aligned_cols=248 Identities=21% Similarity=0.349 Sum_probs=200.8
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCC--hhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKC--PALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIY 589 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~--~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~ 589 (834)
++|...+.+|.|.||.||.|.. .++-.||+|++-.+.- ....+++.+|+++-++|+||||+++||++.+....||++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 5788899999999999999996 4577899999764432 223467899999999999999999999999999999999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccc
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFL 669 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~ 669 (834)
||.++|.|...|.+.... .++....-.++.|+|.||.|+|. +.||||||||+|+|++.++..||+|||.+..-
T Consensus 102 Eya~~gel~k~L~~~~~~----~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGRMK----RFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred EecCCchHHHHHHhcccc----cccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 999999999999854321 24455555799999999999996 79999999999999999999999999998653
Q ss_pred ccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcc
Q 003278 670 TRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPL 749 (834)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
+ .....+.|||..|.+||+..+..++.++|+|++||+.||++.|..||.... .+...+++....
T Consensus 175 p---------~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k~~------ 238 (281)
T KOG0580|consen 175 P---------SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRKVD------ 238 (281)
T ss_pred C---------CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHHcc------
Confidence 2 223456899999999999999999999999999999999999999998655 444444443321
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 750 AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 750 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
+.+| ... ..+ ...++.+|+..+|.+|.+..||+.
T Consensus 239 --~~~p---~~i-s~~---a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 239 --LKFP---STI-SGG---AADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred --ccCC---ccc-Chh---HHHHHHHHhccCccccccHHHHhh
Confidence 1112 111 123 334556899999999999999985
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=330.20 Aligned_cols=261 Identities=25% Similarity=0.333 Sum_probs=200.0
Q ss_pred hhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccCh--------------hhHHHHHHHHHHHHhCCCCceeeE
Q 003278 108 IGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGE--------------RFEKTFAAELVAVAHLRHRNLVRL 173 (834)
Q Consensus 108 ~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~--------------~~~~~~~~E~~~l~~l~H~nIv~l 173 (834)
+..|.|+..+.||+|.||.|-+|+...+++.||||++.++.. ...+...+||.+|++++|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 455889999999999999999999999999999999865321 112567899999999999999999
Q ss_pred eeeEEeC--CEEEEEEEccCCCCHhHHHhcCCCccccCCC-CCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceE
Q 003278 174 RGWCVHE--DQLLLVYDYMPNRSLDRVLFRRPENLEAAAP-LNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVM 250 (834)
Q Consensus 174 ~g~~~~~--~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NIL 250 (834)
+.+..+. +.+|||+|||..|.+... . ...+ |++.+.++|+++++.||+|||.+ +||||||||+|+|
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~---p-----~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLL 242 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWC---P-----PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLL 242 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccC---C-----CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheE
Confidence 9998765 469999999999887432 1 1234 89999999999999999999998 9999999999999
Q ss_pred ECCCCceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCC---CCCcccceeehhhHHHH
Q 003278 251 LDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGS---VATAKSDVFSFGIVVLE 327 (834)
Q Consensus 251 ld~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~---~~~~ksDV~SfGvvl~E 327 (834)
|++++++||+|||.+....... ..... ..-....|||.|||||.+..+. ..+.+.||||+||+||.
T Consensus 243 l~~~g~VKIsDFGVs~~~~~~~--------~~~~d---~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYC 311 (576)
T KOG0585|consen 243 LSSDGTVKISDFGVSNEFPQGS--------DEGSD---DQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYC 311 (576)
T ss_pred EcCCCcEEeeccceeeecccCC--------ccccH---HHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHH
Confidence 9999999999999987542110 00000 0122357999999999987632 44678999999999999
Q ss_pred HHhCCccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhh
Q 003278 328 VVSGRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVS 406 (834)
Q Consensus 328 lltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~ 406 (834)
|+.|+-||-..+ ......++ +..++.-...+ +..+.+.+|++.-|..||+.|-+..+|.....
T Consensus 312 llfG~~PF~~~~------~~~l~~KI---------vn~pL~fP~~p-e~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 312 LLFGQLPFFDDF------ELELFDKI---------VNDPLEFPENP-EINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred hhhccCCcccch------HHHHHHHH---------hcCcccCCCcc-cccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 999999985421 11212221 12222211221 23456788999999999999999998876543
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=343.85 Aligned_cols=261 Identities=23% Similarity=0.312 Sum_probs=199.2
Q ss_pred CcCcCCcccccCCcEEEEEEEC------CCcEEEEEEecCCCChhHHHHHHHHHHHHHhc-cCCCceeEEEEEee-CCeE
Q 003278 514 NFSESQRVAEMDFGTAYQGFLD------NHQYVLVKRLGMSKCPALRTRFSNELQNLARL-RHRNLVQLCGWCTE-QGEM 585 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l-~HpNiv~l~g~~~~-~~~~ 585 (834)
.|...+.||+|+||.||+|... .+..||+|++.........+.+.+|+.++.++ +||||++++++|.. ....
T Consensus 8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~ 87 (337)
T cd05054 8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPL 87 (337)
T ss_pred HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCE
Confidence 4666788999999999999642 24689999987554444446788899999999 89999999998865 4568
Q ss_pred EEEEeccCCCchhhhhhcCCCC-------------------------------------------------------CCC
Q 003278 586 LVIYDYSATRILSHLLFHNNHR-------------------------------------------------------IGH 610 (834)
Q Consensus 586 ~lv~Ey~~~g~L~~~l~~~~~~-------------------------------------------------------~~~ 610 (834)
+++|||+++|+|.+++...... ...
T Consensus 88 ~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (337)
T cd05054 88 MVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYK 167 (337)
T ss_pred EEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhh
Confidence 8999999999999988643210 001
Q ss_pred cccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCCCCCcccccCcccccccc
Q 003278 611 SILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIF 690 (834)
Q Consensus 611 ~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~ 690 (834)
..++|..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++.+..... ........|+.
T Consensus 168 ~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~-----~~~~~~~~~~~ 239 (337)
T cd05054 168 EPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-----YVRKGDARLPL 239 (337)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcc-----hhhccCCCCCc
Confidence 258999999999999999999996 6999999999999999999999999999987543211 01122345678
Q ss_pred CccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCccccccccccCCCCCHHHHHHH
Q 003278 691 GYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRL 769 (834)
Q Consensus 691 ~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 769 (834)
.|||||++.+..++.++|||||||+||||+| |..|+....+...+...... .... . .... ....+
T Consensus 240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~---~~~~---~----~~~~----~~~~~ 305 (337)
T cd05054 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKE---GTRM---R----APEY----ATPEI 305 (337)
T ss_pred cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhc---cCCC---C----CCcc----CCHHH
Confidence 8999999999999999999999999999998 98888653333222211111 0110 0 0111 12346
Q ss_pred HHHHHHhccCCCCCCCChhHHHHHHcc
Q 003278 770 IKLGIACTLSNPELRPSMRQILSILDG 796 (834)
Q Consensus 770 ~~l~~~C~~~~P~~RPtm~~v~~~L~~ 796 (834)
.+++.+||+.+|++|||+.+|++.|+.
T Consensus 306 ~~l~~~cl~~~p~~RPs~~ell~~l~~ 332 (337)
T cd05054 306 YSIMLDCWHNNPEDRPTFSELVEILGD 332 (337)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 677889999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=345.72 Aligned_cols=244 Identities=24% Similarity=0.293 Sum_probs=192.4
Q ss_pred CeeeccCCeEEEEEEECCCCeEEEEEEeccc---ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEccCCC
Q 003278 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK---GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNR 193 (834)
Q Consensus 117 ~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 193 (834)
+.||+|+||.||++....+|..||+|.+... .......+.+|+.++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4799999999999999889999999998653 2233456788999999999999999999999999999999999999
Q ss_pred CHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhhhhh
Q 003278 194 SLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQ 273 (834)
Q Consensus 194 sL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~ 273 (834)
+|..++... ..+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~- 150 (325)
T cd05594 81 ELFFHLSRE-------RVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG- 150 (325)
T ss_pred cHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-
Confidence 999888543 3589999999999999999999972 389999999999999999999999999987421110
Q ss_pred hhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHHHHHH
Q 003278 274 YQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIRRL 353 (834)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~ 353 (834)
.......||+.|+|||.+..+ .++.++|||||||++|||+||+.||...... .+. ...
T Consensus 151 ---------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tG~~Pf~~~~~~---~~~---~~i 208 (325)
T cd05594 151 ---------------ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLF---ELI 208 (325)
T ss_pred ---------------cccccccCCcccCCHHHHccC-CCCCccccccccceeeeeccCCCCCCCCCHH---HHH---HHH
Confidence 012345699999999998654 6789999999999999999999998643211 111 111
Q ss_pred hhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----chhhHHHH
Q 003278 354 SDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRP-----SMKWVIEA 404 (834)
Q Consensus 354 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~~V~~~ 404 (834)
.. +. ..+. ... ...+.++...|++.||++|| ++.++++.
T Consensus 209 ~~-~~------~~~p-~~~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 209 LM-EE------IRFP-RTL----SPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred hc-CC------CCCC-CCC----CHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 11 11 0111 111 13577899999999999997 78887754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=332.67 Aligned_cols=262 Identities=22% Similarity=0.327 Sum_probs=200.7
Q ss_pred HhhCcCcCCcccccCCcEEEEEEEC------CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCe
Q 003278 511 ATNNFSESQRVAEMDFGTAYQGFLD------NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGE 584 (834)
Q Consensus 511 at~~f~~~~~ig~g~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~ 584 (834)
++++|...+.||+|+||.||+|... .+..||||.+..........+|.+|+.++++++||||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3567888899999999999998753 2457999988654444445679999999999999999999999999999
Q ss_pred EEEEEeccCCCchhhhhhcCCCCC----CCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceE
Q 003278 585 MLVIYDYSATRILSHLLFHNNHRI----GHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRL 660 (834)
Q Consensus 585 ~~lv~Ey~~~g~L~~~l~~~~~~~----~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki 660 (834)
.++||||+++|+|.+++....... ....++|..++.++.|++.||+|||+ .+++||||||+|||+++++.+|+
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEE
Confidence 999999999999999986532111 12346888999999999999999996 68999999999999999999999
Q ss_pred eeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHH
Q 003278 661 GSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRV 739 (834)
Q Consensus 661 ~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~ 739 (834)
+|||+++.+...... .......+++.|||||++.++.++.++|||||||++|||+| |..|+....+. ......
T Consensus 161 ~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~-~~~~~~ 234 (277)
T cd05062 161 GDFGMTRDIYETDYY-----RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE-QVLRFV 234 (277)
T ss_pred CCCCCccccCCccee-----ecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHH
Confidence 999998754332210 01112346788999999998999999999999999999999 67777543222 222211
Q ss_pred HHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHc
Q 003278 740 HEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795 (834)
Q Consensus 740 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~ 795 (834)
.. ..... .... .+. .+..++.+||+.+|++|||+.++++.|+
T Consensus 235 ~~-----~~~~~-----~~~~-~~~---~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 235 ME-----GGLLD-----KPDN-CPD---MLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred Hc-----CCcCC-----CCCC-CCH---HHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 11 11111 1111 122 4556677999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=343.21 Aligned_cols=253 Identities=25% Similarity=0.330 Sum_probs=195.4
Q ss_pred CCCCCCeeeccCCeEEEEEEEC---CCCeEEEEEEeccc----ChhhHHHHHHHHHHHHhC-CCCceeeEeeeEEeCCEE
Q 003278 112 GFDEDEVLGSGGFGKVYRAVLP---SDGTVVAVKCLAEK----GERFEKTFAAELVAVAHL-RHRNLVRLRGWCVHEDQL 183 (834)
Q Consensus 112 ~f~~~~~LG~G~fG~Vy~~~~~---~~g~~vAvK~l~~~----~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~ 183 (834)
+|+..+.||+|+||.||+++.. .+|+.||+|++.+. .....+.+..|+.++.++ +||||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4778899999999999998863 46899999998642 223345678899999999 599999999999999999
Q ss_pred EEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeecc
Q 003278 184 LLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFG 263 (834)
Q Consensus 184 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFG 263 (834)
++||||+++|+|.+++..+ ..+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 81 ~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG 150 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR-------DNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFG 150 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCc
Confidence 9999999999999998643 3588999999999999999999985 99999999999999999999999999
Q ss_pred chhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCcc
Q 003278 264 LARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQ 343 (834)
Q Consensus 264 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~ 343 (834)
+++...... ........||+.|||||.+.....++.++|||||||++|||+||+.||........
T Consensus 151 ~~~~~~~~~---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 215 (332)
T cd05614 151 LSKEFLSEE---------------KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT 215 (332)
T ss_pred CCccccccC---------------CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC
Confidence 997532110 00123457999999999986544578899999999999999999999965432221
Q ss_pred chHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----chhhHHH
Q 003278 344 IILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRP-----SMKWVIE 403 (834)
Q Consensus 344 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~~V~~ 403 (834)
. ......... .++.+. ... ...+.++...||+.||++|| ++.++++
T Consensus 216 ~--~~~~~~~~~-------~~~~~~-~~~----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 216 Q--SEVSRRILK-------CDPPFP-SFI----GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred H--HHHHHHHhc-------CCCCCC-CCC----CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 1 111111111 111111 111 13567899999999999999 5556554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=330.85 Aligned_cols=254 Identities=20% Similarity=0.347 Sum_probs=200.6
Q ss_pred hCcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEecc
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYS 592 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~ 592 (834)
++|...++||+|+||.||+|...++..||+|.+.... ...+.|.+|+.++++++||||+++++++.+.+..+++|||+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT--MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc--hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 4577778999999999999998888889999876432 23467999999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccC
Q 003278 593 ATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRN 672 (834)
Q Consensus 593 ~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~ 672 (834)
++|+|.+++.... ...+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||++......
T Consensus 84 ~~~~L~~~l~~~~----~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 84 AKGSLLDFLKSDE----GGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred CCCcHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 9999999986532 1247888999999999999999996 68999999999999999999999999999765322
Q ss_pred CCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCcccc
Q 003278 673 DHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRPLAE 751 (834)
Q Consensus 673 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
.. .......++..|+|||++..+.++.++|||||||++|||+| |..|+....+.. ....+.. . ...
T Consensus 157 ~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-~~~~~~~---~-~~~-- 223 (261)
T cd05072 157 EY------TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD-VMSALQR---G-YRM-- 223 (261)
T ss_pred ce------eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH-HHHHHHc---C-CCC--
Confidence 10 11122346778999999998899999999999999999999 888875433222 1111111 0 000
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHcc
Q 003278 752 LVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDG 796 (834)
Q Consensus 752 ~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~ 796 (834)
...... + ..+.+++.+||..+|++|||+.+|.+.|+.
T Consensus 224 ----~~~~~~-~---~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 224 ----PRMENC-P---DELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred ----CCCCCC-C---HHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 011111 1 235567779999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=339.39 Aligned_cols=245 Identities=22% Similarity=0.317 Sum_probs=192.2
Q ss_pred CeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHHHHHhC-CCCceeeEeeeEEeCCEEEEEEEccCC
Q 003278 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVAVAHL-RHRNLVRLRGWCVHEDQLLLVYDYMPN 192 (834)
Q Consensus 117 ~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 192 (834)
+.||+|+||.||+|....+++.||||++.... ....+.+..|+.++.++ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999998899999999987532 23345678899999888 699999999999999999999999999
Q ss_pred CCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhhhh
Q 003278 193 RSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHEL 272 (834)
Q Consensus 193 gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~ 272 (834)
|+|..++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~L~~~~~~~-------~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~- 149 (327)
T cd05617 81 GDLMFHMQRQ-------RKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP- 149 (327)
T ss_pred CcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCC-
Confidence 9999887542 3589999999999999999999985 9999999999999999999999999998642110
Q ss_pred hhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHHHHH
Q 003278 273 QYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIRR 352 (834)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~ 352 (834)
........||+.|+|||++... .++.++|||||||++|||+||+.||+............++..
T Consensus 150 ---------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~ 213 (327)
T cd05617 150 ---------------GDTTSTFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQ 213 (327)
T ss_pred ---------------CCceecccCCcccCCHHHHCCC-CCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHH
Confidence 0012346799999999998654 678999999999999999999999975433222222233332
Q ss_pred HhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchh
Q 003278 353 LSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMK 399 (834)
Q Consensus 353 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~ 399 (834)
....... ++. ...+ ..+.+++..||+.||.+||++.
T Consensus 214 ~~~~~~~------~~p-~~~~----~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 214 VILEKPI------RIP-RFLS----VKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred HHHhCCC------CCC-CCCC----HHHHHHHHHHhccCHHHcCCCC
Confidence 2221110 111 1111 3567899999999999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=341.38 Aligned_cols=246 Identities=24% Similarity=0.340 Sum_probs=195.6
Q ss_pred CcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCCh-hHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 514 NFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKCP-ALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~-~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
+|...+.||+|+||.||||+.+ +.+.||+|.+...... ...+.+.+|++++++|+|||||.++.+|....++++|.||
T Consensus 3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~ 82 (808)
T KOG0597|consen 3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEY 82 (808)
T ss_pred chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehh
Confidence 4555677999999999999964 4788999998765433 3456688999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccccc
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTR 671 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~ 671 (834)
+.+ +|..+|...+ .|++.....|+.++..||.|||+ .+|+|||+||.||||++.+++|+||||+|+....
T Consensus 83 a~g-~L~~il~~d~------~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~ 152 (808)
T KOG0597|consen 83 AVG-DLFTILEQDG------KLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMST 152 (808)
T ss_pred hhh-hHHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhccc
Confidence 998 9999997654 38888889999999999999997 6999999999999999999999999999987543
Q ss_pred CCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcccc
Q 003278 672 NDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAE 751 (834)
Q Consensus 672 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
+ +...+++.||+.|||||.+.+++|+..+|.||+||+||||.+|+.||....-. ..+.... ..+
T Consensus 153 ~-------t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~----~Lv~~I~--~d~--- 216 (808)
T KOG0597|consen 153 N-------TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSIT----QLVKSIL--KDP--- 216 (808)
T ss_pred C-------ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHH----HHHHHHh--cCC---
Confidence 2 23346789999999999999999999999999999999999999998643211 1111111 111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 752 LVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 752 ~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
... +.+.-..++.+.---+..||.+|-|-.+++.
T Consensus 217 ----v~~---p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 217 ----VKP---PSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred ----CCC---cccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 111 1111122333333567789999999888764
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=333.92 Aligned_cols=267 Identities=20% Similarity=0.272 Sum_probs=194.6
Q ss_pred CcCCcccccCCcEEEEEEE-----CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeC--CeEEEE
Q 003278 516 SESQRVAEMDFGTAYQGFL-----DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQ--GEMLVI 588 (834)
Q Consensus 516 ~~~~~ig~g~~g~vy~~~~-----~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~--~~~~lv 588 (834)
...+.||+|+||+||.+.. .++..||+|.+...........|.+|+++|++++||||++++++|... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 5567899999999987653 356789999987654444567889999999999999999999988653 458899
Q ss_pred EeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccc
Q 003278 589 YDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEF 668 (834)
Q Consensus 589 ~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~ 668 (834)
|||+++|+|.+++... .++|..+..++.|++.||+|||+ .+|+||||||+|||+++++.+|++|||+++.
T Consensus 87 ~e~~~~~~l~~~~~~~-------~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 156 (283)
T cd05080 87 MEYVPLGSLRDYLPKH-------KLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 156 (283)
T ss_pred ecCCCCCCHHHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccc
Confidence 9999999999988542 38899999999999999999996 6899999999999999999999999999986
Q ss_pred cccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCch-hHHHHHHHHHhhcC
Q 003278 669 LTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEG-LLVKRVHEFEARKR 747 (834)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~-~~~~~~~~~~~~~~ 747 (834)
........ .......++..|+|||++.++.++.++|||||||++|||+||..|+......- ....... ......
T Consensus 157 ~~~~~~~~----~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~-~~~~~~ 231 (283)
T cd05080 157 VPEGHEYY----RVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQ-GQMTVV 231 (283)
T ss_pred cCCcchhh----ccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccc-cccchh
Confidence 54321110 00112345677999999998899999999999999999999998875322110 0000000 000000
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccC
Q 003278 748 PLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGN 797 (834)
Q Consensus 748 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~ 797 (834)
.+.+.++..............+.+++.+||+.+|++||||.+|++.|+.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 232 RLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 00111111100000001112455666799999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=330.51 Aligned_cols=256 Identities=23% Similarity=0.345 Sum_probs=202.0
Q ss_pred hCcCcCCcccccCCcEEEEEEECC----CcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDN----HQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVI 588 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~----~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv 588 (834)
++|...+.||+|+||.||+|.... ...||||.+...........|.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 567888999999999999998743 4579999987665555667899999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccc
Q 003278 589 YDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEF 668 (834)
Q Consensus 589 ~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~ 668 (834)
|||+++++|.+++.... ..++|..+..++.|++.||+|||+ .+|+||||||+|||+++++.+|++|||+++.
T Consensus 84 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~ 155 (266)
T cd05033 84 TEYMENGSLDKFLREND-----GKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRR 155 (266)
T ss_pred EEcCCCCCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhc
Confidence 99999999999986532 148899999999999999999996 6899999999999999999999999999987
Q ss_pred cccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcC
Q 003278 669 LTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKR 747 (834)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
........ ......++..|+|||++.+..++.++||||||+++|||+| |..|+..... ......... ...
T Consensus 156 ~~~~~~~~-----~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~-~~~~~~~~~---~~~ 226 (266)
T cd05033 156 LEDSEATY-----TTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN-QDVIKAVED---GYR 226 (266)
T ss_pred ccccccce-----eccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH-HHHHHHHHc---CCC
Confidence 64211110 0112245678999999998899999999999999999998 8888754322 212111111 000
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHcc
Q 003278 748 PLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDG 796 (834)
Q Consensus 748 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~ 796 (834)
. + ..... + ..+.+++.+||+.+|++||++.+|++.|+.
T Consensus 227 -~-----~-~~~~~-~---~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~ 264 (266)
T cd05033 227 -L-----P-PPMDC-P---SALYQLMLDCWQKDRNERPTFSQIVSTLDK 264 (266)
T ss_pred -C-----C-CCCCC-C---HHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 0 0 01111 1 245677779999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=343.22 Aligned_cols=244 Identities=16% Similarity=0.204 Sum_probs=192.6
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCC--ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSK--CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIY 589 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~ 589 (834)
++|...+.||+|+||.||+|... +++.||||.+.... .....+.+.+|+.+|++++|||||++++++.+.+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 45677788999999999999974 57899999986432 1223467889999999999999999999999999999999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccc
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFL 669 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~ 669 (834)
||+++|+|.+++.... .+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 98 e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 168 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG------RFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV 168 (329)
T ss_pred cCCCCChHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEc
Confidence 9999999999887542 36777788899999999999997 68999999999999999999999999999764
Q ss_pred ccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcc
Q 003278 670 TRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPL 749 (834)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
... .....||+.|||||++.+..++.++|||||||++|||+||..||....+.. ....+ ......
T Consensus 169 ~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~i---~~~~~~- 233 (329)
T PTZ00263 169 PDR----------TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR-IYEKI---LAGRLK- 233 (329)
T ss_pred CCC----------cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH-HHHHH---hcCCcC-
Confidence 321 123579999999999999999999999999999999999999986433221 11111 111111
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCC-----hhHHH
Q 003278 750 AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPS-----MRQIL 791 (834)
Q Consensus 750 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPt-----m~~v~ 791 (834)
++...+ .. +..++.+||+.||++||+ +.+++
T Consensus 234 -------~p~~~~-~~---~~~li~~~L~~dP~~R~~~~~~~~~~ll 269 (329)
T PTZ00263 234 -------FPNWFD-GR---ARDLVKGLLQTDHTKRLGTLKGGVADVK 269 (329)
T ss_pred -------CCCCCC-HH---HHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence 111111 23 345556899999999997 56655
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=337.96 Aligned_cols=244 Identities=17% Similarity=0.233 Sum_probs=193.5
Q ss_pred CcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCC--hhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEe
Q 003278 514 NFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKC--PALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYD 590 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~E 590 (834)
+|...+.||+|+||.||+|... +++.||+|.+..... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 5677788999999999999965 588999999864321 2234568899999999999999999999999999999999
Q ss_pred ccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccc
Q 003278 591 YSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLT 670 (834)
Q Consensus 591 y~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~ 670 (834)
|+++|+|.+++.... .+++.....++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++.+.
T Consensus 82 ~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~ 152 (291)
T cd05612 82 YVPGGELFSYLRNSG------RFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR 152 (291)
T ss_pred CCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhcc
Confidence 999999999986532 37888888999999999999996 699999999999999999999999999997643
Q ss_pred cCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCccc
Q 003278 671 RNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLA 750 (834)
Q Consensus 671 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (834)
.. .....||+.|+|||++.+..++.++|||||||++|||+||+.|+....+... ...+. .....
T Consensus 153 ~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~-~~~i~---~~~~~-- 216 (291)
T cd05612 153 DR----------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI-YEKIL---AGKLE-- 216 (291)
T ss_pred CC----------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHH---hCCcC--
Confidence 21 1235799999999999988899999999999999999999999865433221 11111 11111
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCC-----hhHHHH
Q 003278 751 ELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPS-----MRQILS 792 (834)
Q Consensus 751 ~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPt-----m~~v~~ 792 (834)
+....+ .. +.+++.+||+.||.+||+ +.++++
T Consensus 217 ------~~~~~~-~~---~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 217 ------FPRHLD-LY---AKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred ------CCccCC-HH---HHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 111121 23 345556899999999995 666663
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=343.03 Aligned_cols=241 Identities=18% Similarity=0.219 Sum_probs=189.4
Q ss_pred cccccCCcEEEEEEE-CCCcEEEEEEecCCC--ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEeccCCCc
Q 003278 520 RVAEMDFGTAYQGFL-DNHQYVLVKRLGMSK--CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRI 596 (834)
Q Consensus 520 ~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~--~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~~~g~ 596 (834)
.||+|+||.||++.. .++..||||.+.... .......+.+|+.++++++||||+++++++...+..++||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 81 (323)
T cd05571 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCc
Confidence 589999999999986 568899999986432 22234567889999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCCCCC
Q 003278 597 LSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGH 676 (834)
Q Consensus 597 L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~~~~ 676 (834)
|..++.... .+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 82 L~~~l~~~~------~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--- 149 (323)
T cd05571 82 LFFHLSRER------VFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--- 149 (323)
T ss_pred HHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC---
Confidence 998886432 47888888999999999999996 699999999999999999999999999987532111
Q ss_pred cccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCccccccccc
Q 003278 677 RKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLS 756 (834)
Q Consensus 677 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 756 (834)
......+||+.|||||++.+..++.++|||||||++|||+||+.||....... ..... .... ..
T Consensus 150 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-~~~~~---~~~~--------~~ 213 (323)
T cd05571 150 ----ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-LFELI---LMEE--------IR 213 (323)
T ss_pred ----CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH-HHHHH---HcCC--------CC
Confidence 11234679999999999999999999999999999999999999986432221 11111 1100 11
Q ss_pred cCCCCCHHHHHHHHHHHHHhccCCCCCCC-----ChhHHHH
Q 003278 757 LNGEYNHKELMRLIKLGIACTLSNPELRP-----SMRQILS 792 (834)
Q Consensus 757 l~~~~~~~~~~~l~~l~~~C~~~~P~~RP-----tm~~v~~ 792 (834)
+....+ .+ +.+++.+||+.||++|| +..++++
T Consensus 214 ~p~~~~-~~---~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 214 FPRTLS-PE---AKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCCCC-HH---HHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 111222 23 44555589999999999 7888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=331.48 Aligned_cols=260 Identities=22% Similarity=0.337 Sum_probs=202.3
Q ss_pred hCcCcCCcccccCCcEEEEEEECC------CcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDN------HQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEML 586 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~------~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~ 586 (834)
++|...+.||+|+||.||+|...+ +..||||.+......+..+.|.+|+++|.+++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 346666889999999999998643 46899999876555545678999999999999999999999999999999
Q ss_pred EEEeccCCCchhhhhhcCCC--------CCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCc
Q 003278 587 VIYDYSATRILSHLLFHNNH--------RIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNP 658 (834)
Q Consensus 587 lv~Ey~~~g~L~~~l~~~~~--------~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ 658 (834)
+||||+++|+|.+++...+. ......+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCeE
Confidence 99999999999999976432 1122357899999999999999999996 689999999999999999999
Q ss_pred eEeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHH
Q 003278 659 RLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVK 737 (834)
Q Consensus 659 ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~ 737 (834)
|++|||+++.+...... .......+++.|+|||++.++.++.++|||||||++|||+| |..|+....... ...
T Consensus 162 kl~d~g~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~-~~~ 235 (280)
T cd05049 162 KIGDFGMSRDVYTTDYY-----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE-VIE 235 (280)
T ss_pred EECCcccceecccCcce-----ecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-HHH
Confidence 99999999754322110 01122346788999999999999999999999999999999 999886433222 111
Q ss_pred HHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHc
Q 003278 738 RVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795 (834)
Q Consensus 738 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~ 795 (834)
... ....... ... .+. .+.+++.+||+.||++|||+.||++.|+
T Consensus 236 ~~~-----~~~~~~~-----~~~-~~~---~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 236 CIT-----QGRLLQR-----PRT-CPS---EVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHH-----cCCcCCC-----CCC-CCH---HHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 111 1111000 011 122 3556667999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=360.71 Aligned_cols=261 Identities=23% Similarity=0.334 Sum_probs=204.2
Q ss_pred HHhhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCC--
Q 003278 106 LYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHED-- 181 (834)
Q Consensus 106 l~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-- 181 (834)
.....++|...+.||+|+||.||+|....+|+.||||++... .......+.+|+..+..++|+||+++++.+...+
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 344557899999999999999999999889999999998643 3344567889999999999999999988776433
Q ss_pred ------EEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCC
Q 003278 182 ------QLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQY 255 (834)
Q Consensus 182 ------~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~ 255 (834)
.+++||||+++|+|.++|..+.. ...++++.....|+.|++.||.|||+. +|+||||||+|||++.++
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~---~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~ 180 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAK---TNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNG 180 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCC
Confidence 37899999999999999865432 235689999999999999999999985 999999999999999999
Q ss_pred ceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccC
Q 003278 256 NARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAV 335 (834)
Q Consensus 256 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~ 335 (834)
.+||+|||+++.+..... ........||+.|+|||++... .++.++|||||||++|||+||+.||
T Consensus 181 ~vkL~DFGls~~~~~~~~--------------~~~~~~~~Gt~~Y~aPE~~~~~-~~s~k~DVwSlGvilyeLltG~~Pf 245 (496)
T PTZ00283 181 LVKLGDFGFSKMYAATVS--------------DDVGRTFCGTPYYVAPEIWRRK-PYSKKADMFSLGVLLYELLTLKRPF 245 (496)
T ss_pred CEEEEecccCeecccccc--------------ccccccccCCcceeCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 999999999986432110 0012345799999999998654 6799999999999999999999998
Q ss_pred CCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 336 DLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 336 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
.... ....+..... +.... +. ... ...+..++..||+.||.+||++.+++..
T Consensus 246 ~~~~------~~~~~~~~~~-~~~~~-----~~-~~~----~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 246 DGEN------MEEVMHKTLA-GRYDP-----LP-PSI----SPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCC------HHHHHHHHhc-CCCCC-----CC-CCC----CHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 6421 1122222111 11110 11 111 2457889999999999999999999864
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=335.95 Aligned_cols=263 Identities=27% Similarity=0.417 Sum_probs=203.0
Q ss_pred hcCCCCCCCeeeccCCeEEEEEEECC-----CCeEEEEEEecccC-hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCE
Q 003278 109 GSNGFDEDEVLGSGGFGKVYRAVLPS-----DGTVVAVKCLAEKG-ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQ 182 (834)
Q Consensus 109 ~t~~f~~~~~LG~G~fG~Vy~~~~~~-----~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~ 182 (834)
++++|...+.||+|+||.||+|.+.. .+..||+|.+.... ......|.+|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 45779999999999999999999976 67889999886443 3345679999999999999999999999999999
Q ss_pred EEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCC---ceEE
Q 003278 183 LLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQY---NARL 259 (834)
Q Consensus 183 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~---~~kl 259 (834)
.++||||+++|+|.+++............++|..++.++.||+.||+|||+. +++||||||+|||++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence 9999999999999999976543222334689999999999999999999985 899999999999998654 5999
Q ss_pred eeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCC
Q 003278 260 GDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLT 338 (834)
Q Consensus 260 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~ 338 (834)
+|||+++.+...... .......+++.|+|||++..+ .++.++|||||||++|||+| |+.||+..
T Consensus 161 ~dfg~~~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~~g~~pf~~~ 225 (277)
T cd05036 161 ADFGMARDIYRASYY--------------RKGGRAMLPIKWMPPEAFLDG-IFTSKTDVWSFGVLLWEIFSLGYMPYPGR 225 (277)
T ss_pred ccCccccccCCccce--------------ecCCCCCccHhhCCHHHHhcC-CcCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999865221100 001122345789999998655 57999999999999999997 98888643
Q ss_pred CCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhh
Q 003278 339 YPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVS 406 (834)
Q Consensus 339 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~ 406 (834)
... .+. ......... . . .... ...+.+++..|++.+|++||++.+|++.|.
T Consensus 226 ~~~---~~~---~~~~~~~~~-~-----~-~~~~----~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 226 TNQ---EVM---EFVTGGGRL-D-----P-PKGC----PGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CHH---HHH---HHHHcCCcC-C-----C-CCCC----CHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 211 111 111111110 0 0 0111 246788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=329.79 Aligned_cols=260 Identities=22% Similarity=0.347 Sum_probs=205.6
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc---ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK---GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 187 (834)
++|+..+.||+|+||.||+|+...+++.||||.+... .......|.+|+.++++++||||+++++++...+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 5788999999999999999999889999999987532 2344567899999999999999999999999999999999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
||+++|+|.+++..... ....+++.....++.|++.||.|||+. +++||||||+|||++.++.++|+|||++..
T Consensus 82 e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~ 155 (267)
T cd08228 82 ELADAGDLSQMIKYFKK---QKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRF 155 (267)
T ss_pred EecCCCcHHHHHHHhhh---ccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECcccccee
Confidence 99999999988854221 124578899999999999999999985 999999999999999999999999999876
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHH
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILL 347 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~ 347 (834)
+..... ......|++.|+|||.+... ..+.++|||||||++|||+||+.|+..... ...
T Consensus 156 ~~~~~~----------------~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~----~~~ 214 (267)
T cd08228 156 FSSKTT----------------AAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLF 214 (267)
T ss_pred ccchhH----------------HHhcCCCCccccChhhhccC-CCCchhhHHHHHHHHHHHhcCCCCCccccc----cHH
Confidence 532211 01234588999999988654 568899999999999999999999853221 122
Q ss_pred HHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhc
Q 003278 348 DWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSG 407 (834)
Q Consensus 348 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~ 407 (834)
.+...+.. . ..+... .......+.+++..||+.+|++||++.+|++.++.
T Consensus 215 ~~~~~~~~-~-----~~~~~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~ 264 (267)
T cd08228 215 SLCQKIEQ-C-----DYPPLP----TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQ 264 (267)
T ss_pred HHHHHHhc-C-----CCCCCC----hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHH
Confidence 22222111 1 111111 11122468899999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=330.42 Aligned_cols=250 Identities=25% Similarity=0.385 Sum_probs=197.0
Q ss_pred CCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc-ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEcc
Q 003278 112 GFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYM 190 (834)
Q Consensus 112 ~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 190 (834)
+|+..++||+|+||.||+|.+..++..||+|.+... .....+.|.+|+.++.+++||||++++++|...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 577788999999999999999889999999998643 2344567899999999999999999999999999999999999
Q ss_pred CCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhh
Q 003278 191 PNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEH 270 (834)
Q Consensus 191 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~ 270 (834)
++|+|..+. .+++.....++.|++.||.|||+. +|+|+||||+|||++.++.+||+|||++..+..
T Consensus 82 ~~~~l~~~~-----------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~ 147 (279)
T cd06619 82 DGGSLDVYR-----------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN 147 (279)
T ss_pred CCCChHHhh-----------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence 999996542 367788899999999999999985 999999999999999999999999999875321
Q ss_pred hhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccc-hHHHH
Q 003278 271 ELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQI-ILLDW 349 (834)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~-~l~~~ 349 (834)
. ..+...||..|+|||++... .++.++|||||||++|||+||+.||......... ....+
T Consensus 148 ~------------------~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 208 (279)
T cd06619 148 S------------------IAKTYVGTNAYMAPERISGE-QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQL 208 (279)
T ss_pred c------------------cccCCCCChhhcCceeecCC-CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHH
Confidence 1 12335689999999998754 5789999999999999999999998653322211 11111
Q ss_pred HHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 350 IRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 350 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
....... ..+.+..... ...+.+++..|++.+|++||++.++++.
T Consensus 209 ~~~~~~~------~~~~~~~~~~----~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 209 LQCIVDE------DPPVLPVGQF----SEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HHHHhcc------CCCCCCCCcC----CHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 1111111 1111111111 1357889999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=342.81 Aligned_cols=251 Identities=19% Similarity=0.197 Sum_probs=196.4
Q ss_pred CcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCC--hhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEe
Q 003278 514 NFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKC--PALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYD 590 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~E 590 (834)
+|...+.||+|+||.||+|... +++.||||++..... ......+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 5677788999999999999975 478999999864321 2234578899999999999999999999999999999999
Q ss_pred ccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccc
Q 003278 591 YSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLT 670 (834)
Q Consensus 591 y~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~ 670 (834)
|+++|+|.+++.... .+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 82 ~~~g~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~ 152 (333)
T cd05600 82 YVPGGDFRTLLNNLG------VLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV 152 (333)
T ss_pred CCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCcccc
Confidence 999999999986432 37788888999999999999996 689999999999999999999999999997542
Q ss_pred cCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhh-cCcc
Q 003278 671 RNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEAR-KRPL 749 (834)
Q Consensus 671 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~-~~~~ 749 (834)
. ......||+.|+|||++.+..++.++|||||||++|||+||..||....+... ...+..+... ..+
T Consensus 153 ~----------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~- 220 (333)
T cd05600 153 T----------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET-WENLKYWKETLQRP- 220 (333)
T ss_pred c----------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH-HHHHHhccccccCC-
Confidence 2 12345799999999999999999999999999999999999999875443322 1111111000 000
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 750 AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 750 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
...++. ... .. .+..++.+||..+|++|||+.+|++
T Consensus 221 -~~~~~~--~~~-s~---~~~~li~~~l~~~~~rr~s~~~ll~ 256 (333)
T cd05600 221 -VYDDPR--FNL-SD---EAWDLITKLINDPSRRFGSLEDIKN 256 (333)
T ss_pred -CCCccc--ccc-CH---HHHHHHHHHhhChhhhcCCHHHHHh
Confidence 000000 011 22 3445556899999999999999985
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=334.41 Aligned_cols=260 Identities=23% Similarity=0.344 Sum_probs=199.3
Q ss_pred CcCcCCcccccCCcEEEEEEE-----CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEE
Q 003278 514 NFSESQRVAEMDFGTAYQGFL-----DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVI 588 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~-----~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv 588 (834)
+|.-.+.||+|+||.||+|.. ..+..|++|.+...........|.+|+.++++++||||+++++++......++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 85 (283)
T cd05090 6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCML 85 (283)
T ss_pred hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEE
Confidence 455667899999999999984 345789999987555445556799999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhcCCCC-----------CCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCC
Q 003278 589 YDYSATRILSHLLFHNNHR-----------IGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMN 657 (834)
Q Consensus 589 ~Ey~~~g~L~~~l~~~~~~-----------~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~ 657 (834)
|||+++++|.+++...... .....+++...+.++.|++.||+|||+ .+|+||||||+|||+++++.
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 86 FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQLH 162 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCCc
Confidence 9999999999998533210 011247888999999999999999996 68999999999999999999
Q ss_pred ceEeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHH
Q 003278 658 PRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLV 736 (834)
Q Consensus 658 ~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~ 736 (834)
+|++|||+++........ .......++..|+|||++.++.++.++|||||||++|||+| |..|+....+ ....
T Consensus 163 ~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-~~~~ 236 (283)
T cd05090 163 VKISDLGLSREIYSADYY-----RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-QEVI 236 (283)
T ss_pred EEeccccccccccCCcce-----ecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-HHHH
Confidence 999999999765332211 11223456788999999988899999999999999999999 8888754322 1111
Q ss_pred HHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHcc
Q 003278 737 KRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDG 796 (834)
Q Consensus 737 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~ 796 (834)
..+. . .... ......+ . .+..++.+||+.||++||++.+|.+.|.+
T Consensus 237 ~~~~----~-~~~~-----~~~~~~~-~---~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 237 EMVR----K-RQLL-----PCSEDCP-P---RMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHH----c-CCcC-----CCCCCCC-H---HHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1111 1 1110 0111122 2 34556669999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=334.41 Aligned_cols=264 Identities=28% Similarity=0.459 Sum_probs=206.0
Q ss_pred cCCCCCCCeeeccCCeEEEEEEE-----CCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVL-----PSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLL 184 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~-----~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 184 (834)
.++|...+.||+|+||.||++.. ..++..+|+|.+........+.+.+|+.++.+++||||++++++|...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 46788899999999999999985 2345679999987766666778999999999999999999999999999999
Q ss_pred EEEEccCCCCHhHHHhcCCCc------cccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceE
Q 003278 185 LVYDYMPNRSLDRVLFRRPEN------LEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNAR 258 (834)
Q Consensus 185 lV~Ey~~~gsL~~~l~~~~~~------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~k 258 (834)
+||||+++|+|.+++...... ......++|..++.++.|++.||+|||+. +++||||||+|||+++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEE
Confidence 999999999999998653210 01224589999999999999999999985 999999999999999999999
Q ss_pred EeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCC
Q 003278 259 LGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDL 337 (834)
Q Consensus 259 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~ 337 (834)
|+|||+++.+...... .......|++.|+|||.+... .++.++|||||||++|||+| |+.|+..
T Consensus 161 l~dfg~~~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~t~g~~p~~~ 225 (288)
T cd05093 161 IGDFGMSRDVYSTDYY--------------RVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQ 225 (288)
T ss_pred eccCCccccccCCcee--------------ecCCCCCccccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999754321100 011223467899999988644 67899999999999999999 8888754
Q ss_pred CCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 338 TYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 338 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
.... .... . ...+..... . ... ...+.+++..||+.||.+||++.+|.+.|+..
T Consensus 226 ~~~~---~~~~---~-i~~~~~~~~-----~-~~~----~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~ 279 (288)
T cd05093 226 LSNN---EVIE---C-ITQGRVLQR-----P-RTC----PKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL 279 (288)
T ss_pred CCHH---HHHH---H-HHcCCcCCC-----C-CCC----CHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 3221 1111 1 112221111 0 111 13588999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=344.87 Aligned_cols=259 Identities=22% Similarity=0.267 Sum_probs=196.7
Q ss_pred HHhhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc---ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCE
Q 003278 106 LYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK---GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQ 182 (834)
Q Consensus 106 l~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~ 182 (834)
+....++|+..+.||+|+||.||++....+++.||+|.+.+. .....+.+.+|+.+++.++||||+++++++.+++.
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 344567899999999999999999999889999999998642 12234567889999999999999999999999999
Q ss_pred EEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeec
Q 003278 183 LLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDF 262 (834)
Q Consensus 183 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DF 262 (834)
.++||||+++|+|.+++... .+++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+||
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~--------~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DF 186 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSNY--------DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADF 186 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc--------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEec
Confidence 99999999999999988532 467888999999999999999985 9999999999999999999999999
Q ss_pred cchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccC---CCCCcccceeehhhHHHHHHhCCccCCCCC
Q 003278 263 GLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKG---SVATAKSDVFSFGIVVLEVVSGRRAVDLTY 339 (834)
Q Consensus 263 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~---~~~~~ksDV~SfGvvl~ElltG~~p~~~~~ 339 (834)
|+++.+.... .....+..||+.|||||.+... ..++.++|||||||++|||+||+.||....
T Consensus 187 G~a~~~~~~~---------------~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~ 251 (370)
T cd05621 187 GTCMKMDETG---------------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS 251 (370)
T ss_pred ccceecccCC---------------ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC
Confidence 9997542210 0012345699999999998642 236789999999999999999999996432
Q ss_pred CCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCC--CCCchhhHHHH
Q 003278 340 PDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPH--LRPSMKWVIEA 404 (834)
Q Consensus 340 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~--~RPsm~~V~~~ 404 (834)
. .................+ . ..-...+..+...|+..+|. .||++.++++.
T Consensus 252 ~------~~~~~~i~~~~~~~~~p~-----~---~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 252 L------VGTYSKIMDHKNSLNFPE-----D---VEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred H------HHHHHHHHhCCcccCCCC-----c---ccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 1 111122211111111110 0 00113456677778875443 38888888763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=333.01 Aligned_cols=257 Identities=24% Similarity=0.366 Sum_probs=197.9
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCe----EEEEEEecccC-hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGT----VVAVKCLAEKG-ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLL 185 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~----~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 185 (834)
++|+..+.||+|+||.||+|.+..+|. .||+|.+.... .....++..|+..+++++||||++++|++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 357778999999999999999877776 47777775432 2344678889999999999999999998864 55789
Q ss_pred EEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccch
Q 003278 186 VYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLA 265 (834)
Q Consensus 186 V~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla 265 (834)
++||+++|+|.+++.... ..++|..+..|+.|++.||+|||+. +++||||||+|||++.++.+||+|||++
T Consensus 86 i~e~~~~gsL~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~ 156 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR------DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVA 156 (279)
T ss_pred EEEeCCCCcHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccc
Confidence 999999999999996532 3589999999999999999999985 8999999999999999999999999999
Q ss_pred hhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccc
Q 003278 266 RWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQI 344 (834)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~ 344 (834)
+.+..... ....+...|+..|+|||++..+ .++.++|||||||++|||+| |+.|+......
T Consensus 157 ~~~~~~~~--------------~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--- 218 (279)
T cd05111 157 DLLYPDDK--------------KYFYSEHKTPIKWMALESILFG-RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH--- 218 (279)
T ss_pred eeccCCCc--------------ccccCCCCCcccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---
Confidence 86432110 0012334578899999998655 57999999999999999998 99888643211
Q ss_pred hHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcCC
Q 003278 345 ILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGSY 409 (834)
Q Consensus 345 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~~ 409 (834)
.+.++ ...+.... .+. .. ...+..++..||..||..||++.++++.|....
T Consensus 219 ~~~~~----~~~~~~~~--~~~----~~----~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 219 EVPDL----LEKGERLA--QPQ----IC----TIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred HHHHH----HHCCCcCC--CCC----CC----CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 11121 22222111 111 11 134677889999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=329.79 Aligned_cols=256 Identities=22% Similarity=0.333 Sum_probs=200.3
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEcc
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYM 190 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 190 (834)
++|+..+.||+|+||.||+|....+|+.||+|++..........+.+|+.++.+++||||+++++++...+..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 46888999999999999999998899999999987554444566889999999999999999999999999999999999
Q ss_pred CCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhh
Q 003278 191 PNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEH 270 (834)
Q Consensus 191 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~ 270 (834)
++|+|.+++... .++++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.+..
T Consensus 89 ~~~~L~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06646 89 GGGSLQDIYHVT-------GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITA 158 (267)
T ss_pred CCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence 999999988542 3578999999999999999999985 999999999999999999999999999975421
Q ss_pred hhhhhhhcccccccccccccceeeeccccCCCcccccc--CCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHH
Q 003278 271 ELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQK--GSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLD 348 (834)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~ 348 (834)
.. .......|++.|+|||.+.. ...++.++|||||||++|||+||+.|+....+..... .
T Consensus 159 ~~----------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~--~ 220 (267)
T cd06646 159 TI----------------AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF--L 220 (267)
T ss_pred cc----------------cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe--e
Confidence 10 01223458999999998742 3346789999999999999999999985332111100 0
Q ss_pred HHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHh
Q 003278 349 WIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAV 405 (834)
Q Consensus 349 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l 405 (834)
+ ..... ..+... . ...-...+.+++..||+.+|++||++.++++.+
T Consensus 221 ----~-~~~~~---~~~~~~-~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 221 ----M-SKSNF---QPPKLK-D--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred ----e-ecCCC---CCCCCc-c--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0 00000 001110 0 001124678999999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=332.32 Aligned_cols=256 Identities=24% Similarity=0.355 Sum_probs=202.1
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEcc
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYM 190 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 190 (834)
.+|+..+.||+|+||.||+|.+..+++.||+|.+... ....+.+.+|+.++.+++||||++++++|...+..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 4577889999999999999999888999999998654 334567899999999999999999999999999999999999
Q ss_pred CCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhh
Q 003278 191 PNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEH 270 (834)
Q Consensus 191 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~ 270 (834)
++|+|.+++.... ...++|..++.++.|+++||+|||+. +++||||||+|||+++++.+||+|||+++....
T Consensus 85 ~~~~L~~~~~~~~-----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 85 TYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred CCCcHHHHHHhCC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 9999999986532 24589999999999999999999985 999999999999999999999999999975432
Q ss_pred hhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccchHHHH
Q 003278 271 ELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQIILLDW 349 (834)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~ 349 (834)
... .......+++.|+|||++... .++.++|||||||++|||+| |..|+..... ..+
T Consensus 157 ~~~---------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~------~~~ 214 (263)
T cd05052 157 DTY---------------TAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------SQV 214 (263)
T ss_pred cee---------------eccCCCCCccccCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCH------HHH
Confidence 110 001122346789999988644 67889999999999999998 8888754221 111
Q ss_pred HHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 350 IRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 350 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
.... ..+... ... .. ....+.+++.+||+.+|++||+|.++++.|+..
T Consensus 215 ~~~~-~~~~~~-----~~~-~~----~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 215 YELL-EKGYRM-----ERP-EG----CPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHHH-HCCCCC-----CCC-CC----CCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 1111 111100 000 11 124688899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=332.58 Aligned_cols=267 Identities=19% Similarity=0.280 Sum_probs=199.1
Q ss_pred hCcCcCCcccccCCcEEEEEEECC---------------CcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDN---------------HQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCG 577 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~---------------~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g 577 (834)
+.|...++||+|+||.||++...+ ...||||.+...........|.+|++++++++||||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 356667889999999999987542 13589999876555556678999999999999999999999
Q ss_pred EEeeCCeEEEEEeccCCCchhhhhhcCCCC------CCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCcee
Q 003278 578 WCTEQGEMLVIYDYSATRILSHLLFHNNHR------IGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAIT 651 (834)
Q Consensus 578 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~------~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NIL 651 (834)
++...+..++||||+++++|.+++...... .....++|..++.++.|++.||+|||+ .+++||||||+|||
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhEE
Confidence 999999999999999999999988643211 111247889999999999999999996 68999999999999
Q ss_pred ecCCCCceEeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh--CCCccCCC
Q 003278 652 LDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT--GQMAVDFR 729 (834)
Q Consensus 652 ld~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t--G~~p~~~~ 729 (834)
+++++.+||+|||++..+..... ........++..|+|||++.++.++.++|||||||++|||+| |..|+...
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~ 236 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDY-----YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLL 236 (295)
T ss_pred EcCCCcEEecccccccccccCcc-----eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence 99999999999999976432211 011122345778999999998999999999999999999998 45565433
Q ss_pred CCchhHHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHc
Q 003278 730 LPEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795 (834)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~ 795 (834)
.. ................ ... ....... + ..+.+++.+||+.||++||||.+|++.|.
T Consensus 237 ~~-~~~~~~~~~~~~~~~~--~~~-~~~~~~~-~---~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 237 SD-EQVIENTGEFFRNQGR--QIY-LSQTPLC-P---SPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred Ch-HHHHHHHHHhhhhccc--ccc-CCCCCCC-C---HHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 22 2222222111110000 000 0001111 1 25667778999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=338.23 Aligned_cols=242 Identities=26% Similarity=0.338 Sum_probs=189.6
Q ss_pred CeeeccCCeEEEEEEEC---CCCeEEEEEEeccc----ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEc
Q 003278 117 EVLGSGGFGKVYRAVLP---SDGTVVAVKCLAEK----GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDY 189 (834)
Q Consensus 117 ~~LG~G~fG~Vy~~~~~---~~g~~vAvK~l~~~----~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 189 (834)
+.||+|+||.||++... .+++.||||++... .......+.+|+.+|+.++||||++++++|..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 57999999999999863 46889999998643 122345678899999999999999999999999999999999
Q ss_pred cCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhh
Q 003278 190 MPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLE 269 (834)
Q Consensus 190 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~ 269 (834)
+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 82 ~~~~~L~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 151 (323)
T cd05584 82 LSGGELFMHLERE-------GIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESI 151 (323)
T ss_pred CCCchHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecc
Confidence 9999999988643 3577888899999999999999985 99999999999999999999999999987421
Q ss_pred hhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHH
Q 003278 270 HELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDW 349 (834)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~ 349 (834)
... .......||+.|+|||.+... .++.++|||||||++|||+||+.||...... ..
T Consensus 152 ~~~----------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~pf~~~~~~------~~ 208 (323)
T cd05584 152 HEG----------------TVTHTFCGTIEYMAPEILMRS-GHGKAVDWWSLGALMYDMLTGAPPFTAENRK------KT 208 (323)
T ss_pred cCC----------------CcccccCCCccccChhhccCC-CCCCcceecccHHHHHHHhcCCCCCCCCCHH------HH
Confidence 110 012345699999999998654 5688999999999999999999998643211 11
Q ss_pred HHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----chhhHHH
Q 003278 350 IRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRP-----SMKWVIE 403 (834)
Q Consensus 350 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~~V~~ 403 (834)
...+.. +.. .+.+ .. ...+.+++..||+.+|++|| ++.++++
T Consensus 209 ~~~~~~-~~~--~~~~-----~~----~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 209 IDKILK-GKL--NLPP-----YL----TPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred HHHHHc-CCC--CCCC-----CC----CHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 112111 111 0111 11 13577899999999999999 6666654
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=327.97 Aligned_cols=249 Identities=20% Similarity=0.314 Sum_probs=193.3
Q ss_pred CcccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEeccCCCch
Q 003278 519 QRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRIL 597 (834)
Q Consensus 519 ~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~~~g~L 597 (834)
+.||+|+||.||+|.. .+++.||+|.+...........|.+|++++++++||||++++++|......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 3689999999999986 468889999876555555667899999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCCCCCc
Q 003278 598 SHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHR 677 (834)
Q Consensus 598 ~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~~~~~ 677 (834)
.+++.... ..++|..+..++.|++.||+|||+ .+|+||||||+|||++.++.+|++|||++........
T Consensus 81 ~~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~--- 149 (252)
T cd05084 81 LTFLRTEG-----PRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY--- 149 (252)
T ss_pred HHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccc---
Confidence 99986432 247899999999999999999996 6899999999999999999999999999875432110
Q ss_pred ccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCccccccccc
Q 003278 678 KATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLS 756 (834)
Q Consensus 678 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 756 (834)
........++..|+|||++.++.++.++|||||||++|||++ |..|+....+.. ..... ... .. ..
T Consensus 150 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-~~~~~---~~~-~~------~~ 216 (252)
T cd05084 150 --ASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-TREAI---EQG-VR------LP 216 (252)
T ss_pred --cccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-HHHHH---HcC-CC------CC
Confidence 000011123467999999999999999999999999999998 777775433221 11111 000 00 00
Q ss_pred cCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHc
Q 003278 757 LNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795 (834)
Q Consensus 757 l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~ 795 (834)
..... + ..+.+++.+||+.+|++|||+.+|.++|+
T Consensus 217 ~~~~~-~---~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 217 CPELC-P---DAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CcccC-C---HHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 11111 2 24556667999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=341.51 Aligned_cols=264 Identities=28% Similarity=0.417 Sum_probs=201.0
Q ss_pred CCCCCCCeeeccCCeEEEEEEECC-----CCeEEEEEEecccC-hhhHHHHHHHHHHHHhC-CCCceeeEeeeEEeC-CE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPS-----DGTVVAVKCLAEKG-ERFEKTFAAELVAVAHL-RHRNLVRLRGWCVHE-DQ 182 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~-----~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~-~~ 182 (834)
++|+..+.||+|+||.||+|.... +++.||+|++.... ....+.+..|+.++.++ +|+||++++++|... +.
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 468889999999999999997533 35789999986532 23346688899999999 899999999988754 56
Q ss_pred EEEEEEccCCCCHhHHHhcCCCcc------------------------------------------------------cc
Q 003278 183 LLLVYDYMPNRSLDRVLFRRPENL------------------------------------------------------EA 208 (834)
Q Consensus 183 ~~lV~Ey~~~gsL~~~l~~~~~~~------------------------------------------------------~~ 208 (834)
+++||||+++|+|.+++....... ..
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 899999999999999986432100 00
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhhhhhhhhhccccccccccc
Q 003278 209 AAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHL 288 (834)
Q Consensus 209 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~ 288 (834)
..+++|..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+......
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~-------------- 229 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-------------- 229 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcch--------------
Confidence 13689999999999999999999985 9999999999999999999999999999865322110
Q ss_pred ccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccchHHHHHHHHhhcCcccccccccc
Q 003278 289 AETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRL 367 (834)
Q Consensus 289 ~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 367 (834)
.......|+..|+|||++... .++.++|||||||++|||+| |+.||......+. + ......+.....
T Consensus 230 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~----~~~~~~~~~~~~----- 297 (337)
T cd05054 230 VRKGDARLPLKWMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--F----CRRLKEGTRMRA----- 297 (337)
T ss_pred hhccCCCCCccccCcHHhcCC-CCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--H----HHHHhccCCCCC-----
Confidence 012234567889999988654 67999999999999999998 9988865332211 1 111122211110
Q ss_pred CCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 368 SDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 368 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
. . .....+.+++..||+.+|++||++.+|++.|...
T Consensus 298 ~-~----~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~ 333 (337)
T cd05054 298 P-E----YATPEIYSIMLDCWHNNPEDRPTFSELVEILGDL 333 (337)
T ss_pred C-c----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0 0 1124578999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=332.97 Aligned_cols=241 Identities=22% Similarity=0.365 Sum_probs=188.0
Q ss_pred eeeccCCeEEEEEEECCC------------------------CeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeE
Q 003278 118 VLGSGGFGKVYRAVLPSD------------------------GTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRL 173 (834)
Q Consensus 118 ~LG~G~fG~Vy~~~~~~~------------------------g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l 173 (834)
.||+|+||.||+|.+..+ ...||+|.+..........|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 699999999999986321 24689999876555556778899999999999999999
Q ss_pred eeeEEeCCEEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECC
Q 003278 174 RGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDS 253 (834)
Q Consensus 174 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~ 253 (834)
+|+|.+.+..++||||+++|+|..++... ...+++..++.++.|+++||+|||+. +|+||||||+|||++.
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~------~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~ 152 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE------KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLAR 152 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEec
Confidence 99999999999999999999999988642 24578999999999999999999985 9999999999999976
Q ss_pred CC-------ceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHH
Q 003278 254 QY-------NARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVL 326 (834)
Q Consensus 254 ~~-------~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ 326 (834)
.+ .+|++|||++..... .....|+..|+|||.+.....++.++|||||||++|
T Consensus 153 ~~~~~~~~~~~kl~d~g~~~~~~~--------------------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~ 212 (274)
T cd05076 153 LGLAEGTSPFIKLSDPGVSFTALS--------------------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLL 212 (274)
T ss_pred cCcccCccceeeecCCcccccccc--------------------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHH
Confidence 43 379999998763211 112247888999998876556799999999999999
Q ss_pred HHH-hCCccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHh
Q 003278 327 EVV-SGRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAV 405 (834)
Q Consensus 327 Ell-tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l 405 (834)
||+ +|+.|+....+.. ...+. .... .+. ... ...+.+++..||+.+|++||+|.+|++.|
T Consensus 213 el~~~g~~p~~~~~~~~---~~~~~----~~~~-------~~~-~~~----~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 213 EICFDGEVPLKERTPSE---KERFY----EKKH-------RLP-EPS----CKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHhCCCCCccccChHH---HHHHH----Hhcc-------CCC-CCC----ChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 995 7888886432221 11111 1100 111 001 13578899999999999999999999876
Q ss_pred h
Q 003278 406 S 406 (834)
Q Consensus 406 ~ 406 (834)
+
T Consensus 274 ~ 274 (274)
T cd05076 274 T 274 (274)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=342.18 Aligned_cols=264 Identities=23% Similarity=0.308 Sum_probs=193.8
Q ss_pred CCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCC-----EEE
Q 003278 112 GFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHED-----QLL 184 (834)
Q Consensus 112 ~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-----~~~ 184 (834)
.|+..+.||+|+||.||+|+...+|..||||++... .......+.+|+.++++++||||+++++++...+ ..|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 367788999999999999999889999999998643 2233456889999999999999999999986543 489
Q ss_pred EEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccc
Q 003278 185 LVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGL 264 (834)
Q Consensus 185 lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGl 264 (834)
+||||++ ++|.+++... ..+++..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 81 lv~e~~~-~~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~ 149 (338)
T cd07859 81 VVFELME-SDLHQVIKAN-------DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGL 149 (338)
T ss_pred EEEecCC-CCHHHHHHhc-------ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcc
Confidence 9999995 6898887542 3589999999999999999999986 999999999999999999999999999
Q ss_pred hhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccC-CCCCcccceeehhhHHHHHHhCCccCCCCCCCcc
Q 003278 265 ARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKG-SVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQ 343 (834)
Q Consensus 265 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~ 343 (834)
++........ ....+...||+.|+|||++... ..++.++|||||||++|||+||+.||.......
T Consensus 150 ~~~~~~~~~~-------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~- 215 (338)
T cd07859 150 ARVAFNDTPT-------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH- 215 (338)
T ss_pred ccccccccCc-------------cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH-
Confidence 9754221100 0012345699999999987542 367889999999999999999999986432111
Q ss_pred chHHHHHHHHhhc-----------C---ccccccccccC---CCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 344 IILLDWIRRLSDE-----------G---KVLQAGDNRLS---DGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 344 ~~l~~~~~~~~~~-----------~---~~~~~~d~~l~---~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
....+...... . ........... ...+. .....+.+++..||+.||++||++.++++
T Consensus 216 --~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 216 --QLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFP-NADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred --HHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcC-CCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 11111110000 0 00000000000 00000 01134678999999999999999999986
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=328.15 Aligned_cols=250 Identities=17% Similarity=0.291 Sum_probs=192.0
Q ss_pred cccccCCcEEEEEEEC---CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEeccCCCc
Q 003278 520 RVAEMDFGTAYQGFLD---NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRI 596 (834)
Q Consensus 520 ~ig~g~~g~vy~~~~~---~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~~~g~ 596 (834)
.||+|+||.||+|.+. ++..||||.+.........+.|.+|+.++++++||||++++|+|.. +..++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 3899999999999763 3557999998765555556789999999999999999999998854 56899999999999
Q ss_pred hhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCCCCC
Q 003278 597 LSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGH 676 (834)
Q Consensus 597 L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~~~~ 676 (834)
|.+++.... ..+++..+++++.|++.||+|||+ .+++||||||+|||++.++.+|++|||++..........
T Consensus 81 L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 152 (257)
T cd05115 81 LNKFLSGKK-----DEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY 152 (257)
T ss_pred HHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccce
Confidence 999886432 247899999999999999999996 689999999999999999999999999997653322111
Q ss_pred cccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCcccccccc
Q 003278 677 RKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDL 755 (834)
Q Consensus 677 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 755 (834)
. ......++..|+|||++....++.++|||||||++|||++ |..|+....+.. ....+ .....+
T Consensus 153 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~~---~~~~~~------- 217 (257)
T cd05115 153 K----ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE-VMSFI---EQGKRL------- 217 (257)
T ss_pred e----ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH-HHHHH---HCCCCC-------
Confidence 0 0111234678999999988889999999999999999997 998886443322 11111 111110
Q ss_pred ccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccC
Q 003278 756 SLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGN 797 (834)
Q Consensus 756 ~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~ 797 (834)
... .....+ +.+++.+||..+|++||+|.+|.+.|+.+
T Consensus 218 ~~~-~~~~~~---l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 218 DCP-AECPPE---MYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCC-CCCCHH---HHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 011 112233 44566699999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=346.03 Aligned_cols=268 Identities=20% Similarity=0.261 Sum_probs=194.6
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc---ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK---GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 187 (834)
++|+..+.||+|+||.||++....+|+.||||++... .....+.+.+|+.++.+++|||||++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4688889999999999999999999999999998543 1233466888999999999999999999999999999999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
||+++|+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~ 150 (377)
T cd05629 81 EFLPGGDLMTMLIKY-------DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTG 150 (377)
T ss_pred eCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccc
Confidence 999999999998642 3578889999999999999999985 999999999999999999999999999964
Q ss_pred hhhhhhhh--hh--cc-ccccc-----c---------------------cccccceeeeccccCCCccccccCCCCCccc
Q 003278 268 LEHELQYQ--MR--TS-SARNH-----Q---------------------FHLAETTRIGGTIGYLPPESFQKGSVATAKS 316 (834)
Q Consensus 268 ~~~~~~~~--~~--~~-~~~~~-----~---------------------~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ks 316 (834)
+....... .. .. ..... . .........+||+.|+|||++... .++.++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~ 229 (377)
T cd05629 151 FHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ-GYGQEC 229 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC-CCCCce
Confidence 32110000 00 00 00000 0 000001135699999999998654 679999
Q ss_pred ceeehhhHHHHHHhCCccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCC-
Q 003278 317 DVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLR- 395 (834)
Q Consensus 317 DV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~R- 395 (834)
|||||||++|||+||+.||......+ . ..............+. .... ..+.+++..|+. +|.+|
T Consensus 230 DiwSlGvil~elltG~~Pf~~~~~~~---~---~~~i~~~~~~~~~p~~----~~~s----~~~~dli~~lL~-~~~~r~ 294 (377)
T cd05629 230 DWWSLGAIMFECLIGWPPFCSENSHE---T---YRKIINWRETLYFPDD----IHLS----VEAEDLIRRLIT-NAENRL 294 (377)
T ss_pred eeEecchhhhhhhcCCCCCCCCCHHH---H---HHHHHccCCccCCCCC----CCCC----HHHHHHHHHHhc-CHhhcC
Confidence 99999999999999999986432211 1 1111111111111110 0111 245677778887 66665
Q ss_pred --CchhhHHHH
Q 003278 396 --PSMKWVIEA 404 (834)
Q Consensus 396 --Psm~~V~~~ 404 (834)
|++.+++..
T Consensus 295 ~r~~~~~~l~h 305 (377)
T cd05629 295 GRGGAHEIKSH 305 (377)
T ss_pred CCCCHHHHhcC
Confidence 588887764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=333.74 Aligned_cols=268 Identities=23% Similarity=0.352 Sum_probs=199.1
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCC--------------CeEEEEEEeccc-ChhhHHHHHHHHHHHHhCCCCceeeEe
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSD--------------GTVVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNLVRLR 174 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~--------------g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~ 174 (834)
.++|+..+.||+|+||.||+|+.... ...||||.+... .......|.+|+.++++++||||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 35688899999999999999987432 235999998654 333456799999999999999999999
Q ss_pred eeEEeCCEEEEEEEccCCCCHhHHHhcCCCc-----cccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCce
Q 003278 175 GWCVHEDQLLLVYDYMPNRSLDRVLFRRPEN-----LEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNV 249 (834)
Q Consensus 175 g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~-----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NI 249 (834)
+++...+..++||||+++++|.+++...... ......++|..++.++.|++.||+|||+. +++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence 9999999999999999999999998653210 01123478999999999999999999985 999999999999
Q ss_pred EECCCCceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHH
Q 003278 250 MLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVV 329 (834)
Q Consensus 250 Lld~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ell 329 (834)
|+++++.+||+|||+++.+..... ........+++.|+|||++..+ .++.++|||||||++|||+
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~--------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~~l~el~ 225 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDY--------------YRIQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEMF 225 (295)
T ss_pred EEcCCCcEEecccccccccccCcc--------------eeccCcCcCceeecChhhhccC-CcCchhhHHHHHHHHHHHH
Confidence 999999999999999875422100 0011233467899999988655 5799999999999999999
Q ss_pred hC--CccCCCCCCCccchHHHHHHHHhh-cCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhh
Q 003278 330 SG--RRAVDLTYPDDQIILLDWIRRLSD-EGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVS 406 (834)
Q Consensus 330 tG--~~p~~~~~~~~~~~l~~~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~ 406 (834)
|+ ..|+..... .. ....+..... .+.......+. . ....+.+++..||+.+|++||+|.+|++.|.
T Consensus 226 ~~~~~~p~~~~~~--~~-~~~~~~~~~~~~~~~~~~~~~~----~----~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 226 TLCKEQPYSLLSD--EQ-VIENTGEFFRNQGRQIYLSQTP----L----CPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HcCCCCCCcccCh--HH-HHHHHHHhhhhccccccCCCCC----C----CCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 84 445543221 11 1111111111 11111111111 1 1246899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=334.45 Aligned_cols=260 Identities=20% Similarity=0.294 Sum_probs=199.7
Q ss_pred cCcCCcccccCCcEEEEEEEC------CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEE
Q 003278 515 FSESQRVAEMDFGTAYQGFLD------NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVI 588 (834)
Q Consensus 515 f~~~~~ig~g~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv 588 (834)
|...+.||+|+||.||+|... ....+++|.+...........|.+|+.+++.++|||||+++++|...+..+++
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLI 81 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEE
Confidence 556678999999999999853 23568899887555444456799999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhcCCCC------------------CCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCce
Q 003278 589 YDYSATRILSHLLFHNNHR------------------IGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAI 650 (834)
Q Consensus 589 ~Ey~~~g~L~~~l~~~~~~------------------~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NI 650 (834)
+||+.+|+|.+++...... .....++|...+.++.|++.||.|||+ .+|+||||||+||
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~ni 158 (290)
T cd05045 82 VEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNV 158 (290)
T ss_pred EEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhheE
Confidence 9999999999988643210 112358899999999999999999996 6999999999999
Q ss_pred eecCCCCceEeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCC
Q 003278 651 TLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFR 729 (834)
Q Consensus 651 Lld~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~ 729 (834)
|+++++.+||+|||+++........ .......++..|+|||++.+..++.++|||||||++|||+| |..|+...
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 233 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSY-----VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 233 (290)
T ss_pred EEcCCCcEEeccccccccccCccch-----hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence 9999999999999999764322110 01122356778999999988889999999999999999999 88888644
Q ss_pred CCchhHHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccC
Q 003278 730 LPEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGN 797 (834)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~ 797 (834)
.+.. +.... . ... ........ . ..+.+++.+||+.+|++||++.+|++.|+.+
T Consensus 234 ~~~~-~~~~~----~--~~~----~~~~~~~~-~---~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 234 APER-LFNLL----K--TGY----RMERPENC-S---EEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred CHHH-HHHHH----h--CCC----CCCCCCCC-C---HHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 3322 11111 1 100 00111111 1 2455677799999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=328.22 Aligned_cols=256 Identities=21% Similarity=0.299 Sum_probs=190.4
Q ss_pred cccccCCcEEEEEEECC---CcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEeccCCCc
Q 003278 520 RVAEMDFGTAYQGFLDN---HQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRI 596 (834)
Q Consensus 520 ~ig~g~~g~vy~~~~~~---~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~~~g~ 596 (834)
.||+|+||.||+|...+ +..+|+|.+...........|.+|+.++++++||||++++|++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 58999999999998643 346899988765544445678999999999999999999999999899999999999999
Q ss_pred hhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCCCCC
Q 003278 597 LSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGH 676 (834)
Q Consensus 597 L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~~~~ 676 (834)
|.+++...... .....++..+..++.|++.||+|||+ .+++||||||+||+++.++.+|++|||+++.......
T Consensus 82 L~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~-- 155 (269)
T cd05087 82 LKGYLRSCRKA-ELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY-- 155 (269)
T ss_pred HHHHHHHhhhc-ccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcce--
Confidence 99998754321 12246777888999999999999996 6899999999999999999999999999965332211
Q ss_pred cccccCccccccccCccchhccccC-------CCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCc
Q 003278 677 RKATSGNRSVRGIFGYMSPEYIESG-------EATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRP 748 (834)
Q Consensus 677 ~~~~~~~~~~~Gt~~Y~aPE~~~~~-------~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
........|+..|+|||++... .++.++|||||||++|||+| |+.|+....+.......+. ..
T Consensus 156 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~------~~ 226 (269)
T cd05087 156 ---YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVR------EQ 226 (269)
T ss_pred ---eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhh------cc
Confidence 0111234578899999998642 35789999999999999996 9989865433322111110 11
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHc
Q 003278 749 LAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795 (834)
Q Consensus 749 ~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~ 795 (834)
.....++.+.... .+. +..++..|| .+|++|||+.+|+..|+
T Consensus 227 ~~~~~~~~~~~~~-~~~---~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 227 QLKLPKPRLKLPL-SDR---WYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred cCCCCCCccCCCC-ChH---HHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1112222222111 223 344555899 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=343.12 Aligned_cols=268 Identities=23% Similarity=0.311 Sum_probs=201.6
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 187 (834)
++|...+.||+|+||.||+|....+|+.||||++.... ......+.+|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46888899999999999999998899999999986532 234567889999999999999999999999999999999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 e~~~~~~L~~~l~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~ 150 (350)
T cd05573 81 EYMPGGDLMNLLIRK-------DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKK 150 (350)
T ss_pred cCCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCcc
Confidence 999999999998653 3588899999999999999999985 999999999999999999999999999986
Q ss_pred hhhhhhhhhhcc-------------cccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCcc
Q 003278 268 LEHELQYQMRTS-------------SARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRA 334 (834)
Q Consensus 268 ~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p 334 (834)
+........... ................||+.|+|||.+... .++.++|||||||++|||+||+.|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~P 229 (350)
T cd05573 151 MNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYGFPP 229 (350)
T ss_pred CcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCceeeEecchhhhhhccCCCC
Confidence 543210000000 000000000112345699999999998655 679999999999999999999999
Q ss_pred CCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCc-hhhHHHH
Q 003278 335 VDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPS-MKWVIEA 404 (834)
Q Consensus 335 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-m~~V~~~ 404 (834)
|...... .....+.......... .. ... ...+..+...|+. +|.+||+ +.++++.
T Consensus 230 f~~~~~~------~~~~~i~~~~~~~~~p--~~--~~~----~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 230 FYSDTLQ------ETYNKIINWKESLRFP--PD--PPV----SPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CCCCCHH------HHHHHHhccCCcccCC--CC--CCC----CHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 8653211 1111111100000000 00 001 2356788889997 9999999 9999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=346.54 Aligned_cols=261 Identities=20% Similarity=0.305 Sum_probs=199.7
Q ss_pred CcCcCCcccccCCcEEEEEEECC------CcEEEEEEecCCCChhHHHHHHHHHHHHHhcc-CCCceeEEEEEeeCCeEE
Q 003278 514 NFSESQRVAEMDFGTAYQGFLDN------HQYVLVKRLGMSKCPALRTRFSNELQNLARLR-HRNLVQLCGWCTEQGEML 586 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~~~------~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~-HpNiv~l~g~~~~~~~~~ 586 (834)
++...+.||+|+||.||+|...+ +..||||+++........+.|.+|+.+|.++. |||||+++|+|...+..+
T Consensus 38 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~ 117 (401)
T cd05107 38 NLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIY 117 (401)
T ss_pred HeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcE
Confidence 45566889999999999998642 35799999976554445567999999999997 999999999999999999
Q ss_pred EEEeccCCCchhhhhhcCCCC-----------------------------------------------------------
Q 003278 587 VIYDYSATRILSHLLFHNNHR----------------------------------------------------------- 607 (834)
Q Consensus 587 lv~Ey~~~g~L~~~l~~~~~~----------------------------------------------------------- 607 (834)
+||||+++|+|.++++.....
T Consensus 118 iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (401)
T cd05107 118 IITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKG 197 (401)
T ss_pred EEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchh
Confidence 999999999999998754210
Q ss_pred ---------------------------------CCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecC
Q 003278 608 ---------------------------------IGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDP 654 (834)
Q Consensus 608 ---------------------------------~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~ 654 (834)
.....++|...+.|+.|++.||+|||+ .+|+||||||+|||+++
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~NiLl~~ 274 (401)
T cd05107 198 TVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVLICE 274 (401)
T ss_pred hhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceEEEeC
Confidence 011247788889999999999999996 69999999999999999
Q ss_pred CCCceEeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCch
Q 003278 655 DMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEG 733 (834)
Q Consensus 655 ~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~ 733 (834)
++.+|++|||+++........ .......|++.|||||++.+..++.++|||||||++|||++ |+.|+.......
T Consensus 275 ~~~~kL~DfGla~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~ 349 (401)
T cd05107 275 GKLVKICDFGLARDIMRDSNY-----ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE 349 (401)
T ss_pred CCEEEEEecCcceeccccccc-----ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence 999999999999764322110 11123457889999999998889999999999999999998 888875432222
Q ss_pred hHHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHcc
Q 003278 734 LLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDG 796 (834)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~ 796 (834)
.....+. ...++ ...... .. .+.+++.+||..+|++||+|.+|++.|+.
T Consensus 350 ~~~~~~~---~~~~~-------~~p~~~-~~---~l~~li~~cl~~~P~~RPs~~ell~~L~~ 398 (401)
T cd05107 350 QFYNAIK---RGYRM-------AKPAHA-SD---EIYEIMQKCWEEKFEIRPDFSQLVHLVGD 398 (401)
T ss_pred HHHHHHH---cCCCC-------CCCCCC-CH---HHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 1111111 11110 011111 22 35556669999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=335.56 Aligned_cols=262 Identities=26% Similarity=0.351 Sum_probs=190.3
Q ss_pred CCCCCCeeeccCCeEEEEEEECC-CCeEEEEEEecccC--hhhHHHHHHHHHHHHhC---CCCceeeEeeeEEe-----C
Q 003278 112 GFDEDEVLGSGGFGKVYRAVLPS-DGTVVAVKCLAEKG--ERFEKTFAAELVAVAHL---RHRNLVRLRGWCVH-----E 180 (834)
Q Consensus 112 ~f~~~~~LG~G~fG~Vy~~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l---~H~nIv~l~g~~~~-----~ 180 (834)
+|+..+.||+|+||.||+|.... +|+.||||.+.... ......+.+|+.+++.+ +||||++++++|.. .
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 58888999999999999999743 57899999886432 22334566777777665 69999999999863 3
Q ss_pred CEEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEe
Q 003278 181 DQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLG 260 (834)
Q Consensus 181 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~ 260 (834)
..+++||||++ ++|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~-----~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~ 152 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVP-----EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 152 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCC-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEc
Confidence 46899999996 68988886532 23589999999999999999999985 99999999999999999999999
Q ss_pred eccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCC
Q 003278 261 DFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYP 340 (834)
Q Consensus 261 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~ 340 (834)
|||+++..... .......||+.|+|||.+... .++.++|||||||++|||+||+.||.....
T Consensus 153 Dfg~~~~~~~~-----------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~~f~~~~~ 214 (290)
T cd07862 153 DFGLARIYSFQ-----------------MALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSD 214 (290)
T ss_pred cccceEeccCC-----------------cccccccccccccChHHHhCC-CCCCccchHHHHHHHHHHHcCCCCcCCCCH
Confidence 99999753211 012345699999999998654 678899999999999999999999875322
Q ss_pred CccchHHHHHHHHhh---cCcccc---ccccccCC-CCCCH-----HHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 341 DDQIILLDWIRRLSD---EGKVLQ---AGDNRLSD-GSYKL-----CDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 341 ~~~~~l~~~~~~~~~---~~~~~~---~~d~~l~~-~~~~~-----~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
.+ ....+..... .....+ ........ ..... .....+.++...|++.||++||++.++++
T Consensus 215 ~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 215 VD---QLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred HH---HHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 11 1111111100 000000 00000000 00000 01134678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=328.08 Aligned_cols=260 Identities=25% Similarity=0.359 Sum_probs=204.6
Q ss_pred HHHhhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEE
Q 003278 105 ELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLL 184 (834)
Q Consensus 105 el~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 184 (834)
|++.+++++.....||+|+||.||+|.+..++..||+|.+........+.+.+|+.++++++|+||+++++++...+..+
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 45678889988899999999999999998889999999987766666778999999999999999999999999999999
Q ss_pred EEEEccCCCCHhHHHhcCCCccccCCCC--CHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECC-CCceEEee
Q 003278 185 LVYDYMPNRSLDRVLFRRPENLEAAAPL--NWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDS-QYNARLGD 261 (834)
Q Consensus 185 lV~Ey~~~gsL~~~l~~~~~~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~-~~~~kl~D 261 (834)
+|+||+++++|.+++.... .++ ++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|
T Consensus 82 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~d 152 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKW------GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISD 152 (268)
T ss_pred EEEecCCCCCHHHHHHHhc------ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEec
Confidence 9999999999999986532 234 7888899999999999999985 9999999999999986 67899999
Q ss_pred ccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCC-CCCcccceeehhhHHHHHHhCCccCCCCCC
Q 003278 262 FGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGS-VATAKSDVFSFGIVVLEVVSGRRAVDLTYP 340 (834)
Q Consensus 262 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~ksDV~SfGvvl~ElltG~~p~~~~~~ 340 (834)
||++..+.... .......|++.|+|||++..+. .++.++|||||||++|||++|+.|+.....
T Consensus 153 fg~~~~~~~~~----------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~ 216 (268)
T cd06624 153 FGTSKRLAGIN----------------PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGE 216 (268)
T ss_pred chhheecccCC----------------CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccC
Confidence 99987542110 0012234889999999986542 368899999999999999999999853221
Q ss_pred CccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 341 DDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 341 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
.. ...|...... ..+.+. ......+..++.+||+.+|.+||++.++++.
T Consensus 217 ~~---~~~~~~~~~~-------~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 217 PQ---AAMFKVGMFK-------IHPEIP-----ESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred hh---hhHhhhhhhc-------cCCCCC-----cccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 11 1111111100 011111 1112457789999999999999999999863
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=329.48 Aligned_cols=258 Identities=21% Similarity=0.355 Sum_probs=201.4
Q ss_pred hhCcCcCCcccccCCcEEEEEEECC-C---cEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEE
Q 003278 512 TNNFSESQRVAEMDFGTAYQGFLDN-H---QYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLV 587 (834)
Q Consensus 512 t~~f~~~~~ig~g~~g~vy~~~~~~-~---~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~l 587 (834)
+++|...+.||+|+||.||+|.... + ..+|+|.+.........+.|.+|++++++++||||+++++++.+.+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 3567788899999999999999742 3 37999998765555556789999999999999999999999999999999
Q ss_pred EEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecc
Q 003278 588 IYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAE 667 (834)
Q Consensus 588 v~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~ 667 (834)
||||+++++|..++.... ..++|..+..++.|++.||+|||+ .+|+||||||+||++++++.+|++|||++.
T Consensus 84 v~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~ 155 (268)
T cd05063 84 ITEYMENGALDKYLRDHD-----GEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSR 155 (268)
T ss_pred EEEcCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccce
Confidence 999999999999986532 247899999999999999999996 689999999999999999999999999997
Q ss_pred ccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhc
Q 003278 668 FLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARK 746 (834)
Q Consensus 668 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~ 746 (834)
........ .........+..|+|||++..+.++.++|||||||++|||+| |..|+....... ....+.. .
T Consensus 156 ~~~~~~~~----~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~-~~~~i~~---~- 226 (268)
T cd05063 156 VLEDDPEG----TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE-VMKAIND---G- 226 (268)
T ss_pred eccccccc----ceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHHHHhc---C-
Confidence 65432111 001111233567999999998899999999999999999998 999986443221 2221111 0
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHcc
Q 003278 747 RPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDG 796 (834)
Q Consensus 747 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~ 796 (834)
..... ... ....+.+++.+||+.+|++||+|.+|++.|+.
T Consensus 227 ~~~~~------~~~----~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~ 266 (268)
T cd05063 227 FRLPA------PMD----CPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK 266 (268)
T ss_pred CCCCC------CCC----CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 00000 001 11345677889999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=332.91 Aligned_cols=262 Identities=27% Similarity=0.427 Sum_probs=204.3
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECC-----CCeEEEEEEecccChh-hHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPS-----DGTVVAVKCLAEKGER-FEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQL 183 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~-----~g~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 183 (834)
.++|...+.||+|+||.||+|.... ++..||||.+...... ..+.|.+|+.++.+++||||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3458888999999999999998742 3578999998765433 567899999999999999999999999999999
Q ss_pred EEEEEccCCCCHhHHHhcCCCc-------cccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCc
Q 003278 184 LLVYDYMPNRSLDRVLFRRPEN-------LEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYN 256 (834)
Q Consensus 184 ~lV~Ey~~~gsL~~~l~~~~~~-------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~ 256 (834)
++||||+++|+|.+++...... ......+++.....++.|++.||.|||+. +++||||||+|||++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence 9999999999999999754321 11235689999999999999999999985 9999999999999999999
Q ss_pred eEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccC
Q 003278 257 ARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAV 335 (834)
Q Consensus 257 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~ 335 (834)
+||+|||+++.+...... .......+++.|+|||++..+ .++.++|||||||++|||+| |+.|+
T Consensus 161 ~kl~d~g~~~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~e~~~~g~~p~ 225 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYY--------------RVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVVLWEIFTYGKQPW 225 (280)
T ss_pred EEECCcccceecccCcce--------------ecCCCCcccceecChhhhccC-CcchhhhHHHHHHHHHHHHhcCCCCC
Confidence 999999998754221100 001223467899999998655 67999999999999999999 99987
Q ss_pred CCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhh
Q 003278 336 DLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVS 406 (834)
Q Consensus 336 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~ 406 (834)
..... ......+. .+...... .. ....+.+++..||+.||++||++.||++.|.
T Consensus 226 ~~~~~---~~~~~~~~----~~~~~~~~------~~----~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 226 YGLSN---EEVIECIT----QGRLLQRP------RT----CPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred CCCCH---HHHHHHHH----cCCcCCCC------CC----CCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 54321 11222221 22211110 11 1246789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=328.51 Aligned_cols=251 Identities=21% Similarity=0.339 Sum_probs=196.4
Q ss_pred CcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEeccC
Q 003278 514 NFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSA 593 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~~ 593 (834)
+|...+.||+|+||.||.|...++..+|||.+..... ..+.|.+|+.++.+++||||++++++|.+.+..++||||++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc--cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 3455678999999999999987777799998864332 23578999999999999999999999999899999999999
Q ss_pred CCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCC
Q 003278 594 TRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRND 673 (834)
Q Consensus 594 ~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~ 673 (834)
+|+|.+++..... .++|..++.++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++......
T Consensus 83 ~~~l~~~i~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05113 83 NGCLLNYLREHGK-----RFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE 154 (256)
T ss_pred CCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCc
Confidence 9999998865322 47899999999999999999996 699999999999999999999999999987653221
Q ss_pred CCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCccccc
Q 003278 674 HGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRPLAEL 752 (834)
Q Consensus 674 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (834)
. .......|+..|+|||++.++.++.++|||||||++|||+| |..|+....+. ........ ..+..
T Consensus 155 ~------~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-~~~~~~~~---~~~~~--- 221 (256)
T cd05113 155 Y------TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS-ETVEKVSQ---GLRLY--- 221 (256)
T ss_pred e------eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-HHHHHHhc---CCCCC---
Confidence 1 00112246678999999998899999999999999999999 88887643322 11111111 11110
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHc
Q 003278 753 VDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795 (834)
Q Consensus 753 ~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~ 795 (834)
..... . ..+.+++.+||+.+|++|||+.+|+..|+
T Consensus 222 ----~~~~~-~---~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 222 ----RPHLA-S---EKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ----CCCCC-C---HHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 00111 1 34566777999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=332.74 Aligned_cols=252 Identities=23% Similarity=0.302 Sum_probs=196.6
Q ss_pred CCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEE
Q 003278 112 GFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYD 188 (834)
Q Consensus 112 ~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 188 (834)
+|+..++||+|+||.||++....+++.||||.+.... ......+.+|+.++++++||||+++++++..++.+++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4778899999999999999998889999999986432 2233557889999999999999999999999999999999
Q ss_pred ccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhh
Q 003278 189 YMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWL 268 (834)
Q Consensus 189 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~ 268 (834)
|+++|+|..++.... ...+++..+..++.|++.||.|||+. +|+||||||+|||+++++.++|+|||+++.+
T Consensus 81 ~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 152 (285)
T cd05605 81 LMNGGDLKFHIYNMG-----NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEI 152 (285)
T ss_pred ccCCCcHHHHHHhcC-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceec
Confidence 999999998886432 24589999999999999999999985 9999999999999999999999999998754
Q ss_pred hhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHH
Q 003278 269 EHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLD 348 (834)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~ 348 (834)
.... ......||+.|+|||.+... .++.++|||||||++|||++|+.||....... ...
T Consensus 153 ~~~~-----------------~~~~~~~~~~y~aPE~~~~~-~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~---~~~ 211 (285)
T cd05605 153 PEGE-----------------TIRGRVGTVGYMAPEVVKNE-RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV---KRE 211 (285)
T ss_pred CCCC-----------------ccccccCCCCccCcHHhcCC-CCCccccchhHHHHHHHHHHCCCCCCCCchhh---HHH
Confidence 2110 01234689999999998654 67899999999999999999999987432211 111
Q ss_pred HHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----chhhHHH
Q 003278 349 WIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRP-----SMKWVIE 403 (834)
Q Consensus 349 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~~V~~ 403 (834)
.+........ . .+...-...+.+++..||+.||.+|| ++.+++.
T Consensus 212 ~~~~~~~~~~------~-----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 212 EVERRVKEDQ------E-----EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred HHHHHhhhcc------c-----ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 1111111100 0 01111124578899999999999999 5666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=338.97 Aligned_cols=236 Identities=25% Similarity=0.325 Sum_probs=186.3
Q ss_pred CeeeccCCeEEEEEEECCCCeEEEEEEeccc---ChhhHHHHHHHHHHHHhC-CCCceeeEeeeEEeCCEEEEEEEccCC
Q 003278 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK---GERFEKTFAAELVAVAHL-RHRNLVRLRGWCVHEDQLLLVYDYMPN 192 (834)
Q Consensus 117 ~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 192 (834)
++||+|+||.||+|....+|+.||||++... .....+.+..|..++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999999888999999998653 223345677888888865 799999999999999999999999999
Q ss_pred CCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhhhh
Q 003278 193 RSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHEL 272 (834)
Q Consensus 193 gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~ 272 (834)
|+|...+... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~ 150 (321)
T cd05591 81 GDLMFQIQRS-------RKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG 150 (321)
T ss_pred CcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC
Confidence 9999888543 3588999999999999999999985 99999999999999999999999999986421110
Q ss_pred hhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHHHHH
Q 003278 273 QYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIRR 352 (834)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~ 352 (834)
.......||+.|+|||++... .++.++|||||||++|||+||+.||...... .+ ...
T Consensus 151 ----------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~~~---~~---~~~ 207 (321)
T cd05591 151 ----------------VTTTTFCGTPDYIAPEILQEL-EYGPSVDWWALGVLMYEMMAGQPPFEADNED---DL---FES 207 (321)
T ss_pred ----------------ccccccccCccccCHHHHcCC-CCCCccceechhHHHHHHhcCCCCCCCCCHH---HH---HHH
Confidence 012345699999999988654 6789999999999999999999999743211 11 111
Q ss_pred HhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCc
Q 003278 353 LSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPS 397 (834)
Q Consensus 353 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs 397 (834)
... +.. ..+ ... ...+.++...|++.||++||+
T Consensus 208 i~~-~~~---~~p----~~~----~~~~~~ll~~~L~~dp~~R~~ 240 (321)
T cd05591 208 ILH-DDV---LYP----VWL----SKEAVSILKAFMTKNPNKRLG 240 (321)
T ss_pred HHc-CCC---CCC----CCC----CHHHHHHHHHHhccCHHHcCC
Confidence 111 110 000 011 135778999999999999994
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=334.67 Aligned_cols=238 Identities=29% Similarity=0.340 Sum_probs=185.1
Q ss_pred CeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHH-HHHhCCCCceeeEeeeEEeCCEEEEEEEccCC
Q 003278 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELV-AVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPN 192 (834)
Q Consensus 117 ~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~-~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 192 (834)
++||+|+||.||+|+...+|..||+|++.... ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999998899999999986432 223344555654 67889999999999999999999999999999
Q ss_pred CCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhhhh
Q 003278 193 RSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHEL 272 (834)
Q Consensus 193 gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~ 272 (834)
|+|..++... ..+++.....++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~- 149 (321)
T cd05603 81 GELFFHLQRE-------RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP- 149 (321)
T ss_pred CCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCC-
Confidence 9998887542 3577888899999999999999985 9999999999999999999999999998742110
Q ss_pred hhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHHHHH
Q 003278 273 QYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIRR 352 (834)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~ 352 (834)
........||+.|+|||.+... .++.++|||||||++|||+||+.||.... .......
T Consensus 150 ---------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~ 207 (321)
T cd05603 150 ---------------EETTSTFCGTPEYLAPEVLRKE-PYDRTVDWWCLGAVLYEMLYGLPPFYSRD------VSQMYDN 207 (321)
T ss_pred ---------------CCccccccCCcccCCHHHhcCC-CCCCcCcccccchhhhhhhcCCCCCCCCC------HHHHHHH
Confidence 0112345799999999998654 67899999999999999999999986431 1111111
Q ss_pred HhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchh
Q 003278 353 LSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMK 399 (834)
Q Consensus 353 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~ 399 (834)
... +. . .+. .. ....+.++...|++.+|.+||+..
T Consensus 208 i~~-~~-~-----~~~-~~----~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 208 ILH-KP-L-----QLP-GG----KTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred Hhc-CC-C-----CCC-CC----CCHHHHHHHHHHccCCHhhcCCCC
Confidence 111 11 0 111 11 123577899999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=334.95 Aligned_cols=239 Identities=29% Similarity=0.337 Sum_probs=186.8
Q ss_pred CeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHH-HHHhCCCCceeeEeeeEEeCCEEEEEEEccCC
Q 003278 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELV-AVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPN 192 (834)
Q Consensus 117 ~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~-~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 192 (834)
+.||+|+||+||+|+...+|+.||||++.... ....+.+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999999899999999986432 122344555554 56789999999999999999999999999999
Q ss_pred CCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhhhh
Q 003278 193 RSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHEL 272 (834)
Q Consensus 193 gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~ 272 (834)
|+|..++... ..+++.....++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 g~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~- 149 (323)
T cd05575 81 GELFFHLQRE-------RSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH- 149 (323)
T ss_pred CCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-
Confidence 9999888643 3578899999999999999999985 9999999999999999999999999998742110
Q ss_pred hhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHHHHH
Q 003278 273 QYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIRR 352 (834)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~ 352 (834)
........||+.|+|||.+... .++.++|||||||++|||+||+.||..... ......
T Consensus 150 ---------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~------~~~~~~ 207 (323)
T cd05575 150 ---------------SKTTSTFCGTPEYLAPEVLRKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDT------AEMYDN 207 (323)
T ss_pred ---------------CCccccccCChhhcChhhhcCC-CCCccccccccchhhhhhhcCCCCCCCCCH------HHHHHH
Confidence 0113445799999999998654 678999999999999999999999864311 111112
Q ss_pred HhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhh
Q 003278 353 LSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKW 400 (834)
Q Consensus 353 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~ 400 (834)
... +.. .+. ... ...+.++...|++.||.+||++.+
T Consensus 208 i~~-~~~------~~~-~~~----~~~~~~li~~~l~~~p~~R~~~~~ 243 (323)
T cd05575 208 ILN-KPL------RLK-PNI----SVSARHLLEGLLQKDRTKRLGAKD 243 (323)
T ss_pred HHc-CCC------CCC-CCC----CHHHHHHHHHHhhcCHHhCCCCCC
Confidence 111 110 111 111 235778999999999999999863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=343.98 Aligned_cols=245 Identities=15% Similarity=0.181 Sum_probs=193.3
Q ss_pred hCcCcCCcccccCCcEEEEEEECC--CcEEEEEEecCCC--ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDN--HQYVLVKRLGMSK--CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVI 588 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~--~~~vavK~~~~~~--~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv 588 (834)
++|...+.||+|+||.||+|...+ +..||+|.+.... .....+.+.+|+.+++.++|||||++++++.+.+..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 457777889999999999998643 3589999885432 223346788999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccc
Q 003278 589 YDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEF 668 (834)
Q Consensus 589 ~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~ 668 (834)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 110 ~Ey~~~g~L~~~i~~~~------~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~ 180 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNK------RFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKV 180 (340)
T ss_pred EeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCee
Confidence 99999999999986542 37888889999999999999996 6999999999999999999999999999976
Q ss_pred cccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCc
Q 003278 669 LTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRP 748 (834)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
+... ..+..||+.|||||++.+..++.++|||||||++|||+||..||....+.. ....+. .....
T Consensus 181 ~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-~~~~i~---~~~~~ 246 (340)
T PTZ00426 181 VDTR----------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL-IYQKIL---EGIIY 246 (340)
T ss_pred cCCC----------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH-HHHHHh---cCCCC
Confidence 4321 224679999999999998889999999999999999999999997543321 111111 11000
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----ChhHHHH
Q 003278 749 LAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRP-----SMRQILS 792 (834)
Q Consensus 749 ~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RP-----tm~~v~~ 792 (834)
.+... ...+ ..++.+|++.||++|+ |+.++.+
T Consensus 247 --------~p~~~-~~~~---~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 247 --------FPKFL-DNNC---KHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred --------CCCCC-CHHH---HHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 11111 2333 3455589999999995 7888765
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=332.76 Aligned_cols=263 Identities=19% Similarity=0.221 Sum_probs=195.5
Q ss_pred CcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCC-ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 514 NFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSK-CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
+|...+.||+|+||.||+|... ++..||||++.... .....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY 81 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence 5677788999999999999975 57889999987543 233456788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccccc
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTR 671 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~ 671 (834)
++++++..+.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++..+..
T Consensus 82 ~~~~~l~~~~~~~------~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 152 (287)
T cd07848 82 VEKNMLELLEEMP------NGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSE 152 (287)
T ss_pred CCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence 9998887554321 237888889999999999999996 6999999999999999999999999999986533
Q ss_pred CCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhh------
Q 003278 672 NDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEAR------ 745 (834)
Q Consensus 672 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~------ 745 (834)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........+.. .......
T Consensus 153 ~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~ 225 (287)
T cd07848 153 GSN------ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFT-IQKVLGPLPAEQM 225 (287)
T ss_pred ccc------ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHhhCCCCHHHH
Confidence 211 112245799999999999988999999999999999999999999865432221111 1110000
Q ss_pred ----cCc-cccccccccCCCCCH------HHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 746 ----KRP-LAELVDLSLNGEYNH------KELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 746 ----~~~-~~~~~d~~l~~~~~~------~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
..+ ......+........ ..-..+.+++.+|++.||++|||+.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 226 KLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred HhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000 000000000000000 00123566777999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=341.08 Aligned_cols=242 Identities=24% Similarity=0.281 Sum_probs=191.2
Q ss_pred CCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHHHHHhC-CCCceeeEeeeEEeCCEEEEEE
Q 003278 112 GFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVAVAHL-RHRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 112 ~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~ 187 (834)
+|+..+.||+|+||.||+|....++..||||.+.... ....+.+..|..++..+ +|++|+++++++...+.+++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999998899999999986532 22334567788888776 5899999999999999999999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
||+++|+|..++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 E~~~~g~L~~~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~ 150 (323)
T cd05616 81 EYVNGGDLMYQIQQV-------GRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 150 (323)
T ss_pred cCCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCcee
Confidence 999999999888543 3588899999999999999999985 999999999999999999999999999874
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHH
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILL 347 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~ 347 (834)
.... ........||+.|+|||++... .++.++|||||||++|||+||+.||..... ..+.
T Consensus 151 ~~~~----------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~---~~~~ 210 (323)
T cd05616 151 NMWD----------------GVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELF 210 (323)
T ss_pred cCCC----------------CCccccCCCChhhcCHHHhcCC-CCCCccchhchhHHHHHHHhCCCCCCCCCH---HHHH
Confidence 2110 0112345799999999998754 679999999999999999999999964321 1121
Q ss_pred HHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCch
Q 003278 348 DWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSM 398 (834)
Q Consensus 348 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm 398 (834)
..+ .. ... ... ... ...+.+++..|++.+|.+||+.
T Consensus 211 ~~i---~~-~~~------~~p-~~~----s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 211 QSI---ME-HNV------AYP-KSM----SKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred HHH---Hh-CCC------CCC-CcC----CHHHHHHHHHHcccCHHhcCCC
Confidence 111 11 111 010 111 2357789999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=322.52 Aligned_cols=267 Identities=27% Similarity=0.347 Sum_probs=201.4
Q ss_pred CCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccCh--hhHHHHHHHHHHHHhCCCCc-eeeEeeeEEeCC------E
Q 003278 112 GFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGE--RFEKTFAAELVAVAHLRHRN-LVRLRGWCVHED------Q 182 (834)
Q Consensus 112 ~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~H~n-Iv~l~g~~~~~~------~ 182 (834)
.|...++||+|+||+||+|+.+.+|+.||+|++.-..+ .......+|+.+|.+|+|+| ||+|++++...+ .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 45666789999999999999999999999999865433 35566789999999999999 999999999887 7
Q ss_pred EEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeec
Q 003278 183 LLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDF 262 (834)
Q Consensus 183 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DF 262 (834)
++||+||+. -+|..++...+... ..++-..++.++.|+++||+|||++ +|+||||||.|||+++++.+||+||
T Consensus 92 l~lvfe~~d-~DL~~ymd~~~~~~---~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDF 164 (323)
T KOG0594|consen 92 LYLVFEFLD-RDLKKYMDSLPKKP---QGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADF 164 (323)
T ss_pred EEEEEEeec-ccHHHHHHhccccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeecc
Confidence 999999985 58999987653210 3455688999999999999999996 9999999999999999999999999
Q ss_pred cchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCc
Q 003278 263 GLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDD 342 (834)
Q Consensus 263 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~ 342 (834)
|+|+...-. ...-+..++|.+|.|||++.....|+...||||+||++.||++++.-|......+
T Consensus 165 GlAra~~ip----------------~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ 228 (323)
T KOG0594|consen 165 GLARAFSIP----------------MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEID 228 (323)
T ss_pred chHHHhcCC----------------cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHH
Confidence 999853211 1113556799999999999877789999999999999999999998876554322
Q ss_pred cchHHHHHHHHhhcC---c---cccccccc--cCC--CCCCHHH-----HHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 343 QIILLDWIRRLSDEG---K---VLQAGDNR--LSD--GSYKLCD-----MEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 343 ~~~l~~~~~~~~~~~---~---~~~~~d~~--l~~--~~~~~~~-----~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
+ ..-+.+..... . +....|-. ... +..+... .....++...|++.+|.+|.|....+++
T Consensus 229 q---l~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 229 Q---LFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred H---HHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 2 12222222110 0 00000100 000 0000000 1346788999999999999999988764
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=339.81 Aligned_cols=239 Identities=21% Similarity=0.303 Sum_probs=186.1
Q ss_pred CeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHHHHHh-CCCCceeeEeeeEEeCCEEEEEEEccCC
Q 003278 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVAVAH-LRHRNLVRLRGWCVHEDQLLLVYDYMPN 192 (834)
Q Consensus 117 ~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~-l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 192 (834)
+.||+|+||.||+|....+++.||||++.... ....+.+..|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999998899999999986531 2233445667777664 5899999999999999999999999999
Q ss_pred CCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhhhh
Q 003278 193 RSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHEL 272 (834)
Q Consensus 193 gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~ 272 (834)
|+|..++... ..+++.....++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~~~~~-------~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~ 150 (316)
T cd05592 81 GDLMFHIQSS-------GRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE 150 (316)
T ss_pred CcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC
Confidence 9999888543 3578889999999999999999985 99999999999999999999999999997432110
Q ss_pred hhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHHHHH
Q 003278 273 QYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIRR 352 (834)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~ 352 (834)
.......||+.|+|||.+... .++.++|||||||++|||++|+.||...... .....
T Consensus 151 ----------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~Pf~~~~~~------~~~~~ 207 (316)
T cd05592 151 ----------------GKASTFCGTPDYIAPEILKGQ-KYNESVDWWSFGVLLYEMLIGQSPFHGEDED------ELFDS 207 (316)
T ss_pred ----------------CccccccCCccccCHHHHcCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCHH------HHHHH
Confidence 113345799999999988644 6789999999999999999999998643211 11111
Q ss_pred HhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhh
Q 003278 353 LSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKW 400 (834)
Q Consensus 353 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~ 400 (834)
+... .+.+. ... ...+.+++..||+.||.+||++.+
T Consensus 208 i~~~-------~~~~~-~~~----~~~~~~ll~~~l~~~P~~R~~~~~ 243 (316)
T cd05592 208 ILND-------RPHFP-RWI----SKEAKDCLSKLFERDPTKRLGVDG 243 (316)
T ss_pred HHcC-------CCCCC-CCC----CHHHHHHHHHHccCCHHHcCCChH
Confidence 1111 00110 111 134678899999999999999863
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=332.19 Aligned_cols=264 Identities=15% Similarity=0.209 Sum_probs=193.5
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
++|...++||+|+||.||+|... ++..||+|.+...........+.+|+.++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 35777889999999999999864 57899999987554333345678999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccccc
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTR 671 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~ 671 (834)
+++ +|.+++...+ ..+++.....++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++....
T Consensus 85 ~~~-~l~~~l~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~ 155 (288)
T cd07871 85 LDS-DLKQYLDNCG-----NLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSV 155 (288)
T ss_pred CCc-CHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccC
Confidence 985 8888775432 236788888999999999999996 6999999999999999999999999999975432
Q ss_pred CCCCCcccccCccccccccCccchhcccc-CCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhh-cCc-
Q 003278 672 NDHGHRKATSGNRSVRGIFGYMSPEYIES-GEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEAR-KRP- 748 (834)
Q Consensus 672 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~-~~~- 748 (834)
.. .......||+.|||||++.+ ..++.++|||||||++|||+||+.||........+.......... ...
T Consensus 156 ~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 228 (288)
T cd07871 156 PT-------KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETW 228 (288)
T ss_pred CC-------ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHh
Confidence 11 11123468999999998865 568999999999999999999999986544332221111100000 000
Q ss_pred --------cccccccccCCCCC----HHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 749 --------LAELVDLSLNGEYN----HKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 749 --------~~~~~d~~l~~~~~----~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
+.....+....... ...-....++..+|+..||.+|||+.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 229 PGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00000000000000 000123456666899999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=338.49 Aligned_cols=241 Identities=24% Similarity=0.303 Sum_probs=188.1
Q ss_pred CCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHHHH---HhCCCCceeeEeeeEEeCCEEEEE
Q 003278 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVAV---AHLRHRNLVRLRGWCVHEDQLLLV 186 (834)
Q Consensus 113 f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l---~~l~H~nIv~l~g~~~~~~~~~lV 186 (834)
|+..+.||+|+||.||+|.+..+|+.||||++.... ....+.+.+|+.++ ++++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 556789999999999999998899999999986432 22334566676554 577899999999999999999999
Q ss_pred EEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchh
Q 003278 187 YDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLAR 266 (834)
Q Consensus 187 ~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~ 266 (834)
|||+++|+|..++.. ..+++.....++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~E~~~~~~L~~~~~~--------~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~ 149 (324)
T cd05589 81 MEYAAGGDLMMHIHT--------DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK 149 (324)
T ss_pred EcCCCCCcHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCc
Confidence 999999999888743 3589999999999999999999985 99999999999999999999999999986
Q ss_pred hhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchH
Q 003278 267 WLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIIL 346 (834)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l 346 (834)
..... ........||+.|||||.+... .++.++|||||||++|||+||+.||......
T Consensus 150 ~~~~~----------------~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~G~~pf~~~~~~----- 207 (324)
T cd05589 150 EGMGF----------------GDRTSTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIYEMLVGESPFPGDDEE----- 207 (324)
T ss_pred cCCCC----------------CCcccccccCccccCHhHhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCHH-----
Confidence 42110 0012346799999999988654 6789999999999999999999998643211
Q ss_pred HHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchh
Q 003278 347 LDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMK 399 (834)
Q Consensus 347 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~ 399 (834)
.....+.. +.. ... ... ...+.+++..||+.||.+||++.
T Consensus 208 -~~~~~i~~-~~~------~~p-~~~----~~~~~~li~~~L~~dP~~R~~~~ 247 (324)
T cd05589 208 -EVFDSIVN-DEV------RYP-RFL----SREAISIMRRLLRRNPERRLGSG 247 (324)
T ss_pred -HHHHHHHh-CCC------CCC-CCC----CHHHHHHHHHHhhcCHhHcCCCC
Confidence 11111111 111 010 111 13567899999999999999654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=322.40 Aligned_cols=251 Identities=27% Similarity=0.393 Sum_probs=202.1
Q ss_pred CCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEc
Q 003278 112 GFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDY 189 (834)
Q Consensus 112 ~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 189 (834)
+|+..+.||+|+||.||+|....+|+.||+|.+... .....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 477788999999999999999889999999987643 344567799999999999999999999999999999999999
Q ss_pred cCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhh
Q 003278 190 MPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLE 269 (834)
Q Consensus 190 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~ 269 (834)
+++++|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.+.
T Consensus 81 ~~~~~L~~~l~~~~-----~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~ 152 (256)
T cd08529 81 AENGDLHKLLKMQR-----GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS 152 (256)
T ss_pred CCCCcHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceecc
Confidence 99999999987532 24689999999999999999999985 99999999999999999999999999987543
Q ss_pred hhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHH
Q 003278 270 HELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDW 349 (834)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~ 349 (834)
.... ......|++.|+|||++..+ .++.++|||||||+++||+||+.|+.... .......
T Consensus 153 ~~~~----------------~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~ 212 (256)
T cd08529 153 DNTN----------------FANTIVGTPYYLSPELCEDK-PYNEKSDVWALGVVLYECCTGKHPFDANN---QGALILK 212 (256)
T ss_pred Cccc----------------hhhccccCccccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCC---HHHHHHH
Confidence 2110 12334588999999998765 57889999999999999999999986432 1111111
Q ss_pred HHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 350 IRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 350 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
+ ..+.... +. .. ....+.+++..||+.+|++||+|.++++.
T Consensus 213 ~----~~~~~~~-----~~-~~----~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 213 I----IRGVFPP-----VS-QM----YSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred H----HcCCCCC-----Cc-cc----cCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1 1111111 11 11 12468899999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=326.55 Aligned_cols=250 Identities=23% Similarity=0.386 Sum_probs=205.6
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc---ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK---GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 187 (834)
..|++.+.||+|.||.|-+++....|+.||||.+++. +++..-.+.+|+++|+.|+||||+.+|..|...+.+.|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 4577788999999999999998889999999998764 3444456789999999999999999999999999999999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
||..+|.|.+++.++ ..|++.....+++||..|+.|||.. +++|||||.+|||||.++++||+||||+-+
T Consensus 133 EYaS~GeLYDYiSer-------~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNl 202 (668)
T KOG0611|consen 133 EYASGGELYDYISER-------GSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNL 202 (668)
T ss_pred EecCCccHHHHHHHh-------ccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhh
Confidence 999999999999765 4688999999999999999999985 999999999999999999999999999987
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHH
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILL 347 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~ 347 (834)
+..+.. -+++||+|-|.+||.+....+-.+.+|-||+||+||.|+.|..||+... ...+
T Consensus 203 y~~~kf-----------------LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D---hk~l- 261 (668)
T KOG0611|consen 203 YADKKF-----------------LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD---HKRL- 261 (668)
T ss_pred hccccH-----------------HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch---HHHH-
Confidence 543321 4678999999999988665555778999999999999999999998532 2222
Q ss_pred HHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhh
Q 003278 348 DWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVS 406 (834)
Q Consensus 348 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~ 406 (834)
++++. .|...+... .....-|+.+.|..||++|-++.+|.....
T Consensus 262 --vrQIs-~GaYrEP~~------------PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 262 --VRQIS-RGAYREPET------------PSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred --HHHhh-cccccCCCC------------CchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 22222 232222111 112345777888999999999999988754
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=338.03 Aligned_cols=239 Identities=24% Similarity=0.337 Sum_probs=188.6
Q ss_pred CeeeccCCeEEEEEEECCCCeEEEEEEeccc---ChhhHHHHHHHHHHHHhC-CCCceeeEeeeEEeCCEEEEEEEccCC
Q 003278 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK---GERFEKTFAAELVAVAHL-RHRNLVRLRGWCVHEDQLLLVYDYMPN 192 (834)
Q Consensus 117 ~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 192 (834)
++||+|+||.||+|..+.+++.||||++... .....+.+..|..++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999889999999998643 223345677888888876 699999999999999999999999999
Q ss_pred CCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhhhh
Q 003278 193 RSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHEL 272 (834)
Q Consensus 193 gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~ 272 (834)
|+|..++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 g~L~~~i~~~-------~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~- 149 (320)
T cd05590 81 GDLMFHIQKS-------RRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN- 149 (320)
T ss_pred chHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC-
Confidence 9999888643 3588899999999999999999985 9999999999999999999999999998742110
Q ss_pred hhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHHHHH
Q 003278 273 QYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIRR 352 (834)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~ 352 (834)
........||+.|+|||.+... .++.++|||||||++|||+||+.||...... .+ ...
T Consensus 150 ---------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~---~~---~~~ 207 (320)
T cd05590 150 ---------------GKTTSTFCGTPDYIAPEILQEM-LYGPSVDWWAMGVLLYEMLCGHAPFEAENED---DL---FEA 207 (320)
T ss_pred ---------------CCcccccccCccccCHHHHcCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HH---HHH
Confidence 0113345799999999998654 6788999999999999999999998643211 11 111
Q ss_pred HhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhh
Q 003278 353 LSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKW 400 (834)
Q Consensus 353 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~ 400 (834)
... +... .+ ... ...+.++...|++.||.+||+..+
T Consensus 208 i~~-~~~~---~~----~~~----~~~~~~li~~~L~~dP~~R~~~~~ 243 (320)
T cd05590 208 ILN-DEVV---YP----TWL----SQDAVDILKAFMTKNPTMRLGSLT 243 (320)
T ss_pred Hhc-CCCC---CC----CCC----CHHHHHHHHHHcccCHHHCCCCCC
Confidence 111 1110 00 111 135678999999999999999843
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=327.38 Aligned_cols=259 Identities=28% Similarity=0.454 Sum_probs=202.0
Q ss_pred hcCCCCCCCeeeccCCeEEEEEEECCCCe---EEEEEEeccc-ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEE
Q 003278 109 GSNGFDEDEVLGSGGFGKVYRAVLPSDGT---VVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLL 184 (834)
Q Consensus 109 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~---~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 184 (834)
.+++|+..+.||+|+||.||+|.++.++. .+|||.+... .....+.|.+|+.++.+++||||+++++++...+..+
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM 82 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence 45678889999999999999999865554 7999998654 2344567899999999999999999999999999999
Q ss_pred EEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccc
Q 003278 185 LVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGL 264 (834)
Q Consensus 185 lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGl 264 (834)
+||||+++++|.+++... ...++|.++..++.|++.||+|||+. +++||||||+|||++.++.+||+|||+
T Consensus 83 lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~ 153 (268)
T cd05063 83 IITEYMENGALDKYLRDH------DGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGL 153 (268)
T ss_pred EEEEcCCCCCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCcc
Confidence 999999999999998643 24589999999999999999999985 999999999999999999999999999
Q ss_pred hhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCcc
Q 003278 265 ARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQ 343 (834)
Q Consensus 265 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~ 343 (834)
+......... . ........++.|+|||++..+ .++.++|||||||++|||+| |+.|+.....
T Consensus 154 ~~~~~~~~~~----------~---~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~il~ell~~g~~p~~~~~~--- 216 (268)
T cd05063 154 SRVLEDDPEG----------T---YTTSGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSFGERPYWDMSN--- 216 (268)
T ss_pred ceeccccccc----------c---eeccCCCcCceecCHHHhhcC-CcChHhHHHHHHHHHHHHHhCCCCCCCcCCH---
Confidence 8754321100 0 001112235679999988654 57899999999999999998 9999854321
Q ss_pred chHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhc
Q 003278 344 IILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSG 407 (834)
Q Consensus 344 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~ 407 (834)
..+...+.. +... +. .......+.+++..||+.+|++||+|.+|++.|..
T Consensus 217 ---~~~~~~i~~-~~~~----~~------~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~ 266 (268)
T cd05063 217 ---HEVMKAIND-GFRL----PA------PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK 266 (268)
T ss_pred ---HHHHHHHhc-CCCC----CC------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 112222211 1100 00 00112467899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=331.60 Aligned_cols=242 Identities=25% Similarity=0.423 Sum_probs=190.0
Q ss_pred CeeeccCCeEEEEEEECCCCe-------EEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEc
Q 003278 117 EVLGSGGFGKVYRAVLPSDGT-------VVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDY 189 (834)
Q Consensus 117 ~~LG~G~fG~Vy~~~~~~~g~-------~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 189 (834)
+.||+|+||.||+|.....+. .||+|.+........+.|.+|+.+++.++|||||++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998865443 4888988665555667889999999999999999999999999999999999
Q ss_pred cCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCc--------eEEee
Q 003278 190 MPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYN--------ARLGD 261 (834)
Q Consensus 190 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~--------~kl~D 261 (834)
+++|+|..++.... ..++|..++.++.|++.||+|||+. +|+||||||+|||++.++. ++++|
T Consensus 81 ~~~g~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d 151 (258)
T cd05078 81 VKFGSLDTYLKKNK------NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD 151 (258)
T ss_pred CCCCcHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecc
Confidence 99999999987542 2578999999999999999999985 9999999999999987765 58999
Q ss_pred ccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCC-ccCCCCCC
Q 003278 262 FGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR-RAVDLTYP 340 (834)
Q Consensus 262 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~-~p~~~~~~ 340 (834)
||++..... .....|++.|+|||++..+..++.++|||||||++|||++|. .|+.....
T Consensus 152 ~g~~~~~~~--------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~ 211 (258)
T cd05078 152 PGISITVLP--------------------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS 211 (258)
T ss_pred cccccccCC--------------------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH
Confidence 998764211 123458899999999976556789999999999999999995 44432111
Q ss_pred CccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhh
Q 003278 341 DDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVS 406 (834)
Q Consensus 341 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~ 406 (834)
. .... .... .. .+. . .....+.+++..||+.+|++||++.++++.|+
T Consensus 212 ~------~~~~-~~~~--~~-----~~~-~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 212 Q------KKLQ-FYED--RH-----QLP-A----PKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred H------HHHH-HHHc--cc-----cCC-C----CCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 1 1111 1110 00 111 0 11245789999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=334.54 Aligned_cols=259 Identities=25% Similarity=0.372 Sum_probs=200.4
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc-ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEc
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDY 189 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 189 (834)
++|+..+.||+|+||.||++.+..+|..||+|.+... .......+.+|+.++.+++||||++++++|..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 4688999999999999999999889999999988644 233456788999999999999999999999999999999999
Q ss_pred cCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhh
Q 003278 190 MPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLE 269 (834)
Q Consensus 190 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~ 269 (834)
+++++|.+++... ..+++..+..++.|+++||.|||+. .+++||||||+|||++.++.+||+|||++..+.
T Consensus 81 ~~~~~L~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 151 (308)
T cd06615 81 MDGGSLDQVLKKA-------GRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 151 (308)
T ss_pred cCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCccccc
Confidence 9999999998643 3578899999999999999999973 389999999999999999999999999986532
Q ss_pred hhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHH
Q 003278 270 HELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDW 349 (834)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~ 349 (834)
.. ......|++.|+|||.+.. ..++.++|||||||++|||+||+.|+...... .+..+
T Consensus 152 ~~------------------~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~---~~~~~ 209 (308)
T cd06615 152 DS------------------MANSFVGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK---ELEAM 209 (308)
T ss_pred cc------------------ccccCCCCcCccChhHhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCcchh---hHHHh
Confidence 11 0233468999999998754 46789999999999999999999998643211 11111
Q ss_pred HHHHhhcCcc---------------------------ccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHH
Q 003278 350 IRRLSDEGKV---------------------------LQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVI 402 (834)
Q Consensus 350 ~~~~~~~~~~---------------------------~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~ 402 (834)
.......... .....+.+.... ....+.+++.+||+.+|++||++.+|+
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~li~~~l~~~P~~Rpt~~~ll 285 (308)
T cd06615 210 FGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGA----FSDEFQDFVDKCLKKNPKERADLKELT 285 (308)
T ss_pred hcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcc----cCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 1100000000 000000000000 113478999999999999999999998
Q ss_pred HH
Q 003278 403 EA 404 (834)
Q Consensus 403 ~~ 404 (834)
+.
T Consensus 286 ~~ 287 (308)
T cd06615 286 KH 287 (308)
T ss_pred cC
Confidence 75
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=342.26 Aligned_cols=263 Identities=21% Similarity=0.256 Sum_probs=200.4
Q ss_pred cHHHHHhhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc---ChhhHHHHHHHHHHHHhCCCCceeeEeeeEE
Q 003278 102 SYAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK---GERFEKTFAAELVAVAHLRHRNLVRLRGWCV 178 (834)
Q Consensus 102 ~~~el~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~ 178 (834)
...++....++|+..+.||+|+||.||+|....+++.||+|++... .....+.+.+|+.++..++||||+++++++.
T Consensus 34 ~~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~ 113 (371)
T cd05622 34 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 113 (371)
T ss_pred HHhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 4555667778999999999999999999999999999999998642 1223456788999999999999999999999
Q ss_pred eCCEEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceE
Q 003278 179 HEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNAR 258 (834)
Q Consensus 179 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~k 258 (834)
+.+..++||||+++|+|.+++... .++...+..++.|++.||+|||+. +|+||||||+|||++.++.+|
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~~~~~--------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ik 182 (371)
T cd05622 114 DDRYLYMVMEYMPGGDLVNLMSNY--------DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLK 182 (371)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHhc--------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEE
Confidence 999999999999999999988532 367788889999999999999985 999999999999999999999
Q ss_pred EeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccC---CCCCcccceeehhhHHHHHHhCCccC
Q 003278 259 LGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKG---SVATAKSDVFSFGIVVLEVVSGRRAV 335 (834)
Q Consensus 259 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~---~~~~~ksDV~SfGvvl~ElltG~~p~ 335 (834)
|+|||+++.+.... ........||+.|||||++... ..++.++|||||||++|||++|+.||
T Consensus 183 L~DfG~a~~~~~~~---------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf 247 (371)
T cd05622 183 LADFGTCMKMNKEG---------------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247 (371)
T ss_pred EEeCCceeEcCcCC---------------cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCC
Confidence 99999997542210 0012345699999999998642 23688999999999999999999999
Q ss_pred CCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCC--CCchhhHHHH
Q 003278 336 DLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHL--RPSMKWVIEA 404 (834)
Q Consensus 336 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPsm~~V~~~ 404 (834)
..... ......+..........+. ... ...+..++..|+..++.+ ||++.++.+.
T Consensus 248 ~~~~~------~~~~~~i~~~~~~~~~~~~----~~~----s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 248 YADSL------VGTYSKIMNHKNSLTFPDD----NDI----SKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred CCCCH------HHHHHHHHcCCCcccCCCc----CCC----CHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 64321 1111222211111111111 111 134667888898743332 6777777764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=328.57 Aligned_cols=255 Identities=24% Similarity=0.389 Sum_probs=199.6
Q ss_pred hhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhC-CCCceeeEeeeEEeC------
Q 003278 108 IGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHL-RHRNLVRLRGWCVHE------ 180 (834)
Q Consensus 108 ~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~------ 180 (834)
.+++.|+..+.||+|+||.||+|....+++.||+|++.... .....+.+|+.++.++ +||||++++++|...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 45677888999999999999999998899999999986543 3345788999999998 799999999998763
Q ss_pred CEEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEe
Q 003278 181 DQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLG 260 (834)
Q Consensus 181 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~ 260 (834)
+..++||||+++|+|.+++.... ...++|..+..++.|++.||+|||+. +|+||||||+||++++++.+||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~ 153 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTK-----GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLV 153 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEc
Confidence 46899999999999999986532 24688999999999999999999985 99999999999999999999999
Q ss_pred eccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCcccccc----CCCCCcccceeehhhHHHHHHhCCccCC
Q 003278 261 DFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQK----GSVATAKSDVFSFGIVVLEVVSGRRAVD 336 (834)
Q Consensus 261 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~----~~~~~~ksDV~SfGvvl~ElltG~~p~~ 336 (834)
|||+++.+.... .......||+.|+|||++.. +..++.++|||||||++|||++|+.|+.
T Consensus 154 Dfg~~~~~~~~~----------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~ 217 (272)
T cd06637 154 DFGVSAQLDRTV----------------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC 217 (272)
T ss_pred cCCCceeccccc----------------ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 999987542210 11234569999999998852 2346889999999999999999999985
Q ss_pred CCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 337 LTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 337 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
..... ..+.. .... ..+.+..... ...+.+++..||+.+|.+||++.+|++
T Consensus 218 ~~~~~-----~~~~~--~~~~-----~~~~~~~~~~----~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 218 DMHPM-----RALFL--IPRN-----PAPRLKSKKW----SKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred ccCHH-----HHHHH--HhcC-----CCCCCCCCCc----CHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 32211 11110 0111 1111111111 235788999999999999999999876
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=330.61 Aligned_cols=244 Identities=24% Similarity=0.308 Sum_probs=189.1
Q ss_pred eeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEccCCCCH
Q 003278 119 LGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNRSL 195 (834)
Q Consensus 119 LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 195 (834)
||+|+||+||+|....+|+.||||.+.... ....+.+..|+.++++++||||+++.+++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999998899999999986432 12335678899999999999999999999999999999999999999
Q ss_pred hHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhhhhhhh
Q 003278 196 DRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQ 275 (834)
Q Consensus 196 ~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 275 (834)
..++..... ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 81 ~~~~~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~--- 151 (280)
T cd05608 81 RYHIYNVDE---ENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--- 151 (280)
T ss_pred HHHHHhccc---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCC---
Confidence 988754321 234689999999999999999999985 99999999999999999999999999987542210
Q ss_pred hhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHHHHHHhh
Q 003278 276 MRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIRRLSD 355 (834)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~ 355 (834)
.......||+.|+|||.+... .++.++|||||||++|||+||+.||........ ..........
T Consensus 152 -------------~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~ 215 (280)
T cd05608 152 -------------SKTKGYAGTPGFMAPELLQGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRILN 215 (280)
T ss_pred -------------ccccccCCCcCccCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--HHHHHHhhcc
Confidence 012335699999999998755 678999999999999999999999864322111 1111111110
Q ss_pred cCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchh
Q 003278 356 EGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMK 399 (834)
Q Consensus 356 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~ 399 (834)
. .. .+.......+.+++..||+.||++||++.
T Consensus 216 -~--------~~---~~~~~~~~~~~~li~~~l~~~P~~R~~~~ 247 (280)
T cd05608 216 -D--------SV---TYPDKFSPASKSFCEALLAKDPEKRLGFR 247 (280)
T ss_pred -c--------CC---CCcccCCHHHHHHHHHHhcCCHHHhcCCC
Confidence 0 00 00111124577899999999999999553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=326.64 Aligned_cols=249 Identities=25% Similarity=0.387 Sum_probs=194.3
Q ss_pred CeeeccCCeEEEEEEECCCCeEEEEEEeccc-ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEccCCCCH
Q 003278 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNRSL 195 (834)
Q Consensus 117 ~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 195 (834)
+.||+|+||.||+|.+..+|+.||+|.+... .......|.+|+.++++++||||++++++|...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 4699999999999999889999999987643 234556799999999999999999999999999999999999999999
Q ss_pred hHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhhhhhhh
Q 003278 196 DRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQ 275 (834)
Q Consensus 196 ~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 275 (834)
.+++... ...++|..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~~~~~~------~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-- 149 (252)
T cd05084 81 LTFLRTE------GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY-- 149 (252)
T ss_pred HHHHHhC------CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccc--
Confidence 9998643 23588999999999999999999985 999999999999999999999999999875322100
Q ss_pred hhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccchHHHHHHHHh
Q 003278 276 MRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQIILLDWIRRLS 354 (834)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 354 (834)
........++..|+|||.+..+ .++.++|||||||++|||++ |..|+...... . .....
T Consensus 150 ------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~---~----~~~~~ 209 (252)
T cd05084 150 ------------ASTGGMKQIPVKWTAPEALNYG-RYSSESDVWSFGILLWEAFSLGAVPYANLSNQ---Q----TREAI 209 (252)
T ss_pred ------------cccCCCCCCceeecCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccCHH---H----HHHHH
Confidence 0000111235679999998665 57889999999999999998 88777532211 1 11111
Q ss_pred hcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhh
Q 003278 355 DEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVS 406 (834)
Q Consensus 355 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~ 406 (834)
..+.... ........+.+++..|++.+|++||++.+|.++|.
T Consensus 210 ~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 210 EQGVRLP----------CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HcCCCCC----------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 1111000 00111246788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=327.11 Aligned_cols=241 Identities=22% Similarity=0.380 Sum_probs=188.8
Q ss_pred CeeeccCCeEEEEEEECCC------------CeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEE
Q 003278 117 EVLGSGGFGKVYRAVLPSD------------GTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLL 184 (834)
Q Consensus 117 ~~LG~G~fG~Vy~~~~~~~------------g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 184 (834)
+.||+|+||.||+|.+..+ ...||+|.+..........|.+|+.++..++||||++++++|......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 4689999999999986322 2368999887665556678899999999999999999999999999999
Q ss_pred EEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCc-------e
Q 003278 185 LVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYN-------A 257 (834)
Q Consensus 185 lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~-------~ 257 (834)
+||||+++|+|..++... ..++++..+..|+.|+++||+|||+. +|+||||||+|||++.++. +
T Consensus 81 lv~e~~~~~~l~~~~~~~------~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~ 151 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK------SDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFI 151 (262)
T ss_pred EEEecccCCCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCcee
Confidence 999999999999888643 24589999999999999999999985 9999999999999987654 8
Q ss_pred EEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHH-hCCccCC
Q 003278 258 RLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVV-SGRRAVD 336 (834)
Q Consensus 258 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ell-tG~~p~~ 336 (834)
|++|||++..... .....||..|+|||++..+..++.++|||||||++|||+ +|+.|+.
T Consensus 152 ~l~d~g~~~~~~~--------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~ 211 (262)
T cd05077 152 KLSDPGIPITVLS--------------------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLK 211 (262)
T ss_pred EeCCCCCCccccC--------------------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999864321 122347889999998875567899999999999999998 5777764
Q ss_pred CCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHh
Q 003278 337 LTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAV 405 (834)
Q Consensus 337 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l 405 (834)
.....+ . ..... +.. . .. . .....+.+|+..||+.||.+||++.++++.|
T Consensus 212 ~~~~~~----~---~~~~~-~~~-~-----~~-~----~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 212 DKTLAE----K---ERFYE-GQC-M-----LV-T----PSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred CcchhH----H---HHHHh-cCc-c-----CC-C----CChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 321111 0 01111 110 0 00 0 0124578899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=349.40 Aligned_cols=276 Identities=24% Similarity=0.280 Sum_probs=212.4
Q ss_pred HHhhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCC-CCceeeEeee-EEeC---
Q 003278 106 LYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLR-HRNLVRLRGW-CVHE--- 180 (834)
Q Consensus 106 l~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~-~~~~--- 180 (834)
+.++..+.++.++|.+|||+.||.|.....|..||+|++-..++...+...+||.+|++|. |||||.+++. ....
T Consensus 32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~ 111 (738)
T KOG1989|consen 32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN 111 (738)
T ss_pred EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence 4566778888999999999999999997777999999987777888889999999999997 9999999993 2221
Q ss_pred ---CEEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCce
Q 003278 181 ---DQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNA 257 (834)
Q Consensus 181 ---~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~ 257 (834)
-+.+|.||||.+|+|-+++..+.. ..|++.++++|+.|+++|+++||.. .++|||||||-+||||+.+++.
T Consensus 112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq-----~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~ 185 (738)
T KOG1989|consen 112 NGVWEVLLLMEYCKGGSLVDFMNTRLQ-----TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNY 185 (738)
T ss_pred CceeEEEeehhhccCCcHHHHHHHHHh-----ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCE
Confidence 268999999999999999976532 3499999999999999999999984 7899999999999999999999
Q ss_pred EEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccc--cCCCCCcccceeehhhHHHHHHhCCccC
Q 003278 258 RLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQ--KGSVATAKSDVFSFGIVVLEVVSGRRAV 335 (834)
Q Consensus 258 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~--~~~~~~~ksDV~SfGvvl~ElltG~~p~ 335 (834)
||||||.|...-..... . .....+...-...-|+-|+|||.+. .+...+.|+|||+|||+||-|+....||
T Consensus 186 KLCDFGSatt~~~~~~~----~---~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PF 258 (738)
T KOG1989|consen 186 KLCDFGSATTKILSPTS----A---QEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPF 258 (738)
T ss_pred EeCcccccccccCCCcc----H---HHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCc
Confidence 99999998642111100 0 0000000011123589999999864 4667899999999999999999999999
Q ss_pred CCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcCCCCCCC
Q 003278 336 DLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGSYSGKLP 414 (834)
Q Consensus 336 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~~~~~~p 414 (834)
+.... +.+++....-+.+ ..--..+..|+..||+.||.+||++-+|++.+......+.|
T Consensus 259 e~sg~-------------------laIlng~Y~~P~~-p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~ 317 (738)
T KOG1989|consen 259 EESGK-------------------LAILNGNYSFPPF-PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCP 317 (738)
T ss_pred CcCcc-------------------eeEEeccccCCCC-ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCC
Confidence 74311 1111111110111 11235788999999999999999999999998776555544
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=339.45 Aligned_cols=242 Identities=18% Similarity=0.227 Sum_probs=190.0
Q ss_pred CcccccCCcEEEEEEE-CCCcEEEEEEecCCC--ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEeccCCC
Q 003278 519 QRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSK--CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATR 595 (834)
Q Consensus 519 ~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~--~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~~~g 595 (834)
+.||+|+||.||++.. .++..||||.+.... .......+.+|+.+|++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 3589999999999985 468899999986432 2233467889999999999999999999999999999999999999
Q ss_pred chhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCCCC
Q 003278 596 ILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHG 675 (834)
Q Consensus 596 ~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~~~ 675 (834)
+|..++.... .+++.....++.|++.||+|||+ .+|+||||||+||||+.++.+||+|||+++......
T Consensus 81 ~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-- 149 (328)
T cd05593 81 ELFFHLSRER------VFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-- 149 (328)
T ss_pred CHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc--
Confidence 9988875432 47888899999999999999996 699999999999999999999999999987532211
Q ss_pred CcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcccccccc
Q 003278 676 HRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDL 755 (834)
Q Consensus 676 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 755 (834)
......+||+.|||||++.+..++.++|||||||++|||+||+.||........ ... .... +.
T Consensus 150 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~-~~~---~~~~--------~~ 212 (328)
T cd05593 150 -----ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-FEL---ILME--------DI 212 (328)
T ss_pred -----cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH-HHH---hccC--------Cc
Confidence 112346799999999999989999999999999999999999999864332211 111 1000 01
Q ss_pred ccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----ChhHHHH
Q 003278 756 SLNGEYNHKELMRLIKLGIACTLSNPELRP-----SMRQILS 792 (834)
Q Consensus 756 ~l~~~~~~~~~~~l~~l~~~C~~~~P~~RP-----tm~~v~~ 792 (834)
.++...+ .+ +.++..+||+.||++|| ++.++++
T Consensus 213 ~~p~~~~-~~---~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 213 KFPRTLS-AD---AKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred cCCCCCC-HH---HHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 1111222 23 44555689999999997 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=339.74 Aligned_cols=241 Identities=18% Similarity=0.219 Sum_probs=188.8
Q ss_pred cccccCCcEEEEEEE-CCCcEEEEEEecCCC--ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEeccCCCc
Q 003278 520 RVAEMDFGTAYQGFL-DNHQYVLVKRLGMSK--CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRI 596 (834)
Q Consensus 520 ~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~--~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~~~g~ 596 (834)
.||+|+||.||++.. .++..||+|.+.... .......+.+|+.++++++||||+++++++...+..++||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (323)
T cd05595 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCc
Confidence 589999999999985 468899999986432 22334567889999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCCCCC
Q 003278 597 LSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGH 676 (834)
Q Consensus 597 L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~~~~ 676 (834)
|..++.... .+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 82 L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--- 149 (323)
T cd05595 82 LFFHLSRER------VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--- 149 (323)
T ss_pred HHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC---
Confidence 988875432 37888899999999999999996 699999999999999999999999999987532211
Q ss_pred cccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCccccccccc
Q 003278 677 RKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLS 756 (834)
Q Consensus 677 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 756 (834)
.......||+.|||||++.++.++.++|||||||++|||+||+.||......... .. ...... .
T Consensus 150 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~-~~---~~~~~~--------~ 213 (323)
T cd05595 150 ----ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF-EL---ILMEEI--------R 213 (323)
T ss_pred ----CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHH-HH---HhcCCC--------C
Confidence 1123467999999999999999999999999999999999999998643322111 11 111110 1
Q ss_pred cCCCCCHHHHHHHHHHHHHhccCCCCCCC-----ChhHHHH
Q 003278 757 LNGEYNHKELMRLIKLGIACTLSNPELRP-----SMRQILS 792 (834)
Q Consensus 757 l~~~~~~~~~~~l~~l~~~C~~~~P~~RP-----tm~~v~~ 792 (834)
++...+ +++ .++..+||+.||++|| ++.++++
T Consensus 214 ~p~~~~-~~~---~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 214 FPRTLS-PEA---KSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCCCC-HHH---HHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 111222 333 3455589999999998 7777764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=326.58 Aligned_cols=255 Identities=25% Similarity=0.393 Sum_probs=201.2
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEc
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDY 189 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 189 (834)
.++|+..++||+|+||.||+|.. .++..||+|.+.... ...+.+.+|+.++++++|+||+++++++...+..++||||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 35688899999999999999997 567789999876532 2356789999999999999999999999999999999999
Q ss_pred cCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhh
Q 003278 190 MPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLE 269 (834)
Q Consensus 190 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~ 269 (834)
+++|+|.+++.... ...+++..++.++.|+++||+|||+. +++||||||+|||++.++.+||+|||+++...
T Consensus 83 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 154 (261)
T cd05072 83 MAKGSLLDFLKSDE-----GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIE 154 (261)
T ss_pred CCCCcHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecC
Confidence 99999999986532 24688999999999999999999985 99999999999999999999999999997543
Q ss_pred hhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccchHHH
Q 003278 270 HELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQIILLD 348 (834)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~ 348 (834)
.... .......++..|+|||++..+ .++.++|||||||++|||+| |+.|+.... ......
T Consensus 155 ~~~~---------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~---~~~~~~ 215 (261)
T cd05072 155 DNEY---------------TAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLYEIVTYGKIPYPGMS---NSDVMS 215 (261)
T ss_pred CCce---------------eccCCCccceecCCHHHhccC-CCChhhhhhhhHHHHHHHHccCCCCCCCCC---HHHHHH
Confidence 2100 001223467889999988654 57889999999999999999 888885321 111222
Q ss_pred HHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhc
Q 003278 349 WIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSG 407 (834)
Q Consensus 349 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~ 407 (834)
++. .+... +.. ... ...+.+++..|++.+|++||++.++.+.|+.
T Consensus 216 ~~~----~~~~~----~~~--~~~----~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 216 ALQ----RGYRM----PRM--ENC----PDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred HHH----cCCCC----CCC--CCC----CHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 211 11110 000 111 2457889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=329.50 Aligned_cols=267 Identities=20% Similarity=0.285 Sum_probs=202.1
Q ss_pred hCcCcCCcccccCCcEEEEEEECC-----------------CcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDN-----------------HQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQL 575 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l 575 (834)
+.|...+.||+|+||.||++...+ ...||+|.+.........+.|.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 456777899999999999988543 245899998766655666789999999999999999999
Q ss_pred EEEEeeCCeEEEEEeccCCCchhhhhhcCCCC-----CCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCce
Q 003278 576 CGWCTEQGEMLVIYDYSATRILSHLLFHNNHR-----IGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAI 650 (834)
Q Consensus 576 ~g~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~-----~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NI 650 (834)
+++|...+..+++|||+++++|..++...... .....+++...+.++.|++.||+|||+ .+|+||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhce
Confidence 99999999999999999999999998754311 112258899999999999999999996 6899999999999
Q ss_pred eecCCCCceEeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh--CCCccCC
Q 003278 651 TLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT--GQMAVDF 728 (834)
Q Consensus 651 Lld~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t--G~~p~~~ 728 (834)
++++++.+|++|||+++.+...+.. .......+|+.|||||++.++.++.++|||||||++|||+| |..|+..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 236 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYY-----RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236 (296)
T ss_pred eecCCCceEEccccceeecccCcce-----eecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence 9999999999999999765332210 11223456789999999998899999999999999999998 5566643
Q ss_pred CCCchhHHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHc
Q 003278 729 RLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795 (834)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~ 795 (834)
.. ....................... ... .+ .++.+++.+||+.||++|||+.+|++.|+
T Consensus 237 ~~-~~~~~~~~~~~~~~~~~~~~~~~---~~~-~~---~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 237 LT-DQQVIENAGHFFRDDGRQIYLPR---PPN-CP---KDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred cC-hHHHHHHHHhccccccccccCCC---ccC-CC---HHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 22 22222222211100000000000 011 11 35667778999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=333.21 Aligned_cols=265 Identities=16% Similarity=0.208 Sum_probs=192.4
Q ss_pred hhCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEe
Q 003278 512 TNNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYD 590 (834)
Q Consensus 512 t~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~E 590 (834)
.++|...+.||+|+||.||+|... ++..||||.+...........+.+|+.++++++|||||++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 357888899999999999999975 6789999998754433333467889999999999999999999999999999999
Q ss_pred ccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccc
Q 003278 591 YSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLT 670 (834)
Q Consensus 591 y~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~ 670 (834)
|++ ++|.+++.... ..+++.....++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++...
T Consensus 84 ~~~-~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 84 YVH-TDLCQYMDKHP-----GGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred CCC-cCHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 996 56666665432 236778888999999999999996 689999999999999999999999999987532
Q ss_pred cCCCCCcccccCccccccccCccchhcccc-CCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhc--C
Q 003278 671 RNDHGHRKATSGNRSVRGIFGYMSPEYIES-GEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARK--R 747 (834)
Q Consensus 671 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~--~ 747 (834)
... .......||+.|||||++.+ ..++.++|||||||++|||+||+.||.................... .
T Consensus 155 ~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 227 (303)
T cd07869 155 VPS-------HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNED 227 (303)
T ss_pred CCC-------ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChh
Confidence 211 11123468999999999865 4578899999999999999999999975433222222221110000 0
Q ss_pred cccc-----ccccc-c--CCCCCHH-------HHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 748 PLAE-----LVDLS-L--NGEYNHK-------ELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 748 ~~~~-----~~d~~-l--~~~~~~~-------~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
.+.. ..++. . ....... ....+.+++..|++.||++|||+.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 228 TWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000 00000 0 0000000 0123445666899999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=328.22 Aligned_cols=261 Identities=23% Similarity=0.377 Sum_probs=205.3
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc---ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK---GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 187 (834)
++|+..+.||+|+||.||+|....+|..||||.+... .......|.+|+.+++.++||||+++++++..++..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999999889999999987542 2334567899999999999999999999999999999999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
||+++++|.+++..... ....++|..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++..
T Consensus 82 e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd08229 82 ELADAGDLSRMIKHFKK---QKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRF 155 (267)
T ss_pred EecCCCCHHHHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhc
Confidence 99999999998864321 234689999999999999999999985 999999999999999999999999999875
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHH
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILL 347 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~ 347 (834)
+.... .......|+..|+|||++... .++.++|||||||++|||++|..|+.....+ ..
T Consensus 156 ~~~~~----------------~~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~ 214 (267)
T cd08229 156 FSSKT----------------TAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LY 214 (267)
T ss_pred cccCC----------------cccccccCCcCccCHHHhcCC-CccchhhHHHHHHHHHHHHhCCCCcccccch----HH
Confidence 43210 001234589999999988654 5788999999999999999999998532211 11
Q ss_pred HHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 348 DWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 348 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
.+..... ....+.+... .....+.+++..||+.+|.+||+|.+|++.+...
T Consensus 215 ~~~~~~~------~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 215 SLCKKIE------QCDYPPLPSD----HYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred HHhhhhh------cCCCCCCCcc----cccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 1111111 1111111111 1224678899999999999999999999988654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=333.06 Aligned_cols=262 Identities=23% Similarity=0.298 Sum_probs=201.8
Q ss_pred hCcCcCCcccccCCcEEEEEEECC------CcEEEEEEecCCCChhHHHHHHHHHHHHHhc-cCCCceeEEEEEeeCCeE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDN------HQYVLVKRLGMSKCPALRTRFSNELQNLARL-RHRNLVQLCGWCTEQGEM 585 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~------~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l-~HpNiv~l~g~~~~~~~~ 585 (834)
++|...+.||+|+||.||+|...+ ...+|+|.+...........+.+|+.++.++ +||||++++++|...+..
T Consensus 12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (293)
T cd05053 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPL 91 (293)
T ss_pred hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCe
Confidence 456777889999999999998642 3579999987655544556789999999999 899999999999999999
Q ss_pred EEEEeccCCCchhhhhhcCCC----------CCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCC
Q 003278 586 LVIYDYSATRILSHLLFHNNH----------RIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPD 655 (834)
Q Consensus 586 ~lv~Ey~~~g~L~~~l~~~~~----------~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~ 655 (834)
+++|||+++|+|..++..... ......++|..++.++.|++.||+|||+ .+|+||||||+|||++++
T Consensus 92 ~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~~~~ 168 (293)
T cd05053 92 YVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVTED 168 (293)
T ss_pred EEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEEcCC
Confidence 999999999999999865321 0122358899999999999999999996 699999999999999999
Q ss_pred CCceEeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchh
Q 003278 656 MNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGL 734 (834)
Q Consensus 656 ~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~ 734 (834)
+.+|++|||+++.+...... .......++..|+|||++.+..++.++|||||||++|||++ |..|+...... .
T Consensus 169 ~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-~ 242 (293)
T cd05053 169 HVMKIADFGLARDIHHIDYY-----RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE-E 242 (293)
T ss_pred CeEEeCccccccccccccce-----eccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH-H
Confidence 99999999999865432210 01112245678999999988899999999999999999998 88887543222 1
Q ss_pred HHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccC
Q 003278 735 LVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGN 797 (834)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~ 797 (834)
+..... ....+ ..... ....+.+++.+||..||++||||.+|++.|+.+
T Consensus 243 ~~~~~~---~~~~~-------~~~~~----~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 243 LFKLLK---EGYRM-------EKPQN----CTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred HHHHHH---cCCcC-------CCCCC----CCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 111111 11100 00111 123466777899999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=345.38 Aligned_cols=260 Identities=21% Similarity=0.253 Sum_probs=193.7
Q ss_pred CcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCC--ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEe
Q 003278 514 NFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSK--CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYD 590 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~--~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~E 590 (834)
.|...+.||+|+||+||+|.. .++..||||++.... .......+.+|+.+|.+++|||||++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 567778999999999999985 557899999986432 22334678999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccc
Q 003278 591 YSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLT 670 (834)
Q Consensus 591 y~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~ 670 (834)
|+++|+|.+++.... .+++.....++.|++.||+|||+ .+|+||||||+||||+.++.+||+|||+++.+.
T Consensus 82 ~~~gg~L~~~l~~~~------~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~ 152 (381)
T cd05626 82 YIPGGDMMSLLIRME------VFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFR 152 (381)
T ss_pred cCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCcccc
Confidence 999999999986532 36777778899999999999996 699999999999999999999999999986432
Q ss_pred cCCCCCc----------------------------------------ccccCccccccccCccchhccccCCCCccCcch
Q 003278 671 RNDHGHR----------------------------------------KATSGNRSVRGIFGYMSPEYIESGEATSMADVY 710 (834)
Q Consensus 671 ~~~~~~~----------------------------------------~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~ 710 (834)
....... .......+.+||+.|||||++.+..++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Diw 232 (381)
T cd05626 153 WTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWW 232 (381)
T ss_pred cccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCcccee
Confidence 1100000 000011246799999999999988999999999
Q ss_pred hhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHH
Q 003278 711 SFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQI 790 (834)
Q Consensus 711 SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v 790 (834)
||||++|||+||+.||....+...... ...+ .... .+ + .....+ .++..++.- +.|+..+|..||++.+|
T Consensus 233 SlG~il~elltG~~Pf~~~~~~~~~~~-i~~~---~~~~-~~--~-~~~~~s-~~~~dli~~-ll~~~~~~~~R~~~~~~ 302 (381)
T cd05626 233 SVGVILFEMLVGQPPFLAPTPTETQLK-VINW---ENTL-HI--P-PQVKLS-PEAVDLITK-LCCSAEERLGRNGADDI 302 (381)
T ss_pred ehhhHHHHHHhCCCCCcCCCHHHHHHH-HHcc---cccc-CC--C-CCCCCC-HHHHHHHHH-HccCcccccCCCCHHHH
Confidence 999999999999999975443322111 1110 0000 00 0 001122 344444432 23777788889999999
Q ss_pred HH
Q 003278 791 LS 792 (834)
Q Consensus 791 ~~ 792 (834)
+.
T Consensus 303 l~ 304 (381)
T cd05626 303 KA 304 (381)
T ss_pred hc
Confidence 85
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=338.14 Aligned_cols=241 Identities=22% Similarity=0.299 Sum_probs=188.7
Q ss_pred CeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHHHHHh-CCCCceeeEeeeEEeCCEEEEEEEccCC
Q 003278 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVAVAH-LRHRNLVRLRGWCVHEDQLLLVYDYMPN 192 (834)
Q Consensus 117 ~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~-l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 192 (834)
+.||+|+||+||+|.+..+++.||||.+.... ....+.+..|..++.. ++||||+++++++.+.+.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999998889999999986531 2234456677888775 5999999999999999999999999999
Q ss_pred CCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhhhh
Q 003278 193 RSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHEL 272 (834)
Q Consensus 193 gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~ 272 (834)
|+|..++... ..+++.....++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 g~L~~~l~~~-------~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~- 149 (316)
T cd05619 81 GDLMFHIQSC-------HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG- 149 (316)
T ss_pred CcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCC-
Confidence 9999988542 3588899999999999999999985 9999999999999999999999999998632110
Q ss_pred hhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHHHHH
Q 003278 273 QYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIRR 352 (834)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~ 352 (834)
........||+.|+|||.+... .++.++|||||||++|||+||+.||..... ..+...+.
T Consensus 150 ---------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~---~~~~~~i~- 209 (316)
T cd05619 150 ---------------DAKTCTFCGTPDYIAPEILLGQ-KYNTSVDWWSFGVLLYEMLIGQSPFHGHDE---EELFQSIR- 209 (316)
T ss_pred ---------------CCceeeecCCccccCHHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCH---HHHHHHHH-
Confidence 0113445799999999998654 679999999999999999999999864321 11111111
Q ss_pred HhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchh-hHH
Q 003278 353 LSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMK-WVI 402 (834)
Q Consensus 353 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~-~V~ 402 (834)
.+. +... ... ...+.++...||+.||.+||++. ++.
T Consensus 210 ---~~~------~~~~-~~~----~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 210 ---MDN------PCYP-RWL----TREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred ---hCC------CCCC-ccC----CHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 110 1111 111 13467889999999999999997 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=337.48 Aligned_cols=242 Identities=24% Similarity=0.283 Sum_probs=191.2
Q ss_pred CCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc---ChhhHHHHHHHHHHHHhCCCC-ceeeEeeeEEeCCEEEEEE
Q 003278 112 GFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK---GERFEKTFAAELVAVAHLRHR-NLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 112 ~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~-nIv~l~g~~~~~~~~~lV~ 187 (834)
+|+..+.||+|+||.||+|....+++.||||++... .....+.+..|+.++..++|+ +|+++++++...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 477889999999999999999888999999998643 223446678899999999765 5888999999999999999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
||+++|+|..++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 E~~~~g~L~~~~~~~-------~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~ 150 (324)
T cd05587 81 EYVNGGDLMYHIQQV-------GKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKE 150 (324)
T ss_pred cCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCccee
Confidence 999999999888543 3578999999999999999999985 999999999999999999999999999863
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHH
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILL 347 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~ 347 (834)
.... ........||+.|+|||++... .++.++|||||||++|||+||+.||...... .+.
T Consensus 151 ~~~~----------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~ 210 (324)
T cd05587 151 NIFG----------------GKTTRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---ELF 210 (324)
T ss_pred cCCC----------------CCceeeecCCccccChhhhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHH
Confidence 2110 0112345799999999998654 5789999999999999999999998643211 111
Q ss_pred HHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCch
Q 003278 348 DWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSM 398 (834)
Q Consensus 348 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm 398 (834)
..+ . ... ..+. ... ...+.+++..||+.||.+||+.
T Consensus 211 ~~i---~-~~~------~~~~-~~~----~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 211 QSI---M-EHN------VSYP-KSL----SKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred HHH---H-cCC------CCCC-CCC----CHHHHHHHHHHhhcCHHHcCCC
Confidence 111 1 111 0111 111 1357789999999999999987
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=332.55 Aligned_cols=263 Identities=26% Similarity=0.417 Sum_probs=205.0
Q ss_pred CCCCCCCeeeccCCeEEEEEEEC-----CCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLP-----SDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLL 185 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~-----~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 185 (834)
.+|...+.||+|+||.||+|... .++..+|+|.+........+.|.+|+.++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 35777889999999999999853 3456799999876666666789999999999999999999999999999999
Q ss_pred EEEccCCCCHhHHHhcCCCc---------cccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCc
Q 003278 186 VYDYMPNRSLDRVLFRRPEN---------LEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYN 256 (834)
Q Consensus 186 V~Ey~~~gsL~~~l~~~~~~---------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~ 256 (834)
||||+++++|.+++...... ......++|..++.++.|++.||+|||+. +|+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence 99999999999999754211 01123589999999999999999999985 9999999999999999999
Q ss_pred eEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccC
Q 003278 257 ARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAV 335 (834)
Q Consensus 257 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~ 335 (834)
+||+|||+++....... ....+...|+..|+|||++... .++.++|||||||++|||+| |+.|+
T Consensus 162 ~~l~dfg~a~~~~~~~~--------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~ 226 (291)
T cd05094 162 VKIGDFGMSRDVYSTDY--------------YRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVILWEIFTYGKQPW 226 (291)
T ss_pred EEECCCCcccccCCCce--------------eecCCCCCcceeecChHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999999975422110 0011233478899999988654 67889999999999999999 99887
Q ss_pred CCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 336 DLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 336 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
...... ..... ...+...... . .....+.+++.+||+.+|.+||++.+|++.|...
T Consensus 227 ~~~~~~---~~~~~----~~~~~~~~~~------~----~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~ 282 (291)
T cd05094 227 FQLSNT---EVIEC----ITQGRVLERP------R----VCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282 (291)
T ss_pred CCCCHH---HHHHH----HhCCCCCCCC------c----cCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 543221 11111 1122211110 0 1124578999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=324.67 Aligned_cols=261 Identities=25% Similarity=0.283 Sum_probs=194.3
Q ss_pred CCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCC-----EEEEE
Q 003278 112 GFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHED-----QLLLV 186 (834)
Q Consensus 112 ~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-----~~~lV 186 (834)
.|...+++|.|+||.||+|...+++..||||+.-.... --.+|+.+|+.+.|||||+|.-+|.... .+.||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 35667899999999999999999999999998644321 1236899999999999999998887543 24689
Q ss_pred EEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCC-CceEEeeccch
Q 003278 187 YDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQ-YNARLGDFGLA 265 (834)
Q Consensus 187 ~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~-~~~kl~DFGla 265 (834)
|||||. +|.+.+.... .....++...++-++.|+.+||+|||+. +|+||||||+|||+|.+ +.+||||||.|
T Consensus 101 leymP~-tL~~~~r~~~---~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYT---RANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred HHhchH-HHHHHHHHHh---hcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcc
Confidence 999986 8888886421 1123455567788999999999999995 99999999999999965 89999999999
Q ss_pred hhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccch
Q 003278 266 RWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQII 345 (834)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~ 345 (834)
+.+..+. ...+...|..|.|||.+.....|+.+.||||.|||+.||+-|++-|......++..
T Consensus 174 K~L~~~e-----------------pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~ 236 (364)
T KOG0658|consen 174 KVLVKGE-----------------PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLV 236 (364)
T ss_pred eeeccCC-----------------CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHH
Confidence 9765331 12345578999999999988899999999999999999999999887654443322
Q ss_pred HHHHHHHHhh----------cCccccccccccCCCC----CCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 346 LLDWIRRLSD----------EGKVLQAGDNRLSDGS----YKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 346 l~~~~~~~~~----------~~~~~~~~d~~l~~~~----~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
+ .++ ++. ..+..+...+.+.... +........+++...+++.+|.+|-+..|++.
T Consensus 237 e--Iik-~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 237 E--IIK-VLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred H--HHH-HhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 2 111 111 0111122222222211 11112235678999999999999999988875
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=323.31 Aligned_cols=247 Identities=19% Similarity=0.278 Sum_probs=195.6
Q ss_pred cccccCCcEEEEEEECCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEeccCCCchhh
Q 003278 520 RVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRILSH 599 (834)
Q Consensus 520 ~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~~~g~L~~ 599 (834)
.||+|+||.||+|...++..+|+|.+...........|.+|++++++++||||++++++|...+..++||||+++++|.+
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS 81 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence 58999999999999888899999998765555555679999999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCCCCCccc
Q 003278 600 LLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKA 679 (834)
Q Consensus 600 ~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~ 679 (834)
++.... ..++|..++.++.|++.||.|||+ .+++||||||+||++++++.+|++|||++........
T Consensus 82 ~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~----- 148 (250)
T cd05085 82 FLRKKK-----DELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY----- 148 (250)
T ss_pred HHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceecccccc-----
Confidence 886432 237899999999999999999996 6999999999999999999999999999875432111
Q ss_pred ccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCccccccccccC
Q 003278 680 TSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLN 758 (834)
Q Consensus 680 ~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 758 (834)
.......++..|+|||++.++.++.++|||||||++|||+| |..|+....... ..... .. .... ...
T Consensus 149 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~-~~~~~---~~--~~~~-----~~~ 216 (250)
T cd05085 149 -SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ-AREQV---EK--GYRM-----SCP 216 (250)
T ss_pred -ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH-HHHHH---Hc--CCCC-----CCC
Confidence 11112245678999999999999999999999999999999 888885432221 11111 11 1000 011
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHc
Q 003278 759 GEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795 (834)
Q Consensus 759 ~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~ 795 (834)
... ...+.+++.+||..+|++|||+.+|.+.|.
T Consensus 217 ~~~----~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 217 QKC----PDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCC----CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 111 134566777999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=325.94 Aligned_cols=259 Identities=24% Similarity=0.393 Sum_probs=198.1
Q ss_pred CCCCCeeeccCCeEEEEEEECCCC---eEEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCE-----
Q 003278 113 FDEDEVLGSGGFGKVYRAVLPSDG---TVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQ----- 182 (834)
Q Consensus 113 f~~~~~LG~G~fG~Vy~~~~~~~g---~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~----- 182 (834)
|...+.||+|+||.||+|.+..++ ..||||.+... .......+.+|+..++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 456789999999999999986543 78999998643 23345678999999999999999999999876654
Q ss_pred -EEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEee
Q 003278 183 -LLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGD 261 (834)
Q Consensus 183 -~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~D 261 (834)
.++||||+++|+|..++...... .....+++.....++.|++.||.|||+. +|+||||||+|||+++++.+||+|
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~-~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~d 156 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLG-GLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVAD 156 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhcc-CCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECC
Confidence 79999999999999998654211 1224689999999999999999999985 999999999999999999999999
Q ss_pred ccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCC
Q 003278 262 FGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYP 340 (834)
Q Consensus 262 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~ 340 (834)
||+++.......+ .......++..|+|||++... .++.++|||||||++|||++ |..|+.....
T Consensus 157 fg~~~~~~~~~~~--------------~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~ 221 (273)
T cd05035 157 FGLSKKIYSGDYY--------------RQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGQTPYPGVEN 221 (273)
T ss_pred ccceeeccccccc--------------cccccccCCccccCHhhcccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999864322110 001122356789999988544 67899999999999999999 8888754221
Q ss_pred CccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhc
Q 003278 341 DDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSG 407 (834)
Q Consensus 341 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~ 407 (834)
..+..++. .+.... .. . .....+.+++..||+.||.+||++.+|++.|..
T Consensus 222 ---~~~~~~~~----~~~~~~-----~~-~----~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~ 271 (273)
T cd05035 222 ---HEIYDYLR----HGNRLK-----QP-E----DCLDELYDLMYSCWRADPKDRPTFTKLREVLEN 271 (273)
T ss_pred ---HHHHHHHH----cCCCCC-----CC-c----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 11222211 111111 11 1 112468899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=333.65 Aligned_cols=268 Identities=26% Similarity=0.396 Sum_probs=204.7
Q ss_pred HHhhcCCCCCCCeeeccCCeEEEEEEECCC-----CeEEEEEEeccc-ChhhHHHHHHHHHHHHhC-CCCceeeEeeeEE
Q 003278 106 LYIGSNGFDEDEVLGSGGFGKVYRAVLPSD-----GTVVAVKCLAEK-GERFEKTFAAELVAVAHL-RHRNLVRLRGWCV 178 (834)
Q Consensus 106 l~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~-----g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~ 178 (834)
+....++|+..+.||+|+||.||+|..... ...+|+|.+... .......+.+|+.++.++ +|+||++++++|.
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 344556788899999999999999987533 378999998653 233446688999999999 8999999999999
Q ss_pred eCCEEEEEEEccCCCCHhHHHhcCCCc---------cccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCce
Q 003278 179 HEDQLLLVYDYMPNRSLDRVLFRRPEN---------LEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNV 249 (834)
Q Consensus 179 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~---------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NI 249 (834)
..+..++||||+++|+|..++...... ......++|..++.++.|++.||+|||+. +|+||||||+||
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Ni 163 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNV 163 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeE
Confidence 999999999999999999999654210 01235689999999999999999999985 999999999999
Q ss_pred EECCCCceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHH
Q 003278 250 MLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVV 329 (834)
Q Consensus 250 Lld~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ell 329 (834)
|++.++.+||+|||+++.+...... ...+...++..|+|||.+... .++.++|||||||++|||+
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~ 228 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYY--------------RKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIF 228 (293)
T ss_pred EEcCCCeEEeCccccccccccccce--------------eccCCCCCCccccCHHHhccC-CcCcccceeehhhHHHHHh
Confidence 9999999999999999865322100 001222356789999987654 6789999999999999999
Q ss_pred h-CCccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 330 S-GRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 330 t-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
+ |..|+...... .+. .....+.... ........+.+|+..||+.+|.+||+|.++++.|...
T Consensus 229 ~~g~~p~~~~~~~---~~~----~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 229 TLGGSPYPGIPVE---ELF----KLLKEGYRME----------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred cCCCCCCCCCCHH---HHH----HHHHcCCcCC----------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 8 88887532111 111 1111111110 0111124678999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=329.58 Aligned_cols=259 Identities=23% Similarity=0.310 Sum_probs=197.6
Q ss_pred cCcCCcccccCCcEEEEEEECC------CcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEE
Q 003278 515 FSESQRVAEMDFGTAYQGFLDN------HQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVI 588 (834)
Q Consensus 515 f~~~~~ig~g~~g~vy~~~~~~------~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv 588 (834)
|...+.||+|+||.||+|...+ +..||||++.........+.|.+|+.++++++|||||++++++.+.+..+++
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~ 86 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI 86 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence 3345679999999999998632 4679999987655555567899999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhcCCC----------CCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCc
Q 003278 589 YDYSATRILSHLLFHNNH----------RIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNP 658 (834)
Q Consensus 589 ~Ey~~~g~L~~~l~~~~~----------~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ 658 (834)
+||+++++|..++..... ......+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+
T Consensus 87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05091 87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLNV 163 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCCce
Confidence 999999999998853211 0011247888899999999999999996 689999999999999999999
Q ss_pred eEeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHH
Q 003278 659 RLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVK 737 (834)
Q Consensus 659 ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~ 737 (834)
||+|||+++.+..... ........+++.|||||++.++.++.++|||||||++|||+| |..|+...... ....
T Consensus 164 kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-~~~~ 237 (283)
T cd05091 164 KISDLGLFREVYAADY-----YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ-DVIE 237 (283)
T ss_pred Eecccccccccccchh-----eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH-HHHH
Confidence 9999999876533221 011123356788999999998999999999999999999998 77776543222 1111
Q ss_pred HHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHcc
Q 003278 738 RVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDG 796 (834)
Q Consensus 738 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~ 796 (834)
.+. . ..... .... .+. .+..++.+||+.+|++||+|.+|++.|+.
T Consensus 238 ~i~---~--~~~~~-----~~~~-~~~---~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 238 MIR---N--RQVLP-----CPDD-CPA---WVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHH---c--CCcCC-----CCCC-CCH---HHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 111 1 11111 1111 223 35566679999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=336.88 Aligned_cols=259 Identities=25% Similarity=0.386 Sum_probs=208.1
Q ss_pred HHHHhhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEE
Q 003278 104 AELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQL 183 (834)
Q Consensus 104 ~el~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 183 (834)
++.+....+.....+||-|-||+||.|+|+...-.||||.+++. ....++|+.|..+|+.++|||+|+|+|.|..+..+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 34444444566678999999999999999999999999999764 45567899999999999999999999999999999
Q ss_pred EEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeecc
Q 003278 184 LLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFG 263 (834)
Q Consensus 184 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFG 263 (834)
|||.|||.+|+|.++|.+... ..++---.+.++.||+.|++||... .+|||||...|+|+.++..+||+|||
T Consensus 339 YIiTEfM~yGNLLdYLRecnr-----~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFG 410 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNR-----SEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFG 410 (1157)
T ss_pred EEEEecccCccHHHHHHHhch-----hhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccc
Confidence 999999999999999976532 2344456688999999999999985 99999999999999999999999999
Q ss_pred chhhhhhhhhhhhhcccccccccccccceeeec---cccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCC
Q 003278 264 LARWLEHELQYQMRTSSARNHQFHLAETTRIGG---TIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTY 339 (834)
Q Consensus 264 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G---t~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~ 339 (834)
|+|++..+.. |...| .+.|.|||.+..+ .++.|+|||+|||+||||.| |..|+.
T Consensus 411 LsRlMtgDTY------------------TAHAGAKFPIKWTAPEsLAyN-tFSiKSDVWAFGVLLWEIATYGMsPYP--- 468 (1157)
T KOG4278|consen 411 LSRLMTGDTY------------------TAHAGAKFPIKWTAPESLAYN-TFSIKSDVWAFGVLLWEIATYGMSPYP--- 468 (1157)
T ss_pred hhhhhcCCce------------------ecccCccCcccccCccccccc-ccccchhhHHHHHHHHHHHhcCCCCCC---
Confidence 9999865421 11122 4789999998766 67999999999999999998 665543
Q ss_pred CCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhc
Q 003278 340 PDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSG 407 (834)
Q Consensus 340 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~ 407 (834)
.-+ ...+..++..|-.++... -+...+.+|+..||+.+|.+||++.|+-+.++.
T Consensus 469 -Gid---lSqVY~LLEkgyRM~~Pe----------GCPpkVYeLMraCW~WsPsDRPsFaeiHqafEt 522 (1157)
T KOG4278|consen 469 -GID---LSQVYGLLEKGYRMDGPE----------GCPPKVYELMRACWNWSPSDRPSFAEIHQAFET 522 (1157)
T ss_pred -Ccc---HHHHHHHHhccccccCCC----------CCCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence 222 123444555554333221 123579999999999999999999998877654
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=340.30 Aligned_cols=217 Identities=24% Similarity=0.357 Sum_probs=173.4
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 187 (834)
++|+..+.||+|+||.||+|+...+++.||||++.... ......+.+|+.+|.+++||||+++++.+.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36888999999999999999998899999999986432 223456889999999999999999999999999999999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
||+++|+|.+++... ..+++.....++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|..
T Consensus 81 E~~~~g~L~~~i~~~-------~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~ 150 (376)
T cd05598 81 DYIPGGDMMSLLIRL-------GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTG 150 (376)
T ss_pred eCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcc
Confidence 999999999998643 3578888899999999999999985 999999999999999999999999999853
Q ss_pred hhhhhhhh------------hhcccc--------------cc-cccccccceeeeccccCCCccccccCCCCCcccceee
Q 003278 268 LEHELQYQ------------MRTSSA--------------RN-HQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFS 320 (834)
Q Consensus 268 ~~~~~~~~------------~~~~~~--------------~~-~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~S 320 (834)
+....... ...... .. ........+...||+.|||||++... .++.++||||
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwS 229 (376)
T cd05598 151 FRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWS 229 (376)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCC-CCCcceeeee
Confidence 31100000 000000 00 00000112346799999999998654 6789999999
Q ss_pred hhhHHHHHHhCCccCCCC
Q 003278 321 FGIVVLEVVSGRRAVDLT 338 (834)
Q Consensus 321 fGvvl~ElltG~~p~~~~ 338 (834)
|||++|||+||+.||...
T Consensus 230 lGvilyell~G~~Pf~~~ 247 (376)
T cd05598 230 VGVILYEMLVGQPPFLAD 247 (376)
T ss_pred ccceeeehhhCCCCCCCC
Confidence 999999999999999754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=327.24 Aligned_cols=257 Identities=23% Similarity=0.312 Sum_probs=192.7
Q ss_pred cCCcccccCCcEEEEEEECCC-c--EEEEEEecCCC-ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeC------CeEE
Q 003278 517 ESQRVAEMDFGTAYQGFLDNH-Q--YVLVKRLGMSK-CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQ------GEML 586 (834)
Q Consensus 517 ~~~~ig~g~~g~vy~~~~~~~-~--~vavK~~~~~~-~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~------~~~~ 586 (834)
-.+.||+|+||.||+|...+. . .||+|.++... .....+.|.+|++++++++||||++++++|... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 456799999999999997553 2 58999887543 233456789999999999999999999988532 2468
Q ss_pred EEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeec
Q 003278 587 VIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALA 666 (834)
Q Consensus 587 lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla 666 (834)
++|||+++|+|..++...........++|.....++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCCcc
Confidence 999999999999887543222222358899999999999999999996 69999999999999999999999999999
Q ss_pred cccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhh
Q 003278 667 EFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEAR 745 (834)
Q Consensus 667 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~ 745 (834)
+........ .......+++.|+|||++.+..++.++|||||||++|||++ |+.|+....+ ........ ..
T Consensus 160 ~~~~~~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-~~~~~~~~---~~ 230 (272)
T cd05075 160 KKIYNGDYY-----RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-SEIYDYLR---QG 230 (272)
T ss_pred cccCcccce-----ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHH---cC
Confidence 865332110 01122346778999999998899999999999999999999 7778754322 11111111 11
Q ss_pred cCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHcc
Q 003278 746 KRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDG 796 (834)
Q Consensus 746 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~ 796 (834)
.. . . .... ... .+.+++.+||+.||++|||+.+|++.|+.
T Consensus 231 ~~-~-~-----~~~~-~~~---~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 231 NR-L-K-----QPPD-CLD---GLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred CC-C-C-----CCCC-CCH---HHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 10 0 0 0111 112 35566779999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=326.18 Aligned_cols=254 Identities=20% Similarity=0.308 Sum_probs=197.6
Q ss_pred CcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEecc
Q 003278 514 NFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYS 592 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~ 592 (834)
+|...+.||+|+||.||+|... .+..||+|.+..+. .....|.+|++++.+++||||++++++|...+..+++|||+
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc--hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 4666788999999999999964 47889999886432 22467899999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccC
Q 003278 593 ATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRN 672 (834)
Q Consensus 593 ~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~ 672 (834)
++++|.+++..... ..++|..++.++.|+++||+|||+ .+|+||||||+|||+++++.+||+|||++......
T Consensus 85 ~~~~L~~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 85 TYGNLLDYLRECNR----QEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred CCCcHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 99999999865321 248899999999999999999996 68999999999999999999999999999765432
Q ss_pred CCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCcccc
Q 003278 673 DHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRPLAE 751 (834)
Q Consensus 673 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
.. .......++..|+|||++.+..++.++|||||||++|||+| |..|+....... ..... ... .
T Consensus 158 ~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-~~~~~---~~~---~-- 222 (263)
T cd05052 158 TY------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELL---EKG---Y-- 222 (263)
T ss_pred ee------eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHH---HCC---C--
Confidence 11 11112234678999999999999999999999999999999 888875432221 11111 100 0
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccC
Q 003278 752 LVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGN 797 (834)
Q Consensus 752 ~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~ 797 (834)
.+...... +. .+.+++.+||+.+|++||||.++.+.|+.+
T Consensus 223 --~~~~~~~~-~~---~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 223 --RMERPEGC-PP---KVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred --CCCCCCCC-CH---HHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 01111111 23 345566699999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=332.38 Aligned_cols=262 Identities=24% Similarity=0.387 Sum_probs=200.5
Q ss_pred CCCCCCCeeeccCCeEEEEEEEC----CCCeEEEEEEecccC-hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLP----SDGTVVAVKCLAEKG-ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLL 185 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~----~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 185 (834)
++|+..+.||+|+||.||+|.+. .++..||+|.+.... ......|.+|+.++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 45777899999999999999852 356789999986432 3344678999999999999999999999999999999
Q ss_pred EEEccCCCCHhHHHhcCCCc----------cccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCC
Q 003278 186 VYDYMPNRSLDRVLFRRPEN----------LEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQY 255 (834)
Q Consensus 186 V~Ey~~~gsL~~~l~~~~~~----------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~ 255 (834)
||||+++|+|.+++...... ......+++.+.+.++.|++.||.|||+. +|+||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 99999999999998643211 01123588999999999999999999985 999999999999999999
Q ss_pred ceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCcc
Q 003278 256 NARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRA 334 (834)
Q Consensus 256 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p 334 (834)
.+||+|||+++.+...... .......++..|+|||++..+ .++.++|||||||++|||+| |..|
T Consensus 162 ~~kl~dfg~~~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~g~~p 226 (283)
T cd05090 162 HVKISDLGLSREIYSADYY--------------RVQPKSLLPIRWMPPEAIMYG-KFSSDSDIWSFGVVLWEIFSFGLQP 226 (283)
T ss_pred cEEeccccccccccCCcce--------------ecccCCCccceecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCC
Confidence 9999999999754321100 012233467889999988654 57899999999999999999 8888
Q ss_pred CCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhc
Q 003278 335 VDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSG 407 (834)
Q Consensus 335 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~ 407 (834)
+..... ..+.. ......... .. ... ...+..++..||+.+|.+||++.+|.+.|.+
T Consensus 227 ~~~~~~---~~~~~----~~~~~~~~~-----~~-~~~----~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 227 YYGFSN---QEVIE----MVRKRQLLP-----CS-EDC----PPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred CCCCCH---HHHHH----HHHcCCcCC-----CC-CCC----CHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 753221 11111 111111111 00 111 2457889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=325.09 Aligned_cols=261 Identities=20% Similarity=0.290 Sum_probs=202.0
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCC--CChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMS--KCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIY 589 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~--~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~ 589 (834)
++|...+.||+|+||.||+|.. .++..||||.+... ........|.+|++++++++||||+++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 4677788899999999999985 46889999987642 23344567899999999999999999999999999999999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccc
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFL 669 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~ 669 (834)
||+++|+|..++..... ....+++.....++.|++.||+|||+ .+|+||||||+|||++.++.++++|||++...
T Consensus 82 e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~ 156 (267)
T cd08228 82 ELADAGDLSQMIKYFKK--QKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EecCCCcHHHHHHHhhh--ccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceec
Confidence 99999999988864322 12347788889999999999999996 69999999999999999999999999999765
Q ss_pred ccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcc
Q 003278 670 TRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPL 749 (834)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
.... .......|++.|+|||++.+..++.++|||||||++|||+||+.|+........ ......... .
T Consensus 157 ~~~~-------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~--~- 224 (267)
T cd08228 157 SSKT-------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF--SLCQKIEQC--D- 224 (267)
T ss_pred cchh-------HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHH--HHHHHHhcC--C-
Confidence 4321 111234688999999999888899999999999999999999999854322111 111111100 0
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccC
Q 003278 750 AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGN 797 (834)
Q Consensus 750 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~ 797 (834)
.+..... ..-..+.+++.+||+.+|++|||+.+|++.|+..
T Consensus 225 ----~~~~~~~---~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 225 ----YPPLPTE---HYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred ----CCCCChh---hcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 1111111 1113455666799999999999999999999765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=334.95 Aligned_cols=244 Identities=26% Similarity=0.279 Sum_probs=189.4
Q ss_pred CeeeccCCeEEEEEEECCCCeEEEEEEeccc---ChhhHHHHHHHHH-HHHhCCCCceeeEeeeEEeCCEEEEEEEccCC
Q 003278 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK---GERFEKTFAAELV-AVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPN 192 (834)
Q Consensus 117 ~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~---~~~~~~~~~~E~~-~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 192 (834)
+.||+|+||+||+|....+|+.||||++... .....+.+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999999899999999998653 1223345566655 57789999999999999999999999999999
Q ss_pred CCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhhhh
Q 003278 193 RSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHEL 272 (834)
Q Consensus 193 gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~ 272 (834)
|+|..++... ..+++.....++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~L~~~l~~~-------~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~- 149 (325)
T cd05604 81 GELFFHLQRE-------RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ- 149 (325)
T ss_pred CCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-
Confidence 9998887542 4688999999999999999999985 9999999999999999999999999998742110
Q ss_pred hhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHHHHH
Q 003278 273 QYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIRR 352 (834)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~ 352 (834)
........||+.|+|||.+... .++.++|||||||++|||++|+.||...... .....
T Consensus 150 ---------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~------~~~~~ 207 (325)
T cd05604 150 ---------------SDTTTTFCGTPEYLAPEVIRKQ-PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA------EMYDN 207 (325)
T ss_pred ---------------CCCcccccCChhhCCHHHHcCC-CCCCcCccccccceehhhhcCCCCCCCCCHH------HHHHH
Confidence 0113456799999999998654 5789999999999999999999998643211 11111
Q ss_pred HhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHh
Q 003278 353 LSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAV 405 (834)
Q Consensus 353 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l 405 (834)
... +.. ...+ .. ...+.++...|++.+|.+||++.+.++.+
T Consensus 208 ~~~-~~~--~~~~-----~~----~~~~~~ll~~ll~~~p~~R~~~~~~~~~i 248 (325)
T cd05604 208 ILH-KPL--VLRP-----GA----SLTAWSILEELLEKDRQRRLGAKEDFLEI 248 (325)
T ss_pred HHc-CCc--cCCC-----CC----CHHHHHHHHHHhccCHHhcCCCCCCHHHH
Confidence 111 111 0111 11 13467889999999999999997554443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=323.95 Aligned_cols=256 Identities=23% Similarity=0.331 Sum_probs=187.2
Q ss_pred cccccCCcEEEEEEECC---CcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEeccCCCc
Q 003278 520 RVAEMDFGTAYQGFLDN---HQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRI 596 (834)
Q Consensus 520 ~ig~g~~g~vy~~~~~~---~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~~~g~ 596 (834)
.||+|+||.||+|...+ ...+++|.+...........|.+|+.+++.++||||++++|+|.+....++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 346888887655444455678999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCCCCC
Q 003278 597 LSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGH 676 (834)
Q Consensus 597 L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~~~~ 676 (834)
|.+++....... ....++...+.++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||++.........
T Consensus 82 L~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~- 156 (269)
T cd05042 82 LKNYLRSNRGMV-AQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY- 156 (269)
T ss_pred HHHHHHhccccc-cccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchhe-
Confidence 999987643211 1235677788999999999999997 68999999999999999999999999998653222110
Q ss_pred cccccCccccccccCccchhcccc-------CCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCc
Q 003278 677 RKATSGNRSVRGIFGYMSPEYIES-------GEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRP 748 (834)
Q Consensus 677 ~~~~~~~~~~~Gt~~Y~aPE~~~~-------~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
.......+++.|+|||++.. ..++.++|||||||++|||+| |..|+....+...+...... .
T Consensus 157 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~------~ 226 (269)
T cd05042 157 ----ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVRE------Q 226 (269)
T ss_pred ----eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhc------c
Confidence 01122346778999998743 356789999999999999999 66776543222211111110 1
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHc
Q 003278 749 LAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795 (834)
Q Consensus 749 ~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~ 795 (834)
...+.++.+...++ . .+.+++..|| .||++|||+.+|++.|.
T Consensus 227 ~~~~~~~~~~~~~~-~---~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 227 DIKLPKPQLDLKYS-D---RWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CccCCCCcccccCC-H---HHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 11122222222222 2 2334555788 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=327.88 Aligned_cols=248 Identities=26% Similarity=0.328 Sum_probs=193.0
Q ss_pred eeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEccCCCCH
Q 003278 119 LGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNRSL 195 (834)
Q Consensus 119 LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 195 (834)
||+|+||.||++..+.+|+.||+|++.... ....+.+..|+.++.+++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999998899999999986431 12234556799999999999999999999999999999999999999
Q ss_pred hHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhhhhhhh
Q 003278 196 DRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQ 275 (834)
Q Consensus 196 ~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 275 (834)
..++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.++|+|||++..+....
T Consensus 81 ~~~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--- 149 (277)
T cd05607 81 KYHIYNVG-----ERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--- 149 (277)
T ss_pred HHHHHhcc-----ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---
Confidence 98886432 24588999999999999999999985 99999999999999999999999999987542210
Q ss_pred hhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHHHHHHhh
Q 003278 276 MRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIRRLSD 355 (834)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~ 355 (834)
..+...||+.|+|||++... .++.++|||||||++|||+||+.|+...... ............
T Consensus 150 --------------~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~ 212 (277)
T cd05607 150 --------------TITQRAGTNGYMAPEILKEE-PYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK--VAKEELKRRTLE 212 (277)
T ss_pred --------------eeeccCCCCCccCHHHHccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCcch--hhHHHHHHHhhc
Confidence 12234589999999998765 4799999999999999999999998643221 111111121111
Q ss_pred cCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHh
Q 003278 356 EGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAV 405 (834)
Q Consensus 356 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l 405 (834)
.... .....+ ...+.+++..||+.||.+||++.|+++.+
T Consensus 213 -~~~~------~~~~~~----~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 213 -DEVK------FEHQNF----TEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred -cccc------cccccC----CHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 1100 000111 13578899999999999999998877544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=336.32 Aligned_cols=239 Identities=26% Similarity=0.333 Sum_probs=188.7
Q ss_pred CeeeccCCeEEEEEEE---CCCCeEEEEEEecccC--hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEccC
Q 003278 117 EVLGSGGFGKVYRAVL---PSDGTVVAVKCLAEKG--ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMP 191 (834)
Q Consensus 117 ~~LG~G~fG~Vy~~~~---~~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 191 (834)
+.||+|+||.||++.. ..+|+.||+|++.... ......+.+|+.++++++||||+++++++..++..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999876 3578999999986532 2234557789999999999999999999999999999999999
Q ss_pred CCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhhh
Q 003278 192 NRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHE 271 (834)
Q Consensus 192 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~~ 271 (834)
+|+|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 151 (318)
T cd05582 82 GGDLFTRLSKE-------VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 151 (318)
T ss_pred CCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCC
Confidence 99999988542 3589999999999999999999985 9999999999999999999999999998753211
Q ss_pred hhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHHHH
Q 003278 272 LQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIR 351 (834)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~ 351 (834)
. .......||+.|+|||.+... .++.++|||||||++|||+||+.||..... .... .
T Consensus 152 ~----------------~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~---~~~~---~ 208 (318)
T cd05582 152 E----------------KKAYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGSLPFQGKDR---KETM---T 208 (318)
T ss_pred C----------------CceecccCChhhcCHHHHcCC-CCCCccceeccceEeeeeccCCCCCCCCCH---HHHH---H
Confidence 0 112345799999999988654 568899999999999999999999864321 1111 1
Q ss_pred HHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhh
Q 003278 352 RLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKW 400 (834)
Q Consensus 352 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~ 400 (834)
.... ... .+. ... ...+..+...||+.||.+||++.+
T Consensus 209 ~i~~-~~~------~~p-~~~----~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 209 MILK-AKL------GMP-QFL----SPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred HHHc-CCC------CCC-CCC----CHHHHHHHHHHhhcCHhHcCCCCC
Confidence 1111 110 010 111 135678899999999999999766
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=325.44 Aligned_cols=249 Identities=18% Similarity=0.307 Sum_probs=192.2
Q ss_pred cccccCCcEEEEEEE---CCCcEEEEEEecCCC-ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEeccCCC
Q 003278 520 RVAEMDFGTAYQGFL---DNHQYVLVKRLGMSK-CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATR 595 (834)
Q Consensus 520 ~ig~g~~g~vy~~~~---~~~~~vavK~~~~~~-~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~~~g 595 (834)
.||+|+||.||+|.+ .++..+|+|+++... .+...+.|.+|+.++++++||||++++|++.. +..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 589999999999975 356789999986443 33456789999999999999999999999864 5678999999999
Q ss_pred chhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCCCC
Q 003278 596 ILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHG 675 (834)
Q Consensus 596 ~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~~~ 675 (834)
+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++.+......
T Consensus 81 ~L~~~l~~~~------~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~ 151 (257)
T cd05116 81 PLNKFLQKNK------HVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY 151 (257)
T ss_pred cHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCe
Confidence 9999986432 37888999999999999999996 68999999999999999999999999999765432210
Q ss_pred CcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCccccccc
Q 003278 676 HRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRPLAELVD 754 (834)
Q Consensus 676 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 754 (834)
........++..|||||.+..+.++.++|||||||++|||+| |+.|+...... .....+. ....
T Consensus 152 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-~~~~~i~---~~~~------- 216 (257)
T cd05116 152 ----YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN-EVTQMIE---SGER------- 216 (257)
T ss_pred ----eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHH---CCCC-------
Confidence 001112245678999999988889999999999999999998 88888643322 1212111 1111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccC
Q 003278 755 LSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGN 797 (834)
Q Consensus 755 ~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~ 797 (834)
+..+... +. .+.+++.+||+.||++||+|.+|+..|+..
T Consensus 217 ~~~~~~~-~~---~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 217 MECPQRC-PP---EMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCC-CH---HHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 1111122 23 345566699999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=345.52 Aligned_cols=267 Identities=22% Similarity=0.358 Sum_probs=203.6
Q ss_pred hhcCCCCCCCeeeccCCeEEEEEEEC-----CCCeEEEEEEecccC-hhhHHHHHHHHHHHHhCC-CCceeeEeeeEEeC
Q 003278 108 IGSNGFDEDEVLGSGGFGKVYRAVLP-----SDGTVVAVKCLAEKG-ERFEKTFAAELVAVAHLR-HRNLVRLRGWCVHE 180 (834)
Q Consensus 108 ~~t~~f~~~~~LG~G~fG~Vy~~~~~-----~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~ 180 (834)
+..++|...+.||+|+||.||+|++. ..+..||||++.... ....+.+.+|+.+|.++. |||||+++|+|...
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 34456788899999999999999864 245689999997542 233457889999999997 99999999999999
Q ss_pred CEEEEEEEccCCCCHhHHHhcCCCcc------------------------------------------------------
Q 003278 181 DQLLLVYDYMPNRSLDRVLFRRPENL------------------------------------------------------ 206 (834)
Q Consensus 181 ~~~~lV~Ey~~~gsL~~~l~~~~~~~------------------------------------------------------ 206 (834)
+..++||||+++|+|.++|++.....
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 99999999999999999997542100
Q ss_pred -------------------------------------ccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCce
Q 003278 207 -------------------------------------EAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNV 249 (834)
Q Consensus 207 -------------------------------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NI 249 (834)
.....++|.....|+.|++.||.|||+. +|+||||||+||
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~Ni 270 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNV 270 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceE
Confidence 1123578899999999999999999985 999999999999
Q ss_pred EECCCCceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHH
Q 003278 250 MLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVV 329 (834)
Q Consensus 250 Lld~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ell 329 (834)
|+++++.+||+|||+++.+...... .......|++.|||||.+... .++.++|||||||++|||+
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~e~l 335 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSNY--------------ISKGSTFLPLKWMAPESIFNN-LYTTLSDVWSFGILLWEIF 335 (401)
T ss_pred EEeCCCEEEEEecCcceeccccccc--------------ccCCCcCCCCceeChHHhcCC-CCCcHhHHHHHHHHHHHHH
Confidence 9999999999999999754221100 011233578899999988654 5789999999999999999
Q ss_pred h-CCccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 330 S-GRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 330 t-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
+ |+.|+......+ ........+.... .+ .. ....+.+++..||+.+|..||+|.+|++.|+..
T Consensus 336 ~~g~~P~~~~~~~~------~~~~~~~~~~~~~--~p----~~----~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 336 TLGGTPYPELPMNE------QFYNAIKRGYRMA--KP----AH----ASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred HcCCCCCCCCCchH------HHHHHHHcCCCCC--CC----CC----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 8 888875432111 1111111121110 00 11 124688999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=329.42 Aligned_cols=261 Identities=23% Similarity=0.293 Sum_probs=200.1
Q ss_pred hhCcCcCCcccccCCcEEEEEEECC------CcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeE
Q 003278 512 TNNFSESQRVAEMDFGTAYQGFLDN------HQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEM 585 (834)
Q Consensus 512 t~~f~~~~~ig~g~~g~vy~~~~~~------~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~ 585 (834)
+++|...+.||+|+||.||+|...+ +..||+|.+...........|.+|+.++++++||||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4678888899999999999998753 5678999886555455556799999999999999999999999998999
Q ss_pred EEEEeccCCCchhhhhhcCCCCC-CCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCC---CceEe
Q 003278 586 LVIYDYSATRILSHLLFHNNHRI-GHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDM---NPRLG 661 (834)
Q Consensus 586 ~lv~Ey~~~g~L~~~l~~~~~~~-~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~---~~ki~ 661 (834)
++||||+++++|.+++....... ....++|..++.++.||+.||+|||+ .+++||||||+|||++.++ .+|++
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEec
Confidence 99999999999999987643211 12358999999999999999999997 6899999999999998754 58999
Q ss_pred eeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHH
Q 003278 662 SFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVH 740 (834)
Q Consensus 662 DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~ 740 (834)
|||+++.+..... ........++..|||||++.++.++.++|||||||++|||+| |..||....... ....+.
T Consensus 162 dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~-~~~~~~ 235 (277)
T cd05036 162 DFGMARDIYRASY-----YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE-VMEFVT 235 (277)
T ss_pred cCccccccCCccc-----eecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHH
Confidence 9999986532211 000112234567999999999999999999999999999997 888886443322 111111
Q ss_pred HHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHc
Q 003278 741 EFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795 (834)
Q Consensus 741 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~ 795 (834)
..... ...... + ..+.+++.+||+.+|++|||+.+|++.|+
T Consensus 236 ----~~~~~------~~~~~~-~---~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 236 ----GGGRL------DPPKGC-P---GPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred ----cCCcC------CCCCCC-C---HHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11100 011111 1 24556667999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=328.14 Aligned_cols=267 Identities=20% Similarity=0.274 Sum_probs=199.6
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-----------------CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-----------------NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQL 575 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l 575 (834)
++|...+.||+|+||.||++... +...||+|.+...........|.+|+++|++++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 45777788999999999997532 2346899998765555566789999999999999999999
Q ss_pred EEEEeeCCeEEEEEeccCCCchhhhhhcCCCCC-----CCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCce
Q 003278 576 CGWCTEQGEMLVIYDYSATRILSHLLFHNNHRI-----GHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAI 650 (834)
Q Consensus 576 ~g~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~-----~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NI 650 (834)
++++...+..++||||+++|+|.+++....... ....+++.....++.|++.||+|||+ .+|+||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChheE
Confidence 999999999999999999999999987643211 12347888999999999999999996 6899999999999
Q ss_pred eecCCCCceEeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh--CCCccCC
Q 003278 651 TLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT--GQMAVDF 728 (834)
Q Consensus 651 Lld~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t--G~~p~~~ 728 (834)
|+++++.+|++|||+++.+..... ........+++.|+|||+...+.++.++|||||||++|||+| |..|+..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~ 236 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDY-----YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcc-----eeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence 999999999999999976432211 001112345678999999888899999999999999999998 6667653
Q ss_pred CCCchhHHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHc
Q 003278 729 RLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795 (834)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~ 795 (834)
..+.. .......+...... ....+ .... .+ ..+.+++.+||+.||++||||.+|++.|+
T Consensus 237 ~~~~~-~~~~~~~~~~~~~~--~~~~~-~~~~-~~---~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 237 LSDEQ-VIENTGEFFRDQGR--QVYLP-KPAL-CP---DSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred cChHH-HHHHHHHHHhhccc--cccCC-CCCC-CC---HHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 32222 22211111110000 00000 0111 12 34567777999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=327.90 Aligned_cols=244 Identities=17% Similarity=0.207 Sum_probs=185.5
Q ss_pred ccccCCcEEEEEEE-CCCcEEEEEEecCCCCh--hHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEeccCCCch
Q 003278 521 VAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCP--ALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRIL 597 (834)
Q Consensus 521 ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~--~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~~~g~L 597 (834)
||+|+||+||++.. .++..+|||.+...... ...+.|..|+.++++++||||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 68999999999985 46789999998643221 2235678899999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCCCCCc
Q 003278 598 SHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHR 677 (834)
Q Consensus 598 ~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~~~~~ 677 (834)
..++..... ....+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||++..+....
T Consensus 81 ~~~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~---- 151 (280)
T cd05608 81 RYHIYNVDE--ENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ---- 151 (280)
T ss_pred HHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC----
Confidence 888754321 12348899999999999999999996 699999999999999999999999999997653321
Q ss_pred ccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcccccccccc
Q 003278 678 KATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSL 757 (834)
Q Consensus 678 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 757 (834)
.......||+.|||||++.+..++.++|||||||++|||+||+.||................ ...+ ...
T Consensus 152 ---~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~--~~~~------~~~ 220 (280)
T cd05608 152 ---SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRI--LNDS------VTY 220 (280)
T ss_pred ---ccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhh--cccC------CCC
Confidence 11224579999999999999999999999999999999999999986432211110000000 0000 011
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCCChh
Q 003278 758 NGEYNHKELMRLIKLGIACTLSNPELRPSMR 788 (834)
Q Consensus 758 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~ 788 (834)
...++ . .+.+++.+||+.||++||+++
T Consensus 221 ~~~~~-~---~~~~li~~~l~~~P~~R~~~~ 247 (280)
T cd05608 221 PDKFS-P---ASKSFCEALLAKDPEKRLGFR 247 (280)
T ss_pred cccCC-H---HHHHHHHHHhcCCHHHhcCCC
Confidence 11111 2 344566689999999999543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=354.34 Aligned_cols=265 Identities=21% Similarity=0.272 Sum_probs=192.5
Q ss_pred hcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeC--------
Q 003278 109 GSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHE-------- 180 (834)
Q Consensus 109 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-------- 180 (834)
..++|...++||+|+||.||+|+...+++.||||++.... ....+|+.+|+.++|||||++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 4567999999999999999999998899999999885432 2245799999999999999999987542
Q ss_pred CEEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCC-ceEE
Q 003278 181 DQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQY-NARL 259 (834)
Q Consensus 181 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~-~~kl 259 (834)
..+++||||+++ +|.+++.... .....+++.....++.|++.||+|||+. +|+||||||+|||++.++ .+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~---~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL 212 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYA---RNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKL 212 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHh---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceee
Confidence 246799999985 6766664321 1235689999999999999999999986 999999999999999654 6999
Q ss_pred eeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCC
Q 003278 260 GDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTY 339 (834)
Q Consensus 260 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~ 339 (834)
+|||+|+.+.... ......||+.|+|||++.....++.++|||||||++|||+||+.||....
T Consensus 213 ~DFGla~~~~~~~-----------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 275 (440)
T PTZ00036 213 CDFGSAKNLLAGQ-----------------RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQS 275 (440)
T ss_pred eccccchhccCCC-----------------CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999998542210 12334689999999988665568999999999999999999999986533
Q ss_pred CCccchHHHHHHHHhhcC----------ccccccccccCCC----CCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 340 PDDQIILLDWIRRLSDEG----------KVLQAGDNRLSDG----SYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 340 ~~~~~~l~~~~~~~~~~~----------~~~~~~d~~l~~~----~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
..+. +...+. ..... ...+..-+..... .++......+.+|+..||+.||.+||++.+++..
T Consensus 276 ~~~~--~~~i~~-~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 276 SVDQ--LVRIIQ-VLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred hHHH--HHHHHH-HhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 2211 111111 00000 0000000000000 0011112457889999999999999999998753
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=329.68 Aligned_cols=267 Identities=24% Similarity=0.388 Sum_probs=199.6
Q ss_pred CCCCCCCeeeccCCeEEEEEEEC----------------CCCeEEEEEEeccc-ChhhHHHHHHHHHHHHhCCCCceeeE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLP----------------SDGTVVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNLVRL 173 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~----------------~~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l 173 (834)
++|+..+.||+|+||.||++... .++..||+|.+... .....+.|.+|+.++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 56888999999999999998542 23457999998754 33455789999999999999999999
Q ss_pred eeeEEeCCEEEEEEEccCCCCHhHHHhcCCCcc----ccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCce
Q 003278 174 RGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENL----EAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNV 249 (834)
Q Consensus 174 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NI 249 (834)
++++...+..++||||+++|+|.+++....... .....++|.+...++.|++.||+|||+. +|+||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence 999999999999999999999999987643211 1124588999999999999999999985 999999999999
Q ss_pred EECCCCceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHH
Q 003278 250 MLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVV 329 (834)
Q Consensus 250 Lld~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ell 329 (834)
|++.++.++|+|||+++.+...... .......+++.|+|||....+ .++.++|||||||++|||+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~--------------~~~~~~~~~~~~~~pe~~~~~-~~~~~~DiwSlG~~l~el~ 226 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYY--------------RIQGRAVLPIRWMSWESILLG-KFTTASDVWAFGVTLWEIL 226 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcce--------------eccCcCcCccccCCHHHHhcC-CccchhhhhHHHHHHHHHH
Confidence 9999999999999999754221100 001223356789999987655 5799999999999999999
Q ss_pred h--CCccCCCCCCCccchHHHHHHHHhh-cCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhh
Q 003278 330 S--GRRAVDLTYPDDQIILLDWIRRLSD-EGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVS 406 (834)
Q Consensus 330 t--G~~p~~~~~~~~~~~l~~~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~ 406 (834)
| |..|+...... . .......... .+..... +.. .. ....+.+++.+||+.||.+||+|.+|++.|+
T Consensus 227 ~~~~~~p~~~~~~~--~-~~~~~~~~~~~~~~~~~~--~~~--~~----~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 227 TLCKEQPYSQLSDE--Q-VIENTGEFFRDQGRQVYL--PKP--AL----CPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HhCCCCCccccChH--H-HHHHHHHHHhhccccccC--CCC--CC----CCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 9 55666432211 1 1111111111 1110100 000 11 1256889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=325.42 Aligned_cols=254 Identities=20% Similarity=0.315 Sum_probs=199.8
Q ss_pred hCcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEecc
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYS 592 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~ 592 (834)
++|...+.||+|+||.||+|...++..||||.+..... ..+.|.+|+.++++++||||+++++++...+..++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM--DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc--cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 45777789999999999999987888899999865432 2456899999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccC
Q 003278 593 ATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRN 672 (834)
Q Consensus 593 ~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~ 672 (834)
++++|.+++.... ...++|.....++.|++.||.|||+ .+|+||||||+||++++++.+||+|||+++.....
T Consensus 84 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 84 KYGSLLEYLQGGA----GRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred cCCcHHHHHhccC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 9999999986532 1247899999999999999999996 68999999999999999999999999999875422
Q ss_pred CCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCcccc
Q 003278 673 DHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRPLAE 751 (834)
Q Consensus 673 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
.. .......++..|+|||++.+..++.++|||||||++|||+| |+.|+....+. .+...+. .....
T Consensus 157 ~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-~~~~~~~----~~~~~-- 223 (261)
T cd05068 157 IY------EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA-EVLQQVD----QGYRM-- 223 (261)
T ss_pred cc------cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH-HHHHHHH----cCCCC--
Confidence 11 01111233467999999998999999999999999999999 88887543322 1111111 10000
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHcc
Q 003278 752 LVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDG 796 (834)
Q Consensus 752 ~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~ 796 (834)
..... ....+.+++.+||..+|++||+|.+|.+.|+.
T Consensus 224 ----~~~~~----~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 ----PCPPG----CPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred ----CCCCc----CCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 00111 11345667779999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=326.39 Aligned_cols=257 Identities=28% Similarity=0.417 Sum_probs=201.5
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCC---CeEEEEEEeccc-ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSD---GTVVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLL 185 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~---g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 185 (834)
.++|+..+.||+|+||.||+|.+..+ ...||||.+... .......|.+|+.++.+++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 35788999999999999999998643 457999988654 23345678999999999999999999999999999999
Q ss_pred EEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccch
Q 003278 186 VYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLA 265 (834)
Q Consensus 186 V~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla 265 (834)
||||+++|+|.+++.... ..++|..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++
T Consensus 83 v~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~ 153 (266)
T cd05033 83 ITEYMENGSLDKFLREND------GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLS 153 (266)
T ss_pred EEEcCCCCCHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchh
Confidence 999999999999986532 3689999999999999999999985 9999999999999999999999999999
Q ss_pred hhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccc
Q 003278 266 RWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQI 344 (834)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~ 344 (834)
+.+..... . ..+....+++.|+|||.+... .++.++|||||||++|||+| |..|+.... ..
T Consensus 154 ~~~~~~~~------~--------~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~---~~ 215 (266)
T cd05033 154 RRLEDSEA------T--------YTTKGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSYGERPYWDMS---NQ 215 (266)
T ss_pred hccccccc------c--------eeccCCCCCccccChhhhccC-CCccccchHHHHHHHHHHHccCCCCCCCCC---HH
Confidence 86531100 0 001122356789999988654 67899999999999999998 988875321 11
Q ss_pred hHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhc
Q 003278 345 ILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSG 407 (834)
Q Consensus 345 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~ 407 (834)
.+...+. .+... +.. . .....+.+++..||+.+|++||+|.+|++.|..
T Consensus 216 ~~~~~~~----~~~~~----~~~--~----~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~ 264 (266)
T cd05033 216 DVIKAVE----DGYRL----PPP--M----DCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264 (266)
T ss_pred HHHHHHH----cCCCC----CCC--C----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 1222211 11110 000 1 112467899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=342.10 Aligned_cols=261 Identities=18% Similarity=0.206 Sum_probs=193.9
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCC--ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSK--CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIY 589 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~ 589 (834)
++|...+.||+|+||+||++... ++..||||.+.... .......+.+|+.++.+++|||||++++++.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 36777889999999999999854 57899999986432 1223456888999999999999999999999999999999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccc
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFL 669 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~ 669 (834)
||+++|+|.+++...+ .+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+
T Consensus 81 E~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~ 151 (363)
T cd05628 81 EFLPGGDMMTLLMKKD------TLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGL 151 (363)
T ss_pred cCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCcccc
Confidence 9999999999986532 37888889999999999999996 69999999999999999999999999999764
Q ss_pred ccCCCCC----------------------------cccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh
Q 003278 670 TRNDHGH----------------------------RKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT 721 (834)
Q Consensus 670 ~~~~~~~----------------------------~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t 721 (834)
....... ..........+||+.|||||++.+..++.++|||||||+||||+|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~ 231 (363)
T cd05628 152 KKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231 (363)
T ss_pred cccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHh
Confidence 3211000 000001124689999999999999999999999999999999999
Q ss_pred CCCccCCCCCchhHHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 722 GQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 722 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
|+.||....+.... ..+..+ ... +..+.. ... ..++..++.-+ .|...++..||++.||++
T Consensus 232 G~~Pf~~~~~~~~~-~~i~~~---~~~---~~~p~~-~~~-s~~~~~li~~l-~~~~~~r~~r~~~~ei~~ 292 (363)
T cd05628 232 GYPPFCSETPQETY-KKVMNW---KET---LIFPPE-VPI-SEKAKDLILRF-CCEWEHRIGAPGVEEIKT 292 (363)
T ss_pred CCCCCCCCCHHHHH-HHHHcC---cCc---ccCCCc-CCC-CHHHHHHHHHH-cCChhhcCCCCCHHHHhC
Confidence 99999754433221 111110 000 101100 011 23444444322 244445667899999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=345.02 Aligned_cols=264 Identities=23% Similarity=0.305 Sum_probs=197.4
Q ss_pred CCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCC-----EEE
Q 003278 112 GFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHED-----QLL 184 (834)
Q Consensus 112 ~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-----~~~ 184 (834)
+|+..+.||+|+||.||+|....+|+.||||++... .....+.+.+|+.+++.++||||+++++++...+ ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478889999999999999999889999999998643 2234567889999999999999999999998877 799
Q ss_pred EEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccc
Q 003278 185 LVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGL 264 (834)
Q Consensus 185 lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGl 264 (834)
+||||+. ++|...+... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 81 lv~e~~~-~~l~~~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~ 149 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP-------QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGL 149 (372)
T ss_pred EEeeccc-cCHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccc
Confidence 9999997 5777776432 4689999999999999999999985 999999999999999999999999999
Q ss_pred hhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccc
Q 003278 265 ARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQI 344 (834)
Q Consensus 265 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~ 344 (834)
++....... ...+...||+.|+|||.+.....++.++|||||||++|||+||+.||....+....
T Consensus 150 a~~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 214 (372)
T cd07853 150 ARVEEPDES---------------KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQL 214 (372)
T ss_pred eeecccCcc---------------ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHH
Confidence 975321100 01223458999999999876556789999999999999999999999754322111
Q ss_pred hHHH----------------HHHHHh-hcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 345 ILLD----------------WIRRLS-DEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 345 ~l~~----------------~~~~~~-~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
..+. ...... ......... ..+. .......+.+.+++..|++.||.+||++.++++.
T Consensus 215 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 215 DLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSL-PVLY--TLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCch-HHhc--ccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 1000 000000 000000000 0000 0000112457889999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=325.98 Aligned_cols=252 Identities=25% Similarity=0.389 Sum_probs=199.1
Q ss_pred CCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEccCC
Q 003278 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPN 192 (834)
Q Consensus 113 f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 192 (834)
|+..+.||+|+||.||+|....++..+|+|.+........+.|.+|+.+++.++||||++++++|...+..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 45667899999999999999888999999998766656667899999999999999999999999999999999999999
Q ss_pred CCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhhhh
Q 003278 193 RSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHEL 272 (834)
Q Consensus 193 gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~ 272 (834)
|+|..++.+. ..+++|..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 87 ~~l~~~~~~~------~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~ 157 (282)
T cd06643 87 GAVDAVMLEL------ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 157 (282)
T ss_pred CcHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc
Confidence 9999887642 24689999999999999999999985 99999999999999999999999999987532110
Q ss_pred hhhhhcccccccccccccceeeeccccCCCccccc----cCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHH
Q 003278 273 QYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQ----KGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLD 348 (834)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~----~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~ 348 (834)
.......||+.|+|||++. .+..++.++|||||||++|||++|+.|+....... ....
T Consensus 158 ----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~~~~ 219 (282)
T cd06643 158 ----------------QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR--VLLK 219 (282)
T ss_pred ----------------cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH--HHHH
Confidence 0122345899999999874 23356789999999999999999999986432111 1111
Q ss_pred HHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 349 WIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 349 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
... ........+ ..+ ...+.+++..||+.+|.+||++.++++.
T Consensus 220 ----~~~-~~~~~~~~~----~~~----~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 220 ----IAK-SEPPTLAQP----SRW----SSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred ----Hhh-cCCCCCCCc----ccc----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111 100000000 111 1357889999999999999999998753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=326.39 Aligned_cols=260 Identities=22% Similarity=0.321 Sum_probs=202.3
Q ss_pred hCcCcCCcccccCCcEEEEEEECC------CcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDN------HQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEML 586 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~------~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~ 586 (834)
++|...+.||+|+||.||+|...+ +..||+|.+...........|.+|+.++..++||||++++|++......+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL 85 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence 456777889999999999998643 35799999875554455567999999999999999999999999999999
Q ss_pred EEEeccCCCchhhhhhcCCCCC----CCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEee
Q 003278 587 VIYDYSATRILSHLLFHNNHRI----GHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGS 662 (834)
Q Consensus 587 lv~Ey~~~g~L~~~l~~~~~~~----~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~D 662 (834)
+||||+++|+|.+++....... ....++|..++.++.|++.||+|||+ .+|+||||||+|||+++++.+||+|
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEECC
Confidence 9999999999999987543211 12347899999999999999999996 6999999999999999999999999
Q ss_pred eeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHH
Q 003278 663 FALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHE 741 (834)
Q Consensus 663 fGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~ 741 (834)
||+++.+...... .......||..|+|||.+.++.++.++|||||||++|||+| |+.|+....+.. ......
T Consensus 163 fg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-~~~~~~- 235 (277)
T cd05032 163 FGMTRDIYETDYY-----RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE-VLKFVI- 235 (277)
T ss_pred cccchhhccCccc-----ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH-HHHHHh-
Confidence 9999765432211 11123357889999999998899999999999999999999 888875433322 111111
Q ss_pred HHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHc
Q 003278 742 FEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795 (834)
Q Consensus 742 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~ 795 (834)
..... ...... + ..+.+++.+||+.+|++|||+.+|++.|+
T Consensus 236 ----~~~~~-----~~~~~~-~---~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 236 ----DGGHL-----DLPENC-P---DKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred ----cCCCC-----CCCCCC-C---HHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 11100 111111 2 24556777999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=342.12 Aligned_cols=216 Identities=25% Similarity=0.342 Sum_probs=173.3
Q ss_pred CCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEE
Q 003278 112 GFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYD 188 (834)
Q Consensus 112 ~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 188 (834)
.|+..++||+|+||.||+|+...+++.||||++.... ....+.+.+|+.++++++|||||+++++|.+.+.+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888899999999999999999999999999986532 2334578899999999999999999999999999999999
Q ss_pred ccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhh
Q 003278 189 YMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWL 268 (834)
Q Consensus 189 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~ 268 (834)
||++|+|.+++.+. ..+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+
T Consensus 82 ~~~gg~L~~~l~~~-------~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~ 151 (382)
T cd05625 82 YIPGGDMMSLLIRM-------GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (382)
T ss_pred CCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccc
Confidence 99999999998643 3578888899999999999999986 9999999999999999999999999998643
Q ss_pred hhhhhhh---hh----cccc------------------------cccccccccceeeeccccCCCccccccCCCCCcccc
Q 003278 269 EHELQYQ---MR----TSSA------------------------RNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSD 317 (834)
Q Consensus 269 ~~~~~~~---~~----~~~~------------------------~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksD 317 (834)
....... .. .... ..............||+.|+|||.+... .++.++|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~D 230 (382)
T cd05625 152 RWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCD 230 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC-CCCCeee
Confidence 2100000 00 0000 0000000012345799999999988654 5789999
Q ss_pred eeehhhHHHHHHhCCccCCCC
Q 003278 318 VFSFGIVVLEVVSGRRAVDLT 338 (834)
Q Consensus 318 V~SfGvvl~ElltG~~p~~~~ 338 (834)
||||||++|||+||+.||...
T Consensus 231 iwSlGvil~elltG~~Pf~~~ 251 (382)
T cd05625 231 WWSVGVILYEMLVGQPPFLAQ 251 (382)
T ss_pred EEechHHHHHHHhCCCCCCCC
Confidence 999999999999999999653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=344.74 Aligned_cols=195 Identities=24% Similarity=0.309 Sum_probs=167.5
Q ss_pred hcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEE
Q 003278 109 GSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYD 188 (834)
Q Consensus 109 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 188 (834)
..++|+..+.||+|+||.||+|....+++.||+|... .+.+.+|+.++++++|||||++++++...+..++|||
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 3467999999999999999999999999999999653 2356789999999999999999999999999999999
Q ss_pred ccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhh
Q 003278 189 YMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWL 268 (834)
Q Consensus 189 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~ 268 (834)
++. ++|..++... ..+++..++.|+.|++.||.|||+. +|+||||||+|||++.++.+||+|||+|+..
T Consensus 164 ~~~-~~L~~~l~~~-------~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~ 232 (391)
T PHA03212 164 RYK-TDLYCYLAAK-------RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFP 232 (391)
T ss_pred cCC-CCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccc
Confidence 985 7888877542 3578999999999999999999985 9999999999999999999999999999743
Q ss_pred hhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCC
Q 003278 269 EHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVD 336 (834)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~ 336 (834)
.... ........||+.|+|||++... .++.++|||||||++|||+||+.|+-
T Consensus 233 ~~~~---------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~ 284 (391)
T PHA03212 233 VDIN---------------ANKYYGWAGTIATNAPELLARD-PYGPAVDIWSAGIVLFEMATCHDSLF 284 (391)
T ss_pred cccc---------------ccccccccCccCCCChhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 2110 0012345799999999998654 67999999999999999999998764
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=331.12 Aligned_cols=264 Identities=20% Similarity=0.330 Sum_probs=202.8
Q ss_pred hCcCcCCcccccCCcEEEEEEEC------CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD------NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEML 586 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~ 586 (834)
.+|...+.||+|+||.||++... ++..+|+|.+.... ....+.|.+|++++.+++||||++++++|...+..+
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 45677788999999999999752 24568899876432 334567999999999999999999999999999999
Q ss_pred EEEeccCCCchhhhhhcCCC-------CCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCce
Q 003278 587 VIYDYSATRILSHLLFHNNH-------RIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPR 659 (834)
Q Consensus 587 lv~Ey~~~g~L~~~l~~~~~-------~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~k 659 (834)
+||||+++++|.+++..... ......++|..++.++.|++.||+|||+ .+|+||||||+|||+++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEE
Confidence 99999999999999865321 1112348999999999999999999996 6899999999999999999999
Q ss_pred EeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHH
Q 003278 660 LGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKR 738 (834)
Q Consensus 660 i~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~ 738 (834)
|+|||+++....... ........|+..|+|||++.+..++.++|||||||++|||+| |..|+....+.. ....
T Consensus 161 l~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-~~~~ 234 (288)
T cd05093 161 IGDFGMSRDVYSTDY-----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-VIEC 234 (288)
T ss_pred eccCCccccccCCce-----eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHH
Confidence 999999976532211 011122346788999999998899999999999999999999 888875433222 1111
Q ss_pred HHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCcc
Q 003278 739 VHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDKR 800 (834)
Q Consensus 739 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~~ 800 (834)
... .... ......+ ..+.+++.+||+.||.+|||+.+|.+.|+.+.+.
T Consensus 235 i~~-----~~~~-----~~~~~~~----~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 235 ITQ-----GRVL-----QRPRTCP----KEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHc-----CCcC-----CCCCCCC----HHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 111 1100 0111122 2456777799999999999999999999877653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=329.24 Aligned_cols=256 Identities=26% Similarity=0.385 Sum_probs=205.2
Q ss_pred hcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEE
Q 003278 109 GSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYD 188 (834)
Q Consensus 109 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 188 (834)
+..+|+..+.||+|+||.||+|.+.. +..+|+|.+..........+..|+.+++.++||||+++++++...+..++|||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 44568889999999999999999965 89999999877655556779999999999999999999999999999999999
Q ss_pred ccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhh
Q 003278 189 YMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWL 268 (834)
Q Consensus 189 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~ 268 (834)
|+++|+|.+++.... ...++|..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||++..+
T Consensus 83 ~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~ 154 (261)
T cd05148 83 LMEKGSLLAFLRSPE-----GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLI 154 (261)
T ss_pred ecccCCHHHHHhcCC-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhc
Confidence 999999999996532 24689999999999999999999985 8999999999999999999999999999764
Q ss_pred hhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccchHH
Q 003278 269 EHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQIILL 347 (834)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~ 347 (834)
..... ......++..|+|||.+..+ .++.++|||||||++|||++ |+.|+..... ....
T Consensus 155 ~~~~~----------------~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~---~~~~ 214 (261)
T cd05148 155 KEDVY----------------LSSDKKIPYKWTAPEAASHG-TFSTKSDVWSFGILLYEMFTYGQVPYPGMNN---HEVY 214 (261)
T ss_pred CCccc----------------cccCCCCceEecCHHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcCCH---HHHH
Confidence 32110 01123367889999988654 67889999999999999999 8888854321 1122
Q ss_pred HHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhc
Q 003278 348 DWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSG 407 (834)
Q Consensus 348 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~ 407 (834)
..+. .+.... . .......+.+++.+||+.+|.+||++.++++.|+.
T Consensus 215 ~~~~----~~~~~~-----~-----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 215 DQIT----AGYRMP-----C-----PAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred HHHH----hCCcCC-----C-----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 2211 111110 0 01112467899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=332.23 Aligned_cols=263 Identities=25% Similarity=0.390 Sum_probs=201.2
Q ss_pred CCCCCCeeeccCCeEEEEEEECC-----CCeEEEEEEecccC-hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEE
Q 003278 112 GFDEDEVLGSGGFGKVYRAVLPS-----DGTVVAVKCLAEKG-ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLL 185 (834)
Q Consensus 112 ~f~~~~~LG~G~fG~Vy~~~~~~-----~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 185 (834)
+|...+.||+|+||.||+|+... ....+|+|.+.... ....+.+.+|+.+++.++||||++++++|...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 46778899999999999998742 23579999876443 2345678999999999999999999999999999999
Q ss_pred EEEccCCCCHhHHHhcCCCc-----------------cccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCc
Q 003278 186 VYDYMPNRSLDRVLFRRPEN-----------------LEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSN 248 (834)
Q Consensus 186 V~Ey~~~gsL~~~l~~~~~~-----------------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~N 248 (834)
||||+++|+|.+++...... .....+++|.++..++.|++.||.|||+. +|+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 99999999999998643211 11224689999999999999999999985 99999999999
Q ss_pred eEECCCCceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHH
Q 003278 249 VMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEV 328 (834)
Q Consensus 249 ILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~El 328 (834)
||+++++.+||+|||+++.+.....+ .......++..|+|||.+... .++.++|||||||++|||
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~--------------~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el 222 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSY--------------VKRSKGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEI 222 (290)
T ss_pred EEEcCCCcEEeccccccccccCccch--------------hcccCCCCCccccCHHHHccC-CcchHhHHHHHHHHHHHH
Confidence 99999999999999999754322110 011223467789999987644 678999999999999999
Q ss_pred Hh-CCccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhc
Q 003278 329 VS-GRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSG 407 (834)
Q Consensus 329 lt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~ 407 (834)
+| |+.|+....+ ..+..+ ...+..... . ... ...+.+++..||+.+|.+||++.++++.|+.
T Consensus 223 ~t~g~~p~~~~~~---~~~~~~----~~~~~~~~~-----~-~~~----~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~ 285 (290)
T cd05045 223 VTLGGNPYPGIAP---ERLFNL----LKTGYRMER-----P-ENC----SEEMYNLMLTCWKQEPDKRPTFADISKELEK 285 (290)
T ss_pred HhcCCCCCCCCCH---HHHHHH----HhCCCCCCC-----C-CCC----CHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 99 9888854321 112222 111111100 0 111 2467889999999999999999999999986
Q ss_pred CC
Q 003278 408 SY 409 (834)
Q Consensus 408 ~~ 409 (834)
.+
T Consensus 286 ~~ 287 (290)
T cd05045 286 MM 287 (290)
T ss_pred HH
Confidence 53
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=327.01 Aligned_cols=256 Identities=27% Similarity=0.379 Sum_probs=200.7
Q ss_pred hcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEE
Q 003278 109 GSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYD 188 (834)
Q Consensus 109 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 188 (834)
..++|+..+.||+|+||.||+|.+ .+++.||||.+.... ...+.|.+|+.++++++||||+++++++...+..++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLW-NNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred chhheeeEEEecccCCccEEEEEe-cCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 456788899999999999999998 456789999986543 335678999999999999999999999999999999999
Q ss_pred ccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhh
Q 003278 189 YMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWL 268 (834)
Q Consensus 189 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~ 268 (834)
|+++++|.+++.... ...++|..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++.+
T Consensus 82 ~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 153 (261)
T cd05068 82 LMKYGSLLEYLQGGA-----GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVI 153 (261)
T ss_pred cccCCcHHHHHhccC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEc
Confidence 999999999986532 24689999999999999999999985 9999999999999999999999999999865
Q ss_pred hhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccchHH
Q 003278 269 EHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQIILL 347 (834)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~ 347 (834)
..... .......++..|+|||++... .++.++|||||||++|||+| |+.|+.... ...+.
T Consensus 154 ~~~~~---------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~---~~~~~ 214 (261)
T cd05068 154 KEDIY---------------EAREGAKFPIKWTAPEAALYN-RFSIKSDVWSFGILLTEIVTYGRMPYPGMT---NAEVL 214 (261)
T ss_pred cCCcc---------------cccCCCcCceeccCccccccC-CCCchhhHHHHHHHHHHHHhcCCCCCCCCC---HHHHH
Confidence 32110 001112234689999988654 67899999999999999999 888875321 11111
Q ss_pred HHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhc
Q 003278 348 DWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSG 407 (834)
Q Consensus 348 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~ 407 (834)
.. . ....... . .......+.+++.+|++.+|.+||+|.++++.|+.
T Consensus 215 ~~---~-~~~~~~~-----~-----~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 215 QQ---V-DQGYRMP-----C-----PPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred HH---H-HcCCCCC-----C-----CCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 11 1 1111000 0 00112468899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=336.58 Aligned_cols=252 Identities=18% Similarity=0.193 Sum_probs=189.5
Q ss_pred CcCcCCcccccCCcEEEEEEE----CCCcEEEEEEecCCC---ChhHHHHHHHHHHHHHhc-cCCCceeEEEEEeeCCeE
Q 003278 514 NFSESQRVAEMDFGTAYQGFL----DNHQYVLVKRLGMSK---CPALRTRFSNELQNLARL-RHRNLVQLCGWCTEQGEM 585 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~----~~~~~vavK~~~~~~---~~~~~~~f~~E~~~l~~l-~HpNiv~l~g~~~~~~~~ 585 (834)
+|...+.||+|+||.||++.. .++..||+|.+.... .....+.+.+|+.++.++ +||||+++++++.+.+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 356677899999999999875 357899999986321 222345688899999999 599999999999999999
Q ss_pred EEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeee
Q 003278 586 LVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFAL 665 (834)
Q Consensus 586 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGl 665 (834)
++||||+++|+|.+++.... .+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~ 151 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD------NFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGL 151 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcC
Confidence 99999999999999886532 37888888999999999999996 6899999999999999999999999999
Q ss_pred ccccccCCCCCcccccCccccccccCccchhccccC-CCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHh
Q 003278 666 AEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESG-EATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEA 744 (834)
Q Consensus 666 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~ 744 (834)
++....... .......||+.|||||++.+. .++.++|||||||++|||+||+.||..................
T Consensus 152 ~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 225 (332)
T cd05614 152 SKEFLSEEK------ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK 225 (332)
T ss_pred CccccccCC------CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc
Confidence 975432211 112346799999999999765 4788999999999999999999998643221111111111111
Q ss_pred hcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----ChhHHHH
Q 003278 745 RKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRP-----SMRQILS 792 (834)
Q Consensus 745 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RP-----tm~~v~~ 792 (834)
. ++.+....+ .. +..++.+||+.||++|| ++.++++
T Consensus 226 ~--------~~~~~~~~~-~~---~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 226 C--------DPPFPSFIG-PE---AQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred C--------CCCCCCCCC-HH---HHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 0 111111222 23 34555689999999999 5556653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=334.28 Aligned_cols=242 Identities=19% Similarity=0.216 Sum_probs=187.7
Q ss_pred CcccccCCcEEEEEEE----CCCcEEEEEEecCCC---ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 519 QRVAEMDFGTAYQGFL----DNHQYVLVKRLGMSK---CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 519 ~~ig~g~~g~vy~~~~----~~~~~vavK~~~~~~---~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
+.||+|+||.||++.. .+++.||||.+.... .......+.+|+.+|++++||||+++++++...+..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5699999999999985 357889999986421 122335678899999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccccc
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTR 671 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~ 671 (834)
+++|+|..++...+ .+.+.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 152 (323)
T cd05584 82 LSGGELFMHLEREG------IFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH 152 (323)
T ss_pred CCCchHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc
Confidence 99999999886532 36677778899999999999996 6999999999999999999999999999875322
Q ss_pred CCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcccc
Q 003278 672 NDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAE 751 (834)
Q Consensus 672 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
.. .......||+.|||||++.+..++.++|||||||++|||+||+.||........ ..........
T Consensus 153 ~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~----~~~~~~~~~~--- 218 (323)
T cd05584 153 EG-------TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT----IDKILKGKLN--- 218 (323)
T ss_pred CC-------CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH----HHHHHcCCCC---
Confidence 11 112345799999999999988899999999999999999999999864332211 1111111111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----ChhHHHH
Q 003278 752 LVDLSLNGEYNHKELMRLIKLGIACTLSNPELRP-----SMRQILS 792 (834)
Q Consensus 752 ~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RP-----tm~~v~~ 792 (834)
+.... ..+ +..++.+||+.+|++|| ++.++++
T Consensus 219 -----~~~~~-~~~---~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 219 -----LPPYL-TPE---ARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred -----CCCCC-CHH---HHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 11111 223 44555689999999999 6777654
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=333.12 Aligned_cols=261 Identities=28% Similarity=0.416 Sum_probs=199.7
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCe--EEEEEEeccc-ChhhHHHHHHHHHHHHhC-CCCceeeEeeeEEeCCEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGT--VVAVKCLAEK-GERFEKTFAAELVAVAHL-RHRNLVRLRGWCVHEDQLLLV 186 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~--~vAvK~l~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV 186 (834)
++|+..+.||+|+||.||+|.+..++. .+|+|.++.. .....+.|.+|+.++.++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 568888999999999999999877664 4788887642 334456789999999999 799999999999999999999
Q ss_pred EEccCCCCHhHHHhcCCCcc---------ccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCce
Q 003278 187 YDYMPNRSLDRVLFRRPENL---------EAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNA 257 (834)
Q Consensus 187 ~Ey~~~gsL~~~l~~~~~~~---------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~ 257 (834)
|||+++|+|.+++....... .....+++..+..|+.|++.||+|||+. +|+||||||+|||++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 99999999999996532110 1124589999999999999999999985 99999999999999999999
Q ss_pred EEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCC
Q 003278 258 RLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVD 336 (834)
Q Consensus 258 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~ 336 (834)
||+|||++....... ......++..|+|||++... .++.++|||||||++|||+| |+.||.
T Consensus 159 kl~dfg~~~~~~~~~-----------------~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~t~g~~pf~ 220 (297)
T cd05089 159 KIADFGLSRGEEVYV-----------------KKTMGRLPVRWMAIESLNYS-VYTTKSDVWSFGVLLWEIVSLGGTPYC 220 (297)
T ss_pred EECCcCCCcccccee-----------------ccCCCCcCccccCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 999999986321100 01111235679999988654 57899999999999999998 999986
Q ss_pred CCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcCC
Q 003278 337 LTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGSY 409 (834)
Q Consensus 337 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~~ 409 (834)
..... .+.... ..+.. .... ... ...+.+++..||+.+|.+||++.++++.|....
T Consensus 221 ~~~~~------~~~~~~-~~~~~-----~~~~-~~~----~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 276 (297)
T cd05089 221 GMTCA------ELYEKL-PQGYR-----MEKP-RNC----DDEVYELMRQCWRDRPYERPPFAQISVQLSRML 276 (297)
T ss_pred CCCHH------HHHHHH-hcCCC-----CCCC-CCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 43221 111111 11110 0010 111 135788999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=325.30 Aligned_cols=259 Identities=21% Similarity=0.285 Sum_probs=195.9
Q ss_pred CcCCcccccCCcEEEEEEECC----CcEEEEEEecCCCC-hhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCe------
Q 003278 516 SESQRVAEMDFGTAYQGFLDN----HQYVLVKRLGMSKC-PALRTRFSNELQNLARLRHRNLVQLCGWCTEQGE------ 584 (834)
Q Consensus 516 ~~~~~ig~g~~g~vy~~~~~~----~~~vavK~~~~~~~-~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~------ 584 (834)
...+.||+|+||.||+|.... +..||||++..... ......|.+|+..++.++||||++++|++.+.+.
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 81 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK 81 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence 345779999999999998643 36799999875433 3344679999999999999999999999876554
Q ss_pred EEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeee
Q 003278 585 MLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFA 664 (834)
Q Consensus 585 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfG 664 (834)
.+++|||+++|+|..++...........+++.....++.|++.||+|||+ .+|+||||||+||++++++.+||+|||
T Consensus 82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCcc
Confidence 79999999999999988654322222358899999999999999999996 689999999999999999999999999
Q ss_pred eccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHH
Q 003278 665 LAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFE 743 (834)
Q Consensus 665 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~ 743 (834)
+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..|+....+ .........
T Consensus 159 ~~~~~~~~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~-~~~~~~~~~-- 230 (273)
T cd05035 159 LSKKIYSGDYY-----RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN-HEIYDYLRH-- 230 (273)
T ss_pred ceeeccccccc-----cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHc--
Confidence 99865432210 01112235678999999988899999999999999999999 7777754322 222121111
Q ss_pred hhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccC
Q 003278 744 ARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGN 797 (834)
Q Consensus 744 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~ 797 (834)
... . .....+ ...+.+++.+||+.||++|||+.+|++.|+.+
T Consensus 231 --~~~-~-----~~~~~~----~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 --GNR-L-----KQPEDC----LDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred --CCC-C-----CCCcCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 011 0 011111 22456677799999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=328.72 Aligned_cols=252 Identities=15% Similarity=0.206 Sum_probs=193.3
Q ss_pred CcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCC--hhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEe
Q 003278 514 NFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKC--PALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYD 590 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~--~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~E 590 (834)
+|...+.||+|+||.||++.. .++..||||.+..... ......+.+|+.++++++|||||++++++.+.+..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 356677899999999999986 4688999999864322 2233567889999999999999999999999999999999
Q ss_pred ccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccc
Q 003278 591 YSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLT 670 (834)
Q Consensus 591 y~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~ 670 (834)
|+++|+|..++..... ..+++.....++.|++.||+|||+ .+|+||||||+||++++++.++|+|||+++...
T Consensus 81 ~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 153 (285)
T cd05605 81 LMNGGDLKFHIYNMGN----PGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIP 153 (285)
T ss_pred ccCCCcHHHHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecC
Confidence 9999999988764321 248899999999999999999997 689999999999999999999999999997643
Q ss_pred cCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCccc
Q 003278 671 RNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLA 750 (834)
Q Consensus 671 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (834)
... ......||+.|||||++.+..++.++|||||||++|||++|+.||......... ..+..... ...
T Consensus 154 ~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~-~~~~~~~~-~~~-- 221 (285)
T cd05605 154 EGE--------TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR-EEVERRVK-EDQ-- 221 (285)
T ss_pred CCC--------ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH-HHHHHHhh-hcc--
Confidence 211 112357899999999999889999999999999999999999999754322111 11111100 000
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----ChhHHHH
Q 003278 751 ELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRP-----SMRQILS 792 (834)
Q Consensus 751 ~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RP-----tm~~v~~ 792 (834)
......++ ..+.+++.+||+.||++|| ++.++.+
T Consensus 222 ----~~~~~~~~----~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 222 ----EEYSEKFS----EAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred ----cccCcccC----HHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 00111111 2345666799999999999 5666643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=323.61 Aligned_cols=262 Identities=23% Similarity=0.364 Sum_probs=207.2
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc---ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK---GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLV 186 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 186 (834)
+++|+..+.||+|+||.||+|....+|+.||+|.++.. .....+.+.+|+.++++++|+||+++++++...+..++|
T Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV 80 (267)
T ss_pred CCceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 36789999999999999999999889999999987532 233456789999999999999999999999999999999
Q ss_pred EEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchh
Q 003278 187 YDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLAR 266 (834)
Q Consensus 187 ~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~ 266 (834)
|||+++|+|..++..... ....+++.++..++.+++.||.|||+. +|+||||||+||+++.++.++|+|||+++
T Consensus 81 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~ 154 (267)
T cd08224 81 LELADAGDLSRMIKHFKK---QKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGR 154 (267)
T ss_pred EecCCCCCHHHHHHHhcc---cCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceee
Confidence 999999999998864321 234689999999999999999999985 99999999999999999999999999987
Q ss_pred hhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchH
Q 003278 267 WLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIIL 346 (834)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l 346 (834)
.+.... .......|++.|+|||.+... .++.++|||||||++|||++|+.|+.... ..+
T Consensus 155 ~~~~~~----------------~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~ 213 (267)
T cd08224 155 FFSSKT----------------TAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNL 213 (267)
T ss_pred eccCCC----------------cccceecCCccccCHHHhccC-CCCchhcHHHHHHHHHHHHHCCCCcccCC----ccH
Confidence 543210 012234588999999988644 57889999999999999999999985332 222
Q ss_pred HHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 347 LDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 347 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
..+..... .+... ... .......+.+++..||..+|++||++.+|++.|+..
T Consensus 214 ~~~~~~~~-~~~~~-----~~~----~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 214 YSLCKKIE-KCDYP-----PLP----ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred HHHHhhhh-cCCCC-----CCC----hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 22222211 11111 111 001224578899999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=323.36 Aligned_cols=254 Identities=20% Similarity=0.297 Sum_probs=190.4
Q ss_pred CcccccCCcEEEEEEECC----CcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEe-eCCeEEEEEeccC
Q 003278 519 QRVAEMDFGTAYQGFLDN----HQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCT-EQGEMLVIYDYSA 593 (834)
Q Consensus 519 ~~ig~g~~g~vy~~~~~~----~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~-~~~~~~lv~Ey~~ 593 (834)
+.||+|+||.||+|...+ ...||+|++.........+.|.+|+.+++.++||||++++++|. .++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 368999999999998532 35799998865444445578899999999999999999999876 4556889999999
Q ss_pred CCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCC
Q 003278 594 TRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRND 673 (834)
Q Consensus 594 ~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~ 673 (834)
+|+|.+++..... .+.+..++.++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++.+....
T Consensus 81 ~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~ 152 (262)
T cd05058 81 HGDLRNFIRSETH-----NPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE 152 (262)
T ss_pred CCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCc
Confidence 9999999865322 25677788999999999999996 699999999999999999999999999997543221
Q ss_pred CCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcccccc
Q 003278 674 HGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELV 753 (834)
Q Consensus 674 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (834)
.. .........++..|+|||++.+..++.++|||||||++|||+||..|+............+ .....+
T Consensus 153 ~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~---~~~~~~----- 221 (262)
T cd05058 153 YY---SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYL---LQGRRL----- 221 (262)
T ss_pred ce---eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH---hcCCCC-----
Confidence 10 0011123456788999999998899999999999999999999655543222222111111 111000
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccC
Q 003278 754 DLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGN 797 (834)
Q Consensus 754 d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~ 797 (834)
... ...+ ..+.+++.+||+.+|++||++.+|++.|+..
T Consensus 222 --~~~-~~~~---~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 222 --LQP-EYCP---DPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred --CCC-CcCC---HHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 001 1112 2456677799999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=337.73 Aligned_cols=241 Identities=22% Similarity=0.281 Sum_probs=188.1
Q ss_pred CeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHHHHHh-CCCCceeeEeeeEEeCCEEEEEEEccCC
Q 003278 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVAVAH-LRHRNLVRLRGWCVHEDQLLLVYDYMPN 192 (834)
Q Consensus 117 ~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~-l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 192 (834)
++||+|+||.||+|.+..+|..||||+++... ....+.+..|..++.. ++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999999899999999986532 2233456678877765 5899999999999999999999999999
Q ss_pred CCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhhhh
Q 003278 193 RSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHEL 272 (834)
Q Consensus 193 gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~ 272 (834)
|+|..++... ..+++.....++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 g~L~~~i~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 149 (316)
T cd05620 81 GDLMFHIQDK-------GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG- 149 (316)
T ss_pred CcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccC-
Confidence 9999888543 3578889999999999999999985 9999999999999999999999999998632110
Q ss_pred hhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHHHHH
Q 003278 273 QYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIRR 352 (834)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~ 352 (834)
....+...||+.|+|||.+... .++.++|||||||++|||+||+.||..... ..+.. .
T Consensus 150 ---------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~Pf~~~~~---~~~~~---~ 207 (316)
T cd05620 150 ---------------DNRASTFCGTPDYIAPEILQGL-KYTFSVDWWSFGVLLYEMLIGQSPFHGDDE---DELFE---S 207 (316)
T ss_pred ---------------CCceeccCCCcCccCHHHHcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHHH---H
Confidence 0113456799999999998654 678999999999999999999999864321 11111 1
Q ss_pred HhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchh-hHH
Q 003278 353 LSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMK-WVI 402 (834)
Q Consensus 353 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~-~V~ 402 (834)
+.. + .+.+. ... ...+.++...||+.||.+||++. ++.
T Consensus 208 ~~~-~------~~~~~-~~~----~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 208 IRV-D------TPHYP-RWI----TKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred HHh-C------CCCCC-CCC----CHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 111 1 01111 111 13567899999999999999984 444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=327.32 Aligned_cols=262 Identities=25% Similarity=0.400 Sum_probs=203.8
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCC-----CeEEEEEEecccC-hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSD-----GTVVAVKCLAEKG-ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQL 183 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~-----g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 183 (834)
.++|...+.||+|+||.||+|..... +..||+|.+.... ......|.+|+.++..++||||+++++++...+..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 46788899999999999999987533 4789999986442 23456788999999999999999999999999999
Q ss_pred EEEEEccCCCCHhHHHhcCCCcc---ccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEe
Q 003278 184 LLVYDYMPNRSLDRVLFRRPENL---EAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLG 260 (834)
Q Consensus 184 ~lV~Ey~~~gsL~~~l~~~~~~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~ 260 (834)
++||||+++|+|.+++....... .....++|..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence 99999999999999997543211 1234589999999999999999999985 99999999999999999999999
Q ss_pred eccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCC
Q 003278 261 DFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTY 339 (834)
Q Consensus 261 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~ 339 (834)
|||+++.+...... ...+...||..|+|||.+..+ .++.++|||||||++||++| |+.|+....
T Consensus 162 dfg~~~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~ 226 (277)
T cd05032 162 DFGMTRDIYETDYY--------------RKGGKGLLPVRWMAPESLKDG-VFTTKSDVWSFGVVLWEMATLAEQPYQGLS 226 (277)
T ss_pred CcccchhhccCccc--------------ccCCCCCccccccCHHHHhcC-CCCcccchHHHHHHHHHhhccCCCCCccCC
Confidence 99999754322110 012233478899999988655 57899999999999999998 888875322
Q ss_pred CCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhh
Q 003278 340 PDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVS 406 (834)
Q Consensus 340 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~ 406 (834)
. ..+..++. .+...... ... ...+.+++..||+.+|.+||++.++++.|+
T Consensus 227 ~---~~~~~~~~----~~~~~~~~------~~~----~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 227 N---EEVLKFVI----DGGHLDLP------ENC----PDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred H---HHHHHHHh----cCCCCCCC------CCC----CHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 1 11222221 12111111 111 346889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=328.30 Aligned_cols=269 Identities=22% Similarity=0.332 Sum_probs=202.6
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCC----------------CeEEEEEEecccC-hhhHHHHHHHHHHHHhCCCCceee
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSD----------------GTVVAVKCLAEKG-ERFEKTFAAELVAVAHLRHRNLVR 172 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~----------------g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~ 172 (834)
..+|+..+.||+|+||.||+|.+... +..||+|.+.... ....+.|.+|+.++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 35688899999999999999987543 3568999987543 345677899999999999999999
Q ss_pred EeeeEEeCCEEEEEEEccCCCCHhHHHhcCCCcc----ccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCc
Q 003278 173 LRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENL----EAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSN 248 (834)
Q Consensus 173 l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~N 248 (834)
++++|..++..++||||+++++|..++....... .....+++..+..++.|++.||+|||+. +|+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 9999999999999999999999999997543110 1123689999999999999999999985 99999999999
Q ss_pred eEECCCCceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHH
Q 003278 249 VMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEV 328 (834)
Q Consensus 249 ILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~El 328 (834)
||++.++.++|+|||+++.+...... .......+|+.|+|||++..+ .++.++|||||||++|||
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el 225 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYY--------------RVQGRAPLPIRWMAWESVLLG-KFTTKSDVWAFGVTLWEI 225 (296)
T ss_pred eeecCCCceEEccccceeecccCcce--------------eecCcCCCCceecCHHHhhcC-CCCccchhhhhHHHHHHH
Confidence 99999999999999998754221100 012234467899999988654 579999999999999999
Q ss_pred Hh--CCccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhh
Q 003278 329 VS--GRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVS 406 (834)
Q Consensus 329 lt--G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~ 406 (834)
++ |..|+.... .......+............... .......+.+++..||+.+|.+||++.+|++.|+
T Consensus 226 ~~~~~~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 226 LTLCREQPYEHLT---DQQVIENAGHFFRDDGRQIYLPR-------PPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HhcCCCCCCCCcC---hHHHHHHHHhccccccccccCCC-------ccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 98 555654321 11122222222111111111100 0011246889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=336.73 Aligned_cols=263 Identities=21% Similarity=0.294 Sum_probs=198.1
Q ss_pred hCcCcCCcccccCCcEEEEEEE------CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhc-cCCCceeEEEEEeeC-Ce
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL------DNHQYVLVKRLGMSKCPALRTRFSNELQNLARL-RHRNLVQLCGWCTEQ-GE 584 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l-~HpNiv~l~g~~~~~-~~ 584 (834)
++|...+.||+|+||.||+|.. .++..||||.+...........+.+|+.+|.++ +|||||+++++|... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 4577788999999999999973 346789999987654444456788999999999 689999999988654 46
Q ss_pred EEEEEeccCCCchhhhhhcCCCCC--------------------------------------------------------
Q 003278 585 MLVIYDYSATRILSHLLFHNNHRI-------------------------------------------------------- 608 (834)
Q Consensus 585 ~~lv~Ey~~~g~L~~~l~~~~~~~-------------------------------------------------------- 608 (834)
.++||||+++|+|.+++.......
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 789999999999999986532100
Q ss_pred -----CCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCCCCCcccccCc
Q 003278 609 -----GHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGN 683 (834)
Q Consensus 609 -----~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~~~~~ 683 (834)
....++|..++.++.|+++||+|||+ .+|+||||||+|||+++++.+||+|||++......... ...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-----~~~ 238 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-----VRK 238 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcch-----hhc
Confidence 01247888899999999999999996 69999999999999999999999999999764322110 111
Q ss_pred cccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCccccccccccCCCCC
Q 003278 684 RSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYN 762 (834)
Q Consensus 684 ~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 762 (834)
....+++.|||||++.+..++.++|||||||++|||++ |..|+............... ... . ......+
T Consensus 239 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~---~~~--~-----~~~~~~~ 308 (343)
T cd05103 239 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE---GTR--M-----RAPDYTT 308 (343)
T ss_pred CCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhc---cCC--C-----CCCCCCC
Confidence 22356778999999998899999999999999999997 88887543222222111111 000 0 0011111
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccC
Q 003278 763 HKELMRLIKLGIACTLSNPELRPSMRQILSILDGN 797 (834)
Q Consensus 763 ~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~ 797 (834)
..+.+++.+||+.||++|||+.+|++.|+..
T Consensus 309 ----~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 309 ----PEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339 (343)
T ss_pred ----HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 2466777899999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=328.93 Aligned_cols=264 Identities=23% Similarity=0.280 Sum_probs=204.3
Q ss_pred hCcCcCCcccccCCcEEEEEEECC-----CcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEee-CCeEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDN-----HQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTE-QGEML 586 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~-----~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~-~~~~~ 586 (834)
++|...+.||+|+||.||+|...+ +..|++|++.........+.+.+|+.++++++||||++++|++.. ....+
T Consensus 6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 85 (280)
T cd05043 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPF 85 (280)
T ss_pred hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCE
Confidence 467777889999999999999765 678999998765555556789999999999999999999998876 46789
Q ss_pred EEEeccCCCchhhhhhcCCCC--CCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeee
Q 003278 587 VIYDYSATRILSHLLFHNNHR--IGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFA 664 (834)
Q Consensus 587 lv~Ey~~~g~L~~~l~~~~~~--~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfG 664 (834)
+++||+++|+|..++...... .....+++..+..++.|++.||+|||+ .+++||||||+|||+++++.+||+|||
T Consensus 86 ~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d~g 162 (280)
T cd05043 86 VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNA 162 (280)
T ss_pred EEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECCCC
Confidence 999999999999998654221 112458999999999999999999996 699999999999999999999999999
Q ss_pred eccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHH
Q 003278 665 LAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFE 743 (834)
Q Consensus 665 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~ 743 (834)
+++.+...... .......++..|+|||++.+..++.++|||||||++||++| |+.|+....+.. .....
T Consensus 163 ~~~~~~~~~~~-----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~~---- 232 (280)
T cd05043 163 LSRDLFPMDYH-----CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE-MAAYL---- 232 (280)
T ss_pred CcccccCCceE-----EeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH-HHHHH----
Confidence 99865332210 01122356778999999998889999999999999999999 999986543322 11111
Q ss_pred hhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCc
Q 003278 744 ARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDK 799 (834)
Q Consensus 744 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~ 799 (834)
....... ..... ++ .+.+++.+||..||++|||+.+|++.|+.+.+
T Consensus 233 ~~~~~~~------~~~~~-~~---~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 233 KDGYRLA------QPINC-PD---ELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred HcCCCCC------CCCcC-CH---HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1111100 00111 22 45567779999999999999999999976543
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=337.15 Aligned_cols=248 Identities=24% Similarity=0.373 Sum_probs=203.0
Q ss_pred CCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEE
Q 003278 112 GFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYD 188 (834)
Q Consensus 112 ~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 188 (834)
-|..++.||.|+-|.|-.|++..+|+.+|||++.+.. +.......+|+.+|+-+.||||++||+.+.+...+|||.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 3777899999999999999999999999999987652 2334567899999999999999999999999999999999
Q ss_pred ccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhh
Q 003278 189 YMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWL 268 (834)
Q Consensus 189 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~ 268 (834)
|+++|.|.++|.++ ++|+.....+++.||+.|+.|||.. +|+||||||+|+|||..+++||+|||+|.+-
T Consensus 93 yv~gGELFdylv~k-------G~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe 162 (786)
T KOG0588|consen 93 YVPGGELFDYLVRK-------GPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLE 162 (786)
T ss_pred ecCCchhHHHHHhh-------CCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecc
Confidence 99999999999764 5788899999999999999999996 9999999999999999999999999999753
Q ss_pred hhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHH
Q 003278 269 EHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLD 348 (834)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~ 348 (834)
..+. --.+-||+|.|.|||.+....+...++||||.|||||-||||+-||+. ++-..|+.
T Consensus 163 ~~gk-----------------lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD---dNir~LLl 222 (786)
T KOG0588|consen 163 VPGK-----------------LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD---DNIRVLLL 222 (786)
T ss_pred cCCc-----------------cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC---ccHHHHHH
Confidence 2211 123457999999999998877788999999999999999999999972 22112222
Q ss_pred HHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 349 WIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 349 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
-+ ..|. .++.+. .. ....+|....+..||..|-+|.+|.+.
T Consensus 223 KV----~~G~-f~MPs~------Is----~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 223 KV----QRGV-FEMPSN------IS----SEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred HH----HcCc-ccCCCc------CC----HHHHHHHHHHhccCccccccHHHHhhC
Confidence 11 1221 122111 11 235567778889999999999999985
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=330.26 Aligned_cols=203 Identities=26% Similarity=0.350 Sum_probs=172.2
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc---ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK---GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 187 (834)
++|+..+.||+|+||.||++....+++.||||++.+. .....+.|.+|+.++..++|+||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4688899999999999999999889999999998642 1223456888999999999999999999999999999999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
||+++|+|.+++.+. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 e~~~g~~L~~~l~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 151 (331)
T cd05597 81 DYYVGGDLLTLLSKF------EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLR 151 (331)
T ss_pred ecCCCCcHHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceee
Confidence 999999999998642 23578889999999999999999986 999999999999999999999999999865
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCcccccc----CCCCCcccceeehhhHHHHHHhCCccCCC
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQK----GSVATAKSDVFSFGIVVLEVVSGRRAVDL 337 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~----~~~~~~ksDV~SfGvvl~ElltG~~p~~~ 337 (834)
+..... .......||+.|||||++.. ...++.++|||||||++|||++|+.||..
T Consensus 152 ~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 152 LLADGT---------------VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred cCCCCC---------------ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 322100 01223469999999999863 23468899999999999999999999864
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=326.11 Aligned_cols=258 Identities=23% Similarity=0.324 Sum_probs=191.5
Q ss_pred CeeeccCCeEEEEEEECC--CCeEEEEEEecccC-hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEccCCC
Q 003278 117 EVLGSGGFGKVYRAVLPS--DGTVVAVKCLAEKG-ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNR 193 (834)
Q Consensus 117 ~~LG~G~fG~Vy~~~~~~--~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 193 (834)
+.||+|+||.||+|.+.. ++..+|+|.+.... ......|.+|+.++++++||||++++|+|.+.+..++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998643 34679999886543 234457899999999999999999999999999999999999999
Q ss_pred CHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhhhhh
Q 003278 194 SLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQ 273 (834)
Q Consensus 194 sL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~ 273 (834)
+|.+++...... ....+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~L~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~ 155 (269)
T cd05087 81 DLKGYLRSCRKA--ELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY 155 (269)
T ss_pred cHHHHHHHhhhc--ccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcce
Confidence 999999754221 123567888899999999999999985 999999999999999999999999999874322110
Q ss_pred hhhhcccccccccccccceeeeccccCCCccccccC------CCCCcccceeehhhHHHHHHh-CCccCCCCCCCccchH
Q 003278 274 YQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKG------SVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQIIL 346 (834)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~------~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l 346 (834)
........|+..|+|||++... ..++.++|||||||++|||++ |+.||......+ .
T Consensus 156 --------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~ 218 (269)
T cd05087 156 --------------YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---V 218 (269)
T ss_pred --------------eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---H
Confidence 0012234578899999988532 124789999999999999996 999986432211 1
Q ss_pred HHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhh
Q 003278 347 LDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVS 406 (834)
Q Consensus 347 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~ 406 (834)
.... ..+......++.+. ....+.+..++..|+ .+|++||++.+|+..|+
T Consensus 219 ~~~~----~~~~~~~~~~~~~~-----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 219 LTYT----VREQQLKLPKPRLK-----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred HHHH----hhcccCCCCCCccC-----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1111 01111112222221 111234677888998 58999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=330.21 Aligned_cols=261 Identities=26% Similarity=0.380 Sum_probs=199.7
Q ss_pred CCCCCCeeeccCCeEEEEEEECC-----CCeEEEEEEecccCh-hhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEE
Q 003278 112 GFDEDEVLGSGGFGKVYRAVLPS-----DGTVVAVKCLAEKGE-RFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLL 185 (834)
Q Consensus 112 ~f~~~~~LG~G~fG~Vy~~~~~~-----~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 185 (834)
+|...+.||+|+||.||+|.... ++..||||++..... ...+.|.+|+.++.+++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 46667899999999999998743 357899999875432 345678899999999999999999999999999999
Q ss_pred EEEccCCCCHhHHHhcCCCc---------cccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCc
Q 003278 186 VYDYMPNRSLDRVLFRRPEN---------LEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYN 256 (834)
Q Consensus 186 V~Ey~~~gsL~~~l~~~~~~---------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~ 256 (834)
++||+++++|..++...... ......+++..+..++.|++.||.|||+. +|+||||||+|||+++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence 99999999999998533210 01124588999999999999999999985 9999999999999999999
Q ss_pred eEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccC
Q 003278 257 ARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAV 335 (834)
Q Consensus 257 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~ 335 (834)
+||+|||+++.+...... .......+++.|+|||.+..+ .++.++|||||||++|||+| |..|+
T Consensus 163 ~kl~Dfg~~~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~ 227 (283)
T cd05091 163 VKISDLGLFREVYAADYY--------------KLMGNSLLPIRWMSPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPY 227 (283)
T ss_pred eEecccccccccccchhe--------------eeccCccCCccccCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCC
Confidence 999999998854321100 011223467899999998655 57899999999999999998 77777
Q ss_pred CCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhc
Q 003278 336 DLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSG 407 (834)
Q Consensus 336 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~ 407 (834)
..... ..+..... .+..... . .. ....+..++..||+.+|.+||+|.+|+..|..
T Consensus 228 ~~~~~------~~~~~~i~-~~~~~~~-----~-~~----~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 228 CGYSN------QDVIEMIR-NRQVLPC-----P-DD----CPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred CCCCH------HHHHHHHH-cCCcCCC-----C-CC----CCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 53211 11222211 1211111 0 11 12457899999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=333.96 Aligned_cols=242 Identities=24% Similarity=0.322 Sum_probs=191.3
Q ss_pred CeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHHHHHhC-CCCceeeEeeeEEeCCEEEEEEEccCC
Q 003278 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVAVAHL-RHRNLVRLRGWCVHEDQLLLVYDYMPN 192 (834)
Q Consensus 117 ~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 192 (834)
+.||+|+||.||+|.+..++..||||++.... ......+..|..++..+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999998889999999987532 23345677888888887 799999999999999999999999999
Q ss_pred CCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhhhh
Q 003278 193 RSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHEL 272 (834)
Q Consensus 193 gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~ 272 (834)
|+|..++... ..+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 81 ~~L~~~~~~~-------~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~- 149 (318)
T cd05570 81 GDLMFHIQRS-------GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG- 149 (318)
T ss_pred CCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcC-
Confidence 9999888543 3589999999999999999999985 9999999999999999999999999998632110
Q ss_pred hhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHHHHH
Q 003278 273 QYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIRR 352 (834)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~ 352 (834)
........||+.|+|||++... .++.++|||||||++|||+||+.||..... ..+ ...
T Consensus 150 ---------------~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslGvil~~l~~G~~pf~~~~~---~~~---~~~ 207 (318)
T cd05570 150 ---------------GVTTSTFCGTPDYIAPEILSYQ-PYGPAVDWWALGVLLYEMLAGQSPFEGDDE---DEL---FQS 207 (318)
T ss_pred ---------------CCcccceecCccccCHHHhcCC-CCCcchhhhhHHHHHHHHhhCCCCCCCCCH---HHH---HHH
Confidence 0112345799999999998654 678999999999999999999999864321 111 111
Q ss_pred HhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCch-----hhHHH
Q 003278 353 LSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSM-----KWVIE 403 (834)
Q Consensus 353 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm-----~~V~~ 403 (834)
... ... ... ... ...+.+++..||+.||.+||++ .++++
T Consensus 208 i~~-~~~------~~~-~~~----~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 208 ILE-DEV------RYP-RWL----SKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred HHc-CCC------CCC-CcC----CHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 111 111 010 111 2357889999999999999999 66654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=362.40 Aligned_cols=279 Identities=20% Similarity=0.301 Sum_probs=204.7
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc---ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK---GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 187 (834)
++|+..++||+|+||.||+|++..+|+.||||++... .....+.|.+|+.++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 4688899999999999999999889999999998643 2344567999999999999999999999999999999999
Q ss_pred EccCCCCHhHHHhcCCCc----cccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeecc
Q 003278 188 DYMPNRSLDRVLFRRPEN----LEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFG 263 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFG 263 (834)
||+++|+|.+++...... ......+++..++.|+.|+++||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 999999999998642110 11124567888999999999999999985 99999999999999999999999999
Q ss_pred chhhhhhhhhh--hhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCC
Q 003278 264 LARWLEHELQY--QMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPD 341 (834)
Q Consensus 264 la~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~ 341 (834)
+++........ .....................||+.|||||.+... .++.++|||||||++|||+||+.||......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~-~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV-PASESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC-CCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 99865221100 00000000000001112345799999999988654 6799999999999999999999998642211
Q ss_pred ccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCC-chhhHHHHhhcC
Q 003278 342 DQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRP-SMKWVIEAVSGS 408 (834)
Q Consensus 342 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-sm~~V~~~l~~~ 408 (834)
. +. + ........+ .. . . ..-...+.+++..|++.||++|| ++.++.+.|...
T Consensus 238 k---i~-~------~~~i~~P~~--~~-p-~-~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 238 K---IS-Y------RDVILSPIE--VA-P-Y-REIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred h---hh-h------hhhccChhh--cc-c-c-ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1 00 0 000000000 00 0 0 01123577899999999999995 677777777654
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=327.13 Aligned_cols=264 Identities=25% Similarity=0.380 Sum_probs=198.4
Q ss_pred CCCCCCCeeeccCCeEEEEEEE----CCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeC--CEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVL----PSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHE--DQLL 184 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~----~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~ 184 (834)
++|...+.||+|+||.||+|.. ..++..||||.+........+.|.+|+.++++++||||+++++++... ..++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4678889999999999999974 346889999998776666667899999999999999999999987643 4689
Q ss_pred EEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccc
Q 003278 185 LVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGL 264 (834)
Q Consensus 185 lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGl 264 (834)
+||||+++|+|.+++... ...++|..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+
T Consensus 84 lv~e~~~~~~L~~~l~~~------~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~ 154 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH------RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGL 154 (284)
T ss_pred EEEEecCCCCHHHHHHhc------CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcc
Confidence 999999999999998643 23589999999999999999999985 999999999999999999999999999
Q ss_pred hhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCc--
Q 003278 265 ARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDD-- 342 (834)
Q Consensus 265 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~-- 342 (834)
++.+....... .......++..|+|||++..+ .++.++|||||||++|||+||..+.......-
T Consensus 155 ~~~~~~~~~~~-------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~ 220 (284)
T cd05081 155 TKVLPQDKEYY-------------KVREPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMR 220 (284)
T ss_pred cccccCCCcce-------------eecCCCCCceEeeCHHHhccC-CcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhh
Confidence 98653221100 001112245569999988654 67899999999999999999987653221100
Q ss_pred ------c-chHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhc
Q 003278 343 ------Q-IILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSG 407 (834)
Q Consensus 343 ------~-~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~ 407 (834)
. ..+..........+.. .. ........+.+++..||+.+|++||+|.+|++.|+.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~-------~~---~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05081 221 MMGNDKQGQMIVYHLIELLKNNGR-------LP---APPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA 282 (284)
T ss_pred hcccccccccchHHHHHHHhcCCc-------CC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence 0 0000111111111110 00 000112468899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=329.50 Aligned_cols=203 Identities=24% Similarity=0.337 Sum_probs=172.2
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc---ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK---GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 187 (834)
++|+..++||+|+||.||++..+.+++.||+|++.+. .......|.+|+.++..++|+||+++++++.+.+.+++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 4688889999999999999999888999999998642 1223345888999999999999999999999999999999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
||+++|+|.+++.+. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 ey~~~g~L~~~l~~~------~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~ 151 (332)
T cd05623 81 DYYVGGDLLTLLSKF------EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLK 151 (332)
T ss_pred eccCCCcHHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchhee
Confidence 999999999999653 23588899999999999999999985 999999999999999999999999999874
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCcccccc----CCCCCcccceeehhhHHHHHHhCCccCCC
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQK----GSVATAKSDVFSFGIVVLEVVSGRRAVDL 337 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~----~~~~~~ksDV~SfGvvl~ElltG~~p~~~ 337 (834)
+..... .......||+.|+|||++.. ...++.++|||||||++|||++|+.||..
T Consensus 152 ~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~ 210 (332)
T cd05623 152 LMEDGT---------------VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (332)
T ss_pred cccCCc---------------ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC
Confidence 321100 01223569999999998852 23578899999999999999999999864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=333.06 Aligned_cols=262 Identities=16% Similarity=0.227 Sum_probs=193.9
Q ss_pred hCcCcCCcccccCCcEEEEEE-ECCCcEEEEEEecCCCChhHHHHHHHHHHHHHhcc-CCCceeEEEEEeeCC-eEEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGF-LDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLR-HRNLVQLCGWCTEQG-EMLVIY 589 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~-HpNiv~l~g~~~~~~-~~~lv~ 589 (834)
+.|...+++|.|.||+||+|+ ...+..||||+++..--.-..--=.+|++.|++|+ |||||+|..++.+++ .+++||
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf 89 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF 89 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence 345566789999999999999 56789999999875432211111257999999999 999999999999988 999999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccc
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFL 669 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~ 669 (834)
|||.. +|.+++.+.+ ..++.....+|+.||..||+|+|. +|+.|||+||+|||+..+..+||+||||||.+
T Consensus 90 E~Md~-NLYqLmK~R~-----r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 90 EFMDC-NLYQLMKDRN-----RLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred Hhhhh-hHHHHHhhcC-----CcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEeccccccccc
Confidence 99976 6777877653 358899999999999999999996 69999999999999999999999999999976
Q ss_pred ccCCCCCcccccCccccccccCccchhcc-ccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhh--c
Q 003278 670 TRNDHGHRKATSGNRSVRGIFGYMSPEYI-ESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEAR--K 746 (834)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~-~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~--~ 746 (834)
... ...+.++.|.-|.|||++ +.+.|+.+.|+|++|||++|+.+-+.-|.... +-+.+..+.+.... +
T Consensus 161 ~Sk--------pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~s-E~Dqi~KIc~VLGtP~~ 231 (538)
T KOG0661|consen 161 RSK--------PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGAS-EIDQIYKICEVLGTPDK 231 (538)
T ss_pred ccC--------CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCc-HHHHHHHHHHHhCCCcc
Confidence 432 234457889999999976 67889999999999999999999875553222 21222222222110 0
Q ss_pred Cccc------cccccccC--CCCC-----HHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 747 RPLA------ELVDLSLN--GEYN-----HKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 747 ~~~~------~~~d~~l~--~~~~-----~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
..+. ..+...++ .... +....+.++++-+|+.-||.+|||+.+.++
T Consensus 232 ~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~ 290 (538)
T KOG0661|consen 232 DSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ 290 (538)
T ss_pred ccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence 0000 00000000 0000 113345667777899999999999999986
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=330.50 Aligned_cols=203 Identities=25% Similarity=0.340 Sum_probs=172.6
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc---ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK---GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 187 (834)
++|...+.||+|+||.||+++...+++.||||.+.+. .......+.+|+.++..++|+||+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4688899999999999999999889999999998642 1223455788999999999999999999999999999999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 Ey~~gg~L~~~l~~~------~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~ 151 (331)
T cd05624 81 DYYVGGDLLTLLSKF------EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLK 151 (331)
T ss_pred eCCCCCcHHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceee
Confidence 999999999999653 13578889999999999999999985 999999999999999999999999999875
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCccccccC----CCCCcccceeehhhHHHHHHhCCccCCC
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKG----SVATAKSDVFSFGIVVLEVVSGRRAVDL 337 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~----~~~~~ksDV~SfGvvl~ElltG~~p~~~ 337 (834)
+..... .......||+.|+|||++... ..++.++|||||||+||||+||+.||..
T Consensus 152 ~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 210 (331)
T cd05624 152 MNQDGT---------------VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred ccCCCc---------------eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence 422110 012335699999999988541 2468899999999999999999999864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=332.48 Aligned_cols=261 Identities=29% Similarity=0.436 Sum_probs=200.1
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeE--EEEEEeccc-ChhhHHHHHHHHHHHHhC-CCCceeeEeeeEEeCCEEEE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTV--VAVKCLAEK-GERFEKTFAAELVAVAHL-RHRNLVRLRGWCVHEDQLLL 185 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~--vAvK~l~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~l 185 (834)
.++|+..+.||+|+||.||+|.+..+|.. +|+|.+... .....+.|.+|+.++.++ +||||+++++++...+..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 46788899999999999999998777754 577776543 234456788999999999 89999999999999999999
Q ss_pred EEEccCCCCHhHHHhcCCCcc---------ccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCc
Q 003278 186 VYDYMPNRSLDRVLFRRPENL---------EAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYN 256 (834)
Q Consensus 186 V~Ey~~~gsL~~~l~~~~~~~---------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~ 256 (834)
||||+++|+|.+++....... .....+++.+++.++.|++.||+|||+. +|+||||||+|||++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCc
Confidence 999999999999997543110 1124689999999999999999999985 9999999999999999999
Q ss_pred eEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccC
Q 003278 257 ARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAV 335 (834)
Q Consensus 257 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~ 335 (834)
+||+|||+++...... ......++..|+|||++... .++.++|||||||++|||+| |..||
T Consensus 163 ~kl~dfg~~~~~~~~~-----------------~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~ 224 (303)
T cd05088 163 AKIADFGLSRGQEVYV-----------------KKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPY 224 (303)
T ss_pred EEeCccccCcccchhh-----------------hcccCCCcccccCHHHHhcc-CCcccccchhhhhHHHHHHhcCCCCc
Confidence 9999999986321100 01112346789999988544 57899999999999999998 99988
Q ss_pred CCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 336 DLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 336 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
...... +..... ..+. +.. ........+.+++..||+.+|++||++.++++.|...
T Consensus 225 ~~~~~~------~~~~~~-~~~~-------~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 225 CGMTCA------ELYEKL-PQGY-------RLE---KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred ccCChH------HHHHHH-hcCC-------cCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 532211 111111 1110 000 0001123578899999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=330.96 Aligned_cols=263 Identities=20% Similarity=0.333 Sum_probs=201.3
Q ss_pred CcCcCCcccccCCcEEEEEEEC------CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEE
Q 003278 514 NFSESQRVAEMDFGTAYQGFLD------NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLV 587 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~l 587 (834)
+|.-.+.||+|+||.||+|... ++..+++|.+.... ....+.|.+|++++++++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc-HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 4556678999999999999742 34568899876433 2334678999999999999999999999999999999
Q ss_pred EEeccCCCchhhhhhcCCCC----------CCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCC
Q 003278 588 IYDYSATRILSHLLFHNNHR----------IGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMN 657 (834)
Q Consensus 588 v~Ey~~~g~L~~~l~~~~~~----------~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~ 657 (834)
||||+++++|.+++...... .....++|..++.++.|++.||+|||+ .+|+||||||+|||+++++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCc
Confidence 99999999999998754311 112348999999999999999999996 69999999999999999999
Q ss_pred ceEeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHH
Q 003278 658 PRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLV 736 (834)
Q Consensus 658 ~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~ 736 (834)
+||+|||++........ ........|+..|||||++.+..++.++|||||||++|||+| |+.|+....+.. ..
T Consensus 162 ~~l~dfg~a~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-~~ 235 (291)
T cd05094 162 VKIGDFGMSRDVYSTDY-----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-VI 235 (291)
T ss_pred EEECCCCcccccCCCce-----eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-HH
Confidence 99999999975432211 011123457888999999999999999999999999999999 888875433221 11
Q ss_pred HHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCcc
Q 003278 737 KRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDKR 800 (834)
Q Consensus 737 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~~ 800 (834)
... .. ...... . ...+ ..+.+++.+||+.+|++|||+.+|++.|+.+.+.
T Consensus 236 ~~~---~~--~~~~~~-----~-~~~~---~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 236 ECI---TQ--GRVLER-----P-RVCP---KEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HHH---hC--CCCCCC-----C-ccCC---HHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 111 11 111110 0 1112 2455677799999999999999999999877553
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=324.15 Aligned_cols=250 Identities=24% Similarity=0.388 Sum_probs=194.1
Q ss_pred eeeccCCeEEEEEEE--CCCCeEEEEEEecccC--hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEccCCC
Q 003278 118 VLGSGGFGKVYRAVL--PSDGTVVAVKCLAEKG--ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNR 193 (834)
Q Consensus 118 ~LG~G~fG~Vy~~~~--~~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 193 (834)
.||+|+||.||+|.+ ..++..||+|+++... ....+.|.+|+.+++.++||||++++|++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999975 3567899999986432 345678999999999999999999999885 45679999999999
Q ss_pred CHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhhhhh
Q 003278 194 SLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQ 273 (834)
Q Consensus 194 sL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~ 273 (834)
+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 81 ~L~~~l~~~-------~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~ 150 (257)
T cd05116 81 PLNKFLQKN-------KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADEN 150 (257)
T ss_pred cHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCC
Confidence 999998542 3588999999999999999999985 999999999999999999999999999976532210
Q ss_pred hhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccchHHHHHHH
Q 003278 274 YQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQIILLDWIRR 352 (834)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~ 352 (834)
. ....+...+++.|+|||.+..+ .++.++|||||||++|||+| |+.||..... ..+...
T Consensus 151 ~-------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~--- 210 (257)
T cd05116 151 Y-------------YKAKTHGKWPVKWYAPECMNYY-KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG---NEVTQM--- 210 (257)
T ss_pred e-------------eeecCCCCCCccccCHhHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH---
Confidence 0 0001222356889999988654 57889999999999999998 9999864321 112121
Q ss_pred HhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcCC
Q 003278 353 LSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGSY 409 (834)
Q Consensus 353 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~~ 409 (834)
...+..... . ... ...+.+++..||+.||++||+|.+|++.|...|
T Consensus 211 -i~~~~~~~~-----~-~~~----~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05116 211 -IESGERMEC-----P-QRC----PPEMYDLMKLCWTYGVDERPGFAVVELRLRNYY 256 (257)
T ss_pred -HHCCCCCCC-----C-CCC----CHHHHHHHHHHhccCchhCcCHHHHHHHHhccc
Confidence 122221111 1 111 245789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=325.34 Aligned_cols=257 Identities=23% Similarity=0.375 Sum_probs=203.3
Q ss_pred HhhCcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEe
Q 003278 511 ATNNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYD 590 (834)
Q Consensus 511 at~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~E 590 (834)
+..+|...+.||+|+||.||+|...++..+++|.+..... .....+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL-LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch-hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 3456777788999999999999988889999999865432 234578999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccc
Q 003278 591 YSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLT 670 (834)
Q Consensus 591 y~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~ 670 (834)
|+++++|.+++..... ..++|..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++....
T Consensus 83 ~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~ 155 (261)
T cd05148 83 LMEKGSLLAFLRSPEG----QVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIK 155 (261)
T ss_pred ecccCCHHHHHhcCCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcC
Confidence 9999999999875321 247899999999999999999996 689999999999999999999999999997653
Q ss_pred cCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCcc
Q 003278 671 RNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRPL 749 (834)
Q Consensus 671 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
.... ......++..|+|||++.++.++.++||||||+++|||+| |+.|+...... ....... ...+.
T Consensus 156 ~~~~-------~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~-~~~~~~~---~~~~~- 223 (261)
T cd05148 156 EDVY-------LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH-EVYDQIT---AGYRM- 223 (261)
T ss_pred Cccc-------cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH-HHHHHHH---hCCcC-
Confidence 2211 0112346778999999988899999999999999999999 78888643322 2222111 11010
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccC
Q 003278 750 AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGN 797 (834)
Q Consensus 750 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~ 797 (834)
...... + ..+.+++.+||..||++|||+.++.+.|+.+
T Consensus 224 ------~~~~~~-~---~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 224 ------PCPAKC-P---QEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred ------CCCCCC-C---HHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 011111 1 2455677799999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=330.42 Aligned_cols=261 Identities=20% Similarity=0.294 Sum_probs=198.2
Q ss_pred hCcCcCCcccccCCcEEEEEEECC-Cc--EEEEEEecCCCChhHHHHHHHHHHHHHhc-cCCCceeEEEEEeeCCeEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDN-HQ--YVLVKRLGMSKCPALRTRFSNELQNLARL-RHRNLVQLCGWCTEQGEMLVI 588 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~-~~--~vavK~~~~~~~~~~~~~f~~E~~~l~~l-~HpNiv~l~g~~~~~~~~~lv 588 (834)
++|...+.||+|+||.||+|...+ +. .+++|.++........+.|.+|+++++++ +||||+++++++.+.+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 456777889999999999998754 32 47888877544444556799999999999 799999999999999999999
Q ss_pred EeccCCCchhhhhhcCCCCC----------CCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCc
Q 003278 589 YDYSATRILSHLLFHNNHRI----------GHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNP 658 (834)
Q Consensus 589 ~Ey~~~g~L~~~l~~~~~~~----------~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ 658 (834)
|||+++|+|.+++....... ....+++.....|+.|++.||+|||+ .+|+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeE
Confidence 99999999999986532110 11248889999999999999999996 699999999999999999999
Q ss_pred eEeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHH
Q 003278 659 RLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVK 737 (834)
Q Consensus 659 ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~ 737 (834)
||+|||++...... .......++..|+|||++.+..++.++|||||||++|||+| |..||....+.... .
T Consensus 159 kl~dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~-~ 229 (297)
T cd05089 159 KIADFGLSRGEEVY--------VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELY-E 229 (297)
T ss_pred EECCcCCCccccce--------eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-H
Confidence 99999998642110 00111233567999999998899999999999999999998 98998654332211 1
Q ss_pred HHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCc
Q 003278 738 RVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDK 799 (834)
Q Consensus 738 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~ 799 (834)
.. ... . ........+ . .+.+++.+||+.+|.+|||+.+|++.|+....
T Consensus 230 ~~---~~~---~----~~~~~~~~~-~---~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 230 KL---PQG---Y----RMEKPRNCD-D---EVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred HH---hcC---C----CCCCCCCCC-H---HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11 000 0 001111111 2 35566779999999999999999998875544
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=328.62 Aligned_cols=261 Identities=24% Similarity=0.342 Sum_probs=201.5
Q ss_pred hhCcCcCCcccccCCcEEEEEEEC------CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeE
Q 003278 512 TNNFSESQRVAEMDFGTAYQGFLD------NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEM 585 (834)
Q Consensus 512 t~~f~~~~~ig~g~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~ 585 (834)
.++|...+.||+|+||.||++... ++..||+|.+...........|.+|+.++++++||||++++++|.+.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 357888899999999999999863 35789999987665555567899999999999999999999999999999
Q ss_pred EEEEeccCCCchhhhhhcCCCC----------------CCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCc
Q 003278 586 LVIYDYSATRILSHLLFHNNHR----------------IGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSA 649 (834)
Q Consensus 586 ~lv~Ey~~~g~L~~~l~~~~~~----------------~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~N 649 (834)
++||||+++|+|.+++...... .....+++..++.++.|++.||+|||+ .+++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhh
Confidence 9999999999999998743211 112347889999999999999999996 699999999999
Q ss_pred eeecCCCCceEeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCC
Q 003278 650 ITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDF 728 (834)
Q Consensus 650 ILld~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~ 728 (834)
||+++++.+|++|||++..+...... .......++..|+|||++.++.++.++|||||||++|||+| |..|+..
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~ 235 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYY-----KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG 235 (288)
T ss_pred eEecCCCceEECccccceecccCccc-----cccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999998754322110 00112234677999999998999999999999999999998 7777753
Q ss_pred CCCchhHHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHc
Q 003278 729 RLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795 (834)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~ 795 (834)
..+.. ..... . . ..... .... .+ .++.+++.+||+.+|++|||+.||++.|+
T Consensus 236 ~~~~~-~~~~~---~-~-~~~~~-----~~~~-~~---~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 236 MAHEE-VIYYV---R-D-GNVLS-----CPDN-CP---LELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred CCHHH-HHHHH---h-c-CCCCC-----CCCC-CC---HHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 32221 11111 1 0 11100 0111 11 34566777999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=328.31 Aligned_cols=269 Identities=21% Similarity=0.352 Sum_probs=210.5
Q ss_pred cCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEeccC
Q 003278 515 FSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSA 593 (834)
Q Consensus 515 f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~~ 593 (834)
|+..+.||+|+||.||+|.. .++..||+|.+.........+.|.+|+.++++++||||+++++++......++||||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 44456799999999999986 45778999998755545556789999999999999999999999999999999999999
Q ss_pred CCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCC
Q 003278 594 TRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRND 673 (834)
Q Consensus 594 ~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~ 673 (834)
+++|.+++.. ..+++.....++.|++.||+|||+ .+|+|+||+|+||++++++.+|++|||++..+....
T Consensus 86 ~~~L~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 86 GGSALDLLKP-------GPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCcHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence 9999988753 137888889999999999999996 699999999999999999999999999997654221
Q ss_pred CCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcccccc
Q 003278 674 HGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELV 753 (834)
Q Consensus 674 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (834)
.......|+..|+|||++.+..++.++|||||||++|||+||+.|+....+.... ... ... .
T Consensus 156 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-~~~-----~~~-----~ 217 (277)
T cd06642 156 -------IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL-FLI-----PKN-----S 217 (277)
T ss_pred -------hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH-hhh-----hcC-----C
Confidence 1112346889999999999889999999999999999999999997643322111 100 000 0
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCccccccCccccchHHHhhhchhchHHHHHHHH
Q 003278 754 DLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDKRFMEDGQMTENLEEWKQRNECSLSLIKRIQA 830 (834)
Q Consensus 754 d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (834)
.+.+.+.. ...+..++.+||+.+|++||||.+|++.- -+..|..+-++=+++++|++.
T Consensus 218 ~~~~~~~~----~~~~~~li~~~l~~~p~~Rp~~~~il~~~---------------~~~~~~~~~~~~~~~~~~~~~ 275 (277)
T cd06642 218 PPTLEGQY----SKPFKEFVEACLNKDPRFRPTAKELLKHK---------------FITRYTKKTSFLTELIDRYKR 275 (277)
T ss_pred CCCCCccc----CHHHHHHHHHHccCCcccCcCHHHHHHhH---------------HHHHHhhhHHHHHHHHHHhhc
Confidence 11111111 22455666799999999999999999752 245566667777888888764
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=329.35 Aligned_cols=266 Identities=23% Similarity=0.325 Sum_probs=204.6
Q ss_pred ccHHHHHhhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhC-CCCceeeEeeeEE-
Q 003278 101 FSYAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHL-RHRNLVRLRGWCV- 178 (834)
Q Consensus 101 f~~~el~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~- 178 (834)
+.++.+..++++|+..+.||+|+||.||+|....+++.+|+|.+.... .....+.+|+.++.++ +||||++++++|.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 455667778899999999999999999999998899999999876432 2345688899999999 6999999999985
Q ss_pred ----eCCEEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCC
Q 003278 179 ----HEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQ 254 (834)
Q Consensus 179 ----~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~ 254 (834)
..+.+++||||+++|+|.+++..... ....+++..+..++.|+++||.|||+. +|+||||||+||+++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~ 160 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLK---RGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTE 160 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhc---cCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCC
Confidence 34568999999999999998864321 234688999999999999999999985 99999999999999999
Q ss_pred CceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCcccccc----CCCCCcccceeehhhHHHHHHh
Q 003278 255 YNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQK----GSVATAKSDVFSFGIVVLEVVS 330 (834)
Q Consensus 255 ~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~----~~~~~~ksDV~SfGvvl~Ellt 330 (834)
+.+||+|||+++.+.... .......||+.|+|||++.. +..++.++|||||||++|||+|
T Consensus 161 ~~~kl~dfg~~~~~~~~~----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~ 224 (286)
T cd06638 161 GGVKLVDFGVSAQLTSTR----------------LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGD 224 (286)
T ss_pred CCEEEccCCceeecccCC----------------CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhc
Confidence 999999999987542210 01123458999999998753 2346889999999999999999
Q ss_pred CCccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 331 GRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 331 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
|+.|+....... .+.. . .........++ ..+ ...+..++..||+.+|++||++.++++.
T Consensus 225 g~~p~~~~~~~~--~~~~----~-~~~~~~~~~~~----~~~----~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 225 GDPPLADLHPMR--ALFK----I-PRNPPPTLHQP----ELW----SNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred CCCCCCCCchhH--HHhh----c-cccCCCcccCC----CCc----CHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 999986432111 0100 0 00100011111 011 1357889999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=320.63 Aligned_cols=255 Identities=17% Similarity=0.267 Sum_probs=187.0
Q ss_pred cccccCCcEEEEEEECCC---cEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEeccCCCc
Q 003278 520 RVAEMDFGTAYQGFLDNH---QYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRI 596 (834)
Q Consensus 520 ~ig~g~~g~vy~~~~~~~---~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~~~g~ 596 (834)
.||+|+||.||+|...++ ..+++|.+.........+.|.+|+.+++.++|||||+++|+|.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999975433 34667777655444456789999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCCCCC
Q 003278 597 LSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGH 676 (834)
Q Consensus 597 L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~~~~ 676 (834)
|.+++...... ...+++.....++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||++........
T Consensus 82 L~~~l~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~-- 154 (268)
T cd05086 82 LKSYLSQEQWH--RRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY-- 154 (268)
T ss_pred HHHHHHhhhcc--cccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchh--
Confidence 99998754221 1235666677899999999999996 6899999999999999999999999999864221110
Q ss_pred cccccCccccccccCccchhcccc-------CCCCccCcchhhHHHHHHHHhC-CCccCCCCCchhHHHHHHHHHhhcCc
Q 003278 677 RKATSGNRSVRGIFGYMSPEYIES-------GEATSMADVYSFGVVVLEVVTG-QMAVDFRLPEGLLVKRVHEFEARKRP 748 (834)
Q Consensus 677 ~~~~~~~~~~~Gt~~Y~aPE~~~~-------~~~~~k~DV~SfGvvl~E~~tG-~~p~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
........|+..|+|||++.. ..++.++|||||||++|||+|+ ..|+....+........ . ..
T Consensus 155 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~----~--~~ 225 (268)
T cd05086 155 ---IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVI----K--DQ 225 (268)
T ss_pred ---hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH----h--hc
Confidence 011224568899999998743 2457899999999999999985 55664332222111111 1 11
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHc
Q 003278 749 LAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795 (834)
Q Consensus 749 ~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~ 795 (834)
...+.++.+...+.. . +.+++..|| .+|++||||.+|++.|.
T Consensus 226 ~~~~~~~~~~~~~~~-~---~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 226 QVKLFKPQLELPYSE-R---WYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred ccccCCCccCCCCcH-H---HHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 123334444333332 2 334555799 67999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=322.68 Aligned_cols=250 Identities=23% Similarity=0.353 Sum_probs=194.7
Q ss_pred CcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEeccC
Q 003278 514 NFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSA 593 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~~ 593 (834)
+|...+.||+|+||.||+|...++..+|+|.+..... ....|.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM--SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 3556678999999999999987777899998764322 23568899999999999999999999999999999999999
Q ss_pred CCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCC
Q 003278 594 TRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRND 673 (834)
Q Consensus 594 ~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~ 673 (834)
+++|.+++..... .++|...+.++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~ 154 (256)
T cd05059 83 NGCLLNYLRERKG-----KLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ 154 (256)
T ss_pred CCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceeccccc
Confidence 9999999865321 47899999999999999999997 689999999999999999999999999997643211
Q ss_pred CCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCccccc
Q 003278 674 HGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRPLAEL 752 (834)
Q Consensus 674 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (834)
. .......++..|+|||++.+..++.++|||||||++|||+| |+.|+....+ ........ ...
T Consensus 155 ~------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-~~~~~~~~---~~~------ 218 (256)
T cd05059 155 Y------TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN-SEVVESVS---AGY------ 218 (256)
T ss_pred c------cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH-HHHHHHHH---cCC------
Confidence 0 00111234567999999998999999999999999999999 7888764322 22111111 000
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHH
Q 003278 753 VDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSIL 794 (834)
Q Consensus 753 ~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L 794 (834)
....... .+ ..+.+++.+||..+|++||||.+|++.|
T Consensus 219 -~~~~~~~-~~---~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 219 -RLYRPKL-AP---TEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred -cCCCCCC-CC---HHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 0111111 12 2456677799999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=326.89 Aligned_cols=239 Identities=22% Similarity=0.312 Sum_probs=183.5
Q ss_pred cccccCCcEEEEEEECC-------------------------CcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCcee
Q 003278 520 RVAEMDFGTAYQGFLDN-------------------------HQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQ 574 (834)
Q Consensus 520 ~ig~g~~g~vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~ 574 (834)
.||+|+||.||+|.+.. ...|++|.+.... ......|.+|+.++++++|||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~~~~l~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH-RDIALAFFETASLMSQVSHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH-HHHHHHHHHHHHHHhcCCCCCeee
Confidence 58999999999998521 1358889886433 233467889999999999999999
Q ss_pred EEEEEeeCCeEEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecC
Q 003278 575 LCGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDP 654 (834)
Q Consensus 575 l~g~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~ 654 (834)
++|+|.+....++||||+++|+|..++.... ..+++..+++++.|+++||+|||+ .+|+||||||+|||+++
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~ 152 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEK-----GRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLAR 152 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEec
Confidence 9999999999999999999999998886432 237888899999999999999996 69999999999999986
Q ss_pred CC-------CceEeeeeeccccccCCCCCcccccCccccccccCccchhcccc-CCCCccCcchhhHHHHHHHH-hCCCc
Q 003278 655 DM-------NPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIES-GEATSMADVYSFGVVVLEVV-TGQMA 725 (834)
Q Consensus 655 ~~-------~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~k~DV~SfGvvl~E~~-tG~~p 725 (834)
++ .+|++|||++...... ....|+..|+|||++.+ ..++.++|||||||++|||+ +|+.|
T Consensus 153 ~~~~~~~~~~~kl~d~g~~~~~~~~-----------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p 221 (274)
T cd05076 153 LGLAEGTSPFIKLSDPGVSFTALSR-----------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVP 221 (274)
T ss_pred cCcccCccceeeecCCccccccccc-----------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 54 3799999998543211 12357788999998865 56899999999999999995 78888
Q ss_pred cCCCCCchhHHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHc
Q 003278 726 VDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795 (834)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~ 795 (834)
+....+... .. ....... .....+ ..+..++.+||+.+|++||||.+|++.|+
T Consensus 222 ~~~~~~~~~-~~----~~~~~~~--------~~~~~~----~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 222 LKERTPSEK-ER----FYEKKHR--------LPEPSC----KELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred ccccChHHH-HH----HHHhccC--------CCCCCC----hHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 865433221 11 1111111 111111 24566777999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=334.16 Aligned_cols=267 Identities=20% Similarity=0.263 Sum_probs=197.3
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC-hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEc
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG-ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDY 189 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 189 (834)
++|...+.||+|+||.||+|+...++..||+|.+.... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 46888899999999999999998899999999986432 23345678899999999999999999999999999999999
Q ss_pred cCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhh
Q 003278 190 MPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLE 269 (834)
Q Consensus 190 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~ 269 (834)
+++ +|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 86 ~~~-~l~~~~~~~------~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 155 (309)
T cd07872 86 LDK-DLKQYMDDC------GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKS 155 (309)
T ss_pred CCC-CHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecC
Confidence 985 888777543 23578899999999999999999985 99999999999999999999999999987432
Q ss_pred hhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHH-
Q 003278 270 HELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLD- 348 (834)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~- 348 (834)
... .......||+.|+|||.+.....++.++|||||||++|||+||+.||......+......
T Consensus 156 ~~~----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 219 (309)
T cd07872 156 VPT----------------KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFR 219 (309)
T ss_pred CCc----------------cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 110 001233579999999988665567899999999999999999999986543222111110
Q ss_pred --------HHHHHhhcCccccccccccCC----CCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 349 --------WIRRLSDEGKVLQAGDNRLSD----GSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 349 --------~~~~~~~~~~~~~~~d~~l~~----~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
+...............+.... ..... -...+.++...|++.||.+||++.|+++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 220 LLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPR-LDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred HhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccC-CCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 000000000000000000000 00000 01346789999999999999999999863
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=327.88 Aligned_cols=251 Identities=23% Similarity=0.350 Sum_probs=200.1
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEcc
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYM 190 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 190 (834)
.+|+..+.||+|+||.||+|+...++..||+|.+........+.+.+|+.+++.++||||++++++|...+..++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 45788889999999999999998899999999987655555677899999999999999999999999999999999999
Q ss_pred CCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhh
Q 003278 191 PNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEH 270 (834)
Q Consensus 191 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~ 270 (834)
++++|.+++.. ..+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 100 ~~~~L~~~~~~--------~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~ 168 (296)
T cd06654 100 AGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (296)
T ss_pred CCCCHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence 99999998853 2478899999999999999999985 999999999999999999999999999875322
Q ss_pred hhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHHH
Q 003278 271 ELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWI 350 (834)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~ 350 (834)
.. .......|++.|+|||.+... ..+.++|||||||++|||+||+.||....+... +..
T Consensus 169 ~~----------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~--~~~-- 227 (296)
T cd06654 169 EQ----------------SKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LYL-- 227 (296)
T ss_pred cc----------------cccCcccCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh--HHH--
Confidence 10 001234589999999988654 568999999999999999999999865432111 111
Q ss_pred HHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 351 RRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 351 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
....+. +.+. ....-...+.+++..||..+|++||++.++++.
T Consensus 228 --~~~~~~------~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 228 --IATNGT------PELQ---NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred --HhcCCC------CCCC---CccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 111110 0110 000112357789999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=334.02 Aligned_cols=242 Identities=14% Similarity=0.190 Sum_probs=185.1
Q ss_pred CcccccCCcEEEEEEEC-CCcEEEEEEecCCC--ChhHHHHHHHHHHHHHhc-cCCCceeEEEEEeeCCeEEEEEeccCC
Q 003278 519 QRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSK--CPALRTRFSNELQNLARL-RHRNLVQLCGWCTEQGEMLVIYDYSAT 594 (834)
Q Consensus 519 ~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~E~~~l~~l-~HpNiv~l~g~~~~~~~~~lv~Ey~~~ 594 (834)
+.||+|+||.||++... +++.||+|.+.... .....+.+.+|+.++.++ +|||||++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 35899999999999964 57889999987532 223345678899998877 899999999999999999999999999
Q ss_pred CchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCCC
Q 003278 595 RILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDH 674 (834)
Q Consensus 595 g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~~ 674 (834)
|+|..++.... .+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~~L~~~~~~~~------~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~- 150 (329)
T cd05618 81 GDLMFHMQRQR------KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG- 150 (329)
T ss_pred CCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-
Confidence 99988875432 37888889999999999999996 699999999999999999999999999987532211
Q ss_pred CCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCC----chhHHHHHHHHHhhcCccc
Q 003278 675 GHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLP----EGLLVKRVHEFEARKRPLA 750 (834)
Q Consensus 675 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~----~~~~~~~~~~~~~~~~~~~ 750 (834)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||..... ................
T Consensus 151 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--- 221 (329)
T cd05618 151 ------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--- 221 (329)
T ss_pred ------CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC---
Confidence 112346799999999999999999999999999999999999999853211 1111111111111100
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCh
Q 003278 751 ELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSM 787 (834)
Q Consensus 751 ~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm 787 (834)
..++...+ . .+..++.+||..||++|||.
T Consensus 222 ----~~~p~~~~-~---~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 222 ----IRIPRSLS-V---KAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred ----CCCCCCCC-H---HHHHHHHHHhcCCHHHcCCC
Confidence 01111222 2 34456668999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=328.97 Aligned_cols=261 Identities=28% Similarity=0.414 Sum_probs=202.1
Q ss_pred CCCCCCCeeeccCCeEEEEEEEC-----CCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLP-----SDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLL 185 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~-----~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 185 (834)
++|...++||+|+||.||++... .++..+|+|.+........+.|.+|+.+++.++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46777899999999999999742 3567899999887766677889999999999999999999999999999999
Q ss_pred EEEccCCCCHhHHHhcCCCc--------cccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCce
Q 003278 186 VYDYMPNRSLDRVLFRRPEN--------LEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNA 257 (834)
Q Consensus 186 V~Ey~~~gsL~~~l~~~~~~--------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~ 257 (834)
||||+++|+|.+++...... ......++|..++.++.|++.||+|||+. +|+||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCE
Confidence 99999999999998754321 11124589999999999999999999985 99999999999999999999
Q ss_pred EEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCC
Q 003278 258 RLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVD 336 (834)
Q Consensus 258 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~ 336 (834)
||+|||+++.......+ .......+++.|+|||.+... .++.++|||||||++|||+| |+.||.
T Consensus 162 kL~dfg~~~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~ 226 (280)
T cd05092 162 KIGDFGMSRDIYSTDYY--------------RVGGRTMLPIRWMPPESILYR-KFTTESDIWSFGVVLWEIFTYGKQPWY 226 (280)
T ss_pred EECCCCceeEcCCCcee--------------ecCCCccccccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCc
Confidence 99999998754221000 001223357889999988654 57999999999999999999 888875
Q ss_pred CCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhh
Q 003278 337 LTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVS 406 (834)
Q Consensus 337 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~ 406 (834)
..... .. .... ..+..... + ... ...+.+++..||+.||.+||++.+|.+.|+
T Consensus 227 ~~~~~---~~---~~~~-~~~~~~~~--~----~~~----~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 227 QLSNT---EA---IECI-TQGRELER--P----RTC----PPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred cCCHH---HH---HHHH-HcCccCCC--C----CCC----CHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 32211 11 1111 11111100 0 111 235789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=353.41 Aligned_cols=258 Identities=20% Similarity=0.232 Sum_probs=198.6
Q ss_pred HHhhCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCC-ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCC----
Q 003278 510 SATNNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSK-CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQG---- 583 (834)
Q Consensus 510 ~at~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~-~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~---- 583 (834)
...++|...+.||+|+||+||+|.. .+++.||||.+.... .......+.+|+.++..++|+|||+++..+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 3456788888999999999999984 568999999987543 3444567899999999999999999987664322
Q ss_pred ----eEEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCce
Q 003278 584 ----EMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPR 659 (834)
Q Consensus 584 ----~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~k 659 (834)
.+++||||+++|+|.+++...... ...+++.....++.|++.||.|||+ .+|+||||||+||||+.++.+|
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~--~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKT--NRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEE
Confidence 368999999999999998754321 2357888889999999999999996 6999999999999999999999
Q ss_pred EeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHH
Q 003278 660 LGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRV 739 (834)
Q Consensus 660 i~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~ 739 (834)
|+|||+++....... ........||+.|||||++.+..++.++|||||||+||||+||+.||........ ....
T Consensus 184 L~DFGls~~~~~~~~-----~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~-~~~~ 257 (496)
T PTZ00283 184 LGDFGFSKMYAATVS-----DDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEV-MHKT 257 (496)
T ss_pred EEecccCeecccccc-----ccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHH
Confidence 999999986533211 1112356899999999999999999999999999999999999999864332211 1111
Q ss_pred HHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 740 HEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 740 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
... .. ++ +.... .. .+..++.+||+.||++|||+.++++
T Consensus 258 ---~~~--~~----~~-~~~~~-~~---~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 258 ---LAG--RY----DP-LPPSI-SP---EMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred ---hcC--CC----CC-CCCCC-CH---HHHHHHHHHcccChhhCcCHHHHHh
Confidence 100 00 00 11112 22 3445666899999999999999875
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=306.23 Aligned_cols=200 Identities=21% Similarity=0.295 Sum_probs=175.3
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChh--HHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPA--LRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIY 589 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~--~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~ 589 (834)
++|....-+|.|+||.|...+. .+|...|+|.++...--. ..+-..+|-.+|+.+.||.+|+|++.|.+.+.+++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 4577778899999999999885 457889999987543222 2244678999999999999999999999999999999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccc
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFL 669 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~ 669 (834)
||.++|-|..+|+..++ ++.....-+|.||+.||+|||+ ..||+|||||+|||||++|.+||.|||+|+.+
T Consensus 124 eyv~GGElFS~Lrk~~r------F~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v 194 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGR------FSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRV 194 (355)
T ss_pred eccCCccHHHHHHhcCC------CCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEe
Confidence 99999999999986543 6777777899999999999997 69999999999999999999999999999875
Q ss_pred ccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCC
Q 003278 670 TRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLP 731 (834)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~ 731 (834)
.. .+-+.|||+.|+|||.+.+..|..++|.|||||++|||+.|..||....+
T Consensus 195 ~~----------rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~ 246 (355)
T KOG0616|consen 195 SG----------RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP 246 (355)
T ss_pred cC----------cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence 42 24468999999999999999999999999999999999999999986555
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=338.18 Aligned_cols=200 Identities=20% Similarity=0.276 Sum_probs=163.1
Q ss_pred cCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCC-ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeC-----CeEEE
Q 003278 515 FSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSK-CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQ-----GEMLV 587 (834)
Q Consensus 515 f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~-~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~-----~~~~l 587 (834)
|...+.||+|+||.||+|.. .++..||||++.... ......++.+|+.++++++|||||++++++... ...++
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence 45567899999999999995 468899999986432 222335688999999999999999999988543 24799
Q ss_pred EEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecc
Q 003278 588 IYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAE 667 (834)
Q Consensus 588 v~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~ 667 (834)
||||+. ++|.+++.... .+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 82 v~e~~~-~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~ 151 (338)
T cd07859 82 VFELME-SDLHQVIKAND------DLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLAR 151 (338)
T ss_pred EEecCC-CCHHHHHHhcc------cCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCcccc
Confidence 999996 67888775432 37889999999999999999997 689999999999999999999999999997
Q ss_pred ccccCCCCCcccccCccccccccCccchhcccc--CCCCccCcchhhHHHHHHHHhCCCccCC
Q 003278 668 FLTRNDHGHRKATSGNRSVRGIFGYMSPEYIES--GEATSMADVYSFGVVVLEVVTGQMAVDF 728 (834)
Q Consensus 668 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~k~DV~SfGvvl~E~~tG~~p~~~ 728 (834)
........ ........||+.|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus 152 ~~~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~ 210 (338)
T cd07859 152 VAFNDTPT----AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 210 (338)
T ss_pred ccccccCc----cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 64322110 111234579999999999875 6789999999999999999999999854
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=323.35 Aligned_cols=259 Identities=26% Similarity=0.395 Sum_probs=195.6
Q ss_pred CCCCCeeeccCCeEEEEEEECCCCe--EEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeC------CE
Q 003278 113 FDEDEVLGSGGFGKVYRAVLPSDGT--VVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHE------DQ 182 (834)
Q Consensus 113 f~~~~~LG~G~fG~Vy~~~~~~~g~--~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------~~ 182 (834)
|...+.||+|+||.||+|.+..++. .||||.++.. .....+.|.+|+.+++.++||||++++++|... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3456899999999999999876665 6999987643 234456789999999999999999999988643 24
Q ss_pred EEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeec
Q 003278 183 LLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDF 262 (834)
Q Consensus 183 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DF 262 (834)
.++||||+++|+|.+++...... .....++|.....++.|++.||+|||+. +|+||||||+|||+++++.+||+||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Df 156 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLG-DCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADF 156 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhccc-CCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCC
Confidence 78999999999999887432111 1234589999999999999999999985 9999999999999999999999999
Q ss_pred cchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCC
Q 003278 263 GLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPD 341 (834)
Q Consensus 263 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~ 341 (834)
|+++.+...... .......+++.|+|||++... .++.++|||||||++|||++ |+.|+....
T Consensus 157 g~~~~~~~~~~~--------------~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~-- 219 (272)
T cd05075 157 GLSKKIYNGDYY--------------RQGRIAKMPVKWIAIESLADR-VYTTKSDVWSFGVTMWEIATRGQTPYPGVE-- 219 (272)
T ss_pred CcccccCcccce--------------ecCCcccCCcccCCHHHccCC-CcChHHHHHHHHHHHHHHHcCCCCCCCCCC--
Confidence 999864321100 001223467789999988654 67899999999999999999 788875421
Q ss_pred ccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhc
Q 003278 342 DQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSG 407 (834)
Q Consensus 342 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~ 407 (834)
...+.. ....+..... . . .....+.+++..||+.+|++||++.++++.|..
T Consensus 220 -~~~~~~----~~~~~~~~~~-----~-~----~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 220 -NSEIYD----YLRQGNRLKQ-----P-P----DCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred -HHHHHH----HHHcCCCCCC-----C-C----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 111111 1112211110 0 1 112457899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=326.99 Aligned_cols=257 Identities=28% Similarity=0.425 Sum_probs=204.7
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc-ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEc
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDY 189 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 189 (834)
++|+..+.||+|+||+||+|....+|+.||+|++... .....+.|.+|+.+++.++||||+++++++...+.+++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 4677888999999999999999888999999987643 244567899999999999999999999999999999999999
Q ss_pred cCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhh
Q 003278 190 MPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLE 269 (834)
Q Consensus 190 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~ 269 (834)
+++|+|..++... .++++.....++.+++.||.|||+. .+++||||||+||++++++.++|+|||++....
T Consensus 85 ~~~~~L~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~ 155 (284)
T cd06620 85 MDCGSLDRIYKKG-------GPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI 155 (284)
T ss_pred CCCCCHHHHHHhc-------cCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence 9999999887542 3589999999999999999999973 389999999999999999999999999986432
Q ss_pred hhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCc-----cc
Q 003278 270 HELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDD-----QI 344 (834)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~-----~~ 344 (834)
.. ......||..|+|||++..+ .++.++|||||||++|||+||+.||+.....+ ..
T Consensus 156 ~~------------------~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~ 216 (284)
T cd06620 156 NS------------------IADTFVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPM 216 (284)
T ss_pred hh------------------ccCccccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhh
Confidence 11 01234689999999988655 67889999999999999999999997544321 11
Q ss_pred hHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHh
Q 003278 345 ILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAV 405 (834)
Q Consensus 345 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l 405 (834)
.+..++.....+. .+.+.... ....+.+++..|++.||++||++.+|++..
T Consensus 217 ~~~~~~~~~~~~~------~~~~~~~~----~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 217 GILDLLQQIVQEP------PPRLPSSD----FPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred HHHHHHHHHhhcc------CCCCCchh----cCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 1223333322111 11111111 123578899999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=335.95 Aligned_cols=242 Identities=19% Similarity=0.226 Sum_probs=189.0
Q ss_pred cccccCCcEEEEEEE-CCCcEEEEEEecCCC--ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEeccCCCc
Q 003278 520 RVAEMDFGTAYQGFL-DNHQYVLVKRLGMSK--CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRI 596 (834)
Q Consensus 520 ~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~--~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~~~g~ 596 (834)
.||+|+||.||++.. .++..||+|.+.... .......+.+|++++..++||||+++++++...+..++||||+++|+
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (325)
T cd05594 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (325)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCc
Confidence 589999999999985 568899999986432 22234567889999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCCCCC
Q 003278 597 LSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGH 676 (834)
Q Consensus 597 L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~~~~ 676 (834)
|..++.... .+++.....++.|++.||+|||+. .+|+||||||+|||+++++.+||+|||+++......
T Consensus 82 L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--- 150 (325)
T cd05594 82 LFFHLSRER------VFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--- 150 (325)
T ss_pred HHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC---
Confidence 988875432 478889999999999999999962 589999999999999999999999999987532211
Q ss_pred cccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCccccccccc
Q 003278 677 RKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLS 756 (834)
Q Consensus 677 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 756 (834)
.......||+.|||||++.++.++.++|||||||+||||+||+.||........ ... ..... ..
T Consensus 151 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~-~~~---i~~~~--------~~ 214 (325)
T cd05594 151 ----ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-FEL---ILMEE--------IR 214 (325)
T ss_pred ----cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH-HHH---HhcCC--------CC
Confidence 112245799999999999999999999999999999999999999864332211 111 10000 01
Q ss_pred cCCCCCHHHHHHHHHHHHHhccCCCCCCC-----ChhHHHH
Q 003278 757 LNGEYNHKELMRLIKLGIACTLSNPELRP-----SMRQILS 792 (834)
Q Consensus 757 l~~~~~~~~~~~l~~l~~~C~~~~P~~RP-----tm~~v~~ 792 (834)
+....+ .++ ..+..+||+.||++|| ++.++++
T Consensus 215 ~p~~~~-~~~---~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 215 FPRTLS-PEA---KSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred CCCCCC-HHH---HHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 111222 333 4455589999999997 8888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=324.03 Aligned_cols=257 Identities=22% Similarity=0.357 Sum_probs=199.3
Q ss_pred hCcCcCCcccccCCcEEEEEEEC----CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD----NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVI 588 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~----~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv 588 (834)
++|...+.||+|+||.||+|... .+..+|+|.++........+.|.+|+.++.+++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 35666788999999999999863 23379999887655555567899999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccc
Q 003278 589 YDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEF 668 (834)
Q Consensus 589 ~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~ 668 (834)
|||+++++|.+++.... ..+++..++.|+.|++.||+|||+ .+++||||||+|||++.++.+|++|||++..
T Consensus 84 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd05066 84 TEYMENGSLDAFLRKHD-----GQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRV 155 (267)
T ss_pred EEcCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCcccc
Confidence 99999999999986542 247889999999999999999996 6899999999999999999999999999986
Q ss_pred cccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcC
Q 003278 669 LTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKR 747 (834)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
+....... .......++..|+|||++.++.++.++|||||||++||+++ |..|+....+.. ....... ..+
T Consensus 156 ~~~~~~~~----~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~-~~~~~~~---~~~ 227 (267)
T cd05066 156 LEDDPEAA----YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD-VIKAIEE---GYR 227 (267)
T ss_pred ccccccee----eecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH-HHHHHhC---CCc
Confidence 54321110 01112234568999999998899999999999999999887 999986433322 1111111 000
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHcc
Q 003278 748 PLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDG 796 (834)
Q Consensus 748 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~ 796 (834)
....... + ..+.+++.+||+.+|.+||||.+|++.|+.
T Consensus 228 -------~~~~~~~-~---~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 228 -------LPAPMDC-P---AALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred -------CCCCCCC-C---HHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 0011111 1 245567779999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=327.45 Aligned_cols=262 Identities=18% Similarity=0.234 Sum_probs=189.2
Q ss_pred CcCcCCcccccCCcEEEEEEE--CCCcEEEEEEecCCCC-hhHHHHHHHHHHHHHhc---cCCCceeEEEEEe-----eC
Q 003278 514 NFSESQRVAEMDFGTAYQGFL--DNHQYVLVKRLGMSKC-PALRTRFSNELQNLARL---RHRNLVQLCGWCT-----EQ 582 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~--~~~~~vavK~~~~~~~-~~~~~~f~~E~~~l~~l---~HpNiv~l~g~~~-----~~ 582 (834)
+|...+.||+|+||.||+|.. .++..||||.+..... ......+.+|+.+++++ +||||++++++|. ..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 466678899999999999985 3467899998865432 22234566788777766 6999999999985 24
Q ss_pred CeEEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEee
Q 003278 583 GEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGS 662 (834)
Q Consensus 583 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~D 662 (834)
...++||||++ ++|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~D 153 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVPE----PGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLAD 153 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEcc
Confidence 56899999997 588888764321 247889999999999999999996 6999999999999999999999999
Q ss_pred eeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHH
Q 003278 663 FALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEF 742 (834)
Q Consensus 663 fGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~ 742 (834)
||+++..... .......||+.|+|||++.+..++.++|||||||++|||+||+.||........+.. +.+.
T Consensus 154 fg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~-i~~~ 224 (290)
T cd07862 154 FGLARIYSFQ--------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK-ILDV 224 (290)
T ss_pred ccceEeccCC--------cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHH-HHHH
Confidence 9999764321 112345789999999999988999999999999999999999999875443332222 2111
Q ss_pred HhhcC--cccc---ccccccC--CCCCHHH-----HHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 743 EARKR--PLAE---LVDLSLN--GEYNHKE-----LMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 743 ~~~~~--~~~~---~~d~~l~--~~~~~~~-----~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
..... .+.. +....+. .....+. -..+.+++.+|++.||++|||+.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 225 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 10000 0000 0000000 0000000 123456777999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=333.30 Aligned_cols=262 Identities=24% Similarity=0.361 Sum_probs=202.7
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC-hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEc
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG-ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDY 189 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 189 (834)
......++||+|-||+|.+|.. ..+..||||.++... .....+|..|+++|.+|+|||||+|+|.|..++.+++|+||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 4455668999999999999998 457999999998654 34568999999999999999999999999999999999999
Q ss_pred cCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhh
Q 003278 190 MPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLE 269 (834)
Q Consensus 190 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~ 269 (834)
|++|+|.++|..+.... +.-....+|+.|||.||+||.+- ++|||||.+.|+|+|.++++||+|||++|-+.
T Consensus 617 mEnGDLnqFl~aheapt-----~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPT-----AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred HhcCcHHHHHHhccCcc-----cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccc
Confidence 99999999997652211 23345578999999999999985 99999999999999999999999999999664
Q ss_pred hhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh--CCccCCCCCCCccchHH
Q 003278 270 HELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS--GRRAVDLTYPDDQIILL 347 (834)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt--G~~p~~~~~~~~~~~l~ 347 (834)
....+.. ..+.+=...|||||.+..+ .+|.+||||+|||++||+++ ..+|+.....+ ..+
T Consensus 689 sg~yy~v--------------qgr~vlpiRwmawEsillg-kFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e---~vv 750 (807)
T KOG1094|consen 689 SGDYYRV--------------QGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE---QVV 750 (807)
T ss_pred cCCceee--------------ecceeeeeeehhHHHHHhc-cccchhhhhhhHHHHHHHHHHHhhCchhhhhHH---HHH
Confidence 4332211 2233446889999999887 57999999999999999875 66676532211 122
Q ss_pred HHHHHHhhcCccccc-cccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhc
Q 003278 348 DWIRRLSDEGKVLQA-GDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSG 407 (834)
Q Consensus 348 ~~~~~~~~~~~~~~~-~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~ 407 (834)
+-...++..+-.... ..|+ .....+.++++.||..+-.+||+++++...|..
T Consensus 751 en~~~~~~~~~~~~~l~~P~--------~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~ 803 (807)
T KOG1094|consen 751 ENAGEFFRDQGRQVVLSRPP--------ACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE 803 (807)
T ss_pred HhhhhhcCCCCcceeccCCC--------cCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence 222333322211111 1111 223568899999999999999999999887754
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=325.55 Aligned_cols=257 Identities=23% Similarity=0.333 Sum_probs=188.1
Q ss_pred eeeccCCeEEEEEEECC--CCeEEEEEEeccc-ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEccCCCC
Q 003278 118 VLGSGGFGKVYRAVLPS--DGTVVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNRS 194 (834)
Q Consensus 118 ~LG~G~fG~Vy~~~~~~--~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 194 (834)
.||+|+||.||+|.... ....+|+|.+... .......|.+|+.+++.++||||++++++|...+..++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 68999999999997532 3457899987543 23445678899999999999999999999999999999999999999
Q ss_pred HhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhhhhhh
Q 003278 195 LDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQY 274 (834)
Q Consensus 195 L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~ 274 (834)
|.+++....... ....++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 82 L~~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 82 LKNYLRSNRGMV--AQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred HHHHHHhccccc--cccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence 999997643211 23456888899999999999999986 9999999999999999999999999998643221100
Q ss_pred hhhcccccccccccccceeeeccccCCCcccccc------CCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccchHH
Q 003278 275 QMRTSSARNHQFHLAETTRIGGTIGYLPPESFQK------GSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQIILL 347 (834)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~------~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~ 347 (834)
.......+++.|+|||++.. ...++.++|||||||++|||++ |..|+...... . .
T Consensus 157 --------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--~-~- 218 (269)
T cd05042 157 --------------ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE--Q-V- 218 (269)
T ss_pred --------------eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH--H-H-
Confidence 00122346788999998743 2346789999999999999999 67776532211 1 1
Q ss_pred HHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhh
Q 003278 348 DWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVS 406 (834)
Q Consensus 348 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~ 406 (834)
......++ .....++.+. ..+ ...+..+...|| .||++||++.+|++.|+
T Consensus 219 --~~~~~~~~-~~~~~~~~~~-~~~----~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 219 --LKQVVREQ-DIKLPKPQLD-LKY----SDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred --HHHHhhcc-CccCCCCccc-ccC----CHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 11111111 1112222211 111 234566778888 49999999999998864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=326.92 Aligned_cols=266 Identities=24% Similarity=0.390 Sum_probs=202.3
Q ss_pred hhcCCCCCCCeeeccCCeEEEEEEECC-----CCeEEEEEEecccC-hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCC
Q 003278 108 IGSNGFDEDEVLGSGGFGKVYRAVLPS-----DGTVVAVKCLAEKG-ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHED 181 (834)
Q Consensus 108 ~~t~~f~~~~~LG~G~fG~Vy~~~~~~-----~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~ 181 (834)
+++++|+..+.||+|+||.||+|..+. .+..||+|.+.... ......+.+|+.+++.++||||+++++++...+
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 456789999999999999999997642 35689999876443 233456889999999999999999999999999
Q ss_pred EEEEEEEccCCCCHhHHHhcCCCcc---ccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceE
Q 003278 182 QLLLVYDYMPNRSLDRVLFRRPENL---EAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNAR 258 (834)
Q Consensus 182 ~~~lV~Ey~~~gsL~~~l~~~~~~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~k 258 (834)
..++||||+++|+|.+++....... .....+++.....++.|++.||.|||+. +|+||||||+|||+++++.+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEE
Confidence 9999999999999999997532211 1124567888999999999999999985 999999999999999999999
Q ss_pred EeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCC
Q 003278 259 LGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDL 337 (834)
Q Consensus 259 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~ 337 (834)
|+|||+++.+...... .......++..|+|||.+..+ .++.++|||||||++|||++ |..|+..
T Consensus 160 L~Dfg~~~~~~~~~~~--------------~~~~~~~~~~~y~~pE~~~~~-~~~~~~DvwslG~~l~el~~~~~~p~~~ 224 (288)
T cd05061 160 IGDFGMTRDIYETDYY--------------RKGGKGLLPVRWMAPESLKDG-VFTTSSDMWSFGVVLWEITSLAEQPYQG 224 (288)
T ss_pred ECcCCccccccccccc--------------cccCCCcccccccCHHHhccC-CCChHhHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999754321100 001223457789999998655 57899999999999999999 6777753
Q ss_pred CCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 338 TYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 338 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
.... ++...... +.... .. ......+.+++..|++.+|++||+|.++++.|...
T Consensus 225 ~~~~------~~~~~~~~-~~~~~-----~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 225 LSNE------QVLKFVMD-GGYLD-----QP-----DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred CCHH------HHHHHHHc-CCCCC-----CC-----CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 2211 11111111 11111 00 01124688999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=320.48 Aligned_cols=250 Identities=24% Similarity=0.363 Sum_probs=192.6
Q ss_pred eeeccCCeEEEEEEEC--CCCeEEEEEEecccC-hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEccCCCC
Q 003278 118 VLGSGGFGKVYRAVLP--SDGTVVAVKCLAEKG-ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNRS 194 (834)
Q Consensus 118 ~LG~G~fG~Vy~~~~~--~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 194 (834)
.||+|+||.||+|.+. .++..||||.+.... ....+.|.+|+.++++++||||++++++|. .+..++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999874 445679999986543 334567999999999999999999999885 457899999999999
Q ss_pred HhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhhhhhh
Q 003278 195 LDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQY 274 (834)
Q Consensus 195 L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~ 274 (834)
|.+++... ...+++..+++++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++.+......
T Consensus 81 L~~~l~~~------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~ 151 (257)
T cd05115 81 LNKFLSGK------KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY 151 (257)
T ss_pred HHHHHHhC------CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccc
Confidence 99998643 23689999999999999999999985 9999999999999999999999999999754322110
Q ss_pred hhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccchHHHHHHHH
Q 003278 275 QMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQIILLDWIRRL 353 (834)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~ 353 (834)
....+...+++.|+|||.+... .++.++|||||||++||+++ |+.|+...... ++...
T Consensus 152 -------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~~- 210 (257)
T cd05115 152 -------------YKARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP------EVMSF- 210 (257)
T ss_pred -------------eeccCCCCCCcccCCHHHHccC-CCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH------HHHHH-
Confidence 0001112246789999988654 57889999999999999996 99998643211 11111
Q ss_pred hhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 354 SDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 354 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
...+...+. +......+.+++..||+.+|++||+|.+|.+.|...
T Consensus 211 ~~~~~~~~~----------~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 211 IEQGKRLDC----------PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HHCCCCCCC----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 122221111 011125678899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=334.12 Aligned_cols=245 Identities=27% Similarity=0.315 Sum_probs=188.5
Q ss_pred CeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHH-HHHHhCCCCceeeEeeeEEeCCEEEEEEEccCC
Q 003278 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAEL-VAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPN 192 (834)
Q Consensus 117 ~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~-~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 192 (834)
+.||+|+||.||+|+...++..||+|++.... ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999998899999999986532 12233444454 457889999999999999999999999999999
Q ss_pred CCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhhhh
Q 003278 193 RSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHEL 272 (834)
Q Consensus 193 gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~ 272 (834)
|+|..++... ..+++.....++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~L~~~~~~~-------~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~- 149 (325)
T cd05602 81 GELFYHLQRE-------RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH- 149 (325)
T ss_pred CcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccC-
Confidence 9999988643 3467788888999999999999985 9999999999999999999999999998742111
Q ss_pred hhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHHHHH
Q 003278 273 QYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIRR 352 (834)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~ 352 (834)
........||+.|+|||.+... .++.++|||||||++|||++|+.||..... ..+.. .
T Consensus 150 ---------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~---~ 207 (325)
T cd05602 150 ---------------NGTTSTFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNT---AEMYD---N 207 (325)
T ss_pred ---------------CCCcccccCCccccCHHHHcCC-CCCCccccccccHHHHHHhcCCCCCCCCCH---HHHHH---H
Confidence 0113445799999999988654 678999999999999999999999864221 11111 1
Q ss_pred HhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhh
Q 003278 353 LSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVS 406 (834)
Q Consensus 353 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~ 406 (834)
.... .. ...+. . ...+.++...|++.+|.+||+..+.+..+.
T Consensus 208 i~~~-~~--~~~~~-----~----~~~~~~li~~~l~~~p~~R~~~~~~~~~i~ 249 (325)
T cd05602 208 ILNK-PL--QLKPN-----I----TNSARHLLEGLLQKDRTKRLGAKDDFMEIK 249 (325)
T ss_pred HHhC-Cc--CCCCC-----C----CHHHHHHHHHHcccCHHHCCCCCCCHHHHh
Confidence 1111 00 01111 1 135778899999999999999886554443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=328.65 Aligned_cols=258 Identities=23% Similarity=0.316 Sum_probs=200.5
Q ss_pred hCcCcCCcccccCCcEEEEEEEC------CCcEEEEEEecCCCChhHHHHHHHHHHHHHhc-cCCCceeEEEEEeeCCeE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD------NHQYVLVKRLGMSKCPALRTRFSNELQNLARL-RHRNLVQLCGWCTEQGEM 585 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l-~HpNiv~l~g~~~~~~~~ 585 (834)
++|...+.||+|+||.||+|... .+..||||.++........+.|.+|+.+++++ +||||++++++|...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 46788899999999999999741 24579999887554445557899999999999 799999999999999999
Q ss_pred EEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeee
Q 003278 586 LVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFAL 665 (834)
Q Consensus 586 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGl 665 (834)
++||||+++|+|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+|++|||+
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRE----SFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCcc
Confidence 999999999999999864321 237899999999999999999996 6899999999999999999999999999
Q ss_pred ccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHh
Q 003278 666 AEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEA 744 (834)
Q Consensus 666 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~ 744 (834)
++.+...... .......++..|+|||++.++.++.++|||||||++|||+| |..|+...............
T Consensus 188 ~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~--- 259 (302)
T cd05055 188 ARDIMNDSNY-----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE--- 259 (302)
T ss_pred cccccCCCce-----eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHc---
Confidence 9765332110 01122356788999999999999999999999999999998 88887643332222111110
Q ss_pred hcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHcc
Q 003278 745 RKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDG 796 (834)
Q Consensus 745 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~ 796 (834)
.... ..... ... ++.+++.+||+.+|++|||+.+|++.|+.
T Consensus 260 ~~~~-------~~~~~-~~~---~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 260 GYRM-------AQPEH-APA---EIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred CCcC-------CCCCC-CCH---HHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 0000 00111 112 45566679999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=321.72 Aligned_cols=260 Identities=19% Similarity=0.291 Sum_probs=201.4
Q ss_pred CcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCC--ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEe
Q 003278 514 NFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSK--CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYD 590 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~--~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~E 590 (834)
+|...+.||.|+||.||+|.. .++..++||.+.... ......+|.+|+.++++++||||+++++++.+.+..+++||
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 566677899999999999995 578899999876432 23345689999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccc
Q 003278 591 YSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLT 670 (834)
Q Consensus 591 y~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~ 670 (834)
|+++++|.+++..... ....++|.....++.|++.||+|||+ .+|+|+||||+||+++.++.++++|||++....
T Consensus 83 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 83 LADAGDLSRMIKHFKK--QKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred ecCCCCHHHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence 9999999998864322 12358899999999999999999996 699999999999999999999999999987653
Q ss_pred cCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCccc
Q 003278 671 RNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLA 750 (834)
Q Consensus 671 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (834)
... .......|+..|+|||++.+..++.++||||||+++|||+||..|+........ ...... .
T Consensus 158 ~~~-------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~-------~ 221 (267)
T cd08229 158 SKT-------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY--SLCKKI-------E 221 (267)
T ss_pred cCC-------cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH--HHhhhh-------h
Confidence 221 111235689999999999988899999999999999999999999854322111 100111 0
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccC
Q 003278 751 ELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGN 797 (834)
Q Consensus 751 ~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~ 797 (834)
....+.+....... .+..++.+||+.||++||||.+|++++...
T Consensus 222 ~~~~~~~~~~~~~~---~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 222 QCDYPPLPSDHYSE---ELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred cCCCCCCCcccccH---HHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 11111111111223 345566699999999999999999988653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=322.87 Aligned_cols=240 Identities=21% Similarity=0.354 Sum_probs=183.9
Q ss_pred CcccccCCcEEEEEEECC-------------CcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeE
Q 003278 519 QRVAEMDFGTAYQGFLDN-------------HQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEM 585 (834)
Q Consensus 519 ~~ig~g~~g~vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~ 585 (834)
+.||+|+||.||+|.+.. ...|++|.+.... ......|.+|+.+++.++|||||+++|++.+....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 358999999999998632 2258888876433 23346788999999999999999999999999999
Q ss_pred EEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCC-------c
Q 003278 586 LVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMN-------P 658 (834)
Q Consensus 586 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~-------~ 658 (834)
++||||+++|+|..++.... ..+++..++.++.|+++||+|||+ .+|+||||||+|||++.++. +
T Consensus 80 ~lv~e~~~~~~l~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~ 151 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRKS-----DVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFI 151 (262)
T ss_pred EEEEecccCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCcee
Confidence 99999999999988876432 247888899999999999999996 69999999999999987664 8
Q ss_pred eEeeeeeccccccCCCCCcccccCccccccccCccchhccc-cCCCCccCcchhhHHHHHHHH-hCCCccCCCCCchhHH
Q 003278 659 RLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIE-SGEATSMADVYSFGVVVLEVV-TGQMAVDFRLPEGLLV 736 (834)
Q Consensus 659 ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-~~~~~~k~DV~SfGvvl~E~~-tG~~p~~~~~~~~~~~ 736 (834)
|++|||++..... .....||..|||||++. +..++.++|||||||++|||+ +|..|+.......
T Consensus 152 ~l~d~g~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--- 217 (262)
T cd05077 152 KLSDPGIPITVLS-----------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE--- 217 (262)
T ss_pred EeCCCCCCccccC-----------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH---
Confidence 9999999865321 11245788999999986 466899999999999999998 5777765322111
Q ss_pred HHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHc
Q 003278 737 KRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795 (834)
Q Consensus 737 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~ 795 (834)
...+..... ... .. .. ..+..++.+||+.||++||++.+|++.|+
T Consensus 218 --~~~~~~~~~---~~~-----~~-~~---~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 218 --KERFYEGQC---MLV-----TP-SC---KELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred --HHHHHhcCc---cCC-----CC-Ch---HHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 111111100 011 01 12 24556777999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=335.66 Aligned_cols=265 Identities=25% Similarity=0.397 Sum_probs=199.4
Q ss_pred CCCCCCCeeeccCCeEEEEEEE-----CCCCeEEEEEEecccC-hhhHHHHHHHHHHHHhC-CCCceeeEeeeEEeC-CE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVL-----PSDGTVVAVKCLAEKG-ERFEKTFAAELVAVAHL-RHRNLVRLRGWCVHE-DQ 182 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~-----~~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~-~~ 182 (834)
++|+..+.||+|+||.||+|.+ ..+++.||||+++... ......+.+|+.++.++ +|||||+++++|... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 5688999999999999999974 2467899999986532 33456788999999999 689999999988765 46
Q ss_pred EEEEEEccCCCCHhHHHhcCCCcc--------------------------------------------------------
Q 003278 183 LLLVYDYMPNRSLDRVLFRRPENL-------------------------------------------------------- 206 (834)
Q Consensus 183 ~~lV~Ey~~~gsL~~~l~~~~~~~-------------------------------------------------------- 206 (834)
.++||||+++|+|.+++.......
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 799999999999999986532100
Q ss_pred ----ccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhhhhhhhhhccccc
Q 003278 207 ----EAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSAR 282 (834)
Q Consensus 207 ----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~~ 282 (834)
.....++|.++..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++.+......
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-------- 235 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-------- 235 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcch--------
Confidence 0013578999999999999999999985 9999999999999999999999999999754221110
Q ss_pred ccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccchHHHHHHHHhhcCcccc
Q 003278 283 NHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQIILLDWIRRLSDEGKVLQ 361 (834)
Q Consensus 283 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 361 (834)
.......+++.|+|||.+... .++.++|||||||++|||++ |..|+........ + ......+....
T Consensus 236 ------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~----~~~~~~~~~~~ 302 (343)
T cd05103 236 ------VRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--F----CRRLKEGTRMR 302 (343)
T ss_pred ------hhcCCCCCCcceECcHHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--H----HHHHhccCCCC
Confidence 011223467789999988654 67899999999999999997 8888754322111 1 11111221111
Q ss_pred ccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcCC
Q 003278 362 AGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGSY 409 (834)
Q Consensus 362 ~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~~ 409 (834)
. ... ....+.+++..||+.+|++||++.+|++.|...+
T Consensus 303 ~-------~~~---~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 303 A-------PDY---TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred C-------CCC---CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1 011 1135788999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=326.87 Aligned_cols=268 Identities=24% Similarity=0.354 Sum_probs=196.4
Q ss_pred CCCCCeeeccCCeEEEEEEE----CCCCeEEEEEEecccC-hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeC--CEEEE
Q 003278 113 FDEDEVLGSGGFGKVYRAVL----PSDGTVVAVKCLAEKG-ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHE--DQLLL 185 (834)
Q Consensus 113 f~~~~~LG~G~fG~Vy~~~~----~~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~l 185 (834)
|...+.||+|+||+||++.. ..++..||+|.+.... ......|.+|+.++++++||||++++++|... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37778999999999987653 3568899999986542 23456788999999999999999999998764 35899
Q ss_pred EEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccch
Q 003278 186 VYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLA 265 (834)
Q Consensus 186 V~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla 265 (834)
||||+++|+|.+++.. ..++|..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||++
T Consensus 86 v~e~~~~~~l~~~~~~--------~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~ 154 (283)
T cd05080 86 IMEYVPLGSLRDYLPK--------HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLA 154 (283)
T ss_pred EecCCCCCCHHHHHHH--------cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccc
Confidence 9999999999999853 2489999999999999999999985 9999999999999999999999999999
Q ss_pred hhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccch
Q 003278 266 RWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQII 345 (834)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~ 345 (834)
+.+....... .......++..|+|||.+..+ ..+.++|||||||++|||+||+.|+......-. .
T Consensus 155 ~~~~~~~~~~-------------~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~ 219 (283)
T cd05080 155 KAVPEGHEYY-------------RVREDGDSPVFWYAVECLKEN-KFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-E 219 (283)
T ss_pred cccCCcchhh-------------ccCCCCCCCceeeCHhHhccc-CCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-h
Confidence 8654321100 001122356779999988654 578999999999999999999999754321100 0
Q ss_pred HHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhc
Q 003278 346 LLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSG 407 (834)
Q Consensus 346 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~ 407 (834)
+..+...........+..+.... ...+......+.+++..||+.+|++||+|.+|++.|+.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~ 280 (283)
T cd05080 220 MIGPKQGQMTVVRLIELLERGMR-LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKE 280 (283)
T ss_pred hhcccccccchhhhhhhhhcCCC-CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 00000000000001111111110 00011123468899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=335.24 Aligned_cols=244 Identities=23% Similarity=0.226 Sum_probs=189.4
Q ss_pred CcccccCCcEEEEEEE----CCCcEEEEEEecCCCC-hhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEeccC
Q 003278 519 QRVAEMDFGTAYQGFL----DNHQYVLVKRLGMSKC-PALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSA 593 (834)
Q Consensus 519 ~~ig~g~~g~vy~~~~----~~~~~vavK~~~~~~~-~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~~ 593 (834)
+.||+|+||.||++.. .+++.+|+|++..... ......+.+|+++|++++|||||++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 4689999999999874 3578999999864321 2233567889999999999999999999999999999999999
Q ss_pred CCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCC
Q 003278 594 TRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRND 673 (834)
Q Consensus 594 ~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~ 673 (834)
+|+|.+++.... .+++.....++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++......
T Consensus 82 ~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 152 (318)
T cd05582 82 GGDLFTRLSKEV------MFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 152 (318)
T ss_pred CCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC
Confidence 999998885432 47889999999999999999996 699999999999999999999999999987543211
Q ss_pred CCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcccccc
Q 003278 674 HGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELV 753 (834)
Q Consensus 674 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (834)
.......||+.|||||++.+..++.++|||||||++|||+||+.|+........ ... .......
T Consensus 153 -------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~-~~~---i~~~~~~----- 216 (318)
T cd05582 153 -------KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET-MTM---ILKAKLG----- 216 (318)
T ss_pred -------CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH-HHH---HHcCCCC-----
Confidence 112346799999999999988899999999999999999999999865432211 111 1111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhH--HHHHH
Q 003278 754 DLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQ--ILSIL 794 (834)
Q Consensus 754 d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~--v~~~L 794 (834)
++... ... +..++.+||+.||++|||+.+ +.+.+
T Consensus 217 ---~p~~~-~~~---~~~li~~~l~~~P~~R~~a~~~~~~~~~ 252 (318)
T cd05582 217 ---MPQFL-SPE---AQSLLRALFKRNPANRLGAGPDGVEEIK 252 (318)
T ss_pred ---CCCCC-CHH---HHHHHHHHhhcCHhHcCCCCCCCHHHHh
Confidence 11111 223 344556899999999999766 44444
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=327.06 Aligned_cols=247 Identities=23% Similarity=0.316 Sum_probs=193.3
Q ss_pred CCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEc
Q 003278 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDY 189 (834)
Q Consensus 113 f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 189 (834)
|+..+.||+|+||+||+|.+..+++.||+|.+.... ......+.+|+.++++++|+||+.+++++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 666789999999999999998899999999986432 22345578899999999999999999999999999999999
Q ss_pred cCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhh
Q 003278 190 MPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLE 269 (834)
Q Consensus 190 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~ 269 (834)
+++|+|..++.... ...+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||++....
T Consensus 82 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 153 (285)
T cd05632 82 MNGGDLKFHIYNMG-----NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIP 153 (285)
T ss_pred ccCccHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecC
Confidence 99999998886432 23689999999999999999999985 99999999999999999999999999986432
Q ss_pred hhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHH
Q 003278 270 HELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDW 349 (834)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~ 349 (834)
... ......||+.|+|||++... .++.++|||||||++|||+||+.||....... ....+
T Consensus 154 ~~~-----------------~~~~~~g~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~--~~~~~ 213 (285)
T cd05632 154 EGE-----------------SIRGRVGTVGYMAPEVLNNQ-RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV--KREEV 213 (285)
T ss_pred CCC-----------------cccCCCCCcCccChHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHH--HHHHH
Confidence 110 01234689999999998654 67899999999999999999999986432211 11111
Q ss_pred HHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchh
Q 003278 350 IRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMK 399 (834)
Q Consensus 350 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~ 399 (834)
.... .... .. .. ..+ ...+.+|+..|++.||++||++.
T Consensus 214 ~~~~-~~~~--~~----~~-~~~----~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05632 214 DRRV-LETE--EV----YS-AKF----SEEAKSICKMLLTKDPKQRLGCQ 251 (285)
T ss_pred HHhh-hccc--cc----cC-ccC----CHHHHHHHHHHccCCHhHcCCCc
Confidence 1111 1110 00 00 111 23567899999999999999954
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=326.46 Aligned_cols=257 Identities=18% Similarity=0.277 Sum_probs=197.3
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCc----EEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQ----YVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLV 587 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~----~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~l 587 (834)
++|...+.||+|+||+||+|.. .++. .||+|.+...........+.+|+.++.+++||||++++|+|... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEE
Confidence 4577778999999999999984 3444 48999987655555567899999999999999999999999764 5778
Q ss_pred EEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecc
Q 003278 588 IYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAE 667 (834)
Q Consensus 588 v~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~ 667 (834)
++||+++|+|.+++.... ..+++..++.++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++
T Consensus 86 ~~~~~~~g~l~~~l~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~ 157 (279)
T cd05109 86 VTQLMPYGCLLDYVRENK-----DRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (279)
T ss_pred EEEcCCCCCHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCcee
Confidence 999999999999986532 247889999999999999999996 689999999999999999999999999998
Q ss_pred ccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhc
Q 003278 668 FLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARK 746 (834)
Q Consensus 668 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~ 746 (834)
.+..... ........++..|||||.+.++.++.++|||||||++|||+| |..|+...... .....+. ...
T Consensus 158 ~~~~~~~-----~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-~~~~~~~---~~~ 228 (279)
T cd05109 158 LLDIDET-----EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR-EIPDLLE---KGE 228 (279)
T ss_pred ecccccc-----eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHHH---CCC
Confidence 6542211 000112235678999999998999999999999999999999 88887643221 1111111 111
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCC
Q 003278 747 RPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGND 798 (834)
Q Consensus 747 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~ 798 (834)
.+ ...... .. .+.+++.+||+.||++|||+.++++.|+...
T Consensus 229 ~~-------~~~~~~-~~---~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 229 RL-------PQPPIC-TI---DVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred cC-------CCCccC-CH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 10 001111 12 4556667999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=328.79 Aligned_cols=262 Identities=18% Similarity=0.278 Sum_probs=197.8
Q ss_pred CcCcCCcccccCCcEEEEEEE-----CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeC--CeEE
Q 003278 514 NFSESQRVAEMDFGTAYQGFL-----DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQ--GEML 586 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~-----~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~--~~~~ 586 (834)
.|...+.||+|+||.||.+.+ .++..||+|.+...........|.+|++++++++||||+++++++.+. ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 456678899999999999975 346789999987655455557899999999999999999999998775 5689
Q ss_pred EEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeec
Q 003278 587 VIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALA 666 (834)
Q Consensus 587 lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla 666 (834)
+||||+++++|.+++.... ..++|..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 85 lv~e~~~g~~L~~~l~~~~-----~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~ 156 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNK-----NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLT 156 (284)
T ss_pred EEEEccCCCCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCccc
Confidence 9999999999999986432 247899999999999999999996 69999999999999999999999999999
Q ss_pred cccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCC---------chh-HH
Q 003278 667 EFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLP---------EGL-LV 736 (834)
Q Consensus 667 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~---------~~~-~~ 736 (834)
+.+...... ........|+..|+|||++.+..++.++|||||||++|||+|++.|...... .+. ..
T Consensus 157 ~~~~~~~~~----~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd05079 157 KAIETDKEY----YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTV 232 (284)
T ss_pred cccccCccc----eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccH
Confidence 865432110 0111234577889999999888999999999999999999998765422110 000 00
Q ss_pred HHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccC
Q 003278 737 KRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGN 797 (834)
Q Consensus 737 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~ 797 (834)
............ ......+ ...+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus 233 ~~~~~~~~~~~~------~~~~~~~----~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 233 TRLVRVLEEGKR------LPRPPNC----PEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHHHHcCcc------CCCCCCC----CHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 001000000000 0011111 13466677799999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=329.17 Aligned_cols=259 Identities=27% Similarity=0.393 Sum_probs=201.4
Q ss_pred cCCCCCCCeeeccCCeEEEEEEE-----CCCCeEEEEEEecccC-hhhHHHHHHHHHHHHhC-CCCceeeEeeeEEeCCE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVL-----PSDGTVVAVKCLAEKG-ERFEKTFAAELVAVAHL-RHRNLVRLRGWCVHEDQ 182 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~-----~~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~ 182 (834)
.++|...+.||+|+||.||+|.. ..++..||||+++... ....+.+.+|+.+++++ +||||++++++|...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 35799999999999999999975 2346689999986542 33456789999999999 79999999999999999
Q ss_pred EEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeec
Q 003278 183 LLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDF 262 (834)
Q Consensus 183 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DF 262 (834)
.++||||+++|+|.+++.... ...+++.++..++.|++.||+|||+. +|+|+||||+|||++.++.+||+||
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~-----~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~df 185 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKR-----ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDF 185 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCC-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCC
Confidence 999999999999999986532 13489999999999999999999985 9999999999999999999999999
Q ss_pred cchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCC
Q 003278 263 GLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPD 341 (834)
Q Consensus 263 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~ 341 (834)
|+++.+...... .......+++.|+|||.+..+ .++.++|||||||++|||+| |+.|+......
T Consensus 186 g~~~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslGvil~el~t~g~~p~~~~~~~ 250 (302)
T cd05055 186 GLARDIMNDSNY--------------VVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSNPYPGMPVD 250 (302)
T ss_pred cccccccCCCce--------------eecCCCCcccccCCHhhhccC-CCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch
Confidence 999754321100 001223467889999988655 57899999999999999998 99887643221
Q ss_pred ccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhc
Q 003278 342 DQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSG 407 (834)
Q Consensus 342 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~ 407 (834)
. .+.. ....+.... . ... ....+.+++..|++.+|++||++.+|++.|..
T Consensus 251 ~--~~~~----~~~~~~~~~-----~-~~~----~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 251 S--KFYK----LIKEGYRMA-----Q-PEH----APAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred H--HHHH----HHHcCCcCC-----C-CCC----CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 1 1111 111111100 0 011 12468899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=322.11 Aligned_cols=252 Identities=22% Similarity=0.294 Sum_probs=192.3
Q ss_pred cccccCCcEEEEEEECC-Cc--EEEEEEecCCCChhHHHHHHHHHHHHHhc-cCCCceeEEEEEeeCCeEEEEEeccCCC
Q 003278 520 RVAEMDFGTAYQGFLDN-HQ--YVLVKRLGMSKCPALRTRFSNELQNLARL-RHRNLVQLCGWCTEQGEMLVIYDYSATR 595 (834)
Q Consensus 520 ~ig~g~~g~vy~~~~~~-~~--~vavK~~~~~~~~~~~~~f~~E~~~l~~l-~HpNiv~l~g~~~~~~~~~lv~Ey~~~g 595 (834)
.||+|+||.||+|...+ +. .+++|.+.........+.|.+|++++.++ +||||++++++|...+..++||||+++|
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 58999999999999754 33 47888887544445556899999999999 8999999999999999999999999999
Q ss_pred chhhhhhcCCCC----------CCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeee
Q 003278 596 ILSHLLFHNNHR----------IGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFAL 665 (834)
Q Consensus 596 ~L~~~l~~~~~~----------~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGl 665 (834)
+|.+++...... .....+++..+..++.|++.||+|||+ .+++||||||+|||+++++.+|++|||+
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCCC
Confidence 999998653210 111247899999999999999999996 6999999999999999999999999999
Q ss_pred ccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHh
Q 003278 666 AEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEA 744 (834)
Q Consensus 666 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~ 744 (834)
+...... .......++..|+|||++....++.++|||||||++|||+| |..||....... ...... .
T Consensus 159 ~~~~~~~--------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-~~~~~~---~ 226 (270)
T cd05047 159 SRGQEVY--------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-LYEKLP---Q 226 (270)
T ss_pred ccccchh--------hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH-HHHHHh---C
Confidence 8532110 00111234667999999988889999999999999999997 988885432221 111110 0
Q ss_pred hcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccC
Q 003278 745 RKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGN 797 (834)
Q Consensus 745 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~ 797 (834)
... . ...... . ..+.+++.+||..+|.+|||+.+|+..|+.+
T Consensus 227 ~~~-----~--~~~~~~-~---~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 227 GYR-----L--EKPLNC-D---DEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred CCC-----C--CCCCcC-C---HHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 000 0 011111 1 2456777799999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=323.74 Aligned_cols=252 Identities=25% Similarity=0.391 Sum_probs=200.0
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEcc
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYM 190 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 190 (834)
++|+..+.||+|+||.||+|....++..||+|.+........+.+.+|+.++++++||||+++++++..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 45888899999999999999998889999999997766666788999999999999999999999999999999999999
Q ss_pred CCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhh
Q 003278 191 PNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEH 270 (834)
Q Consensus 191 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~ 270 (834)
++++|..++... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 92 ~~~~l~~~~~~~------~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 162 (292)
T cd06644 92 PGGAVDAIMLEL------DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK 162 (292)
T ss_pred CCCcHHHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence 999998887543 23589999999999999999999985 999999999999999999999999998864321
Q ss_pred hhhhhhhcccccccccccccceeeeccccCCCcccccc----CCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchH
Q 003278 271 ELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQK----GSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIIL 346 (834)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~----~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l 346 (834)
.. .......|++.|+|||++.. ...++.++|||||||++|||+||+.|+......
T Consensus 163 ~~----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----- 221 (292)
T cd06644 163 TL----------------QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM----- 221 (292)
T ss_pred cc----------------cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-----
Confidence 10 01233458899999998842 234578899999999999999999998532211
Q ss_pred HHHHHHHhhcCccccccccccC-CCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 347 LDWIRRLSDEGKVLQAGDNRLS-DGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 347 ~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
........ .. .+.+. .... ...+.+++..||+.+|++||++.+|++
T Consensus 222 -~~~~~~~~-~~-----~~~~~~~~~~----~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 222 -RVLLKIAK-SE-----PPTLSQPSKW----SMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred -HHHHHHhc-CC-----CccCCCCccc----CHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11111111 10 11110 0111 135778999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=333.48 Aligned_cols=242 Identities=18% Similarity=0.214 Sum_probs=188.0
Q ss_pred CcccccCCcEEEEEEEC-CCcEEEEEEecCCC--ChhHHHHHHHHHHHHHhc-cCCCceeEEEEEeeCCeEEEEEeccCC
Q 003278 519 QRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSK--CPALRTRFSNELQNLARL-RHRNLVQLCGWCTEQGEMLVIYDYSAT 594 (834)
Q Consensus 519 ~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~E~~~l~~l-~HpNiv~l~g~~~~~~~~~lv~Ey~~~ 594 (834)
+.||+|+||.||+|... +++.||||.+.... .....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 35899999999999865 47899999986432 223345678899999866 799999999999999999999999999
Q ss_pred CchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCCC
Q 003278 595 RILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDH 674 (834)
Q Consensus 595 g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~~ 674 (834)
|+|..++.... .+++.....++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~- 150 (321)
T cd05591 81 GDLMFQIQRSR------KFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG- 150 (321)
T ss_pred CcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCC-
Confidence 99998886432 37888888999999999999997 689999999999999999999999999987532211
Q ss_pred CCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCccccccc
Q 003278 675 GHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVD 754 (834)
Q Consensus 675 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 754 (834)
.......||+.|||||++.+..++.++|||||||++|||+||+.||....+... ...+. .... .
T Consensus 151 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~-~~~i~---~~~~-----~- 214 (321)
T cd05591 151 ------VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL-FESIL---HDDV-----L- 214 (321)
T ss_pred ------ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH-HHHHH---cCCC-----C-
Confidence 112346799999999999998999999999999999999999999975433221 11111 1100 0
Q ss_pred cccCCCCCHHHHHHHHHHHHHhccCCCCCCC-------ChhHHHH
Q 003278 755 LSLNGEYNHKELMRLIKLGIACTLSNPELRP-------SMRQILS 792 (834)
Q Consensus 755 ~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RP-------tm~~v~~ 792 (834)
.+. ....+ +..+...|++.||++|| ++.++++
T Consensus 215 --~p~-~~~~~---~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 215 --YPV-WLSKE---AVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred --CCC-CCCHH---HHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 011 11233 44555689999999999 6666663
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=319.28 Aligned_cols=251 Identities=19% Similarity=0.314 Sum_probs=194.3
Q ss_pred CcccccCCcEEEEEEECC----CcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEeccCC
Q 003278 519 QRVAEMDFGTAYQGFLDN----HQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSAT 594 (834)
Q Consensus 519 ~~ig~g~~g~vy~~~~~~----~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~~~ 594 (834)
++||+|+||.||+|.... +..+|+|.+.........++|.+|++++++++|||||++++++.. +..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence 368999999999997532 257999998766554455789999999999999999999998864 467999999999
Q ss_pred CchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCCC
Q 003278 595 RILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDH 674 (834)
Q Consensus 595 g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~~ 674 (834)
|+|.+++.... .++|..+..++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++.......
T Consensus 80 ~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~ 150 (257)
T cd05060 80 GPLLKYLKKRR------EIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150 (257)
T ss_pred CcHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence 99999987542 47899999999999999999996 6899999999999999999999999999986543221
Q ss_pred CCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCcccccc
Q 003278 675 GHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRPLAELV 753 (834)
Q Consensus 675 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (834)
.. .......++..|+|||.+.+..++.++|||||||++|||+| |..|+....+. .+...+. .. ...
T Consensus 151 ~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~-~~~~~~~---~~-~~~---- 217 (257)
T cd05060 151 YY----RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA-EVIAMLE---SG-ERL---- 217 (257)
T ss_pred cc----ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH-HHHHHHH---cC-CcC----
Confidence 11 11112235678999999999999999999999999999998 88888644322 1212111 11 110
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCC
Q 003278 754 DLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGND 798 (834)
Q Consensus 754 d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~ 798 (834)
...... +. .+.+++.+||..+|++|||+.+|++.|+++.
T Consensus 218 --~~~~~~-~~---~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 218 --PRPEEC-PQ---EIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred --CCCCCC-CH---HHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 011111 12 4556777999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=348.23 Aligned_cols=252 Identities=20% Similarity=0.230 Sum_probs=194.2
Q ss_pred cCcCCcccccCCcEEEEEEEC-C-CcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEecc
Q 003278 515 FSESQRVAEMDFGTAYQGFLD-N-HQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYS 592 (834)
Q Consensus 515 f~~~~~ig~g~~g~vy~~~~~-~-~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~ 592 (834)
|...+.||.|+||.||+|... + +..||+|.+.... ......+.+|+.+|++++|||||++++++...+..+|||||+
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 555678999999999999853 3 5678888765433 333456788999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccC
Q 003278 593 ATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRN 672 (834)
Q Consensus 593 ~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~ 672 (834)
++|+|.+++..... ....+++.....++.|++.||.|||+ .+|+||||||+||||+.++.+||+|||+++.+...
T Consensus 148 ~gg~L~~~l~~~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 148 SGGDLNKQIKQRLK--EHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred CCCCHHHHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 99999988864321 12357888888999999999999996 69999999999999999999999999999865432
Q ss_pred CCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCccccc
Q 003278 673 DHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAEL 752 (834)
Q Consensus 673 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (834)
.. .....+.+||++|||||++.+..++.++|||||||++|||+||+.|+....... ...... ....
T Consensus 223 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~-~~~~~~---~~~~----- 288 (478)
T PTZ00267 223 VS-----LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE-IMQQVL---YGKY----- 288 (478)
T ss_pred cc-----cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH---hCCC-----
Confidence 11 111235679999999999999999999999999999999999999986432211 111111 1100
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 753 VDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 753 ~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
++ .....+ . .+.+++.+||+.||++|||+.+++.
T Consensus 289 -~~-~~~~~s-~---~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 289 -DP-FPCPVS-S---GMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -CC-CCccCC-H---HHHHHHHHHhccChhhCcCHHHHHh
Confidence 00 111111 2 3555666899999999999999864
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=340.66 Aligned_cols=209 Identities=19% Similarity=0.202 Sum_probs=173.3
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCC--ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSK--CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIY 589 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~ 589 (834)
++|...+.||+|+||.||+|... +++.||||++.... .......+.+|+.+|..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 36777889999999999999964 58899999986432 1233456889999999999999999999999999999999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccc
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFL 669 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~ 669 (834)
||+++|+|.+++...+ .+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+
T Consensus 81 E~~~~g~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 151 (364)
T cd05599 81 EYLPGGDMMTLLMKKD------TFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGL 151 (364)
T ss_pred CCCCCcHHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceec
Confidence 9999999999986532 37888888999999999999997 68999999999999999999999999998764
Q ss_pred ccCCCCCcc--c-----------------------------ccCccccccccCccchhccccCCCCccCcchhhHHHHHH
Q 003278 670 TRNDHGHRK--A-----------------------------TSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLE 718 (834)
Q Consensus 670 ~~~~~~~~~--~-----------------------------~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E 718 (834)
......... . .....+.+||+.|||||++....++.++|||||||++||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e 231 (364)
T cd05599 152 KKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYE 231 (364)
T ss_pred cccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHH
Confidence 322100000 0 000113579999999999999999999999999999999
Q ss_pred HHhCCCccCCCC
Q 003278 719 VVTGQMAVDFRL 730 (834)
Q Consensus 719 ~~tG~~p~~~~~ 730 (834)
|+||..||....
T Consensus 232 l~~G~~Pf~~~~ 243 (364)
T cd05599 232 MLVGYPPFCSDN 243 (364)
T ss_pred hhcCCCCCCCCC
Confidence 999999997543
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=319.19 Aligned_cols=262 Identities=20% Similarity=0.320 Sum_probs=203.6
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCC--ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSK--CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIY 589 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~ 589 (834)
++|...+.||+|+||.||+|... +++.||+|.++... .....+.+.+|++++++++|+||+++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 56777888999999999999976 78899999886422 2334578999999999999999999999999999999999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccc
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFL 669 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~ 669 (834)
||+++|+|..++..... ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++++|||++..+
T Consensus 82 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~ 156 (267)
T cd08224 82 ELADAGDLSRMIKHFKK--QKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred ecCCCCCHHHHHHHhcc--cCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeec
Confidence 99999999998865322 12347899999999999999999996 69999999999999999999999999998765
Q ss_pred ccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcc
Q 003278 670 TRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPL 749 (834)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
.... .......|+..|+|||++.+..++.++|||||||++|||+||+.|+...... .......... ...
T Consensus 157 ~~~~-------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~--~~~ 225 (267)
T cd08224 157 SSKT-------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEK--CDY 225 (267)
T ss_pred cCCC-------cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc--HHHHHhhhhc--CCC
Confidence 3321 1122346889999999999888999999999999999999999998533211 1111111110 000
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCC
Q 003278 750 AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGND 798 (834)
Q Consensus 750 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~ 798 (834)
. ..... .....+.+++.+||..+|++|||+.+|+++|+.+.
T Consensus 226 ~-----~~~~~---~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 226 P-----PLPAD---HYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred C-----CCChh---hcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 0 01110 11123556667899999999999999999997653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=321.10 Aligned_cols=259 Identities=19% Similarity=0.264 Sum_probs=196.9
Q ss_pred HHHHHhhCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeE
Q 003278 507 EIISATNNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEM 585 (834)
Q Consensus 507 el~~at~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~ 585 (834)
|++.+++++.....||+|+||.||+|.. +++..|++|.+...... ..+.|.+|+.++++++||||++++|++...+..
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR-YVQPLHEEIALHSYLKHRNIVQYLGSDSENGFF 80 (268)
T ss_pred CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHH-HHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEE
Confidence 3566788998889999999999999985 45778999988654332 346789999999999999999999999999999
Q ss_pred EEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecC-CCCceEeeee
Q 003278 586 LVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDP-DMNPRLGSFA 664 (834)
Q Consensus 586 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~-~~~~ki~DfG 664 (834)
++|+||+++++|..++...... ...++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg 154 (268)
T cd06624 81 KIFMEQVPGGSLSALLRSKWGP---LKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFG 154 (268)
T ss_pred EEEEecCCCCCHHHHHHHhccc---CCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecch
Confidence 9999999999999998753211 112677788899999999999996 69999999999999986 6789999999
Q ss_pred eccccccCCCCCcccccCccccccccCccchhccccCC--CCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHH
Q 003278 665 LAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGE--ATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEF 742 (834)
Q Consensus 665 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~--~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~ 742 (834)
++..+.... .......|+..|+|||++.++. ++.++|||||||++|||+||+.|+............. ..
T Consensus 155 ~~~~~~~~~-------~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~-~~ 226 (268)
T cd06624 155 TSKRLAGIN-------PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKV-GM 226 (268)
T ss_pred hheecccCC-------CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhh-hh
Confidence 987543221 1122346889999999987654 7889999999999999999999985322111111000 00
Q ss_pred HhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 743 EARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 743 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
... .+.+.... .+ .+..++.+||+.+|.+||||.+|+.
T Consensus 227 -~~~-------~~~~~~~~-~~---~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 227 -FKI-------HPEIPESL-SA---EAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred -hcc-------CCCCCccc-CH---HHHHHHHHHcCCCchhCCCHHHHHh
Confidence 000 01111111 12 3455667999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=333.21 Aligned_cols=243 Identities=23% Similarity=0.285 Sum_probs=190.8
Q ss_pred CCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc---ChhhHHHHHHHHHHHHhCC-CCceeeEeeeEEeCCEEEEEE
Q 003278 112 GFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK---GERFEKTFAAELVAVAHLR-HRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 112 ~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~ 187 (834)
+|+..+.||+|+||.||+|..+.+|+.||||++... .....+.+..|..++..+. |++|+++++++...+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 477789999999999999999889999999998653 1233456778888888876 577888999999999999999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
||+++|+|..++... ..+++.++..|+.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 Ey~~~g~L~~~i~~~-------~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~ 150 (323)
T cd05615 81 EYVNGGDLMYHIQQV-------GKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 150 (323)
T ss_pred cCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccc
Confidence 999999999988543 4589999999999999999999985 999999999999999999999999999874
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHH
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILL 347 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~ 347 (834)
..... .......||+.|+|||++... .++.++|||||||++|||+||+.||..... ..+.
T Consensus 151 ~~~~~----------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~ 210 (323)
T cd05615 151 HMVDG----------------VTTRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAYGVLLYEMLAGQPPFDGEDE---DELF 210 (323)
T ss_pred cCCCC----------------ccccCccCCccccCHHHHcCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCH---HHHH
Confidence 21110 012345699999999988654 678999999999999999999999864321 1111
Q ss_pred HHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchh
Q 003278 348 DWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMK 399 (834)
Q Consensus 348 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~ 399 (834)
. .+.. ... ... ... ...+.++...|++.+|.+|++..
T Consensus 211 ~---~i~~-~~~------~~p-~~~----~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 211 Q---SIME-HNV------SYP-KSL----SKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred H---HHHh-CCC------CCC-ccC----CHHHHHHHHHHcccCHhhCCCCC
Confidence 1 1111 110 010 111 13567899999999999999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=340.06 Aligned_cols=192 Identities=23% Similarity=0.253 Sum_probs=163.9
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
++|...+.||+|+||.||++.. .+++.||+|... +..+.+|+++|++++|||||++++++......++|+||
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 4688889999999999999985 457889999643 24577899999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccccc
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTR 671 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~ 671 (834)
+. ++|..++.... .+++...+.|+.|++.||+|||+ .+||||||||+|||++.++.+||+|||+|+....
T Consensus 165 ~~-~~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~ 234 (391)
T PHA03212 165 YK-TDLYCYLAAKR------NIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVD 234 (391)
T ss_pred CC-CCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCccccccc
Confidence 86 67777765432 37888899999999999999997 6999999999999999999999999999975322
Q ss_pred CCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccC
Q 003278 672 NDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVD 727 (834)
Q Consensus 672 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~ 727 (834)
.. ........||+.|+|||++.+..++.++|||||||++|||+||+.|+.
T Consensus 235 ~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~ 284 (391)
T PHA03212 235 IN------ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF 284 (391)
T ss_pred cc------ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 11 111234679999999999999999999999999999999999998764
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=324.36 Aligned_cols=254 Identities=22% Similarity=0.367 Sum_probs=199.3
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEcc
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYM 190 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 190 (834)
++|...+.||+|+||.||+|....+++.||+|.++.........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46777889999999999999998899999999987654444566889999999999999999999999999999999999
Q ss_pred CCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhh
Q 003278 191 PNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEH 270 (834)
Q Consensus 191 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~ 270 (834)
++++|.+++... ..+++.+...++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++..+..
T Consensus 89 ~~~~L~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06645 89 GGGSLQDIYHVT-------GPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITA 158 (267)
T ss_pred CCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence 999999988543 3588999999999999999999986 999999999999999999999999999865421
Q ss_pred hhhhhhhcccccccccccccceeeeccccCCCccccc--cCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHH
Q 003278 271 ELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQ--KGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLD 348 (834)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~--~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~ 348 (834)
.. .......||+.|+|||++. ....++.++|||||||++|||++|+.|+....+....
T Consensus 159 ~~----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~---- 218 (267)
T cd06645 159 TI----------------AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL---- 218 (267)
T ss_pred cc----------------cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH----
Confidence 10 0123346899999999874 2335688999999999999999999997543221110
Q ss_pred HHHHHhhcCccccccccccCC-CCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 349 WIRRLSDEGKVLQAGDNRLSD-GSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 349 ~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
..... .... .+.... ..+ ...+.+++..|++.+|++||++.+|++.
T Consensus 219 --~~~~~-~~~~---~~~~~~~~~~----~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 219 --FLMTK-SNFQ---PPKLKDKMKW----SNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred --Hhhhc-cCCC---CCcccccCCC----CHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 00000 1100 011110 011 1357789999999999999999998763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=328.24 Aligned_cols=199 Identities=20% Similarity=0.294 Sum_probs=172.6
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
++|...+.||+|+||.||++... ++..+|+|.+..........++.+|++++.+++||||++++++|.+.+..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36778889999999999999854 57788999887654555567799999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccccc
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTR 671 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~ 671 (834)
+++++|.+++.... .+++.....++.|+++||+|||+. .+++||||||+|||+++++.+||+|||++..+..
T Consensus 81 ~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (308)
T cd06615 81 MDGGSLDQVLKKAG------RIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 152 (308)
T ss_pred cCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCcccccc
Confidence 99999999986532 377888889999999999999962 4899999999999999999999999999865422
Q ss_pred CCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCC
Q 003278 672 NDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDF 728 (834)
Q Consensus 672 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~ 728 (834)
. ......|+..|+|||++.+..++.++|||||||++|||+||+.|+..
T Consensus 153 ~---------~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~ 200 (308)
T cd06615 153 S---------MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPP 200 (308)
T ss_pred c---------ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 1 12245789999999999888899999999999999999999999854
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=328.09 Aligned_cols=262 Identities=21% Similarity=0.294 Sum_probs=199.5
Q ss_pred hCcCcCCcccccCCcEEEEEEEC--------CCcEEEEEEecCCCChhHHHHHHHHHHHHHhc-cCCCceeEEEEEeeCC
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD--------NHQYVLVKRLGMSKCPALRTRFSNELQNLARL-RHRNLVQLCGWCTEQG 583 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~--------~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l-~HpNiv~l~g~~~~~~ 583 (834)
++|...+.||+|+||.||+|... ++..||+|.+.........+.+.+|+.++..+ +||||+++++++....
T Consensus 15 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 94 (304)
T cd05101 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 94 (304)
T ss_pred HHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCC
Confidence 45667788999999999999741 23479999887544444456789999999999 8999999999999999
Q ss_pred eEEEEEeccCCCchhhhhhcCCCC----------CCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeec
Q 003278 584 EMLVIYDYSATRILSHLLFHNNHR----------IGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLD 653 (834)
Q Consensus 584 ~~~lv~Ey~~~g~L~~~l~~~~~~----------~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld 653 (834)
..++||||+++|+|.+++...... .....++|..++.++.|++.||+|||+ .+|+||||||+|||++
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nili~ 171 (304)
T cd05101 95 PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVLVT 171 (304)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEEEc
Confidence 999999999999999998764221 012357889999999999999999996 6999999999999999
Q ss_pred CCCCceEeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCc
Q 003278 654 PDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPE 732 (834)
Q Consensus 654 ~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~ 732 (834)
+++.+||+|||+++.+...... .......+++.|+|||++.+..++.++|||||||++|||+| |..|+... +.
T Consensus 172 ~~~~~kl~D~g~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~ 245 (304)
T cd05101 172 ENNVMKIADFGLARDVNNIDYY-----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PV 245 (304)
T ss_pred CCCcEEECCCccceeccccccc-----ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC-CH
Confidence 9999999999999765332110 11122346778999999998899999999999999999999 66776433 22
Q ss_pred hhHHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccC
Q 003278 733 GLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGN 797 (834)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~ 797 (834)
..+..... ..... ... ..... .+..++.+||..+|++||||.+|++.|+.+
T Consensus 246 ~~~~~~~~---~~~~~-------~~~-~~~~~---~~~~li~~cl~~~p~~Rps~~e~l~~l~~~ 296 (304)
T cd05101 246 EELFKLLK---EGHRM-------DKP-ANCTN---ELYMMMRDCWHAIPSHRPTFKQLVEDLDRI 296 (304)
T ss_pred HHHHHHHH---cCCcC-------CCC-CCCCH---HHHHHHHHHcccChhhCCCHHHHHHHHHHH
Confidence 22222111 11110 000 11123 355566699999999999999999999654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=327.23 Aligned_cols=263 Identities=29% Similarity=0.446 Sum_probs=202.5
Q ss_pred hcCCCCCCCeeeccCCeEEEEEEEC-----CCCeEEEEEEecccC-hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCE
Q 003278 109 GSNGFDEDEVLGSGGFGKVYRAVLP-----SDGTVVAVKCLAEKG-ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQ 182 (834)
Q Consensus 109 ~t~~f~~~~~LG~G~fG~Vy~~~~~-----~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~ 182 (834)
..++|+..+.||+|+||.||+|... .++..||+|.+.... ....+.|.+|+.++++++||||++++++|...+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 4577999999999999999999874 257899999986543 3445679999999999999999999999999999
Q ss_pred EEEEEEccCCCCHhHHHhcCCCcc---------------ccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCC
Q 003278 183 LLLVYDYMPNRSLDRVLFRRPENL---------------EAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTS 247 (834)
Q Consensus 183 ~~lV~Ey~~~gsL~~~l~~~~~~~---------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~ 247 (834)
.++||||+++|+|.+++....... .....+++..++.++.|++.||.|||+. +++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHh
Confidence 999999999999999997532110 1123588999999999999999999985 9999999999
Q ss_pred ceEECCCCceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHH
Q 003278 248 NVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLE 327 (834)
Q Consensus 248 NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~E 327 (834)
|||++.++.+||+|||+++.+...... .......+++.|+|||.+... .++.++|||||||++||
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~e 224 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYY--------------KASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWE 224 (288)
T ss_pred heEecCCCceEECccccceecccCccc--------------cccCCCccChhhcCHHHHhcC-CCCchhHHHHHHHHHHH
Confidence 999999999999999998754221100 001122346789999988654 67999999999999999
Q ss_pred HHh-CCccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhh
Q 003278 328 VVS-GRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVS 406 (834)
Q Consensus 328 llt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~ 406 (834)
|++ |..|+..... ..+.... ..+...... .. ....+.+++.+||+.+|.+||++.|+++.|+
T Consensus 225 l~~~~~~p~~~~~~------~~~~~~~-~~~~~~~~~------~~----~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 225 IFSYGMQPYYGMAH------EEVIYYV-RDGNVLSCP------DN----CPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred HHhCCCCCCCCCCH------HHHHHHH-hcCCCCCCC------CC----CCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 998 8777743211 1222221 122221111 11 1246888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=322.79 Aligned_cols=250 Identities=27% Similarity=0.407 Sum_probs=195.8
Q ss_pred CCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEccC
Q 003278 112 GFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMP 191 (834)
Q Consensus 112 ~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 191 (834)
+|+..+.||+|+||.||+|.+. ++..+|+|.+.... .....|.+|+.++++++||||+++++++...+..++||||++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HcchhhhhccCCCceEEEeEec-CCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 4778899999999999999984 56789999886432 234568899999999999999999999999999999999999
Q ss_pred CCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhhh
Q 003278 192 NRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHE 271 (834)
Q Consensus 192 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~~ 271 (834)
+++|.+++.... ..++|..+..|+.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 83 ~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~ 153 (256)
T cd05059 83 NGCLLNYLRERK------GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD 153 (256)
T ss_pred CCCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccc
Confidence 999999986532 3589999999999999999999985 8999999999999999999999999998754321
Q ss_pred hhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccchHHHHH
Q 003278 272 LQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQIILLDWI 350 (834)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~ 350 (834)
.. .......++..|+|||.+... .++.++|||||||++|||+| |+.|+...... ....
T Consensus 154 ~~---------------~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~-- 212 (256)
T cd05059 154 QY---------------TSSQGTKFPVKWAPPEVFDYS-RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS---EVVE-- 212 (256)
T ss_pred cc---------------cccCCCCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHhccCCCCCCCCCHH---HHHH--
Confidence 00 001111245689999988654 57889999999999999999 78887643211 1111
Q ss_pred HHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHh
Q 003278 351 RRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAV 405 (834)
Q Consensus 351 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l 405 (834)
.. ..+... ... . .....+.+++..||+.+|++||+|.++++.|
T Consensus 213 -~~-~~~~~~-----~~~-~----~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 213 -SV-SAGYRL-----YRP-K----LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred -HH-HcCCcC-----CCC-C----CCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 11 111100 000 1 1234688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=323.61 Aligned_cols=264 Identities=25% Similarity=0.425 Sum_probs=200.7
Q ss_pred CCCCCCCeeeccCCeEEEEEEE----CCCCeEEEEEEecccC-hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeC--CEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVL----PSDGTVVAVKCLAEKG-ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHE--DQL 183 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~----~~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~ 183 (834)
..|...+.||+|+||.||++.+ ..++..||+|.+.... ....+.|.+|+.++++++||||+++++++... +..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3477889999999999999975 3568899999986542 34456799999999999999999999999875 568
Q ss_pred EEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeecc
Q 003278 184 LLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFG 263 (834)
Q Consensus 184 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFG 263 (834)
++||||+++++|.+++... ...++|..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 84 ~lv~e~~~g~~L~~~l~~~------~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg 154 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN------KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFG 154 (284)
T ss_pred EEEEEccCCCCHHHHHHhc------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCc
Confidence 9999999999999998543 13589999999999999999999985 99999999999999999999999999
Q ss_pred chhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCC--
Q 003278 264 LARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPD-- 341 (834)
Q Consensus 264 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~-- 341 (834)
+++.+...... ........|+..|+|||++..+ .++.++|||||||++|||+|++.|...+...
T Consensus 155 ~~~~~~~~~~~-------------~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~ 220 (284)
T cd05079 155 LTKAIETDKEY-------------YTVKDDLDSPVFWYAPECLIQS-KFYIASDVWSFGVTLYELLTYCDSESSPMTLFL 220 (284)
T ss_pred cccccccCccc-------------eeecCCCCCCccccCHHHhccC-CCCccccchhhhhhhhhhhcCCCCCccccchhh
Confidence 99865322100 0011234577889999988654 5788999999999999999988764322110
Q ss_pred -------ccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 342 -------DQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 342 -------~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
.+.....++ .....+...... .. ....+.+++..|++.+|++||++.++++.++..
T Consensus 221 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~------~~----~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 221 KMIGPTHGQMTVTRLV-RVLEEGKRLPRP------PN----CPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred hhcccccccccHHHHH-HHHHcCccCCCC------CC----CCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 111111111 111222111100 11 134688999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=321.83 Aligned_cols=249 Identities=15% Similarity=0.238 Sum_probs=193.2
Q ss_pred CcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEecc
Q 003278 514 NFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYS 592 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~ 592 (834)
+|...+.||+|+||.||+|.. .+++.||+|.+..........+|.+|+.++++++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 455667899999999999985 5678899999876544555577999999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccC
Q 003278 593 ATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRN 672 (834)
Q Consensus 593 ~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~ 672 (834)
++++|..+. .+++.....++.|++.||+|||+ .+|+|+||||+|||++.++.+||+|||++..+...
T Consensus 82 ~~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~ 148 (279)
T cd06619 82 DGGSLDVYR----------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS 148 (279)
T ss_pred CCCChHHhh----------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc
Confidence 999996542 25677788999999999999996 69999999999999999999999999999754321
Q ss_pred CCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHH--HHHHHHHhhcCccc
Q 003278 673 DHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLV--KRVHEFEARKRPLA 750 (834)
Q Consensus 673 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~--~~~~~~~~~~~~~~ 750 (834)
......||..|+|||++.+..++.++|||||||++|||+||+.|+.......... ...........
T Consensus 149 ---------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--- 216 (279)
T cd06619 149 ---------IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED--- 216 (279)
T ss_pred ---------cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC---
Confidence 1223578999999999998899999999999999999999999986432211100 00001100000
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHH
Q 003278 751 ELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSI 793 (834)
Q Consensus 751 ~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~ 793 (834)
.+.+....... .+.+++.+||+.+|++||++.+|++.
T Consensus 217 ---~~~~~~~~~~~---~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 217 ---PPVLPVGQFSE---KFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred ---CCCCCCCcCCH---HHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 01111111112 34566679999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=325.50 Aligned_cols=251 Identities=24% Similarity=0.339 Sum_probs=195.8
Q ss_pred CCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEc
Q 003278 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDY 189 (834)
Q Consensus 113 f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 189 (834)
|+..+.||+|+||.||+|....+++.||||.+.... ....+.+.+|+.++++++|+||+.+++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667789999999999999999999999999886432 22335678899999999999999999999999999999999
Q ss_pred cCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhh
Q 003278 190 MPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLE 269 (834)
Q Consensus 190 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~ 269 (834)
+++|+|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+|||+++++.++|+|||++....
T Consensus 82 ~~g~~L~~~l~~~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 153 (285)
T cd05630 82 MNGGDLKFHIYHMG-----EAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVP 153 (285)
T ss_pred cCCCcHHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecC
Confidence 99999999886432 23588999999999999999999985 99999999999999999999999999986432
Q ss_pred hhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHH
Q 003278 270 HELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDW 349 (834)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~ 349 (834)
... ......||+.|+|||.+... .++.++|||||||++|||++|+.||........ . .-
T Consensus 154 ~~~-----------------~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~--~-~~ 212 (285)
T cd05630 154 EGQ-----------------TIKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK--R-EE 212 (285)
T ss_pred CCc-----------------cccCCCCCccccChHHHcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCccch--H-HH
Confidence 110 01223589999999998655 578999999999999999999999975322111 0 00
Q ss_pred HHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCc-----hhhHHH
Q 003278 350 IRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPS-----MKWVIE 403 (834)
Q Consensus 350 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----m~~V~~ 403 (834)
........ .. ... ..+. ..+.+++..||+.||.+||+ +.++++
T Consensus 213 ~~~~~~~~--~~----~~~-~~~~----~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 213 VERLVKEV--QE----EYS-EKFS----PDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred HHhhhhhh--hh----hcC-ccCC----HHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 11111100 00 010 1111 34678999999999999999 666664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=327.81 Aligned_cols=267 Identities=25% Similarity=0.344 Sum_probs=205.9
Q ss_pred cccHHHHHhhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhC-CCCceeeEeeeEE
Q 003278 100 IFSYAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHL-RHRNLVRLRGWCV 178 (834)
Q Consensus 100 ~f~~~el~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~ 178 (834)
.|+..++..++++|+..+.||+|+||.||+|....+++.+|+|.+.... .....+.+|+.++.++ +||||++++++|.
T Consensus 11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 4566777778999999999999999999999998899999999986532 2345678899999998 8999999999987
Q ss_pred eCC-----EEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECC
Q 003278 179 HED-----QLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDS 253 (834)
Q Consensus 179 ~~~-----~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~ 253 (834)
..+ ..++||||+++|+|.+++..... ....++|..+..++.|++.||.|||+. +|+||||||+||+++.
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~ 163 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLI---CGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTT 163 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcC
Confidence 643 58999999999999998864321 234689999999999999999999985 9999999999999999
Q ss_pred CCceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCC----CCCcccceeehhhHHHHHH
Q 003278 254 QYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGS----VATAKSDVFSFGIVVLEVV 329 (834)
Q Consensus 254 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~----~~~~ksDV~SfGvvl~Ell 329 (834)
++.+||+|||+++.+..... ......|+..|+|||.+..+. .++.++|||||||++|||+
T Consensus 164 ~~~~kl~dfg~~~~~~~~~~----------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~ 227 (291)
T cd06639 164 EGGVKLVDFGVSAQLTSTRL----------------RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELG 227 (291)
T ss_pred CCCEEEeecccchhcccccc----------------cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHh
Confidence 99999999999875432100 012235889999999875432 2578999999999999999
Q ss_pred hCCccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 330 SGRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 330 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
||+.|+...... ..+..+ . .+......++ . .....+.+++..||+.+|++||++.++++.
T Consensus 228 ~g~~p~~~~~~~--~~~~~~----~-~~~~~~~~~~----~----~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 228 DGDPPLFDMHPV--KTLFKI----P-RNPPPTLLHP----E----KWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred hCCCCCCCCcHH--HHHHHH----h-cCCCCCCCcc----c----ccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 999998643211 111111 0 1111111110 0 112357889999999999999999999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=326.53 Aligned_cols=263 Identities=21% Similarity=0.308 Sum_probs=200.2
Q ss_pred HhhCcCcCCcccccCCcEEEEEEECC------CcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCe
Q 003278 511 ATNNFSESQRVAEMDFGTAYQGFLDN------HQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGE 584 (834)
Q Consensus 511 at~~f~~~~~ig~g~~g~vy~~~~~~------~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~ 584 (834)
.+++|...+.||+|+||.||+|...+ +..||+|.+...........|.+|+.++++++||||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 34677888899999999999997542 447999988755444445678899999999999999999999999999
Q ss_pred EEEEEeccCCCchhhhhhcCCC----CCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceE
Q 003278 585 MLVIYDYSATRILSHLLFHNNH----RIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRL 660 (834)
Q Consensus 585 ~~lv~Ey~~~g~L~~~l~~~~~----~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki 660 (834)
.++||||+++|+|.+++..... ..+...+++.....++.|++.||+|||+ ++|+||||||+|||+++++.+|+
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999975321 1122346777888999999999999996 69999999999999999999999
Q ss_pred eeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHH
Q 003278 661 GSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRV 739 (834)
Q Consensus 661 ~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~ 739 (834)
+|||+++.+...... .......++..|+|||++.++.++.++|||||||++|||++ |..|+....... .....
T Consensus 161 ~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~-~~~~~ 234 (288)
T cd05061 161 GDFGMTRDIYETDYY-----RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ-VLKFV 234 (288)
T ss_pred CcCCccccccccccc-----cccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHH
Confidence 999999765332210 01112345778999999999999999999999999999999 677775332221 11111
Q ss_pred HHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHcc
Q 003278 740 HEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDG 796 (834)
Q Consensus 740 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~ 796 (834)
.. .... ..... .+ ..+.+++.+||+.+|++|||+.++++.|..
T Consensus 235 ~~-----~~~~-----~~~~~-~~---~~~~~li~~~l~~~p~~Rps~~~ll~~l~~ 277 (288)
T cd05061 235 MD-----GGYL-----DQPDN-CP---ERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 277 (288)
T ss_pred Hc-----CCCC-----CCCCC-CC---HHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 10 0000 00111 11 245666779999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=330.43 Aligned_cols=239 Identities=17% Similarity=0.203 Sum_probs=183.4
Q ss_pred cccccCCcEEEEEEEC-CCcEEEEEEecCCC--ChhHHHHHHHHHHHHHh-ccCCCceeEEEEEeeCCeEEEEEeccCCC
Q 003278 520 RVAEMDFGTAYQGFLD-NHQYVLVKRLGMSK--CPALRTRFSNELQNLAR-LRHRNLVQLCGWCTEQGEMLVIYDYSATR 595 (834)
Q Consensus 520 ~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~E~~~l~~-l~HpNiv~l~g~~~~~~~~~lv~Ey~~~g 595 (834)
.||+|+||.||+|... ++..||||.++... .....+.+..|..++.. .+||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg 81 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 5899999999999964 47889999986432 12223455667777765 48999999999999999999999999999
Q ss_pred chhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCCCC
Q 003278 596 ILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHG 675 (834)
Q Consensus 596 ~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~~~ 675 (834)
+|..++.... .+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~L~~~~~~~~------~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-- 150 (316)
T cd05592 82 DLMFHIQSSG------RFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-- 150 (316)
T ss_pred cHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--
Confidence 9998886432 37778888899999999999997 699999999999999999999999999997542211
Q ss_pred CcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcccccccc
Q 003278 676 HRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDL 755 (834)
Q Consensus 676 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 755 (834)
.......||+.|||||++.+..++.++|||||||++|||+||+.||....... +...+ . ...+
T Consensus 151 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~-~~~~i---~-~~~~------- 213 (316)
T cd05592 151 -----GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE-LFDSI---L-NDRP------- 213 (316)
T ss_pred -----CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH-HHHHH---H-cCCC-------
Confidence 11234679999999999998899999999999999999999999986443221 11111 1 1111
Q ss_pred ccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHH
Q 003278 756 SLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQI 790 (834)
Q Consensus 756 ~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v 790 (834)
.++... ..++ ..++.+||+.||++||++.+.
T Consensus 214 ~~~~~~-~~~~---~~ll~~~l~~~P~~R~~~~~~ 244 (316)
T cd05592 214 HFPRWI-SKEA---KDCLSKLFERDPTKRLGVDGD 244 (316)
T ss_pred CCCCCC-CHHH---HHHHHHHccCCHHHcCCChHH
Confidence 111111 2333 345558999999999998643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=321.51 Aligned_cols=250 Identities=24% Similarity=0.382 Sum_probs=195.8
Q ss_pred CCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEccC
Q 003278 112 GFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMP 191 (834)
Q Consensus 112 ~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 191 (834)
+|...+.||+|+||.||+|.+. ++..||||.+.... ...+.|.+|+.++.+++||||++++++|...+..++||||++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4677789999999999999884 45679999886432 334678999999999999999999999999999999999999
Q ss_pred CCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhhh
Q 003278 192 NRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHE 271 (834)
Q Consensus 192 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~~ 271 (834)
+|+|.+++.... ..++|..++.++.|++.||+|||+. +++|+||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~l~~~i~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05113 83 NGCLLNYLREHG------KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD 153 (256)
T ss_pred CCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence 999999986432 2589999999999999999999985 9999999999999999999999999998754221
Q ss_pred hhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccchHHHHH
Q 003278 272 LQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQIILLDWI 350 (834)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~ 350 (834)
.. .......++..|+|||.+..+ .++.++|||||||++|||+| |+.|+...... .....+
T Consensus 154 ~~---------------~~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~ 214 (256)
T cd05113 154 EY---------------TSSVGSKFPVRWSPPEVLLYS-KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS---ETVEKV 214 (256)
T ss_pred ce---------------eecCCCccChhhCCHHHHhcC-cccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHHH
Confidence 00 001122366789999998654 57889999999999999999 98887543211 111111
Q ss_pred HHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHh
Q 003278 351 RRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAV 405 (834)
Q Consensus 351 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l 405 (834)
..+..... + .. ....+.+++..||+.+|.+||++.++++.|
T Consensus 215 ----~~~~~~~~--~----~~----~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 215 ----SQGLRLYR--P----HL----ASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred ----hcCCCCCC--C----CC----CCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 11111100 0 11 125688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=323.04 Aligned_cols=248 Identities=21% Similarity=0.336 Sum_probs=197.8
Q ss_pred CcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEecc
Q 003278 514 NFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYS 592 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~ 592 (834)
.|...++||+|+||.||+|... ++..||||.+...........|.+|+.++++++||||+++++++.+....++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4566778999999999999864 578899999876554555578999999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccC
Q 003278 593 ATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRN 672 (834)
Q Consensus 593 ~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~ 672 (834)
++|+|.+++... .+++.....++.|++.||+|||+ .+++|+||+|+||++++++.++++|||++..+...
T Consensus 85 ~~~~L~~~i~~~-------~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06640 85 GGGSALDLLRAG-------PFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred CCCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence 999999988532 36778888999999999999996 69999999999999999999999999999765432
Q ss_pred CCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCccccc
Q 003278 673 DHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAEL 752 (834)
Q Consensus 673 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (834)
.. ......||..|+|||++.+..++.++|||||||++|||+||+.|+....+.... ... ....
T Consensus 155 ~~-------~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-~~~----~~~~----- 217 (277)
T cd06640 155 QI-------KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL-FLI----PKNN----- 217 (277)
T ss_pred cc-------ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh-hhh----hcCC-----
Confidence 11 122346888999999999888999999999999999999999998654332211 100 0000
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHH
Q 003278 753 VDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSI 793 (834)
Q Consensus 753 ~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~ 793 (834)
.+.+ .......+.+++.+||+.+|++|||+.+|++.
T Consensus 218 -~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 218 -PPTL----TGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred -CCCC----chhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 0111 11222345667779999999999999999763
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=336.27 Aligned_cols=217 Identities=23% Similarity=0.351 Sum_probs=175.1
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc---ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK---GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 187 (834)
++|+..+.||+|+||.||+|....+++.||||++... .......+.+|+.++.+++||||+++++++.+.+.+++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4688889999999999999999889999999998643 1233456888999999999999999999999999999999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
||+++|+|.+++... ..+++.....++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 E~~~gg~L~~~l~~~-------~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~ 150 (360)
T cd05627 81 EFLPGGDMMTLLMKK-------DTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTG 150 (360)
T ss_pred eCCCCccHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcc
Confidence 999999999998643 3578899999999999999999985 999999999999999999999999999875
Q ss_pred hhhhhhhhhhcc--------------c-cccc----ccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHH
Q 003278 268 LEHELQYQMRTS--------------S-ARNH----QFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEV 328 (834)
Q Consensus 268 ~~~~~~~~~~~~--------------~-~~~~----~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~El 328 (834)
+........... . .... ..........+||+.|+|||++... .++.++|||||||++|||
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyel 229 (360)
T cd05627 151 LKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEM 229 (360)
T ss_pred cccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC-CCCCcceeccccceeeec
Confidence 532110000000 0 0000 0000012345799999999998654 678999999999999999
Q ss_pred HhCCccCCCC
Q 003278 329 VSGRRAVDLT 338 (834)
Q Consensus 329 ltG~~p~~~~ 338 (834)
+||+.||...
T Consensus 230 ~tG~~Pf~~~ 239 (360)
T cd05627 230 LIGYPPFCSE 239 (360)
T ss_pred ccCCCCCCCC
Confidence 9999998643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=323.01 Aligned_cols=260 Identities=19% Similarity=0.299 Sum_probs=193.6
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-----CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEee--CCeE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-----NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTE--QGEM 585 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-----~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~--~~~~ 585 (834)
.+|...+.||+|+||.||+|..+ ++..||+|.+.... ....+.|.+|++++++++|||||++++++.. ....
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 35666788999999999999753 47789999986443 3344678999999999999999999998754 3468
Q ss_pred EEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeee
Q 003278 586 LVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFAL 665 (834)
Q Consensus 586 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGl 665 (834)
++||||+++|+|.+++.... ..++|..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~-----~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~ 154 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHR-----ERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGL 154 (284)
T ss_pred EEEEEecCCCCHHHHHHhcC-----cCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCcc
Confidence 89999999999999986432 248899999999999999999996 6899999999999999999999999999
Q ss_pred ccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHH--------
Q 003278 666 AEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVK-------- 737 (834)
Q Consensus 666 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~-------- 737 (834)
++.+........ ......++..|+|||++.++.++.++|||||||++|||+||..|..... .....
T Consensus 155 ~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~--~~~~~~~~~~~~~ 228 (284)
T cd05081 155 TKVLPQDKEYYK----VREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPP--AEFMRMMGNDKQG 228 (284)
T ss_pred cccccCCCccee----ecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcc--hhhhhhccccccc
Confidence 987543221100 0111234456999999998899999999999999999999876643211 10000
Q ss_pred -----HHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccC
Q 003278 738 -----RVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGN 797 (834)
Q Consensus 738 -----~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~ 797 (834)
...+....... ....... + ..+.+++.+||+.+|++||||.+|++.|+.+
T Consensus 229 ~~~~~~~~~~~~~~~~------~~~~~~~-~---~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 229 QMIVYHLIELLKNNGR------LPAPPGC-P---AEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred ccchHHHHHHHhcCCc------CCCCCCC-C---HHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 00000000000 0001111 1 2456677799999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=322.98 Aligned_cols=254 Identities=28% Similarity=0.434 Sum_probs=194.4
Q ss_pred CeeeccCCeEEEEEEECCCCe--EEEEEEeccc-ChhhHHHHHHHHHHHHhC-CCCceeeEeeeEEeCCEEEEEEEccCC
Q 003278 117 EVLGSGGFGKVYRAVLPSDGT--VVAVKCLAEK-GERFEKTFAAELVAVAHL-RHRNLVRLRGWCVHEDQLLLVYDYMPN 192 (834)
Q Consensus 117 ~~LG~G~fG~Vy~~~~~~~g~--~vAvK~l~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 192 (834)
++||+|+||.||+|.+..++. .+|+|.+... .....+.+.+|+.++.++ +||||++++++|...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 469999999999999977775 4688888643 234556789999999999 899999999999999999999999999
Q ss_pred CCHhHHHhcCCCc---------cccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeecc
Q 003278 193 RSLDRVLFRRPEN---------LEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFG 263 (834)
Q Consensus 193 gsL~~~l~~~~~~---------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFG 263 (834)
|+|.+++...... ......+++.++..++.|++.||+|||+. +++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 9999998654211 01123589999999999999999999985 99999999999999999999999999
Q ss_pred chhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCc
Q 003278 264 LARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDD 342 (834)
Q Consensus 264 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~ 342 (834)
+++...... ......+++.|+|||++... .++.++|||||||++|||+| |+.||......
T Consensus 158 l~~~~~~~~-----------------~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~~- 218 (270)
T cd05047 158 LSRGQEVYV-----------------KKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA- 218 (270)
T ss_pred Cccccchhh-----------------hccCCCCccccCChHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCccccCHH-
Confidence 986321100 01112246789999988654 57899999999999999997 99988542211
Q ss_pred cchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 343 QIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 343 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
+...... .+..... . . .....+.+++..||+.+|.+||++.+++..|...
T Consensus 219 -----~~~~~~~-~~~~~~~-----~-~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 219 -----ELYEKLP-QGYRLEK-----P-L----NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred -----HHHHHHh-CCCCCCC-----C-C----cCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 1111111 1111100 0 0 1123578999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=323.73 Aligned_cols=257 Identities=25% Similarity=0.387 Sum_probs=199.3
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCe----EEEEEEeccc-ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGT----VVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLL 184 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~----~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 184 (834)
.++|+..++||+|+||.||+|.+..+|. .||||.+... .....+.+.+|+.++..++||||++++++|... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 3568888999999999999999866665 4899988643 334567789999999999999999999999754 578
Q ss_pred EEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccc
Q 003278 185 LVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGL 264 (834)
Q Consensus 185 lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGl 264 (834)
++|||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+
T Consensus 85 l~~~~~~~g~l~~~l~~~------~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~ 155 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN------KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGL 155 (279)
T ss_pred EEEEcCCCCCHHHHHhhc------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCc
Confidence 999999999999998653 23589999999999999999999985 999999999999999999999999999
Q ss_pred hhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCcc
Q 003278 265 ARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQ 343 (834)
Q Consensus 265 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~ 343 (834)
++.+...... .......+++.|+|||.+... .++.++|||||||++|||+| |..|++....
T Consensus 156 ~~~~~~~~~~--------------~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--- 217 (279)
T cd05109 156 ARLLDIDETE--------------YHADGGKVPIKWMALESILHR-RFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--- 217 (279)
T ss_pred eeecccccce--------------eecCCCccchhhCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---
Confidence 9865321100 001112356789999988654 57899999999999999998 8888754321
Q ss_pred chHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 344 IILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 344 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
..+..++. .+..... . .. ....+.+++..||+.||+.||++.++++.|...
T Consensus 218 ~~~~~~~~----~~~~~~~-~-----~~----~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~ 268 (279)
T cd05109 218 REIPDLLE----KGERLPQ-P-----PI----CTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268 (279)
T ss_pred HHHHHHHH----CCCcCCC-C-----cc----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 11222222 1111110 0 11 123578899999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=322.77 Aligned_cols=257 Identities=21% Similarity=0.348 Sum_probs=197.2
Q ss_pred cCcCCcccccCCcEEEEEEECC-C---cEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEe
Q 003278 515 FSESQRVAEMDFGTAYQGFLDN-H---QYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYD 590 (834)
Q Consensus 515 f~~~~~ig~g~~g~vy~~~~~~-~---~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~E 590 (834)
+...+.||+|+||.||+|.... + ..||||.+...........|..|+.++++++||||+++++++.+....++|||
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 85 (269)
T cd05065 6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITE 85 (269)
T ss_pred eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEe
Confidence 4556789999999999999643 2 36999998765555566789999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccc
Q 003278 591 YSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLT 670 (834)
Q Consensus 591 y~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~ 670 (834)
|+++|+|..++.... ..+++..++.++.|++.||+|||+ .+++||||||+|||++.++.+|++|||++....
T Consensus 86 ~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 86 FMENGALDSFLRQND-----GQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred cCCCCcHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccc
Confidence 999999999986542 247899999999999999999996 699999999999999999999999999997654
Q ss_pred cCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCcc
Q 003278 671 RNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRPL 749 (834)
Q Consensus 671 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
....... ........++..|+|||++.++.++.++|||||||++|||++ |..|+...... .....+. .....
T Consensus 158 ~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~-~~~~~i~----~~~~~ 230 (269)
T cd05065 158 DDTSDPT--YTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-DVINAIE----QDYRL 230 (269)
T ss_pred cCccccc--cccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH-HHHHHHH----cCCcC
Confidence 3221100 000001112457999999999999999999999999999887 98888643322 1111111 10000
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHcc
Q 003278 750 AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDG 796 (834)
Q Consensus 750 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~ 796 (834)
...... + ..+.+++.+||+.+|++||+|.+|+..|+.
T Consensus 231 ------~~~~~~-~---~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 231 ------PPPMDC-P---TALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred ------CCcccC-C---HHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 001111 1 235567779999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=335.63 Aligned_cols=247 Identities=21% Similarity=0.334 Sum_probs=194.6
Q ss_pred CcccccCCcEEEEEEECC----CcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEeccCC
Q 003278 519 QRVAEMDFGTAYQGFLDN----HQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSAT 594 (834)
Q Consensus 519 ~~ig~g~~g~vy~~~~~~----~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~~~ 594 (834)
++||+|.||.|++|.+.. ...||||.+...........|.+|+.+|-+|+|||+|+|||+..+ ....+|+|.++.
T Consensus 116 e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELapl 194 (1039)
T KOG0199|consen 116 ELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPL 194 (1039)
T ss_pred HHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhccc
Confidence 468999999999999754 346999999876655567899999999999999999999999988 678899999999
Q ss_pred CchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCCC
Q 003278 595 RILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDH 674 (834)
Q Consensus 595 g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~~ 674 (834)
|+|.+.|++.. ...|--....+++.|||.||.||-+ +..|||||..+|+||.....+||+||||.+.+..++.
T Consensus 195 GSLldrLrka~----~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 195 GSLLDRLRKAK----KAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred chHHHHHhhcc----ccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 99999998622 1346666778899999999999986 7999999999999999999999999999998876654
Q ss_pred CCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCcccccc
Q 003278 675 GHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRPLAELV 753 (834)
Q Consensus 675 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (834)
.+.... . ..-.+.|.|||.++.+.++.+||||+|||++|||+| |+.|+-.. +.-.+++.+. .+++.
T Consensus 268 ~Yvm~p--~--rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~-~g~qIL~~iD---~~erL----- 334 (1039)
T KOG0199|consen 268 MYVMAP--Q--RKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC-RGIQILKNID---AGERL----- 334 (1039)
T ss_pred ceEecC--C--CcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC-CHHHHHHhcc---ccccC-----
Confidence 331111 1 123467999999999999999999999999999998 56676432 2222233222 11111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 754 DLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 754 d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
-...++.+ ++..+|+.||..+|++||||..|..
T Consensus 335 ---pRPk~cse---dIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 335 ---PRPKYCSE---DIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred ---CCCCCChH---HHHHHHHHhccCCccccccHHHHHH
Confidence 11244554 4556667999999999999999974
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=339.27 Aligned_cols=257 Identities=20% Similarity=0.234 Sum_probs=195.9
Q ss_pred CcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCC--ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEe
Q 003278 514 NFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSK--CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYD 590 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~E 590 (834)
+|...+.||+|+||+||+|... ++..||||++.... .......|.+|+.++..++||||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 5677788999999999999965 68899999986432 12334678899999999999999999999999999999999
Q ss_pred ccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccc
Q 003278 591 YSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLT 670 (834)
Q Consensus 591 y~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~ 670 (834)
|+++|+|.+++...+ .+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++..+.
T Consensus 82 ~~~~~~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~ 152 (350)
T cd05573 82 YMPGGDLMNLLIRKD------VFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMN 152 (350)
T ss_pred CCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCc
Confidence 999999999987542 37788888999999999999997 799999999999999999999999999997654
Q ss_pred cCCCC----------------------CcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCC
Q 003278 671 RNDHG----------------------HRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDF 728 (834)
Q Consensus 671 ~~~~~----------------------~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~ 728 (834)
..... ............||+.|+|||++.+..++.++|||||||+||||+||+.||..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~ 232 (350)
T cd05573 153 KAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYS 232 (350)
T ss_pred ccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCC
Confidence 32200 00000112345799999999999999999999999999999999999999875
Q ss_pred CCCchhHHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCC-hhHHHH
Q 003278 729 RLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPS-MRQILS 792 (834)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPt-m~~v~~ 792 (834)
..+... ...+..+ ... ..-+. ...+ ..++ ..+..+|+. ||.+||+ +.++++
T Consensus 233 ~~~~~~-~~~i~~~---~~~---~~~p~-~~~~-~~~~---~~li~~ll~-dp~~R~~s~~~ll~ 284 (350)
T cd05573 233 DTLQET-YNKIINW---KES---LRFPP-DPPV-SPEA---IDLICRLLC-DPEDRLGSFEEIKS 284 (350)
T ss_pred CCHHHH-HHHHhcc---CCc---ccCCC-CCCC-CHHH---HHHHHHHcc-ChhhcCCCHHHHhc
Confidence 432211 1111110 000 00000 0011 2333 344457887 9999999 999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=360.22 Aligned_cols=259 Identities=23% Similarity=0.342 Sum_probs=199.8
Q ss_pred hhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeC--CEE
Q 003278 108 IGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHE--DQL 183 (834)
Q Consensus 108 ~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~ 183 (834)
...++|.+.+.||+|+||.||+|....++..||+|.+... .......|..|+.+|.+|+|||||+++++|... +.+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 3456899999999999999999999999999999988643 334557789999999999999999999988654 568
Q ss_pred EEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccC----CCeecCCCCCCceEECCC-----
Q 003278 184 LLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLE----TQIIHRDVKTSNVMLDSQ----- 254 (834)
Q Consensus 184 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~----~~iiHrDlKp~NILld~~----- 254 (834)
||||||+++|+|..+|..... ....+++..++.|+.||+.||.|||+... .+||||||||+||||+.+
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~---~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYK---MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 999999999999999865321 13468999999999999999999998531 359999999999999642
Q ss_pred ------------CceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCcccccc-CCCCCcccceeeh
Q 003278 255 ------------YNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQK-GSVATAKSDVFSF 321 (834)
Q Consensus 255 ------------~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~ksDV~Sf 321 (834)
..+||+|||+++.+.... ......||+.|+|||.+.. ...++.++|||||
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s-----------------~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSL 229 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIES-----------------MAHSCVGTPYYWSPELLLHETKSYDDKSDMWAL 229 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccccc-----------------cccccCCCccccCHHHHhccCCCCCchhHHHHH
Confidence 348999999997542210 1234469999999998853 2357889999999
Q ss_pred hhHHHHHHhCCccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhH
Q 003278 322 GIVVLEVVSGRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWV 401 (834)
Q Consensus 322 Gvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V 401 (834)
||+||||+||+.||..... ....+..+ ..+. +..+ ..+ ...+.+|+..||+.+|.+||++.++
T Consensus 230 G~ILYELLTGk~PF~~~~~-----~~qli~~l-k~~p-----~lpi--~~~----S~eL~dLI~~~L~~dPeeRPSa~Ql 292 (1021)
T PTZ00266 230 GCIIYELCSGKTPFHKANN-----FSQLISEL-KRGP-----DLPI--KGK----SKELNILIKNLLNLSAKERPSALQC 292 (1021)
T ss_pred HHHHHHHHHCCCCCCcCCc-----HHHHHHHH-hcCC-----CCCc--CCC----CHHHHHHHHHHhcCChhHCcCHHHH
Confidence 9999999999999864221 11112211 1110 1111 111 1357889999999999999999999
Q ss_pred HH
Q 003278 402 IE 403 (834)
Q Consensus 402 ~~ 403 (834)
+.
T Consensus 293 L~ 294 (1021)
T PTZ00266 293 LG 294 (1021)
T ss_pred hc
Confidence 84
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=356.54 Aligned_cols=268 Identities=18% Similarity=0.251 Sum_probs=199.0
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCC--ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSK--CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIY 589 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~ 589 (834)
++|...++||+|+||.||+|... ++..||||++.... .+...++|.+|++++++++|||||++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 35677789999999999999864 58899999987542 3345678999999999999999999999999999999999
Q ss_pred eccCCCchhhhhhcCCCC-----CCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeee
Q 003278 590 DYSATRILSHLLFHNNHR-----IGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFA 664 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~-----~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfG 664 (834)
||+++|+|.+++...... .....+++...+.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecC
Confidence 999999999988642110 011246778889999999999999996 689999999999999999999999999
Q ss_pred eccccccCCCCCc-----------ccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCch
Q 003278 665 LAEFLTRNDHGHR-----------KATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEG 733 (834)
Q Consensus 665 la~~~~~~~~~~~-----------~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~ 733 (834)
+++.......... ..........||+.|||||++.+..++.++|||||||++|||+||+.|+.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9987522110000 00011123579999999999999999999999999999999999999986432211
Q ss_pred hHHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCC-ChhHHHHHHcc
Q 003278 734 LLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRP-SMRQILSILDG 796 (834)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RP-tm~~v~~~L~~ 796 (834)
.... .....+. ... + .... +. .+.+++.+|++.||++|| ++.++.+.|+.
T Consensus 239 i~~~-----~~i~~P~-~~~-p--~~~i-P~---~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~ 289 (932)
T PRK13184 239 ISYR-----DVILSPI-EVA-P--YREI-PP---FLSQIAMKALAVDPAERYSSVQELKQDLEP 289 (932)
T ss_pred hhhh-----hhccChh-hcc-c--cccC-CH---HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1000 0000000 000 0 0011 12 345666799999999996 56667766654
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=331.73 Aligned_cols=241 Identities=13% Similarity=0.172 Sum_probs=185.3
Q ss_pred cccccCCcEEEEEEEC-CCcEEEEEEecCCC--ChhHHHHHHHHHHHHHhc-cCCCceeEEEEEeeCCeEEEEEeccCCC
Q 003278 520 RVAEMDFGTAYQGFLD-NHQYVLVKRLGMSK--CPALRTRFSNELQNLARL-RHRNLVQLCGWCTEQGEMLVIYDYSATR 595 (834)
Q Consensus 520 ~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~E~~~l~~l-~HpNiv~l~g~~~~~~~~~lv~Ey~~~g 595 (834)
.||+|+||.||++... ++..||||.++... .....+.+.+|+.++.++ +|||||++++++.+.+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g 81 (329)
T cd05588 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG 81 (329)
T ss_pred eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 5899999999999864 57889999987532 223345688999999998 7999999999999999999999999999
Q ss_pred chhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCCCC
Q 003278 596 ILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHG 675 (834)
Q Consensus 596 ~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~~~ 675 (834)
+|..++...+ .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~L~~~~~~~~------~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--- 149 (329)
T cd05588 82 DLMFHMQRQR------KLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--- 149 (329)
T ss_pred CHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccC---
Confidence 9988875432 38889999999999999999996 69999999999999999999999999998642211
Q ss_pred CcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCC----chhHHHHHHHHHhhcCcccc
Q 003278 676 HRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLP----EGLLVKRVHEFEARKRPLAE 751 (834)
Q Consensus 676 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~ 751 (834)
........||+.|||||++.+..++.++|||||||++|||+||+.||+.... .............. ..
T Consensus 150 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~--- 221 (329)
T cd05588 150 ----GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE-KQ--- 221 (329)
T ss_pred ----CCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc-CC---
Confidence 1112346899999999999999999999999999999999999999963211 11111111111111 11
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCh
Q 003278 752 LVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSM 787 (834)
Q Consensus 752 ~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm 787 (834)
..++...+ . .+..++.+|+..||.+|||+
T Consensus 222 ---~~~p~~~~-~---~~~~li~~~L~~dP~~R~~~ 250 (329)
T cd05588 222 ---IRIPRSLS-V---KASSVLKGFLNKDPKERLGC 250 (329)
T ss_pred ---CCCCCCCC-H---HHHHHHHHHhccCHHHcCCC
Confidence 01111222 2 34455668999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=322.58 Aligned_cols=255 Identities=23% Similarity=0.381 Sum_probs=202.2
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEc
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDY 189 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 189 (834)
.++|+..+.||+|+||.||+|.+..++..||+|.+........+.|.+|+.++++++||||+++++++...+..++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 35688889999999999999999888999999998766566667899999999999999999999999999999999999
Q ss_pred cCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhh
Q 003278 190 MPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLE 269 (834)
Q Consensus 190 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~ 269 (834)
+++++|.+++... ..++++.....++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++....
T Consensus 84 ~~~~~L~~~~~~~------~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~ 154 (280)
T cd06611 84 CDGGALDSIMLEL------ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNK 154 (280)
T ss_pred cCCCcHHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhc
Confidence 9999999998643 23589999999999999999999986 99999999999999999999999999986532
Q ss_pred hhhhhhhhcccccccccccccceeeeccccCCCcccccc----CCCCCcccceeehhhHHHHHHhCCccCCCCCCCccch
Q 003278 270 HELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQK----GSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQII 345 (834)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~----~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~ 345 (834)
... .......||+.|+|||.+.. ...++.++|||||||++|||++|+.|+...... ..
T Consensus 155 ~~~----------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~--~~ 216 (280)
T cd06611 155 STL----------------QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM--RV 216 (280)
T ss_pred ccc----------------cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH--HH
Confidence 210 01234568999999998742 234677999999999999999999998643211 11
Q ss_pred HHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 346 LLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 346 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
+ .... .+.......+ ..+ ...+.+++..||+.+|.+||++.+|++.
T Consensus 217 ~----~~~~-~~~~~~~~~~----~~~----~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 217 L----LKIL-KSEPPTLDQP----SKW----SSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred H----HHHh-cCCCCCcCCc----ccC----CHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 1 1111 1110000000 011 1357789999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=335.52 Aligned_cols=242 Identities=26% Similarity=0.323 Sum_probs=185.9
Q ss_pred eeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHHHHHhC---CCCceeeEeeeEEeCCEEEEEEEccCC
Q 003278 119 LGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVAVAHL---RHRNLVRLRGWCVHEDQLLLVYDYMPN 192 (834)
Q Consensus 119 LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l---~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 192 (834)
||+|+||+||+|+...+|+.||||++.... ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999998899999999986432 12233455677777655 799999999999999999999999999
Q ss_pred CCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhhhh
Q 003278 193 RSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHEL 272 (834)
Q Consensus 193 gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~ 272 (834)
|+|..++... ..+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~l~~~-------~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~ 150 (330)
T cd05586 81 GELFWHLQKE-------GRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN 150 (330)
T ss_pred ChHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC
Confidence 9999888542 3588899999999999999999985 99999999999999999999999999987421110
Q ss_pred hhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHHHHH
Q 003278 273 QYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIRR 352 (834)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~ 352 (834)
.......||+.|+|||.+.....++.++|||||||++|||+||+.||...... .....
T Consensus 151 ----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~------~~~~~ 208 (330)
T cd05586 151 ----------------KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ------QMYRN 208 (330)
T ss_pred ----------------CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH------HHHHH
Confidence 01234569999999999875555789999999999999999999998643211 11111
Q ss_pred HhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 353 LSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 353 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
. ..+.. ++.....+ ..+.++...||+.||.+||++.+.++
T Consensus 209 i-~~~~~------~~~~~~~~----~~~~~li~~~L~~~P~~R~~~~~~~~ 248 (330)
T cd05586 209 I-AFGKV------RFPKNVLS----DEGRQFVKGLLNRNPQHRLGAHRDAV 248 (330)
T ss_pred H-HcCCC------CCCCccCC----HHHHHHHHHHcCCCHHHCCCCCCCHH
Confidence 1 11111 11111111 34678899999999999996554333
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=318.17 Aligned_cols=252 Identities=22% Similarity=0.371 Sum_probs=195.6
Q ss_pred CcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEeccC
Q 003278 514 NFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSA 593 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~~ 593 (834)
+|...++||+|+||.||+|...++..||+|.+...... .+.|.+|+.++++++||||+++++++.+ ...+++|||++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~--~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~ 83 (260)
T cd05070 7 SLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS--PESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMS 83 (260)
T ss_pred HhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC--HHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecC
Confidence 45667889999999999999888888999998754332 3579999999999999999999998854 56889999999
Q ss_pred CCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCC
Q 003278 594 TRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRND 673 (834)
Q Consensus 594 ~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~ 673 (834)
+++|.+++.... ...+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+|++|||++..+....
T Consensus 84 ~~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 84 KGSLLDFLKDGE----GRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred CCcHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 999999986532 1247899999999999999999997 689999999999999999999999999997654321
Q ss_pred CCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCccccc
Q 003278 674 HGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRPLAEL 752 (834)
Q Consensus 674 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (834)
. .......|+..|+|||++.+..++.++|||||||++|||+| |..|+...... ....... .. ..
T Consensus 157 ~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-~~~~~~~---~~-~~---- 221 (260)
T cd05070 157 Y------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR-EVLEQVE---RG-YR---- 221 (260)
T ss_pred c------ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH-HHHHHHH---cC-CC----
Confidence 1 01112245678999999988899999999999999999999 78887543221 1111111 00 00
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHcc
Q 003278 753 VDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDG 796 (834)
Q Consensus 753 ~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~ 796 (834)
....... + ..+.+++.+||..+|++|||+.++.+.|+.
T Consensus 222 --~~~~~~~-~---~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 222 --MPCPQDC-P---ISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred --CCCCCcC-C---HHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0111111 1 245667779999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=332.69 Aligned_cols=252 Identities=26% Similarity=0.384 Sum_probs=203.9
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCC-ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCe-EEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSK-CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGE-MLVIY 589 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~-~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~-~~lv~ 589 (834)
++|...+.+|+|+||.++.... .+...+++|.+.... .+..++.-.+|+.++++++|||||.+++.+.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 3566678899999999987663 345678899887654 33345567899999999999999999999998888 99999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccc
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFL 669 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~ 669 (834)
+||.||+|.+.+.... ...++....++++.|++.|++|||+ ..|+|||||++||+++++..+||+|||+|+.+
T Consensus 84 ~Y~eGg~l~~~i~~~k----~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l 156 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK----GVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKIL 156 (426)
T ss_pred eecCCCCHHHHHHHHh----hccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhc
Confidence 9999999999997654 2347888889999999999999995 68999999999999999999999999999987
Q ss_pred ccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcc
Q 003278 670 TRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPL 749 (834)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
...+ ....++.||+.||.||.+.+.+|+.|+||||+||++|||++-+.+|......+...+....
T Consensus 157 ~~~~-------~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~-------- 221 (426)
T KOG0589|consen 157 NPED-------SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRG-------- 221 (426)
T ss_pred CCch-------hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhc--------
Confidence 5542 1345789999999999999999999999999999999999999999866555544332221
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHH
Q 003278 750 AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSI 793 (834)
Q Consensus 750 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~ 793 (834)
.++| +++.+. .++..+++ .|+..+|+.||++.+++..
T Consensus 222 --~~~P-lp~~ys-~el~~lv~---~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 222 --LYSP-LPSMYS-SELRSLVK---SMLRKNPEHRPSALELLRR 258 (426)
T ss_pred --cCCC-CCcccc-HHHHHHHH---HHhhcCCccCCCHHHHhhC
Confidence 1111 222222 34444444 8999999999999999875
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=340.40 Aligned_cols=209 Identities=22% Similarity=0.265 Sum_probs=170.9
Q ss_pred CcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCC--ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEe
Q 003278 514 NFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSK--CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYD 590 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~--~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~E 590 (834)
.|...+.||+|+||.||+|.. .+++.||||.+.... .......+.+|+.++++++|||||++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 477788999999999999985 557889999986432 12334578899999999999999999999999999999999
Q ss_pred ccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccc
Q 003278 591 YSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLT 670 (834)
Q Consensus 591 y~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~ 670 (834)
|+++|+|.+++...+ .+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++..+.
T Consensus 82 ~~~gg~L~~~l~~~~------~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~ 152 (382)
T cd05625 82 YIPGGDMMSLLIRMG------IFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 152 (382)
T ss_pred CCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCcccc
Confidence 999999999886532 36677777899999999999997 689999999999999999999999999975321
Q ss_pred cCCCCC---------------------------------------c-ccccCccccccccCccchhccccCCCCccCcch
Q 003278 671 RNDHGH---------------------------------------R-KATSGNRSVRGIFGYMSPEYIESGEATSMADVY 710 (834)
Q Consensus 671 ~~~~~~---------------------------------------~-~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~ 710 (834)
...... . .......+.+||+.|||||++.+..++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Diw 232 (382)
T cd05625 153 WTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW 232 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEE
Confidence 100000 0 000011245799999999999999999999999
Q ss_pred hhHHHHHHHHhCCCccCCCCC
Q 003278 711 SFGVVVLEVVTGQMAVDFRLP 731 (834)
Q Consensus 711 SfGvvl~E~~tG~~p~~~~~~ 731 (834)
||||+||||+||+.||....+
T Consensus 233 SlGvil~elltG~~Pf~~~~~ 253 (382)
T cd05625 233 SVGVILYEMLVGQPPFLAQTP 253 (382)
T ss_pred echHHHHHHHhCCCCCCCCCH
Confidence 999999999999999975543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=320.79 Aligned_cols=248 Identities=17% Similarity=0.185 Sum_probs=188.1
Q ss_pred ccccCCcEEEEEEE-CCCcEEEEEEecCCCC--hhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEeccCCCch
Q 003278 521 VAEMDFGTAYQGFL-DNHQYVLVKRLGMSKC--PALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRIL 597 (834)
Q Consensus 521 ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~--~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~~~g~L 597 (834)
||+|+||.||++.. .++..+|+|.+..... ......+..|++++++++||||+++++++.+....++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 68999999999986 4588999999864321 11234456799999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCCCCCc
Q 003278 598 SHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHR 677 (834)
Q Consensus 598 ~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~~~~~ 677 (834)
..++..... ..+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---- 149 (277)
T cd05607 81 KYHIYNVGE----RGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---- 149 (277)
T ss_pred HHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc----
Confidence 888754322 247889999999999999999996 699999999999999999999999999987653221
Q ss_pred ccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcccccccccc
Q 003278 678 KATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSL 757 (834)
Q Consensus 678 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 757 (834)
......||..|+|||++.++.++.++|||||||++|||+||+.|+................ ....+...
T Consensus 150 ----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~------~~~~~~~~- 218 (277)
T cd05607 150 ----TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRT------LEDEVKFE- 218 (277)
T ss_pred ----eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHh------hccccccc-
Confidence 1123468999999999999899999999999999999999999986432211110100000 00000000
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHH
Q 003278 758 NGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSIL 794 (834)
Q Consensus 758 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L 794 (834)
...+ ..+ +.+++..||+.||++||+++|+++.+
T Consensus 219 ~~~~-~~~---~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 219 HQNF-TEE---SKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred cccC-CHH---HHHHHHHHhccCHhhCCCCccchhhh
Confidence 0111 223 44555689999999999998876433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=316.25 Aligned_cols=267 Identities=24% Similarity=0.313 Sum_probs=202.0
Q ss_pred hcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecc--cChhhHHHHHHHHHHHHhCCCCceeeEeeeEEe-----CC
Q 003278 109 GSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAE--KGERFEKTFAAELVAVAHLRHRNLVRLRGWCVH-----ED 181 (834)
Q Consensus 109 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-----~~ 181 (834)
....|...+.||+|+||.|..+..+.+|..||||++.. .+....++-.+|+++|+.++|+|||.+++.+.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 34456667899999999999999999999999999863 344556778899999999999999999998876 24
Q ss_pred EEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEee
Q 003278 182 QLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGD 261 (834)
Q Consensus 182 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~D 261 (834)
.+|+|+|+| ..+|.+.+... ..|+......++.|+++||.|+|+. +|+||||||+|+|++.+..+||||
T Consensus 100 DvYiV~elM-etDL~~iik~~-------~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~D 168 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQ-------QDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICD 168 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcC-------ccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEecc
Confidence 689999999 56898888643 3488889999999999999999984 999999999999999999999999
Q ss_pred ccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCC
Q 003278 262 FGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPD 341 (834)
Q Consensus 262 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~ 341 (834)
||+||..... ......|..+-|.+|.|||.+.....||...||||.|||+.||++|++-|.....-
T Consensus 169 FGLAR~~~~~--------------~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v 234 (359)
T KOG0660|consen 169 FGLARYLDKF--------------FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYV 234 (359)
T ss_pred ccceeecccc--------------CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchH
Confidence 9999965321 01112466778999999999988889999999999999999999999988654433
Q ss_pred ccchHHH-----------------HHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 342 DQIILLD-----------------WIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 342 ~~~~l~~-----------------~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
.+..++- -+++.... .......... ..++ ......++|....|..||.+|+|..|.++.
T Consensus 235 ~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~s--lp~~p~~~f~-~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 235 HQLQLILELLGTPSEEDLQKIRSEKARPYIKS--LPQIPKQPFS-SIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHHHHhcCCCCHHHHHHhccHHHHHHHHh--CCCCCCCCHH-HHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 3322210 01111000 0000000000 0011 111245678888899999999999987753
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=326.95 Aligned_cols=251 Identities=24% Similarity=0.354 Sum_probs=200.1
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEcc
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYM 190 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 190 (834)
.+|+..+.||+|+||.||+|....++..||+|.+........+.+.+|+.+++.++||||++++++|...+..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 46888899999999999999998899999999987655555677889999999999999999999999999999999999
Q ss_pred CCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhh
Q 003278 191 PNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEH 270 (834)
Q Consensus 191 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~ 270 (834)
++++|.+++.. ..+++.++..++.|++.||.|||+. +|+||||||+|||++.++.++|+|||++.....
T Consensus 99 ~~~~L~~~~~~--------~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~ 167 (297)
T cd06656 99 AGGSLTDVVTE--------TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (297)
T ss_pred CCCCHHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence 99999998853 2478899999999999999999985 999999999999999999999999999874322
Q ss_pred hhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHHH
Q 003278 271 ELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWI 350 (834)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~ 350 (834)
.. .......|++.|+|||.+... .++.++|||||||++|+|+||+.||....+.....
T Consensus 168 ~~----------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~----- 225 (297)
T cd06656 168 EQ----------------SKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY----- 225 (297)
T ss_pred Cc----------------cCcCcccCCccccCHHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee-----
Confidence 10 001234588999999988654 57899999999999999999999986433221100
Q ss_pred HHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 351 RRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 351 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
.....+ .+.+. ........+.+++..||+.+|++||++.+|++.
T Consensus 226 -~~~~~~------~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 226 -LIATNG------TPELQ---NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred -eeccCC------CCCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 00000 001112346788999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=329.08 Aligned_cols=263 Identities=22% Similarity=0.290 Sum_probs=199.8
Q ss_pred hCcCcCCcccccCCcEEEEEEEC--------CCcEEEEEEecCCCChhHHHHHHHHHHHHHhc-cCCCceeEEEEEeeCC
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD--------NHQYVLVKRLGMSKCPALRTRFSNELQNLARL-RHRNLVQLCGWCTEQG 583 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~--------~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l-~HpNiv~l~g~~~~~~ 583 (834)
++|...+.||+|+||.||++... +...+|+|.+...........+.+|+.++.++ +||||++++++|.+.+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 45777789999999999998742 23469999987654444456788999999999 7999999999999999
Q ss_pred eEEEEEeccCCCchhhhhhcCCCC----------CCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeec
Q 003278 584 EMLVIYDYSATRILSHLLFHNNHR----------IGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLD 653 (834)
Q Consensus 584 ~~~lv~Ey~~~g~L~~~l~~~~~~----------~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld 653 (834)
..++||||+++|+|.+++...... .....++|..+++++.|++.||+|||+ .+++||||||+|||++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEEc
Confidence 999999999999999999754321 112358899999999999999999996 6999999999999999
Q ss_pred CCCCceEeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCc
Q 003278 654 PDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPE 732 (834)
Q Consensus 654 ~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~ 732 (834)
+++.+||+|||+++........ .......+++.|||||++.+..++.++|||||||++|||+| |..|+... +.
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~-~~ 248 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYY-----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PV 248 (307)
T ss_pred CCCcEEECCCcccccccccchh-----hccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC-CH
Confidence 9999999999998765322110 01111234578999999998899999999999999999999 77777532 22
Q ss_pred hhHHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCC
Q 003278 733 GLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGND 798 (834)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~ 798 (834)
..+...... . .. .+ ... ... ..+.+++.+||..+|++||||.+|++.|+.+-
T Consensus 249 ~~~~~~~~~---~-~~-~~-----~~~-~~~---~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~ 300 (307)
T cd05098 249 EELFKLLKE---G-HR-MD-----KPS-NCT---NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300 (307)
T ss_pred HHHHHHHHc---C-CC-CC-----CCC-cCC---HHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 222221111 0 00 00 011 112 24556667999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=306.17 Aligned_cols=253 Identities=25% Similarity=0.403 Sum_probs=203.4
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc-----C---hhhHHHHHHHHHHHHhC-CCCceeeEeeeEEeCC
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK-----G---ERFEKTFAAELVAVAHL-RHRNLVRLRGWCVHED 181 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~-----~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~ 181 (834)
++|...++||+|+.++|-++..+.+|..+|+|++... . ....+.-.+|+.+|+++ .||||++|.+++..+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 5678889999999999999999999999999998532 1 22345567899999997 5999999999999999
Q ss_pred EEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEee
Q 003278 182 QLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGD 261 (834)
Q Consensus 182 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~D 261 (834)
.+++|+|.|+.|.|.++|... ..++++...+|+.|+.+|++|||.. .|+||||||+|||+|++.++||+|
T Consensus 97 F~FlVFdl~prGELFDyLts~-------VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isD 166 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSK-------VTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISD 166 (411)
T ss_pred hhhhhhhhcccchHHHHhhhh-------eeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEec
Confidence 999999999999999999643 4688899999999999999999996 999999999999999999999999
Q ss_pred ccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCcccccc-----CCCCCcccceeehhhHHHHHHhCCccCC
Q 003278 262 FGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQK-----GSVATAKSDVFSFGIVVLEVVSGRRAVD 336 (834)
Q Consensus 262 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-----~~~~~~ksDV~SfGvvl~ElltG~~p~~ 336 (834)
||+|+.++.... -+..||||||+|||.+.. ...|+..+|+||.||++|.|+.|.+||-
T Consensus 167 FGFa~~l~~Gek-----------------LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw 229 (411)
T KOG0599|consen 167 FGFACQLEPGEK-----------------LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFW 229 (411)
T ss_pred cceeeccCCchh-----------------HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchh
Confidence 999998754321 356789999999998742 3357888999999999999999999985
Q ss_pred CCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 337 LTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 337 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
.. .+..++ ++..+|+..- -.+. +... .....+|+.+||+.||.+|-|.+|++..
T Consensus 230 HR---kQmlML----R~ImeGkyqF-~spe-----Wadi-s~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 230 HR---KQMLML----RMIMEGKYQF-RSPE-----WADI-SATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred HH---HHHHHH----HHHHhccccc-CCcc-----hhhc-cccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 32 222222 2333444221 1111 1111 1246789999999999999999998863
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=339.88 Aligned_cols=253 Identities=19% Similarity=0.171 Sum_probs=191.9
Q ss_pred hhCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCC--ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEE
Q 003278 512 TNNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSK--CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVI 588 (834)
Q Consensus 512 t~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv 588 (834)
.++|...+.||+|+||.||++... ++..||+|.+.... .......|.+|+.+++.++||||+++++++.+.+..++|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 467888899999999999999864 57899999986421 122234578899999999999999999999999999999
Q ss_pred EeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccc
Q 003278 589 YDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEF 668 (834)
Q Consensus 589 ~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~ 668 (834)
|||+++|+|.+++... .++......++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||++..
T Consensus 122 ~Ey~~gg~L~~~l~~~-------~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 122 MEYMPGGDLVNLMSNY-------DIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred EcCCCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 9999999999988542 25666677899999999999996 6999999999999999999999999999976
Q ss_pred cccCCCCCcccccCccccccccCccchhccccC----CCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHh
Q 003278 669 LTRNDHGHRKATSGNRSVRGIFGYMSPEYIESG----EATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEA 744 (834)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~----~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~ 744 (834)
...... ......+||+.|||||++.+. .++.++|||||||+||||+||+.||......... .. ...
T Consensus 192 ~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~-~~---i~~ 261 (370)
T cd05596 192 MDANGM------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY-SK---IMD 261 (370)
T ss_pred ccCCCc------ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHH-HH---HHc
Confidence 432211 112245799999999998653 4788999999999999999999999754432211 11 111
Q ss_pred hcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCC--CCChhHHHH
Q 003278 745 RKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPEL--RPSMRQILS 792 (834)
Q Consensus 745 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~--RPtm~~v~~ 792 (834)
....+ .. +. .... ..++ ..++.+|+..+|++ |||+.++++
T Consensus 262 ~~~~~-~~--~~-~~~~-s~~~---~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 262 HKNSL-TF--PD-DIEI-SKQA---KDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred CCCcC-CC--CC-cCCC-CHHH---HHHHHHHccChhhccCCCCHHHHhc
Confidence 11100 00 00 0011 2333 44555899888987 999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=330.18 Aligned_cols=241 Identities=17% Similarity=0.243 Sum_probs=186.0
Q ss_pred CcccccCCcEEEEEEEC-CCcEEEEEEecCCC--ChhHHHHHHHHHHHHHh-ccCCCceeEEEEEeeCCeEEEEEeccCC
Q 003278 519 QRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSK--CPALRTRFSNELQNLAR-LRHRNLVQLCGWCTEQGEMLVIYDYSAT 594 (834)
Q Consensus 519 ~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~E~~~l~~-l~HpNiv~l~g~~~~~~~~~lv~Ey~~~ 594 (834)
+.||+|+||.||+|... ++..||||.+.... .......+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 35899999999999965 47889999986432 12223456678888876 4999999999999999999999999999
Q ss_pred CchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCCC
Q 003278 595 RILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDH 674 (834)
Q Consensus 595 g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~~ 674 (834)
|+|..++.... .+++.....++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++......
T Consensus 81 g~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 150 (316)
T cd05619 81 GDLMFHIQSCH------KFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD- 150 (316)
T ss_pred CcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-
Confidence 99999886432 37888889999999999999996 699999999999999999999999999986432111
Q ss_pred CCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCccccccc
Q 003278 675 GHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVD 754 (834)
Q Consensus 675 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 754 (834)
.......||+.|||||++.+..++.++|||||||++|||+||+.||...... .+...+. . ..+
T Consensus 151 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-~~~~~i~---~-~~~------ 213 (316)
T cd05619 151 ------AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE-ELFQSIR---M-DNP------ 213 (316)
T ss_pred ------CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH-HHHHHHH---h-CCC------
Confidence 1123467999999999999989999999999999999999999998654322 1111111 1 111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhccCCCCCCCChh-HHH
Q 003278 755 LSLNGEYNHKELMRLIKLGIACTLSNPELRPSMR-QIL 791 (834)
Q Consensus 755 ~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~-~v~ 791 (834)
...... ..+ +..+..+||+.||++||++. ++.
T Consensus 214 -~~~~~~-~~~---~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 214 -CYPRWL-TRE---AKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred -CCCccC-CHH---HHHHHHHHhccCHhhcCCChHHHH
Confidence 111111 223 34555689999999999997 553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=330.56 Aligned_cols=238 Identities=16% Similarity=0.195 Sum_probs=185.0
Q ss_pred CcccccCCcEEEEEEEC-CCcEEEEEEecCCC--ChhHHHHHHHHHHHHHhc-cCCCceeEEEEEeeCCeEEEEEeccCC
Q 003278 519 QRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSK--CPALRTRFSNELQNLARL-RHRNLVQLCGWCTEQGEMLVIYDYSAT 594 (834)
Q Consensus 519 ~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~E~~~l~~l-~HpNiv~l~g~~~~~~~~~lv~Ey~~~ 594 (834)
+.||+|+||.||+|... +++.||||.+.... .....+.+..|+.++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 35899999999999964 57899999986432 223345677899998876 699999999999999999999999999
Q ss_pred CchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCCC
Q 003278 595 RILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDH 674 (834)
Q Consensus 595 g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~~ 674 (834)
|+|..++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~i~~~~------~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~- 150 (320)
T cd05590 81 GDLMFHIQKSR------RFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG- 150 (320)
T ss_pred chHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-
Confidence 99998886432 37888889999999999999996 699999999999999999999999999987532111
Q ss_pred CCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCccccccc
Q 003278 675 GHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVD 754 (834)
Q Consensus 675 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 754 (834)
.......||+.|||||++.+..++.++|||||||++|||+||+.||....... +...+ ......
T Consensus 151 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-~~~~i---~~~~~~------ 214 (320)
T cd05590 151 ------KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD-LFEAI---LNDEVV------ 214 (320)
T ss_pred ------CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH-HHHHH---hcCCCC------
Confidence 11234579999999999999999999999999999999999999986443221 11111 110000
Q ss_pred cccCCCCCHHHHHHHHHHHHHhccCCCCCCCChh
Q 003278 755 LSLNGEYNHKELMRLIKLGIACTLSNPELRPSMR 788 (834)
Q Consensus 755 ~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~ 788 (834)
.... ...+ +.+++.+|++.||++||++.
T Consensus 215 --~~~~-~~~~---~~~li~~~L~~dP~~R~~~~ 242 (320)
T cd05590 215 --YPTW-LSQD---AVDILKAFMTKNPTMRLGSL 242 (320)
T ss_pred --CCCC-CCHH---HHHHHHHHcccCHHHCCCCC
Confidence 1111 1233 34555689999999999983
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=332.78 Aligned_cols=240 Identities=15% Similarity=0.187 Sum_probs=183.8
Q ss_pred CcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCC--ChhHHHHHHHHHHHH---HhccCCCceeEEEEEeeCCeEEEEE
Q 003278 516 SESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSK--CPALRTRFSNELQNL---ARLRHRNLVQLCGWCTEQGEMLVIY 589 (834)
Q Consensus 516 ~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~E~~~l---~~l~HpNiv~l~g~~~~~~~~~lv~ 589 (834)
...+.||+|+||.||+|... +++.||||.+.... .....+.+.+|+.++ ++++||||+++++++...+..++||
T Consensus 2 ~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~ 81 (324)
T cd05589 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVM 81 (324)
T ss_pred eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEE
Confidence 34567999999999999864 58899999986432 122334566676554 5778999999999999999999999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccc
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFL 669 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~ 669 (834)
||+++|+|..++.. ..+++.....++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++..
T Consensus 82 E~~~~~~L~~~~~~-------~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05589 82 EYAAGGDLMMHIHT-------DVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEG 151 (324)
T ss_pred cCCCCCcHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence 99999999887743 138899999999999999999996 69999999999999999999999999998643
Q ss_pred ccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcc
Q 003278 670 TRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPL 749 (834)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
.... .......||+.|||||++.+..++.++|||||||++|||+||+.||....... ....+ .....
T Consensus 152 ~~~~-------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~-~~~~i---~~~~~-- 218 (324)
T cd05589 152 MGFG-------DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE-VFDSI---VNDEV-- 218 (324)
T ss_pred CCCC-------CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH-HHHHH---HhCCC--
Confidence 2111 11234679999999999999999999999999999999999999986443221 11111 11100
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChh
Q 003278 750 AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMR 788 (834)
Q Consensus 750 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~ 788 (834)
......+ . .+..++.+||..||++||++.
T Consensus 219 ------~~p~~~~-~---~~~~li~~~L~~dP~~R~~~~ 247 (324)
T cd05589 219 ------RYPRFLS-R---EAISIMRRLLRRNPERRLGSG 247 (324)
T ss_pred ------CCCCCCC-H---HHHHHHHHHhhcCHhHcCCCC
Confidence 0111122 2 344556689999999999543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=364.74 Aligned_cols=545 Identities=19% Similarity=0.221 Sum_probs=352.7
Q ss_pred CCCCCCeeeccCCeEEEEEEECCC-CeEEEEEEecccC--hhhHHHHHHHHHHHHhCC-CCceeeEeeeEEeCCEEEEEE
Q 003278 112 GFDEDEVLGSGGFGKVYRAVLPSD-GTVVAVKCLAEKG--ERFEKTFAAELVAVAHLR-HRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 112 ~f~~~~~LG~G~fG~Vy~~~~~~~-g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~ 187 (834)
.|...+.||+|+|+.|-......+ ...+|+|.+.... ....+....|..+-..+. |+|++++++...+.+..++++
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 466677899999999988876433 4567777765442 334444555777777776 999999999999999999999
Q ss_pred EccCCCCHhHHHh-cCCCccccCCCCCHHHHHHHHHHHHHHHHHHH-hccCCCeecCCCCCCceEECCCC-ceEEeeccc
Q 003278 188 DYMPNRSLDRVLF-RRPENLEAAAPLNWEQRKKIIRGLAAALHYLH-EQLETQIIHRDVKTSNVMLDSQY-NARLGDFGL 264 (834)
Q Consensus 188 Ey~~~gsL~~~l~-~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~iiHrDlKp~NILld~~~-~~kl~DFGl 264 (834)
||..+|++...+. .. ....+-.....+..|+..++.|+| . .++.||||||+|.+++..+ ..|++|||+
T Consensus 101 ~~s~g~~~f~~i~~~~------~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~ 171 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPD------STGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGL 171 (601)
T ss_pred CcccccccccccccCC------ccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchh
Confidence 9999999987773 21 112333456679999999999999 5 4999999999999999998 999999999
Q ss_pred hhhhhh-hhhhhhhcccccccccccccceeeec-cccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCc
Q 003278 265 ARWLEH-ELQYQMRTSSARNHQFHLAETTRIGG-TIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDD 342 (834)
Q Consensus 265 a~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~G-t~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~ 342 (834)
|..... +.. .......+| ++.|+|||............|+||.|+++.-+++|..|++......
T Consensus 172 At~~~~~~g~--------------~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~ 237 (601)
T KOG0590|consen 172 ATAYRNKNGA--------------ERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD 237 (601)
T ss_pred hccccccCCc--------------ceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc
Confidence 976533 110 011233457 9999999988653455778999999999999999999988765443
Q ss_pred cchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcCCCCCCCCCCCccCC
Q 003278 343 QIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGSYSGKLPALPSFQSH 422 (834)
Q Consensus 343 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~~~~~~p~~ps~~s~ 422 (834)
+. ...|... .+......-..+. .....+...++..+|..|.+.+++...
T Consensus 238 ~~-~~~~~~~---~~~~~~~~~~~~~---------~~~~~~l~k~l~~~~~~r~s~~~~~~d------------------ 286 (601)
T KOG0590|consen 238 GR-YSSWKSN---KGRFTQLPWNSIS---------DQAHDLLHKILKENPSNRLSIEELKLD------------------ 286 (601)
T ss_pred cc-ceeeccc---ccccccCccccCC---------hhhhhcccccccCCchhcccccccccc------------------
Confidence 21 1222211 0000011111111 123444555666788888887654321
Q ss_pred CcccccCCCCCCCCCCCccccccCcccCCCcccCCCCCcccccccccccccccCCCcCCCCCCccccccCcccccCCCcc
Q 003278 423 PLYISLSSPTNTSTSNTETTRSTNTTASNTTIASPSSNYVTAAGETIYATAECGGNTESKSNNSRSQRRNSFFMVETPRE 502 (834)
Q Consensus 423 p~~~s~ssp~~~s~s~~~~s~ss~ss~s~~~~~spssn~v~a~~~~~~a~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 502 (834)
++..... ......+ +. ..... .. . ..
T Consensus 287 ~~~~~~~---------------~~~~~~n-----~~-~~~~~-----------~~--------------------~--~~ 312 (601)
T KOG0590|consen 287 NWLSSKR---------------NGFSKSN-----PC-ADSLT-----------IA--------------------K--SP 312 (601)
T ss_pred ccccccc---------------ccccccc-----cc-ccccc-----------cc--------------------c--Cc
Confidence 1111000 0000000 00 00000 00 0 00
Q ss_pred ccHHHHHHHhhCc-CcCCcccccCCcEEEEEEEC-CCcEEEEEEec----CCCCh-hHHHHHHHHHHHHHhccCCCceeE
Q 003278 503 ISFKEIISATNNF-SESQRVAEMDFGTAYQGFLD-NHQYVLVKRLG----MSKCP-ALRTRFSNELQNLARLRHRNLVQL 575 (834)
Q Consensus 503 ~~~~el~~at~~f-~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~----~~~~~-~~~~~f~~E~~~l~~l~HpNiv~l 575 (834)
+++ +..| .....+|+|.+|.|+..... .....+.|... ..... .....+..|..+-..++|||++..
T Consensus 313 ~~~------~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~ 386 (601)
T KOG0590|consen 313 IGF------SEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIET 386 (601)
T ss_pred ccc------ccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhh
Confidence 000 0001 12356899999977766532 22223333221 11111 111225668888889999999887
Q ss_pred EEEEeeCCeEEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCC
Q 003278 576 CGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPD 655 (834)
Q Consensus 576 ~g~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~ 655 (834)
+..+.+....+-.||||++ +|..++.... .+.-..+-.++.|+..||.|||+ .+|.|||||++|++++.+
T Consensus 387 l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~------~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~ 456 (601)
T KOG0590|consen 387 LDIVQEIDGILQSMEYCPY-DLFSLVMSNG------KLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTEN 456 (601)
T ss_pred HHHHhhcccchhhhhcccH-HHHHHHhccc------ccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecC
Confidence 7777776666666999999 9998886542 24555667799999999999997 699999999999999999
Q ss_pred CCceEeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCcc-CcchhhHHHHHHHHhCCCccCCCCCchh
Q 003278 656 MNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSM-ADVYSFGVVVLEVVTGQMAVDFRLPEGL 734 (834)
Q Consensus 656 ~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k-~DV~SfGvvl~E~~tG~~p~~~~~~~~~ 734 (834)
+.+||+|||.+......... .......++|+-.|+|||++....|++. .||||.||++..|++|+.|+-.......
T Consensus 457 g~lki~Dfg~~~vf~~~~e~---~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~ 533 (601)
T KOG0590|consen 457 GILKIIDFGAASVFRYPWEK---NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDN 533 (601)
T ss_pred CceEEeecCcceeeccCcch---hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccccccc
Confidence 99999999998764322111 1122345789999999999999999986 8999999999999999999854322211
Q ss_pred HHHHHHHHHhhcCccccccccccCCCCC--HHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 735 LVKRVHEFEARKRPLAELVDLSLNGEYN--HKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~--~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
... .. ...... . ...+... ...-.+...++.+.++.||.+|-||.+|++
T Consensus 534 ~~~---~~-~~~~~~-~----~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 534 SFK---TN-NYSDQR-N----IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred chh---hh-cccccc-c----cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 100 00 000000 0 0001000 011123455666889999999999999985
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=327.09 Aligned_cols=258 Identities=22% Similarity=0.297 Sum_probs=196.4
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCc--EEEEEEecCCCChhHHHHHHHHHHHHHhc-cCCCceeEEEEEeeCCeEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQ--YVLVKRLGMSKCPALRTRFSNELQNLARL-RHRNLVQLCGWCTEQGEMLVI 588 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~--~vavK~~~~~~~~~~~~~f~~E~~~l~~l-~HpNiv~l~g~~~~~~~~~lv 588 (834)
++|...+.||+|+||.||+|... ++. .+++|.+...........|.+|+.++.++ +||||+++++++.+.+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 46677788999999999999864 343 46788776544445557889999999999 899999999999999999999
Q ss_pred EeccCCCchhhhhhcCCCC----------CCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCc
Q 003278 589 YDYSATRILSHLLFHNNHR----------IGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNP 658 (834)
Q Consensus 589 ~Ey~~~g~L~~~l~~~~~~----------~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ 658 (834)
|||+++|+|.+++...... .....+++..++.++.|++.||+|||+ .+|+||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCcE
Confidence 9999999999998754311 112357899999999999999999996 699999999999999999999
Q ss_pred eEeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHH
Q 003278 659 RLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVK 737 (834)
Q Consensus 659 ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~ 737 (834)
||+|||++...... .......++..|+|||++.+..++.++|||||||++|||+| |..|+....... ...
T Consensus 164 kl~dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-~~~ 234 (303)
T cd05088 164 KIADFGLSRGQEVY--------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-LYE 234 (303)
T ss_pred EeCccccCcccchh--------hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH-HHH
Confidence 99999998632110 00111234678999999988889999999999999999998 988885432221 111
Q ss_pred HHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHcc
Q 003278 738 RVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDG 796 (834)
Q Consensus 738 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~ 796 (834)
... . .. ........ .. .+.+++.+||+.+|++|||+.++++.|+.
T Consensus 235 ~~~---~--~~-----~~~~~~~~-~~---~~~~li~~~l~~~p~~Rp~~~~il~~l~~ 279 (303)
T cd05088 235 KLP---Q--GY-----RLEKPLNC-DD---EVYDLMRQCWREKPYERPSFAQILVSLNR 279 (303)
T ss_pred HHh---c--CC-----cCCCCCCC-CH---HHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 110 0 00 00001111 12 35567779999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=338.93 Aligned_cols=243 Identities=22% Similarity=0.372 Sum_probs=192.6
Q ss_pred CcccccCCcEEEEEEEC-CCcEEE---EEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCe--EEEEEecc
Q 003278 519 QRVAEMDFGTAYQGFLD-NHQYVL---VKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGE--MLVIYDYS 592 (834)
Q Consensus 519 ~~ig~g~~g~vy~~~~~-~~~~va---vK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~--~~lv~Ey~ 592 (834)
..||+|.|-+||||... .|..|| ||.-+....+...++|..|+.+|+.|+|||||++|.++.+... +-+|.|.+
T Consensus 46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~ 125 (632)
T KOG0584|consen 46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELF 125 (632)
T ss_pred hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecc
Confidence 35899999999999863 355565 3433345667777999999999999999999999998876544 78899999
Q ss_pred CCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCC-CCceEeeeeecccccc
Q 003278 593 ATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPD-MNPRLGSFALAEFLTR 671 (834)
Q Consensus 593 ~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~-~~~ki~DfGla~~~~~ 671 (834)
..|+|..|+.+..+ ++-.....+++||++||.|||++ .+||||||||..||+|+.+ |.+||+|+|||..+..
T Consensus 126 TSGtLr~Y~kk~~~------vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 126 TSGTLREYRKKHRR------VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred cCCcHHHHHHHhcc------CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 99999999986543 45556678999999999999987 6899999999999999864 8999999999987532
Q ss_pred CCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcccc
Q 003278 672 NDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAE 751 (834)
Q Consensus 672 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
+...++.|||.+||||++. ..|++.+||||||++++||+|+..|+..-.....+.+.+..+. ....+..
T Consensus 199 ---------s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGi-KP~sl~k 267 (632)
T KOG0584|consen 199 ---------SHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGI-KPAALSK 267 (632)
T ss_pred ---------cccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCC-CHHHhhc
Confidence 2234589999999999997 7899999999999999999999999875444444444433221 1111222
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 752 LVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 752 ~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
+ ...++.++|+ .|+.. .++|||+.|++.
T Consensus 268 V---------~dPevr~fIe---kCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 268 V---------KDPEVREFIE---KCLAT-KSERLSAKELLK 295 (632)
T ss_pred c---------CCHHHHHHHH---HHhcC-chhccCHHHHhh
Confidence 2 2346666665 89999 999999999985
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=318.83 Aligned_cols=253 Identities=21% Similarity=0.341 Sum_probs=196.4
Q ss_pred hCcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEecc
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYS 592 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~ 592 (834)
+.|...++||+|+||.||+|...+...||+|.+..... ..++|.+|++++++++||||+++++++.+ +..++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc--CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 34666788999999999999987777899999874332 23578999999999999999999998754 5578999999
Q ss_pred CCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccC
Q 003278 593 ATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRN 672 (834)
Q Consensus 593 ~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~ 672 (834)
++|+|.+++.... ...++|..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++.+...
T Consensus 83 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 83 SKGSLLDFLKGEM----GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred CCCcHHHHHhhcc----ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 9999999986432 1247899999999999999999996 68999999999999999999999999999765432
Q ss_pred CCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCcccc
Q 003278 673 DHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRPLAE 751 (834)
Q Consensus 673 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
.. .......|+..|+|||++.++.++.++|||||||++|||+| |..|+....+... .... ... ...
T Consensus 156 ~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~-~~~~---~~~-~~~-- 222 (262)
T cd05071 156 EY------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-LDQV---ERG-YRM-- 222 (262)
T ss_pred cc------ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH-HHHH---hcC-CCC--
Confidence 21 11112346778999999998999999999999999999999 7777754433221 1111 000 000
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHcc
Q 003278 752 LVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDG 796 (834)
Q Consensus 752 ~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~ 796 (834)
... ......+.+++.+||+.+|++|||+.++.+.|+.
T Consensus 223 ----~~~----~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 223 ----PCP----PECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred ----CCc----cccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 001 1122345677789999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=335.27 Aligned_cols=194 Identities=27% Similarity=0.409 Sum_probs=165.7
Q ss_pred hhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEE
Q 003278 108 IGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 108 ~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 187 (834)
....+|+..+.||+|+||.||+|....++..||+|..... ....|+.++++++|||||++++++...+..++||
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 4556899999999999999999999888999999975432 2356899999999999999999999999999999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
||+. |+|.+++... ..+++|..+..|+.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 137 e~~~-~~l~~~l~~~------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 206 (357)
T PHA03209 137 PHYS-SDLYTYLTKR------SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF 206 (357)
T ss_pred EccC-CcHHHHHHhc------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccc
Confidence 9995 6888887543 24689999999999999999999986 999999999999999999999999999874
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccC
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAV 335 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~ 335 (834)
.... .......||+.|+|||++... .++.++|||||||++|||+++..++
T Consensus 207 ~~~~-----------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 207 PVVA-----------------PAFLGLAGTVETNAPEVLARD-KYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cccC-----------------cccccccccccccCCeecCCC-CCCchhhHHHHHHHHHHHHHcCCcc
Confidence 2111 012345699999999998654 5799999999999999999976654
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=316.78 Aligned_cols=251 Identities=20% Similarity=0.316 Sum_probs=195.7
Q ss_pred CcccccCCcEEEEEEECC--C--cEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEeccCC
Q 003278 519 QRVAEMDFGTAYQGFLDN--H--QYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSAT 594 (834)
Q Consensus 519 ~~ig~g~~g~vy~~~~~~--~--~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~~~ 594 (834)
+.||+|+||.||+|...+ + ..||||.+.........+.|.+|++++++++|||||++++++.+ ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 358999999999998643 3 35899998765544556789999999999999999999999988 889999999999
Q ss_pred CchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCCC
Q 003278 595 RILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDH 674 (834)
Q Consensus 595 g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~~ 674 (834)
|+|.+++..... ..++|.....++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++.+.....
T Consensus 80 ~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 152 (257)
T cd05040 80 GSLLDRLRKDAL----GHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED 152 (257)
T ss_pred CcHHHHHHhccc----ccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEecccccccccccccc
Confidence 999999876431 348899999999999999999996 6999999999999999999999999999987643221
Q ss_pred CCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCcccccc
Q 003278 675 GHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRPLAELV 753 (834)
Q Consensus 675 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (834)
.. .......|+.+|+|||++.+..++.++|||||||++|||+| |..|+....... ...... .. .. ...
T Consensus 153 ~~----~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-~~~~~~---~~-~~--~~~ 221 (257)
T cd05040 153 HY----VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ-ILKKID---KE-GE--RLE 221 (257)
T ss_pred ce----ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHH---hc-CC--cCC
Confidence 10 01123467889999999998899999999999999999999 999885432221 111111 10 10 000
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHc
Q 003278 754 DLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795 (834)
Q Consensus 754 d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~ 795 (834)
.... .+ ..+..++.+||+.+|++|||+.+|++.|.
T Consensus 222 ---~~~~-~~---~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 ---RPEA-CP---QDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ---CCcc-CC---HHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0111 12 24556667999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=321.35 Aligned_cols=253 Identities=19% Similarity=0.320 Sum_probs=194.4
Q ss_pred HHhhCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCChhHHHHHHHHHHHHHhc-cCCCceeEEEEEeeC-----
Q 003278 510 SATNNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKCPALRTRFSNELQNLARL-RHRNLVQLCGWCTEQ----- 582 (834)
Q Consensus 510 ~at~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l-~HpNiv~l~g~~~~~----- 582 (834)
.+++.|...+.||+|+||.||+|... +++.||+|.+..... ....+.+|+.++.++ +||||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD--EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc--cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 46677888889999999999999864 578899999865432 235688899999999 799999999998753
Q ss_pred -CeEEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEe
Q 003278 583 -GEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLG 661 (834)
Q Consensus 583 -~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~ 661 (834)
...+++|||+++|+|.+++.... ...++|.....++.|++.||+|||+ .+|+||||||+||++++++.+||+
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~ 153 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTK----GNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLV 153 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEc
Confidence 46899999999999999987532 1247888899999999999999997 689999999999999999999999
Q ss_pred eeeeccccccCCCCCcccccCccccccccCccchhccc-----cCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHH
Q 003278 662 SFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIE-----SGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLV 736 (834)
Q Consensus 662 DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-----~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~ 736 (834)
|||++..+.... .......||..|+|||++. ...++.++|||||||++|||+||+.|+....+.....
T Consensus 154 Dfg~~~~~~~~~-------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~ 226 (272)
T cd06637 154 DFGVSAQLDRTV-------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF 226 (272)
T ss_pred cCCCceeccccc-------ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH
Confidence 999997643211 1123457999999999986 3468889999999999999999999986433221111
Q ss_pred HHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 737 KRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 737 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
.....+.....+ ..... .+.+++.+||..+|.+|||+.+|++
T Consensus 227 ------~~~~~~~~~~~~-----~~~~~---~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 227 ------LIPRNPAPRLKS-----KKWSK---KFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred ------HHhcCCCCCCCC-----CCcCH---HHHHHHHHHcCCChhhCCCHHHHhh
Confidence 011111111111 11122 3456667999999999999999874
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=343.56 Aligned_cols=194 Identities=28% Similarity=0.340 Sum_probs=165.5
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEcc
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYM 190 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 190 (834)
.+|...+.||+|+||.||+|.+..+++.||||... ...+.+|+.+|++++|+|||++++++...+..++||||+
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~ 242 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY 242 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence 36888899999999999999999899999999642 234678999999999999999999999999999999999
Q ss_pred CCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhh
Q 003278 191 PNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEH 270 (834)
Q Consensus 191 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~ 270 (834)
. ++|..++... ...++|.+++.|+.|+++||.|||+. +||||||||+|||++.++.+||+|||+++.+..
T Consensus 243 ~-~~L~~~l~~~------~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 312 (461)
T PHA03211 243 R-SDLYTYLGAR------LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARG 312 (461)
T ss_pred C-CCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccc
Confidence 5 7888887543 23689999999999999999999985 999999999999999999999999999986432
Q ss_pred hhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccC
Q 003278 271 ELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAV 335 (834)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~ 335 (834)
... ........||+.|+|||++... .++.++|||||||+||||++|..++
T Consensus 313 ~~~--------------~~~~~~~~GT~~Y~APE~~~~~-~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 313 SWS--------------TPFHYGIAGTVDTNAPEVLAGD-PYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred ccc--------------cccccccCCCcCCcCHHHHcCC-CCCchHHHHHHHHHHHHHHHcCCCc
Confidence 100 0012345699999999998654 6799999999999999999998765
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=326.08 Aligned_cols=266 Identities=24% Similarity=0.384 Sum_probs=203.2
Q ss_pred hcCCCCCCCeeeccCCeEEEEEEEC-------CCCeEEEEEEecccC-hhhHHHHHHHHHHHHhC-CCCceeeEeeeEEe
Q 003278 109 GSNGFDEDEVLGSGGFGKVYRAVLP-------SDGTVVAVKCLAEKG-ERFEKTFAAELVAVAHL-RHRNLVRLRGWCVH 179 (834)
Q Consensus 109 ~t~~f~~~~~LG~G~fG~Vy~~~~~-------~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~ 179 (834)
..++|...+.||+|+||.||+|... .++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3456888899999999999999752 235689999886432 34456789999999999 89999999999999
Q ss_pred CCEEEEEEEccCCCCHhHHHhcCCCcc---------ccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceE
Q 003278 180 EDQLLLVYDYMPNRSLDRVLFRRPENL---------EAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVM 250 (834)
Q Consensus 180 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~---------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NIL 250 (834)
.+..++||||+++|+|.+++....... .....++|.++..++.|+++||.|||+. +|+||||||+|||
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEE
Confidence 999999999999999999997642210 0124689999999999999999999985 9999999999999
Q ss_pred ECCCCceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh
Q 003278 251 LDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS 330 (834)
Q Consensus 251 ld~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt 330 (834)
++.++.+||+|||+++.+...... .......+++.|+|||.+... .++.++|||||||++|||+|
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~ 234 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYY--------------KKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFT 234 (304)
T ss_pred EcCCCcEEECCCccceeccccccc--------------ccccCCCCCceeeCchhhccC-CCCchhhHHHHHHHHHHHHc
Confidence 999999999999999865321100 012223467889999988654 57899999999999999998
Q ss_pred -CCccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcCC
Q 003278 331 -GRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGSY 409 (834)
Q Consensus 331 -G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~~ 409 (834)
|..|+.... ...+...+ ..+..... .......+..++..||+.+|.+||+|.+|++.|..+.
T Consensus 235 ~g~~p~~~~~------~~~~~~~~-~~~~~~~~----------~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~ 297 (304)
T cd05101 235 LGGSPYPGIP------VEELFKLL-KEGHRMDK----------PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL 297 (304)
T ss_pred CCCCCcccCC------HHHHHHHH-HcCCcCCC----------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence 777764321 12222222 11111110 0011246788999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=348.95 Aligned_cols=272 Identities=20% Similarity=0.308 Sum_probs=196.3
Q ss_pred cHHHHHhhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCC------CceeeEee
Q 003278 102 SYAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRH------RNLVRLRG 175 (834)
Q Consensus 102 ~~~el~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H------~nIv~l~g 175 (834)
..+++...+++|+..++||+|+||+||+|.+..++..||||+++... ...+.+..|+.++..++| ++|+++++
T Consensus 120 ~~~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~ 198 (467)
T PTZ00284 120 LGEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQR 198 (467)
T ss_pred cCCccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEE
Confidence 34556667889999999999999999999998889999999986432 233455667777776655 45899999
Q ss_pred eEEeC-CEEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCC
Q 003278 176 WCVHE-DQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQ 254 (834)
Q Consensus 176 ~~~~~-~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~ 254 (834)
+|... +..++|||++ +++|.+++... ..+++..+..|+.||+.||.|||+. .+||||||||+|||++.+
T Consensus 199 ~~~~~~~~~~iv~~~~-g~~l~~~l~~~-------~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~ 268 (467)
T PTZ00284 199 YFQNETGHMCIVMPKY-GPCLLDWIMKH-------GPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETS 268 (467)
T ss_pred EEEcCCceEEEEEecc-CCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecC
Confidence 98765 4789999988 67888887543 3689999999999999999999973 489999999999999876
Q ss_pred C----------------ceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccce
Q 003278 255 Y----------------NARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDV 318 (834)
Q Consensus 255 ~----------------~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV 318 (834)
+ .+||+|||++..... ..+...||+.|||||++... .++.++||
T Consensus 269 ~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-------------------~~~~~~gt~~Y~APE~~~~~-~~~~~~Di 328 (467)
T PTZ00284 269 DTVVDPVTNRALPPDPCRVRICDLGGCCDERH-------------------SRTAIVSTRHYRSPEVVLGL-GWMYSTDM 328 (467)
T ss_pred CcccccccccccCCCCceEEECCCCccccCcc-------------------ccccccCCccccCcHHhhcC-CCCcHHHH
Confidence 5 499999998753110 13456799999999998654 67999999
Q ss_pred eehhhHHHHHHhCCccCCCCCCCccchHH---------HHHHH--------Hhh-cCccccccccc----cCCC--CCCH
Q 003278 319 FSFGIVVLEVVSGRRAVDLTYPDDQIILL---------DWIRR--------LSD-EGKVLQAGDNR----LSDG--SYKL 374 (834)
Q Consensus 319 ~SfGvvl~ElltG~~p~~~~~~~~~~~l~---------~~~~~--------~~~-~~~~~~~~d~~----l~~~--~~~~ 374 (834)
|||||++|||+||+.||+.....+...++ .|... +.. .+.+....++. +... ....
T Consensus 329 wSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (467)
T PTZ00284 329 WSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREV 408 (467)
T ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhh
Confidence 99999999999999999754322211111 11100 000 00000000000 0000 0001
Q ss_pred HHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 375 CDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 375 ~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
.....+.+|+..||+.||.+||++.|+++.
T Consensus 409 ~~~~~~~dli~~mL~~dP~~R~ta~e~L~H 438 (467)
T PTZ00284 409 IRDDLLCDLIYGLLHYDRQKRLNARQMTTH 438 (467)
T ss_pred hchHHHHHHHHHhCCcChhhCCCHHHHhcC
Confidence 112456789999999999999999999873
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=316.79 Aligned_cols=254 Identities=23% Similarity=0.360 Sum_probs=199.0
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC-----hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG-----ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLL 185 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 185 (834)
++|...+.||+|+||.||+|....++..||+|.+.... ....+.+.+|+.++++++||||+++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57999999999999999999998889999999875431 1223568899999999999999999999999999999
Q ss_pred EEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccch
Q 003278 186 VYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLA 265 (834)
Q Consensus 186 V~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla 265 (834)
||||+++++|.+++... ..+++.....++.|++.||.|||+. +|+||||||+||++++++.++|+|||++
T Consensus 82 v~e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~ 151 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY-------GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGAS 151 (263)
T ss_pred EEEECCCCcHHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccc
Confidence 99999999999988643 3578889999999999999999985 9999999999999999999999999998
Q ss_pred hhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccch
Q 003278 266 RWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQII 345 (834)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~ 345 (834)
+.+..... .........|+..|+|||.+... .++.++|||||||++|||++|+.||...... .
T Consensus 152 ~~~~~~~~-------------~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~ 214 (263)
T cd06625 152 KRLQTICS-------------SGTGMKSVTGTPYWMSPEVISGE-GYGRKADVWSVGCTVVEMLTEKPPWAEFEAM---A 214 (263)
T ss_pred eecccccc-------------ccccccCCCcCccccCcceeccC-CCCchhhhHHHHHHHHHHHhCCCCccccchH---H
Confidence 75422100 00001234588999999998754 5789999999999999999999998542111 1
Q ss_pred HHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 346 LLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 346 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
.. ......... ..+. .. ....+.++...||..+|.+||++.++++.
T Consensus 215 ~~---~~~~~~~~~-----~~~~-~~----~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 215 AI---FKIATQPTN-----PQLP-SH----VSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HH---HHHhccCCC-----CCCC-cc----CCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 11 111111100 0111 11 12357789999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=316.44 Aligned_cols=250 Identities=22% Similarity=0.362 Sum_probs=198.4
Q ss_pred CcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCC-ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 514 NFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSK-CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
+|...+.||+|+||.||+|... ++..|++|.+.... .......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 3566678999999999999864 57889999886432 334567899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccccc
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTR 671 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~ 671 (834)
+++++|.+++.... ...+++.....++.|++.||.|||+ .+|+||||||+||+++.++.+|++|||+++.+..
T Consensus 81 ~~~~~L~~~l~~~~----~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~ 153 (256)
T cd08529 81 AENGDLHKLLKMQR----GRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD 153 (256)
T ss_pred CCCCcHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccC
Confidence 99999999987542 1248888899999999999999996 6999999999999999999999999999876543
Q ss_pred CCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcccc
Q 003278 672 NDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAE 751 (834)
Q Consensus 672 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
.. .......|++.|+|||++.++.++.++|||||||++|||+||+.|+..... ........ . ....
T Consensus 154 ~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~---~--~~~~- 219 (256)
T cd08529 154 NT-------NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ-GALILKII---R--GVFP- 219 (256)
T ss_pred cc-------chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHH---c--CCCC-
Confidence 21 112235688999999999999999999999999999999999999864432 22111111 0 1110
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 752 LVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 752 ~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
.+...++ ..+.+++.+||+.+|++||+|.+|++
T Consensus 220 ----~~~~~~~----~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 220 ----PVSQMYS----QQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred ----CCccccC----HHHHHHHHHHccCCcccCcCHHHHhh
Confidence 1111111 24556667999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=337.14 Aligned_cols=205 Identities=17% Similarity=0.168 Sum_probs=171.4
Q ss_pred HHhhCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCC--ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEE
Q 003278 510 SATNNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSK--CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEML 586 (834)
Q Consensus 510 ~at~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~ 586 (834)
...++|...+.||+|+||.||++... ++..+|+|.+.... .......+.+|+.+++.++|||||++++++.+.+..+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 34577888899999999999999965 57889999885321 1223356889999999999999999999999999999
Q ss_pred EEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeec
Q 003278 587 VIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALA 666 (834)
Q Consensus 587 lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla 666 (834)
+||||+++|+|.+++... .+++.....++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||++
T Consensus 120 lv~Ey~~gg~L~~~l~~~-------~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a 189 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY-------DVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTC 189 (370)
T ss_pred EEEcCCCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccc
Confidence 999999999999988532 26677788899999999999996 69999999999999999999999999999
Q ss_pred cccccCCCCCcccccCccccccccCccchhccccC----CCCccCcchhhHHHHHHHHhCCCccCCCC
Q 003278 667 EFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESG----EATSMADVYSFGVVVLEVVTGQMAVDFRL 730 (834)
Q Consensus 667 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~----~~~~k~DV~SfGvvl~E~~tG~~p~~~~~ 730 (834)
..+..... ....+..||+.|||||++.+. .++.++|||||||+||||+||+.||....
T Consensus 190 ~~~~~~~~------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~ 251 (370)
T cd05621 190 MKMDETGM------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS 251 (370)
T ss_pred eecccCCc------eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC
Confidence 76532211 112346799999999998653 37889999999999999999999997543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=317.77 Aligned_cols=250 Identities=26% Similarity=0.399 Sum_probs=200.5
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEcc
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYM 190 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 190 (834)
++|+..+.||+|+||.||+|.+..++..||+|.+..... .+.+.+|+.++++++||||+++++++...+..++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 678889999999999999999988899999999865432 678999999999999999999999999999999999999
Q ss_pred CCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhh
Q 003278 191 PNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEH 270 (834)
Q Consensus 191 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~ 270 (834)
++++|.+++... ...++|.....++.|+++||.|||+. +|+||||+|+||+++.++.+||+|||++..+..
T Consensus 81 ~~~~L~~~l~~~------~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~ 151 (256)
T cd06612 81 GAGSVSDIMKIT------NKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD 151 (256)
T ss_pred CCCcHHHHHHhC------ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhccc
Confidence 999999998543 24689999999999999999999985 999999999999999999999999999876432
Q ss_pred hhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHHH
Q 003278 271 ELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWI 350 (834)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~ 350 (834)
.. .......|+..|+|||++... .++.++|||||||++|||+||+.|+....+..... .
T Consensus 152 ~~----------------~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~--~-- 210 (256)
T cd06612 152 TM----------------AKRNTVIGTPFWMAPEVIQEI-GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF--M-- 210 (256)
T ss_pred Cc----------------cccccccCCccccCHHHHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh--h--
Confidence 11 012234588999999988654 67899999999999999999999986432221100 0
Q ss_pred HHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 351 RRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 351 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
......+.+. ....-...+.+++..||+.+|.+||++.+|++
T Consensus 211 --------~~~~~~~~~~---~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 211 --------IPNKPPPTLS---DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred --------hccCCCCCCC---chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 0000000110 00001135788999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=339.52 Aligned_cols=209 Identities=18% Similarity=0.174 Sum_probs=171.1
Q ss_pred CcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCC--ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEe
Q 003278 514 NFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSK--CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYD 590 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~--~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~E 590 (834)
+|...+.||+|+||.||++.. .++..||||.+.... .....+.+.+|++++.+++|||||++++++.+.+..++|||
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E 81 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME 81 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence 577778999999999999985 568899999885422 22334678899999999999999999999999999999999
Q ss_pred ccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccc
Q 003278 591 YSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLT 670 (834)
Q Consensus 591 y~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~ 670 (834)
|+++|+|.+++.... .+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 82 ~~~gg~L~~~l~~~~------~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~ 152 (377)
T cd05629 82 FLPGGDLMTMLIKYD------TFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFH 152 (377)
T ss_pred CCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeecccccccc
Confidence 999999999886432 36777778899999999999996 699999999999999999999999999996322
Q ss_pred cCCCCC----------ccc------------------------------ccCccccccccCccchhccccCCCCccCcch
Q 003278 671 RNDHGH----------RKA------------------------------TSGNRSVRGIFGYMSPEYIESGEATSMADVY 710 (834)
Q Consensus 671 ~~~~~~----------~~~------------------------------~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~ 710 (834)
...... ... .....+.+||+.|||||++.+..++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 232 (377)
T cd05629 153 KQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWW 232 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeE
Confidence 110000 000 0001135799999999999988999999999
Q ss_pred hhHHHHHHHHhCCCccCCCCC
Q 003278 711 SFGVVVLEVVTGQMAVDFRLP 731 (834)
Q Consensus 711 SfGvvl~E~~tG~~p~~~~~~ 731 (834)
||||+||||+||..||....+
T Consensus 233 SlGvil~elltG~~Pf~~~~~ 253 (377)
T cd05629 233 SLGAIMFECLIGWPPFCSENS 253 (377)
T ss_pred ecchhhhhhhcCCCCCCCCCH
Confidence 999999999999999965443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=323.71 Aligned_cols=254 Identities=18% Similarity=0.265 Sum_probs=198.8
Q ss_pred CcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEecc
Q 003278 514 NFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYS 592 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~ 592 (834)
+|...+.||+|+||+||++.. .++..||+|.+.....+...+.|.+|+++++.++||||+++++++...+..++||||+
T Consensus 6 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (284)
T cd06620 6 DLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFM 85 (284)
T ss_pred HHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecC
Confidence 455567899999999999985 4588899998876555556678999999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccC
Q 003278 593 ATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRN 672 (834)
Q Consensus 593 ~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~ 672 (834)
++++|..++...+ .+++.....++.+++.||.|||+. .+|+||||||+||++++++.++|+|||++......
T Consensus 86 ~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 86 DCGSLDRIYKKGG------PIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred CCCCHHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 9999998875432 378888999999999999999963 57999999999999999999999999998643211
Q ss_pred CCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchh-------HHHHHHHHHhh
Q 003278 673 DHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGL-------LVKRVHEFEAR 745 (834)
Q Consensus 673 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~-------~~~~~~~~~~~ 745 (834)
......||..|+|||++.++.++.++|||||||++|||+||+.|+....+... +..........
T Consensus 158 ---------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd06620 158 ---------IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE 228 (284)
T ss_pred ---------ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc
Confidence 11235789999999999888999999999999999999999999875433210 11111111100
Q ss_pred cCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHH
Q 003278 746 KRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSIL 794 (834)
Q Consensus 746 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L 794 (834)
. .+.+.....+ ..+..++.+||+.||++|||+.+|++..
T Consensus 229 ~-------~~~~~~~~~~---~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 229 P-------PPRLPSSDFP---EDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred c-------CCCCCchhcC---HHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 0 0111111111 2355666799999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=316.03 Aligned_cols=250 Identities=27% Similarity=0.418 Sum_probs=194.6
Q ss_pred CeeeccCCeEEEEEEECCCC---eEEEEEEecccCh-hhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEccCC
Q 003278 117 EVLGSGGFGKVYRAVLPSDG---TVVAVKCLAEKGE-RFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPN 192 (834)
Q Consensus 117 ~~LG~G~fG~Vy~~~~~~~g---~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 192 (834)
++||+|+||.||+|.+...+ ..||+|.+..... ...+.+.+|+.++++++|||||++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 47999999999999875544 7899999875433 35567999999999999999999999876 4568999999999
Q ss_pred CCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhhhh
Q 003278 193 RSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHEL 272 (834)
Q Consensus 193 gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~ 272 (834)
|+|.+++... ..++|..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++.+....
T Consensus 80 ~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~ 149 (257)
T cd05060 80 GPLLKYLKKR-------REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGS 149 (257)
T ss_pred CcHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCC
Confidence 9999999653 2578999999999999999999985 89999999999999999999999999998653221
Q ss_pred hhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccchHHHHHH
Q 003278 273 QYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQIILLDWIR 351 (834)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~ 351 (834)
.. ........++..|+|||.+..+ .++.++|||||||++|||+| |+.|+..... ..+..++.
T Consensus 150 ~~-------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~~ 212 (257)
T cd05060 150 DY-------------YRATTAGRWPLKWYAPECINYG-KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAMLE 212 (257)
T ss_pred cc-------------cccccCccccccccCHHHhcCC-CCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHH
Confidence 10 0001122356789999988654 67899999999999999998 9998864321 12222222
Q ss_pred HHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 352 RLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 352 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
.+...... ... ...+.+++.+||+.+|.+||++.+|++.|...
T Consensus 213 ----~~~~~~~~------~~~----~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 213 ----SGERLPRP------EEC----PQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred ----cCCcCCCC------CCC----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 11111110 111 24678999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=330.31 Aligned_cols=242 Identities=17% Similarity=0.194 Sum_probs=187.8
Q ss_pred CcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCC--ChhHHHHHHHHHHHHHhccCC-CceeEEEEEeeCCeEEEEE
Q 003278 514 NFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSK--CPALRTRFSNELQNLARLRHR-NLVQLCGWCTEQGEMLVIY 589 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~E~~~l~~l~Hp-Niv~l~g~~~~~~~~~lv~ 589 (834)
+|...+.||+|+||.||+|... ++..||||.+.... .....+.+..|+.++..++|+ +|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 3566788999999999999865 46789999986432 223345688899999999775 5788999999999999999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccc
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFL 669 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~ 669 (834)
||+++|+|..++.... .+++.....++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++..
T Consensus 81 E~~~~g~L~~~~~~~~------~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05587 81 EYVNGGDLMYHIQQVG------KFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKEN 151 (324)
T ss_pred cCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceec
Confidence 9999999998886432 37888899999999999999996 69999999999999999999999999998642
Q ss_pred ccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcc
Q 003278 670 TRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPL 749 (834)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
.... .......||+.|+|||++.+..++.++|||||||++|||+||+.||....... ....+. ....
T Consensus 152 ~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~-~~~~i~---~~~~-- 218 (324)
T cd05587 152 IFGG-------KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE-LFQSIM---EHNV-- 218 (324)
T ss_pred CCCC-------CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-HHHHHH---cCCC--
Confidence 2111 11234679999999999999999999999999999999999999987543221 111111 1110
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCh
Q 003278 750 AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSM 787 (834)
Q Consensus 750 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm 787 (834)
.+....+ . .+..++.+||..||.+||+.
T Consensus 219 ------~~~~~~~-~---~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 219 ------SYPKSLS-K---EAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred ------CCCCCCC-H---HHHHHHHHHhhcCHHHcCCC
Confidence 1111122 2 34455668999999999987
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=314.24 Aligned_cols=247 Identities=24% Similarity=0.393 Sum_probs=193.4
Q ss_pred CeeeccCCeEEEEEEECCCCeEEEEEEecccC-hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEccCCCCH
Q 003278 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG-ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNRSL 195 (834)
Q Consensus 117 ~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 195 (834)
++||+|+||.||+|.. .++..||+|.+.... ......|.+|+.++++++||||++++++|...+..++||||+++|+|
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 4799999999999997 478899999886543 33455789999999999999999999999999999999999999999
Q ss_pred hHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhhhhhhh
Q 003278 196 DRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQ 275 (834)
Q Consensus 196 ~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~ 275 (834)
.+++... ...++|..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 80 ~~~~~~~------~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-- 148 (250)
T cd05085 80 LSFLRKK------KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-- 148 (250)
T ss_pred HHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceecccccc--
Confidence 9988543 23578999999999999999999985 999999999999999999999999999874322110
Q ss_pred hhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccchHHHHHHHHh
Q 003278 276 MRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQIILLDWIRRLS 354 (834)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 354 (834)
.......+++.|+|||++..+ .++.++|||||||++||++| |..||...... .... . .
T Consensus 149 -------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~---~~~~---~-~ 207 (250)
T cd05085 149 -------------SSSGLKQIPIKWTAPEALNYG-RYSSESDVWSYGILLWETFSLGVCPYPGMTNQ---QARE---Q-V 207 (250)
T ss_pred -------------ccCCCCCCcccccCHHHhccC-CCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH---HHHH---H-H
Confidence 001122356789999998655 57889999999999999999 88888532111 1111 1 1
Q ss_pred hcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhh
Q 003278 355 DEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVS 406 (834)
Q Consensus 355 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~ 406 (834)
..+..... .......+.+++..|++.+|++||+|.++++.|.
T Consensus 208 ~~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 208 EKGYRMSC----------PQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HcCCCCCC----------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 11111110 0011246889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=327.84 Aligned_cols=251 Identities=24% Similarity=0.374 Sum_probs=200.6
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEcc
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYM 190 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 190 (834)
.+|+..+.||.|+||.||+|....+|+.||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 45888899999999999999998899999999987655555677899999999999999999999999999999999999
Q ss_pred CCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhh
Q 003278 191 PNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEH 270 (834)
Q Consensus 191 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~ 270 (834)
++++|..++.. ..++|.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++..+..
T Consensus 99 ~~~~L~~~~~~--------~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~ 167 (296)
T cd06655 99 AGGSLTDVVTE--------TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP 167 (296)
T ss_pred CCCcHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence 99999998843 3588999999999999999999985 999999999999999999999999999875422
Q ss_pred hhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHHH
Q 003278 271 ELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWI 350 (834)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~ 350 (834)
... ......|++.|+|||.+... .++.++|||||||++|||+||+.||........ .
T Consensus 168 ~~~----------------~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~------~ 224 (296)
T cd06655 168 EQS----------------KRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------L 224 (296)
T ss_pred ccc----------------cCCCcCCCccccCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------H
Confidence 110 01234589999999988654 578899999999999999999999865432111 1
Q ss_pred HHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 351 RRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 351 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
....... ......+ ... ...+.+++..||..+|.+||++.+++..
T Consensus 225 ~~~~~~~-~~~~~~~----~~~----~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 225 YLIATNG-TPELQNP----EKL----SPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred HHHHhcC-CcccCCc----ccC----CHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 1111110 0000000 111 1357788999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=332.61 Aligned_cols=242 Identities=17% Similarity=0.265 Sum_probs=196.1
Q ss_pred CCcccccCCcEEEEEE-ECCCcEEEEEEecCC--CChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEeccCC
Q 003278 518 SQRVAEMDFGTAYQGF-LDNHQYVLVKRLGMS--KCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSAT 594 (834)
Q Consensus 518 ~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~--~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~~~ 594 (834)
++-+|.|+-|.|-.|+ ...|+.+|||.+... ..........+||.+|+-|.||||++||+++.++.++|+|.||+++
T Consensus 17 gkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~g 96 (786)
T KOG0588|consen 17 GKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPG 96 (786)
T ss_pred cccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCC
Confidence 4569999999999998 467999999998654 2223345678899999999999999999999999999999999999
Q ss_pred CchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCCC
Q 003278 595 RILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDH 674 (834)
Q Consensus 595 g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~~ 674 (834)
|-|.++|..++ .|..+...+++.||..|+.|||. .+|+||||||+|+|||..+++||+|||+|.+-..+
T Consensus 97 GELFdylv~kG------~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g-- 165 (786)
T KOG0588|consen 97 GELFDYLVRKG------PLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG-- 165 (786)
T ss_pred chhHHHHHhhC------CCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccCC--
Confidence 99999998764 37888889999999999999997 68999999999999999999999999999763332
Q ss_pred CCcccccCccccccccCccchhccccCCCC-ccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcccccc
Q 003278 675 GHRKATSGNRSVRGIFGYMSPEYIESGEAT-SMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELV 753 (834)
Q Consensus 675 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (834)
....+-||++.|.|||++.+.+|+ .++||||.|||||.|+||+.||+...-...+. .+.. ...++.
T Consensus 166 ------klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLl-KV~~------G~f~MP 232 (786)
T KOG0588|consen 166 ------KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLL-KVQR------GVFEMP 232 (786)
T ss_pred ------ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHH-HHHc------CcccCC
Confidence 123456999999999999999997 47999999999999999999998543333222 2221 112222
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 754 DLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 754 d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
.+-..++..|+. ++++-||+.|-|++||.+
T Consensus 233 ------s~Is~eaQdLLr---~ml~VDp~~RiT~~eI~k 262 (786)
T KOG0588|consen 233 ------SNISSEAQDLLR---RMLDVDPSTRITTEEILK 262 (786)
T ss_pred ------CcCCHHHHHHHH---HHhccCccccccHHHHhh
Confidence 112245555554 678899999999999987
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=319.21 Aligned_cols=256 Identities=28% Similarity=0.461 Sum_probs=199.0
Q ss_pred CCCCCCeeeccCCeEEEEEEECCCCe---EEEEEEeccc-ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEE
Q 003278 112 GFDEDEVLGSGGFGKVYRAVLPSDGT---VVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 112 ~f~~~~~LG~G~fG~Vy~~~~~~~g~---~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 187 (834)
+|+..+.||+|+||.||+|.+..++. .||||.+... .....+.|..|+.++++++||||+++++++...+..++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 46778899999999999999876654 6999998654 3445678999999999999999999999999999999999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
||+++|+|.+++... ...+++.++..++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++.
T Consensus 85 e~~~~~~L~~~l~~~------~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~ 155 (269)
T cd05065 85 EFMENGALDSFLRQN------DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRF 155 (269)
T ss_pred ecCCCCcHHHHHhhC------CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccc
Confidence 999999999998643 23589999999999999999999985 999999999999999999999999999876
Q ss_pred hhhhhhhhhhcccccccccccccceeee--ccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccc
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIG--GTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQI 344 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~ 344 (834)
+...... . ....... ++..|+|||++..+ .++.++|||||||++||+++ |..|+..... .
T Consensus 156 ~~~~~~~---------~----~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~---~ 218 (269)
T cd05065 156 LEDDTSD---------P----TYTSSLGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMSN---Q 218 (269)
T ss_pred cccCccc---------c----ccccccCCCcceeecCHhHhccC-cccchhhhhhhHHHHHHHhcCCCCCCCCCCH---H
Confidence 5322100 0 0011111 24679999998654 57899999999999999887 9998854321 1
Q ss_pred hHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhc
Q 003278 345 ILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSG 407 (834)
Q Consensus 345 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~ 407 (834)
....++.. ..... . .... ...+.+++..||+.+|.+||+|.+|+..|+.
T Consensus 219 ~~~~~i~~---~~~~~------~-~~~~----~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 219 DVINAIEQ---DYRLP------P-PMDC----PTALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred HHHHHHHc---CCcCC------C-cccC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 22222211 10000 0 0111 2457889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=327.28 Aligned_cols=264 Identities=25% Similarity=0.378 Sum_probs=201.2
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECC-------CCeEEEEEEeccc-ChhhHHHHHHHHHHHHhC-CCCceeeEeeeEEeC
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPS-------DGTVVAVKCLAEK-GERFEKTFAAELVAVAHL-RHRNLVRLRGWCVHE 180 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~-------~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~ 180 (834)
.++|...+.||+|+||.||+|.... ++..+|+|.+... .......+.+|+.++.++ +||||++++++|...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 3568889999999999999998632 2357999998753 233456788899999999 799999999999999
Q ss_pred CEEEEEEEccCCCCHhHHHhcCCCcc---------ccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEE
Q 003278 181 DQLLLVYDYMPNRSLDRVLFRRPENL---------EAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVML 251 (834)
Q Consensus 181 ~~~~lV~Ey~~~gsL~~~l~~~~~~~---------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILl 251 (834)
+..++||||+++|+|.+++....... .....++|.+++.++.|++.||+|||+. +++||||||+|||+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEE
Confidence 99999999999999999997643210 1124589999999999999999999985 99999999999999
Q ss_pred CCCCceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-
Q 003278 252 DSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS- 330 (834)
Q Consensus 252 d~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt- 330 (834)
+.++.+||+|||+++.+...... ...+...+++.|+|||.+... .++.++|||||||++|||++
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~~ 238 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYY--------------KKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTL 238 (307)
T ss_pred cCCCcEEECCCcccccccccchh--------------hccccCCCccceeChHHhccC-CCCcHHHHHHHHHHHHHHHcC
Confidence 99999999999998754321100 001122356789999988654 57899999999999999998
Q ss_pred CCccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 331 GRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 331 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
|..|+.... .......+ ..+..... .......+.+++..||+.+|.+||+|.+|++.|...
T Consensus 239 g~~p~~~~~------~~~~~~~~-~~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~ 299 (307)
T cd05098 239 GGSPYPGVP------VEELFKLL-KEGHRMDK----------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299 (307)
T ss_pred CCCCCCcCC------HHHHHHHH-HcCCCCCC----------CCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 888875321 11111111 11111110 001124677899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=312.85 Aligned_cols=247 Identities=24% Similarity=0.408 Sum_probs=204.9
Q ss_pred CCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEccCC
Q 003278 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPN 192 (834)
Q Consensus 113 f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 192 (834)
|++..+||+|+||.|||+.++.+|..||||.+.-. ...++...|+.+|.+...|.+|++||.+.....+|+|||||.-
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 77888999999999999999999999999987543 3356788999999999999999999999999999999999999
Q ss_pred CCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhhhh
Q 003278 193 RSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHEL 272 (834)
Q Consensus 193 gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~ 272 (834)
||..+++.-+. .+|++..+..|+...++||+|||.. .-||||||..||||+.+|.+||+|||.|-.+.+..
T Consensus 113 GSiSDI~R~R~------K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM 183 (502)
T KOG0574|consen 113 GSISDIMRARR------KPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM 183 (502)
T ss_pred CcHHHHHHHhc------CCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhH
Confidence 99999997653 5789999999999999999999986 78999999999999999999999999998776543
Q ss_pred hhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHHHHH
Q 003278 273 QYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIRR 352 (834)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~ 352 (834)
. ...++.|||.|||||+++.- .|..++||||+|++..||..|++|+....+-..
T Consensus 184 A----------------KRNTVIGTPFWMAPEVI~EI-GY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA--------- 237 (502)
T KOG0574|consen 184 A----------------KRNTVIGTPFWMAPEVIEEI-GYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA--------- 237 (502)
T ss_pred H----------------hhCccccCcccccHHHHHHh-ccchhhhHhhhcchhhhhhcCCCCcccccccce---------
Confidence 2 24678899999999999765 468899999999999999999999865433211
Q ss_pred HhhcCccccccccccCCCCC-CHHH-HHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 353 LSDEGKVLQAGDNRLSDGSY-KLCD-MEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 353 ~~~~~~~~~~~d~~l~~~~~-~~~~-~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
+.-+.-. . ++.+ ..+. ...+.+....||-.+|++|-+..++++.
T Consensus 238 ------IFMIPT~-P-PPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 238 ------IFMIPTK-P-PPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred ------eEeccCC-C-CCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 1111111 1 1222 2222 2457789999999999999999888764
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=335.98 Aligned_cols=253 Identities=17% Similarity=0.192 Sum_probs=193.7
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCC--ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSK--CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIY 589 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~--~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~ 589 (834)
++|...+.||+|+||.||++.. .++..||||.+.... .....+.|.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 3577778999999999999986 468899999987432 2234467889999999999999999999999999999999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccc
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFL 669 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~ 669 (834)
||+++|+|.+++.... ..+++.....++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++..+
T Consensus 81 e~~~~~~L~~~l~~~~-----~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 152 (330)
T cd05601 81 EYQPGGDLLSLLNRYE-----DQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARL 152 (330)
T ss_pred CCCCCCCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeEC
Confidence 9999999999987542 247888888999999999999996 69999999999999999999999999999765
Q ss_pred ccCCCCCcccccCccccccccCccchhccc------cCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHH
Q 003278 670 TRNDHGHRKATSGNRSVRGIFGYMSPEYIE------SGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFE 743 (834)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~------~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~ 743 (834)
..... .......||+.|+|||++. ...++.++|||||||++|||+||+.||......... ..+.
T Consensus 153 ~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~-~~i~--- 222 (330)
T cd05601 153 TANKM------VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTY-NNIM--- 222 (330)
T ss_pred CCCCc------eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHH-HHHH---
Confidence 43221 0112347999999999986 466789999999999999999999998654332211 1111
Q ss_pred hhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 744 ARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 744 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
...... ...+ ... ...++.. +...|+. +|++|||+.+++.
T Consensus 223 ~~~~~~-~~~~---~~~-~~~~~~~---li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 223 NFQRFL-KFPE---DPK-VSSDFLD---LIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred cCCCcc-CCCC---CCC-CCHHHHH---HHHHHcc-ChhhCCCHHHHhC
Confidence 111100 0000 001 1233444 4446886 9999999999874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=330.56 Aligned_cols=242 Identities=16% Similarity=0.200 Sum_probs=188.3
Q ss_pred CcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCC--ChhHHHHHHHHHHHHHhc-cCCCceeEEEEEeeCCeEEEEE
Q 003278 514 NFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSK--CPALRTRFSNELQNLARL-RHRNLVQLCGWCTEQGEMLVIY 589 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~E~~~l~~l-~HpNiv~l~g~~~~~~~~~lv~ 589 (834)
+|...+.||+|+||.||+|... ++..||||.+.... .....+.+..|..++..+ +||||+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4666788999999999999865 46789999986432 122334567788888877 5899999999999999999999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccc
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFL 669 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~ 669 (834)
||+++|+|..++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++..
T Consensus 81 E~~~~g~L~~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~ 151 (323)
T cd05616 81 EYVNGGDLMYQIQQVG------RFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 151 (323)
T ss_pred cCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceec
Confidence 9999999998886432 37888899999999999999996 69999999999999999999999999998753
Q ss_pred ccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcc
Q 003278 670 TRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPL 749 (834)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
.... .......||+.|||||++.+..++.++|||||||++|||+||+.||....+.. +...+.. ...
T Consensus 152 ~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~-~~~~i~~---~~~-- 218 (323)
T cd05616 152 MWDG-------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-LFQSIME---HNV-- 218 (323)
T ss_pred CCCC-------CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH-HHHHHHh---CCC--
Confidence 2111 11234679999999999999999999999999999999999999997543322 2111111 110
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCh
Q 003278 750 AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSM 787 (834)
Q Consensus 750 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm 787 (834)
..+...+ . .+..++.+|++.||++|++.
T Consensus 219 ------~~p~~~s-~---~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 ------AYPKSMS-K---EAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ------CCCCcCC-H---HHHHHHHHHcccCHHhcCCC
Confidence 0111122 2 34556668999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=341.59 Aligned_cols=194 Identities=22% Similarity=0.234 Sum_probs=164.6
Q ss_pred hhCcCcCCcccccCCcEEEEEEECC-CcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEe
Q 003278 512 TNNFSESQRVAEMDFGTAYQGFLDN-HQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYD 590 (834)
Q Consensus 512 t~~f~~~~~ig~g~~g~vy~~~~~~-~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~E 590 (834)
..+|...+.||+|+||.||+|...+ ++.||||.... ..+.+|+++|++|+|||||++++++...+..++|||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 4578888999999999999999754 67899996421 346789999999999999999999999999999999
Q ss_pred ccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccc
Q 003278 591 YSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLT 670 (834)
Q Consensus 591 y~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~ 670 (834)
|+. ++|..++.... ..++|..++.|+.|++.||+|||+ .+||||||||+||||+.++.+||+|||+++.+.
T Consensus 241 ~~~-~~L~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~ 311 (461)
T PHA03211 241 KYR-SDLYTYLGARL-----RPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFAR 311 (461)
T ss_pred ccC-CCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceecc
Confidence 995 67777775432 248999999999999999999996 699999999999999999999999999998653
Q ss_pred cCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCcc
Q 003278 671 RNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAV 726 (834)
Q Consensus 671 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~ 726 (834)
.... ........||+.|||||++.+..++.++|||||||+||||++|..|+
T Consensus 312 ~~~~-----~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 312 GSWS-----TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred cccc-----cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 3211 11122467999999999999999999999999999999999988665
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=319.36 Aligned_cols=239 Identities=26% Similarity=0.442 Sum_probs=188.1
Q ss_pred CeeeccCCeEEEEEEECCCC----------eEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEE
Q 003278 117 EVLGSGGFGKVYRAVLPSDG----------TVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLV 186 (834)
Q Consensus 117 ~~LG~G~fG~Vy~~~~~~~g----------~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 186 (834)
+.||+|+||.||+|.+..++ ..|++|.+...... ...|.+|+.++++++||||++++|+|.. +..++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999997666 35888877654333 6789999999999999999999999988 788999
Q ss_pred EEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCC-------ceEE
Q 003278 187 YDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQY-------NARL 259 (834)
Q Consensus 187 ~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~-------~~kl 259 (834)
|||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++ .+||
T Consensus 79 ~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl 149 (259)
T cd05037 79 EEYVKFGPLDVFLHREK------NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKL 149 (259)
T ss_pred EEcCCCCcHHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEe
Confidence 99999999999987542 2688999999999999999999985 999999999999999887 7999
Q ss_pred eeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccC-CCCCcccceeehhhHHHHHHhC-CccCCC
Q 003278 260 GDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKG-SVATAKSDVFSFGIVVLEVVSG-RRAVDL 337 (834)
Q Consensus 260 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~ksDV~SfGvvl~ElltG-~~p~~~ 337 (834)
+|||+++.+.. .....|+..|+|||++... ..++.++|||||||++|||++| ..|+..
T Consensus 150 ~Dfg~a~~~~~--------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~ 209 (259)
T cd05037 150 SDPGIPITVLS--------------------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLST 209 (259)
T ss_pred CCCCccccccc--------------------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCccc
Confidence 99999875321 1123467789999998654 3578899999999999999995 655543
Q ss_pred CCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHh
Q 003278 338 TYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAV 405 (834)
Q Consensus 338 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l 405 (834)
..... +.... .... .+... ....+.+++..||..+|.+||++.+|++.|
T Consensus 210 ~~~~~------~~~~~-~~~~-------~~~~~-----~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 210 LSSSE------KERFY-QDQH-------RLPMP-----DCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred CCchh------HHHHH-hcCC-------CCCCC-----CchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 32111 11111 0010 00000 115688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=320.57 Aligned_cols=257 Identities=28% Similarity=0.428 Sum_probs=199.7
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCC---eEEEEEEecccC-hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDG---TVVAVKCLAEKG-ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLV 186 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g---~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 186 (834)
.+|+..+.||+|+||.||+|.+..++ ..+|+|.++... ....+.|.+|+.++.+++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46888899999999999999875443 479999886532 33456889999999999999999999999999999999
Q ss_pred EEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchh
Q 003278 187 YDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLAR 266 (834)
Q Consensus 187 ~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~ 266 (834)
|||+++|+|.+++.... ..+++.++..|+.|++.||+|||+. +++||||||+|||++.++.+||+|||+++
T Consensus 84 ~e~~~~~~L~~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~ 154 (267)
T cd05066 84 TEYMENGSLDAFLRKHD------GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSR 154 (267)
T ss_pred EEcCCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccc
Confidence 99999999999986532 3589999999999999999999985 99999999999999999999999999998
Q ss_pred hhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccch
Q 003278 267 WLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQII 345 (834)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~ 345 (834)
.+...... ........++..|+|||++..+ .++.++|||||||++||+++ |+.|+...... .
T Consensus 155 ~~~~~~~~-------------~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~---~ 217 (267)
T cd05066 155 VLEDDPEA-------------AYTTRGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ---D 217 (267)
T ss_pred ccccccce-------------eeecCCCccceeecCHhHhccC-ccCchhhhHHHHHHHHHHhcCCCCCcccCCHH---H
Confidence 65322100 0001122346789999998654 57999999999999999887 99988543211 1
Q ss_pred HHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhc
Q 003278 346 LLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSG 407 (834)
Q Consensus 346 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~ 407 (834)
...++. ++... ... .. ....+.+++..|++.+|.+||+|.++++.|..
T Consensus 218 ~~~~~~----~~~~~-----~~~-~~----~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 218 VIKAIE----EGYRL-----PAP-MD----CPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred HHHHHh----CCCcC-----CCC-CC----CCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 222211 11100 000 11 12457889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=321.12 Aligned_cols=247 Identities=16% Similarity=0.205 Sum_probs=189.9
Q ss_pred cCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCC--hhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 515 FSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKC--PALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 515 f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~--~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
|...+.||+|+||+||+|.. .+++.||+|.+..... ......+.+|+++|.+++|+||+++.+++...+..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 45567799999999999986 4688999999864322 22234578899999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccccc
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTR 671 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~ 671 (834)
+++++|..++..... ..+++.....++.|++.||.|||+ .+|+||||||+||++++++.+||+|||++.....
T Consensus 82 ~~~~~L~~~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05632 82 MNGGDLKFHIYNMGN----PGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE 154 (285)
T ss_pred ccCccHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCC
Confidence 999999988764321 248899999999999999999996 6899999999999999999999999999865432
Q ss_pred CCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcccc
Q 003278 672 NDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAE 751 (834)
Q Consensus 672 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
.. ......||..|+|||++.+..++.++|||||||++|||+||..||................... ..
T Consensus 155 ~~--------~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~----~~ 222 (285)
T cd05632 155 GE--------SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLET----EE 222 (285)
T ss_pred CC--------cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcc----cc
Confidence 11 1123578999999999998999999999999999999999999987543221111111100000 00
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChh
Q 003278 752 LVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMR 788 (834)
Q Consensus 752 ~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~ 788 (834)
....... . .+.+++..||+.||++|||+.
T Consensus 223 ----~~~~~~~-~---~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05632 223 ----VYSAKFS-E---EAKSICKMLLTKDPKQRLGCQ 251 (285)
T ss_pred ----ccCccCC-H---HHHHHHHHHccCCHhHcCCCc
Confidence 0111121 2 344566689999999999954
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=327.77 Aligned_cols=264 Identities=22% Similarity=0.302 Sum_probs=200.5
Q ss_pred hCcCcCCcccccCCcEEEEEEEC--------CCcEEEEEEecCCCChhHHHHHHHHHHHHHhc-cCCCceeEEEEEeeCC
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD--------NHQYVLVKRLGMSKCPALRTRFSNELQNLARL-RHRNLVQLCGWCTEQG 583 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~--------~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l-~HpNiv~l~g~~~~~~ 583 (834)
++|...+.||+|+||.||++... ....||+|.+...........|.+|+.++.++ +|||||+++++|.+.+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 45667789999999999998742 24568999887554444556789999999999 6999999999999999
Q ss_pred eEEEEEeccCCCchhhhhhcCCC----------CCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeec
Q 003278 584 EMLVIYDYSATRILSHLLFHNNH----------RIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLD 653 (834)
Q Consensus 584 ~~~lv~Ey~~~g~L~~~l~~~~~----------~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld 653 (834)
..+++|||+++|+|.+++..... ......++|...+.++.|++.||+|||+ .+|+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEEc
Confidence 99999999999999999875421 0112358899999999999999999996 6999999999999999
Q ss_pred CCCCceEeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCc
Q 003278 654 PDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPE 732 (834)
Q Consensus 654 ~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~ 732 (834)
+++.+|++|||+++........ .......++..|||||++.++.++.++|||||||++|||+| |..|+....+.
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~ 243 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYY-----KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE 243 (314)
T ss_pred CCCcEEEccccccccccccccc-----cccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999765322110 00111234567999999998999999999999999999999 78887543222
Q ss_pred hhHHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCc
Q 003278 733 GLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDK 799 (834)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~ 799 (834)
.+...... ... .+ .... ... .+..++.+||..+|++|||+.+|++.|+....
T Consensus 244 -~~~~~~~~----~~~-~~-----~~~~-~~~---~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 244 -ELFKLLRE----GHR-MD-----KPSN-CTH---ELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred -HHHHHHHc----CCC-CC-----CCCC-CCH---HHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 22221111 000 00 1111 122 44566679999999999999999999976543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=331.84 Aligned_cols=245 Identities=25% Similarity=0.385 Sum_probs=197.5
Q ss_pred CCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChh---hHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEc
Q 003278 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGER---FEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDY 189 (834)
Q Consensus 113 f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 189 (834)
|...+.||.|+||.||-+++..+...||||++.-.+.+ ....++.||..|.+++|||+|.+.|||..+...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 66778999999999999999999999999998654433 345688999999999999999999999999999999999
Q ss_pred cCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhh
Q 003278 190 MPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLE 269 (834)
Q Consensus 190 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~ 269 (834)
|- ||-.++|.-. ..+|..-.+..|..+++.||+|||+. +.||||||..||||.+.+.+||+|||.|....
T Consensus 108 Cl-GSAsDlleVh------kKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~ 177 (948)
T KOG0577|consen 108 CL-GSASDLLEVH------KKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMA 177 (948)
T ss_pred Hh-ccHHHHHHHH------hccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcC
Confidence 95 5777777543 24688888999999999999999996 89999999999999999999999999886532
Q ss_pred hhhhhhhhcccccccccccccceeeeccccCCCcccccc--CCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHH
Q 003278 270 HELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQK--GSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILL 347 (834)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~ 347 (834)
...+++|||.|||||++.. .+.|+.|+||||+|++..||.-.++|.-.. +..
T Consensus 178 --------------------PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM------NAM 231 (948)
T KOG0577|consen 178 --------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM------NAM 231 (948)
T ss_pred --------------------chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc------hHH
Confidence 1456789999999998853 347899999999999999999999986432 111
Q ss_pred HHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 348 DWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 348 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
.-... +.+.-.|.+..+++. +.+..+.-.||+.-|.+|||..+++.
T Consensus 232 SALYH------IAQNesPtLqs~eWS----~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 232 SALYH------IAQNESPTLQSNEWS----DYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred HHHHH------HHhcCCCCCCCchhH----HHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 11111 222233444333332 45778888999999999999877654
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=320.81 Aligned_cols=254 Identities=24% Similarity=0.342 Sum_probs=193.9
Q ss_pred CcccccCCcEEEEEEECC-------CcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 519 QRVAEMDFGTAYQGFLDN-------HQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 519 ~~ig~g~~g~vy~~~~~~-------~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
+.||+|+||.||+|...+ +..+|||.+...........|.+|+.++++++||||++++++|...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 358999999999998643 2578999876544344556899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCC-CCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCC-----CceEeeeee
Q 003278 592 SATRILSHLLFHNNHRI-GHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDM-----NPRLGSFAL 665 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~-~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~-----~~ki~DfGl 665 (834)
+++++|.+++....... ....++|..++.++.|++.||+|||+ .+++|+||||+||+++.+. .+|++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999987543211 22347899999999999999999996 6899999999999999877 899999999
Q ss_pred ccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHh
Q 003278 666 AEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEA 744 (834)
Q Consensus 666 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~ 744 (834)
++.+...... .......++..|+|||++.++.++.++|||||||++|||+| |+.|+....... ..... ..
T Consensus 158 ~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~-~~~~~---~~ 228 (269)
T cd05044 158 ARDIYKSDYY-----RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE-VLQHV---TA 228 (269)
T ss_pred cccccccccc-----ccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH-HHHHH---hc
Confidence 9765322110 01112345778999999999999999999999999999998 888875432211 11111 00
Q ss_pred hcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHc
Q 003278 745 RKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795 (834)
Q Consensus 745 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~ 795 (834)
.... ... ...+. .+.+++.+||..+|.+||++.+|++.|+
T Consensus 229 ~~~~-------~~~-~~~~~---~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 229 GGRL-------QKP-ENCPD---KIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred CCcc-------CCc-ccchH---HHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 0000 001 11123 3456667999999999999999999885
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=331.36 Aligned_cols=239 Identities=18% Similarity=0.199 Sum_probs=182.8
Q ss_pred CcccccCCcEEEEEEEC-CCcEEEEEEecCCC--ChhHHHHHHHHHH-HHHhccCCCceeEEEEEeeCCeEEEEEeccCC
Q 003278 519 QRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSK--CPALRTRFSNELQ-NLARLRHRNLVQLCGWCTEQGEMLVIYDYSAT 594 (834)
Q Consensus 519 ~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~E~~-~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~~~ 594 (834)
+.||+|+||+||+|... +++.||||.+.... .......+..|.. +++.++|||||++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 35899999999999964 68899999986432 1122234555544 56889999999999999999999999999999
Q ss_pred CchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCCC
Q 003278 595 RILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDH 674 (834)
Q Consensus 595 g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~~ 674 (834)
|+|..++.... .+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~- 150 (323)
T cd05575 81 GELFFHLQRER------SFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS- 150 (323)
T ss_pred CCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-
Confidence 99998886532 37788888899999999999996 699999999999999999999999999987532111
Q ss_pred CCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCccccccc
Q 003278 675 GHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVD 754 (834)
Q Consensus 675 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 754 (834)
.......||+.|||||++.+..++.++|||||||++|||+||+.||....... +.... .. .+.
T Consensus 151 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~i---~~--~~~----- 213 (323)
T cd05575 151 ------KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE-MYDNI---LN--KPL----- 213 (323)
T ss_pred ------CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH-HHHHH---Hc--CCC-----
Confidence 11234679999999999999999999999999999999999999986433221 11111 11 111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhH
Q 003278 755 LSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQ 789 (834)
Q Consensus 755 ~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~ 789 (834)
.+.... ... +..+..+|++.||++||++.+
T Consensus 214 -~~~~~~-~~~---~~~li~~~l~~~p~~R~~~~~ 243 (323)
T cd05575 214 -RLKPNI-SVS---ARHLLEGLLQKDRTKRLGAKD 243 (323)
T ss_pred -CCCCCC-CHH---HHHHHHHHhhcCHHhCCCCCC
Confidence 111112 223 445555899999999999863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=326.81 Aligned_cols=204 Identities=22% Similarity=0.399 Sum_probs=162.3
Q ss_pred CCeeeccCCeEEEEEEEC--CCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEe--CCEEEEEEEccC
Q 003278 116 DEVLGSGGFGKVYRAVLP--SDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVH--EDQLLLVYDYMP 191 (834)
Q Consensus 116 ~~~LG~G~fG~Vy~~~~~--~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~lV~Ey~~ 191 (834)
.++||+|+||+||+|+.+ .+++.||+|.+.... ....+.+|+.++++++||||+++++++.. ....++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999975 356899999986542 23457789999999999999999999865 456899999986
Q ss_pred CCCHhHHHhcCCCc--cccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEE----CCCCceEEeeccch
Q 003278 192 NRSLDRVLFRRPEN--LEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVML----DSQYNARLGDFGLA 265 (834)
Q Consensus 192 ~gsL~~~l~~~~~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILl----d~~~~~kl~DFGla 265 (834)
++|..++...... ......+++.....|+.|++.||.|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5787776432111 11224589999999999999999999986 99999999999999 45678999999999
Q ss_pred hhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCC
Q 003278 266 RWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLT 338 (834)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~ 338 (834)
+....... .........||+.|+|||++.....++.++|||||||++|||+||++||...
T Consensus 160 ~~~~~~~~-------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLK-------------PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCc-------------cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 86432110 0111234578999999999876556789999999999999999999998644
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=322.92 Aligned_cols=256 Identities=24% Similarity=0.379 Sum_probs=199.5
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc-ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEc
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDY 189 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 189 (834)
++|+..+.||+|+||.||+|.+..+|..||+|.+... .......+.+|+.++.+++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 3577889999999999999999889999999988643 233456789999999999999999999999999999999999
Q ss_pred cCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhh
Q 003278 190 MPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLE 269 (834)
Q Consensus 190 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~ 269 (834)
+++++|..++.... ....+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||++..+.
T Consensus 81 ~~~~~l~~~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 154 (286)
T cd06622 81 MDAGSLDKLYAGGV----ATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV 154 (286)
T ss_pred cCCCCHHHHHHhcc----ccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99999999886431 124689999999999999999999973 489999999999999999999999999987542
Q ss_pred hhhhhhhhcccccccccccccceeeeccccCCCccccccCC-----CCCcccceeehhhHHHHHHhCCccCCCCCCCccc
Q 003278 270 HELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGS-----VATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQI 344 (834)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-----~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~ 344 (834)
.. ......|++.|+|||.+.... .++.++|||||||++|||+||+.||......
T Consensus 155 ~~------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--- 213 (286)
T cd06622 155 AS------------------LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA--- 213 (286)
T ss_pred CC------------------ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh---
Confidence 11 022345889999999875432 3478999999999999999999998643211
Q ss_pred hHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 345 ILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 345 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
....-..... .+. .+.+. .. ....+.+++..||+.+|++||++.++++.
T Consensus 214 ~~~~~~~~~~-~~~-----~~~~~-~~----~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 214 NIFAQLSAIV-DGD-----PPTLP-SG----YSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred hHHHHHHHHh-hcC-----CCCCC-cc----cCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 1111111111 111 01111 11 12457789999999999999999998863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=315.73 Aligned_cols=251 Identities=22% Similarity=0.323 Sum_probs=199.3
Q ss_pred CCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc-ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEcc
Q 003278 112 GFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYM 190 (834)
Q Consensus 112 ~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 190 (834)
+|+..+.||+|+||.||++....++..||+|.+... .....+.+.+|+.++++++||||+++++++...+.+++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 467788999999999999999889999999987542 3344567889999999999999999999999999999999999
Q ss_pred CCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhh
Q 003278 191 PNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEH 270 (834)
Q Consensus 191 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~ 270 (834)
++|+|.+++.... ...+++.....++.|++.||.|||+. +|+|+||||+|||+++++.++|+|||+++.+..
T Consensus 81 ~~~~l~~~~~~~~-----~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 152 (255)
T cd08219 81 DGGDLMQKIKLQR-----GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS 152 (255)
T ss_pred CCCcHHHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecc
Confidence 9999998885432 24578899999999999999999985 999999999999999999999999999875432
Q ss_pred hhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHHH
Q 003278 271 ELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWI 350 (834)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~ 350 (834)
... ......|++.|+|||.+... .++.++||||||+++|+|++|+.||..... ....
T Consensus 153 ~~~----------------~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~------~~~~ 209 (255)
T cd08219 153 PGA----------------YACTYVGTPYYVPPEIWENM-PYNNKSDIWSLGCILYELCTLKHPFQANSW------KNLI 209 (255)
T ss_pred ccc----------------ccccccCCccccCHHHHccC-CcCchhhhhhhchhheehhhccCCCCCCCH------HHHH
Confidence 110 02234589999999988654 578999999999999999999999864211 1111
Q ss_pred HHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 351 RRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 351 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
.... .+.... +. ... ...+.+++..||+.||++||++.+++..
T Consensus 210 ~~~~-~~~~~~-~~-----~~~----~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 210 LKVC-QGSYKP-LP-----SHY----SYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHh-cCCCCC-CC-----ccc----CHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1111 111111 10 111 1347788999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=320.85 Aligned_cols=256 Identities=25% Similarity=0.383 Sum_probs=197.6
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEc
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDY 189 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 189 (834)
.++|+..+.||+|+||.||+|.+..+ ..||+|++.... ...+.|.+|+.++++++||||+++++++. .+..++||||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 81 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence 35688899999999999999998544 569999987532 23467899999999999999999999875 4568999999
Q ss_pred cCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhh
Q 003278 190 MPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLE 269 (834)
Q Consensus 190 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~ 269 (834)
+++|+|.+++.... ...++|..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++.+.
T Consensus 82 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~ 153 (262)
T cd05071 82 MSKGSLLDFLKGEM-----GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIE 153 (262)
T ss_pred CCCCcHHHHHhhcc-----ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecc
Confidence 99999999996532 23578999999999999999999985 99999999999999999999999999997543
Q ss_pred hhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccchHHH
Q 003278 270 HELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQIILLD 348 (834)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~ 348 (834)
.... .......|+..|+|||+...+ .++.++|||||||++|||+| |+.|+...... .+
T Consensus 154 ~~~~---------------~~~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~---~~-- 212 (262)
T cd05071 154 DNEY---------------TARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EV-- 212 (262)
T ss_pred cccc---------------ccccCCcccceecCHhHhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCChH---HH--
Confidence 2110 001123467889999987654 57999999999999999999 77777543211 11
Q ss_pred HHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcCC
Q 003278 349 WIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGSY 409 (834)
Q Consensus 349 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~~ 409 (834)
.... ..+... .. .......+.+++..|++.+|++||++.++++.|+..+
T Consensus 213 -~~~~-~~~~~~-----~~-----~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 213 -LDQV-ERGYRM-----PC-----PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred -HHHH-hcCCCC-----CC-----ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 1111 111000 00 1112346789999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=329.83 Aligned_cols=242 Identities=17% Similarity=0.192 Sum_probs=188.5
Q ss_pred CcccccCCcEEEEEEEC-CCcEEEEEEecCCC--ChhHHHHHHHHHHHHHhc-cCCCceeEEEEEeeCCeEEEEEeccCC
Q 003278 519 QRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSK--CPALRTRFSNELQNLARL-RHRNLVQLCGWCTEQGEMLVIYDYSAT 594 (834)
Q Consensus 519 ~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~E~~~l~~l-~HpNiv~l~g~~~~~~~~~lv~Ey~~~ 594 (834)
+.||+|+||.||++... ++..||||.+.... .......+..|+.++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 35899999999999875 47789999986432 223345678899999888 799999999999999999999999999
Q ss_pred CchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCCC
Q 003278 595 RILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDH 674 (834)
Q Consensus 595 g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~~ 674 (834)
|+|..++.... .+++.....++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++......
T Consensus 81 ~~L~~~~~~~~------~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 150 (318)
T cd05570 81 GDLMFHIQRSG------RFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG- 150 (318)
T ss_pred CCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-
Confidence 99998876432 38899999999999999999996 699999999999999999999999999986532111
Q ss_pred CCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCccccccc
Q 003278 675 GHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVD 754 (834)
Q Consensus 675 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 754 (834)
......+||+.|||||++.+..++.++|||||||++|||+||+.||...... ...... ... ..
T Consensus 151 ------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~-~~~~~i---~~~-~~------ 213 (318)
T cd05570 151 ------VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED-ELFQSI---LED-EV------ 213 (318)
T ss_pred ------CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH-HHHHHH---HcC-CC------
Confidence 1123457999999999999999999999999999999999999998643322 111111 110 10
Q ss_pred cccCCCCCHHHHHHHHHHHHHhccCCCCCCCCh-----hHHHH
Q 003278 755 LSLNGEYNHKELMRLIKLGIACTLSNPELRPSM-----RQILS 792 (834)
Q Consensus 755 ~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm-----~~v~~ 792 (834)
...... ..+ +..++.+||+.||++|||+ .++++
T Consensus 214 -~~~~~~-~~~---~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 214 -RYPRWL-SKE---AKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred -CCCCcC-CHH---HHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 011111 223 4455568999999999999 66654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=317.30 Aligned_cols=252 Identities=21% Similarity=0.359 Sum_probs=194.8
Q ss_pred CcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEeccC
Q 003278 514 NFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSA 593 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~~ 593 (834)
.|.....||+|+||.||+|...++..+|+|.+.... ...+.|.+|++++++++||||+++++++.+ +..+++|||++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05069 7 SLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT--MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMG 83 (260)
T ss_pred HeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC--ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCC
Confidence 456667899999999999998777789999876432 234678999999999999999999998854 56889999999
Q ss_pred CCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCC
Q 003278 594 TRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRND 673 (834)
Q Consensus 594 ~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~ 673 (834)
+|+|.+++.... ...++|..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++.......
T Consensus 84 ~~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 84 KGSLLDFLKEGD----GKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred CCCHHHHHhhCC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 999999986532 1247899999999999999999996 689999999999999999999999999997653221
Q ss_pred CCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCccccc
Q 003278 674 HGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRPLAEL 752 (834)
Q Consensus 674 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (834)
. .......++..|+|||++.++.++.++|||||||++|||+| |..|+....+.. ..... .....+
T Consensus 157 ~------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-~~~~~---~~~~~~---- 222 (260)
T cd05069 157 Y------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE-VLEQV---ERGYRM---- 222 (260)
T ss_pred c------cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHH---HcCCCC----
Confidence 1 11112346788999999998999999999999999999999 888876433322 11111 110000
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHcc
Q 003278 753 VDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDG 796 (834)
Q Consensus 753 ~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~ 796 (834)
..... .+. .+.+++.+||..||++||++.+|.+.|+.
T Consensus 223 ---~~~~~-~~~---~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 ---PCPQG-CPE---SLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ---CCCcc-cCH---HHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 00111 122 34556668999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=324.16 Aligned_cols=247 Identities=26% Similarity=0.414 Sum_probs=197.5
Q ss_pred CCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC-hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEccC
Q 003278 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG-ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMP 191 (834)
Q Consensus 113 f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 191 (834)
|+..+.||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 555678999999999999998889999999986432 3445678999999999999999999999999999999999999
Q ss_pred CCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhhh
Q 003278 192 NRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHE 271 (834)
Q Consensus 192 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~~ 271 (834)
+++|.+++.. ..+++..+..++.|+++||.|||+. +++|+||+|+||++++++.++|+|||+++.+...
T Consensus 86 ~~~L~~~~~~--------~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06642 86 GGSALDLLKP--------GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred CCcHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCc
Confidence 9999988743 3578999999999999999999985 9999999999999999999999999998754321
Q ss_pred hhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHHHH
Q 003278 272 LQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIR 351 (834)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~ 351 (834)
.. ......|+..|+|||++... .++.++|||||||++|||+||+.|+....+.. ...+
T Consensus 155 ~~----------------~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~~-- 212 (277)
T cd06642 155 QI----------------KRNTFVGTPFWMAPEVIKQS-AYDFKADIWSLGITAIELAKGEPPNSDLHPMR---VLFL-- 212 (277)
T ss_pred ch----------------hhhcccCcccccCHHHhCcC-CCchhhhHHHHHHHHHHHHhCCCCCcccchhh---HHhh--
Confidence 10 01234588999999998654 57889999999999999999999975332211 1111
Q ss_pred HHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 352 RLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 352 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
...+. .+.+. + .....+.+++..||+.+|++||+|.+|+..
T Consensus 213 --~~~~~-----~~~~~-~----~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 213 --IPKNS-----PPTLE-G----QYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred --hhcCC-----CCCCC-c----ccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 11111 11111 1 122457889999999999999999999974
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=322.88 Aligned_cols=262 Identities=26% Similarity=0.351 Sum_probs=190.0
Q ss_pred CCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC--hhhHHHHHHHHHHHHhC---CCCceeeEeeeEEeC-----C
Q 003278 112 GFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG--ERFEKTFAAELVAVAHL---RHRNLVRLRGWCVHE-----D 181 (834)
Q Consensus 112 ~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l---~H~nIv~l~g~~~~~-----~ 181 (834)
+|+..+.||+|+||.||+|....+|+.||+|.+.... ......+.+|+.++..+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 3777889999999999999999899999999886432 22233456677766655 799999999988652 4
Q ss_pred EEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEee
Q 003278 182 QLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGD 261 (834)
Q Consensus 182 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~D 261 (834)
..++||||++ ++|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~d 151 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVP-----PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLAD 151 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECc
Confidence 5899999998 48888886532 23489999999999999999999986 999999999999999999999999
Q ss_pred ccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCC
Q 003278 262 FGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPD 341 (834)
Q Consensus 262 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~ 341 (834)
||+++.+.... ..+...||+.|+|||.+... .++.++|||||||++|||++|++||......
T Consensus 152 fg~~~~~~~~~-----------------~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~ 213 (288)
T cd07863 152 FGLARIYSCQM-----------------ALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEA 213 (288)
T ss_pred cCccccccCcc-----------------cCCCccccccccCchHhhCC-CCCCcchhhhHHHHHHHHHhCCcCcCCCCHH
Confidence 99997542210 12334689999999988654 5799999999999999999999998643221
Q ss_pred ccchHHHHHHHHhhc---Cccc---cccccccCCCC------CCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 342 DQIILLDWIRRLSDE---GKVL---QAGDNRLSDGS------YKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 342 ~~~~l~~~~~~~~~~---~~~~---~~~d~~l~~~~------~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
+. +.... ..... .... ........... ......+.+.+++..|++.||++||++.+++.
T Consensus 214 ~~--~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 214 DQ--LGKIF-DLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred HH--HHHHH-HHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 11 11111 10000 0000 00000000000 00011245678999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=320.45 Aligned_cols=254 Identities=19% Similarity=0.265 Sum_probs=194.2
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
++|...+.||+|+||.||+|.. .++..||+|.+...... ....+.+|+.++.+++||||+++++++...+..++||||
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~-~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD-DFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc-hHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 4677788999999999999996 56788999998654322 235678899999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccccc
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTR 671 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~ 671 (834)
+++++|.+++...+ .+++..+..++.|++.||.|||+ .+|+||||||+||++++++.+||+|||++..+..
T Consensus 88 ~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06646 88 CGGGSLQDIYHVTG------PLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITA 158 (267)
T ss_pred CCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence 99999999886432 37888899999999999999996 6999999999999999999999999999976532
Q ss_pred CCCCCcccccCccccccccCccchhccc---cCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCc
Q 003278 672 NDHGHRKATSGNRSVRGIFGYMSPEYIE---SGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRP 748 (834)
Q Consensus 672 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~---~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
.. .......|+..|+|||.+. ...++.++|||||||++|||+||+.|+....+....... ...
T Consensus 159 ~~-------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~------~~~- 224 (267)
T cd06646 159 TI-------AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM------SKS- 224 (267)
T ss_pred cc-------cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee------ecC-
Confidence 11 1122356899999999884 455788999999999999999999998533222111000 000
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHH
Q 003278 749 LAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSIL 794 (834)
Q Consensus 749 ~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L 794 (834)
....+..... ......+.+++.+||..+|++|||+++|++.|
T Consensus 225 --~~~~~~~~~~--~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 225 --NFQPPKLKDK--TKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred --CCCCCCCccc--cccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0000111100 01112455666799999999999999998643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=335.17 Aligned_cols=198 Identities=28% Similarity=0.339 Sum_probs=166.1
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCC------
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHED------ 181 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~------ 181 (834)
.++|...+.||+|+||.||+|....+|..||||.+... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 36799999999999999999999889999999998643 2334567889999999999999999999987543
Q ss_pred EEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEee
Q 003278 182 QLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGD 261 (834)
Q Consensus 182 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~D 261 (834)
..|+||||+++ +|...+. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|
T Consensus 100 ~~~lv~e~~~~-~l~~~~~---------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~D 166 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIH---------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD 166 (359)
T ss_pred eeEEEEeCCCc-CHHHHHh---------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEec
Confidence 47999999975 5555553 2377888999999999999999985 999999999999999999999999
Q ss_pred ccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCC
Q 003278 262 FGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLT 338 (834)
Q Consensus 262 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~ 338 (834)
||+++..... ...+...||+.|+|||.+... .++.++|||||||++|||+||+.||...
T Consensus 167 fg~a~~~~~~-----------------~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 167 FGLARTACTN-----------------FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred CCCccccccC-----------------ccCCCCcccCCCCCchhccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 9999743211 012334689999999998644 6789999999999999999999998643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=326.07 Aligned_cols=263 Identities=26% Similarity=0.401 Sum_probs=200.2
Q ss_pred CCCCCCCeeeccCCeEEEEEEEC-------CCCeEEEEEEecccC-hhhHHHHHHHHHHHHhC-CCCceeeEeeeEEeCC
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLP-------SDGTVVAVKCLAEKG-ERFEKTFAAELVAVAHL-RHRNLVRLRGWCVHED 181 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~-------~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~ 181 (834)
++|...+.||+|+||.||+|... .....||+|.+.... ......+.+|+.++.++ +||||++++++|...+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 46788899999999999999752 235679999987532 33456788999999999 6999999999999999
Q ss_pred EEEEEEEccCCCCHhHHHhcCCCc---------cccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEEC
Q 003278 182 QLLLVYDYMPNRSLDRVLFRRPEN---------LEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLD 252 (834)
Q Consensus 182 ~~~lV~Ey~~~gsL~~~l~~~~~~---------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld 252 (834)
..++||||+++|+|.+++...... ......++|.+++.++.|++.||.|||+. +|+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEc
Confidence 999999999999999999654211 01124689999999999999999999985 999999999999999
Q ss_pred CCCceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-C
Q 003278 253 SQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-G 331 (834)
Q Consensus 253 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G 331 (834)
.++.+||+|||+++........ .......+++.|||||.+..+ .++.++|||||||++|||+| |
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~~g 233 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYY--------------KKTSNGRLPVKWMAPEALFDR-VYTHQSDVWSFGILMWEIFTLG 233 (314)
T ss_pred CCCcEEEccccccccccccccc--------------cccccCCCCccccCHHHHccC-CcCccchhhHHHHHHHHHHhCC
Confidence 9999999999999854321100 001112345689999988654 67899999999999999999 8
Q ss_pred CccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 332 RRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 332 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
..|+...... .+.. ....+...... . .....+.+++..||+.+|++||++.++++.|...
T Consensus 234 ~~p~~~~~~~---~~~~----~~~~~~~~~~~------~----~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 293 (314)
T cd05099 234 GSPYPGIPVE---ELFK----LLREGHRMDKP------S----NCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293 (314)
T ss_pred CCCCCCCCHH---HHHH----HHHcCCCCCCC------C----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 8887532211 1111 11122111110 1 1123577899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=329.33 Aligned_cols=206 Identities=21% Similarity=0.266 Sum_probs=167.2
Q ss_pred CCCeeecc--CCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEcc
Q 003278 115 EDEVLGSG--GFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYM 190 (834)
Q Consensus 115 ~~~~LG~G--~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 190 (834)
..++||+| +||+||++..+.+|..||||++... .....+.+.+|+.+++.++|||||+++++|..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35689999 7899999999999999999998653 2344566788999999999999999999999999999999999
Q ss_pred CCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhh
Q 003278 191 PNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEH 270 (834)
Q Consensus 191 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~ 270 (834)
++|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.++++|||.+..+..
T Consensus 82 ~~~~l~~~~~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~ 153 (327)
T cd08227 82 AYGSAKDLICTHF-----MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMIN 153 (327)
T ss_pred CCCcHHHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccc
Confidence 9999999986432 13589999999999999999999985 999999999999999999999999987643321
Q ss_pred hhhhhhhcccccccccccccceeeeccccCCCccccccC-CCCCcccceeehhhHHHHHHhCCccCCC
Q 003278 271 ELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKG-SVATAKSDVFSFGIVVLEVVSGRRAVDL 337 (834)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~ksDV~SfGvvl~ElltG~~p~~~ 337 (834)
.... .. ..........++..|+|||++..+ ..++.++|||||||++|||+||+.||..
T Consensus 154 ~~~~-----~~----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 154 HGQR-----LR----VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred cccc-----cc----ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 1000 00 000001223477889999998653 3578999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=328.83 Aligned_cols=241 Identities=17% Similarity=0.184 Sum_probs=185.3
Q ss_pred CcccccCCcEEEEEEEC-CCcEEEEEEecCCCC--hhHHHHHHHHHHHHHhc-cCCCceeEEEEEeeCCeEEEEEeccCC
Q 003278 519 QRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKC--PALRTRFSNELQNLARL-RHRNLVQLCGWCTEQGEMLVIYDYSAT 594 (834)
Q Consensus 519 ~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~E~~~l~~l-~HpNiv~l~g~~~~~~~~~lv~Ey~~~ 594 (834)
+.||+|+||.||+|... ++..||||.++.... ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 35899999999999964 578999999864321 22234567788888754 899999999999999999999999999
Q ss_pred CchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCCC
Q 003278 595 RILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDH 674 (834)
Q Consensus 595 g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~~ 674 (834)
|+|..++.... .+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~i~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 150 (316)
T cd05620 81 GDLMFHIQDKG------RFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD- 150 (316)
T ss_pred CcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-
Confidence 99998886532 37788888999999999999996 699999999999999999999999999986422111
Q ss_pred CCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCccccccc
Q 003278 675 GHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVD 754 (834)
Q Consensus 675 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 754 (834)
......+||+.|+|||++.+..++.++|||||||++|||+||+.||....... +.... ... .
T Consensus 151 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~-~~~~~---~~~-~------- 212 (316)
T cd05620 151 ------NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE-LFESI---RVD-T------- 212 (316)
T ss_pred ------CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-HHHHH---HhC-C-------
Confidence 11234679999999999999999999999999999999999999986443221 11111 110 1
Q ss_pred cccCCCCCHHHHHHHHHHHHHhccCCCCCCCChh-HHH
Q 003278 755 LSLNGEYNHKELMRLIKLGIACTLSNPELRPSMR-QIL 791 (834)
Q Consensus 755 ~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~-~v~ 791 (834)
+.+... ...++ ..++.+||+.||++||++. ++.
T Consensus 213 ~~~~~~-~~~~~---~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 213 PHYPRW-ITKES---KDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCCC-CCHHH---HHHHHHHccCCHHHcCCChHHHH
Confidence 111111 12333 4455589999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=323.17 Aligned_cols=257 Identities=19% Similarity=0.204 Sum_probs=195.4
Q ss_pred hhCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCCh--hHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEE
Q 003278 512 TNNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCP--ALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVI 588 (834)
Q Consensus 512 t~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~--~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv 588 (834)
.++|.....||+|+||.||.+.- +.|.++|+|+++.+..- ...+-.+.|=.+|...++|+||+||-.|.+.+.+|||
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 46888899999999999999985 55899999999754321 1223456788999999999999999999999999999
Q ss_pred EeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccc
Q 003278 589 YDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEF 668 (834)
Q Consensus 589 ~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~ 668 (834)
|||++||++..+|...+ .|+......++.+++.|++-||. .|+|||||||+|+|||..|++|++||||+.-
T Consensus 220 MEylPGGD~mTLL~~~~------~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLMRKD------TLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred EEecCCccHHHHHHhcC------cCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccch
Confidence 99999999999997643 47776677789999999999997 6999999999999999999999999999964
Q ss_pred cccCCC-------------------CCccc--c-c------------------CccccccccCccchhccccCCCCccCc
Q 003278 669 LTRNDH-------------------GHRKA--T-S------------------GNRSVRGIFGYMSPEYIESGEATSMAD 708 (834)
Q Consensus 669 ~~~~~~-------------------~~~~~--~-~------------------~~~~~~Gt~~Y~aPE~~~~~~~~~k~D 708 (834)
+..... ..... + . ...+.+|||-|||||++.+..|+..+|
T Consensus 291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD 370 (550)
T KOG0605|consen 291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD 370 (550)
T ss_pred hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc
Confidence 322100 00000 0 0 012357999999999999999999999
Q ss_pred chhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHh-hcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCC-
Q 003278 709 VYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEA-RKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPS- 786 (834)
Q Consensus 709 V~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPt- 786 (834)
.||+|||+|||+.|-.||....|.... ..+..+.. ...|.. .....++.. |+.+|+. ||++|--
T Consensus 371 wWSLG~ImyEmLvGyPPF~s~tp~~T~-rkI~nwr~~l~fP~~---------~~~s~eA~D---LI~rll~-d~~~RLG~ 436 (550)
T KOG0605|consen 371 WWSLGCIMYEMLVGYPPFCSETPQETY-RKIVNWRETLKFPEE---------VDLSDEAKD---LITRLLC-DPENRLGS 436 (550)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhhhccCCCc---------CcccHHHHH---HHHHHhc-CHHHhcCc
Confidence 999999999999999999887776543 22333221 111111 111244444 4447777 9999975
Q ss_pred --hhHHH
Q 003278 787 --MRQIL 791 (834)
Q Consensus 787 --m~~v~ 791 (834)
+.||-
T Consensus 437 ~G~~EIK 443 (550)
T KOG0605|consen 437 KGAEEIK 443 (550)
T ss_pred ccHHHHh
Confidence 44443
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=327.54 Aligned_cols=265 Identities=22% Similarity=0.287 Sum_probs=197.7
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC-hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEc
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG-ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDY 189 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 189 (834)
++|...+.||+|+||.||+|....++..||+|.+.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 46888899999999999999998889999999986432 23345678899999999999999999999999999999999
Q ss_pred cCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhh
Q 003278 190 MPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLE 269 (834)
Q Consensus 190 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~ 269 (834)
++ ++|..++... ...+++.....++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 86 ~~-~~l~~~l~~~------~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 155 (301)
T cd07873 86 LD-KDLKQYLDDC------GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKS 155 (301)
T ss_pred cc-cCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence 97 5888887543 23578899999999999999999985 99999999999999999999999999987432
Q ss_pred hhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHH
Q 003278 270 HELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDW 349 (834)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~ 349 (834)
... .......+|+.|+|||.+.....++.++|||||||++|||+||+.||......+. ...
T Consensus 156 ~~~----------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~---~~~ 216 (301)
T cd07873 156 IPT----------------KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ---LHF 216 (301)
T ss_pred CCC----------------CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHH
Confidence 110 0012234789999999886655678899999999999999999999864332111 111
Q ss_pred HHHHh------------hcCccccccccccCCCC---CCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 350 IRRLS------------DEGKVLQAGDNRLSDGS---YKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 350 ~~~~~------------~~~~~~~~~d~~l~~~~---~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
+.... ..........+...... ....-...+.+|+..|++.||.+||++.++++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 217 IFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred HHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 11110 00000000000000000 000011346789999999999999999999863
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=320.74 Aligned_cols=264 Identities=24% Similarity=0.296 Sum_probs=199.6
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC--hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG--ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYD 188 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 188 (834)
++|+..+.||+|+||.||+|.++.+|+.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888899999999999999998889999999886432 2344668899999999999999999999999999999999
Q ss_pred ccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhh
Q 003278 189 YMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWL 268 (834)
Q Consensus 189 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~ 268 (834)
|+++++|..++... ..++|..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++..+
T Consensus 81 ~~~~~~l~~~~~~~-------~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 150 (286)
T cd07847 81 YCDHTVLNELEKNP-------RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARIL 150 (286)
T ss_pred ccCccHHHHHHhCC-------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceec
Confidence 99999988776432 3589999999999999999999985 9999999999999999999999999999764
Q ss_pred hhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHH
Q 003278 269 EHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLD 348 (834)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~ 348 (834)
..... ......|+..|+|||++.....++.++|||||||++|||+||+.||......+. +..
T Consensus 151 ~~~~~----------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~--~~~ 212 (286)
T cd07847 151 TGPGD----------------DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ--LYL 212 (286)
T ss_pred CCCcc----------------cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH--HHH
Confidence 32110 012334788999999986555678899999999999999999999864332211 111
Q ss_pred HHHHH----------hhcCccc-cccccccCCCCCCHH-----HHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 349 WIRRL----------SDEGKVL-QAGDNRLSDGSYKLC-----DMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 349 ~~~~~----------~~~~~~~-~~~d~~l~~~~~~~~-----~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
..... ....... ....+.. ....+.. ....+.++...||+.+|++||++.+++.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 213 IRKTLGDLIPRHQQIFSTNQFFKGLSIPEP-ETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred HHHHhCCCChHHhhhcccccccccccCCCc-ccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 11100 0000000 0000000 0000100 1245778999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=328.89 Aligned_cols=264 Identities=25% Similarity=0.383 Sum_probs=201.4
Q ss_pred CCCCCCCeeeccCCeEEEEEEECC-------CCeEEEEEEecccC-hhhHHHHHHHHHHHHhC-CCCceeeEeeeEEeCC
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPS-------DGTVVAVKCLAEKG-ERFEKTFAAELVAVAHL-RHRNLVRLRGWCVHED 181 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~-------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~ 181 (834)
.+|...+.||+|+||.||+|.... .+..||+|.+.... ....+.+.+|+.++.++ +||||++++++|...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 458888999999999999997532 23479999886532 33456789999999999 8999999999999999
Q ss_pred EEEEEEEccCCCCHhHHHhcCCCc---------cccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEEC
Q 003278 182 QLLLVYDYMPNRSLDRVLFRRPEN---------LEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLD 252 (834)
Q Consensus 182 ~~~lV~Ey~~~gsL~~~l~~~~~~---------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld 252 (834)
..++||||+++|+|.+++...... ......++|.+++.++.|++.||.|||+. +|+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEc
Confidence 999999999999999999754211 01234589999999999999999999985 999999999999999
Q ss_pred CCCceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-C
Q 003278 253 SQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-G 331 (834)
Q Consensus 253 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G 331 (834)
.++.+||+|||+++.+...... .......++..|+|||.+... .++.++|||||||++|||++ |
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g 233 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYY--------------KKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLG 233 (334)
T ss_pred CCCcEEECCcccceeccccccc--------------ccccCCCcCceEcCHHHhccC-CcCchhhhHHHHHHHHHHHhcC
Confidence 9999999999999754321100 001223356789999988654 57889999999999999999 7
Q ss_pred CccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcCC
Q 003278 332 RRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGSY 409 (834)
Q Consensus 332 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~~ 409 (834)
..|+.... ..++...+. .+...... . .....+..++..||+.+|.+||+|.++++.|....
T Consensus 234 ~~p~~~~~------~~~~~~~~~-~~~~~~~~------~----~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 234 GSPYPGIP------VEELFKLLK-EGHRMDKP------A----NCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred CCCCCCCC------HHHHHHHHH-cCCCCCCC------C----CCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 87775321 122222221 11111110 1 11246789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=321.10 Aligned_cols=264 Identities=23% Similarity=0.322 Sum_probs=196.3
Q ss_pred CCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEc
Q 003278 112 GFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDY 189 (834)
Q Consensus 112 ~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 189 (834)
+|+..+.||+|+||.||+|+...+|..||||.+... .....+.+.+|+.++.+++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 477788999999999999999889999999988543 223346788999999999999999999999999999999999
Q ss_pred cCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhh
Q 003278 190 MPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLE 269 (834)
Q Consensus 190 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~ 269 (834)
++ ++|.+++..... ...+++..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~-~~l~~~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 152 (285)
T cd07861 81 LS-MDLKKYLDSLPK----GQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFG 152 (285)
T ss_pred CC-CCHHHHHhcCCC----CCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecC
Confidence 97 688888754321 24689999999999999999999985 99999999999999999999999999987432
Q ss_pred hhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHH
Q 003278 270 HELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDW 349 (834)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~ 349 (834)
... ...+...|++.|+|||.+.....++.++|||||||+++||+||+.|+....... .+...
T Consensus 153 ~~~----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~--~~~~~ 214 (285)
T cd07861 153 IPV----------------RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID--QLFRI 214 (285)
T ss_pred CCc----------------ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHH
Confidence 110 001223478999999988665567889999999999999999999986432111 11111
Q ss_pred HHHHhhc-----------C----ccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 350 IRRLSDE-----------G----KVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 350 ~~~~~~~-----------~----~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
...+... . .........+... .. .-...+.+++..||+.||.+||++.+|+.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 215 FRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSA-VK-NLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHhCCCChhhhhcchhhHHHHhhccccCcchhHHh-cC-CCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000 0 0000000000000 00 01135678999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=339.61 Aligned_cols=209 Identities=22% Similarity=0.267 Sum_probs=170.2
Q ss_pred CcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCC--ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEe
Q 003278 514 NFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSK--CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYD 590 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~--~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~E 590 (834)
+|...+.||+|+||.||++.. .++..||||.+.... .......+.+|+.+|.+++||||+++++++.+.+.+++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 577788999999999999985 457899999986321 11234568899999999999999999999999999999999
Q ss_pred ccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccc
Q 003278 591 YSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLT 670 (834)
Q Consensus 591 y~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~ 670 (834)
|+++|+|.+++...+ .++......++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+|..+.
T Consensus 82 ~~~~g~L~~~i~~~~------~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~ 152 (376)
T cd05598 82 YIPGGDMMSLLIRLG------IFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 152 (376)
T ss_pred CCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCcccc
Confidence 999999999986532 36677777899999999999996 699999999999999999999999999985321
Q ss_pred cCCCCC--------c----------------------------ccccCccccccccCccchhccccCCCCccCcchhhHH
Q 003278 671 RNDHGH--------R----------------------------KATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGV 714 (834)
Q Consensus 671 ~~~~~~--------~----------------------------~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGv 714 (834)
...... . ........+.||+.|||||++.+..++.++|||||||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 232 (376)
T cd05598 153 WTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 232 (376)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccc
Confidence 000000 0 0000112457999999999999999999999999999
Q ss_pred HHHHHHhCCCccCCCCC
Q 003278 715 VVLEVVTGQMAVDFRLP 731 (834)
Q Consensus 715 vl~E~~tG~~p~~~~~~ 731 (834)
+||||+||+.||....+
T Consensus 233 ilyell~G~~Pf~~~~~ 249 (376)
T cd05598 233 ILYEMLVGQPPFLADTP 249 (376)
T ss_pred eeeehhhCCCCCCCCCH
Confidence 99999999999975543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=314.15 Aligned_cols=250 Identities=28% Similarity=0.410 Sum_probs=200.2
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEc
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDY 189 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 189 (834)
.++|+..+.||+|+||.||+|.. .|+.||||.+..... ..+.+.+|+.++++++|+||+++++++...+..++||||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 35688889999999999999987 478999999876543 467899999999999999999999999999999999999
Q ss_pred cCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhh
Q 003278 190 MPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLE 269 (834)
Q Consensus 190 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~ 269 (834)
+++++|.+++.... ...++|..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus 82 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~ 153 (256)
T cd05039 82 MAKGSLVDYLRSRG-----RAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEAS 153 (256)
T ss_pred cCCCcHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccc
Confidence 99999999986542 23689999999999999999999985 99999999999999999999999999997542
Q ss_pred hhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccchHHH
Q 003278 270 HELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQIILLD 348 (834)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~ 348 (834)
.. .+...++..|+|||++..+ .++.++|||||||+++|+++ |+.|+..... ..+..
T Consensus 154 ~~-------------------~~~~~~~~~~~ape~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~ 210 (256)
T cd05039 154 QG-------------------QDSGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVP 210 (256)
T ss_pred cc-------------------cccCCCcccccCchhhcCC-cCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH---HHHHH
Confidence 11 1122346789999998655 57889999999999999997 9888753211 11111
Q ss_pred HHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhc
Q 003278 349 WIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSG 407 (834)
Q Consensus 349 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~ 407 (834)
....+...... . .....+.+++.+||..+|++||++.++++.|+.
T Consensus 211 ----~~~~~~~~~~~------~----~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 211 ----HVEKGYRMEAP------E----GCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred ----HHhcCCCCCCc------c----CCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 11111111000 0 112467889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=316.39 Aligned_cols=253 Identities=21% Similarity=0.373 Sum_probs=197.7
Q ss_pred hCcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEecc
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYS 592 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~ 592 (834)
++|...++||+|+||.||+|...++..||+|.+...... ...|.+|+.++++++||||+++++++. .+..+++|||+
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS--PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred HHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc--HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 456667889999999999999988899999998754332 357899999999999999999999875 45689999999
Q ss_pred CCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccC
Q 003278 593 ATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRN 672 (834)
Q Consensus 593 ~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~ 672 (834)
++++|.+++..... ..+++..+..++.|++.||+|||+ .+++||||||+||++++++.++++|||++......
T Consensus 83 ~~~~L~~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 83 ENGSLVDFLKTPEG----IKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred CCCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 99999998865321 247899999999999999999996 68999999999999999999999999999765422
Q ss_pred CCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCcccc
Q 003278 673 DHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRPLAE 751 (834)
Q Consensus 673 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
.. .......++..|+|||++..+.++.++|||||||++|||+| |+.|+....... ...... .....
T Consensus 156 ~~------~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~~~---~~~~~--- 222 (260)
T cd05067 156 EY------TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE-VIQNLE---RGYRM--- 222 (260)
T ss_pred Cc------ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH-HHHHHH---cCCCC---
Confidence 11 01122346788999999998999999999999999999999 998886443222 111111 11000
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHcc
Q 003278 752 LVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDG 796 (834)
Q Consensus 752 ~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~ 796 (834)
..... .+. ++.+++.+||..+|++|||++++...|+.
T Consensus 223 ----~~~~~-~~~---~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 ----PRPDN-CPE---ELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ----CCCCC-CCH---HHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 01111 122 45666779999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=327.02 Aligned_cols=267 Identities=22% Similarity=0.312 Sum_probs=198.8
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC--hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG--ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYD 188 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 188 (834)
++|+..+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++.++||||++++++|..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888899999999999999998889999999876432 2345678899999999999999999999999999999999
Q ss_pred ccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhh
Q 003278 189 YMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWL 268 (834)
Q Consensus 189 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~ 268 (834)
|+++++|..+.... ..++|..++.++.|+++||+|||+. +|+||||+|+||++++++.++|+|||++..+
T Consensus 81 ~~~~~~l~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~ 150 (286)
T cd07846 81 FVDHTVLDDLEKYP-------NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL 150 (286)
T ss_pred cCCccHHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeec
Confidence 99999998876432 3489999999999999999999985 9999999999999999999999999998754
Q ss_pred hhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccc-hHH
Q 003278 269 EHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQI-ILL 347 (834)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~-~l~ 347 (834)
.... ...+...|+..|+|||++.....++.++|||||||++|||+||++|+......+.. .+.
T Consensus 151 ~~~~----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~ 214 (286)
T cd07846 151 AAPG----------------EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHII 214 (286)
T ss_pred cCCc----------------cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH
Confidence 2210 01223458899999999875556788999999999999999999888643211100 000
Q ss_pred HHHH-------HHhhcCccc-cccccccCCCC----CCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 348 DWIR-------RLSDEGKVL-QAGDNRLSDGS----YKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 348 ~~~~-------~~~~~~~~~-~~~d~~l~~~~----~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
.+.. ......... ....+...... ........+.+++..||+.+|++||+|.++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 215 KCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0000 000000000 00000000000 00011245889999999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=315.53 Aligned_cols=256 Identities=24% Similarity=0.352 Sum_probs=202.6
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEc
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDY 189 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 189 (834)
.++|+..+.||+|+||.||+|....+++.+|+|.+........+.+.+|+.++++++||||+++++++...+.++++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 35788889999999999999999888999999998765555567899999999999999999999999999999999999
Q ss_pred cCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhh
Q 003278 190 MPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLE 269 (834)
Q Consensus 190 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~ 269 (834)
+++++|..++... ...+++..+..++.|++.||.|||+. +|+|+||||+||++++++.+||+|||++..+.
T Consensus 82 ~~~~~l~~~~~~~------~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~ 152 (262)
T cd06613 82 CGGGSLQDIYQVT------RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLT 152 (262)
T ss_pred CCCCcHHHHHHhh------ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhh
Confidence 9999999988643 14588999999999999999999985 99999999999999999999999999987543
Q ss_pred hhhhhhhhcccccccccccccceeeeccccCCCccccccC--CCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHH
Q 003278 270 HELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKG--SVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILL 347 (834)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~ 347 (834)
.... ......|+..|+|||.+... ..++.++|||||||++|||+||+.|+........ ..
T Consensus 153 ~~~~----------------~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~--~~ 214 (262)
T cd06613 153 ATIA----------------KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA--LF 214 (262)
T ss_pred hhhh----------------ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HH
Confidence 2210 12234588999999987543 2568899999999999999999999864322111 10
Q ss_pred HHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 348 DWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 348 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
. ... ... ..+.+. ........+.+++.+||..+|..||++.+|+.
T Consensus 215 ~----~~~-~~~---~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 215 L----ISK-SNF---PPPKLK---DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred H----HHh-ccC---CCcccc---chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 000 100 001110 11112345789999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=317.43 Aligned_cols=250 Identities=24% Similarity=0.404 Sum_probs=200.5
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC-hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEc
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG-ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDY 189 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 189 (834)
++|+..+.||.|+||.||+|....++..||+|.+.... ......+.+|+.+++.++|+||+++++++.++..+++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 35778889999999999999998899999999986542 33456788999999999999999999999999999999999
Q ss_pred cCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhh
Q 003278 190 MPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLE 269 (834)
Q Consensus 190 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~ 269 (834)
+++++|.+++.. .++++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||+++.+.
T Consensus 81 ~~~~~L~~~~~~--------~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~ 149 (274)
T cd06609 81 CGGGSCLDLLKP--------GKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLT 149 (274)
T ss_pred eCCCcHHHHHhh--------cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeec
Confidence 999999998853 2689999999999999999999985 89999999999999999999999999997653
Q ss_pred hhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHH
Q 003278 270 HELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDW 349 (834)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~ 349 (834)
... .......|++.|+|||++... .++.++|||||||++|||+||+.|+....+.. .
T Consensus 150 ~~~----------------~~~~~~~~~~~y~~PE~~~~~-~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~------~ 206 (274)
T cd06609 150 STM----------------SKRNTFVGTPFWMAPEVIKQS-GYDEKADIWSLGITAIELAKGEPPLSDLHPMR------V 206 (274)
T ss_pred ccc----------------cccccccCCccccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccCchHH------H
Confidence 221 012334688999999998755 47999999999999999999999986432211 1
Q ss_pred HHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 350 IRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 350 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
.... ..+. .+.+....+ ...+.+++..||..+|++||++.+++..
T Consensus 207 ~~~~-~~~~-----~~~~~~~~~----~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 207 LFLI-PKNN-----PPSLEGNKF----SKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred HHHh-hhcC-----CCCCccccc----CHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1111 1111 111111111 1357788999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=326.95 Aligned_cols=256 Identities=18% Similarity=0.317 Sum_probs=196.0
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCc----EEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQ----YVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLV 587 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~----~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~l 587 (834)
++|...+.||+|+||.||+|.. .++. .||+|.+..........+|.+|+.++++++||||++++|+|... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 4567778899999999999985 3443 47889887655444456789999999999999999999999764 4678
Q ss_pred EEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecc
Q 003278 588 IYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAE 667 (834)
Q Consensus 588 v~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~ 667 (834)
++||+++|+|.+++.... ..+++..++.++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++
T Consensus 86 v~e~~~~g~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~ 157 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHK-----DNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (303)
T ss_pred eehhcCCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccc
Confidence 999999999999886532 237888899999999999999996 699999999999999999999999999998
Q ss_pred ccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhc
Q 003278 668 FLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARK 746 (834)
Q Consensus 668 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~ 746 (834)
........ .......++..|||||++.+..++.++|||||||++|||+| |+.|+..... ......+ ...
T Consensus 158 ~~~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~-~~~~~~~----~~~ 227 (303)
T cd05110 158 LLEGDEKE-----YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT-REIPDLL----EKG 227 (303)
T ss_pred cccCcccc-----cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHH----HCC
Confidence 65432110 11122346778999999998899999999999999999998 8888754321 1111111 111
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccC
Q 003278 747 RPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGN 797 (834)
Q Consensus 747 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~ 797 (834)
... . ...... ..+..++..||..+|++||+|.+|++.|+..
T Consensus 228 ~~~---~---~~~~~~----~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 228 ERL---P---QPPICT----IDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred CCC---C---CCCCCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 100 0 001111 2456677799999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=320.37 Aligned_cols=258 Identities=21% Similarity=0.331 Sum_probs=195.9
Q ss_pred CcCcCCcccccCCcEEEEEEEC------CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEE
Q 003278 514 NFSESQRVAEMDFGTAYQGFLD------NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLV 587 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~l 587 (834)
++.-..+||+|+||.||++... ++..+|+|.+... .......|.+|++++++++||||+++++++.+.+..++
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC-CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 4555678999999999999642 3457889987643 33445689999999999999999999999999999999
Q ss_pred EEeccCCCchhhhhhcCCC---------CCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCc
Q 003278 588 IYDYSATRILSHLLFHNNH---------RIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNP 658 (834)
Q Consensus 588 v~Ey~~~g~L~~~l~~~~~---------~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ 658 (834)
+|||+++|+|.+++..... ......++|..++.++.|++.||+|||+ .+|+||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCE
Confidence 9999999999999875421 1112348899999999999999999996 699999999999999999999
Q ss_pred eEeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHH
Q 003278 659 RLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVK 737 (834)
Q Consensus 659 ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~ 737 (834)
||+|||++........ ........+++.|+|||++.+..++.++|||||||++|||+| |..|+....... ...
T Consensus 162 kL~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-~~~ 235 (280)
T cd05092 162 KIGDFGMSRDIYSTDY-----YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE-AIE 235 (280)
T ss_pred EECCCCceeEcCCCce-----eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH-HHH
Confidence 9999999975432211 000112345788999999998999999999999999999999 888875332221 111
Q ss_pred HHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHc
Q 003278 738 RVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795 (834)
Q Consensus 738 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~ 795 (834)
.. .... .. ...... +.. +.+++.+||+.||.+||++.+|.+.|+
T Consensus 236 ~~---~~~~-~~------~~~~~~-~~~---~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 236 CI---TQGR-EL------ERPRTC-PPE---VYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HH---HcCc-cC------CCCCCC-CHH---HHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 11 1111 10 001111 223 445666999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=327.32 Aligned_cols=243 Identities=15% Similarity=0.184 Sum_probs=186.0
Q ss_pred CcccccCCcEEEEEEE-CCCcEEEEEEecCCCC--hhHHHHHHHHHHHHHhc-cCCCceeEEEEEeeCCeEEEEEeccCC
Q 003278 519 QRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKC--PALRTRFSNELQNLARL-RHRNLVQLCGWCTEQGEMLVIYDYSAT 594 (834)
Q Consensus 519 ~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~--~~~~~~f~~E~~~l~~l-~HpNiv~l~g~~~~~~~~~lv~Ey~~~ 594 (834)
+.||+|+||.||+|.. .++..||||.+..... ....+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 3589999999999986 4578899999875422 23345688999999988 699999999999999999999999999
Q ss_pred CchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCCC
Q 003278 595 RILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDH 674 (834)
Q Consensus 595 g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~~ 674 (834)
|+|..++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~~L~~~~~~~~------~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~- 150 (327)
T cd05617 81 GDLMFHMQRQR------KLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG- 150 (327)
T ss_pred CcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-
Confidence 99988876432 38899999999999999999997 699999999999999999999999999987422111
Q ss_pred CCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchh--HHHHHHHHHhhcCccccc
Q 003278 675 GHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGL--LVKRVHEFEARKRPLAEL 752 (834)
Q Consensus 675 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 752 (834)
......+||+.|||||++.+..++.++|||||||+||||+||+.||........ ........... .+.
T Consensus 151 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~--- 220 (327)
T cd05617 151 ------DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE-KPI--- 220 (327)
T ss_pred ------CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh-CCC---
Confidence 112346799999999999999999999999999999999999999964322111 01111111111 111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChh
Q 003278 753 VDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMR 788 (834)
Q Consensus 753 ~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~ 788 (834)
.++...+ .. +..++.+||..||++||++.
T Consensus 221 ---~~p~~~~-~~---~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 221 ---RIPRFLS-VK---ASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred ---CCCCCCC-HH---HHHHHHHHhccCHHHcCCCC
Confidence 1111112 23 34555689999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=317.80 Aligned_cols=253 Identities=27% Similarity=0.393 Sum_probs=196.1
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEcc
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYM 190 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 190 (834)
++|+..+.||+|+||.||+|... ++..||+|.+..... ..+.|.+|+.++++++|+||+++++++. .+..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred HHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 46788899999999999999884 677899999865432 3467999999999999999999999875 45689999999
Q ss_pred CCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhh
Q 003278 191 PNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEH 270 (834)
Q Consensus 191 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~ 270 (834)
++++|.+++.... ...+++.++..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++..+..
T Consensus 83 ~~~~L~~~~~~~~-----~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 83 SKGSLLDFLKDGE-----GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred CCCcHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 9999999986532 24589999999999999999999985 899999999999999999999999999975432
Q ss_pred hhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccchHHHH
Q 003278 271 ELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQIILLDW 349 (834)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~ 349 (834)
... .......|+..|+|||.+... .++.++|||||||++|||+| |+.|+.... ......+
T Consensus 155 ~~~---------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~---~~~~~~~ 215 (260)
T cd05070 155 NEY---------------TARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMN---NREVLEQ 215 (260)
T ss_pred ccc---------------ccccCCCCCccccChHHHhcC-CCcchhhhHHHHHHHHHHHhcCCCCCCCCC---HHHHHHH
Confidence 110 001122356789999987644 67899999999999999999 888885422 1112221
Q ss_pred HHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhc
Q 003278 350 IRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSG 407 (834)
Q Consensus 350 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~ 407 (834)
+.. +... ... . .....+.+++..|+..+|.+||+|.++.+.|+.
T Consensus 216 ---~~~-~~~~-----~~~-~----~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 216 ---VER-GYRM-----PCP-Q----DCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ---HHc-CCCC-----CCC-C----cCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 111 1000 010 1 112468899999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=316.35 Aligned_cols=254 Identities=26% Similarity=0.397 Sum_probs=190.6
Q ss_pred CeeeccCCeEEEEEEECC---CCeEEEEEEeccc-ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEe-CCEEEEEEEccC
Q 003278 117 EVLGSGGFGKVYRAVLPS---DGTVVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNLVRLRGWCVH-EDQLLLVYDYMP 191 (834)
Q Consensus 117 ~~LG~G~fG~Vy~~~~~~---~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-~~~~~lV~Ey~~ 191 (834)
+.||+|+||.||+|.+.. ++..||+|.+... .....+.+.+|+.+++.++||||++++++|.. ++..++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998643 3467999988543 23445678899999999999999999998764 556899999999
Q ss_pred CCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhhh
Q 003278 192 NRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHE 271 (834)
Q Consensus 192 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~~ 271 (834)
+|+|.+++.... ..+++..++.++.|+++||.|||+. +++||||||+|||+++++.+||+|||+++.+...
T Consensus 81 ~~~L~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~ 151 (262)
T cd05058 81 HGDLRNFIRSET------HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDK 151 (262)
T ss_pred CCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCC
Confidence 999999986532 2467788899999999999999985 9999999999999999999999999999754321
Q ss_pred hhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCc-cCCCCCCCccchHHHHH
Q 003278 272 LQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRR-AVDLTYPDDQIILLDWI 350 (834)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~-p~~~~~~~~~~~l~~~~ 350 (834)
... .........+++.|+|||++... .++.++|||||||++|||+||.. |+... ... ...
T Consensus 152 ~~~------------~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~---~~~---~~~ 212 (262)
T cd05058 152 EYY------------SVHNHTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDV---DSF---DIT 212 (262)
T ss_pred cce------------eecccccCcCCccccChhHhccC-ccchHHHHHHHHHHHHHHHcCCCCCCCCC---CHH---HHH
Confidence 100 00011233467889999988654 57899999999999999999654 44321 111 112
Q ss_pred HHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcCC
Q 003278 351 RRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGSY 409 (834)
Q Consensus 351 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~~ 409 (834)
.... .+.... . .. .....+.+++..||+.+|++||++.+|++.|+..+
T Consensus 213 ~~~~-~~~~~~-----~-~~----~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 213 VYLL-QGRRLL-----Q-PE----YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred HHHh-cCCCCC-----C-CC----cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 2111 111100 0 01 11246889999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=343.29 Aligned_cols=262 Identities=17% Similarity=0.222 Sum_probs=185.6
Q ss_pred hhCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeC--------
Q 003278 512 TNNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQ-------- 582 (834)
Q Consensus 512 t~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~-------- 582 (834)
+.+|...+.||+|+||.||+|.. .++..||||++.... ....+|+.+|++++|||||++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 35677888999999999999986 457899999885432 2235699999999999999999876432
Q ss_pred CeEEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCC-CceEe
Q 003278 583 GEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDM-NPRLG 661 (834)
Q Consensus 583 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~-~~ki~ 661 (834)
..+++||||+++ +|..++..... ....+++.....++.|++.||+|||+ .+|+||||||+||||+.++ .+||+
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~--~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~ 213 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYAR--NNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLC 213 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeee
Confidence 246789999986 56555543221 11247888888999999999999997 6899999999999999664 79999
Q ss_pred eeeeccccccCCCCCcccccCccccccccCccchhccccC-CCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHH
Q 003278 662 SFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESG-EATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVH 740 (834)
Q Consensus 662 DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~ 740 (834)
|||+|+.+.... ......||+.|||||++.+. .++.++|||||||+||||+||..||....+...+.....
T Consensus 214 DFGla~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~ 285 (440)
T PTZ00036 214 DFGSAKNLLAGQ--------RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQ 285 (440)
T ss_pred ccccchhccCCC--------CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 999998653221 12245789999999998654 689999999999999999999999876544333222211
Q ss_pred HHHh--------hcCccccccccccC-----CCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 741 EFEA--------RKRPLAELVDLSLN-----GEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 741 ~~~~--------~~~~~~~~~d~~l~-----~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
.... ......++--+... ..++.....++..++.+||..||.+|||+.|+++
T Consensus 286 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 286 VLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 1000 00000000000000 0000001124556667999999999999999874
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=326.84 Aligned_cols=204 Identities=22% Similarity=0.399 Sum_probs=161.8
Q ss_pred CCeeeccCCeEEEEEEECC--CCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEe--CCEEEEEEEccC
Q 003278 116 DEVLGSGGFGKVYRAVLPS--DGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVH--EDQLLLVYDYMP 191 (834)
Q Consensus 116 ~~~LG~G~fG~Vy~~~~~~--~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~lV~Ey~~ 191 (834)
..+||+|+||.||+|.... ++..||+|.+.... ....+.+|+.++++++||||+++++++.. ....++||||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 3689999999999999753 56789999986542 23457889999999999999999999864 457899999987
Q ss_pred CCCHhHHHhcCCC--ccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEE----CCCCceEEeeccch
Q 003278 192 NRSLDRVLFRRPE--NLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVML----DSQYNARLGDFGLA 265 (834)
Q Consensus 192 ~gsL~~~l~~~~~--~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILl----d~~~~~kl~DFGla 265 (834)
+ +|.+++..... .......+++..+..++.|++.||.|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 67666643211 111234689999999999999999999985 99999999999999 45678999999999
Q ss_pred hhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCC
Q 003278 266 RWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLT 338 (834)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~ 338 (834)
+....... .........||+.|+|||.+.....++.++|||||||++|||+||+.||...
T Consensus 160 ~~~~~~~~-------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLK-------------PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcc-------------cccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 86432210 0111234568999999999876556789999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=316.99 Aligned_cols=251 Identities=27% Similarity=0.420 Sum_probs=195.8
Q ss_pred CeeeccCCeEEEEEEECC-CC--eEEEEEEecccCh-hhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEccCC
Q 003278 117 EVLGSGGFGKVYRAVLPS-DG--TVVAVKCLAEKGE-RFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPN 192 (834)
Q Consensus 117 ~~LG~G~fG~Vy~~~~~~-~g--~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 192 (834)
+.||+|+||.||+|.+.. .+ ..||||.+..... ...+.|.+|+.++++++||||+++++++.. +..++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999854 33 3699999876544 566789999999999999999999999988 889999999999
Q ss_pred CCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhhhh
Q 003278 193 RSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHEL 272 (834)
Q Consensus 193 gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~ 272 (834)
|+|.+++..... ..++|.....++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++.+....
T Consensus 80 ~~L~~~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~ 151 (257)
T cd05040 80 GSLLDRLRKDAL-----GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE 151 (257)
T ss_pred CcHHHHHHhccc-----ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccc
Confidence 999999875421 4689999999999999999999985 99999999999999999999999999998653321
Q ss_pred hhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccchHHHHHH
Q 003278 273 QYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQIILLDWIR 351 (834)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~ 351 (834)
.. ........|+..|+|||++... .++.++|||||||++|||+| |+.|+...... +...
T Consensus 152 ~~-------------~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------~~~~ 211 (257)
T cd05040 152 DH-------------YVMEEHLKVPFAWCAPESLRTR-TFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS------QILK 211 (257)
T ss_pred cc-------------eecccCCCCCceecCHHHhccc-CcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH------HHHH
Confidence 00 0011234578899999988654 57889999999999999999 99998532111 1111
Q ss_pred HHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhh
Q 003278 352 RLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVS 406 (834)
Q Consensus 352 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~ 406 (834)
.......... .. . .....+.+++..|++.+|.+||++.+|++.|.
T Consensus 212 ~~~~~~~~~~-----~~-~----~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 212 KIDKEGERLE-----RP-E----ACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHHhcCCcCC-----CC-c----cCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 1111111110 00 1 11246888999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=322.92 Aligned_cols=262 Identities=22% Similarity=0.303 Sum_probs=199.1
Q ss_pred CcCcCCcccccCCcEEEEEEEC-----CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEee--CCeEE
Q 003278 514 NFSESQRVAEMDFGTAYQGFLD-----NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTE--QGEML 586 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~~-----~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~--~~~~~ 586 (834)
.|...+.||+|+||.||+|.+. .+..+|||.+.........+.|.+|++++++++||||+++++++.. ....+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 3455578999999999999864 3578999998765444345789999999999999999999999887 55789
Q ss_pred EEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeec
Q 003278 587 VIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALA 666 (834)
Q Consensus 587 lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla 666 (834)
++|||+++++|.+++..... .++|..+..++.|++.||+|||+ .+|+||||||+||+++.++.+|++|||++
T Consensus 85 lv~e~~~~~~l~~~l~~~~~-----~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 156 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHRD-----QINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLA 156 (284)
T ss_pred EEEecCCCCCHHHHHHhCcc-----ccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccccc
Confidence 99999999999999865432 48899999999999999999996 68999999999999999999999999999
Q ss_pred cccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchh----------HH
Q 003278 667 EFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGL----------LV 736 (834)
Q Consensus 667 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~----------~~ 736 (834)
.......... .......++..|+|||++.+..++.++||||||+++|||+||..|+........ ..
T Consensus 157 ~~~~~~~~~~----~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd05038 157 KVLPEDKDYY----YVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIV 232 (284)
T ss_pred cccccCCcce----eccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccH
Confidence 8754221100 011122455679999999988999999999999999999999988753221110 01
Q ss_pred HHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccC
Q 003278 737 KRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGN 797 (834)
Q Consensus 737 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~ 797 (834)
............. ..... ...++.+++.+||..+|++||||.+|+++|+.+
T Consensus 233 ~~~~~~~~~~~~~------~~~~~----~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 233 TRLLELLKEGERL------PRPPS----CPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHHHcCCcC------CCCcc----CCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1111111100000 00011 113566777899999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=314.44 Aligned_cols=248 Identities=28% Similarity=0.399 Sum_probs=194.8
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEe-CCEEEEEEEc
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVH-EDQLLLVYDY 189 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-~~~~~lV~Ey 189 (834)
++|...+.||+|+||.||+|.. .|..||+|.+... ...+.|.+|+.++++++|+||+++++++.. .+..++||||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 4688889999999999999987 4788999988643 235678999999999999999999998654 4578999999
Q ss_pred cCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhh
Q 003278 190 MPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLE 269 (834)
Q Consensus 190 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~ 269 (834)
+++|+|.+++.... ...++|..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 82 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~ 153 (256)
T cd05082 82 MAKGSLVDYLRSRG-----RSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 153 (256)
T ss_pred CCCCcHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceecc
Confidence 99999999986542 23588999999999999999999985 99999999999999999999999999987432
Q ss_pred hhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccchHHH
Q 003278 270 HELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQIILLD 348 (834)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~ 348 (834)
.. .....++..|+|||++... .++.++|||||||++|||+| |+.|+.... +..
T Consensus 154 ~~-------------------~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~------~~~ 207 (256)
T cd05082 154 ST-------------------QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIP------LKD 207 (256)
T ss_pred cc-------------------CCCCccceeecCHHHHccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCC------HHH
Confidence 11 1223356789999988654 67889999999999999998 888875321 112
Q ss_pred HHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhc
Q 003278 349 WIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSG 407 (834)
Q Consensus 349 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~ 407 (834)
...... .+.... .. . .....+.+++..|++.+|++||++.++++.|..
T Consensus 208 ~~~~~~-~~~~~~-----~~-~----~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 208 VVPRVE-KGYKMD-----AP-D----GCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred HHHHHh-cCCCCC-----CC-C----CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 222211 111110 10 0 112467889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=330.46 Aligned_cols=244 Identities=17% Similarity=0.167 Sum_probs=186.0
Q ss_pred CcccccCCcEEEEEEE-CCCcEEEEEEecCCC--ChhHHHHHHHHHH-HHHhccCCCceeEEEEEeeCCeEEEEEeccCC
Q 003278 519 QRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSK--CPALRTRFSNELQ-NLARLRHRNLVQLCGWCTEQGEMLVIYDYSAT 594 (834)
Q Consensus 519 ~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~--~~~~~~~f~~E~~-~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~~~ 594 (834)
+.||+|+||.||+|.. .+++.+|||.+.... .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 3589999999999985 568899999986432 1222345555654 56789999999999999999999999999999
Q ss_pred CchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCCC
Q 003278 595 RILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDH 674 (834)
Q Consensus 595 g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~~ 674 (834)
|+|..++.... .+++.....++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++.....
T Consensus 81 ~~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-- 149 (325)
T cd05604 81 GELFFHLQRER------SFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-- 149 (325)
T ss_pred CCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC--
Confidence 99988876432 37888888999999999999996 69999999999999999999999999998753211
Q ss_pred CCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCccccccc
Q 003278 675 GHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVD 754 (834)
Q Consensus 675 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 754 (834)
........||+.|||||++.++.++.++|||||||++|||+||+.||....... +..... . ...
T Consensus 150 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~-~~~~~~---~--~~~----- 213 (325)
T cd05604 150 -----SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE-MYDNIL---H--KPL----- 213 (325)
T ss_pred -----CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH-HHHHHH---c--CCc-----
Confidence 111234679999999999999999999999999999999999999986543221 111111 1 110
Q ss_pred cccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHH
Q 003278 755 LSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSIL 794 (834)
Q Consensus 755 ~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L 794 (834)
.+..... . .+..+..+|++.+|.+||++++.++.+
T Consensus 214 -~~~~~~~-~---~~~~ll~~ll~~~p~~R~~~~~~~~~i 248 (325)
T cd05604 214 -VLRPGAS-L---TAWSILEELLEKDRQRRLGAKEDFLEI 248 (325)
T ss_pred -cCCCCCC-H---HHHHHHHHHhccCHHhcCCCCCCHHHH
Confidence 0111111 2 344555689999999999987544433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=332.95 Aligned_cols=262 Identities=25% Similarity=0.268 Sum_probs=194.9
Q ss_pred hcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC--hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeC------
Q 003278 109 GSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG--ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHE------ 180 (834)
Q Consensus 109 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------ 180 (834)
..++|...+.||+|+||.||+|....++..||||++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 3467999999999999999999998899999999986532 22345677899999999999999999988643
Q ss_pred CEEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEe
Q 003278 181 DQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLG 260 (834)
Q Consensus 181 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~ 260 (834)
...++++|++ +++|..++.. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~ 160 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC--------QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRIL 160 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEc
Confidence 3579999987 7899887742 3588999999999999999999985 99999999999999999999999
Q ss_pred eccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCC
Q 003278 261 DFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYP 340 (834)
Q Consensus 261 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~ 340 (834)
|||+++..... .+...||+.|+|||.+.....++.++|||||||++|||++|+.||.....
T Consensus 161 Dfg~~~~~~~~-------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 221 (343)
T cd07878 161 DFGLARQADDE-------------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY 221 (343)
T ss_pred CCccceecCCC-------------------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCH
Confidence 99999753211 23346899999999987655678999999999999999999999864321
Q ss_pred CccchHHHHHHHH-----------hhcC--ccccccccccCCCCCC---HHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 341 DDQIILLDWIRRL-----------SDEG--KVLQAGDNRLSDGSYK---LCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 341 ~~~~~l~~~~~~~-----------~~~~--~~~~~~d~~l~~~~~~---~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
.+ .+..+.... .... ...... +........ ......+.+++..|++.||.+||++.++++.
T Consensus 222 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 222 ID--QLKRIMEVVGTPSPEVLKKISSEHARKYIQSL-PHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HH--HHHHHHHHhCCCCHHHHHhcchhhHHHHhhcc-ccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 11 111111000 0000 000000 000000000 0001246789999999999999999999863
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=322.79 Aligned_cols=249 Identities=20% Similarity=0.313 Sum_probs=196.2
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
..|...+.||+|+||.||+|.. .++..|++|.+....... .+.+.+|+.+++.++||||+++++++......++||||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~-~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch-HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 3566677899999999999985 568899999887554333 36688999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccccc
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTR 671 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~ 671 (834)
+++++|..++... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++.....
T Consensus 99 ~~~~~L~~~~~~~-------~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~ 168 (296)
T cd06654 99 LAGGSLTDVVTET-------CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (296)
T ss_pred cCCCCHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence 9999999988532 36788899999999999999996 6899999999999999999999999999875432
Q ss_pred CCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcccc
Q 003278 672 NDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAE 751 (834)
Q Consensus 672 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
.. .......|++.|+|||++.+..++.++|||||||++|||+||+.||....+...... ......+ .
T Consensus 169 ~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~----~~~~~~~--~ 235 (296)
T cd06654 169 EQ-------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL----IATNGTP--E 235 (296)
T ss_pred cc-------cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHH----HhcCCCC--C
Confidence 21 111234688999999999988899999999999999999999999865443222111 1111110 0
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 752 LVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 752 ~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
+.. .... ...+.+++.+||..+|++|||+.+|++
T Consensus 236 ~~~---~~~~----~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 236 LQN---PEKL----SAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CCC---cccc----CHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 000 0111 123556667999999999999999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=319.62 Aligned_cols=265 Identities=20% Similarity=0.340 Sum_probs=203.6
Q ss_pred hcCCCCCCCeeeccCCeEEEEEEECC----CCeEEEEEEeccc-ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEe-CCE
Q 003278 109 GSNGFDEDEVLGSGGFGKVYRAVLPS----DGTVVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNLVRLRGWCVH-EDQ 182 (834)
Q Consensus 109 ~t~~f~~~~~LG~G~fG~Vy~~~~~~----~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-~~~ 182 (834)
..++|...++||+|+||.||+|.+.. .+..||+|.+... .....+.+.+|+.++++++||||+++++++.. .+.
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 45678889999999999999999864 2688999988654 33445678899999999999999999999876 467
Q ss_pred EEEEEEccCCCCHhHHHhcCCCc-cccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEee
Q 003278 183 LLLVYDYMPNRSLDRVLFRRPEN-LEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGD 261 (834)
Q Consensus 183 ~~lV~Ey~~~gsL~~~l~~~~~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~D 261 (834)
.++++||+++|+|..++...... ......+++.++..++.|++.||+|||+. +++||||||+|||+++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998654211 11125689999999999999999999985 999999999999999999999999
Q ss_pred ccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCC
Q 003278 262 FGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYP 340 (834)
Q Consensus 262 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~ 340 (834)
||+++.+...... .......++..|+|||++... .++.++|||||||++||++| |+.|+....+
T Consensus 161 ~g~~~~~~~~~~~--------------~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 225 (280)
T cd05043 161 NALSRDLFPMDYH--------------CLGDNENRPVKWMALESLVNK-EYSSASDVWSFGVLLWELMTLGQTPYVEIDP 225 (280)
T ss_pred CCCcccccCCceE--------------EeCCCCCcchhccCHHHHhcC-CCCchhhHHHhHHHHHHHhcCCCCCcCcCCH
Confidence 9999854321100 001123467889999988654 57899999999999999999 9998864321
Q ss_pred CccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 341 DDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 341 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
..+..++. . +.... .+ ......+.+++.+||..+|++||++.+|++.|+..
T Consensus 226 ---~~~~~~~~---~-~~~~~--~~--------~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 226 ---FEMAAYLK---D-GYRLA--QP--------INCPDELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred ---HHHHHHHH---c-CCCCC--CC--------CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 12222221 1 11100 00 01124678999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=320.54 Aligned_cols=255 Identities=26% Similarity=0.392 Sum_probs=194.9
Q ss_pred CeeeccCCeEEEEEEECCCC------eEEEEEEecccC-hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEc
Q 003278 117 EVLGSGGFGKVYRAVLPSDG------TVVAVKCLAEKG-ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDY 189 (834)
Q Consensus 117 ~~LG~G~fG~Vy~~~~~~~g------~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 189 (834)
+.||+|+||.||+|.....+ ..||||.+.... ......|.+|+.+++.++||||++++++|...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 46999999999999875433 689999876432 23456789999999999999999999999999999999999
Q ss_pred cCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCC-----ceEEeeccc
Q 003278 190 MPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQY-----NARLGDFGL 264 (834)
Q Consensus 190 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~-----~~kl~DFGl 264 (834)
+++|+|.+++............++|.+++.++.|++.||+|||+. +++|+||||+|||++.+. .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999975432211234589999999999999999999985 899999999999999877 899999999
Q ss_pred hhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCcc
Q 003278 265 ARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQ 343 (834)
Q Consensus 265 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~ 343 (834)
++.+...... .......++..|+|||++..+ .++.++|||||||++|||+| |+.|+.... .
T Consensus 158 ~~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~ellt~g~~p~~~~~---~ 219 (269)
T cd05044 158 ARDIYKSDYY--------------RKEGEGLLPVRWMAPESLLDG-KFTTQSDVWSFGVLMWEILTLGQQPYPALN---N 219 (269)
T ss_pred cccccccccc--------------ccCcccCCCccccCHHHHccC-CcccchhHHHHHHHHHHHHHcCCCCCcccC---H
Confidence 9754321100 001122357889999998765 57999999999999999998 998875321 1
Q ss_pred chHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhh
Q 003278 344 IILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVS 406 (834)
Q Consensus 344 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~ 406 (834)
......+ ..+.... . . ......+.+++.+||+.+|.+||+|.+|.+.|+
T Consensus 220 ~~~~~~~----~~~~~~~-----~--~---~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 220 QEVLQHV----TAGGRLQ-----K--P---ENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred HHHHHHH----hcCCccC-----C--c---ccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 1111111 1111110 0 0 011246789999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=318.82 Aligned_cols=263 Identities=27% Similarity=0.409 Sum_probs=200.8
Q ss_pred CCCCCCeeeccCCeEEEEEEECC----CCeEEEEEEecccChh-hHHHHHHHHHHHHhCCCCceeeEeeeEEe--CCEEE
Q 003278 112 GFDEDEVLGSGGFGKVYRAVLPS----DGTVVAVKCLAEKGER-FEKTFAAELVAVAHLRHRNLVRLRGWCVH--EDQLL 184 (834)
Q Consensus 112 ~f~~~~~LG~G~fG~Vy~~~~~~----~g~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~ 184 (834)
.|...+.||+|+||.||+|.+.. ++..||||.+...... ..+.|.+|+.+++.++||||+++++++.. ....+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 46677899999999999998743 4789999998765443 56789999999999999999999999987 55799
Q ss_pred EEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccc
Q 003278 185 LVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGL 264 (834)
Q Consensus 185 lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGl 264 (834)
+||||+++++|.+++.... ..++|..+..++.|++.||+|||+. +++||||||+|||++.++.++|+|||+
T Consensus 85 lv~e~~~~~~l~~~l~~~~------~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 155 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHR------DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGL 155 (284)
T ss_pred EEEecCCCCCHHHHHHhCc------cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccc
Confidence 9999999999999996542 2589999999999999999999985 999999999999999999999999999
Q ss_pred hhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccc
Q 003278 265 ARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQI 344 (834)
Q Consensus 265 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~ 344 (834)
+......... ........++..|+|||.+... .++.++|||||||+++||+||+.|+.........
T Consensus 156 ~~~~~~~~~~-------------~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~ 221 (284)
T cd05038 156 AKVLPEDKDY-------------YYVKEPGESPIFWYAPECLRTS-KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR 221 (284)
T ss_pred ccccccCCcc-------------eeccCCCCCcccccCcHHHccC-CCCcccchHHHhhhhheeeccCCCcccccchhcc
Confidence 9865321100 0001122356679999988655 6788999999999999999999987543221100
Q ss_pred ---------hHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 345 ---------ILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 345 ---------~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
....+.. ....+.. .. . .......+.+++.+||+.+|.+||+|.+|+++|...
T Consensus 222 ~~~~~~~~~~~~~~~~-~~~~~~~-------~~--~-~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 222 MIGIAQGQMIVTRLLE-LLKEGER-------LP--R-PPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred ccccccccccHHHHHH-HHHcCCc-------CC--C-CccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 0111111 1111110 00 0 011124688999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=319.96 Aligned_cols=239 Identities=21% Similarity=0.338 Sum_probs=182.9
Q ss_pred cccccCCcEEEEEEECC-C-------cEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 520 RVAEMDFGTAYQGFLDN-H-------QYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 520 ~ig~g~~g~vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
.||.|+||.||+|.... + ..|++|.+.... ....+.|.+|+.+++.++|||||++++++...+..++||||
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 58999999999998632 2 247788765332 23346788999999999999999999999998899999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCC--------ceEeee
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMN--------PRLGSF 663 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~--------~ki~Df 663 (834)
+++|+|..++..... .++|..++.++.|++.||+|||+ .+|+||||||+|||++.++. +|++||
T Consensus 81 ~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 81 VKFGSLDTYLKKNKN-----LINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred CCCCcHHHHHhcCCC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEeccc
Confidence 999999999875432 47888999999999999999996 69999999999999988766 488888
Q ss_pred eeccccccCCCCCcccccCccccccccCccchhcccc-CCCCccCcchhhHHHHHHHHhCC-CccCCCCCchhHHHHHHH
Q 003278 664 ALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIES-GEATSMADVYSFGVVVLEVVTGQ-MAVDFRLPEGLLVKRVHE 741 (834)
Q Consensus 664 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~k~DV~SfGvvl~E~~tG~-~p~~~~~~~~~~~~~~~~ 741 (834)
|++..... .....|+..|||||++.+ ..++.++|||||||++|||++|. .|+....+... ..
T Consensus 153 g~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-----~~ 216 (258)
T cd05078 153 GISITVLP-----------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-----LQ 216 (258)
T ss_pred ccccccCC-----------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-----HH
Confidence 88754221 123568889999999976 45799999999999999999995 44432222111 01
Q ss_pred HHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHc
Q 003278 742 FEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795 (834)
Q Consensus 742 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~ 795 (834)
....... ++... ...+.+++.+||+.||++|||+++|++.|+
T Consensus 217 ~~~~~~~--------~~~~~----~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 217 FYEDRHQ--------LPAPK----WTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred HHHcccc--------CCCCC----cHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 1111111 11111 124566777999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=323.15 Aligned_cols=264 Identities=22% Similarity=0.265 Sum_probs=198.1
Q ss_pred CCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC-----hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEE
Q 003278 112 GFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG-----ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLV 186 (834)
Q Consensus 112 ~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 186 (834)
+|+..+.||+|+||.||+|....+|+.||||.+.... ......+..|+.++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 3777889999999999999998889999999986542 22345677899999999999999999999999999999
Q ss_pred EEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchh
Q 003278 187 YDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLAR 266 (834)
Q Consensus 187 ~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~ 266 (834)
|||+ +|+|.+++.... ..++|..+..++.|+++||.|||+. +|+|+||||+|||++.++.+||+|||+++
T Consensus 81 ~e~~-~~~L~~~i~~~~------~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~ 150 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS------IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLAR 150 (298)
T ss_pred Eccc-CCCHHHHHhccC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeee
Confidence 9999 999999986431 3689999999999999999999986 99999999999999999999999999997
Q ss_pred hhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchH
Q 003278 267 WLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIIL 346 (834)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l 346 (834)
...... ...+...+++.|+|||.+.....++.++|||||||++|||++|..++......+ .+
T Consensus 151 ~~~~~~----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~--~~ 212 (298)
T cd07841 151 SFGSPN----------------RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID--QL 212 (298)
T ss_pred eccCCC----------------ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH--HH
Confidence 543210 001223468899999988655567889999999999999999977775432211 11
Q ss_pred HHHHHHHh--------hcCccccccccccCCCCCC-----HHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 347 LDWIRRLS--------DEGKVLQAGDNRLSDGSYK-----LCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 347 ~~~~~~~~--------~~~~~~~~~d~~l~~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
........ .............. ...+ ......+.+++..||+.+|.+||++.+|++.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 213 GKIFEALGTPTEENWPGVTSLPDYVEFKPF-PPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred HHHHHHcCCCchhhhhhccccccccccccc-CCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 01000000 00000000000000 0000 1113467899999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=317.82 Aligned_cols=258 Identities=17% Similarity=0.253 Sum_probs=189.3
Q ss_pred hhCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCC---------hhH----HHHHHHHHHHHHhccCCCceeEEE
Q 003278 512 TNNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKC---------PAL----RTRFSNELQNLARLRHRNLVQLCG 577 (834)
Q Consensus 512 t~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~---------~~~----~~~f~~E~~~l~~l~HpNiv~l~g 577 (834)
-+.|.-...||.|.||.|-+|.. .+++.||||++..... +.. .++..+||.+|++++|||||+|+.
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 36677788899999999999984 5689999999864321 111 257889999999999999999999
Q ss_pred EEeeC--CeEEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCC
Q 003278 578 WCTEQ--GEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPD 655 (834)
Q Consensus 578 ~~~~~--~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~ 655 (834)
+-.+. +.+|||+|||..|.+...= .....|...+..++++++..||+|||. ++||||||||+|+||+++
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p------~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCP------PDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSD 246 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCC------CCcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCC
Confidence 88754 6799999999999885431 111228888889999999999999996 799999999999999999
Q ss_pred CCceEeeeeeccccccCCCCCcccccCccccccccCccchhccccCC---C-CccCcchhhHHHHHHHHhCCCccCCCCC
Q 003278 656 MNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGE---A-TSMADVYSFGVVVLEVVTGQMAVDFRLP 731 (834)
Q Consensus 656 ~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~---~-~~k~DV~SfGvvl~E~~tG~~p~~~~~~ 731 (834)
+++||+|||.+-........... .......||+++||||...++. + +.+.||||+||+||-|+-|+.||.....
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d--~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~ 324 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSD--DQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE 324 (576)
T ss_pred CcEEeeccceeeecccCCccccH--HHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH
Confidence 99999999999765332111111 1112358999999999987743 3 3568999999999999999999964332
Q ss_pred chhHHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHH
Q 003278 732 EGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSIL 794 (834)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L 794 (834)
.... ..+. ..++ .-...++.-..+-.|+++.++.||++|-+..+|....
T Consensus 325 ~~l~-~KIv-----n~pL--------~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 325 LELF-DKIV-----NDPL--------EFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred HHHH-HHHh-----cCcc--------cCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 1111 1110 1111 1111111223344455578889999999999997644
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=315.85 Aligned_cols=252 Identities=25% Similarity=0.378 Sum_probs=192.5
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC-----hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeC--CEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG-----ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHE--DQL 183 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~ 183 (834)
++|+..+.||+|+||.||+|....++..||+|.+.... ....+.+.+|+.++++++||||+++++++.+. +..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 57899999999999999999998889999999875321 22345688999999999999999999988763 578
Q ss_pred EEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeecc
Q 003278 184 LLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFG 263 (834)
Q Consensus 184 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFG 263 (834)
+++|||+++++|.+++... ..+++.....++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 82 ~l~~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg 151 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY-------GALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFG 151 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCC
Confidence 9999999999999998642 3578899999999999999999985 99999999999999999999999999
Q ss_pred chhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCcc
Q 003278 264 LARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQ 343 (834)
Q Consensus 264 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~ 343 (834)
+++.+..... .........|+..|+|||++.. ..++.++|||||||++|||+||+.||......
T Consensus 152 ~~~~~~~~~~-------------~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~-- 215 (266)
T cd06651 152 ASKRLQTICM-------------SGTGIRSVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM-- 215 (266)
T ss_pred Cccccccccc-------------cCCccccCCccccccCHHHhCC-CCCCchhhhHHHHHHHHHHHHCCCCccccchH--
Confidence 9875422100 0001223458999999998864 46789999999999999999999998643111
Q ss_pred chHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 344 IILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 344 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
..+....... ..+.+. ......+..+ +.||..+|++||+|.+|+.
T Consensus 216 ----~~~~~~~~~~-----~~~~~~-----~~~~~~~~~l-i~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 216 ----AAIFKIATQP-----TNPQLP-----SHISEHARDF-LGCIFVEARHRPSAEELLR 260 (266)
T ss_pred ----HHHHHHhcCC-----CCCCCc-----hhcCHHHHHH-HHHhcCChhhCcCHHHHhc
Confidence 1111111111 111111 1111223344 4799999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=315.97 Aligned_cols=238 Identities=24% Similarity=0.365 Sum_probs=184.8
Q ss_pred CcccccCCcEEEEEEECCCc-----------EEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEE
Q 003278 519 QRVAEMDFGTAYQGFLDNHQ-----------YVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLV 587 (834)
Q Consensus 519 ~~ig~g~~g~vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~l 587 (834)
+.||+|+||.||+|...+.. .|++|.+...... ...|.+|+.++++++||||++++|+|.. +..++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l 77 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM 77 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence 35899999999999975433 4777876543322 5679999999999999999999999988 77899
Q ss_pred EEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCC-------CceE
Q 003278 588 IYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDM-------NPRL 660 (834)
Q Consensus 588 v~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~-------~~ki 660 (834)
||||+++|+|..++..... .+++..++.++.|++.||+|||+ .+|+||||||+|||++.++ .+|+
T Consensus 78 v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl 149 (259)
T cd05037 78 VEEYVKFGPLDVFLHREKN-----NVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKL 149 (259)
T ss_pred EEEcCCCCcHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEe
Confidence 9999999999999875432 47888899999999999999996 6999999999999999888 7999
Q ss_pred eeeeeccccccCCCCCcccccCccccccccCccchhccccC--CCCccCcchhhHHHHHHHHhC-CCccCCCCCchhHHH
Q 003278 661 GSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESG--EATSMADVYSFGVVVLEVVTG-QMAVDFRLPEGLLVK 737 (834)
Q Consensus 661 ~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~~~k~DV~SfGvvl~E~~tG-~~p~~~~~~~~~~~~ 737 (834)
+|||++..... .....|+..|+|||++... .++.++|||||||++|||++| ..|+....+...
T Consensus 150 ~Dfg~a~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~--- 215 (259)
T cd05037 150 SDPGIPITVLS-----------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK--- 215 (259)
T ss_pred CCCCccccccc-----------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH---
Confidence 99999975432 1123567789999999876 789999999999999999995 666543322111
Q ss_pred HHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHc
Q 003278 738 RVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795 (834)
Q Consensus 738 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~ 795 (834)
.... .. .. .... ... ..+.+++.+||..+|++|||+.+|++.|+
T Consensus 216 -~~~~-~~-~~--~~~~------~~~---~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 216 -ERFY-QD-QH--RLPM------PDC---AELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -HHHH-hc-CC--CCCC------CCc---hHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0001 10 00 0000 011 35666777999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=333.24 Aligned_cols=265 Identities=23% Similarity=0.244 Sum_probs=194.3
Q ss_pred hcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCC-----
Q 003278 109 GSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHED----- 181 (834)
Q Consensus 109 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~----- 181 (834)
..++|...+.||+|+||.||++....+++.||||.+... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 346799999999999999999999888999999998643 2334567889999999999999999999886543
Q ss_pred -EEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEe
Q 003278 182 -QLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLG 260 (834)
Q Consensus 182 -~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~ 260 (834)
..++||||+++ +|...+. ..+++..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~---------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~ 161 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ---------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL 161 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh---------hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEe
Confidence 57999999975 5666553 2478889999999999999999985 99999999999999999999999
Q ss_pred eccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCC
Q 003278 261 DFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYP 340 (834)
Q Consensus 261 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~ 340 (834)
|||+++...... ......||+.|+|||.+... .++.++|||||||++|||++|+.||.....
T Consensus 162 Dfg~~~~~~~~~-----------------~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~ 223 (355)
T cd07874 162 DFGLARTAGTSF-----------------MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDY 223 (355)
T ss_pred eCcccccCCCcc-----------------ccCCccccCCccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999997532110 12334689999999988644 678999999999999999999999864321
Q ss_pred Cccch-HH---------------HHHHHHhhc-Ccccccccccc-CC------CCCCHHHHHHHHHHHHHhcccCCCCCC
Q 003278 341 DDQII-LL---------------DWIRRLSDE-GKVLQAGDNRL-SD------GSYKLCDMEHLTHLALLCTLHNPHLRP 396 (834)
Q Consensus 341 ~~~~~-l~---------------~~~~~~~~~-~~~~~~~d~~l-~~------~~~~~~~~~~l~~l~~~Cl~~~p~~RP 396 (834)
.+... .. ..+...... ........+.. .+ ..........+.+++..|++.||++||
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rp 303 (355)
T cd07874 224 IDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 303 (355)
T ss_pred HHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcC
Confidence 11000 00 000000000 00000000000 00 000111124578999999999999999
Q ss_pred chhhHHHH
Q 003278 397 SMKWVIEA 404 (834)
Q Consensus 397 sm~~V~~~ 404 (834)
|+.|+++.
T Consensus 304 s~~ell~h 311 (355)
T cd07874 304 SVDEALQH 311 (355)
T ss_pred CHHHHhcC
Confidence 99999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=319.05 Aligned_cols=261 Identities=23% Similarity=0.378 Sum_probs=202.7
Q ss_pred cHHHHHhhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhC-CCCceeeEeeeEEe-
Q 003278 102 SYAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHL-RHRNLVRLRGWCVH- 179 (834)
Q Consensus 102 ~~~el~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~- 179 (834)
++.++..+.+.|+..+.||+|+||.||+|.+..+++.||+|.+.... .....+..|+.++.++ +||||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 55666667788999999999999999999998899999999886542 3345688899999998 79999999999863
Q ss_pred -----CCEEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCC
Q 003278 180 -----EDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQ 254 (834)
Q Consensus 180 -----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~ 254 (834)
.+..++||||+++|+|.+++.... ...+++..+..++.|+++||.|||+. +|+||||||+||+++.+
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~ 157 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK-----GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTEN 157 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHcc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCC
Confidence 457899999999999999986532 23578888999999999999999986 99999999999999999
Q ss_pred CceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCcccccc----CCCCCcccceeehhhHHHHHHh
Q 003278 255 YNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQK----GSVATAKSDVFSFGIVVLEVVS 330 (834)
Q Consensus 255 ~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~----~~~~~~ksDV~SfGvvl~Ellt 330 (834)
+.++|+|||+++...... .......|++.|+|||.+.. ...++.++|||||||++|||+|
T Consensus 158 ~~~~l~dfg~~~~~~~~~----------------~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~ 221 (282)
T cd06636 158 AEVKLVDFGVSAQLDRTV----------------GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAE 221 (282)
T ss_pred CCEEEeeCcchhhhhccc----------------cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHh
Confidence 999999999987542110 01233568999999998752 2356789999999999999999
Q ss_pred CCccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 331 GRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 331 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
|+.||....+..... . +.....+.+....++ ..+.+++..||+.||.+||++.++++
T Consensus 222 g~~p~~~~~~~~~~~------~------~~~~~~~~~~~~~~~----~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 222 GAPPLCDMHPMRALF------L------IPRNPPPKLKSKKWS----KKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred CCCCccccCHHhhhh------h------HhhCCCCCCcccccC----HHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 999985432111100 0 000111111111122 35788999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=313.84 Aligned_cols=247 Identities=21% Similarity=0.320 Sum_probs=192.0
Q ss_pred CcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEe-eCCeEEEEEecc
Q 003278 514 NFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCT-EQGEMLVIYDYS 592 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~-~~~~~~lv~Ey~ 592 (834)
+|...+.||+|+||.||+|... +..||+|.+.... ..+.|.+|+.++++++||||++++|++. +....+++|||+
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 7 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred hCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc---hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 5666788999999999999875 5678999876432 2457899999999999999999999765 456789999999
Q ss_pred CCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccC
Q 003278 593 ATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRN 672 (834)
Q Consensus 593 ~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~ 672 (834)
++++|.+++..... ..++|..++.++.|++.||+|||+ .+|+||||||+||++++++.+|++|||++......
T Consensus 83 ~~~~L~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 83 AKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred CCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 99999999865432 247899999999999999999996 68999999999999999999999999998753221
Q ss_pred CCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCcccc
Q 003278 673 DHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRPLAE 751 (834)
Q Consensus 673 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
.....++..|||||++.+..++.++|||||||++|||+| |+.|+....... ....+ ..... ..
T Consensus 156 ----------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~-~~~~~---~~~~~--~~ 219 (256)
T cd05082 156 ----------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-VVPRV---EKGYK--MD 219 (256)
T ss_pred ----------CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHH---hcCCC--CC
Confidence 112345678999999998899999999999999999998 888875332211 11111 11100 01
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHcc
Q 003278 752 LVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDG 796 (834)
Q Consensus 752 ~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~ 796 (834)
.. ...+. .+..++.+||..+|++|||+.++++.|+.
T Consensus 220 -----~~-~~~~~---~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 220 -----AP-DGCPP---VVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred -----CC-CCCCH---HHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 11 11122 34556679999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=319.14 Aligned_cols=254 Identities=31% Similarity=0.472 Sum_probs=198.1
Q ss_pred CCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhH--HHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEcc
Q 003278 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFE--KTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYM 190 (834)
Q Consensus 113 f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~--~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 190 (834)
|+..+.||+|+||.||++....++..||+|++........ ....+|+.++.+++||||+++++++...+..++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 3456799999999999999999999999999876543322 23456999999999999999999999999999999999
Q ss_pred CCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhh
Q 003278 191 PNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEH 270 (834)
Q Consensus 191 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~ 270 (834)
++++|.+++.. ...+++..+..++.|+++||.|||+. +|+||||||+|||+++++.++|+|||++.....
T Consensus 81 ~~~~L~~~l~~-------~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~ 150 (260)
T PF00069_consen 81 PGGSLQDYLQK-------NKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSE 150 (260)
T ss_dssp TTEBHHHHHHH-------HSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTS
T ss_pred ccccccccccc-------cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc
Confidence 99999999972 24679999999999999999999996 999999999999999999999999999864310
Q ss_pred hhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHHH
Q 003278 271 ELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWI 350 (834)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~ 350 (834)
. ........||..|+|||.+..+...+.++||||+|+++++|++|+.|+......+.... .
T Consensus 151 ~----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~---~ 211 (260)
T PF00069_consen 151 N----------------NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEI---I 211 (260)
T ss_dssp T----------------TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHH---H
T ss_pred c----------------ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhh---h
Confidence 0 01134456899999999987455789999999999999999999999875411111111 1
Q ss_pred HHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 351 RRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 351 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
..... ..... ... ........+.++...||+.||++||++.++++
T Consensus 212 ~~~~~-~~~~~---~~~----~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 212 EKILK-RPLPS---SSQ----QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHHH-THHHH---HTT----SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred hhccc-ccccc---ccc----ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11110 00000 000 00001257899999999999999999999986
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=323.30 Aligned_cols=257 Identities=26% Similarity=0.412 Sum_probs=197.7
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCe----EEEEEEecccC-hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGT----VVAVKCLAEKG-ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLL 184 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~----~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 184 (834)
.++|+..+.||+|+||.||+|.+..+|. .||+|.+.... ......+.+|+.+++.++||||++++|+|... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 3567888999999999999999876765 57889876542 23345788999999999999999999999764 467
Q ss_pred EEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccc
Q 003278 185 LVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGL 264 (834)
Q Consensus 185 lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGl 264 (834)
+|+||+++|+|.+++.... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 85 ~v~e~~~~g~l~~~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~ 155 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHK------DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGL 155 (303)
T ss_pred eeehhcCCCCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccc
Confidence 9999999999999986532 3578999999999999999999985 999999999999999999999999999
Q ss_pred hhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCcc
Q 003278 265 ARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQ 343 (834)
Q Consensus 265 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~ 343 (834)
++.+...... .......++..|+|||++... .++.++|||||||++|||+| |+.|+.... .
T Consensus 156 ~~~~~~~~~~--------------~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~el~t~g~~p~~~~~---~ 217 (303)
T cd05110 156 ARLLEGDEKE--------------YNADGGKMPIKWMALECIHYR-KFTHQSDVWSYGVTIWELMTFGGKPYDGIP---T 217 (303)
T ss_pred cccccCcccc--------------cccCCCccccccCCHHHhccC-CCChHHHHHHHHHHHHHHHhCCCCCCCCCC---H
Confidence 9865321100 001223467889999988644 67899999999999999998 888875421 1
Q ss_pred chHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 344 IILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 344 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
..+..++ ..+.... .+ ... ...+..++..||..+|+.||+|.++++.|...
T Consensus 218 ~~~~~~~----~~~~~~~--~~----~~~----~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 218 REIPDLL----EKGERLP--QP----PIC----TIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred HHHHHHH----HCCCCCC--CC----CCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1122221 1111110 00 111 23578899999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=318.55 Aligned_cols=251 Identities=17% Similarity=0.245 Sum_probs=192.1
Q ss_pred cCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCC--hhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 515 FSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKC--PALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 515 f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~--~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
|...+.||+|+||.||++.. .+++.||||.+..... ......+.+|+.++++++|+||+++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 55667899999999999986 4578999998864322 22235678899999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccccc
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTR 671 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~ 671 (834)
+++++|..++..... ..+++..+..++.|++.||.|||+ .+|+||||||+||++++++.++|+|||++.....
T Consensus 82 ~~g~~L~~~l~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05630 82 MNGGDLKFHIYHMGE----AGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 154 (285)
T ss_pred cCCCcHHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCC
Confidence 999999988864321 247888899999999999999996 6999999999999999999999999999875432
Q ss_pred CCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcccc
Q 003278 672 NDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAE 751 (834)
Q Consensus 672 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
.. ......||..|||||++.+..++.++|||||||++|||++|+.||........ .......... ...
T Consensus 155 ~~--------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~-~~~~~~~~~~---~~~ 222 (285)
T cd05630 155 GQ--------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-REEVERLVKE---VQE 222 (285)
T ss_pred Cc--------cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch-HHHHHhhhhh---hhh
Confidence 21 11234689999999999999999999999999999999999999864322110 0111111000 000
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCC-----hhHHHH
Q 003278 752 LVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPS-----MRQILS 792 (834)
Q Consensus 752 ~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPt-----m~~v~~ 792 (834)
.....+. .+ +..++.+||+.||++||| +.++++
T Consensus 223 ----~~~~~~~-~~---~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 223 ----EYSEKFS-PD---ARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred ----hcCccCC-HH---HHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 0111122 23 345556899999999999 667764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=311.48 Aligned_cols=254 Identities=24% Similarity=0.367 Sum_probs=199.0
Q ss_pred CcccccCCcEEEEEEECC----CcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEeccCC
Q 003278 519 QRVAEMDFGTAYQGFLDN----HQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSAT 594 (834)
Q Consensus 519 ~~ig~g~~g~vy~~~~~~----~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~~~ 594 (834)
+.||+|+||.||+|.... +..|++|.+.........+.+.+|+.++.+++||||+++++++.+....++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 368999999999999754 7789999987665544567899999999999999999999999999999999999999
Q ss_pred CchhhhhhcCCCC---CCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccccc
Q 003278 595 RILSHLLFHNNHR---IGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTR 671 (834)
Q Consensus 595 g~L~~~l~~~~~~---~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~ 671 (834)
++|.+++...... .....+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+|++|||++.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999998764211 001358999999999999999999996 7999999999999999999999999999987543
Q ss_pred CCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCccc
Q 003278 672 NDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRPLA 750 (834)
Q Consensus 672 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (834)
... ........++..|+|||.+....++.++|||||||++|||++ |..|+....+ ..+...... ...
T Consensus 158 ~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-~~~~~~~~~---~~~--- 225 (262)
T cd00192 158 DDY-----YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-EEVLEYLRK---GYR--- 225 (262)
T ss_pred ccc-----cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH-HHHHHHHHc---CCC---
Confidence 321 011223567889999999998899999999999999999999 5888865422 222221111 000
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHc
Q 003278 751 ELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795 (834)
Q Consensus 751 ~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~ 795 (834)
....... + .++..++.+||..+|++|||+.++++.|+
T Consensus 226 ----~~~~~~~-~---~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 ----LPKPEYC-P---DELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ----CCCCccC-C---hHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0011111 2 24556666899999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=312.46 Aligned_cols=250 Identities=20% Similarity=0.335 Sum_probs=195.1
Q ss_pred CcccccCCcEEEEEEECCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEeccCCCchh
Q 003278 519 QRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRILS 598 (834)
Q Consensus 519 ~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~~~g~L~ 598 (834)
++||+|+||.||++...++..|++|.+...........|.+|++++++++||||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 36899999999999987789999999876555545678999999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCCCCCcc
Q 003278 599 HLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRK 678 (834)
Q Consensus 599 ~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~~~~~~ 678 (834)
+++..... .+++...+.++.+++.||+|||+ .+++||||||+|||++.++.+||+|||++........
T Consensus 81 ~~l~~~~~-----~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~---- 148 (251)
T cd05041 81 TFLRKKKN-----RLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIY---- 148 (251)
T ss_pred HHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcc----
Confidence 99865322 37788889999999999999996 6899999999999999999999999999975432111
Q ss_pred cccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCcccccccccc
Q 003278 679 ATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSL 757 (834)
Q Consensus 679 ~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 757 (834)
........++..|+|||++.++.++.++|||||||++|||+| |..|+....+. ....... ... ... .
T Consensus 149 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~-~~~~~~~---~~~----~~~---~ 216 (251)
T cd05041 149 -TVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ-QTRERIE---SGY----RMP---A 216 (251)
T ss_pred -eeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH-HHHHHHh---cCC----CCC---C
Confidence 001112234667999999998899999999999999999999 77776543221 1111110 000 000 0
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHcc
Q 003278 758 NGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDG 796 (834)
Q Consensus 758 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~ 796 (834)
....+ ..+.+++.+||..+|++|||+.+|++.|++
T Consensus 217 -~~~~~---~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 217 -PQLCP---EEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred -CccCC---HHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 01111 245667779999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=317.30 Aligned_cols=248 Identities=23% Similarity=0.379 Sum_probs=198.9
Q ss_pred CCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC-hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEcc
Q 003278 112 GFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG-ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYM 190 (834)
Q Consensus 112 ~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 190 (834)
.|+..+.||+|+||.||+|.+..++..||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 3667789999999999999998889999999986432 345577899999999999999999999999999999999999
Q ss_pred CCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhh
Q 003278 191 PNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEH 270 (834)
Q Consensus 191 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~ 270 (834)
++|+|.+++.. .++++.+...++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++..+..
T Consensus 85 ~~~~L~~~i~~--------~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06640 85 GGGSALDLLRA--------GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred CCCcHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence 99999998853 3578889999999999999999985 999999999999999999999999999975432
Q ss_pred hhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHHH
Q 003278 271 ELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWI 350 (834)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~ 350 (834)
.. .......||..|+|||++... ..+.++|||||||++|||+||+.|+....+... .
T Consensus 154 ~~----------------~~~~~~~~~~~y~apE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~------~ 210 (277)
T cd06640 154 TQ----------------IKRNTFVGTPFWMAPEVIQQS-AYDSKADIWSLGITAIELAKGEPPNSDMHPMRV------L 210 (277)
T ss_pred Cc----------------cccccccCcccccCHhHhccC-CCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH------h
Confidence 11 012234588999999988654 578999999999999999999999864322110 0
Q ss_pred HHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 351 RRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 351 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
... ..+. .+ .........+.+++..||+.+|++||++.+++..
T Consensus 211 ~~~-~~~~-----~~-----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 211 FLI-PKNN-----PP-----TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred hhh-hcCC-----CC-----CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 000 0000 01 1112233567899999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=313.69 Aligned_cols=254 Identities=22% Similarity=0.297 Sum_probs=196.4
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCCh----hHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCP----ALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLV 587 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~----~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~l 587 (834)
++|...+.||+|+||.||+|.. .++..||+|.+...... ...+.+.+|++++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5788889999999999999985 46889999987643221 123578899999999999999999999999999999
Q ss_pred EEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecc
Q 003278 588 IYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAE 667 (834)
Q Consensus 588 v~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~ 667 (834)
|+||+++++|.+++.... .+++.....++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++
T Consensus 82 v~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~ 152 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG------ALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASK 152 (263)
T ss_pred EEEECCCCcHHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccce
Confidence 999999999999886432 37788888999999999999996 699999999999999999999999999987
Q ss_pred ccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcC
Q 003278 668 FLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKR 747 (834)
Q Consensus 668 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
....... .........|+..|+|||++.+..++.++|||||||++|||+||+.|+......... ..... .
T Consensus 153 ~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~----~~~~~--~ 222 (263)
T cd06625 153 RLQTICS----SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI----FKIAT--Q 222 (263)
T ss_pred ecccccc----ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH----HHHhc--c
Confidence 5432111 011112356888999999999988999999999999999999999998643221111 11100 0
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHH
Q 003278 748 PLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSI 793 (834)
Q Consensus 748 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~ 793 (834)
.. .+.+....+ . .+..++.+||..+|.+|||+.++++.
T Consensus 223 ~~----~~~~~~~~~-~---~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 223 PT----NPQLPSHVS-P---DARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CC----CCCCCccCC-H---HHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 00 011111122 2 34455568999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=326.08 Aligned_cols=251 Identities=23% Similarity=0.341 Sum_probs=199.3
Q ss_pred cCCcccccCCcEEEEEEECCC-----cEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 517 ESQRVAEMDFGTAYQGFLDNH-----QYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 517 ~~~~ig~g~~g~vy~~~~~~~-----~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
..+.||+|-||.||+|.+.+. ..||||..+.+..++.++.|..|+-+|++++|||||+|+|.|.+. ..+||||.
T Consensus 393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmEL 471 (974)
T KOG4257|consen 393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVMEL 471 (974)
T ss_pred HHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEec
Confidence 356799999999999997442 358999998888888889999999999999999999999999874 68999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccccc
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTR 671 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~ 671 (834)
++-|-|..||..+.. .|+....+.++.||+.||+|||+ ...|||||..+|||+...--+|++||||++.+..
T Consensus 472 ~~~GELr~yLq~nk~-----sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 472 APLGELREYLQQNKD-----SLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSRYLED 543 (974)
T ss_pred ccchhHHHHHHhccc-----cchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhhhccc
Confidence 999999999987643 37777778899999999999996 7899999999999999999999999999999876
Q ss_pred CCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCccc
Q 003278 672 NDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRPLA 750 (834)
Q Consensus 672 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (834)
..... ++ ...=...|||||.+.-..+|.+||||-|||++||+++ |..||..-...+ ++-.+ +.+++.
T Consensus 544 ~~yYk--aS----~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD-VI~~i---EnGeRl-- 611 (974)
T KOG4257|consen 544 DAYYK--AS----RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD-VIGHI---ENGERL-- 611 (974)
T ss_pred cchhh--cc----ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc-eEEEe---cCCCCC--
Confidence 54322 11 1122356999999999999999999999999999886 888885322211 11111 111111
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccC
Q 003278 751 ELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGN 797 (834)
Q Consensus 751 ~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~ 797 (834)
...+.++ ..+..||.+||+.+|.+||+|.+|...|+.+
T Consensus 612 ------P~P~nCP---p~LYslmskcWayeP~kRPrftei~~~lsdv 649 (974)
T KOG4257|consen 612 ------PCPPNCP---PALYSLMSKCWAYEPSKRPRFTEIKAILSDV 649 (974)
T ss_pred ------CCCCCCC---hHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence 0112223 3455777899999999999999999888654
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=328.53 Aligned_cols=262 Identities=22% Similarity=0.294 Sum_probs=199.6
Q ss_pred CcCcCCcccccCCcEEEEEEEC--------CCcEEEEEEecCCCChhHHHHHHHHHHHHHhc-cCCCceeEEEEEeeCCe
Q 003278 514 NFSESQRVAEMDFGTAYQGFLD--------NHQYVLVKRLGMSKCPALRTRFSNELQNLARL-RHRNLVQLCGWCTEQGE 584 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~~--------~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l-~HpNiv~l~g~~~~~~~ 584 (834)
.|...+.||+|+||.||++... ....||+|.+.........+.|.+|++++.++ +||||++++++|.+.+.
T Consensus 13 ~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 92 (334)
T cd05100 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 92 (334)
T ss_pred HeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCc
Confidence 4566788999999999999742 12368999887554444567899999999999 89999999999999999
Q ss_pred EEEEEeccCCCchhhhhhcCCC----------CCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecC
Q 003278 585 MLVIYDYSATRILSHLLFHNNH----------RIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDP 654 (834)
Q Consensus 585 ~~lv~Ey~~~g~L~~~l~~~~~----------~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~ 654 (834)
.+++|||+++|+|.+++..... ......++|..++.++.|++.||+|||+ .+|+||||||+|||+++
T Consensus 93 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nill~~ 169 (334)
T cd05100 93 LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLVTE 169 (334)
T ss_pred eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcC
Confidence 9999999999999999875321 0122358899999999999999999996 69999999999999999
Q ss_pred CCCceEeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCch
Q 003278 655 DMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEG 733 (834)
Q Consensus 655 ~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~ 733 (834)
++.+||+|||+++....... ........++..|||||++.+..++.++|||||||++|||++ |..|+......
T Consensus 170 ~~~~kL~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~- 243 (334)
T cd05100 170 DNVMKIADFGLARDVHNIDY-----YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE- 243 (334)
T ss_pred CCcEEECCcccceecccccc-----cccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence 99999999999976532211 011112345678999999999999999999999999999999 77777533221
Q ss_pred hHHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCC
Q 003278 734 LLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGND 798 (834)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~ 798 (834)
.....+. ..... . ..... ...+.+++.+||+.+|++||||.+|++.|+.+.
T Consensus 244 ~~~~~~~---~~~~~--~-----~~~~~----~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 244 ELFKLLK---EGHRM--D-----KPANC----THELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred HHHHHHH---cCCCC--C-----CCCCC----CHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 1111111 10000 0 11111 124556777999999999999999999997665
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=334.05 Aligned_cols=210 Identities=16% Similarity=0.170 Sum_probs=174.1
Q ss_pred HHHHHHHhhCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCC--ChhHHHHHHHHHHHHHhccCCCceeEEEEEee
Q 003278 505 FKEIISATNNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSK--CPALRTRFSNELQNLARLRHRNLVQLCGWCTE 581 (834)
Q Consensus 505 ~~el~~at~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~ 581 (834)
+.++....++|...+.||+|+||.||++... ++..+|+|.+.... .......+.+|+.+++.++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4445555688999999999999999999965 57889999885321 12233567899999999999999999999999
Q ss_pred CCeEEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEe
Q 003278 582 QGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLG 661 (834)
Q Consensus 582 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~ 661 (834)
.+..++||||+++|+|.+++... .++...+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~ 184 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY-------DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLA 184 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEE
Confidence 99999999999999999988542 25667777899999999999996 699999999999999999999999
Q ss_pred eeeeccccccCCCCCcccccCccccccccCccchhccccC----CCCccCcchhhHHHHHHHHhCCCccCCCC
Q 003278 662 SFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESG----EATSMADVYSFGVVVLEVVTGQMAVDFRL 730 (834)
Q Consensus 662 DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~----~~~~k~DV~SfGvvl~E~~tG~~p~~~~~ 730 (834)
|||+++.+..... .......||+.|||||++... .++.++|||||||++|||+||+.||....
T Consensus 185 DfG~a~~~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 251 (371)
T cd05622 185 DFGTCMKMNKEGM------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251 (371)
T ss_pred eCCceeEcCcCCc------ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC
Confidence 9999976532211 112346799999999998653 37899999999999999999999997543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=313.82 Aligned_cols=265 Identities=22% Similarity=0.237 Sum_probs=203.5
Q ss_pred hcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccCh---hhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEE
Q 003278 109 GSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGE---RFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLL 185 (834)
Q Consensus 109 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 185 (834)
.-+.|+..+.||.|.-|+||++.+..++..+|+|++.+..- ....+.+.|-+||+.++||.+++||+.+..++..||
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl 154 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCL 154 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEE
Confidence 34568888999999999999999998899999999976532 233456779999999999999999999999999999
Q ss_pred EEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccch
Q 003278 186 VYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLA 265 (834)
Q Consensus 186 V~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla 265 (834)
|||||+||+|..++++++. ..++...+..++.+|+-||+|||-. |||.|||||+||||-++|++.|+||-|+
T Consensus 155 ~meyCpGGdL~~LrqkQp~-----~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS 226 (459)
T KOG0610|consen 155 VMEYCPGGDLHSLRQKQPG-----KRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLS 226 (459)
T ss_pred EEecCCCccHHHHHhhCCC-----CccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeecccc
Confidence 9999999999999887653 5789999999999999999999986 9999999999999999999999999998
Q ss_pred hhhhhhhhhhh-----------------------h-cccccc----------------cccccccceeeeccccCCCccc
Q 003278 266 RWLEHELQYQM-----------------------R-TSSARN----------------HQFHLAETTRIGGTIGYLPPES 305 (834)
Q Consensus 266 ~~~~~~~~~~~-----------------------~-~~~~~~----------------~~~~~~~~~~~~Gt~~Y~aPE~ 305 (834)
.......+... + ...... .......+..++||-.|+|||+
T Consensus 227 ~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEv 306 (459)
T KOG0610|consen 227 LRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEV 306 (459)
T ss_pred ccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccccee
Confidence 76422111100 0 000000 0111133457889999999999
Q ss_pred cccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHH
Q 003278 306 FQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLAL 385 (834)
Q Consensus 306 ~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~ 385 (834)
+... -.+..+|+|+|||+||||+.|+.||...... ..+.+. +-..+.-.... .....+.+|+.
T Consensus 307 I~G~-GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~--~Tl~NI-------------v~~~l~Fp~~~-~vs~~akDLIr 369 (459)
T KOG0610|consen 307 IRGE-GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNK--ETLRNI-------------VGQPLKFPEEP-EVSSAAKDLIR 369 (459)
T ss_pred eecC-CCCchhhHHHHHHHHHHHHhCCCCcCCCCch--hhHHHH-------------hcCCCcCCCCC-cchhHHHHHHH
Confidence 9754 5788999999999999999999999764332 222221 11111111111 22345778888
Q ss_pred HhcccCCCCCCch
Q 003278 386 LCTLHNPHLRPSM 398 (834)
Q Consensus 386 ~Cl~~~p~~RPsm 398 (834)
.-|..||.+|-..
T Consensus 370 ~LLvKdP~kRlg~ 382 (459)
T KOG0610|consen 370 KLLVKDPSKRLGS 382 (459)
T ss_pred HHhccChhhhhcc
Confidence 9999999999873
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=331.64 Aligned_cols=258 Identities=17% Similarity=0.233 Sum_probs=191.1
Q ss_pred CcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCC-ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCC-----eEE
Q 003278 514 NFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSK-CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQG-----EML 586 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~-~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~-----~~~ 586 (834)
+|+..+.||+|+||.||++.. .++..||||.+.... .....+++.+|+.+|+.++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477788999999999999985 568899999886432 2233467889999999999999999999998766 789
Q ss_pred EEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeec
Q 003278 587 VIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALA 666 (834)
Q Consensus 587 lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla 666 (834)
+||||+. ++|..++... ..+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 81 lv~e~~~-~~l~~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a 150 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP------QPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLA 150 (372)
T ss_pred EEeeccc-cCHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccce
Confidence 9999997 4676666432 247888899999999999999996 68999999999999999999999999999
Q ss_pred cccccCCCCCcccccCccccccccCccchhccccC-CCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHh-
Q 003278 667 EFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESG-EATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEA- 744 (834)
Q Consensus 667 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~- 744 (834)
+....... .......||+.|+|||++.+. .++.++|||||||++|||+||+.||....+...+ ..+.....
T Consensus 151 ~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~i~~~~g~ 223 (372)
T cd07853 151 RVEEPDES------KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQL-DLITDLLGT 223 (372)
T ss_pred eecccCcc------ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHH-HHHHHHcCC
Confidence 76432211 112234688999999998764 4789999999999999999999998754432211 11111000
Q ss_pred -----------------hcCcc--cccccc-ccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 745 -----------------RKRPL--AELVDL-SLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 745 -----------------~~~~~--~~~~d~-~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
...+. ...... .+.... ...+.+++.+|++.||++|||+.++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 224 PSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQA----THEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred CCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCC----CHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 00000 000000 000111 124556777999999999999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=321.69 Aligned_cols=269 Identities=22% Similarity=0.283 Sum_probs=196.5
Q ss_pred hcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC-hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEE
Q 003278 109 GSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG-ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 109 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 187 (834)
++++|...+.||+|+||.||+|....+|..||+|++.... ......+.+|+.+++.++|+||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4678999999999999999999998889999999986432 223346788999999999999999999999999999999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
||++ ++|...+... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 83 e~~~-~~l~~~~~~~------~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~ 152 (291)
T cd07870 83 EYMH-TDLAQYMIQH------PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARA 152 (291)
T ss_pred eccc-CCHHHHHHhC------CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccc
Confidence 9996 6776666432 13477888999999999999999985 999999999999999999999999999874
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHH
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILL 347 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~ 347 (834)
..... .......+++.|+|||.+.....++.++|||||||++|||+||+.||+......+....
T Consensus 153 ~~~~~----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~ 216 (291)
T cd07870 153 KSIPS----------------QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEK 216 (291)
T ss_pred cCCCC----------------CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHH
Confidence 32110 00122347899999998865445688999999999999999999998743321111111
Q ss_pred HHHH----------HHhhcCccccccccccCCCCC-----CHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 348 DWIR----------RLSDEGKVLQAGDNRLSDGSY-----KLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 348 ~~~~----------~~~~~~~~~~~~d~~l~~~~~-----~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
.|.. .+...........+....... .......+.+++..|++.||.+|||+.+++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 217 IWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred HHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 1100 000000000000000000000 0011245678999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=313.36 Aligned_cols=262 Identities=23% Similarity=0.348 Sum_probs=204.2
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC-hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEc
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG-ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDY 189 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 189 (834)
++|+..+.||.|+||+||+|....++..+|+|++.... ....+.+.+|+.+++.++|+||+++++.+...+..++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888999999999999999998889999999986432 23557789999999999999999999999999999999999
Q ss_pred cCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhh
Q 003278 190 MPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLE 269 (834)
Q Consensus 190 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~ 269 (834)
+++++|.+++..... ...+++.....++.|++.||+|||+. +|+||||||+||++++++.+||+|||++..+.
T Consensus 81 ~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~ 153 (267)
T cd06610 81 LSGGSLLDIMKSSYP----RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLA 153 (267)
T ss_pred cCCCcHHHHHHHhcc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhc
Confidence 999999999865321 24589999999999999999999985 99999999999999999999999999997653
Q ss_pred hhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHH
Q 003278 270 HELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDW 349 (834)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~ 349 (834)
..... .........|+..|+|||++......+.++|||||||+++||+||+.|+...... ..+...
T Consensus 154 ~~~~~------------~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--~~~~~~ 219 (267)
T cd06610 154 DGGDR------------TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM--KVLMLT 219 (267)
T ss_pred cCccc------------cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh--hhHHHH
Confidence 32110 0001234568999999999876656799999999999999999999998643221 111111
Q ss_pred HHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 350 IRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 350 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
.. . ..+.+........-...+.+++..||+.||++||++.++++
T Consensus 220 ~~----~------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 220 LQ----N------DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred hc----C------CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 11 0 11111100000011245788999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=328.01 Aligned_cols=241 Identities=18% Similarity=0.195 Sum_probs=181.9
Q ss_pred cccccCCcEEEEEEEC-CCcEEEEEEecCCCC--hhHHHHHHHHH-HHHHhccCCCceeEEEEEeeCCeEEEEEeccCCC
Q 003278 520 RVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKC--PALRTRFSNEL-QNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATR 595 (834)
Q Consensus 520 ~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~E~-~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~~~g 595 (834)
.||+|+||.||+|... ++..||+|.+..... ......+..|. .+++.++||||+++++++.+.+..++||||+++|
T Consensus 2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05602 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG 81 (325)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence 5899999999999864 567899999864321 11123344444 4578899999999999999999999999999999
Q ss_pred chhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCCCC
Q 003278 596 ILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHG 675 (834)
Q Consensus 596 ~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~~~ 675 (834)
+|..++.... .+.......++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~L~~~~~~~~------~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-- 150 (325)
T cd05602 82 ELFYHLQRER------CFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-- 150 (325)
T ss_pred cHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC--
Confidence 9999886532 25566677799999999999996 699999999999999999999999999997532211
Q ss_pred CcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcccccccc
Q 003278 676 HRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDL 755 (834)
Q Consensus 676 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 755 (834)
.......||+.|||||++.+..++.++|||||||++|||++|+.||....... ...... . .+.
T Consensus 151 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~---~--~~~------ 213 (325)
T cd05602 151 -----GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-MYDNIL---N--KPL------ 213 (325)
T ss_pred -----CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH-HHHHHH---h--CCc------
Confidence 11234679999999999999999999999999999999999999986433221 111111 1 111
Q ss_pred ccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 756 SLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 756 ~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
.+.... ...+. .+..+|++.||.+||++.+.+.
T Consensus 214 ~~~~~~-~~~~~---~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 214 QLKPNI-TNSAR---HLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred CCCCCC-CHHHH---HHHHHHcccCHHHCCCCCCCHH
Confidence 011111 23334 4445899999999999876543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=317.94 Aligned_cols=253 Identities=18% Similarity=0.272 Sum_probs=195.5
Q ss_pred CcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEecc
Q 003278 514 NFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYS 592 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~ 592 (834)
+|...+.||+|+||.||++... ++..||+|.+.....+.....|.+|+.++.+++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 4555678999999999999975 688999998876544444578999999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccC
Q 003278 593 ATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRN 672 (834)
Q Consensus 593 ~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~ 672 (834)
++++|..++..... ...+++..+..++.|++.||.|||+. .+|+||||||+||+++.++.+||+|||++..+...
T Consensus 82 ~~~~l~~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 82 DAGSLDKLYAGGVA---TEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred CCCCHHHHHHhccc---cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence 99999988865321 22488999999999999999999963 58999999999999999999999999998754321
Q ss_pred CCCCcccccCccccccccCccchhccccCC------CCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhc
Q 003278 673 DHGHRKATSGNRSVRGIFGYMSPEYIESGE------ATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARK 746 (834)
Q Consensus 673 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~------~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~ 746 (834)
......|+.+|+|||++.+.. ++.++|||||||++|||+||+.||........ ..........
T Consensus 157 ---------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~- 225 (286)
T cd06622 157 ---------LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI-FAQLSAIVDG- 225 (286)
T ss_pred ---------ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH-HHHHHHHhhc-
Confidence 122346888999999986543 47899999999999999999999864332221 1111111111
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 747 RPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 747 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
.. +.+...++ ..+..++.+||+.+|++||++.+++.
T Consensus 226 -~~-----~~~~~~~~----~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 226 -DP-----PTLPSGYS----DDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred -CC-----CCCCcccC----HHHHHHHHHHcccCcccCCCHHHHhc
Confidence 00 11111111 23445666999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=318.07 Aligned_cols=255 Identities=25% Similarity=0.368 Sum_probs=194.4
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC-hhhHHHHHHHHHH-HHhCCCCceeeEeeeEEeCCEEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG-ERFEKTFAAELVA-VAHLRHRNLVRLRGWCVHEDQLLLVYD 188 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~-~~~~~~~~~E~~~-l~~l~H~nIv~l~g~~~~~~~~~lV~E 188 (834)
++|+..+.||+|+||.||+|+...+|+.||+|++.... ......+..|+.. ++.++||||+++++++...+..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888899999999999999998899999999986542 2234456666664 667899999999999999999999999
Q ss_pred ccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhh
Q 003278 189 YMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWL 268 (834)
Q Consensus 189 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~ 268 (834)
|++ |+|.+++..... ....+++..+..++.|++.||+|||+. .+++||||||+|||++.++.+||+|||+++.+
T Consensus 81 ~~~-~~l~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~ 154 (283)
T cd06617 81 VMD-TSLDKFYKKVYD---KGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYL 154 (283)
T ss_pred hhc-ccHHHHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 996 788888764321 235689999999999999999999974 38999999999999999999999999998754
Q ss_pred hhhhhhhhhcccccccccccccceeeeccccCCCccccccC---CCCCcccceeehhhHHHHHHhCCccCCCCCCCccch
Q 003278 269 EHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKG---SVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQII 345 (834)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~---~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~ 345 (834)
.... ..+...||..|+|||.+... ..++.++|||||||++|||++|+.|+...... ...
T Consensus 155 ~~~~-----------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~ 216 (283)
T cd06617 155 VDSV-----------------AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-FQQ 216 (283)
T ss_pred cccc-----------------ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-HHH
Confidence 2210 01234588999999987532 34578999999999999999999998532111 011
Q ss_pred HHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 346 LLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 346 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
+ ..... ...+.+....+ ...+.+++..||..+|++||++.+|++
T Consensus 217 ~----~~~~~------~~~~~~~~~~~----~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 217 L----KQVVE------EPSPQLPAEKF----SPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred H----HHHHh------cCCCCCCcccc----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1 11111 11111111111 135788999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=322.32 Aligned_cols=248 Identities=22% Similarity=0.358 Sum_probs=196.4
Q ss_pred CCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEccCCC
Q 003278 114 DEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNR 193 (834)
Q Consensus 114 ~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 193 (834)
+....||+|+||.||+|....+++.||||.+........+.+.+|+.++..++||||+++++++..++..++||||++++
T Consensus 24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~ 103 (297)
T cd06659 24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG 103 (297)
T ss_pred HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCC
Confidence 33457999999999999998889999999987654455677889999999999999999999999999999999999999
Q ss_pred CHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhhhhh
Q 003278 194 SLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQ 273 (834)
Q Consensus 194 sL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~ 273 (834)
+|..++.. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++..+....
T Consensus 104 ~L~~~~~~--------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~- 171 (297)
T cd06659 104 ALTDIVSQ--------TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV- 171 (297)
T ss_pred CHHHHHhh--------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccc-
Confidence 99987743 3478999999999999999999985 99999999999999999999999999987543211
Q ss_pred hhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHHHHHH
Q 003278 274 YQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIRRL 353 (834)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~ 353 (834)
.......|++.|+|||++... .++.++|||||||++|||++|+.|+...... .....+.
T Consensus 172 ---------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---~~~~~~~-- 230 (297)
T cd06659 172 ---------------PKRKSLVGTPYWMAPEVISRT-PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV---QAMKRLR-- 230 (297)
T ss_pred ---------------ccccceecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHh--
Confidence 012335689999999998654 5789999999999999999999998643211 1111111
Q ss_pred hhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 354 SDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 354 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
. ...... ... ... ...+.+++..||+.+|.+||++.++++.
T Consensus 231 -~-~~~~~~--~~~--~~~----~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 231 -D-SPPPKL--KNA--HKI----SPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred -c-cCCCCc--ccc--CCC----CHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 1 100000 000 011 1357789999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=316.92 Aligned_cols=256 Identities=20% Similarity=0.300 Sum_probs=187.5
Q ss_pred eeeccCCeEEEEEEECCC--CeEEEEEEecccC-hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEccCCCC
Q 003278 118 VLGSGGFGKVYRAVLPSD--GTVVAVKCLAEKG-ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNRS 194 (834)
Q Consensus 118 ~LG~G~fG~Vy~~~~~~~--g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 194 (834)
.||+|+||.||+|....+ ...+++|.+.... ....+.|.+|+.+++.++||||++++++|......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 699999999999976333 2356677765432 3456789999999999999999999999999999999999999999
Q ss_pred HhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhhhhhh
Q 003278 195 LDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQY 274 (834)
Q Consensus 195 L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~ 274 (834)
|.+++.+.... ...+++.....++.|+++||+|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 82 L~~~l~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~- 154 (268)
T cd05086 82 LKSYLSQEQWH---RRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY- 154 (268)
T ss_pred HHHHHHhhhcc---cccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchh-
Confidence 99999754221 23467778889999999999999985 999999999999999999999999999864211100
Q ss_pred hhhcccccccccccccceeeeccccCCCcccccc------CCCCCcccceeehhhHHHHHHhC-CccCCCCCCCccchHH
Q 003278 275 QMRTSSARNHQFHLAETTRIGGTIGYLPPESFQK------GSVATAKSDVFSFGIVVLEVVSG-RRAVDLTYPDDQIILL 347 (834)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~------~~~~~~ksDV~SfGvvl~ElltG-~~p~~~~~~~~~~~l~ 347 (834)
........|+..|+|||++.. ...++.++|||||||++|||+++ ..|+..... .
T Consensus 155 -------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------~ 215 (268)
T cd05086 155 -------------IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD------R 215 (268)
T ss_pred -------------hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH------H
Confidence 011233458899999998742 12347789999999999999975 556643211 1
Q ss_pred HHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhh
Q 003278 348 DWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVS 406 (834)
Q Consensus 348 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~ 406 (834)
........+ ......++.+.. .+. ..+.++...|| .+|++||+|.+|++.|.
T Consensus 216 ~~~~~~~~~-~~~~~~~~~~~~-~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 216 EVLNHVIKD-QQVKLFKPQLEL-PYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred HHHHHHHhh-cccccCCCccCC-CCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 122222221 122223333321 122 35667888899 57999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=325.74 Aligned_cols=203 Identities=18% Similarity=0.256 Sum_probs=164.1
Q ss_pred Cccccc--CCcEEEEEEE-CCCcEEEEEEecCCCC-hhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEeccCC
Q 003278 519 QRVAEM--DFGTAYQGFL-DNHQYVLVKRLGMSKC-PALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSAT 594 (834)
Q Consensus 519 ~~ig~g--~~g~vy~~~~-~~~~~vavK~~~~~~~-~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~~~ 594 (834)
+.||+| +||+||++.. .++..||||++..... ....+.+.+|+.+++.++|||||+++++|..++..++||||+++
T Consensus 4 ~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 83 (327)
T cd08227 4 TVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAY 83 (327)
T ss_pred hhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCC
Confidence 468998 7899999986 5688999999876543 33445678899999999999999999999999999999999999
Q ss_pred CchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCCC
Q 003278 595 RILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDH 674 (834)
Q Consensus 595 g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~~ 674 (834)
|+|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.++++|||.+..+.....
T Consensus 84 ~~l~~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 84 GSAKDLICTHFM----DGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CcHHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 999999864321 237899999999999999999996 6899999999999999999999999987644322111
Q ss_pred CCcccccCccccccccCccchhcccc--CCCCccCcchhhHHHHHHHHhCCCccCC
Q 003278 675 GHRKATSGNRSVRGIFGYMSPEYIES--GEATSMADVYSFGVVVLEVVTGQMAVDF 728 (834)
Q Consensus 675 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~k~DV~SfGvvl~E~~tG~~p~~~ 728 (834)
.............++..|||||++.+ ..++.++|||||||++|||+||+.||..
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 00000111122357788999999975 4589999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=314.66 Aligned_cols=253 Identities=23% Similarity=0.400 Sum_probs=197.2
Q ss_pred CCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccCh---------hhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEE
Q 003278 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGE---------RFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQL 183 (834)
Q Consensus 113 f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~---------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 183 (834)
|.....||+|+||.||+|....+++.||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 6677899999999999999988899999998754321 1235688999999999999999999999999999
Q ss_pred EEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeecc
Q 003278 184 LLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFG 263 (834)
Q Consensus 184 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFG 263 (834)
++||||+++++|.+++... ..+++..+..++.|++.||+|||+. +++||||||+|||+++++.+||+|||
T Consensus 82 ~lv~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg 151 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNY-------GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFG 151 (267)
T ss_pred EEEEEecCCCCHHHHHHhc-------cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccC
Confidence 9999999999999998543 3578889999999999999999985 99999999999999999999999999
Q ss_pred chhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCcc
Q 003278 264 LARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQ 343 (834)
Q Consensus 264 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~ 343 (834)
+++.+....... ..........|+..|+|||.+..+ .++.++|||||||++|||+||+.||......
T Consensus 152 ~~~~~~~~~~~~----------~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-- 218 (267)
T cd06628 152 ISKKLEANSLST----------KTNGARPSLQGSVFWMAPEVVKQT-SYTRKADIWSLGCLVVEMLTGKHPFPDCTQL-- 218 (267)
T ss_pred CCcccccccccC----------CccccccccCCCcCccChhHhccC-CCCchhhhHHHHHHHHHHhhCCCCCCCccHH--
Confidence 998654221100 000012234589999999988654 5688999999999999999999998643211
Q ss_pred chHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 344 IILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 344 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
.. +.... . ...+.+. . .....+..++..||+.+|.+||++.+|++
T Consensus 219 ~~----~~~~~-~-----~~~~~~~-~----~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 219 QA----IFKIG-E-----NASPEIP-S----NISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred HH----HHHHh-c-----cCCCcCC-c----ccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 00 11110 0 1111111 1 11246778999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=314.11 Aligned_cols=249 Identities=21% Similarity=0.321 Sum_probs=197.7
Q ss_pred hCcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEecc
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYS 592 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~ 592 (834)
++|...+.||.|+||.||+|... ++.||||.+..... ..++|.+|+.++++++||||+++++++.+....++||||+
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 45666788999999999999875 67899999875433 4567999999999999999999999999889999999999
Q ss_pred CCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccC
Q 003278 593 ATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRN 672 (834)
Q Consensus 593 ~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~ 672 (834)
++++|.+++..... ..++|..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 83 ~~~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~ 155 (256)
T cd05039 83 AKGSLVDYLRSRGR----AVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG 155 (256)
T ss_pred CCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEcccccccccccc
Confidence 99999999865432 248899999999999999999996 69999999999999999999999999999765221
Q ss_pred CCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCcccc
Q 003278 673 DHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRPLAE 751 (834)
Q Consensus 673 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
. ....++..|+|||++..+.++.++||||||+++|||++ |..|+...... .+...+. . .....
T Consensus 156 ~----------~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-~~~~~~~---~--~~~~~ 219 (256)
T cd05039 156 Q----------DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-DVVPHVE---K--GYRME 219 (256)
T ss_pred c----------ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH-HHHHHHh---c--CCCCC
Confidence 1 12235668999999998899999999999999999997 88887643222 2111111 0 00001
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHcc
Q 003278 752 LVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDG 796 (834)
Q Consensus 752 ~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~ 796 (834)
. .... ++ .+.+++.+||..+|++|||+.+++.+|+.
T Consensus 220 ~-----~~~~-~~---~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 220 A-----PEGC-PP---EVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred C-----ccCC-CH---HHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 0 1111 22 45566678999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=295.45 Aligned_cols=262 Identities=16% Similarity=0.255 Sum_probs=192.6
Q ss_pred CcCcCCcccccCCcEEEEEE-ECCCcEEEEEEecCCCCh-hHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 514 NFSESQRVAEMDFGTAYQGF-LDNHQYVLVKRLGMSKCP-ALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~-~~~~~~vavK~~~~~~~~-~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
.|...+++|+|.||.||+|. ..+|+.||||+++...-. .......+||+.|+.++|||||.|++++...+.+-||.||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 35556789999999999999 467899999999865322 2234567899999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccccc
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTR 671 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~ 671 (834)
|+. +|+..+++... .|+-...-.++.++.+||+|||. ..|+||||||.|+|++++|.+||+|||+|+....
T Consensus 83 m~t-dLe~vIkd~~i-----~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~ 153 (318)
T KOG0659|consen 83 MPT-DLEVVIKDKNI-----ILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGS 153 (318)
T ss_pred ccc-cHHHHhccccc-----ccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCC
Confidence 985 78888876543 47777778899999999999997 6899999999999999999999999999998643
Q ss_pred CCCCCcccccCccccccccCccchhcccc-CCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhc--C-
Q 003278 672 NDHGHRKATSGNRSVRGIFGYMSPEYIES-GEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARK--R- 747 (834)
Q Consensus 672 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~--~- 747 (834)
.... .+.-+-|.-|.|||.+.+ ..|+..+|+||.|||+.||+-|..-+. ...+-+.+..+.+..... +
T Consensus 154 p~~~-------~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fp-G~sDidQL~~If~~LGTP~~~~ 225 (318)
T KOG0659|consen 154 PNRI-------QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFP-GDSDIDQLSKIFRALGTPTPDQ 225 (318)
T ss_pred CCcc-------cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCC-CCchHHHHHHHHHHcCCCCccc
Confidence 3211 111256788999998865 469999999999999999999854332 222222222222211110 0
Q ss_pred --cccccccc---------ccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHH
Q 003278 748 --PLAELVDL---------SLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSI 793 (834)
Q Consensus 748 --~~~~~~d~---------~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~ 793 (834)
.+.++.|. .+..-+ +......+.++...+..||.+|+|++|.++.
T Consensus 226 WP~~~~lpdY~~~~~~P~~~~~~lf-~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 226 WPEMTSLPDYVKIQQFPKPPLNNLF-PAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred CccccccccHHHHhcCCCCcccccc-ccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 01111111 111111 1222345677778999999999999999853
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=335.44 Aligned_cols=410 Identities=21% Similarity=0.261 Sum_probs=308.4
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEcc
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYM 190 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 190 (834)
++|+....+|.|.||.|||+++..++...|||+++-.......-.+.|+-+++..+|||||.++|.+...+.++++||||
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEyc 94 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYC 94 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEec
Confidence 57888999999999999999999999999999998665555667788999999999999999999999999999999999
Q ss_pred CCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhh
Q 003278 191 PNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEH 270 (834)
Q Consensus 191 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~ 270 (834)
.+|+|.+.-+. .++|++.++..+.+...+||.|||++ +-+|||||-.|||+++.+.+|++|||.+-.+..
T Consensus 95 gggslQdiy~~-------TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqita 164 (829)
T KOG0576|consen 95 GGGSLQDIYHV-------TGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITA 164 (829)
T ss_pred CCCcccceeee-------cccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhh
Confidence 99999887654 36889999999999999999999996 889999999999999999999999999875532
Q ss_pred hhhhhhhcccccccccccccceeeeccccCCCcccccc--CCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHH
Q 003278 271 ELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQK--GSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLD 348 (834)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~ 348 (834)
. +.....+.||+.|||||+..- ...|..++|||+.|+...|+---++|.-.-.+..
T Consensus 165 t----------------i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr------ 222 (829)
T KOG0576|consen 165 T----------------IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR------ 222 (829)
T ss_pred h----------------hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH------
Confidence 2 223456789999999997632 2257899999999999999988777743211111
Q ss_pred HHHHHh-hcCcccccccc-ccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcCCCCCCCCCCCccCCCccc
Q 003278 349 WIRRLS-DEGKVLQAGDN-RLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGSYSGKLPALPSFQSHPLYI 426 (834)
Q Consensus 349 ~~~~~~-~~~~~~~~~d~-~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~~~~~~p~~ps~~s~p~~~ 426 (834)
+..+. ..+ .++ .+.+.. .--+.+-++...|+..+|++||+....+..
T Consensus 223 -~l~LmTkS~-----~qpp~lkDk~---kws~~fh~fvK~altknpKkRptaeklL~h---------------------- 271 (829)
T KOG0576|consen 223 -ALFLMTKSG-----FQPPTLKDKT---KWSEFFHNFVKGALTKNPKKRPTAEKLLQH---------------------- 271 (829)
T ss_pred -HHHHhhccC-----CCCCcccCCc---cchHHHHHHHHHHhcCCCccCCChhhheec----------------------
Confidence 11111 111 111 121111 112356788888999999999986643220
Q ss_pred ccCCCCCCCCCCCccccccCcccCCCcccCCCCCcccccccccccccccCCCcCCCCCCccccccCcccccCCCccccHH
Q 003278 427 SLSSPTNTSTSNTETTRSTNTTASNTTIASPSSNYVTAAGETIYATAECGGNTESKSNNSRSQRRNSFFMVETPREISFK 506 (834)
Q Consensus 427 s~ssp~~~s~s~~~~s~ss~ss~s~~~~~spssn~v~a~~~~~~a~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 506 (834)
T Consensus 272 -------------------------------------------------------------------------------- 271 (829)
T KOG0576|consen 272 -------------------------------------------------------------------------------- 271 (829)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred HHHHHhhCcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCC-ceeEEEEEeeCCeE
Q 003278 507 EIISATNNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRN-LVQLCGWCTEQGEM 585 (834)
Q Consensus 507 el~~at~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpN-iv~l~g~~~~~~~~ 585 (834)
+.+... ....-++++|.+++||| .|..++-+..++..
T Consensus 272 ------------------------------------~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~ 309 (829)
T KOG0576|consen 272 ------------------------------------PFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYL 309 (829)
T ss_pred ------------------------------------eeeccc------hhhHHHHHHHHHccCCCCcccccccCCccccc
Confidence 000000 00123678999999999 88888888888889
Q ss_pred EEEEeccCCC-chhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeee
Q 003278 586 LVIYDYSATR-ILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFA 664 (834)
Q Consensus 586 ~lv~Ey~~~g-~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfG 664 (834)
.++++|+..+ +...... .....+...+-..+.+.-+++++|||+. .-+||| |||..+ ...|.+||+
T Consensus 310 ~i~~~i~s~~rs~~~~~~-----~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~ 376 (829)
T KOG0576|consen 310 WIPMRICSTGRSSALEMT-----VSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFA 376 (829)
T ss_pred chhhhhhcCCccccccCC-----hhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-ccccccccc
Confidence 9999999887 2221110 0111122233345667788999999973 358999 887665 678999999
Q ss_pred eccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCcc
Q 003278 665 LAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAV 726 (834)
Q Consensus 665 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~ 726 (834)
....+++.. ..++..||+.|||||+...+.+..+.|+||.|+--.+|.-|..|.
T Consensus 377 v~~~L~~~~--------~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 377 VPPQLTRTM--------KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred CCcccCccc--------ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 987765432 234567999999999999999999999999998777877776654
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=322.71 Aligned_cols=260 Identities=15% Similarity=0.235 Sum_probs=191.4
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
++|...+.||+|+||.||+|... ++..||+|.+...........+.+|++++++++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 35677788999999999999864 57789999987554443445678899999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccccc
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTR 671 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~ 671 (834)
+++ +|..++...+ ..+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 86 ~~~-~l~~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 156 (309)
T cd07872 86 LDK-DLKQYMDDCG-----NIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSV 156 (309)
T ss_pred CCC-CHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCC
Confidence 986 6777765432 237788888899999999999996 6999999999999999999999999999975322
Q ss_pred CCCCCcccccCccccccccCccchhcccc-CCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhc----
Q 003278 672 NDHGHRKATSGNRSVRGIFGYMSPEYIES-GEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARK---- 746 (834)
Q Consensus 672 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~---- 746 (834)
.. .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||........+...........
T Consensus 157 ~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 229 (309)
T cd07872 157 PT-------KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETW 229 (309)
T ss_pred Cc-------cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 11 01123467899999998865 4688999999999999999999999865433222111110000000
Q ss_pred ---CccccccccccC-----------CCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 747 ---RPLAELVDLSLN-----------GEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 747 ---~~~~~~~d~~l~-----------~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
....+..+.... ... .. .+.++..+|+..||.+|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~---~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 230 PGISSNDEFKNYNFPKYKPQPLINHAPRL-DT---EGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhcchhhhhhhhcCccCCCchhhhccCC-CH---HHHHHHHHhccCChhhCCCHHHHhc
Confidence 000000000000 001 12 3445667999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=330.97 Aligned_cols=242 Identities=18% Similarity=0.242 Sum_probs=190.1
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCC--ChhHHHHHHHHHHHHHhc-cCCCceeEEEEEeeCCeEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSK--CPALRTRFSNELQNLARL-RHRNLVQLCGWCTEQGEMLVI 588 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~E~~~l~~l-~HpNiv~l~g~~~~~~~~~lv 588 (834)
++|.-...+|+|+||+|+.+.++ +++.+|||.++... ..+..+..+.|-.++... +||.+++|++++...+++|+|
T Consensus 368 ~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fv 447 (694)
T KOG0694|consen 368 DDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFV 447 (694)
T ss_pred cceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEE
Confidence 56777888999999999999975 47899999998653 123345677787777766 599999999999999999999
Q ss_pred EeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccc
Q 003278 589 YDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEF 668 (834)
Q Consensus 589 ~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~ 668 (834)
|||+.||++..+.+. ..++.....-+|..|+.||.|||+ .+||+||||-.|||||.+|.+||+|||+++.
T Consensus 448 mey~~Ggdm~~~~~~-------~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 448 MEYVAGGDLMHHIHT-------DVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEecCCCcEEEEEec-------ccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccc
Confidence 999999996655432 237787777899999999999997 7999999999999999999999999999986
Q ss_pred cccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCc
Q 003278 669 LTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRP 748 (834)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
.... ...+.++|||+.|||||++.+..|+..+|.|||||+||||++|+.||.....+. +...+.. ..
T Consensus 518 ~m~~-------g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee-~FdsI~~----d~- 584 (694)
T KOG0694|consen 518 GMGQ-------GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE-VFDSIVN----DE- 584 (694)
T ss_pred cCCC-------CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHhc----CC-
Confidence 4321 223567999999999999999999999999999999999999999997543332 2222111 00
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCh
Q 003278 749 LAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSM 787 (834)
Q Consensus 749 ~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm 787 (834)
..- ..+...+ .+.++.+-+..+|++|--+
T Consensus 585 ---~~y----P~~ls~e---a~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 585 ---VRY----PRFLSKE---AIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ---CCC----CCcccHH---HHHHHHHHhccCcccccCC
Confidence 011 1122233 3445557788999999877
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=314.29 Aligned_cols=254 Identities=26% Similarity=0.426 Sum_probs=198.3
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEc
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDY 189 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 189 (834)
.++|...++||+|+||.||+|.. .+++.||+|.+.... .....|.+|+.++++++||||+++++++. .+..++||||
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred hHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 45688899999999999999997 578899999986543 23467899999999999999999999864 5678999999
Q ss_pred cCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhh
Q 003278 190 MPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLE 269 (834)
Q Consensus 190 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~ 269 (834)
+++|+|.+++.... ...+++.++..++.|++.||+|||+. +++||||||+||++++++.++|+|||+++...
T Consensus 82 ~~~~~L~~~~~~~~-----~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05067 82 MENGSLVDFLKTPE-----GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIE 153 (260)
T ss_pred CCCCCHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecC
Confidence 99999999986432 24689999999999999999999985 99999999999999999999999999987543
Q ss_pred hhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccchHHH
Q 003278 270 HELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQIILLD 348 (834)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~ 348 (834)
.... .......++..|+|||++..+ .++.++|||||||++|||+| |+.||...... .+..
T Consensus 154 ~~~~---------------~~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~ 214 (260)
T cd05067 154 DNEY---------------TAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP---EVIQ 214 (260)
T ss_pred CCCc---------------ccccCCcccccccCHHHhccC-CcCcccchHHHHHHHHHHHhCCCCCCCCCChH---HHHH
Confidence 1100 001223467889999988654 57889999999999999999 99998643211 1111
Q ss_pred HHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhc
Q 003278 349 WIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSG 407 (834)
Q Consensus 349 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~ 407 (834)
.+ ..+...... .. ....+.+++..|++.+|++||++.++...|+.
T Consensus 215 ---~~-~~~~~~~~~------~~----~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 215 ---NL-ERGYRMPRP------DN----CPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ---HH-HcCCCCCCC------CC----CCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 11 111111100 11 12468899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=317.81 Aligned_cols=261 Identities=25% Similarity=0.333 Sum_probs=201.8
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC-hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeC--CEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG-ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHE--DQLLLVY 187 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lV~ 187 (834)
++|+..+.||.|+||.||+|.+..+++.+|+|.+.... ......+.+|++++++++||||++++++|... +.+++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46888899999999999999998889999999986432 24567789999999999999999999998754 3689999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
||+++++|.+++..... ....+++.....|+.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++..
T Consensus 81 e~~~~~~L~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~ 154 (287)
T cd06621 81 EYCEGGSLDSIYKKVKK---RGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGE 154 (287)
T ss_pred EecCCCCHHHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccc
Confidence 99999999988754321 235688899999999999999999985 999999999999999999999999999864
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCC--ccch
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPD--DQII 345 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~--~~~~ 345 (834)
.... ......++..|+|||.+... .++.++|||||||++|||+||+.|+...... ....
T Consensus 155 ~~~~------------------~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 215 (287)
T cd06621 155 LVNS------------------LAGTFTGTSFYMAPERIQGK-PYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIE 215 (287)
T ss_pred cccc------------------ccccccCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHH
Confidence 3211 01234578899999988654 6788999999999999999999998754321 1112
Q ss_pred HHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 346 LLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 346 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
+..|+.. .......+... ....-...+.+++..||+.+|.+||+|.||++.
T Consensus 216 ~~~~~~~----~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 216 LLSYIVN----MPNPELKDEPG----NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred HHHHHhc----CCchhhccCCC----CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 2222221 11111111110 001123568899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=331.26 Aligned_cols=251 Identities=24% Similarity=0.387 Sum_probs=202.7
Q ss_pred CCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEccCC
Q 003278 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPN 192 (834)
Q Consensus 113 f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 192 (834)
|++...||.|+||.||+|+.+.++-..|-|++..+.+...+.|+-||.+|+...||+||+|++.|+.++.+++..|||+|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 55667899999999999999988888999999888888888999999999999999999999999999999999999999
Q ss_pred CCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhhhh
Q 003278 193 RSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHEL 272 (834)
Q Consensus 193 gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~ 272 (834)
|-.+.++..- ..+|+..++.-+++|++.||.|||++ .|||||||..|||++-+|.++|+|||.+-......
T Consensus 114 GAVDaimlEL------~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~ 184 (1187)
T KOG0579|consen 114 GAVDAIMLEL------GRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR 184 (1187)
T ss_pred chHhHHHHHh------ccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhHH
Confidence 9999887543 46799999999999999999999996 99999999999999999999999999875432221
Q ss_pred hhhhhcccccccccccccceeeeccccCCCcccccc----CCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHH
Q 003278 273 QYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQK----GSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLD 348 (834)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~----~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~ 348 (834)
+ ...++.|||.|||||+... ...|+.++||||||++|.||.-+.+|...-.+ ..
T Consensus 185 q----------------kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp------MR 242 (1187)
T KOG0579|consen 185 Q----------------KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP------MR 242 (1187)
T ss_pred h----------------hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch------HH
Confidence 1 1346789999999998743 45789999999999999999999988643211 11
Q ss_pred HHHHHhhcCccccccccccC-CCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 349 WIRRLSDEGKVLQAGDNRLS-DGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 349 ~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
.+..+... -.|.+. +..+. ..+.++...||..||..||+..++++.
T Consensus 243 VllKiaKS------ePPTLlqPS~Ws----~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 243 VLLKIAKS------EPPTLLQPSHWS----RSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred HHHHHhhc------CCCcccCcchhh----hHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 11111111 111111 11111 346788899999999999999888754
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=318.49 Aligned_cols=257 Identities=18% Similarity=0.291 Sum_probs=198.7
Q ss_pred hCcCcCCcccccCCcEEEEEEECC-Cc----EEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDN-HQ----YVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLV 587 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~-~~----~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~l 587 (834)
.+|...+.||+|+||.||+|...+ +. .+|+|.+...........|.+|+.++++++||||++++|+|.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 345667889999999999998643 32 5899988766555556789999999999999999999999987 78899
Q ss_pred EEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecc
Q 003278 588 IYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAE 667 (834)
Q Consensus 588 v~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~ 667 (834)
||||+++|+|.+++..... .+++...+.++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++
T Consensus 86 v~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~ 157 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKD-----NIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (279)
T ss_pred EEecCCCCcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccc
Confidence 9999999999999875432 38899999999999999999997 699999999999999999999999999998
Q ss_pred ccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhc
Q 003278 668 FLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARK 746 (834)
Q Consensus 668 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~ 746 (834)
.+....... ......++..|||||.+..+.++.++|||||||++||++| |+.|+....+.. +...+. ..
T Consensus 158 ~~~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~~~----~~ 227 (279)
T cd05057 158 LLDVDEKEY-----HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE-IPDLLE----KG 227 (279)
T ss_pred cccCcccce-----ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH-HHHHHh----CC
Confidence 754322110 0111234678999999988899999999999999999999 999986543322 111111 11
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCC
Q 003278 747 RPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGND 798 (834)
Q Consensus 747 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~ 798 (834)
... .. ..... ..+..++.+||..+|.+|||+.++++.|+...
T Consensus 228 ~~~---~~---~~~~~----~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05057 228 ERL---PQ---PPICT----IDVYMVLVKCWMIDAESRPTFKELINEFSKMA 269 (279)
T ss_pred CCC---CC---CCCCC----HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 110 00 11111 23456667999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=316.85 Aligned_cols=255 Identities=23% Similarity=0.339 Sum_probs=197.3
Q ss_pred CcCcCCcccccCCcEEEEEEECC----CcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEE
Q 003278 514 NFSESQRVAEMDFGTAYQGFLDN----HQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIY 589 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~~~----~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~ 589 (834)
+|...+.||+|+||.||+|...+ ...|+||...........+.|.+|+.++++++||||++++++|.+ +..++||
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~ 85 (270)
T cd05056 7 DITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVM 85 (270)
T ss_pred hceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEE
Confidence 45566789999999999998643 246899988765545566789999999999999999999999876 4578999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccc
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFL 669 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~ 669 (834)
||+++|+|.+++.... ..++|..++.++.|++.||+|||+ .+++||||||+|||++.++.+|++|||+++..
T Consensus 86 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 86 ELAPLGELRSYLQVNK-----YSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EcCCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeec
Confidence 9999999999986532 237899999999999999999996 68999999999999999999999999999765
Q ss_pred ccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCc
Q 003278 670 TRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRP 748 (834)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
..... .......++..|+|||++....++.++|||||||++|||++ |..||......... ... ......
T Consensus 158 ~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~-~~~---~~~~~~ 227 (270)
T cd05056 158 EDESY------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI-GRI---ENGERL 227 (270)
T ss_pred ccccc------eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH-HHH---HcCCcC
Confidence 43211 01112345578999999988889999999999999999996 99998644322211 111 111111
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCC
Q 003278 749 LAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGND 798 (834)
Q Consensus 749 ~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~ 798 (834)
..... .+. .+.+++.+||..+|++|||+.++++.|+.+.
T Consensus 228 -------~~~~~-~~~---~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 228 -------PMPPN-CPP---TLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred -------CCCCC-CCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 01111 122 3555666999999999999999999997754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=317.30 Aligned_cols=250 Identities=24% Similarity=0.414 Sum_probs=199.5
Q ss_pred CCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc-ChhhHHHHHHHHHHHHhCC---CCceeeEeeeEEeCCEEEEEE
Q 003278 112 GFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK-GERFEKTFAAELVAVAHLR---HRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 112 ~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~lV~ 187 (834)
.|+..+.||+|+||.||+|.+..++..||||.+... .....+.+.+|+.++++++ ||||++++++|...+..++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477788999999999999999889999999998653 2334567889999999987 999999999999999999999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
||+++++|.+++.. ..+++.....++.|++.||.|||+. +|+|+||+|+||+++.++.++|+|||++..
T Consensus 82 e~~~~~~L~~~~~~--------~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 150 (277)
T cd06917 82 EYAEGGSVRTLMKA--------GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAAL 150 (277)
T ss_pred ecCCCCcHHHHHHc--------cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceee
Confidence 99999999998743 2588999999999999999999985 999999999999999999999999999875
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHH
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILL 347 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~ 347 (834)
+.... .......|+..|+|||++..+..++.++|||||||++|||++|+.|+......
T Consensus 151 ~~~~~----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~------ 208 (277)
T cd06917 151 LNQNS----------------SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF------ 208 (277)
T ss_pred cCCCc----------------cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh------
Confidence 43211 01223458999999999876666789999999999999999999998643211
Q ss_pred HHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 348 DWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 348 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
.+.... .. ...+.+.... ....+.+++..||+.||++||++.+++..
T Consensus 209 ~~~~~~-~~-----~~~~~~~~~~----~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 209 RAMMLI-PK-----SKPPRLEDNG----YSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred hhhhcc-cc-----CCCCCCCccc----CCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 111100 00 0111111111 12467889999999999999999999863
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=325.94 Aligned_cols=192 Identities=17% Similarity=0.213 Sum_probs=162.3
Q ss_pred HhhCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEE
Q 003278 511 ATNNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIY 589 (834)
Q Consensus 511 at~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~ 589 (834)
...+|...+.||+|+||.||+|... ++..||+|..... ....|+.++++++|||||++++++.+.+..++||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 3467899999999999999999975 4678999974322 2356999999999999999999999999999999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccc
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFL 669 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~ 669 (834)
||+. ++|..++.... ..++|..+..|+.|++.||+|||+ .+||||||||+|||++.++.+||+|||+++..
T Consensus 137 e~~~-~~l~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 207 (357)
T PHA03209 137 PHYS-SDLYTYLTKRS-----RPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFP 207 (357)
T ss_pred EccC-CcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCcccccc
Confidence 9995 57777775432 248899999999999999999997 68999999999999999999999999999753
Q ss_pred ccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCcc
Q 003278 670 TRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAV 726 (834)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~ 726 (834)
... .......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 208 ~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 208 VVA--------PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccC--------cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 211 1122457999999999999999999999999999999999976665
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=314.17 Aligned_cols=252 Identities=22% Similarity=0.326 Sum_probs=191.4
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCC----ChhHHHHHHHHHHHHHhccCCCceeEEEEEee--CCeE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSK----CPALRTRFSNELQNLARLRHRNLVQLCGWCTE--QGEM 585 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~----~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~--~~~~ 585 (834)
.+|...+.||+|+||.||+|.. .++..|++|.+.... .......+.+|+.++++++||||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4788889999999999999986 458899999876432 12234578899999999999999999998865 3568
Q ss_pred EEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeee
Q 003278 586 LVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFAL 665 (834)
Q Consensus 586 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGl 665 (834)
++++||+++++|.+++.... .+++.....++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~ 152 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG------ALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGA 152 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCC
Confidence 89999999999999886432 37788888999999999999996 6899999999999999999999999999
Q ss_pred ccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhh
Q 003278 666 AEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEAR 745 (834)
Q Consensus 666 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~ 745 (834)
++.+..... .........|+..|+|||++.+..++.++|||||||++|||+||+.|+........ .....
T Consensus 153 ~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~----~~~~~-- 222 (266)
T cd06651 153 SKRLQTICM----SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA----IFKIA-- 222 (266)
T ss_pred ccccccccc----cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH----HHHHh--
Confidence 976432110 01112235689999999999988899999999999999999999999864322111 11110
Q ss_pred cCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 746 KRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 746 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
... ..+.+.. .+...++.+++||..+|++||||.+|++
T Consensus 223 ~~~----~~~~~~~-----~~~~~~~~li~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 223 TQP----TNPQLPS-----HISEHARDFLGCIFVEARHRPSAEELLR 260 (266)
T ss_pred cCC----CCCCCch-----hcCHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000 0111111 1112223334799999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=331.38 Aligned_cols=198 Identities=26% Similarity=0.319 Sum_probs=166.5
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeC------C
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHE------D 181 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------~ 181 (834)
.++|...+.||+|+||.||+|....+++.||||++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 46799999999999999999999889999999998643 233456788999999999999999999987643 3
Q ss_pred EEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEee
Q 003278 182 QLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGD 261 (834)
Q Consensus 182 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~D 261 (834)
..|+||||+++ +|...+. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|
T Consensus 103 ~~~lv~e~~~~-~l~~~~~---------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~D 169 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQ---------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD 169 (364)
T ss_pred eEEEEEeCCCC-CHHHHHH---------hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEe
Confidence 57999999975 6666663 2377889999999999999999985 999999999999999999999999
Q ss_pred ccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCC
Q 003278 262 FGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLT 338 (834)
Q Consensus 262 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~ 338 (834)
||+++...... ..+...||+.|+|||++... .++.++|||||||++|||+||+.||...
T Consensus 170 fG~a~~~~~~~-----------------~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~ 228 (364)
T cd07875 170 FGLARTAGTSF-----------------MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGT 228 (364)
T ss_pred CCCccccCCCC-----------------cccCCcccCCcCCHHHHhCC-CCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence 99997532110 12334689999999998654 6789999999999999999999998643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=310.47 Aligned_cols=249 Identities=24% Similarity=0.410 Sum_probs=198.2
Q ss_pred CCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC-----hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEE
Q 003278 112 GFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG-----ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLV 186 (834)
Q Consensus 112 ~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 186 (834)
+|+..+.||+|+||.||+|....++..||+|.+.... ....+.+.+|+.+++.++|+||+++++++...+..++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3667789999999999999998789999999875432 23456789999999999999999999999999999999
Q ss_pred EEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchh
Q 003278 187 YDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLAR 266 (834)
Q Consensus 187 ~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~ 266 (834)
|||+++++|.+++... ..+++..+..++.|+++||+|||+. +|+|+||||+||+++.++.+||+|||++.
T Consensus 81 ~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~ 150 (258)
T cd06632 81 LELVPGGSLAKLLKKY-------GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAK 150 (258)
T ss_pred EEecCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccce
Confidence 9999999999998642 3588999999999999999999985 99999999999999999999999999987
Q ss_pred hhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchH
Q 003278 267 WLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIIL 346 (834)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l 346 (834)
...... ......|++.|+|||.+.....++.++|+|||||++|||++|+.||......
T Consensus 151 ~~~~~~-----------------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~----- 208 (258)
T cd06632 151 QVVEFS-----------------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV----- 208 (258)
T ss_pred eccccc-----------------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH-----
Confidence 542211 1233458999999999865533788999999999999999999998643211
Q ss_pred HHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 347 LDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 347 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
.............. +. ... ...+.++...||+.+|.+||++.+++.
T Consensus 209 -~~~~~~~~~~~~~~-~~-----~~~----~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 209 -AAVFKIGRSKELPP-IP-----DHL----SDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred -HHHHHHHhcccCCC-cC-----CCc----CHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 11111111111111 10 111 245678899999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=314.06 Aligned_cols=256 Identities=25% Similarity=0.377 Sum_probs=199.0
Q ss_pred CCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC------hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEE
Q 003278 112 GFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG------ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLL 185 (834)
Q Consensus 112 ~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~------~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 185 (834)
+|+..+.||+|+||.||+|....++..||+|.+.... ....+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4778899999999999999998899999999986432 2245678999999999999999999999999999999
Q ss_pred EEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCC-ceEEeeccc
Q 003278 186 VYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQY-NARLGDFGL 264 (834)
Q Consensus 186 V~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~-~~kl~DFGl 264 (834)
||||+++++|.+++... .++++..+..++.|++.||.|||+. +++||||||+||+++.++ .+||+|||+
T Consensus 81 v~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~ 150 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY-------GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGA 150 (268)
T ss_pred EEeccCCCcHHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccc
Confidence 99999999999998642 3688999999999999999999985 999999999999998765 599999999
Q ss_pred hhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccc
Q 003278 265 ARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQI 344 (834)
Q Consensus 265 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~ 344 (834)
+..+...... . ........||..|+|||.+.. ..++.++||||+||+++||++|+.|+........
T Consensus 151 ~~~~~~~~~~-----~-------~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~- 216 (268)
T cd06630 151 AARLAAKGTG-----A-------GEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH- 216 (268)
T ss_pred cccccccccc-----C-------CccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch-
Confidence 8765332100 0 001223468999999998854 4678999999999999999999999864322111
Q ss_pred hHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 345 ILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 345 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
...+........ . ...+......+.+++..|++.+|.+||++.+++.
T Consensus 217 --~~~~~~~~~~~~-----~-----~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 217 --LALIFKIASATT-----A-----PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred --HHHHHHHhccCC-----C-----CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 111111111000 0 1111112245788999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=314.34 Aligned_cols=257 Identities=24% Similarity=0.389 Sum_probs=197.0
Q ss_pred CCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC----------hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCC
Q 003278 112 GFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG----------ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHED 181 (834)
Q Consensus 112 ~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~----------~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~ 181 (834)
+|...+.||+|+||.||+|....+|+.||||.+.... ....+.+.+|+.++++++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 3567789999999999999998889999999875311 112356788999999999999999999999999
Q ss_pred EEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEee
Q 003278 182 QLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGD 261 (834)
Q Consensus 182 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~D 261 (834)
..++||||+++|+|.+++.+. ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d 151 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-------GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISD 151 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-------cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEee
Confidence 999999999999999998643 4688999999999999999999985 999999999999999999999999
Q ss_pred ccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCC-CCCcccceeehhhHHHHHHhCCccCCCCCC
Q 003278 262 FGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGS-VATAKSDVFSFGIVVLEVVSGRRAVDLTYP 340 (834)
Q Consensus 262 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~ksDV~SfGvvl~ElltG~~p~~~~~~ 340 (834)
||+++...... .........|+..|+|||.+.... .++.++||||||++++|+++|+.|+.....
T Consensus 152 ~~~~~~~~~~~--------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 217 (272)
T cd06629 152 FGISKKSDDIY--------------DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA 217 (272)
T ss_pred ccccccccccc--------------cccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch
Confidence 99987532110 001123456899999999886543 368899999999999999999999853211
Q ss_pred CccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 341 DDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 341 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
...+ ....... .....+.... . .-...+.+++..||+.+|+.||+|.+|++.
T Consensus 218 -----~~~~-~~~~~~~-~~~~~~~~~~-~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 218 -----IAAM-FKLGNKR-SAPPIPPDVS-M----NLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred -----HHHH-HHhhccc-cCCcCCcccc-c----cCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 1111 1111111 1111111110 0 112467889999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=316.05 Aligned_cols=256 Identities=26% Similarity=0.418 Sum_probs=199.2
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCe----EEEEEEecccC-hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGT----VVAVKCLAEKG-ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLL 185 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~----~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 185 (834)
.+|...+.||+|+||.||+|.++.+|. .||+|.+.... ......+.+|+.++.+++||||++++++|.. +..++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 457778999999999999999866654 68999876543 3345678999999999999999999999987 78999
Q ss_pred EEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccch
Q 003278 186 VYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLA 265 (834)
Q Consensus 186 V~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla 265 (834)
||||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 86 v~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~ 156 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHK------DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLA 156 (279)
T ss_pred EEecCCCCcHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccc
Confidence 999999999999986532 3589999999999999999999985 9999999999999999999999999999
Q ss_pred hhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccc
Q 003278 266 RWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQI 344 (834)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~ 344 (834)
+.+...... . ......++..|+|||.+..+ .++.++|||||||++||++| |+.|++.....
T Consensus 157 ~~~~~~~~~-----------~---~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--- 218 (279)
T cd05057 157 KLLDVDEKE-----------Y---HAEGGKVPIKWMALESILHR-IYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV--- 218 (279)
T ss_pred ccccCcccc-----------e---ecCCCcccccccCHHHhhcC-CcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH---
Confidence 865321100 0 01112246789999988654 57889999999999999999 99998643211
Q ss_pred hHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 345 ILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 345 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
++.... ..+... ..+ ... ...+..++..||..+|..||++.++++.|...
T Consensus 219 ---~~~~~~-~~~~~~--~~~----~~~----~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 219 ---EIPDLL-EKGERL--PQP----PIC----TIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred ---HHHHHH-hCCCCC--CCC----CCC----CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 111111 111111 001 111 13577889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=310.43 Aligned_cols=251 Identities=29% Similarity=0.392 Sum_probs=198.4
Q ss_pred CCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeC-CEEEEEEE
Q 003278 112 GFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHE-DQLLLVYD 188 (834)
Q Consensus 112 ~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-~~~~lV~E 188 (834)
+|+..+.||+|+||.||++....+++.||+|.+... .....+.+.+|+.++++++|+||+++++.+... +.+++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 477889999999999999999888999999998643 234456788999999999999999999987644 46899999
Q ss_pred ccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhh
Q 003278 189 YMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWL 268 (834)
Q Consensus 189 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~ 268 (834)
|+++++|.+++.... ...+++.++..++.+++.||+|||+. +|+||||||+||+++.++.++|+|||+++.+
T Consensus 81 ~~~~~~l~~~l~~~~-----~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~ 152 (257)
T cd08223 81 FCEGGDLYHKLKEQK-----GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVL 152 (257)
T ss_pred ccCCCcHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEe
Confidence 999999999986532 24589999999999999999999985 9999999999999999999999999998754
Q ss_pred hhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHH
Q 003278 269 EHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLD 348 (834)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~ 348 (834)
.... .......|++.|+|||.+... .++.++|||||||+++||+||+.|++... ...
T Consensus 153 ~~~~----------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~~~~~~~------~~~ 209 (257)
T cd08223 153 ENQC----------------DMASTLIGTPYYMSPELFSNK-PYNYKSDVWALGCCVYEMATLKHAFNAKD------MNS 209 (257)
T ss_pred cccC----------------CccccccCCcCccChhHhcCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCC------HHH
Confidence 3210 012334589999999988654 57889999999999999999999986422 112
Q ss_pred HHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 349 WIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 349 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
+..... .+.... +. .. ....+.+++..|++.+|.+||++.+++..
T Consensus 210 ~~~~~~-~~~~~~-----~~-~~----~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 210 LVYRII-EGKLPP-----MP-KD----YSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred HHHHHH-hcCCCC-----Cc-cc----cCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 222211 122111 10 11 12468899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=313.25 Aligned_cols=250 Identities=22% Similarity=0.281 Sum_probs=196.2
Q ss_pred cCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEeccC
Q 003278 515 FSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSA 593 (834)
Q Consensus 515 f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~~ 593 (834)
|...+.||+|+||.||++.. .++..+|+|.+.........+.+.+|+.++++++||||+++++++.+.+..+++|||++
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCD 81 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCC
Confidence 45567899999999999985 45788999988655444455778899999999999999999999999999999999999
Q ss_pred CCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCC
Q 003278 594 TRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRND 673 (834)
Q Consensus 594 ~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~ 673 (834)
+|+|.+++.... ...+++.....++.|++.||.|||+ .+|+|+||||+||++++++.++++|||++.......
T Consensus 82 ~~~l~~~~~~~~----~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 82 GGDLMQKIKLQR----GKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred CCcHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence 999998875432 1246788888999999999999996 699999999999999999999999999997653221
Q ss_pred CCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcccccc
Q 003278 674 HGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELV 753 (834)
Q Consensus 674 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (834)
. ......|++.|+|||++.+..++.++||||||+++|||++|..|+........ .... .. .....
T Consensus 155 ~-------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~-~~~~---~~--~~~~~-- 219 (255)
T cd08219 155 A-------YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL-ILKV---CQ--GSYKP-- 219 (255)
T ss_pred c-------ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH-HHHH---hc--CCCCC--
Confidence 1 11235689999999999988899999999999999999999999864332211 1111 10 11100
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHH
Q 003278 754 DLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSI 793 (834)
Q Consensus 754 d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~ 793 (834)
+....+ . .+..++.+||+.||++|||+.+|+..
T Consensus 220 ---~~~~~~-~---~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 ---LPSHYS-Y---ELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ---CCcccC-H---HHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 111111 2 34456669999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=337.01 Aligned_cols=203 Identities=19% Similarity=0.275 Sum_probs=163.1
Q ss_pred HHHHHhhCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCC------CceeEEEEE
Q 003278 507 EIISATNNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHR------NLVQLCGWC 579 (834)
Q Consensus 507 el~~at~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~Hp------Niv~l~g~~ 579 (834)
++...+++|...+.||+|+||+||+|.. ..+..||||+++.. ......+..|++++.+++|. ||+++++++
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV--PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc--hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 3444578899899999999999999986 45788999998632 22234566788888887665 488898888
Q ss_pred eeC-CeEEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCC--
Q 003278 580 TEQ-GEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDM-- 656 (834)
Q Consensus 580 ~~~-~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~-- 656 (834)
... +..++|||++ +++|.+++...+ .+++.....|+.||+.||+|||+. .+||||||||+||||+.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~~------~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~ 271 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKHG------PFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTV 271 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcc
Confidence 654 5788999988 566777765432 488888999999999999999962 4899999999999998765
Q ss_pred --------------CceEeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhC
Q 003278 657 --------------NPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTG 722 (834)
Q Consensus 657 --------------~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG 722 (834)
.+||+|||++.... ......+||+.|||||++.+..|+.++|||||||++|||+||
T Consensus 272 ~~~~~~~~~~~~~~~vkl~DfG~~~~~~----------~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG 341 (467)
T PTZ00284 272 VDPVTNRALPPDPCRVRICDLGGCCDER----------HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTG 341 (467)
T ss_pred cccccccccCCCCceEEECCCCccccCc----------cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhC
Confidence 48999999875321 112356899999999999999999999999999999999999
Q ss_pred CCccCCCC
Q 003278 723 QMAVDFRL 730 (834)
Q Consensus 723 ~~p~~~~~ 730 (834)
+.||+...
T Consensus 342 ~~pf~~~~ 349 (467)
T PTZ00284 342 KLLYDTHD 349 (467)
T ss_pred CCCCCCCC
Confidence 99997543
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=330.61 Aligned_cols=246 Identities=20% Similarity=0.282 Sum_probs=190.1
Q ss_pred cccccCCcEEEEEEEC-CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEeccCCCchh
Q 003278 520 RVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRILS 598 (834)
Q Consensus 520 ~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~~~g~L~ 598 (834)
.+|+|.||+||.|+.. +...+|||.+....+ ...+-+..||.+.++|+|.|||+++|.|.+++.+.|.||-+|||+|.
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekds-r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS-REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccc-hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 4799999999999954 455689999865443 33456788999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeec-CCCCceEeeeeeccccccCCCCCc
Q 003278 599 HLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLD-PDMNPRLGSFALAEFLTRNDHGHR 677 (834)
Q Consensus 599 ~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld-~~~~~ki~DfGla~~~~~~~~~~~ 677 (834)
.+|+..=.+.. -.+.+.--+.+||++||.|||+ ..|||||||-.|||++ -.|.+||+|||-++.+..-
T Consensus 661 sLLrskWGPlK---DNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi----- 729 (1226)
T KOG4279|consen 661 SLLRSKWGPLK---DNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI----- 729 (1226)
T ss_pred HHHHhccCCCc---cchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhccC-----
Confidence 99986422111 1344455688999999999997 6899999999999997 5789999999999865432
Q ss_pred ccccCccccccccCccchhccccCC--CCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcccccccc
Q 003278 678 KATSGNRSVRGIFGYMSPEYIESGE--ATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDL 755 (834)
Q Consensus 678 ~~~~~~~~~~Gt~~Y~aPE~~~~~~--~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 755 (834)
.+.+.++.||..|||||++..|+ |+..+|||||||++.||.||+.||...-.+...+-.+- +... . |
T Consensus 730 --nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVG-myKv-H-------P 798 (1226)
T KOG4279|consen 730 --NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVG-MYKV-H-------P 798 (1226)
T ss_pred --CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhc-ceec-C-------C
Confidence 23456789999999999998765 78899999999999999999999964332222111111 1111 1 1
Q ss_pred ccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 756 SLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 756 ~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
.+ +.+--.+....+++|..+||.+||++.++++
T Consensus 799 ~i----Peelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 799 PI----PEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CC----cHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 11 1222234556778999999999999999875
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=309.79 Aligned_cols=255 Identities=26% Similarity=0.400 Sum_probs=196.0
Q ss_pred CCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC------hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEE
Q 003278 112 GFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG------ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLL 185 (834)
Q Consensus 112 ~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~------~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 185 (834)
+|...+.||+|+||.||+|.. .+|..+|||.+.... ....+.+.+|+.++++++|+||++++++|.+.+..++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 367788999999999999987 578999999875431 2234568899999999999999999999999999999
Q ss_pred EEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccch
Q 003278 186 VYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLA 265 (834)
Q Consensus 186 V~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla 265 (834)
||||+++++|.+++.+. .++++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||++
T Consensus 80 v~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~ 149 (265)
T cd06631 80 FMEFVPGGSISSILNRF-------GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCA 149 (265)
T ss_pred EEecCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhh
Confidence 99999999999998643 3578899999999999999999985 8999999999999999999999999998
Q ss_pred hhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccch
Q 003278 266 RWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQII 345 (834)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~ 345 (834)
+........ ...........||..|+|||++... .++.++|||||||++|||+||+.||.......
T Consensus 150 ~~~~~~~~~----------~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--- 215 (265)
T cd06631 150 RRLAWVGLH----------GTHSNMLKSMHGTPYWMAPEVINES-GYGRKSDIWSIGCTVFEMATGKPPLASMDRLA--- 215 (265)
T ss_pred Hhhhhcccc----------ccccccccccCCCccccChhhhcCC-CCcchhhHHHHHHHHHHHHhCCCccccCChHH---
Confidence 754221000 0000112335689999999998654 56889999999999999999999986432111
Q ss_pred HHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 346 LLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 346 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
.........+. .+.+. ..+ ...+..++..||+.+|.+||++.+|+.
T Consensus 216 --~~~~~~~~~~~-----~~~~~-~~~----~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 216 --AMFYIGAHRGL-----MPRLP-DSF----SAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred --HHHHhhhccCC-----CCCCC-CCC----CHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000011 11111 111 245788999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=312.35 Aligned_cols=251 Identities=24% Similarity=0.415 Sum_probs=197.1
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEcc
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYM 190 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 190 (834)
.+|+..+.||+|+||.||+|.+. ++..+|+|.+.... .....|.+|+.++++++||||+++++++......++||||+
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 45777889999999999999984 57789999886432 23457899999999999999999999999999999999999
Q ss_pred CCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhh
Q 003278 191 PNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEH 270 (834)
Q Consensus 191 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~ 270 (834)
++|+|.+++.... ..++|..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++....
T Consensus 82 ~~~~L~~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 152 (256)
T cd05112 82 EHGCLSDYLRAQR------GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLD 152 (256)
T ss_pred CCCcHHHHHHhCc------cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeeccc
Confidence 9999999986432 3588999999999999999999985 899999999999999999999999999875422
Q ss_pred hhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccchHHHH
Q 003278 271 ELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQIILLDW 349 (834)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~ 349 (834)
... .......++.+|+|||++..+ .++.++|||||||++|||++ |+.|+..... ...
T Consensus 153 ~~~---------------~~~~~~~~~~~~~aPe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~~ 210 (256)
T cd05112 153 DQY---------------TSSTGTKFPVKWSSPEVFSFS-KYSSKSDVWSFGVLMWEVFSEGKTPYENRSN------SEV 210 (256)
T ss_pred Ccc---------------cccCCCccchhhcCHhHhccC-CcChHHHHHHHHHHHHHHHcCCCCCCCcCCH------HHH
Confidence 100 001122356789999988654 57889999999999999998 8888864221 111
Q ss_pred HHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHh
Q 003278 350 IRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAV 405 (834)
Q Consensus 350 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l 405 (834)
...+. ++. ....+.. ....+.+++.+||+.+|++||+|.+|++.|
T Consensus 211 ~~~~~-~~~--~~~~~~~--------~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 211 VETIN-AGF--RLYKPRL--------ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred HHHHh-CCC--CCCCCCC--------CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 11111 111 1111111 125688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=312.49 Aligned_cols=255 Identities=22% Similarity=0.333 Sum_probs=195.9
Q ss_pred cCcCCcccccCCcEEEEEEECCCcEEEEEEecCCCC-----hhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEE
Q 003278 515 FSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKC-----PALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIY 589 (834)
Q Consensus 515 f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~-----~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~ 589 (834)
|...+.||.|+||.||+|...++..+|||.+..... ......+.+|++++++++||||++++++|.+.+..+++|
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM 81 (265)
T ss_pred ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence 455678999999999999988889999998864422 122356889999999999999999999999999999999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccc
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFL 669 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~ 669 (834)
||+++++|.+++...+ .+++.....++.|++.||+|||+ .+|+|+||||+||++++++.+||+|||++...
T Consensus 82 e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 82 EFVPGGSISSILNRFG------PLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred ecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 9999999999986532 36788888999999999999996 68999999999999999999999999998764
Q ss_pred ccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcc
Q 003278 670 TRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPL 749 (834)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
...... ...........||..|+|||++.+..++.++|||||||++|||+||+.|+......... ..........
T Consensus 153 ~~~~~~-~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~ 227 (265)
T cd06631 153 AWVGLH-GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM----FYIGAHRGLM 227 (265)
T ss_pred hhcccc-ccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHH----HHhhhccCCC
Confidence 321110 01111123457899999999999888999999999999999999999998643221111 1111110111
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 750 AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 750 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
+.+...+. . .+..++.+||+.+|++|||+.+|++
T Consensus 228 -----~~~~~~~~-~---~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 228 -----PRLPDSFS-A---AAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -----CCCCCCCC-H---HHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11112222 2 3455666899999999999999874
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=309.70 Aligned_cols=251 Identities=24% Similarity=0.381 Sum_probs=199.9
Q ss_pred CCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEc
Q 003278 112 GFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDY 189 (834)
Q Consensus 112 ~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 189 (834)
+|+..+.||+|+||.||++....+|+.||+|.+... .....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 377789999999999999999889999999998643 234456789999999999999999999999999999999999
Q ss_pred cCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhh
Q 003278 190 MPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLE 269 (834)
Q Consensus 190 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~ 269 (834)
+++++|.+++.... ...+++.++..++.|++.||.|||+. +++|+||+|+|||++.++.++|+|||++....
T Consensus 81 ~~~~~l~~~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~ 152 (256)
T cd08218 81 CEGGDLYKKINAQR-----GVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLN 152 (256)
T ss_pred CCCCcHHHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecC
Confidence 99999999886432 23578999999999999999999985 99999999999999999999999999987543
Q ss_pred hhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHH
Q 003278 270 HELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDW 349 (834)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~ 349 (834)
..... .....|++.|+|||++..+ ..+.++|||||||+++||+||+.|+.... ..+.
T Consensus 153 ~~~~~----------------~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~------~~~~ 209 (256)
T cd08218 153 STVEL----------------ARTCIGTPYYLSPEICENR-PYNNKSDIWALGCVLYEMCTLKHAFEAGN------MKNL 209 (256)
T ss_pred cchhh----------------hhhccCCccccCHHHhCCC-CCCCccchhHHHHHHHHHHcCCCCccCCC------HHHH
Confidence 22110 1223588999999988654 57889999999999999999999986421 1112
Q ss_pred HHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 350 IRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 350 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
+..... +... ... ... ...+.+++..||+.+|.+||+|.+|++.
T Consensus 210 ~~~~~~-~~~~-----~~~-~~~----~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 210 VLKIIR-GSYP-----PVS-SHY----SYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred HHHHhc-CCCC-----CCc-ccC----CHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 222111 1111 010 111 2357889999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=332.21 Aligned_cols=210 Identities=18% Similarity=0.213 Sum_probs=173.5
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCC--ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSK--CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIY 589 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~ 589 (834)
++|...+.||+|+||.||++... ++..||||.+.... .......+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 35777889999999999999864 58899999986421 2233467888999999999999999999999999999999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccc
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFL 669 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~ 669 (834)
||+++|+|.+++.... .+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+
T Consensus 81 E~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~ 151 (360)
T cd05627 81 EFLPGGDMMTLLMKKD------TLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGL 151 (360)
T ss_pred eCCCCccHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCccc
Confidence 9999999999986532 37788888999999999999996 69999999999999999999999999998754
Q ss_pred ccCCCCCc----------------------------ccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh
Q 003278 670 TRNDHGHR----------------------------KATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT 721 (834)
Q Consensus 670 ~~~~~~~~----------------------------~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t 721 (834)
........ .......+.+||+.|||||++.+..++.++|||||||++|||+|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~t 231 (360)
T cd05627 152 KKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231 (360)
T ss_pred ccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeeccc
Confidence 32110000 00000124579999999999999999999999999999999999
Q ss_pred CCCccCCCCC
Q 003278 722 GQMAVDFRLP 731 (834)
Q Consensus 722 G~~p~~~~~~ 731 (834)
|+.||....+
T Consensus 232 G~~Pf~~~~~ 241 (360)
T cd05627 232 GYPPFCSETP 241 (360)
T ss_pred CCCCCCCCCH
Confidence 9999975544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=332.53 Aligned_cols=263 Identities=25% Similarity=0.256 Sum_probs=193.3
Q ss_pred cCCCCCCCeeeccCCeEEEEEEEC--CCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLP--SDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~--~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 187 (834)
...|...+.||+|+||.||+|... .++..||||.+... +.+.+|+.+|++++|||||++++++...+..++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 356999999999999999999764 34678999987643 23567999999999999999999999999999999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
||+. ++|..++.. ...++|..++.|+.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 166 e~~~-~~l~~~l~~-------~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~ 234 (392)
T PHA03207 166 PKYK-CDLFTYVDR-------SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACK 234 (392)
T ss_pred hhcC-CCHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccc
Confidence 9986 688888732 24689999999999999999999985 999999999999999999999999999975
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccch-H
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQII-L 346 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~-l 346 (834)
+..... ........||+.|+|||++... .++.++|||||||++|||++|+.||.......... +
T Consensus 235 ~~~~~~--------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l 299 (392)
T PHA03207 235 LDAHPD--------------TPQCYGWSGTLETNSPELLALD-PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQL 299 (392)
T ss_pred cCcccc--------------cccccccccccCccCHhHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHH
Confidence 432110 0112345699999999988654 67899999999999999999999986433221111 1
Q ss_pred HHHHHHHhhcCc-----------------cccccccccCCCCC--CHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 347 LDWIRRLSDEGK-----------------VLQAGDNRLSDGSY--KLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 347 ~~~~~~~~~~~~-----------------~~~~~d~~l~~~~~--~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
...+. ...... ......+....... .......+..+...|+..||++||++.+++..
T Consensus 300 ~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 300 RSIIR-CMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHHH-HhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 11111 000000 00000000000000 00001245678889999999999999999864
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=311.23 Aligned_cols=249 Identities=21% Similarity=0.327 Sum_probs=197.0
Q ss_pred hCcCcCCcccccCCcEEEEEEECC-CcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDN-HQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~-~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
++|...+.||+|+||.||+|...+ +..+++|.+..... .+.|.+|++++++++||||++++|++.+....++++||
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH---HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 567778889999999999999765 78899999864322 56899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccccc
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTR 671 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~ 671 (834)
+++++|.+++.... ..++|.....++.|++.||.|||+ .+|+||||+|+||++++++.+||+|||++.....
T Consensus 80 ~~~~~L~~~l~~~~-----~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~ 151 (256)
T cd06612 80 CGAGSVSDIMKITN-----KTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD 151 (256)
T ss_pred CCCCcHHHHHHhCc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhccc
Confidence 99999999986433 248899999999999999999996 5899999999999999999999999999976543
Q ss_pred CCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcccc
Q 003278 672 NDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAE 751 (834)
Q Consensus 672 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
... ......|+..|+|||++.+..++.++|||||||++|||+||+.|+....+...... . .....
T Consensus 152 ~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~----~--~~~~~-- 216 (256)
T cd06612 152 TMA-------KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM----I--PNKPP-- 216 (256)
T ss_pred Ccc-------ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh----h--ccCCC--
Confidence 210 11234588999999999988999999999999999999999999864333211100 0 00000
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 752 LVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 752 ~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
+.+. .....-..+.+++.+||+.||++|||+.+|++
T Consensus 217 ---~~~~--~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 217 ---PTLS--DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred ---CCCC--chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 0000 00011123555666999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=324.86 Aligned_cols=238 Identities=20% Similarity=0.216 Sum_probs=181.2
Q ss_pred CcccccCCcEEEEEEE-CCCcEEEEEEecCCC--ChhHHHHHHHHH-HHHHhccCCCceeEEEEEeeCCeEEEEEeccCC
Q 003278 519 QRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSK--CPALRTRFSNEL-QNLARLRHRNLVQLCGWCTEQGEMLVIYDYSAT 594 (834)
Q Consensus 519 ~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~--~~~~~~~f~~E~-~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~~~ 594 (834)
+.||+|+||.||+|.. .++..||+|.+.... .......+..|. .+++.++|||||++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3589999999999996 457899999986432 112234455555 467889999999999999999999999999999
Q ss_pred CchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCCC
Q 003278 595 RILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDH 674 (834)
Q Consensus 595 g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~~ 674 (834)
|+|..++.... .++......++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~~L~~~l~~~~------~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~- 150 (321)
T cd05603 81 GELFFHLQRER------CFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE- 150 (321)
T ss_pred CCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-
Confidence 99988875432 36677777899999999999996 699999999999999999999999999987432111
Q ss_pred CCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCccccccc
Q 003278 675 GHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVD 754 (834)
Q Consensus 675 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 754 (834)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||...... .+...+ . ..+.
T Consensus 151 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i---~--~~~~----- 213 (321)
T cd05603 151 ------ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS-QMYDNI---L--HKPL----- 213 (321)
T ss_pred ------CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH-HHHHHH---h--cCCC-----
Confidence 1123457999999999999889999999999999999999999998643221 111111 1 1110
Q ss_pred cccCCCCCHHHHHHHHHHHHHhccCCCCCCCChh
Q 003278 755 LSLNGEYNHKELMRLIKLGIACTLSNPELRPSMR 788 (834)
Q Consensus 755 ~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~ 788 (834)
.+..... ..+..+..+|++.||.+||+..
T Consensus 214 -~~~~~~~----~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 214 -QLPGGKT----VAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred -CCCCCCC----HHHHHHHHHHccCCHhhcCCCC
Confidence 1111111 2345566689999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=316.27 Aligned_cols=258 Identities=26% Similarity=0.386 Sum_probs=200.2
Q ss_pred hhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhC-CCCceeeEeeeEEeCC-----
Q 003278 108 IGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHL-RHRNLVRLRGWCVHED----- 181 (834)
Q Consensus 108 ~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~----- 181 (834)
.++++|+..+.||+|+||.||+|....++..+|+|.+..... ..+.|.+|+.+++++ +|+||++++++|....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 457889999999999999999999988899999999865433 346789999999999 7999999999997654
Q ss_pred -EEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEe
Q 003278 182 -QLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLG 260 (834)
Q Consensus 182 -~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~ 260 (834)
.+++||||+++++|.+++..... ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~ 155 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRK---KGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLV 155 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEEC
Confidence 48999999999999998864321 135689999999999999999999985 99999999999999999999999
Q ss_pred eccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCcccccc----CCCCCcccceeehhhHHHHHHhCCccCC
Q 003278 261 DFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQK----GSVATAKSDVFSFGIVVLEVVSGRRAVD 336 (834)
Q Consensus 261 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~----~~~~~~ksDV~SfGvvl~ElltG~~p~~ 336 (834)
|||++........ ......||+.|+|||.+.. ...++.++|||||||+++||+||+.||.
T Consensus 156 d~~~~~~~~~~~~----------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 219 (275)
T cd06608 156 DFGVSAQLDSTLG----------------RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLC 219 (275)
T ss_pred CCccceecccchh----------------hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcc
Confidence 9999875422110 1123458999999998743 2346788999999999999999999986
Q ss_pred CCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 337 LTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 337 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
..... ..+. ... .+ ..+.+.. ...-...+.+++..||..||.+||++.++++
T Consensus 220 ~~~~~--~~~~----~~~-~~-----~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 220 DMHPM--RALF----KIP-RN-----PPPTLKS---PENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ccchH--HHHH----Hhh-cc-----CCCCCCc---hhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 32111 1111 111 01 1111110 1111246788999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=312.73 Aligned_cols=253 Identities=27% Similarity=0.385 Sum_probs=195.4
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEcc
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYM 190 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 190 (834)
++|...+.||+|+||.||+|.+. .+..||+|.+.... ...+.|.+|+.++++++||||+++++++. .+..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWN-GTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEc-CCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 45778889999999999999985 44569999876432 34567899999999999999999999875 55689999999
Q ss_pred CCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhh
Q 003278 191 PNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEH 270 (834)
Q Consensus 191 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~ 270 (834)
++|+|.+++.... ...++|..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||+++.+..
T Consensus 83 ~~~~L~~~~~~~~-----~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05069 83 GKGSLLDFLKEGD-----GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIED 154 (260)
T ss_pred CCCCHHHHHhhCC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccC
Confidence 9999999996532 23589999999999999999999985 899999999999999999999999999975422
Q ss_pred hhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccchHHHH
Q 003278 271 ELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQIILLDW 349 (834)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~ 349 (834)
... .......++..|+|||+...+ .++.++|||||||++|||+| |+.|+..... .....+
T Consensus 155 ~~~---------------~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~ 215 (260)
T cd05069 155 NEY---------------TARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMVN---REVLEQ 215 (260)
T ss_pred Ccc---------------cccCCCccchhhCCHHHhccC-CcChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH
Confidence 100 001122367889999988654 57899999999999999999 8888754221 111122
Q ss_pred HHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhc
Q 003278 350 IRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSG 407 (834)
Q Consensus 350 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~ 407 (834)
+. .... .... ......+.+++.+||+.+|.+||++.+|++.|+.
T Consensus 216 ~~---~~~~------~~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 216 VE---RGYR------MPCP-----QGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HH---cCCC------CCCC-----cccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11 1100 0000 0112467889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=309.65 Aligned_cols=255 Identities=29% Similarity=0.443 Sum_probs=199.5
Q ss_pred CeeeccCCeEEEEEEECCC---CeEEEEEEecccChh-hHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEccCC
Q 003278 117 EVLGSGGFGKVYRAVLPSD---GTVVAVKCLAEKGER-FEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPN 192 (834)
Q Consensus 117 ~~LG~G~fG~Vy~~~~~~~---g~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 192 (834)
+.||+|+||.||+|..... +..||||.+...... ..+.+.+|+..+..++|+||+++++++...+..++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 4799999999999999765 889999998765333 367889999999999999999999999999999999999999
Q ss_pred CCHhHHHhcCCCc--cccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhh
Q 003278 193 RSLDRVLFRRPEN--LEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEH 270 (834)
Q Consensus 193 gsL~~~l~~~~~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~ 270 (834)
++|.+++...... ......+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||.++....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999998754210 00125689999999999999999999985 999999999999999999999999999986533
Q ss_pred hhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccchHHHH
Q 003278 271 ELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQIILLDW 349 (834)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~ 349 (834)
... ........+++.|+|||.+... .++.++|||||||++|||++ |+.|+..... ..+
T Consensus 158 ~~~--------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~--- 216 (262)
T cd00192 158 DDY--------------YRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSN---EEV--- 216 (262)
T ss_pred ccc--------------cccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCCCCH---HHH---
Confidence 210 0112334578999999988665 67899999999999999999 5888865421 111
Q ss_pred HHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhh
Q 003278 350 IRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVS 406 (834)
Q Consensus 350 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~ 406 (834)
...+.. +.... .. ... ...+.+++..||+.+|.+||++.++++.|+
T Consensus 217 ~~~~~~-~~~~~-----~~-~~~----~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 217 LEYLRK-GYRLP-----KP-EYC----PDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHHHHc-CCCCC-----CC-ccC----ChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 111111 11111 00 011 246889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=319.56 Aligned_cols=265 Identities=23% Similarity=0.303 Sum_probs=195.9
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC-hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEc
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG-ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDY 189 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 189 (834)
++|+..+.||+|+||.||+|..+.+++.||||.+.... ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888899999999999999998899999999986432 22234577899999999999999999999999999999999
Q ss_pred cCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhh
Q 003278 190 MPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLE 269 (834)
Q Consensus 190 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~ 269 (834)
+++ +|.+++.... ..+++.....++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 85 ~~~-~L~~~~~~~~------~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 154 (291)
T cd07844 85 LDT-DLKQYMDDCG------GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKS 154 (291)
T ss_pred CCC-CHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccC
Confidence 985 9998886532 3578999999999999999999985 99999999999999999999999999986431
Q ss_pred hhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHH
Q 003278 270 HELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDW 349 (834)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~ 349 (834)
... ...+...++..|+|||.+.....++.++|||||||++|||++|+.||.......+ ...-
T Consensus 155 ~~~----------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~--~~~~ 216 (291)
T cd07844 155 VPS----------------KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED--QLHK 216 (291)
T ss_pred CCC----------------ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHH
Confidence 100 0012234688999999886555578899999999999999999999864321111 0000
Q ss_pred HHHHhhc---Cccccc-------------c-ccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 350 IRRLSDE---GKVLQA-------------G-DNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 350 ~~~~~~~---~~~~~~-------------~-d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
+...... ...... . ...+............+.+++..|++.+|++||++.+++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 217 IFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred HHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000000 000000 0 0000000001111245678999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=309.92 Aligned_cols=254 Identities=26% Similarity=0.429 Sum_probs=204.9
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccCh-hhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEc
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGE-RFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDY 189 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 189 (834)
++|+..+.||+|+||.||+|....++..||||++..... ...+.+.+|+..+.+++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 468888999999999999999988899999999876543 4567899999999999999999999999999999999999
Q ss_pred cCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHh-ccCCCeecCCCCCCceEECCCCceEEeeccchhhh
Q 003278 190 MPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHE-QLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWL 268 (834)
Q Consensus 190 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~ 268 (834)
+++++|.+++... .++++..+..++.|+++||+|||+ . +++||||+|+||+++.++.++|+|||++..+
T Consensus 81 ~~~~~L~~~l~~~-------~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~ 150 (264)
T cd06623 81 MDGGSLADLLKKV-------GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVL 150 (264)
T ss_pred cCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceec
Confidence 9999999998643 468899999999999999999998 5 9999999999999999999999999998754
Q ss_pred hhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHH
Q 003278 269 EHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLD 348 (834)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~ 348 (834)
.... .......|+..|+|||.+... .++.++||||||+++|||+||+.|+..........+..
T Consensus 151 ~~~~----------------~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~ 213 (264)
T cd06623 151 ENTL----------------DQCNTFVGTVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQ 213 (264)
T ss_pred ccCC----------------CcccceeecccccCHhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHH
Confidence 3211 011244688999999988655 67889999999999999999999986543212222222
Q ss_pred HHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 349 WIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 349 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
++. . ... +.+.... ....+.+++..|+..+|++||++.++++.
T Consensus 214 ~~~---~-~~~-----~~~~~~~----~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 214 AIC---D-GPP-----PSLPAEE----FSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HHh---c-CCC-----CCCCccc----CCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 221 1 111 1111000 12468889999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=309.69 Aligned_cols=251 Identities=25% Similarity=0.385 Sum_probs=201.3
Q ss_pred CCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEc
Q 003278 112 GFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDY 189 (834)
Q Consensus 112 ~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 189 (834)
+|+..+.||+|+||.||.+....++..+++|.+... .....+.+.+|+.++++++|+||+++++++.+.+.+++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 477889999999999999999889999999987643 344556788999999999999999999999999999999999
Q ss_pred cCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhh
Q 003278 190 MPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLE 269 (834)
Q Consensus 190 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~ 269 (834)
+++|+|.+++.... ...+++.++..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus 81 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~ 152 (256)
T cd08221 81 ANGGTLYDKIVRQK-----GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILG 152 (256)
T ss_pred cCCCcHHHHHHhcc-----ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcc
Confidence 99999999986542 24689999999999999999999985 89999999999999999999999999987543
Q ss_pred hhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHH
Q 003278 270 HELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDW 349 (834)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~ 349 (834)
.... ......||+.|+|||.+... ..+.++|||||||+++||++|+.|++..... ..
T Consensus 153 ~~~~----------------~~~~~~~~~~y~ape~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~ 209 (256)
T cd08221 153 SEYS----------------MAETVVGTPYYMSPELCQGV-KYNFKSDIWALGCVLYELLTLKRTFDATNPL------NL 209 (256)
T ss_pred cccc----------------cccccCCCccccCHhhcCCC-CCCCcchhHHHHHHHHHHHHCCCCCCCCCHH------HH
Confidence 2110 12234589999999988644 5688999999999999999999998643211 11
Q ss_pred HHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 350 IRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 350 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
..... .+...... ... ...+.+++..||+.+|.+||++.++++.
T Consensus 210 ~~~~~-~~~~~~~~------~~~----~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 210 VVKIV-QGNYTPVV------SVY----SSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred HHHHH-cCCCCCCc------ccc----CHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 21211 12211110 111 2357789999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=330.62 Aligned_cols=199 Identities=18% Similarity=0.223 Sum_probs=164.8
Q ss_pred HhhCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCC-ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeC------
Q 003278 511 ATNNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSK-CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQ------ 582 (834)
Q Consensus 511 at~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~-~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~------ 582 (834)
..++|...+.||+|+||.||++.. ..+..||||.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 346788889999999999999985 457889999987532 233456788999999999999999999987543
Q ss_pred CeEEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEee
Q 003278 583 GEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGS 662 (834)
Q Consensus 583 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~D 662 (834)
...++||||+.++ |.+.+.. .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|
T Consensus 95 ~~~~lv~e~~~~~-l~~~~~~--------~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~D 162 (355)
T cd07874 95 QDVYLVMELMDAN-LCQVIQM--------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILD 162 (355)
T ss_pred ceeEEEhhhhccc-HHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEee
Confidence 3579999999764 5454431 26788888999999999999996 6999999999999999999999999
Q ss_pred eeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCC
Q 003278 663 FALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFR 729 (834)
Q Consensus 663 fGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~ 729 (834)
||+++..... .......||..|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 163 fg~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 221 (355)
T cd07874 163 FGLARTAGTS--------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_pred CcccccCCCc--------cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999754221 1122457899999999999889999999999999999999999998643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=312.58 Aligned_cols=254 Identities=22% Similarity=0.384 Sum_probs=199.5
Q ss_pred hCcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEecc
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYS 592 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~ 592 (834)
++|...+.||+|+||.||+|..+++..||||.+..... ..+.|.+|+.++++++||||+++++++......++||||+
T Consensus 6 ~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM--SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc--CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 46777788999999999999988888899999875432 2367899999999999999999999999888999999999
Q ss_pred CCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccC
Q 003278 593 ATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRN 672 (834)
Q Consensus 593 ~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~ 672 (834)
++++|.+++.... ...+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+|++|||++..+...
T Consensus 84 ~~~~L~~~i~~~~----~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 84 SKGSLLDFLKSGE----GKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred CCCCHHHHHhccc----cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccch
Confidence 9999999986532 1248899999999999999999996 68999999999999999999999999998765321
Q ss_pred CCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCcccc
Q 003278 673 DHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRPLAE 751 (834)
Q Consensus 673 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
.. .......++..|+|||.+.+..++.++|||||||++|||+| |+.|+....... ....... . ...
T Consensus 157 ~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-~~~~~~~---~---~~~ 223 (261)
T cd05034 157 EY------TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE-VLEQVER---G---YRM 223 (261)
T ss_pred hh------hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHc---C---CCC
Confidence 10 01112235678999999998889999999999999999999 888885433221 1111111 0 000
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHcc
Q 003278 752 LVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDG 796 (834)
Q Consensus 752 ~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~ 796 (834)
...... +. .+.+++.+||..+|++||++.++.+.|+.
T Consensus 224 ----~~~~~~-~~---~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 ----PRPPNC-PE---ELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ----CCCCCC-CH---HHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 000111 22 45566779999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=313.14 Aligned_cols=256 Identities=27% Similarity=0.399 Sum_probs=198.3
Q ss_pred CCCCCCeeeccCCeEEEEEEECC-CCeEEEEEEeccc----------ChhhHHHHHHHHHHHHh-CCCCceeeEeeeEEe
Q 003278 112 GFDEDEVLGSGGFGKVYRAVLPS-DGTVVAVKCLAEK----------GERFEKTFAAELVAVAH-LRHRNLVRLRGWCVH 179 (834)
Q Consensus 112 ~f~~~~~LG~G~fG~Vy~~~~~~-~g~~vAvK~l~~~----------~~~~~~~~~~E~~~l~~-l~H~nIv~l~g~~~~ 179 (834)
+|+..+.||+|+||.||+|.+.. .+..+|||.+... .......+.+|+.++.+ ++||||++++++|..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788899999999999999976 5789999987532 12234567788888875 799999999999999
Q ss_pred CCEEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEE
Q 003278 180 EDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARL 259 (834)
Q Consensus 180 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl 259 (834)
.+..++||||+++++|.+++..... ....+++..++.++.|++.||.|||+. .+++|+||||+|||++.++.+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l 155 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKE---KKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTI 155 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEE
Confidence 9999999999999999988854211 134689999999999999999999963 38999999999999999999999
Q ss_pred eeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCC
Q 003278 260 GDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTY 339 (834)
Q Consensus 260 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~ 339 (834)
+|||++....... ..+...|+..|+|||.+..+ .++.++|||||||++|||++|+.|+....
T Consensus 156 ~dfg~~~~~~~~~-----------------~~~~~~~~~~~~~Pe~~~~~-~~~~~~Dv~slG~ll~~l~~g~~p~~~~~ 217 (269)
T cd08528 156 TDFGLAKQKQPES-----------------KLTSVVGTILYSCPEIVKNE-PYGEKADVWAFGCILYQMCTLQPPFYSTN 217 (269)
T ss_pred ecccceeeccccc-----------------ccccccCcccCcChhhhcCC-CCchHHHHHHHHHHHHHHHhCCCcccccC
Confidence 9999987532210 12344589999999998754 57899999999999999999999985321
Q ss_pred CCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhh
Q 003278 340 PDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVS 406 (834)
Q Consensus 340 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~ 406 (834)
......... ++...... ...+ ...+.+++.+||+.||++||+|.+|.+++.
T Consensus 218 ------~~~~~~~~~-~~~~~~~~-----~~~~----~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 218 ------MLSLATKIV-EAVYEPLP-----EGMY----SEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ------HHHHHHHHh-hccCCcCC-----cccC----CHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 111111111 11111110 0111 245788999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=312.28 Aligned_cols=251 Identities=23% Similarity=0.386 Sum_probs=195.9
Q ss_pred CcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEeccC
Q 003278 514 NFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSA 593 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~~ 593 (834)
+|...+.||+|+||.||+|...++..+|+|.+..... ....|.+|++++++++||||+++++++......++||||++
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM--SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC--CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4555678999999999999987778899998864332 23568999999999999999999999999999999999999
Q ss_pred CCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCC
Q 003278 594 TRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRND 673 (834)
Q Consensus 594 ~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~ 673 (834)
+++|.+++.... ..++|..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 154 (256)
T cd05112 83 HGCLSDYLRAQR-----GKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ 154 (256)
T ss_pred CCcHHHHHHhCc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCc
Confidence 999999886532 237888899999999999999996 689999999999999999999999999987543211
Q ss_pred CCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCccccc
Q 003278 674 HGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRPLAEL 752 (834)
Q Consensus 674 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (834)
. .......++.+|+|||++.++.++.++|||||||++|||++ |..|+....... ..... ....+ .
T Consensus 155 ~------~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-~~~~~---~~~~~----~ 220 (256)
T cd05112 155 Y------TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE-VVETI---NAGFR----L 220 (256)
T ss_pred c------cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH-HHHHH---hCCCC----C
Confidence 0 00112235678999999998899999999999999999998 888886433221 11111 11001 1
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHc
Q 003278 753 VDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795 (834)
Q Consensus 753 ~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~ 795 (834)
.++.. .. ..+.+++.+||+.+|++||||.+|++.|.
T Consensus 221 ~~~~~----~~---~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 221 YKPRL----AS---QSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCCCC----CC---HHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 11111 11 34667788999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=317.77 Aligned_cols=270 Identities=18% Similarity=0.210 Sum_probs=201.4
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 187 (834)
++|+..+.||+|+||.||++....+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47888999999999999999999899999999986542 223457889999999999999999999999999999999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
||+++|+|.+++... ..+++.....++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++.
T Consensus 81 e~~~g~~L~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~ 150 (305)
T cd05609 81 EYVEGGDCATLLKNI-------GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKI 150 (305)
T ss_pred ecCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccc
Confidence 999999999998542 3588999999999999999999985 999999999999999999999999999874
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHH
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILL 347 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~ 347 (834)
.............. .............|+..|+|||++... .++.++|||||||++|||+||+.||..... .
T Consensus 151 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~vl~el~~g~~pf~~~~~------~ 222 (305)
T cd05609 151 GLMSLTTNLYEGHI-EKDTREFLDKQVCGTPEYIAPEVILRQ-GYGKPVDWWAMGIILYEFLVGCVPFFGDTP------E 222 (305)
T ss_pred cCcCcccccccccc-ccchhhccccCCccCccccCchhccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH------H
Confidence 21110000000000 000000012234689999999998654 578999999999999999999999853211 1
Q ss_pred HHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhc
Q 003278 348 DWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSG 407 (834)
Q Consensus 348 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~ 407 (834)
.+...... +.. ..+... .. ....+..++..||+.+|++||++.++.+.|..
T Consensus 223 ~~~~~~~~-~~~---~~~~~~-~~----~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 223 ELFGQVIS-DDI---EWPEGD-EA----LPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHHHHHHh-ccc---CCCCcc-cc----CCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 11111111 110 111110 11 12357899999999999999998777776654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=312.13 Aligned_cols=253 Identities=21% Similarity=0.352 Sum_probs=197.0
Q ss_pred hCcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEecc
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYS 592 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~ 592 (834)
+.|...++||+|+||.||++...++..+|+|.+... ....+.|.+|++++++++|+||+++++++.+ ...+++|||+
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG--SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred cceeEEeEecCccceEEEEEEecCCccEEEEecCCC--hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 356667889999999999999888888999987643 2234679999999999999999999999887 7789999999
Q ss_pred CCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccC
Q 003278 593 ATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRN 672 (834)
Q Consensus 593 ~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~ 672 (834)
++|+|.+++.... ...++|..++.++.|++.||+|||+ .+++||||||+||+++.++.+|++|||++..+...
T Consensus 83 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 83 AKGSLLDFLKSDE----GSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred CCCcHHHHHHhCC----ccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 9999999986532 1247888999999999999999996 68999999999999999999999999999765332
Q ss_pred CCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCcccc
Q 003278 673 DHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRPLAE 751 (834)
Q Consensus 673 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
.. .......++..|+|||++..+.++.++|||||||++|||+| |..|+....... +..... . ....
T Consensus 156 ~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-~~~~~~----~-~~~~- 222 (260)
T cd05073 156 EY------TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-VIRALE----R-GYRM- 222 (260)
T ss_pred Cc------ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH-HHHHHh----C-CCCC-
Confidence 11 01112346678999999998899999999999999999999 888876432221 111111 0 1000
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHcc
Q 003278 752 LVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDG 796 (834)
Q Consensus 752 ~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~ 796 (834)
......+ ..+..++.+||+.+|++||++.++.+.|+.
T Consensus 223 ----~~~~~~~----~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 ----PRPENCP----EELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ----CCcccCC----HHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0111111 245566679999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=328.00 Aligned_cols=196 Identities=20% Similarity=0.242 Sum_probs=165.2
Q ss_pred hCcCcCCcccccCCcEEEEEEECC---CcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDN---HQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIY 589 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~---~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~ 589 (834)
..|.....||+|+||.||++...+ +..||||.+... ..+.+|+++|++++|||||++++++......++||
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG------KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 468888999999999999997533 467999987532 23567999999999999999999999999999999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccc
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFL 669 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~ 669 (834)
||+. ++|..++... ..++|..++.|+.|++.||+|||+ .+||||||||+|||++.++.+||+|||++..+
T Consensus 166 e~~~-~~l~~~l~~~------~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 166 PKYK-CDLFTYVDRS------GPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKL 235 (392)
T ss_pred hhcC-CCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence 9986 5677777322 248899999999999999999996 68999999999999999999999999999765
Q ss_pred ccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCC
Q 003278 670 TRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFR 729 (834)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~ 729 (834)
..... ........||+.|+|||++....++.++|||||||++|||++|+.||...
T Consensus 236 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 290 (392)
T PHA03207 236 DAHPD-----TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK 290 (392)
T ss_pred Ccccc-----cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 33211 11123467999999999999999999999999999999999999998643
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=325.70 Aligned_cols=243 Identities=16% Similarity=0.190 Sum_probs=188.1
Q ss_pred CcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCC--ChhHHHHHHHHHHHHHhcc-CCCceeEEEEEeeCCeEEEEE
Q 003278 514 NFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSK--CPALRTRFSNELQNLARLR-HRNLVQLCGWCTEQGEMLVIY 589 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~--~~~~~~~f~~E~~~l~~l~-HpNiv~l~g~~~~~~~~~lv~ 589 (834)
+|...+.||+|+||.||++.. .++..||+|.+.... .....+.+..|+.++..+. ||+|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 356667899999999999985 468899999986432 1223456788999998886 567888999999989999999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccc
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFL 669 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~ 669 (834)
||+++|+|.+++.... .+++.....++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++..
T Consensus 81 Ey~~~g~L~~~i~~~~------~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~ 151 (323)
T cd05615 81 EYVNGGDLMYHIQQVG------KFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEH 151 (323)
T ss_pred cCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEecccccccc
Confidence 9999999998886432 38899999999999999999996 69999999999999999999999999998753
Q ss_pred ccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcc
Q 003278 670 TRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPL 749 (834)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
.... .......||+.|||||++.+..++.++|||||||++|||+||+.||....+.. ....+.. ...
T Consensus 152 ~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~-~~~~i~~---~~~-- 218 (323)
T cd05615 152 MVDG-------VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE-LFQSIME---HNV-- 218 (323)
T ss_pred CCCC-------ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH-HHHHHHh---CCC--
Confidence 2211 11234579999999999999999999999999999999999999987543321 1111111 110
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChh
Q 003278 750 AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMR 788 (834)
Q Consensus 750 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~ 788 (834)
..+...+ . .+..+..+||+.+|.+|++..
T Consensus 219 ------~~p~~~~-~---~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 219 ------SYPKSLS-K---EAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred ------CCCccCC-H---HHHHHHHHHcccCHhhCCCCC
Confidence 0111111 2 344566689999999999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=350.69 Aligned_cols=256 Identities=19% Similarity=0.281 Sum_probs=192.5
Q ss_pred hhCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCC-ChhHHHHHHHHHHHHHhccCCCceeEEEEEee--CCeEEE
Q 003278 512 TNNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSK-CPALRTRFSNELQNLARLRHRNLVQLCGWCTE--QGEMLV 587 (834)
Q Consensus 512 t~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~--~~~~~l 587 (834)
.++|.....||+|+||+||++... .+..||+|.+.... .......|..|+.+|++|+|||||++++++.+ ...++|
T Consensus 12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI 91 (1021)
T PTZ00266 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI 91 (1021)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence 356777889999999999999964 46788999886543 33345679999999999999999999998754 456899
Q ss_pred EEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccC----CceeecccccCceeecC---------
Q 003278 588 IYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWN----EQVIHRNITSSAITLDP--------- 654 (834)
Q Consensus 588 v~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~----~~iiHrDlK~~NILld~--------- 654 (834)
||||+++|+|..+|...... ...+++...+.|+.||+.||+|||+... .+||||||||+||||+.
T Consensus 92 VMEY~~gGSL~~lL~k~~~~--~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 92 LMEFCDAGDLSRNIQKCYKM--FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEeCCCCCcHHHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 99999999999988653211 1248899999999999999999997421 46999999999999964
Q ss_pred --------CCCceEeeeeeccccccCCCCCcccccCccccccccCccchhcccc--CCCCccCcchhhHHHHHHHHhCCC
Q 003278 655 --------DMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIES--GEATSMADVYSFGVVVLEVVTGQM 724 (834)
Q Consensus 655 --------~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~k~DV~SfGvvl~E~~tG~~ 724 (834)
...+||+|||++..+.... ......||+.|||||++.. ..++.++||||||||||||+||+.
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s--------~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~ 241 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIES--------MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT 241 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccc--------cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCC
Confidence 2348999999997643211 1234579999999999854 458899999999999999999999
Q ss_pred ccCCCCCchhHHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 725 AVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 725 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
||........+...+ . ..+ .+.......+ +..++..||+.+|.+|||+.+++.
T Consensus 242 PF~~~~~~~qli~~l---k--~~p-------~lpi~~~S~e---L~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 242 PFHKANNFSQLISEL---K--RGP-------DLPIKGKSKE---LNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCCcCCcHHHHHHHH---h--cCC-------CCCcCCCCHH---HHHHHHHHhcCChhHCcCHHHHhc
Confidence 986433222221111 1 111 0110111233 445666899999999999999983
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=319.94 Aligned_cols=265 Identities=24% Similarity=0.334 Sum_probs=199.9
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYD 188 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 188 (834)
++|+..+.||+|+||.||+|.+..++..||||.+... .....+.+.+|+.++++++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 3688889999999999999999888999999988643 23445778999999999999999999999999999999999
Q ss_pred ccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhh
Q 003278 189 YMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWL 268 (834)
Q Consensus 189 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~ 268 (834)
|++++.+..++.. ...+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||++..+
T Consensus 81 ~~~~~~l~~~~~~-------~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~ 150 (288)
T cd07833 81 YVERTLLELLEAS-------PGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARAL 150 (288)
T ss_pred cCCCCHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeeccccc
Confidence 9998777765532 23478999999999999999999985 9999999999999999999999999998764
Q ss_pred hhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHH
Q 003278 269 EHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLD 348 (834)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~ 348 (834)
..... ...+...|+..|+|||++.....++.++|||||||++|||++|+.|+......+. + .
T Consensus 151 ~~~~~---------------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~--~-~ 212 (288)
T cd07833 151 RARPA---------------SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQ--L-Y 212 (288)
T ss_pred CCCcc---------------ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--H-H
Confidence 32210 0123356889999999987654678999999999999999999998864321111 1 0
Q ss_pred HHHHHh------------hcCc-----cccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 349 WIRRLS------------DEGK-----VLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 349 ~~~~~~------------~~~~-----~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
...... .... ..+..++......+.......+.+++..||..+|++||++.+|+.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 213 LIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred HHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 010000 0000 000000000000011111356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=317.21 Aligned_cols=263 Identities=24% Similarity=0.314 Sum_probs=197.1
Q ss_pred CCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC--hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEc
Q 003278 112 GFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG--ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDY 189 (834)
Q Consensus 112 ~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 189 (834)
+|+..+.||+|+||.||+|+...+|..||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 5888899999999999999998899999999886432 23345788999999999999999999999999999999999
Q ss_pred cCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhh
Q 003278 190 MPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLE 269 (834)
Q Consensus 190 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~ 269 (834)
++ ++|..++.... ...+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||+++.+.
T Consensus 81 ~~-~~l~~~~~~~~-----~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~ 151 (284)
T cd07860 81 LH-QDLKKFMDASP-----LSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 151 (284)
T ss_pred cc-cCHHHHHHhCC-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcc
Confidence 96 68888886432 24689999999999999999999985 99999999999999999999999999987542
Q ss_pred hhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHH
Q 003278 270 HELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDW 349 (834)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~ 349 (834)
... ...+...+++.|+|||.+.....++.++|||||||++|||+||+.||...... ..+...
T Consensus 152 ~~~----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~ 213 (284)
T cd07860 152 VPV----------------RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--DQLFRI 213 (284)
T ss_pred cCc----------------cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHH
Confidence 210 00123347899999998866555688999999999999999999998643211 111111
Q ss_pred HHHHhhc---------------CccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 350 IRRLSDE---------------GKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 350 ~~~~~~~---------------~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
...+... ..........+.. ... .-...+.++...|++.||.+||++.+++.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 214 FRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSK-VVP-PLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHhCCCChhhhhhhhHHHHHHhhcccccccCHHH-Hcc-cCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 1110000 0000000000000 000 00134678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=320.78 Aligned_cols=254 Identities=26% Similarity=0.411 Sum_probs=201.3
Q ss_pred CCCCCeeeccCCeEEEEEEECCC----CeEEEEEEeccc-ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEE
Q 003278 113 FDEDEVLGSGGFGKVYRAVLPSD----GTVVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 113 f~~~~~LG~G~fG~Vy~~~~~~~----g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 187 (834)
....++||+|-||.||+|+.... ...||||.-+.. .....+.|+.|..+|++++|||||+|+|.|.+. ..|+||
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wivm 469 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVM 469 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEE
Confidence 34457899999999999987432 245899977653 344578899999999999999999999999864 689999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
|+++-|.|..+|..++. .|+......++.||+.||+|||+. .+|||||...|||+.+...+||+||||+|+
T Consensus 470 EL~~~GELr~yLq~nk~------sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 470 ELAPLGELREYLQQNKD------SLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRY 540 (974)
T ss_pred ecccchhHHHHHHhccc------cchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhh
Confidence 99999999999987643 477788899999999999999995 999999999999999999999999999999
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccchH
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQIIL 346 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l 346 (834)
+..+..|.. +...=...|||||.+.-. .+|..||||=|||.+||+++ |.+||..-...+-+.
T Consensus 541 ~ed~~yYka---------------S~~kLPIKWmaPESINfR-rFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~- 603 (974)
T KOG4257|consen 541 LEDDAYYKA---------------SRGKLPIKWMAPESINFR-RFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG- 603 (974)
T ss_pred ccccchhhc---------------cccccceeecCccccchh-cccchhhHHHHHHHHHHHHHhcCCccccccccceEE-
Confidence 887765421 122235789999998654 67999999999999999886 999997543332111
Q ss_pred HHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcCC
Q 003278 347 LDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGSY 409 (834)
Q Consensus 347 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~~ 409 (834)
....|..+... ......+..|+..||..+|.+||.+.++...|+.++
T Consensus 604 ------~iEnGeRlP~P----------~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~ 650 (974)
T KOG4257|consen 604 ------HIENGERLPCP----------PNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL 650 (974)
T ss_pred ------EecCCCCCCCC----------CCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence 01122222211 122357889999999999999999999988776543
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=318.91 Aligned_cols=263 Identities=19% Similarity=0.272 Sum_probs=201.4
Q ss_pred ccHHHHHHHhhCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhc-cCCCceeEEEEEe
Q 003278 503 ISFKEIISATNNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARL-RHRNLVQLCGWCT 580 (834)
Q Consensus 503 ~~~~el~~at~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l-~HpNiv~l~g~~~ 580 (834)
+++.++..++++|...+.||+|+||.||++.. .+++.+|+|.+.... .....+.+|+.++.++ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS--DVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc--cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 55677778899999999999999999999986 568889999886432 2235678899999999 8999999999987
Q ss_pred eC-----CeEEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCC
Q 003278 581 EQ-----GEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPD 655 (834)
Q Consensus 581 ~~-----~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~ 655 (834)
.. +..++||||+++|+|.+++..... ....++|..+..++.|++.||+|||+ .+|+||||||+||+++++
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~ 164 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLI--CGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTE 164 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCC
Confidence 54 358999999999999998764211 12247899999999999999999996 699999999999999999
Q ss_pred CCceEeeeeeccccccCCCCCcccccCccccccccCccchhccccCC-----CCccCcchhhHHHHHHHHhCCCccCCCC
Q 003278 656 MNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGE-----ATSMADVYSFGVVVLEVVTGQMAVDFRL 730 (834)
Q Consensus 656 ~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-----~~~k~DV~SfGvvl~E~~tG~~p~~~~~ 730 (834)
+.+||+|||++..+..... ......|+..|+|||++..+. ++.++|||||||++|||+||+.|+....
T Consensus 165 ~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~ 237 (291)
T cd06639 165 GGVKLVDFGVSAQLTSTRL-------RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH 237 (291)
T ss_pred CCEEEeecccchhcccccc-------cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCc
Confidence 9999999999876542211 112346889999999986443 6889999999999999999999986443
Q ss_pred CchhHHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 731 PEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
+...+. ... ......+.++ .+....+..++.+||+.+|++||++.+|++
T Consensus 238 ~~~~~~----~~~--~~~~~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 238 PVKTLF----KIP--RNPPPTLLHP-------EKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HHHHHH----HHh--cCCCCCCCcc-------cccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 221111 111 1111111111 111234667778999999999999999985
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=313.05 Aligned_cols=256 Identities=28% Similarity=0.418 Sum_probs=201.1
Q ss_pred hcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEE
Q 003278 109 GSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYD 188 (834)
Q Consensus 109 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 188 (834)
..++|...+.||+|+||.||+|.+. ++..||||.+.... ...+.+.+|+.++++++|+||+++++++...+..++|||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 4567999999999999999999984 56889999987542 335678999999999999999999999999899999999
Q ss_pred ccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhh
Q 003278 189 YMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWL 268 (834)
Q Consensus 189 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~ 268 (834)
|+++++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||+++.+
T Consensus 82 ~~~~~~L~~~i~~~~-----~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~ 153 (261)
T cd05034 82 YMSKGSLLDFLKSGE-----GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLI 153 (261)
T ss_pred ccCCCCHHHHHhccc-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceec
Confidence 999999999996532 24689999999999999999999985 8999999999999999999999999999765
Q ss_pred hhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccchHH
Q 003278 269 EHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQIILL 347 (834)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~ 347 (834)
...... ......++..|+|||.+... .++.++|||||||+++||+| |+.|+..... ....
T Consensus 154 ~~~~~~---------------~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~~~~ 214 (261)
T cd05034 154 EDDEYT---------------AREGAKFPIKWTAPEAANYG-RFTIKSDVWSFGILLTEIVTYGRVPYPGMTN---REVL 214 (261)
T ss_pred cchhhh---------------hhhccCCCccccCHHHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHH
Confidence 422110 01112246789999988644 57899999999999999999 9988853211 1111
Q ss_pred HHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhc
Q 003278 348 DWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSG 407 (834)
Q Consensus 348 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~ 407 (834)
..+ .. +. ....+ ... ...+.+++.+|++.+|++||++.++.+.|+.
T Consensus 215 ~~~---~~-~~--~~~~~----~~~----~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 215 EQV---ER-GY--RMPRP----PNC----PEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHH---Hc-CC--CCCCC----CCC----CHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 111 11 10 00000 011 2468899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=319.44 Aligned_cols=264 Identities=23% Similarity=0.294 Sum_probs=195.2
Q ss_pred CCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEc
Q 003278 112 GFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDY 189 (834)
Q Consensus 112 ~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 189 (834)
+|+..+.||+|+||.||+|+...+|..||+|.+... .......+.+|+.++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 367788999999999999999989999999998643 222345678899999999999999999999999999999999
Q ss_pred cCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhh
Q 003278 190 MPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLE 269 (834)
Q Consensus 190 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~ 269 (834)
++ ++|.+++... ...+++.....++.||++||.|||+. +|+||||||+||+++.++.+||+|||+++.+.
T Consensus 81 ~~-~~l~~~~~~~------~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 150 (284)
T cd07839 81 CD-QDLKKYFDSC------NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFG 150 (284)
T ss_pred CC-CCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccC
Confidence 97 5787776542 24589999999999999999999985 99999999999999999999999999987532
Q ss_pred hhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHH
Q 003278 270 HELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDW 349 (834)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~ 349 (834)
... ...+...+|+.|+|||.+.....++.++|||||||++|||+||+.|+....... .....
T Consensus 151 ~~~----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~--~~~~~ 212 (284)
T cd07839 151 IPV----------------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKR 212 (284)
T ss_pred CCC----------------CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH--HHHHH
Confidence 110 001233578999999998765567899999999999999999999864322111 11111
Q ss_pred HHHHhhcC------cccccccccc---CCCCCC-----HHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 350 IRRLSDEG------KVLQAGDNRL---SDGSYK-----LCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 350 ~~~~~~~~------~~~~~~d~~l---~~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
+....... ...+..+... ...... ......+.+++..||+.||.+|||+.++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 213 IFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred HHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 11100000 0000000000 000000 011245678999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=327.73 Aligned_cols=198 Identities=20% Similarity=0.238 Sum_probs=164.0
Q ss_pred hhCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCC-ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeC------C
Q 003278 512 TNNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSK-CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQ------G 583 (834)
Q Consensus 512 t~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~-~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~------~ 583 (834)
.++|...+.||+|+||.||++.. .++..||||.+.... ......++.+|+.+++.++||||+++++++... .
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 36788888999999999999986 457899999986432 233456788999999999999999999988644 3
Q ss_pred eEEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeee
Q 003278 584 EMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSF 663 (834)
Q Consensus 584 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~Df 663 (834)
..++||||+.++ |...+.. .+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+||
T Consensus 100 ~~~lv~e~~~~~-l~~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Df 167 (359)
T cd07876 100 DVYLVMELMDAN-LCQVIHM--------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDF 167 (359)
T ss_pred eeEEEEeCCCcC-HHHHHhc--------cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecC
Confidence 579999999865 4444421 26777788899999999999997 69999999999999999999999999
Q ss_pred eeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCC
Q 003278 664 ALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFR 729 (834)
Q Consensus 664 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~ 729 (834)
|+++..... .......||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 168 g~a~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 168 GLARTACTN--------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred CCccccccC--------ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 999753221 1123457899999999999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=312.74 Aligned_cols=247 Identities=23% Similarity=0.345 Sum_probs=197.1
Q ss_pred CcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEecc
Q 003278 514 NFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYS 592 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~ 592 (834)
+|...+.||.|+||.||+|... +++.||+|.+...........|.+|+++++.++||||+++++++.+....++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 4666678999999999999964 578999999876544444567899999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccC
Q 003278 593 ATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRN 672 (834)
Q Consensus 593 ~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~ 672 (834)
++++|.+++... .+++.....++.|++.||.|||+ .+|+||||+|+||++++++.++++|||+++.+...
T Consensus 82 ~~~~L~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 151 (274)
T cd06609 82 GGGSCLDLLKPG-------KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTST 151 (274)
T ss_pred CCCcHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence 999999988642 47889999999999999999996 68999999999999999999999999999775432
Q ss_pred CCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCccccc
Q 003278 673 DHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAEL 752 (834)
Q Consensus 673 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (834)
. .......|+..|+|||++.+..++.++|||||||++|||+||+.|+....+.. ...... . ...
T Consensus 152 ~-------~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~-~~~~~~---~--~~~--- 215 (274)
T cd06609 152 M-------SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR-VLFLIP---K--NNP--- 215 (274)
T ss_pred c-------cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH-HHHHhh---h--cCC---
Confidence 1 11223568899999999998889999999999999999999999986433211 111111 1 110
Q ss_pred cccccCCC-CCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 753 VDLSLNGE-YNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 753 ~d~~l~~~-~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
+.+... ++ . .+..++.+||..+|++|||+++|++
T Consensus 216 --~~~~~~~~~-~---~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 216 --PSLEGNKFS-K---PFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred --CCCcccccC-H---HHHHHHHHHhhCChhhCcCHHHHhh
Confidence 111111 11 2 3445666899999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=318.89 Aligned_cols=249 Identities=21% Similarity=0.327 Sum_probs=196.5
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
.+|...+.||.|+||.||+|.. .+++.|++|.+...... ..+.+.+|+.+++.++||||+++++++.+.+..++|+||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP-KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc-hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 3577778899999999999984 56889999988654333 346788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccccc
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTR 671 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~ 671 (834)
+++++|..++... .++|..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++..+..
T Consensus 98 ~~~~~L~~~~~~~-------~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~ 167 (296)
T cd06655 98 LAGGSLTDVVTET-------CMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP 167 (296)
T ss_pred cCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence 9999999987532 37899999999999999999997 6999999999999999999999999999876543
Q ss_pred CCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcccc
Q 003278 672 NDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAE 751 (834)
Q Consensus 672 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
... ......|+..|+|||.+.+..++.++|||||||++|||+||+.||....+...+. .......+ .
T Consensus 168 ~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~----~~~~~~~~--~ 234 (296)
T cd06655 168 EQS-------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY----LIATNGTP--E 234 (296)
T ss_pred ccc-------cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHhcCCc--c
Confidence 211 1123468899999999998889999999999999999999999986543322211 11111111 0
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 752 LVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 752 ~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
... ....+ . .+.+++.+||..||++|||+.+|++
T Consensus 235 ~~~---~~~~~-~---~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 235 LQN---PEKLS-P---IFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred cCC---cccCC-H---HHHHHHHHHhhcChhhCCCHHHHhh
Confidence 000 11111 2 3445566999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=314.04 Aligned_cols=259 Identities=20% Similarity=0.254 Sum_probs=193.7
Q ss_pred CcCCcccccCCcEEEEEEEC----CCcEEEEEEecCCC-ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCC------e
Q 003278 516 SESQRVAEMDFGTAYQGFLD----NHQYVLVKRLGMSK-CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQG------E 584 (834)
Q Consensus 516 ~~~~~ig~g~~g~vy~~~~~----~~~~vavK~~~~~~-~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~------~ 584 (834)
...+.||+|+||.||+|.+. .+..||||.+..+. .....+++.+|++++++++||||+++++++...+ .
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 81 (273)
T cd05074 2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI 81 (273)
T ss_pred cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence 34567999999999999863 35789999987543 2334567899999999999999999999886532 3
Q ss_pred EEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeee
Q 003278 585 MLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFA 664 (834)
Q Consensus 585 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfG 664 (834)
.++++||+.+|+|..++...........+++.....++.|++.||+|||+ .+|+||||||+|||+++++.+|++|||
T Consensus 82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECccc
Confidence 47889999999999887543211122347888899999999999999996 689999999999999999999999999
Q ss_pred eccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHH
Q 003278 665 LAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFE 743 (834)
Q Consensus 665 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~ 743 (834)
+++....... ........+++.|++||.+....++.++|||||||++|||++ |+.|+...... .......
T Consensus 159 ~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~-~~~~~~~--- 229 (273)
T cd05074 159 LSKKIYSGDY-----YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS-EIYNYLI--- 229 (273)
T ss_pred ccccccCCcc-----eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH-HHHHHHH---
Confidence 9986532211 011112345678999999998899999999999999999999 77777533221 1111111
Q ss_pred hhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccC
Q 003278 744 ARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGN 797 (834)
Q Consensus 744 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~ 797 (834)
.. .... .... ....+.+++.+||+.+|++|||+.+|.+.|+++
T Consensus 230 ~~-~~~~------~~~~----~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 230 KG-NRLK------QPPD----CLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred cC-CcCC------CCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 10 1100 0011 123566778899999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=314.20 Aligned_cols=261 Identities=20% Similarity=0.240 Sum_probs=197.2
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeC--CeEEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQ--GEMLVIY 589 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~--~~~~lv~ 589 (834)
++|...++||.|++|.||++... +++.+|+|.+..........+|.+|++++++++||||++++++|.+. +.+++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 35777889999999999999974 57889999987655545567899999999999999999999988653 4689999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccc
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFL 669 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~ 669 (834)
||+++++|.+++..... ....+++.....|+.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~ 155 (287)
T cd06621 81 EYCEGGSLDSIYKKVKK--RGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL 155 (287)
T ss_pred EecCCCCHHHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeeccccccc
Confidence 99999999988754221 12247788889999999999999996 69999999999999999999999999998654
Q ss_pred ccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCc-hhHHHHHHHHHhhcCc
Q 003278 670 TRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPE-GLLVKRVHEFEARKRP 748 (834)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~-~~~~~~~~~~~~~~~~ 748 (834)
.... .....|+..|+|||.+.+..++.++|||||||++|||+||+.|+.....+ ....... ..... ..
T Consensus 156 ~~~~---------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~-~~ 224 (287)
T cd06621 156 VNSL---------AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELL-SYIVN-MP 224 (287)
T ss_pred cccc---------cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHH-HHHhc-CC
Confidence 3211 11345788999999999999999999999999999999999998754211 1111111 11111 01
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 749 LAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 749 ~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
...+.+. .... ......+.+++.+||..+|++||||.||++
T Consensus 225 ~~~~~~~-~~~~--~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 225 NPELKDE-PGNG--IKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred chhhccC-CCCC--CchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 1111111 0000 011234567777999999999999999986
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=318.72 Aligned_cols=249 Identities=25% Similarity=0.377 Sum_probs=196.7
Q ss_pred CCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEccCC
Q 003278 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPN 192 (834)
Q Consensus 113 f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 192 (834)
|.....||+|+||.||++....++..||||.+........+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 34446799999999999999888999999998765555567789999999999999999999999999999999999999
Q ss_pred CCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhhhh
Q 003278 193 RSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHEL 272 (834)
Q Consensus 193 gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~ 272 (834)
++|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++..+....
T Consensus 104 ~~L~~~~~~--------~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~ 172 (292)
T cd06658 104 GALTDIVTH--------TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV 172 (292)
T ss_pred CcHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccc
Confidence 999998743 2478899999999999999999985 99999999999999999999999999987532210
Q ss_pred hhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHHHHH
Q 003278 273 QYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIRR 352 (834)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~ 352 (834)
.......||+.|+|||.+... .++.++|||||||++|||++|+.|+...... ... ..
T Consensus 173 ----------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~~~---~~ 229 (292)
T cd06658 173 ----------------PKRKSLVGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL---QAM---RR 229 (292)
T ss_pred ----------------ccCceeecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH---HH
Confidence 012335689999999988654 5788999999999999999999998642211 111 11
Q ss_pred HhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 353 LSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 353 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
... ...+.+. .... ....+..+...|+..+|.+||++.++++.
T Consensus 230 ~~~------~~~~~~~-~~~~--~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 230 IRD------NLPPRVK-DSHK--VSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHh------cCCCccc-cccc--cCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 100 1111111 0000 11356788889999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=312.32 Aligned_cols=253 Identities=23% Similarity=0.340 Sum_probs=193.3
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC-----hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeC--CEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG-----ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHE--DQL 183 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~ 183 (834)
++|+..+.||+|+||.||+|....+|..||||.+.... ....+.+.+|+.++++++||||+++++++.+. +.+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47888999999999999999998899999999875321 22346788999999999999999999988764 468
Q ss_pred EEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeecc
Q 003278 184 LLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFG 263 (834)
Q Consensus 184 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFG 263 (834)
++||||+++|+|.+++... ..+++....+++.|++.||+|||+. +|+|+||||+|||++.++.+||+|||
T Consensus 82 ~~v~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg 151 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY-------GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFG 151 (265)
T ss_pred EEEEEecCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCc
Confidence 8999999999999988643 3478888999999999999999986 89999999999999999999999999
Q ss_pred chhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCcc
Q 003278 264 LARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQ 343 (834)
Q Consensus 264 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~ 343 (834)
+++.+..... .........||..|+|||.+... .++.++|||||||++|||++|+.|+.....
T Consensus 152 ~~~~~~~~~~-------------~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~--- 214 (265)
T cd06652 152 ASKRLQTICL-------------SGTGMKSVTGTPYWMSPEVISGE-GYGRKADIWSVGCTVVEMLTEKPPWAEFEA--- 214 (265)
T ss_pred cccccccccc-------------cccccccCCCCccccChhhhcCC-CCCcchhHHHHHHHHHHHhhCCCCCCccch---
Confidence 9875422100 00112334589999999988654 578999999999999999999999853211
Q ss_pred chHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 344 IILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 344 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
... +....... ..+. .+......+..+...|+. +|.+||++.+|++.
T Consensus 215 --~~~-~~~~~~~~-----~~~~-----~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 215 --MAA-IFKIATQP-----TNPV-----LPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred --HHH-HHHHhcCC-----CCCC-----CchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 111 11111110 0111 111122356677777885 89999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=311.69 Aligned_cols=256 Identities=26% Similarity=0.396 Sum_probs=200.4
Q ss_pred CCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEe--CCEEEEEE
Q 003278 112 GFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCVH--EDQLLLVY 187 (834)
Q Consensus 112 ~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~lV~ 187 (834)
+|+..+.||.|+||.||++....+|..||+|.+... .....+.+.+|+.++++++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 477788999999999999999889999999998643 33445678899999999999999999998864 34689999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhcc--CCCeecCCCCCCceEECCCCceEEeeccch
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQL--ETQIIHRDVKTSNVMLDSQYNARLGDFGLA 265 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiHrDlKp~NILld~~~~~kl~DFGla 265 (834)
||+++++|.+++..... ...++++..++.++.|++.||.|||..+ ..+++|+||||+||+++.++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKK---ERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccc
Confidence 99999999999865321 2357899999999999999999999332 359999999999999999999999999999
Q ss_pred hhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccch
Q 003278 266 RWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQII 345 (834)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~ 345 (834)
..+..... ......|++.|+|||.+... .++.++||||||+++++|++|+.|+.... ...
T Consensus 158 ~~~~~~~~----------------~~~~~~~~~~~~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~ 217 (265)
T cd08217 158 KILGHDSS----------------FAKTYVGTPYYMSPEQLNHM-SYDEKSDIWSLGCLIYELCALSPPFTARN---QLQ 217 (265)
T ss_pred ccccCCcc----------------cccccccCCCccChhhhcCC-CCCchhHHHHHHHHHHHHHHCCCcccCcC---HHH
Confidence 76432210 01234589999999998655 57889999999999999999999987532 111
Q ss_pred HHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 346 LLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 346 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
+...+ ..+... .+ +......+.+++..|++.+|++||+|.+|++.
T Consensus 218 ~~~~~----~~~~~~-----~~-----~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 218 LASKI----KEGKFR-----RI-----PYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HHHHH----hcCCCC-----CC-----ccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 11111 111111 11 11112467899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=312.47 Aligned_cols=260 Identities=23% Similarity=0.373 Sum_probs=199.8
Q ss_pred hCcCcCCcccccCCcEEEEEEEC------CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD------NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEML 586 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~ 586 (834)
++|.....||+|+||.||+|... +...|++|.+.........+.|.+|++++++++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 46777888999999999999864 245799998865544445678999999999999999999999999989999
Q ss_pred EEEeccCCCchhhhhhcCCCCC---CCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeee
Q 003278 587 VIYDYSATRILSHLLFHNNHRI---GHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSF 663 (834)
Q Consensus 587 lv~Ey~~~g~L~~~l~~~~~~~---~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~Df 663 (834)
+||||+++|+|.+++....... ....++|..+..++.|++.||+|||+ .+|+||||||+|||++.++.+|++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999987543211 11258999999999999999999996 68999999999999999999999999
Q ss_pred eeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHH
Q 003278 664 ALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEF 742 (834)
Q Consensus 664 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~ 742 (834)
|++........ .......++..|+|||.+.++.++.++|||||||++|||++ |..|+...... ........
T Consensus 162 ~~~~~~~~~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~-~~~~~~~~- 233 (275)
T cd05046 162 SLSKDVYNSEY------YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE-EVLNRLQA- 233 (275)
T ss_pred ccccccCcccc------cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH-HHHHHHHc-
Confidence 99875432211 11223356788999999988889999999999999999999 67777532222 11111110
Q ss_pred HhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHc
Q 003278 743 EARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795 (834)
Q Consensus 743 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~ 795 (834)
.... .. ..... +. .+.+++.+||+.+|++|||+.++++.|.
T Consensus 234 ----~~~~-~~---~~~~~-~~---~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 ----GKLE-LP---VPEGC-PS---RLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred ----CCcC-CC---CCCCC-CH---HHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1110 00 01111 22 4556677999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=319.31 Aligned_cols=248 Identities=25% Similarity=0.353 Sum_probs=194.9
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 187 (834)
..|+..+.||+|+||.||+|....+|+.||+|.+.... ....+.+.+|+.+++.++||||++++++|...+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45888899999999999999998889999999886432 233457889999999999999999999999999999999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
||++ |+|.+++... ..++++..+..++.|++.||.|||+. +|+||||+|+||+++.++.+||+|||++..
T Consensus 95 e~~~-g~l~~~~~~~------~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~ 164 (307)
T cd06607 95 EYCL-GSASDILEVH------KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASL 164 (307)
T ss_pred HhhC-CCHHHHHHHc------ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCccee
Confidence 9997 5776666432 23589999999999999999999985 999999999999999999999999999864
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCcccccc--CCCCCcccceeehhhHHHHHHhCCccCCCCCCCccch
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQK--GSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQII 345 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~ 345 (834)
... .....|++.|+|||.+.. ...++.++|||||||++|||+||+.|+......
T Consensus 165 ~~~--------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~---- 220 (307)
T cd06607 165 VSP--------------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---- 220 (307)
T ss_pred cCC--------------------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH----
Confidence 321 123458899999998742 345788999999999999999999998532111
Q ss_pred HHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 346 LLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 346 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
........ .. .+.+. .......+.++...||+.+|++||+|.+|+..
T Consensus 221 --~~~~~~~~-~~-----~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 221 --SALYHIAQ-ND-----SPTLS----SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred --HHHHHHhc-CC-----CCCCC----chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 11111111 00 01111 11112467889999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=322.01 Aligned_cols=257 Identities=19% Similarity=0.183 Sum_probs=189.8
Q ss_pred CcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCC--ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEe
Q 003278 514 NFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSK--CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYD 590 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~E 590 (834)
+|...+.||+|+||.||++... ++..||||.+.... .....+.|.+|+.++..++||||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD 81 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence 5667788999999999999964 57899999986321 12234568899999999999999999999999999999999
Q ss_pred ccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccc
Q 003278 591 YSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLT 670 (834)
Q Consensus 591 y~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~ 670 (834)
|+++|+|.+++..... .+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++..+.
T Consensus 82 ~~~g~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 153 (331)
T cd05597 82 YYVGGDLLTLLSKFED-----RLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLL 153 (331)
T ss_pred cCCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecC
Confidence 9999999999865322 37788888899999999999996 699999999999999999999999999987543
Q ss_pred cCCCCCcccccCccccccccCccchhcccc-----CCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhh
Q 003278 671 RNDHGHRKATSGNRSVRGIFGYMSPEYIES-----GEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEAR 745 (834)
Q Consensus 671 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-----~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~ 745 (834)
.... .......||+.|||||++.. +.++.++|||||||++|||++|+.||......... ......
T Consensus 154 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~----~~i~~~ 223 (331)
T cd05597 154 ADGT------VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY----GKIMNH 223 (331)
T ss_pred CCCC------ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHH----HHHHcC
Confidence 2211 01122469999999999863 45788999999999999999999998643322111 111111
Q ss_pred cCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHH
Q 003278 746 KRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSI 793 (834)
Q Consensus 746 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~ 793 (834)
... ..+. ... .....++..+++-++ |...++..||++.++++.
T Consensus 224 ~~~-~~~~--~~~-~~~~~~~~~li~~ll-~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 224 KEH-FQFP--PDV-TDVSEEAKDLIRRLI-CSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CCc-ccCC--Ccc-CCCCHHHHHHHHHHc-cCcccccCCCCHHHHhcC
Confidence 000 0010 000 112344555554322 555566668899988763
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 834 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-51 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 7e-40 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-50 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-39 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-37 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-26 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-37 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-26 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-37 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-26 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-35 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 9e-26 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-35 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 7e-25 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 7e-35 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 6e-25 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-18 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-10 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-18 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-07 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-18 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-06 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 8e-18 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-07 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 8e-18 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 5e-07 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-08 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-07 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-17 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-09 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-10 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-08 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-17 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 9e-11 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-10 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-10 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-10 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-11 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-10 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-10 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-10 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 7e-10 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-10 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 7e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 7e-10 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-16 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-08 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-16 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 7e-09 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-09 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-09 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-15 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 8e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 9e-05 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-04 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-05 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-05 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 9e-05 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-05 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-04 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-09 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 7e-05 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-04 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 8e-05 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-05 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-04 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-04 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 9e-14 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-15 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-13 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-13 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 8e-05 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-04 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-08 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-13 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-04 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-15 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 6e-05 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-15 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-06 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-15 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-05 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-15 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 7e-06 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-04 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-15 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-06 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 7e-05 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-15 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-13 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-15 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-13 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-15 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-15 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-15 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-15 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-12 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-15 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-05 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-15 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-04 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-10 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-15 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 8e-08 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-04 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-04 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-15 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-07 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-04 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-15 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-06 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-04 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 9e-05 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-04 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-15 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-04 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-09 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-09 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-04 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 7e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-09 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 7e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-09 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 7e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 7e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-08 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-09 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 7e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-09 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 7e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-09 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 7e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-04 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 7e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 7e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-08 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 7e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-09 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 7e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-09 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 9e-05 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 8e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 8e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-08 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 8e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-08 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 9e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-04 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 9e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-08 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 9e-15 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-14 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-14 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-08 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-14 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-08 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-14 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-08 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-14 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-08 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-07 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-14 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-08 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-06 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-08 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-14 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-08 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-14 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-08 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-07 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-07 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-14 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-05 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-14 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 9e-07 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-14 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-04 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-06 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-14 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 8e-05 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-14 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-07 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-14 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-09 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-14 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 7e-05 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-14 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-07 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-14 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-05 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 9e-09 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-07 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-07 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-14 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-05 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-14 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-14 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-10 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-14 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-04 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 5e-14 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-04 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-14 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-04 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-14 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-04 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-14 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-04 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 6e-14 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 7e-08 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-08 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-14 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-04 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 6e-14 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-04 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 7e-14 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-05 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 7e-14 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-04 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 7e-14 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-04 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 9e-08 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 7e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 7e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-07 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 8e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-08 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 8e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 8e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 8e-14 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-06 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-14 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-04 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-14 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-04 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-13 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-06 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-13 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-10 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-13 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-04 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-05 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-13 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-05 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-05 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 7e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-05 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-05 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-13 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-08 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-06 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-10 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-05 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 8e-06 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-06 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-10 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 6e-04 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-06 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-10 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-06 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-06 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-06 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-06 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-04 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-12 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-12 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-12 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-07 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-07 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 7e-10 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 9e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-12 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-12 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-07 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 7e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-04 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 7e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 8e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-09 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 8e-12 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-07 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 8e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 8e-12 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 8e-12 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-07 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 8e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 8e-06 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 9e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-09 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 9e-12 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-07 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 9e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 6e-08 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 9e-12 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-07 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-11 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-07 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-04 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-04 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-04 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-11 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-07 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-04 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-04 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-04 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-04 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-04 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-04 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-04 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-04 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-04 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-04 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-04 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-04 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-04 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-04 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-11 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-07 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-11 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-07 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-11 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-07 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 6e-04 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 6e-04 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-11 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-07 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-11 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-07 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-11 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-07 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-11 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-07 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-11 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-07 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-11 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-07 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-11 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-07 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-11 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-07 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-11 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-07 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-06 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-09 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-11 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-07 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-11 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-07 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-11 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-07 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-09 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-11 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-11 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-08 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-11 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-07 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-11 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-11 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-07 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-11 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-08 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-11 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-08 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-05 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-11 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-07 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-06 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-11 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-11 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-08 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-11 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-08 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 9e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-06 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-11 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-08 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-11 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-08 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-11 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-06 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-05 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-11 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-11 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-06 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-11 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-08 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-11 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-06 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-11 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-07 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-08 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-08 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-11 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-06 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 8e-04 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-08 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-08 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-08 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-11 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-07 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-11 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-11 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-07 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-11 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-11 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-06 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-11 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-06 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-11 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-06 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-08 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-11 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-06 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 6e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 6e-08 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-11 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 7e-04 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 6e-11 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 9e-04 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 6e-11 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 9e-04 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-11 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-11 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-06 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-11 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-11 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 8e-04 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-11 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-06 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-11 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 7e-06 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-11 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 6e-11 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 8e-04 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 7e-11 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 9e-04 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 7e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 7e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-06 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 7e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-04 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 7e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 7e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 7e-11 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 8e-11 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-08 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 8e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-04 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-11 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-06 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 8e-11 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-08 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 9e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-06 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 9e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 5e-04 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 9e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 9e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-06 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 9e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 9e-11 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 9e-11 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-06 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 9e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 9e-11 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-10 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-06 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-10 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-05 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-10 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-06 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-05 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-10 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-08 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-06 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-10 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-10 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-05 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-10 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-05 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-06 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-10 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-06 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-06 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-10 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-07 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-10 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-08 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-06 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-10 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-10 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-08 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-10 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-08 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-10 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-08 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-10 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-10 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-10 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-10 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-10 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-10 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-06 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-10 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-10 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 9e-06 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-08 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 8e-06 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-06 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-06 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-07 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-04 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-04 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 8e-04 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-04 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-04 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-06 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-04 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-10 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-04 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-10 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-10 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 7e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-10 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 7e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 7e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 7e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 7e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-05 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 8e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-06 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 8e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 8e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 9e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-06 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 9e-10 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-04 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 9e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-04 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 9e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 9e-04 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-06 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-05 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-08 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-08 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 8e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-08 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-08 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-04 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-04 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-08 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 6e-04 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-09 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-05 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-04 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-04 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-04 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-09 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-04 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-04 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-09 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-04 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-09 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-09 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-04 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-09 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-04 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-09 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-09 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-06 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-04 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-09 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-04 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-08 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-04 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 7e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 8e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-04 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 8e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 8e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 8e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 8e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 8e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 9e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 7e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 8e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-06 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 9e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-06 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-06 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 8e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 8e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-08 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 8e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 8e-07 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 8e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-06 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 8e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-06 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-05 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-05 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-06 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-05 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-05 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-05 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-05 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-08 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 9e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-04 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-08 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-04 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-04 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-08 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 8e-04 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-04 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 6e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 6e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-08 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-08 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-05 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 6e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 6e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 6e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 6e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 6e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-04 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-08 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-05 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 6e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 7e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 7e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 7e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 7e-08 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 7e-08 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-04 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 7e-08 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 8e-08 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-05 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 8e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 8e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 8e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 8e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 5e-04 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 8e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-05 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 8e-08 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-05 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 9e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 9e-08 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 9e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 9e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-08 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-05 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-04 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 9e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-07 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-07 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-07 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-07 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-07 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 8e-04 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-07 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-07 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 8e-04 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-07 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-07 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 9e-04 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-07 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-07 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 7e-04 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-04 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-07 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-05 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 4e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-07 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-07 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-07 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 7e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 7e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 7e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 7e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 7e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 7e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 7e-07 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 7e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 7e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 7e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 7e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 7e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 8e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 8e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 8e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 8e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 8e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 8e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 8e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 8e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 8e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 8e-07 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 8e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 8e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 8e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 8e-07 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-07 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-04 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 8e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 9e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 9e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-04 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 9e-07 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-06 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-06 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-06 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-06 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-06 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-06 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 9e-05 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-06 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-04 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-06 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-06 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-04 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-06 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 1e-06 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-06 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-05 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-06 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 9e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-06 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 1e-06 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 1e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-06 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-06 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-06 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 8e-05 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-06 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-04 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-06 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-04 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-06 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-04 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-04 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-06 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-04 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-06 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-06 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 9e-05 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-04 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-06 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-04 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-06 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-06 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-04 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-06 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-06 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-04 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-06 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-04 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-06 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-04 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-06 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-04 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-06 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-04 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-06 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-06 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-04 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-06 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-06 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-04 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-06 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-06 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-04 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-06 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-06 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-06 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-06 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-06 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 5e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 6e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 6e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 7e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 8e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 8e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 8e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 9e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 9e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 9e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 9e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 9e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 9e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 9e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 9e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 9e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-05 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-05 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-05 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-05 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-05 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-05 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-05 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-05 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-05 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-05 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-05 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-05 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-05 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-05 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-05 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-05 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-05 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-05 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-05 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-05 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-05 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-05 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-05 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-05 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-05 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-05 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-05 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-05 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 6e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 7e-05 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 8e-05 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-05 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 9e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 9e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 9e-05 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-04 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-04 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-04 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-04 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-04 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-04 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-04 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-04 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-04 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-04 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-04 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-04 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-04 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-04 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-04 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-04 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-04 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-04 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-04 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-04 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-04 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-04 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-04 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-04 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-04 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-04 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-04 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-04 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-04 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-04 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-04 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-04 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-04 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-04 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-04 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-04 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-04 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-04 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-04 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-04 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-04 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 7e-04 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 7e-04 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 7e-04 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-04 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 7e-04 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-04 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 7e-04 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 8e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 8e-04 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 8e-04 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 8e-04 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 9e-04 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 9e-04 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 9e-04 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 344 bits (884), Expect = e-112
Identities = 130/330 (39%), Positives = 193/330 (58%), Gaps = 25/330 (7%)
Query: 81 FHDMEGVQMSEKVGGDNPRIFSYAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVA 140
F D+ + E G + FS EL + S+ F +LG GGFGKVY+ L DGT+VA
Sbjct: 1 FFDVPAEEDPEVHLG-QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVA 58
Query: 141 VKCL-AEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVL 199
VK L E+ + E F E+ ++ HRNL+RLRG+C+ + LLVY YM N S+ L
Sbjct: 59 VKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCL 118
Query: 200 FRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARL 259
RPE+ PL+W +R++I G A L YLH+ + +IIHRDVK +N++LD ++ A +
Sbjct: 119 RERPES---QPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175
Query: 260 GDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVF 319
GDFGLA+ ++++ H+ TT + GTIG++ PE G + K+DVF
Sbjct: 176 GDFGLAKLMDYK-------------DTHV--TTAVRGTIGHIAPEYLSTGKS-SEKTDVF 219
Query: 320 SFGIVVLEVVSGRRAVDLTYP--DDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDM 377
+G+++LE+++G+RA DL DD ++LLDW++ L E K+ D L G+YK ++
Sbjct: 220 GYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDL-QGNYKDEEV 278
Query: 378 EHLTHLALLCTLHNPHLRPSMKWVIEAVSG 407
E L +ALLCT +P RP M V+ + G
Sbjct: 279 EQLIQVALLCTQSSPMERPKMSEVVRMLEG 308
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 256 bits (657), Expect = 7e-79
Identities = 96/325 (29%), Positives = 164/325 (50%), Gaps = 27/325 (8%)
Query: 500 PREISFKEIISATNNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSN 559
+ S +E+ A++NFS + FG Y+G L + V VKRL + +F
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76
Query: 560 ELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRY 619
E++ ++ HRNL++L G+C E L++Y Y A ++ L L W R
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPE--SQPPLDWPKRQ 134
Query: 620 NIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGH--- 676
I A + YLH+ + ++IHR++ ++ I LD + +G F LA+ + D H
Sbjct: 135 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-THVTT 193
Query: 677 RKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEG--- 733
VRG G+++PEY+ +G+++ DV+ +GV++LE++TGQ A D
Sbjct: 194 A--------VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 245
Query: 734 -LLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792
+L+ V K+ L LVD+ L G Y +E+ +LI++ + CT S+P RP M +++
Sbjct: 246 VMLLDWVKGLLKEKK-LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVR 304
Query: 793 ILDGNDKRFMEDGQMTENLEEWKQR 817
+L+G+ + E EEW++
Sbjct: 305 MLEGDG--------LAERWEEWQKE 321
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 317 bits (815), Expect = e-102
Identities = 108/331 (32%), Positives = 159/331 (48%), Gaps = 40/331 (12%)
Query: 88 QMSEKVGGDNPRIFSYAELYIGSNGFDEDE------VLGSGGFGKVYRAVLPSDGTVVAV 141
S +V FS+ EL +N FDE +G GGFG VY+ + + T VAV
Sbjct: 2 NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAV 59
Query: 142 KCLAEKGERF----EKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDR 197
K LA + ++ F E+ +A +H NLV L G+ D L LVY YMPN SL
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 198 VLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNA 257
L PL+W R KI +G A +++LHE IHRD+K++N++LD + A
Sbjct: 120 RLSCLDGT----PPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTA 172
Query: 258 RLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSD 317
++ DFGLAR E A+ T+RI GT Y+ PE +G + T KSD
Sbjct: 173 KISDFGLARASEKF---------AQTVM-----TSRIVGTTAYMAPE-ALRGEI-TPKSD 216
Query: 318 VFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIRR-LSDEGKVLQAGDNRLSDGSYKLCD 376
++SFG+V+LE+++G AVD +LLD +E + D ++
Sbjct: 217 IYSFGVVLLEIITGLPAVDEHREPQ--LLLDIKEEIEDEEKTIEDYIDKKM--NDADSTS 272
Query: 377 MEHLTHLALLCTLHNPHLRPSMKWVIEAVSG 407
+E + +A C + RP +K V + +
Sbjct: 273 VEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 251 bits (644), Expect = 3e-77
Identities = 84/309 (27%), Positives = 139/309 (44%), Gaps = 29/309 (9%)
Query: 500 PREISFKEIISATNNFSESQRVAEMD------FGTAYQGFLDNHQYVLVKRLGMSKCPAL 553
SF E+ + TNNF E + FG Y+G+++N V VK+L
Sbjct: 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITT 70
Query: 554 R---TRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGH 610
+F E++ +A+ +H NLV+L G+ ++ ++ ++Y Y L L G
Sbjct: 71 EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC---LDGT 127
Query: 611 SILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLT 670
L WH R I + A+ I +LHE IHR+I S+ I LD ++ F LA
Sbjct: 128 PPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASE 184
Query: 671 RNDHGH---RKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVD 727
+ R + G YM+PE + GE T +D+YSFGVV+LE++TG AVD
Sbjct: 185 KFAQTVMTSR--------IVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVD 235
Query: 728 FRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSM 787
LL+ E E ++ + + +D + + + + + + C RP +
Sbjct: 236 EHREPQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDI 294
Query: 788 RQILSILDG 796
+++ +L
Sbjct: 295 KKVQQLLQE 303
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 310 bits (796), Expect = 3e-99
Identities = 100/315 (31%), Positives = 158/315 (50%), Gaps = 23/315 (7%)
Query: 90 SEKVGGDNPRIFSYAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGE 149
S + +L +N FD ++G G FGKVY+ VL DG VA+K +
Sbjct: 18 SSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESS 76
Query: 150 RFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAA 209
+ + F E+ ++ RH +LV L G+C ++++L+Y YM N +L R L+
Sbjct: 77 QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLP---T 133
Query: 210 APLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLE 269
++WEQR +I G A LHYLH + IIHRDVK+ N++LD + ++ DFG+++
Sbjct: 134 MSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISK--- 187
Query: 270 HELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVV 329
T + H +T + GT+GY+ PE F KG + T KSDV+SFG+V+ EV+
Sbjct: 188 ------KGTELDQTHL-----STVVKGTLGYIDPEYFIKGRL-TEKSDVYSFGVVLFEVL 235
Query: 330 SGRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTL 389
R A+ + P + + L +W + G++ Q D L + + A+ C
Sbjct: 236 CARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNL-ADKIRPESLRKFGDTAVKCLA 294
Query: 390 HNPHLRPSMKWVIEA 404
+ RPSM V+
Sbjct: 295 LSSEDRPSMGDVLWK 309
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 242 bits (619), Expect = 2e-73
Identities = 94/326 (28%), Positives = 149/326 (45%), Gaps = 21/326 (6%)
Query: 477 GNTESKSNNSRSQRRNSFFMVETP-REISFKEIISATNNFSESQRVAEMDFGTAYQGFLD 535
G+ SK+ NS + +S ++V + ++ ATNNF + FG Y+G L
Sbjct: 2 GSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR 61
Query: 536 NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATR 595
+ V +KR + F E++ L+ RH +LV L G+C E+ EM++IY Y
Sbjct: 62 DGAKVALKRRTPESSQGIE-EFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENG 120
Query: 596 ILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPD 655
L L+ ++ + W R I A + YLH +IHR++ S I LD +
Sbjct: 121 NLKRHLYGSDL--PTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDEN 175
Query: 656 MNPRLGSFALAEFLTRNDHGH---RKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSF 712
P++ F +++ T D H V+G GY+ PEY G T +DVYSF
Sbjct: 176 FVPKITDFGISKKGTELDQTHLSTV--------VKGTLGYIDPEYFIKGRLTEKSDVYSF 227
Query: 713 GVVVLEVVTGQMAVDFRLPEGL--LVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLI 770
GVV+ EV+ + A+ LP + L + E L ++VD +L + + L +
Sbjct: 228 GVVLFEVLCARSAIVQSLPREMVNLAEWAVESH-NNGQLEQIVDPNLADKIRPESLRKFG 286
Query: 771 KLGIACTLSNPELRPSMRQILSILDG 796
+ C + E RPSM +L L+
Sbjct: 287 DTAVKCLALSSEDRPSMGDVLWKLEY 312
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 6e-66
Identities = 74/326 (22%), Positives = 118/326 (36%), Gaps = 45/326 (13%)
Query: 101 FSYAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELV 160
LY S EV G FG V++A L VAVK + ++ E+
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQ-SWQNEYEVY 70
Query: 161 AVAHLRHRNLVRLRGWCVH----EDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQ 216
++ ++H N+++ G + L L+ + SL L ++W +
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV--------VSWNE 122
Query: 217 RKKIIRGLAAALHYLHEQLETQ-------IIHRDVKTSNVMLDSQYNARLGDFGLARWLE 269
I +A L YLHE + I HRD+K+ NV+L + A + DFGLA E
Sbjct: 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE 182
Query: 270 HELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPE----SFQKGSVATAKSDVFSFGIVV 325
+T GT Y+ PE + A + D+++ G+V+
Sbjct: 183 AGKSA--------------GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVL 228
Query: 326 LEVVSGRRAVDLTYPDDQIILLDWIRRLSDEGK-----VLQAGDNRLSDGSYKLCDMEHL 380
E+ S A D + + + I + V + L D K M L
Sbjct: 229 WELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAML 288
Query: 381 THLALLCTLHNPHLRPSMKWVIEAVS 406
C H+ R S V E ++
Sbjct: 289 CETIEECWDHDAEARLSAGCVGERIT 314
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 3e-47
Identities = 60/319 (18%), Positives = 121/319 (37%), Gaps = 38/319 (11%)
Query: 499 TPREISFKEIISATNNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFS 558
+ ++ + + + + A FG ++ L N +YV VK + + +
Sbjct: 10 SGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLN-EYVAVKIFPIQDKQSWQ--NE 66
Query: 559 NELQNLARLRHRNLVQLCGWCTE----QGEMLVIYDYSATRILSHLLFHNNHRIGHSILQ 614
E+ +L ++H N++Q G ++ +I + LS L N ++
Sbjct: 67 YEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-------VVS 119
Query: 615 WHHRYNIIKSLASAILYLHEEWNEQ-------VIHRNITSSAITLDPDMNPRLGSFALAE 667
W+ +I +++A + YLHE+ + HR+I S + L ++ + F LA
Sbjct: 120 WNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL 179
Query: 668 FLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESG-----EATSMADVYSFGVVVLEVVTG 722
K+ G YM+PE +E +A D+Y+ G+V+ E+ +
Sbjct: 180 KFEAG-----KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASR 234
Query: 723 QMAVDFRLPEGLL-----VKRVHEFEARKRP-LAELVDLSLNGEY-NHKELMRLIKLGIA 775
A D + E +L + + E + + + L + H + L +
Sbjct: 235 CTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEE 294
Query: 776 CTLSNPELRPSMRQILSIL 794
C + E R S + +
Sbjct: 295 CWDHDAEARLSAGCVGERI 313
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 2e-54
Identities = 79/326 (24%), Positives = 129/326 (39%), Gaps = 37/326 (11%)
Query: 99 RIFSYAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAE 158
RIF ++L G EVLG G FG+ + G V+ +K L E ++TF E
Sbjct: 5 RIFRPSDLIHG-------EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKE 57
Query: 159 LVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRK 218
+ + L H N+++ G + +L + +Y+ +L ++ + ++ W QR
Sbjct: 58 VKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGII-KSMDS-----QYPWSQRV 111
Query: 219 KIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRT 278
+ +A+ + YLH IIHRD+ + N ++ N + DFGLAR + E
Sbjct: 112 SFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGL 168
Query: 279 SSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLT 338
S + T G ++ PE G K DVFSFGIV+ E++ A
Sbjct: 169 RSLKKPDRKKRYTVV--GNPYWMAPEMI-NGRSYDEKVDVFSFGIVLCEIIGRVNA---- 221
Query: 339 YPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSM 398
PD + + + G C + + C +P RPS
Sbjct: 222 DPD--------YLPRTMDFGLNVRGFLDRYCPPN--CP-PSFFPITVRCCDLDPEKRPSF 270
Query: 399 K---WVIEAVSGSYSGKLPALPSFQS 421
+E + +G LP P +
Sbjct: 271 VKLEHWLETLRMHLAGHLPLGPQLEQ 296
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 9e-27
Identities = 57/297 (19%), Positives = 105/297 (35%), Gaps = 32/297 (10%)
Query: 526 FGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGE 584
FG A + + + +++K L + + F E++ + L H N+++ G +
Sbjct: 23 FGQAIKVTHRETGEVMVMKEL-IRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKR 81
Query: 585 MLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRN 644
+ I +Y L ++ + W R + K +AS + YLH +IHR+
Sbjct: 82 LNFITEYIKGGTLRGII-KSMDSQ----YPWSQRVSFAKDIASGMAYLHSM---NIIHRD 133
Query: 645 ITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNR-------SVRGIFGYMSPEY 697
+ S + + N + F LA + S + +V G +M+PE
Sbjct: 134 LNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEM 193
Query: 698 IESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARK-RPLAELVDLS 756
I DV+SFG+V+ E++ A LP + + P
Sbjct: 194 INGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCP-------- 245
Query: 757 LNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDKRFMEDGQMTENLEE 813
+ C +PE RPS ++ L+ + LE+
Sbjct: 246 ---PNCPPSFFPITV---RCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQLEQ 296
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 4e-52
Identities = 63/350 (18%), Positives = 118/350 (33%), Gaps = 47/350 (13%)
Query: 101 FSYAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELV 160
+ +E + + E++G G +G VY+ L D VAVK + + +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEK-NIY 59
Query: 161 AVAHLRHRNLVRLRGWCVH-----EDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWE 215
V + H N+ R + LLV +Y PN SL + L +W
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT--------SDWV 111
Query: 216 QRKKIIRGLAAALHYLHEQLET------QIIHRDVKTSNVMLDSQYNARLGDFGLARWLE 269
++ + L YLH +L I HRD+ + NV++ + + DFGL+ L
Sbjct: 112 SSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLT 171
Query: 270 HELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPE------SFQKGSVATAKSDVFSFGI 323
+ GTI Y+ PE + + A + D+++ G+
Sbjct: 172 G--------NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGL 223
Query: 324 VVLEVVSGRRAV--DLTYPDDQIILLDWIRR---LSDEGKVLQAGDNRLSDGSYKLCDME 378
+ E+ + + P+ Q+ + D ++ R +
Sbjct: 224 IYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSL 283
Query: 379 HLTHLALL---CTLHNPHLRPSMKWVIEAVSG---SYSGKLPALPSFQSH 422
+ L C + R + + E ++ + P+ H
Sbjct: 284 AVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAHHH 333
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 7e-35
Identities = 60/330 (18%), Positives = 109/330 (33%), Gaps = 53/330 (16%)
Query: 502 EISFKEIISATNNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNEL 561
E + E +N + + +G Y+G LD + V VK + R F NE
Sbjct: 2 EAAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDE-RPVAVKVFSFAN----RQNFINEK 56
Query: 562 Q--NLARLRHRNLVQLCGWCTE-----QGEMLVIYDYSATRILSHLLFHNNHRIGHSILQ 614
+ + H N+ + + E L++ +Y L L +
Sbjct: 57 NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-------TSD 109
Query: 615 WHHRYNIIKSLASAILYLHEE------WNEQVIHRNITSSAITLDPDMNPRLGSFALAEF 668
W + S+ + YLH E + + HR++ S + + D + F L+
Sbjct: 110 WVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR 169
Query: 669 LTRNDHGHRKATSG-NRSVRGIFGYMSPEYIES-------GEATSMADVYSFGVVVLEVV 720
LT N S G YM+PE +E A D+Y+ G++ E+
Sbjct: 170 LTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229
Query: 721 T-------GQMAVDFRLPEGLLVKRVHEFEA--------RKRPLAELVDLSLNGEYNHKE 765
G+ ++++ V FE ++RP + N
Sbjct: 230 MRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRP-----KFPEAWKENSLA 284
Query: 766 LMRLIKLGIACTLSNPELRPSMRQILSILD 795
+ L + C + E R + + +
Sbjct: 285 VRSLKETIEDCWDQDAEARLTAQXAEERMA 314
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 6e-49
Identities = 76/338 (22%), Positives = 140/338 (41%), Gaps = 52/338 (15%)
Query: 68 CHHNTPRKEHSGLFHDMEGVQMSEKVGGDNPRIFSYAELYIGSNGFDEDEVLGSGGFGKV 127
HH+ P ++ + ++ I + E +G+G FG V
Sbjct: 4 HHHHHPMSDYD----------IPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTV 53
Query: 128 YRAVLPSDGTVVAVKCLAEKG--ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLL 185
+RA G+ VAVK L E+ F E+ + LRH N+V G L +
Sbjct: 54 HRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI 111
Query: 186 VYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVK 245
V +Y+ SL R+L + A L+ +R + +A ++YLH + I+HR++K
Sbjct: 112 VTEYLSRGSLYRLLHKS----GAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRNLK 166
Query: 246 TSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPES 305
+ N+++D +Y ++ DFGL+R + S+A GT ++ PE
Sbjct: 167 SPNLLVDKKYTVKVCDFGLSRLKAST--FLSSKSAA--------------GTPEWMAPEV 210
Query: 306 FQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDN 365
+ + KSDV+SFG+++ E+ + ++ P + + + + K L+ N
Sbjct: 211 L-RDEPSNEKSDVYSFGVILWELATLQQ------PWGNLNPAQVVAAVGFKCKRLEIPRN 263
Query: 366 RLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403
+ + + C + P RPS +++
Sbjct: 264 ---------LN-PQVAAIIEGCWTNEPWKRPSFATIMD 291
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 66/307 (21%), Positives = 119/307 (38%), Gaps = 40/307 (13%)
Query: 502 EISFKEIISATNNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKC-PALRTRFSNE 560
+I + ++ + +++ FGT ++ V VK L F E
Sbjct: 33 DIPWCDL-------NIKEKIGAGSFGTVHRAEWHG-SDVAVKILMEQDFHAERVNEFLRE 84
Query: 561 LQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYN 620
+ + RLRH N+V G T+ + ++ +Y + L LL H + L R +
Sbjct: 85 VAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL-HKSGA--REQLDERRRLS 141
Query: 621 IIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKAT 680
+ +A + YLH N ++HRN+ S + +D ++ F L+ + A
Sbjct: 142 MAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA 200
Query: 681 SGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLP-EGLLVKRV 739
G +M+PE + + +DVYSFGV++ E+ T Q P L +V
Sbjct: 201 -------GTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQ------PWGNLNPAQV 247
Query: 740 HEFEARK--RPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGN 797
K R ++ + ++ +I+ C + P RPS I+ +L
Sbjct: 248 VAAVGFKCKRL-----EIP---RNLNPQVAAIIE---GCWTNEPWKRPSFATIMDLLRPL 296
Query: 798 DKRFMED 804
K +
Sbjct: 297 IKSAVPP 303
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 3e-47
Identities = 62/331 (18%), Positives = 134/331 (40%), Gaps = 62/331 (18%)
Query: 86 GVQMSEKVGGDNPRIFSYAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCL- 144
G + + E+ + +G GGFG V++ L D +VVA+K L
Sbjct: 1 GAMGGSEFPKSRLPTLADNEIEYE-------KQIGKGGFGLVHKGRLVKDKSVVAIKSLI 53
Query: 145 ------AEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRV 198
+ + F E+ +++L H N+V+L G + +V +++P L
Sbjct: 54 LGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH--NPPRMVMEFVPCGDLYHR 111
Query: 199 LFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQ---- 254
L + P+ W + +++ +A + Y+ I+HRD+++ N+ L S
Sbjct: 112 LLDKAH------PIKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENA 164
Query: 255 -YNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQ-KGSVA 312
A++ DFGL++ + + + + + G ++ PE+ +
Sbjct: 165 PVCAKVADFGLSQ----QSVHSV---------------SGLLGNFQWMAPETIGAEEESY 205
Query: 313 TAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSY 372
T K+D +SF +++ +++G + + + +I + +EG ++
Sbjct: 206 TEKADTYSFAMILYTILTGEGP----FDEYSYGKIKFINMIREEGLRPTIPED------- 254
Query: 373 KLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403
C L ++ LC +P RP ++++
Sbjct: 255 --CP-PRLRNVIELCWSGDPKKRPHFSYIVK 282
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 63/319 (19%), Positives = 118/319 (36%), Gaps = 53/319 (16%)
Query: 492 NSFFMVETPREISFKEIISATNNFSESQRVAEMDFGTAYQG-FLDNHQYVLVKRL----- 545
S F ++ EI +++ + FG ++G + + V +K L
Sbjct: 5 GSEFPKSRLPTLADNEI-------EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDS 57
Query: 546 -GMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRILSHLLFHN 604
G ++ F E+ ++ L H N+V+L G ++ ++ L H L +
Sbjct: 58 EGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRL-LD 114
Query: 605 NHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFA 664
++W + ++ +A I Y+ N ++HR++ S I L
Sbjct: 115 KAH----PIKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAK 169
Query: 665 LAEF-LTRNDHGHRKATSGNRSVRGIFGYMSPEYI--ESGEATSMADVYSFGVVVLEVVT 721
+A+F L++ GN F +M+PE I E T AD YSF +++ ++T
Sbjct: 170 VADFGLSQQSVHSVSGLLGN------FQWMAPETIGAEEESYTEKADTYSFAMILYTILT 223
Query: 722 GQMAVDFRLP-EGLLVKRVHEFEA----RKRPLAELVDLSLNGEYNHKELMRLIKLGIAC 776
G+ P + ++ RP + E L +I+ C
Sbjct: 224 GEG------PFDEYSYGKIKFINMIREEGLRP-----TIP---EDCPPRLRNVIE---LC 266
Query: 777 TLSNPELRPSMRQILSILD 795
+P+ RP I+ L
Sbjct: 267 WSGDPKKRPHFSYIVKELS 285
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 1e-46
Identities = 78/317 (24%), Positives = 128/317 (40%), Gaps = 51/317 (16%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVR 172
+ +EV+G G FG V +A VA+K + + E K F EL ++ + H N+V+
Sbjct: 10 IEVEEVVGRGAFGVVCKAKW--RAKDVAIKQI--ESESERKAFIVELRQLSRVNHPNIVK 65
Query: 173 LRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLH 232
L G C++ + LV +Y SL VL E + + YLH
Sbjct: 66 LYGACLNP--VCLVMEYAEGGSLYNVLHGA----EPLPYYTAAHAMSWCLQCSQGVAYLH 119
Query: 233 EQLETQIIHRDVKTSNVMLDSQYN-ARLGDFGLARWLEHELQYQMRTSSARNHQFHLAET 291
+IHRD+K N++L + ++ DFG A ++Q M
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHM--------------- 160
Query: 292 TRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRA-VDLTYPDDQIILLDWI 350
T G+ ++ PE F +GS + K DVFS+GI++ EV++ R+ ++ P +I+
Sbjct: 161 TNNKGSAAWMAPEVF-EGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM----- 214
Query: 351 RRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVI---EAVSG 407
V R + + L C +P RPSM+ ++ +
Sbjct: 215 ------WAVHN--GTRPPLIKN--LP-KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263
Query: 408 SYSGKLPALPSFQSHPL 424
+ G L H L
Sbjct: 264 YFPGADEPLQYPCQHSL 280
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 5e-32
Identities = 66/336 (19%), Positives = 126/336 (37%), Gaps = 50/336 (14%)
Query: 502 EISFKEIISATNNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNEL 561
I +KEI + V FG + + V +K++ + + R F EL
Sbjct: 4 MIDYKEI-------EVEEVVGRGAFGVVCKAKWRA-KDVAIKQI---ESESERKAFIVEL 52
Query: 562 QNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNI 621
+ L+R+ H N+V+L G C + ++ +Y+ L ++L H + + H +
Sbjct: 53 RQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVL-HGAEPLPY--YTAAHAMSW 107
Query: 622 IKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMN-PRLGSFALAEFLTRNDHGHRKAT 680
+ + YLH + +IHR++ + L ++ F A + H
Sbjct: 108 CLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA----CDIQTHMTNN 163
Query: 681 SGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMA-VDFRLPEGLLVKRV 739
G+ +M+PE E + DV+S+G+++ EV+T + + P ++ V
Sbjct: 164 KGS------AAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAV 217
Query: 740 HEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD---- 795
H RP L + K + L+ C +P RPSM +I+ I+
Sbjct: 218 HN---GTRP-----PLI---KNLPKPIESLMT---RCWSKDPSQRPSMEEIVKIMTHLMR 263
Query: 796 ----GNDKRFMEDGQMTENLEEWKQRNECSLSLIKR 827
++ E+ + + R
Sbjct: 264 YFPGADEPLQYPCQHSLPPGEDGRVEPYVDFAEFYR 299
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 7e-45
Identities = 82/313 (26%), Positives = 131/313 (41%), Gaps = 64/313 (20%)
Query: 103 YAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCL----AEKGERFEKTFAAE 158
+AEL + E++G GGFGKVYRA G VAVK E + + E
Sbjct: 6 FAELTLE-------EIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQE 56
Query: 159 LVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRK 218
A L+H N++ LRG C+ E L LV ++ L+RVL + + +
Sbjct: 57 AKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR--------IPPDILV 108
Query: 219 KIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNAR--------LGDFGLARWLEH 270
+A ++YLH++ IIHRD+K+SN+++ + + DFGLAR
Sbjct: 109 NWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR---- 164
Query: 271 ELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS 330
E + S+A G ++ PE + S+ + SDV+S+G+++ E+++
Sbjct: 165 EWHRTTKMSAA--------------GAYAWMAPEVI-RASMFSKGSDVWSYGVLLWELLT 209
Query: 331 GRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLH 390
G P I L ++ L C E L C
Sbjct: 210 GEV------PFRGIDGLAVAYGVAMNKLALPIPST---------CP-EPFAKLMEDCWNP 253
Query: 391 NPHLRPSMKWVIE 403
+PH RPS +++
Sbjct: 254 DPHSRPSFTNILD 266
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 65/308 (21%), Positives = 119/308 (38%), Gaps = 55/308 (17%)
Query: 502 EISFKEIISATNNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRL---GMSKCPALRTRFS 558
EI F E+ + + + FG Y+ F V VK
Sbjct: 3 EIDFAEL-------TLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVR 54
Query: 559 NELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHR 618
E + A L+H N++ L G C ++ + ++ +++ L+ +L +
Sbjct: 55 QEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL-SGKR------IPPDIL 107
Query: 619 YNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFA---LAEF-LTRNDH 674
N +A + YLH+E +IHR++ SS I + + S + +F L R
Sbjct: 108 VNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE-- 165
Query: 675 GHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLP-EG 733
+ S G + +M+PE I + + +DV+S+GV++ E++TG++ P G
Sbjct: 166 ---WHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEV------PFRG 216
Query: 734 LLVKRVHEFEARKRPLAELVDLSLNG------EYNHKELMRLIKLGIACTLSNPELRPSM 787
+ LA +++N + +L++ C +P RPS
Sbjct: 217 I------------DGLAVAYGVAMNKLALPIPSTCPEPFAKLME---DCWNPDPHSRPSF 261
Query: 788 RQILSILD 795
IL L
Sbjct: 262 TNILDQLT 269
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 1e-43
Identities = 71/341 (20%), Positives = 127/341 (37%), Gaps = 68/341 (19%)
Query: 103 YAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG--ERFEKTFAAELV 160
+ +L IG E++G G FG+VY + VA++ + + E K F E++
Sbjct: 32 FEQLEIG-------ELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVM 81
Query: 161 AVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKI 220
A RH N+V G C+ L ++ R+L V+ L+ + ++I
Sbjct: 82 AYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKI------VLDVNKTRQI 135
Query: 221 IRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSS 280
+ + + YLH + I+H+D+K+ NV D + DFGL +
Sbjct: 136 AQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISG-------VLQA 184
Query: 281 ARNHQFHLAETTRIGGTIGYLPPESFQKGSVA--------TAKSDVFSFGIVVLEVVSGR 332
R + G + +L PE ++ S + SDVF+ G + E+ +
Sbjct: 185 GRREDKLRIQN----GWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE 240
Query: 333 RAVDLTYPD---DQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTL 389
+ + II Q G + S + ++ + L C
Sbjct: 241 ----WPFKTQPAEAII--------------WQMGTGMKPNLSQIGMG-KEISDILLFCWA 281
Query: 390 HNPHLRPSMKWVIEAVSGSYSGKLPALPSFQSHPLYISLSS 430
RP+ +++ + KLP SHP + S+
Sbjct: 282 FEQEERPTFTKLMDMLE-----KLPKRNRRLSHPGHFWKSA 317
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 54/336 (16%), Positives = 119/336 (35%), Gaps = 60/336 (17%)
Query: 478 NTESKSNNSRSQRRNSFFMVETPREISFKEIISATNNFSESQRVAEMDFGTAYQGFLDNH 537
N S S ++ + + +I F+++ + + + FG Y G H
Sbjct: 5 NLSLLSARSFPRKASQTSIFLQEWDIPFEQL-------EIGELIGKGRFGQVYHGRW--H 55
Query: 538 QYVLVKRLGMSKC-PALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRI 596
V ++ + + + F E+ + RH N+V G C + +I R
Sbjct: 56 GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRT 115
Query: 597 LSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDM 656
L ++ + +L + I + + + YLH + ++H+++ S + D +
Sbjct: 116 LYSVV-RDAKI----VLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NG 166
Query: 657 NPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSM---------A 707
+ F L G R R G +++PE I + +
Sbjct: 167 KVVITDFGLFSISGVLQAGRR--EDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHS 224
Query: 708 DVYSFGVVVLEVVTGQ--------MAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNG 759
DV++ G + E+ + A+ +++ G+ +P L + +
Sbjct: 225 DVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGM------------KP--NLSQIGM-- 268
Query: 760 EYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795
KE+ ++ C E RP+ +++ +L+
Sbjct: 269 ---GKEISDILL---FCWAFEQEERPTFTKLMDMLE 298
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-43
Identities = 53/307 (17%), Positives = 103/307 (33%), Gaps = 58/307 (18%)
Query: 103 YAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLA--EKGERFEKTFAAELV 160
+ +L L G++++ G + VK L + R + F E
Sbjct: 9 FKQLNFL-------TKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECP 59
Query: 161 AVAHLRHRNLVRLRGWCVH--EDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRK 218
+ H N++ + G C L+ +MP SL VL ++ Q
Sbjct: 60 RLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF-----VVDQSQAV 114
Query: 219 KIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRT 278
K +A + +LH LE I + + +VM+D AR+ +
Sbjct: 115 KFALDMARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKF------------ 161
Query: 279 SSARNHQFHLAETTRIGGTIGYLPPESFQKG--SVATAKSDVFSFGIVVLEVVSGRRAVD 336
R+ ++ PE+ QK +D++SF +++ E+V+
Sbjct: 162 --------SFQSPGRM-YAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREV--- 209
Query: 337 LTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRP 396
P + ++ +++ EG H++ L +C +P RP
Sbjct: 210 ---PFADLSNMEIGMKVALEGLRPTIPPG---------IS-PHVSKLMKICMNEDPAKRP 256
Query: 397 SMKWVIE 403
++
Sbjct: 257 KFDMIVP 263
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 51/307 (16%), Positives = 105/307 (34%), Gaps = 59/307 (19%)
Query: 502 EISFKEIISATNNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKC-PALRTRFSNE 560
I FK++ + ++ E G ++G ++VK L + F+ E
Sbjct: 6 GIDFKQL-------NFLTKLNENHSGELWKGRWQG-NDIVVKVLKVRDWSTRKSRDFNEE 57
Query: 561 LQNLARLRHRNLVQLCGWCTE--QGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHR 618
L H N++ + G C +I + L ++L H + ++
Sbjct: 58 CPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVL----HEGTNFVVDQSQA 113
Query: 619 YNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRK 678
+A + +LH + + S ++ +D DM R+ +
Sbjct: 114 VKFALDMARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-------- 164
Query: 679 ATSGNRSVRGIFGYMSPEYIE---SGEATSMADVYSFGVVVLEVVTGQMAVDFRLP-EGL 734
+ +++PE ++ AD++SF V++ E+VT ++ P L
Sbjct: 165 ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREV------PFADL 214
Query: 735 LVKRVHEFEARKRPLAELVDLSLNG------EYNHKELMRLIKLGIACTLSNPELRPSMR 788
+ + ++L G + +L+K C +P RP
Sbjct: 215 ------------SNMEIGMKVALEGLRPTIPPGISPHVSKLMK---ICMNEDPAKRPKFD 259
Query: 789 QILSILD 795
I+ IL+
Sbjct: 260 MIVPILE 266
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-42
Identities = 73/296 (24%), Positives = 117/296 (39%), Gaps = 53/296 (17%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG--ERFEKTFAAELVAVAHLRHRNLVRLR 174
+ +GSG FG VY+ D VAVK L + + F E+ + RH N++
Sbjct: 30 QRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 175 GWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQ 234
G+ QL +V + SL L E ++ I R A + YLH +
Sbjct: 87 GYST-APQLAIVTQWCEGSSLYHHL-HASET-----KFEMKKLIDIARQTARGMDYLHAK 139
Query: 235 LETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRI 294
IIHRD+K++N+ L ++GDFGLA +
Sbjct: 140 ---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLS------------- 183
Query: 295 GGTIGYLPPE--SFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPD----DQIILLD 348
G+I ++ PE Q + + +SDV++FGIV+ E+++G+ L Y + DQII
Sbjct: 184 -GSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ----LPYSNINNRDQII--- 235
Query: 349 WIRRLSDEGKVLQAGDNRLSDGS-YKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403
+++ G C + + L C RPS ++
Sbjct: 236 ---------EMVGRGSLSPDLSKVRSNCP-KRMKRLMAECLKKKRDERPSFPRILA 281
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 75/307 (24%), Positives = 127/307 (41%), Gaps = 55/307 (17%)
Query: 502 EISFKEIISATNNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKC-PALRTRFSNE 560
EI +I + QR+ FGT Y+G V VK L ++ P F NE
Sbjct: 20 EIPDGQI-------TVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNE 70
Query: 561 LQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYN 620
+ L + RH N++ G+ T ++ ++ + L H L + + +
Sbjct: 71 VGVLRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHL-----HASETKFEMKKLID 124
Query: 621 IIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKAT 680
I + A + YLH + +IHR++ S+ I L D ++G F LA +R H+
Sbjct: 125 IARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE- 180
Query: 681 SGNRSVRGIFGYMSPEYIESGEA---TSMADVYSFGVVVLEVVTGQM---------AVDF 728
+ G +M+PE I ++ + +DVY+FG+V+ E++TGQ+ +
Sbjct: 181 ----QLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIE 236
Query: 729 RLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMR 788
+ G L P DLS K + RL+ C + RPS
Sbjct: 237 MVGRGSL-----------SP-----DLSKVRSNCPKRMKRLMA---ECLKKKRDERPSFP 277
Query: 789 QILSILD 795
+IL+ ++
Sbjct: 278 RILAEIE 284
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 3e-40
Identities = 67/306 (21%), Positives = 114/306 (37%), Gaps = 43/306 (14%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGW 176
E +G G +G+V+R G VAVK + + E+ EL LRH N++
Sbjct: 14 ECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEK-SWFRETELYNTVMLRHENILGFIAS 70
Query: 177 CVHED----QLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLH 232
+ QL L+ Y SL L L+ +I+ +A+ L +LH
Sbjct: 71 DMTSRHSSTQLWLITHYHEMGSLYDYLQLTT--------LDTVSCLRIVLSIASGLAHLH 122
Query: 233 EQLETQ-----IIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFH 287
++ I HRD+K+ N+++ + D GLA +Q
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQS-----------TNQLD 171
Query: 288 LAETTRIGGTIGYLPPE-----SFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDD 342
+ R+ GT Y+ PE + + D+++FG+V+ EV R + D
Sbjct: 172 VGNNPRV-GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR-RMVSNGIVEDY 229
Query: 343 QIILLDWIRR---LSDEGKVLQAGDNRLS--DGSYKLCDMEHLTHLALLCTLHNPHLRPS 397
+ D + D KV+ R + + + + L L C NP R +
Sbjct: 230 KPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLT 289
Query: 398 MKWVIE 403
+ +
Sbjct: 290 ALRIKK 295
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 60/306 (19%), Positives = 106/306 (34%), Gaps = 50/306 (16%)
Query: 519 QRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNE--LQNLARLRHRNLVQLC 576
+ V + +G ++G + V VK + E L N LRH N++
Sbjct: 14 ECVGKGRYGEVWRGSWQG-ENVAVKIF----SSRDEKSWFRETELYNTVMLRHENILGFI 68
Query: 577 GWCT----EQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYL 632
++ +I Y L L L I+ S+AS + +L
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYL-QLT------TLDTVSCLRIVLSIASGLAHL 121
Query: 633 HEEWNEQ-----VIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVR 687
H E + HR++ S I + + + LA + + GN
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA---VMHSQSTNQLDVGNNPRV 178
Query: 688 GIFGYMSPEYIES------GEATSMADVYSFGVVVLEVVTG----QMAVDFRLPEGLLVK 737
G YM+PE ++ ++ D+++FG+V+ EV + D++ P +V
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238
Query: 738 RVHEFEA--------RKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQ 789
FE ++RP + + L +L+K C NP R + +
Sbjct: 239 NDPSFEDMRKVVCVDQQRP---NIPNRWFSDPTLTSLAKLMK---ECWYQNPSARLTALR 292
Query: 790 ILSILD 795
I L
Sbjct: 293 IKKTLT 298
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-39
Identities = 67/307 (21%), Positives = 114/307 (37%), Gaps = 43/307 (14%)
Query: 116 DEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRG 175
+ +G G +G+V+ G VAVK E E+ +RH N++
Sbjct: 42 VKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEA-SWFRETEIYQTVLMRHENILGFIA 98
Query: 176 WCVHED----QLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYL 231
+ QL L+ DY N SL L L+ + K+ + L +L
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYLKSTT--------LDAKSMLKLAYSSVSGLCHL 150
Query: 232 HEQLETQ-----IIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQF 286
H ++ + I HRD+K+ N+++ + D GLA + S N
Sbjct: 151 HTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV----------KFISDTNEVD 200
Query: 287 HLAETTRIGGTIGYLPPESFQKGSV-----ATAKSDVFSFGIVVLEVVSGRRAVDLTYPD 341
+ TR+ GT Y+PPE + + +D++SFG+++ EV R +
Sbjct: 201 -IPPNTRV-GTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVAR-RCVSGGIVEE 257
Query: 342 DQIILLDWIRRLSDEGKVLQA---GDNRLSDGSYKLCD--MEHLTHLALLCTLHNPHLRP 396
Q+ D + + + R S + D + + L C HNP R
Sbjct: 258 YQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRL 317
Query: 397 SMKWVIE 403
+ V +
Sbjct: 318 TALRVKK 324
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 5e-27
Identities = 53/299 (17%), Positives = 102/299 (34%), Gaps = 50/299 (16%)
Query: 526 FGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNE--LQNLARLRHRNLVQLCGWCTE-- 581
+G + G + V VK + E + +RH N++ +
Sbjct: 50 YGEVWMGKWRG-EKVAVKVF----FTTEEASWFRETEIYQTVLMRHENILGFIAADIKGT 104
Query: 582 --QGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEE---- 635
++ +I DY L L + L + S S + +LH E
Sbjct: 105 GSWTQLYLITDYHENGSLYDYL-KST------TLDAKSMLKLAYSSVSGLCHLHTEIFST 157
Query: 636 -WNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMS 694
+ HR++ S I + + + LA + + + G YM
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLA---VKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 695 PEYIE------SGEATSMADVYSFGVVVLEVVTG----QMAVDFRLPEGLLVKRVHEFEA 744
PE ++ ++ MAD+YSFG+++ EV + +++LP LV +E
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYED 274
Query: 745 --------RKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795
+ RP + + +++ +L+ C NP R + ++ L
Sbjct: 275 MREIVCIKKLRP---SFPNRWSSDECLRQMGKLMT---ECWAHNPASRLTALRVKKTLA 327
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 4e-38
Identities = 67/307 (21%), Positives = 119/307 (38%), Gaps = 43/307 (14%)
Query: 116 DEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRG 175
E +G G FG+V+R G VAVK + + ER AE+ LRH N++
Sbjct: 47 QESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIA 103
Query: 176 WCVHED----QLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYL 231
++ QL LV DY + SL L R + E K+ A+ L +L
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--------VTVEGMIKLALSTASGLAHL 155
Query: 232 HEQLETQ-----IIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQF 286
H ++ I HRD+K+ N+++ + D GLA + A NH+
Sbjct: 156 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD---SATDTIDIAPNHRV 212
Query: 287 HLAETTRIGGTIGYLPPESFQKGSV-----ATAKSDVFSFGIVVLEVVSGRRAVDLTYPD 341
GT Y+ PE + ++D+++ G+V E+ R ++ + D
Sbjct: 213 ---------GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHED 262
Query: 342 DQIILLDWIRRLSDEGKVLQA---GDNRLS-DGSYKLCD-MEHLTHLALLCTLHNPHLRP 396
Q+ D + ++ + R + ++ C+ + + + C N R
Sbjct: 263 YQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL 322
Query: 397 SMKWVIE 403
+ + +
Sbjct: 323 TALRIKK 329
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 1e-26
Identities = 54/306 (17%), Positives = 102/306 (33%), Gaps = 50/306 (16%)
Query: 519 QRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNE--LQNLARLRHRNLVQLC 576
+ + + FG ++G + V VK + E + LRH N++
Sbjct: 48 ESIGKGRFGEVWRGKWRG-EEVAVKIFS----SREERSWFREAEIYQTVMLRHENILGFI 102
Query: 577 GWCTEQG----EMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYL 632
+ ++ ++ DY L L + + + S AS + +L
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRY------TVTVEGMIKLALSTASGLAHL 155
Query: 633 HEEWNEQ-----VIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVR 687
H E + HR++ S I + + + LA D
Sbjct: 156 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH---DSATDTIDIAPNHRV 212
Query: 688 GIFGYMSPEYIES------GEATSMADVYSFGVVVLEVVT----GQMAVDFRLPEGLLVK 737
G YM+PE ++ E+ AD+Y+ G+V E+ G + D++LP LV
Sbjct: 213 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 272
Query: 738 RVHEFEA--------RKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQ 789
E + RP + + + ++++ C +N R + +
Sbjct: 273 SDPSVEEMRKVVCEQKLRP---NIPNRWQSCEALRVMAKIMR---ECWYANGAARLTALR 326
Query: 790 ILSILD 795
I L
Sbjct: 327 IKKTLS 332
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 8e-36
Identities = 66/304 (21%), Positives = 112/304 (36%), Gaps = 52/304 (17%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLA-EKGERFEKTFAAELVAVAHLRHRNLV 171
F+ + LG GGFG V+ A D A+K + E + E+ A+A L H +V
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 172 RLRGWCVHEDQ------------LLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKK 219
R + ++ L + +L + R E +
Sbjct: 67 RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL----H 122
Query: 220 IIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTS 279
I +A A+ +LH + ++HRD+K SN+ ++GDFGL ++ + + Q +
Sbjct: 123 IFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 280 SARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTY 339
+ H T ++ GT Y+ PE S + K D+FS G+++ E L Y
Sbjct: 180 PMPAYARH---TGQV-GTKLYMSPEQIHGNSY-SHKVDIFSLGLILFE---------LLY 225
Query: 340 P----DDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLR 395
P +++ L +R K L Y + +P R
Sbjct: 226 PFSTQMERVRTLTDVR----NLKF-----PPLFTQKYP-----CEYVMVQDMLSPSPMER 271
Query: 396 PSMK 399
P
Sbjct: 272 PEAI 275
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 48/287 (16%), Positives = 96/287 (33%), Gaps = 47/287 (16%)
Query: 526 FGTAYQGF--LDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQL-------- 575
FG ++ +D+ Y +KR+ + R + E++ LA+L H +V+
Sbjct: 18 FGVVFEAKNKVDDCNYA-IKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKN 76
Query: 576 -CGWCTEQGEMLVIY---DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILY 631
+ +Y L + N R + +I +A A+ +
Sbjct: 77 TTEKLQPSSPKVYLYIQMQLCRKENLKDWM---NGRCTIEERERSVCLHIFLQIAEAVEF 133
Query: 632 LHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFG 691
LH + ++HR++ S I D ++G F L + +++ T R
Sbjct: 134 LHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQ 190
Query: 692 -----YMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFR--LPEGLLVKRVHEFEA 744
YMSPE I + D++S G+++ E + F + + V +
Sbjct: 191 VGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE-----LLYPFSTQMERVRTLTDVRNLKF 245
Query: 745 RKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQIL 791
+ +++ +P RP I+
Sbjct: 246 PPLF-----------TQKYPCEYVMVQ---DMLSPSPMERPEAINII 278
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 70/300 (23%), Positives = 121/300 (40%), Gaps = 41/300 (13%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVR 172
F+E VLG G FG+V +A D A+K + E T +E++ +A L H+ +VR
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVVR 66
Query: 173 LRGWCVHEDQ-------------LLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKK 219
+ L + +Y N +L ++ N + ++ +
Sbjct: 67 YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQR------DEYWR 120
Query: 220 IIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTS 279
+ R + AL Y+H Q IIHRD+K N+ +D N ++GDFGLA+ + L S
Sbjct: 121 LFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 280 SARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTY 339
T+ I GT Y+ E K D++S GI+ E++ +
Sbjct: 178 QNLPGSSDNL-TSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP-----FST 230
Query: 340 PDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMK 399
+++ +L K L++ + M+ + L H+P+ RP +
Sbjct: 231 GMERVNIL----------KKLRSVSIEF-PPDFDDNKMKVEKKIIRLLIDHDPNKRPGAR 279
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 51/323 (15%), Positives = 109/323 (33%), Gaps = 78/323 (24%)
Query: 526 FGTAYQGF--LDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQG 583
FG + LD+ Y +K++ ++ + +E+ LA L H+ +V+ E+
Sbjct: 19 FGQVVKARNALDSRYYA-IKKIRHTE--EKLSTILSEVMLLASLNHQYVVRYYAAWLERR 75
Query: 584 EMLVIYDYSATRILSHLLFHNNHRI------GHSILQWHHRYN----------IIKSLAS 627
+ LF I ++ H N + + +
Sbjct: 76 NFVKPMTAVKK---KSTLF-----IQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILE 127
Query: 628 AILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVR 687
A+ Y+H + +IHR++ I +D N ++G F LA+ + R+ + +
Sbjct: 128 ALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 688 GIF-------GYMSPEYIE-SGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRV 739
Y++ E ++ +G D+YS G++ E++
Sbjct: 185 DNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP----------------- 227
Query: 740 HEFEARKRPLAELVDLSLNGEYN---------HKELMRLIKLGIACTLSNPELRPSMRQI 790
+R ++ + K ++I+L +P RP R +
Sbjct: 228 -FSTGMER--VNILKKLRSVSIEFPPDFDDNKMKVEKKIIRL---LIDHDPNKRPGARTL 281
Query: 791 LSILDGNDKRFMEDGQMTENLEE 813
L+ ++ E ++E
Sbjct: 282 LN------SGWLPVKHQDEVIKE 298
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-34
Identities = 58/226 (25%), Positives = 104/226 (46%), Gaps = 35/226 (15%)
Query: 116 DEVLGSGGFGKVYRAVLPSDG----TVVAVKCL-AEKGERFEKTFAAELVAVAHLRHRNL 170
+VLGSG FG VY+ + +G VA+K L + K E +A + + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 171 VRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHY 230
RL G C+ + L+ MP L + +N+ + LNW +A ++Y
Sbjct: 80 CRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNY 132
Query: 231 LHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAE 290
L ++ +++HRD+ NV++ + + ++ DFGLA+ L E +
Sbjct: 133 LEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE------------ 177
Query: 291 TTRIGGT--IGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRR 333
GG I ++ ES + T +SDV+S+G+ V E+++ G +
Sbjct: 178 ----GGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSK 218
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 1e-12
Identities = 58/289 (20%), Positives = 107/289 (37%), Gaps = 61/289 (21%)
Query: 526 FGTAYQGFL-----DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCT 580
FGT Y+G V +K L + P +E +A + + ++ +L G C
Sbjct: 28 FGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL 87
Query: 581 EQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQV 640
L+ L + + IG L N +A + YL E+ +
Sbjct: 88 TSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYL-EDRR--L 138
Query: 641 IHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIES 700
+HR++ + + + + ++ F LA+ L + A G ++ +M+ E I
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIK----WMALESILH 193
Query: 701 GEATSMADVYSFGVVVLEVVT-GQMAVDFRLP-EGLLVKRVHEFEARKRPLAELVDLSLN 758
T +DV+S+GV V E++T G P +G+ P +E+ +
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSK------PYDGI-------------PASEISSILEK 234
Query: 759 GE------------YNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795
GE Y +MR C + + + RP R+++
Sbjct: 235 GERLPQPPICTIDVY---MIMR------KCWMIDADSRPKFRELIIEFS 274
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-34
Identities = 53/220 (24%), Positives = 90/220 (40%), Gaps = 35/220 (15%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAE-KGERFEKTFAAELVAVAHLRHRNLVRLRG 175
E +G G FG+V+ L +D T+VAVK E + F E + H N+VRL G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 176 WCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQL 235
C + + +V + + L L + +++ AA + YL +
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEGARL------RVKTLLQMVGDAAAGMEYLESK- 232
Query: 236 ETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIG 295
IHRD+ N ++ + ++ DFG++R +
Sbjct: 233 --CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAAS------------------- 271
Query: 296 GTIGYLP-----PESFQKGSVATAKSDVFSFGIVVLEVVS 330
G + +P PE+ G +++SDV+SFGI++ E S
Sbjct: 272 GGLRQVPVKWTAPEALNYG-RYSSESDVWSFGILLWETFS 310
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 3e-14
Identities = 59/275 (21%), Positives = 105/275 (38%), Gaps = 36/275 (13%)
Query: 526 FGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGE 584
FG + G L ++ V VK + P L+ +F E + L + H N+V+L G CT++
Sbjct: 127 FGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP 186
Query: 585 MLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRN 644
+ ++ + L R L+ ++ A+ + YL + IHR+
Sbjct: 187 IYIVMELVQGGDFLTFLRTEGAR-----LRVKTLLQMVGDAAAGMEYLESK---CCIHRD 238
Query: 645 ITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEAT 704
+ + + ++ F ++ + V+ + +PE + G +
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVY-AASGGLRQVPVK----WTAPEALNYGRYS 293
Query: 705 SMADVYSFGVVVLEVVT-GQMAVDFRLP-EGLLVKRVHEF-EARKR-PLAELVDLSLNGE 760
S +DV+SFG+++ E + G P L ++ EF E R P EL ++
Sbjct: 294 SESDVWSFGILLWETFSLGAS------PYPNLSNQQTREFVEKGGRLPCPELCPDAV--- 344
Query: 761 YNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795
LM C P RPS I L
Sbjct: 345 ---FRLME------QCWAYEPGQRPSFSTIYQELQ 370
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 53/221 (23%), Positives = 89/221 (40%), Gaps = 29/221 (13%)
Query: 116 DEVLGSGGFGKVYRAVLPSDGTVVAVKCLAE---KGERFEKTFAAELVAVAHLRHRNLVR 172
++G GG G VY A +VA+K ++E F E L+ ++V
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 173 LRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLH 232
+ + + QL + + L +L R+ PL + I+R + +AL H
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAAMLRRQ-------GPLAPPRAVAIVRQIGSALDAAH 151
Query: 233 EQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETT 292
HRDVK N+++ + A L DFG+A L +
Sbjct: 152 AA---GATHRDVKPENILVSADDFAYLVDFGIASATT---------------DEKLTQLG 193
Query: 293 RIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRR 333
GT+ Y+ PE F S AT ++D+++ V+ E ++G
Sbjct: 194 NTVGTLYYMAPERFS-ESHATYRADIYALTCVLYECLTGSP 233
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 1e-12
Identities = 46/186 (24%), Positives = 72/186 (38%), Gaps = 17/186 (9%)
Query: 540 VLVK--RLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRIL 597
V +K +S P RTR E + RL+ ++V + + G++ V L
Sbjct: 62 VALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDL 121
Query: 598 SHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMN 657
+ +L R G L I++ + SA+ H HR++ I + D
Sbjct: 122 AAML----RRQGP--LAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDF 172
Query: 658 PRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVL 717
L F +A T K T + G YM+PE AT AD+Y+ V+
Sbjct: 173 AYLVDFGIASATTDE-----KLTQLG-NTVGTLYYMAPERFSESHATYRADIYALTCVLY 226
Query: 718 EVVTGQ 723
E +TG
Sbjct: 227 ECLTGS 232
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 84/371 (22%), Positives = 136/371 (36%), Gaps = 79/371 (21%)
Query: 69 HHNTPRKEHSGLFHDMEGVQMSEKVGGDNPRIFSYAELYIGSNGFDEDEVLGSGGFGKVY 128
HH+ H G +++ + GD P +F L LG G FGKV
Sbjct: 3 HHHHHHHHHHGA------LEVLFQGPGD-PTVFHKRYLKKI-------RDLGEGHFGKVS 48
Query: 129 RAVL----PSDGTVVAVKCL-AEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQ- 182
G +VAVK L A+ G + + E+ + L H ++++ +G C
Sbjct: 49 LYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA 108
Query: 183 -LLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIH 241
L LV +Y+P SL L R + Q + + + YLH Q IH
Sbjct: 109 SLQLVMEYVPLGSLRDYLPRHS--------IGLAQLLLFAQQICEGMAYLHAQ---HYIH 157
Query: 242 RDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYL 301
RD+ NV+LD+ ++GDFGLA+ + +Y
Sbjct: 158 RDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD------------------S 199
Query: 302 P-----PESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTY--------PDDQIILL 347
P PE ++ SDV+SFG+ + E+++ + Q+ +L
Sbjct: 200 PVFWYAPECLKEY-KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVL 258
Query: 348 DWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPS---MKWVIEA 404
L + G+ L D C + HL C RP+ + +++
Sbjct: 259 RLTELL-ERGERLPRPDK---------C-PAEVYHLMKNCWETEASFRPTFENLIPILKT 307
Query: 405 VSGSYSGKLPA 415
V Y G+ P+
Sbjct: 308 VHEKYQGQAPS 318
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 61/287 (21%), Positives = 109/287 (37%), Gaps = 41/287 (14%)
Query: 526 FGTAYQGFLDNHQ-----YVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCT 580
FG D V VK L P R+ + E+ L L H ++++ G C
Sbjct: 44 FGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCE 103
Query: 581 EQGE--MLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNE 638
+ G + ++ +Y L L H IG + L + + + YLH +
Sbjct: 104 DAGAASLQLVMEYVPLGSLRDYL--PRHSIGLAQL-----LLFAQQICEGMAYLHA---Q 153
Query: 639 QVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYI 698
IHR++ + + LD D ++G F LA+ + +R G+ V + +PE +
Sbjct: 154 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF----WYAPECL 209
Query: 699 ESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSL 757
+ + +DV+SFGV + E++T + L+ + + L +L
Sbjct: 210 KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQG----QMTVLRLTELLE 265
Query: 758 NGEYNHK---------ELMRLIKLGIACTLSNPELRPSMRQILSILD 795
GE + LM+ C + RP+ ++ IL
Sbjct: 266 RGERLPRPDKCPAEVYHLMKN------CWETEASFRPTFENLIPILK 306
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 6e-33
Identities = 78/338 (23%), Positives = 128/338 (37%), Gaps = 66/338 (19%)
Query: 117 EVLGSGGFGKVYRAVL----PSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVR 172
LG G FG V + G +VAVK L G ++ F E+ + L +V+
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 173 LRGWCVH--EDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHY 230
RG L LV +Y+P+ L L R L+A+ L + + + Y
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLY------SSQICKGMEY 142
Query: 231 LHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAE 290
L + + +HRD+ N++++S+ + ++ DFGLA+ L + Y + +
Sbjct: 143 LGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQ-------- 191
Query: 291 TTRIGGTIGYLP-----PESFQKGSVATAKSDVFSFGIVVLEVVS-GRR--------AVD 336
P PES + + +SDV+SFG+V+ E+ + +
Sbjct: 192 ----------SPIFWYAPESLSDN-IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRM 240
Query: 337 LTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRP 396
+ D L + L +EG+ L A C E + L LC +P RP
Sbjct: 241 MGCERDVPALSRLLELL-EEGQRLPAPPA---------CPAE-VHELMKLCWAPSPQDRP 289
Query: 397 SMKWV-------IEAVSGSYSGKLPALPSFQSHPLYIS 427
S + G + A P + H L S
Sbjct: 290 SFSALGPQLDMLWSGSRGCETHAFTAHPEGKHHSLSFS 327
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 60/290 (20%), Positives = 108/290 (37%), Gaps = 46/290 (15%)
Query: 526 FGTAYQGFLD-----NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCT 580
FG+ D V VK+L P + F E+Q L L +V+ G
Sbjct: 36 FGSVELCRYDPLGDNTGALVAVKQL-QHSGPDQQRDFQREIQILKALHSDFIVKYRGVSY 94
Query: 581 EQGE--MLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNE 638
G + ++ +Y + L L + R+ S L + + YL
Sbjct: 95 GPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRL-----LLYSSQICKGMEYLGSR--- 146
Query: 639 QVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYI 698
+ +HR++ + I ++ + + ++ F LA+ L + + G + + +PE +
Sbjct: 147 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF----WYAPESL 202
Query: 699 ESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSL 757
+ +DV+SFGVV+ E+ T R+ E L+ L++L
Sbjct: 203 SDNIFSRQSDVWSFGVVLYELFTYCDK----SCSPSAEFLRMMGCERDVPALSRLLELLE 258
Query: 758 NGE------------YNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795
G+ + ELM+L C +P+ RPS + LD
Sbjct: 259 EGQRLPAPPACPAEVH---ELMKL------CWAPSPQDRPSFSALGPQLD 299
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 8e-33
Identities = 57/234 (24%), Positives = 104/234 (44%), Gaps = 45/234 (19%)
Query: 116 DEVLGSGGFGKVYRAVLPSDG-------TVVAVKCLAEKGERFEKTFAAELVAVAHLRHR 168
+E LG G F K+++ V G T V +K L + + ++F ++ L H+
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 169 NLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAAL 228
+LV G CV D+ +LV +++ SLD L ++ +N +N + ++ + LAAA+
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYL-KKNKN-----CINILWKLEVAKQLAAAM 126
Query: 229 HYLHEQLETQIIHRDVKTSNVMLDSQYNAR--------LGDFGLARWLEHELQYQMRTSS 280
H+L E +IH +V N++L + + + L D G++ + + Q R
Sbjct: 127 HFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQER--- 180
Query: 281 ARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRR 333
I ++PPE + +D +SFG + E+ S G +
Sbjct: 181 -----------------IPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 8e-10
Identities = 62/294 (21%), Positives = 103/294 (35%), Gaps = 67/294 (22%)
Query: 526 FGTAYQGFL--------DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCG 577
F ++G + VL+K L + F +++L H++LV G
Sbjct: 21 FTKIFKGVRREVGDYGQLHETEVLLKVLDKA-HRNYSESFFEAASMMSKLSHKHLVLNYG 79
Query: 578 WCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWN 637
C E +++ ++ L L N + I + K LA+A+ +L EE
Sbjct: 80 VCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK-----LEVAKQLAAAMHFL-EENT 133
Query: 638 EQVIHR-----NITSSAITLDPDMNPR---LGSFALAEFLTRNDHGHRKATSGNRSVRGI 689
+IH NI NP L ++ + D + +
Sbjct: 134 --LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQER-------IP-- 182
Query: 690 FGYMSPEYIESGEA-TSMADVYSFGVVVLEVVT-GQMAVDFRLP-EGLLVKRVHEF-EAR 745
++ PE IE+ + D +SFG + E+ + G P L +R +F E R
Sbjct: 183 --WVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK------PLSALDSQRKLQFYEDR 234
Query: 746 KR----PLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795
+ AEL N L+ C P+ RPS R I+ L+
Sbjct: 235 HQLPAPKAAEL--------AN---LIN------NCMDYEPDHRPSFRAIIRDLN 271
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 61/226 (26%), Positives = 102/226 (45%), Gaps = 35/226 (15%)
Query: 116 DEVLGSGGFGKVYRAVLPSDG----TVVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNL 170
+VLGSG FG V++ V +G V +K + +K G + + ++A+ L H ++
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 171 VRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHY 230
VRL G C L LV Y+P SL + + L LNW +A ++Y
Sbjct: 78 VRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW------GVQIAKGMYY 130
Query: 231 LHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAE 290
L E ++HR++ NV+L S ++ DFG+A L + + + +
Sbjct: 131 LEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS------------ 175
Query: 291 TTRIGGT--IGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRR 333
I ++ ES G T +SDV+S+G+ V E+++ G
Sbjct: 176 ----EAKTPIKWMALESIHFG-KYTHQSDVWSYGVTVWELMTFGAE 216
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 9e-11
Identities = 61/289 (21%), Positives = 109/289 (37%), Gaps = 61/289 (21%)
Query: 526 FGTAYQGFL-----DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCT 580
FGT ++G V +K + ++ + + L H ++V+L G C
Sbjct: 26 FGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP 85
Query: 581 EQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQV 640
LV Y L + + +G +L N +A + YL EE +
Sbjct: 86 GSSLQLVT-QYLPLGSLLDHVRQHRGALGPQLL-----LNWGVQIAKGMYYL-EEHG--M 136
Query: 641 IHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIES 700
+HRN+ + + L ++ F +A+ L +D + ++ +M+ E I
Sbjct: 137 VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK-QLLYSEAKTPIK----WMALESIHF 191
Query: 701 GEATSMADVYSFGVVVLEVVT-GQMAVDFRLP-EGLLVKRVHEFEARKRPLAELVDLSLN 758
G+ T +DV+S+GV V E++T G P GL LAE+ DL
Sbjct: 192 GKYTHQSDVWSYGVTVWELMTFGAE------PYAGL-------------RLAEVPDLLEK 232
Query: 759 GE------------YNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795
GE Y +M C + + +RP+ +++ +
Sbjct: 233 GERLAQPQICTIDVY---MVMV------KCWMIDENIRPTFKELANEFT 272
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 75/341 (21%), Positives = 129/341 (37%), Gaps = 70/341 (20%)
Query: 95 GDNPRIFSYAELYIGSNGFDEDEVLGSGGFGKVYRAVL----PSDGTVVAVKCLAEKGER 150
G +P F L + LG G FG V + G VVAVK L E
Sbjct: 1 GSDPTQFEERHLKFL-------QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE 53
Query: 151 FEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQ--LLLVYDYMPNRSLDRVLFRRPENLEA 208
+ F E+ + L+H N+V+ +G C + L L+ +Y+P SL L + E ++
Sbjct: 54 HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH 113
Query: 209 AAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWL 268
L + + + YL + + IHRD+ T N++++++ ++GDFGL + L
Sbjct: 114 IKLLQY------TSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVL 164
Query: 269 EHELQYQMRTSSARNHQFHLAETTRIGGTIGYLP-----PESFQKGSVATAKSDVFSFGI 323
+ ++ P PES + + SDV+SFG+
Sbjct: 165 PQDKEFFKVKEPGE------------------SPIFWYAPESLTES-KFSVASDVWSFGV 205
Query: 324 VVLEVVSGRRAVDLTY----------PDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYK 373
V+ E+ + Q+I+ I L L D
Sbjct: 206 VLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL-KNNGRLPRPDG-------- 256
Query: 374 LCDMEHLTHLALLCTLHNPHLRPS---MKWVIEAVSGSYSG 411
C E + + C +N + RPS + ++ + + +G
Sbjct: 257 -CPDE-IYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG 295
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 5e-11
Identities = 61/289 (21%), Positives = 109/289 (37%), Gaps = 43/289 (14%)
Query: 526 FGTAYQGFLD-----NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCT 580
FG+ D + V VK+L S F E++ L L+H N+V+ G C
Sbjct: 23 FGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCY 81
Query: 581 EQGE--MLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNE 638
G + +I +Y L L + RI H L + + YL +
Sbjct: 82 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYLGTK--- 133
Query: 639 QVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYI 698
+ IHR++ + I ++ + ++G F L + L ++ + G + + +PE +
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF----WYAPESL 189
Query: 699 ESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLN 758
+ + +DV+SFGVV+ E+ T E + + + + L++L N
Sbjct: 190 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQ--MIVFHLIELLKN 247
Query: 759 GE------------YNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795
Y +M C +N RPS R + +D
Sbjct: 248 NGRLPRPDGCPDEIY---MIMTE------CWNNNVNQRPSFRDLALRVD 287
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-32
Identities = 53/220 (24%), Positives = 94/220 (42%), Gaps = 27/220 (12%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVK--CLAEKGERFEKTFAAELVAVAHLRHRNLVRLR 174
+ +G G FGK DG +K ++ + + E+ +A+++H N+V+ R
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 175 GWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQ 234
L +V DY L + + + +Q + AL ++H++
Sbjct: 90 ESFEENGSLYIVMDYCEGGDLFKRINAQKG-----VLFQEDQILDWFVQICLALKHVHDR 144
Query: 235 LETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRI 294
+I+HRD+K+ N+ L +LGDFG+AR L ++ LA
Sbjct: 145 ---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE--------------LARA--C 185
Query: 295 GGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRA 334
GT YL PE + KSD+++ G V+ E+ + + A
Sbjct: 186 IGTPYYLSPEICE-NKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 8e-19
Identities = 71/317 (22%), Positives = 116/317 (36%), Gaps = 58/317 (18%)
Query: 526 FGTAYQGF--LDNHQYVL--VKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTE 581
FG A D QYV+ + MS R E+ LA ++H N+VQ E
Sbjct: 37 FGKAILVKSTEDGRQYVIKEINISRMS--SKEREESRREVAVLANMKHPNIVQYRESFEE 94
Query: 582 QGEMLVIYDYSATRILSHLL-FHNNHRIG-HSILQWHHRYNIIKSLASAILYLHEEWNEQ 639
G + ++ DY L + IL W + A+ ++H+ +
Sbjct: 95 NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW------FVQICLALKHVHDR---K 145
Query: 640 VIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIE 699
++HR+I S I L D +LG F +A L A + G Y+SPE E
Sbjct: 146 ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE---LARA----CIGTPYYLSPEICE 198
Query: 700 SGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNG 759
+ + +D+++ G V+ E+ T + H FEA + LV ++G
Sbjct: 199 NKPYNNKSDIWALGCVLYELCTLK----------------HAFEAGS--MKNLVLKIISG 240
Query: 760 EYNH------KELMRLIKLGIACTLSNPELRPSMRQILSILDGNDKRFMEDGQMTENLEE 813
+ +L L+ NP RPS+ IL F+ ++ + L
Sbjct: 241 SFPPVSLHYSYDLRSLVS---QLFKRNPRDRPSVNSILEK------GFIAK-RIEKFLSP 290
Query: 814 WKQRNECSLSLIKRIQA 830
E L + +
Sbjct: 291 QLIAEEFCLKTFSKFGS 307
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-32
Identities = 78/370 (21%), Positives = 134/370 (36%), Gaps = 70/370 (18%)
Query: 66 CFCHHNTPRKEHSGLFHDMEGVQMSEKVGGDNPRIFSYAELYIGSNGFDEDEVLGSGGFG 125
+ HH+ + + M +P F L + LG G FG
Sbjct: 3 YYHHHHHHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFL-------QQLGKGNFG 55
Query: 126 KVYRAVL----PSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHED 181
V + G VVAVK L E + F E+ + L+H N+V+ +G C
Sbjct: 56 SVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 115
Query: 182 Q--LLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQI 239
+ L L+ +Y+P SL L + E ++ L + + + YL + +
Sbjct: 116 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY------TSQICKGMEYLGTK---RY 166
Query: 240 IHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIG 299
IHRD+ T N++++++ ++GDFGL + L + +Y
Sbjct: 167 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGE----------------- 209
Query: 300 YLP-----PESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTY----------PDDQI 344
P PES + + SDV+SFG+V+ E+ + Q+
Sbjct: 210 -SPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 267
Query: 345 ILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPS---MKWV 401
I+ I L L D C E + + C +N + RPS +
Sbjct: 268 IVFHLIELL-KNNGRLPRPDG---------CPDE-IYMIMTECWNNNVNQRPSFRDLALR 316
Query: 402 IEAVSGSYSG 411
++ + +G
Sbjct: 317 VDQIRDQMAG 326
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 9e-11
Identities = 60/289 (20%), Positives = 110/289 (38%), Gaps = 43/289 (14%)
Query: 526 FGTAYQGFLD-----NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCT 580
FG+ D + V VK+L F E++ L L+H N+V+ G C
Sbjct: 54 FGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCY 112
Query: 581 EQGE--MLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNE 638
G + +I +Y L L + RI H L + + YL +
Sbjct: 113 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYLGTK--- 164
Query: 639 QVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYI 698
+ IHR++ + I ++ + ++G F L + L ++ ++ G + + +PE +
Sbjct: 165 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF----WYAPESL 220
Query: 699 ESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLN 758
+ + +DV+SFGVV+ E+ T E + + + + + L++L N
Sbjct: 221 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG--QMIVFHLIELLKN 278
Query: 759 GE------------YNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795
Y +M C +N RPS R + +D
Sbjct: 279 NGRLPRPDGCPDEIY---MIMTE------CWNNNVNQRPSFRDLALRVD 318
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 50/225 (22%), Positives = 99/225 (44%), Gaps = 26/225 (11%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVK--CLAEKGERFEKTFA-AELVAVAHLRHRN 169
F ++ +G G F +VYRA DG VA+K + + + + E+ + L H N
Sbjct: 34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 170 LVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALH 229
+++ + +++L +V + L R++ + + K L +AL
Sbjct: 94 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQ---KRLIPERTVWKYFVQLCSALE 150
Query: 230 YLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLA 289
++H + +++HRD+K +NV + + +LGD GL R+ + A
Sbjct: 151 HMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--------------AA 193
Query: 290 ETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRA 334
+ + GT Y+ PE + KSD++S G ++ E+ + +
Sbjct: 194 HS--LVGTPYYMSPERIH-ENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 55/279 (19%), Positives = 105/279 (37%), Gaps = 43/279 (15%)
Query: 526 FGTAYQGF--LDNHQYVLVKRLGMSKCPALRTRFS--NELQNLARLRHRNLVQLCGWCTE 581
F Y+ LD L K++ + + R E+ L +L H N+++ E
Sbjct: 45 FSEVYRAACLLDGVPVAL-KKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE 103
Query: 582 QGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVI 641
E+ ++ + + LS ++ + + ++ + L SA+ ++H +V+
Sbjct: 104 DNELNIVLELADAGDLSRMI--KHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVM 158
Query: 642 HRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESG 701
HR+I + + + +LG L F + T+ S+ G YMSPE I
Sbjct: 159 HRDIKPANVFITATGVVKLGDLGLGRFFSSK-------TTAAHSLVGTPYYMSPERIHEN 211
Query: 702 EATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEY 761
+D++S G ++ E+ Q F K L L +Y
Sbjct: 212 GYNFKSDIWSLGCLLYEMAALQ----------------SPFYGDKMNLYSLCKKIEQCDY 255
Query: 762 NH-------KELMRLIKLGIACTLSNPELRPSMRQILSI 793
+EL +L+ + C +PE RP + + +
Sbjct: 256 PPLPSDHYSEELRQLVNM---CINPDPEKRPDVTYVYDV 291
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 56/224 (25%), Positives = 85/224 (37%), Gaps = 34/224 (15%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVK--CLAEKGERFEKTFAAELVAVAHL-RHRN 169
F LG G +G+V++ DG + AVK +G + AE+ + + +H
Sbjct: 59 FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPC 118
Query: 170 LVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQR-KKIIRGLAAAL 228
VRL L L + SL + +L E + +R AL
Sbjct: 119 CVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLP-------EAQVWGYLRDTLLAL 170
Query: 229 HYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHL 288
+LH Q ++H DVK +N+ L + +LGDFGL L ++
Sbjct: 171 AHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVEL---------GTAGAGEVQE- 217
Query: 289 AETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
G Y+ PE Q +DVFS G+ +LEV
Sbjct: 218 -------GDPRYMAPELLQGS--YGTAADVFSLGLTILEVACNM 252
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 52/274 (18%), Positives = 98/274 (35%), Gaps = 46/274 (16%)
Query: 526 FGTAYQGF--LDNHQYVLVKRLGMSKCPAL-RTRFSNELQNLARL-RHRNLVQLCGWCTE 581
+G ++ D Y VKR R R E+ + ++ +H V+L E
Sbjct: 70 YGEVFKVRSKEDGRLYA-VKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE 128
Query: 582 QGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVI 641
G + + + + H + + + ++ A+ +LH + ++
Sbjct: 129 GGILYLQTELCGPSLQQHCE-AWGASLPEAQVW-----GYLRDTLLALAHLHSQ---GLV 179
Query: 642 HRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESG 701
H ++ + I L P +LG F L L G G YM+PE ++
Sbjct: 180 HLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGE--------VQEGDPRYMAPELLQGS 231
Query: 702 EATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEY 761
+ ADV+S G+ +LE +A + LP +L L E+
Sbjct: 232 -YGTAADVFSLGLTILE-----VACNMELP----------HGG--EGWQQLRQGYLPPEF 273
Query: 762 NH---KELMRLIKLGIACTLSNPELRPSMRQILS 792
EL ++ + +P+LR + +L+
Sbjct: 274 TAGLSSELRSVLVM---MLEPDPKLRATAEALLA 304
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 4e-32
Identities = 58/226 (25%), Positives = 104/226 (46%), Gaps = 35/226 (15%)
Query: 116 DEVLGSGGFGKVYRAVLPSDG----TVVAVKCL-AEKGERFEKTFAAELVAVAHLRHRNL 170
+VLGSG FG VY+ + +G VA+K L + K E +A + + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 171 VRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHY 230
RL G C+ + L+ MP L + +N+ + LNW +A ++Y
Sbjct: 80 CRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNY 132
Query: 231 LHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAE 290
L ++ +++HRD+ NV++ + + ++ DFGLA+ L E +
Sbjct: 133 LEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE------------ 177
Query: 291 TTRIGGT--IGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRR 333
GG I ++ ES + T +SDV+S+G+ V E+++ G +
Sbjct: 178 ----GGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSK 218
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 57/289 (19%), Positives = 106/289 (36%), Gaps = 61/289 (21%)
Query: 526 FGTAYQGFL-----DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCT 580
FGT Y+G V +K L + P +E +A + + ++ +L G C
Sbjct: 28 FGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL 87
Query: 581 EQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQV 640
L+ L + + IG L N +A + YL E+ +
Sbjct: 88 TSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYL-EDRR--L 138
Query: 641 IHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIES 700
+HR++ + + + + ++ F LA+ L + A G ++ +M+ E I
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK-EYHAEGGKVPIK----WMALESILH 193
Query: 701 GEATSMADVYSFGVVVLEVVT-GQMAVDFRLP-EGLLVKRVHEFEARKRPLAELVDLSLN 758
T +DV+S+GV V E++T G P +G+ P +E+ +
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSK------PYDGI-------------PASEISSILEK 234
Query: 759 GE------------YNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795
GE Y +M C + + + RP R+++
Sbjct: 235 GERLPQPPICTIDVY---MIMV------KCWMIDADSRPKFRELIIEFS 274
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 7e-32
Identities = 70/258 (27%), Positives = 105/258 (40%), Gaps = 51/258 (19%)
Query: 97 NPRIFSYAELYIGSNGFDEDEV----------LGSGGFGKVYRAVLPS-----DGTVVAV 141
NP FS A++Y+ DE EV LG G FG VY V T VA+
Sbjct: 5 NPEYFSAADVYVP----DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAI 60
Query: 142 KCLAEKGERFEKT-FAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVL- 199
K + E E+ F E + ++VRL G L++ + M L L
Sbjct: 61 KTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR 120
Query: 200 FRRPENLE--AAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNA 257
RP AP + + ++ +A + YL+ + +HRD+ N M+ +
Sbjct: 121 SLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV 177
Query: 258 RLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLP-----PESFQKGSVA 312
++GDFG+ R + Y+ G G LP PES + G V
Sbjct: 178 KIGDFGMTRDIYETDYYRK-------------------GGKGLLPVRWMSPESLKDG-VF 217
Query: 313 TAKSDVFSFGIVVLEVVS 330
T SDV+SFG+V+ E+ +
Sbjct: 218 TTYSDVWSFGVVLWEIAT 235
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 9e-14
Identities = 68/292 (23%), Positives = 117/292 (40%), Gaps = 56/292 (19%)
Query: 526 FGTAYQGFLDN------HQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWC 579
FG Y+G V +K + + R F NE + ++V+L G
Sbjct: 38 FGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97
Query: 580 TEQGEMLVIYDYSATR--ILSHLLFHNNHRIGHSILQWHHRYNIIK---SLASAILYLHE 634
++ LVI + TR + S+L + +L +I+ +A + YL
Sbjct: 98 SQGQPTLVIMEL-MTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL-N 155
Query: 635 EWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMS 694
+HR++ + + D ++G F + + D+ +RK G VR +MS
Sbjct: 156 ANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY-YRKGGKGLLPVR----WMS 208
Query: 695 PEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLP-EGLLVKRVHEFEARKRPLAEL 752
PE ++ G T+ +DV+SFGVV+ E+ T + P +GL ++
Sbjct: 209 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQ------PYQGL-------------SNEQV 249
Query: 753 VDLSLNGEYNHK---------ELMRLIKLGIACTLSNPELRPSMRQILSILD 795
+ + G K ELMR C NP++RPS +I+S +
Sbjct: 250 LRFVMEGGLLDKPDNCPDMLFELMR------MCWQYNPKMRPSFLEIISSIK 295
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 7e-32
Identities = 54/245 (22%), Positives = 94/245 (38%), Gaps = 19/245 (7%)
Query: 94 GGDNPRIFSYAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEK 153
G F + I + + + LG GGF V DG A+K + ++ +
Sbjct: 12 SGRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDRE 71
Query: 154 TFAAELVAVAHLRHRNLVRLRGWCVHED----QLLLVYDYMPNRSLDRVLFRRPENLEAA 209
E H N++RL +C+ E + L+ + +L + R +
Sbjct: 72 EAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERL---KDKG 128
Query: 210 APLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLE 269
L +Q ++ G+ L +H + HRD+K +N++L + L D G
Sbjct: 129 NFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185
Query: 270 HELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESF--QKGSVATAKSDVFSFGIVVLE 327
++ + A Q A+ TI Y PE F Q V ++DV+S G V+
Sbjct: 186 IHVE---GSRQALTLQDWAAQR----CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYA 238
Query: 328 VVSGR 332
++ G
Sbjct: 239 MMFGE 243
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 9e-15
Identities = 45/285 (15%), Positives = 94/285 (32%), Gaps = 45/285 (15%)
Query: 526 FGTAY--QGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQG 583
F +G D H Y L KR+ + E H N+++L +C +
Sbjct: 42 FSYVDLVEGLHDGHFYAL-KRILCHEQQDRE-EAQREADMHRLFNHPNILRLVAYCLRER 99
Query: 584 ----EMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQ 639
E ++ + L + + + + L ++ + + +H +
Sbjct: 100 GAKHEAWLLLPFFKRGTLWNEI--ERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KG 154
Query: 640 VIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSG--NRSVRGIFGYMSPEY 697
HR++ + I L + P L + G R+A + + R Y +PE
Sbjct: 155 YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPEL 214
Query: 698 IES---GEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVD 754
DV+S G V+ ++ G+ ++ + + V
Sbjct: 215 FSVQSHCVIDERTDVWSLGCVLYAMMFGE----------------GPYDMVFQK-GDSVA 257
Query: 755 LSLNGEYNH-------KELMRLIKLGIACTLSNPELRPSMRQILS 792
L++ + + L +L+ + +P RP + +LS
Sbjct: 258 LAVQNQLSIPQSPRHSSALWQLLN---SMMTVDPHQRPHIPLLLS 299
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 7e-32
Identities = 79/309 (25%), Positives = 124/309 (40%), Gaps = 65/309 (21%)
Query: 117 EVLGSGGFGKVYRAVLP-----SDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLV 171
LG G FGKV+ A D +VAVK L E E + F E + L+H+++V
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 172 RLRGWCVHEDQLLLVYDYMPNRSLDRVL-FRRPENLEAAA-------PLNWEQRKKIIRG 223
R G C LL+V++YM + L+R L P+ A PL Q +
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 224 LAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARN 283
+AA + YL +HRD+ T N ++ ++GDFG++R +
Sbjct: 167 VAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS------------- 210
Query: 284 HQFHLAETTRIGGTIGYLP-----PESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDL 337
+ R+GG LP PES T +SDV+SFG+V+ E+ + G++
Sbjct: 211 -----TDYYRVGGR-TMLPIRWMPPESILYR-KFTTESDVWSFGVVLWEIFTYGKQP--- 260
Query: 338 TYP---DDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHL 394
+ + + I +G+ L+ C + + C P
Sbjct: 261 -WYQLSNTEAI------DCITQGRELERPRA---------C-PPEVYAIMRGCWQREPQQ 303
Query: 395 RPSMKWVIE 403
R S+K V
Sbjct: 304 RHSIKDVHA 312
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 6e-12
Identities = 59/294 (20%), Positives = 110/294 (37%), Gaps = 56/294 (19%)
Query: 526 FGTAYQGFLDN------HQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWC 579
FG + N V VK L + R F E + L L+H+++V+ G C
Sbjct: 54 FGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQDFQREAELLTMLQHQHIVRFFGVC 112
Query: 580 TEQGEMLVIYDYSA---------TRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAIL 630
TE +L++++Y + L + L + +A+ ++
Sbjct: 113 TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMV 172
Query: 631 YLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIF 690
YL +HR++ + + + ++G F ++ + D+ +R +R
Sbjct: 173 YLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY-YRVGGRTMLPIR--- 225
Query: 691 GYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLP-EGLLVKRVHEF-EARKR 747
+M PE I + T+ +DV+SFGVV+ E+ T G+ P L + +
Sbjct: 226 -WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ------PWYQLSNTEAIDCITQGRE 278
Query: 748 ---PL---AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795
P E+ Y +MR C P+ R S++ + + L
Sbjct: 279 LERPRACPPEV--------YA---IMR------GCWQREPQQRHSIKDVHARLQ 315
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 68/302 (22%), Positives = 112/302 (37%), Gaps = 60/302 (19%)
Query: 117 EVLGSGGFGKVYRAVLPSDG----TVVAVKCL-AEKGERFEKTFAAELVAVAHLRHRNLV 171
LG G FGKV +G VAVK L E G E+ + +L H N+V
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 172 RLRGWCVHEDQ--LLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALH 229
+ +G C + + L+ +++P+ SL L + + L + + +
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKY------AVQICKGMD 140
Query: 230 YLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLA 289
YL + Q +HRD+ NV+++S++ ++GDFGL + +E + +Y
Sbjct: 141 YLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRD------- 190
Query: 290 ETTRIGGTIGYLP-----PESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTY---- 339
P PE + SDV+SFG+ + E+++
Sbjct: 191 -----------SPVFWYAPECLMQS-KFYIASDVWSFGVTLHELLTYCDSDSSPMALFLK 238
Query: 340 ----PDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLR 395
Q+ + + L EGK L N C E + L C P R
Sbjct: 239 MIGPTHGQMTVTRLVNTL-KEGKRLPCPPN---------CPDE-VYQLMRKCWEFQPSNR 287
Query: 396 PS 397
S
Sbjct: 288 TS 289
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 6e-13
Identities = 54/290 (18%), Positives = 103/290 (35%), Gaps = 45/290 (15%)
Query: 526 FGTAYQGFLD-----NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCT 580
FG D + V VK L E++ L L H N+V+ G CT
Sbjct: 34 FGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICT 93
Query: 581 EQGE--MLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNE 638
E G + +I ++ + L L N ++I + + YL
Sbjct: 94 EDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQ-----LKYAVQICKGMDYLGS---R 145
Query: 639 QVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYI 698
Q +HR++ + + ++ + ++G F L + + + + + V + +PE +
Sbjct: 146 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF----WYAPECL 201
Query: 699 ESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSL 757
+ +DV+SFGV + E++T ++ H + + LV+
Sbjct: 202 MQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHG----QMTVTRLVNTLK 257
Query: 758 NGE------------YNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795
G+ Y +LMR C P R S + ++ +
Sbjct: 258 EGKRLPCPPNCPDEVY---QLMRK------CWEFQPSNRTSFQNLIEGFE 298
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 63/228 (27%), Positives = 101/228 (44%), Gaps = 38/228 (16%)
Query: 116 DEVLGSGGFGKVYRAVLPSDG---TVVAVKCL-AEKGERFEKTFAAELVAVAHLRHRNLV 171
++++GSG G+V L G VA+K L A ER + F +E + H N++
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 172 RLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYL 231
RL G ++V +YM N SLD L + +RG+ A + YL
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGM------LRGVGAGMRYL 167
Query: 232 HEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAET 291
+ +HRD+ NV++DS ++ DFGL+R LE + T+ +
Sbjct: 168 SDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGK--------- 215
Query: 292 TRIGGTIGYLP-----PESFQKGSVATAKSDVFSFGIVVLEVVS-GRR 333
+P PE+ ++ SDV+SFG+V+ EV++ G R
Sbjct: 216 ---------IPIRWTAPEAIAFR-TFSSASDVWSFGVVMWEVLAYGER 253
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 42/200 (21%), Positives = 83/200 (41%), Gaps = 16/200 (8%)
Query: 526 FGTAYQGFL----DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTE 581
G G L V +K L R F +E + + H N+++L G T
Sbjct: 62 SGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR 121
Query: 582 QGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVI 641
+++ +Y L L ++ + L +++ + + + YL + +
Sbjct: 122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQL-----VGMLRGVGAGMRYLSD---LGYV 173
Query: 642 HRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESG 701
HR++ + + +D ++ ++ F L+ L + T G +R + +PE I
Sbjct: 174 HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIR----WTAPEAIAFR 229
Query: 702 EATSMADVYSFGVVVLEVVT 721
+S +DV+SFGVV+ EV+
Sbjct: 230 TFSSASDVWSFGVVMWEVLA 249
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 61/233 (26%), Positives = 104/233 (44%), Gaps = 42/233 (18%)
Query: 117 EVLGSGGFGKVYRAVLP-----SDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLV 171
LG G FGKV+ A D +VAVK L + K F E + +L+H ++V
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 172 RLRGWCVHEDQLLLVYDYMPNRSLDRVL-FRRPENLEAAAPLNWEQRKK--------IIR 222
+ G C D L++V++YM + L++ L P+ + + + + I
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 223 GLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSAR 282
+A+ + YL Q +HRD+ T N ++ + ++GDFG++R +
Sbjct: 141 QIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYST----------- 186
Query: 283 NHQFHLAETTRIGGTIGYLP-----PESFQKGSVATAKSDVFSFGIVVLEVVS 330
+ R+GG LP PES T +SDV+SFG+++ E+ +
Sbjct: 187 -------DYYRVGGH-TMLPIRWMPPESIMYR-KFTTESDVWSFGVILWEIFT 230
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 5e-13
Identities = 60/290 (20%), Positives = 114/290 (39%), Gaps = 47/290 (16%)
Query: 526 FGTAYQGFLDN------HQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWC 579
FG + N V VK L A R F E + L L+H ++V+ G C
Sbjct: 28 FGKVFLAECYNLSPTKDKMLVAVKAL-KDPTLAARKDFQREAELLTNLQHEHIVKFYGVC 86
Query: 580 TEQGEMLVIYDY----------SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAI 629
+ ++++++Y A + +L R L +I +AS +
Sbjct: 87 GDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGM 146
Query: 630 LYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGI 689
+YL + +HR++ + + ++ ++G F ++ + D+ +R +R
Sbjct: 147 VYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY-YRVGGHTMLPIR-- 200
Query: 690 FGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLP-EGLLVKRVHEF-EARK 746
+M PE I + T+ +DV+SFGV++ E+ T G+ P L V E +
Sbjct: 201 --WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ------PWFQLSNTEVIECITQGR 252
Query: 747 R-PLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795
+ + Y+ +M C P+ R ++++I IL
Sbjct: 253 VLERPRVCPKEV---YD---VML------GCWQREPQQRLNIKEIYKILH 290
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 58/228 (25%), Positives = 101/228 (44%), Gaps = 26/228 (11%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVK--CLAEKGERFEKTFAAELVAVAHLRHRNL 170
++ +G+G +G+ + SDG ++ K E ++ +E+ + L+H N+
Sbjct: 8 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67
Query: 171 VRLRGWCVHE--DQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAAL 228
VR + L +V +Y L V+ + + L+ E +++ L AL
Sbjct: 68 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKE---RQYLDEEFVLRVMTQLTLAL 124
Query: 229 HYLHEQ--LETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQF 286
H + ++HRD+K +NV LD + N +LGDFGLAR L H+
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS------------- 171
Query: 287 HLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRA 334
A+T GT Y+ PE + S KSD++S G ++ E+ +
Sbjct: 172 -FAKT--FVGTPYYMSPEQMNRMSY-NEKSDIWSLGCLLYELCALMPP 215
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 4e-19
Identities = 56/281 (19%), Positives = 95/281 (33%), Gaps = 46/281 (16%)
Query: 526 FGTAY--QGFLDNHQYVL--VKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCG-WCT 580
+G + D V + M+ A + +E+ L L+H N+V+
Sbjct: 19 YGRCQKIRRKSDGKILVWKELDYGSMT--EAEKQMLVSEVNLLRELKHPNIVRYYDRIID 76
Query: 581 EQGEMLVIY-DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHE--EWN 637
L I +Y L+ ++ L ++ L A+ H +
Sbjct: 77 RTNTTLYIVMEYCEGGDLASVI--TKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGG 134
Query: 638 EQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEY 697
V+HR++ + + LD N +LG F LA L + TS ++ G YMSPE
Sbjct: 135 HTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-------TSFAKTFVGTPYYMSPEQ 187
Query: 698 IESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSL 757
+ +D++S G ++ E+ F A EL
Sbjct: 188 MNRMSYNEKSDIWSLGCLLYELCALM----------------PPFTAFS--QKELAGKIR 229
Query: 758 NGEYNH------KELMRLIKLGIACTLSNPELRPSMRQILS 792
G++ EL +I RPS+ +IL
Sbjct: 230 EGKFRRIPYRYSDELNEIIT---RMLNLKDYHRPSVEEILE 267
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 53/237 (22%), Positives = 102/237 (43%), Gaps = 46/237 (19%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVR 172
F E E++GSGGFG+V++A DG +K + E+ E+ E+ A+A L H N+V
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNIVH 68
Query: 173 LRG----------------WCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQ 216
G L + ++ +L++ + +R L+
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE-----KLDKVL 123
Query: 217 RKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQM 276
++ + + Y+H + ++I+RD+K SN+ L ++GDFGL L+++
Sbjct: 124 ALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND----- 175
Query: 277 RTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRR 333
+ TR GT+ Y+ PE + D+++ G+++ E++
Sbjct: 176 ------------GKRTRSKGTLRYMSPEQIS-SQDYGKEVDLYALGLILAELLHVCD 219
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 66/312 (21%), Positives = 118/312 (37%), Gaps = 72/312 (23%)
Query: 526 FGTAYQGF--LDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQG 583
FG ++ +D YV +KR+ + A R E++ LA+L H N+V G
Sbjct: 24 FGQVFKAKHRIDGKTYV-IKRVKYNNEKAER-----EVKALAKLDHVNIVHYNGCWDGFD 77
Query: 584 EMLVIYDYSATRILSHLLFHNNHRI------GHSILQWHHRYN-----------IIKSLA 626
+++R + LF I ++ QW + + + +
Sbjct: 78 YDPETSSKNSSRSKTKCLF-----IQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQIT 132
Query: 627 SAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSV 686
+ Y+H + ++I+R++ S I L ++G F L L + K T
Sbjct: 133 KGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG----KRTR----S 181
Query: 687 RGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARK 746
+G YMSPE I S + D+Y+ G+++ E LL FE K
Sbjct: 182 KGTLRYMSPEQISSQDYGKEVDLYALGLILAE---------------LLHVCDTAFETSK 226
Query: 747 RPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDKRFMEDGQ 806
+L D ++ ++ K+ L++ PE RP+ +IL L
Sbjct: 227 F-FTDLRDGIISDIFD-KKEKTLLQ---KLLSKKPEDRPNTSEILRTL-----------T 270
Query: 807 MTENLEEWKQRN 818
+ + E +R+
Sbjct: 271 VWKKSPEKNERH 282
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 7e-31
Identities = 61/228 (26%), Positives = 94/228 (41%), Gaps = 37/228 (16%)
Query: 116 DEVLGSGGFGKVYRAVL--PSDGTV-VAVKCLAE---KGERFEKTFAAELVAVAHLRHRN 169
E LG G FG V R PS TV VAVKCL F E+ A+ L HRN
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 170 LVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALH 229
L+RL G + + +V + P SL L + + + +A +
Sbjct: 83 LIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY------AVQVAEGMG 135
Query: 230 YLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLE-HELQYQMRTSSARNHQFHL 288
YL + + IHRD+ N++L ++ ++GDFGL R L ++ Y M+
Sbjct: 136 YLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE---------- 182
Query: 289 AETTRIGGT--IGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRR 333
+ PES + + SD + FG+ + E+ + G+
Sbjct: 183 ------HRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQE 223
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 44/206 (21%), Positives = 76/206 (36%), Gaps = 20/206 (9%)
Query: 526 FGTAYQGFL----DNHQYVLVKRL--GMSKCPALRTRFSNELQNLARLRHRNLVQLCGWC 579
FG +G V VK L + P F E+ + L HRNL++L G
Sbjct: 31 FGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVV 90
Query: 580 TEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQ 639
+V + + L L + L +A + YL ++
Sbjct: 91 LTPPMKMVT-ELAPLGSLLDRLRKHQGHFLLGTL-----SRYAVQVAEGMGYLES---KR 141
Query: 640 VIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIE 699
IHR++ + + L ++G F L L +ND + + +PE ++
Sbjct: 142 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA----WCAPESLK 197
Query: 700 SGEATSMADVYSFGVVVLEVVT-GQM 724
+ + +D + FGV + E+ T GQ
Sbjct: 198 TRTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 8e-31
Identities = 48/242 (19%), Positives = 87/242 (35%), Gaps = 48/242 (19%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVK--CLAEKGERFEKTFAAELVAVAHL-RHRN 169
F E E +GSG FG V++ V DG + A+K G E+ E+ A A L +H +
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 170 LVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALH 229
+VR +D +L+ +Y SL + + + K ++ + L
Sbjct: 73 VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMS---YFKEAELKDLLLQVGRGLR 129
Query: 230 YLHEQLETQIIHRDVKTSNVMLD-------------------SQYNARLGDFGLARWLEH 270
Y+H ++H D+K SN+ + ++ ++GD G
Sbjct: 130 YIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT---- 182
Query: 271 ELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS 330
++ G +L E Q+ K+D+F+ + V+
Sbjct: 183 ----------------RISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAG 226
Query: 331 GR 332
Sbjct: 227 AE 228
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 52/281 (18%), Positives = 100/281 (35%), Gaps = 41/281 (14%)
Query: 526 FGTAYQGF--LDNHQYVLVKRLGMSKC-PALRTRFSNELQNLARL-RHRNLVQLCGWCTE 581
FG+ ++ LD Y +KR E+ A L +H ++V+ E
Sbjct: 24 FGSVFKCVKRLDGCIYA-IKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE 82
Query: 582 QGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVI 641
ML+ +Y L+ + N + + + +++ + + Y+H ++
Sbjct: 83 DDHMLIQNEYCNGGSLADAISENYRIMSY--FKEAELKDLLLQVGRGLRYIHSM---SLV 137
Query: 642 HRNITSSAITLDPDMNPRLGSFALAEFLTRN--------DHGHRKATSGNRSVRGIFGYM 693
H +I S I + P S E + D GH S + G ++
Sbjct: 138 HMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFL 197
Query: 694 SPEYI-ESGEATSMADVYSFGVVVLEVVTGQMAVDFRLP-EGLLVKRVHEFEARKRPLAE 751
+ E + E+ AD+++ + V+ + LP G + R+ L
Sbjct: 198 ANEVLQENYTHLPKADIFALALTVVCAAGAE-----PLPRNGDQWHEI-----RQGRLPR 247
Query: 752 LVD-LSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQIL 791
+ LS +E L+K+ +PE RPS ++
Sbjct: 248 IPQVLS-------QEFTELLKV---MIHPDPERRPSAMALV 278
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 1e-30
Identities = 56/222 (25%), Positives = 96/222 (43%), Gaps = 31/222 (13%)
Query: 116 DEVLGSGGFGKVYRAVLPSDGTVVAVKCLAE---KGERFEKTFAAELVAVAHLRHRNLVR 172
+ LG GG VY A VA+K + + E K F E+ + L H+N+V
Sbjct: 16 VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 173 LRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLH 232
+ +D LV +Y+ +L + PL+ + + + + H
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYIESH-------GPLSVDTAINFTNQILDGIKHAH 128
Query: 233 EQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETT 292
+ +I+HRD+K N+++DS ++ DFG+A+ L + L +T
Sbjct: 129 DM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS---------------ETSLTQTN 170
Query: 293 RIGGTIGYLPPESFQ-KGSVATAKSDVFSFGIVVLEVVSGRR 333
+ GT+ Y PE Q KG +D++S GIV+ E++ G
Sbjct: 171 HVLGTVQYFSPE--QAKGEATDECTDIYSIGIVLYEMLVGEP 210
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 6e-13
Identities = 52/280 (18%), Positives = 103/280 (36%), Gaps = 38/280 (13%)
Query: 540 VLVK--RLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRIL 597
V +K + + RF E+ N ++L H+N+V + E ++ +Y L
Sbjct: 39 VAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTL 98
Query: 598 SHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMN 657
S + G L N + I + H+ +++HR+I I +D +
Sbjct: 99 SEYI----ESHGP--LSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKT 149
Query: 658 PRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVL 717
++ F +A+ L+ T N V G Y SPE + D+YS G+V+
Sbjct: 150 LKIFDFGIAKALSETS-----LTQTN-HVLGTVQYFSPEQAKGEATDECTDIYSIGIVLY 203
Query: 718 EVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELV-DLSLNGEYNHKELMRLIKLGIAC 776
E++ G+ + + +K + ++ ++ D+ + L +I +
Sbjct: 204 EMLVGEPPFNGETAVSIAIKHIQ--DSVPNVTTDVRKDIP-------QSLSNVI---LRA 251
Query: 777 TLSNPELRPS--------MRQILSILDGNDKRFMEDGQMT 808
T + R + +L N+ + D T
Sbjct: 252 TEKDKANRYKTIQEMKDDLSSVLHENRANEDVYELDKMKT 291
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 73/293 (24%), Positives = 115/293 (39%), Gaps = 55/293 (18%)
Query: 116 DEVLGSGGFGKVYRAVLPSDG---TVVAVKCLAEKGERFEKT-FAAELVAVAHLRHRNLV 171
+EV+G G FG VY L + AVK L + E + F E + + H N++
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 172 RLRGWCVHED-QLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHY 230
L G C+ + L+V YM + L + N + +A + Y
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV------KDLIGFGLQVAKGMKY 143
Query: 231 LHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAE 290
L + + +HRD+ N MLD ++ ++ DFGLAR + + Y + +
Sbjct: 144 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTG--------- 191
Query: 291 TTRIGGTIGYLP-----PESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQI 344
LP ES Q T KSDV+SFG+++ E+++ G YPD +
Sbjct: 192 --------AKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPP----YPD--V 236
Query: 345 ILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPS 397
D L +G+ L + C L + L C +RPS
Sbjct: 237 NTFDITVYL-LQGRRLLQPEY---------CPDP-LYEVMLKCWHPKAEMRPS 278
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 57/287 (19%), Positives = 107/287 (37%), Gaps = 54/287 (18%)
Query: 526 FGTAYQGFL----DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTE 581
FG Y G L + VK L ++F E + H N++ L G C
Sbjct: 38 FGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR 97
Query: 582 -QGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQV 640
+G LV+ Y L + + + H L +A + YL + +
Sbjct: 98 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGMKYLASK---KF 149
Query: 641 IHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNR-SVRGIFGYMSPEYIE 699
+HR++ + LD ++ F LA + ++ +G + V+ +M+ E ++
Sbjct: 150 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK----WMALESLQ 205
Query: 700 SGEATSMADVYSFGVVVLEVVT-GQMAVDFRLP-EGLLVKRVHEFEARKRPLAELVDLSL 757
+ + T+ +DV+SFGV++ E++T G P + ++ L
Sbjct: 206 TQKFTTKSDVWSFGVLLWELMTRGAP------PYPDV-------------NTFDITVYLL 246
Query: 758 NGEYNHK---------ELMRLIKLGIACTLSNPELRPSMRQILSILD 795
G + E+M C E+RPS +++S +
Sbjct: 247 QGRRLLQPEYCPDPLYEVML------KCWHPKAEMRPSFSELVSRIS 287
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 72/336 (21%), Positives = 117/336 (34%), Gaps = 60/336 (17%)
Query: 117 EVLGSGGFGKVYRAVLPSDG---TVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLV 171
+LG G FG V A L + VAVK L + F E + H ++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 172 RLRGWCVHED------QLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLA 225
+L G + +++ +M + L L E L + + + +A
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFL-LASRIGENPFNLPLQTLVRFMVDIA 147
Query: 226 AALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQ 285
+ YL + IHRD+ N ML + DFGL+R + Y+ +
Sbjct: 148 CGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCA------ 198
Query: 286 FHLAETTRIGGTIGYLP-----PESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTY 339
LP ES + T SDV++FG+ + E+++ G+ Y
Sbjct: 199 -------------SKLPVKWLALESLADN-LYTVHSDVWAFGVTMWEIMTRGQTP----Y 240
Query: 340 PDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMK 399
I + L G L+ C E + L C +P RPS
Sbjct: 241 AG--IENAEIYNYL-IGGNRLKQPPE---------CMEE-VYDLMYQCWSADPKQRPSFT 287
Query: 400 WVIEAVSGSYSGKLPALPSFQSHPLYISLSSPTNTS 435
+ + + G L L + Q PLYI++ +
Sbjct: 288 CLRMELE-NILGHLSVLSTSQD-PLYINIERAHHHH 321
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 55/292 (18%), Positives = 100/292 (34%), Gaps = 55/292 (18%)
Query: 526 FGTAYQGFLDNH----QYVLVKRLGMSKC-PALRTRFSNELQNLARLRHRNLVQLCGWCT 580
FG+ + L V VK L + F E + H ++ +L G
Sbjct: 36 FGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSL 95
Query: 581 EQG------EMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHE 634
+VI + L L + L + +A + YL
Sbjct: 96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS 155
Query: 635 EWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMS 694
IHR++ + L DM + F L+ + D+ +R+ + V+ +++
Sbjct: 156 R---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDY-YRQGCASKLPVK----WLA 207
Query: 695 PEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLP-EGLLVKRVHEFEARKRPLAEL 752
E + T +DV++FGV + E++T GQ P G+ AE+
Sbjct: 208 LESLADNLYTVHSDVWAFGVTMWEIMTRGQT------PYAGI-------------ENAEI 248
Query: 753 VDLSLNGEYNHK---------ELMRLIKLGIACTLSNPELRPSMRQILSILD 795
+ + G + +LM C ++P+ RPS + L+
Sbjct: 249 YNYLIGGNRLKQPPECMEEVYDLMY------QCWSADPKQRPSFTCLRMELE 294
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 58/220 (26%), Positives = 97/220 (44%), Gaps = 32/220 (14%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGW 176
+ +GSG FG V+ + VA+K + E G E+ F E + L H LV+L G
Sbjct: 14 QEIGSGQFGLVHLGYW-LNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 177 CVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLE 236
C+ + + LV ++M + L L + A L + + + YL E
Sbjct: 72 CLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLG------MCLDVCEGMAYLEEA-- 123
Query: 237 TQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGG 296
+IHRD+ N ++ ++ DFG+ R++ + QY T+ G
Sbjct: 124 -CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QY----------------TSSTGT 165
Query: 297 T--IGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRR 333
+ + PE F ++KSDV+SFG+++ EV S G+
Sbjct: 166 KFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKI 204
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 1e-11
Identities = 64/278 (23%), Positives = 111/278 (39%), Gaps = 46/278 (16%)
Query: 526 FGTAYQGFLDNHQYVLVKRL---GMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQ 582
FG + G+ N V +K + MS+ F E + + +L H LVQL G C EQ
Sbjct: 21 FGLVHLGYWLNKDKVAIKTIREGAMSE-----EDFIEEAEVMMKLSHPKLVQLYGVCLEQ 75
Query: 583 GEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIH 642
+ ++ ++ LS L L + + + YL EE VIH
Sbjct: 76 APICLVTEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLDVCEGMAYL-EEAC--VIH 127
Query: 643 RNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNR-SVRGIFGYMSPEYIESG 701
R++ + + + ++ F + F+ + + +++G + V+ + SPE
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQY---TSSTGTKFPVK----WASPEVFSFS 180
Query: 702 EATSMADVYSFGVVVLEVVT-GQMAVDFRLP-EGLLVKRVHEF-EARKR-PLAELVDLSL 757
+S +DV+SFGV++ EV + G++ P E V E R L +
Sbjct: 181 RYSSKSDVWSFGVLMWEVFSEGKI------PYENRSNSEVVEDISTGFRLYKPRLASTHV 234
Query: 758 NGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795
Y ++M C PE RP+ ++L L
Sbjct: 235 ---Y---QIMN------HCWRERPEDRPAFSRLLRQLA 260
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 58/234 (24%), Positives = 98/234 (41%), Gaps = 43/234 (18%)
Query: 117 EVLGSGGFGKVYRAVLP-----SDGTVVAVKCLAEKGERFEKT-FAAELVAVAHLRHRNL 170
E LG FGKVY+ L VA+K L +K E + F E + A L+H N+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 171 VRLRGWCVHEDQLLLVYDYMPNRSLDRVL-FRRPENLEAAAPLNWEQRKK--------II 221
V L G + L +++ Y + L L R P + + + + ++
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 222 RGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSA 281
+AA + YL ++H+D+ T NV++ + N ++ D GL R + Y++ +
Sbjct: 135 AQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN-- 189
Query: 282 RNHQFHLAETTRIGGTIGYLP-----PESFQKGSVATAKSDVFSFGIVVLEVVS 330
LP PE+ G + SD++S+G+V+ EV S
Sbjct: 190 -----------------SLLPIRWMAPEAIMYG-KFSIDSDIWSYGVVLWEVFS 225
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 9e-11
Identities = 67/296 (22%), Positives = 116/296 (39%), Gaps = 58/296 (19%)
Query: 526 FGTAYQGFLDNH------QYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWC 579
FG Y+G L Q V +K L LR F +E ARL+H N+V L G
Sbjct: 22 FGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVV 81
Query: 580 TEQGEMLVIYDY----------SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAI 629
T+ + +I+ Y S + ++ R S L+ +++ +A+ +
Sbjct: 82 TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGM 141
Query: 630 LYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGI 689
YL V+H+++ + + + +N ++ L + D+ ++ + +R
Sbjct: 142 EYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADY-YKLLGNSLLPIR-- 195
Query: 690 FGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLP-EGLLVKRVHEF-EARK 746
+M+PE I G+ + +D++S+GVV+ EV + G P G + V E R+
Sbjct: 196 --WMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQ------PYCGYSNQDVVEMIRNRQ 247
Query: 747 R-------PLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795
P A + Y LM C P RP + I S L
Sbjct: 248 VLPCPDDCP-AWV--------YA---LMI------ECWNEFPSRRPRFKDIHSRLR 285
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-30
Identities = 64/228 (28%), Positives = 104/228 (45%), Gaps = 38/228 (16%)
Query: 116 DEVLGSGGFGKVYRAVLPSDG---TVVAVKCL-AEKGERFEKTFAAELVAVAHLRHRNLV 171
D+V+G+G FG+V L VA+K L E+ + F E + H N++
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 172 RLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYL 231
RL G +++V +YM N SLD L R+ + Q ++RG+A+ + YL
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDA-----QFTVIQLVGMLRGIASGMKYL 163
Query: 232 HEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAET 291
+ +HRD+ N++++S ++ DFGL R LE + + T +
Sbjct: 164 SDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGK--------- 211
Query: 292 TRIGGTIGYLP-----PESFQKGSVATAKSDVFSFGIVVLEVVS-GRR 333
+P PE+ T+ SDV+S+GIV+ EV+S G R
Sbjct: 212 ---------IPIRWTSPEAIAYR-KFTSASDVWSYGIVLWEVMSYGER 249
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 7e-12
Identities = 66/292 (22%), Positives = 115/292 (39%), Gaps = 66/292 (22%)
Query: 526 FGTAYQGFL----DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTE 581
FG G L V +K L + R F E + + H N+++L G T+
Sbjct: 58 FGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117
Query: 582 QGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVI 641
++++ +Y L L ++ + L +++ +AS + YL + +
Sbjct: 118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL-----VGMLRGIASGMKYL-SDMG--YV 169
Query: 642 HRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESG 701
HR++ + I ++ ++ ++ F L L + G +R + SPE I
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIR----WTSPEAIAYR 225
Query: 702 EATSMADVYSFGVVVLEVVT-GQM------------AVD--FRLPEGLLVKRVHEFEARK 746
+ TS +DV+S+G+V+ EV++ G+ AVD +RLP
Sbjct: 226 KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLP--------------- 270
Query: 747 RPL---AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795
P+ A L Y +LM C + RP QI+SILD
Sbjct: 271 PPMDCPAAL--------Y---QLML------DCWQKDRNNRPKFEQIVSILD 305
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 119 bits (302), Expect = 3e-30
Identities = 56/226 (24%), Positives = 99/226 (43%), Gaps = 37/226 (16%)
Query: 116 DEVLGSGGFGKVYRAVLPSDG---TVVAVKCL-AEKGERFEKTFAAELVAVAHLRHRNLV 171
+ +LG G FG+VY V + VAVK + ++ F +E V + +L H ++V
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 172 RLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYL 231
+L G E+ ++ + P L L R +L+ + + + A+ YL
Sbjct: 77 KLIGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLY------SLQICKAMAYL 129
Query: 232 HEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAET 291
+HRD+ N+++ S +LGDFGL+R++E E +
Sbjct: 130 ESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE------------------DY 168
Query: 292 TRIGGT---IGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRR 333
+ T I ++ PES T SDV+ F + + E++S G++
Sbjct: 169 YKASVTRLPIKWMSPESINFR-RFTTASDVWMFAVCMWEILSFGKQ 213
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 50/201 (24%), Positives = 84/201 (41%), Gaps = 21/201 (10%)
Query: 526 FGTAYQGFLDNHQ----YVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTE 581
FG Y+G NH+ V VK + +F +E + L H ++V+L G E
Sbjct: 25 FGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE 84
Query: 582 QGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVI 641
+ +I + L H L N + + L + A+ YL E N +
Sbjct: 85 E-PTWIIMELYPYGELGHYLERNKNSLKVLTL-----VLYSLQICKAMAYL-ESIN--CV 135
Query: 642 HRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNR-SVRGIFGYMSPEYIES 700
HR+I I + +LG F L+ ++ D+ S R ++ +MSPE I
Sbjct: 136 HRDIAVRNILVASPECVKLGDFGLSRYIEDEDY---YKASVTRLPIK----WMSPESINF 188
Query: 701 GEATSMADVYSFGVVVLEVVT 721
T+ +DV+ F V + E+++
Sbjct: 189 RRFTTASDVWMFAVCMWEILS 209
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 52/219 (23%), Positives = 98/219 (44%), Gaps = 25/219 (11%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGW 176
VLG G +G VY S+ +A+K + E+ R+ + E+ HL+H+N+V+ G
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 177 CVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLE 236
+ + + +P SL +L + N + + + L YLH+
Sbjct: 88 FSENGFIKIFMEQVPGGSLSALL----RSKWGPLKDNEQTIGFYTKQILEGLKYLHDN-- 141
Query: 237 TQIIHRDVKTSNVMLDSQY-NARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIG 295
QI+HRD+K NV++++ ++ DFG ++ ++ + F
Sbjct: 142 -QIVHRDIKGDNVLINTYSGVLKISDFGTSK--------RLAGINPCTETFT-------- 184
Query: 296 GTIGYLPPESFQKGSV-ATAKSDVFSFGIVVLEVVSGRR 333
GT+ Y+ PE KG +D++S G ++E+ +G+
Sbjct: 185 GTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKP 223
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 53/258 (20%), Positives = 94/258 (36%), Gaps = 50/258 (19%)
Query: 526 FGTAYQGF-LDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGE 584
+G Y G L N + +K + + E+ L+H+N+VQ G +E G
Sbjct: 35 YGIVYAGRDLSNQVRIAIKEIPERDSRYSQ-PLHEEIALHKHLKHKNIVQYLGSFSENGF 93
Query: 585 MLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAIL----YLHEEWNEQV 640
+ + + LS LL + + I IL YLH+ Q+
Sbjct: 94 IKIFMEQVPGGSLSALLRSKWGPLKDN-------EQTIGFYTKQILEGLKYLHDN---QI 143
Query: 641 IHRNITSSAITLDPDM-NPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIE 699
+HR+I + ++ ++ F ++ L + G YM+PE I+
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLA-------GINPCTETFTGTLQYMAPEIID 196
Query: 700 SGE--ATSMADVYSFGVVVLEVVTGQ---------MAVDFR---------LPEGL----- 734
G AD++S G ++E+ TG+ A F+ +PE +
Sbjct: 197 KGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAK 256
Query: 735 -LVKRVHEFEARKRPLAE 751
+ + E + KR A
Sbjct: 257 AFILKCFEPDPDKRACAN 274
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 55/225 (24%), Positives = 96/225 (42%), Gaps = 32/225 (14%)
Query: 115 EDEVLGSGGFGKVYRAVLPSDG--TVVAVKCL-AEKGERFEKTFAAELVAVAHLRHRNLV 171
D LG G FG V + V VA+K L + + E + L + +V
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 172 RLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYL 231
RL G C E L+LV + L + L + E + + + ++ + YL
Sbjct: 74 RLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAEL------LHQVSMGMKYL 126
Query: 232 HEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAET 291
E+ +HRD+ NV+L +++ A++ DFGL++ L + Y T
Sbjct: 127 EEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY---------------YT 168
Query: 292 TRIGGT--IGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRR 333
R G + + PE +++SDV+S+G+ + E +S G++
Sbjct: 169 ARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQK 212
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 44/203 (21%), Positives = 87/203 (42%), Gaps = 17/203 (8%)
Query: 526 FGTAYQGFL---DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQ 582
FG+ QG V +K L A E Q + +L + +V+L G C +
Sbjct: 23 FGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE 82
Query: 583 GEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIH 642
MLV+ + L+ + + ++ ++ + YL EE N +H
Sbjct: 83 ALMLVMEMAGGGPLHKFLVGKREE------IPVSNVAELLHQVSMGMKYL-EEKN--FVH 133
Query: 643 RNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGE 702
R++ + + L ++ F L++ L +D + ++G ++ + +PE I +
Sbjct: 134 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK----WYAPECINFRK 189
Query: 703 ATSMADVYSFGVVVLEVVT-GQM 724
+S +DV+S+GV + E ++ GQ
Sbjct: 190 FSSRSDVWSYGVTMWEALSYGQK 212
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-30
Identities = 81/348 (23%), Positives = 139/348 (39%), Gaps = 72/348 (20%)
Query: 116 DEVLGSGGFGKVYRAVLPSDG--TVVAVKCLAEKGERFEKT-FAAELVAVAHL-RHRNLV 171
+V+G G FG+V +A + DG A+K + E + + FA EL + L H N++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 172 RLRGWCVHEDQLLLVYDYMPNRSLDRVL-FRRPENLE--------AAAPLNWEQRKKIIR 222
L G C H L L +Y P+ +L L R + A+ L+ +Q
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 223 GLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSAR 282
+A + YL ++ Q IHRD+ N+++ Y A++ DFGL+R + ++ + R
Sbjct: 150 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMGR 202
Query: 283 NHQFHLAETTRIGGTIGYLP-----PESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVD 336
LP ES V T SDV+S+G+++ E+VS G
Sbjct: 203 ------------------LPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTP-- 241
Query: 337 LTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRP 396
Y + + +L +G L+ N CD E + L C P+ RP
Sbjct: 242 --YCG--MTCAELYEKL-PQGYRLEKPLN---------CDDE-VYDLMRQCWREKPYERP 286
Query: 397 SMKWVIEAVSGSYSGKLPALPSFQSHPLYISLSSPTNTSTSNTETTRS 444
S ++ L + + Y++ + + + + +
Sbjct: 287 SFAQILV--------SLNRM--LEERKTYVNTTLYEKFTYAGIDCSAE 324
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 72/321 (22%), Positives = 125/321 (38%), Gaps = 71/321 (22%)
Query: 526 FGTAYQGFLDNHQY---VLVKRLGMSKCPALRTRFSNELQNLARL-RHRNLVQLCGWCTE 581
FG + + +KR+ F+ EL+ L +L H N++ L G C
Sbjct: 38 FGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH 97
Query: 582 QGEMLVIYDYSATRILSH--LL-FHNNHRIGHSILQWHHRYNIIKSL------------A 626
+G + + +Y H LL F R+ + + + +L A
Sbjct: 98 RGYLYLAIEY-----APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 152
Query: 627 SAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSV 686
+ YL ++ Q IHR++ + I + + ++ F L+ R + K T G V
Sbjct: 153 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS----RGQEVYVKKTMGRLPV 205
Query: 687 RGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLP-EGLLVKRVHEF-E 743
R +M+ E + T+ +DV+S+GV++ E+V+ G P G+ ++E
Sbjct: 206 R----WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT------PYCGMTCAELYEKLP 255
Query: 744 ARKR---PL---AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGN 797
R PL E+ Y +LMR C P RPS QIL L+
Sbjct: 256 QGYRLEKPLNCDDEV--------Y---DLMR------QCWREKPYERPSFAQILVSLN-- 296
Query: 798 DKRFMEDGQMTENLEEWKQRN 818
R +E+ + N +++
Sbjct: 297 --RMLEERKTYVNTTLYEKFT 315
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 60/220 (27%), Positives = 94/220 (42%), Gaps = 32/220 (14%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGW 176
+ LGSG FG V VAVK + E G E F E + L H LV+ G
Sbjct: 14 KELGSGQFGVVKLGKW-KGQYDVAVKMIKE-GSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 177 CVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLE 236
C E + +V +Y+ N L L + LE + L + + + +L
Sbjct: 72 CSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLE------MCYDVCEGMAFLESH-- 123
Query: 237 TQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGG 296
Q IHRD+ N ++D ++ DFG+ R++ + QY + +G
Sbjct: 124 -QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD-QY----------------VSSVGT 165
Query: 297 T--IGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRR 333
+ + PE F ++KSDV++FGI++ EV S G+
Sbjct: 166 KFPVKWSAPEVFHYF-KYSSKSDVWAFGILMWEVFSLGKM 204
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 5e-11
Identities = 58/292 (19%), Positives = 114/292 (39%), Gaps = 74/292 (25%)
Query: 526 FGTAYQGFLDNHQYVLVKRL---GMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQ 582
FG G V VK + MS F E Q + +L H LV+ G C+++
Sbjct: 21 FGVVKLGKWKGQYDVAVKMIKEGSMS-----EDEFFQEAQTMMKLSHPKLVKFYGVCSKE 75
Query: 583 GEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIH 642
+ ++ +Y + L + L + + S L + + + +L Q IH
Sbjct: 76 YPIYIVTEYISNGCLLNYLRSHGKGLEPSQL-----LEMCYDVCEGMAFLESH---QFIH 127
Query: 643 RNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNR-SVRGIFGYMSPEYIESG 701
R++ + +D D+ ++ F + ++ + + ++ G + V+ + +PE
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY---VSSVGTKFPVK----WSAPEVFHYF 180
Query: 702 EATSMADVYSFGVVVLEVVT-GQM------------AVD--FRLPEGLLVKRVHEFEARK 746
+ +S +DV++FG+++ EV + G+M V RL
Sbjct: 181 KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLY--------------- 225
Query: 747 RPL---AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795
RP + Y ++M +C PE RP+ +Q+LS ++
Sbjct: 226 RPHLASDTI--------Y---QIMY------SCWHELPEKRPTFQQLLSSIE 260
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-30
Identities = 56/220 (25%), Positives = 95/220 (43%), Gaps = 30/220 (13%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGW 176
LG G +G+VY V VAVK L E + F E + ++H NLV+L G
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 177 CVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLE 236
C E ++ ++M +L L R E ++ + +++A+ YL ++
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYL-RECNRQE----VSAVVLLYMATQISSAMEYLEKK-- 130
Query: 237 TQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGG 296
IHRD+ N ++ + ++ DFGL+R + + Y T G
Sbjct: 131 -NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TY----------------TAHAGA 172
Query: 297 T--IGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRR 333
I + PES + KSDV++FG+++ E+ + G
Sbjct: 173 KFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMS 211
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 64/310 (20%), Positives = 122/310 (39%), Gaps = 68/310 (21%)
Query: 526 FGTAYQGFLDNHQY-VLVKRLGMSKCPAL-RTRFSNELQNLARLRHRNLVQLCGWCTEQG 583
+G Y+G + V VK L K + F E + ++H NLVQL G CT +
Sbjct: 26 YGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 82
Query: 584 EMLVIYDYSATR--ILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVI 641
+I ++ T +L +L N + +L + ++SA+ YL E+ N I
Sbjct: 83 PFYIITEF-MTYGNLLDYLRECNRQEVSAVVL-----LYMATQISSAMEYL-EKKN--FI 133
Query: 642 HRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESG 701
HR++ + + + ++ F L+ + + ++ + +PE +
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIK----WTAPESLAYN 187
Query: 702 EATSMADVYSFGVVVLEVVT-GQMAVDFRLP-EGLLVKRVHEFEARKRPLAELVDLSLNG 759
+ + +DV++FGV++ E+ T G P G+ L+++ +L
Sbjct: 188 KFSIKSDVWAFGVLLWEIATYGMS------PYPGI-------------DLSQVYELLEKD 228
Query: 760 E------------YNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDKRFMEDGQM 807
Y ELMR AC NP RPS +I + ++ +
Sbjct: 229 YRMERPEGCPEKVY---ELMR------ACWQWNPSDRPSFAEIHQAFE----TMFQESSI 275
Query: 808 TENLEEWKQR 817
++ +E+ +
Sbjct: 276 SDEVEKELGK 285
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-30
Identities = 50/229 (21%), Positives = 87/229 (37%), Gaps = 39/229 (17%)
Query: 117 EVLGSGGFGKVYRAVLPSDG---TVVAVKCLAEKG--ERFEKTFAAELVAVAHLRHRNLV 171
++LG G FG V L + VAVK + +R + F +E + H N++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 172 RLRGWCVHED-----QLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAA 226
RL G C+ + +++ +M L L + + K + +A
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYL-LYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 227 ALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQF 286
+ YL + +HRD+ N ML + DFGL++ + Y+
Sbjct: 159 GMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRI------- 208
Query: 287 HLAETTRIGGTIGYLP-----PESFQKGSVATAKSDVFSFGIVVLEVVS 330
+P ES V T+KSDV++FG+ + E+ +
Sbjct: 209 ------------AKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIAT 244
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 57/291 (19%), Positives = 107/291 (36%), Gaps = 54/291 (18%)
Query: 526 FGTAYQGFLDNH----QYVLVKRL-GMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCT 580
FG+ +G L V VK + + F +E + H N+++L G C
Sbjct: 47 FGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106
Query: 581 EQG-----EMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEE 635
E + +VI + L L ++ G + + +A + YL
Sbjct: 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR 166
Query: 636 WNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSP 695
+HR++ + L DM + F L++ + D+ +R+ V+ +++
Sbjct: 167 ---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDY-YRQGRIAKMPVK----WIAI 218
Query: 696 EYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLP-EGLLVKRVHEFEARKRPLAELV 753
E + TS +DV++FGV + E+ T G P G+ E+
Sbjct: 219 ESLADRVYTSKSDVWAFGVTMWEIATRGMT------PYPGV-------------QNHEMY 259
Query: 754 DLSLNGEYNHK---------ELMRLIKLGIACTLSNPELRPSMRQILSILD 795
D L+G + E+M +C ++P RP+ + L+
Sbjct: 260 DYLLHGHRLKQPEDCLDELYEIMY------SCWRTDPLDRPTFSVLRLQLE 304
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 6e-30
Identities = 51/214 (23%), Positives = 92/214 (42%), Gaps = 25/214 (11%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGW 176
LG G +G+VY V VAVK L E + F E + ++H NLV+L G
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 177 CVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLE 236
C E ++ ++M +L L R ++ + +++A+ YL ++
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYL-RECNR----QEVSAVVLLYMATQISSAMEYLEKK-- 337
Query: 237 TQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGG 296
IHR++ N ++ + ++ DFGL+R + + Y +
Sbjct: 338 -NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKF-------------- 381
Query: 297 TIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS 330
I + PES + KSDV++FG+++ E+ +
Sbjct: 382 PIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIAT 414
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 6e-11
Identities = 58/298 (19%), Positives = 120/298 (40%), Gaps = 44/298 (14%)
Query: 526 FGTAYQGFLDNHQY-VLVKRLGMSKCPAL-RTRFSNELQNLARLRHRNLVQLCGWCTEQG 583
+G Y+G + V VK K + F E + ++H NLVQL G CT +
Sbjct: 233 YGEVYEGVWKKYSLTVAVK---TLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 289
Query: 584 EMLVIYDYSAT-RILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIH 642
+I ++ +L +L N + +L + ++SA+ YL + + IH
Sbjct: 290 PFYIITEFMTYGNLLDYLRECNRQEVSAVVL-----LYMATQISSAMEYLEK---KNFIH 341
Query: 643 RNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGE 702
RN+ + + + ++ F L+ + + ++ + +PE + +
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIK----WTAPESLAYNK 395
Query: 703 ATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPL---AELVDLSLNG 759
+ +DV++FGV++ E+ T M+ + + + + + +RP ++
Sbjct: 396 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV------- 448
Query: 760 EYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDKRFMEDGQMTENLEEWKQR 817
ELMR AC NP RPS +I + ++ +++ +E+ +
Sbjct: 449 ----YELMR------ACWQWNPSDRPSFAEIHQAFE----TMFQESSISDEVEKELGK 492
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 7e-30
Identities = 62/229 (27%), Positives = 105/229 (45%), Gaps = 39/229 (17%)
Query: 116 DEVLGSGGFGKVYRAVLPSDG----TVVAVKCLAE-KGERFEKTFAAELVAVAHLRHRNL 170
+V+G+G FG+VY+ +L + VA+K L E+ F E + H N+
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 171 VRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHY 230
+RL G ++++ +YM N +LD+ L + + +RG+AA + Y
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGM------LRGIAAGMKY 162
Query: 231 LHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAE 290
L +HRD+ N++++S ++ DFGL+R LE + + TS +
Sbjct: 163 LANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGK-------- 211
Query: 291 TTRIGGTIGYLP-----PESFQKGSVATAKSDVFSFGIVVLEVVS-GRR 333
+P PE+ T+ SDV+SFGIV+ EV++ G R
Sbjct: 212 ----------IPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGER 249
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 64/293 (21%), Positives = 114/293 (38%), Gaps = 67/293 (22%)
Query: 526 FGTAYQGFL-----DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCT 580
FG Y+G L V +K L R F E + + H N+++L G +
Sbjct: 57 FGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS 116
Query: 581 EQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQV 640
+ M++I +Y L L + L +++ +A+ + YL
Sbjct: 117 KYKPMMIITEYMENGALDKFLREKDGEFSVLQL-----VGMLRGIAAGMKYLANM---NY 168
Query: 641 IHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIES 700
+HR++ + I ++ ++ ++ F L+ L + + G +R + +PE I
Sbjct: 169 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR----WTAPEAISY 224
Query: 701 GEATSMADVYSFGVVVLEVVT-GQM------------AVD--FRLPEGLLVKRVHEFEAR 745
+ TS +DV+SFG+V+ EV+T G+ A++ FRLP
Sbjct: 225 RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP-------------- 270
Query: 746 KRPL---AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795
P+ + + Y +LM + C RP I+SILD
Sbjct: 271 -TPMDCPSAI--------Y---QLM------MQCWQQERARRPKFADIVSILD 305
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-30
Identities = 58/228 (25%), Positives = 100/228 (43%), Gaps = 38/228 (16%)
Query: 115 EDEVLGSGGFGKVYRAVL--PSDGTVVAVKCLAEKGERFEKT----FAAELVAVAHLRHR 168
ED+ LGSG FG V + VAVK L K E + AE + L +
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL--KNEANDPALKDELLAEANVMQQLDNP 78
Query: 169 NLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAAL 228
+VR+ G C E +LV + L++ L ++ +++ + + ++ +
Sbjct: 79 YIVRMIGICEAE-SWMLVMEMAELGPLNKYL-QQNRHVKDKNIIEL------VHQVSMGM 130
Query: 229 HYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHL 288
YL E +HRD+ NV+L +Q+ A++ DFGL++ L + Y
Sbjct: 131 KYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY------------- 174
Query: 289 AETTRIGGT--IGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRR 333
+ G + + PE ++KSDV+SFG+++ E S G++
Sbjct: 175 --KAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQK 219
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 6e-10
Identities = 51/206 (24%), Positives = 97/206 (47%), Gaps = 23/206 (11%)
Query: 526 FGTAYQGFLDNHQY---VLVKRL---GMSKCPALRTRFSNELQNLARLRHRNLVQLCGWC 579
FGT +G+ + V VK L PAL+ E + +L + +V++ G C
Sbjct: 30 FGTVKKGYYQMKKVVKTVAVKILKNEAND--PALKDELLAEANVMQQLDNPYIVRMIGIC 87
Query: 580 TEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQ 639
+ MLV+ + + L+ L N H +I++ + ++ + YL EE N
Sbjct: 88 EAESWMLVM-EMAELGPLNKYLQQNRHVKDKNIIEL------VHQVSMGMKYL-EESN-- 137
Query: 640 VIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIE 699
+HR++ + + L ++ F L++ L +++ ++ T G V+ + +PE I
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK----WYAPECIN 193
Query: 700 SGEATSMADVYSFGVVVLEVVT-GQM 724
+ +S +DV+SFGV++ E + GQ
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFSYGQK 219
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 7e-30
Identities = 57/225 (25%), Positives = 90/225 (40%), Gaps = 37/225 (16%)
Query: 116 DEVLGSGGFGKVYRAVLPSDG---TVVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNLV 171
+EV+G G FG VY L + AVK L F E + + H N++
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 172 RLRGWCVH-EDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHY 230
L G C+ E L+V YM + L + N + +A + +
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV------KDLIGFGLQVAKGMKF 207
Query: 231 LHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAE 290
L + + +HRD+ N MLD ++ ++ DFGLAR + + +
Sbjct: 208 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN------------ 252
Query: 291 TTRIGGTIGYLP-----PESFQKGSVATAKSDVFSFGIVVLEVVS 330
T LP ES Q T KSDV+SFG+++ E+++
Sbjct: 253 -----KTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMT 291
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 64/384 (16%), Positives = 129/384 (33%), Gaps = 55/384 (14%)
Query: 430 SPTNTSTSNTETTRSTNTTASNTTIASPSSNYVTAAGETIYATAECGGNTESKSNNSRSQ 489
P + R++ SP + + + E + + G+ + +
Sbjct: 5 DPMGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTV 64
Query: 490 RRNSFFMVETPREISFKEIISATNNFSESQRV-AEMDFGTAYQGFL----DNHQYVLVKR 544
+ + + +I ++ V FG Y G L + VK
Sbjct: 65 HIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS 124
Query: 545 LGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTE-QGEMLVIYDYSATRILSHLLFH 603
L ++F E + H N++ L G C +G LV+ Y L + + +
Sbjct: 125 LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN 184
Query: 604 NNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSF 663
H L +A + +L + + +HR++ + LD ++ F
Sbjct: 185 ETHNPTVKDL-----IGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADF 236
Query: 664 ALAEFLTRND-HGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT- 721
LA + + T V+ +M+ E +++ + T+ +DV+SFGV++ E++T
Sbjct: 237 GLARDMYDKEFDSVHNKTGAKLPVK----WMALESLQTQKFTTKSDVWSFGVLLWELMTR 292
Query: 722 GQMAVDFRLP-EGLLVKRVHEFEARKRPLAELVDLSLNGEYNHK---------ELMRLIK 771
G P + ++ L G + E+M
Sbjct: 293 GAP------PYPDV-------------NTFDITVYLLQGRRLLQPEYCPDPLYEVML--- 330
Query: 772 LGIACTLSNPELRPSMRQILSILD 795
C E+RPS +++S +
Sbjct: 331 ---KCWHPKAEMRPSFSELVSRIS 351
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 8e-30
Identities = 75/334 (22%), Positives = 117/334 (35%), Gaps = 66/334 (19%)
Query: 117 EVLGSGGFGKVYRAVLP-----SDGTVVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNL 170
LG G FG+VY + VAVK L E E+ E F E + ++ H+N+
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 171 VRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHY 230
VR G + ++ + M L L + L + R +A Y
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 231 LHEQLETQIIHRDVKTSNVMLDSQYNARL---GDFGLARWLEHELQYQMRTSSARNHQFH 287
L E IHRD+ N +L R+ GDFG+AR + Y+
Sbjct: 156 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK----------- 201
Query: 288 LAETTRIGGTIGYLP-----PESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPD 341
G LP PE+F +G + T+K+D +SFG+++ E+ S G YP
Sbjct: 202 --------GGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMP----YPS 248
Query: 342 ---DQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSM 398
+++ G + N C + + C H P RP+
Sbjct: 249 KSNQEVL------EFVTSGGRMDPPKN---------CPGP-VYRIMTQCWQHQPEDRPNF 292
Query: 399 KWVIEAVSGSYSGKLPALPSFQSHPLYISLSSPT 432
++E + P + L I
Sbjct: 293 AIILERI-----EYCTQDPDVINTALPIEYGPLV 321
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 3e-12
Identities = 64/291 (21%), Positives = 102/291 (35%), Gaps = 54/291 (18%)
Query: 526 FGTAYQGFLDN------HQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWC 579
FG Y+G + V VK L F E +++ H+N+V+ G
Sbjct: 43 FGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVS 102
Query: 580 TEQGEMLVIYDYSAT-RILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNE 638
+ ++ + A + S L S L ++ + +A YL E
Sbjct: 103 LQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN--- 159
Query: 639 QVIH-----RNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYM 693
IH RN + P ++G F +A + R + +RK V+ +M
Sbjct: 160 HFIHRDIAARNCLLT--CPGPGRVAKIGDFGMARDIYRASY-YRKGGCAMLPVK----WM 212
Query: 694 SPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLP-EGLLVKRVHEF-EARKR--- 747
PE G TS D +SFGV++ E+ + G M P + V EF + R
Sbjct: 213 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM------PYPSKSNQEVLEFVTSGGRMDP 266
Query: 748 PL---AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795
P + Y +M C PE RP+ IL ++
Sbjct: 267 PKNCPGPV--------Y---RIMT------QCWQHQPEDRPNFAIILERIE 300
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 9e-30
Identities = 73/334 (21%), Positives = 116/334 (34%), Gaps = 66/334 (19%)
Query: 117 EVLGSGGFGKVYRAVLP-----SDGTVVAVKCLAEKGERFEKT-FAAELVAVAHLRHRNL 170
LG G FG+VY + VAVK L E ++ F E + ++ H+N+
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 171 VRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHY 230
VR G + ++ + M L L + L + R +A Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 231 LHEQLETQIIHRDVKTSNVMLDSQYNARL---GDFGLARWLEHELQYQMRTSSARNHQFH 287
L E IHRD+ N +L R+ GDFG+AR + Y+
Sbjct: 197 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRK----------- 242
Query: 288 LAETTRIGGTIGYLP-----PESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPD 341
G LP PE+F +G + T+K+D +SFG+++ E+ S G YP
Sbjct: 243 --------GGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMP----YPS 289
Query: 342 ---DQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSM 398
+++ G + N C + + C H P RP+
Sbjct: 290 KSNQEVL------EFVTSGGRMDPPKN---------C-PGPVYRIMTQCWQHQPEDRPNF 333
Query: 399 KWVIEAVSGSYSGKLPALPSFQSHPLYISLSSPT 432
++E + P + L I
Sbjct: 334 AIILERI-----EYCTQDPDVINTALPIEYGPLV 362
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 65/292 (22%), Positives = 103/292 (35%), Gaps = 56/292 (19%)
Query: 526 FGTAYQGFLDN------HQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWC 579
FG Y+G + V VK L F E +++ H+N+V+ G
Sbjct: 84 FGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVS 143
Query: 580 TEQGEMLVIYDYSAT-RILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNE 638
+ ++ + A + S L S L ++ + +A YL E
Sbjct: 144 LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN--- 200
Query: 639 QVIHRNITSSA------ITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGY 692
IHR+I A P ++G F +A + R + +RK V+ +
Sbjct: 201 HFIHRDI---AARNCLLTCPGPGRVAKIGDFGMARDIYRAGY-YRKGGCAMLPVK----W 252
Query: 693 MSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLP-EGLLVKRVHEF-EARKR-- 747
M PE G TS D +SFGV++ E+ + G M P + V EF + R
Sbjct: 253 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM------PYPSKSNQEVLEFVTSGGRMD 306
Query: 748 -PL---AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795
P + Y +M C PE RP+ IL ++
Sbjct: 307 PPKNCPGPV--------YR---IMT------QCWQHQPEDRPNFAIILERIE 341
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 9e-30
Identities = 56/220 (25%), Positives = 102/220 (46%), Gaps = 32/220 (14%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGW 176
+ LG+G FG V VA+K + E G E F E + +L H LV+L G
Sbjct: 30 KELGTGQFGVVKYGKW-RGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 177 CVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLE 236
C + + ++ +YM N L L R + +Q ++ + + A+ YL +
Sbjct: 88 CTKQRPIFIITEYMANGCLLNYL-REMRH-----RFQTQQLLEMCKDVCEAMEYLESK-- 139
Query: 237 TQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGG 296
Q +HRD+ N +++ Q ++ DFGL+R++ + +Y T+ +G
Sbjct: 140 -QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EY----------------TSSVGS 181
Query: 297 T--IGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRR 333
+ + PPE ++KSD+++FG+++ E+ S G+
Sbjct: 182 KFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKM 220
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 5e-11
Identities = 60/276 (21%), Positives = 113/276 (40%), Gaps = 42/276 (15%)
Query: 526 FGTAYQGFLDNHQYVLVKRLGMSKCPAL-RTRFSNELQNLARLRHRNLVQLCGWCTEQGE 584
FG G V +K + K ++ F E + + L H LVQL G CT+Q
Sbjct: 37 FGVVKYGKWRGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP 93
Query: 585 MLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRN 644
+ +I +Y A L + L HR L + K + A+ YL E +HR+
Sbjct: 94 IFIITEYMANGCLLNYLREMRHRFQTQQL-----LEMCKDVCEAMEYL-ESKQ--FLHRD 145
Query: 645 ITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNR-SVRGIFGYMSPEYIESGEA 703
+ + ++ ++ F L+ ++ +++ ++ G++ VR + PE + +
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDEY---TSSVGSKFPVR----WSPPEVLMYSKF 198
Query: 704 TSMADVYSFGVVVLEVVT-GQMAVDFRLP-EGLLVKRVHEF-EARKR-PLAELVDLSLNG 759
+S +D+++FGV++ E+ + G+M P E E R L +
Sbjct: 199 SSKSDIWAFGVLMWEIYSLGKM------PYERFTNSETAEHIAQGLRLYRPHLASEKV-- 250
Query: 760 EYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795
Y +M +C + RP+ + +LS +
Sbjct: 251 -Y---TIMY------SCWHEKADERPTFKILLSNIL 276
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 53/224 (23%), Positives = 95/224 (42%), Gaps = 35/224 (15%)
Query: 117 EVLGSGGFGKVYRAVLPSDG---TVVAVKCL-AEKGERFEKTFAAELVAVAHLRHRNLVR 172
+G G FG V++ + S VA+K + + F E + + H ++V+
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 173 LRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLH 232
L G E+ + ++ + L L R +L+ A+ + + L+ AL YL
Sbjct: 81 LIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILY------AYQLSTALAYLE 133
Query: 233 EQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETT 292
+ + +HRD+ NV++ S +LGDFGL+R++E
Sbjct: 134 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-----------------TYYK 173
Query: 293 RIGGT--IGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRR 333
G I ++ PES T+ SDV+ FG+ + E++ G +
Sbjct: 174 ASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVK 216
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 3e-09
Identities = 60/289 (20%), Positives = 108/289 (37%), Gaps = 63/289 (21%)
Query: 526 FGTAYQGFLDNH----QYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTE 581
FG +QG + V +K ++R +F E + + H ++V+L G TE
Sbjct: 28 FGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE 87
Query: 582 QGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVI 641
+ +I + L L + + + L L++A+ YL E +
Sbjct: 88 N-PVWIIMELCTLGELRSFLQVRKYSLDLASL-----ILYAYQLSTALAYL-ESKR--FV 138
Query: 642 HRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESG 701
HR+I + + + + +LG F L+ ++ + + KA+ G ++ +M+PE I
Sbjct: 139 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY--YKASKGKLPIK----WMAPESINFR 192
Query: 702 EATSMADVYSFGVVVLEVVT-GQM------------AVD--FRLPEGLLVKRVHEFEARK 746
TS +DV+ FGV + E++ G ++ RLP
Sbjct: 193 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP--------------- 237
Query: 747 RPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795
P L Y LM C +P RP ++ + L
Sbjct: 238 MPPNCPPTL-----Y---SLMTK------CWAYDPSRRPRFTELKAQLS 272
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 56/226 (24%), Positives = 92/226 (40%), Gaps = 37/226 (16%)
Query: 115 EDEVLGSGGFGKVYRAVLPSDG---TVVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNL 170
D V+G G FG VY A+K L+ + + F E + + L H N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 171 VRLRGWCVHED-QLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALH 229
+ L G + + ++ YM + L + + R P+ + +A +
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFI-RSPQR-----NPTVKDLISFGLQVARGME 138
Query: 230 YLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLA 289
YL EQ + +HRD+ N MLD + ++ DFGLAR + Y ++
Sbjct: 139 YLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQ----------- 184
Query: 290 ETTRIGGTIGYLP-----PESFQKGSVATAKSDVFSFGIVVLEVVS 330
LP ES Q T KSDV+SFG+++ E+++
Sbjct: 185 ------HRHARLPVKWTALESLQTY-RFTTKSDVWSFGVLLWELLT 223
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 54/282 (19%), Positives = 105/282 (37%), Gaps = 44/282 (15%)
Query: 526 FGTAYQGFL----DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCT- 580
FG Y G N +K L F E + L H N++ L G
Sbjct: 34 FGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLP 93
Query: 581 EQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQV 640
+G V+ Y L + L + +A + YL E+ +
Sbjct: 94 PEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL-----ISFGLQVARGMEYLAEQ---KF 145
Query: 641 IHRNITSSAITLDPDMNPRLGSFALAEFLTRNDH-GHRKATSGNRSVRGIFGYMSPEYIE 699
+HR++ + LD ++ F LA + ++ ++ V+ + + E ++
Sbjct: 146 VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVK----WTALESLQ 201
Query: 700 SGEATSMADVYSFGVVVLEVVT-GQMAVDFRLP-EGLLVKRVHEFEAR----KRPLAELV 753
+ T+ +DV+SFGV++ E++T G P + + F A+ +P
Sbjct: 202 TYRFTTKSDVWSFGVLLWELLTRGAP------PYRHIDPFDLTHFLAQGRRLPQPEYCPD 255
Query: 754 DLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795
L Y ++M+ C ++P +RP+ R ++ ++
Sbjct: 256 SL-----Y---QVMQ------QCWEADPAVRPTFRVLVGEVE 283
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 68/234 (29%), Positives = 102/234 (43%), Gaps = 42/234 (17%)
Query: 116 DEVLGSGGFGKVYRAVLP-----SDGTVVAVKCLAEKGERFEKT-FAAELVAVAHL-RHR 168
+ LG+G FGKV A VAVK L EK +EL ++HL +H
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 169 NLVRLRGWCVHEDQLLLVYDYMPN-------RSLDRVLFRRPENLEAAAPLNWEQRKKII 221
N+V L G C H +L++ +Y R RVL P A + +
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 222 RGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSA 281
+A + +L + IHRDV NV+L + + A++GDFGLAR + ++ Y ++ +
Sbjct: 171 SQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN-- 225
Query: 282 RNHQFHLAETTRIGGTIGYLP-----PESFQKGSVATAKSDVFSFGIVVLEVVS 330
LP PES V T +SDV+S+GI++ E+ S
Sbjct: 226 -----------------ARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFS 261
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 5e-10
Identities = 64/296 (21%), Positives = 112/296 (37%), Gaps = 58/296 (19%)
Query: 526 FGTAYQGFL------DNHQYVLVKRLGMSKCPALRTRFSNELQNLARL-RHRNLVQLCGW 578
FG + D V VK L + + +EL+ ++ L +H N+V L G
Sbjct: 59 FGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGA 118
Query: 579 CTEQGEMLVIYDYSATRILSHLL--------FHNNHRIGHSILQWHHRYNIIKSLASAIL 630
CT G +LVI +Y L + L I +S + +A +
Sbjct: 119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMA 178
Query: 631 YLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIF 690
+L + IHR++ + + L ++G F LA + + + + + V+
Sbjct: 179 FLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN-YIVKGNARLPVK--- 231
Query: 691 GYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLP-EGLLVKRVHEFEARKRP 748
+M+PE I T +DV+S+G+++ E+ + G P G+LV
Sbjct: 232 -WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLN------PYPGILVNS---------- 274
Query: 749 LAELVDLSLNGEYNHK---------ELMRLIKLGIACTLSNPELRPSMRQILSILD 795
+ L +G + +M+ AC P RP+ +QI S L
Sbjct: 275 --KFYKLVKDGYQMAQPAFAPKNIYSIMQ------ACWALEPTHRPTFQQICSFLQ 322
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-29
Identities = 46/234 (19%), Positives = 85/234 (36%), Gaps = 42/234 (17%)
Query: 116 DEVLGSGGFGKVYRAV-LPSDGTVVAVKCLAEKG-ERFEKTFAAELVAVAHLRHRNLVRL 173
+ GG G +Y A+ +G V +K L G + AE +A + H ++V++
Sbjct: 85 KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQI 144
Query: 174 RGWCVHEDQLL-----LVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAAL 228
+ H D+ +V +Y+ +SL R L + + + AL
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK---------GQKLPVAEAIAYLLEILPAL 195
Query: 229 HYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHL 288
YLH +++ D+K N+ML + +L D G +
Sbjct: 196 SYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVS--------------------RI 231
Query: 289 AETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDD 342
+ GT G+ PE + T +D+++ G + + + Y D
Sbjct: 232 NSFGYLYGTPGFQAPE--IVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDG 283
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 63.0 bits (153), Expect = 3e-10
Identities = 34/199 (17%), Positives = 64/199 (32%), Gaps = 49/199 (24%)
Query: 540 VLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY--SATRIL 597
V++K L S + E Q LA + H ++VQ I+++ R
Sbjct: 109 VVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQ-------------IFNFVEHTDRHG 155
Query: 598 SHLLFHNNHRI------GHSI-------LQWHHRYNIIKSLASAILYLHEEWNEQVIHRN 644
+ + I G S+ L + + A+ YLH +++ +
Sbjct: 156 DPVGY-----IVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSI---GLVYND 207
Query: 645 ITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEAT 704
+ I L + +L + S + G G+ +PE I T
Sbjct: 208 LKPENIMLTEE-QLKLIDLGAV----------SRINSFG-YLYGTPGFQAPE-IVRTGPT 254
Query: 705 SMADVYSFGVVVLEVVTGQ 723
D+Y+ G + +
Sbjct: 255 VATDIYTVGRTLAALTLDL 273
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 6e-29
Identities = 62/226 (27%), Positives = 100/226 (44%), Gaps = 33/226 (14%)
Query: 116 DEVLGSGGFGKVYRAVLPSDGTVVAVKCLAE---KGERFEKTFAAELVAVAHLRHRNLVR 172
E+LG GG +V+ A D VAVK L + F F E A L H +V
Sbjct: 17 GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 173 LRGWCVHEDQLL----LVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAAL 228
+ E +V +Y+ +L ++ P+ ++ ++I AL
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-------GPMTPKRAIEVIADACQAL 129
Query: 229 HYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHL 288
++ H+ IIHRDVK +N+M+ + ++ DFG+AR + + +
Sbjct: 130 NFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR-------------AIADSGNSV 173
Query: 289 AETTRIGGTIGYLPPESFQ-KGSVATAKSDVFSFGIVVLEVVSGRR 333
+T + GT YL PE Q +G A+SDV+S G V+ EV++G
Sbjct: 174 TQTAAVIGTAQYLSPE--QARGDSVDARSDVYSLGCVLYEVLTGEP 217
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 9e-12
Identities = 55/283 (19%), Positives = 103/283 (36%), Gaps = 39/283 (13%)
Query: 540 VLVK--RLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIY----DYSA 593
V VK R +++ P+ RF E QN A L H +V + + + +Y
Sbjct: 40 VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVD 99
Query: 594 TRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLD 653
L ++ H G + +I A+ + H+ +IHR++ + I +
Sbjct: 100 GVTLRDIV----HTEGP--MTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMIS 150
Query: 654 PDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFG 713
++ F +A + + + T +V G Y+SPE + +DVYS G
Sbjct: 151 ATNAVKVMDFGIARAIADSGNS---VTQTA-AVIGTAQYLSPEQARGDSVDARSDVYSLG 206
Query: 714 VVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLG 773
V+ EV+TG+ P + + V E E + L+ ++
Sbjct: 207 CVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLD---------AVV--- 254
Query: 774 IACTLSNPELRPS--------MRQILSILDGNDKRFMEDGQMT 808
+ NPE R + ++ + + + D + T
Sbjct: 255 LKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKVLTDAERT 297
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-29
Identities = 57/289 (19%), Positives = 100/289 (34%), Gaps = 50/289 (17%)
Query: 116 DEVLGSGGFGKVYRAVLPSDGTVVAVK--CLAEKGERFEKTFAAELVAVAHLRHRNLVRL 173
D +G G F VY+ + VA + + + F E + L+H N+VR
Sbjct: 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90
Query: 174 RGWCV----HEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALH 229
+ ++LV + M + +L L R + + + R + L
Sbjct: 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-------VMKIKVLRSWCRQILKGLQ 143
Query: 230 YLHEQLETQIIHRDVKTSNVMLDSQY-NARLGDFGLARWLEHELQYQMRTSSARNHQFHL 288
+LH + IIHRD+K N+ + + ++GD GLA +
Sbjct: 144 FLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI----------- 191
Query: 289 AETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLD 348
GT ++ PE +++ DV++FG+ +LE+ + YP +
Sbjct: 192 -------GTPEFMAPEMYEEK--YDESVDVYAFGMCMLEMATSE------YPYSECQNAA 236
Query: 349 WIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPS 397
I R G + D + + C N R S
Sbjct: 237 QIYRRVTSGVKPASFDKVAI---------PEVKEIIEGCIRQNKDERYS 276
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 56/281 (19%), Positives = 107/281 (38%), Gaps = 53/281 (18%)
Query: 526 FGTAYQGF-LDNHQYVLVKRLGMSKCP-ALRTRFSNELQNLARLRHRNLVQLCG-W--CT 580
F T Y+G + V L K + R RF E + L L+H N+V+ W
Sbjct: 39 FKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 98
Query: 581 EQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRY-----NIIKSLASAIL----Y 631
+ + +V+ T +++ ++ + R+ +++S IL +
Sbjct: 99 KGKKCIVLV----TELMT----------SGTLKTYLKRFKVMKIKVLRSWCRQILKGLQF 144
Query: 632 LHEEWNEQVIHRNITSSAITLD-PDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIF 690
LH +IHR++ I + P + ++G LA + ++V G
Sbjct: 145 LHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA---------KAVIGTP 194
Query: 691 GYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLA 750
+M+PE E DVY+FG+ +LE+ T + + +RV +
Sbjct: 195 EFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVKPASFD 252
Query: 751 ELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQIL 791
++ E+ +I+ C N + R S++ +L
Sbjct: 253 KVAI---------PEVKEIIEG---CIRQNKDERYSIKDLL 281
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 7e-29
Identities = 67/220 (30%), Positives = 107/220 (48%), Gaps = 32/220 (14%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGW 176
E LG+G FG+V+ + T VAVK L + G F AE + L+H+ LVRL
Sbjct: 19 ERLGAGQFGEVWMGYY-NGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYA- 75
Query: 177 CVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLE 236
V ++ + ++ +YM N SL L + P L + + +A + ++ E+
Sbjct: 76 VVTQEPIYIITEYMENGSLVDFL-KTPSG----IKLTINKLLDMAAQIAEGMAFIEER-- 128
Query: 237 TQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGG 296
IHRD++ +N+++ + ++ DFGLAR +E +Y T R G
Sbjct: 129 -NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-EY----------------TAREGA 170
Query: 297 T--IGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRR 333
I + PE+ G T KSDV+SFGI++ E+V+ GR
Sbjct: 171 KFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRI 209
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 3e-10
Identities = 60/284 (21%), Positives = 118/284 (41%), Gaps = 58/284 (20%)
Query: 526 FGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEM 585
FG + G+ + H V VK L + F E + +L+H+ LV+L T++
Sbjct: 26 FGEVWMGYYNGHTKVAVKSL--KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIY 83
Query: 586 LVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNI 645
++ ++ L + ++ + L ++ +A + ++ EE N IHR++
Sbjct: 84 IITEYMENGSLVDFLKTPSGIKLTINKL-----LDMAAQIAEGMAFI-EERN--YIHRDL 135
Query: 646 TSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATS 705
++ I + ++ ++ F LA + N++ R+ ++ + +PE I G T
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEYTARE--GAKFPIK----WTAPEAINYGTFTI 189
Query: 706 MADVYSFGVVVLEVVT-GQMAVDFRLP-EGLLVKRVHEFEARKRPLAELVDLSLNGE--- 760
+DV+SFG+++ E+VT G++ P G+ E++ G
Sbjct: 190 KSDVWSFGILLTEIVTHGRI------PYPGM-------------TNPEVIQNLERGYRMV 230
Query: 761 ---------YNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795
Y +LMR C PE RP+ + S+L+
Sbjct: 231 RPDNCPEELY---QLMR------LCWKERPEDRPTFDYLRSVLE 265
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-29
Identities = 56/218 (25%), Positives = 88/218 (40%), Gaps = 28/218 (12%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGW 176
+G G FG+V+R G AVK + R E ELVA A L +V L G
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKV-----RLEVFRVEELVACAGLSSPRIVPLYGA 118
Query: 177 CVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLE 236
+ + + + SL ++ ++ L ++ + L YLH +
Sbjct: 119 VREGPWVNIFMELLEGGSLGQL-------IKQMGCLPEDRALYYLGQALEGLEYLHTR-- 169
Query: 237 TQIIHRDVKTSNVMLDSQ-YNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIG 295
+I+H DVK NV+L S A L DFG A L+ + + S
Sbjct: 170 -RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD---GLGKSLLTGDYIP-------- 217
Query: 296 GTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRR 333
GT ++ PE G AK D++S ++L +++G
Sbjct: 218 GTETHMAPEVV-MGKPCDAKVDIWSSCCMMLHMLNGCH 254
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 45/307 (14%), Positives = 95/307 (30%), Gaps = 64/307 (20%)
Query: 526 FGTAYQGF-LDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGE 584
FG ++ VK++ + EL A L +V L G +G
Sbjct: 71 FGEVHRMKDKQTGFQCAVKKVRLEVFR------VEELVACAGLSSPRIVPLYG-AVREGP 123
Query: 585 MLVIY-DY----SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQ 639
+ I+ + S +++ + R + + Q ++ L YLH +
Sbjct: 124 WVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQ------ALEGLE----YLHTR---R 170
Query: 640 VIHRNITSSAITLDPDMNP-RLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYI 698
++H ++ + + L D + L F A L G K+ + G +M+PE +
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQ--PDGLGKSLLTGDYIPGTETHMAPEVV 228
Query: 699 ESGEATSMADVYSFGVVVLEVVTG--------QMAVDFRLPEGLLVKRVHEFEARKRPLA 750
+ D++S ++L ++ G + + ++ R +
Sbjct: 229 MGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE---------PPPIREIP 279
Query: 751 ELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDKRFMEDGQMTEN 810
+ + I+ P R S ++ K ++
Sbjct: 280 P--SCA-------PLTAQAIQE---GLRKEPVHRASAMELR------RKVGKALQEVGGL 321
Query: 811 LEEWKQR 817
WK
Sbjct: 322 KSPWKGE 328
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 8e-29
Identities = 60/242 (24%), Positives = 104/242 (42%), Gaps = 51/242 (21%)
Query: 117 EVLGSGGFGKVYRAVLP-----SDGTVVAVKCLAEKGERFEKT-FAAELVAVAHLRHRNL 170
+G G FG+V++A P T+VAVK L E+ + F E +A + N+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 171 VRLRGWCVHEDQLLLVYDYMPNRSLDRVL-FRRPENLEAAA----------------PLN 213
V+L G C + L+++YM L+ L P + + + PL+
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 214 WEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQ 273
++ I R +AA + YL E+ + +HRD+ T N ++ ++ DFGL+R +
Sbjct: 173 CAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229
Query: 274 YQMRTSSARNHQFHLAETTRIGGTIGYLP-----PESFQKGSVATAKSDVFSFGIVVLEV 328
Y+ + +P PES T +SDV+++G+V+ E+
Sbjct: 230 YKADGN-------------------DAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEI 269
Query: 329 VS 330
S
Sbjct: 270 FS 271
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 66/316 (20%), Positives = 113/316 (35%), Gaps = 62/316 (19%)
Query: 526 FGTAYQGFLDN------HQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWC 579
FG +Q V VK L ++ F E +A + N+V+L G C
Sbjct: 60 FGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 119
Query: 580 TEQGEMLVIYDY------------------SATRILSHLLFHNNHRIGHSILQWHHRYNI 621
M ++++Y + G L + I
Sbjct: 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCI 179
Query: 622 IKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATS 681
+ +A+ + YL E + +HR++ + + +M ++ F L+ + D+ ++ +
Sbjct: 180 ARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY-YKADGN 235
Query: 682 GNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLP-EGLLVKRV 739
+R +M PE I T+ +DV+++GVV+ E+ + G P G+ + V
Sbjct: 236 DAIPIR----WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ------PYYGMAHEEV 285
Query: 740 HEF-EARKR---PLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795
+ P E L L YN LMR C P RPS I IL
Sbjct: 286 IYYVRDGNILACP--ENCPLEL---YN---LMR------LCWSKLPADRPSFCSIHRILQ 331
Query: 796 GNDKRFMEDGQMTENL 811
R E + T +
Sbjct: 332 ----RMCERAEGTVGV 343
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 8e-29
Identities = 61/230 (26%), Positives = 100/230 (43%), Gaps = 27/230 (11%)
Query: 108 IGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCL-AEKGERFEKTFAAEL-VAVAHL 165
+ + +G G +G V + V G ++AVK + + E+ +K +L V +
Sbjct: 19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSS 78
Query: 166 RHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLA 225
+V+ G E + + M + S D+ L+ + E KI
Sbjct: 79 DCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDD--VIPEEILGKITLATV 135
Query: 226 AALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQ 285
AL++L E L +IIHRD+K SN++LD N +L DFG++ Q+ S A+
Sbjct: 136 KALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISG--------QLVDSIAK--- 182
Query: 286 FHLAETTRIGGTIGYLPPESFQKGSVA---TAKSDVFSFGIVVLEVVSGR 332
TR G Y+ PE + +SDV+S GI + E+ +GR
Sbjct: 183 ------TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 43/207 (20%), Positives = 81/207 (39%), Gaps = 24/207 (11%)
Query: 526 FGTAYQG-FLDNHQYVLVKRLGMSKCPALRTRFSNELQ-NLARLRHRNLVQLCGWCTEQG 583
+G+ + + Q + VKR+ + + + +L + +VQ G +G
Sbjct: 35 YGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREG 94
Query: 584 EMLVIYDY---SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQV 640
+ + + S + ++ + I IL I + A+ +L E +
Sbjct: 95 DCWICMELMSTSFDKFYKYVYSVLDDVIPEEILG-----KITLATVKALNHLKENLK--I 147
Query: 641 IHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIES 700
IHR+I S I LD N +L F ++ L + G YM+PE I+
Sbjct: 148 IHRDIKPSNILLDRSGNIKLCDFGISGQLV--------DSIAKTRDAGCRPYMAPERIDP 199
Query: 701 GEA----TSMADVYSFGVVVLEVVTGQ 723
+ +DV+S G+ + E+ TG+
Sbjct: 200 SASRQGYDVRSDVWSLGITLYELATGR 226
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-28
Identities = 54/224 (24%), Positives = 97/224 (43%), Gaps = 32/224 (14%)
Query: 116 DEVLGSGGFGKVYRAVLPSDG--TVVAVKCL-AEKGERFEKTFAAELVAVAHLRHRNLVR 172
D LG G FG V + V VA+K L + + E + L + +VR
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 173 LRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLH 232
L G C E L+LV + L + L + E + +++ ++ + YL
Sbjct: 401 LIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEI------PVSNVAELLHQVSMGMKYLE 453
Query: 233 EQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETT 292
E+ +HR++ NV+L +++ A++ DFGL++ L + Y T
Sbjct: 454 EK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY---------------YTA 495
Query: 293 RIGGT--IGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRR 333
R G + + PE +++SDV+S+G+ + E +S G++
Sbjct: 496 RSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQK 538
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 2e-10
Identities = 45/203 (22%), Positives = 88/203 (43%), Gaps = 17/203 (8%)
Query: 526 FGTAYQGFLDNHQY---VLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQ 582
FG+ QG + V +K L A E Q + +L + +V+L G C +
Sbjct: 349 FGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE 408
Query: 583 GEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIH 642
MLV+ + L+ + + ++ ++ + YL EE N +H
Sbjct: 409 ALMLVMEMAGGGPLHKFLVGKREE------IPVSNVAELLHQVSMGMKYL-EEKN--FVH 459
Query: 643 RNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGE 702
RN+ + + L ++ F L++ L +D + ++G ++ + +PE I +
Sbjct: 460 RNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK----WYAPECINFRK 515
Query: 703 ATSMADVYSFGVVVLEVVT-GQM 724
+S +DV+S+GV + E ++ GQ
Sbjct: 516 FSSRSDVWSYGVTMWEALSYGQK 538
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 2e-28
Identities = 52/221 (23%), Positives = 93/221 (42%), Gaps = 34/221 (15%)
Query: 116 DEVLGSGGFGKVYRAVLPSDG---TVVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNLV 171
+G G FG V++ + S VA+K + + F E + + H ++V
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 172 RLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYL 231
+L G E+ + ++ + L L R +L+ A+ + + L+ AL YL
Sbjct: 455 KLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILY------AYQLSTALAYL 507
Query: 232 HEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAET 291
+ + +HRD+ NV++ S +LGDFGL+R++E
Sbjct: 508 ESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-----------------TYY 547
Query: 292 TRIGGT--IGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS 330
G I ++ PES T+ SDV+ FG+ + E++
Sbjct: 548 KASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILM 587
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 4e-10
Identities = 59/285 (20%), Positives = 109/285 (38%), Gaps = 55/285 (19%)
Query: 526 FGTAYQGFL----DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTE 581
FG +QG + V +K ++R +F E + + H ++V+L G TE
Sbjct: 403 FGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE 462
Query: 582 QGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVI 641
+ +I + L L + + L L++A+ YL E +
Sbjct: 463 N-PVWIIMELCTLGELRSFLQVRKFSLDLASL-----ILYAYQLSTALAYL-ESKR--FV 513
Query: 642 HRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESG 701
HR+I + + + + +LG F L+ ++ + + KA+ G ++ +M+PE I
Sbjct: 514 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY--YKASKGKLPIK----WMAPESINFR 567
Query: 702 EATSMADVYSFGVVVLEVVT-GQMAVDFRLP-EGLLVKRVHEFEARKRPLAELVDLSLNG 759
TS +DV+ FGV + E++ G P +G+ +++ NG
Sbjct: 568 RFTSASDVWMFGVCMWEILMHGVK------PFQGV-------------KNNDVIGRIENG 608
Query: 760 EYNHK---------ELMRLIKLGIACTLSNPELRPSMRQILSILD 795
E LM C +P RP ++ + L
Sbjct: 609 ERLPMPPNCPPTLYSLMT------KCWAYDPSRRPRFTELKAQLS 647
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 57/243 (23%), Positives = 94/243 (38%), Gaps = 51/243 (20%)
Query: 116 DEVLGSGGFGKVYRAVLP-----SDGTVVAVKCLAEKGERFEKT-FAAELVAVAHLRHRN 169
+ LG G FGKV +A + T VAVK L E E +E + + H +
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 170 LVRLRGWCVHEDQLLLVYDYMPNRSLDRVL-FRRPENLEAAAPLNWEQRKKIIRGL---- 224
+++L G C + LLL+ +Y SL L R +
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 225 ------------AAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHEL 272
+ + YL E +++HRD+ N+++ ++ DFGL+R + E
Sbjct: 148 TMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 273 QYQMRTSSARNHQFHLAETTRIGGTIGYLP-----PESFQKGSVATAKSDVFSFGIVVLE 327
Y R+ G +P ES + T +SDV+SFG+++ E
Sbjct: 205 SYVKRSQ-------------------GRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWE 244
Query: 328 VVS 330
+V+
Sbjct: 245 IVT 247
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 2e-11
Identities = 58/303 (19%), Positives = 108/303 (35%), Gaps = 64/303 (21%)
Query: 526 FGTAYQGFL------DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWC 579
FG + + V VK L + P+ +E L ++ H ++++L G C
Sbjct: 36 FGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC 95
Query: 580 TEQGEMLVIYDYSATR--ILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHE--E 635
++ G +L+I +Y A + L G+ + + L + +
Sbjct: 96 SQDGPLLLIVEY-AKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLIS 154
Query: 636 WNEQV------------IHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGN 683
+ Q+ +HR++ + I + ++ F L+ + D + K + G
Sbjct: 155 FAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS-YVKRSQGR 213
Query: 684 RSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLP-EGLLVKRVHE 741
V+ +M+ E + T+ +DV+SFGV++ E+VT G P G+
Sbjct: 214 IPVK----WMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN------PYPGI------- 256
Query: 742 FEARKRPLAELVDLSLNGEYNHK---------ELMRLIKLGIACTLSNPELRPSMRQILS 792
P L +L G + LM C P+ RP I
Sbjct: 257 ------PPERLFNLLKTGHRMERPDNCSEEMYRLML------QCWKQEPDKRPVFADISK 304
Query: 793 ILD 795
L+
Sbjct: 305 DLE 307
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 117 bits (293), Expect = 2e-28
Identities = 28/247 (11%), Positives = 49/247 (19%), Gaps = 53/247 (21%)
Query: 116 DEVLGSGGFGKVYRAVLPSDGTVVAVKCL---AEKGERFEKTFAAELVAVAHLRHRNLVR 172
E L G V+ A+K AE + A A L +
Sbjct: 67 VEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEE 126
Query: 173 LRGWC--------------------------VHEDQLLLVYDYMPNRSLDRVLFRRPENL 206
R LL+ + L+ +
Sbjct: 127 ARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLFSTLDFVY 185
Query: 207 EAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLAR 266
+ L L + ++H N+ + LGD
Sbjct: 186 VFRGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALW 242
Query: 267 WLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQ-KGSVATAKSDVFSFGIVV 325
+ + Y P E + T + + G+ +
Sbjct: 243 KVG-------------------TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSI 283
Query: 326 LEVVSGR 332
V
Sbjct: 284 YRVWCLF 290
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 65.5 bits (159), Expect = 2e-11
Identities = 26/298 (8%), Positives = 65/298 (21%), Gaps = 51/298 (17%)
Query: 526 FGTAYQGF-LDNHQYVLVKRLGMSK--CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQ 582
+ ++ + +K M + R ARL + +
Sbjct: 75 RSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLL 134
Query: 583 GEMLVIYDYSATRILSHLLFHNNHRIG--------------------------HSILQWH 616
+ S +++ +
Sbjct: 135 LPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGIL 194
Query: 617 HRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGH 676
+ + L L + ++H + T + + PD LG +
Sbjct: 195 ALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSAL---------- 241
Query: 677 RKATSGNRSVRGIFGYMSPEYIESGEA--TSMADVYSFGVVVLEVVTGQMAVDFRLPEGL 734
K + + Y E++ + A T + + G+ + V + P
Sbjct: 242 WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK 301
Query: 735 LVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792
+ + + + LI + R + +
Sbjct: 302 GSWKRPSLRVPGTDSLAFGSCTPLPD----FVKTLIG---RFLNFDRRRRLLPLEAME 352
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 82/340 (24%), Positives = 139/340 (40%), Gaps = 72/340 (21%)
Query: 116 DEVLGSGGFGKVYRAVL-------PSDGTVVAVKCLAEKGERFEKT-FAAELVAVAHL-R 166
+ LG G FG+V A P + VAVK L + + + +E+ + + +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 167 HRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVL-FRRPENLEAAA--------PLNWEQR 217
H+N++ L G C + L ++ +Y +L L RRP +E + + ++
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 218 KKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMR 277
LA + YL Q + IHRD+ NV++ ++ DFGLAR + + Y+
Sbjct: 160 VSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 278 TSSARNHQFHLAETTRIGGTIGYLP-----PESFQKGSVATAKSDVFSFGIVVLEVVS-G 331
T+ G LP PE+ V T +SDV+SFG+++ E+ + G
Sbjct: 217 TN-------------------GRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLG 256
Query: 332 RRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHN 391
YP I ++ + +L EG + N C E L + C
Sbjct: 257 GSP----YPG---IPVEELFKLLKEGHRMDKPAN---------CTNE-LYMMMRDCWHAV 299
Query: 392 PHLRPSMKWVIEAVSGSYSGKLPALPSFQSHPLYISLSSP 431
P RP+ K ++E L + + ++ Y+ LS P
Sbjct: 300 PSQRPTFKQLVE--------DLDRILTLTTNEEYLDLSQP 331
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 65/300 (21%), Positives = 119/300 (39%), Gaps = 63/300 (21%)
Query: 526 FGTAYQGFL--------DNHQYVLVKRLGMSKCPALRTRFSNELQNLARL-RHRNLVQLC 576
FG V VK L + +E++ + + +H+N++ L
Sbjct: 48 FGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLL 107
Query: 577 GWCTEQGEMLVIYDYS----------ATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLA 626
G CT+ G + VI +Y+ A R ++ +R+ + + + LA
Sbjct: 108 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLA 167
Query: 627 SAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSV 686
+ YL + + IHR++ + + + + ++ F LA + D+ ++K T+G V
Sbjct: 168 RGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDY-YKKTTNGRLPV 223
Query: 687 RGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLP-EGLLVKRVHEFEA 744
+ +M+PE + T +DV+SFGV++ E+ T G P G+
Sbjct: 224 K----WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS------PYPGI---------- 263
Query: 745 RKRPLAELVDLSLNGEYNHK---------ELMRLIKLGIACTLSNPELRPSMRQILSILD 795
P+ EL L G K +MR C + P RP+ +Q++ LD
Sbjct: 264 ---PVEELFKLLKEGHRMDKPANCTNELYMMMR------DCWHAVPSQRPTFKQLVEDLD 314
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 58/227 (25%), Positives = 101/227 (44%), Gaps = 16/227 (7%)
Query: 108 IGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLA-EKGERFEKTFAAELVAVAHLR 166
I + ++ EV+GSG V A VA+K + EK + E+ A++
Sbjct: 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH 71
Query: 167 HRNLVRLRGWCVHEDQLLLVYDYMPNRSL-DRVLFRRPENLEAAAPLNWEQRKKIIRGLA 225
H N+V V +D+L LV + S+ D + + + L+ I+R +
Sbjct: 72 HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 226 AALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQ 285
L YLH+ IHRDVK N++L + ++ DFG++ +L + + R
Sbjct: 132 EGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGG--DITRNKVRK-- 184
Query: 286 FHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
T + GT ++ PE ++ K+D++SFGI +E+ +G
Sbjct: 185 ------TFV-GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 49/238 (20%), Positives = 95/238 (39%), Gaps = 24/238 (10%)
Query: 496 MVETPREISFKEIISATNNFSESQRVAEMDFGTAYQGF-LDNHQYVLVKRLGMSKCPALR 554
M E + + +++ + + + + V +KR+ + KC
Sbjct: 1 MSEDSSALPWS---INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSM 57
Query: 555 TRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY----SATRILSHLLFHNNHRIGH 610
E+Q +++ H N+V + E+ ++ S I+ H++ H+ G
Sbjct: 58 DELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSG- 116
Query: 611 SILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLT 670
+L I++ + + YLH IHR++ + I L D + ++ F ++ FL
Sbjct: 117 -VLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLA 172
Query: 671 RNDHGHRKATSGNRSVRGIF-G---YMSPEYIESGEA-TSMADVYSFGVVVLEVVTGQ 723
R VR F G +M+PE +E AD++SFG+ +E+ TG
Sbjct: 173 TGGDITRN------KVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 51/230 (22%), Positives = 99/230 (43%), Gaps = 28/230 (12%)
Query: 108 IGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCL-AEKGERFEKTFAAEL-VAVAHL 165
+ ++ + LG G +G V + G ++AVK + A + +K +L +++ +
Sbjct: 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTV 63
Query: 166 RHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLA 225
V G E + + + M + SLD+ + ++ + + KI +
Sbjct: 64 DCPFTVTFYGALFREGDVWICMELM-DTSLDKFY---KQVIDKGQTIPEDILGKIAVSIV 119
Query: 226 AALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQ 285
AL +LH +L +IHRDVK SNV++++ ++ DFG++ + A++
Sbjct: 120 KALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISG--------YLVDDVAKD-- 167
Query: 286 FHLAETTRIGGTIGYLPPE---SFQKGSVATAKSDVFSFGIVVLEVVSGR 332
G Y+ PE + KSD++S GI ++E+ R
Sbjct: 168 ------IDA-GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 5e-09
Identities = 46/279 (16%), Positives = 102/279 (36%), Gaps = 44/279 (15%)
Query: 526 FGTAYQG-FLDNHQYVLVKRLGMSKCPALRTRFSNELQ-NLARLRHRNLVQLCGWCTEQG 583
+G + + + Q + VKR+ + + R +L ++ + V G +G
Sbjct: 20 YGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREG 79
Query: 584 EMLVIYDY---SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQV 640
++ + + S + ++ I IL I S+ A+ +LH + + V
Sbjct: 80 DVWICMELMDTSLDKFYKQVIDKG-QTIPEDILG-----KIAVSIVKALEHLHSKLS--V 131
Query: 641 IHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIES 700
IHR++ S + ++ ++ F ++ +L G YM+PE I
Sbjct: 132 IHRDVKPSNVLINALGQVKMCDFGISGYLVD--------DVAKDIDAGCKPYMAPERINP 183
Query: 701 GEA----TSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDL- 755
+ +D++S G+ ++E+ + F F+ L ++V+
Sbjct: 184 ELNQKGYSVKSDIWSLGITMIELAILR----FPYDS-----WGTPFQQ----LKQVVEEP 230
Query: 756 --SLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792
L + E + C N + RP+ +++
Sbjct: 231 SPQLPADKFSAEFVDFTS---QCLKKNSKERPTYPELMQ 266
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 9e-28
Identities = 59/214 (27%), Positives = 96/214 (44%), Gaps = 27/214 (12%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGW 176
LG G FG+V+ + T VA+K L G + F E + LRH LV+L
Sbjct: 190 VKLGQGCFGEVWMGTW-NGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYA- 246
Query: 177 CVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLE 236
V E+ + +V +YM SL L + L Q + +A+ + Y+
Sbjct: 247 VVSEEPIYIVTEYMSKGSLLDFL-KGET----GKYLRLPQLVDMAAQIASGMAYVERM-- 299
Query: 237 TQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGG 296
+HRD++ +N+++ ++ DFGLAR +E +Y R + +
Sbjct: 300 -NYVHRDLRAANILVGENLVCKVADFGLARLIEDN-EYTAR------------QGAKF-- 343
Query: 297 TIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS 330
I + PE+ G T KSDV+SFGI++ E+ +
Sbjct: 344 PIKWTAPEAALYG-RFTIKSDVWSFGILLTELTT 376
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 55/273 (20%), Positives = 103/273 (37%), Gaps = 36/273 (13%)
Query: 526 FGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEM 585
FG + G + V +K L F E Q + +LRH LVQL +E+
Sbjct: 197 FGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIY 254
Query: 586 LVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNI 645
+V S +L L + L ++ +AS + Y+ +HR++
Sbjct: 255 IVTEYMSKGSLLDFLKGETGKYLRLPQL-----VDMAAQIASGMAYVERM---NYVHRDL 306
Query: 646 TSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATS 705
++ I + ++ ++ F LA + N++ R+ ++ + +PE G T
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNEYTARQ--GAKFPIK----WTAPEAALYGRFTI 360
Query: 706 MADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPL---AELVDLSLNGEYN 762
+DV+SFG+++ E+ T + ++ +V P L
Sbjct: 361 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL---------- 410
Query: 763 HKELMRLIKLGIACTLSNPELRPSMRQILSILD 795
+LM C PE RP+ + + L+
Sbjct: 411 -HDLMC------QCWRKEPEERPTFEYLQAFLE 436
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 9e-28
Identities = 65/221 (29%), Positives = 97/221 (43%), Gaps = 38/221 (17%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGW 176
+ +G G FG V G VAVKC+ K + + F AE + LRH NLV+L G
Sbjct: 27 QTIGKGEFGDVMLGDY--RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGV 82
Query: 177 CVHED-QLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQL 235
V E L +V +YM SL L R + L + K + A+ YL
Sbjct: 83 IVEEKGGLYIVTEYMAKGSLVDYL-RSRGR----SVLGGDCLLKFSLDVCEAMEYLEGN- 136
Query: 236 ETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIG 295
+HRD+ NV++ A++ DFGL + A +T+
Sbjct: 137 --NFVHRDLAARNVLVSEDNVAKVSDFGLTK---------------------EASSTQDT 173
Query: 296 GT--IGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRR 333
G + + PE+ ++ + KSDV+SFGI++ E+ S GR
Sbjct: 174 GKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRV 213
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 3e-09
Identities = 60/275 (21%), Positives = 111/275 (40%), Gaps = 44/275 (16%)
Query: 526 FGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCT-EQGE 584
FG G ++ V VK + K A F E + +LRH NLVQL G E+G
Sbjct: 34 FGDVMLGDYRGNK-VAVKCI---KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 89
Query: 585 MLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRN 644
+ ++ +Y A L L G S+L + A+ YL +HR+
Sbjct: 90 LYIVTEYMAKGSLVDYLRSR----GRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRD 142
Query: 645 ITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEAT 704
+ + + + D ++ F L + +G V+ + +PE + + +
Sbjct: 143 LAARNVLVSEDNVAKVSDFGLT----KEA--SSTQDTGKLPVK----WTAPEALREKKFS 192
Query: 705 SMADVYSFGVVVLEVVT-GQMAVDFRLP-EGLLVKRVHEF-EARKR-PLAELVDLSLNGE 760
+ +DV+SFG+++ E+ + G++ P + +K V E + + ++
Sbjct: 193 TKSDVWSFGILLWEIYSFGRV------PYPRIPLKDVVPRVEKGYKMDAPDGCPPAV--- 243
Query: 761 YNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795
Y E+M+ C + +RPS Q+ L+
Sbjct: 244 Y---EVMK------NCWHLDAAMRPSFLQLREQLE 269
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 9e-28
Identities = 61/238 (25%), Positives = 103/238 (43%), Gaps = 46/238 (19%)
Query: 116 DEVLGSGGFGKVYRAVL-------PSDGTVVAVKCLAEKGERFEKT-FAAELVAVAHL-R 166
+ LG G FG+V A P + VAVK L + + + +E+ + + +
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 167 HRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVL-FRRPENLEAAAPLNWEQRK------- 218
H+N++ L G C + L ++ +Y +L L RRP +E + +N +
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 219 -KIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMR 277
LA + YL Q + IHRD+ NV++ ++ DFGLAR + + Y+
Sbjct: 206 VSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262
Query: 278 TSSARNHQFHLAETTRIGGTIGYLP-----PESFQKGSVATAKSDVFSFGIVVLEVVS 330
T+ G LP PE+ V T +SDV+SFG+++ E+ +
Sbjct: 263 TN-------------------GRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFT 300
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 5e-11
Identities = 66/305 (21%), Positives = 116/305 (38%), Gaps = 73/305 (23%)
Query: 526 FGTAYQGFL--------DNHQYVLVKRLGMSKCPALRTRFSNELQNLARL-RHRNLVQLC 576
FG V VK L + +E++ + + +H+N++ L
Sbjct: 94 FGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLL 153
Query: 577 GWCTEQGEMLVIYDY----------SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLA 626
G CT+ G + VI +Y A R ++ +R+ + + + LA
Sbjct: 154 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLA 213
Query: 627 SAILYLHEEWNEQVIH-----RNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATS 681
+ YL ++ IH RN + + + ++ F LA + D+ ++K T+
Sbjct: 214 RGMEYLAS---QKCIHRDLAARN-----VLVTENNVMKIADFGLARDINNIDY-YKKTTN 264
Query: 682 GNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLP-EGLLVKRV 739
G V+ +M+PE + T +DV+SFGV++ E+ T G P G+
Sbjct: 265 GRLPVK----WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS------PYPGI----- 309
Query: 740 HEFEARKRPLAELVDLSLNGEYNHK---------ELMRLIKLGIACTLSNPELRPSMRQI 790
P+ EL L G K +MR C + P RP+ +Q+
Sbjct: 310 --------PVEELFKLLKEGHRMDKPANCTNELYMMMR------DCWHAVPSQRPTFKQL 355
Query: 791 LSILD 795
+ LD
Sbjct: 356 VEDLD 360
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 9e-28
Identities = 59/238 (24%), Positives = 96/238 (40%), Gaps = 46/238 (19%)
Query: 116 DEVLGSGGFGKVYRAVLP-----SDGTVVAVKCLAEKGERFEKT-FAAELVAVAHL-RHR 168
+ LG+G FGKV A VAVK L E+ +EL +++L H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 169 NLVRLRGWCVHEDQLLLVYDYMPNRSLDRVL-FRRPENLEAAAPLNWEQRKKIIRGL--- 224
N+V L G C L++ +Y L L +R + + + ++ L
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 225 -------AAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMR 277
A + +L + IHRD+ N++L ++ DFGLAR ++++ Y ++
Sbjct: 148 LSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 278 TSSARNHQFHLAETTRIGGTIGYLP-----PESFQKGSVATAKSDVFSFGIVVLEVVS 330
+ LP PES V T +SDV+S+GI + E+ S
Sbjct: 205 GN-------------------ARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFS 242
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 1e-11
Identities = 66/298 (22%), Positives = 115/298 (38%), Gaps = 58/298 (19%)
Query: 526 FGTAYQGFL------DNHQYVLVKRLGMSKCPALRTRFSNELQNLARL-RHRNLVQLCGW 578
FG + D V VK L S R +EL+ L+ L H N+V L G
Sbjct: 36 FGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGA 95
Query: 579 CTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSL------------A 626
CT G LVI +Y L + L S + +L A
Sbjct: 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVA 155
Query: 627 SAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSV 686
+ +L + IHR++ + I L ++ F LA + + + + + V
Sbjct: 156 KGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN-YVVKGNARLPV 211
Query: 687 RGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQ-----MAVDFRLPEGLLVKRVH 740
+ +M+PE I + T +DV+S+G+ + E+ + G M VD + + ++K
Sbjct: 212 K----WMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK--MIKEGF 265
Query: 741 EFEARKRPL---AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795
P AE+ Y+ +M+ C ++P RP+ +QI+ +++
Sbjct: 266 RML---SPEHAPAEM--------YD---IMK------TCWDADPLKRPTFKQIVQLIE 303
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 57/221 (25%), Positives = 101/221 (45%), Gaps = 29/221 (13%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCL-AEKGERFEKTFAAELVAVAHLRHRNLV 171
F++ LG+G G V++ G V+A K + E EL + +V
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 172 RLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYL 231
G + ++ + ++M SLD+VL + A + + K+ + L YL
Sbjct: 95 GFYGAFYSDGEISICMEHMDGGSLDQVL-------KKAGRIPEQILGKVSIAVIKGLTYL 147
Query: 232 HEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAET 291
E+ +I+HRDVK SN++++S+ +L DFG++ L S N
Sbjct: 148 REKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---------IDSMAN-------- 188
Query: 292 TRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
+ + GT Y+ PE Q G+ + +SD++S G+ ++E+ GR
Sbjct: 189 SFV-GTRSYMSPERLQ-GTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 5e-11
Identities = 51/296 (17%), Positives = 99/296 (33%), Gaps = 46/296 (15%)
Query: 526 FGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGE 584
G ++ + + K + + PA+R + ELQ L +V G GE
Sbjct: 46 GGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE 105
Query: 585 MLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRN 644
+ + ++ L +L RI IL + ++ + YL E+ ++HR+
Sbjct: 106 ISICMEHMDGGSLDQVL-KKAGRIPEQILG-----KVSIAVIKGLTYLREKHK--IMHRD 157
Query: 645 ITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEAT 704
+ S I ++ +L F ++ L S S G YMSPE ++ +
Sbjct: 158 VKPSNILVNSRGEIKLCDFGVSGQLID---------SMANSFVGTRSYMSPERLQGTHYS 208
Query: 705 SMADVYSFGVVVLEVVTGQ----------MAVDFRLPEGLLVKRVHEFEARKRPLAELVD 754
+D++S G+ ++E+ G+ + + F
Sbjct: 209 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFG 268
Query: 755 LSLNGEYNHKELMRLIKLGI------------------ACTLSNPELRPSMRQILS 792
+ EL+ I C + NP R ++Q++
Sbjct: 269 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-27
Identities = 61/220 (27%), Positives = 106/220 (48%), Gaps = 32/220 (14%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGW 176
+ LG+G FG+V+ A + T VAVK + G + F AE + L+H LV+L
Sbjct: 194 KKLGAGQFGEVWMATY-NKHTKVAVKTMKP-GSMSVEAFLAEANVMKTLQHDKLVKLHA- 250
Query: 177 CVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLE 236
V ++ + ++ ++M SL L + E + + +A + ++ ++
Sbjct: 251 VVTKEPIYIITEFMAKGSLLDFL-KSDEG----SKQPLPKLIDFSAQIAEGMAFIEQR-- 303
Query: 237 TQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGG 296
IHRD++ +N+++ + ++ DFGLAR +E +Y T R G
Sbjct: 304 -NYIHRDLRAANILVSASLVCKIADFGLARVIEDN-EY----------------TAREGA 345
Query: 297 T--IGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRR 333
I + PE+ G T KSDV+SFGI+++E+V+ GR
Sbjct: 346 KFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRI 384
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 3e-11
Identities = 58/289 (20%), Positives = 111/289 (38%), Gaps = 68/289 (23%)
Query: 526 FGTAYQGFLDNHQYVLVKRLGMSKCPAL-RTRFSNELQNLARLRHRNLVQLCGWCTEQGE 584
FG + + H V VK + K ++ F E + L+H LV+L T++
Sbjct: 201 FGEVWMATYNKHTKVAVKTM---KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPI 257
Query: 585 MLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRN 644
++ + +L L + L + +A + ++ + IHR+
Sbjct: 258 YIITEFMAKGSLLDFLKSDEGSKQPLPKL-----IDFSAQIAEGMAFIEQ---RNYIHRD 309
Query: 645 ITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEAT 704
+ ++ I + + ++ F LA + D+ + ++ + +PE I G T
Sbjct: 310 LRAANILVSASLVCKIADFGLARVI--EDNEYTAREGAKFPIK----WTAPEAINFGSFT 363
Query: 705 SMADVYSFGVVVLEVVT-GQM------------AVD--FRLPEGLLVKRVHEFEARKRPL 749
+DV+SFG++++E+VT G++ A++ +R+P RP
Sbjct: 364 IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP---------------RPE 408
Query: 750 ---AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795
EL +M C + PE RP+ I S+LD
Sbjct: 409 NCPEEL-----------YNIMM------RCWKNRPEERPTFEYIQSVLD 440
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-27
Identities = 60/238 (25%), Positives = 104/238 (43%), Gaps = 46/238 (19%)
Query: 116 DEVLGSGGFGKVYRAVL-------PSDGTVVAVKCLAEKGERFEKT-FAAELVAVAHL-R 166
+ LG G FG+V A P+ T VAVK L + + +E+ + + +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 167 HRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVL-FRRPENLEAAAPLNWEQRKKIIRG-- 223
H+N++ L G C + L ++ +Y +L L RRP LE + + +++
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 224 ------LAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMR 277
+A + YL + + IHRD+ NV++ ++ DFGLAR + H Y+
Sbjct: 194 VSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250
Query: 278 TSSARNHQFHLAETTRIGGTIGYLP-----PESFQKGSVATAKSDVFSFGIVVLEVVS 330
T+ G LP PE+ + T +SDV+SFG+++ E+ +
Sbjct: 251 TN-------------------GRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFT 288
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 66/300 (22%), Positives = 116/300 (38%), Gaps = 63/300 (21%)
Query: 526 FGTAYQGFL--------DNHQYVLVKRLGMSKCPALRTRFSNELQNLARL-RHRNLVQLC 576
FG + V VK L + +E++ + + +H+N++ L
Sbjct: 82 FGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLL 141
Query: 577 GWCTEQGEMLVIYDYS----------ATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLA 626
G CT+ G + VI +Y+ A R +N L + +A
Sbjct: 142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVA 201
Query: 627 SAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSV 686
+ YL + + IHR++ + + + D ++ F LA + D+ ++K T+G V
Sbjct: 202 RGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY-YKKTTNGRLPV 257
Query: 687 RGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLP-EGLLVKRVHEFEA 744
+ +M+PE + T +DV+SFGV++ E+ T G P G+
Sbjct: 258 K----WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS------PYPGV---------- 297
Query: 745 RKRPLAELVDLSLNGEYNHK---------ELMRLIKLGIACTLSNPELRPSMRQILSILD 795
P+ EL L G K +MR C + P RP+ +Q++ LD
Sbjct: 298 ---PVEELFKLLKEGHRMDKPSNCTNELYMMMR------DCWHAVPSQRPTFKQLVEDLD 348
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 57/237 (24%), Positives = 95/237 (40%), Gaps = 45/237 (18%)
Query: 116 DEVLGSGGFGKVYRAVLP-----SDGTVVAVKCLAEKGERFEKT-FAAELVAVAHL-RHR 168
+ LG G FG+V A + VAVK L E E +EL + H+ H
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 169 NLVRLRGWCVHEDQ-LLLVYDYMPNRSLDRVL-FRRPENLEAAAPLNWEQRKKIIRG--- 223
N+V L G C L+++ ++ +L L +R E + + +
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 224 -----LAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRT 278
+A + +L + + IHRD+ N++L + ++ DFGLAR + + Y +
Sbjct: 152 CYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 208
Query: 279 SSARNHQFHLAETTRIGGTIGYLP-----PESFQKGSVATAKSDVFSFGIVVLEVVS 330
LP PE+ V T +SDV+SFG+++ E+ S
Sbjct: 209 D-------------------ARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFS 245
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 55/299 (18%), Positives = 100/299 (33%), Gaps = 61/299 (20%)
Query: 526 FGTAYQGFLDN------HQYVLVKRLGMSKCPALRTRFSNELQNLARL-RHRNLVQLCGW 578
FG + + V VK L + +EL+ L + H N+V L G
Sbjct: 40 FGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 99
Query: 579 CTEQGE-MLVIYDY----------SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLAS 627
CT+ G ++VI ++ + R + L H +A
Sbjct: 100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAK 159
Query: 628 AILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVR 687
+ +L + IHR++ + I L ++ F LA + ++ + + ++
Sbjct: 160 GMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLK 215
Query: 688 GIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLP-EGLLVKRVHEFEAR 745
+M+PE I T +DV+SFGV++ E+ + G P G+ +
Sbjct: 216 ----WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS------PYPGVKIDE------- 258
Query: 746 KRPLAELVDLSLNGEYNHK---------ELMRLIKLGIACTLSNPELRPSMRQILSILD 795
E G + M C P RP+ +++ L
Sbjct: 259 -----EFCRRLKEGTRMRAPDYTTPEMYQTML------DCWHGEPSQRPTFSELVEHLG 306
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-27
Identities = 63/219 (28%), Positives = 96/219 (43%), Gaps = 34/219 (15%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGW 176
+ +G G FG V G VAVKC+ K + + F AE + LRH NLV+L G
Sbjct: 199 QTIGKGEFGDVMLGDY--RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGV 254
Query: 177 CVHED-QLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQL 235
V E L +V +YM SL L R + L + K + A+ YL
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGR-----SVLGGDCLLKFSLDVCEAMEYLEGN- 308
Query: 236 ETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIG 295
+HRD+ NV++ A++ DFGL + +T ++
Sbjct: 309 --NFVHRDLAARNVLVSEDNVAKVSDFGLTK-----------------EASSTQDTGKL- 348
Query: 296 GTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRR 333
+ + PE+ ++ + KSDV+SFGI++ E+ S GR
Sbjct: 349 -PVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRV 385
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 55/293 (18%), Positives = 104/293 (35%), Gaps = 80/293 (27%)
Query: 526 FGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEM 585
FG G ++ V VK + K A F E + +LRH NLVQL G E+
Sbjct: 206 FGDVMLGDYRGNK-VAVKCI---KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 261
Query: 586 LVIYDYSATRI---------LSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEW 636
L I + + +L +G L + A+ YL
Sbjct: 262 LYI-------VTEYMAKGSLVDYLRSRGRSVLGGDCL-----LKFSLDVCEAMEYLEGN- 308
Query: 637 NEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPE 696
+HR++ + + + D ++ F L + + + V+ + +PE
Sbjct: 309 --NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP------VK----WTAPE 356
Query: 697 YIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLP-EGLLVKRVHEFEARKRPLAELVD 754
+ + ++ +DV+SFG+++ E+ + G++ P + PL ++V
Sbjct: 357 ALREKKFSTKSDVWSFGILLWEIYSFGRV------PYPRI-------------PLKDVVP 397
Query: 755 LSLNGE------------YNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795
G Y ++M+ C + RP+ Q+ L+
Sbjct: 398 RVEKGYKMDAPDGCPPAVY---DVMK------NCWHLDAATRPTFLQLREQLE 441
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 3e-27
Identities = 58/214 (27%), Positives = 94/214 (43%), Gaps = 27/214 (12%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGW 176
LG G FG+V+ V A+K L G + F E + LRH LV+L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRV-AIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYA- 329
Query: 177 CVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLE 236
V E+ + +V +YM SL L + L Q + +A+ + Y+
Sbjct: 330 VVSEEPIYIVTEYMSKGSLLDFL-KGET----GKYLRLPQLVDMAAQIASGMAYVERM-- 382
Query: 237 TQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGG 296
+HRD++ +N+++ ++ DFGLAR +E +Y R + +
Sbjct: 383 -NYVHRDLRAANILVGENLVCKVADFGLARLIEDN-EYTAR------------QGAKF-- 426
Query: 297 TIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS 330
I + PE+ G T KSDV+SFGI++ E+ +
Sbjct: 427 PIKWTAPEAALYG-RFTIKSDVWSFGILLTELTT 459
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 3e-11
Identities = 55/273 (20%), Positives = 103/273 (37%), Gaps = 36/273 (13%)
Query: 526 FGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEM 585
FG + G + V +K L F E Q + +LRH LVQL +E+
Sbjct: 280 FGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIY 337
Query: 586 LVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNI 645
+V S +L L + L ++ +AS + Y+ +HR++
Sbjct: 338 IVTEYMSKGSLLDFLKGETGKYLRLPQL-----VDMAAQIASGMAYVERM---NYVHRDL 389
Query: 646 TSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATS 705
++ I + ++ ++ F LA + N++ R+ ++ + +PE G T
Sbjct: 390 RAANILVGENLVCKVADFGLARLIEDNEYTARQ--GAKFPIK----WTAPEAALYGRFTI 443
Query: 706 MADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPL---AELVDLSLNGEYN 762
+DV+SFG+++ E+ T + ++ +V P L
Sbjct: 444 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL---------- 493
Query: 763 HKELMRLIKLGIACTLSNPELRPSMRQILSILD 795
+LM C PE RP+ + + L+
Sbjct: 494 -HDLMC------QCWRKEPEERPTFEYLQAFLE 519
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 51/231 (22%), Positives = 95/231 (41%), Gaps = 32/231 (13%)
Query: 108 IGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCL-AEKGERFEKTFAAEL-VAVAHL 165
N + +GSG G+V++ G V+AVK + + K +L V +
Sbjct: 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSH 81
Query: 166 RHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLA 225
+V+ G + + + + M +++ R P+ K+ +
Sbjct: 82 DCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQG------PIPERILGKMTVAIV 134
Query: 226 AALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQ 285
AL+YL E+ +IHRDVK SN++LD + +L DFG++ ++ A++
Sbjct: 135 KALYYLKEKH--GVIHRDVKPSNILLDERGQIKLCDFGISG--------RLVDDKAKD-- 182
Query: 286 FHLAETTRIGGTIGYLPPESFQ----KGSVATAKSDVFSFGIVVLEVVSGR 332
G Y+ PE ++DV+S GI ++E+ +G+
Sbjct: 183 ------RSA-GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 44/205 (21%), Positives = 75/205 (36%), Gaps = 23/205 (11%)
Query: 526 FGTAYQGF-LDNHQYVLVKRLGMSKCPALRTRFSNELQNLARL-RHRNLVQLCGWCTEQG 583
G ++ + VK++ S R +L + + +VQ G
Sbjct: 38 CGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT 97
Query: 584 EMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHR 643
++ + + T L I IL + ++ A+ YL E+ VIHR
Sbjct: 98 DVFIAMELMGTCAEK-LKKRMQGPIPERILG-----KMTVAIVKALYYLKEKHG--VIHR 149
Query: 644 NITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEA 703
++ S I LD +L F ++ L G YM+PE I+ +
Sbjct: 150 DVKPSNILLDERGQIKLCDFGISGRLV--------DDKAKDRSAGCAAYMAPERIDPPDP 201
Query: 704 -----TSMADVYSFGVVVLEVVTGQ 723
ADV+S G+ ++E+ TGQ
Sbjct: 202 TKPDYDIRADVWSLGISLVELATGQ 226
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-27
Identities = 52/269 (19%), Positives = 91/269 (33%), Gaps = 62/269 (23%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLA-EKGERFEKTFAAELVAVAHLRHRNLV 171
F+ + +G GGFG V+ A D A+K + E + E+ A+A L H +V
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 172 RLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRK------------- 218
R + + D + + + R+
Sbjct: 68 RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127
Query: 219 ----------------------------------------KIIRGLAAALHYLHEQLETQ 238
I +A A+ +LH +
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK---G 184
Query: 239 IIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTI 298
++HRD+K SN+ ++GDFGL ++ + + Q + + H T GT
Sbjct: 185 LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATH----TGQVGTK 240
Query: 299 GYLPPESFQKGSVATAKSDVFSFGIVVLE 327
Y+ PE G+ + K D+FS G+++ E
Sbjct: 241 LYMSPEQIH-GNNYSHKVDIFSLGLILFE 268
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 79.2 bits (195), Expect = 6e-16
Identities = 49/327 (14%), Positives = 103/327 (31%), Gaps = 82/327 (25%)
Query: 526 FGTAYQG--FLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLV---------- 573
FG ++ +D+ Y +KR+ + R + E++ LA+L H +V
Sbjct: 19 FGVVFEAKNKVDDCNYA-IKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETP 77
Query: 574 -----------QLCGWCTEQGEMLVIYDYSATRILSHLLFHNNHRI-------------- 608
L T+ + + + + +
Sbjct: 78 PEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLY 137
Query: 609 -------GHSILQWHHRYN------------IIKSLASAILYLHEEWNEQVIHRNITSSA 649
++ W +R I +A A+ +LH ++ ++HR++ S
Sbjct: 138 IQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSN 194
Query: 650 ITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFG-----YMSPEYIESGEAT 704
I D ++G F L + +++ T YMSPE I +
Sbjct: 195 IFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYS 254
Query: 705 SMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHK 764
D++S G+++ E++ R+ ++ V R L +
Sbjct: 255 HKVDIFSLGLILFELLYSFSTQMERV---RIITDV-----RNLKFPLLFTQK------YP 300
Query: 765 ELMRLIKLGIACTLSNPELRPSMRQIL 791
+ +++ +P RP I+
Sbjct: 301 QEHMMVQD---MLSPSPTERPEATDII 324
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 5e-27
Identities = 50/234 (21%), Positives = 93/234 (39%), Gaps = 41/234 (17%)
Query: 118 VLGSGGFGKVYRAVLPSDGTVVAVKCL----AEKGERFEKTFAAELVAVA---------- 163
L G F K+ D A+K EK F K+ ++ +
Sbjct: 38 TLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQ 95
Query: 164 ---HLRHRNLVRLRGWCVHEDQLLLVYDYMPNRSL-DRVLFRRPENLEAAAPLNWEQRKK 219
+++ + G + D++ ++Y+YM N S+ + + + + K
Sbjct: 96 IITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKC 155
Query: 220 IIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTS 279
II+ + + Y+H + I HRDVK SN+++D +L DFG + ++ + ++ S
Sbjct: 156 IIKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK---IKGS 210
Query: 280 SARNHQFHLAETTRIGGTIGYLPPESFQ-KGSVATAKSDVFSFGIVVLEVVSGR 332
GT ++PPE F + S AK D++S GI + +
Sbjct: 211 R---------------GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 48/280 (17%), Positives = 94/280 (33%), Gaps = 45/280 (16%)
Query: 534 LDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSA 593
L+ + + F NELQ + +++ + G T E+ +IY+Y
Sbjct: 67 LEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEY-M 125
Query: 594 TR--ILSHLLFHNNHRIGHSILQWHHRY-NIIKSLASAILYLHEEWNEQVIHRNITSSAI 650
IL + ++ IIKS+ ++ Y+H E N + HR++ S I
Sbjct: 126 ENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNI 183
Query: 651 TLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATS--MAD 708
+D + +L F +E++ K S RG + +M PE+ + + + D
Sbjct: 184 LMDKNGRVKLSDFGESEYMV---DKKIK-GS-----RGTYEFMPPEFFSNESSYNGAKVD 234
Query: 709 VYSFGVVVLEVVTGQ----------------MAVDFRLPEGLLVKRVHEFEARKRPLAEL 752
++S G+ + + + P +
Sbjct: 235 IWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTC---- 290
Query: 753 VDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792
+ + E + +KL + NP R + L
Sbjct: 291 -----SNNFLSNEDIDFLKLFLR---KNPAERITSEDALK 322
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 60/260 (23%), Positives = 97/260 (37%), Gaps = 21/260 (8%)
Query: 84 MEGVQMSEKVGGDNPRIFSYAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKC 143
M G G + F + +G VL GGF VY A G A+K
Sbjct: 1 MAGPGSLGGASGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKR 60
Query: 144 LAEKGERFEKTFAAELVAVAHLR-HRNLVRLRGWCVHEDQ--------LLLVYDYMPNRS 194
L E + E+ + L H N+V+ + LL+ + +
Sbjct: 61 LLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQL 120
Query: 195 LDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQ 254
++ + PL+ + KI A+ ++H Q + IIHRD+K N++L +Q
Sbjct: 121 VEFLKKMESRG-----PLSCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQ 174
Query: 255 YNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPE--SFQKGSVA 312
+L DFG A + H Y + SA+ E TR T Y PE
Sbjct: 175 GTIKLCDFGSATTISHYPDY---SWSAQRRALVEEEITRN-TTPMYRTPEIIDLYSNFPI 230
Query: 313 TAKSDVFSFGIVVLEVVSGR 332
K D+++ G ++ + +
Sbjct: 231 GEKQDIWALGCILYLLCFRQ 250
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 55/295 (18%), Positives = 97/295 (32%), Gaps = 58/295 (19%)
Query: 526 FGTAY--QGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLR-HRNLVQLCGWC--- 579
F Y Q +Y L KRL ++ R E+ + +L H N+VQ C
Sbjct: 41 FAFVYEAQDVGSGREYAL-KRLLSNEEEKNR-AIIQEVCFMKKLSGHPNIVQFCSAASIG 98
Query: 580 -----TEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHE 634
T Q E L++ + +++ L L I A+ ++H
Sbjct: 99 KEESDTGQAEFLLLTELCKGQLVEFL----KKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 635 EWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGN-----RSVRGI 689
+ +IHR++ + L +L F A ++ A +
Sbjct: 155 Q-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 690 FGYMSPEYIES---GEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARK 746
Y +PE I+ D+++ G ++ + Q F E R+
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP--F---EDGAKLRI------- 261
Query: 747 RPLAELVDLSLNGEYNH-------KELMRLIKLGIACTLSNPELRPSMRQILSIL 794
+NG+Y+ LI+ A NPE R S+ +++ L
Sbjct: 262 ----------VNGKYSIPPHDTQYTVFHSLIR---AMLQVNPEERLSIAEVVHQL 303
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-26
Identities = 46/232 (19%), Positives = 83/232 (35%), Gaps = 35/232 (15%)
Query: 108 IGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHL-R 166
+G F +VLG G G + + D VAVK + + E+ +
Sbjct: 21 VGKISFCPKDVLGHGAEGTIVYRGM-FDNRDVAVKRILPE---CFSFADREVQLLRESDE 76
Query: 167 HRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAA 226
H N++R + + + V + +L +++ +
Sbjct: 77 HPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEP-------ITLLQQTTS 129
Query: 227 ALHYLHEQLETQIIHRDVKTSNVML-----DSQYNARLGDFGLARWLEHELQYQMRTSSA 281
L +LH I+HRD+K N+++ + A + DFGL + L
Sbjct: 130 GLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA------------ 174
Query: 282 RNHQFHLAETTRIGGTIGYLPPESFQKGSVA--TAKSDVFSFGIVVLEVVSG 331
+ + + + GT G++ PE + T D+FS G V V+S
Sbjct: 175 -VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 51/285 (17%), Positives = 94/285 (32%), Gaps = 56/285 (19%)
Query: 526 FGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARL-RHRNLVQLCGWCTEQGE 584
GT + +++ V VKR+ E+Q L H N+++ +CTE+
Sbjct: 37 EGTIVYRGMFDNRDVAVKRILPECFSFAD----REVQLLRESDEHPNVIRY--FCTEKDR 90
Query: 585 MLVIYDYSAT---------RILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEE 635
Y A + H +++ S + +LH
Sbjct: 91 QFQ---YIAIELCAATLQEYVEQKDFAHLGLEP----------ITLLQQTTSGLAHLHSL 137
Query: 636 WNEQVIHR-----NITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIF 690
++HR NI S + + F L + L H + S V G
Sbjct: 138 ---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH----SFSRRSGVPGTE 190
Query: 691 GYMSPEYIES---GEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKR 747
G+++PE + T D++S G V V++ P G ++R
Sbjct: 191 GWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE-----GSHPFGKSLQRQ-ANILLGA 244
Query: 748 PLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792
+ + + + +EL+ +P+ RPS + +L
Sbjct: 245 CSLDCLHPEKHEDVIARELIE------KMIAMDPQKRPSAKHVLK 283
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-26
Identities = 66/243 (27%), Positives = 101/243 (41%), Gaps = 51/243 (20%)
Query: 116 DEVLGSGGFGKVYRAVL-----PSDGTVVAVKCLAEKGERFEKT-FAAELVAVAHL-RHR 168
+VLGSG FGKV A VAVK L EK + E+ +EL + L H
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 169 NLVRLRGWCVHEDQLLLVYDYMPNRSLDRVL-FRRPENLEAAAPLNWEQRKKIIRGL--- 224
N+V L G C + L+++Y L L +R + E ++R + L
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 225 ------------AAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHEL 272
A + +L + +HRD+ NV++ ++ DFGLAR + +
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226
Query: 273 QYQMRTSSARNHQFHLAETTRIGGTIGYLP-----PESFQKGSVATAKSDVFSFGIVVLE 327
Y +R + LP PES +G + T KSDV+S+GI++ E
Sbjct: 227 NYVVRGN-------------------ARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWE 266
Query: 328 VVS 330
+ S
Sbjct: 267 IFS 269
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 55/302 (18%), Positives = 109/302 (36%), Gaps = 61/302 (20%)
Query: 526 FGTAYQGFL------DNHQYVLVKRLGMSKCPALRTRFSNELQNLARL-RHRNLVQLCGW 578
FG V VK L + R +EL+ + +L H N+V L G
Sbjct: 58 FGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGA 117
Query: 579 CTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHE--EW 636
CT G + +I++Y L + L + +++ ++ + + +L + +
Sbjct: 118 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCF 177
Query: 637 NEQV------------IHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNR 684
QV +HR++ + + + ++ F LA + + + + +
Sbjct: 178 AYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN-YVVRGNARL 236
Query: 685 SVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLP-EGLLVKRVHEF 742
V+ +M+PE + G T +DV+S+G+++ E+ + G P G+ V
Sbjct: 237 PVK----WMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN------PYPGIPVDA---- 282
Query: 743 EARKRPLAELVDLSLNGEYNHK---------ELMRLIKLGIACTLSNPELRPSMRQILSI 793
L NG + +M+ +C + RPS + S
Sbjct: 283 --------NFYKLIQNGFKMDQPFYATEEIYIIMQ------SCWAFDSRKRPSFPNLTSF 328
Query: 794 LD 795
L
Sbjct: 329 LG 330
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 35/220 (15%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVKCLAEK---GERFEKTFAAELVAVAHLRHRNLVRLRG 175
LG G F VYRA G VA+K + +K + E+ L+H +++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 176 WCVHEDQLLLVYDYMPNRSLDRVLFRRPENL---EAAAPLNWEQRKKIIRGLAAALHYLH 232
+ + + LV + N ++R L R + EA + + + YLH
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR---------HFMHQIITGMLYLH 129
Query: 233 EQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETT 292
I+HRD+ SN++L N ++ DFGLA L+ T
Sbjct: 130 SH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP--------------HEKHYT- 171
Query: 293 RIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
+ GT Y+ PE S +SDV+S G + ++ GR
Sbjct: 172 -LCGTPNYISPEIAT-RSAHGLESDVWSLGCMFYTLLIGR 209
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 57.9 bits (141), Expect = 3e-09
Identities = 50/284 (17%), Positives = 94/284 (33%), Gaps = 90/284 (31%)
Query: 553 LRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATR-----ILSHL----LFH 603
+ R NE++ +L+H ++++L Y+Y +L +
Sbjct: 54 MVQRVQNEVKIHCQLKHPSILEL-------------YNYFEDSNYVYLVLEMCHNGEMNR 100
Query: 604 NNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSF 663
+ R+ + + + +LYLH ++HR++T S + L +MN ++ F
Sbjct: 101 YLKNRVKPFSENEARH-FMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADF 156
Query: 664 ALAEFLTRNDHGHRKATS-G--NRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVV 720
LA L + T G N Y+SPE +DV+S G + ++
Sbjct: 157 GLATQLKMP--HEKHYTLCGTPN--------YISPEIATRSAHGLESDVWSLGCMFYTLL 206
Query: 721 TGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLG---IACT 777
G R P F+ K + + L +
Sbjct: 207 IG------RPP----------FDTD----------------TVKNTLNKVVLADYEMPSF 234
Query: 778 LS-------------NPELRPSMRQILS---ILDGNDKRFMEDG 805
LS NP R S+ +L + + + ++G
Sbjct: 235 LSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSSTKSKDEG 278
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 30/253 (11%), Positives = 61/253 (24%), Gaps = 51/253 (20%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCL---AEKGERFEKTFAAELVAVAHLR--- 166
VLG A G V K E++ + LR
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 167 ----------------------HRNLVRLRGWCVHEDQLLLVYDYM-PNRSLDRVLFRRP 203
+ ++R+R L + Y +L
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 204 ENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFG 263
+ L R ++ + L LH ++H ++ +++LD + L F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFE 256
Query: 264 LARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQ----KGSVATAKSDVF 319
R+ ++ R ++ T D +
Sbjct: 257 HLV---------------RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTW 301
Query: 320 SFGIVVLEVVSGR 332
+ G+ + +
Sbjct: 302 TLGLAIYWIWCAD 314
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 30/270 (11%), Positives = 67/270 (24%), Gaps = 49/270 (18%)
Query: 537 HQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQG-----EMLVIYDY 591
+ + ++ L K + ++ ++ ++ +Y
Sbjct: 127 EEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPR 186
Query: 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAIT 651
+ + + +H H L H R + + + LH ++H + I
Sbjct: 187 MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIV 243
Query: 652 LDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYI----------ESG 701
LD L F G + R G+ PE
Sbjct: 244 LDQRGGVFLTGFEHLVRD-----GASAVSPIGR------GFAPPETTAERMLPFGQHHPT 292
Query: 702 EATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEY 761
T D ++ G+ + + + G + +P+ L+
Sbjct: 293 LMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSCKNIPQPVRALL-------- 344
Query: 762 NHKELMRLIKLGIACTLSNPELRPSMRQIL 791
++ E R Q +
Sbjct: 345 -----EGFLRY-------PKEDRLLPLQAM 362
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 59/223 (26%), Positives = 101/223 (45%), Gaps = 32/223 (14%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK---GERFEKTFAAELVAVAHLRHRN 169
F+ LG G FG VY A ++A+K L + E E+ +HLRH N
Sbjct: 11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 170 LVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALH 229
++RL G+ ++ L+ +Y P ++ +R L+ + + ++ I LA AL
Sbjct: 71 ILRLYGYFHDATRVYLILEYAPLGTV----YRE---LQKLSKFDEQRTATYITELANALS 123
Query: 230 YLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLA 289
Y H + ++IHRD+K N++L S ++ DFG + + +
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDL------------- 167
Query: 290 ETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
GT+ YLPPE + G + K D++S G++ E + G+
Sbjct: 168 -----CGTLDYLPPEMIE-GRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 4e-07
Identities = 50/238 (21%), Positives = 84/238 (35%), Gaps = 44/238 (18%)
Query: 559 NELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHR 618
E++ + LRH N+++L G+ + + +I +Y+ + L +
Sbjct: 58 REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK------FDEQRT 111
Query: 619 YNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRK 678
I LA+A+ Y H + +VIHR+I + L ++ F + R
Sbjct: 112 ATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRT 165
Query: 679 ATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKR 738
G Y+ PE IE D++S GV+ E + G + P
Sbjct: 166 DLCGTLD------YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG------KPP------- 206
Query: 739 VHEFEARKRPLAELVDLSLNGEYN-----HKELMRLIKLGIACTLSNPELRPSMRQIL 791
FEA E E+ + LI NP RP +R++L
Sbjct: 207 ---FEANTYQ--ETYKRISRVEFTFPDFVTEGARDLIS---RLLKHNPSQRPMLREVL 256
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 53/222 (23%), Positives = 90/222 (40%), Gaps = 36/222 (16%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK---GERFEKTFAAELVAVAHLRHRNLVRL 173
LG GGF K + V A K + + + + E+ L H+++V
Sbjct: 47 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106
Query: 174 RGWCVHEDQLLLVYDYMPNRSLDRVLFRR---PENLEAAAPLNWEQRKKIIRGLAAALHY 230
G+ D + +V + RSL + RR E EA +R + Y
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEP-EAR---------YYLRQIVLGCQY 156
Query: 231 LHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAE 290
LH ++IHRD+K N+ L+ ++GDFGLA +E++ +
Sbjct: 157 LHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD------------GERK--- 198
Query: 291 TTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
+ GT Y+ PE K + + DV+S G ++ ++ G+
Sbjct: 199 KV-LCGTPNYIAPEVLSKKG-HSFEVDVWSIGCIMYTLLVGK 238
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 47/263 (17%), Positives = 90/263 (34%), Gaps = 78/263 (29%)
Query: 553 LRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATR-----ILSHL----LFH 603
R + S E+ L H+++V + + +L L
Sbjct: 84 QREKMSMEISIHRSLAHQHVVGF-------------HGFFEDNDFVFVVLELCRRRSLLE 130
Query: 604 NNHRIGHSILQWHHRYN------IIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMN 657
+ + ++ + YLH +VIHR++ + L+ D+
Sbjct: 131 --------LHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLE 179
Query: 658 PRLGSFALAEFLTRNDHGHRKATS-G--NRSVRGIFGYMSPEYIESGEATSMADVYSFGV 714
++G F LA + + G RK G N Y++PE + + DV+S G
Sbjct: 180 VKIGDFGLATKVEYD--GERKKVLCGTPN--------YIAPEVLSKKGHSFEVDVWSIGC 229
Query: 715 VVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYN-----HKELMRL 769
++ ++ G + P FE L E EY+ + L
Sbjct: 230 IMYTLLVG------KPP----------FET--SCLKETYLRIKKNEYSIPKHINPVAASL 271
Query: 770 IKLGIACTLSNPELRPSMRQILS 792
I+ ++P RP++ ++L+
Sbjct: 272 IQ---KMLQTDPTARPTINELLN 291
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 5e-25
Identities = 52/219 (23%), Positives = 90/219 (41%), Gaps = 30/219 (13%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAE---KGERFEKTFAAELVAVAHLRHRNLVRL 173
LG GGF K + V A K + + + + E+ L H+++V
Sbjct: 21 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80
Query: 174 RGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHE 233
G+ D + +V + RSL + RR E A + +R + YLH
Sbjct: 81 HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEA-------RYYLRQIVLGCQYLHR 133
Query: 234 QLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTR 293
++IHRD+K N+ L+ ++GDFGLA +E++ +
Sbjct: 134 N---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD------------GERK---KV- 174
Query: 294 IGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
+ GT Y+ PE K + + DV+S G ++ ++ G+
Sbjct: 175 LCGTPNYIAPEVLSKKG-HSFEVDVWSIGCIMYTLLVGK 212
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 58.7 bits (143), Expect = 2e-09
Identities = 47/263 (17%), Positives = 90/263 (34%), Gaps = 78/263 (29%)
Query: 553 LRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATR-----ILSHL----LFH 603
R + S E+ L H+++V + + +L L
Sbjct: 58 QREKMSMEISIHRSLAHQHVVGF-------------HGFFEDNDFVFVVLELCRRRSLLE 104
Query: 604 NNHRIGHSILQWHHRYN------IIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMN 657
+ + ++ + YLH +VIHR++ + L+ D+
Sbjct: 105 --------LHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLE 153
Query: 658 PRLGSFALAEFLTRNDHGHRKATS-G--NRSVRGIFGYMSPEYIESGEATSMADVYSFGV 714
++G F LA + + G RK G N Y++PE + + DV+S G
Sbjct: 154 VKIGDFGLATKVEYD--GERKKVLCGTPN--------YIAPEVLSKKGHSFEVDVWSIGC 203
Query: 715 VVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYN-----HKELMRL 769
++ ++ G + P FE L E EY+ + L
Sbjct: 204 IMYTLLVG------KPP----------FET--SCLKETYLRIKKNEYSIPKHINPVAASL 245
Query: 770 IKLGIACTLSNPELRPSMRQILS 792
I+ ++P RP++ ++L+
Sbjct: 246 IQ---KMLQTDPTARPTINELLN 265
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 57/220 (25%), Positives = 102/220 (46%), Gaps = 29/220 (13%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLA-EKGERFEKTFAAELVAVAHLRHRNLV 171
F + E +G G FG+V++ + VVA+K + E+ E + E+ ++ +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 172 RLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYL 231
+ G + + +L ++ +Y+ S +L PL+ Q I+R + L YL
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLL--------EPGPLDETQIATILREILKGLDYL 135
Query: 232 HEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAET 291
H + + IHRD+K +NV+L +L DFG+A L T RN
Sbjct: 136 HSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD-------TQIKRN-------- 177
Query: 292 TRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSG 331
T + GT ++ PE ++ + +K+D++S GI +E+ G
Sbjct: 178 TFV-GTPFWMAPEVIKQSAY-DSKADIWSLGITAIELARG 215
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 58/287 (20%), Positives = 113/287 (39%), Gaps = 52/287 (18%)
Query: 496 MVETPREISFKEIISATNN----FSESQRVAEMDFGTAYQGF-LDNHQYVLVKRLGMSKC 550
M +P + + + + F++ +++ + FG ++G + V +K + + +
Sbjct: 1 MAHSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA 60
Query: 551 PALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY----SATRILSHLLFHNNH 606
E+ L++ + + G + ++ +I +Y SA +L
Sbjct: 61 EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQ 120
Query: 607 RIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALA 666
I I++ + + YLH +E+ IHR+I ++ + L +L F +A
Sbjct: 121 -IAT----------ILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVA 166
Query: 667 EFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQ--- 723
LT ++ T G +M+PE I+ S AD++S G+ +E+ G+
Sbjct: 167 GQLTDT--QIKRNT-----FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPH 219
Query: 724 -----MAVDFRLP-------EGLLVKRVHEF-------EARKRPLAE 751
M V F +P EG K + EF E RP A+
Sbjct: 220 SELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAK 266
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 58/224 (25%), Positives = 104/224 (46%), Gaps = 31/224 (13%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLA-EKGERFEKTFAAELVAVAHLRHRNLV 171
++ LG G FGKVY+A G + A K + + E E + E+ +A H +V
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELE-DYIVEIEILATCDHPYIV 79
Query: 172 RLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYL 231
+L G H+ +L ++ ++ P ++D ++ L Q + + R + AL++L
Sbjct: 80 KLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDR------GLTEPQIQVVCRQMLEALNFL 133
Query: 232 HEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAET 291
H + +IIHRD+K NV++ + + RL DFG++ T R+
Sbjct: 134 HSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK-------TLQKRD-------- 175
Query: 292 TRIGGTIGYLPPE----SFQKGSVATAKSDVFSFGIVVLEVVSG 331
+ I GT ++ PE K + K+D++S GI ++E+
Sbjct: 176 SFI-GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 37/233 (15%), Positives = 88/233 (37%), Gaps = 35/233 (15%)
Query: 505 FKEIISATN---NFSESQRVAEMDFGTAYQGF-LDNHQYVLVKRLGMSKCPALRTRFSNE 560
++ + + + + + FG Y+ + K + L + E
Sbjct: 8 YEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED-YIVE 66
Query: 561 LQNLARLRHRNLVQLCGWCTEQGEMLVIYDY----SATRILSHLLFHNNHRIGHSILQWH 616
++ LA H +V+L G G++ ++ ++ + I+ L L
Sbjct: 67 IEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLEL---------DRGLTEP 117
Query: 617 HRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGH 676
+ + + A+ +LH ++++IHR++ + + + + + RL F ++
Sbjct: 118 QIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL------ 168
Query: 677 RKATSGNR-SVRGIFGYMSPEYIESGEAT-----SMADVYSFGVVVLEVVTGQ 723
T R S G +M+PE + AD++S G+ ++E+ +
Sbjct: 169 --KTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-25
Identities = 48/230 (20%), Positives = 103/230 (44%), Gaps = 41/230 (17%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKC--LAEKGERFEKTFAAELVAVAHLRHRNL--VR 172
+ +GSGG KV++ + + A+K L E + ++ E+ + L+ + +R
Sbjct: 34 KQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 92
Query: 173 LRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLH 232
L + + + + +V + N L+ L ++ ++ +RK + + A+H +H
Sbjct: 93 LYDYEITDQYIYMVMECG-NIDLNSWLKKK-------KSIDPWERKSYWKNMLEAVHTIH 144
Query: 233 EQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETT 292
+ I+H D+K +N ++ +L DFG+A ++ + ++ S
Sbjct: 145 QH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV----------- 189
Query: 293 RIGGTIGYLPPESFQKGSVA----------TAKSDVFSFGIVVLEVVSGR 332
GT+ Y+PPE+ + S + + KSDV+S G ++ + G+
Sbjct: 190 ---GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 43/288 (14%), Positives = 105/288 (36%), Gaps = 57/288 (19%)
Query: 526 FGTAYQGFLDNHQYVLVKRLGMSKC-PALRTRFSNELQNLARLRHRNL--VQLCGWCTEQ 582
+Q + Q +K + + + + NE+ L +L+ + ++L +
Sbjct: 41 SSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 100
Query: 583 GEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIH 642
+ ++ + L+ L I + + K++ A+ +H+ ++H
Sbjct: 101 QYIYMVMECGNID-LNSWL-KKKKSIDPWERK-----SYWKNMLEAVHTIHQH---GIVH 150
Query: 643 RNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGE 702
++ + + D +L F +A + + K S G YM PE I+
Sbjct: 151 SDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVK-----DSQVGTVNYMPPEAIKDMS 204
Query: 703 ATSM-----------ADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAE 751
++ +DV+S G ++ + G + P F+ +++
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYG------KTP----------FQQIINQISK 248
Query: 752 LVDLSLNGEYN-------HKELMRLIKLGIACTLSNPELRPSMRQILS 792
L + ++ + K+L ++K C +P+ R S+ ++L+
Sbjct: 249 LHAI-IDPNHEIEFPDIPEKDLQDVLK---CCLKRDPKQRISIPELLA 292
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-24
Identities = 72/374 (19%), Positives = 127/374 (33%), Gaps = 58/374 (15%)
Query: 108 IGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLA-EKGERFEKTFAAELVAVAHLR 166
++ + ++LG G V+R G + A+K R E + L
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 167 HRNLVRLRGWCVHED----QLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIR 222
H+N+V+L + E+ +L+ ++ P S L+ E A L + ++R
Sbjct: 66 HKNIVKLF--AIEEETTTRHKVLIMEFCPCGS----LYTVLEEPSNAYGLPESEFLIVLR 119
Query: 223 GLAAALHYLHEQLETQIIHRDVKTSNVML----DSQYNARLGDFGLARWLEHELQYQMRT 278
+ +++L E I+HR++K N+M D Q +L DFG AR LE Q +
Sbjct: 120 DVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED--DEQFVS 174
Query: 279 SSARNHQFHLAETTRIGGTIGYLPPESFQKGSVA-------TAKSDVFSFGIVVLEVVSG 331
GT YL P+ +++ + A D++S G+ +G
Sbjct: 175 LY---------------GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219
Query: 332 RRA-VDLTYPDDQIILLDWIRRL--SDEGKVLQAGDNRLSDGSYKLCDMEHLTHLA---- 384
P ++ I S +Q +N D S + L+
Sbjct: 220 SLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLL 279
Query: 385 ------LLCTLHNPHLRPSMKWVIEAVSGSYSGKLPALPSFQSHPLYISLSSPTNTSTSN 438
+L + S + + S Q + NT+T
Sbjct: 280 TPVLANILEA--DQEKCWGFDQFFAETSDILHRMVIHVFSLQQMTAHKIYIHSYNTATIF 337
Query: 439 TET-TRSTNTTASN 451
E + T +SN
Sbjct: 338 HELVYKQTKIISSN 351
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 8e-05
Identities = 44/308 (14%), Positives = 86/308 (27%), Gaps = 62/308 (20%)
Query: 526 FGTAYQGF-LDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGE 584
++G +K E + L +L H+N+V+L
Sbjct: 22 TANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA------- 74
Query: 585 MLVIYDYSATRI-----------LSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLH 633
+ + + L +L ++ G L +++ + + +L
Sbjct: 75 --IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG---LPESEFLIVLRDVVGGMNHLR 129
Query: 634 EEWNEQVIHR-----NITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRG 688
E ++HR NI I D +L F A L ++ S+ G
Sbjct: 130 E---NGIVHRNIKPGNIMRV-IGEDGQSVYKLTDFGAARELEDDEQFV--------SLYG 177
Query: 689 IFGYMSPEYIESGEATSM--------ADVYSFGVVVLEVVTG------------QMAVDF 728
Y+ P+ E D++S GV TG V +
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237
Query: 729 RLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLS-NPELRPSM 787
++ G + + + + + L L+ +A L + E
Sbjct: 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF 297
Query: 788 RQILSILD 795
Q +
Sbjct: 298 DQFFAETS 305
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 55/279 (19%), Positives = 117/279 (41%), Gaps = 43/279 (15%)
Query: 70 HNTPRKEHSGLFHDMEGVQMSEKVGGDNPRIFSYAELYIGSNG--FDEDEVLGSGGFGKV 127
+ KE + + + + + D+ + S A I G + + +GSGG KV
Sbjct: 13 RGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKV 72
Query: 128 YRAVLPSDGTVVAVKC--LAEKGERFEKTFAAELVAVAHLRHRNL--VRLRGWCVHEDQL 183
++ L + A+K L E + ++ E+ + L+ + +RL + + + +
Sbjct: 73 FQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 131
Query: 184 LLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRD 243
+V + N L+ L ++ ++ +RK + + A+H +H+ I+H D
Sbjct: 132 YMVMEC-GNIDLNSWLKKK-------KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSD 180
Query: 244 VKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPP 303
+K +N ++ +L DFG+A ++ + ++ S G + Y+PP
Sbjct: 181 LKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV--------------GAVNYMPP 225
Query: 304 ESFQ----------KGSVATAKSDVFSFGIVVLEVVSGR 332
E+ + S + KSDV+S G ++ + G+
Sbjct: 226 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 8e-11
Identities = 42/287 (14%), Positives = 103/287 (35%), Gaps = 55/287 (19%)
Query: 526 FGTAYQGFLDNHQYVLVKRLGMSKC-PALRTRFSNELQNLARLRHRNL--VQLCGWCTEQ 582
+Q + Q +K + + + + NE+ L +L+ + ++L +
Sbjct: 69 SSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 128
Query: 583 GEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIH 642
+ ++ + + S L I + + K++ A+ +H+ ++H
Sbjct: 129 QYIYMVMECGNIDLNSWL--KKKKSIDPWERK-----SYWKNMLEAVHTIHQH---GIVH 178
Query: 643 RNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGE 702
++ + + D +L F +A + + K + G YM PE I+
Sbjct: 179 SDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDS-----QVGAVNYMPPEAIKDMS 232
Query: 703 ATSM-----------ADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAE 751
++ +DV+S G ++ + G + P F+ +++
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYG------KTP----------FQQIINQISK 276
Query: 752 LVDLSLNG------EYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792
L + + K+L ++K C +P+ R S+ ++L+
Sbjct: 277 LHAIIDPNHEIEFPDIPEKDLQDVLK---CCLKRDPKQRISIPELLA 320
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 49/230 (21%), Positives = 103/230 (44%), Gaps = 41/230 (17%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKC--LAEKGERFEKTFAAELVAVAHLRHRNL--VR 172
+ +GSGG KV++ L + A+K L E + ++ E+ + L+ + +R
Sbjct: 15 KQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 73
Query: 173 LRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLH 232
L + + + + +V + N L+ L ++ ++ +RK + + A+H +H
Sbjct: 74 LYDYEITDQYIYMVMEC-GNIDLNSWLKKK-------KSIDPWERKSYWKNMLEAVHTIH 125
Query: 233 EQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETT 292
+ I+H D+K +N ++ +L DFG+A ++ + ++ S
Sbjct: 126 QH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV----------- 170
Query: 293 RIGGTIGYLPPESFQKGSVA----------TAKSDVFSFGIVVLEVVSGR 332
GT+ Y+PPE+ + S + + KSDV+S G ++ + G+
Sbjct: 171 ---GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 41/294 (13%), Positives = 105/294 (35%), Gaps = 69/294 (23%)
Query: 526 FGTAYQGFLDNHQYVLVKRLGMSKC-PALRTRFSNELQNLARLRHRNL--VQLCGWCTEQ 582
+Q + Q +K + + + + NE+ L +L+ + ++L +
Sbjct: 22 SSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 81
Query: 583 GEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYN------IIKSLASAILYLHEEW 636
+ ++ + + +S L+ + K++ A+ +H+
Sbjct: 82 QYIYMVMECGNIDL-------------NSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH- 127
Query: 637 NEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPE 696
++H ++ + + D +L F +A + + K + G YM PE
Sbjct: 128 --GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDS-----QVGTVNYMPPE 179
Query: 697 YIESGEATSM-----------ADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEAR 745
I+ ++ +DV+S G ++ + G + P F+
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG------KTP----------FQQI 223
Query: 746 KRPLAELVDLSLNGEYN-------HKELMRLIKLGIACTLSNPELRPSMRQILS 792
+++L + ++ + K+L ++K C +P+ R S+ ++L+
Sbjct: 224 INQISKLHAI-IDPNHEIEFPDIPEKDLQDVLK---CCLKRDPKQRISIPELLA 273
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 105 bits (262), Expect = 2e-24
Identities = 33/255 (12%), Positives = 64/255 (25%), Gaps = 62/255 (24%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCL---AEKGERFEKTFAAELVAVAHLR------- 166
VLG A G V K E++ + LR
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 167 ------------------HRNLVRLRGWCVHEDQLLLVYDYM-PNRSLDRVLFRRPENLE 207
+ ++R+R L + Y +L +
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 208 AAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267
L R ++ + L LH ++H ++ +++LD + L F
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLV- 254
Query: 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPE----------SFQKGSVATAKSD 317
+ G+ PPE + ++ T D
Sbjct: 255 -------------------RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFD 295
Query: 318 VFSFGIVVLEVVSGR 332
++ G+V+ +
Sbjct: 296 AWALGLVIYWIWCAD 310
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 36/266 (13%), Positives = 75/266 (28%), Gaps = 49/266 (18%)
Query: 541 LVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEM--LVIYDYSATRILS 598
L++ + K + RF + + + ++++ + + +Y + + +
Sbjct: 129 LLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQT 188
Query: 599 HLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNP 658
+H H L H R + + + LH + ++H + I LD
Sbjct: 189 FGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGV 245
Query: 659 RLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYI-----------ESGEATSMA 707
L F G R +S +R G+ PE T
Sbjct: 246 FLTGFEHLV-----RDGARVVSSVSR------GFEPPELEARRATISYHRDRRTLMTFSF 294
Query: 708 DVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYN-HKEL 766
D ++ G+V+ + LP + N + +
Sbjct: 295 DAWALGLVIYWIWCA------DLP----------ITK--DAALGGSEWIFRSCKNIPQPV 336
Query: 767 MRLIKLGIACTLSNPELRPSMRQILS 792
L++ E R Q +
Sbjct: 337 RALLE---GFLRYPKEDRLLPLQAME 359
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-24
Identities = 48/225 (21%), Positives = 81/225 (36%), Gaps = 22/225 (9%)
Query: 113 FDEDEVLGSG--GFGKVYRAVLPSDGTVVAVKC--LAEKGERFEKTFAAELVAVAHLRHR 168
++ V+G G V A G V V+ L EL H
Sbjct: 27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86
Query: 169 NLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAAL 228
N+V R + +++L +V +M S ++ + +N I++G+ AL
Sbjct: 87 NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMD-----GMNELAIAYILQGVLKAL 141
Query: 229 HYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHL 288
Y+H +HR VK S++++ L M + R H
Sbjct: 142 DYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSN--------LSMISHGQRQRVVHD 190
Query: 289 AETTRIGGTIGYLPPESFQKGSVA-TAKSDVFSFGIVVLEVVSGR 332
+ + +L PE Q+ AKSD++S GI E+ +G
Sbjct: 191 FPKYSV-KVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 52/307 (16%), Positives = 91/307 (29%), Gaps = 53/307 (17%)
Query: 526 FGTAYQGF-LDNHQYVLVKRLGMSKCPALRTRF-SNELQNLARLRHRNLVQLCGWCTEQG 583
T +YV V+R+ + C F EL H N+V
Sbjct: 40 LMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN 99
Query: 584 EMLVIYDY----SATRILSHLLFH--NNHRIGHSILQWHHRYNIIKSLASAILYLHEEWN 637
E+ V+ + SA ++ N I I++ + A+ Y+H
Sbjct: 100 ELWVVTSFMAYGSAKDLICTHFMDGMNELAIA----------YILQGVLKALDYIHHM-- 147
Query: 638 EQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEY 697
+HR++ +S I + D L + + R + + ++SPE
Sbjct: 148 -GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEV 206
Query: 698 IESGEA--TSMADVYSFGVVVLEVVTGQ--------MAVDFRLPEG----LLVKRVHEFE 743
++ + +D+YS G+ E+ G + G LL E
Sbjct: 207 LQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAE 266
Query: 744 ARKRPLAELVDLSLNGEYNHKELMRLIKLGI------------------ACTLSNPELRP 785
+ V S + R C NP+ RP
Sbjct: 267 ELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARP 326
Query: 786 SMRQILS 792
S +L+
Sbjct: 327 SASTLLN 333
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 57/223 (25%), Positives = 99/223 (44%), Gaps = 32/223 (14%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK---GERFEKTFAAELVAVAHLRHRN 169
FD LG G FG VY A + ++A+K L + E E E+ +HLRH N
Sbjct: 16 FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 75
Query: 170 LVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALH 229
++R+ + ++ L+ ++ P L ++ L+ + ++ + LA ALH
Sbjct: 76 ILRMYNYFHDRKRIYLMLEFAPRGEL----YKE---LQKHGRFDEQRSATFMEELADALH 128
Query: 230 YLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLA 289
Y HE+ ++IHRD+K N+++ + ++ DFG + + M
Sbjct: 129 YCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTM------------- 172
Query: 290 ETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
GT+ YLPPE + G K D++ G++ E + G
Sbjct: 173 -----CGTLDYLPPEMIE-GKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 1e-05
Identities = 32/181 (17%), Positives = 70/181 (38%), Gaps = 24/181 (13%)
Query: 542 VKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRILSHLL 601
+++ G+ + E++ + LRH N++++ + ++ + ++ +++ L L
Sbjct: 52 LEKEGVEH------QLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL 105
Query: 602 FHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLG 661
+ ++ LA A+ Y HE +VIHR+I + + ++
Sbjct: 106 QKHGR------FDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIA 156
Query: 662 SFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT 721
F + R+ G Y+ PE IE D++ GV+ E +
Sbjct: 157 DFGWS---VHAPSLRRRTMCGTLD------YLPPEMIEGKTHDEKVDLWCAGVLCYEFLV 207
Query: 722 G 722
G
Sbjct: 208 G 208
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 53/241 (21%), Positives = 95/241 (39%), Gaps = 42/241 (17%)
Query: 108 IGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLA-EKGERFEKTFAAELVAVAHLR 166
++ + ++LG G V+R G + A+K R E + L
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 167 HRNLVRLRGWCVHED----QLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIR 222
H+N+V+L + E+ +L+ ++ P S L+ E A L + ++R
Sbjct: 66 HKNIVKLFA--IEEETTTRHKVLIMEFCPCGS----LYTVLEEPSNAYGLPESEFLIVLR 119
Query: 223 GLAAALHYLHEQLETQIIHRDVKTSNVML----DSQYNARLGDFGLARWLEHELQYQMRT 278
+ +++L E I+HR++K N+M D Q +L DFG AR LE + Q +
Sbjct: 120 DVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD--EQFVS 174
Query: 279 SSARNHQFHLAETTRIGGTIGYLPPESFQKGSVA-------TAKSDVFSFGIVVLEVVSG 331
GT YL P+ +++ + A D++S G+ +G
Sbjct: 175 LY---------------GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219
Query: 332 R 332
Sbjct: 220 S 220
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 44/305 (14%), Positives = 87/305 (28%), Gaps = 62/305 (20%)
Query: 526 FGTAYQGF-LDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGE 584
++G +K E + L +L H+N+V+L
Sbjct: 22 TANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA------- 74
Query: 585 MLVIYDYSATRI-----------LSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLH 633
+ + + L +L ++ G L +++ + + +L
Sbjct: 75 --IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG---LPESEFLIVLRDVVGGMNHLR 129
Query: 634 EEWNEQVIHR-----NITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRG 688
E ++HR NI I D +L F A L ++ S+ G
Sbjct: 130 E---NGIVHRNIKPGNIMRV-IGEDGQSVYKLTDFGAARELEDDEQFV--------SLYG 177
Query: 689 IFGYMSPEYIESGEATSM--------ADVYSFGVVVLEVVTG------------QMAVDF 728
Y+ P+ E D++S GV TG V +
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237
Query: 729 RLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTL-SNPELRPSM 787
++ G + + + + + L L+ +A L ++ E
Sbjct: 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF 297
Query: 788 RQILS 792
Q +
Sbjct: 298 DQFFA 302
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 9e-24
Identities = 53/220 (24%), Positives = 99/220 (45%), Gaps = 30/220 (13%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLA-EKGERFEKTFAAELVAVAHLRHRNLV 171
+ E +G G G VY A+ + G VA++ + ++ + E E++ + ++ N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN-EILVMRENKNPNIV 80
Query: 172 RLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYL 231
+ D+L +V +Y+ SL V+ ++ Q + R AL +L
Sbjct: 81 NYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--------MDEGQIAAVCRECLQALEFL 132
Query: 232 HEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAET 291
H Q+IHRD+K+ N++L + +L DFG + S R+
Sbjct: 133 HSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-------EQSKRS-------- 174
Query: 292 TRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSG 331
T + GT ++ PE + + K D++S GI+ +E++ G
Sbjct: 175 TMV-GTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEG 212
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 44/226 (19%), Positives = 94/226 (41%), Gaps = 30/226 (13%)
Query: 506 KEIISATN---NFSESQRVAEMDFGTAYQGF-LDNHQYVLVKRLGMSKCPALRTRFSNEL 561
+ I+S + ++ +++ + GT Y + Q V ++++ + + P NE+
Sbjct: 10 RSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII-NEI 68
Query: 562 QNLARLRHRNLVQLCGWCTEQGEMLVIYDY----SATRILSHLLFHNNHRIGHSILQWHH 617
+ ++ N+V E+ V+ +Y S T +++ I
Sbjct: 69 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ-IAA------- 120
Query: 618 RYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHR 677
+ + A+ +LH + QVIHR+I S I L D + +L F +T + R
Sbjct: 121 ---VCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT-PEQSKR 173
Query: 678 KATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQ 723
++ G +M+PE + D++S G++ +E++ G+
Sbjct: 174 S------TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 26/232 (11%), Positives = 61/232 (26%), Gaps = 59/232 (25%)
Query: 116 DEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVAVAHLRHRNLVR 172
G + ++A+ + VA+ + +G + + + + ++ + + R
Sbjct: 36 LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 173 LRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLH 232
+ L+V +++ SL V P + A ++ LAAA H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIR---------AMQSLAAAADAAH 146
Query: 233 EQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETT 292
+ S V + + L
Sbjct: 147 RA---GVALSIDHPSRVRVSIDGDVVLAYP------------------------------ 173
Query: 293 RIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQI 344
+P A + D+ G + ++ R + +
Sbjct: 174 ------ATMPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL 211
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 22/249 (8%), Positives = 59/249 (23%), Gaps = 56/249 (22%)
Query: 540 VLVK--RLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRIL 597
V + + + L+R+ + ++ + LV+ ++ L
Sbjct: 59 VALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSL 118
Query: 598 SHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMN 657
+ + ++SLA+A H V S + + D +
Sbjct: 119 QEVA--------DTSPSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGD 167
Query: 658 PRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVL 717
L M A D+ G +
Sbjct: 168 VVLAY---------------------------PATMPD-------ANPQDDIRGIGASLY 193
Query: 718 EVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACT 777
++ + + L A + + ++ + ++ +
Sbjct: 194 ALLVNRWPLPEAGVRSGLAP------AERDTAGQPIEPADIDRDIPFQISAVA---ARSV 244
Query: 778 LSNPELRPS 786
+ +R +
Sbjct: 245 QGDGGIRSA 253
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 55/220 (25%), Positives = 96/220 (43%), Gaps = 30/220 (13%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLA-EKGERFEKTFAAELVAVAHLRHRNLV 171
D +G G G V A G VAVK + K +R E F E+V + +H N+V
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFN-EVVIMRDYQHFNVV 105
Query: 172 RLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYL 231
+ + ++L ++ +++ +L ++ + LN EQ + + AL YL
Sbjct: 106 EMYKSYLVGEELWVLMEFLQGGALTDIV--------SQVRLNEEQIATVCEAVLQALAYL 157
Query: 232 HEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAET 291
H Q +IHRD+K+ +++L +L DFG + R
Sbjct: 158 HAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK-------DVPKRK-------- 199
Query: 292 TRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSG 331
+ + GT ++ PE + + D++S GI+V+E+V G
Sbjct: 200 SLV-GTPYWMAPEVISRSL-YATEVDIWSLGIMVIEMVDG 237
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 50/249 (20%), Positives = 101/249 (40%), Gaps = 30/249 (12%)
Query: 483 SNNSRSQRRNSFFMVETPREISFKEIISATN---NFSESQRVAEMDFGTAYQGF-LDNHQ 538
+ + S + + + + ++ + ++ E G + +
Sbjct: 12 DLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGR 71
Query: 539 YVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY----SAT 594
V VK + + K R NE+ + +H N+V++ E+ V+ ++ + T
Sbjct: 72 QVAVKMMDLRKQQR-RELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALT 130
Query: 595 RILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDP 654
I+S + + I + +++ A+ YLH + VIHR+I S +I L
Sbjct: 131 DIVSQVRLNEEQ-IAT----------VCEAVLQALAYLH---AQGVIHRDIKSDSILLTL 176
Query: 655 DMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGV 714
D +L F ++ D RK S+ G +M+PE I + D++S G+
Sbjct: 177 DGRVKLSDFGFCAQIS-KDVPKRK------SLVGTPYWMAPEVISRSLYATEVDIWSLGI 229
Query: 715 VVLEVVTGQ 723
+V+E+V G+
Sbjct: 230 MVIEMVDGE 238
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 39/252 (15%), Positives = 76/252 (30%), Gaps = 38/252 (15%)
Query: 98 PRIFSYAELYIGSNGFDEDEVLGSGGFGKVYRAVLPS-----DGTVVAVKCLAEKGERFE 152
P I E +GS +LG G F +VY A + +K + +E
Sbjct: 52 PAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQ-KPANPWE 110
Query: 153 KTFAAELVAV-AHLRHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAP 211
+L+ ++ + ++ +LV + +L + E P
Sbjct: 111 FYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMP 170
Query: 212 LNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNA-----------RLG 260
+ + +H+ +IIH D+K N +L + + L
Sbjct: 171 Q--GLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALI 225
Query: 261 DFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFS 320
D G + ++ + + T+ T G+ E + D F
Sbjct: 226 DLGQSIDMKLFPKGTIFTAKC--------------ETSGFQCVE-MLSNKPWNYQIDYFG 270
Query: 321 FGIVVLEVVSGR 332
V ++ G
Sbjct: 271 VAATVYCMLFGT 282
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 31/250 (12%), Positives = 68/250 (27%), Gaps = 15/250 (6%)
Query: 526 FGTAYQGFLDNHQYVLVKRLGMSKC--PALRTRFSNELQNLARLR---HRNLVQLCGWCT 580
F Y+ + K+ + K PA F Q + RL+ ++
Sbjct: 78 FAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137
Query: 581 EQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQV 640
Q +++ + + L + + + + Q + I +H+ ++
Sbjct: 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVIS-FAMRMLYMIEQVHDC---EI 193
Query: 641 IHRNI------TSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMS 694
IH +I + D + AL + D + + G+
Sbjct: 194 IHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQC 253
Query: 695 PEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVD 754
E + + D + V ++ G + + E
Sbjct: 254 VEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFH 313
Query: 755 LSLNGEYNHK 764
+ LN H
Sbjct: 314 VMLNIPDCHH 323
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 32/221 (14%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKC--LAEKGERFEKTFAAELVAVAHLRHRNL 170
FD E LG G +G VY+A+ G +VA+K + + K E+ + ++
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIK----EISIMQQCDSPHV 86
Query: 171 VRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHY 230
V+ G L +V +Y S+ ++ R + L ++ I++ L Y
Sbjct: 87 VKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK------TLTEDEIATILQSTLKGLEY 140
Query: 231 LHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAE 290
LH + IHRD+K N++L+++ +A+L DFG+A L T + RN
Sbjct: 141 LHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD-------TMAKRN------- 183
Query: 291 TTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSG 331
T I GT ++ PE Q+ +D++S GI +E+ G
Sbjct: 184 -TVI-GTPFWMAPEVIQEIGY-NCVADIWSLGITAIEMAEG 221
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 46/228 (20%), Positives = 95/228 (41%), Gaps = 32/228 (14%)
Query: 505 FKEIISATN---NFSESQRVAEMDFGTAYQGF-LDNHQYVLVKRLGMSKCPALRTRFSNE 560
E F +++ E +G+ Y+ + Q V +K++ + E
Sbjct: 18 LDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQE---IIKE 74
Query: 561 LQNLARLRHRNLVQLCGWCTEQGEMLVIYDY----SATRILSHLLFHNNHRIGHSILQWH 616
+ + + ++V+ G + ++ ++ +Y S + I+ R+ + L
Sbjct: 75 ISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII---------RLRNKTLTED 125
Query: 617 HRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGH 676
I++S + YLH + IHR+I + I L+ + + +L F +A LT
Sbjct: 126 EIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLT------ 176
Query: 677 RKATSGNR-SVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQ 723
T R +V G +M+PE I+ +AD++S G+ +E+ G+
Sbjct: 177 --DTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-22
Identities = 58/224 (25%), Positives = 89/224 (39%), Gaps = 35/224 (15%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCL---AEKGERFEKTFAAELVAVAHLRHRN 169
F + +G G FG VY A + VVA+K + ++ + E+ + LRH N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 170 LVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALH 229
++ RG + E LV +Y + D + + PL + + G L
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK-------KPLQEVEIAAVTHGALQGLA 168
Query: 230 YLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLA 289
YLH +IHRDVK N++L +LGDFG A M + N
Sbjct: 169 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSAS--------IM---APAN------ 208
Query: 290 ETTRIGGTIGYLPPE--SFQKGSVATAKSDVFSFGIVVLEVVSG 331
+ + GT ++ PE K DV+S GI +E+
Sbjct: 209 --SFV-GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 249
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 9e-06
Identities = 49/258 (18%), Positives = 95/258 (36%), Gaps = 35/258 (13%)
Query: 478 NTESKSNNSRSQRRNSFFMVETPREISFKEIISATN---NFSESQRVAEMDFGTAYQGF- 533
TE+ + + ++ E+ + FS+ + + FG Y
Sbjct: 16 TTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARD 75
Query: 534 LDNHQYVLVKRLGMSKCPAL--RTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591
+ N + V +K++ S + E++ L +LRH N +Q G + ++ +Y
Sbjct: 76 VRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 135
Query: 592 ---SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSS 648
SA+ +L + LQ + + YLH + +IHR++ +
Sbjct: 136 CLGSASDLL---------EVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAG 183
Query: 649 AITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEAT---S 705
I L +LG F A + + S G +M+PE I + +
Sbjct: 184 NILLSEPGLVKLGDFGSASIMAPAN-----------SFVGTPYWMAPEVILAMDEGQYDG 232
Query: 706 MADVYSFGVVVLEVVTGQ 723
DV+S G+ +E+ +
Sbjct: 233 KVDVWSLGITCIELAERK 250
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 4e-22
Identities = 62/230 (26%), Positives = 99/230 (43%), Gaps = 36/230 (15%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHL-RHRNLV 171
F+ E++G+G +G+VY+ G + A+K + G+ E E+ + HRN+
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEE-EIKQEINMLKKYSHHRNIA 84
Query: 172 RLRG------WCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLA 225
G +DQL LV ++ S+ ++ L E I R +
Sbjct: 85 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI-----KNTKGNTLKEEWIAYICREIL 139
Query: 226 AALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQ 285
L +LH+ ++IHRD+K NV+L +L DFG++ L+ RT RN
Sbjct: 140 RGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD-------RTVGRRN-- 187
Query: 286 FHLAETTRIGGTIGYLPPESFQKGSVATA----KSDVFSFGIVVLEVVSG 331
T I GT ++ PE A KSD++S GI +E+ G
Sbjct: 188 ------TFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 44/214 (20%), Positives = 83/214 (38%), Gaps = 51/214 (23%)
Query: 621 IIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKAT 680
I + + + +LH+ +VIHR+I + L + +L F ++ L R T
Sbjct: 134 ICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR--------T 182
Query: 681 SGNR-SVRGIFGYMSPEYIESGEAT-----SMADVYSFGVVVLEVVTGQ--------MAV 726
G R + G +M+PE I E +D++S G+ +E+ G M
Sbjct: 183 VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA 242
Query: 727 DFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPS 786
F +P R L + K+ I+ C + N RP+
Sbjct: 243 LFLIP-------------RNPA------PRLKSKKWSKKFQSFIES---CLVKNHSQRPA 280
Query: 787 MRQILS---ILDGNDKRFMEDGQMTENLEEWKQR 817
Q++ I D ++R + Q+ ++++ K++
Sbjct: 281 TEQLMKHPFIRDQPNERQVRI-QLKDHIDRTKKK 313
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-22
Identities = 63/247 (25%), Positives = 99/247 (40%), Gaps = 38/247 (15%)
Query: 116 DEVLGSGGFGKVYRAVLPSDGTVVAVKCLA-EKGERFEKTFAAELVAVAHLRHRNLVRL- 173
E LG+GGFG V R + G VA+K E + + + E+ + L H N+V
Sbjct: 19 KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 78
Query: 174 -----RGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAAL 228
D LL +Y L + L + E L + ++ +++AL
Sbjct: 79 EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQF----ENCCGLKEGPIRTLLSDISSAL 134
Query: 229 HYLHEQLETQIIHRDVKTSNVMLDS---QYNARLGDFGLARWLEHELQYQMRTSSARNHQ 285
YLHE +IIHRD+K N++L + ++ D G A+ L+
Sbjct: 135 RYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-------------- 177
Query: 286 FHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQII 345
L GT+ YL PE ++ T D +SFG + E ++G R P+ Q +
Sbjct: 178 -ELCTEFV--GTLQYLAPELLEQKKY-TVTVDYWSFGTLAFECITGFRPF---LPNWQPV 230
Query: 346 LLDWIRR 352
R
Sbjct: 231 QWHGKVR 237
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 46/215 (21%), Positives = 80/215 (37%), Gaps = 36/215 (16%)
Query: 526 FGTAYQGF-LDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGE 584
FG + D + V +K+ P R R+ E+Q + +L H N+V E
Sbjct: 27 FGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR-------E 79
Query: 585 MLVIYDYSATRILSHL---------LFHNNHRIGH-SILQWHHRYNIIKSLASAILYLHE 634
+ A L L L ++ + L+ ++ ++SA+ YLHE
Sbjct: 80 VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE 139
Query: 635 EWNEQVIHR-----NITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGI 689
++IHR NI + ++ A+ L + + G
Sbjct: 140 N---RIIHRDLKPENIVLQP--GPQRLIHKIIDLGYAKELDQGELCT--------EFVGT 186
Query: 690 FGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQM 724
Y++PE +E + T D +SFG + E +TG
Sbjct: 187 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 8e-22
Identities = 48/244 (19%), Positives = 85/244 (34%), Gaps = 50/244 (20%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLR----HR 168
+++LG G G V G VAVK + F E + L H
Sbjct: 17 VVSEKILGYGSSGTVVFQGS-FQGRPVAVKRMLID---FCDIALME---IKLLTESDDHP 69
Query: 169 NLVRLRGWCVHEDQ--LLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAA 226
N++R +C L + + +L ++ + + E ++R +A+
Sbjct: 70 NVIRY--YCSETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 227 ALHYLHEQLETQIIHRDVKTSNVMLDSQ-------------YNARLGDFGLARWLEHELQ 273
+ +LH +IIHRD+K N+++ + + DFGL + L+
Sbjct: 127 GVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS--- 180
Query: 274 YQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVA------TAKSDVFSFGIVVLE 327
GT G+ PE ++ + T D+FS G V
Sbjct: 181 ---------GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYY 231
Query: 328 VVSG 331
++S
Sbjct: 232 ILSK 235
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 53/306 (17%), Positives = 104/306 (33%), Gaps = 77/306 (25%)
Query: 526 FGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARL-RHRNLVQLCGWCTEQGE 584
GT + V VKR+ + C E++ L H N+++ +C+E +
Sbjct: 28 SGTVVFQGSFQGRPVAVKRMLIDFC----DIALMEIKLLTESDDHPNVIRY--YCSETTD 81
Query: 585 MLVIYDYSAT---------RILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEE 635
+ Y A + S + N + + ++ ++++ +AS + +LH
Sbjct: 82 RFL---YIALELCNLNLQDLVESKNVSDENL----KLQKEYNPISLLRQIASGVAHLHSL 134
Query: 636 WNEQVIHR-----NI--------TSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSG 682
++IHR NI T+ T ++ + F L + L R +
Sbjct: 135 ---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNN 191
Query: 683 NRSVRGIFGYMSPEYIESGEA-------TSMADVYSFGVVVLEVVTGQMAVDFRLPEGLL 735
G G+ +PE +E T D++S G V +L
Sbjct: 192 ---PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYY---------------IL 233
Query: 736 VKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGI---------ACTLSNPELRPS 786
K H F + + + + G ++ E+ L + +P RP+
Sbjct: 234 SKGKHPFGDKYSRESNI----IRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPT 289
Query: 787 MRQILS 792
++L
Sbjct: 290 AMKVLR 295
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 47/214 (21%), Positives = 85/214 (39%), Gaps = 32/214 (14%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVR 172
+ E LG G FG V+R V S K + KG E+ + RHRN++
Sbjct: 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL-VKKEISILNIARHRNILH 65
Query: 173 LRGWCVHEDQLLLVYDYMPNRSL-DRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYL 231
L ++L+++++++ + +R+ E E + + AL +L
Sbjct: 66 LHESFESMEELVMIFEFISGLDIFERINTSAFELNEREI-------VSYVHQVCEALQFL 118
Query: 232 HEQLETQIIHRDVKTSNVMLDSQYNARL--GDFGLARWLEHELQYQMRTSSARNHQFHLA 289
H I H D++ N++ ++ ++ + +FG AR L+ R
Sbjct: 119 HSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--DNFRL----------- 162
Query: 290 ETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGI 323
+ Y PE Q V+TA +D++S G
Sbjct: 163 ----LFTAPEYYAPEVHQHDVVSTA-TDMWSLGT 191
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 3e-21
Identities = 55/223 (24%), Positives = 99/223 (44%), Gaps = 37/223 (16%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK---GERFEKTFAAELVAVAHLRHRNLVRL 173
VLG G FG+V G AVK ++++ + +++ E+ + L H N+++L
Sbjct: 32 RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91
Query: 174 RGWCVHEDQLLLVYDYMPNRSL-DRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLH 232
+ + LV + L D ++ R+ + AA +IIR + + + Y+H
Sbjct: 92 YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA--------RIIRQVLSGITYMH 143
Query: 233 EQLETQIIHRDVKTSNVMLDSQ---YNARLGDFGLARWLEHELQYQMRTSSARNHQFHLA 289
+ +I+HRD+K N++L+S+ N R+ DFGL+ E +
Sbjct: 144 KN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM--------------- 185
Query: 290 ETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
GT Y+ PE K DV+S G+++ ++SG
Sbjct: 186 --KDKIGTAYYIAPEVLHGTY--DEKCDVWSTGVILYILLSGC 224
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 5e-05
Identities = 40/207 (19%), Positives = 76/207 (36%), Gaps = 46/207 (22%)
Query: 526 FGTAYQGF-LDNHQYVLVKRLGMSK--CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQ 582
FG Q VK + + + E+Q L +L H N+++L + ++
Sbjct: 39 FGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDK 98
Query: 583 GEMLVIYDYSA-----TRILSHLLFHNNHRIGHSILQWHHRYN------IIKSLASAILY 631
G ++ + I+S R++ II+ + S I Y
Sbjct: 99 GYFYLVGEVYTGGELFDEIISR-----------------KRFSEVDAARIIRQVLSGITY 141
Query: 632 LHEEWNEQVIHRNITSSAI---TLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRG 688
+H+ +++HR++ + + D N R+ F L+ + K G
Sbjct: 142 MHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI--------G 190
Query: 689 IFGYMSPEYIESGEATSMADVYSFGVV 715
Y++PE + G DV+S GV+
Sbjct: 191 TAYYIAPEVLH-GTYDEKCDVWSTGVI 216
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 4e-21
Identities = 38/152 (25%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVK--CLAEKGERFEKTFAAELVAVAHLRHRNLVRLR 174
++G G +G V + G +VA+K ++ + +K E+ + LRH NLV L
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90
Query: 175 GWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQ 234
C + + LV++++ + ++ L P L+++ +K + + + + H
Sbjct: 91 EVCKKKKRWYLVFEFV-DHTILDDLELFPN------GLDYQVVQKYLFQIINGIGFCHSH 143
Query: 235 LETQIIHRDVKTSNVMLDSQYNARLGDFGLAR 266
IIHRD+K N+++ +L DFG AR
Sbjct: 144 ---NIIHRDIKPENILVSQSGVVKLCDFGFAR 172
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 6e-21
Identities = 51/224 (22%), Positives = 93/224 (41%), Gaps = 36/224 (16%)
Query: 116 DEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRL 173
+ LGSG +G+V A+K + + E+ + L H N+++L
Sbjct: 42 VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKL 101
Query: 174 RGWCVHEDQLLLVYDYMPNRSL-DRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLH 232
+ + LV + L D ++ R N AA II+ + + + YLH
Sbjct: 102 YDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAA--------VIIKQVLSGVTYLH 153
Query: 233 EQLETQIIHRDVKTSNVMLDSQ---YNARLGDFGLARWLEHELQYQMRTSSARNHQFHLA 289
+ I+HRD+K N++L+S+ ++ DFGL+ E++ +
Sbjct: 154 KH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM--------------- 195
Query: 290 ETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRR 333
GT Y+ PE +K K DV+S G+++ +++G
Sbjct: 196 --KERLGTAYYIAPEVLRKKY--DEKCDVWSIGVILFILLAGYP 235
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 30/181 (16%), Positives = 67/181 (37%), Gaps = 43/181 (23%)
Query: 556 RFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSA-----TRILSHLLFHNNHRIGH 610
+ E+ L L H N+++L + ++ ++ + I+
Sbjct: 82 KLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHR----------- 130
Query: 611 SILQWHHRYN------IIKSLASAILYLHEEWNEQVIHRNITSSAI---TLDPDMNPRLG 661
++N IIK + S + YLH+ ++HR++ + + + D ++
Sbjct: 131 ------MKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIV 181
Query: 662 SFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT 721
F L+ + G Y++PE + + DV+S GV++ ++
Sbjct: 182 DFGLSAVFENQKKMKERL--------GTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLA 232
Query: 722 G 722
G
Sbjct: 233 G 233
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 6e-21
Identities = 49/215 (22%), Positives = 89/215 (41%), Gaps = 31/215 (14%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVR 172
+D E LGSG FG V+R V + G V K + + T E+ + L H L+
Sbjct: 53 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 112
Query: 173 LRGWCVHEDQLLLVYDYMPNRSL-DRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYL 231
L + +++L+ +++ L DR+ + EA +R L ++
Sbjct: 113 LHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEV-------INYMRQACEGLKHM 165
Query: 232 HEQLETQIIHRDVKTSNVMLDSQYNARL--GDFGLARWLEHELQYQMRTSSARNHQFHLA 289
HE I+H D+K N+M +++ + + DFGLA L + ++ T
Sbjct: 166 HEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT----------- 211
Query: 290 ETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIV 324
T + PE + V +D+++ G++
Sbjct: 212 ------ATAEFAAPEIVDREPV-GFYTDMWAIGVL 239
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 8e-21
Identities = 40/152 (26%), Positives = 67/152 (44%), Gaps = 12/152 (7%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGER--FEKTFAAELVAVAHLRHRNLVRLR 174
+G G +G V++ G +VA+K E + +K E+ + L+H NLV L
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLL 68
Query: 175 GWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQ 234
+ +L LV++Y + ++ L R + K I A+++ H+
Sbjct: 69 EVFRRKRRLHLVFEYC-DHTVLHELDRYQR------GVPEHLVKSITWQTLQAVNFCHKH 121
Query: 235 LETQIIHRDVKTSNVMLDSQYNARLGDFGLAR 266
IHRDVK N+++ +L DFG AR
Sbjct: 122 ---NCIHRDVKPENILITKHSVIKLCDFGFAR 150
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 9e-21
Identities = 53/282 (18%), Positives = 105/282 (37%), Gaps = 56/282 (19%)
Query: 69 HHNTPRKEHSGLFHDMEGVQMSEKVGGDNPRIFSYAELYIGSNGFDEDEVLGSGGFGKVY 128
HH+ L+ + V +I LGSG +G+V
Sbjct: 3 HHHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFK---------VRKLGSGAYGEVL 53
Query: 129 RAVLPSDGTVVAVKCLA-------------EKGERFEKTFAAELVAVAHLRHRNLVRLRG 175
+ + A+K + + E+F + E+ + L H N+++L
Sbjct: 54 LCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113
Query: 176 WCVHEDQLLLVYDYMPNRSL-DRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQ 234
+ LV ++ L ++++ R + AA I++ + + + YLH+
Sbjct: 114 VFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA--------NIMKQILSGICYLHKH 165
Query: 235 LETQIIHRDVKTSNVMLDSQ-YNARL--GDFGLARWLEHELQYQMRTSSARNHQFHLAET 291
I+HRD+K N++L+++ + DFGL+ + + +
Sbjct: 166 ---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL----------------- 205
Query: 292 TRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRR 333
GT Y+ PE +K K DV+S G+++ ++ G
Sbjct: 206 RDRLGTAYYIAPEVLKKKY--NEKCDVWSCGVIMYILLCGYP 245
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 6e-05
Identities = 33/174 (18%), Positives = 71/174 (40%), Gaps = 43/174 (24%)
Query: 556 RFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSA-----TRILSHLLFHNNHRIGH 610
NE+ L L H N+++L ++ ++ ++ +I++
Sbjct: 92 EIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN------------ 139
Query: 611 SILQWHHRYN------IIKSLASAILYLHEEWNEQVIHRNITSSAI---TLDPDMNPRLG 661
H+++ I+K + S I YLH+ ++HR+I I + +N ++
Sbjct: 140 -----RHKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIV 191
Query: 662 SFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVV 715
F L+ F +++ + G Y++PE ++ + DV+S GV+
Sbjct: 192 DFGLSSFFSKDYKLRDRL--------GTAYYIAPEVLK-KKYNEKCDVWSCGVI 236
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 1e-20
Identities = 48/257 (18%), Positives = 90/257 (35%), Gaps = 56/257 (21%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKC-----LAEKGERFEKTFAAELVAVAHLRHRNLV 171
+G G +G V A+ + A+K + + + + E+ + L H N+
Sbjct: 32 GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIA 91
Query: 172 RLRGWCVHEDQLLLVYDYMPNRSL-DRVLFRRPENLEAAAPLNWEQR------------- 217
RL E + LV + L D++ ++ A + +
Sbjct: 92 RLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAIN 151
Query: 218 -------------------KKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNAR 258
I+R + +ALHYLH Q I HRD+K N + + +
Sbjct: 152 GSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFE 208
Query: 259 L--GDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVA-TAK 315
+ DFGL++ + + T GT ++ PE + + K
Sbjct: 209 IKLVDFGLSKEFY------------KLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256
Query: 316 SDVFSFGIVVLEVVSGR 332
D +S G+++ ++ G
Sbjct: 257 CDAWSAGVLLHLLLMGA 273
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 6e-04
Identities = 31/239 (12%), Positives = 68/239 (28%), Gaps = 61/239 (25%)
Query: 526 FGTAYQGF--LDNHQY---VLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCT 580
+G ++ K P R E++ + +L H N+ +L
Sbjct: 39 YGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE 98
Query: 581 EQGEMLVIYDY----------------------------SATRILSHLLFHNNHRIGHSI 612
++ + ++ + N I
Sbjct: 99 DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFR 158
Query: 613 LQWHHRYN------IIKSLASAILYLHEEWNEQVIHR-----NITSSAITLDPDMNPRLG 661
I++ + SA+ YLH + + HR N + + +L
Sbjct: 159 ESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFL---FSTNKSFEIKLV 212
Query: 662 SFALAEFLTRNDHGHRKATSGNRSVRGIFG---YMSPEYIESGEA--TSMADVYSFGVV 715
F L++ + ++G + G +++PE + + D +S GV+
Sbjct: 213 DFGLSKEFYKLNNGE------YYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 42/155 (27%), Positives = 72/155 (46%), Gaps = 11/155 (7%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLA-EKGERFEKTFAAELVAVAHLRHRNLV 171
+ + + LG G + VY+ +VA+K + E E T E+ + L+H N+V
Sbjct: 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 63
Query: 172 RLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYL 231
L E L LV++Y+ ++ L + L + K + L L Y
Sbjct: 64 TLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMH------NVKLFLFQLLRGLAYC 116
Query: 232 HEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLAR 266
H Q +++HRD+K N++++ + +L DFGLAR
Sbjct: 117 HRQ---KVLHRDLKPQNLLINERGELKLADFGLAR 148
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 91.8 bits (229), Expect = 2e-20
Identities = 43/156 (27%), Positives = 76/156 (48%), Gaps = 11/156 (7%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVK--CLAEKGERFEKTFAAELVAVAHLRHRNL 170
F + E +G G +G VY+A G VVA+K L + E T E+ + L H N+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 171 VRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHY 230
V+L E++L LV++++ + L + + + K + L L +
Sbjct: 65 VKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALT-----GIPLPLIKSYLFQLLQGLAF 118
Query: 231 LHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLAR 266
H +++HRD+K N++++++ +L DFGLAR
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR 151
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 52/228 (22%), Positives = 89/228 (39%), Gaps = 40/228 (17%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAV-----------AHL 165
+LG GGFG V+ +D VA+K + + + ++ V A
Sbjct: 37 PLLGKGGFGTVFAGHRLTDRLQVAIKVI-PRNRVLGWSPLSDSVTCPLEVALLWKVGAGG 95
Query: 166 RHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLA 225
H ++RL W ++ +LV + P + D LF + PL + +
Sbjct: 96 GHPGVIRLLDWFETQEGFMLVLER-PLPAQD--LFDY---ITEKGPLGEGPSRCFFGQVV 149
Query: 226 AALHYLHEQLETQIIHRDVKTSNVMLDSQYNA-RLGDFGLARWLEHELQYQMRTSSARNH 284
AA+ + H + ++HRD+K N+++D + +L DFG L E
Sbjct: 150 AAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP---YTDFD---- 199
Query: 285 QFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
GT Y PPE + + V+S GI++ ++V G
Sbjct: 200 -----------GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 2e-20
Identities = 51/214 (23%), Positives = 94/214 (43%), Gaps = 31/214 (14%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVR 172
+D E LG+G FG V+R + G A K + E ++T E+ ++ LRH LV
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 218
Query: 173 LRGWCVHEDQLLLVYDYMPNRSL-DRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYL 231
L +++++++Y++M L ++V + E A + +R + L ++
Sbjct: 219 LHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEA-------VEYMRQVCKGLCHM 271
Query: 232 HEQLETQIIHRDVKTSNVMLDSQYNARL--GDFGLARWLEHELQYQMRTSSARNHQFHLA 289
HE +H D+K N+M ++ + L DFGL L+ + ++ T
Sbjct: 272 HEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT----------- 317
Query: 290 ETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGI 323
GT + PE + V +D++S G+
Sbjct: 318 ------GTAEFAAPEVAEGKPVGYY-TDMWSVGV 344
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 91.0 bits (227), Expect = 3e-20
Identities = 38/156 (24%), Positives = 74/156 (47%), Gaps = 12/156 (7%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKC--LAEKGERFEKTFAAELVAVAHLRHRNL 170
+++ E +G G +G V++A +VA+K L + E + E+ + L+H+N+
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 171 VRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHY 230
VRL + +L LV+++ L + +L+ K + L L +
Sbjct: 64 VRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPE------IVKSFLFQLLKGLGF 116
Query: 231 LHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLAR 266
H + ++HRD+K N++++ +L +FGLAR
Sbjct: 117 CHSR---NVLHRDLKPQNLLINRNGELKLANFGLAR 149
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 52/225 (23%), Positives = 86/225 (38%), Gaps = 36/225 (16%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCL------AEKGERFEKTFAAELVAVAHLRHR-- 168
+LGSGGFG VY + SD VA+K + E+V + +
Sbjct: 49 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108
Query: 169 NLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAAL 228
++RL W D +L+ + P D LF + L E + + A+
Sbjct: 109 GVIRLLDWFERPDSFVLILER-PEPVQD--LFDF---ITERGALQEELARSFFWQVLEAV 162
Query: 229 HYLHEQLETQIIHRDVKTSNVMLDS-QYNARLGDFGLARWLEHELQYQMRTSSARNHQFH 287
+ H ++HRD+K N+++D + +L DFG L+ +
Sbjct: 163 RHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFD------- 209
Query: 288 LAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
GT Y PPE + + V+S GI++ ++V G
Sbjct: 210 --------GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 5e-20
Identities = 46/156 (29%), Positives = 75/156 (48%), Gaps = 8/156 (5%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLA-EKGERFEKTFAAELVAVAHLRHRNLV 171
F + E LG+G + VY+ + + G VA+K + + E T E+ + L+H N+V
Sbjct: 7 FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIV 66
Query: 172 RLRGWCVHEDQLLLVYDYMPNRSLD-RVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHY 230
RL E++L LV+++M D + L K L L +
Sbjct: 67 RLYDVIHTENKLTLVFEFM---DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123
Query: 231 LHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLAR 266
HE +I+HRD+K N++++ + +LGDFGLAR
Sbjct: 124 CHEN---KILHRDLKPQNLLINKRGQLKLGDFGLAR 156
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 7e-20
Identities = 45/214 (21%), Positives = 94/214 (43%), Gaps = 31/214 (14%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVR 172
+ E+LG G FG+V++ + G +A K + +G + ++ E+ + L H NL++
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 173 LRGWCVHEDQLLLVYDYMPNRSL-DRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYL 231
L ++ ++LV +Y+ L DR++ E ++ + + ++
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDT-------ILFMKQICEGIRHM 203
Query: 232 HEQLETQIIHRDVKTSNVMLDSQYNARL--GDFGLARWLEHELQYQMRTSSARNHQFHLA 289
H+ I+H D+K N++ ++ ++ DFGLAR + +++
Sbjct: 204 HQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR--EKLKV----------- 247
Query: 290 ETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGI 323
GT +L PE V + +D++S G+
Sbjct: 248 ----NFGTPEFLAPEVVNYDFV-SFPTDMWSVGV 276
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 8e-20
Identities = 37/162 (22%), Positives = 73/162 (45%), Gaps = 16/162 (9%)
Query: 115 EDEVLGSGGFGKVYRAV--LPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVR 172
E +G G +G VY+A D A+K + +G + E+ + L+H N++
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI--EGTGISMSACREIALLRELKHPNVIS 82
Query: 173 LRGWCVH--EDQLLLVYDYMPNRSLDRVL--FRRPENLEAAAPLNWEQRKKIIRGLAAAL 228
L+ + + ++ L++DY L ++ R + + L K ++ + +
Sbjct: 83 LQKVFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141
Query: 229 HYLHEQLETQIIHRDVKTSNVMLDSQYNAR----LGDFGLAR 266
HYLH ++HRD+K +N+++ + R + D G AR
Sbjct: 142 HYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 180
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 1e-19
Identities = 43/159 (27%), Positives = 75/159 (47%), Gaps = 15/159 (9%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVK-----CLAEKGERFEKTFAAELVAVAHLRH 167
+++ + LG G F VY+A + +VA+K +E + +T E+ + L H
Sbjct: 12 YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 71
Query: 168 RNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAA 227
N++ L H+ + LV+D+M L+ ++ L + K +
Sbjct: 72 PNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPS------HIKAYMLMTLQG 124
Query: 228 LHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLAR 266
L YLH+ I+HRD+K +N++LD +L DFGLA+
Sbjct: 125 LEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 41/161 (25%), Positives = 75/161 (46%), Gaps = 18/161 (11%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVK--CLAEKGERFEKTFAAELVAVAHLRHRNL 170
+ LG G +G+VY+A+ VA+K L + E T E+ + L+HRN+
Sbjct: 36 YRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNI 95
Query: 171 VRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHY 230
+ L+ H +L L+++Y L + + + P ++ K + L +++
Sbjct: 96 IELKSVIHHNHRLHLIFEYA-ENDLKKYMDKNP-------DVSMRVIKSFLYQLINGVNF 147
Query: 231 LHEQLETQIIHRDVKTSNVMLDSQYNAR-----LGDFGLAR 266
H + + +HRD+K N++L + +GDFGLAR
Sbjct: 148 CHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 2e-19
Identities = 49/223 (21%), Positives = 92/223 (41%), Gaps = 36/223 (16%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLR 174
+LG G FG+V + AVK + + + T E+ + L H N+++L
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 175 GWCVHEDQLLLVYDYMPNRSL-DRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHE 233
+V + L D ++ R+ + AA +II+ + + + Y+H+
Sbjct: 88 EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA--------RIIKQVFSGITYMHK 139
Query: 234 QLETQIIHRDVKTSNVMLDSQ-YNARL--GDFGLARWLEHELQYQMRTSSARNHQFHLAE 290
I+HRD+K N++L+S+ + + DFGL+ + +
Sbjct: 140 H---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---------------- 180
Query: 291 TTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRR 333
GT Y+ PE + K DV+S G+++ ++SG
Sbjct: 181 -KDRIGTAYYIAPEVLRGTY--DEKCDVWSAGVILYILLSGTP 220
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 53/225 (23%), Positives = 85/225 (37%), Gaps = 46/225 (20%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLR---------- 166
E+LG G V R + AVK + G + + A L+
Sbjct: 23 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82
Query: 167 HRNLVRLRGWCVHEDQLLLVYDYMPNRSL-DRVLFRRPENL-EAAAPLNWEQRKKIIRGL 224
H N+++L+ LV+D M L D + + L E +KI+R L
Sbjct: 83 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKET-------RKIMRAL 133
Query: 225 AAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNH 284
+ LH+ I+HRD+K N++LD N +L DFG + L+ ++R
Sbjct: 134 LEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLRE------ 182
Query: 285 QFHLAETTRIGGTIGYLPPESFQKGSVATAKS-----DVFSFGIV 324
+ GT YL PE + D++S G++
Sbjct: 183 ---------VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVI 218
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 3e-19
Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 36/214 (16%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGW 176
EVLGSG F +V+ G + A+KC+ + + + E+ + ++H N+V L
Sbjct: 15 EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74
Query: 177 CVHEDQLLLVYDYMPNRSL-DRVLFRRPENL-EAAAPLNWEQRKKIIRGLAAALHYLHEQ 234
LV + L DR+L R E A +I+ + +A+ YLHE
Sbjct: 75 YESTTHYYLVMQLVSGGELFDRILER--GVYTEKDA-------SLVIQQVLSAVKYLHEN 125
Query: 235 LETQIIHRDVKTSNVMLDSQY-NARL--GDFGLARWLEHELQYQMRTSSARNHQFHLAET 291
I+HRD+K N++ + N+++ DFGL++ ++ M T
Sbjct: 126 ---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG---IMST------------- 166
Query: 292 TRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVV 325
GT GY+ PE + + A D +S G++
Sbjct: 167 --ACGTPGYVAPEVLAQKPYSKA-VDCWSIGVIT 197
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 5e-19
Identities = 55/220 (25%), Positives = 81/220 (36%), Gaps = 39/220 (17%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKC-----LAEKGERFEKTFAAELVAVAHLRHRNLV 171
EV+G G F V R + G AVK + E L+H ++V
Sbjct: 30 EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 172 RLRGWCVHEDQLLLVYDYMPNRSL-DRVLFRRPENL---EAAAPLNWEQRKKIIRGLAAA 227
L + L +V+++M L ++ R EA A +R + A
Sbjct: 90 ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA-------SHYMRQILEA 142
Query: 228 LHYLHEQLETQIIHRDVKTSNVMLDSQYNA---RLGDFGLARWLEHELQYQMRTSSARNH 284
L Y H+ IIHRDVK V+L S+ N+ +LG FG+A L E
Sbjct: 143 LRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG-ESGLVAGG------ 192
Query: 285 QFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIV 324
GT ++ PE K DV+ G++
Sbjct: 193 ---------RVGTPHFMAPEVV-KREPYGKPVDVWGCGVI 222
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 6e-19
Identities = 46/212 (21%), Positives = 82/212 (38%), Gaps = 34/212 (16%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGW 176
+G G +G+V AV A K + + F E+ + L H N++RL
Sbjct: 15 NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET 74
Query: 177 CVHEDQLLLVYDYMPNRSL-DRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQL 235
+ LV + L +RV+ +R AA +I++ + +A+ Y H+
Sbjct: 75 FEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA--------RIMKDVLSAVAYCHKL- 125
Query: 236 ETQIIHRDVKTSNVMLDSQ---YNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETT 292
+ HRD+K N + + +L DFGLA + T
Sbjct: 126 --NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM----------------RT 167
Query: 293 RIGGTIGYLPPESFQKGSVATAKSDVFSFGIV 324
++ GT Y+ P+ + + D +S G++
Sbjct: 168 KV-GTPYYVSPQVLEGLY--GPECDEWSAGVM 196
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 7e-19
Identities = 49/157 (31%), Positives = 78/157 (49%), Gaps = 15/157 (9%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCL---AEKGERFEKTFAAELVAVAHLRHRN 169
+ + E +G G +G VY+A S G +VA+K + AE E T E+ + L H N
Sbjct: 23 YQKLEKVGEGTYGVVYKA-KDSQGRIVALKRIRLDAED-EGIPSTAIREISLLKELHHPN 80
Query: 170 LVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALH 229
+V L E L LV+++M L +VL L+ + Q K + L +
Sbjct: 81 IVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDS------QIKIYLYQLLRGVA 133
Query: 230 YLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLAR 266
+ H+ +I+HRD+K N++++S +L DFGLAR
Sbjct: 134 HCHQH---RILHRDLKPQNLLINSDGALKLADFGLAR 167
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 49/214 (22%), Positives = 90/214 (42%), Gaps = 36/214 (16%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLR 174
+LG G FG+V + AVK + + + T E+ + L H N+++L
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 175 GWCVHEDQLLLVYDYMPNRSL-DRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHE 233
+V + L D ++ R+ + E A +II+ + + + Y+H+
Sbjct: 88 EILEDSSSFYIVGELYTGGELFDEIIKRKRFS-EHDA-------ARIIKQVFSGITYMHK 139
Query: 234 QLETQIIHRDVKTSNVMLDSQ---YNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAE 290
I+HRD+K N++L+S+ + ++ DFGL+ + +
Sbjct: 140 H---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---------------- 180
Query: 291 TTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIV 324
RI GT Y+ PE + K DV+S G++
Sbjct: 181 KDRI-GTAYYIAPEVLRGTY--DEKCDVWSAGVI 211
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 89.6 bits (222), Expect = 2e-18
Identities = 56/234 (23%), Positives = 94/234 (40%), Gaps = 40/234 (17%)
Query: 108 IGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCL------AEKGERF---EKTFAAE 158
+ N F ++G GGFG+VY G + A+KCL ++GE E+
Sbjct: 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM--- 242
Query: 159 LVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRK 218
L V+ +V + D+L + D M L L + EA +
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE-- 300
Query: 219 KIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRT 278
+ L ++H + +++RD+K +N++LD + R+ D GLA
Sbjct: 301 -----IILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC------------ 340
Query: 279 SSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
F + GT GY+ PE QKG + +D FS G ++ +++ G
Sbjct: 341 ------DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 2e-18
Identities = 57/257 (22%), Positives = 94/257 (36%), Gaps = 53/257 (20%)
Query: 93 VGGDNPRIFSYAELYIGSNGFDE---------DEVLGSGGFGKVYRAVLPSDGTVVAVKC 143
+ ++F + +L + + LGSG G+V A VA++
Sbjct: 108 LSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRI 167
Query: 144 LA--------EKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNRSL 195
++ + E+ + L H +++++ + + +V + M L
Sbjct: 168 ISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL 226
Query: 196 -DRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQ 254
D+V+ + EA K + A+ YLHE IIHRD+K NV+L SQ
Sbjct: 227 FDKVVGNKRLK-EATC-------KLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQ 275
Query: 255 ---YNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSV 311
++ DFG ++ L MRT GT YL PE
Sbjct: 276 EEDCLIKITDFGHSKILGE--TSLMRTLC---------------GTPTYLAPEVLVSVGT 318
Query: 312 A--TAKSDVFSFGIVVL 326
A D +S G V+L
Sbjct: 319 AGYNRAVDCWSLG-VIL 334
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 47/220 (21%), Positives = 89/220 (40%), Gaps = 37/220 (16%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLA-EKGERFEKTFAAELVAVAHLRHRNLV 171
F LGSG FG V+ S G +K + ++ + + AE+ + L H N++
Sbjct: 24 FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 172 RLRGWCVHEDQLLLVYDYMPNRSL-DRVLFRRPENL---EAAAPLNWEQRKKIIRGLAAA 227
++ + +V + L +R++ + E ++++ + A
Sbjct: 84 KIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYV-------AELMKQMMNA 136
Query: 228 LHYLHEQLETQIIHRDVKTSNVMLDSQY-NARL--GDFGLARWLEHELQYQMRTSSARNH 284
L Y H Q ++H+D+K N++ ++ + DFGLA + +
Sbjct: 137 LAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---------- 183
Query: 285 QFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIV 324
T GT Y+ PE F++ T K D++S G+V
Sbjct: 184 ------TNAA-GTALYMAPEVFKRDV--TFKCDIWSAGVV 214
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 8e-04
Identities = 38/211 (18%), Positives = 73/211 (34%), Gaps = 52/211 (24%)
Query: 526 FGTAYQGF-LDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGE 584
FG + + ++K + + + E++ L L H N++++
Sbjct: 35 FGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKI--------- 85
Query: 585 MLVIYDYSATRILSHL---------LFHNNHRIGHSILQWHHRYN------IIKSLASAI 629
++ ++ L RI S + ++K + +A+
Sbjct: 86 ----FEVFEDYHNMYIVMETCEGGELLE---RI-VSAQARGKALSEGYVAELMKQMMNAL 137
Query: 630 LYLHEEWNEQVIHR-----NITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNR 684
Y H + V+H+ NI P ++ F LAE ++H A
Sbjct: 138 AYFHS---QHVVHKDLKPENILFQ--DTSPHSPIKIIDFGLAELFKSDEHSTNAA----- 187
Query: 685 SVRGIFGYMSPEYIESGEATSMADVYSFGVV 715
G YM+PE + + T D++S GVV
Sbjct: 188 ---GTALYMAPEVFK-RDVTFKCDIWSAGVV 214
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 3e-18
Identities = 41/157 (26%), Positives = 77/157 (49%), Gaps = 15/157 (9%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCL---AEKGERFEKTFAAELVAVAHLRHRN 169
+ E +G G +G VY+A G A+K + E E T E+ + L+H N
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNNY-GETFALKKIRLEKED-EGIPSTTIREISILKELKHSN 61
Query: 170 LVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALH 229
+V+L + +L+LV++++ L ++L LE+ K + L +
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESV------TAKSFLLQLLNGIA 114
Query: 230 YLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLAR 266
Y H++ +++HRD+K N++++ + ++ DFGLAR
Sbjct: 115 YCHDR---RVLHRDLKPQNLLINREGELKIADFGLAR 148
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 4e-18
Identities = 54/213 (25%), Positives = 92/213 (43%), Gaps = 37/213 (17%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGW 176
LG G VYR A+K L + + +K E+ + L H N+++L+
Sbjct: 59 SELGRGATSIVYRCKQKGTQKPYALKVLKKTVD--KKIVRTEIGVLLRLSHPNIIKLKEI 116
Query: 177 CVHEDQLLLVYDYMPNRSL-DRVLFRRPENL-EAAAPLNWEQRKKIIRGLAAALHYLHEQ 234
++ LV + + L DR++ + E A ++ + A+ YLHE
Sbjct: 117 FETPTEISLVLELVTGGELFDRIVEK--GYYSERDA-------ADAVKQILEAVAYLHEN 167
Query: 235 LETQIIHRDVKTSNVMLDSQY-NARL--GDFGLARWLEHELQYQMRTSSARNHQFHLAET 291
I+HRD+K N++ + +A L DFGL++ +EH Q M+T
Sbjct: 168 ---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH--QVLMKT------------- 209
Query: 292 TRIGGTIGYLPPESFQKGSVATAKSDVFSFGIV 324
+ GT GY PE + + + D++S GI+
Sbjct: 210 --VCGTPGYCAPEILRGCAY-GPEVDMWSVGII 239
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 4e-18
Identities = 45/216 (20%), Positives = 88/216 (40%), Gaps = 42/216 (19%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHL-RHRNLVRLRG 175
E +G G + R + + AVK + + + E+ + +H N++ L+
Sbjct: 28 EDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EIEILLRYGQHPNIITLKD 83
Query: 176 WCVHEDQ--LLLVYDYMPNRSL-DRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLH 232
V++D + +V + M L D++L ++ + E A ++ + + YLH
Sbjct: 84 --VYDDGKYVYVVTELMKGGELLDKILRQKFFS-EREA-------SAVLFTITKTVEYLH 133
Query: 233 EQLETQIIHRDVKTSNVMLDSQYNA----RLGDFGLARWLEHELQYQMRTSSARNHQFHL 288
Q ++HRD+K SN++ + R+ DFG A+ L E + T
Sbjct: 134 AQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE-NGLLMT---------- 179
Query: 289 AETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIV 324
T ++ PE + A D++S G++
Sbjct: 180 -----PCYTANFVAPEVL-ERQGYDAACDIWSLGVL 209
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 5e-18
Identities = 51/246 (20%), Positives = 94/246 (38%), Gaps = 61/246 (24%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAH-------------- 164
+G G +G V A +D T A+K L++K + F
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 165 ------------LRHRNLVRLRGWCV----HEDQLLLVYDYMPNRSLDRVLFRRPENLEA 208
L H N+V+L V +ED L +V++ + + +
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLV--EVLDDPNEDHLYMVFELVNQG----PVM----EVPT 130
Query: 209 AAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWL 268
PL+ +Q + + L + YLH Q +IIHRD+K SN+++ + ++ DFG++
Sbjct: 131 LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187
Query: 269 EHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQ--KGSVATAKSDVFSFGIVVL 326
+ + + GT ++ PES + + DV++ G+ +
Sbjct: 188 KGS-DALLSNTV---------------GTPAFMAPESLSETRKIFSGKALDVWAMGVTLY 231
Query: 327 EVVSGR 332
V G+
Sbjct: 232 CFVFGQ 237
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 6e-18
Identities = 57/216 (26%), Positives = 85/216 (39%), Gaps = 39/216 (18%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK---GERFEKTFAAELVAVAHLRHRNLVRL 173
E LG G F V R V + G A K + K F+K E L+H N+VRL
Sbjct: 12 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-LEREARICRKLQHPNIVRL 70
Query: 174 RGWCVHEDQLLLVYDYMPNRSL-DRVLFRRPENL-EAAAPLNWEQRKKIIRGLAAALHYL 231
E LV+D + L + ++ R E EA A I+ + ++ Y
Sbjct: 71 HDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEADA-------SHCIQQILESIAYC 121
Query: 232 HEQLETQIIHRDVKTSNVMLDSQYNA---RLGDFGLARWLEHELQYQMRTSSARNHQFHL 288
H I+HR++K N++L S+ +L DFGLA +
Sbjct: 122 HSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--SEAWHG---------- 166
Query: 289 AETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIV 324
GT GYL PE K + D+++ G++
Sbjct: 167 -----FAGTPGYLSPEVL-KKDPYSKPVDIWACGVI 196
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 8e-18
Identities = 50/221 (22%), Positives = 83/221 (37%), Gaps = 48/221 (21%)
Query: 116 DEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHL-RHRNLVRLR 174
+VLG G GKV G A+K L + + E+ ++V +
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALKLL-YDSPKARQ----EVDHHWQASGGPHIVCIL 88
Query: 175 GWCVHEDQ------LLLVYDYMPNRSL-DRVLFRRPENL-EAAAPLNWEQRKKIIRGLAA 226
V+E+ LL++ + M L R+ R + E A +I+R +
Sbjct: 89 D--VYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREA-------AEIMRDIGT 139
Query: 227 ALHYLHEQLETQIIHRDVKTSNVMLDSQY-NA--RLGDFGLARWLEHELQYQMRTSSARN 283
A+ +LH I HRDVK N++ S+ +A +L DFG A+ ++T
Sbjct: 140 AIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN---ALQT----- 188
Query: 284 HQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIV 324
T Y+ PE D++S G++
Sbjct: 189 ----------PCYTPYYVAPEVLGPEKY-DKSCDMWSLGVI 218
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 8e-18
Identities = 45/220 (20%), Positives = 90/220 (40%), Gaps = 33/220 (15%)
Query: 116 DEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLR-HRNLVRLR 174
++VLG G +V + AVK + ++ E+ + + HRN++ L
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 175 GWCVHEDQ--LLLVYDYMPNRSL-DRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYL 231
E++ LV++ M S+ + RR N A+ +++ +A+AL +L
Sbjct: 78 E--FFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS--------VVVQDVASALDFL 127
Query: 232 HEQLETQIIHRDVKTSNVMLDSQYNA---RLGDFGLARWLEHELQYQMRTSSARNHQFHL 288
H + I HRD+K N++ + ++ DF L ++ ++
Sbjct: 128 HNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPEL------ 178
Query: 289 AETTRIGGTIGYLPPESFQKGSVATA----KSDVFSFGIV 324
T G+ Y+ PE + S + + D++S G++
Sbjct: 179 --LTPC-GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVI 215
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 9e-18
Identities = 57/224 (25%), Positives = 87/224 (38%), Gaps = 45/224 (20%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVA-----VAHLR----H 167
+V+G G V R V + G AVK + ER E+ LR H
Sbjct: 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159
Query: 168 RNLVRLRGWCVHEDQLLLVYDYMPNRSL-DRVLFRRPENL-EAAAPLNWEQRKKIIRGLA 225
+++ L + LV+D M L D + + L E + I+R L
Sbjct: 160 PHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK--VALSEKET-------RSIMRSLL 210
Query: 226 AALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQ 285
A+ +LH I+HRD+K N++LD RL DFG + LE ++R
Sbjct: 211 EAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG--EKLRE------- 258
Query: 286 FHLAETTRIGGTIGYLPPESFQKGSVATAKS-----DVFSFGIV 324
+ GT GYL PE + T D+++ G++
Sbjct: 259 --------LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVI 294
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-17
Identities = 50/224 (22%), Positives = 93/224 (41%), Gaps = 42/224 (18%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAA------ELVAVAHLR 166
+D E LGSG F V + S G A K + ++ R + E+ + +
Sbjct: 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 167 HRNLVRLRGWCVHEDQLLLVYDYMPNRSL-DRVLFRRPENL-EAAAPLNWEQRKKIIRGL 224
H N++ L + ++L+ + + L D + + E+L E A I+ +
Sbjct: 74 HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQK--ESLSEEEA-------TSFIKQI 124
Query: 225 AAALHYLHEQLETQIIHRDVKTSNVMLDSQ----YNARLGDFGLARWLEHELQYQMRTSS 280
++YLH + +I H D+K N+ML + + +L DFGLA +E + +
Sbjct: 125 LDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED--GVEFKN-- 177
Query: 281 ARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIV 324
I GT ++ PE + ++D++S G++
Sbjct: 178 -------------IFGTPEFVAPEIVNYEPL-GLEADMWSIGVI 207
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 2e-17
Identities = 46/165 (27%), Positives = 80/165 (48%), Gaps = 22/165 (13%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCL---AEKGERFEKTFAAELVAVAHLRHRN 169
+++ +G G FG+V++A G VA+K + EK E F T E+ + L+H N
Sbjct: 19 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHEN 77
Query: 170 LVRLRGWCV--------HEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKII 221
+V L C + + LV+D+ + L +L + + K+++
Sbjct: 78 VVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLS------EIKRVM 130
Query: 222 RGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLAR 266
+ L L+Y+H +I+HRD+K +NV++ +L DFGLAR
Sbjct: 131 QMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 172
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 57/216 (26%), Positives = 86/216 (39%), Gaps = 39/216 (18%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK---GERFEKTFAAELVAVAHLRHRNLVRL 173
E LG G F V R V + G A K + K F+K E L+H N+VRL
Sbjct: 35 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-LEREARICRKLQHPNIVRL 93
Query: 174 RGWCVHEDQLLLVYDYMPNRSL-DRVLFRRPENL-EAAAPLNWEQRKKIIRGLAAALHYL 231
E LV+D + L + ++ R E EA A I+ + ++ Y
Sbjct: 94 HDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEADA-------SHCIQQILESIAYC 144
Query: 232 HEQLETQIIHRDVKTSNVMLDSQYNA---RLGDFGLARWLEHELQYQMRTSSARNHQFHL 288
H I+HR++K N++L S+ +L DFGLA + +
Sbjct: 145 HSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW-------------- 187
Query: 289 AETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIV 324
GT GYL PE K + D+++ G++
Sbjct: 188 --HGFA-GTPGYLSPEVL-KKDPYSKPVDIWACGVI 219
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-17
Identities = 53/214 (24%), Positives = 84/214 (39%), Gaps = 34/214 (15%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERF--EKTFAAELVAVAHLRHRNLVRLR 174
E LG G F V R V G A + K + E L+H N+VRL
Sbjct: 17 EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 76
Query: 175 GWCVHEDQLLLVYDYMPNRSL-DRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHE 233
E L++D + L + ++ R + EA A I+ + A+ + H+
Sbjct: 77 DSISEEGHHYLIFDLVTGGELFEDIVAREYYS-EADA-------SHCIQQILEAVLHCHQ 128
Query: 234 QLETQIIHRDVKTSNVMLDSQYNA---RLGDFGLARWLEHELQYQMRTSSARNHQFHLAE 290
++HR++K N++L S+ +L DFGLA +E E Q
Sbjct: 129 M---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE-QQAWFG------------ 172
Query: 291 TTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIV 324
GT GYL PE + D+++ G++
Sbjct: 173 ---FAGTPGYLSPEVL-RKDPYGKPVDLWACGVI 202
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 2e-17
Identities = 47/175 (26%), Positives = 78/175 (44%), Gaps = 22/175 (12%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCL-----AEKGERFEKTFAAE---LVAVAH 164
++ +G G +G VY+A P G VA+K + G + E L +
Sbjct: 11 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEA 70
Query: 165 LRHRNLVRLRGWCV-----HEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKK 219
H N+VRL C E ++ LV++++ ++ L L + P L E K
Sbjct: 71 FEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPP-----GLPAETIKD 124
Query: 220 IIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQY 274
++R L +LH I+HRD+K N+++ S +L DFGLAR +++
Sbjct: 125 LMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL 176
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 49/220 (22%), Positives = 92/220 (41%), Gaps = 42/220 (19%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAA------ELVAVAHLRHRNL 170
E LGSG F V + S G A K + ++ R + + E+ + + H N+
Sbjct: 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 171 VRLRGWCVHEDQLLLVYDYMPNRSL-DRVLFRRPENL-EAAAPLNWEQRKKIIRGLAAAL 228
+ L + ++L+ + + L D + + E+L E A I+ + +
Sbjct: 78 ITLHDVYENRTDVVLILELVSGGELFDFLAQK--ESLSEEEA-------TSFIKQILDGV 128
Query: 229 HYLHEQLETQIIHRDVKTSNVMLDSQ----YNARLGDFGLARWLEHELQYQMRTSSARNH 284
+YLH + +I H D+K N+ML + + +L DFGLA +E + +
Sbjct: 129 NYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED--GVEFKN------ 177
Query: 285 QFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIV 324
I GT ++ PE + ++D++S G++
Sbjct: 178 ---------IFGTPEFVAPEIVNYEPL-GLEADMWSIGVI 207
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 3e-17
Identities = 49/234 (20%), Positives = 83/234 (35%), Gaps = 54/234 (23%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCL--------AEKGERFEKTFAAELVAVAHLRHR 168
LGSG FG V+ AV V VK + + E+ ++ + H
Sbjct: 30 SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89
Query: 169 NLVRLRGWCVHEDQLLLV----------YDYMPNRSLDRVLFRRPENLEAAAPLNWEQRK 218
N++++ ++ LV + ++ R E A
Sbjct: 90 NIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP------RLDEP-LA---------S 133
Query: 219 KIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRT 278
I R L +A+ YL + IIHRD+K N+++ + +L DFG
Sbjct: 134 YIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGS-------------- 176
Query: 279 SSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
+A + L T GTI Y PE + +++S G+ + +V
Sbjct: 177 -AAYLERGKLFYTF--CGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 4e-17
Identities = 59/226 (26%), Positives = 91/226 (40%), Gaps = 46/226 (20%)
Query: 116 DEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK----GERFEKTFAAEL---VAV-AHLRH 167
+ LGSG G+V A VA+K ++++ G E A + + + L H
Sbjct: 15 SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74
Query: 168 RNLVRLRGWCVHEDQLLLVYDYMPNRSL-DRVLFRRPENL-EAAAPLNWEQRKKIIRGLA 225
+++++ + + +V + M L D+V+ + L EA K +
Sbjct: 75 PCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGN--KRLKEATC-------KLYFYQML 124
Query: 226 AALHYLHEQLETQIIHRDVKTSNVMLDSQ---YNARLGDFGLARWLEHELQYQMRTSSAR 282
A+ YLHE IIHRD+K NV+L SQ ++ DFG ++ L MRT
Sbjct: 125 LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLC-- 177
Query: 283 NHQFHLAETTRIGGTIGYLPPESFQKGSVA--TAKSDVFSFGIVVL 326
GT YL PE A D +S G V+L
Sbjct: 178 -------------GTPTYLAPEVLVSVGTAGYNRAVDCWSLG-VIL 209
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 4e-17
Identities = 47/221 (21%), Positives = 86/221 (38%), Gaps = 44/221 (19%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAV-------AHLRHRN 169
E LGSG F V + G A K + K + +RH N
Sbjct: 11 EELGSGQFAIVRKCRQKGTGKEYAAKFIK-KRRLSSSRRGVSREEIEREVNILREIRHPN 69
Query: 170 LVRLRGWCVHEDQLLLVYDYMPNRSL-DRVLFRRPENL-EAAAPLNWEQRKKIIRGLAAA 227
++ L ++ ++L+ + + L D + + E+L E A + ++ +
Sbjct: 70 IITLHDIFENKTDVVLILELVSGGELFDFLAEK--ESLTEDEA-------TQFLKQILDG 120
Query: 228 LHYLHEQLETQIIHRDVKTSNVMLDSQYNA----RLGDFGLARWLEHELQYQMRTSSARN 283
+HYLH + +I H D+K N+ML + +L DFG+A +E + +
Sbjct: 121 VHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA--GNEFKN----- 170
Query: 284 HQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIV 324
I GT ++ PE + +D++S G++
Sbjct: 171 ----------IFGTPEFVAPEIVNYEPLGLE-ADMWSIGVI 200
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 5e-17
Identities = 56/215 (26%), Positives = 90/215 (41%), Gaps = 25/215 (11%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVKCLA-EKGERFEKTFAAELVAVAHLRHRNLVRLRGWC 177
LG G +G+V AV VAVK + ++ + E+ L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 178 VHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLET 237
+ L +Y L F R +E + ++ L A + YLH
Sbjct: 75 REGNIQYLFLEYCSGGEL----FDR---IEPDIGMPEPDAQRFFHQLMAGVVYLHGI--- 124
Query: 238 QIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGT 297
I HRD+K N++LD + N ++ DFGLA + N++ L GT
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRY------------NNRERLLNKM--CGT 170
Query: 298 IGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
+ Y+ PE ++ DV+S GIV+ +++G
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 5e-17
Identities = 55/241 (22%), Positives = 101/241 (41%), Gaps = 33/241 (13%)
Query: 95 GDNPRIFSYAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCL--AEKGERFE 152
G++ + + +IG+ + + +G G F KV A G VA+K + +
Sbjct: 1 GNSIASCADEQPHIGN--YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSL 58
Query: 153 KTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNRSL-DRVLFRRPENLEAAAP 211
+ E+ + L H N+V+L E L L+ +Y + D L A
Sbjct: 59 QKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDY--------LVAHGR 110
Query: 212 LNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHE 271
+ ++ + R + +A+ Y H++ +I+HRD+K N++LD+ N ++ DFG +
Sbjct: 111 MKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167
Query: 272 LQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSG 331
++ G Y PE FQ + DV+S G+++ +VSG
Sbjct: 168 --GKLDAFC---------------GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210
Query: 332 R 332
Sbjct: 211 S 211
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 6e-17
Identities = 51/221 (23%), Positives = 85/221 (38%), Gaps = 47/221 (21%)
Query: 116 DEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHL-RHRNLVRLR 174
+VLG G GKV + A+K L + + + E+ + ++VR+
Sbjct: 67 SQVLGLGINGKVLQIFNKRTQEKFALKML-QDCPKARR----EVELHWRASQCPHIVRIV 121
Query: 175 GWCVHEDQ------LLLVYDYMPNRSL-DRVLFRRPENL-EAAAPLNWEQRKKIIRGLAA 226
V+E+ LL+V + + L R+ R + E A +I++ +
Sbjct: 122 D--VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREA-------SEIMKSIGE 172
Query: 227 ALHYLHEQLETQIIHRDVKTSNVMLDSQY-NA--RLGDFGLARWLEHELQYQMRTSSARN 283
A+ YLH I HRDVK N++ S+ NA +L DFG A+ + T
Sbjct: 173 AIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NSLTT----- 222
Query: 284 HQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIV 324
T Y+ PE D++S G++
Sbjct: 223 ----------PCYTPYYVAPEVLGPEKY-DKSCDMWSLGVI 252
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 6e-17
Identities = 67/341 (19%), Positives = 123/341 (36%), Gaps = 67/341 (19%)
Query: 16 DEIGPYEKSRVHNVVSRKQEVKEQHGRGCGRRILSFIADKLQRLYEAKWVCFCHHNTPRK 75
D + YE + + + + + G ++ + +L V C +
Sbjct: 85 DGVAEYEVTPDDKRKACGRNLTQNFLSHTGPDLIPEVPRQL--------VTNCTQRLEQG 136
Query: 76 EHSGLFHDMEGVQMSEKVGGDNPRIFSYAELY-------------IGSNGFDEDEVLGSG 122
LF ++ + E + + + + + N F + VLG G
Sbjct: 137 PCKDLFQELTRLTH-EYLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKG 195
Query: 123 GFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFA-AELVAVAHLRHRNLVRLRGWCV 178
GFG+V + + G + A K L EK +R + A E + + R +V L
Sbjct: 196 GFGEVCACQVRATGKMYACKKL-EKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE 254
Query: 179 HEDQLLLVYDYMPNRSL-------DRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYL 231
+D L LV M L + F + AA + L L
Sbjct: 255 TKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE------------ICCGLEDL 302
Query: 232 HEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAET 291
H + +I++RD+K N++LD + R+ D GLA +
Sbjct: 303 HRE---RIVYRDLKPENILLDDHGHIRISDLGLAV----HVPEGQTIK------------ 343
Query: 292 TRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
R+ GT+GY+ PE + + D ++ G ++ E+++G+
Sbjct: 344 GRV-GTVGYMAPEVVKNERYTFS-PDWWALGCLLYEMIAGQ 382
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 7e-17
Identities = 50/216 (23%), Positives = 89/216 (41%), Gaps = 40/216 (18%)
Query: 116 DEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLR-HRNLVRLR 174
D+ LG G F + V AVK ++ +R E E+ A+ H N+V+L
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIIS---KRMEANTQKEITALKLCEGHPNIVKLH 72
Query: 175 GWCVHEDQ--LLLVYDYMPNRSL-DRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYL 231
V DQ LV + + L +R+ ++ + E A I+R L +A+ ++
Sbjct: 73 E--VFHDQLHTFLVMELLNGGELFERIKKKKHFS-ETEA-------SYIMRKLVSAVSHM 122
Query: 232 HEQLETQIIHRDVKTSNVMLDSQY-NA--RLGDFGLARWLEHELQYQMRTSSARNHQFHL 288
H+ ++HRD+K N++ + N ++ DFG AR + ++T
Sbjct: 123 HDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD-NQPLKT---------- 168
Query: 289 AETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIV 324
T+ Y PE + D++S G++
Sbjct: 169 -----PCFTLHYAAPELL-NQNGYDESCDLWSLGVI 198
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 9e-17
Identities = 47/218 (21%), Positives = 91/218 (41%), Gaps = 36/218 (16%)
Query: 115 EDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHR-NLV 171
+ LG G F V + + S G A K L ++ G+ E+ + + ++
Sbjct: 33 TSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVI 92
Query: 172 RLRGWCVHEDQLLLVYDYMPNRSL-DRVLFRRPENL-EAAAPLNWEQRKKIIRGLAAALH 229
L + +++L+ +Y + L E + E ++I+ + ++
Sbjct: 93 NLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDV-------IRLIKQILEGVY 145
Query: 230 YLHEQLETQIIHRDVKTSNVMLDSQY---NARLGDFGLARWLEHELQYQMRTSSARNHQF 286
YLH+ I+H D+K N++L S Y + ++ DFG++R + H ++R
Sbjct: 146 YLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH--ACELRE-------- 192
Query: 287 HLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIV 324
I GT YL PE + T +D+++ GI+
Sbjct: 193 -------IMGTPEYLAPEILNYDPI-TTATDMWNIGII 222
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 9e-17
Identities = 54/242 (22%), Positives = 94/242 (38%), Gaps = 42/242 (17%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLA----EKGERFEKTFAAELVAVAHLRHRNLVR 172
++LG G +GKV + AVK L + E E+ + LRH+N+++
Sbjct: 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 173 LRGWCVHE--DQLLLVYDYMPNRS---LDRVLFRR-PENLEAAAPLNWEQRKKIIRGLAA 226
L +E ++ +V +Y LD V +R P +A L
Sbjct: 71 LVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVC-QA---------HGYFCQLID 120
Query: 227 ALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQF 286
L YLH Q I+H+D+K N++L + ++ G+A L
Sbjct: 121 GLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF------------AAD 165
Query: 287 HLAETTRIGGTIGYLPPESFQ-KGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQII 345
T++ G+ + PPE + + K D++S G+ + + +G + D I
Sbjct: 166 DTCRTSQ--GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL----YPFEGDNIY 219
Query: 346 LL 347
L
Sbjct: 220 KL 221
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 43/162 (26%), Positives = 70/162 (43%), Gaps = 29/162 (17%)
Query: 116 DEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHL-RHRNLVRLR 174
+VLG G GKV + A+K L + + + E+ + ++VR+
Sbjct: 23 SQVLGLGINGKVLQIFNKRTQEKFALKML-QDCPKARR----EVELHWRASQCPHIVRIV 77
Query: 175 GWCVHEDQ------LLLVYDYMPNRSL-DRVLFRRPENL-EAAAPLNWEQRKKIIRGLAA 226
V+E+ LL+V + + L R+ R + E A +I++ +
Sbjct: 78 D--VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREA-------SEIMKSIGE 128
Query: 227 ALHYLHEQLETQIIHRDVKTSNVMLDSQY-NA--RLGDFGLA 265
A+ YLH I HRDVK N++ S+ NA +L DFG A
Sbjct: 129 AIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 1e-16
Identities = 57/223 (25%), Positives = 91/223 (40%), Gaps = 36/223 (16%)
Query: 118 VLGSGGFGKVYRAVLPSDGTVVAVKCLA----EKGERFEKTFAAELVAVAHLRHRNLVRL 173
+G G FGKV + A+K + + F EL + L H LV L
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFK-ELQIMQGLEHPFLVNL 80
Query: 174 RGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKI-IRGLAAALHYLH 232
E+ + +V D + L R ++ + + E+ K+ I L AL YL
Sbjct: 81 WYSFQDEEDMFMVVDLLLGGDL-RYHLQQNVHFK-------EETVKLFICELVMALDYLQ 132
Query: 233 EQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETT 292
Q +IIHRD+K N++LD + + DF +A L + + ++
Sbjct: 133 NQ---RIIHRDMKPDNILLDEHGHVHITDFNIAA----MLPRETQITT------------ 173
Query: 293 RIGGTIGYLPPESFQKGSVA--TAKSDVFSFGIVVLEVVSGRR 333
+ GT Y+ PE F A + D +S G+ E++ GRR
Sbjct: 174 -MAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 57/234 (24%), Positives = 89/234 (38%), Gaps = 50/234 (21%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAH-------- 164
F ++LG G F V A + A+K L EK + V +
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKIL-------EKRHIIKENKVPYVTRERDVM 84
Query: 165 --LRHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIR 222
L H V+L +++L Y N L + + + E R
Sbjct: 85 SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-----------R 133
Query: 223 GLAA----ALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRT 278
A AL YLH + IIHRD+K N++L+ + ++ DFG A+ L E Q R
Sbjct: 134 FYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE-SKQARA 189
Query: 279 SSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
+S GT Y+ PE A SD+++ G ++ ++V+G
Sbjct: 190 NS-------------FVGTAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGL 229
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 2e-04
Identities = 27/103 (26%), Positives = 50/103 (48%), Gaps = 16/103 (15%)
Query: 625 LASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNR 684
+ SA+ YLH + +IHR++ I L+ DM+ ++ F A+ L+ R +
Sbjct: 139 IVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS---- 191
Query: 685 SVRGIF-G---YMSPEYIESGEATSMADVYSFGVVVLEVVTGQ 723
F G Y+SPE + A +D+++ G ++ ++V G
Sbjct: 192 -----FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 3e-16
Identities = 59/185 (31%), Positives = 83/185 (44%), Gaps = 30/185 (16%)
Query: 94 GGDNPRIFSYAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEK 153
G D P+ SY + +V+G+G FG VY+A L G +VA+K + +K
Sbjct: 47 GPDRPQEVSYTDT----------KVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQDK 91
Query: 154 TFAA-ELVAVAHLRHRNLVRLR------GWCVHEDQLLLVYDYMPNRSLDRVLFRRPENL 206
F EL + L H N+VRLR G E L LV DY+P ++ RV
Sbjct: 92 RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAK 150
Query: 207 EAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNA-RLGDFGLA 265
+ L K + L +L Y+H I HRD+K N++LD +L DFG A
Sbjct: 151 Q---TLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA 204
Query: 266 RWLEH 270
+ L
Sbjct: 205 KQLVR 209
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 56/215 (26%), Positives = 90/215 (41%), Gaps = 25/215 (11%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVKCLA-EKGERFEKTFAAELVAVAHLRHRNLVRLRGWC 177
LG G +G+V AV VAVK + ++ + E+ L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 178 VHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLET 237
+ L +Y L F R +E + ++ L A + YLH
Sbjct: 75 REGNIQYLFLEYCSGGEL----FDR---IEPDIGMPEPDAQRFFHQLMAGVVYLHGI--- 124
Query: 238 QIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGT 297
I HRD+K N++LD + N ++ DFGLA + N++ L GT
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRY------------NNRERLLNKM--CGT 170
Query: 298 IGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
+ Y+ PE ++ DV+S GIV+ +++G
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 4e-16
Identities = 47/174 (27%), Positives = 82/174 (47%), Gaps = 22/174 (12%)
Query: 113 FDEDEVLGSGGFGKVYRAV-LPSDGTVVAVKCL---AEKGERFEKTFAAE---LVAVAHL 165
++ +G G +GKV++A L + G VA+K + + E + E L +
Sbjct: 13 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETF 71
Query: 166 RHRNLVRLRGWCV-----HEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKI 220
H N+VRL C E +L LV++++ ++ L L + PE + E K +
Sbjct: 72 EHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEP-----GVPTETIKDM 125
Query: 221 IRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQY 274
+ L L +LH +++HRD+K N+++ S +L DFGLAR ++
Sbjct: 126 MFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL 176
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 4e-16
Identities = 60/231 (25%), Positives = 96/231 (41%), Gaps = 32/231 (13%)
Query: 108 IGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFA-AELVAVA 163
+G + F + VLG GGFG+V+ + + G + A K L K +R A E +A
Sbjct: 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKL-NKKRLKKRKGYQGAMVEKKILA 240
Query: 164 HLRHRNLVRLRGWCVH-EDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKI-I 221
+ R +V L + + L LV M + N++ P E R
Sbjct: 241 KVHSRFIVSLA-YAFETKTDLCLVMTIMNGGD----IRYHIYNVDEDNPGFQEPRAIFYT 295
Query: 222 RGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSA 281
+ + L +LH++ II+RD+K NV+LD N R+ D GLA Q +T
Sbjct: 296 AQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAV---ELKAGQTKTK-- 347
Query: 282 RNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
GT G++ PE + D F+ G+ + E+++ R
Sbjct: 348 ----------GYA-GTPGFMAPELLLGEEYDFS-VDYFALGVTLYEMIAAR 386
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 7e-16
Identities = 47/224 (20%), Positives = 95/224 (42%), Gaps = 42/224 (18%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAA------ELVAVAHLR 166
+D E LGSG F V + S G A K + ++ + + + E+ + ++
Sbjct: 13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 167 HRNLVRLRGWCVHEDQLLLVYDYMPNRSL-DRVLFRRPENL-EAAAPLNWEQRKKIIRGL 224
H N++ L ++ ++L+ + + L D + + E+L E A + ++ +
Sbjct: 73 HPNVITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEA-------TEFLKQI 123
Query: 225 AAALHYLHEQLETQIIHRDVKTSNVMLDSQYNA----RLGDFGLARWLEHELQYQMRTSS 280
++YLH QI H D+K N+ML + ++ DFGLA ++ + +
Sbjct: 124 LNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--NEFKN-- 176
Query: 281 ARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIV 324
I GT ++ PE + ++D++S G++
Sbjct: 177 -------------IFGTPEFVAPEIVNYEPL-GLEADMWSIGVI 206
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 2e-15
Identities = 59/288 (20%), Positives = 113/288 (39%), Gaps = 50/288 (17%)
Query: 54 DKLQRLYEAKWVCFCHHNTPRKEHSGLFHDMEGVQMSEKVGGDNPRIFSYAELYIGSNGF 113
D L LY+ C+++ R+E + + E + P ++ + F
Sbjct: 32 DILICLYDE-----CNNSPLRREKN----------ILEYLEWAKPFTSKVKQMRLHREDF 76
Query: 114 DEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKT----FAAELVAVAHLRHRN 169
+ +V+G G FG+V L + V A+K L K E ++ F E + + +
Sbjct: 77 EILKVIGRGAFGEVAVVKLKNADKVFAMKIL-NKWEMLKRAETACFREERDVLVNGDSKW 135
Query: 170 LVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKI-IRGLAAAL 228
+ L ++ L LV DY L +L + + L E+ + + + A+
Sbjct: 136 ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLP-------EEMARFYLAEMVIAI 188
Query: 229 HYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHL 288
+H+ +HRD+K N+++D + RL DFG + +
Sbjct: 189 DSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGS---------------CLKLMEDGT 230
Query: 289 AETTRIGGTIGYLPPE---SFQKGSVATAKS-DVFSFGIVVLEVVSGR 332
+++ GT Y+ PE + + G D +S G+ + E++ G
Sbjct: 231 VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 3e-15
Identities = 52/290 (17%), Positives = 103/290 (35%), Gaps = 52/290 (17%)
Query: 54 DKLQRLYEAKWVCFCHHNTPRKEHSGLFHDMEGVQMSEKVGGDNPRIFSYAELYIGSNGF 113
D L +++ + ++ +++ + P + E+ + + F
Sbjct: 19 DLLLGVHQE-----LGASELAQDKY----------VADFLQWAEPIVVRLKEVRLQRDDF 63
Query: 114 DEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKT----FAAELVAVAHLRHRN 169
+ +V+G G F +V + G V A+K + K + ++ F E + + R
Sbjct: 64 EILKVIGRGAFSEVAVVKMKQTGQVYAMKIM-NKWDMLKRGEVSCFREERDVLVNGDRRW 122
Query: 170 LVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKI-IRGLAAAL 228
+ +L E+ L LV +Y L +L + E + + + + + A+
Sbjct: 123 ITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIP-------AEMARFYLAEIVMAI 175
Query: 229 HYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHL 288
+H +HRD+K N++LD + RL DFG +
Sbjct: 176 DSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGS---------------CLKLRADGT 217
Query: 289 AETTRIGGTIGYLPPESFQKGSVATAKS------DVFSFGIVVLEVVSGR 332
+ GT YL PE Q D ++ G+ E+ G+
Sbjct: 218 VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 3e-15
Identities = 63/291 (21%), Positives = 105/291 (36%), Gaps = 59/291 (20%)
Query: 54 DKLQRLYEAKWVCFCHHNTPRKEHSGLFHDMEGVQMSEKVGGDNPRIFSYAELYIGSNGF 113
D L L RK + + + I +L + + +
Sbjct: 27 DGLDALVYD-----LDFPALRKNKN----------IDNFLSRYKDTINKIRDLRMKAEDY 71
Query: 114 DEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKT----FAAELVAVAHLRHRN 169
+ +V+G G FG+V S V A+K L K E +++ F E +A
Sbjct: 72 EVVKVIGRGAFGEVQLVRHKSTRKVYAMKLL-SKFEMIKRSDSAFFWEERDIMAFANSPW 130
Query: 170 LVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRR--PENLE---AAAPLNWEQRKKIIRGL 224
+V+L + L +V +YMP L ++ PE A E +
Sbjct: 131 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTA-----E--------V 177
Query: 225 AAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNH 284
AL +H IHRDVK N++LD + +L DFG ++ + +R +A
Sbjct: 178 VLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTC--MKMNKEGMVRCDTA--- 229
Query: 285 QFHLAETTRIGGTIGYLPPESFQKGSVATA--KS-DVFSFGIVVLEVVSGR 332
GT Y+ PE + + D +S G+ + E++ G
Sbjct: 230 ----------VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 4e-15
Identities = 50/232 (21%), Positives = 91/232 (39%), Gaps = 56/232 (24%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVK----------CLAEKGERFEKTFAAELVAVAHLR 166
+ LG G FGKV G VAVK + K +R E+ + R
Sbjct: 17 DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR-------EIQNLKLFR 69
Query: 167 HRNLVRLRGWCVHE-----DQLLLVYDYMPNRSL-DRVLFRRPENLEAAAPLNWEQRKKI 220
H ++++L ++ +V +Y+ L D + + + +++
Sbjct: 70 HPHIIKL-----YQVISTPTDFFMVMEYVSGGELFDYICKHGR--------VEEMEARRL 116
Query: 221 IRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSS 280
+ + +A+ Y H ++HRD+K NV+LD+ NA++ DFGL S
Sbjct: 117 FQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGL---------------S 158
Query: 281 ARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
T+ G+ Y PE A + D++S G+++ ++ G
Sbjct: 159 NMMSDGEFLRTS--CGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGT 208
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 4e-15
Identities = 40/163 (24%), Positives = 66/163 (40%), Gaps = 18/163 (11%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVK-CLAEKGERFEKTFAAELVAVAHLRHRNLVRLRG 175
+ G G FG V S G VA+K + + RF + +A L H N+V+L+
Sbjct: 29 RMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP--RFRNRELQIMQDLAVLHHPNIVQLQ- 85
Query: 176 WCVH--------EDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAA 227
+ + L +V +Y+P+ +L R K + L +
Sbjct: 86 SYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQV---APPPILIKVFLFQLIRS 141
Query: 228 LHYLHEQLETQIIHRDVKTSNVMLDSQYNA-RLGDFGLARWLE 269
+ LH + HRD+K NV+++ +L DFG A+ L
Sbjct: 142 IGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS 183
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 65/291 (22%), Positives = 111/291 (38%), Gaps = 58/291 (19%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCV 178
+GSG FG +VAVK + E+G ++ E++ LRH N+VR + +
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYI-ERGAAIDENVQREIINHRSLRHPNIVRFKEVIL 86
Query: 179 HEDQLLLVYDYMPNRSL-DRVLFRR--PENLEAAAPLNWEQRKKIIRGLAAALHYLHEQL 235
L ++ +Y L +R+ E+ EA + + L + + Y H
Sbjct: 87 TPTHLAIIMEYASGGELYERICNAGRFSED-EA---------RFFFQQLLSGVSYCHSM- 135
Query: 236 ETQIIHRDVKTSNVMLDSQYNARL--GDFGLARWLEHELQYQMRTSSARNHQFHLAETTR 293
QI HRD+K N +LD RL DFG S + ++T
Sbjct: 136 --QICHRDLKLENTLLDGSPAPRLKICDFGY---------------SKSSVLHSQPKST- 177
Query: 294 IGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYP-DDQIILLDWIRR 352
GT Y+ PE + +DV+S G+ + ++ G YP +D
Sbjct: 178 -VGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGA------YPFEDP--------- 221
Query: 353 LSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLA--LLCTL--HNPHLRPSMK 399
+E + + R+ Y + D ++ L+ + +P R S+
Sbjct: 222 --EEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIP 270
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 52/189 (27%), Positives = 82/189 (43%), Gaps = 27/189 (14%)
Query: 94 GGDNPRIFSYAELYIGSNGFDED------EVLGSGGFGKVYRAVLPSDGTVVAVK-CLAE 146
D+P G G + +V+G+G FG V++A L VA+K L +
Sbjct: 17 PLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESD-EVAIKKVLQD 75
Query: 147 KGERFEKTFAAELVAVAHLRHRNLVRLR------GWCVHEDQLLLVYDYMPNRSLDRVLF 200
K RF+ EL + ++H N+V L+ G E L LV +Y+P ++ R
Sbjct: 76 K--RFKNR---ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP-ETVYRASR 129
Query: 201 RRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNA-RL 259
+ + + K + L +L Y+H I HRD+K N++LD +L
Sbjct: 130 HYAKLKQ---TMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKL 183
Query: 260 GDFGLARWL 268
DFG A+ L
Sbjct: 184 IDFGSAKIL 192
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 56/240 (23%), Positives = 100/240 (41%), Gaps = 52/240 (21%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAA-----ELVAVAHLRH 167
F +LG G +G V A G +VA+K K E F+K A E+ + H +H
Sbjct: 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIK----KIEPFDKPLFALRTLREIKILKHFKH 68
Query: 168 RNLVRLR-----GWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKK--- 219
N++ + + +++ ++ + M L RV+ + L + +
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVI--STQMLS-------DDHIQYFI 118
Query: 220 --IIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMR 277
+R + LH + +IHRD+K SN++++S + ++ DFGLAR ++
Sbjct: 119 YQTLRAV----KVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSE 171
Query: 278 TSSARNHQFHLAE--TTRIGGTIGYLPPE---SFQKGSVATAKSDVFSFGIVVLEVVSGR 332
+ Q + E TR Y PE + K + DV+S G ++ E+ R
Sbjct: 172 PTG---QQSGMVEFVATR-----WYRAPEVMLTSAK---YSRAMDVWSCGCILAELFLRR 220
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 5e-14
Identities = 35/183 (19%), Positives = 73/183 (39%), Gaps = 24/183 (13%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAA-----ELVAVAHLRH 167
++ ++G+G +G V A + VVA+K + FE E+ + L H
Sbjct: 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV---FEDLIDCKRILREIAILNRLNH 111
Query: 168 RNLVRLR-----GWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIR 222
++V++ D+L +V + ++ L K ++
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLF-------RTPVYLTELHIKTLLY 163
Query: 223 GLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSAR 282
L + Y+H I+HRD+K +N +++ + ++ DFGLAR +++ + +
Sbjct: 164 NLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISP 220
Query: 283 NHQ 285
Sbjct: 221 RED 223
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 6e-14
Identities = 48/257 (18%), Positives = 99/257 (38%), Gaps = 46/257 (17%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAA-----ELVAVAHLRH 167
+ ++G G +G VY A + VA+K + FE E+ + L+
Sbjct: 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM---FEDLIDCKRILREITILNRLKS 84
Query: 168 RNLVRLRGWCVHEDQ-----LLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKK--- 219
++RL + +D L +V + L ++ + P L E+ K
Sbjct: 85 DYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLF-KTPIFLT-------EEHIKTIL 135
Query: 220 --IIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMR 277
++ G +++HE + IIHRD+K +N +L+ + ++ DFGLAR + E +
Sbjct: 136 YNLLLGE----NFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIV 188
Query: 278 TSSARNHQFHLAETTRIGGTIGYL------PPE---SFQKGSVATAKSDVFSFGIVVLEV 328
N + ++ PE + + + D++S G + E+
Sbjct: 189 NDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSI---DIWSTGCIFAEL 245
Query: 329 VSGRRAVDLTYPDDQII 345
++ ++ + +
Sbjct: 246 LNMLQSHINDPTNRFPL 262
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 9e-14
Identities = 55/240 (22%), Positives = 96/240 (40%), Gaps = 71/240 (29%)
Query: 116 DEVLGSGGFGKVYRAVLPSDGTVVAVK----------CLAEKGERFEKTFAAELVAVAHL 165
E LG G FGKV A VA+K + + ER E+ + L
Sbjct: 14 RETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVER-------EISYLKLL 66
Query: 166 RHRNLVRLRGWCVHE-----DQLLLV--------YDYMPNRSLDRVLFRRPENLEAAAPL 212
RH ++++L ++ +++V +DY+ + R E+ E
Sbjct: 67 RHPHIIKL-----YDVITTPTDIVMVIEYAGGELFDYIVEKK------RMTED-EG---- 110
Query: 213 NWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHEL 272
++ + + A+ Y H +I+HRD+K N++LD N ++ DFGL+ +
Sbjct: 111 -----RRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG- 161
Query: 273 QYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
+ +T+ G+ Y PE A + DV+S GIV+ ++ GR
Sbjct: 162 --------------NFLKTS--CGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 39/167 (23%), Positives = 73/167 (43%), Gaps = 27/167 (16%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAA-----ELVAVAHLRHRNLV 171
+GSG +G V A+ G VA+K L+ F+ A EL+ + H++H N++
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRP---FQSEIFAKRAYRELLLLKHMQHENVI 86
Query: 172 RLR------GWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLA 225
L + LV +M L +++ + E+ + ++ +
Sbjct: 87 GLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIM---------GLKFSEEKIQYLVYQML 136
Query: 226 AALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHEL 272
L Y+H ++HRD+K N+ ++ ++ DFGLAR + E+
Sbjct: 137 KGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM 180
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 53/235 (22%), Positives = 89/235 (37%), Gaps = 57/235 (24%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAH-------- 164
FD + LG+G FG+V G A+K L +K +L + H
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL-------DKQKVVKLKQIEHTLNEKRIL 95
Query: 165 --LRHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIR 222
+ LV+L L +V +Y+ + L RR E +
Sbjct: 96 QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFS-------EPHARFYA 147
Query: 223 G-LAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSA 281
+ YLH +I+RD+K N+++D Q ++ DFG A+ ++ RT +
Sbjct: 148 AQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWT- 197
Query: 282 RNHQFHLAETTRIGGTIGYLPPESFQ-KG---SVATAKSDVFSFGIVVLEVVSGR 332
+ GT L PE KG +V D ++ G+++ E+ +G
Sbjct: 198 ------------LCGTPEALAPEIILSKGYNKAV-----DWWALGVLIYEMAAGY 235
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 47/194 (24%), Positives = 76/194 (39%), Gaps = 37/194 (19%)
Query: 94 GGDNPRIFSYAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVK------CLAEK 147
G+ AEL+ + + + SG +G V V S+G VA+K
Sbjct: 5 KGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGV-DSEGIPVAIKRVFNTVSDGRT 63
Query: 148 GERFEKTFAA-----ELVAVAHLRHRNLVRLRGWCVHEDQ-----LLLVYDYMPNRSLDR 197
+F E+ + H H N++ LR VH ++ L LV + M L +
Sbjct: 64 VNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQ 122
Query: 198 VLFRRPENLEAAAPLNWEQRKK-----IIRGLAAALHYLHEQLETQIIHRDVKTSNVMLD 252
V+ + + Q + I+ GL H LHE ++HRD+ N++L
Sbjct: 123 VIHDQRIVIS-------PQHIQYFMYHILLGL----HVLHE---AGVVHRDLHPGNILLA 168
Query: 253 SQYNARLGDFGLAR 266
+ + DF LAR
Sbjct: 169 DNNDITICDFNLAR 182
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 51/235 (21%), Positives = 93/235 (39%), Gaps = 49/235 (20%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAA-----ELVAVAHLRH 167
+ +G G +G V A + VA+K K FE E+ + RH
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIK----KISPFEHQTYCQRTLREIKILLRFRH 84
Query: 168 RNLVRLRGWCVHE-----DQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIR 222
N++ + + +V D M L ++L L+ + +
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL--------KTQHLSNDHICYFLY 135
Query: 223 GLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSAR 282
+ L Y+H ++HRD+K SN++L++ + ++ DFGLAR + +
Sbjct: 136 QILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD----------H 182
Query: 283 NHQFHLAE--TTRIGGTIGYLPPE---SFQKGSVATAKSDVFSFGIVVLEVVSGR 332
+H L E TR Y PE + + + + D++S G ++ E++S R
Sbjct: 183 DHTGFLTEYVATR-----WYRAPEIMLNSKGYTKSI---DIWSVGCILAEMLSNR 229
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 70.3 bits (171), Expect = 5e-13
Identities = 45/252 (17%), Positives = 75/252 (29%), Gaps = 53/252 (21%)
Query: 98 PRIFSYAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFA- 156
P FS+ + + E +G G FG+V++ + D T VA+K +A +G
Sbjct: 10 PVPFSH---CLPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQ 64
Query: 157 ----------------AELVAVAHLRHRNLVRLRGWCVHED----QLLLVYDYM------ 190
+ L R + L + LL +D+
Sbjct: 65 KTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGS 124
Query: 191 ----PNRSLDRVLFRRPENLEAAAPL--------NWEQRKKIIRGLAAALHYLHEQLETQ 238
P+ D LF E L + K I+ L A+L L +
Sbjct: 125 ANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL--R 182
Query: 239 IIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTI 298
HRD+ NV+L +L + + L+ R G +
Sbjct: 183 FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPS----CGLQVSIIDYTLSRLERDGIVV 238
Query: 299 ---GYLPPESFQ 307
+ + F
Sbjct: 239 FCDVSMDEDLFT 250
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 5e-13
Identities = 44/167 (26%), Positives = 70/167 (41%), Gaps = 26/167 (15%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAA-----ELVAVAHLRHRNLV 171
+GSG +G V A G VAVK L+ F+ A EL + H++H N++
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSIIHAKRTYRELRLLKHMKHENVI 91
Query: 172 RLR------GWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLA 225
L + + LV M L+ ++ L + + +I +
Sbjct: 92 GLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIV--------KCQKLTDDHVQFLIYQIL 142
Query: 226 AALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHEL 272
L Y+H IIHRD+K SN+ ++ ++ DFGLAR E+
Sbjct: 143 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM 186
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 5e-13
Identities = 43/167 (25%), Positives = 71/167 (42%), Gaps = 26/167 (15%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAA-----ELVAVAHLRHRNLV 171
+ +GSG +G V AV G VA+K L F+ A EL + H+RH N++
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP---FQSELFAKRAYRELRLLKHMRHENVI 87
Query: 172 RLR------GWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLA 225
L LV +M L +++ L ++ + ++ +
Sbjct: 88 GLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLM--------KHEKLGEDRIQFLVYQML 138
Query: 226 AALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHEL 272
L Y+H IIHRD+K N+ ++ ++ DFGLAR + E+
Sbjct: 139 KGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM 182
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 7e-13
Identities = 53/234 (22%), Positives = 92/234 (39%), Gaps = 60/234 (25%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCL----------AEKGERFEKTFAAELVAVAHLR 166
+ LG G FGKV G VAVK L K R E+ + R
Sbjct: 22 DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR-------EIQNLKLFR 74
Query: 167 HRNLVRLRGWCVHE-----DQLLLVYDYMPNRSL-DRVLF--RRPENLEAAAPLNWEQRK 218
H ++++L ++ + +V +Y+ L D + R E E+ +
Sbjct: 75 HPHIIKL-----YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEK-ES---------R 119
Query: 219 KIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRT 278
++ + + + + Y H ++HRD+K NV+LD+ NA++ DFGL
Sbjct: 120 RLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGL-------------- 162
Query: 279 SSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
S T+ G+ Y PE A + D++S G+++ ++ G
Sbjct: 163 -SNMMSDGEFLRTS--CGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGT 213
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 9e-13
Identities = 41/165 (24%), Positives = 71/165 (43%), Gaps = 27/165 (16%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAA-----ELVAVAHLRH 167
+ + +GSG G V A VA+K L+ F+ A ELV + + H
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP---FQNQTHAKRAYRELVLMKCVNH 83
Query: 168 RNLVRLR------GWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKII 221
+N++ L + +V + M +L +V+ L+ E+ ++
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVI---------QMELDHERMSYLL 133
Query: 222 RGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLAR 266
+ + +LH IIHRD+K SN+++ S ++ DFGLAR
Sbjct: 134 YQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 175
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 9e-13
Identities = 54/242 (22%), Positives = 99/242 (40%), Gaps = 54/242 (22%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAA-----ELVAVAHLRH 167
+ + + LG GG G V+ AV VA+K + + E+ + L H
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV-----LTDPQSVKHALREIKIIRRLDH 67
Query: 168 RNLVRLR--------------GWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLN 213
N+V++ G + + +V +YM L VL PL
Sbjct: 68 DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVL--------EQGPLL 118
Query: 214 WEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQ-YNARLGDFGLARWLEHEL 272
E + + L L Y+H ++HRD+K +N+ ++++ ++GDFGLAR ++
Sbjct: 119 EEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPH- 174
Query: 273 QYQMRTSSARNHQFHLAE--TTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS 330
+H+ HL+E T+ Y P + T D+++ G + E+++
Sbjct: 175 ---------YSHKGHLSEGLVTK-----WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT 220
Query: 331 GR 332
G+
Sbjct: 221 GK 222
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 1e-12
Identities = 42/165 (25%), Positives = 71/165 (43%), Gaps = 27/165 (16%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAA-----ELVAVAHLRH 167
+ + +GSG G V A VA+K L+ F+ A ELV + + H
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP---FQNQTHAKRAYRELVLMKCVNH 120
Query: 168 RNLVRLR------GWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKII 221
+N++ L + LV + M +L +V+ L+ E+ ++
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVI---------QMELDHERMSYLL 170
Query: 222 RGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLAR 266
+ + +LH IIHRD+K SN+++ S ++ DFGLAR
Sbjct: 171 YQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 212
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 37/149 (24%), Positives = 61/149 (40%), Gaps = 28/149 (18%)
Query: 187 YDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKT 246
++ +SL V L E +A + +L + + IHRD+
Sbjct: 165 SGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 221
Query: 247 SNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLP---- 302
N++L + ++ DFGLAR + + Y +R AR LP
Sbjct: 222 RNILLSEKNVVKICDFGLARDIYKDPDY-VRKGDAR------------------LPLKWM 262
Query: 303 -PESFQKGSVATAKSDVFSFGIVVLEVVS 330
PE+ V T +SDV+SFG+++ E+ S
Sbjct: 263 APETIFDR-VYTIQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 31/163 (19%), Positives = 63/163 (38%), Gaps = 30/163 (18%)
Query: 639 QVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYI 698
+ IHR++ + I L ++ F LA + ++ + + ++ +M+PE I
Sbjct: 213 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLK----WMAPETI 267
Query: 699 ESGEATSMADVYSFGVVVLEVVT-GQ-----MAVDFRLPEGLLVKRVHEFEARKRPLAEL 752
T +DV+SFGV++ E+ + G + +D +K P
Sbjct: 268 FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR--RLKEGTRMR---AP---- 318
Query: 753 VDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795
+Y E+ + + C P RP+ +++ L
Sbjct: 319 -------DYTTPEMYQTML---DCWHGEPSQRPTFSELVEHLG 351
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 40/193 (20%), Positives = 70/193 (36%), Gaps = 52/193 (26%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGW 176
+ LG+G FG V G A+K K + + EL + L H N+++L
Sbjct: 13 KTLGTGSFGIVCEVFDIESGKRFALK----KVLQDPRYKNRELDIMKVLDHVNIIKLV-D 67
Query: 177 CVH---------------------------------------EDQLLLVYDYMPNRSLDR 197
+ L ++ +Y+P+ +L +
Sbjct: 68 YFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHK 126
Query: 198 VLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNA 257
VL + + I L A+ ++H I HRD+K N++++S+ N
Sbjct: 127 VLKSFIRSGR---SIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSKDNT 180
Query: 258 -RLGDFGLARWLE 269
+L DFG A+ L
Sbjct: 181 LKLCDFGSAKKLI 193
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 3e-12
Identities = 68/302 (22%), Positives = 110/302 (36%), Gaps = 83/302 (27%)
Query: 69 HHNTPRKEHSGLFHDMEGVQMSEKVGGDNPRIFSYAELYIGSNG---------FDEDEVL 119
HH+ +E G G GG+ + G F+ +VL
Sbjct: 3 HHHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVL 62
Query: 120 GSGGFGKVY---RAVLPSDGTVVAVKCL-----AEKGERFEKTFAAE---LVAVAHLRHR 168
G+G +GKV+ + G + A+K L +K + E T E L +
Sbjct: 63 GTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRT-ERQVLEHIRQ--SP 119
Query: 169 NLVRLRGWCVH-----EDQLLLVYDYMP--------NR----SLDRVLFRRPENLEAAAP 211
LV L H E +L L+ DY+ ++ + V E
Sbjct: 120 FLVTL-----HYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGE------- 167
Query: 212 LNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHE 271
+ AL +LH+ II+RD+K N++LDS + L DFGL++ E
Sbjct: 168 ------------IVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK--EFV 210
Query: 272 LQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKS-DVFSFGIVVLEVVS 330
R GTI Y+ P+ + G K+ D +S G+++ E+++
Sbjct: 211 ADETERAYD-------------FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT 257
Query: 331 GR 332
G
Sbjct: 258 GA 259
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 4e-12
Identities = 56/246 (22%), Positives = 92/246 (37%), Gaps = 79/246 (32%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAH-------- 164
F LG+G FG+V+ +G A+K L +K L V H
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVL-------KKEIVVRLKQVEHTNDERLML 60
Query: 165 --LRHRNLVRLRGWCVHEDQLLLVYDYMP-----------NR-SLDRVLFRRPENLEAAA 210
+ H ++R+ G Q+ ++ DY+ R F E
Sbjct: 61 SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAE------ 114
Query: 211 PLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEH 270
+ AL YLH + II+RD+K N++LD + ++ DFG A+++
Sbjct: 115 -------------VCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158
Query: 271 ELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQ-KG---SVATAKSDVFSFGIVVL 326
T + + GT Y+ PE K S+ D +SFGI++
Sbjct: 159 ------VTYT-------------LCGTPDYIAPEVVSTKPYNKSI-----DWWSFGILIY 194
Query: 327 EVVSGR 332
E+++G
Sbjct: 195 EMLAGY 200
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 6e-12
Identities = 42/163 (25%), Positives = 72/163 (44%), Gaps = 22/163 (13%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLR-HRNLVRLRG 175
LG G + +V+ A+ ++ V VK L K + +K E+ + +LR N++ L
Sbjct: 42 RKLGRGKYSEVFEAINITNNEKVVVKIL--KPVKKKKIKR-EIKILENLRGGPNIITLAD 98
Query: 176 WCVHEDQ---LLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLH 232
V + LV++++ N ++ L + + + AL Y H
Sbjct: 99 -IVKDPVSRTPALVFEHVNNTDFKQLY----------QTLTDYDIRFYMYEILKALDYCH 147
Query: 233 EQLETQIIHRDVKTSNVMLDSQYNA-RLGDFGLARWLEHELQY 274
I+HRDVK NVM+D ++ RL D+GLA + +Y
Sbjct: 148 SM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY 187
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 9e-12
Identities = 64/235 (27%), Positives = 95/235 (40%), Gaps = 63/235 (26%)
Query: 118 VLGSGGFGKVYRAVLPSDGTVVAVKCL-----AEKGERFEKTFAAELVAVAHLRHRNLVR 172
V+G G FGKV A ++ AVK L +K E + + V + +++H LV
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEE-KHIMSERNVLLKNVKHPFLVG 103
Query: 173 LRGWCVH-----EDQLLLVYDYMPNRSL-----DRVLFRRPENLEAAAPLNWEQRKKI-I 221
L H D+L V DY+ L F E R +
Sbjct: 104 L-----HFSFQTADKLYFVLDYINGGELFYHLQRERCFL-------------EPRARFYA 145
Query: 222 RGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSA 281
+A+AL YLH I++RD+K N++LDSQ + L DFGL + +++ TS+
Sbjct: 146 AEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNSTTST- 198
Query: 282 RNHQFHLAETTRIGGTIGYLPPESFQKG----SVATAKSDVFSFGIVVLEVVSGR 332
GT YL PE K +V D + G V+ E++ G
Sbjct: 199 ------------FCGTPEYLAPEVLHKQPYDRTV-----DWWCLGAVLYEMLYGL 236
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 63/270 (23%), Positives = 104/270 (38%), Gaps = 46/270 (17%)
Query: 75 KEHSGLFHDMEGVQMSEKVGGDNPRI-FSYAELYIGSNGFDEDEVLGSGGFGKVYRAVLP 133
K+ + D S+ G + + + + + N F+ ++LG G FGKV
Sbjct: 111 KKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEK 170
Query: 134 SDGTVVAVKCL-----AEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYD 188
+ G A+K L K E T E + + RH L L+ D+L V +
Sbjct: 171 ATGRYYAMKILKKEVIVAKDE-VAHTLT-ENRVLQNSRHPFLTALKYSFQTHDRLCFVME 228
Query: 189 YMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRG------LAAALHYLHEQLETQIIHR 242
Y L F L+ E+ R + +AL YLH + +++R
Sbjct: 229 YANGGEL---FFH----------LSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYR 273
Query: 243 DVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLP 302
D+K N+MLD + ++ DFGL + ++ + GT YL
Sbjct: 274 DLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKT-------------FCGTPEYLA 317
Query: 303 PESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
PE + A D + G+V+ E++ GR
Sbjct: 318 PEVLEDNDYGRA-VDWWGLGVVMYEMMCGR 346
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 4e-11
Identities = 57/226 (25%), Positives = 87/226 (38%), Gaps = 46/226 (20%)
Query: 118 VLGSGGFGKVYRAVLPSDGTVVAVKCL-----AEKGERFEKTFAAELVAVAHLRHRNLVR 172
+LG G FGKV + G A+K L K E T E + + RH L
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE-VAHTVT-ESRVLQNTRHPFLTA 69
Query: 173 LRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRG------LAA 226
L+ D+L V +Y L F L+ E+ R + +
Sbjct: 70 LKYAFQTHDRLCFVMEYANGGEL---FFH----------LSRERVFTEERARFYGAEIVS 116
Query: 227 ALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQF 286
AL YLH + +++RD+K N+MLD + ++ DFGL + + +
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKT------ 164
Query: 287 HLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
GT YL PE + A D + G+V+ E++ GR
Sbjct: 165 -------FCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGR 202
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 55/229 (24%), Positives = 104/229 (45%), Gaps = 28/229 (12%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAA-----ELVAVAHLR-HRNL 170
+ LG G +G V++++ G VVAVK + + F+ + A E++ + L H N+
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA---FQNSTDAQRTFREIMILTELSGHENI 71
Query: 171 VRLRGWCVHED--QLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAAL 228
V L ++ + LV+DYM L V+ A L ++ ++ L +
Sbjct: 72 VNLLNVLRADNDRDVYLVFDYMET-DLHAVI--------RANILEPVHKQYVVYQLIKVI 122
Query: 229 HYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHL 288
YLH ++HRD+K SN++L+++ + ++ DFGL+R + + + N
Sbjct: 123 KYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179
Query: 289 AETTRIG-----GTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
+ + T Y PE + T D++S G ++ E++ G+
Sbjct: 180 FDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 71/306 (23%), Positives = 122/306 (39%), Gaps = 56/306 (18%)
Query: 67 FCHHNTPRK-----EHSGLFHDMEGVQMSEKVGGDNPRIFSYAELYIGSNGFDEDEVLGS 121
+ HH+ + F G + E+ N R A +G FD V+G
Sbjct: 3 YYHHHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGR 62
Query: 122 GGFGKVYRAVLPSDGTVVAVKCLAEKG-----ERFEKTFAAELVAVAHLRHRNLVRLRGW 176
G + KV L + A++ + +K E + + V H LV L
Sbjct: 63 GSYAKVLLVRLKKTDRIYAMRVV-KKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH-S 120
Query: 177 CVH-EDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKI-IRGLAAALHYLHEQ 234
C E +L V +Y+ L +F ++ L E+ + ++ AL+YLHE+
Sbjct: 121 CFQTESRLFFVIEYVNGGDL---MFH----MQRQRKLP-EEHARFYSAEISLALNYLHER 172
Query: 235 LETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRI 294
II+RD+K NV+LDS+ + +L D+G+ + L+ TS+
Sbjct: 173 ---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTST-------------F 213
Query: 295 GGTIGYLPPESFQKG----SVATAKSDVFSFGIVVLEVVSGR------RAVDLTYPDDQI 344
GT Y+ PE + SV D ++ G+++ E+++GR + D + +
Sbjct: 214 CGTPNYIAPEILRGEDYGFSV-----DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTED 268
Query: 345 ILLDWI 350
L I
Sbjct: 269 YLFQVI 274
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 7e-11
Identities = 49/198 (24%), Positives = 79/198 (39%), Gaps = 44/198 (22%)
Query: 118 VLGSGGFGKVYRAVLPSDGTVVAVKCL-----AEKGERFEKTFAAELVAVAHLRHRNLVR 172
VLG G FGKV A + G + AVK L + + E T + + H L +
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDD-VECTMTEKRILSLARNHPFLTQ 88
Query: 173 LRGWCVHEDQLLLVYDYMPNRSL-----DRVLFRRPENLEAAAPLNWEQRKKIIRG-LAA 226
L D+L V +++ L F E R + + +
Sbjct: 89 LFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD-------------EARARFYAAEIIS 135
Query: 227 ALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQF 286
AL +LH++ II+RD+K NV+LD + + +L DFG+ + + + T++
Sbjct: 136 ALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK---EGICNGVTTAT------ 183
Query: 287 HLAETTRIGGTIGYLPPE 304
GT Y+ PE
Sbjct: 184 -------FCGTPDYIAPE 194
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 8e-11
Identities = 63/267 (23%), Positives = 108/267 (40%), Gaps = 57/267 (21%)
Query: 118 VLGSGGFGKVYRAVLPSDGTVVAVKCL----AEKGERFEKTFAAELVAVAHLRHRNLVRL 173
V+G G + KV L + A+K + E + + V H LV L
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 174 RGWCVH-EDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKI-IRGLAAALHYL 231
C E +L V +Y+ L +F ++ L E+ + ++ AL+YL
Sbjct: 76 H-SCFQTESRLFFVIEYVNGGDL---MFH----MQRQRKLP-EEHARFYSAEISLALNYL 126
Query: 232 HEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAET 291
HE+ II+RD+K NV+LDS+ + +L D+G+ + L+ TS+
Sbjct: 127 HER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTST----------- 169
Query: 292 TRIGGTIGYLPPESFQKG----SVATAKSDVFSFGIVVLEVVSGR------RAVDLTYPD 341
GT Y+ PE + SV D ++ G+++ E+++GR + D +
Sbjct: 170 --FCGTPNYIAPEILRGEDYGFSV-----DWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 222
Query: 342 DQIILLDWI--------RRLSDEGKVL 360
+ L I R LS + +
Sbjct: 223 TEDYLFQVILEKQIRIPRSLSVKAASV 249
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 63.3 bits (155), Expect = 8e-11
Identities = 55/244 (22%), Positives = 94/244 (38%), Gaps = 78/244 (31%)
Query: 118 VLGSGGFGKVY---RAVLPSDGTVVAVKCL-----AEKGERFEKTFAAELVAVAHLRHRN 169
VLG GG+GKV+ + + G + A+K L + T A E + ++H
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKA-ERNILEEVKHPF 82
Query: 170 LVRLRGWCVH-----EDQLLLVYDYMP--------NR----SLDRVLFRRPENLEAAAPL 212
+V L +L L+ +Y+ R D F E
Sbjct: 83 IVDL-----IYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAE-------- 129
Query: 213 NWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHEL 272
++ AL +LH++ II+RD+K N+ML+ Q + +L DFGL + +
Sbjct: 130 -----------ISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK---ESI 172
Query: 273 QYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKG----SVATAKSDVFSFGIVVLEV 328
T + GTI Y+ PE + +V D +S G ++ ++
Sbjct: 173 HDGTVTHT-------------FCGTIEYMAPEILMRSGHNRAV-----DWWSLGALMYDM 214
Query: 329 VSGR 332
++G
Sbjct: 215 LTGA 218
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 64.3 bits (156), Expect = 1e-10
Identities = 55/232 (23%), Positives = 92/232 (39%), Gaps = 47/232 (20%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG-----ERFEKTFAAELVAVAHLRH 167
F+ VLG G FGKV + + AVK L +K + E T + V +
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKIL-KKDVVIQDDDVECTMVEKRVLALPGKP 401
Query: 168 RNLVRLRGWCVH-EDQLLLVYDYMPNRSL-----DRVLFRRPENLEAAAPLNWEQRKKII 221
L +L C D+L V +Y+ L F+ E
Sbjct: 402 PFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK-------------EPHAVFY 447
Query: 222 RG-LAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSS 280
+A L +L + II+RD+K NVMLDS+ + ++ DFG+ + + + T +
Sbjct: 448 AAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGVTTKT 501
Query: 281 ARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
GT Y+ PE + D ++FG+++ E+++G+
Sbjct: 502 -------------FCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQ 539
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 2e-10
Identities = 49/199 (24%), Positives = 75/199 (37%), Gaps = 46/199 (23%)
Query: 118 VLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG-----ERFEKTFAAELVAVAHLRHRNLVR 172
VLG G FGKV + + AVK L +K + E T + V + L +
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKIL-KKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 85
Query: 173 LRGWCVH-EDQLLLVYDYMPNRSL-----DRVLFRRPENLEAAAPLNWEQRKKIIRG-LA 225
L C D+L V +Y+ L F+ E +A
Sbjct: 86 LH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK-------------EPHAVFYAAEIA 131
Query: 226 AALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQ 285
L +L + II+RD+K NVMLDS+ + ++ DFG+ + + + T +
Sbjct: 132 IGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGVTTKT----- 180
Query: 286 FHLAETTRIGGTIGYLPPE 304
GT Y+ PE
Sbjct: 181 --------FCGTPDYIAPE 191
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 3e-10
Identities = 43/205 (20%), Positives = 72/205 (35%), Gaps = 58/205 (28%)
Query: 118 VLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG-----ERFEKTFAAELVAVAHLRHRNLVR 172
+LG G FGKV+ A A+K L +K + E T + V H L
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIKAL-KKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 82
Query: 173 LRGWCVH-EDQLLLVYDYMP--------NR----SLDRVLFRRPENLEAAAPLNWEQRKK 219
+ ++ L V +Y+ L R F E
Sbjct: 83 MF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAE--------------- 126
Query: 220 IIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTS 279
+ L +LH + I++RD+K N++LD + ++ DFG+ + + +T+
Sbjct: 127 ----IILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK---ENMLGDAKTN 176
Query: 280 SARNHQFHLAETTRIGGTIGYLPPE 304
+ GT Y+ PE
Sbjct: 177 T-------------FCGTPDYIAPE 188
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 60.6 bits (148), Expect = 5e-10
Identities = 59/236 (25%), Positives = 99/236 (41%), Gaps = 64/236 (27%)
Query: 118 VLGSGGFGKVY---RAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVAVAHLRHRNLV 171
VLG G FGKV+ + + A+K L +K R E + + H +V
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVL-KKATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 172 RLRGWCVH-----EDQLLLVYDYMPNRSL-----DRVLFRRPENLEAAAPLNWEQRKKI- 220
+L H E +L L+ D++ L V+F E+ K
Sbjct: 90 KL-----HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFT-------------EEDVKFY 131
Query: 221 IRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSS 280
+ LA AL +LH II+RD+K N++LD + + +L DFGL++ + ++ + S
Sbjct: 132 LAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYS 185
Query: 281 ARNHQFHLAETTRIGGTIGYLPPESFQKG----SVATAKSDVFSFGIVVLEVVSGR 332
GT+ Y+ PE + S D +SFG+++ E+++G
Sbjct: 186 -------------FCGTVEYMAPEVVNRRGHTQSA-----DWWSFGVLMFEMLTGT 223
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 7e-10
Identities = 32/177 (18%), Positives = 69/177 (38%), Gaps = 30/177 (16%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLR---------- 166
LG G F V+ A + T VA+K + + + + E+ + +
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 167 -HRNLVRLRGWCVH----EDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKII 221
++++L H +++V++ + +L ++ + + K+I
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHR-----GIPLIYVKQIS 137
Query: 222 RGLAAALHYLHEQLETQIIHRDVKTSNVMLD------SQYNARLGDFGLARWLEHEL 272
+ L L Y+H + IIH D+K NV+++ + ++ D G A W +
Sbjct: 138 KQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 192
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 58.7 bits (141), Expect = 8e-09
Identities = 66/504 (13%), Positives = 137/504 (27%), Gaps = 169/504 (33%)
Query: 2 QQLNRLCFILPADVDEIGPYEKSRVHNVVSRKQEVKEQ--------HG-RGCGRRILSFI 52
+Q +RL D Y SR+ + +Q + E G G G+ ++
Sbjct: 114 EQRDRLY----NDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALD 169
Query: 53 A---DKLQRLYEAK--WVCFCHHNTPR---KEHSGLFHDMEGVQMSEKVGGDNPRIFSYA 104
K+Q + K W+ + N+P + L + ++ S N ++
Sbjct: 170 VCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKL---- 225
Query: 105 ELYIGSNGFDEDEVLGSGGFGKVYRAVLP-----SDGTVVA---VKCLAEKGERFEKTFA 156
L K Y L + + C K
Sbjct: 226 ------RIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSC---------KILL 270
Query: 157 -------AELVAVAHLRHRNLVRLRGWCVHEDQ---LLLVYDYMPNRSLDRVLFRRPENL 206
+ ++ A H +L + D+ LLL Y + L P +
Sbjct: 271 TTRFKQVTDFLSAATTTHISLDHHS-MTLTPDEVKSLLLKYLDCRPQDL-------PREV 322
Query: 207 EAAAPL-----------------NWEQ--RKKIIRGLAAALHYLHEQLETQ-------II 240
P NW+ K+ + ++L+ L E E + +
Sbjct: 323 LTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVL-EPAEYRKMFDRLSVF 381
Query: 241 HRDVK-TSNV---------------MLDSQYNARLGDFGLARWLE------HELQYQMRT 278
+ + +++ + L + + + + +++
Sbjct: 382 PPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSL----VEKQPKESTISIPSIYLELKV 437
Query: 279 SSARNHQFH--LAETTRIGGTIGYLPPESFQKGSVATAKSD--VFSF------GIVVLEV 328
+ H + + Y P++F + D +S I E
Sbjct: 438 KLENEYALHRSIVDH--------YNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPER 489
Query: 329 VSGRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGS----------YK--LCD 376
++ R V + D ++ + K+ + GS YK +CD
Sbjct: 490 MTLFRMV---FLD-----FRFLEQ-----KIRHDSTAWNASGSILNTLQQLKFYKPYICD 536
Query: 377 MEHLTHLALLCTL------HNPHL 394
+ L+ + +L
Sbjct: 537 -NDPKYERLVNAILDFLPKIEENL 559
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.2 bits (111), Expect = 2e-05
Identities = 74/604 (12%), Positives = 153/604 (25%), Gaps = 210/604 (34%)
Query: 13 ADVDEI--GPYEKSRVH---NVVSRKQE--VKEQHGRGCGRRILSFIADKLQRLYEAKWV 65
++D I S + KQE V++ F+ + L+ Y+ ++
Sbjct: 49 EEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQK------------FVEEVLRINYK--FL 94
Query: 66 CFCHHNTPRK----------EHSGLFHDMEGVQMSEKVGGDNPRIFSYAELYIGSNGFDE 115
R+ + L++D Q+ K + R+ Y +L E
Sbjct: 95 MSPIKTEQRQPSMMTRMYIEQRDRLYND---NQVFAK--YNVSRLQPYLKL---RQALLE 146
Query: 116 DE------VLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRN 169
+ G G GK T VA+ + + ++
Sbjct: 147 LRPAKNVLIDGVLGSGK----------TWVALDVCLS--YKVQCKMDFKIF--------- 185
Query: 170 LVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALH 229
W ++ + N + + + L NW R + +H
Sbjct: 186 ------W-LN----------LKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIH 228
Query: 230 YLHEQLETQIIHRDVKTSNVMLDSQYNARL--------------GDFGLARWLEHELQYQ 275
+ +L + + + ++L + NA+ + +L
Sbjct: 229 SIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLS-AATTT 287
Query: 276 MRTSSARNHQFHLAETTRI-----GGTIGYLPPESFQKGS------VATAKSD------- 317
+ + E + LP E + +A + D
Sbjct: 288 HISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREV-LTTNPRRLSIIAESIRDGLATWDN 346
Query: 318 -----------VFSFGIVVLEVVSGRRA-VDLT-YPDD-----QIILLDWIRRLSDEGKV 359
+ + VLE R+ L+ +P ++ L W + + V
Sbjct: 347 WKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMV 406
Query: 360 LQAGDNRLS-------DGSYKLCDMEHLTHLALLC------TLHNP-------------- 392
+ ++ S + + + +L L LH
Sbjct: 407 VVNKLHKYSLVEKQPKESTISI----PSIYLELKVKLENEYALHRSIVDHYNIPKTFDSD 462
Query: 393 -----------------HLRP---------------SMKWV---IEAVSGSYSGKLPALP 417
HL+ +++ I S +++ L
Sbjct: 463 DLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILN 522
Query: 418 SFQSHPLY---ISLSSPTNTSTSNTETTRSTNTTASNTTIASPSSNYVTAA----GETIY 470
+ Q Y I + P N I S ++ + A E I+
Sbjct: 523 TLQQLKFYKPYICDNDPKYERLVNAILDFLPK--IEENLICSKYTDLLRIALMAEDEAIF 580
Query: 471 ATAE 474
A
Sbjct: 581 EEAH 584
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.1 bits (98), Expect = 9e-04
Identities = 70/547 (12%), Positives = 126/547 (23%), Gaps = 195/547 (35%)
Query: 335 VDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLS----DGSYKLCDMEHLTHLALLCTLH 390
Y D + D D V + LS D D T L
Sbjct: 14 HQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLS 73
Query: 391 NPH----------LRPSMKWVIEAVSGSYSGKLPALPSFQSHPLYISLSSP---TNTSTS 437
LR + K+++ + + P++ + +YI N +
Sbjct: 74 KQEEMVQKFVEEVLRINYKFLMSPIKTEQ--RQPSMMT----RMYIEQRDRLYNDNQVFA 127
Query: 438 NTETTRSTNTTASNTTIASPSSN-YVTAAGETIYATAECGGNTESKSNNSRSQRRNSFFM 496
+R + V I G K ++
Sbjct: 128 KYNVSRLQPYLKLRQALLELRPAKNV-----LIDGVLGSG-----K----------TWVA 167
Query: 497 VETPREISFKEIISATNNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTR 556
++ + +MDF + L + C + T
Sbjct: 168 LDVCLSYKVQC---------------KMDFKIFW--------------LNLKNCNSPETV 198
Query: 557 FSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQ-- 614
LQ L N + + + +S L LL + +L
Sbjct: 199 LEM-LQKLLYQIDPNWTSRS----DHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNV 253
Query: 615 WHHRYNIIKS--LASAILYLHEEWNEQVIHRNIT-----SSAITLDPDMNPRLGSFALAE 667
+ + + L+ IL + R S+A T ++ + E
Sbjct: 254 QNAK--AWNAFNLSCKIL---------LTTRFKQVTDFLSAATTTHISLDHHSMTLTPDE 302
Query: 668 FLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVD 727
V+ + +Y++ D
Sbjct: 303 ------------------VKSLLL----KYLD----CRPQD------------------- 317
Query: 728 FRLPEGLLVKRVHEFEARKR-PLAELVDLSLNGE--------------YNHKELMRLIKL 772
LP E P LS+ E N +L +I+
Sbjct: 318 --LPR----------EVLTTNPRR----LSIIAESIRDGLATWDNWKHVNCDKLTTIIES 361
Query: 773 GIACTLSNPELRPSMRQILSILDGNDKRFMEDGQMTENLEE--WKQR---------NEC- 820
+ L E R + LS+ F + L W N+
Sbjct: 362 SLNV-LEPAEYRKMFDR-LSV-------FPPSAHIPTILLSLIWFDVIKSDVMVVVNKLH 412
Query: 821 SLSLIKR 827
SL+++
Sbjct: 413 KYSLVEK 419
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 35/166 (21%), Positives = 68/166 (40%), Gaps = 34/166 (20%)
Query: 116 DEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHR------N 169
+V+G G FG+V +A VA+K + + +RF + A E+ + HLR + N
Sbjct: 102 LKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMN 160
Query: 170 LVRLRGWCVHEDQLLLV--------YDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKII 221
++ + + + + Y+ + F+ + +K
Sbjct: 161 VIHMLENFTFRNHICMTFELLSMNLYELIKKNK-----FQ---------GFSLPLVRKFA 206
Query: 222 RGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNA--RLGDFGLA 265
+ L LH+ +IIH D+K N++L Q + ++ DFG +
Sbjct: 207 HSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSS 249
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 34/157 (21%), Positives = 69/157 (43%), Gaps = 16/157 (10%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHR------NL 170
++G G FG+V +A + VA+K + K + F E+ + + +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYI 118
Query: 171 VRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHY 230
V L+ + + L LV++ + + +L +L ++ +K + + AL +
Sbjct: 119 VHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFR-----GVSLNLTRKFAQQMCTALLF 172
Query: 231 LHEQLETQIIHRDVKTSNVMLDSQYNA--RLGDFGLA 265
L E IIH D+K N++L + + ++ DFG +
Sbjct: 173 LATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 5e-07
Identities = 30/178 (16%), Positives = 65/178 (36%), Gaps = 31/178 (17%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHR-----NLV 171
+G G FG+V + AVK + +++ ++ E + +++ N+V
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIV 99
Query: 172 RLRGWCVHEDQLLLV--------YDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRG 223
+ G ++ D + L+ Y+ + + + + E K
Sbjct: 100 KYHGKFMYYDHMCLIFEPLGPSLYEIITRNN-----YN---------GFHIEDIKLYCIE 145
Query: 224 LAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSA 281
+ AL+YL + + H D+K N++LD Y + ++Q S+
Sbjct: 146 ILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTG 200
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 4e-06
Identities = 34/176 (19%), Positives = 65/176 (36%), Gaps = 44/176 (25%)
Query: 119 LGSGGFGKVYRAVLPSDGTV--------VAVKCLAEKGERF-EKTF---------AAELV 160
G +Y A S T ++K A+ G F E+ F +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 161 AVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRK-- 218
+ + G+ VH+D+ Y ++ VL +L++A L+ +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDK----YRFL-------VLPSLGRSLQSA--LDVSPKHVL 156
Query: 219 --KIIRGLA----AALHYLHEQLETQIIHRDVKTSNVMLDSQYNAR--LGDFGLAR 266
+ + +A AL +LHE + +H +V N+ +D + ++ L +G A
Sbjct: 157 SERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 6e-06
Identities = 31/153 (20%), Positives = 60/153 (39%), Gaps = 33/153 (21%)
Query: 117 EVLGSGGFGKVYRAV-LPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHR------N 169
+ LG G FGKV + + G VAVK + +R+ + +E+ + HL
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFR 78
Query: 170 LVRLRGWCVHEDQLLLV--------YDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKII 221
V++ W H + +V YD++ F P + +K+
Sbjct: 79 CVQMLEWFEHHGHICIVFELLGLSTYDFIKENG-----FL---------PFRLDHIRKMA 124
Query: 222 RGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQ 254
+ ++++LH ++ H D+K N++
Sbjct: 125 YQICKSVNFLHSN---KLTHTDLKPENILFVQS 154
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 1e-05
Identities = 31/190 (16%), Positives = 67/190 (35%), Gaps = 37/190 (19%)
Query: 117 EVLGSGGFGKVYRAV-LPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHR------N 169
LG G FGKV + + VA+K + ++ + E+ + ++ +
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFL 83
Query: 170 LVRLRGWCVHEDQLLLV--------YDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKII 221
V + W + + ++++ + F+ P + +
Sbjct: 84 CVLMSDWFNFHGHMCIAFELLGKNTFEFLKENN-----FQ---------PYPLPHVRHMA 129
Query: 222 RGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRT--- 278
L AL +LHE Q+ H D+K N++ + L + + + +R
Sbjct: 130 YQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADF 186
Query: 279 -SSARNHQFH 287
S+ +H+ H
Sbjct: 187 GSATFDHEHH 196
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 37/181 (20%), Positives = 66/181 (36%), Gaps = 39/181 (21%)
Query: 102 SYAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGE----RFEKTFAA 157
S L +G N F + +G G FG++ VA+K K E F
Sbjct: 1 SMGVLMVGPN-FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYK 59
Query: 158 ELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQR 217
+L + + ++ + +V + + SL E+L + R
Sbjct: 60 QLGSGDGI-----PQVYYFGPCGKYNAMVLELL-GPSL--------EDL-----FDLCDR 100
Query: 218 K---KIIRGLA----AALHYLHEQLETQIIHRDVKTSNVMLDSQYNAR-----LGDFGLA 265
K + +A + + Y+H + +I+RDVK N ++ N + DF LA
Sbjct: 101 TFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157
Query: 266 R 266
+
Sbjct: 158 K 158
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 8e-05
Identities = 32/167 (19%), Positives = 60/167 (35%), Gaps = 38/167 (22%)
Query: 116 DEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGE----RFEKTFAAELVAVAHLRHRNLV 171
+G G FG ++ + VA+K + + R E L +
Sbjct: 15 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGI-----P 69
Query: 172 RLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRK---KIIRGLA--- 225
+ + +LV D + SL E+L L+ RK K + A
Sbjct: 70 NVYYFGQEGLHNVLVIDLLG-PSL--------EDL-----LDLCGRKFSVKTVAMAAKQM 115
Query: 226 -AALHYLHEQLETQIIHRDVKTSNVMLDSQYNAR-----LGDFGLAR 266
A + +HE+ +++RD+K N ++ + + DFG+ +
Sbjct: 116 LARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 38/172 (22%), Positives = 66/172 (38%), Gaps = 36/172 (20%)
Query: 119 LGSGGFGKVYRAVLPSDGTV-----VAVKCLAEKGE--RFEKTF---AAELVAVAHLRHR 168
+G GGFG +Y A + S +V VK E F AA+ +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 169 NLVRLRG-----WCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRK---KI 220
++ G D+ Y +M ++ R +L+ ++ K
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFM-------IMDRFGSDLQKI--YEANAKRFSRKT 153
Query: 221 IRGLA----AALHYLHEQLETQIIHRDVKTSNVMLDSQYNAR--LGDFGLAR 266
+ L+ L Y+HE + +H D+K SN++L+ + + L D+GLA
Sbjct: 154 VLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 42/176 (23%), Positives = 67/176 (38%), Gaps = 37/176 (21%)
Query: 105 ELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGE----RFEKTFAAELV 160
EL +G+ + +GSG FG +Y + G VA+K K + E +
Sbjct: 4 ELRVGNR-YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 62
Query: 161 AVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRK-- 218
+ +R D ++V + + SL E+L N+ RK
Sbjct: 63 GGVG-----IPTIRWCGAEGDYNVMVMELL-GPSL--------EDL-----FNFCSRKFS 103
Query: 219 -KIIRGLA----AALHYLHEQLETQIIHRDVKTSNVMLDSQYNA---RLGDFGLAR 266
K + LA + + Y+H IHRDVK N ++ + DFGLA+
Sbjct: 104 LKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 7e-04
Identities = 35/173 (20%), Positives = 59/173 (34%), Gaps = 41/173 (23%)
Query: 119 LGSGGFGKVYRAVLPSDGTVVAVKCLAEKGER-------FEKTF---AAELVAVAHLRHR 168
+GSGGFG +Y A + A K E E F A+ + R
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARH--VVKVEYQENGPLFSELKFYQRVAKKDCIKKWIER 102
Query: 169 NLVRLRG-----WCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKK---- 219
+ G + Y +M V+ R +L+ Q
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFM-------VMERLGIDLQKI----SGQNGTFKKS 151
Query: 220 ----IIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNAR--LGDFGLAR 266
+ + L Y+HE + +H D+K +N++L + + L D+GL+
Sbjct: 152 TVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 834 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-55 Score=473.25 Aligned_cols=257 Identities=24% Similarity=0.300 Sum_probs=206.2
Q ss_pred CCcccccCCcEEEEEEEC------CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 518 SQRVAEMDFGTAYQGFLD------NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 518 ~~~ig~g~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
.++||+|+||+||+|.+. +++.||||+++.......+++|.+|+.+|++++|||||+|+|+|.+.+..+|||||
T Consensus 31 ~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey 110 (308)
T 4gt4_A 31 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSY 110 (308)
T ss_dssp EEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEc
Confidence 457999999999999973 46789999998665555678899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCC----------CCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEe
Q 003278 592 SATRILSHLLFHNNHR----------IGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLG 661 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~----------~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~ 661 (834)
|++|+|.++|...... .....++|..+++|+.|||+||+|||+ .+||||||||+|||||+++.+||+
T Consensus 111 ~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~~~Ki~ 187 (308)
T 4gt4_A 111 CSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLNVKIS 187 (308)
T ss_dssp CSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEEC
T ss_pred CCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCCCCEEEC
Confidence 9999999999754321 112358999999999999999999997 689999999999999999999999
Q ss_pred eeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHH
Q 003278 662 SFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVH 740 (834)
Q Consensus 662 DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~ 740 (834)
|||+|+.+...+. .......+||+.|||||++.++.|+.++|||||||+||||+| |+.||....+ ..+...+.
T Consensus 188 DFGlar~~~~~~~-----~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~-~~~~~~i~ 261 (308)
T 4gt4_A 188 DLGLFREVYAADY-----YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-QDVVEMIR 261 (308)
T ss_dssp CSCCBCGGGGGGC-----BCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH-HHHHHHHH
T ss_pred CcccceeccCCCc-----eeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH-HHHHHHHH
Confidence 9999987654321 112335689999999999999999999999999999999999 8889865432 22322221
Q ss_pred HHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccC
Q 003278 741 EFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGN 797 (834)
Q Consensus 741 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~ 797 (834)
. ..+ .. .+. .++. .+.+++.+||+.||++||||.||++.|++.
T Consensus 262 ~---~~~--~~-----~p~-~~~~---~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 262 N---RQV--LP-----CPD-DCPA---WVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp T---TCC--CC-----CCT-TCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred c---CCC--CC-----Ccc-cchH---HHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1 111 11 111 2223 355677799999999999999999999865
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-55 Score=470.44 Aligned_cols=261 Identities=26% Similarity=0.380 Sum_probs=200.1
Q ss_pred CcCcCCcccccCCcEEEEEEECCCcEEEEEEecCC-CChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEecc
Q 003278 514 NFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMS-KCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYS 592 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~-~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~ 592 (834)
+|.-.++||+|+||+||+|.+.+ .||||.++.. ..+...++|.+|+.+|++++|||||+++|+|.+ +.++||||||
T Consensus 37 ~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~ 113 (307)
T 3omv_A 37 EVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWC 113 (307)
T ss_dssp SCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcC
Confidence 44556789999999999998754 5999998754 345566889999999999999999999999876 5689999999
Q ss_pred CCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccC
Q 003278 593 ATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRN 672 (834)
Q Consensus 593 ~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~ 672 (834)
++|+|.++|.... ..++|..+++|+.|||+||+|||+ ++||||||||+|||||+++.+||+|||+|+.....
T Consensus 114 ~gGsL~~~l~~~~-----~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 114 EGSSLYKHLHVQE-----TKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp SSCBHHHHHHTSC-----CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred CCCCHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 9999999997543 248999999999999999999997 69999999999999999999999999999875432
Q ss_pred CCCCcccccCccccccccCccchhccc---cCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcc
Q 003278 673 DHGHRKATSGNRSVRGIFGYMSPEYIE---SGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPL 749 (834)
Q Consensus 673 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~---~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
.. .....+.+||+.|||||++. .+.|+.++|||||||+||||+||+.||....+...+...+... ...+.
T Consensus 186 ~~-----~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~--~~~p~ 258 (307)
T 3omv_A 186 SG-----SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRG--YASPD 258 (307)
T ss_dssp -------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTT--CCCCC
T ss_pred Cc-----ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcC--CCCCC
Confidence 21 11234568999999999996 3569999999999999999999999997544433322222110 01110
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCcc
Q 003278 750 AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDKR 800 (834)
Q Consensus 750 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~~ 800 (834)
+ +.+... .++ .+.+++.+||+.||++||||.||++.|+.++..
T Consensus 259 --~--~~~~~~-~~~---~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 259 --L--SKLYKN-CPK---AMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp --S--TTSCTT-SCH---HHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred --c--cccccc-chH---HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 0 011111 223 355666799999999999999999999766543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-55 Score=467.81 Aligned_cols=264 Identities=28% Similarity=0.448 Sum_probs=211.1
Q ss_pred cCCCCCCCeeeccCCeEEEEEEEC-----CCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLP-----SDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLL 184 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~-----~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 184 (834)
.++|...+.||+|+||+||+|++. .+++.||||+++.......+.|.+|+.+|++++|||||+++|+|.+++.++
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 356778899999999999999874 358899999998777777889999999999999999999999999999999
Q ss_pred EEEEccCCCCHhHHHhcCCC------ccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceE
Q 003278 185 LVYDYMPNRSLDRVLFRRPE------NLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNAR 258 (834)
Q Consensus 185 lV~Ey~~~gsL~~~l~~~~~------~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~k 258 (834)
||||||++|+|.++|+.... .......|+|.+++.|+.|||+||+|||++ +||||||||+||||++++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEE
Confidence 99999999999999976431 012235799999999999999999999995 999999999999999999999
Q ss_pred EeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCC
Q 003278 259 LGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDL 337 (834)
Q Consensus 259 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~ 337 (834)
|+|||+|+........ .......||+.|||||++..+ .++.|+|||||||+||||+| |+.||..
T Consensus 169 i~DFGla~~~~~~~~~--------------~~~~~~~gt~~ymAPE~~~~~-~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~ 233 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYY--------------RVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQ 233 (299)
T ss_dssp ECCCSCHHHHTGGGCE--------------EETTTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred ECCcccceecCCCCce--------------eecCceecChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 9999999865432110 112345799999999999765 68999999999999999999 8999864
Q ss_pred CCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 338 TYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 338 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
... ..+... ...+...... ... ...+.+|+..||+.||++||||.+|++.|+..
T Consensus 234 ~~~---~~~~~~----i~~~~~~~~p------~~~----~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~ 287 (299)
T 4asz_A 234 LSN---NEVIEC----ITQGRVLQRP------RTC----PQEVYELMLGCWQREPHMRKNIKGIHTLLQNL 287 (299)
T ss_dssp SCH---HHHHHH----HHHTCCCCCC------TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCH---HHHHHH----HHcCCCCCCC------ccc----hHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 321 112222 2223322211 111 24688999999999999999999999988764
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-55 Score=468.37 Aligned_cols=261 Identities=20% Similarity=0.322 Sum_probs=206.6
Q ss_pred CcCcCCcccccCCcEEEEEEEC------CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEE
Q 003278 514 NFSESQRVAEMDFGTAYQGFLD------NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLV 587 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~l 587 (834)
+|.-.+.||+|+||+||+|.+. ++..||||+++.. ....+++|.+|+++|++++|||||+++|+|.+.+..+|
T Consensus 14 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 14 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC-ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 4555678999999999999864 3678999999754 34556789999999999999999999999999999999
Q ss_pred EEeccCCCchhhhhhcCCC-------CCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceE
Q 003278 588 IYDYSATRILSHLLFHNNH-------RIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRL 660 (834)
Q Consensus 588 v~Ey~~~g~L~~~l~~~~~-------~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki 660 (834)
|||||++|+|.++|...+. ......++|..+++|+.|||+||+|||+ ++||||||||+|||||+++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEEE
Confidence 9999999999999976431 1123469999999999999999999997 68999999999999999999999
Q ss_pred eeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHH
Q 003278 661 GSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRV 739 (834)
Q Consensus 661 ~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~ 739 (834)
+|||+|+.....+. ........||+.|||||++.++.|+.++|||||||+||||+| |+.||....+ ..+...+
T Consensus 170 ~DFGla~~~~~~~~-----~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~-~~~~~~i 243 (299)
T 4asz_A 170 GDFGMSRDVYSTDY-----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-NEVIECI 243 (299)
T ss_dssp CCCSCHHHHTGGGC-----EEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-HHHHHHH
T ss_pred CCcccceecCCCCc-----eeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHH
Confidence 99999987543321 111234579999999999999999999999999999999999 8999875433 2333322
Q ss_pred HHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCC
Q 003278 740 HEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGND 798 (834)
Q Consensus 740 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~ 798 (834)
.. ...+ ..+. ..++ ++.+++.+||+.||++||||.+|++.|+.+.
T Consensus 244 ~~---~~~~-------~~p~-~~~~---~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~ 288 (299)
T 4asz_A 244 TQ---GRVL-------QRPR-TCPQ---EVYELMLGCWQREPHMRKNIKGIHTLLQNLA 288 (299)
T ss_dssp HH---TCCC-------CCCT-TCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred Hc---CCCC-------CCCc-cchH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 22 1111 1111 1223 3556677999999999999999999997654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-54 Score=470.27 Aligned_cols=264 Identities=29% Similarity=0.429 Sum_probs=206.0
Q ss_pred cCCCCCCCeeeccCCeEEEEEEEC-----CCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLP-----SDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLL 184 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~-----~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 184 (834)
.++|...++||+|+||+||+|+++ .+++.||||+++.......+.|.+|+.+|++++|||||+|+|+|.+.+.+|
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 356777889999999999999875 358899999998777777889999999999999999999999999999999
Q ss_pred EEEEccCCCCHhHHHhcCCCcc--------ccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCc
Q 003278 185 LVYDYMPNRSLDRVLFRRPENL--------EAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYN 256 (834)
Q Consensus 185 lV~Ey~~~gsL~~~l~~~~~~~--------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~ 256 (834)
||||||++|+|.++|+...... ....+++|.+++.|+.|||+||+|||+. +||||||||+||||++++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCc
Confidence 9999999999999997653211 1235799999999999999999999985 9999999999999999999
Q ss_pred eEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccC
Q 003278 257 ARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAV 335 (834)
Q Consensus 257 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~ 335 (834)
+||+|||+|+.+...... ...+...||+.|||||++... .++.++|||||||+||||+| |+.||
T Consensus 197 ~Ki~DFGla~~~~~~~~~--------------~~~~~~~gt~~ymAPE~~~~~-~~~~~sDvwS~Gvvl~Ellt~G~~Pf 261 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYY--------------RVGGRTMLPIRWMPPESILYR-KFTTESDVWSFGVVLWEIFTYGKQPW 261 (329)
T ss_dssp EEECCCC------------------------------CCCCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred EEEcccccceeccCCCcc--------------eecCcccccccccChhhhcCC-CCCccccccchHHHHHHHHcCCCCCC
Confidence 999999999865432111 113456799999999998755 68999999999999999999 89998
Q ss_pred CCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 336 DLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 336 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
.... ...+...+ ..+...... ... ...+.+|+..||+.||++||||.||++.|+..
T Consensus 262 ~~~~---~~~~~~~i----~~g~~~~~p------~~~----~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l 317 (329)
T 4aoj_A 262 YQLS---NTEAIDCI----TQGRELERP------RAC----PPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317 (329)
T ss_dssp CSSC---HHHHHHHH----HHTCCCCCC------TTC----CHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCC---HHHHHHHH----HcCCCCCCc------ccc----cHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 6432 11122222 223221111 111 24688999999999999999999999999865
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-54 Score=470.05 Aligned_cols=261 Identities=20% Similarity=0.301 Sum_probs=201.5
Q ss_pred CcCcCCcccccCCcEEEEEEEC------CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEE
Q 003278 514 NFSESQRVAEMDFGTAYQGFLD------NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLV 587 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~l 587 (834)
+|.-.++||+|+||+||+|.+. +++.||||+++.. ....+++|.+|+++|++++|||||+++|+|.+.+.++|
T Consensus 42 d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 42 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 3444567999999999999874 4678999999743 45556889999999999999999999999999999999
Q ss_pred EEeccCCCchhhhhhcCCCC---------CCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCc
Q 003278 588 IYDYSATRILSHLLFHNNHR---------IGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNP 658 (834)
Q Consensus 588 v~Ey~~~g~L~~~l~~~~~~---------~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ 658 (834)
|||||++|+|.++|...... .....++|..+++|+.|||+||+|||+ ++||||||||+|||||+++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcE
Confidence 99999999999999764321 122469999999999999999999997 689999999999999999999
Q ss_pred eEeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHH
Q 003278 659 RLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVK 737 (834)
Q Consensus 659 ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~ 737 (834)
||+|||+|+.+...+. ........||+.|||||++.+..|+.++|||||||+||||+| |+.||..... ..+..
T Consensus 198 Ki~DFGla~~~~~~~~-----~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~-~~~~~ 271 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDY-----YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-TEAID 271 (329)
T ss_dssp EECCCC---------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH-HHHHH
T ss_pred EEcccccceeccCCCc-----ceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH-HHHHH
Confidence 9999999987643321 111234679999999999999999999999999999999999 8999875432 22333
Q ss_pred HHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCC
Q 003278 738 RVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGND 798 (834)
Q Consensus 738 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~ 798 (834)
.+.. ..++ ..+. ..++ ++.+++.+||+.||++||||.||++.|+.+.
T Consensus 272 ~i~~---g~~~-------~~p~-~~~~---~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~ 318 (329)
T 4aoj_A 272 CITQ---GREL-------ERPR-ACPP---EVYAIMRGCWQREPQQRHSIKDVHARLQALA 318 (329)
T ss_dssp HHHH---TCCC-------CCCT-TCCH---HHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHHc---CCCC-------CCcc-cccH---HHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence 2222 1111 1111 2223 3556667999999999999999999998654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-54 Score=466.42 Aligned_cols=261 Identities=25% Similarity=0.350 Sum_probs=207.7
Q ss_pred CCCCCeeeccCCeEEEEEEEC-----CCCeEEEEEEecccC-hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEE
Q 003278 113 FDEDEVLGSGGFGKVYRAVLP-----SDGTVVAVKCLAEKG-ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLV 186 (834)
Q Consensus 113 f~~~~~LG~G~fG~Vy~~~~~-----~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 186 (834)
++..+.||+|+||+||+|.+. .+++.||||+++... ....+.|.+|+.+|++++|||||+|+|+|.+++.++||
T Consensus 28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV 107 (308)
T 4gt4_A 28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMI 107 (308)
T ss_dssp EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEE
Confidence 455678999999999999974 357899999997543 34567899999999999999999999999999999999
Q ss_pred EEccCCCCHhHHHhcCCCcc---------ccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCce
Q 003278 187 YDYMPNRSLDRVLFRRPENL---------EAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNA 257 (834)
Q Consensus 187 ~Ey~~~gsL~~~l~~~~~~~---------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~ 257 (834)
||||++|||.++|..+.... .....++|..++.|+.|||+||+|||++ +||||||||+||||++++++
T Consensus 108 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~~ 184 (308)
T 4gt4_A 108 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNV 184 (308)
T ss_dssp EECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCE
T ss_pred EEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCCE
Confidence 99999999999997543211 1135699999999999999999999996 99999999999999999999
Q ss_pred EEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCC
Q 003278 258 RLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVD 336 (834)
Q Consensus 258 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~ 336 (834)
||+|||+|+.+..... ....+...||+.|||||++..+ .++.++|||||||+||||+| |+.||.
T Consensus 185 Ki~DFGlar~~~~~~~--------------~~~~~~~~gt~~ymAPE~l~~~-~~s~ksDVwSfGvvl~El~t~g~~Pf~ 249 (308)
T 4gt4_A 185 KISDLGLFREVYAADY--------------YKLLGNSLLPIRWMAPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYC 249 (308)
T ss_dssp EECCSCCBCGGGGGGC--------------BCSSSSSCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred EECCcccceeccCCCc--------------eeEecccccCCcccCHHHHhCC-CCCccchhhhHHHHHHHHHhCCCCCCC
Confidence 9999999986543211 0113456799999999999766 68999999999999999999 899986
Q ss_pred CCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 337 LTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 337 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
... ...+... ...+...... .. ....+.+|+..||+.||++||+|.+|++.|+..
T Consensus 250 ~~~---~~~~~~~----i~~~~~~~~p------~~----~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 250 GYS---NQDVVEM----IRNRQVLPCP------DD----CPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp TCC---HHHHHHH----HHTTCCCCCC------TT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred CCC---HHHHHHH----HHcCCCCCCc------cc----chHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 432 1122222 2233322211 11 124688999999999999999999999999763
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-54 Score=460.02 Aligned_cols=262 Identities=26% Similarity=0.367 Sum_probs=201.7
Q ss_pred hhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEE
Q 003278 108 IGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLL 185 (834)
Q Consensus 108 ~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 185 (834)
+..++|...+.||+|+||+||+|++.. .||||+++.. .....+.|.+|+.+|++++|||||+++|+|.+ +.++|
T Consensus 33 i~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~i 108 (307)
T 3omv_A 33 IEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAI 108 (307)
T ss_dssp CCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred EcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEE
Confidence 344667888999999999999998742 5999998643 34456789999999999999999999999865 56899
Q ss_pred EEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccch
Q 003278 186 VYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLA 265 (834)
Q Consensus 186 V~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla 265 (834)
|||||+||+|.++|+.. ..+++|.+++.|+.|||+||+|||++ +||||||||+||||++++++||+|||+|
T Consensus 109 VmEy~~gGsL~~~l~~~------~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla 179 (307)
T 3omv_A 109 VTQWCEGSSLYKHLHVQ------ETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLA 179 (307)
T ss_dssp EEECCSSCBHHHHHHTS------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSC
T ss_pred EEEcCCCCCHHHHHhhc------CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCc
Confidence 99999999999999754 24699999999999999999999995 9999999999999999999999999999
Q ss_pred hhhhhhhhhhhhcccccccccccccceeeeccccCCCcccccc--CCCCCcccceeehhhHHHHHHhCCccCCCCCCCcc
Q 003278 266 RWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQK--GSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQ 343 (834)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~ 343 (834)
+....... ....+..+||+.|||||++.. ...++.|+|||||||+||||+||+.||.......
T Consensus 180 ~~~~~~~~--------------~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~- 244 (307)
T 3omv_A 180 TVKSRWSG--------------SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD- 244 (307)
T ss_dssp BC--------------------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-
T ss_pred eecccCCc--------------ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH-
Confidence 86533211 011345679999999999853 2357999999999999999999999996432211
Q ss_pred chHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 344 IILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 344 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
.+......+... +.+. .........+.+|+..||+.||++||||.+|++.|+..
T Consensus 245 -----~~~~~~~~~~~~----p~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 245 -----QIIFMVGRGYAS----PDLS--KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp -----HHHHHHHTTCCC----CCST--TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred -----HHHHHHhcCCCC----CCcc--cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 111222222111 1111 01111124688999999999999999999999988653
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=440.62 Aligned_cols=247 Identities=23% Similarity=0.340 Sum_probs=197.0
Q ss_pred CCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEe----CCEEEEEE
Q 003278 114 DEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCVH----EDQLLLVY 187 (834)
Q Consensus 114 ~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~lV~ 187 (834)
...++||+|+||+||+|.+..++..||||++... .....+.|.+|+.+|++++|||||+++++|.+ ++.+||||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 4456899999999999999999999999998643 34456789999999999999999999999875 34689999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECC-CCceEEeeccchh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDS-QYNARLGDFGLAR 266 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~-~~~~kl~DFGla~ 266 (834)
|||++|+|.++|.+. .++++..+..|+.||+.||+|||++ .++||||||||+||||+. ++.+||+|||+|+
T Consensus 109 Ey~~gg~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~ 180 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF-------KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp ECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred eCCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence 999999999999653 4689999999999999999999986 234999999999999984 7899999999997
Q ss_pred hhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchH
Q 003278 267 WLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIIL 346 (834)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l 346 (834)
.... ...++.+||+.|||||.+. + .++.++|||||||+||||+||+.||......
T Consensus 181 ~~~~------------------~~~~~~~GTp~YmAPE~~~-~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~----- 235 (290)
T 3fpq_A 181 LKRA------------------SFAKAVIGTPEFMAPEMYE-E-KYDESVDVYAFGMCMLEMATSEYPYSECQNA----- 235 (290)
T ss_dssp GCCT------------------TSBEESCSSCCCCCGGGGG-T-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----
T ss_pred eCCC------------------CccCCcccCccccCHHHcC-C-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH-----
Confidence 5321 1145678999999999885 3 4899999999999999999999999642211
Q ss_pred HHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 347 LDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 347 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
...... ...+......+.. . ...+.+|+..||+.||++|||+.|+++
T Consensus 236 ~~~~~~-i~~~~~~~~~~~~-----~----~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 236 AQIYRR-VTSGVKPASFDKV-----A----IPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHHHHH-HTTTCCCGGGGGC-----C----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHH-HHcCCCCCCCCcc-----C----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111111 1222111111111 1 135788999999999999999999986
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-53 Score=455.37 Aligned_cols=269 Identities=22% Similarity=0.279 Sum_probs=199.8
Q ss_pred CCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCC----EEEEEE
Q 003278 112 GFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHED----QLLLVY 187 (834)
Q Consensus 112 ~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~----~~~lV~ 187 (834)
++...+.||+|+||+||+|++ +|+.||||+++.... ....+..|+..+.+++|||||+++|+|.+++ .+||||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 356678999999999999998 589999999965432 2223445677778899999999999998764 689999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhcc-----CCCeecCCCCCCceEECCCCceEEeec
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQL-----ETQIIHRDVKTSNVMLDSQYNARLGDF 262 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~iiHrDlKp~NILld~~~~~kl~DF 262 (834)
|||++|+|.++|+.. +++|..+.+|+.|+|+||+|||+++ .++||||||||+|||||.++++||+||
T Consensus 81 Ey~~~gsL~~~l~~~--------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DF 152 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRY--------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp ECCTTCBHHHHHHHC--------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred cCCCCCcHHHHHHhC--------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeC
Confidence 999999999999653 5899999999999999999999752 458999999999999999999999999
Q ss_pred cchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCC-----CCCcccceeehhhHHHHHHhCCccCCC
Q 003278 263 GLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGS-----VATAKSDVFSFGIVVLEVVSGRRAVDL 337 (834)
Q Consensus 263 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-----~~~~ksDV~SfGvvl~ElltG~~p~~~ 337 (834)
|+|+....... ......+..+||+.|||||++.... .++.|+|||||||+||||+||+.|+..
T Consensus 153 Gla~~~~~~~~------------~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~ 220 (303)
T 3hmm_A 153 GLAVRHDSATD------------TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp TTCEEEETTTT------------EESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred CCCccccCCCC------------ceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCc
Confidence 99986533210 0011134567999999999986431 356799999999999999999887643
Q ss_pred CCCCc---------cchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 338 TYPDD---------QIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 338 ~~~~~---------~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
..... ...... +.....++ ..++.+.+.....+....+.+|+..||+.||++||||.||++.|+..
T Consensus 221 ~~~~~~p~~~~~~~~~~~~~-~~~~~~~~----~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l 295 (303)
T 3hmm_A 221 HEDYQLPYYDLVPSDPSVEE-MRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CCCCCCTTTTTSCSSCCHHH-HHHHHTTS----CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccccccchhcccccchHHH-HHHHHhcc----cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 22111 111111 22211111 12222221112234556788999999999999999999999998764
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-52 Score=449.25 Aligned_cols=263 Identities=18% Similarity=0.234 Sum_probs=195.1
Q ss_pred CCcccccCCcEEEEEEECCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCC----eEEEEEeccC
Q 003278 518 SQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQG----EMLVIYDYSA 593 (834)
Q Consensus 518 ~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~----~~~lv~Ey~~ 593 (834)
.++||+|+||+||+|.+ +|+.||||+++... .....+..|+..+.+++|||||+++|+|.+.+ .++||||||+
T Consensus 8 ~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~--~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~ 84 (303)
T 3hmm_A 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE 84 (303)
T ss_dssp EEEEEECSSSEEEEEEE-TTEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCT
T ss_pred EEEEeeCCCeEEEEEEE-CCEEEEEEEECccc--hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCC
Confidence 46799999999999998 57899999986432 22223455777778999999999999998654 6899999999
Q ss_pred CCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhcc-----CCceeecccccCceeecCCCCceEeeeeeccc
Q 003278 594 TRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEW-----NEQVIHRNITSSAITLDPDMNPRLGSFALAEF 668 (834)
Q Consensus 594 ~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~-----~~~iiHrDlK~~NILld~~~~~ki~DfGla~~ 668 (834)
+|+|.++|... .++|..+++|+.|+|+||+|||+.. .++||||||||+|||||+++.+||+|||+|+.
T Consensus 85 ~gsL~~~l~~~-------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 85 HGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp TCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CCcHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 99999999753 3899999999999999999999742 35899999999999999999999999999987
Q ss_pred cccCCCCCcccccCccccccccCccchhccccC------CCCccCcchhhHHHHHHHHhCCCccCCCC----------Cc
Q 003278 669 LTRNDHGHRKATSGNRSVRGIFGYMSPEYIESG------EATSMADVYSFGVVVLEVVTGQMAVDFRL----------PE 732 (834)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~------~~~~k~DV~SfGvvl~E~~tG~~p~~~~~----------~~ 732 (834)
...... .......+.+||+.|||||++.+. .|+.++|||||||+||||+||+.|+.... +.
T Consensus 158 ~~~~~~---~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~ 234 (303)
T 3hmm_A 158 HDSATD---TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp EETTTT---EESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred ccCCCC---ceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccc
Confidence 643321 111122346899999999999754 47889999999999999999987653211 11
Q ss_pred hhHHHHHHHHHhhcCccccccccccCCCC-CHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCC
Q 003278 733 GLLVKRVHEFEARKRPLAELVDLSLNGEY-NHKELMRLIKLGIACTLSNPELRPSMRQILSILDGND 798 (834)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~ 798 (834)
......+..... ....+|.++... ..+....+.+++.+||+.||++||||.||++.|+.+.
T Consensus 235 ~~~~~~~~~~~~-----~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~ 296 (303)
T 3hmm_A 235 DPSVEEMRKVVC-----EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp SCCHHHHHHHHT-----TSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred cchHHHHHHHHh-----cccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 111111111111 111222222211 2245566788889999999999999999999997653
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-52 Score=451.69 Aligned_cols=252 Identities=25% Similarity=0.378 Sum_probs=202.2
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYD 188 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 188 (834)
++|+..+.||+|+||+||+|+++.+|+.||||++... .....+.|.+|+.+|++|+|||||++++++.+++.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 6799999999999999999999999999999998653 34456789999999999999999999999999999999999
Q ss_pred ccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhh
Q 003278 189 YMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWL 268 (834)
Q Consensus 189 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~ 268 (834)
||++|+|.++|.... ...+++...+.|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+.+
T Consensus 104 y~~gg~L~~~i~~~~-----~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 175 (350)
T 4b9d_A 104 YCEGGDLFKRINAQK-----GVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVL 175 (350)
T ss_dssp CCTTCBHHHHHHHTT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCC
T ss_pred CCCCCcHHHHHHHcC-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceee
Confidence 999999999997542 24678999999999999999999996 9999999999999999999999999999876
Q ss_pred hhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHH
Q 003278 269 EHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLD 348 (834)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~ 348 (834)
..... ..++.+||+.|||||.+.. ..++.++|||||||+||||+||+.||.... ..+
T Consensus 176 ~~~~~----------------~~~~~~GT~~YmAPE~l~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~------~~~ 232 (350)
T 4b9d_A 176 NSTVE----------------LARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGS------MKN 232 (350)
T ss_dssp CHHHH----------------HHHHHHSCCTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHH
T ss_pred cCCcc----------------cccccCCCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcC------HHH
Confidence 44321 1345679999999999864 468999999999999999999999996432 112
Q ss_pred HHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 349 WIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 349 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
.+..... +... .+. ..++ ..+.+|+..||+.||.+|||+.|+++.
T Consensus 233 ~~~~i~~-~~~~-----~~~-~~~s----~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 233 LVLKIIS-GSFP-----PVS-LHYS----YDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp HHHHHHH-TCCC-----CCC-TTSC----HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHc-CCCC-----CCC-ccCC----HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2222222 2111 111 1122 357889999999999999999999863
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-52 Score=457.63 Aligned_cols=263 Identities=22% Similarity=0.306 Sum_probs=209.7
Q ss_pred hCcCcCCcccccCCcEEEEEEECC------CcEEEEEEecCCCChhHHHHHHHHHHHHHhccC-CCceeEEEEEeeC-Ce
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDN------HQYVLVKRLGMSKCPALRTRFSNELQNLARLRH-RNLVQLCGWCTEQ-GE 584 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~------~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~H-pNiv~l~g~~~~~-~~ 584 (834)
++|.-.+.||+|+||+||+|...+ ++.||||.+.........+.|.+|+++|++++| ||||+++|+|.+. +.
T Consensus 64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~ 143 (353)
T 4ase_A 64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 143 (353)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCE
Confidence 456667889999999999998643 357999999877666667789999999999976 8999999999764 56
Q ss_pred EEEEEeccCCCchhhhhhcCCCC----------CCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecC
Q 003278 585 MLVIYDYSATRILSHLLFHNNHR----------IGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDP 654 (834)
Q Consensus 585 ~~lv~Ey~~~g~L~~~l~~~~~~----------~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~ 654 (834)
++||||||++|+|.++|+..... .....++|..++.|+.|||+||+|||+ ++||||||||+||||++
T Consensus 144 ~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~~NILl~~ 220 (353)
T 4ase_A 144 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSE 220 (353)
T ss_dssp CEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECG
T ss_pred EEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCccceeeCC
Confidence 89999999999999999764321 112358999999999999999999997 68999999999999999
Q ss_pred CCCceEeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCch
Q 003278 655 DMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEG 733 (834)
Q Consensus 655 ~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~ 733 (834)
++.+||+|||+|+.+...... ....+.+||+.|||||++.++.|+.++|||||||+||||+| |+.||.......
T Consensus 221 ~~~vKi~DFGlar~~~~~~~~-----~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~ 295 (353)
T 4ase_A 221 KNVVKICDFGLARDIYKDPDY-----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 295 (353)
T ss_dssp GGCEEECCCGGGSCTTTCTTS-----EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred CCCEEECcchhhhhcccCCCc-----eeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999876543211 11235689999999999999999999999999999999999 899987544443
Q ss_pred hHHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccC
Q 003278 734 LLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGN 797 (834)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~ 797 (834)
.+...+... .++ ..+ ...++ ++.+++.+||+.||++||||.+|++.|+.+
T Consensus 296 ~~~~~i~~g---~~~-------~~p-~~~~~---~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 296 EFCRRLKEG---TRM-------RAP-DYTTP---EMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp HHHHHHHHT---CCC-------CCC-TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHcC---CCC-------CCC-ccCCH---HHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 333333221 111 111 12223 355666799999999999999999998654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-52 Score=451.06 Aligned_cols=250 Identities=24% Similarity=0.349 Sum_probs=204.8
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEcc
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYM 190 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 190 (834)
..|+..+.||+|+||+||+|+++.+|+.||||++........+.+.+|+.+|++++|||||+++++|.+++.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 45888899999999999999999999999999997654445567889999999999999999999999999999999999
Q ss_pred CCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhh
Q 003278 191 PNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEH 270 (834)
Q Consensus 191 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~ 270 (834)
++|+|.+++.. ..+++..+..|+.||+.||+|||++ +||||||||+||||+.++++||+|||+|+.+..
T Consensus 154 ~gg~L~~~l~~--------~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 222 (346)
T 4fih_A 154 EGGALTDIVTH--------TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 222 (346)
T ss_dssp TTEEHHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred CCCcHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCC
Confidence 99999999864 3589999999999999999999996 999999999999999999999999999986532
Q ss_pred hhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHHH
Q 003278 271 ELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWI 350 (834)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~ 350 (834)
.. ...++.+||+.|||||.+... .++.++|||||||++|||+||+.||.... ...+...+
T Consensus 223 ~~----------------~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~---~~~~~~~i 282 (346)
T 4fih_A 223 EV----------------PRRKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEP---PLKAMKMI 282 (346)
T ss_dssp SS----------------CCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHH
T ss_pred CC----------------CcccccccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcC---HHHHHHHH
Confidence 11 124567899999999988644 67999999999999999999999996421 11122111
Q ss_pred HHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 351 RRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 351 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
. . + ..+.+.. ...-...+.+|+..||+.||++|||+.|+++
T Consensus 283 ~---~-~-----~~~~~~~---~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 283 R---D-N-----LPPRLKN---LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp H---H-S-----SCCCCSC---GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred H---c-C-----CCCCCCc---cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1 1 1 1111110 0011145778999999999999999999875
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=447.65 Aligned_cols=258 Identities=23% Similarity=0.223 Sum_probs=203.6
Q ss_pred hcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEE
Q 003278 109 GSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYD 188 (834)
Q Consensus 109 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 188 (834)
..+.|...++||+|+||+||+|+++.+|+.||||+++.... +.+|+.+|++++|||||+++++|.+++.+|||||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE 130 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFME 130 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 34568888899999999999999999999999999965421 2469999999999999999999999999999999
Q ss_pred ccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCC-ceEEeeccchhh
Q 003278 189 YMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQY-NARLGDFGLARW 267 (834)
Q Consensus 189 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~-~~kl~DFGla~~ 267 (834)
||+||+|.++|... .++++.....|+.||+.||+|||++ +||||||||+||||+.++ .+||+|||+|+.
T Consensus 131 y~~gg~L~~~l~~~-------~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~ 200 (336)
T 4g3f_A 131 LLEGGSLGQLIKQM-------GCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALC 200 (336)
T ss_dssp CCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEE
T ss_pred ccCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeE
Confidence 99999999999643 4689999999999999999999986 999999999999999987 599999999987
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHH
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILL 347 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~ 347 (834)
+..+.... .......++||+.|||||.+.. ..++.++|||||||+||||+||+.||........ +
T Consensus 201 ~~~~~~~~-----------~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~- 265 (336)
T 4g3f_A 201 LQPDGLGK-----------SLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL--C- 265 (336)
T ss_dssp C-----------------------CCCCCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC--H-
T ss_pred ccCCCccc-----------ceecCCccccCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH--H-
Confidence 64331100 0011345689999999999865 4689999999999999999999999975433321 1
Q ss_pred HHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 348 DWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 348 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
. .+.........+. ...+ ..+.+++..||+.||.+|||+.|+++.|...
T Consensus 266 ~---~i~~~~~~~~~~~-----~~~s----~~~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 266 L---KIASEPPPIREIP-----PSCA----PLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp H---HHHHSCCGGGGSC-----TTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H---HHHcCCCCchhcC-----ccCC----HHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 1 1111111111111 1111 3577899999999999999999999887653
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-52 Score=454.38 Aligned_cols=274 Identities=24% Similarity=0.347 Sum_probs=216.4
Q ss_pred ccHHHHHhhcCCCCCCCeeeccCCeEEEEEEECCC-----CeEEEEEEecccC-hhhHHHHHHHHHHHHhCCC-CceeeE
Q 003278 101 FSYAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSD-----GTVVAVKCLAEKG-ERFEKTFAAELVAVAHLRH-RNLVRL 173 (834)
Q Consensus 101 f~~~el~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~-----g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H-~nIv~l 173 (834)
+...+.++..++|+..+.||+|+||+||+|.+... ++.||||++.... ....+.|.+|+.+|.+++| ||||+|
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 34456667788999999999999999999987543 4689999997643 3445779999999999965 899999
Q ss_pred eeeEEeC-CEEEEEEEccCCCCHhHHHhcCCCcc---------ccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCC
Q 003278 174 RGWCVHE-DQLLLVYDYMPNRSLDRVLFRRPENL---------EAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRD 243 (834)
Q Consensus 174 ~g~~~~~-~~~~lV~Ey~~~gsL~~~l~~~~~~~---------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrD 243 (834)
+|+|.+. +.++||||||++|+|.++|+...... .....++|..++.|+.|||+||+|||++ +|||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCc
Confidence 9999775 56899999999999999997643211 1134689999999999999999999996 999999
Q ss_pred CCCCceEECCCCceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhh
Q 003278 244 VKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGI 323 (834)
Q Consensus 244 lKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGv 323 (834)
|||+||||++++.+||+|||+|+.+..+.. ...++..+||+.|||||++..+ .++.++|||||||
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~--------------~~~~~~~~gt~~ymAPE~l~~~-~y~~ksDVwS~Gv 275 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPD--------------YVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGV 275 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTT--------------SEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHH
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCC--------------ceeeccccccccccCHHHHhcC-CCCCcccEeehHH
Confidence 999999999999999999999986543211 1123456799999999999765 6899999999999
Q ss_pred HHHHHHh-CCccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHH
Q 003278 324 VVLEVVS-GRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVI 402 (834)
Q Consensus 324 vl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~ 402 (834)
+||||+| |+.||....... .+.....++......+ .. ...+.+++..||+.||.+||||.+|+
T Consensus 276 ~l~El~t~G~~Pf~~~~~~~------~~~~~i~~g~~~~~p~------~~----~~~~~~li~~c~~~dP~~RPt~~eil 339 (353)
T 4ase_A 276 LLWEIFSLGASPYPGVKIDE------EFCRRLKEGTRMRAPD------YT----TPEMYQTMLDCWHGEPSQRPTFSELV 339 (353)
T ss_dssp HHHHHTTTSCCSSTTCCCSH------HHHHHHHHTCCCCCCT------TC----CHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHhCCCCCCCCCCHHH------HHHHHHHcCCCCCCCc------cC----CHHHHHHHHHHcCcChhHCcCHHHHH
Confidence 9999998 899986543221 1222223333222111 11 24578899999999999999999999
Q ss_pred HHhhcC
Q 003278 403 EAVSGS 408 (834)
Q Consensus 403 ~~l~~~ 408 (834)
+.|+..
T Consensus 340 ~~L~~l 345 (353)
T 4ase_A 340 EHLGNL 345 (353)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 998764
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=451.70 Aligned_cols=249 Identities=24% Similarity=0.356 Sum_probs=205.4
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEcc
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYM 190 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 190 (834)
+.|+..+.||+|+||.||+|+++.+|+.||||++........+.+.+|+.+|++++|||||+++++|.+.+.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 46899999999999999999999999999999997655555567899999999999999999999999999999999999
Q ss_pred CCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhh
Q 003278 191 PNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEH 270 (834)
Q Consensus 191 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~ 270 (834)
++|+|.+++.. ..+++..+..|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+.+..
T Consensus 231 ~gG~L~~~i~~--------~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~ 299 (423)
T 4fie_A 231 EGGALTDIVTH--------TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 299 (423)
T ss_dssp TTEEHHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCS
T ss_pred CCCcHHHHHhc--------cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCC
Confidence 99999999854 3589999999999999999999996 999999999999999999999999999986532
Q ss_pred hhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHHH
Q 003278 271 ELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWI 350 (834)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~ 350 (834)
.. ...++.+||+.|||||.+... .|+.++|||||||++|||+||+.||.... ...+...+
T Consensus 300 ~~----------------~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~---~~~~~~~i 359 (423)
T 4fie_A 300 EV----------------PRRKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEP---PLKAMKMI 359 (423)
T ss_dssp SC----------------CCBCCCEECTTTCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHH
T ss_pred CC----------------ccccccccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcC---HHHHHHHH
Confidence 11 124567899999999988644 68999999999999999999999996421 11122111
Q ss_pred HHHhhcCccccccccccCC-CCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 351 RRLSDEGKVLQAGDNRLSD-GSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 351 ~~~~~~~~~~~~~d~~l~~-~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
.. + ..+.+.. ...+ ..+.+|+..||+.||++||++.|+++
T Consensus 360 ---~~-~-----~~~~~~~~~~~s----~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 360 ---RD-N-----LPPRLKNLHKVS----PSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp ---HH-S-----CCCCCSCTTSSC----HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---Hc-C-----CCCCCcccccCC----HHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11 1 1111110 1111 35778999999999999999999875
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=427.11 Aligned_cols=248 Identities=23% Similarity=0.395 Sum_probs=191.5
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc---ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK---GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 187 (834)
++|+..+.||+|+||+||+|+.+.+|+.||||++.+. .....+.+.+|+.+|++++|||||++++++.+++.+||||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 5799999999999999999999999999999998653 2334567999999999999999999999999999999999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
||| +|+|.+++..+ .++++.....|+.||+.||+|||++ +|+||||||+|||+++++++||+|||+|+.
T Consensus 93 Ey~-~g~L~~~l~~~-------~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~ 161 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR-------DKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNI 161 (275)
T ss_dssp ECC-CEEHHHHHHHS-------CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC--
T ss_pred eCC-CCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCee
Confidence 999 68999988653 4689999999999999999999996 999999999999999999999999999986
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHH
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILL 347 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~ 347 (834)
..... ..++.+||+.|||||.+.....++.++||||+||++|||+||+.||.... ..
T Consensus 162 ~~~~~-----------------~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~------~~ 218 (275)
T 3hyh_A 162 MTDGN-----------------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES------IP 218 (275)
T ss_dssp ------------------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HH
T ss_pred cCCCC-----------------ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC------HH
Confidence 43211 13456799999999999765455789999999999999999999996421 11
Q ss_pred HHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 348 DWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 348 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
........ +.. .+. ...+ ..+.+|...||+.||++|||+.|+++.
T Consensus 219 ~~~~~i~~-~~~------~~p-~~~s----~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 219 VLFKNISN-GVY------TLP-KFLS----PGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp HHHHHHHH-TCC------CCC-TTSC----HHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred HHHHHHHc-CCC------CCC-CCCC----HHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 12222211 111 111 1111 357789999999999999999999873
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=431.48 Aligned_cols=244 Identities=21% Similarity=0.328 Sum_probs=191.7
Q ss_pred CcccccCCcEEEEEEEC-CCcEEEEEEecCCC-ChhHHHHHHHHHHHHHhccCCCceeEEEEEee----CCeEEEEEecc
Q 003278 519 QRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSK-CPALRTRFSNELQNLARLRHRNLVQLCGWCTE----QGEMLVIYDYS 592 (834)
Q Consensus 519 ~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~----~~~~~lv~Ey~ 592 (834)
..||+|+||+||+|... ++..||||.+.... ....+++|.+|+.+|++|+|||||+++++|.+ .+.++||||||
T Consensus 32 ~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~ 111 (290)
T 3fpq_A 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM 111 (290)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred eEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCC
Confidence 46999999999999964 57899999986433 34456789999999999999999999999865 34689999999
Q ss_pred CCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecC-CCCceEeeeeecccccc
Q 003278 593 ATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDP-DMNPRLGSFALAEFLTR 671 (834)
Q Consensus 593 ~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~-~~~~ki~DfGla~~~~~ 671 (834)
++|+|.+++.... .+++.....|+.||+.||+|||+. .++||||||||+||||+. ++.+||+|||+|+....
T Consensus 112 ~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 112 TSGTLKTYLKRFK------VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp CSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred CCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 9999999997532 488999999999999999999974 235999999999999984 79999999999975321
Q ss_pred CCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcccc
Q 003278 672 NDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAE 751 (834)
Q Consensus 672 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
....+++||+.|||||++. +.|+.++|||||||+||||+||+.||........+...+. ....+ .
T Consensus 185 ---------~~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~---~~~~~--~ 249 (290)
T 3fpq_A 185 ---------SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT---SGVKP--A 249 (290)
T ss_dssp ---------TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHT---TTCCC--G
T ss_pred ---------CccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHH---cCCCC--C
Confidence 1234578999999999986 4699999999999999999999999965443333222221 11111 1
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 752 LVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 752 ~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
...... .++ +..++.+||+.||++|||+.|+++
T Consensus 250 ----~~~~~~-~~~---~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 250 ----SFDKVA-IPE---VKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ----GGGGCC-CHH---HHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----CCCccC-CHH---HHHHHHHHccCChhHCcCHHHHhc
Confidence 111111 233 445556899999999999999874
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-51 Score=442.73 Aligned_cols=251 Identities=24% Similarity=0.350 Sum_probs=197.8
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCC-ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEe
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSK-CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYD 590 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~-~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~E 590 (834)
++|...+.||+|+||+||+|.. .+++.||||++.... ....+++|.+|+.+|++|+|||||++++++.+.+.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 4677788999999999999996 568999999997553 34456789999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccc
Q 003278 591 YSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLT 670 (834)
Q Consensus 591 y~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~ 670 (834)
||++|+|.++|..... ..+++.....|+.||+.||+|||+ .+||||||||+||||++++.+||+|||+|+.+.
T Consensus 104 y~~gg~L~~~i~~~~~----~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 176 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKG----VLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN 176 (350)
T ss_dssp CCTTCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCC
T ss_pred CCCCCcHHHHHHHcCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeec
Confidence 9999999999975432 247888888999999999999997 699999999999999999999999999998753
Q ss_pred cCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCccc
Q 003278 671 RNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLA 750 (834)
Q Consensus 671 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (834)
... ....+.+||+.|||||++.+..|+.++|||||||+||||+||+.||........ ...+.. ...+
T Consensus 177 ~~~-------~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~-~~~i~~---~~~~-- 243 (350)
T 4b9d_A 177 STV-------ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL-VLKIIS---GSFP-- 243 (350)
T ss_dssp HHH-------HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHH---TCCC--
T ss_pred CCc-------ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH-HHHHHc---CCCC--
Confidence 211 112357899999999999999999999999999999999999999975443322 222211 1111
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 751 ELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 751 ~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
.+...++ .+ +..++.+||+.||++|||+.|+++
T Consensus 244 -----~~~~~~s-~~---~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 244 -----PVSLHYS-YD---LRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp -----CCCTTSC-HH---HHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----CCCccCC-HH---HHHHHHHHccCChhHCcCHHHHhc
Confidence 1111222 33 445556899999999999999975
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-51 Score=436.02 Aligned_cols=249 Identities=21% Similarity=0.309 Sum_probs=204.9
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc---ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK---GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 187 (834)
++|+..+.||+|+||+||+|+.+.+|+.||||++.+. .....+.+.+|+.+|++++|||||++++++.+++.+||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4699999999999999999999999999999999653 2234567999999999999999999999999999999999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
|||++|+|.++|.+. ..+++.....|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+.
T Consensus 112 Ey~~gG~L~~~i~~~-------~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~ 181 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI-------GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKV 181 (311)
T ss_dssp CCCTTEEHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCcee
Confidence 999999999999643 4689999999999999999999996 999999999999999999999999999986
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHH
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILL 347 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~ 347 (834)
+..+.. .....+++||+.|||||.+... .++.++||||+||+||||+||+.||.... ...+.
T Consensus 182 ~~~~~~--------------~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~---~~~~~ 243 (311)
T 4aw0_A 182 LSPESK--------------QARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGN---EGLIF 243 (311)
T ss_dssp CCTTTT--------------CCCBCCCCSCGGGCCHHHHHHS-CBCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHH
T ss_pred cCCCCC--------------cccccCcccCcccCCHHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCC---HHHHH
Confidence 532210 1124567899999999998654 67999999999999999999999996432 11222
Q ss_pred HHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHH
Q 003278 348 DWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVI 402 (834)
Q Consensus 348 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~ 402 (834)
. .... +.. .+. ...+ ..+.+|...||+.||.+||++.|++
T Consensus 244 ~---~i~~-~~~------~~p-~~~s----~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 244 A---KIIK-LEY------DFP-EKFF----PKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp H---HHHH-TCC------CCC-TTCC----HHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred H---HHHc-CCC------CCC-cccC----HHHHHHHHHHccCCHhHCcChHHHc
Confidence 2 2111 111 111 1112 3577899999999999999999864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=440.43 Aligned_cols=249 Identities=20% Similarity=0.293 Sum_probs=200.1
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
..|...++||+|+||+||+|.. .+|+.||||++...... ..+.|.+|+.+|++++|||||++++++.+.+.+||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~-~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ-RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS-SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 3577778899999999999996 46899999998654322 235688999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccccc
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTR 671 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~ 671 (834)
|++|+|.+++... .+++.....|+.||+.||+|||+ .+||||||||+||||+.++.+||+|||+|+.+..
T Consensus 153 ~~gg~L~~~l~~~-------~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 222 (346)
T 4fih_A 153 LEGGALTDIVTHT-------RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 222 (346)
T ss_dssp CTTEEHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred CCCCcHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCC
Confidence 9999999998642 38899999999999999999997 6999999999999999999999999999987643
Q ss_pred CCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcccc
Q 003278 672 NDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAE 751 (834)
Q Consensus 672 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
.. ....+.+||+.|||||++.+..|+.++|||||||+||||+||+.||....+.. ....+.. ...+...
T Consensus 223 ~~-------~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-~~~~i~~---~~~~~~~ 291 (346)
T 4fih_A 223 EV-------PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-AMKMIRD---NLPPRLK 291 (346)
T ss_dssp SS-------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHH---SSCCCCS
T ss_pred CC-------CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-HHHHHHc---CCCCCCC
Confidence 21 12345799999999999999999999999999999999999999997543322 2222211 1111000
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 752 LVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 752 ~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
. .... .++ +..++.+||+.||++|||+.|+++
T Consensus 292 --~---~~~~-s~~---~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 292 --N---LHKV-SPS---LKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp --C---GGGS-CHH---HHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --c---cccC-CHH---HHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 0011 233 344556899999999999999875
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=438.66 Aligned_cols=254 Identities=17% Similarity=0.183 Sum_probs=199.3
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
+.|...++||+|+||.||+|.. .+|+.||||+++.... +.+|+.+|++++|||||++++++.+.+.++|||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 3466667899999999999996 4589999999975432 24699999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCC-CceEeeeeeccccc
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDM-NPRLGSFALAEFLT 670 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~-~~ki~DfGla~~~~ 670 (834)
|++|+|.++|...+ .+++.....|+.||+.||+|||+ .+||||||||+||||+.++ .+||+|||+|+.+.
T Consensus 132 ~~gg~L~~~l~~~~------~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~ 202 (336)
T 4g3f_A 132 LEGGSLGQLIKQMG------CLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQ 202 (336)
T ss_dssp CTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-
T ss_pred cCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEcc
Confidence 99999999997543 48899999999999999999996 6999999999999999987 59999999998765
Q ss_pred cCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCccc
Q 003278 671 RNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLA 750 (834)
Q Consensus 671 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (834)
...... .......++||+.|||||++.+..|+.++|||||||+||||+||+.||........+. .+.. ...+..
T Consensus 203 ~~~~~~--~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-~i~~---~~~~~~ 276 (336)
T 4g3f_A 203 PDGLGK--SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL-KIAS---EPPPIR 276 (336)
T ss_dssp -------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHH-HHHH---SCCGGG
T ss_pred CCCccc--ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH-HHHc---CCCCch
Confidence 432111 1112235789999999999999999999999999999999999999997654443322 2211 111111
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHcc
Q 003278 751 ELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDG 796 (834)
Q Consensus 751 ~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~ 796 (834)
+ +....+ .++ .+++.+||+.||++|||+.||++.|..
T Consensus 277 ~-----~~~~~s-~~~---~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 277 E-----IPPSCA-PLT---AQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp G-----SCTTSC-HHH---HHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred h-----cCccCC-HHH---HHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 1 112222 333 445558999999999999999987753
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=443.11 Aligned_cols=249 Identities=20% Similarity=0.291 Sum_probs=201.0
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
+.|...++||+|+||.||+|.. .+|+.||||++...... .++.|.+|+.+|++++|||||++++++.+.+.+||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~-~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ-RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS-SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh-HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 4577888999999999999996 46899999999754332 245688999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccccc
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTR 671 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~ 671 (834)
|++|+|.+++... .+++.....|+.||+.||+|||+ .+||||||||+||||+.++.+||+|||+|+.+..
T Consensus 230 ~~gG~L~~~i~~~-------~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~ 299 (423)
T 4fie_A 230 LEGGALTDIVTHT-------RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 299 (423)
T ss_dssp CTTEEHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCS
T ss_pred CCCCcHHHHHhcc-------CCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCC
Confidence 9999999998643 27888999999999999999997 6999999999999999999999999999987643
Q ss_pred CCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcccc
Q 003278 672 NDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAE 751 (834)
Q Consensus 672 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
.. ....+++||+.|||||++.+..|+.++|||||||+||||+||+.||....+.. +...+.. ...+.
T Consensus 300 ~~-------~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-~~~~i~~---~~~~~-- 366 (423)
T 4fie_A 300 EV-------PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-AMKMIRD---NLPPR-- 366 (423)
T ss_dssp SC-------CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHH---SCCCC--
T ss_pred CC-------ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-HHHHHHc---CCCCC--
Confidence 21 12346799999999999999999999999999999999999999997543322 2222211 11110
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 752 LVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 752 ~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
+ ...... ..++ ..++.+||+.||++|||+.|+++
T Consensus 367 ~---~~~~~~-s~~~---~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 367 L---KNLHKV-SPSL---KGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp C---SCTTSS-CHHH---HHHHHHHSCSSTTTSCCHHHHTT
T ss_pred C---cccccC-CHHH---HHHHHHHcCCChhHCcCHHHHhc
Confidence 0 001112 2344 44555899999999999999875
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=426.12 Aligned_cols=249 Identities=17% Similarity=0.228 Sum_probs=201.6
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCC--ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSK--CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIY 589 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~--~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~ 589 (834)
++|...+.||+|+||+||+|.. .+++.||||.+.... .....+.+.+|+++|++|+|||||++++++.+.+.+||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4677788999999999999995 568999999986432 1223467899999999999999999999999999999999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccc
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFL 669 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~ 669 (834)
|||++|+|.+++...+ .+++.....++.||+.||+|||+ .+||||||||+||||++++.+||+|||+|+.+
T Consensus 112 Ey~~gG~L~~~i~~~~------~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~ 182 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG------SFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVL 182 (311)
T ss_dssp CCCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceec
Confidence 9999999999997543 38888889999999999999997 69999999999999999999999999999876
Q ss_pred ccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcc
Q 003278 670 TRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPL 749 (834)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
..... .....+++||+.|||||++.+..|+.++||||+||+||||+||+.||...... .+...+.. ..-
T Consensus 183 ~~~~~-----~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-~~~~~i~~---~~~-- 251 (311)
T 4aw0_A 183 SPESK-----QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG-LIFAKIIK---LEY-- 251 (311)
T ss_dssp CTTTT-----CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHH---TCC--
T ss_pred CCCCC-----cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHc---CCC--
Confidence 43321 11234679999999999999999999999999999999999999999754332 22222221 111
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHH
Q 003278 750 AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQIL 791 (834)
Q Consensus 750 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~ 791 (834)
.++...+ +++ ..+..+|++.||++|||+.|+.
T Consensus 252 ------~~p~~~s-~~~---~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 ------DFPEKFF-PKA---RDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp ------CCCTTCC-HHH---HHHHHHHSCSSGGGSTTSGGGT
T ss_pred ------CCCcccC-HHH---HHHHHHHccCCHhHCcChHHHc
Confidence 1112222 334 4455589999999999999974
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-50 Score=428.89 Aligned_cols=243 Identities=25% Similarity=0.323 Sum_probs=190.1
Q ss_pred CCCCCCCeeeccCCeEEEEEEEC---CCCeEEEEEEecccC--hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLP---SDGTVVAVKCLAEKG--ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLL 185 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~---~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 185 (834)
++|+..+.||+|+||+||+|+.. .+++.||||+++... ......+.+|+.+|++++|||||++++++.+++.+||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 46999999999999999999873 467899999986432 1223468889999999999999999999999999999
Q ss_pred EEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccch
Q 003278 186 VYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLA 265 (834)
Q Consensus 186 V~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla 265 (834)
|||||++|+|.++|.+. ..+++.....|+.||+.||+|||++ +||||||||+|||++.++++||+|||+|
T Consensus 104 vmEy~~gg~L~~~l~~~-------~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla 173 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE-------VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLS 173 (304)
T ss_dssp EECCCTTCEEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEE
T ss_pred EEEcCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccc
Confidence 99999999999999653 4689999999999999999999996 9999999999999999999999999999
Q ss_pred hhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccch
Q 003278 266 RWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQII 345 (834)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~ 345 (834)
+...... ...++.+||+.|||||.+... .++.++|||||||+||||+||+.||.... ...
T Consensus 174 ~~~~~~~----------------~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~---~~~ 233 (304)
T 3ubd_A 174 KESIDHE----------------KKAYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGTLPFQGKD---RKE 233 (304)
T ss_dssp EC---------------------CCCCSCCCCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHH
T ss_pred eeccCCC----------------ccccccccCcccCCHHHhccC-CCCCCCcccchHHHHHHHHhCCCCCCCcC---HHH
Confidence 8543211 113457899999999998654 67999999999999999999999996432 111
Q ss_pred HHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCch
Q 003278 346 LLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSM 398 (834)
Q Consensus 346 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm 398 (834)
+ ...... +.. ... ...+ ..+.+|...||+.||++||+.
T Consensus 234 ~---~~~i~~-~~~------~~p-~~~s----~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 234 T---MTMILK-AKL------GMP-QFLS----PEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp H---HHHHHH-CCC------CCC-TTSC----HHHHHHHHHHTCSSGGGSTTC
T ss_pred H---HHHHHc-CCC------CCC-CcCC----HHHHHHHHHHcccCHHHCCCC
Confidence 2 122211 111 111 1111 357789999999999999985
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=413.83 Aligned_cols=246 Identities=20% Similarity=0.326 Sum_probs=185.8
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCC--ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSK--CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIY 589 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~--~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~ 589 (834)
++|...+.||+|+||+||+|.. .+++.||||.+.... .....++|.+|+++|++++|||||++++++.+.+..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 5788888999999999999985 568999999987543 2334567999999999999999999999999999999999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccc
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFL 669 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~ 669 (834)
||+ +|+|.+++...+ .+++.....++.|++.||+|||+ .+||||||||+||||++++.+||+|||+|+..
T Consensus 93 Ey~-~g~L~~~l~~~~------~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 162 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD------KMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIM 162 (275)
T ss_dssp ECC-CEEHHHHHHHSC------SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC---
T ss_pred eCC-CCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeec
Confidence 999 678888887543 38899999999999999999997 69999999999999999999999999999865
Q ss_pred ccCCCCCcccccCccccccccCccchhccccCCC-CccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCc
Q 003278 670 TRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEA-TSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRP 748 (834)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
.... ...+.+||+.|||||++.+..| +.++||||+||+||||+||+.||...... .+...+. .....
T Consensus 163 ~~~~--------~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~-~~~~~i~---~~~~~ 230 (275)
T 3hyh_A 163 TDGN--------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP-VLFKNIS---NGVYT 230 (275)
T ss_dssp --------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHH---HTCCC
T ss_pred CCCC--------ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHH---cCCCC
Confidence 4321 1235789999999999998887 47899999999999999999999754322 2222221 11111
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 749 LAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 749 ~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
++...+ +++ ..+..+||+.||++|||+.|+++
T Consensus 231 --------~p~~~s-~~~---~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 231 --------LPKFLS-PGA---AGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp --------CCTTSC-HHH---HHHHHHHSCSSGGGSCCHHHHHH
T ss_pred --------CCCCCC-HHH---HHHHHHHccCChhHCcCHHHHHc
Confidence 111222 334 44556899999999999999986
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-49 Score=422.35 Aligned_cols=262 Identities=23% Similarity=0.295 Sum_probs=187.7
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC-hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCE-------
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG-ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQ------- 182 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~------- 182 (834)
++|+..+.||+|+||+||+|+++.+|+.||||++.... +...+.+.+|+.+|++++|||||+++++|.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 35888999999999999999999999999999986543 3455789999999999999999999999986553
Q ss_pred -----EEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCce
Q 003278 183 -----LLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNA 257 (834)
Q Consensus 183 -----~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~ 257 (834)
+|+|||||++|+|.+++..+.. ....++..++.|+.||++||+|||++ +||||||||+||||+.++.+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~----~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~v 157 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCT----IEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVV 157 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCS----GGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCE
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCC----CChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcE
Confidence 7999999999999999976532 12356778899999999999999996 99999999999999999999
Q ss_pred EEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCC
Q 003278 258 RLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDL 337 (834)
Q Consensus 258 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~ 337 (834)
||+|||+|+.+........... ........++.+||+.|||||.+.. ..++.++|||||||++|||++ ||..
T Consensus 158 Kl~DFGla~~~~~~~~~~~~~~----~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyell~---Pf~~ 229 (299)
T 4g31_A 158 KVGDFGLVTAMDQDEEEQTVLT----PMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY---PFST 229 (299)
T ss_dssp EECCCCCC------------------------------CCCTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred EEccCccceecCCCcccccccc----ccccccccCCcccCccccCHHHHcC-CCCCCHHHHHHHHHHHHHHcc---CCCC
Confidence 9999999997654322110000 0001112356789999999999864 468999999999999999997 5532
Q ss_pred CCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 338 TYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 338 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
. ......+... ......... ......+..|+..||+.||.+|||+.|+++
T Consensus 230 ----~-~~~~~~~~~~-~~~~~p~~~----------~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 230 ----Q-MERVRTLTDV-RNLKFPPLF----------TQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp ----H-HHHHHHHHHH-HTTCCCHHH----------HHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----c-cHHHHHHHHH-hcCCCCCCC----------cccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1 1111111111 111111000 011234567899999999999999999986
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=425.28 Aligned_cols=257 Identities=18% Similarity=0.279 Sum_probs=187.4
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCC--------
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQG-------- 583 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~-------- 583 (834)
++|...+.||+|+||+||+|.. .+++.||||++.....+..+++|.+|+++|++|+|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 4578888999999999999986 4688999999986666666788999999999999999999999987544
Q ss_pred ----eEEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCce
Q 003278 584 ----EMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPR 659 (834)
Q Consensus 584 ----~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~k 659 (834)
.+++|||||++|+|.+++..... ....++...+.|+.||++||+|||+ .+||||||||+||||+.++.+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~---~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vK 158 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCT---IEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVK 158 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCS---GGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEE
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCC---CChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEE
Confidence 36899999999999999975432 2235677778999999999999997 6999999999999999999999
Q ss_pred EeeeeeccccccCCCCCcc-----cccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchh
Q 003278 660 LGSFALAEFLTRNDHGHRK-----ATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGL 734 (834)
Q Consensus 660 i~DfGla~~~~~~~~~~~~-----~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~ 734 (834)
|+|||+|+.+......... .....++.+||+.|||||++.+..|+.++|||||||+||||++ ||.... .
T Consensus 159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~---~ 232 (299)
T 4g31_A 159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM---E 232 (299)
T ss_dssp ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH---H
T ss_pred EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc---H
Confidence 9999999876543211100 1112245689999999999999999999999999999999997 664221 1
Q ss_pred HHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 735 LVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
......... ........ ......+..++.+||+.||++|||+.||++
T Consensus 233 ~~~~~~~~~--~~~~p~~~---------~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 233 RVRTLTDVR--NLKFPPLF---------TQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHHHHH--TTCCCHHH---------HHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHh--cCCCCCCC---------cccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111111111 11111110 111123345667999999999999999985
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-49 Score=422.10 Aligned_cols=243 Identities=22% Similarity=0.233 Sum_probs=188.3
Q ss_pred hCcCcCCcccccCCcEEEEEEE----CCCcEEEEEEecCCCC-hhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL----DNHQYVLVKRLGMSKC-PALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLV 587 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~----~~~~~vavK~~~~~~~-~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~l 587 (834)
++|...+.||+|+||+||+|.. ..++.||||.++.... .....+|.+|+++|++++|||||++++++.+.+..+|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 4677788999999999999985 2467899999864321 1223468899999999999999999999999999999
Q ss_pred EEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecc
Q 003278 588 IYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAE 667 (834)
Q Consensus 588 v~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~ 667 (834)
|||||++|+|.+++...+ .+++.....++.|++.||+|||+ .+||||||||+|||+++++.+||+|||+|+
T Consensus 104 vmEy~~gg~L~~~l~~~~------~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~ 174 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV------MFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK 174 (304)
T ss_dssp EECCCTTCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEE
T ss_pred EEEcCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccce
Confidence 999999999999997543 48888999999999999999997 699999999999999999999999999998
Q ss_pred ccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcC
Q 003278 668 FLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKR 747 (834)
Q Consensus 668 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
...... ....+.+||+.|||||++.+..|+.++|||||||+||||+||+.||....... +...+.. ...
T Consensus 175 ~~~~~~-------~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~-~~~~i~~---~~~ 243 (304)
T 3ubd_A 175 ESIDHE-------KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE-TMTMILK---AKL 243 (304)
T ss_dssp C------------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHH---CCC
T ss_pred eccCCC-------ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH-HHHHHHc---CCC
Confidence 643321 12345789999999999999999999999999999999999999997543322 2222211 111
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCh
Q 003278 748 PLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSM 787 (834)
Q Consensus 748 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm 787 (834)
+ .+...+ .++ ..++.+||+.||++|||.
T Consensus 244 ~--------~p~~~s-~~~---~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 244 G--------MPQFLS-PEA---QSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp C--------CCTTSC-HHH---HHHHHHHTCSSGGGSTTC
T ss_pred C--------CCCcCC-HHH---HHHHHHHcccCHHHCCCC
Confidence 1 111222 334 445568999999999995
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=418.79 Aligned_cols=267 Identities=24% Similarity=0.298 Sum_probs=201.4
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC--hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeC------CE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG--ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHE------DQ 182 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------~~ 182 (834)
++|+..+.||+|+||+||+|+++.+|+.||||++.... ....+.+.+|+.+|++++|||||++++++... +.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999999999999999996542 34456789999999999999999999987643 57
Q ss_pred EEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeec
Q 003278 183 LLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDF 262 (834)
Q Consensus 183 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DF 262 (834)
+|||||||+ |+|.+++... .++++..+..|+.||+.||.|||++ +||||||||+|||++.++.+||+||
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~-------~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DF 202 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSS-------QPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDF 202 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSS-------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCC
T ss_pred EEEEEeCCC-CCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeec
Confidence 899999996 7899988643 4699999999999999999999996 9999999999999999999999999
Q ss_pred cchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCc
Q 003278 263 GLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDD 342 (834)
Q Consensus 263 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~ 342 (834)
|+|+.+...... .....++.+||+.|||||.+.....++.++||||+||++|||+||+.||.....
T Consensus 203 Gla~~~~~~~~~------------~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~-- 268 (398)
T 4b99_A 203 GMARGLCTSPAE------------HQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY-- 268 (398)
T ss_dssp TTCBCC-------------------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSH--
T ss_pred ceeeecccCccc------------cccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCH--
Confidence 999865432110 011245678999999999987666779999999999999999999999964321
Q ss_pred cchHHHHHHHHhhcCc--cccccc--------cccCC-CCCCHH-----HHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 343 QIILLDWIRRLSDEGK--VLQAGD--------NRLSD-GSYKLC-----DMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 343 ~~~l~~~~~~~~~~~~--~~~~~d--------~~l~~-~~~~~~-----~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
......+........ ...... ..+.. ...+.. ....+.+|...||+.||.+|||+.|+++
T Consensus 269 -~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 269 -VHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp -HHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -HHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 112222211111000 000000 00000 000000 0135678999999999999999999875
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=410.74 Aligned_cols=303 Identities=31% Similarity=0.601 Sum_probs=242.1
Q ss_pred CCccccHHHHHHHhhCcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEE
Q 003278 499 TPREISFKEIISATNNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGW 578 (834)
Q Consensus 499 ~~~~~~~~el~~at~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~ 578 (834)
..+.+++.++..++++|...+.||+|+||.||+|...+++.||||++...........|.+|+.++++++|||||+++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 35678999999999999999999999999999999888999999998765443333468999999999999999999999
Q ss_pred EeeCCeEEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCc
Q 003278 579 CTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNP 658 (834)
Q Consensus 579 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ 658 (834)
|.+.+..++||||+++|+|.+++..... ....++|..+..|+.|++.||+|||+...++|+||||||+|||++.++.+
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~ 173 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPE--SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 173 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCST--TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCE
Confidence 9999999999999999999999976532 23458999999999999999999998544499999999999999999999
Q ss_pred eEeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCC----CCchh
Q 003278 659 RLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFR----LPEGL 734 (834)
Q Consensus 659 ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~----~~~~~ 734 (834)
||+|||+++....... .......||+.|+|||++.++.++.++|||||||++|||+||+.||... .....
T Consensus 174 kl~Dfg~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 247 (326)
T 3uim_A 174 VVGDFGLAKLMDYKDT------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 247 (326)
T ss_dssp EECCCSSCEECCSSSS------CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSB
T ss_pred EeccCccccccCcccc------cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchh
Confidence 9999999986543221 1123456999999999999999999999999999999999999998521 11111
Q ss_pred HHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCccccccCccccchHHH
Q 003278 735 LVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDKRFMEDGQMTENLEEW 814 (834)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~~~~~~~~~~~~~~~~ 814 (834)
...++. ..........+.+..+...+.......+.+++.+||+.||++|||+.+|++.|++. .+.+++++|
T Consensus 248 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~--------~~~~~~~~~ 318 (326)
T 3uim_A 248 LLDWVK-GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD--------GLAERWEEW 318 (326)
T ss_dssp HHHHHT-TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS--------SCSSSCC--
T ss_pred HHHHHH-HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc--------chhhhhhhh
Confidence 112111 11223345566677777778888888999999999999999999999999999874 355678888
Q ss_pred hhhc
Q 003278 815 KQRN 818 (834)
Q Consensus 815 ~~~~ 818 (834)
++.+
T Consensus 319 ~~~~ 322 (326)
T 3uim_A 319 QKEE 322 (326)
T ss_dssp ----
T ss_pred hHHH
Confidence 7653
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=432.17 Aligned_cols=246 Identities=24% Similarity=0.340 Sum_probs=196.8
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHH---HHHHHHHhCCCCceeeEeeeEEeCCEE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFA---AELVAVAHLRHRNLVRLRGWCVHEDQL 183 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~---~E~~~l~~l~H~nIv~l~g~~~~~~~~ 183 (834)
-++|+..++||+|+||+||+|+.+.+|+.||||++.+.. ......+. .++.+++.++|||||+|+++|.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 368999999999999999999999999999999986431 11122233 346677788999999999999999999
Q ss_pred EEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeecc
Q 003278 184 LLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFG 263 (834)
Q Consensus 184 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFG 263 (834)
|||||||+||+|..+|.+. ..+++.....|+.||+.||+|||++ +||||||||+|||||.++++||+|||
T Consensus 268 ylVmEy~~GGdL~~~l~~~-------~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFG 337 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQH-------GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLG 337 (689)
T ss_dssp EEEECCCCSCBHHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEecCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccc
Confidence 9999999999999999653 4689999999999999999999986 99999999999999999999999999
Q ss_pred chhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCcc
Q 003278 264 LARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQ 343 (834)
Q Consensus 264 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~ 343 (834)
+|+.+... .+.+.+||+.|||||++..+..++.++|||||||+||||+||+.||......+.
T Consensus 338 lA~~~~~~------------------~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~ 399 (689)
T 3v5w_A 338 LACDFSKK------------------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 399 (689)
T ss_dssp TCEECSSC------------------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH
T ss_pred eeeecCCC------------------CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 99854221 134568999999999997666789999999999999999999999965333222
Q ss_pred chHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCch
Q 003278 344 IILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSM 398 (834)
Q Consensus 344 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm 398 (834)
..+. ..... ... .+. ...+ ..+.+|+..||+.||.+|++.
T Consensus 400 ~~i~---~~i~~-~~~------~~p-~~~S----~~a~dLI~~lL~~dP~~Rl~~ 439 (689)
T 3v5w_A 400 HEID---RMTLT-MAV------ELP-DSFS----PELRSLLEGLLQRDVNRRLGC 439 (689)
T ss_dssp HHHH---HHHHH-CCC------CCC-TTSC----HHHHHHHHHHTCSCGGGCTTC
T ss_pred HHHH---HhhcC-CCC------CCC-ccCC----HHHHHHHHHHccCCHhHCCCC
Confidence 1111 11111 111 111 1122 357789999999999999983
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=400.71 Aligned_cols=287 Identities=34% Similarity=0.574 Sum_probs=241.8
Q ss_pred ccccHHHHHhhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEE
Q 003278 99 RIFSYAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCV 178 (834)
Q Consensus 99 ~~f~~~el~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~ 178 (834)
..+++.++..++++|+..+.||+|+||.||+|.+ .+|..||||++........+.|.+|+.++++++||||++++++|.
T Consensus 27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 105 (321)
T 2qkw_B 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD 105 (321)
T ss_dssp ---CCSCCCCCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECC
T ss_pred eeecHHHHHHHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 4566777888999999999999999999999997 578999999987766666788999999999999999999999999
Q ss_pred eCCEEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceE
Q 003278 179 HEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNAR 258 (834)
Q Consensus 179 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~k 258 (834)
+.+..++||||+++|+|.+++..... ....++|..+..++.|++.||.|||+. +|+||||||+|||++.++.+|
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~k 179 (321)
T 2qkw_B 106 ERNEMILIYKYMENGNLKRHLYGSDL---PTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPK 179 (321)
T ss_dssp CTTCCEEEEECCTTCBTGGGSSSSCC---CSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEE
T ss_pred CCCeEEEEEEcCCCCcHHHHHhccCC---CccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEE
Confidence 99999999999999999999865432 234689999999999999999999995 999999999999999999999
Q ss_pred EeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCC
Q 003278 259 LGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLT 338 (834)
Q Consensus 259 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~ 338 (834)
|+|||+++...... .....+...||+.|+|||.+..+ .++.++|||||||++|||+||+.||...
T Consensus 180 l~Dfg~~~~~~~~~--------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~p~~~~ 244 (321)
T 2qkw_B 180 ITDFGISKKGTELD--------------QTHLSTVVKGTLGYIDPEYFIKG-RLTEKSDVYSFGVVLFEVLCARSAIVQS 244 (321)
T ss_dssp ECCCTTCEECSSSS--------------CCCCBCCCEEETTTCCHHHHHHC-BCCTHHHHHHHHHHHHHHHHCCTTCSCS
T ss_pred Eeeccccccccccc--------------ccccccccCCCccccCHHHhcCC-CCCcccchHhHHHHHHHHHhCCCccccc
Confidence 99999997532110 00113445699999999998765 5799999999999999999999999877
Q ss_pred CCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 339 YPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 339 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
.+.+...+..|.......+.+.+.+++.+. ..........+.+++..||+.||++||++.+|++.|+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 245 LPREMVNLAEWAVESHNNGQLEQIVDPNLA-DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp SSSSCCCHHHHTHHHHTTTCCCSSSSSSCT-TCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CcHHHHHHHHHhhhccccccHHHhcChhhc-cccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 666666677787776666777777776664 344566678899999999999999999999999998764
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=407.20 Aligned_cols=215 Identities=27% Similarity=0.370 Sum_probs=171.6
Q ss_pred hhcCCCCCCCeeeccCCeEEEEEEEC---CCCeEEEEEEecccChhhHHHHHHHHHHHHhC-CCCceeeEeeeEEeCCEE
Q 003278 108 IGSNGFDEDEVLGSGGFGKVYRAVLP---SDGTVVAVKCLAEKGERFEKTFAAELVAVAHL-RHRNLVRLRGWCVHEDQL 183 (834)
Q Consensus 108 ~~t~~f~~~~~LG~G~fG~Vy~~~~~---~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~ 183 (834)
.-.+.|+..+.||+|+||+||+|+.+ .+++.||||++.... ....+.+|+.+|..+ +|||||++++++.+.+.+
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 34578999999999999999999864 357899999986543 245688999999998 699999999999999999
Q ss_pred EEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCC-CceEEeec
Q 003278 184 LLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQ-YNARLGDF 262 (834)
Q Consensus 184 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~-~~~kl~DF 262 (834)
|||||||++|+|.+++. .+++.+...|+.|++.||+|||++ +||||||||+|||++.+ +.+||+||
T Consensus 96 ~lvmE~~~g~~L~~~~~----------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DF 162 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN----------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDF 162 (361)
T ss_dssp EEEEECCCCCCHHHHHT----------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred EEEEeCCCcccHHHHHc----------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcC
Confidence 99999999999999882 378899999999999999999996 99999999999999876 79999999
Q ss_pred cchhhhhhhhhhhhhc--cccc------c----cccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh
Q 003278 263 GLARWLEHELQYQMRT--SSAR------N----HQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS 330 (834)
Q Consensus 263 Gla~~~~~~~~~~~~~--~~~~------~----~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt 330 (834)
|+|+............ .... . ........++.+||++|||||.+.....++.++||||+||++|||+|
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~ 242 (361)
T 4f9c_A 163 GLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLS 242 (361)
T ss_dssp TTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHH
T ss_pred CCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHH
Confidence 9998653321100000 0000 0 00000113456799999999998766568999999999999999999
Q ss_pred CCccCCC
Q 003278 331 GRRAVDL 337 (834)
Q Consensus 331 G~~p~~~ 337 (834)
|+.||..
T Consensus 243 G~~Pf~~ 249 (361)
T 4f9c_A 243 GRYPFYK 249 (361)
T ss_dssp TCSSSSC
T ss_pred CCCCCCC
Confidence 9999954
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-46 Score=404.93 Aligned_cols=291 Identities=43% Similarity=0.760 Sum_probs=243.0
Q ss_pred CCccccHHHHHhhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccCh-hhHHHHHHHHHHHHhCCCCceeeEee
Q 003278 97 NPRIFSYAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGE-RFEKTFAAELVAVAHLRHRNLVRLRG 175 (834)
Q Consensus 97 ~~~~f~~~el~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g 175 (834)
..+.|++.++..++++|+..+.||+|+||.||+|.. .+|+.||||++..... .....|.+|+.++++++||||+++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 456799999999999999999999999999999986 5789999999865422 22336889999999999999999999
Q ss_pred eEEeCCEEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCC
Q 003278 176 WCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQY 255 (834)
Q Consensus 176 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~ 255 (834)
+|...+..++||||+++|+|.+++..... ...+++|..+..|+.|++.||+|||+.+.++|+||||||+|||++.++
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~ 171 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPE---SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF 171 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCST---TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC
Confidence 99999999999999999999999976532 235699999999999999999999997666999999999999999999
Q ss_pred ceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccC
Q 003278 256 NARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAV 335 (834)
Q Consensus 256 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~ 335 (834)
.+||+|||+++...... ........||+.|+|||.+..+ .++.++|||||||++|||+||+.||
T Consensus 172 ~~kl~Dfg~~~~~~~~~---------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf 235 (326)
T 3uim_A 172 EAVVGDFGLAKLMDYKD---------------THVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAF 235 (326)
T ss_dssp CEEECCCSSCEECCSSS---------------SCEECCCCSCGGGCCHHHHHHS-EECHHHHHHHHHHHHHHHHHCCCSB
T ss_pred CEEeccCccccccCccc---------------ccccccccCCcCccCHHHhccC-CCCccccchhHHHHHHHHHhCCCcc
Confidence 99999999997543210 0113345699999999998655 5799999999999999999999999
Q ss_pred CCC--CCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 336 DLT--YPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 336 ~~~--~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
+.. .......+..|+.............+..+. ..+.......+.+++..||+.||.+||++.+|++.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 236 DLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQ-GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp CHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCT-TSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred cccccccccchhHHHHHHHHhhchhhhhhcChhhc-cccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 631 123345567888777766666666666654 456677778899999999999999999999999999863
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=401.81 Aligned_cols=264 Identities=17% Similarity=0.191 Sum_probs=195.9
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCC-ChhHHHHHHHHHHHHHhccCCCceeEEEEEee------CCe
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSK-CPALRTRFSNELQNLARLRHRNLVQLCGWCTE------QGE 584 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~-~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~------~~~ 584 (834)
++|...+.||+|+||+||+|.. .+|+.||||++.... .....+++.+|+++|++|+|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 4577788999999999999996 568999999997543 33445778999999999999999999998754 367
Q ss_pred EEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeee
Q 003278 585 MLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFA 664 (834)
Q Consensus 585 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfG 664 (834)
+|||||||. |+|.+++...+ .+++.....|+.||+.||+|||+ .+||||||||+|||++.++.+||+|||
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~------~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFG 203 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQ------PLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFG 203 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSS------CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEeCCC-CCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecc
Confidence 899999996 67888886532 48899999999999999999997 699999999999999999999999999
Q ss_pred eccccccCCCCCcccccCccccccccCccchhccccC-CCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHH
Q 003278 665 LAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESG-EATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFE 743 (834)
Q Consensus 665 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~ 743 (834)
+|+.+...... ......+.+||+.|||||++.+. .|+.++||||+||++|||+||+.||........ +..+....
T Consensus 204 la~~~~~~~~~---~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~-l~~I~~~~ 279 (398)
T 4b99_A 204 MARGLCTSPAE---HQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQ-LQLIMMVL 279 (398)
T ss_dssp TCBCC----------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH-HHHHHHHH
T ss_pred eeeecccCccc---cccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHH-HHHHHHhc
Confidence 99876432211 11223467999999999998775 468999999999999999999999975443322 22222211
Q ss_pred hhcCcccccccc-----------ccCC--CCCHHH-----HHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 744 ARKRPLAELVDL-----------SLNG--EYNHKE-----LMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 744 ~~~~~~~~~~d~-----------~l~~--~~~~~~-----~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
.. +....... .+.. ...... -.+++.+..+|+..||++|||+.|+++
T Consensus 280 g~--p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 280 GT--PSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp CC--CCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CC--CChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 10 00000000 0000 000000 023455666999999999999999986
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=422.18 Aligned_cols=252 Identities=22% Similarity=0.335 Sum_probs=206.2
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEcc
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYM 190 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 190 (834)
++|++.+.||+|+||+||+|+.+.+|+.||||++........+.+.+|+.+|+.++|||||+|+++|.+.+.+|||||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 67999999999999999999999999999999997766666778999999999999999999999999999999999999
Q ss_pred CCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCC--CceEEeeccchhhh
Q 003278 191 PNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQ--YNARLGDFGLARWL 268 (834)
Q Consensus 191 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~--~~~kl~DFGla~~~ 268 (834)
++|+|.++|... ...+++.....|+.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||+|+.+
T Consensus 237 ~gg~L~~~i~~~------~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~ 307 (573)
T 3uto_A 237 SGGELFEKVADE------HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307 (573)
T ss_dssp CCCBHHHHHTCT------TSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred CCCcHHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence 999999998543 24689999999999999999999996 99999999999999854 78999999999865
Q ss_pred hhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHH
Q 003278 269 EHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLD 348 (834)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~ 348 (834)
... ...+..+||+.|||||.+.. ..++.++|||||||++|||++|+.||..... ..+.
T Consensus 308 ~~~-----------------~~~~~~~GT~~y~APEv~~~-~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~---~~~~- 365 (573)
T 3uto_A 308 DPK-----------------QSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGEND---DETL- 365 (573)
T ss_dssp CTT-----------------SEEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHH-
T ss_pred cCC-----------------CceeeeEECccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHHH-
Confidence 322 11345689999999999865 4689999999999999999999999964321 1111
Q ss_pred HHHHHhh-cCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 349 WIRRLSD-EGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 349 ~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
..+.. ........-+. .+ ..+.+|+..||+.||.+||++.|+++.
T Consensus 366 --~~i~~~~~~~~~~~~~~-----~s----~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 366 --RNVKSCDWNMDDSAFSG-----IS----EDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp --HHHHTTCCCCCSGGGTT-----SC----HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --HHHHhCCCCCCcccccC-----CC----HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11111 11111111011 11 356789999999999999999999874
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=392.02 Aligned_cols=285 Identities=30% Similarity=0.505 Sum_probs=232.0
Q ss_pred cccHHHHHHHhhCcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEee
Q 003278 502 EISFKEIISATNNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTE 581 (834)
Q Consensus 502 ~~~~~el~~at~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~ 581 (834)
.+++.++..++++|...+.||+|+||.||+|...++..||||++..... ...+.|.+|+.++++++|||||+++++|.+
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 106 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS-QGIEEFETEIETLSFCRHPHLVSLIGFCDE 106 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCS-SHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccCh-HHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 3445556677899999999999999999999988899999999875433 345779999999999999999999999999
Q ss_pred CCeEEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEe
Q 003278 582 QGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLG 661 (834)
Q Consensus 582 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~ 661 (834)
.+..++||||+++|+|.+++..... ....++|..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~ 181 (321)
T 2qkw_B 107 RNEMILIYKYMENGNLKRHLYGSDL--PTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKIT 181 (321)
T ss_dssp TTCCEEEEECCTTCBTGGGSSSSCC--CSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEEC
T ss_pred CCeEEEEEEcCCCCcHHHHHhccCC--CccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEe
Confidence 9999999999999999999865432 22358999999999999999999997 699999999999999999999999
Q ss_pred eeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhH--HHHH
Q 003278 662 SFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLL--VKRV 739 (834)
Q Consensus 662 DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~--~~~~ 739 (834)
|||+++....... ........||+.|+|||++.++.++.++|||||||++|||+||+.|+....+.... ..+.
T Consensus 182 Dfg~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~ 256 (321)
T 2qkw_B 182 DFGISKKGTELDQ-----THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA 256 (321)
T ss_dssp CCTTCEECSSSSC-----CCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHT
T ss_pred ecccccccccccc-----cccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHh
Confidence 9999976433221 11123457999999999999999999999999999999999999999765543321 1111
Q ss_pred HHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCC
Q 003278 740 HEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGND 798 (834)
Q Consensus 740 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~ 798 (834)
.. ......+..++++.+...........+.+++.+||+.||++|||+.+|++.|+...
T Consensus 257 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l 314 (321)
T 2qkw_B 257 VE-SHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314 (321)
T ss_dssp HH-HHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hh-ccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 11 12233455666666666667777788889999999999999999999999997543
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=379.05 Aligned_cols=285 Identities=30% Similarity=0.531 Sum_probs=228.3
Q ss_pred CccccHHHHHHHhhCcCcC------CcccccCCcEEEEEEECCCcEEEEEEecCCC---ChhHHHHHHHHHHHHHhccCC
Q 003278 500 PREISFKEIISATNNFSES------QRVAEMDFGTAYQGFLDNHQYVLVKRLGMSK---CPALRTRFSNELQNLARLRHR 570 (834)
Q Consensus 500 ~~~~~~~el~~at~~f~~~------~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~---~~~~~~~f~~E~~~l~~l~Hp 570 (834)
...|++.++..+|++|+.. +.||+|+||.||+|.. ++..||||.+.... .....+.|.+|+.++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 3568999999999999988 8899999999999986 57789999986432 344567899999999999999
Q ss_pred CceeEEEEEeeCCeEEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCce
Q 003278 571 NLVQLCGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAI 650 (834)
Q Consensus 571 Niv~l~g~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NI 650 (834)
||+++++++.+.+..++||||+++|+|.+++..... ...++|..+..|+.|++.||+|||+ .+|+||||||+||
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Ni 164 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG---TPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANI 164 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG---CCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGE
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHE
Confidence 999999999999999999999999999999865322 2358999999999999999999997 6999999999999
Q ss_pred eecCCCCceEeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCC
Q 003278 651 TLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRL 730 (834)
Q Consensus 651 Lld~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~ 730 (834)
|+++++.+||+|||+++....... ........||+.|+|||.+. +.++.++|||||||++|||+||..|+....
T Consensus 165 li~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~g~~~y~aPE~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 238 (307)
T 2nru_A 165 LLDEAFTAKISDFGLARASEKFAQ-----TVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHR 238 (307)
T ss_dssp EECTTCCEEECCCTTCEECCSCSS-----CEECSSCCSCGGGCCHHHHT-TEECTHHHHHHHHHHHHHHHHCCCSBCTTB
T ss_pred EEcCCCcEEEeecccccccccccc-----cccccccCCCcCcCChHHhc-CCCCccchhHHHHHHHHHHHHCCCCcccCc
Confidence 999999999999999976543211 11122457999999999886 468999999999999999999999997654
Q ss_pred CchhHHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCC
Q 003278 731 PEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGND 798 (834)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~ 798 (834)
..................+...++..+. .........+.+++.+||+.||.+|||+.+|++.|+.+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 239 EPQLLLDIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp SSSBTTHHHHHHHTTSCCHHHHSCSSCS-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred chHHHHHHHHHhhhhhhhhhhhcccccc-ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 4333333222222222233334443332 234455567788888999999999999999999998654
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=393.00 Aligned_cols=207 Identities=18% Similarity=0.250 Sum_probs=169.2
Q ss_pred HhhCcCcCCcccccCCcEEEEEEEC----CCcEEEEEEecCCCChhHHHHHHHHHHHHHhc-cCCCceeEEEEEeeCCeE
Q 003278 511 ATNNFSESQRVAEMDFGTAYQGFLD----NHQYVLVKRLGMSKCPALRTRFSNELQNLARL-RHRNLVQLCGWCTEQGEM 585 (834)
Q Consensus 511 at~~f~~~~~ig~g~~g~vy~~~~~----~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l-~HpNiv~l~g~~~~~~~~ 585 (834)
..+.|...+.||+|+||+||+|..+ .++.||||++..... ..++.+|+++|..+ +|||||++++++.+.+..
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~---~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH---PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC---HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC---HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 4577888899999999999999742 467899999865432 24678899999998 699999999999999999
Q ss_pred EEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCC-CCceEeeee
Q 003278 586 LVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPD-MNPRLGSFA 664 (834)
Q Consensus 586 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~-~~~ki~DfG 664 (834)
++||||+++|+|.+++. .+++.....++.|++.||+|||+ .+||||||||+||||+.+ +.+||+|||
T Consensus 96 ~lvmE~~~g~~L~~~~~---------~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFG 163 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN---------SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFG 163 (361)
T ss_dssp EEEEECCCCCCHHHHHT---------TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEeCCCcccHHHHHc---------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCC
Confidence 99999999999999883 27788888999999999999997 699999999999999977 789999999
Q ss_pred eccccccCCCCCc---------------------ccccCccccccccCccchhccccC-CCCccCcchhhHHHHHHHHhC
Q 003278 665 LAEFLTRNDHGHR---------------------KATSGNRSVRGIFGYMSPEYIESG-EATSMADVYSFGVVVLEVVTG 722 (834)
Q Consensus 665 la~~~~~~~~~~~---------------------~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~k~DV~SfGvvl~E~~tG 722 (834)
+|+.......... .......+.+||+.|||||++.+. .|+.++||||+||++|||+||
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G 243 (361)
T 4f9c_A 164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG 243 (361)
T ss_dssp TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence 9986533211000 000112346899999999999775 489999999999999999999
Q ss_pred CCccCCCCCc
Q 003278 723 QMAVDFRLPE 732 (834)
Q Consensus 723 ~~p~~~~~~~ 732 (834)
+.||.....+
T Consensus 244 ~~Pf~~~~~~ 253 (361)
T 4f9c_A 244 RYPFYKASDD 253 (361)
T ss_dssp CSSSSCCSSH
T ss_pred CCCCCCCCCH
Confidence 9999654443
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=379.87 Aligned_cols=264 Identities=22% Similarity=0.356 Sum_probs=212.8
Q ss_pred CccccHHHHHhhcCC----------CCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCC
Q 003278 98 PRIFSYAELYIGSNG----------FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRH 167 (834)
Q Consensus 98 ~~~f~~~el~~~t~~----------f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H 167 (834)
+..|+++++..+++. |+..+.||+|+||.||+|+...+|+.||||++........+.+.+|+.++++++|
T Consensus 22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence 456899999988875 6667799999999999999988999999999976655566789999999999999
Q ss_pred CceeeEeeeEEeCCEEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCC
Q 003278 168 RNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTS 247 (834)
Q Consensus 168 ~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~ 247 (834)
|||++++++|...+..++||||+++|+|.+++.. ..++|..+..++.|++.||.|||+. +|+||||||+
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--------~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~ 170 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--------VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSD 170 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT--------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGG
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHH
Confidence 9999999999999999999999999999998853 3589999999999999999999995 9999999999
Q ss_pred ceEECCCCceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHH
Q 003278 248 NVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLE 327 (834)
Q Consensus 248 NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~E 327 (834)
|||++.++.+||+|||+++.+.... .......||+.|+|||.+... .++.++|||||||++||
T Consensus 171 NIll~~~~~~kl~Dfg~~~~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~e 233 (321)
T 2c30_A 171 SILLTLDGRVKLSDFGFCAQISKDV----------------PKRKSLVGTPYWMAPEVISRS-LYATEVDIWSLGIMVIE 233 (321)
T ss_dssp GEEECTTCCEEECCCTTCEECCSSS----------------CCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHH
T ss_pred HEEECCCCcEEEeeeeeeeecccCc----------------cccccccCCccccCHhhhcCC-CCCchhhHHHHHHHHHH
Confidence 9999999999999999987543210 112445799999999998654 67899999999999999
Q ss_pred HHhCCccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 328 VVSGRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 328 lltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
|+||+.||.... ..... ..+... ..+.+.. .......+.+++..||+.||.+||++.++++.
T Consensus 234 l~~g~~pf~~~~---~~~~~---~~~~~~------~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 234 MVDGEPPYFSDS---PVQAM---KRLRDS------PPPKLKN---SHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHSSCTTTTSC---HHHHH---HHHHHS------SCCCCTT---GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHhCCCCCCCCC---HHHHH---HHHhcC------CCCCcCc---cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 999999986432 11111 111111 1111110 00112457889999999999999999999874
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=373.29 Aligned_cols=251 Identities=22% Similarity=0.335 Sum_probs=204.3
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEcc
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYM 190 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 190 (834)
++|+..+.||+|+||.||+|....+|+.||||++........+.+.+|+.++++++|||||+++++|...+..++||||+
T Consensus 20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 99 (297)
T 3fxz_A 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (297)
T ss_dssp GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECC
Confidence 56899999999999999999998999999999987655555677899999999999999999999999999999999999
Q ss_pred CCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhh
Q 003278 191 PNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEH 270 (834)
Q Consensus 191 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~ 270 (834)
++|+|.+++... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 100 ~~~~L~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (297)
T 3fxz_A 100 AGGSLTDVVTET--------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (297)
T ss_dssp TTCBHHHHHHHS--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred CCCCHHHHHhhc--------CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 999999998642 488999999999999999999996 999999999999999999999999999875432
Q ss_pred hhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHHH
Q 003278 271 ELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWI 350 (834)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~ 350 (834)
.. .......||+.|+|||.+... .++.++|||||||++|||+||+.||...... ...
T Consensus 169 ~~----------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~ 225 (297)
T 3fxz_A 169 EQ----------------SKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RAL 225 (297)
T ss_dssp TT----------------CCBCCCCSCGGGCCHHHHHCS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHH
T ss_pred cc----------------cccCCccCCcCccChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHH
Confidence 11 113445799999999998654 6799999999999999999999998643211 111
Q ss_pred HHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 351 RRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 351 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
......+... ... .......+.+++..||+.||.+||++.++++.
T Consensus 226 ~~~~~~~~~~-~~~--------~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 226 YLIATNGTPE-LQN--------PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp HHHHHHCSCC-CSC--------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHhCCCCC-CCC--------ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1111111110 000 01112457889999999999999999999863
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=407.36 Aligned_cols=249 Identities=17% Similarity=0.169 Sum_probs=193.0
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCC-----CChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMS-----KCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEML 586 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~ 586 (834)
++|...+.||+|+||.||+|.. .+|+.||||.+... ...........++.+++.++|||||++++++.+.+.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 5788889999999999999996 45899999998632 11122223344577888889999999999999999999
Q ss_pred EEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeec
Q 003278 587 VIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALA 666 (834)
Q Consensus 587 lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla 666 (834)
||||||+||+|..+|...+ .+++.....++.||+.||+|||+ .+||||||||+|||||.++.+||+|||+|
T Consensus 269 lVmEy~~GGdL~~~l~~~~------~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA 339 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHG------VFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLA 339 (689)
T ss_dssp EEECCCCSCBHHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEeccccee
Confidence 9999999999999997543 38888888999999999999996 79999999999999999999999999999
Q ss_pred cccccCCCCCcccccCccccccccCccchhcccc-CCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhh
Q 003278 667 EFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIES-GEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEAR 745 (834)
Q Consensus 667 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~ 745 (834)
+.+... ...+.+||+.|||||++.. ..|+.++||||+||+||||+||+.||......... .........
T Consensus 340 ~~~~~~---------~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~-~i~~~i~~~ 409 (689)
T 3v5w_A 340 CDFSKK---------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTM 409 (689)
T ss_dssp EECSSC---------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH-HHHHHHHHC
T ss_pred eecCCC---------CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHhhcCC
Confidence 865432 1235789999999999975 47999999999999999999999999653332211 111111111
Q ss_pred cCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCC-----hhHHHH
Q 003278 746 KRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPS-----MRQILS 792 (834)
Q Consensus 746 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPt-----m~~v~~ 792 (834)
.. .++...+ .++. .++.+|++.||++|++ +.||.+
T Consensus 410 ~~--------~~p~~~S-~~a~---dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 410 AV--------ELPDSFS-PELR---SLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp CC--------CCCTTSC-HHHH---HHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred CC--------CCCccCC-HHHH---HHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 11 1111222 3444 4555899999999998 567653
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=408.92 Aligned_cols=251 Identities=16% Similarity=0.253 Sum_probs=200.8
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
++|...+.||+|+||.||+|.. .+|+.||||.+.... ....+.+.+|+.+|+.|+|||||+|++++.+.+.++|||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc-hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 5678888999999999999996 468999999986543 33456789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCC--CCceEeeeeecccc
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPD--MNPRLGSFALAEFL 669 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~--~~~ki~DfGla~~~ 669 (834)
|.+|+|.+++.... ..+++.....++.||+.||.|||+ .+|+||||||+||||+.+ +.+||+|||+|+.+
T Consensus 236 ~~gg~L~~~i~~~~-----~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~ 307 (573)
T 3uto_A 236 MSGGELFEKVADEH-----NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307 (573)
T ss_dssp CCCCBHHHHHTCTT-----SCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred cCCCcHHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence 99999999886432 248888999999999999999997 699999999999999854 88999999999876
Q ss_pred ccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcc
Q 003278 670 TRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPL 749 (834)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
.... ...+.+||+.|||||++.+..|+.++||||+||+||||++|..||........ ...+. .....+
T Consensus 308 ~~~~--------~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~-~~~i~---~~~~~~ 375 (573)
T 3uto_A 308 DPKQ--------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET-LRNVK---SCDWNM 375 (573)
T ss_dssp CTTS--------EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHHHH---TTCCCC
T ss_pred cCCC--------ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH-HHHHH---hCCCCC
Confidence 4321 12356899999999999999999999999999999999999999975433222 22111 111111
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 750 AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 750 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
. + ......+ ++ +..++.+||+.||++|||+.|+++
T Consensus 376 ~---~-~~~~~~s-~~---~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 376 D---D-SAFSGIS-ED---GKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp C---S-GGGTTSC-HH---HHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C---c-ccccCCC-HH---HHHHHHHHccCChhHCcCHHHHhc
Confidence 1 1 1111122 33 345556899999999999999986
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=377.70 Aligned_cols=268 Identities=24% Similarity=0.381 Sum_probs=209.6
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEcc
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYM 190 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 190 (834)
++|...+.||+|+||.||+|.+..+|..||+|.+........+.|.+|+.++++++||||++++++|.+.+..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 46888899999999999999999999999999987766777788999999999999999999999999999999999999
Q ss_pred CCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhh
Q 003278 191 PNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEH 270 (834)
Q Consensus 191 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~ 270 (834)
++|+|.+++... ...++|..+..|+.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 90 ~~~~L~~~l~~~------~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 160 (310)
T 3s95_A 90 KGGTLRGIIKSM------DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVD 160 (310)
T ss_dssp TTCBHHHHHHHC------CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred CCCcHHHHHHhc------cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence 999999999753 24689999999999999999999996 999999999999999999999999999986543
Q ss_pred hhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccc---hHH
Q 003278 271 ELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQI---ILL 347 (834)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~---~l~ 347 (834)
........... ............||+.|+|||.+.. ..++.++|||||||++|||+||..|+......... ...
T Consensus 161 ~~~~~~~~~~~--~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~ 237 (310)
T 3s95_A 161 EKTQPEGLRSL--KKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVR 237 (310)
T ss_dssp ---------------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHH
T ss_pred ccccccccccc--cccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhh
Confidence 32110000000 0000011235679999999999865 46799999999999999999999988653332211 111
Q ss_pred HHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 348 DWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 348 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
...... ..+. .+ ..+.+++..||+.||.+||++.++++.|+..
T Consensus 238 ~~~~~~---------~~~~-----~~----~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l 280 (310)
T 3s95_A 238 GFLDRY---------CPPN-----CP----PSFFPITVRCCDLDPEKRPSFVKLEHWLETL 280 (310)
T ss_dssp HHHHHT---------CCTT-----CC----TTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cccccc---------CCCC-----CC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111110 0011 11 2477899999999999999999999988764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=370.97 Aligned_cols=283 Identities=37% Similarity=0.593 Sum_probs=227.2
Q ss_pred CCccccHHHHHhhcCCCCCC------CeeeccCCeEEEEEEECCCCeEEEEEEeccc----ChhhHHHHHHHHHHHHhCC
Q 003278 97 NPRIFSYAELYIGSNGFDED------EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK----GERFEKTFAAELVAVAHLR 166 (834)
Q Consensus 97 ~~~~f~~~el~~~t~~f~~~------~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~----~~~~~~~~~~E~~~l~~l~ 166 (834)
....|++.|+..+|++|+.. +.||+|+||.||+|.. +++.||||++... .....+.|.+|+.++++++
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 88 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ 88 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence 34679999999999999988 8999999999999986 6889999998643 2345678999999999999
Q ss_pred CCceeeEeeeEEeCCEEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCC
Q 003278 167 HRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKT 246 (834)
Q Consensus 167 H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp 246 (834)
||||+++++++.+.+..++||||+++|+|.+++.... ...+++|..+..|+.|++.||.|||+. +|+||||||
T Consensus 89 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp 161 (307)
T 2nru_A 89 HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD----GTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKS 161 (307)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG----GCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCG
T ss_pred CCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc----CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCH
Confidence 9999999999999999999999999999999986432 235699999999999999999999996 999999999
Q ss_pred CceEECCCCceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHH
Q 003278 247 SNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVL 326 (834)
Q Consensus 247 ~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ 326 (834)
+|||++.++.+||+|||+++...... .........||+.|+|||.+.. .++.++|||||||++|
T Consensus 162 ~Nili~~~~~~kl~Dfg~~~~~~~~~--------------~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~ 225 (307)
T 2nru_A 162 ANILLDEAFTAKISDFGLARASEKFA--------------QTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLL 225 (307)
T ss_dssp GGEEECTTCCEEECCCTTCEECCSCS--------------SCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHH
T ss_pred HHEEEcCCCcEEEeeccccccccccc--------------ccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHH
Confidence 99999999999999999987542210 0011234569999999998753 4688999999999999
Q ss_pred HHHhCCccCCCCCCCccchHHHHHHHHhh-cCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHh
Q 003278 327 EVVSGRRAVDLTYPDDQIILLDWIRRLSD-EGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAV 405 (834)
Q Consensus 327 ElltG~~p~~~~~~~~~~~l~~~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l 405 (834)
||+||+.|+....... .+..+...... ...+...+++.+. .........+.+++..||+.||.+||++.+|++.|
T Consensus 226 ~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L 301 (307)
T 2nru_A 226 EIITGLPAVDEHREPQ--LLLDIKEEIEDEEKTIEDYIDKKMN--DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301 (307)
T ss_dssp HHHHCCCSBCTTBSSS--BTTHHHHHHHTTSCCHHHHSCSSCS--CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred HHHHCCCCcccCcchH--HHHHHHHHhhhhhhhhhhhcccccc--ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 9999999997543332 22233333222 1223333444442 23445567889999999999999999999999998
Q ss_pred hcC
Q 003278 406 SGS 408 (834)
Q Consensus 406 ~~~ 408 (834)
+..
T Consensus 302 ~~l 304 (307)
T 2nru_A 302 QEM 304 (307)
T ss_dssp HHH
T ss_pred HHH
Confidence 764
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=378.47 Aligned_cols=251 Identities=24% Similarity=0.365 Sum_probs=205.1
Q ss_pred hcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEE
Q 003278 109 GSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLV 186 (834)
Q Consensus 109 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 186 (834)
..++|...+.||+|+||.||+|.+..+|+.||||++... .....+.+.+|+.+|+.++||||+++++++...+..++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 346799999999999999999999999999999998654 334556788999999999999999999999999999999
Q ss_pred EEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchh
Q 003278 187 YDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLAR 266 (834)
Q Consensus 187 ~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~ 266 (834)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 93 ~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 162 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAH-------GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSN 162 (328)
T ss_dssp ECCCTTCBHHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCG
T ss_pred EECCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCce
Confidence 9999999999998653 3588999999999999999999996 99999999999999999999999999997
Q ss_pred hhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchH
Q 003278 267 WLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIIL 346 (834)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l 346 (834)
..... ...+..+||+.|+|||.+......+.++|||||||++|||+||+.||+... .
T Consensus 163 ~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~ 219 (328)
T 3fe3_A 163 EFTVG-----------------GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN------L 219 (328)
T ss_dssp GGSSS-----------------CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS------H
T ss_pred ecCCC-----------------CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC------H
Confidence 54221 012345799999999999766555689999999999999999999996432 1
Q ss_pred HHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 347 LDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 347 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
......... +.. .+. ... ...+.++...||+.||.+||++.++++.
T Consensus 220 ~~~~~~i~~-~~~------~~p-~~~----s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 220 KELRERVLR-GKY------RIP-FYM----STDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp HHHHHHHHH-CCC------CCC-TTS----CHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred HHHHHHHHh-CCC------CCC-CCC----CHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 112222211 111 110 011 1357789999999999999999999863
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=376.86 Aligned_cols=269 Identities=26% Similarity=0.440 Sum_probs=202.3
Q ss_pred ccHHHHHhhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC--hhhHHHHHHHHHHHHhCCCCceeeEeeeEE
Q 003278 101 FSYAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG--ERFEKTFAAELVAVAHLRHRNLVRLRGWCV 178 (834)
Q Consensus 101 f~~~el~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~ 178 (834)
++..++.+..++|+..+.||+|+||.||+|.+ +|+.||||++.... ....+.|.+|+.++++++||||+++++++.
T Consensus 27 ~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 104 (309)
T 3p86_A 27 MDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT 104 (309)
T ss_dssp -----CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCcccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 34444555667899999999999999999987 58899999986543 344567999999999999999999999999
Q ss_pred eCCEEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCC--eecCCCCCCceEECCCCc
Q 003278 179 HEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQ--IIHRDVKTSNVMLDSQYN 256 (834)
Q Consensus 179 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--iiHrDlKp~NILld~~~~ 256 (834)
..+..++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+. + |+||||||+|||++.++.
T Consensus 105 ~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~ 177 (309)
T 3p86_A 105 QPPNLSIVTEYLSRGSLYRLLHKSGA----REQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYT 177 (309)
T ss_dssp STTCCEEEEECCTTCBHHHHHHSTTH----HHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCC
T ss_pred ECCceEEEEecCCCCcHHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCc
Confidence 99999999999999999999975421 12489999999999999999999986 6 999999999999999999
Q ss_pred eEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCC
Q 003278 257 ARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVD 336 (834)
Q Consensus 257 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~ 336 (834)
+||+|||+++...... .......||+.|+|||.+... .++.++|||||||++|||+||+.||.
T Consensus 178 ~kL~Dfg~a~~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~ 240 (309)
T 3p86_A 178 VKVCDFGLSRLKASTF----------------LSSKSAAGTPEWMAPEVLRDE-PSNEKSDVYSFGVILWELATLQQPWG 240 (309)
T ss_dssp EEECCCC---------------------------------CCTTSCHHHHTTC-CCCTTHHHHHHHHHHHHHHHCCCTTT
T ss_pred EEECCCCCCccccccc----------------cccccCCCCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999997543211 012345699999999998654 57999999999999999999999986
Q ss_pred CCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcCCCC
Q 003278 337 LTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGSYSG 411 (834)
Q Consensus 337 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~~~~ 411 (834)
..... .. ............ +. ... ...+.+++..||+.||.+||++.++++.|+.....
T Consensus 241 ~~~~~---~~---~~~~~~~~~~~~-----~~-~~~----~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 241 NLNPA---QV---VAAVGFKCKRLE-----IP-RNL----NPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp TSCHH---HH---HHHHHHSCCCCC-----CC-TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred CCCHH---HH---HHHHHhcCCCCC-----CC-ccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 43211 11 111111111111 10 111 14578999999999999999999999999876543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=381.28 Aligned_cols=263 Identities=22% Similarity=0.297 Sum_probs=207.8
Q ss_pred hCcCcCCcccccCCcEEEEEEE--------CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhc-cCCCceeEEEEEeeCC
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL--------DNHQYVLVKRLGMSKCPALRTRFSNELQNLARL-RHRNLVQLCGWCTEQG 583 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~--------~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l-~HpNiv~l~g~~~~~~ 583 (834)
++|...+.||+|+||.||+|.. .++..||||.+.........+.|.+|+.+|+++ +|||||+++++|.+.+
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 160 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 160 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence 4677778899999999999985 235679999998766666667899999999999 8999999999999999
Q ss_pred eEEEEEeccCCCchhhhhhcCCCC----------CCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeec
Q 003278 584 EMLVIYDYSATRILSHLLFHNNHR----------IGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLD 653 (834)
Q Consensus 584 ~~~lv~Ey~~~g~L~~~l~~~~~~----------~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld 653 (834)
..++||||+++|+|.+++...... .....++|..++.++.|++.||+|||+ .+|+||||||+|||++
T Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~ 237 (370)
T 2psq_A 161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVT 237 (370)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEC
T ss_pred CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEEC
Confidence 999999999999999999865321 112348899999999999999999997 6999999999999999
Q ss_pred CCCCceEeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCc
Q 003278 654 PDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPE 732 (834)
Q Consensus 654 ~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~ 732 (834)
.++.+||+|||+++.+...... .......||+.|||||++.+..++.++|||||||++|||+| |+.||......
T Consensus 238 ~~~~~kl~DFG~a~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~ 312 (370)
T 2psq_A 238 ENNVMKIADFGLARDINNIDYY-----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 312 (370)
T ss_dssp TTCCEEECCCSSCEETTCCCTT-----CTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred CCCCEEEccccCCcccCcccce-----ecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 9999999999999865432211 11223467899999999999999999999999999999999 88888654322
Q ss_pred hhHHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCC
Q 003278 733 GLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGND 798 (834)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~ 798 (834)
.+...+. ....+ ...... .. .+.+++.+||+.||++|||+.||++.|+.+-
T Consensus 313 -~~~~~~~---~~~~~-------~~~~~~-~~---~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 313 -ELFKLLK---EGHRM-------DKPANC-TN---ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp -GHHHHHH---TTCCC-------CCCTTS-CH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HHHHHHh---cCCCC-------CCCCCC-CH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 2222111 11110 111122 22 3555666999999999999999999997653
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=381.59 Aligned_cols=271 Identities=27% Similarity=0.333 Sum_probs=205.9
Q ss_pred hhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCC----EE
Q 003278 108 IGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHED----QL 183 (834)
Q Consensus 108 ~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~----~~ 183 (834)
...++|+..+.||+|+||.||+|++. ++.||||++.... .....+..|+.++++++|||||++++++...+ .+
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 97 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL 97 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceE
Confidence 34567999999999999999999984 7999999986543 33445667999999999999999999998754 47
Q ss_pred EEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhcc-------CCCeecCCCCCCceEECCCCc
Q 003278 184 LLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQL-------ETQIIHRDVKTSNVMLDSQYN 256 (834)
Q Consensus 184 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------~~~iiHrDlKp~NILld~~~~ 256 (834)
++||||+++|+|.+++... .++|..+..|+.|++.||+|||+.+ .++|+||||||+|||++.++.
T Consensus 98 ~lv~e~~~~g~L~~~l~~~--------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~ 169 (322)
T 3soc_A 98 WLITAFHEKGSLSDFLKAN--------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT 169 (322)
T ss_dssp EEEEECCTTCBHHHHHHHC--------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCC
T ss_pred EEEEecCCCCCHHHHHHhc--------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCe
Confidence 9999999999999999642 4899999999999999999999741 238999999999999999999
Q ss_pred eEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccC----CCCCcccceeehhhHHHHHHhCC
Q 003278 257 ARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKG----SVATAKSDVFSFGIVVLEVVSGR 332 (834)
Q Consensus 257 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~----~~~~~ksDV~SfGvvl~ElltG~ 332 (834)
+||+|||+++.+..... ........||+.|+|||.+... ..++.++|||||||++|||+||+
T Consensus 170 ~kL~DFg~a~~~~~~~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~ 235 (322)
T 3soc_A 170 ACIADFGLALKFEAGKS--------------AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRC 235 (322)
T ss_dssp EEECCCTTCEEECTTSC--------------CCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTB
T ss_pred EEEccCCcccccccccC--------------ccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCC
Confidence 99999999976532210 0112345699999999998653 23456889999999999999999
Q ss_pred ccCCCCCCCccchH----------HHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHH
Q 003278 333 RAVDLTYPDDQIIL----------LDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVI 402 (834)
Q Consensus 333 ~p~~~~~~~~~~~l----------~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~ 402 (834)
.||........... ..+....... .. .+.+............+.+|+..||+.||.+|||+.+|+
T Consensus 236 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell 310 (322)
T 3soc_A 236 TAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHK-KK----RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVG 310 (322)
T ss_dssp TTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTS-CC----CCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCCCcchhccchhhhhccCCchhhhhhhhhcc-cC----CCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHH
Confidence 99976543322111 1111111111 11 111110001223446689999999999999999999999
Q ss_pred HHhhcC
Q 003278 403 EAVSGS 408 (834)
Q Consensus 403 ~~l~~~ 408 (834)
+.|+..
T Consensus 311 ~~L~~l 316 (322)
T 3soc_A 311 ERITQM 316 (322)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 998754
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=374.70 Aligned_cols=259 Identities=20% Similarity=0.299 Sum_probs=203.6
Q ss_pred CcCcCCcccccCCcEEEEEEEC----CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEE
Q 003278 514 NFSESQRVAEMDFGTAYQGFLD----NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIY 589 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~~----~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~ 589 (834)
.|...+.||+|+||.||+|... .+..||||.+.........+.|.+|+.+|++++|||||++++++.+.+..++||
T Consensus 50 ~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 129 (325)
T 3kul_A 50 RIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVT 129 (325)
T ss_dssp GEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEE
T ss_pred HeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEe
Confidence 4455688999999999999974 345699999987666666788999999999999999999999999999999999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccc
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFL 669 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~ 669 (834)
||+++|+|.+++.... ..+++..++.|+.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 130 e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 130 EYMENGSLDTFLRTHD-----GQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp ECCTTCBHHHHHHTTT-----TCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred eCCCCCcHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 9999999999986542 248899999999999999999997 68999999999999999999999999999876
Q ss_pred ccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCc
Q 003278 670 TRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRP 748 (834)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
....... .......||+.|+|||++.+..++.++|||||||++|||+| |..||....... +...+. .....
T Consensus 202 ~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-~~~~~~---~~~~~ 273 (325)
T 3kul_A 202 EDDPDAA----YTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD-VISSVE---EGYRL 273 (325)
T ss_dssp C----CC----EECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-HHHHHH---TTCCC
T ss_pred ccCccce----eeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH-HHHHHH---cCCCC
Confidence 4332111 11123457888999999999999999999999999999999 999986443222 111111 11010
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCc
Q 003278 749 LAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDK 799 (834)
Q Consensus 749 ~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~ 799 (834)
.....+ +. .+.+++.+||+.||++|||+.+|++.|+.+.+
T Consensus 274 -------~~~~~~-~~---~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~ 313 (325)
T 3kul_A 274 -------PAPMGC-PH---ALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313 (325)
T ss_dssp -------CCCTTC-CH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------CCCCCc-CH---HHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 011112 22 45566679999999999999999999987654
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=373.21 Aligned_cols=268 Identities=21% Similarity=0.310 Sum_probs=207.9
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
++|...+.||+|+||+||+|... ++..||+|.+... .....+.|.+|++++++++|||||++++++.+.+..++||||
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF-DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 45677788999999999999974 5889999988543 445567899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccccc
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTR 671 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~ 671 (834)
+++|+|.+++.... ..++|..++.|+.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 89 ~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 160 (310)
T 3s95_A 89 IKGGTLRGIIKSMD-----SQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVD 160 (310)
T ss_dssp CTTCBHHHHHHHCC-----TTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred cCCCcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence 99999999997643 248899999999999999999997 6899999999999999999999999999987543
Q ss_pred CCCCCcc-------cccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHH-HHHHHHH
Q 003278 672 NDHGHRK-------ATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLV-KRVHEFE 743 (834)
Q Consensus 672 ~~~~~~~-------~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~-~~~~~~~ 743 (834)
....... .........||+.|+|||++.+..++.++|||||||++|||+||..|+....+..... .......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~ 240 (310)
T 3s95_A 161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL 240 (310)
T ss_dssp -------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH
T ss_pred ccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc
Confidence 3211000 0011124679999999999999999999999999999999999998876543322110 0011111
Q ss_pred hhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCccccc
Q 003278 744 ARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDKRFME 803 (834)
Q Consensus 744 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~~~~~ 803 (834)
.. ......+ . .+.+++.+||+.||++|||+.+|++.|+.+......
T Consensus 241 ~~----------~~~~~~~-~---~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~ 286 (310)
T 3s95_A 241 DR----------YCPPNCP-P---SFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG 286 (310)
T ss_dssp HH----------TCCTTCC-T---THHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred cc----------cCCCCCC-H---HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence 10 0111111 2 345566799999999999999999999887765443
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=369.54 Aligned_cols=261 Identities=21% Similarity=0.297 Sum_probs=208.1
Q ss_pred ccccHHHHHHHhhC----------cCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccC
Q 003278 501 REISFKEIISATNN----------FSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRH 569 (834)
Q Consensus 501 ~~~~~~el~~at~~----------f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~H 569 (834)
..++++++..++++ |...+.||+|+||.||+|... +|+.||||++..... ...+.|.+|+.++++++|
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CSHHHHHHHHHHHTTCCC
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch-hHHHHHHHHHHHHHhCCC
Confidence 45889999999876 555678999999999999976 689999999875433 234678999999999999
Q ss_pred CCceeEEEEEeeCCeEEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCc
Q 003278 570 RNLVQLCGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSA 649 (834)
Q Consensus 570 pNiv~l~g~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~N 649 (834)
||||++++++...+..++||||+++|+|.+++... .++|..+..++.|++.||+|||+ .+|+||||||+|
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~N 171 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV-------RLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDS 171 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGG
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHH
Confidence 99999999999999999999999999999988532 38899999999999999999997 699999999999
Q ss_pred eeecCCCCceEeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCC
Q 003278 650 ITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFR 729 (834)
Q Consensus 650 ILld~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~ 729 (834)
||++.++.+||+|||++....... .......||+.|+|||++.++.++.++|||||||++|||+||+.|+...
T Consensus 172 Ill~~~~~~kl~Dfg~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~ 244 (321)
T 2c30_A 172 ILLTLDGRVKLSDFGFCAQISKDV-------PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD 244 (321)
T ss_dssp EEECTTCCEEECCCTTCEECCSSS-------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred EEECCCCcEEEeeeeeeeecccCc-------cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999997654321 1123467999999999999999999999999999999999999998654
Q ss_pred CCchhHHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 730 LPEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
.+.. ....+ .....+ .+... ... ..+ +.+++.+||+.||++|||+.+|++
T Consensus 245 ~~~~-~~~~~---~~~~~~--~~~~~---~~~-~~~---l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 245 SPVQ-AMKRL---RDSPPP--KLKNS---HKV-SPV---LRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp CHHH-HHHHH---HHSSCC--CCTTG---GGS-CHH---HHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CHHH-HHHHH---hcCCCC--CcCcc---ccC-CHH---HHHHHHHHccCChhhCcCHHHHhc
Confidence 3221 11111 111111 11000 011 123 445566899999999999999986
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=387.86 Aligned_cols=260 Identities=20% Similarity=0.315 Sum_probs=205.6
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
++|...+.||+|+||.||+|... +++.||||.+.........++|.+|+.+|++++|||||+++|+|.+.+..++||||
T Consensus 114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 193 (377)
T 3cbl_A 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL 193 (377)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEc
Confidence 34566788999999999999985 68899999987655555667899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccccc
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTR 671 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~ 671 (834)
+++|+|.+++...+ ..+++..++.++.|+|.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 194 ~~~g~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 194 VQGGDFLTFLRTEG-----ARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp CTTCBHHHHHHHHG-----GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred CCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 99999999997543 247889999999999999999997 6899999999999999999999999999976432
Q ss_pred CCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCccc
Q 003278 672 NDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRPLA 750 (834)
Q Consensus 672 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (834)
.. .........+|+.|+|||++.++.++.++|||||||++|||+| |..|+...... .....+ ....+.
T Consensus 266 ~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~-~~~~~~---~~~~~~-- 334 (377)
T 3cbl_A 266 GV-----YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ-QTREFV---EKGGRL-- 334 (377)
T ss_dssp SE-----EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH-HHHHHH---HTTCCC--
T ss_pred Cc-----eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHH---HcCCCC--
Confidence 11 0111112346788999999999999999999999999999999 88888643321 111111 111110
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCcc
Q 003278 751 ELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDKR 800 (834)
Q Consensus 751 ~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~~ 800 (834)
..+ ...+.+ +.+++.+||+.||++||||.+|++.|+.+.++
T Consensus 335 -----~~~-~~~~~~---l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 335 -----PCP-ELCPDA---VFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp -----CCC-TTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----CCC-CCCCHH---HHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 011 112233 45566799999999999999999999876553
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=373.58 Aligned_cols=255 Identities=24% Similarity=0.329 Sum_probs=201.8
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC-hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEc
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG-ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDY 189 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 189 (834)
++|+..+.||+|+||.||+|++..+++.||||++.... ....+.+.+|+.+++.++|||||++++++.+.+..++||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 57889999999999999999998899999999986432 23346788999999999999999999999999999999999
Q ss_pred cCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhh
Q 003278 190 MPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLE 269 (834)
Q Consensus 190 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~ 269 (834)
+++|+|.+++... ..+++..+..|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+.
T Consensus 87 ~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 156 (323)
T 3tki_A 87 CSGGELFDRIEPD-------IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR 156 (323)
T ss_dssp CTTEEGGGGSBTT-------TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred CCCCcHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceec
Confidence 9999999988532 3589999999999999999999985 99999999999999999999999999997543
Q ss_pred hhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHH
Q 003278 270 HELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDW 349 (834)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~ 349 (834)
.... ........||+.|+|||.+......+.++|||||||++|||+||+.||........ ....|
T Consensus 157 ~~~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~ 221 (323)
T 3tki_A 157 YNNR--------------ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDW 221 (323)
T ss_dssp ETTE--------------ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHH
T ss_pred cCCc--------------ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHH
Confidence 2110 01123567999999999987665557899999999999999999999975433221 11222
Q ss_pred HHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 350 IRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 350 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
.. ....... ... ....+.+|+..||+.||.+||++.|+++.
T Consensus 222 ~~----~~~~~~~-~~~---------~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 222 KE----KKTYLNP-WKK---------IDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp HT----TCTTSTT-GGG---------SCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred hc----ccccCCc-ccc---------CCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 11 1110000 001 12456789999999999999999999864
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=385.78 Aligned_cols=259 Identities=23% Similarity=0.350 Sum_probs=195.3
Q ss_pred hCcCcCCcccccCCcEEEEEEEC----CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD----NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVI 588 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~----~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv 588 (834)
++|...+.||+|+||.||+|... ++..||||.+........++.|.+|+.+|++++|||||+++|+|.+.+..++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 46788889999999999999864 56789999998766666678899999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccc
Q 003278 589 YDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEF 668 (834)
Q Consensus 589 ~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~ 668 (834)
|||+++|+|.+++.... ..+++..++.|+.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 125 ~e~~~~~sL~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHD-----AQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp EECCTTCBHHHHHHTTT-----TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EeCCCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 99999999999997543 248899999999999999999997 6899999999999999999999999999987
Q ss_pred cccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcC
Q 003278 669 LTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKR 747 (834)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
....... ........||+.|+|||++.++.++.++|||||||++|||+| |+.|+...... .+...+ ....+
T Consensus 197 ~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~-~~~~~i---~~~~~ 268 (373)
T 2qol_A 197 LEDDPEA----AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ-DVIKAV---DEGYR 268 (373)
T ss_dssp ---------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH-HHHHHH---HTTEE
T ss_pred cccCCcc----ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHH---HcCCC
Confidence 5432211 011122346788999999999999999999999999999998 99998643322 121111 11100
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCC
Q 003278 748 PLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGND 798 (834)
Q Consensus 748 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~ 798 (834)
. ..... .+ ..+.+++.+||+.||++||||.+|++.|+.+.
T Consensus 269 ~-------~~~~~-~~---~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 308 (373)
T 2qol_A 269 L-------PPPMD-CP---AALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308 (373)
T ss_dssp C-------CCCTT-CB---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C-------CCCcc-cc---HHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence 0 00111 12 24566777999999999999999999997653
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=371.51 Aligned_cols=246 Identities=26% Similarity=0.321 Sum_probs=193.0
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhC-CCCceeeEeeeEEeCCEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHL-RHRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~ 187 (834)
++|+..++||+|+||+||+|.+..+|+.||||++... .......+..|+..+.++ +|||||+++++|.+.+..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 5699999999999999999999889999999997643 233344556666666555 9999999999999999999999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
||+ +|+|.+++... ...++|..+..|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 137 e~~-~~~L~~~~~~~------~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~ 206 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAW------GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVE 206 (311)
T ss_dssp ECC-CCBHHHHHHHH------CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEE
T ss_pred ecc-CCCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeee
Confidence 999 67998888653 24699999999999999999999996 999999999999999999999999999875
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHH
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILL 347 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~ 347 (834)
..... ..+...||++|+|||++.. .++.++|||||||++|||+||+.|+... .
T Consensus 207 ~~~~~-----------------~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~-----~--- 259 (311)
T 3p1a_A 207 LGTAG-----------------AGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGG-----E--- 259 (311)
T ss_dssp CC-----------------------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSH-----H---
T ss_pred cccCC-----------------CCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCc-----c---
Confidence 43211 1234569999999998863 5799999999999999999998765321 1
Q ss_pred HHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 348 DWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 348 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
.|. . ...+.........+ ...+.+++..||+.||.+||++.++++.
T Consensus 260 ~~~-~-~~~~~~~~~~~~~~---------~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 260 GWQ-Q-LRQGYLPPEFTAGL---------SSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp HHH-H-HTTTCCCHHHHTTS---------CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHH-H-HhccCCCcccccCC---------CHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 111 1 11111111111111 2468899999999999999999999863
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=365.83 Aligned_cols=266 Identities=20% Similarity=0.273 Sum_probs=199.7
Q ss_pred hCcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCCChhHHHHHHHHHHHHHh--ccCCCceeEEEEEeeC----CeEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLAR--LRHRNLVQLCGWCTEQ----GEML 586 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~--l~HpNiv~l~g~~~~~----~~~~ 586 (834)
++|...+.||+|+||+||+|.. +++.||||++... ....+..|.+++.. ++|||||++++++.+. ...+
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 8 RDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred CcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 5677788999999999999988 5788999998542 23456667777766 8999999999987643 4589
Q ss_pred EEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhcc-----CCceeecccccCceeecCCCCceEe
Q 003278 587 VIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEW-----NEQVIHRNITSSAITLDPDMNPRLG 661 (834)
Q Consensus 587 lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~-----~~~iiHrDlK~~NILld~~~~~ki~ 661 (834)
+||||+++|+|.+++... .+++..++.|+.|++.||+|||+.. ..+|+||||||+|||++.++.+||+
T Consensus 83 lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQLT-------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEECCCTTCBHHHHHTTC-------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred EehhhccCCCHHHHHhhc-------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEe
Confidence 999999999999998532 3889999999999999999999311 2799999999999999999999999
Q ss_pred eeeeccccccCCCCCcccccCccccccccCccchhccccC------CCCccCcchhhHHHHHHHHhC----------CCc
Q 003278 662 SFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESG------EATSMADVYSFGVVVLEVVTG----------QMA 725 (834)
Q Consensus 662 DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~------~~~~k~DV~SfGvvl~E~~tG----------~~p 725 (834)
|||+++........ .........||+.|+|||++.+. .++.++|||||||++|||+|| +.|
T Consensus 156 Dfg~a~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~p 232 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQ---LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP 232 (301)
T ss_dssp CCTTCEEEETTTTE---EECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred eCCCeeeccccccc---ccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccc
Confidence 99999765433211 11122345799999999999876 566799999999999999999 777
Q ss_pred cCCCCCchhHHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccC
Q 003278 726 VDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGN 797 (834)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~ 797 (834)
|....+....................+.. ..........+.+++.+||+.||++|||+.+|++.|+.+
T Consensus 233 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 233 FYDVVPNDPSFEDMRKVVCVDQQRPNIPN----RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCG----GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccCCCCcchhhhhHHHhccCCCCCCCh----hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 76544433222222222111111111100 011123445677788899999999999999999999764
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=381.18 Aligned_cols=264 Identities=25% Similarity=0.403 Sum_probs=207.4
Q ss_pred cCCCCCCCeeeccCCeEEEEEEE-----CCCCeEEEEEEeccc-ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVL-----PSDGTVVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQL 183 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~-----~~~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 183 (834)
.++|...+.||+|+||.||+|.+ ..++..||||++... .......+.+|+.++++++|||||++++++...+..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 46788899999999999999995 346789999998653 344566799999999999999999999999999999
Q ss_pred EEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCC---ceEEe
Q 003278 184 LLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQY---NARLG 260 (834)
Q Consensus 184 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~---~~kl~ 260 (834)
++||||+++|+|.+++............+++..++.|+.|+++||+|||+. +|+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEEC
Confidence 999999999999999976543333345699999999999999999999996 999999999999999544 59999
Q ss_pred eccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCC
Q 003278 261 DFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTY 339 (834)
Q Consensus 261 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~ 339 (834)
|||+++.+...... .......||+.|+|||.+..+ .++.++|||||||++|||+| |+.||....
T Consensus 227 DFG~a~~~~~~~~~--------------~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~pf~~~~ 291 (367)
T 3l9p_A 227 DFGMARDIYRAGYY--------------RKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 291 (367)
T ss_dssp CCHHHHHHHHHSSC--------------TTCCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CCcccccccccccc--------------ccCCCcCCcccEECHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999865432110 112344589999999998765 67999999999999999998 999986432
Q ss_pred CCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 340 PDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 340 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
. ..+.. .. ..+...... ... ...+.+|+..||+.||.+||++.+|++.|...
T Consensus 292 ~---~~~~~---~i-~~~~~~~~~------~~~----~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 292 N---QEVLE---FV-TSGGRMDPP------KNC----PGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp H---HHHHH---HH-HTTCCCCCC------TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H---HHHHH---HH-HcCCCCCCC------ccC----CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1 11111 11 112111110 111 24578999999999999999999999998764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=378.81 Aligned_cols=275 Identities=24% Similarity=0.357 Sum_probs=214.4
Q ss_pred cccHHHHHhhcCCCCCCCeeeccCCeEEEEEE-----ECCCCeEEEEEEecccC-hhhHHHHHHHHHHHHhC-CCCceee
Q 003278 100 IFSYAELYIGSNGFDEDEVLGSGGFGKVYRAV-----LPSDGTVVAVKCLAEKG-ERFEKTFAAELVAVAHL-RHRNLVR 172 (834)
Q Consensus 100 ~f~~~el~~~t~~f~~~~~LG~G~fG~Vy~~~-----~~~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~ 172 (834)
.+...+.....++|...+.||+|+||.||+|. ...+++.||||++.... ....+.|.+|+.++.++ +|||||+
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 35566777788999999999999999999998 44567899999997543 34456799999999999 8999999
Q ss_pred EeeeEEeCCE-EEEEEEccCCCCHhHHHhcCCCccc--------------------------------------------
Q 003278 173 LRGWCVHEDQ-LLLVYDYMPNRSLDRVLFRRPENLE-------------------------------------------- 207 (834)
Q Consensus 173 l~g~~~~~~~-~~lV~Ey~~~gsL~~~l~~~~~~~~-------------------------------------------- 207 (834)
++++|.+.+. .++||||+++|+|.+++........
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 9999988654 8999999999999999976532100
Q ss_pred ---------------cCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhhhh
Q 003278 208 ---------------AAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHEL 272 (834)
Q Consensus 208 ---------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~ 272 (834)
....+++..+..|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 012389999999999999999999996 99999999999999999999999999998543221
Q ss_pred hhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccchHHHHHH
Q 003278 273 QYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQIILLDWIR 351 (834)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~ 351 (834)
. ....+...||+.|+|||.+... .++.++|||||||++|||+| |+.||........ +.
T Consensus 248 ~--------------~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~---- 306 (359)
T 3vhe_A 248 D--------------YVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FC---- 306 (359)
T ss_dssp T--------------CEEC--CEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH--HH----
T ss_pred c--------------chhccccCCCceeEChhhhcCC-CCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH--HH----
Confidence 0 0113455689999999998754 67999999999999999999 9999865433221 11
Q ss_pred HHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 352 RLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 352 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
.....+...... ... ...+.+++..||+.||.+||+|.+|++.|+..
T Consensus 307 ~~~~~~~~~~~~------~~~----~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 307 RRLKEGTRMRAP------DYT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp HHHHHTCCCCCC------TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHcCCCCCCC------CCC----CHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 111112111111 111 14578899999999999999999999998764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=361.94 Aligned_cols=260 Identities=22% Similarity=0.345 Sum_probs=203.7
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc---ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK---GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 187 (834)
++|+..+.||+|+||.||+|....+++.||||.+... .....+.|.+|+.++++++||||+++++++.+.+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 5688899999999999999999889999999997532 3345578999999999999999999999999999999999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
||+++|+|.+++... .++++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 91 e~~~g~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 160 (294)
T 4eqm_A 91 EYIEGPTLSEYIESH-------GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKA 160 (294)
T ss_dssp ECCCSCBHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTT
T ss_pred eCCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccc
Confidence 999999999998643 3689999999999999999999996 999999999999999999999999999986
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHH
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILL 347 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~ 347 (834)
+..... .......||+.|+|||.+... .++.++|||||||++|||+||+.||......
T Consensus 161 ~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------ 218 (294)
T 4eqm_A 161 LSETSL---------------TQTNHVLGTVQYFSPEQAKGE-ATDECTDIYSIGIVLYEMLVGEPPFNGETAV------ 218 (294)
T ss_dssp C----------------------------CCSSCCHHHHHTC-CCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH------
T ss_pred cccccc---------------cccCccccCccccCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChH------
Confidence 532210 113345699999999998654 6789999999999999999999998643211
Q ss_pred HHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCC-chhhHHHHhhcCC
Q 003278 348 DWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRP-SMKWVIEAVSGSY 409 (834)
Q Consensus 348 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-sm~~V~~~l~~~~ 409 (834)
......... ...... .... ... ...+.+++..|++.||.+|| ++.++.+.|....
T Consensus 219 ~~~~~~~~~-~~~~~~-~~~~-~~~----~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 219 SIAIKHIQD-SVPNVT-TDVR-KDI----PQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp HHHHHHHSS-CCCCHH-HHSC-TTS----CHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred HHHHHHhhc-cCCCcc-hhcc-cCC----CHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 111111111 111100 0000 111 24688899999999999998 8999999998754
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=371.53 Aligned_cols=262 Identities=24% Similarity=0.347 Sum_probs=197.9
Q ss_pred hCcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCC-ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSK-CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~-~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
++|...+.||+|+||+||+|.. +++.||||.+.... .....++|.+|+.+|++++|||||++++++.+.+..++||||
T Consensus 37 ~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 115 (309)
T 3p86_A 37 CDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEY 115 (309)
T ss_dssp GGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEEC
T ss_pred hHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEec
Confidence 4677778999999999999987 57789999987554 344457899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccccc
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTR 671 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~ 671 (834)
+++|+|.+++..... ...+++..++.++.|++.||+|||+. .++|+||||||+|||++.++.+||+|||+++....
T Consensus 116 ~~~~~L~~~l~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~-~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 191 (309)
T 3p86_A 116 LSRGSLYRLLHKSGA---REQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS 191 (309)
T ss_dssp CTTCBHHHHHHSTTH---HHHSCHHHHHHHHHHHHHHHHHHHTS-SSCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred CCCCcHHHHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHcC-CCCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence 999999999975432 12488999999999999999999973 12399999999999999999999999999975432
Q ss_pred CCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcccc
Q 003278 672 NDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAE 751 (834)
Q Consensus 672 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
.. .......||+.|+|||++.+..++.++|||||||++|||+||+.||....+.... ... ... ...
T Consensus 192 ~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~-~~~---~~~-~~~-- 257 (309)
T 3p86_A 192 TF-------LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVV-AAV---GFK-CKR-- 257 (309)
T ss_dssp -----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHH-HHH---HHS-CCC--
T ss_pred cc-------cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHH---Hhc-CCC--
Confidence 11 1123467999999999999999999999999999999999999999754332211 111 101 110
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCcc
Q 003278 752 LVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDKR 800 (834)
Q Consensus 752 ~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~~ 800 (834)
..+....+ .+ +.+++.+||+.||++|||+.+|++.|+..-++
T Consensus 258 ---~~~~~~~~-~~---l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 258 ---LEIPRNLN-PQ---VAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp ---CCCCTTSC-HH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred ---CCCCccCC-HH---HHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 11112222 23 44566689999999999999999999766543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=364.84 Aligned_cols=249 Identities=20% Similarity=0.300 Sum_probs=199.9
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
+.|...+.||+|+||+||+|.. .+++.||||.+...... ..+.+.+|+.++++++|||||++++++...+..++||||
T Consensus 20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc-HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 5688889999999999999985 66889999998654332 246789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccccc
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTR 671 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~ 671 (834)
+++|+|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++.....
T Consensus 99 ~~~~~L~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (297)
T 3fxz_A 99 LAGGSLTDVVTET-------CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (297)
T ss_dssp CTTCBHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred CCCCCHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 9999999998653 37888999999999999999997 6999999999999999999999999999976543
Q ss_pred CCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcccc
Q 003278 672 NDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAE 751 (834)
Q Consensus 672 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
.. .......||+.|+|||++.+..++.++|||||||++|||+||+.||....+....... .....+.
T Consensus 169 ~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~----~~~~~~~-- 235 (297)
T 3fxz_A 169 EQ-------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI----ATNGTPE-- 235 (297)
T ss_dssp TT-------CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH----HHHCSCC--
T ss_pred cc-------cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----HhCCCCC--
Confidence 21 1123467999999999999999999999999999999999999999654332221111 1111110
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 752 LVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 752 ~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
...+ ... .. .+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~---~~~-~~---~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 236 LQNP---EKL-SA---IFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp CSCG---GGS-CH---HHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCc---ccc-CH---HHHHHHHHHccCChhHCcCHHHHhh
Confidence 1000 111 12 3445666999999999999999985
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=378.14 Aligned_cols=273 Identities=15% Similarity=0.168 Sum_probs=204.5
Q ss_pred hCcCcCCcccccCCcEEEEEEECC------CcEEEEEEecCCCChhH----------HHHHHHHHHHHHhccCCCceeEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDN------HQYVLVKRLGMSKCPAL----------RTRFSNELQNLARLRHRNLVQLC 576 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~------~~~vavK~~~~~~~~~~----------~~~f~~E~~~l~~l~HpNiv~l~ 576 (834)
++|...+.||+|+||.||+|...+ +..||||.+........ ...+..|+..+..++|||||+++
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~ 114 (364)
T 3op5_A 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW 114 (364)
T ss_dssp CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence 467778899999999999998765 36799999865432111 02234566677888999999999
Q ss_pred EEEeeC----CeEEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceee
Q 003278 577 GWCTEQ----GEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITL 652 (834)
Q Consensus 577 g~~~~~----~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILl 652 (834)
+++... ...++||||+ +++|.+++.... ..+++..++.|+.|++.||+|||+ .+|+||||||+||||
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~-----~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill 185 (364)
T 3op5_A 115 GSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-----KRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLL 185 (364)
T ss_dssp EEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEE
T ss_pred eeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEE
Confidence 998764 4589999999 999999987642 248999999999999999999997 699999999999999
Q ss_pred c--CCCCceEeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCC
Q 003278 653 D--PDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRL 730 (834)
Q Consensus 653 d--~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~ 730 (834)
+ .++.+||+|||+++.+..................||+.|||||++.+..++.++|||||||+||||+||+.||....
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 9 88999999999998765432211111122245679999999999999999999999999999999999999997544
Q ss_pred CchhHHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCc
Q 003278 731 PEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDK 799 (834)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~ 799 (834)
............. ...+.+++++.+.....+.++. +++..||+.||++|||+.+|++.|+..-+
T Consensus 266 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~---~li~~cl~~~p~~RP~~~~l~~~l~~~~~ 329 (364)
T 3op5_A 266 KDPKYVRDSKIRY--RENIASLMDKCFPAANAPGEIA---KYMETVKLLDYTEKPLYENLRDILLQGLK 329 (364)
T ss_dssp TCHHHHHHHHHHH--HHCHHHHHHHHSCTTCCCHHHH---HHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHh--hhhHHHHHHHhcccccCHHHHH---HHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence 4333222221111 1223444444443333344444 45558999999999999999998875443
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=378.50 Aligned_cols=264 Identities=25% Similarity=0.388 Sum_probs=207.5
Q ss_pred cCCCCCCCeeeccCCeEEEEEEEC-------CCCeEEEEEEeccc-ChhhHHHHHHHHHHHHhC-CCCceeeEeeeEEeC
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLP-------SDGTVVAVKCLAEK-GERFEKTFAAELVAVAHL-RHRNLVRLRGWCVHE 180 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~-------~~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~ 180 (834)
.++|...+.||+|+||.||+|.+. .++..||||++... .....+.+.+|+.+++++ +|||||+++++|...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 467888999999999999999863 34678999998754 334557799999999999 899999999999999
Q ss_pred CEEEEEEEccCCCCHhHHHhcCCCc---------cccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEE
Q 003278 181 DQLLLVYDYMPNRSLDRVLFRRPEN---------LEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVML 251 (834)
Q Consensus 181 ~~~~lV~Ey~~~gsL~~~l~~~~~~---------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILl 251 (834)
+.+|+||||+++|+|.+++...... ......++|..++.|+.||+.||+|||+. +|+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence 9999999999999999999765321 01124589999999999999999999996 99999999999999
Q ss_pred CCCCceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-
Q 003278 252 DSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS- 330 (834)
Q Consensus 252 d~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt- 330 (834)
+.++.+||+|||+++.+..... ........||+.|+|||.+... .++.++|||||||++|||+|
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~--------------~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~ 301 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDY--------------YKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTL 301 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCT--------------TCTTTTTTSCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHTT
T ss_pred CCCCCEEEccccCCcccCcccc--------------eecccCCCcccceECHhHhcCC-CCCcHHHHHHHHHHHHHHHcC
Confidence 9999999999999985432110 0112334578999999988654 68999999999999999999
Q ss_pred CCccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 331 GRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 331 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
|+.||...... .+... ...+..... . ... ...+.+++..||+.||.+||++.++++.|+..
T Consensus 302 g~~p~~~~~~~---~~~~~----~~~~~~~~~-----~-~~~----~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 302 GGSPYPGIPVE---ELFKL----LKEGHRMDK-----P-ANC----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp SCCSSTTCCGG---GHHHH----HHTTCCCCC-----C-TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCHH---HHHHH----HhcCCCCCC-----C-CCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 99998653221 12211 112211111 0 111 24688899999999999999999999998764
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=382.78 Aligned_cols=261 Identities=28% Similarity=0.431 Sum_probs=196.3
Q ss_pred hcCCCCCCCeeeccCCeEEEEEEEC---CCCeEEEEEEeccc-ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEE
Q 003278 109 GSNGFDEDEVLGSGGFGKVYRAVLP---SDGTVVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLL 184 (834)
Q Consensus 109 ~t~~f~~~~~LG~G~fG~Vy~~~~~---~~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 184 (834)
..++|+..+.||+|+||.||+|++. .++..||||++... .....+.|.+|+.++++++|||||+++++|.+.+..+
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 3457999999999999999999875 45778999998754 3445678999999999999999999999999999999
Q ss_pred EEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccc
Q 003278 185 LVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGL 264 (834)
Q Consensus 185 lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGl 264 (834)
+||||+++|+|.+++... ...++|..+..|+.|+++||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 123 lv~e~~~~~sL~~~l~~~------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 193 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKH------DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGL 193 (373)
T ss_dssp EEEECCTTCBHHHHHHTT------TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--
T ss_pred EEEeCCCCCcHHHHHHhC------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcc
Confidence 999999999999999653 24689999999999999999999996 999999999999999999999999999
Q ss_pred hhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCcc
Q 003278 265 ARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQ 343 (834)
Q Consensus 265 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~ 343 (834)
++.+....... .......||+.|+|||++... .++.++|||||||++|||+| |+.||.....
T Consensus 194 a~~~~~~~~~~-------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~--- 256 (373)
T 2qol_A 194 GRVLEDDPEAA-------------YTTRGGKIPIRWTSPEAIAYR-KFTSASDVWSYGIVLWEVMSYGERPYWEMSN--- 256 (373)
T ss_dssp ---------------------------------CTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH---
T ss_pred ccccccCCccc-------------eeccCCCcCCCccChhhhccC-CcCchhcHHHHHHHHHHHHhCCCCCCCCCCH---
Confidence 98654321100 011223467899999998755 67999999999999999998 9999864321
Q ss_pred chHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcCC
Q 003278 344 IILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGSY 409 (834)
Q Consensus 344 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~~ 409 (834)
..+. .. ...+.... ........+.+++..||+.||.+||+|.+|++.|+...
T Consensus 257 ~~~~---~~-i~~~~~~~----------~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 308 (373)
T 2qol_A 257 QDVI---KA-VDEGYRLP----------PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308 (373)
T ss_dssp HHHH---HH-HHTTEECC----------CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHH---HH-HHcCCCCC----------CCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence 1111 11 11111110 00111246889999999999999999999999997653
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=366.11 Aligned_cols=265 Identities=24% Similarity=0.384 Sum_probs=203.4
Q ss_pred CCCCCCCeeeccCCeEEEEEE----ECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeC--CEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAV----LPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHE--DQLL 184 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~----~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~ 184 (834)
++|+..+.||+|+||.||+|+ ...+|+.||||++........+.|.+|+.++++++||||++++++|... ...+
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 568888999999999999998 4567899999999877666678899999999999999999999998654 4589
Q ss_pred EEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccc
Q 003278 185 LVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGL 264 (834)
Q Consensus 185 lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGl 264 (834)
+||||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 90 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKHK------ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL 160 (295)
T ss_dssp EEEECCTTCBHHHHHHHCG------GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred EEEEeCCCCCHHHHHHhcc------cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcc
Confidence 9999999999999997542 3589999999999999999999995 999999999999999999999999999
Q ss_pred hhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCC---
Q 003278 265 ARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPD--- 341 (834)
Q Consensus 265 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~--- 341 (834)
++.+....... .......||+.|+|||.+... .++.++|||||||++|||+||..|+......
T Consensus 161 ~~~~~~~~~~~-------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~ 226 (295)
T 3ugc_A 161 TKVLPQDKEFF-------------KVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMR 226 (295)
T ss_dssp CC--------------------------CTTCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHH
T ss_pred cccccCCccee-------------eeccCCCCccceeCcHHhcCC-CCChHHHHHHHHHHHHHHHhcccccCCChHHHHh
Confidence 98654332110 012233478889999998755 5799999999999999999999887532110
Q ss_pred ------ccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 342 ------DQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 342 ------~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
........+......+..... . ... ...+.+++..||+.||.+||++.++++.|+..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~-~~~----~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l 289 (295)
T 3ugc_A 227 MIGNDKQGQMIVFHLIELLKNNGRLPR-----P-DGC----PDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289 (295)
T ss_dssp HHCTTCCTHHHHHHHHHHHHTTCCCCC-----C-TTC----CHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hhcCccccchhHHHHHHHHhccCcCCC-----C-cCc----CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 000111111221221111111 0 111 24688999999999999999999999998764
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=372.01 Aligned_cols=266 Identities=22% Similarity=0.324 Sum_probs=200.7
Q ss_pred hCcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCC----eEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQG----EMLVI 588 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~----~~~lv 588 (834)
++|...+.||+|+||+||+|... ++.||||++... ......+.+|+.+|++++|||||++++++.+.. ..++|
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ--DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG--GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhchhhheecccCceEEEEEEEC-CCEEEEEEeecC--chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 45677788999999999999876 688999998643 223345677999999999999999999998743 47999
Q ss_pred EeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhcc-------CCceeecccccCceeecCCCCceEe
Q 003278 589 YDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEW-------NEQVIHRNITSSAITLDPDMNPRLG 661 (834)
Q Consensus 589 ~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~-------~~~iiHrDlK~~NILld~~~~~ki~ 661 (834)
|||+++|+|.+++... .++|..+..|+.|++.||+|||+.. .++|+||||||+|||++.++.+||+
T Consensus 101 ~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 101 TAFHEKGSLSDFLKAN-------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EECCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred EecCCCCCHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence 9999999999999653 3889999999999999999999620 1299999999999999999999999
Q ss_pred eeeeccccccCCCCCcccccCccccccccCccchhcccc-----CCCCccCcchhhHHHHHHHHhCCCccCCCCCchhH-
Q 003278 662 SFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIES-----GEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLL- 735 (834)
Q Consensus 662 DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-----~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~- 735 (834)
|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|||+||+.||.........
T Consensus 174 DFg~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~ 248 (322)
T 3soc_A 174 DFGLALKFEAGKS-----AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248 (322)
T ss_dssp CCTTCEEECTTSC-----CCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCT
T ss_pred cCCcccccccccC-----ccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccc
Confidence 9999987643321 111234679999999999976 35677899999999999999999998643321110
Q ss_pred ----------HHHHHHHHhhcCccccccccccCCCC-CHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCC
Q 003278 736 ----------VKRVHEFEARKRPLAELVDLSLNGEY-NHKELMRLIKLGIACTLSNPELRPSMRQILSILDGND 798 (834)
Q Consensus 736 ----------~~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~ 798 (834)
.......... .. ..+.+.... .......+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~-~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 249 FEEEIGQHPSLEDMQEVVVH-KK----KRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp THHHHCSSCCHHHHHHHHTT-SC----CCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhhhhccCCchhhhhhhhhc-cc----CCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0111111000 00 011111110 1123445777788999999999999999999997654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=369.70 Aligned_cols=250 Identities=26% Similarity=0.314 Sum_probs=202.4
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc---ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK---GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLV 186 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 186 (834)
.++|+..+.||+|+||.||+|+.+.+|+.||||++.+. .....+.+.+|+.+|.+++||||+++++++...+.+++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 35788999999999999999999989999999998653 223456788999999999999999999999999999999
Q ss_pred EEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchh
Q 003278 187 YDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLAR 266 (834)
Q Consensus 187 ~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~ 266 (834)
|||+++|+|..++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 84 ~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~ 153 (337)
T 1o6l_A 84 MEYANGGELFFHLSRE-------RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK 153 (337)
T ss_dssp EECCTTCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EeCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchh
Confidence 9999999999998643 3588999999999999999999996 99999999999999999999999999997
Q ss_pred hhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchH
Q 003278 267 WLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIIL 346 (834)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l 346 (834)
..... .......+||+.|+|||.+... .++.++|||||||++|||+||+.||.... ...+
T Consensus 154 ~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~ 213 (337)
T 1o6l_A 154 EGISD----------------GATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HERL 213 (337)
T ss_dssp CSCCT----------------TCCBCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHH
T ss_pred hcccC----------------CCcccccccChhhCChhhhcCC-CCCchhhcccchhHHHHHhcCCCCCCCCC---HHHH
Confidence 42111 0113456899999999998654 67999999999999999999999986421 1111
Q ss_pred HHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----chhhHHHH
Q 003278 347 LDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRP-----SMKWVIEA 404 (834)
Q Consensus 347 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~~V~~~ 404 (834)
....... .. ++. ...+ ..+.+++..||+.||.+|| ++.++++.
T Consensus 214 ---~~~i~~~-~~------~~p-~~~s----~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 214 ---FELILME-EI------RFP-RTLS----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ---HHHHHHC-CC------CCC-TTSC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ---HHHHHcC-CC------CCC-CCCC----HHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 1111111 11 111 1111 3578899999999999999 78888764
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=371.78 Aligned_cols=260 Identities=28% Similarity=0.420 Sum_probs=204.2
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCC---eEEEEEEeccc-ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDG---TVVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLL 185 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g---~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 185 (834)
.++|+..+.||+|+||.||+|.+..+| ..||||++... .....+.|.+|+.++++++||||++++++|.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 345777899999999999999997544 46999998754 34456789999999999999999999999999999999
Q ss_pred EEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccch
Q 003278 186 VYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLA 265 (834)
Q Consensus 186 V~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla 265 (834)
||||+++|+|.+++... ...+++..+..|+.|++.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 128 v~e~~~~~~L~~~l~~~------~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 198 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTH------DGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLS 198 (325)
T ss_dssp EEECCTTCBHHHHHHTT------TTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSC
T ss_pred EeeCCCCCcHHHHHHhc------ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcc
Confidence 99999999999999643 24689999999999999999999996 9999999999999999999999999999
Q ss_pred hhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccc
Q 003278 266 RWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQI 344 (834)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~ 344 (834)
+.+...... ........||+.|+|||.+... .++.++|||||||++|||+| |+.||..... .
T Consensus 199 ~~~~~~~~~-------------~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~---~ 261 (325)
T 3kul_A 199 RVLEDDPDA-------------AYTTTGGKIPIRWTAPEAIAFR-TFSSASDVWSFGVVMWEVLAYGERPYWNMTN---R 261 (325)
T ss_dssp EECC----C-------------CEECC---CCGGGSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTSCH---H
T ss_pred cccccCccc-------------eeeccCCCCcccccCHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCcccCCH---H
Confidence 865432110 0112334578899999998654 67999999999999999999 9999854321 1
Q ss_pred hHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcCC
Q 003278 345 ILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGSY 409 (834)
Q Consensus 345 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~~ 409 (834)
.+ .... ..+.... .. .. ....+.+|+..||+.||.+||++.+|++.|+...
T Consensus 262 ~~---~~~~-~~~~~~~-----~~-~~----~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~ 312 (325)
T 3kul_A 262 DV---ISSV-EEGYRLP-----AP-MG----CPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312 (325)
T ss_dssp HH---HHHH-HTTCCCC-----CC-TT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH---HHHH-HcCCCCC-----CC-CC----cCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11 1111 1111110 00 11 1246889999999999999999999999998753
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=377.16 Aligned_cols=251 Identities=26% Similarity=0.370 Sum_probs=203.0
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 187 (834)
++|...+.||+|+||.||+|....+|+.||||++.... ....+.+.+|+.+|.+++|||||+++++|.+.+..|+||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 56889999999999999999999999999999986432 233467889999999999999999999999999999999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
||+++|+|..++... ..+++..+..|+.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 95 e~~~gg~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~ 164 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQN-------VHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAM 164 (384)
T ss_dssp CCCTTEEHHHHHHTT-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred ecCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeee
Confidence 999999999998643 4589999999999999999999996 999999999999999999999999999975
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCcccccc--CCCCCcccceeehhhHHHHHHhCCccCCCCCCCccch
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQK--GSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQII 345 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~ 345 (834)
+... ...+..+||+.|+|||.+.. +..++.++|||||||++|||+||+.||..........
T Consensus 165 ~~~~-----------------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~ 227 (384)
T 4fr4_A 165 LPRE-----------------TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKE 227 (384)
T ss_dssp CCTT-----------------CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHH
T ss_pred ccCC-----------------CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHH
Confidence 4321 11355679999999999864 3357889999999999999999999997544333222
Q ss_pred HHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCc-hhhHHH
Q 003278 346 LLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPS-MKWVIE 403 (834)
Q Consensus 346 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-m~~V~~ 403 (834)
+...+. . ... ... ..+ ...+..|+..||+.||.+||+ +.+|.+
T Consensus 228 ~~~~~~---~-~~~------~~p-~~~----s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 228 IVHTFE---T-TVV------TYP-SAW----SQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HHHHHH---H-CCC------CCC-TTS----CHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred HHHHHh---h-ccc------CCC-CcC----CHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 222111 1 110 000 111 146788999999999999998 666654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=382.12 Aligned_cols=260 Identities=24% Similarity=0.372 Sum_probs=207.1
Q ss_pred hhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC-hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEE
Q 003278 108 IGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG-ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLV 186 (834)
Q Consensus 108 ~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 186 (834)
...++|...+.||+|+||.||+|.+..+++.||||.+.... ....+.|.+|+.+|++++|||||+++|+|...+..++|
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 44567888999999999999999998899999999987542 33456789999999999999999999999999999999
Q ss_pred EEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchh
Q 003278 187 YDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLAR 266 (834)
Q Consensus 187 ~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~ 266 (834)
|||+++|+|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 191 ~e~~~~g~L~~~l~~~------~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~ 261 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTE------GARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSR 261 (377)
T ss_dssp EECCTTCBHHHHHHHH------GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEcCCCCCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCce
Confidence 9999999999999643 23588999999999999999999996 99999999999999999999999999997
Q ss_pred hhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccch
Q 003278 267 WLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQII 345 (834)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~ 345 (834)
....... ........+|+.|+|||.+..+ .++.++|||||||++|||+| |+.|+..... ..
T Consensus 262 ~~~~~~~--------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~t~g~~p~~~~~~---~~ 323 (377)
T 3cbl_A 262 EEADGVY--------------AASGGLRQVPVKWTAPEALNYG-RYSSESDVWSFGILLWETFSLGASPYPNLSN---QQ 323 (377)
T ss_dssp ECTTSEE--------------ECCSSCCEEEGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH---HH
T ss_pred ecCCCce--------------eecCCCCCCCcCcCCHhHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HH
Confidence 5322100 0011223468899999998755 57999999999999999999 9988864321 11
Q ss_pred HHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 346 LLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 346 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
. ......+...... ... ...+.+|+..||+.||.+||++.+|++.|+..
T Consensus 324 ~----~~~~~~~~~~~~~------~~~----~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 324 T----REFVEKGGRLPCP------ELC----PDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp H----HHHHHTTCCCCCC------TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H----HHHHHcCCCCCCC------CCC----CHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 1 1222222211110 111 24678899999999999999999999998753
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=372.33 Aligned_cols=256 Identities=24% Similarity=0.381 Sum_probs=196.8
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeE----EEEEEeccc-ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTV----VAVKCLAEK-GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLL 185 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~----vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 185 (834)
++|+..+.||+|+||.||+|++..+|+. ||+|.+... .....+.|.+|+.++++++|||||+++++|...+ .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 5688899999999999999998777765 577877543 2345678999999999999999999999998765 789
Q ss_pred EEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccch
Q 003278 186 VYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLA 265 (834)
Q Consensus 186 V~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla 265 (834)
|+||+++|+|.+++.... ..+++..++.|+.|++.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 94 v~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a 164 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHK------DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp EEECCTTCBHHHHHHHST------TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHH
T ss_pred EEEecCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcce
Confidence 999999999999997642 4689999999999999999999996 9999999999999999999999999999
Q ss_pred hhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccc
Q 003278 266 RWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQI 344 (834)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~ 344 (834)
+.+..... ........||+.|+|||.+... .++.++|||||||++|||+| |+.||+.....
T Consensus 165 ~~~~~~~~--------------~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--- 226 (327)
T 3poz_A 165 KLLGAEEK--------------EYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--- 226 (327)
T ss_dssp HHHTTTCC---------------------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---
T ss_pred eEccCCcc--------------cccccCCCccccccChHHhccC-CCCchhhhhhhHHHHHHHHhcCCCCccCCCHH---
Confidence 86533210 0112334578999999998755 67999999999999999999 99998754322
Q ss_pred hHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 345 ILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 345 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
.+... ...+..... .......+..++..||+.||.+||+|.+|++.|+..
T Consensus 227 ~~~~~----~~~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 227 EISSI----LEKGERLPQ----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp GHHHH----HHTTCCCCC----------CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred HHHHH----HHcCCCCCC----------CccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 12111 111111110 011124688899999999999999999999998764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=376.90 Aligned_cols=272 Identities=21% Similarity=0.278 Sum_probs=211.3
Q ss_pred cHHHHHHHhhCcCcCCcccccCCcEEEEEEE------CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhc-cCCCceeEE
Q 003278 504 SFKEIISATNNFSESQRVAEMDFGTAYQGFL------DNHQYVLVKRLGMSKCPALRTRFSNELQNLARL-RHRNLVQLC 576 (834)
Q Consensus 504 ~~~el~~at~~f~~~~~ig~g~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l-~HpNiv~l~ 576 (834)
...+.....++|...+.||+|+||.||+|.. .++..||||++.........+.|.+|++++.++ +|||||+++
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 3344444567888889999999999999974 335789999998766656667899999999999 899999999
Q ss_pred EEEeeCC-eEEEEEeccCCCchhhhhhcCCCCC-----------------------------------------------
Q 003278 577 GWCTEQG-EMLVIYDYSATRILSHLLFHNNHRI----------------------------------------------- 608 (834)
Q Consensus 577 g~~~~~~-~~~lv~Ey~~~g~L~~~l~~~~~~~----------------------------------------------- 608 (834)
++|.+.+ ..++||||+++|+|.+++.......
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 9998755 4899999999999999997653210
Q ss_pred -------------CCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCCCC
Q 003278 609 -------------GHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHG 675 (834)
Q Consensus 609 -------------~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~~~ 675 (834)
....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+......
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 249 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence 01128899999999999999999997 68999999999999999999999999999865432211
Q ss_pred CcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCccccccc
Q 003278 676 HRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRPLAELVD 754 (834)
Q Consensus 676 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 754 (834)
.......||+.|||||++.+..++.++|||||||++|||+| |+.||........+...+.. ....
T Consensus 250 -----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~---~~~~------ 315 (359)
T 3vhe_A 250 -----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE---GTRM------ 315 (359)
T ss_dssp -----EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHH---TCCC------
T ss_pred -----hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHc---CCCC------
Confidence 11234578999999999999999999999999999999999 99998755443333222221 1110
Q ss_pred cccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccC
Q 003278 755 LSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGN 797 (834)
Q Consensus 755 ~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~ 797 (834)
...... .. .+.+++.+||+.||++|||+.+|++.|+.+
T Consensus 316 -~~~~~~-~~---~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 316 -RAPDYT-TP---EMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp -CCCTTC-CH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCCCC-CH---HHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 011112 22 355566799999999999999999999764
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=384.51 Aligned_cols=268 Identities=20% Similarity=0.248 Sum_probs=209.4
Q ss_pred cccHHHHHhhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHHHHHhCCCCceeeEeee
Q 003278 100 IFSYAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVAVAHLRHRNLVRLRGW 176 (834)
Q Consensus 100 ~f~~~el~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~ 176 (834)
.+.+.++...+++|+..++||+|+||+||+|+++.+++.||||++.+.. ....+.+.+|+.++..++|||||+++++
T Consensus 63 ~~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~ 142 (437)
T 4aw2_A 63 TSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYA 142 (437)
T ss_dssp HHHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred cchhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 3567788888999999999999999999999999899999999986531 1122348899999999999999999999
Q ss_pred EEeCCEEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCc
Q 003278 177 CVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYN 256 (834)
Q Consensus 177 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~ 256 (834)
|.+.+.+|||||||++|+|.++|... ...+++..+..++.|++.||.|||+. +||||||||+||||+.++.
T Consensus 143 ~~~~~~~~lV~Ey~~gg~L~~~l~~~------~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~ 213 (437)
T 4aw2_A 143 FQDDNNLYLVMDYYVGGDLLTLLSKF------EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGH 213 (437)
T ss_dssp EECSSEEEEEECCCTTCBHHHHHHTT------TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSC
T ss_pred EeeCCEEEEEEecCCCCcHHHHHHHc------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCC
Confidence 99999999999999999999999753 24689999999999999999999996 9999999999999999999
Q ss_pred eEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCcccccc----CCCCCcccceeehhhHHHHHHhCC
Q 003278 257 ARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQK----GSVATAKSDVFSFGIVVLEVVSGR 332 (834)
Q Consensus 257 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~----~~~~~~ksDV~SfGvvl~ElltG~ 332 (834)
+||+|||+|+.+.... ....+..+||+.|+|||++.. ...++.++|||||||++|||+||+
T Consensus 214 vkL~DFGla~~~~~~~---------------~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~ 278 (437)
T 4aw2_A 214 IRLADFGSCLKLMEDG---------------TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278 (437)
T ss_dssp EEECCCTTCEECCTTS---------------CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSS
T ss_pred EEEcchhhhhhcccCC---------------CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCC
Confidence 9999999997543211 011344679999999999862 345789999999999999999999
Q ss_pred ccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCC--CCchhhHHHH
Q 003278 333 RAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHL--RPSMKWVIEA 404 (834)
Q Consensus 333 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPsm~~V~~~ 404 (834)
.||..... .... ..+......... +... ...+ ..+.+|+..||..+|++ ||++.++++.
T Consensus 279 ~Pf~~~~~---~~~~---~~i~~~~~~~~~--p~~~-~~~s----~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 279 TPFYAESL---VETY---GKIMNHKERFQF--PTQV-TDVS----ENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp CTTCCSSH---HHHH---HHHHTHHHHCCC--CSSC-CCSC----HHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred CCCCCCCh---hHHH---HhhhhccccccC--Cccc-ccCC----HHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 99964321 1111 111110000000 0000 0111 35677888888777777 9999999864
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=369.83 Aligned_cols=252 Identities=21% Similarity=0.293 Sum_probs=201.8
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccCh------hhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGE------RFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQL 183 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 183 (834)
.+.|+..+.||+|+||.||+|....+|+.||||++..... ...+.+.+|+.+|.+++|||||++++++.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 3568889999999999999999999999999999865432 1357799999999999999999999999999999
Q ss_pred EEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCC----ceEE
Q 003278 184 LLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQY----NARL 259 (834)
Q Consensus 184 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~----~~kl 259 (834)
++||||+++|+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++ .+||
T Consensus 91 ~lv~e~~~gg~L~~~l~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl 160 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQK-------ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKL 160 (361)
T ss_dssp EEEEECCCSCBHHHHHTTC-------SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEE
T ss_pred EEEEEcCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEE
Confidence 9999999999999998542 4689999999999999999999996 999999999999998776 7999
Q ss_pred eeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCC
Q 003278 260 GDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTY 339 (834)
Q Consensus 260 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~ 339 (834)
+|||+++.+... .......||+.|+|||.+... .++.++|||||||++|||++|+.||....
T Consensus 161 ~DFG~a~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~~ll~g~~Pf~~~~ 222 (361)
T 2yab_A 161 IDFGLAHEIEDG-----------------VEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDT 222 (361)
T ss_dssp CCCSSCEECCTT-----------------CCCCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred EecCCceEcCCC-----------------CccccCCCCccEECchHHcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999754321 012445799999999988654 67999999999999999999999996432
Q ss_pred CCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 340 PDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 340 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
...+. ..+.. +... .++... ... ...+.+++..||..||.+||++.++++
T Consensus 223 ---~~~~~---~~i~~-~~~~--~~~~~~-~~~----s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 223 ---KQETL---ANITA-VSYD--FDEEFF-SQT----SELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp ---HHHHH---HHHHT-TCCC--CCHHHH-TTS----CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---HHHHH---HHHHh-cCCC--CCchhc-cCC----CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11111 11111 1100 000000 011 135778999999999999999999886
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=364.10 Aligned_cols=253 Identities=19% Similarity=0.271 Sum_probs=203.4
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEc
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDY 189 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 189 (834)
.++|...+.||+|+||.||+|....+|..||+|.+.... .....+.+|+.++..++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 367888999999999999999999999999999987543 3456788999999999999999999999999999999999
Q ss_pred cCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECC--CCceEEeeccchhh
Q 003278 190 MPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDS--QYNARLGDFGLARW 267 (834)
Q Consensus 190 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~--~~~~kl~DFGla~~ 267 (834)
+++|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++.
T Consensus 83 ~~g~~L~~~l~~~------~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~ 153 (321)
T 1tki_A 83 ISGLDIFERINTS------AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153 (321)
T ss_dssp CCCCBHHHHHTSS------SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred CCCCCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeE
Confidence 9999999998643 24689999999999999999999996 9999999999999987 78999999999975
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHH
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILL 347 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~ 347 (834)
+... .......||+.|+|||.+... .++.++|||||||++|||+||+.||..... .
T Consensus 154 ~~~~-----------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~--- 209 (321)
T 1tki_A 154 LKPG-----------------DNFRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETN---Q--- 209 (321)
T ss_dssp CCTT-----------------CEEEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSH---H---
T ss_pred CCCC-----------------CccccccCChhhcCcHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcCCCH---H---
Confidence 4321 113456799999999988654 578999999999999999999999864321 1
Q ss_pred HHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 348 DWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 348 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
......... .... ..... ... ...+.+++..||+.||.+||++.|+++.
T Consensus 210 ~~~~~i~~~-~~~~-~~~~~--~~~----s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 210 QIIENIMNA-EYTF-DEEAF--KEI----SIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHHHHHHT-CCCC-CHHHH--TTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHcC-CCCC-Chhhh--ccC----CHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111221111 1100 00000 011 1357889999999999999999999874
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=377.63 Aligned_cols=252 Identities=24% Similarity=0.333 Sum_probs=197.8
Q ss_pred hcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHHHHHhC-CCCceeeEeeeEEeCCEEE
Q 003278 109 GSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVAVAHL-RHRNLVRLRGWCVHEDQLL 184 (834)
Q Consensus 109 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~ 184 (834)
..++|+..++||+|+||+||+|+.+.+++.||||++.+.. ....+.+.+|..++.++ +|||||+++++|.+.+.++
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 3467999999999999999999999999999999987542 22234578899999876 8999999999999999999
Q ss_pred EEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccc
Q 003278 185 LVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGL 264 (834)
Q Consensus 185 lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGl 264 (834)
|||||+++|+|..++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 130 lV~E~~~gg~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGl 199 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQ-------RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGM 199 (396)
T ss_dssp EEEECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEcCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecce
Confidence 999999999999998653 3589999999999999999999996 999999999999999999999999999
Q ss_pred hhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCcc-
Q 003278 265 ARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQ- 343 (834)
Q Consensus 265 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~- 343 (834)
++..... .......+||+.|+|||++... .++.++|||||||++|||+||+.||......+.
T Consensus 200 a~~~~~~----------------~~~~~~~~gt~~Y~aPE~l~~~-~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~ 262 (396)
T 4dc2_A 200 CKEGLRP----------------GDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP 262 (396)
T ss_dssp CBCCCCT----------------TCCBCCCCBCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSTTTTC----
T ss_pred eeecccC----------------CCccccccCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccccccc
Confidence 9742111 0124567899999999998654 679999999999999999999999964322211
Q ss_pred -chHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCch
Q 003278 344 -IILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSM 398 (834)
Q Consensus 344 -~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm 398 (834)
.....++......+.. .+. ...+ ..+.+|+..||+.||.+||+.
T Consensus 263 ~~~~~~~~~~~i~~~~~------~~p-~~~s----~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 263 DQNTEDYLFQVILEKQI------RIP-RSLS----VKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp --CCHHHHHHHHHHCCC------CCC-TTSC----HHHHHHHHHHTCSCTTTSTTC
T ss_pred chhhHHHHHHHHhcccc------CCC-CcCC----HHHHHHHHHHhcCCHhHcCCC
Confidence 1111122221111111 111 1111 357789999999999999996
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=362.65 Aligned_cols=271 Identities=21% Similarity=0.253 Sum_probs=209.5
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC-hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCC--EEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG-ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHED--QLLLVY 187 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~--~~~lV~ 187 (834)
++|...++||+|+||.||+|.+..+|+.||||++.... ....+.+.+|+.++++++||||+++++++...+ ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 46888899999999999999999899999999987532 334567889999999999999999999998765 789999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEE----CCCCceEEeecc
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVML----DSQYNARLGDFG 263 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILl----d~~~~~kl~DFG 263 (834)
||+++|+|.+++..... ...+++..+..|+.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||
T Consensus 89 e~~~~~~L~~~l~~~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg 161 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSN----AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (319)
T ss_dssp ECCTTCBHHHHHHSGGG----TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred eCCCCCCHHHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCC
Confidence 99999999999975422 23489999999999999999999996 99999999999999 788889999999
Q ss_pred chhhhhhhhhhhhhcccccccccccccceeeeccccCCCcccccc-------CCCCCcccceeehhhHHHHHHhCCccCC
Q 003278 264 LARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQK-------GSVATAKSDVFSFGIVVLEVVSGRRAVD 336 (834)
Q Consensus 264 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-------~~~~~~ksDV~SfGvvl~ElltG~~p~~ 336 (834)
+++.+.... ......||+.|+|||.+.. +..++.++|||||||++|||+||+.||.
T Consensus 162 ~a~~~~~~~-----------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 224 (319)
T 4euu_A 162 AARELEDDE-----------------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFR 224 (319)
T ss_dssp TCEECCTTC-----------------CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEE
T ss_pred CceecCCCC-----------------ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 997543211 1234569999999998752 3467899999999999999999999996
Q ss_pred CCCCCccchHHHHHHHHhhcC---cccccc---------cccc-CCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 337 LTYPDDQIILLDWIRRLSDEG---KVLQAG---------DNRL-SDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 337 ~~~~~~~~~l~~~~~~~~~~~---~~~~~~---------d~~l-~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
........ ...+..+.... ...... +..+ ............+..+...||+.||++||++.|+++
T Consensus 225 ~~~~~~~~--~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~ 302 (319)
T 4euu_A 225 PFEGPRRN--KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (319)
T ss_dssp CTTCGGGC--HHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred CCCccchh--HHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhh
Confidence 43322211 11122221110 000000 0011 011233444567889999999999999999999999
Q ss_pred Hhhc
Q 003278 404 AVSG 407 (834)
Q Consensus 404 ~l~~ 407 (834)
..+.
T Consensus 303 h~~d 306 (319)
T 4euu_A 303 ETSD 306 (319)
T ss_dssp HHHH
T ss_pred ccHH
Confidence 8764
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=362.40 Aligned_cols=251 Identities=24% Similarity=0.321 Sum_probs=194.7
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccCh--------------------------hhHHHHHHHHHHHH
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGE--------------------------RFEKTFAAELVAVA 163 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~--------------------------~~~~~~~~E~~~l~ 163 (834)
.++|...+.||+|+||.||+|+...+|+.||||++..... ...+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 4679999999999999999999999999999999864321 11356889999999
Q ss_pred hCCCCceeeEeeeEEe--CCEEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeec
Q 003278 164 HLRHRNLVRLRGWCVH--EDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIH 241 (834)
Q Consensus 164 ~l~H~nIv~l~g~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH 241 (834)
+++||||+++++++.+ .+..++||||+++|+|.+++. ..++++..+..++.|+++||+|||+. +|+|
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--------~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH 160 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--------LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIH 160 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--------SSCCCHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--------cCCCCHHHHHHHHHHHHHHHHHHHHC---Ceec
Confidence 9999999999999987 568999999999999977542 24689999999999999999999996 9999
Q ss_pred CCCCCCceEECCCCceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCC--CCccccee
Q 003278 242 RDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSV--ATAKSDVF 319 (834)
Q Consensus 242 rDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~--~~~ksDV~ 319 (834)
|||||+|||++.++.+||+|||+++.+.... .......||+.|+|||.+..... .+.++|||
T Consensus 161 ~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~ 224 (298)
T 2zv2_A 161 RDIKPSNLLVGEDGHIKIADFGVSNEFKGSD----------------ALLSNTVGTPAFMAPESLSETRKIFSGKALDVW 224 (298)
T ss_dssp CCCCGGGEEECTTSCEEECCCTTCEECSSSS----------------CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHH
T ss_pred cCCCHHHEEECCCCCEEEecCCCcccccccc----------------ccccCCcCCccccChhhhccCCCCCCCchhhhH
Confidence 9999999999999999999999997542210 01234569999999998865432 37789999
Q ss_pred ehhhHHHHHHhCCccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchh
Q 003278 320 SFGIVVLEVVSGRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMK 399 (834)
Q Consensus 320 SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~ 399 (834)
||||++|||+||+.||.... ...+...... .... ..+. ...+ ..+.+++..||+.||.+||++.
T Consensus 225 slG~~l~~l~~g~~pf~~~~------~~~~~~~~~~-~~~~-~~~~----~~~~----~~l~~li~~~l~~dp~~R~s~~ 288 (298)
T 2zv2_A 225 AMGVTLYCFVFGQCPFMDER------IMCLHSKIKS-QALE-FPDQ----PDIA----EDLKDLITRMLDKNPESRIVVP 288 (298)
T ss_dssp HHHHHHHHHHHSSCSSCCSS------HHHHHHHHHH-CCCC-CCSS----SCCC----HHHHHHHHHHTCSCTTTSCCHH
T ss_pred hHHHHHHHHHHCCCCCCCcc------HHHHHHHHhc-ccCC-CCCc----cccC----HHHHHHHHHHhhcChhhCCCHH
Confidence 99999999999999986421 1112222211 1111 0000 1111 4578899999999999999999
Q ss_pred hHHH
Q 003278 400 WVIE 403 (834)
Q Consensus 400 ~V~~ 403 (834)
++++
T Consensus 289 e~l~ 292 (298)
T 2zv2_A 289 EIKL 292 (298)
T ss_dssp HHTT
T ss_pred HHhc
Confidence 9875
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=366.89 Aligned_cols=253 Identities=19% Similarity=0.272 Sum_probs=196.9
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
++|...+.||+|+||.||+|... +++.||||.+.........+.+.+|+.++++++|||||++++++.+.+..++||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 56777889999999999999965 68899999987655444456789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccccc
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTR 671 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~ 671 (834)
+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+..
T Consensus 87 ~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 157 (323)
T 3tki_A 87 CSGGELFDRIEPDI------GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (323)
T ss_dssp CTTEEGGGGSBTTT------BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred CCCCcHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceecc
Confidence 99999999885432 38899999999999999999997 6999999999999999999999999999976533
Q ss_pred CCCCCcccccCccccccccCccchhccccCCC-CccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCccc
Q 003278 672 NDHGHRKATSGNRSVRGIFGYMSPEYIESGEA-TSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLA 750 (834)
Q Consensus 672 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (834)
... ........||+.|+|||++.+..+ +.++|||||||++|||+||+.||........... ..........
T Consensus 158 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~---~~~~~~~~~~ 229 (323)
T 3tki_A 158 NNR-----ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---DWKEKKTYLN 229 (323)
T ss_dssp TTE-----ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHH---HHHTTCTTST
T ss_pred CCc-----ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHH---HHhcccccCC
Confidence 211 111234689999999999987776 7789999999999999999999975433222111 1111111100
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 751 ELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 751 ~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
+ ....+ . .+.+++.+||+.||++|||+.||++
T Consensus 230 ----~--~~~~~-~---~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 230 ----P--WKKID-S---APLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp ----T--GGGSC-H---HHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----c--cccCC-H---HHHHHHHHHccCChhhCcCHHHHhh
Confidence 0 00111 2 3445666999999999999999985
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=372.38 Aligned_cols=245 Identities=24% Similarity=0.335 Sum_probs=194.4
Q ss_pred hcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc---ChhhHHHHHHHHHHHHhC-CCCceeeEeeeEEeCCEEE
Q 003278 109 GSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK---GERFEKTFAAELVAVAHL-RHRNLVRLRGWCVHEDQLL 184 (834)
Q Consensus 109 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~ 184 (834)
..++|+..+.||+|+||.||+|+.+.+|+.||||++... .....+.+.+|..++..+ +|||||++++++.+.+.+|
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 346899999999999999999999999999999998653 223456688899999988 7999999999999999999
Q ss_pred EEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccc
Q 003278 185 LVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGL 264 (834)
Q Consensus 185 lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGl 264 (834)
+||||+++|+|..++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 101 lv~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~ 170 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKS-------RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGM 170 (353)
T ss_dssp EEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccc
Confidence 999999999999998653 3589999999999999999999996 999999999999999999999999999
Q ss_pred hhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccc
Q 003278 265 ARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQI 344 (834)
Q Consensus 265 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~ 344 (834)
++..... .......+||+.|+|||.+... .++.++|||||||++|||+||+.||..... .
T Consensus 171 a~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~---~ 230 (353)
T 3txo_A 171 CKEGICN----------------GVTTATFCGTPDYIAPEILQEM-LYGPAVDWWAMGVLLYEMLCGHAPFEAENE---D 230 (353)
T ss_dssp CBCSCC-------------------------CCGGGCCHHHHHHH-HCTTHHHHHHHHHHHHHHHHSSCSSCCSSH---H
T ss_pred eeecccC----------------CccccccCCCcCeEChhhcCCC-CcCCccCCCcchHHHHHHHhCCCCCCCCCH---H
Confidence 9742211 0113456799999999988654 578999999999999999999999964321 1
Q ss_pred hHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCch
Q 003278 345 ILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSM 398 (834)
Q Consensus 345 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm 398 (834)
.+ ...+.. +... .. ... ...+..++..||+.||.+||++
T Consensus 231 ~~---~~~i~~-~~~~------~p-~~~----~~~~~~li~~lL~~dP~~R~~~ 269 (353)
T 3txo_A 231 DL---FEAILN-DEVV------YP-TWL----HEDATGILKSFMTKNPTMRLGS 269 (353)
T ss_dssp HH---HHHHHH-CCCC------CC-TTS----CHHHHHHHHHHTCSSGGGSTTS
T ss_pred HH---HHHHHc-CCCC------CC-CCC----CHHHHHHHHHHhhhCHHHccCC
Confidence 11 122221 1110 00 111 1357789999999999999998
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=365.63 Aligned_cols=247 Identities=20% Similarity=0.305 Sum_probs=200.0
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCC-ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEe
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSK-CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYD 590 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~-~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~E 590 (834)
++|...+.||+|+||.||+|.. .+++.||||++.... .+...+++.+|+++|++++|||||++++++...+..++|||
T Consensus 15 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 94 (328)
T 3fe3_A 15 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIME 94 (328)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEE
Confidence 5677888999999999999996 678999999986543 34456778999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccc
Q 003278 591 YSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLT 670 (834)
Q Consensus 591 y~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~ 670 (834)
|+++|+|.+++...+ .+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 95 ~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 95 YASGGEVFDYLVAHG------RMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp CCTTCBHHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred CCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 999999999986543 37888899999999999999997 699999999999999999999999999997653
Q ss_pred cCCCCCcccccCccccccccCccchhccccCCCC-ccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcc
Q 003278 671 RNDHGHRKATSGNRSVRGIFGYMSPEYIESGEAT-SMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPL 749 (834)
Q Consensus 671 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
... .....+||+.|+|||++.+..++ .++|||||||++|||+||+.||....... +...+. .....
T Consensus 166 ~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~---~~~~~- 232 (328)
T 3fe3_A 166 VGG--------KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE-LRERVL---RGKYR- 232 (328)
T ss_dssp SSC--------GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHH---HCCCC-
T ss_pred CCC--------ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH-HHHHHH---hCCCC-
Confidence 321 12346899999999999888875 78999999999999999999997543322 111111 11111
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 750 AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 750 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
++... ..+ +..++.+||..||++|||+.|+++
T Consensus 233 -------~p~~~-s~~---~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 233 -------IPFYM-STD---CENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp -------CCTTS-CHH---HHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred -------CCCCC-CHH---HHHHHHHHCCCChhHCcCHHHHhc
Confidence 11111 233 445556899999999999999986
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=362.09 Aligned_cols=267 Identities=23% Similarity=0.330 Sum_probs=198.9
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHh--CCCCceeeEeeeEEeC----CEE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAH--LRHRNLVRLRGWCVHE----DQL 183 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~g~~~~~----~~~ 183 (834)
.++|+..+.||+|+||.||+|.+ +|+.||||++... ..+.+..|.+++.. ++||||+++++++... +..
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 45788999999999999999998 6899999998654 23456667776665 8999999999997653 458
Q ss_pred EEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhcc-----CCCeecCCCCCCceEECCCCceE
Q 003278 184 LLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQL-----ETQIIHRDVKTSNVMLDSQYNAR 258 (834)
Q Consensus 184 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~iiHrDlKp~NILld~~~~~k 258 (834)
++||||+++|+|.+++.. ..+++..+..|+.|++.||+|||... ..+|+||||||+|||++.++.+|
T Consensus 82 ~lv~e~~~~g~L~~~l~~--------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~k 153 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQL--------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCC 153 (301)
T ss_dssp EEEECCCTTCBHHHHHTT--------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEE
T ss_pred EEehhhccCCCHHHHHhh--------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEE
Confidence 999999999999999943 35899999999999999999999211 25999999999999999999999
Q ss_pred EeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCC-----CCCcccceeehhhHHHHHHhC--
Q 003278 259 LGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGS-----VATAKSDVFSFGIVVLEVVSG-- 331 (834)
Q Consensus 259 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-----~~~~ksDV~SfGvvl~ElltG-- 331 (834)
|+|||+++........ .........||+.|+|||.+.... .++.++|||||||++|||+||
T Consensus 154 l~Dfg~a~~~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~ 221 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQ------------LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMV 221 (301)
T ss_dssp ECCCTTCEEEETTTTE------------EECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBC
T ss_pred EeeCCCeeeccccccc------------ccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhc
Confidence 9999999764322110 001123346999999999986542 234689999999999999999
Q ss_pred --------CccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 332 --------RRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 332 --------~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
+.||......... ............. .+.+............+.+++..||+.||.+||++.+|++
T Consensus 222 ~~~~~~~~~~pf~~~~~~~~~-~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 222 SNGIVEDYKPPFYDVVPNDPS-FEDMRKVVCVDQQ-----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp BTTBCCCCCCTTTTTSCSSCC-HHHHHHHHTTSCC-----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CccccccccccccccCCCCcc-hhhhhHHHhccCC-----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 7777543333221 1111111111111 1111111112234567899999999999999999999999
Q ss_pred Hhhc
Q 003278 404 AVSG 407 (834)
Q Consensus 404 ~l~~ 407 (834)
.|+.
T Consensus 296 ~L~~ 299 (301)
T 3q4u_A 296 TLTK 299 (301)
T ss_dssp HHHH
T ss_pred HHhc
Confidence 9874
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=360.47 Aligned_cols=254 Identities=25% Similarity=0.389 Sum_probs=204.0
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCC-------eEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDG-------TVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQ 182 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g-------~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~ 182 (834)
.++|...+.||+|+||.||+|.+..++ ..||+|.+........+.|.+|+.++++++||||++++++|...+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 356888899999999999999987666 5799999977666677889999999999999999999999999999
Q ss_pred EEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCc------
Q 003278 183 LLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYN------ 256 (834)
Q Consensus 183 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~------ 256 (834)
.++||||+++|+|.+++.... ..+++..+..|+.|++.||.|||+. +|+||||||+|||++.++.
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~ 157 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNK------NCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNP 157 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTG------GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBC
T ss_pred CEEEEECCCCCCHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCccccccc
Confidence 999999999999999997542 3488999999999999999999996 9999999999999998887
Q ss_pred --eEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCcc
Q 003278 257 --ARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRA 334 (834)
Q Consensus 257 --~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p 334 (834)
+||+|||+++..... ....||+.|+|||.+.....++.++|||||||++|||+||..|
T Consensus 158 ~~~kl~Dfg~~~~~~~~--------------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~ 217 (289)
T 4fvq_A 158 PFIKLSDPGISITVLPK--------------------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217 (289)
T ss_dssp CEEEECCCCSCTTTSCH--------------------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ceeeeccCcccccccCc--------------------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCC
Confidence 999999998754221 2234899999999987645689999999999999999997655
Q ss_pred CCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcCCC
Q 003278 335 VDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGSYS 410 (834)
Q Consensus 335 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~~~ 410 (834)
+...... .... .......... ... ...+.+++..||+.||.+||++.++++.|+..+.
T Consensus 218 ~~~~~~~--~~~~---~~~~~~~~~~----~~~---------~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 218 PLSALDS--QRKL---QFYEDRHQLP----APK---------AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp TTTTSCH--HHHH---HHHHTTCCCC----CCS---------SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred Cccccch--HHHH---HHhhccCCCC----CCC---------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 4322111 1111 1111111111 011 1246789999999999999999999999998653
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=370.39 Aligned_cols=248 Identities=22% Similarity=0.345 Sum_probs=200.0
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 187 (834)
++|...+.||+|+||.||+|.+..+|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57889999999999999999999999999999986431 122357889999999999999999999999999999999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
||+ +|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 89 E~~-~g~l~~~l~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~ 157 (336)
T 3h4j_B 89 EYA-GGELFDYIVEK-------KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNI 157 (336)
T ss_dssp CCC-CEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBT
T ss_pred ECC-CCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEecccee
Confidence 999 78998888643 3589999999999999999999996 999999999999999999999999999975
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHH
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILL 347 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~ 347 (834)
..... .....+||+.|+|||.+......+.++|||||||++|||+||+.||+........
T Consensus 158 ~~~~~-----------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~--- 217 (336)
T 3h4j_B 158 MTDGN-----------------FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF--- 217 (336)
T ss_dssp TTTSB-----------------TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB---
T ss_pred ccCCc-----------------ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH---
Confidence 43210 1234569999999999875544478999999999999999999999754322110
Q ss_pred HHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 348 DWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 348 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
..+... ...+. ... ...+.+++..||+.||.+|||+.|+++.
T Consensus 218 ---------~~i~~~-~~~~p-~~~----s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 218 ---------KKVNSC-VYVMP-DFL----SPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp ---------CCCCSS-CCCCC-TTS----CHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred ---------HHHHcC-CCCCc-ccC----CHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 000000 00111 111 2357789999999999999999999763
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=367.25 Aligned_cols=266 Identities=15% Similarity=0.173 Sum_probs=207.1
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhC-CCCceeeEeeeEEeCCEEEEEEE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHL-RHRNLVRLRGWCVHEDQLLLVYD 188 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E 188 (834)
.++|+..+.||+|+||.||+|....+|+.||||++..... .+.+.+|+.+++++ +||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 3679999999999999999999989999999999865422 24588999999999 99999999999999999999999
Q ss_pred ccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCc-----eEEeecc
Q 003278 189 YMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYN-----ARLGDFG 263 (834)
Q Consensus 189 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~-----~kl~DFG 263 (834)
|+ +|+|.+++... ...+++..+..|+.|++.||+|||+. +|+||||||+|||++.++. +||+|||
T Consensus 86 ~~-~~~L~~~~~~~------~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg 155 (330)
T 2izr_A 86 LL-GPSLEDLFDLC------DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFA 155 (330)
T ss_dssp CC-CCBHHHHHHHT------TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCT
T ss_pred eC-CCCHHHHHHHc------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcc
Confidence 99 99999998753 24689999999999999999999996 9999999999999998887 9999999
Q ss_pred chhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCcc
Q 003278 264 LARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQ 343 (834)
Q Consensus 264 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~ 343 (834)
+++.+...... ............||+.|+|||.+... .++.++|||||||++|||+||+.||........
T Consensus 156 ~a~~~~~~~~~---------~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~ 225 (330)
T 2izr_A 156 LAKEYIDPETK---------KHIPYREHKSLTGTARYMSINTHLGK-EQSRRDDLEALGHMFMYFLRGSLPWQGLKADTL 225 (330)
T ss_dssp TCEESBCTTTC---------CBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSH
T ss_pred cceeeecCCCC---------ccccccccCCcCCCccccChHHHcCC-CCCchhHHHHHHHHHHHHhcCCCCccccccccH
Confidence 99864322110 00001123456799999999998654 679999999999999999999999976543332
Q ss_pred chHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 344 IILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 344 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
......+........ . ..+. .. ...+..++..||+.||.+||++.+|++.|...
T Consensus 226 ~~~~~~i~~~~~~~~-~----~~~~-~~-----~p~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 226 KERYQKIGDTKRATP-I----EVLC-EN-----FPEMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp HHHHHHHHHHHHHSC-H----HHHT-TT-----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred HHHHHHHHhhhccCC-H----HHHh-cc-----ChHHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 222222211100000 0 0000 00 11688999999999999999999999988754
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=372.53 Aligned_cols=258 Identities=18% Similarity=0.287 Sum_probs=195.9
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCc----EEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQ----YVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLV 587 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~----~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~l 587 (834)
++|...+.||+|+||+||+|... ++. .||+|.+.........++|.+|+.++++++|||||+++++|.+.. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 45777889999999999999953 343 368888865554455678999999999999999999999998755 788
Q ss_pred EEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecc
Q 003278 588 IYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAE 667 (834)
Q Consensus 588 v~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~ 667 (834)
|+||+++|+|.+++..... .+++..++.|+.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 94 v~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEECCTTCBHHHHHHHSTT-----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred EEEecCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCccee
Confidence 9999999999999976432 48899999999999999999997 699999999999999999999999999998
Q ss_pred ccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhc
Q 003278 668 FLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARK 746 (834)
Q Consensus 668 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~ 746 (834)
....... ........||+.|+|||++.++.++.++|||||||++|||+| |+.||...... .+...+. ...
T Consensus 166 ~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~~~~~~---~~~ 236 (327)
T 3poz_A 166 LLGAEEK-----EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-EISSILE---KGE 236 (327)
T ss_dssp HHTTTCC------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-GHHHHHH---TTC
T ss_pred EccCCcc-----cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH-HHHHHHH---cCC
Confidence 7643321 111223467889999999999999999999999999999999 99998654332 2222111 111
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCc
Q 003278 747 RPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDK 799 (834)
Q Consensus 747 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~ 799 (834)
.. ....... ..+..++.+||+.||++||||.+|++.|+...+
T Consensus 237 ~~-------~~~~~~~----~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 237 RL-------PQPPICT----IDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp CC-------CCCTTBC----HHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred CC-------CCCccCC----HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 10 0011111 245667779999999999999999999876543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=354.82 Aligned_cols=256 Identities=19% Similarity=0.339 Sum_probs=205.1
Q ss_pred hCcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEecc
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYS 592 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~ 592 (834)
++|...+.||+|+||.||+|...++..||||.+...... .++|.+|++++.+++||||+++++++.+.+..++||||+
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS--EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc--HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 456677889999999999999998889999998754432 367899999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccC
Q 003278 593 ATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRN 672 (834)
Q Consensus 593 ~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~ 672 (834)
++++|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 86 ~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 86 SNGCLLNYLRSHG-----KGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp TTCBHHHHHHHHG-----GGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred CCCcHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 9999999987543 248899999999999999999997 69999999999999999999999999999865432
Q ss_pred CCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCcccc
Q 003278 673 DHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRPLAE 751 (834)
Q Consensus 673 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
.. .......||+.|+|||.+.+..++.++||||||+++|||+| |+.|+......... .. .......
T Consensus 158 ~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-~~---~~~~~~~--- 224 (268)
T 3sxs_A 158 QY------VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV-LK---VSQGHRL--- 224 (268)
T ss_dssp CE------EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-HH---HHTTCCC---
T ss_pred hh------hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHH-HH---HHcCCCC---
Confidence 11 11123457788999999999899999999999999999999 99898644332211 11 1111111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCc
Q 003278 752 LVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDK 799 (834)
Q Consensus 752 ~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~ 799 (834)
..+ ....+ .+.+++.+||+.||++|||+.+|++.|+.+.+
T Consensus 225 -~~~----~~~~~---~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 225 -YRP----HLASD---TIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp -CCC----TTSCH---HHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred -CCC----CcChH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 011 11123 34556669999999999999999999988754
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=376.93 Aligned_cols=263 Identities=22% Similarity=0.278 Sum_probs=205.5
Q ss_pred hCcCcCCcccccCCcEEEEEEEC------CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD------NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEML 586 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~ 586 (834)
++|...+.||+|+||.||+|... ++..||||++...........|.+|+.++++++|||||++++++.+.+..+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 45666788999999999999953 356899999976655666678999999999999999999999999999999
Q ss_pred EEEeccCCCchhhhhhcCCCC-CCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCC---CceEee
Q 003278 587 VIYDYSATRILSHLLFHNNHR-IGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDM---NPRLGS 662 (834)
Q Consensus 587 lv~Ey~~~g~L~~~l~~~~~~-~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~---~~ki~D 662 (834)
+||||+++|+|.+++...... .....+++..++.|+.|++.||+|||+ .+|+||||||+||||+.++ .+||+|
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEECC
Confidence 999999999999999764322 122358899999999999999999997 6999999999999999544 599999
Q ss_pred eeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHH
Q 003278 663 FALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHE 741 (834)
Q Consensus 663 fGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~ 741 (834)
||+++.+..... ........||+.|||||++.++.++.++|||||||++|||+| |..||....... +...+.
T Consensus 228 FG~a~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~-~~~~i~- 300 (367)
T 3l9p_A 228 FGMARDIYRAGY-----YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-VLEFVT- 300 (367)
T ss_dssp CHHHHHHHHHSS-----CTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-HHHHHH-
T ss_pred Cccccccccccc-----cccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHH-
Confidence 999986533221 111234578999999999999999999999999999999998 888886543221 111111
Q ss_pred HHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCC
Q 003278 742 FEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGND 798 (834)
Q Consensus 742 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~ 798 (834)
..... ...... +. .+.+++.+||+.||++|||+.+|++.|+...
T Consensus 301 --~~~~~-------~~~~~~-~~---~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 301 --SGGRM-------DPPKNC-PG---PVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp --TTCCC-------CCCTTC-CH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --cCCCC-------CCCccC-CH---HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 11110 011111 22 3556667999999999999999999997543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=366.90 Aligned_cols=270 Identities=24% Similarity=0.337 Sum_probs=190.6
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC-hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG-ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYD 188 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 188 (834)
.++|+..+.||+|+||.||+|....+|+.||||++.... ....+.+.+|+.++++++|||||++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 457899999999999999999998899999999986542 2334678899999999999999999999999999999999
Q ss_pred ccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhh
Q 003278 189 YMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWL 268 (834)
Q Consensus 189 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~ 268 (834)
|++ |+|.+++...... .....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 84 ~~~-~~L~~~l~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVG-NTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp CCC-CBHHHHHHHHHSS-SCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred ecC-CCHHHHHHhcccc-ccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 998 6999988653211 1224589999999999999999999996 9999999999999999999999999999754
Q ss_pred hhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHH
Q 003278 269 EHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLD 348 (834)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~ 348 (834)
.... .......||+.|+|||.+.....++.++|||||||++|||+||+.||...... ....
T Consensus 159 ~~~~----------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~ 219 (317)
T 2pmi_A 159 GIPV----------------NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE---EQLK 219 (317)
T ss_dssp TSCC----------------CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHH
T ss_pred CCCc----------------ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH---HHHH
Confidence 2110 01234468999999999876556799999999999999999999998643221 1222
Q ss_pred HHHHHhhcC--cc-cc-----ccccccCC---CC--------CCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 349 WIRRLSDEG--KV-LQ-----AGDNRLSD---GS--------YKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 349 ~~~~~~~~~--~~-~~-----~~d~~l~~---~~--------~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
.+....... .. .. ...+.+.. .. ........+.+++..||+.||.+||++.++++
T Consensus 220 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 220 LIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp HHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 222211100 00 00 00000000 00 00001235789999999999999999999876
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=363.79 Aligned_cols=252 Identities=21% Similarity=0.302 Sum_probs=201.1
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccCh------hhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGE------RFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLL 184 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 184 (834)
+.|+..+.||+|+||.||+|....+|..||||.+..... ...+.+.+|+.+|++++||||+++++++.+.+..+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 458888999999999999999998999999999865321 13577999999999999999999999999999999
Q ss_pred EEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCC----ceEEe
Q 003278 185 LVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQY----NARLG 260 (834)
Q Consensus 185 lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~----~~kl~ 260 (834)
+||||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++ .+||+
T Consensus 91 lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~ 160 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEK-------ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKII 160 (326)
T ss_dssp EEEECCCSCBHHHHHTTS-------SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEEC
T ss_pred EEEEcCCCCCHHHHHHhc-------CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEE
Confidence 999999999999998542 4689999999999999999999986 999999999999999877 79999
Q ss_pred eccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCC
Q 003278 261 DFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYP 340 (834)
Q Consensus 261 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~ 340 (834)
|||+++.+... .......||+.|+|||.+... .++.++|||||||++|||+||+.||.....
T Consensus 161 Dfg~a~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 222 (326)
T 2y0a_A 161 DFGLAHKIDFG-----------------NEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTK 222 (326)
T ss_dssp CCTTCEECCTT-----------------SCCCCCCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred ECCCCeECCCC-----------------CccccccCCcCcCCceeecCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCH
Confidence 99999754321 012345699999999988644 679999999999999999999999864321
Q ss_pred CccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 341 DDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 341 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
.... ..... ... ...+... ... ...+.+++..||+.||.+||++.++++.
T Consensus 223 ---~~~~---~~~~~-~~~-~~~~~~~--~~~----~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 223 ---QETL---ANVSA-VNY-EFEDEYF--SNT----SALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp ---HHHH---HHHHH-TCC-CCCHHHH--TTS----CHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ---HHHH---HHHHh-cCC-CcCcccc--ccC----CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111 11111 100 0000000 011 1357789999999999999999999873
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=355.61 Aligned_cols=255 Identities=21% Similarity=0.353 Sum_probs=203.9
Q ss_pred hCcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEecc
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYS 592 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~ 592 (834)
++|...+.||+|+||.||+|...++..||||++...... .++|.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC--HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 456667889999999999999988889999998754332 357999999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccC
Q 003278 593 ATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRN 672 (834)
Q Consensus 593 ~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~ 672 (834)
++|+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 88 ~~~~L~~~l~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 88 EHGCLSDYLRTQR-----GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp TTCBHHHHHHTTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred CCCcHHHHHHhcC-----cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 9999999986543 248899999999999999999997 68999999999999999999999999999765322
Q ss_pred CCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCcccc
Q 003278 673 DHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRPLAE 751 (834)
Q Consensus 673 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
. ........||+.|+|||++.+..++.++|||||||++|||+| |+.|+....... ....+ ......
T Consensus 160 ~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~-~~~~~---~~~~~~--- 226 (269)
T 4hcu_A 160 Q------YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-VVEDI---STGFRL--- 226 (269)
T ss_dssp H------HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHHHH---HTTCCC---
T ss_pred c------cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH-HHHHH---hcCccC---
Confidence 1 111223467889999999999999999999999999999999 888886543322 11111 111111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCC
Q 003278 752 LVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGND 798 (834)
Q Consensus 752 ~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~ 798 (834)
...... .. .+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 227 ----~~~~~~-~~---~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~ 265 (269)
T 4hcu_A 227 ----YKPRLA-ST---HVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 265 (269)
T ss_dssp ----CCCTTS-CH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCCcC-CH---HHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence 011111 23 3455666899999999999999999997654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=368.75 Aligned_cols=271 Identities=27% Similarity=0.413 Sum_probs=212.5
Q ss_pred HHHHhhcCCCCCCCeeeccCCeEEEEEEEC-----CCCeEEEEEEeccc-ChhhHHHHHHHHHHHHhCCCCceeeEeeeE
Q 003278 104 AELYIGSNGFDEDEVLGSGGFGKVYRAVLP-----SDGTVVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNLVRLRGWC 177 (834)
Q Consensus 104 ~el~~~t~~f~~~~~LG~G~fG~Vy~~~~~-----~~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~ 177 (834)
.++....++|...+.||+|+||.||+|.+. .+++.||||++... .....+.|.+|+.++++++||||++++++|
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 344566788999999999999999999986 34589999998754 344567899999999999999999999999
Q ss_pred EeCCEEEEEEEccCCCCHhHHHhcCCCcc-----------------ccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCee
Q 003278 178 VHEDQLLLVYDYMPNRSLDRVLFRRPENL-----------------EAAAPLNWEQRKKIIRGLAAALHYLHEQLETQII 240 (834)
Q Consensus 178 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~-----------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ii 240 (834)
.+.+..++||||+++|+|.+++....... .....+++..++.|+.|+++||.|||+. +|+
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~iv 196 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFV 196 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 99999999999999999999997642110 0125799999999999999999999996 999
Q ss_pred cCCCCCCceEECCCCceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceee
Q 003278 241 HRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFS 320 (834)
Q Consensus 241 HrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~S 320 (834)
||||||+|||++.++.+||+|||+++.+...... .......||+.|+|||.+... .++.++||||
T Consensus 197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~--------------~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~s 261 (343)
T 1luf_A 197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYY--------------KADGNDAIPIRWMPPESIFYN-RYTTESDVWA 261 (343)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCB--------------C----CCBCGGGCCHHHHHHC-CCCHHHHHHH
T ss_pred cCCCCcceEEECCCCeEEEeecCCCcccccCccc--------------cccCCCcccceecChhhhccC-CcCcccccHH
Confidence 9999999999999999999999999865332110 112344689999999988755 5799999999
Q ss_pred hhhHHHHHHh-CCccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchh
Q 003278 321 FGIVVLEVVS-GRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMK 399 (834)
Q Consensus 321 fGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~ 399 (834)
|||++|||+| |+.||..... ..+ ... ...+...... ... ...+.+++..||+.||.+||++.
T Consensus 262 lG~il~el~t~g~~p~~~~~~---~~~---~~~-~~~~~~~~~~------~~~----~~~l~~li~~~l~~~p~~Rps~~ 324 (343)
T 1luf_A 262 YGVVLWEIFSYGLQPYYGMAH---EEV---IYY-VRDGNILACP------ENC----PLELYNLMRLCWSKLPADRPSFC 324 (343)
T ss_dssp HHHHHHHHHTTTCCTTTTSCH---HHH---HHH-HHTTCCCCCC------TTC----CHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHHHHHHHHhcCCCcCCCCCh---HHH---HHH-HhCCCcCCCC------CCC----CHHHHHHHHHHcccCcccCCCHH
Confidence 9999999999 9999864321 111 111 1222221111 111 24688899999999999999999
Q ss_pred hHHHHhhcCC
Q 003278 400 WVIEAVSGSY 409 (834)
Q Consensus 400 ~V~~~l~~~~ 409 (834)
+|++.|+...
T Consensus 325 ~~~~~L~~~~ 334 (343)
T 1luf_A 325 SIHRILQRMC 334 (343)
T ss_dssp HHHHHHHHTT
T ss_pred HHHHHHHHHH
Confidence 9999998754
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=385.41 Aligned_cols=265 Identities=24% Similarity=0.399 Sum_probs=210.4
Q ss_pred cHHHHHhhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCC
Q 003278 102 SYAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHED 181 (834)
Q Consensus 102 ~~~el~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~ 181 (834)
...+.++..++|...+.||+|+||.||+|.+ .++..||||++.... ...+.|.+|+.+|++++|||||++++++. .+
T Consensus 179 ~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~ 255 (454)
T 1qcf_A 179 EKDAWEIPRESLKLEKKLGAGQFGEVWMATY-NKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KE 255 (454)
T ss_dssp CTTCSBCCGGGEEEEEEEECCSSEEEEEEEE-TTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred cccceeechHHeEEEEEcccCCceEEEEEEE-CCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CC
Confidence 3444566778899999999999999999999 467889999997543 34678999999999999999999999986 56
Q ss_pred EEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEee
Q 003278 182 QLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGD 261 (834)
Q Consensus 182 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~D 261 (834)
..++||||+++|+|.++|.... ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|
T Consensus 256 ~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~D 327 (454)
T 1qcf_A 256 PIYIITEFMAKGSLLDFLKSDE-----GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIAD 327 (454)
T ss_dssp SCEEEECCCTTCBHHHHHHSHH-----HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECS
T ss_pred ccEEEEeecCCCcHHHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEee
Confidence 7899999999999999996432 23578899999999999999999996 999999999999999999999999
Q ss_pred ccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCC
Q 003278 262 FGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYP 340 (834)
Q Consensus 262 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~ 340 (834)
||+++.+...... ......+|+.|+|||.+..+ .++.++|||||||++|||+| |+.||.....
T Consensus 328 FG~a~~~~~~~~~---------------~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~t~g~~P~~~~~~ 391 (454)
T 1qcf_A 328 FGLARVIEDNEYT---------------AREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSN 391 (454)
T ss_dssp TTGGGGBCCHHHH---------------TTCSSSSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred CCCceEcCCCcee---------------ccCCCcccccccCHHHhccC-CCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH
Confidence 9999865432110 01223478899999998765 57999999999999999999 9999864321
Q ss_pred CccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcCCC
Q 003278 341 DDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGSYS 410 (834)
Q Consensus 341 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~~~ 410 (834)
..+.. .+ ..+..... + .. ....+.+|+..||+.||.+||+|.+|++.|+..+.
T Consensus 392 ---~~~~~---~i-~~~~~~~~--~----~~----~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 392 ---PEVIR---AL-ERGYRMPR--P----EN----CPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp ---HHHHH---HH-HHTCCCCC--C----TT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred ---HHHHH---HH-HcCCCCCC--C----CC----CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 11111 11 11211110 0 11 12468899999999999999999999999987653
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=356.83 Aligned_cols=254 Identities=26% Similarity=0.514 Sum_probs=201.1
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChh--h-----HHHHHHHHHHHHhCCCCceeeEeeeEEeCCE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGER--F-----EKTFAAELVAVAHLRHRNLVRLRGWCVHEDQ 182 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~--~-----~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~ 182 (834)
.++|+..+.||+|+||.||+|.+..+++.||||++...... . .+.|.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 46788899999999999999999989999999998543211 1 167899999999999999999999987665
Q ss_pred EEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCC--eecCCCCCCceEECCCCc----
Q 003278 183 LLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQ--IIHRDVKTSNVMLDSQYN---- 256 (834)
Q Consensus 183 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--iiHrDlKp~NILld~~~~---- 256 (834)
++||||+++|+|.+.+... ..++++..+..++.|++.||+|||+. + |+||||||+|||++.++.
T Consensus 97 -~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~ 166 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDK------AHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPV 166 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCT------TSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSC
T ss_pred -eEEEEecCCCCHHHHHhcc------cCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCce
Confidence 7999999999999888653 24689999999999999999999986 6 999999999999988776
Q ss_pred -eEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCcccccc-CCCCCcccceeehhhHHHHHHhCCcc
Q 003278 257 -ARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQK-GSVATAKSDVFSFGIVVLEVVSGRRA 334 (834)
Q Consensus 257 -~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~ksDV~SfGvvl~ElltG~~p 334 (834)
+||+|||+++.... ......||+.|+|||.+.. ...++.++|||||||++|||+||+.|
T Consensus 167 ~~kl~Dfg~~~~~~~-------------------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p 227 (287)
T 4f0f_A 167 CAKVADFGLSQQSVH-------------------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP 227 (287)
T ss_dssp CEEECCCTTCBCCSS-------------------CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCT
T ss_pred eEEeCCCCccccccc-------------------cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCC
Confidence 99999999874211 1344569999999998842 33468899999999999999999999
Q ss_pred CCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhc
Q 003278 335 VDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSG 407 (834)
Q Consensus 335 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~ 407 (834)
|....... . .+.......+... .+. ... ...+.+++..||+.||.+||++.++++.|+.
T Consensus 228 f~~~~~~~-~---~~~~~~~~~~~~~-----~~~-~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 228 FDEYSYGK-I---KFINMIREEGLRP-----TIP-EDC----PPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp TTTCCCCH-H---HHHHHHHHSCCCC-----CCC-TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred CccccccH-H---HHHHHHhccCCCC-----CCC-ccc----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 97543221 1 1111111111111 111 111 2468899999999999999999999999864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=368.23 Aligned_cols=268 Identities=23% Similarity=0.314 Sum_probs=209.8
Q ss_pred HhhCcCcCCcccccCCcEEEEEEEC------CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCe
Q 003278 511 ATNNFSESQRVAEMDFGTAYQGFLD------NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGE 584 (834)
Q Consensus 511 at~~f~~~~~ig~g~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~ 584 (834)
..++|...+.||+|+||.||+|... ++..||||.+.........+.|.+|+.++++++|||||+++++|.+.+.
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 3467888889999999999999974 3478999999876666667889999999999999999999999999999
Q ss_pred EEEEEeccCCCchhhhhhcCCCCC------------------CCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccc
Q 003278 585 MLVIYDYSATRILSHLLFHNNHRI------------------GHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNIT 646 (834)
Q Consensus 585 ~~lv~Ey~~~g~L~~~l~~~~~~~------------------~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK 646 (834)
.++||||+++|+|.+++....... ....+++..++.|+.|++.||+|||+ .+|+|||||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlk 201 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLA 201 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCS
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCC
Confidence 999999999999999997642110 11458999999999999999999997 699999999
Q ss_pred cCceeecCCCCceEeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCc
Q 003278 647 SSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMA 725 (834)
Q Consensus 647 ~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p 725 (834)
|+|||++.++.+||+|||+++....... ........||+.|+|||++.++.++.++|||||||++|||+| |..|
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 276 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADY-----YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGC-----BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred cceEEECCCCeEEEeecCCCcccccCcc-----ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence 9999999999999999999976543221 111234568999999999999999999999999999999999 9889
Q ss_pred cCCCCCchhHHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCccc
Q 003278 726 VDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDKRF 801 (834)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~~~ 801 (834)
+....... ....+. . .... .....+ +. .+.+++.+||+.||++|||+.+|++.|+.+..+.
T Consensus 277 ~~~~~~~~-~~~~~~---~--~~~~-----~~~~~~-~~---~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 277 YYGMAHEE-VIYYVR---D--GNIL-----ACPENC-PL---ELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp TTTSCHHH-HHHHHH---T--TCCC-----CCCTTC-CH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred CCCCChHH-HHHHHh---C--CCcC-----CCCCCC-CH---HHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 86433221 111111 1 1111 111122 23 3455666999999999999999999998876543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=361.36 Aligned_cols=263 Identities=25% Similarity=0.316 Sum_probs=199.3
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYD 188 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 188 (834)
++|+..+.||+|+||.||+|.+ .+|+.||||++... .....+.+.+|+.++++++|||||++++++.+.+..++|||
T Consensus 21 ~~y~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 21 EKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp CEEEEEEEEEECSSCEEEEEEE-TTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred hhhHhhhhccCCCCeEEEEEEE-CCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 6788899999999999999999 46999999998643 23345678899999999999999999999999999999999
Q ss_pred ccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhh
Q 003278 189 YMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWL 268 (834)
Q Consensus 189 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~ 268 (834)
|+++ +|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 100 ~~~~-~l~~~~~~~------~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 169 (311)
T 3niz_A 100 FMEK-DLKKVLDEN------KTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF 169 (311)
T ss_dssp CCSE-EHHHHHHTC------TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEET
T ss_pred CCCC-CHHHHHHhc------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceec
Confidence 9984 788877543 24589999999999999999999996 9999999999999999999999999999754
Q ss_pred hhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHH
Q 003278 269 EHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLD 348 (834)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~ 348 (834)
.... ...+...||+.|+|||.+.....++.++|||||||++|||+||+.||......+. ..
T Consensus 170 ~~~~----------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~ 230 (311)
T 3niz_A 170 GIPV----------------RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ---LP 230 (311)
T ss_dssp TSCC----------------C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH---HH
T ss_pred CCCc----------------ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH---HH
Confidence 2110 1123456899999999987655689999999999999999999999975443322 11
Q ss_pred HHHHHhhcCccc---cccc------cccCC-CCCCH-----HHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 349 WIRRLSDEGKVL---QAGD------NRLSD-GSYKL-----CDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 349 ~~~~~~~~~~~~---~~~d------~~l~~-~~~~~-----~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
.+.......... ...+ ..... ..... .....+.+|+..||+.||.+|||+.|+++
T Consensus 231 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 231 KIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 122211110000 0000 00000 00000 01135778999999999999999999986
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=366.90 Aligned_cols=250 Identities=24% Similarity=0.335 Sum_probs=198.0
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc---ChhhHHHHHHHHHHHHhC-CCCceeeEeeeEEeCCEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK---GERFEKTFAAELVAVAHL-RHRNLVRLRGWCVHEDQLLLV 186 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV 186 (834)
++|+..+.||+|+||.||+|+.+.+|+.||||++... .....+.+.+|+.++.++ +|||||++++++.+.+.+|+|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 5688899999999999999999999999999998754 233456788999999987 899999999999999999999
Q ss_pred EEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchh
Q 003278 187 YDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLAR 266 (834)
Q Consensus 187 ~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~ 266 (834)
|||+++|+|..++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++++||+|||+++
T Consensus 89 ~e~~~gg~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~ 158 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ-------RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK 158 (345)
T ss_dssp ECCCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCB
T ss_pred EeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccc
Confidence 9999999999998643 3589999999999999999999996 99999999999999999999999999997
Q ss_pred hhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccc--
Q 003278 267 WLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQI-- 344 (834)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~-- 344 (834)
..... .......+||+.|+|||.+... .++.++|||||||++|||+||+.||.........
T Consensus 159 ~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~ 221 (345)
T 3a8x_A 159 EGLRP----------------GDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 221 (345)
T ss_dssp CSCCT----------------TCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTTTC------
T ss_pred cccCC----------------CCcccccCCCccccCccccCCC-CCChHHhHHHHHHHHHHHHhCCCCcCCccccccccc
Confidence 42111 0113456799999999998654 6799999999999999999999999643221110
Q ss_pred hHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCch
Q 003278 345 ILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSM 398 (834)
Q Consensus 345 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm 398 (834)
.....+......+.. .+. ...+ ..+.+++..||+.||.+||++
T Consensus 222 ~~~~~~~~~i~~~~~------~~p-~~~s----~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 222 NTEDYLFQVILEKQI------RIP-RSLS----VKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp -CHHHHHHHHHHCCC------CCC-TTSC----HHHHHHHHHHTCSSTTTSTTC
T ss_pred ccHHHHHHHHHcCCC------CCC-CCCC----HHHHHHHHHHhcCCHhHCCCC
Confidence 011112111111111 111 1111 357789999999999999996
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=365.69 Aligned_cols=270 Identities=23% Similarity=0.379 Sum_probs=195.1
Q ss_pred HHHHhhcCCCCCCCeeeccCCeEEEEEEECCCCe---EEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEE
Q 003278 104 AELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGT---VVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCV 178 (834)
Q Consensus 104 ~el~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~---~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~ 178 (834)
+++....++|+..+.||+|+||.||+|.+..++. .||||++... .....+.|.+|+.++++++||||+++++++.
T Consensus 16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 95 (323)
T 3qup_A 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSL 95 (323)
T ss_dssp CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence 3445566789999999999999999999876664 8999998654 3345678999999999999999999999998
Q ss_pred eCCEE------EEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEEC
Q 003278 179 HEDQL------LLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLD 252 (834)
Q Consensus 179 ~~~~~------~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld 252 (834)
..+.. ++||||+++|+|.+++...... .....+++..+..|+.|+++||+|||+. +|+||||||+|||++
T Consensus 96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~ 171 (323)
T 3qup_A 96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIG-ENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLA 171 (323)
T ss_dssp CC-------CEEEEEECCTTCBHHHHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred ccccccCCCccEEEEEeccCCcHHHHHHhhhcc-ccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEc
Confidence 87665 9999999999999998653211 1223689999999999999999999996 999999999999999
Q ss_pred CCCceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-C
Q 003278 253 SQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-G 331 (834)
Q Consensus 253 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G 331 (834)
.++.+||+|||+++........ .......||+.|+|||.+... .++.++|||||||++|||+| |
T Consensus 172 ~~~~~kl~Dfg~a~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g 236 (323)
T 3qup_A 172 EDMTVCVADFGLSRKIYSGDYY--------------RQGCASKLPVKWLALESLADN-LYTVHSDVWAFGVTMWEIMTRG 236 (323)
T ss_dssp TTSCEEECCCCC-------------------------------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTS
T ss_pred CCCCEEEeeccccccccccccc--------------cccccccCcccccCchhhcCC-CCCCccchhhHHHHHHHHHhCC
Confidence 9999999999999865432111 012334578899999998655 67999999999999999999 8
Q ss_pred CccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcCC
Q 003278 332 RRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGSY 409 (834)
Q Consensus 332 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~~ 409 (834)
+.||...... .+... ... +..... . ... ...+.+++..||+.||.+||++.++++.|+...
T Consensus 237 ~~p~~~~~~~---~~~~~---~~~-~~~~~~-~-----~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l 297 (323)
T 3qup_A 237 QTPYAGIENA---EIYNY---LIG-GNRLKQ-P-----PEC----MEEVYDLMYQCWSADPKQRPSFTCLRMELENIL 297 (323)
T ss_dssp CCTTTTCCGG---GHHHH---HHT-TCCCCC-C-----TTC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCccccChH---HHHHH---Hhc-CCCCCC-C-----Ccc----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 9998653222 12111 111 111110 0 111 246889999999999999999999999998754
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=364.55 Aligned_cols=266 Identities=16% Similarity=0.139 Sum_probs=204.6
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhc-cCCCceeEEEEEeeCCeEEEEEe
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARL-RHRNLVQLCGWCTEQGEMLVIYD 590 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l-~HpNiv~l~g~~~~~~~~~lv~E 590 (834)
++|...+.||+|+||.||+|.. .+++.||||.+...... +.|.+|+.+++++ +||||+++++++...+..++|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA---PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS---CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch---HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 5677788999999999999995 66889999998654322 3578899999999 99999999999999999999999
Q ss_pred ccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCC-----ceEeeeee
Q 003278 591 YSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMN-----PRLGSFAL 665 (834)
Q Consensus 591 y~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~-----~ki~DfGl 665 (834)
|+ +++|.+++.... ..+++..++.|+.|++.||+|||+ .+|+||||||+|||++.++. +||+|||+
T Consensus 86 ~~-~~~L~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~ 156 (330)
T 2izr_A 86 LL-GPSLEDLFDLCD-----RTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFAL 156 (330)
T ss_dssp CC-CCBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTT
T ss_pred eC-CCCHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEccc
Confidence 99 999999987642 248899999999999999999997 69999999999999998887 99999999
Q ss_pred ccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhh
Q 003278 666 AEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEAR 745 (834)
Q Consensus 666 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~ 745 (834)
++.+..................||+.|+|||++.+..++.++|||||||++|||+||+.||........ ..........
T Consensus 157 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~-~~~~~~i~~~ 235 (330)
T 2izr_A 157 AKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTL-KERYQKIGDT 235 (330)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSH-HHHHHHHHHH
T ss_pred ceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccH-HHHHHHHHhh
Confidence 987543322111111123457899999999999999999999999999999999999999975433221 1111111111
Q ss_pred cCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCc
Q 003278 746 KRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDK 799 (834)
Q Consensus 746 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~ 799 (834)
..+.. ...+. ...+ .+.+++..||+.||.+||++.+|++.|+...+
T Consensus 236 ~~~~~---~~~~~-~~~p----~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~ 281 (330)
T 2izr_A 236 KRATP---IEVLC-ENFP----EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFD 281 (330)
T ss_dssp HHHSC---HHHHT-TTCH----HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred hccCC---HHHHh-ccCh----HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHH
Confidence 11100 00001 1122 45566668999999999999999999875443
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=370.02 Aligned_cols=212 Identities=24% Similarity=0.337 Sum_probs=183.6
Q ss_pred CCccccHHHHHhhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCC-----CCcee
Q 003278 97 NPRIFSYAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLR-----HRNLV 171 (834)
Q Consensus 97 ~~~~f~~~el~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-----H~nIv 171 (834)
....|++.+.....++|...+.||+|+||.||+|++..+++.||||++... ....+.+..|+.++..++ |||||
T Consensus 21 ~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv 99 (360)
T 3llt_A 21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIV 99 (360)
T ss_dssp GGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred cceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence 345577777777889999999999999999999999989999999998643 344567788999999987 99999
Q ss_pred eEeeeEEeCCEEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEE
Q 003278 172 RLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVML 251 (834)
Q Consensus 172 ~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILl 251 (834)
++++++...+..++||||+ +++|.+++.... ...+++..+..|+.|++.||+|||+. +|+||||||+|||+
T Consensus 100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll 170 (360)
T 3llt_A 100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNN-----YNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILL 170 (360)
T ss_dssp CEEEEEEETTEEEEEECCC-CCBHHHHHHHTT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred cccceeeECCeeEEEEcCC-CCCHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEE
Confidence 9999999999999999999 999999997643 23589999999999999999999996 99999999999999
Q ss_pred CC-------------------------CCceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCcccc
Q 003278 252 DS-------------------------QYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESF 306 (834)
Q Consensus 252 d~-------------------------~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~ 306 (834)
+. ++.+||+|||+++.... ......||+.|+|||.+
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-------------------~~~~~~gt~~y~aPE~~ 231 (360)
T 3llt_A 171 DDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-------------------YHGSIINTRQYRAPEVI 231 (360)
T ss_dssp SCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS-------------------CCCSCCSCGGGCCHHHH
T ss_pred ccccccccccchhcccccccccccccCCCCEEEEeccCceecCC-------------------CCcCccCcccccCcHHH
Confidence 75 78899999999974321 12345699999999998
Q ss_pred ccCCCCCcccceeehhhHHHHHHhCCccCCCC
Q 003278 307 QKGSVATAKSDVFSFGIVVLEVVSGRRAVDLT 338 (834)
Q Consensus 307 ~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~ 338 (834)
... .++.++|||||||++|||+||+.||...
T Consensus 232 ~~~-~~~~~~DiwslG~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 232 LNL-GWDVSSDMWSFGCVLAELYTGSLLFRTH 262 (360)
T ss_dssp TTC-CCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cCC-CCCCccchHHHHHHHHHHHHCCCCCCCC
Confidence 755 6799999999999999999999999643
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=379.68 Aligned_cols=263 Identities=21% Similarity=0.258 Sum_probs=207.1
Q ss_pred cHHHHHhhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHHHHHhCCCCceeeEeeeEE
Q 003278 102 SYAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVAVAHLRHRNLVRLRGWCV 178 (834)
Q Consensus 102 ~~~el~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~ 178 (834)
.+.++....++|+..++||+|+||+||+|+.+.+++.||||++.+.. ....+.+.+|+.++..++|||||+++++|.
T Consensus 60 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 139 (410)
T 3v8s_A 60 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 139 (410)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred HHHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 45567778899999999999999999999999999999999986421 112235788999999999999999999999
Q ss_pred eCCEEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceE
Q 003278 179 HEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNAR 258 (834)
Q Consensus 179 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~k 258 (834)
+.+.+|||||||++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+|
T Consensus 140 ~~~~~~lV~E~~~gg~L~~~l~~~--------~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ik 208 (410)
T 3v8s_A 140 DDRYLYMVMEYMPGGDLVNLMSNY--------DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLK 208 (410)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEE
T ss_pred ECCEEEEEEeCCCCCcHHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEE
Confidence 999999999999999999998642 478899999999999999999996 999999999999999999999
Q ss_pred EeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCC---CCCcccceeehhhHHHHHHhCCccC
Q 003278 259 LGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGS---VATAKSDVFSFGIVVLEVVSGRRAV 335 (834)
Q Consensus 259 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~---~~~~ksDV~SfGvvl~ElltG~~p~ 335 (834)
|+|||+++.+.... .....+.+||+.|+|||++.... .++.++|||||||++|||+||+.||
T Consensus 209 L~DFG~a~~~~~~~---------------~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf 273 (410)
T 3v8s_A 209 LADFGTCMKMNKEG---------------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273 (410)
T ss_dssp ECCCTTCEECCTTS---------------EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTT
T ss_pred EeccceeEeeccCC---------------cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCC
Confidence 99999997543210 01134567999999999986532 2678999999999999999999999
Q ss_pred CCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCC--CCchhhHHHH
Q 003278 336 DLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHL--RPSMKWVIEA 404 (834)
Q Consensus 336 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPsm~~V~~~ 404 (834)
.... ...+ ...+..........+. ...+ ..+.+|+..||+.+|.+ ||++.+|++.
T Consensus 274 ~~~~---~~~~---~~~i~~~~~~~~~p~~----~~~s----~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 274 YADS---LVGT---YSKIMNHKNSLTFPDD----NDIS----KEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp CCSS---HHHH---HHHHHTHHHHCCCCTT----CCCC----HHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred CCCC---hhhH---HHHHHhccccccCCCc----cccc----HHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 6432 1111 1111111000001100 1111 35778999999988988 9999999874
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=362.13 Aligned_cols=245 Identities=23% Similarity=0.351 Sum_probs=200.5
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 187 (834)
++|+..+.||+|+||.||+|+...+|+.||||++.... ....+.+.+|+.+++.++|||||++++++.+.+..|+||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 56888999999999999999999899999999986532 223467889999999999999999999999999999999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 86 e~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~ 155 (318)
T 1fot_A 86 DYIEGGELFSLLRKS-------QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKY 155 (318)
T ss_dssp CCCCSCBHHHHHHHT-------SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred eCCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCccee
Confidence 999999999999653 3588999999999999999999985 999999999999999999999999999975
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHH
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILL 347 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~ 347 (834)
... .....+||+.|+|||.+... .++.++|||||||++|||+||+.||.... . .
T Consensus 156 ~~~-------------------~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~---~---~ 209 (318)
T 1fot_A 156 VPD-------------------VTYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSN---T---M 209 (318)
T ss_dssp CSS-------------------CBCCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSS---H---H
T ss_pred cCC-------------------ccccccCCccccCHhHhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCC---H---H
Confidence 321 13346799999999988654 67999999999999999999999986421 1 1
Q ss_pred HHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----chhhHHH
Q 003278 348 DWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRP-----SMKWVIE 403 (834)
Q Consensus 348 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~~V~~ 403 (834)
.....+... .. +.. ..++ ..+.+++..||+.||.+|| ++.++++
T Consensus 210 ~~~~~i~~~-~~------~~p-~~~~----~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 210 KTYEKILNA-EL------RFP-PFFN----EDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp HHHHHHHHC-CC------CCC-TTSC----HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHHHHHhC-CC------CCC-CCCC----HHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 112222221 11 111 1111 3578899999999999999 7777765
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=384.49 Aligned_cols=257 Identities=21% Similarity=0.341 Sum_probs=204.1
Q ss_pred hCcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEecc
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYS 592 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~ 592 (834)
++|...+.||+|+||.||+|...++..||||.++... ...+.|.+|+.+|++++|||||++++++. .+..++||||+
T Consensus 188 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~ 264 (454)
T 1qcf_A 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM 264 (454)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred HHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC--ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence 4566678899999999999999888999999987543 23578999999999999999999999987 56789999999
Q ss_pred CCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccC
Q 003278 593 ATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRN 672 (834)
Q Consensus 593 ~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~ 672 (834)
++|+|.+++..... ..+++..++.++.|+|.||+|||+ .+|+||||||+||||+.++.+||+|||+++.....
T Consensus 265 ~~g~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 265 AKGSLLDFLKSDEG----SKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp TTCBHHHHHHSHHH----HTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred CCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 99999999975321 247888899999999999999997 68999999999999999999999999999865322
Q ss_pred CCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCcccc
Q 003278 673 DHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRPLAE 751 (834)
Q Consensus 673 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
. ........+|+.|+|||++..+.++.++|||||||+||||+| |+.||...... .+...+.. ..+.
T Consensus 338 ~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~-~~~~~i~~---~~~~--- 404 (454)
T 1qcf_A 338 E------YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-EVIRALER---GYRM--- 404 (454)
T ss_dssp H------HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-HHHHHHHH---TCCC---
T ss_pred c------eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHc---CCCC---
Confidence 1 011123457889999999999999999999999999999999 99998643322 22222211 1110
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCcc
Q 003278 752 LVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDKR 800 (834)
Q Consensus 752 ~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~~ 800 (834)
..... .++ .+.+++.+||+.||++||||.+|++.|+.+...
T Consensus 405 ----~~~~~-~~~---~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 405 ----PRPEN-CPE---ELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp ----CCCTT-SCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred ----CCCCC-CCH---HHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 01111 223 355666799999999999999999999987653
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=393.06 Aligned_cols=262 Identities=23% Similarity=0.353 Sum_probs=210.9
Q ss_pred HHhhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEE
Q 003278 106 LYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLL 185 (834)
Q Consensus 106 l~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 185 (834)
.++..++|...+.||+|+||.||+|.+..++..||||.+.... ...+.|.+|+.+|++++|||||+++|+|...+..+|
T Consensus 215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 293 (495)
T 1opk_A 215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 293 (495)
T ss_dssp CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence 3445667888899999999999999998889999999997543 335779999999999999999999999999999999
Q ss_pred EEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccch
Q 003278 186 VYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLA 265 (834)
Q Consensus 186 V~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla 265 (834)
||||+++|+|.++|.... ...+++..++.|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 294 v~E~~~~g~L~~~l~~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a 365 (495)
T 1opk_A 294 ITEFMTYGNLLDYLRECN-----RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLS 365 (495)
T ss_dssp EEECCTTCBHHHHHHHSC-----TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCE
T ss_pred EEEccCCCCHHHHHHhcC-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccc
Confidence 999999999999997542 24589999999999999999999996 9999999999999999999999999999
Q ss_pred hhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccc
Q 003278 266 RWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQI 344 (834)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~ 344 (834)
+.+..... .......||+.|+|||.+..+ .++.++|||||||++|||+| |+.|+......
T Consensus 366 ~~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~--- 426 (495)
T 1opk_A 366 RLMTGDTY---------------TAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--- 426 (495)
T ss_dssp ECCTTCCE---------------ECCTTCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---
T ss_pred eeccCCce---------------eecCCCcCCcceeCHhHHhcC-CCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH---
Confidence 86532110 011223468899999998755 57999999999999999999 99888653221
Q ss_pred hHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcCC
Q 003278 345 ILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGSY 409 (834)
Q Consensus 345 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~~ 409 (834)
.+...+ ..+..... . .. ....+.+|+..||+.||.+||+|.+|++.|+..+
T Consensus 427 ~~~~~~----~~~~~~~~-----~-~~----~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 427 QVYELL----EKDYRMER-----P-EG----CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp GHHHHH----HTTCCCCC-----C-TT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HHHHHH----HcCCCCCC-----C-CC----CCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 122211 11111110 0 11 1246888999999999999999999999998764
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=368.53 Aligned_cols=255 Identities=22% Similarity=0.310 Sum_probs=194.0
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEc
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDY 189 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 189 (834)
.++|...+.||+|+||.||+|+...+|+.||||++.... ...+.+.+|+.++++++|||||++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 467899999999999999999999899999999986542 2345688999999999999999999999999999999999
Q ss_pred cCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCc--eEEeeccchhh
Q 003278 190 MPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYN--ARLGDFGLARW 267 (834)
Q Consensus 190 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~--~kl~DFGla~~ 267 (834)
+++|+|.+++... ..+++..+..|+.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++.
T Consensus 98 ~~~~~L~~~l~~~-------~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~ 167 (361)
T 3uc3_A 98 ASGGELYERICNA-------GRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167 (361)
T ss_dssp CCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred CCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence 9999999998643 3589999999999999999999986 9999999999999987765 99999999974
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHH
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILL 347 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~ 347 (834)
.... .......||+.|+|||.+......+.++|||||||++|||+||+.||........ ..
T Consensus 168 ~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~ 228 (361)
T 3uc3_A 168 SVLH-----------------SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YR 228 (361)
T ss_dssp ------------------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HH
T ss_pred cccc-----------------CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HH
Confidence 2211 0123456999999999987654434459999999999999999999975433221 22
Q ss_pred HHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 348 DWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 348 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
..+....... .....+.. . ...+.+|+..||+.||.+|||+.++++.
T Consensus 229 ~~~~~~~~~~-~~~~~~~~-----~----s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 229 KTIQRILSVK-YSIPDDIR-----I----SPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp HHHHHHHTTC-CCCCTTSC-----C----CHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHhcCC-CCCCCcCC-----C----CHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 2222222111 00000001 1 1457889999999999999999999874
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=357.39 Aligned_cols=267 Identities=14% Similarity=0.195 Sum_probs=208.0
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhC-CCCceeeEeeeEEeCCEEEEEEE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHL-RHRNLVRLRGWCVHEDQLLLVYD 188 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E 188 (834)
.++|...+.||+|+||.||+|....+|+.||||++.... ..+.+.+|+.++.++ +|+||+++++++...+..++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 356899999999999999999998899999999986442 234578899999999 89999999999999999999999
Q ss_pred ccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCc-----eEEeecc
Q 003278 189 YMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYN-----ARLGDFG 263 (834)
Q Consensus 189 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~-----~kl~DFG 263 (834)
|+ +|+|.+++... ..++++..+..|+.|++.||+|||+. +|+||||||+|||++.++. +||+|||
T Consensus 87 ~~-~~~L~~~l~~~------~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg 156 (298)
T 1csn_A 87 LL-GPSLEDLLDLC------GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFG 156 (298)
T ss_dssp CC-CCBHHHHHHHT------TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred ec-CCCHHHHHHHh------ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECc
Confidence 99 99999999754 23589999999999999999999985 9999999999999987776 9999999
Q ss_pred chhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCcc
Q 003278 264 LARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQ 343 (834)
Q Consensus 264 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~ 343 (834)
+++.+...... ............||+.|+|||.+... .++.++|||||||++|||+||+.||........
T Consensus 157 ~~~~~~~~~~~---------~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 226 (298)
T 1csn_A 157 MVKFYRDPVTK---------QHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN 226 (298)
T ss_dssp TCEESBCTTTC---------CBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH
T ss_pred ccccccccccc---------ccccccCccCCCCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHcCCCCcchhhcccc
Confidence 99865432110 00001123456799999999998654 679999999999999999999999976443332
Q ss_pred chHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 344 IILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 344 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
......+............ . ... ...+.+++..||+.||.+||++.+|++.|...
T Consensus 227 ~~~~~~~~~~~~~~~~~~~-~-----~~~----~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~ 281 (298)
T 1csn_A 227 KQKYERIGEKKQSTPLREL-C-----AGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 281 (298)
T ss_dssp HHHHHHHHHHHHHSCHHHH-T-----TTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred HHHHHHHHhhccCccHHHH-H-----hhC----cHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence 2222222111111110000 0 111 14688999999999999999999999998765
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=390.98 Aligned_cols=256 Identities=21% Similarity=0.302 Sum_probs=204.3
Q ss_pred hCcCcCCcccccCCcEEEEEEECC-CcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDN-HQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~-~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
++|...+.||+|+||.||+|...+ +..||||.+..... ..+.|.+|+.+|++++|||||+++|+|.+.+..++||||
T Consensus 220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc--chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 346667889999999999999865 78899999875432 246799999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccccc
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTR 671 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~ 671 (834)
+++|+|.+++..... ..+++..++.|+.|+|.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 298 ~~~g~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 298 MTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp CTTCBHHHHHHHSCT----TTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred cCCCCHHHHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 999999999976432 248899999999999999999997 6899999999999999999999999999987543
Q ss_pred CCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCccc
Q 003278 672 NDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRPLA 750 (834)
Q Consensus 672 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (834)
... .......||+.|+|||++..+.++.++|||||||+||||+| |..|+...... .+...+ ....+.
T Consensus 371 ~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~-~~~~~~---~~~~~~-- 438 (495)
T 1opk_A 371 DTY------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QVYELL---EKDYRM-- 438 (495)
T ss_dssp CCE------ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-GHHHHH---HTTCCC--
T ss_pred Cce------eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH-HHHHHH---HcCCCC--
Confidence 211 11223457889999999999999999999999999999999 88888643322 222211 111110
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCC
Q 003278 751 ELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGND 798 (834)
Q Consensus 751 ~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~ 798 (834)
..... .+. .+.+++.+||+.||++||||.+|++.|+.+.
T Consensus 439 -----~~~~~-~~~---~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 439 -----ERPEG-CPE---KVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp -----CCCTT-CCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred -----CCCCC-CCH---HHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 01111 223 3556667999999999999999999998764
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=368.46 Aligned_cols=256 Identities=24% Similarity=0.316 Sum_probs=200.9
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC-----hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG-----ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLL 185 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 185 (834)
+.|+..+.||+|+||.||+|..+.+|+.||||++.... ....+.+.+|+.++.+++|||||++++++.+.+..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 45888999999999999999999999999999985421 1235779999999999999999999999999999999
Q ss_pred EEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCc---eEEeec
Q 003278 186 VYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYN---ARLGDF 262 (834)
Q Consensus 186 V~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~---~kl~DF 262 (834)
|||||++|+|.+.+..... ....+++..+..|+.|++.||.|||+. +|+||||||+|||++.++. +||+||
T Consensus 104 v~e~~~g~~L~~~l~~~~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRAD---AGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp EEECCSSCBHHHHHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred EEeCCCCCCHHHHHHHhcc---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecC
Confidence 9999999999888764321 234689999999999999999999996 9999999999999986554 999999
Q ss_pred cchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCc
Q 003278 263 GLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDD 342 (834)
Q Consensus 263 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~ 342 (834)
|+++.+.... .......||+.|+|||.+... .++.++|||||||++|||+||+.||...
T Consensus 178 g~a~~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~---- 236 (351)
T 3c0i_A 178 GVAIQLGESG----------------LVAGGRVGTPHFMAPEVVKRE-PYGKPVDVWGCGVILFILLSGCLPFYGT---- 236 (351)
T ss_dssp TTCEECCTTS----------------CBCCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCSS----
T ss_pred cceeEecCCC----------------eeecCCcCCcCccCHHHHcCC-CCCchHhhHHHHHHHHHHHHCCCCCCCc----
Confidence 9997543210 012345699999999998654 5799999999999999999999998642
Q ss_pred cchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 343 QIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 343 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
...+.. .... +... .++... ... ...+.+++..||+.||.+||++.++++.
T Consensus 237 ~~~~~~---~i~~-~~~~--~~~~~~-~~~----s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 237 KERLFE---GIIK-GKYK--MNPRQW-SHI----SESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp HHHHHH---HHHH-TCCC--CCHHHH-TTS----CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHH---HHHc-CCCC--CCcccc-ccC----CHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 111111 1111 1110 000000 011 1457889999999999999999999863
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=369.65 Aligned_cols=253 Identities=20% Similarity=0.258 Sum_probs=203.8
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEcc
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYM 190 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 190 (834)
++|+..+.||+|+||.||+|....+|+.||+|.+..........+.+|+.+|++++|||||++++++.+.+..++||||+
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 130 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 130 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcC
Confidence 57999999999999999999999999999999997665555678999999999999999999999999999999999999
Q ss_pred CCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECC--CCceEEeeccchhhh
Q 003278 191 PNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDS--QYNARLGDFGLARWL 268 (834)
Q Consensus 191 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~--~~~~kl~DFGla~~~ 268 (834)
++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++.+
T Consensus 131 ~gg~L~~~l~~~------~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~ 201 (387)
T 1kob_A 131 SGGELFDRIAAE------DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL 201 (387)
T ss_dssp CCCBHHHHTTCT------TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred CCCcHHHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceec
Confidence 999999988643 23589999999999999999999996 9999999999999974 567999999999854
Q ss_pred hhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHH
Q 003278 269 EHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLD 348 (834)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~ 348 (834)
.... ......||+.|+|||.+... .++.++|||||||++|||+||+.||.... ......
T Consensus 202 ~~~~-----------------~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~---~~~~~~ 260 (387)
T 1kob_A 202 NPDE-----------------IVKVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGED---DLETLQ 260 (387)
T ss_dssp CTTS-----------------CEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHH
T ss_pred CCCc-----------------ceeeeccCCCccCchhccCC-CCCCcccEeeHhHHHHHHHhCCCCCCCCC---HHHHHH
Confidence 3210 12345699999999988654 67999999999999999999999986432 111111
Q ss_pred HHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 349 WIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 349 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
.+.. .... .++... ... ...+.+++..||+.||.+||++.++++.
T Consensus 261 ---~i~~-~~~~--~~~~~~-~~~----s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 261 ---NVKR-CDWE--FDEDAF-SSV----SPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp ---HHHH-CCCC--CCSSTT-TTS----CHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ---HHHh-CCCC--CCcccc-ccC----CHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 1111 1110 011000 011 2457899999999999999999999864
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=382.35 Aligned_cols=254 Identities=27% Similarity=0.386 Sum_probs=203.9
Q ss_pred HhhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCC-EEEE
Q 003278 107 YIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHED-QLLL 185 (834)
Q Consensus 107 ~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-~~~l 185 (834)
.+..++|...+.||+|+||.||+|.+. |+.||||+++... ..+.|.+|+.+|++++|||||+++++|...+ ..++
T Consensus 189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~i 264 (450)
T 1k9a_A 189 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 264 (450)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEE
T ss_pred ccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEE
Confidence 345567888999999999999999983 7899999997543 4567999999999999999999999988765 7999
Q ss_pred EEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccch
Q 003278 186 VYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLA 265 (834)
Q Consensus 186 V~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla 265 (834)
||||+++|+|.+++.... ...+++..++.++.|+++||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 265 v~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a 336 (450)
T 1k9a_A 265 VTEYMAKGSLVDYLRSRG-----RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLT 336 (450)
T ss_dssp EEECCTTCBHHHHHHHHC-----TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEecCCCcHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCc
Confidence 999999999999997542 23478999999999999999999996 9999999999999999999999999999
Q ss_pred hhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccc
Q 003278 266 RWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQI 344 (834)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~ 344 (834)
+..... .....+|+.|+|||.+... .++.++|||||||++|||+| |+.|+......+
T Consensus 337 ~~~~~~-------------------~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-- 394 (450)
T 1k9a_A 337 KEASST-------------------QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-- 394 (450)
T ss_dssp EECC-------------------------CCCTTTSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--
T ss_pred cccccc-------------------ccCCCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--
Confidence 743211 1123578999999998655 67999999999999999999 999987543221
Q ss_pred hHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcCC
Q 003278 345 ILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGSY 409 (834)
Q Consensus 345 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~~ 409 (834)
+... ...+...... ... ...+.+|+..||+.||.+||++.++++.|+...
T Consensus 395 -~~~~----i~~~~~~~~p------~~~----~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 395 -VVPR----VEKGYKMDAP------DGC----PPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp -HHHH----HHTTCCCCCC------TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HHHH----HHcCCCCCCC------CcC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1111 1222111111 111 246889999999999999999999999987653
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=368.07 Aligned_cols=251 Identities=20% Similarity=0.279 Sum_probs=200.8
Q ss_pred hhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHHHHHhC-CCCceeeEeeeEEeCCEE
Q 003278 108 IGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVAVAHL-RHRNLVRLRGWCVHEDQL 183 (834)
Q Consensus 108 ~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~ 183 (834)
...++|...+.||+|+||.||+|+.+.+|+.||||++.... ....+.+..|..++..+ +||||+++++++.+.+.+
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 45578999999999999999999999999999999986532 23345678899999876 999999999999999999
Q ss_pred EEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeecc
Q 003278 184 LLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFG 263 (834)
Q Consensus 184 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFG 263 (834)
|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 94 ~lv~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG 163 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSC-------HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFG 163 (345)
T ss_dssp EEEEECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred EEEEeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeECh
Confidence 9999999999999998642 3589999999999999999999996 99999999999999999999999999
Q ss_pred chhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCcc
Q 003278 264 LARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQ 343 (834)
Q Consensus 264 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~ 343 (834)
+++..... .......+||+.|+|||.+... .++.++|||||||++|||+||+.||.... .
T Consensus 164 ~a~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~---~ 223 (345)
T 1xjd_A 164 MCKENMLG----------------DAKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQD---E 223 (345)
T ss_dssp TCBCCCCT----------------TCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSS---H
T ss_pred hhhhcccC----------------CCcccCCCCCcccCChhhhcCC-CCCChhhhHHHHHHHHHHhcCCCCCCCCC---H
Confidence 99743111 0114556899999999998654 67999999999999999999999986432 1
Q ss_pred chHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchh-hHHH
Q 003278 344 IILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMK-WVIE 403 (834)
Q Consensus 344 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~-~V~~ 403 (834)
..+.. .+.. +. +... ... ...+.+++..||+.||.+||++. ++.+
T Consensus 224 ~~~~~---~i~~-~~------~~~p-~~~----s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 224 EELFH---SIRM-DN------PFYP-RWL----EKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp HHHHH---HHHH-CC------CCCC-TTS----CHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred HHHHH---HHHh-CC------CCCC-ccc----CHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 11211 1111 11 1111 111 13577899999999999999997 5543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=353.64 Aligned_cols=255 Identities=24% Similarity=0.376 Sum_probs=204.8
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEc
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDY 189 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 189 (834)
.++|+..+.||+|+||.||+|.+. ++..||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 356888899999999999999995 68889999987543 2346799999999999999999999999999999999999
Q ss_pred cCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhh
Q 003278 190 MPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLE 269 (834)
Q Consensus 190 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~ 269 (834)
+++|+|.+++... ...+++..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 87 ~~~~~L~~~l~~~------~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 157 (269)
T 4hcu_A 87 MEHGCLSDYLRTQ------RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVL 157 (269)
T ss_dssp CTTCBHHHHHHTT------TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred CCCCcHHHHHHhc------CcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccc
Confidence 9999999999653 24689999999999999999999996 99999999999999999999999999998654
Q ss_pred hhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccchHHH
Q 003278 270 HELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQIILLD 348 (834)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~ 348 (834)
..... ......||+.|+|||.+... .++.++|||||||++|||+| |+.||...... .
T Consensus 158 ~~~~~---------------~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~------~ 215 (269)
T 4hcu_A 158 DDQYT---------------SSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------E 215 (269)
T ss_dssp CHHHH---------------STTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------H
T ss_pred ccccc---------------cccCcccccccCCHHHhcCC-CCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH------H
Confidence 32211 12233478899999998655 57999999999999999999 99888643211 1
Q ss_pred HHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 349 WIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 349 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
....... +. ....+ ... ...+.+++..||+.||.+||++.++++.|...
T Consensus 216 ~~~~~~~-~~--~~~~~----~~~----~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 216 VVEDIST-GF--RLYKP----RLA----STHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp HHHHHHT-TC--CCCCC----TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHhc-Cc--cCCCC----CcC----CHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 1111111 11 01111 111 24578899999999999999999999998764
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=372.22 Aligned_cols=274 Identities=15% Similarity=0.218 Sum_probs=205.7
Q ss_pred hcCCCCCCCeeeccCCeEEEEEEECCC-----CeEEEEEEecccChhhH-----------HHHHHHHHHHHhCCCCceee
Q 003278 109 GSNGFDEDEVLGSGGFGKVYRAVLPSD-----GTVVAVKCLAEKGERFE-----------KTFAAELVAVAHLRHRNLVR 172 (834)
Q Consensus 109 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~-----g~~vAvK~l~~~~~~~~-----------~~~~~E~~~l~~l~H~nIv~ 172 (834)
.+++|...+.||+|+||.||+|.+..+ ++.||||++........ ..+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 456899999999999999999998654 57899999865432211 22445666788889999999
Q ss_pred EeeeEEeC----CEEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCc
Q 003278 173 LRGWCVHE----DQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSN 248 (834)
Q Consensus 173 l~g~~~~~----~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~N 248 (834)
+++++... ...+|||||+ +|+|.+++... ...++|..++.|+.|++.||+|||+. +|+||||||+|
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~------~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~N 182 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN------AKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASN 182 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT------TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGG
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHH
Confidence 99999875 4589999999 99999999653 24699999999999999999999996 99999999999
Q ss_pred eEEC--CCCceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHH
Q 003278 249 VMLD--SQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVL 326 (834)
Q Consensus 249 ILld--~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ 326 (834)
||++ .++.+||+|||+++.+...... ............||+.|+|||.+... .++.++|||||||++|
T Consensus 183 ill~~~~~~~~kl~DFG~a~~~~~~~~~---------~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~ 252 (364)
T 3op5_A 183 LLLNYKNPDQVYLVDYGLAYRYCPEGVH---------KAYAADPKRCHDGTIEFTSIDAHNGV-APSRRGDLEILGYCMI 252 (364)
T ss_dssp EEEESSCTTCEEECCCTTCEESSGGGCC---------CCSSCCSSCCCCCCTTTCCHHHHTTC-CCCHHHHHHHHHHHHH
T ss_pred EEEecCCCCeEEEEECCcceecccCCcc---------cccccCcccccCCCCCccCHHHhCCC-CCCchhhHHHHHHHHH
Confidence 9999 8899999999999865432110 00011112455699999999988654 5799999999999999
Q ss_pred HHHhCCccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhh
Q 003278 327 EVVSGRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVS 406 (834)
Q Consensus 327 ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~ 406 (834)
||+||+.||.....+. ....+...... ..+....++.+.....+ ..+.+++..||+.+|.+||++.+|++.|.
T Consensus 253 el~~g~~Pf~~~~~~~--~~~~~~~~~~~-~~~~~~~~~~~~~~~~~----~~~~~li~~cl~~~p~~RP~~~~l~~~l~ 325 (364)
T 3op5_A 253 QWLTGHLPWEDNLKDP--KYVRDSKIRYR-ENIASLMDKCFPAANAP----GEIAKYMETVKLLDYTEKPLYENLRDILL 325 (364)
T ss_dssp HHHHSCCTTGGGTTCH--HHHHHHHHHHH-HCHHHHHHHHSCTTCCC----HHHHHHHHHHHTCCTTCCCCHHHHHHHHH
T ss_pred HHHhCCCCccccccCH--HHHHHHHHHhh-hhHHHHHHHhcccccCH----HHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Confidence 9999999997533222 12222221111 12233333333212222 46788999999999999999999999987
Q ss_pred cCC
Q 003278 407 GSY 409 (834)
Q Consensus 407 ~~~ 409 (834)
..+
T Consensus 326 ~~~ 328 (364)
T 3op5_A 326 QGL 328 (364)
T ss_dssp HHH
T ss_pred HHH
Confidence 643
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=381.29 Aligned_cols=268 Identities=20% Similarity=0.229 Sum_probs=208.8
Q ss_pred ccccHHHHHhhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHHHHHhCCCCceeeEee
Q 003278 99 RIFSYAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVAVAHLRHRNLVRLRG 175 (834)
Q Consensus 99 ~~f~~~el~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g 175 (834)
..+.+.++....++|+..+.||+|+||+||+|+.+.+|+.||||++.+.. ....+.+.+|+.++.+++|||||++++
T Consensus 49 ~~~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~ 128 (412)
T 2vd5_A 49 IVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHF 128 (412)
T ss_dssp HHHHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEE
T ss_pred hhhhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEE
Confidence 34667788888999999999999999999999999899999999986532 122345788999999999999999999
Q ss_pred eEEeCCEEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCC
Q 003278 176 WCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQY 255 (834)
Q Consensus 176 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~ 255 (834)
+|.+.+.+||||||+++|+|.++|.+. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++
T Consensus 129 ~~~~~~~~~lVmE~~~gg~L~~~l~~~------~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g 199 (412)
T 2vd5_A 129 AFQDENYLYLVMEYYVGGDLLTLLSKF------GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCG 199 (412)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHHH------SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTS
T ss_pred EEeeCCEEEEEEcCCCCCcHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCC
Confidence 999999999999999999999999653 23689999999999999999999996 999999999999999999
Q ss_pred ceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCcccccc------CCCCCcccceeehhhHHHHHH
Q 003278 256 NARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQK------GSVATAKSDVFSFGIVVLEVV 329 (834)
Q Consensus 256 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~------~~~~~~ksDV~SfGvvl~Ell 329 (834)
++||+|||+++.+.... .......+||+.|+|||++.. +..++.++|||||||++|||+
T Consensus 200 ~vkL~DFGla~~~~~~~---------------~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyell 264 (412)
T 2vd5_A 200 HIRLADFGSCLKLRADG---------------TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMF 264 (412)
T ss_dssp CEEECCCTTCEECCTTS---------------CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHH
T ss_pred CEEEeechhheeccCCC---------------ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHH
Confidence 99999999997543210 011234679999999999863 235789999999999999999
Q ss_pred hCCccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCC---CchhhHHHH
Q 003278 330 SGRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLR---PSMKWVIEA 404 (834)
Q Consensus 330 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~R---Psm~~V~~~ 404 (834)
||+.||..... .... ..+........ -+... ...+ ..+.+++..||. +|.+| |++.++.+.
T Consensus 265 tG~~Pf~~~~~---~~~~---~~i~~~~~~~~--~p~~~-~~~s----~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 265 YGQTPFYADST---AETY---GKIVHYKEHLS--LPLVD-EGVP----EEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HSSCTTCCSSH---HHHH---HHHHTHHHHCC--CC-----CCC----HHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred hCCCCCCCCCH---HHHH---HHHHhcccCcC--CCccc-cCCC----HHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 99999964321 1111 11111000000 01000 1111 357789999999 99998 588888753
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=367.60 Aligned_cols=253 Identities=25% Similarity=0.327 Sum_probs=201.8
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 187 (834)
.++|+..+.||+|+||.||+|....+|..||||++... .....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 45799999999999999999999999999999998654 2344567899999999999999999999999999999999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCC---CceEEeeccc
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQ---YNARLGDFGL 264 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~---~~~kl~DFGl 264 (834)
||+++|+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||+
T Consensus 108 e~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~ 177 (362)
T 2bdw_A 108 DLVTGGELFEDIVAR-------EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGL 177 (362)
T ss_dssp CCCCSCBHHHHHTTC-------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred ecCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCc
Confidence 999999999988643 4589999999999999999999996 99999999999999865 4599999999
Q ss_pred hhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccc
Q 003278 265 ARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQI 344 (834)
Q Consensus 265 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~ 344 (834)
++..... .......||+.|+|||.+... .++.++|||||||++|||+||+.||.... ..
T Consensus 178 a~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~Pf~~~~---~~ 236 (362)
T 2bdw_A 178 AIEVNDS-----------------EAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDED---QH 236 (362)
T ss_dssp CBCCTTC-----------------CSCCCSCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HH
T ss_pred ceEecCC-----------------cccccCCCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCC---HH
Confidence 9754321 012345799999999998654 67999999999999999999999986421 11
Q ss_pred hHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 345 ILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 345 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
.+...+. .+... ...+.. .. ....+.+++..||+.||.+||++.++++.
T Consensus 237 ~~~~~i~----~~~~~-~~~~~~--~~----~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 237 RLYAQIK----AGAYD-YPSPEW--DT----VTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp HHHHHHH----HTCCC-CCTTGG--GG----SCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHHHH----hCCCC-CCcccc--cC----CCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1221111 11110 000000 00 12457889999999999999999998764
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=358.09 Aligned_cols=264 Identities=23% Similarity=0.292 Sum_probs=198.0
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC--hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG--ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYD 188 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 188 (834)
++|+..+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence 4688889999999999999999 679999999986432 2234678899999999999999999999999999999999
Q ss_pred ccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhh
Q 003278 189 YMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWL 268 (834)
Q Consensus 189 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~ 268 (834)
|+++ +|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~~~-~l~~~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 150 (288)
T 1ob3_A 81 HLDQ-DLKKLLDVC------EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF 150 (288)
T ss_dssp CCSE-EHHHHHHTS------TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHH
T ss_pred ecCC-CHHHHHHhc------ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECcccccc
Confidence 9985 898888643 24589999999999999999999996 9999999999999999999999999999754
Q ss_pred hhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHH
Q 003278 269 EHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLD 348 (834)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~ 348 (834)
.... ...+...||+.|+|||.+.....++.++|||||||++|||+||+.||...... ....
T Consensus 151 ~~~~----------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~ 211 (288)
T 1ob3_A 151 GIPV----------------RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA---DQLM 211 (288)
T ss_dssp CC-------------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHH
T ss_pred Cccc----------------cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHH
Confidence 3210 01234468999999999876556899999999999999999999998643211 1111
Q ss_pred HHHHHhhcCcc---c-----cccccccCCC------CCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 349 WIRRLSDEGKV---L-----QAGDNRLSDG------SYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 349 ~~~~~~~~~~~---~-----~~~d~~l~~~------~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
.+......... . ...++..... .........+.+++..||+.||.+||++.++++.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 212 RIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp HHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 11111111000 0 0001110000 0000112457789999999999999999999863
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=354.27 Aligned_cols=266 Identities=15% Similarity=0.171 Sum_probs=205.7
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhc-cCCCceeEEEEEeeCCeEEEEEe
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARL-RHRNLVQLCGWCTEQGEMLVIYD 590 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l-~HpNiv~l~g~~~~~~~~~lv~E 590 (834)
++|...+.||+|+||.||+|.. .+++.||||.+...... +.+.+|+.++.++ +||||+++++++.+....++|||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA---PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS---CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc---HHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 4677788999999999999995 67889999998644322 3577899999999 89999999999999999999999
Q ss_pred ccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCC-----ceEeeeee
Q 003278 591 YSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMN-----PRLGSFAL 665 (834)
Q Consensus 591 y~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~-----~ki~DfGl 665 (834)
|+ +++|.+++...+. .+++..+..|+.|++.||+|||+ .+|+||||||+|||++.++. +||+|||+
T Consensus 87 ~~-~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~ 157 (298)
T 1csn_A 87 LL-GPSLEDLLDLCGR-----KFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 157 (298)
T ss_dssp CC-CCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred ec-CCCHHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence 99 9999999976432 38899999999999999999996 69999999999999987776 99999999
Q ss_pred ccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCch--hHHHHHHHHH
Q 003278 666 AEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEG--LLVKRVHEFE 743 (834)
Q Consensus 666 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~--~~~~~~~~~~ 743 (834)
++....................||+.|+|||++.+..++.++|||||||++|||+||+.||....... .....+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (298)
T 1csn_A 158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK 237 (298)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred ccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhc
Confidence 98765432211111112345679999999999999999999999999999999999999997543221 1112111111
Q ss_pred hhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCcc
Q 003278 744 ARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDKR 800 (834)
Q Consensus 744 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~~ 800 (834)
. ..+..++ ...++ + .+.+++.+||+.||++|||+.+|++.|+.+.++
T Consensus 238 ~-~~~~~~~-----~~~~~-~---~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~ 284 (298)
T 1csn_A 238 Q-STPLREL-----CAGFP-E---EFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 284 (298)
T ss_dssp H-HSCHHHH-----TTTSC-H---HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred c-CccHHHH-----HhhCc-H---HHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence 1 1111111 11122 2 455566689999999999999999999876543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=354.89 Aligned_cols=261 Identities=18% Similarity=0.283 Sum_probs=201.4
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCC--ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSK--CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIY 589 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~--~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~ 589 (834)
+.|...+.||+|+||.||+|.. .++..||||.+.... .....++|.+|+.++++++|||||++++++.+.+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 4567778899999999999985 468899999985432 3445678999999999999999999999999999999999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccc
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFL 669 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~ 669 (834)
||+++|+|.+++...+ .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 91 e~~~g~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 161 (294)
T 4eqm_A 91 EYIEGPTLSEYIESHG------PLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL 161 (294)
T ss_dssp ECCCSCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC
T ss_pred eCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCcccc
Confidence 9999999999986542 48899999999999999999997 68999999999999999999999999999765
Q ss_pred ccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcc
Q 003278 670 TRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPL 749 (834)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
.... ........||+.|+|||++.+..++.++|||||||++|||+||+.||............. ....
T Consensus 162 ~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~------~~~~ 229 (294)
T 4eqm_A 162 SETS------LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHI------QDSV 229 (294)
T ss_dssp -------------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHH------SSCC
T ss_pred cccc------ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh------hccC
Confidence 3321 111234679999999999999999999999999999999999999997543322211111 1111
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCC-ChhHHHHHHccCCc
Q 003278 750 AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRP-SMRQILSILDGNDK 799 (834)
Q Consensus 750 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RP-tm~~v~~~L~~~~~ 799 (834)
... ........+ . .+.+++.+||+.||++|| ++.++.+.|+..-.
T Consensus 230 ~~~-~~~~~~~~~-~---~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 230 PNV-TTDVRKDIP-Q---SLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp CCH-HHHSCTTSC-H---HHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred CCc-chhcccCCC-H---HHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 111 011111222 2 345566699999999999 89999999986543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=375.26 Aligned_cols=254 Identities=23% Similarity=0.278 Sum_probs=201.2
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC--hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG--ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 187 (834)
+++|+..+.||+|+||.||+|....+|+.||+|++.... ....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 356888999999999999999999999999999986543 234567899999999999999999999999999999999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEEC---CCCceEEeeccc
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLD---SQYNARLGDFGL 264 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld---~~~~~kl~DFGl 264 (834)
||+++|+|.+.+... ..+++..+..++.|++.||.|||+. +|+||||||+|||++ .++.+||+|||+
T Consensus 90 E~~~gg~L~~~i~~~-------~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~ 159 (444)
T 3soa_A 90 DLVTGGELFEDIVAR-------EYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGL 159 (444)
T ss_dssp CCCBCCBHHHHHHHC-------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSS
T ss_pred EeCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCce
Confidence 999999999988653 4589999999999999999999996 999999999999998 467899999999
Q ss_pred hhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccc
Q 003278 265 ARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQI 344 (834)
Q Consensus 265 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~ 344 (834)
++...... .......||+.|+|||.+... .++.++|||||||++|||++|+.||.... ..
T Consensus 160 a~~~~~~~----------------~~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyell~G~~Pf~~~~---~~ 219 (444)
T 3soa_A 160 AIEVEGEQ----------------QAWFGFAGTPGYLSPEVLRKD-PYGKPVDLWACGVILYILLVGYPPFWDED---QH 219 (444)
T ss_dssp CBCCCTTC----------------CBCCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSCCCSS---HH
T ss_pred eEEecCCC----------------ceeecccCCcccCCHHHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCcc---HH
Confidence 97543210 112345799999999998654 67999999999999999999999985421 11
Q ss_pred hHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 345 ILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 345 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
.+.. .+. .+... ...+.. ... ...+.+++..||+.||.+||++.++++.
T Consensus 220 ~~~~---~i~-~~~~~-~~~~~~--~~~----s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 220 RLYQ---QIK-AGAYD-FPSPEW--DTV----TPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp HHHH---HHH-HTCCC-CCTTTT--TTS----CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHH---HHH-hCCCC-CCcccc--ccC----CHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1211 111 11111 111100 011 1457889999999999999999999873
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=368.41 Aligned_cols=248 Identities=26% Similarity=0.403 Sum_probs=199.6
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 187 (834)
+.|+..+.||+|+||.||+|+...+|+.||||++.... ....+.|.+|+.++++++|||||+++++|...+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 45888899999999999999998899999999986432 233467899999999999999999999999999999999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
||++ |+|.+++... ..++++..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 134 e~~~-g~l~~~l~~~------~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 203 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH------KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASI 203 (348)
T ss_dssp ECCS-EEHHHHHHHH------TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred ecCC-CCHHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCcee
Confidence 9997 6888777532 24689999999999999999999996 999999999999999999999999999975
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCcccccc--CCCCCcccceeehhhHHHHHHhCCccCCCCCCCccch
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQK--GSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQII 345 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~ 345 (834)
... .....||+.|+|||.+.. +..++.++|||||||++|||+||+.||....
T Consensus 204 ~~~--------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~------ 257 (348)
T 1u5q_A 204 MAP--------------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------ 257 (348)
T ss_dssp SSS--------------------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------
T ss_pred cCC--------------------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC------
Confidence 321 234569999999998852 3467899999999999999999999985421
Q ss_pred HHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 346 LLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 346 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
....+....... .+.+....++ ..+.+++..||+.||.+||++.++++.
T Consensus 258 ~~~~~~~~~~~~------~~~~~~~~~~----~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 258 AMSALYHIAQNE------SPALQSGHWS----EYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp HHHHHHHHHHSC------CCCCCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred hHHHHHHHHhcC------CCCCCCCCCC----HHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 111222222211 1111111222 357889999999999999999999864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=357.24 Aligned_cols=266 Identities=22% Similarity=0.270 Sum_probs=200.3
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYD 188 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 188 (834)
++|+..+.||+|+||+||+|....+|+.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 4688889999999999999999999999999998643 33445778999999999999999999999999999999999
Q ss_pred ccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhh
Q 003278 189 YMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWL 268 (834)
Q Consensus 189 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~ 268 (834)
|+++ +|.+.+... ...+++..+..|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 82 ~~~~-~l~~~~~~~------~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~ 151 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSC------NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF 151 (292)
T ss_dssp CCSE-EHHHHHHHT------TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred cCCC-CHHHHHHhC------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 9986 555555432 24689999999999999999999996 9999999999999999999999999999754
Q ss_pred hhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHH
Q 003278 269 EHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLD 348 (834)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~ 348 (834)
... ....+...||+.|+|||.+.....++.++|||||||++|||+||+.|+..... ......
T Consensus 152 ~~~----------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~--~~~~~~ 213 (292)
T 3o0g_A 152 GIP----------------VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLK 213 (292)
T ss_dssp CSC----------------CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--HHHHHH
T ss_pred CCc----------------cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC--HHHHHH
Confidence 211 01123456899999999987665679999999999999999999988643211 111122
Q ss_pred HHHHHhhcCc---c---ccccccc---c-----CCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 349 WIRRLSDEGK---V---LQAGDNR---L-----SDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 349 ~~~~~~~~~~---~---~~~~d~~---l-----~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
.+........ . ....+.. . ............+.+++..||+.||.+|||+.|+++.
T Consensus 214 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 214 RIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp HHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 2222111100 0 0000000 0 0000001112457789999999999999999999863
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=364.85 Aligned_cols=254 Identities=21% Similarity=0.314 Sum_probs=189.1
Q ss_pred hhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEE
Q 003278 108 IGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 108 ~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 187 (834)
...++|+..+.||+|+||.||+|.+..+++.||||++.... ..+.+.+|+.++++++||||++++++|...+..++||
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 34577999999999999999999998899999999987542 3466889999999999999999999999999999999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECC---CCceEEeeccc
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDS---QYNARLGDFGL 264 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~---~~~~kl~DFGl 264 (834)
||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+
T Consensus 128 e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~ 197 (349)
T 2w4o_A 128 ELVTGGELFDRIVEK-------GYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGL 197 (349)
T ss_dssp CCCCSCBHHHHHTTC-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC-
T ss_pred EeCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCcc
Confidence 999999999998643 3589999999999999999999996 9999999999999975 88999999999
Q ss_pred hhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccc
Q 003278 265 ARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQI 344 (834)
Q Consensus 265 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~ 344 (834)
++...... ......||+.|+|||.+... .++.++|||||||++|||+||+.||...... .
T Consensus 198 a~~~~~~~-----------------~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~ 257 (349)
T 2w4o_A 198 SKIVEHQV-----------------LMKTVCGTPGYCAPEILRGC-AYGPEVDMWSVGIITYILLCGFEPFYDERGD--Q 257 (349)
T ss_dssp --------------------------------CGGGSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH--H
T ss_pred ccccCccc-----------------ccccccCCCCccCHHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCccc--H
Confidence 98643211 12345699999999998654 6799999999999999999999998643221 1
Q ss_pred hHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 345 ILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 345 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
.+. ..... +... ...+.. ... ...+.+++..||+.||.+||++.++++.
T Consensus 258 ~~~---~~i~~-~~~~-~~~~~~--~~~----~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 258 FMF---RRILN-CEYY-FISPWW--DEV----SLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp HHH---HHHHT-TCCC-CCTTTT--TTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHH---HHHHh-CCCc-cCCchh--hhC----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111 11111 1110 011100 111 2457889999999999999999999873
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=352.49 Aligned_cols=253 Identities=28% Similarity=0.435 Sum_probs=191.8
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC----hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG----ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLL 185 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 185 (834)
.++|+..+.||+|+||.||+|.+ .|..||||++.... ....+.+.+|+.+++.++||||++++++|...+..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 46788899999999999999998 48999999986432 2334678999999999999999999999999999999
Q ss_pred EEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECC--------CCce
Q 003278 186 VYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDS--------QYNA 257 (834)
Q Consensus 186 V~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~--------~~~~ 257 (834)
||||+++|+|.+++.. ..+++..+..++.|++.||.|||+....+|+||||||+|||++. ++.+
T Consensus 84 v~e~~~~~~L~~~~~~--------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~ 155 (271)
T 3dtc_A 84 VMEFARGGPLNRVLSG--------KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKIL 155 (271)
T ss_dssp EEECCTTEEHHHHHTS--------SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCE
T ss_pred EEEcCCCCCHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcce
Confidence 9999999999999843 35899999999999999999999973234999999999999986 6779
Q ss_pred EEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCC
Q 003278 258 RLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDL 337 (834)
Q Consensus 258 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~ 337 (834)
||+|||+++...... .....||+.|+|||.+... .++.++|||||||++|||+||+.||..
T Consensus 156 kl~Dfg~~~~~~~~~------------------~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~ 216 (271)
T 3dtc_A 156 KITDFGLAREWHRTT------------------KMSAAGAYAWMAPEVIRAS-MFSKGSDVWSYGVLLWELLTGEVPFRG 216 (271)
T ss_dssp EECCCCC-------------------------------CCGGGSCHHHHHHC-CCSHHHHHHHHHHHHHHHHHCCCTTTT
T ss_pred EEccCCccccccccc------------------ccCCCCccceeCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999997543221 2234699999999988654 679999999999999999999999864
Q ss_pred CCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhc
Q 003278 338 TYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSG 407 (834)
Q Consensus 338 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~ 407 (834)
.... . ........ .... ... ... ...+.+++..||+.||.+||++.++++.|+.
T Consensus 217 ~~~~---~---~~~~~~~~-~~~~----~~~-~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 217 IDGL---A---VAYGVAMN-KLAL----PIP-STC----PEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp SCHH---H---HHHHHHTS-CCCC----CCC-TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred CCHH---H---HHHhhhcC-CCCC----CCC-ccc----CHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 3211 1 11111111 1110 010 111 2468899999999999999999999999864
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=370.63 Aligned_cols=264 Identities=22% Similarity=0.286 Sum_probs=207.8
Q ss_pred hCcCcCCcccccCCcEEEEEEE--------CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhc-cCCCceeEEEEEeeCC
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL--------DNHQYVLVKRLGMSKCPALRTRFSNELQNLARL-RHRNLVQLCGWCTEQG 583 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~--------~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l-~HpNiv~l~g~~~~~~ 583 (834)
++|...+.||+|+||.||+|.. .++..||||++.........++|.+|+++++++ +|||||+++++|.+.+
T Consensus 69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 148 (382)
T 3tt0_A 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 148 (382)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCC
Confidence 4566678899999999999985 224579999998766666667899999999999 9999999999999999
Q ss_pred eEEEEEeccCCCchhhhhhcCCCC----------CCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeec
Q 003278 584 EMLVIYDYSATRILSHLLFHNNHR----------IGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLD 653 (834)
Q Consensus 584 ~~~lv~Ey~~~g~L~~~l~~~~~~----------~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld 653 (834)
..++||||+++|+|.+++...... .....+++..++.|+.|++.||+|||+ .+|+||||||+||||+
T Consensus 149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~ 225 (382)
T 3tt0_A 149 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT 225 (382)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEC
T ss_pred ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceEEEc
Confidence 999999999999999999765321 112358999999999999999999997 6999999999999999
Q ss_pred CCCCceEeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCc
Q 003278 654 PDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPE 732 (834)
Q Consensus 654 ~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~ 732 (834)
+++.+||+|||+++....... ........||+.|+|||++.+..++.++|||||||++|||+| |..|+......
T Consensus 226 ~~~~~kL~DFG~a~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~ 300 (382)
T 3tt0_A 226 EDNVMKIADFGLARDIHHIDY-----YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300 (382)
T ss_dssp TTCCEEECSCSCCCCSSCCCT-----TCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred CCCcEEEcccCcccccccccc-----cccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999986543221 111233468899999999999999999999999999999999 88888643322
Q ss_pred hhHHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCc
Q 003278 733 GLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDK 799 (834)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~ 799 (834)
.+...+. ..... ...... .. .+.+++.+||+.||++|||+.+|++.|+.+..
T Consensus 301 -~~~~~~~---~~~~~-------~~~~~~-~~---~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 352 (382)
T 3tt0_A 301 -ELFKLLK---EGHRM-------DKPSNC-TN---ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 352 (382)
T ss_dssp -HHHHHHH---TTCCC-------CCCSSC-CH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHHHHH---cCCCC-------CCCccC-CH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 2211111 11110 111112 23 35556669999999999999999999986643
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=360.01 Aligned_cols=265 Identities=16% Similarity=0.271 Sum_probs=188.1
Q ss_pred hhCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEe
Q 003278 512 TNNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYD 590 (834)
Q Consensus 512 t~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~E 590 (834)
.++|...+.||+|+||.||+|.. .+++.||||.+.........+.+.+|+.+|++++|||||++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 35678888999999999999986 45889999998765444444678899999999999999999999999999999999
Q ss_pred ccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccc
Q 003278 591 YSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLT 670 (834)
Q Consensus 591 y~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~ 670 (834)
|++ |+|.+++...........+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 999 5888888654322222358888999999999999999997 699999999999999999999999999997653
Q ss_pred cCCCCCcccccCccccccccCccchhcccc-CCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhc-Cc
Q 003278 671 RNDHGHRKATSGNRSVRGIFGYMSPEYIES-GEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARK-RP 748 (834)
Q Consensus 671 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~-~~ 748 (834)
... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||........ ...+....... ..
T Consensus 160 ~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~ 231 (317)
T 2pmi_A 160 IPV-------NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ-LKLIFDIMGTPNES 231 (317)
T ss_dssp SCC-------CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCSCCTT
T ss_pred CCc-------ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCChh
Confidence 221 11224578999999999976 4689999999999999999999999975443322 22222211100 00
Q ss_pred -cc---------------------cccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 749 -LA---------------------ELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 749 -~~---------------------~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
+. +.+.+......+ . .+..++.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~---~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 232 LWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLD-G---NLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp TCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCC-H---HHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HhhhhhhhhhcccccccccchhHHHhhcccccccCC-H---HHHHHHHHHCCCCcccCCCHHHHhC
Confidence 00 000011111111 2 3556666999999999999999875
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=358.83 Aligned_cols=265 Identities=20% Similarity=0.296 Sum_probs=198.2
Q ss_pred hCcCcCCcccccCCcEEEEEEE-----CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeC--CeE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-----DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQ--GEM 585 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-----~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~--~~~ 585 (834)
++|...+.||+|+||+||+|.+ .+++.||||++... .....+.|.+|+.+|++++|||||+++++|... ...
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 4566678899999999999985 35789999998744 344457899999999999999999999998653 558
Q ss_pred EEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeee
Q 003278 586 LVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFAL 665 (834)
Q Consensus 586 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGl 665 (834)
++||||+++|+|.+++..... .+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKE-----RIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGL 160 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGG-----GCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred EEEEEeCCCCCHHHHHHhccc-----ccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCcc
Confidence 999999999999999976432 38899999999999999999997 6999999999999999999999999999
Q ss_pred ccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCc----------hhH
Q 003278 666 AEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPE----------GLL 735 (834)
Q Consensus 666 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~----------~~~ 735 (834)
++........ ........||..|+|||.+.+..++.++|||||||++|||+||..|+...... ...
T Consensus 161 ~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T 3ugc_A 161 TKVLPQDKEF----FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 236 (295)
T ss_dssp CC-----------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHH
T ss_pred cccccCCcce----eeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccch
Confidence 9875433211 11122345788899999999999999999999999999999999887532110 000
Q ss_pred -HHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCcc
Q 003278 736 -VKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDKR 800 (834)
Q Consensus 736 -~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~~ 800 (834)
............ ....... .++ .+.+++.+||+.||++|||+.+|++.|+.+.++
T Consensus 237 ~~~~~~~~~~~~~------~~~~~~~-~~~---~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 237 IVFHLIELLKNNG------RLPRPDG-CPD---EIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHHHHHHHTTC------CCCCCTT-CCH---HHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hHHHHHHHHhccC------cCCCCcC-cCH---HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 001111000000 0011111 223 355566699999999999999999999876554
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=355.76 Aligned_cols=265 Identities=23% Similarity=0.267 Sum_probs=199.7
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC--hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG--ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYD 188 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 188 (834)
++|+..+.||+|+||.||+|.+..+|+.||||++.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 56888999999999999999998899999999885432 3345778899999999999999999999999999999999
Q ss_pred ccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhh
Q 003278 189 YMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWL 268 (834)
Q Consensus 189 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~ 268 (834)
|+++++|..++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 83 ~~~~~~l~~~~~~~-------~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 152 (311)
T 4agu_A 83 YCDHTVLHELDRYQ-------RGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLL 152 (311)
T ss_dssp CCSEEHHHHHHHTS-------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred eCCCchHHHHHhhh-------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhc
Confidence 99999999887542 4589999999999999999999996 9999999999999999999999999999764
Q ss_pred hhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHH
Q 003278 269 EHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLD 348 (834)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~ 348 (834)
..... ......||+.|+|||.+.....++.++|||||||++|||+||+.||......+.. .
T Consensus 153 ~~~~~----------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~ 213 (311)
T 4agu_A 153 TGPSD----------------YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQL---Y 213 (311)
T ss_dssp C----------------------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---H
T ss_pred cCccc----------------ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH---H
Confidence 32210 1234468999999999876557799999999999999999999998653322111 1
Q ss_pred HHHHH-----------hhcCccccccccccCCCCCCH-----HHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 349 WIRRL-----------SDEGKVLQAGDNRLSDGSYKL-----CDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 349 ~~~~~-----------~~~~~~~~~~d~~l~~~~~~~-----~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
.+... ..................... .....+.+++..||+.||.+|||+.++++.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 214 LIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp HHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred HHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 11111 011110000000000000000 012357889999999999999999999864
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=357.35 Aligned_cols=269 Identities=16% Similarity=0.174 Sum_probs=205.3
Q ss_pred hCcCcCCcccccCCcEEEEEEECC-CcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCC--eEEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDN-HQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQG--EMLVIY 589 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~-~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~--~~~lv~ 589 (834)
+.|...+.||+|+||+||+|.... ++.||||++.........+.+.+|+++|++++|||||++++++.+.. ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 346667889999999999999754 88999999875443344567889999999999999999999988655 789999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceee----cCCCCceEeeeee
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITL----DPDMNPRLGSFAL 665 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILl----d~~~~~ki~DfGl 665 (834)
||+++|+|.+++...... ..+++..+..|+.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||+
T Consensus 89 e~~~~~~L~~~l~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNA---YGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp ECCTTCBHHHHHHSGGGT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred eCCCCCCHHHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 999999999999764322 238899999999999999999997 699999999999999 7888899999999
Q ss_pred ccccccCCCCCcccccCccccccccCccchhccc--------cCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHH
Q 003278 666 AEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIE--------SGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVK 737 (834)
Q Consensus 666 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~--------~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~ 737 (834)
++...... ......||+.|+|||++. +..++.++|||||||++|||+||+.||...........
T Consensus 163 a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 234 (319)
T 4euu_A 163 ARELEDDE--------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234 (319)
T ss_dssp CEECCTTC--------CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHH
T ss_pred ceecCCCC--------ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHH
Confidence 98654321 122457999999999986 57889999999999999999999999964333222222
Q ss_pred HHHHHHhhcCc--cccc-------c----ccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHc
Q 003278 738 RVHEFEARKRP--LAEL-------V----DLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795 (834)
Q Consensus 738 ~~~~~~~~~~~--~~~~-------~----d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~ 795 (834)
..........+ +..+ + +...........-..+..+..+||+.||++|||+.|+++..+
T Consensus 235 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp HHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred HHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 22222111110 0000 0 001111223344445667778999999999999999998775
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=368.88 Aligned_cols=249 Identities=19% Similarity=0.290 Sum_probs=195.1
Q ss_pred CCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEccCCCC
Q 003278 115 EDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNRS 194 (834)
Q Consensus 115 ~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 194 (834)
..+.||+|+||.||+|....+|+.||||++........+.|.+|+.++.+++|||||+++++|.+.+..+|||||+++|+
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 35689999999999999988999999999987665667789999999999999999999999999999999999999999
Q ss_pred HhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEE--CCCCceEEeeccchhhhhhhh
Q 003278 195 LDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVML--DSQYNARLGDFGLARWLEHEL 272 (834)
Q Consensus 195 L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILl--d~~~~~kl~DFGla~~~~~~~ 272 (834)
|.+++.... ..+++..+..|+.|+++||.|||+. +|+||||||+|||+ +.++.+||+|||+++.+....
T Consensus 173 L~~~l~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~ 243 (373)
T 2x4f_A 173 LFDRIIDES------YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243 (373)
T ss_dssp EHHHHHHTG------GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred HHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence 999886532 3589999999999999999999996 99999999999999 567889999999998543210
Q ss_pred hhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHHHHH
Q 003278 273 QYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIRR 352 (834)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~ 352 (834)
......||+.|+|||.+... .++.++|||||||++|||+||+.||..... . .....
T Consensus 244 -----------------~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~---~---~~~~~ 299 (373)
T 2x4f_A 244 -----------------KLKVNFGTPEFLAPEVVNYD-FVSFPTDMWSVGVIAYMLLSGLSPFLGDND---A---ETLNN 299 (373)
T ss_dssp -----------------BCCCCCSSCTTCCHHHHTTC-BCCHHHHHHHHHHHHHHHHHSSCTTCCSSH---H---HHHHH
T ss_pred -----------------ccccccCCCcEeChhhccCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCH---H---HHHHH
Confidence 12334699999999988644 679999999999999999999999864321 1 11112
Q ss_pred HhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 353 LSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 353 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
+..... ...+... ... ...+.+++..||+.||.+||++.++++.
T Consensus 300 i~~~~~--~~~~~~~--~~~----~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 300 ILACRW--DLEDEEF--QDI----SEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp HHHTCC--CSCSGGG--TTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHhccC--CCChhhh--ccC----CHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 211110 0000000 111 1457889999999999999999999873
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=359.39 Aligned_cols=258 Identities=22% Similarity=0.344 Sum_probs=195.9
Q ss_pred hCcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEecc
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYS 592 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~ 592 (834)
++|...+.||+|+||.||+|... +..||||.+... ...+.|.+|+.+|++++|||||+++|++.+ ..++||||+
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~ 81 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA 81 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST---THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh---hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence 35666788999999999999875 578999998632 345789999999999999999999998874 478999999
Q ss_pred CCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCC-ceEeeeeecccccc
Q 003278 593 ATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMN-PRLGSFALAEFLTR 671 (834)
Q Consensus 593 ~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~-~ki~DfGla~~~~~ 671 (834)
++|+|.+++..... ...+++..++.++.|+++||+|||+....+|+||||||+|||++.++. +||+|||++.....
T Consensus 82 ~~~~L~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 82 EGGSLYNVLHGAEP---LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp TTCBHHHHHHCSSS---EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred CCCCHHHHHhccCC---CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 99999999975432 224778889999999999999999754468999999999999998886 79999999965422
Q ss_pred CCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcccc
Q 003278 672 NDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAE 751 (834)
Q Consensus 672 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
. .....||+.|+|||++.+..++.++|||||||++|||+||+.||........... ........+
T Consensus 159 ~----------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~--~~~~~~~~~--- 223 (307)
T 2eva_A 159 H----------MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM--WAVHNGTRP--- 223 (307)
T ss_dssp ----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHH--HHHHTTCCC---
T ss_pred c----------cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHH--HHHhcCCCC---
Confidence 1 1234699999999999999999999999999999999999999864332211111 111111111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCcccc
Q 003278 752 LVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDKRFM 802 (834)
Q Consensus 752 ~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~~~~ 802 (834)
......+ . .+.+++.+||+.||++|||+.+|++.|+.+.+.+.
T Consensus 224 ----~~~~~~~-~---~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 266 (307)
T 2eva_A 224 ----PLIKNLP-K---PIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP 266 (307)
T ss_dssp ----CCBTTCC-H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred ----CcccccC-H---HHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence 1111222 2 34556669999999999999999999987766554
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=366.84 Aligned_cols=263 Identities=21% Similarity=0.348 Sum_probs=203.2
Q ss_pred cCcCCcccccCCcEEEEEEEC-----CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeC--CeEEE
Q 003278 515 FSESQRVAEMDFGTAYQGFLD-----NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQ--GEMLV 587 (834)
Q Consensus 515 f~~~~~ig~g~~g~vy~~~~~-----~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~--~~~~l 587 (834)
|...+.||+|+||+||++.+. +++.||||++.........+.|.+|+++|++++|||||++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 356678999999999998753 57889999998776666678899999999999999999999999874 67899
Q ss_pred EEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecc
Q 003278 588 IYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAE 667 (834)
Q Consensus 588 v~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~ 667 (834)
||||+++|+|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++.
T Consensus 113 v~e~~~~~~L~~~l~~~-------~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH-------SIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp EECCCTTCBHHHHGGGS-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEecccCCcHHHHHhhC-------CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCccccc
Confidence 99999999999998643 27899999999999999999997 689999999999999999999999999998
Q ss_pred ccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCc---------hhH-HH
Q 003278 668 FLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPE---------GLL-VK 737 (834)
Q Consensus 668 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~---------~~~-~~ 737 (834)
........ ........||..|+|||++.+..++.++|||||||++|||+||+.|+...... +.. ..
T Consensus 183 ~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 258 (318)
T 3lxp_A 183 AVPEGHEY----YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVL 258 (318)
T ss_dssp ECCTTCSE----EEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHH
T ss_pred cccccccc----cccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHH
Confidence 75432210 11122346888999999999999999999999999999999999998532111 000 00
Q ss_pred HHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCccc
Q 003278 738 RVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDKRF 801 (834)
Q Consensus 738 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~~~ 801 (834)
.......... .......+ +. .+.+++.+||+.||++|||+.+|++.|+.+.+++
T Consensus 259 ~~~~~~~~~~------~~~~~~~~-~~---~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 259 RLTELLERGE------RLPRPDKC-PA---EVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp HHHHHHHTTC------CCCCCTTC-CH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHhccc------CCCCCccc-cH---HHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 0111100000 00111112 22 4556666999999999999999999998765544
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=366.32 Aligned_cols=270 Identities=26% Similarity=0.366 Sum_probs=208.8
Q ss_pred HHhhcCCCCCCCeeeccCCeEEEEEEE-----CCCCeEEEEEEecccC-hhhHHHHHHHHHHHHhC-CCCceeeEeeeEE
Q 003278 106 LYIGSNGFDEDEVLGSGGFGKVYRAVL-----PSDGTVVAVKCLAEKG-ERFEKTFAAELVAVAHL-RHRNLVRLRGWCV 178 (834)
Q Consensus 106 l~~~t~~f~~~~~LG~G~fG~Vy~~~~-----~~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~ 178 (834)
.....++|...+.||+|+||.||+|.+ ..++..||||++.... ....+.+.+|+.++.++ +||||++++++|.
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 345667899999999999999999997 2456789999986542 33456789999999999 9999999999999
Q ss_pred eCCEEEEEEEccCCCCHhHHHhcCCCcc----------------ccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecC
Q 003278 179 HEDQLLLVYDYMPNRSLDRVLFRRPENL----------------EAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHR 242 (834)
Q Consensus 179 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~----------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHr 242 (834)
..+..++||||+++|+|.+++....... .....++|..+..|+.|++.||.|||+. +|+||
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~ 196 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHR 196 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccC
Confidence 9999999999999999999997643211 0123589999999999999999999996 99999
Q ss_pred CCCCCceEECCCCceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehh
Q 003278 243 DVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFG 322 (834)
Q Consensus 243 DlKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfG 322 (834)
||||+|||++.++.+||+|||+++.+..... ........||+.|+|||.+..+ .++.++||||||
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--------------~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG 261 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSN--------------YVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYG 261 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTT--------------SEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHH
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCcc--------------ceeccCccCccCccCHHHhccC-CCChhHhHHHHH
Confidence 9999999999999999999999986533210 0112345689999999988655 579999999999
Q ss_pred hHHHHHHh-CCccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhH
Q 003278 323 IVVLEVVS-GRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWV 401 (834)
Q Consensus 323 vvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V 401 (834)
|++|||+| |+.||....... .+.. ....+.... .. .. ....+..|+..||+.||.+||++.+|
T Consensus 262 ~il~el~t~g~~p~~~~~~~~--~~~~----~~~~~~~~~-----~~-~~----~~~~l~~li~~~l~~dp~~Rps~~~l 325 (344)
T 1rjb_A 262 ILLWEIFSLGVNPYPGIPVDA--NFYK----LIQNGFKMD-----QP-FY----ATEEIYIIMQSCWAFDSRKRPSFPNL 325 (344)
T ss_dssp HHHHHHTTTSCCSSTTCCCSH--HHHH----HHHTTCCCC-----CC-TT----CCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHcCCCCCcccCCcHH--HHHH----HHhcCCCCC-----CC-CC----CCHHHHHHHHHHcCCCchhCcCHHHH
Confidence 99999998 999986543221 1111 112221110 00 11 12468889999999999999999999
Q ss_pred HHHhhcCC
Q 003278 402 IEAVSGSY 409 (834)
Q Consensus 402 ~~~l~~~~ 409 (834)
++.|....
T Consensus 326 ~~~l~~~~ 333 (344)
T 1rjb_A 326 TSFLGCQL 333 (344)
T ss_dssp HHHHHHHC
T ss_pred HHHHHHHH
Confidence 99998754
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=361.27 Aligned_cols=250 Identities=19% Similarity=0.290 Sum_probs=178.5
Q ss_pred CCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCC-CCceeeEeeeEEeCCEEEEEEEccCCCC
Q 003278 116 DEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLR-HRNLVRLRGWCVHEDQLLLVYDYMPNRS 194 (834)
Q Consensus 116 ~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 194 (834)
.+.||+|+||.||+|.+..+|+.||||++... ....+.+|+.++..+. |||||++++++.+.+..++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 47899999999999999999999999998643 3466788999999997 9999999999999999999999999999
Q ss_pred HhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCC---ceEEeeccchhhhhhh
Q 003278 195 LDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQY---NARLGDFGLARWLEHE 271 (834)
Q Consensus 195 L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~---~~kl~DFGla~~~~~~ 271 (834)
|.+++... ..+++..+..|+.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+++.....
T Consensus 93 L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 162 (325)
T 3kn6_A 93 LFERIKKK-------KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162 (325)
T ss_dssp HHHHHHHC-------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred HHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence 99999653 4689999999999999999999996 999999999999997655 7999999999754321
Q ss_pred hhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCcc-chHHHHH
Q 003278 272 LQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQ-IILLDWI 350 (834)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~-~~l~~~~ 350 (834)
. .......||+.|+|||.+... .++.++|||||||++|||+||+.||........ .......
T Consensus 163 ~----------------~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~ 225 (325)
T 3kn6_A 163 N----------------QPLKTPCFTLHYAAPELLNQN-GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM 225 (325)
T ss_dssp -------------------------------------C-CCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHH
T ss_pred C----------------CcccccCCCcCccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHH
Confidence 1 012345689999999998654 679999999999999999999999975432211 1111212
Q ss_pred HHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 351 RRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 351 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
... ..+..... .... ......+.+|+..||+.||.+||++.++++
T Consensus 226 ~~i-~~~~~~~~-~~~~------~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 226 KKI-KKGDFSFE-GEAW------KNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HHH-TTTCCCCC-SHHH------HTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred HHH-HcCCCCCC-cccc------cCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 221 11211000 0000 001245788999999999999999998865
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=360.48 Aligned_cols=258 Identities=18% Similarity=0.263 Sum_probs=196.5
Q ss_pred hhCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCC-------
Q 003278 512 TNNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQG------- 583 (834)
Q Consensus 512 t~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~------- 583 (834)
.++|...+.||+|+||.||+|... +++.||||++.....+...+.|.+|+.+|++++|||||+++++|.+.+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 356778889999999999999975 789999999976665666788999999999999999999999986543
Q ss_pred --------------------------------------------------eEEEEEeccCCCchhhhhhcCCCCCCCccc
Q 003278 584 --------------------------------------------------EMLVIYDYSATRILSHLLFHNNHRIGHSIL 613 (834)
Q Consensus 584 --------------------------------------------------~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l 613 (834)
..++||||+++|+|.+++..... ....
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~ 161 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS---LEDR 161 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS---GGGS
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC---ccch
Confidence 37999999999999999976542 2346
Q ss_pred CHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCCCCCcc-----cccCcccccc
Q 003278 614 QWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRK-----ATSGNRSVRG 688 (834)
Q Consensus 614 ~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~~~~~~-----~~~~~~~~~G 688 (834)
++..++.|+.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++........... .........|
T Consensus 162 ~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g 238 (332)
T 3qd2_B 162 EHGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238 (332)
T ss_dssp CHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred hhHHHHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence 777788999999999999997 68999999999999999999999999999876543211000 0112234579
Q ss_pred ccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCccccccccccCCCCCHHHHHH
Q 003278 689 IFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMR 768 (834)
Q Consensus 689 t~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 768 (834)
|+.|+|||++.+..++.++|||||||++|||+||..|+.. ......... ....... .......
T Consensus 239 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~------~~~~~~~~~--~~~~~~~---------~~~~~~~ 301 (332)
T 3qd2_B 239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME------RVRIITDVR--NLKFPLL---------FTQKYPQ 301 (332)
T ss_dssp CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH------HHHHHHHHH--TTCCCHH---------HHHHCHH
T ss_pred CcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH------HHHHHHHhh--ccCCCcc---------cccCChh
Confidence 9999999999999999999999999999999999765421 111111111 1111000 0111234
Q ss_pred HHHHHHHhccCCCCCCCChhHHHH
Q 003278 769 LIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 769 l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
+..++.+||+.||++|||+.|+++
T Consensus 302 ~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 302 EHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHccCCCCcCCCHHHHhh
Confidence 456777999999999999999985
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=393.97 Aligned_cols=252 Identities=19% Similarity=0.275 Sum_probs=195.9
Q ss_pred cccccCCcEEEEEEEC---CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEeccCCCc
Q 003278 520 RVAEMDFGTAYQGFLD---NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRI 596 (834)
Q Consensus 520 ~ig~g~~g~vy~~~~~---~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~~~g~ 596 (834)
.||+|+||.||+|.+. ++..||||+++........+.|.+|+++|++++|||||+++|+|.+ +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 6999999999999864 4567999999866555556789999999999999999999999976 56899999999999
Q ss_pred hhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCCCCC
Q 003278 597 LSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGH 676 (834)
Q Consensus 597 L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~~~~ 676 (834)
|.+++.... ..+++..++.|+.||+.||+|||+ .+||||||||+||||+.++.+||+|||+++.+......
T Consensus 422 L~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~- 492 (613)
T 2ozo_A 422 LHKFLVGKR-----EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY- 492 (613)
T ss_dssp HHHHHTTCT-----TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC------
T ss_pred HHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCce-
Confidence 999986532 248899999999999999999997 69999999999999999999999999999875432211
Q ss_pred cccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCcccccccc
Q 003278 677 RKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDL 755 (834)
Q Consensus 677 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 755 (834)
........||+.|||||++.++.++.++|||||||+||||+| |+.||....... +...+. ...+.
T Consensus 493 ---~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-~~~~i~---~~~~~------- 558 (613)
T 2ozo_A 493 ---YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-VMAFIE---QGKRM------- 558 (613)
T ss_dssp ------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH-HHHHHH---TTCCC-------
T ss_pred ---eeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-HHHHHH---cCCCC-------
Confidence 111122356789999999999999999999999999999998 999987544322 222111 11110
Q ss_pred ccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCc
Q 003278 756 SLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDK 799 (834)
Q Consensus 756 ~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~ 799 (834)
..... .+. .+.+++.+||+.||++||||.+|++.|+....
T Consensus 559 ~~p~~-~~~---~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 598 (613)
T 2ozo_A 559 ECPPE-CPP---ELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 598 (613)
T ss_dssp CCCTT-CCH---HHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCc-CCH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 01111 223 45566679999999999999999999976543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=361.62 Aligned_cols=255 Identities=26% Similarity=0.370 Sum_probs=193.4
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc---ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCC----EE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK---GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHED----QL 183 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~----~~ 183 (834)
++|+..+.||+|+||.||+|.+..+|+.||||++... .....+.|.+|+.++.+++||||+++++++...+ ..
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 5788999999999999999999899999999998654 2344567899999999999999999999987654 35
Q ss_pred EEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeecc
Q 003278 184 LLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFG 263 (834)
Q Consensus 184 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFG 263 (834)
|+||||+++|+|.+++... .++++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 92 ~lv~e~~~g~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg 161 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHTE-------GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFG 161 (311)
T ss_dssp EEEEECCCEEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCS
T ss_pred EEEEecCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeecc
Confidence 9999999999999998643 3589999999999999999999996 99999999999999999999999999
Q ss_pred chhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCcc
Q 003278 264 LARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQ 343 (834)
Q Consensus 264 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~ 343 (834)
+++.+...... ........||+.|+|||.+... .++.++|||||||++|||+||+.||......
T Consensus 162 ~a~~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-- 225 (311)
T 3ork_A 162 IARAIADSGNS-------------VTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-- 225 (311)
T ss_dssp CC-------------------------------CCTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--
T ss_pred Ccccccccccc-------------cccccccCcCcccCCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChH--
Confidence 99865432110 1113445699999999998654 6799999999999999999999998643211
Q ss_pred chHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 344 IILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 344 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
................ ..... ...+.+++..||+.||.+||+..+++.
T Consensus 226 ----~~~~~~~~~~~~~~~~----~~~~~----~~~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 226 ----SVAYQHVREDPIPPSA----RHEGL----SADLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp ----HHHHHHHHCCCCCHHH----HSTTC----CHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred ----HHHHHHhcCCCCCccc----ccCCC----CHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence 1111212211111000 00111 145788999999999999998777664
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=364.98 Aligned_cols=245 Identities=22% Similarity=0.294 Sum_probs=200.8
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 187 (834)
++|+..+.||+|+||.||+|+...+|+.||||++.... ....+.+.+|+.++.+++||||+++++++.+.+.+|+||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 46888999999999999999999899999999986532 233567889999999999999999999999999999999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 121 e~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~ 190 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI-------GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKR 190 (350)
T ss_dssp ECCTTCBHHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred cCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEccccccee
Confidence 999999999999653 3589999999999999999999996 999999999999999999999999999975
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHH
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILL 347 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~ 347 (834)
... .....+||+.|+|||.+... .++.++|||||||++|||+||+.||.... ..
T Consensus 191 ~~~-------------------~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~--- 244 (350)
T 1rdq_E 191 VKG-------------------RTWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQ---PI--- 244 (350)
T ss_dssp CSS-------------------CBCCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HH---
T ss_pred ccC-------------------CcccccCCccccCHHHhcCC-CCCCcCCEecccHhHhHHhhCCCCCCCCC---HH---
Confidence 321 13456799999999998654 67999999999999999999999986432 11
Q ss_pred HHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCc-----hhhHHH
Q 003278 348 DWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPS-----MKWVIE 403 (834)
Q Consensus 348 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----m~~V~~ 403 (834)
.....+.. +.. .+. ..++ ..+.+++..||+.||.+||+ +.+|.+
T Consensus 245 ~~~~~i~~-~~~------~~p-~~~~----~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 245 QIYEKIVS-GKV------RFP-SHFS----SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHHHHHHH-CCC------CCC-TTCC----HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHHHHHc-CCC------CCC-CCCC----HHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 11222211 111 111 1112 35788999999999999998 777765
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=373.01 Aligned_cols=264 Identities=20% Similarity=0.303 Sum_probs=193.5
Q ss_pred cCcCCcccccCCcEEEEEEEC--CC--cEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEee-CCeEEEEE
Q 003278 515 FSESQRVAEMDFGTAYQGFLD--NH--QYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTE-QGEMLVIY 589 (834)
Q Consensus 515 f~~~~~ig~g~~g~vy~~~~~--~~--~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~-~~~~~lv~ 589 (834)
|...+.||+|+||.||+|... ++ ..||||.+.........++|.+|+.+|++++|||||+++++|.+ .+..++||
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~ 170 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 170 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence 344567999999999999863 22 46899998765555667889999999999999999999998764 45789999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccc
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFL 669 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~ 669 (834)
||+++|+|.+++..... .+++..++.++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++.+
T Consensus 171 e~~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 171 PYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp ECCTTCBHHHHHHCTTC-----CCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred ECCCCCCHHHHHhhccc-----CCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeeccccccc
Confidence 99999999999975432 37888999999999999999997 69999999999999999999999999999865
Q ss_pred ccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCc
Q 003278 670 TRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRP 748 (834)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
...... .........||+.|||||++.+..++.++|||||||++|||+| |..|+...... .....+. .....
T Consensus 243 ~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~-~~~~~~~---~~~~~ 315 (373)
T 3c1x_A 243 YDKEFD---SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DITVYLL---QGRRL 315 (373)
T ss_dssp ------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS-CHHHHHH---TTCCC
T ss_pred cccccc---cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH-HHHHHHH---cCCCC
Confidence 432211 1111233467889999999999999999999999999999999 55555433222 2222111 11111
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCcccccc
Q 003278 749 LAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDKRFMED 804 (834)
Q Consensus 749 ~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~~~~~~ 804 (834)
.. ....+.+ +.+++.+||+.||++|||+.+|++.|+.+...+.++
T Consensus 316 ----~~----p~~~~~~---l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~ 360 (373)
T 3c1x_A 316 ----LQ----PEYCPDP---LYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 360 (373)
T ss_dssp ----CC----CTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred ----CC----CCCCCHH---HHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence 01 1122233 455666999999999999999999998877666544
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=359.50 Aligned_cols=263 Identities=23% Similarity=0.293 Sum_probs=207.6
Q ss_pred hCcCcCCcccccCCcEEEEEEE------CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhc-cCCCceeEEEEEeeCCeE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL------DNHQYVLVKRLGMSKCPALRTRFSNELQNLARL-RHRNLVQLCGWCTEQGEM 585 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l-~HpNiv~l~g~~~~~~~~ 585 (834)
++|...+.||+|+||.||+|.. .++..||||.+.........+.|.+|+.+++++ +|||||++++++.+.+..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 102 (313)
T 1t46_A 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (313)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCc
Confidence 4567778899999999999985 346789999998766656668899999999999 999999999999999999
Q ss_pred EEEEeccCCCchhhhhhcCCCC------------CCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeec
Q 003278 586 LVIYDYSATRILSHLLFHNNHR------------IGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLD 653 (834)
Q Consensus 586 ~lv~Ey~~~g~L~~~l~~~~~~------------~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld 653 (834)
++||||+++|+|.+++...... .....+++..+..++.|++.||+|||+ .+|+||||||+|||++
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~ 179 (313)
T 1t46_A 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLT 179 (313)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEE
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEc
Confidence 9999999999999999765321 011248899999999999999999997 6999999999999999
Q ss_pred CCCCceEeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCc
Q 003278 654 PDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPE 732 (834)
Q Consensus 654 ~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~ 732 (834)
.++.+||+|||++......... .......||+.|+|||++.+..++.++|||||||++|||+| |+.|+......
T Consensus 180 ~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 254 (313)
T 1t46_A 180 HGRITKICDFGLARDIKNDSNY-----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (313)
T ss_dssp TTTEEEECCCGGGSCTTSCTTS-----EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred CCCCEEEccccccccccccccc-----eeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence 9999999999999865433210 11223467889999999999999999999999999999999 99888654433
Q ss_pred hhHHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccC
Q 003278 733 GLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGN 797 (834)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~ 797 (834)
......... .... ...... +. .+..++.+||+.||.+|||+.+|++.|+..
T Consensus 255 ~~~~~~~~~---~~~~-------~~~~~~-~~---~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 305 (313)
T 1t46_A 255 SKFYKMIKE---GFRM-------LSPEHA-PA---EMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (313)
T ss_dssp HHHHHHHHH---TCCC-------CCCTTS-CH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hHHHHHhcc---CCCC-------CCcccC-CH---HHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 322222111 1111 011111 23 345566699999999999999999999754
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=366.67 Aligned_cols=265 Identities=19% Similarity=0.273 Sum_probs=203.9
Q ss_pred hCcCcCCcccccCCcEEEEEEE------CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhc-cCCCceeEEEEEeeCCeE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL------DNHQYVLVKRLGMSKCPALRTRFSNELQNLARL-RHRNLVQLCGWCTEQGEM 585 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l-~HpNiv~l~g~~~~~~~~ 585 (834)
++|...+.||+|+||.||+|.. .++..||||.+.........+.|.+|+.+|.++ +||||+++++++...+..
T Consensus 45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 124 (344)
T 1rjb_A 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 124 (344)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCcc
Confidence 5677788999999999999986 245689999997654444557899999999999 999999999999999999
Q ss_pred EEEEeccCCCchhhhhhcCCCCC-----------------CCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccC
Q 003278 586 LVIYDYSATRILSHLLFHNNHRI-----------------GHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSS 648 (834)
Q Consensus 586 ~lv~Ey~~~g~L~~~l~~~~~~~-----------------~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~ 648 (834)
++||||+++|+|.+++....... ....++|..++.++.|++.||+|||+ .+|+||||||+
T Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~ 201 (344)
T 1rjb_A 125 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAAR 201 (344)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGG
T ss_pred EEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChh
Confidence 99999999999999997653210 11247899999999999999999997 69999999999
Q ss_pred ceeecCCCCceEeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccC
Q 003278 649 AITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVD 727 (834)
Q Consensus 649 NILld~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~ 727 (834)
|||++.++.+||+|||++......... .......||+.|+|||++.++.++.++|||||||++|||+| |..||.
T Consensus 202 NIll~~~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 202 NVLVTHGKVVKICDFGLARDIMSDSNY-----VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTS-----EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred hEEEcCCCcEEeCCCccCcccccCccc-----eeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 999999999999999999865432211 11223568899999999999999999999999999999999 999987
Q ss_pred CCCCchhHHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCc
Q 003278 728 FRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDK 799 (834)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~ 799 (834)
.............. ... +..... .+++ +..++.+||+.||++|||+.+|++.|+....
T Consensus 277 ~~~~~~~~~~~~~~---~~~-------~~~~~~-~~~~---l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 277 GIPVDANFYKLIQN---GFK-------MDQPFY-ATEE---IYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp TCCCSHHHHHHHHT---TCC-------CCCCTT-CCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred cCCcHHHHHHHHhc---CCC-------CCCCCC-CCHH---HHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 54433322221111 100 011111 1233 4556669999999999999999999976543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=362.86 Aligned_cols=263 Identities=23% Similarity=0.283 Sum_probs=197.1
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc-ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCC--------
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHED-------- 181 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-------- 181 (834)
++|+..+.||+|+||.||+|++..+|+.||||++... .....+.+.+|+.+|++++|||||+++++|.+.+
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 4688899999999999999999889999999998643 3345678999999999999999999999987654
Q ss_pred -------------------------------------------------EEEEEEEccCCCCHhHHHhcCCCccccCCCC
Q 003278 182 -------------------------------------------------QLLLVYDYMPNRSLDRVLFRRPENLEAAAPL 212 (834)
Q Consensus 182 -------------------------------------------------~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l 212 (834)
..++|||||++|+|.+++..... ....
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~----~~~~ 161 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS----LEDR 161 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS----GGGS
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC----ccch
Confidence 38999999999999999976542 2346
Q ss_pred CHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhhhhhhhhhcccccccccccccce
Q 003278 213 NWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETT 292 (834)
Q Consensus 213 ~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (834)
++..+..|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+........... ........+
T Consensus 162 ~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~----~~~~~~~~~ 234 (332)
T 3qd2_B 162 EHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT----PMPAYATHT 234 (332)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC------------------CCC
T ss_pred hhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccc----ccccccccc
Confidence 7788999999999999999986 999999999999999999999999999986543211100000 000001124
Q ss_pred eeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCC
Q 003278 293 RIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSY 372 (834)
Q Consensus 293 ~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 372 (834)
...||+.|+|||.+... .++.++|||||||++|||+||..|+.. ....... .........
T Consensus 235 ~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~~~~~~~--------~~~~~~~-~~~~~~~~~---------- 294 (332)
T 3qd2_B 235 GQVGTKLYMSPEQIHGN-NYSHKVDIFSLGLILFELLYSFSTQME--------RVRIITD-VRNLKFPLL---------- 294 (332)
T ss_dssp SCC-CGGGSCHHHHHCC-CCCTHHHHHHHHHHHHHHHSCCCCHHH--------HHHHHHH-HHTTCCCHH----------
T ss_pred ccCCCcCccChHHhcCC-CCcchhhHHHHHHHHHHHHHcCCChhH--------HHHHHHH-hhccCCCcc----------
Confidence 45799999999998654 679999999999999999998765321 0111111 111111100
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 373 KLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 373 ~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
.......+.+++..||+.||.+||++.++++.
T Consensus 295 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 295 FTQKYPQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred cccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 01112456789999999999999999999874
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=379.47 Aligned_cols=251 Identities=20% Similarity=0.293 Sum_probs=199.6
Q ss_pred hCcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCC-eEEEEEec
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQG-EMLVIYDY 591 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~-~~~lv~Ey 591 (834)
++|...+.||+|+||.||+|... ++.||||.++... ..+.|.+|+.+|++++|||||+++|+|.+.+ ..++||||
T Consensus 193 ~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 193 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred HHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 45666788999999999999986 6789999997543 3467999999999999999999999987765 79999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccccc
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTR 671 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~ 671 (834)
+++|+|.+++...+. ..+++..++.++.|+|.||+|||+ .+|+||||||+|||+++++.+||+|||+++....
T Consensus 269 ~~~g~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp CTTCBHHHHHHHHCT----TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred cCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 999999999976432 247888999999999999999997 6999999999999999999999999999975321
Q ss_pred CCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCccc
Q 003278 672 NDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRPLA 750 (834)
Q Consensus 672 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (834)
. .....+|+.|||||++.++.++.++|||||||+||||+| |+.|+....... +...+. ...+.
T Consensus 342 ~----------~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-~~~~i~---~~~~~-- 405 (450)
T 1k9a_A 342 T----------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-VVPRVE---KGYKM-- 405 (450)
T ss_dssp ---------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT-HHHHHH---TTCCC--
T ss_pred c----------ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHH---cCCCC--
Confidence 1 112367889999999999999999999999999999999 999986543322 222211 11110
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCc
Q 003278 751 ELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDK 799 (834)
Q Consensus 751 ~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~ 799 (834)
..+.. .+. .+.+++.+||+.||++||||.+|++.|+.+.+
T Consensus 406 -----~~p~~-~~~---~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 406 -----DAPDG-CPP---AVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp -----CCCTT-CCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----CCCCc-CCH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 11111 223 34556669999999999999999999986543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=355.28 Aligned_cols=253 Identities=27% Similarity=0.430 Sum_probs=194.9
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEcc
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYM 190 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 190 (834)
++|+..+.||+|+||.||+|.+ .++.||||.+... ...+.|.+|+.++++++||||+++++++.+ ..++||||+
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~ 81 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA 81 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred hHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence 4688889999999999999998 4789999998643 345789999999999999999999998873 479999999
Q ss_pred CCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCc-eEEeeccchhhhh
Q 003278 191 PNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYN-ARLGDFGLARWLE 269 (834)
Q Consensus 191 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~-~kl~DFGla~~~~ 269 (834)
++|+|.+++..... ...+++..++.++.|+++||+|||+....+|+||||||+|||++.++. +||+|||+++...
T Consensus 82 ~~~~L~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~ 157 (307)
T 2eva_A 82 EGGSLYNVLHGAEP----LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ 157 (307)
T ss_dssp TTCBHHHHHHCSSS----EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred CCCCHHHHHhccCC----CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence 99999999975432 235788999999999999999999854458999999999999988876 7999999997542
Q ss_pred hhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHH
Q 003278 270 HELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDW 349 (834)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~ 349 (834)
.. .+...||+.|+|||.+... .++.++|||||||++|||+||+.||....... ....|
T Consensus 158 ~~-------------------~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~ 215 (307)
T 2eva_A 158 TH-------------------MTNNKGSAAWMAPEVFEGS-NYSEKCDVFSWGIILWEVITRRKPFDEIGGPA--FRIMW 215 (307)
T ss_dssp --------------------------CCTTSSCHHHHTCC-CCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH--HHHHH
T ss_pred cc-------------------cccCCCCCceEChhhhCCC-CCCcHHHHHHHHHHHHHHHHCCCCchhhCccH--HHHHH
Confidence 21 1234599999999998654 67999999999999999999999986432221 11111
Q ss_pred HHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 350 IRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 350 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
. . ..+.... .. ... ...+.+++..||+.||.+||++.++++.|+..
T Consensus 216 ~--~-~~~~~~~-----~~-~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 261 (307)
T 2eva_A 216 A--V-HNGTRPP-----LI-KNL----PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 261 (307)
T ss_dssp H--H-HTTCCCC-----CB-TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H--H-hcCCCCC-----cc-ccc----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 1 1 1111111 11 111 14578899999999999999999999998764
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=366.82 Aligned_cols=245 Identities=19% Similarity=0.237 Sum_probs=189.3
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCC-ChhHHHHHHHHHHHHHhc-cCCCceeEEEEEeeCCeEEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSK-CPALRTRFSNELQNLARL-RHRNLVQLCGWCTEQGEMLVIY 589 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~f~~E~~~l~~l-~HpNiv~l~g~~~~~~~~~lv~ 589 (834)
++|...++||+|+||+||+|... ++..||||++.... ......++..|+..+.++ +|||||+++++|.+.+..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57888899999999999999975 68999999976543 333445666777777666 9999999999999999999999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccc
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFL 669 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~ 669 (834)
||+ +++|.+++...+ ..++|..+..|+.|++.||+|||+ .+|+||||||+||||+.++.+||+|||++...
T Consensus 137 e~~-~~~L~~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~ 207 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWG-----ASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL 207 (311)
T ss_dssp ECC-CCBHHHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred ecc-CCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeec
Confidence 999 668888776543 248999999999999999999997 68999999999999999999999999998765
Q ss_pred ccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcc
Q 003278 670 TRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPL 749 (834)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
.... ......||++|+|||++.+ .++.++|||||||++|||+||..|+.... . ..... ...
T Consensus 208 ~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~----~---~~~~~--~~~- 268 (311)
T 3p1a_A 208 GTAG--------AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE----G---WQQLR--QGY- 268 (311)
T ss_dssp C--------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----H---HHHHT--TTC-
T ss_pred ccCC--------CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc----H---HHHHh--ccC-
Confidence 3221 1234569999999999875 79999999999999999999977654211 0 11110 010
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 750 AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 750 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
..+.+....+ ..+.+++.+||+.||++|||+.++++
T Consensus 269 ---~~~~~~~~~~----~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 269 ---LPPEFTAGLS----SELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp ---CCHHHHTTSC----HHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---CCcccccCCC----HHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 1111111111 24556667999999999999999985
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=352.59 Aligned_cols=257 Identities=25% Similarity=0.373 Sum_probs=204.9
Q ss_pred hcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEE
Q 003278 109 GSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYD 188 (834)
Q Consensus 109 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 188 (834)
..++|+..+.||+|+||.||+|.+. ++..||||++.... ...+.+.+|+.++.+++||||++++++|.+.+..++|||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 3467888999999999999999984 67889999987543 234678999999999999999999999999999999999
Q ss_pred ccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhh
Q 003278 189 YMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWL 268 (834)
Q Consensus 189 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~ 268 (834)
|+++|+|.+++... ...+++..+..|+.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 84 ~~~~~~L~~~l~~~------~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 154 (268)
T 3sxs_A 84 YISNGCLLNYLRSH------GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYV 154 (268)
T ss_dssp CCTTCBHHHHHHHH------GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEEC
T ss_pred ccCCCcHHHHHHHc------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceec
Confidence 99999999999653 23589999999999999999999996 9999999999999999999999999999754
Q ss_pred hhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccchHH
Q 003278 269 EHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQIILL 347 (834)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~ 347 (834)
..... .......||+.|+|||.+... .++.++|||||||++|||+| |+.||+.....
T Consensus 155 ~~~~~---------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------ 212 (268)
T 3sxs_A 155 LDDQY---------------VSSVGTKFPVKWSAPEVFHYF-KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS------ 212 (268)
T ss_dssp CTTCE---------------EECCSCCCCGGGCCHHHHHHS-EEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH------
T ss_pred chhhh---------------hcccCCCcCcccCCHHHHhcc-CCchhhhhHHHHHHHHHHHcCCCCCccccChH------
Confidence 32210 012233477889999988654 57889999999999999999 99998643211
Q ss_pred HHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcCC
Q 003278 348 DWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGSY 409 (834)
Q Consensus 348 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~~ 409 (834)
....... .+... ..+ ... ...+.+++..||+.||.+||++.++++.|+...
T Consensus 213 ~~~~~~~-~~~~~--~~~----~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 213 EVVLKVS-QGHRL--YRP----HLA----SDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp HHHHHHH-TTCCC--CCC----TTS----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred HHHHHHH-cCCCC--CCC----CcC----hHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 1111111 11110 011 111 245788999999999999999999999998753
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=354.55 Aligned_cols=257 Identities=24% Similarity=0.393 Sum_probs=194.2
Q ss_pred hcCCCCCCCeeeccCCeEEEEEEECCC---CeEEEEEEeccc-ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEE
Q 003278 109 GSNGFDEDEVLGSGGFGKVYRAVLPSD---GTVVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLL 184 (834)
Q Consensus 109 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~---g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 184 (834)
..++|+..+.||+|+||.||+|.+..+ +..||||.+... .....+.|.+|+.++++++||||+++++++. .+..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 446788899999999999999998543 567999998653 3445678999999999999999999999984 56789
Q ss_pred EEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccc
Q 003278 185 LVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGL 264 (834)
Q Consensus 185 lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGl 264 (834)
+||||+++|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 92 lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 162 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVR------KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGL 162 (281)
T ss_dssp EEEECCTTEEHHHHHHHT------TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---
T ss_pred EEEecCCCCCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcccc
Confidence 999999999999999654 23589999999999999999999996 999999999999999999999999999
Q ss_pred hhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCcc
Q 003278 265 ARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQ 343 (834)
Q Consensus 265 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~ 343 (834)
++........ ......||+.|+|||.+... .++.++|||||||++|||+| |+.||......
T Consensus 163 ~~~~~~~~~~---------------~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~-- 224 (281)
T 1mp8_A 163 SRYMEDSTYY---------------KASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-- 224 (281)
T ss_dssp -------------------------------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--
T ss_pred ccccCccccc---------------ccccCCCcccccChhhcccC-CCCCccCchHHHHHHHHHHhcCCCCCCcCCHH--
Confidence 9865332110 12234578899999998654 67999999999999999997 99998654322
Q ss_pred chHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 344 IILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 344 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
.+...+. .+.... +. ... ...+.+++..||+.||.+||++.++++.|+..
T Consensus 225 -~~~~~i~----~~~~~~-----~~-~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 225 -DVIGRIE----NGERLP-----MP-PNC----PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp -GHHHHHH----TTCCCC-----CC-TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHHHHHH----cCCCCC-----CC-CCC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1222111 111111 11 111 24678899999999999999999999998754
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=364.99 Aligned_cols=257 Identities=25% Similarity=0.383 Sum_probs=198.8
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeE----EEEEEecccC-hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTV----VAVKCLAEKG-ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLL 185 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~----vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 185 (834)
++|...+.||+|+||.||+|.+..++.. ||+|.+.... ....+.+.+|+.++++++||||++++++|. .+..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 4688889999999999999999877765 7777764332 223356788999999999999999999986 456899
Q ss_pred EEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccch
Q 003278 186 VYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLA 265 (834)
Q Consensus 186 V~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla 265 (834)
||||+++|+|.+++.... ..+++..+..|+.|++.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 92 v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a 162 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHR------GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVA 162 (325)
T ss_dssp EEECCTTCBSHHHHHSSG------GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGG
T ss_pred EEEeCCCCCHHHHHHHcc------ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcc
Confidence 999999999999996542 3588899999999999999999996 9999999999999999999999999999
Q ss_pred hhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccc
Q 003278 266 RWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQI 344 (834)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~ 344 (834)
+.+..... ....+...||+.|+|||.+..+ .++.++|||||||++|||+| |+.||.......
T Consensus 163 ~~~~~~~~--------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-- 225 (325)
T 3kex_A 163 DLLPPDDK--------------QLLYSEAKTPIKWMALESIHFG-KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE-- 225 (325)
T ss_dssp GGSCCCTT--------------CCC-----CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH--
T ss_pred cccCcccc--------------cccccCCCCcccccChHHhccC-CCChhhHhHHhHHHHHHHHhCCCCCccccCHHH--
Confidence 86532210 0112445688999999998755 57999999999999999999 999987543221
Q ss_pred hHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcCC
Q 003278 345 ILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGSY 409 (834)
Q Consensus 345 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~~ 409 (834)
+... ...+...... . .. ...+..++..||+.||.+||++.++++.|....
T Consensus 226 -~~~~----~~~~~~~~~~--~----~~----~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 226 -VPDL----LEKGERLAQP--Q----IC----TIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp -HHHH----HHTTCBCCCC--T----TB----CTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred -HHHH----HHcCCCCCCC--C----cC----cHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1111 1122111111 0 00 123667899999999999999999999998753
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=361.52 Aligned_cols=262 Identities=21% Similarity=0.326 Sum_probs=206.9
Q ss_pred hCcCcCCcccccCCcEEEEEEE------CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL------DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEML 586 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~ 586 (834)
++|...+.||+|+||.||+|.. .++..||||.+.........+.|.+|+.+|++++|||||++++++.+.+..+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 102 (314)
T 2ivs_A 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLL 102 (314)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred hheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceE
Confidence 4566778899999999999985 3457899999986666666678999999999999999999999999999999
Q ss_pred EEEeccCCCchhhhhhcCCCCC------------------CCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccC
Q 003278 587 VIYDYSATRILSHLLFHNNHRI------------------GHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSS 648 (834)
Q Consensus 587 lv~Ey~~~g~L~~~l~~~~~~~------------------~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~ 648 (834)
+||||+++|+|.+++....... ....+++..+..++.|++.||+|||+ .+|+||||||+
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dikp~ 179 (314)
T 2ivs_A 103 LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAAR 179 (314)
T ss_dssp EEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGG
T ss_pred EEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccchh
Confidence 9999999999999997643210 11248899999999999999999997 68999999999
Q ss_pred ceeecCCCCceEeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccC
Q 003278 649 AITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVD 727 (834)
Q Consensus 649 NILld~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~ 727 (834)
|||+++++.+||+|||+++....... ........||+.|+|||.+.+..++.++|||||||++|||+| |+.|+.
T Consensus 180 NIli~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 254 (314)
T 2ivs_A 180 NILVAEGRKMKISDFGLSRDVYEEDS-----YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254 (314)
T ss_dssp GEEEETTTEEEECCCTTCEECTTTSC-----EECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred eEEEcCCCCEEEcccccccccccccc-----ceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999986543221 111223467889999999999999999999999999999999 999986
Q ss_pred CCCCchhHHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccC
Q 003278 728 FRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGN 797 (834)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~ 797 (834)
...+.. +...+. .... .......+ + .+.+++.+||+.||++|||+.+|++.|+.+
T Consensus 255 ~~~~~~-~~~~~~---~~~~-------~~~~~~~~-~---~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 255 GIPPER-LFNLLK---TGHR-------MERPDNCS-E---EMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp TCCGGG-HHHHHH---TTCC-------CCCCTTCC-H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCHHH-HHHHhh---cCCc-------CCCCccCC-H---HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 544332 211111 1110 01111222 2 355566699999999999999999999764
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=361.21 Aligned_cols=267 Identities=24% Similarity=0.385 Sum_probs=209.0
Q ss_pred HhhcCCCCCCCeeeccCCeEEEEEEE-----CCCCeEEEEEEeccc-ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeC
Q 003278 107 YIGSNGFDEDEVLGSGGFGKVYRAVL-----PSDGTVVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHE 180 (834)
Q Consensus 107 ~~~t~~f~~~~~LG~G~fG~Vy~~~~-----~~~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~ 180 (834)
....++|...+.||+|+||.||+|.. ..++..||||++... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 98 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD 98 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence 34456788899999999999999987 345689999998754 334557799999999999999999999999999
Q ss_pred CEEEEEEEccCCCCHhHHHhcCCCcc-----------------ccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCC
Q 003278 181 DQLLLVYDYMPNRSLDRVLFRRPENL-----------------EAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRD 243 (834)
Q Consensus 181 ~~~~lV~Ey~~~gsL~~~l~~~~~~~-----------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrD 243 (834)
+..++||||+++|+|.+++....... .....+++..+..++.|+++||.|||+. +|+|||
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~d 175 (314)
T 2ivs_A 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRD 175 (314)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccc
Confidence 99999999999999999997643210 0123489999999999999999999996 999999
Q ss_pred CCCCceEECCCCceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhh
Q 003278 244 VKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGI 323 (834)
Q Consensus 244 lKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGv 323 (834)
|||+|||++.++.+||+|||+++....... ........||+.|+|||.+... .++.++|||||||
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~--------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~ 240 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDS--------------YVKRSQGRIPVKWMAIESLFDH-IYTTQSDVWSFGV 240 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSC--------------EECSSCCCSCGGGCCHHHHHHC-EECHHHHHHHHHH
T ss_pred cchheEEEcCCCCEEEcccccccccccccc--------------ceeccCCCCcccccChhhhcCC-CcCchhhHHHHHH
Confidence 999999999999999999999975432210 0112334578999999988654 5799999999999
Q ss_pred HHHHHHh-CCccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHH
Q 003278 324 VVLEVVS-GRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVI 402 (834)
Q Consensus 324 vl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~ 402 (834)
++|||+| |+.|+...... .+...+ ..+..... . ... ...+.+++..||+.||.+||++.+++
T Consensus 241 il~el~t~g~~p~~~~~~~---~~~~~~----~~~~~~~~-----~-~~~----~~~~~~li~~~l~~dp~~Rps~~~l~ 303 (314)
T 2ivs_A 241 LLWEIVTLGGNPYPGIPPE---RLFNLL----KTGHRMER-----P-DNC----SEEMYRLMLQCWKQEPDKRPVFADIS 303 (314)
T ss_dssp HHHHHHTTSCCSSTTCCGG---GHHHHH----HTTCCCCC-----C-TTC----CHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHhCCCCCCCCCCHH---HHHHHh----hcCCcCCC-----C-ccC----CHHHHHHHHHHccCChhhCcCHHHHH
Confidence 9999999 99998654322 122211 11211111 0 111 24688999999999999999999999
Q ss_pred HHhhcC
Q 003278 403 EAVSGS 408 (834)
Q Consensus 403 ~~l~~~ 408 (834)
+.|+..
T Consensus 304 ~~l~~~ 309 (314)
T 2ivs_A 304 KDLEKM 309 (314)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 998764
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=351.71 Aligned_cols=253 Identities=21% Similarity=0.316 Sum_probs=197.3
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC-hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEc
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG-ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDY 189 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 189 (834)
++|...+.||+|+||.||+|....+|..||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 45888899999999999999999899999999986542 33457889999999999999999999999999999999999
Q ss_pred cCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEE---CCCCceEEeeccchh
Q 003278 190 MPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVML---DSQYNARLGDFGLAR 266 (834)
Q Consensus 190 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILl---d~~~~~kl~DFGla~ 266 (834)
+++|+|.+++..... ....+++..+..|+.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++
T Consensus 102 ~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 102 CEGGELLERIVSAQA---RGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp CSCCBHHHHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred CCCCcHHHHHHhhhh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 999999998864321 235689999999999999999999996 99999999999999 456789999999997
Q ss_pred hhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchH
Q 003278 267 WLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIIL 346 (834)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l 346 (834)
.+.... ......||+.|+|||.+.. .++.++|||||||++|||+||+.||......
T Consensus 176 ~~~~~~-----------------~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~----- 231 (285)
T 3is5_A 176 LFKSDE-----------------HSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE----- 231 (285)
T ss_dssp C---------------------------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----
T ss_pred ecCCcc-----------------cCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHH-----
Confidence 643221 1234569999999998853 5789999999999999999999998643211
Q ss_pred HHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 347 LDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 347 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
................. ... ...+.+++..||+.||.+||++.||++
T Consensus 232 -~~~~~~~~~~~~~~~~~-----~~~----~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 232 -EVQQKATYKEPNYAVEC-----RPL----TPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp -HHHHHHHHCCCCCCC-------CCC----CHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred -HHHhhhccCCccccccc-----CcC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11111111110000000 011 145778999999999999999999986
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=357.68 Aligned_cols=259 Identities=18% Similarity=0.265 Sum_probs=196.3
Q ss_pred hCcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCCC-hhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKC-PALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~-~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
++|...+.||+|+||+||+|...++..||||++..... ......+.+|+++|++++|||||++++++.+.+..++||||
T Consensus 21 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 100 (311)
T 3niz_A 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEF 100 (311)
T ss_dssp CEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEEC
T ss_pred hhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcC
Confidence 45677788999999999999998899999999875432 33456789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccccc
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTR 671 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~ 671 (834)
+++ +|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 101 ~~~-~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 101 MEK-DLKKVLDENK-----TGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp CSE-EHHHHHHTCT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred CCC-CHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 985 6777765432 237888999999999999999997 6999999999999999999999999999976532
Q ss_pred CCCCCcccccCccccccccCccchhcccc-CCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCc--
Q 003278 672 NDHGHRKATSGNRSVRGIFGYMSPEYIES-GEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRP-- 748 (834)
Q Consensus 672 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~-- 748 (834)
.. .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||........+.. +........+
T Consensus 172 ~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~-i~~~~~~~~~~~ 243 (311)
T 3niz_A 172 PV-------RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPK-IFSILGTPNPRE 243 (311)
T ss_dssp CC-------C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHH-HHHHHCCCCTTT
T ss_pred Cc-------ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHH-HHHHHCCCChHH
Confidence 21 11223578999999999876 5689999999999999999999999976544433222 2221111000
Q ss_pred ccccc-------------c----cccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 749 LAELV-------------D----LSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 749 ~~~~~-------------d----~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
+.... + ..+...++ .++.+++.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 244 WPQVQELPLWKQRTFQVFEKKPWSSIIPGFC----QEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp SGGGTTSHHHHSCCCCCCCCCCHHHHSTTCC----HHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhhhccchhhhcccccccCCcHHHhCcccC----HHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00000 0 00001111 24556667999999999999999986
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=370.23 Aligned_cols=268 Identities=24% Similarity=0.365 Sum_probs=209.8
Q ss_pred HhhcCCCCCCCeeeccCCeEEEEEEEC-------CCCeEEEEEEeccc-ChhhHHHHHHHHHHHHhC-CCCceeeEeeeE
Q 003278 107 YIGSNGFDEDEVLGSGGFGKVYRAVLP-------SDGTVVAVKCLAEK-GERFEKTFAAELVAVAHL-RHRNLVRLRGWC 177 (834)
Q Consensus 107 ~~~t~~f~~~~~LG~G~fG~Vy~~~~~-------~~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~ 177 (834)
....++|...+.||+|+||.||+|.+. .++..||||++... .....+.+.+|+.+++++ +|||||+++++|
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 345578999999999999999999864 23468999998654 334557799999999999 999999999999
Q ss_pred EeCCEEEEEEEccCCCCHhHHHhcCCCc---------cccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCc
Q 003278 178 VHEDQLLLVYDYMPNRSLDRVLFRRPEN---------LEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSN 248 (834)
Q Consensus 178 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~---------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~N 248 (834)
...+..++||||+++|+|.+++...... ......+++..++.|+.|++.||+|||+. +|+||||||+|
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N 221 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARN 221 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGG
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcce
Confidence 9999999999999999999999765321 01124699999999999999999999996 99999999999
Q ss_pred eEECCCCceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHH
Q 003278 249 VMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEV 328 (834)
Q Consensus 249 ILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~El 328 (834)
||++.++.+||+|||+++.+..... ........||+.|+|||.+... .++.++|||||||++|||
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~--------------~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el 286 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDY--------------YKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEI 286 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCT--------------TCCCTTCCCGGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHH
T ss_pred EEEcCCCcEEEcccCcccccccccc--------------cccccCCCCCcceeCHHHhcCC-CCCchhHHHHHHHHHHHH
Confidence 9999999999999999985432110 0112334588999999998654 679999999999999999
Q ss_pred Hh-CCccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhc
Q 003278 329 VS-GRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSG 407 (834)
Q Consensus 329 lt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~ 407 (834)
+| |+.|+..... ..... ....+...... ... ...+.+++..||+.||.+||++.+|++.|+.
T Consensus 287 lt~g~~p~~~~~~------~~~~~-~~~~~~~~~~~------~~~----~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 349 (382)
T 3tt0_A 287 FTLGGSPYPGVPV------EELFK-LLKEGHRMDKP------SNC----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 349 (382)
T ss_dssp HTTSCCSSTTCCH------HHHHH-HHHTTCCCCCC------SSC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HhCCCCCCCCCCH------HHHHH-HHHcCCCCCCC------ccC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 99 9999864321 11111 12222111111 111 2468899999999999999999999999977
Q ss_pred CC
Q 003278 408 SY 409 (834)
Q Consensus 408 ~~ 409 (834)
..
T Consensus 350 ~~ 351 (382)
T 3tt0_A 350 IV 351 (382)
T ss_dssp HH
T ss_pred HH
Confidence 53
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=355.05 Aligned_cols=249 Identities=28% Similarity=0.459 Sum_probs=199.7
Q ss_pred hcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEE
Q 003278 109 GSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLL 185 (834)
Q Consensus 109 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 185 (834)
+.++|+..+.||+|+||.||+|....++..||||++.... ....+.+.+|+.++++++||||++++++|.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3467889999999999999999999999999999985432 2235678899999999999999999999999999999
Q ss_pred EEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccch
Q 003278 186 VYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLA 265 (834)
Q Consensus 186 V~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla 265 (834)
||||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 87 v~e~~~~~~l~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~ 156 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKL-------SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 156 (279)
T ss_dssp EECCCTTEEHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEE
T ss_pred EEecCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEecccc
Confidence 99999999999998643 3589999999999999999999985 9999999999999999999999999998
Q ss_pred hhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccch
Q 003278 266 RWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQII 345 (834)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~ 345 (834)
...... ......||+.|+|||.+... .++.++|||||||++|||++|+.||.....
T Consensus 157 ~~~~~~------------------~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~----- 212 (279)
T 3fdn_A 157 VHAPSS------------------RRTDLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTY----- 212 (279)
T ss_dssp SCC--------------------------CCCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----
T ss_pred ccCCcc------------------cccccCCCCCccCHhHhccC-CCCccchhHhHHHHHHHHHHCCCCCCCCcH-----
Confidence 643221 12345699999999988644 678999999999999999999999864321
Q ss_pred HHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 346 LLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 346 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
......... .. .... ... ...+.+++..||+.||.+||++.++++.
T Consensus 213 -~~~~~~~~~-~~------~~~~-~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 213 -QETYKRISR-VE------FTFP-DFV----TEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp -HHHHHHHHH-TC------CCCC-TTS----CHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred -HHHHHHHHh-CC------CCCC-CcC----CHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 111111111 10 0111 111 2457789999999999999999999974
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=368.78 Aligned_cols=212 Identities=21% Similarity=0.282 Sum_probs=178.3
Q ss_pred cCCCCCCCeeecc--CCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEE
Q 003278 110 SNGFDEDEVLGSG--GFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLL 185 (834)
Q Consensus 110 t~~f~~~~~LG~G--~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 185 (834)
.++|+..+.||+| +||.||+|+...+|+.||||++... .....+.+.+|+.++++++|||||+++++|.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 3568999999999 9999999999989999999998654 23455778899999999999999999999999999999
Q ss_pred EEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccch
Q 003278 186 VYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLA 265 (834)
Q Consensus 186 V~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla 265 (834)
|||||++|+|.+++.... ...+++..+..|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 104 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~ 175 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHF-----MDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSN 175 (389)
T ss_dssp EEECCTTCBHHHHHHHTC-----TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGC
T ss_pred EEEccCCCCHHHHHhhhc-----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccc
Confidence 999999999999997542 24589999999999999999999996 9999999999999999999999999998
Q ss_pred hhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccC-CCCCcccceeehhhHHHHHHhCCccCCCC
Q 003278 266 RWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKG-SVATAKSDVFSFGIVVLEVVSGRRAVDLT 338 (834)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~ksDV~SfGvvl~ElltG~~p~~~~ 338 (834)
......... ............||+.|+|||.+... ..++.++|||||||++|||+||+.||...
T Consensus 176 ~~~~~~~~~---------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 240 (389)
T 3gni_B 176 LSMISHGQR---------QRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 240 (389)
T ss_dssp EECEETTEE---------CSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred eeecccccc---------ccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCC
Confidence 654221100 00000112234699999999998753 46789999999999999999999999654
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=358.91 Aligned_cols=267 Identities=25% Similarity=0.360 Sum_probs=209.3
Q ss_pred hhcCCCCCCCeeeccCCeEEEEEEE-----CCCCeEEEEEEecccC-hhhHHHHHHHHHHHHhC-CCCceeeEeeeEEeC
Q 003278 108 IGSNGFDEDEVLGSGGFGKVYRAVL-----PSDGTVVAVKCLAEKG-ERFEKTFAAELVAVAHL-RHRNLVRLRGWCVHE 180 (834)
Q Consensus 108 ~~t~~f~~~~~LG~G~fG~Vy~~~~-----~~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~ 180 (834)
...++|...+.||+|+||.||+|.+ ..+++.||||++.... ....+.+.+|+.++.++ +||||++++++|...
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 3456788999999999999999985 3567899999987543 23457799999999999 999999999999999
Q ss_pred CEEEEEEEccCCCCHhHHHhcCCCc-----------cccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCce
Q 003278 181 DQLLLVYDYMPNRSLDRVLFRRPEN-----------LEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNV 249 (834)
Q Consensus 181 ~~~~lV~Ey~~~gsL~~~l~~~~~~-----------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NI 249 (834)
+..++||||+++|+|.+++...... .....++++..+..++.|++.||.|||+. +|+||||||+||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Ni 176 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNI 176 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceE
Confidence 9999999999999999999765321 01123589999999999999999999996 999999999999
Q ss_pred EECCCCceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHH
Q 003278 250 MLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVV 329 (834)
Q Consensus 250 Lld~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ell 329 (834)
|++.++.+||+|||+++....... ........||+.|+|||.+... .++.++|||||||++|||+
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~--------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ell 241 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSN--------------YVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELF 241 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTT--------------SEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHH
T ss_pred EEcCCCCEEEcccccccccccccc--------------ceeccCCCCcceeeChHHhcCC-CCChHHHHHHHHHHHHHHH
Confidence 999999999999999986532210 0112344588999999988755 6799999999999999999
Q ss_pred h-CCccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 330 S-GRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 330 t-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
| |+.||....... .+.. ....+... ... ... ...+.+++..||+.||.+||++.++++.|+..
T Consensus 242 t~g~~p~~~~~~~~--~~~~----~~~~~~~~-~~~-----~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 305 (313)
T 1t46_A 242 SLGSSPYPGMPVDS--KFYK----MIKEGFRM-LSP-----EHA----PAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (313)
T ss_dssp TTTCCSSTTCCSSH--HHHH----HHHHTCCC-CCC-----TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hCCCCCCCcccchh--HHHH----HhccCCCC-CCc-----ccC----CHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 9 999986543221 1111 11111110 000 111 24688999999999999999999999998764
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=352.23 Aligned_cols=255 Identities=21% Similarity=0.318 Sum_probs=192.3
Q ss_pred hCcCcCCcccccCCcEEEEEEECC----CcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDN----HQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVI 588 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~----~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv 588 (834)
++|...+.||+|+||.||+|.... +..||||.+.........+.|.+|+.++++++|||||++++++.+ +..++|
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~lv 93 (281)
T 1mp8_A 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWII 93 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc-CccEEE
Confidence 456667889999999999998743 457999998766666667889999999999999999999999854 568899
Q ss_pred EeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccc
Q 003278 589 YDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEF 668 (834)
Q Consensus 589 ~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~ 668 (834)
|||+++|+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 94 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 94 MELCTLGELRSFLQVRK-----YSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp EECCTTEEHHHHHHHTT-----TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred EecCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECccccccc
Confidence 99999999999997543 248899999999999999999997 6999999999999999999999999999986
Q ss_pred cccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcC
Q 003278 669 LTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKR 747 (834)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
...... .......||+.|+|||++.+..++.++|||||||++|||+| |..||....... ....+. ....
T Consensus 166 ~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~-~~~~i~---~~~~ 235 (281)
T 1mp8_A 166 MEDSTY------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-VIGRIE---NGER 235 (281)
T ss_dssp -------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-HHHHHH---TTCC
T ss_pred cCcccc------cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH-HHHHHH---cCCC
Confidence 543211 11123457889999999999999999999999999999997 888886543322 222111 1111
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccC
Q 003278 748 PLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGN 797 (834)
Q Consensus 748 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~ 797 (834)
. .+.... +. .+.+++.+||+.||++|||+.+|++.|+.+
T Consensus 236 ~-------~~~~~~-~~---~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 236 L-------PMPPNC-PP---TLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp C-------CCCTTC-CH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C-------CCCCCC-CH---HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0 111122 23 344566699999999999999999999764
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=360.44 Aligned_cols=251 Identities=16% Similarity=0.209 Sum_probs=199.0
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCCh-----hHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKCP-----ALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEML 586 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~ 586 (834)
+.|...+.||+|+||.||+|... ++..||||.+...... ...+.|.+|+.+|++++|||||++++++.+.+..+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 45777889999999999999974 5889999998754321 23577999999999999999999999999999999
Q ss_pred EEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCC----CceEee
Q 003278 587 VIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDM----NPRLGS 662 (834)
Q Consensus 587 lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~----~~ki~D 662 (834)
+||||+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++ .+||+|
T Consensus 91 lv~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 161 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEK------ESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIID 161 (326)
T ss_dssp EEEECCCSCBHHHHHTTS------SCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECC
T ss_pred EEEEcCCCCCHHHHHHhc------CCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEE
Confidence 999999999999998643 248899999999999999999997 6999999999999999887 799999
Q ss_pred eeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHH
Q 003278 663 FALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEF 742 (834)
Q Consensus 663 fGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~ 742 (834)
||+++...... ......||+.|+|||++.+..++.++|||||||++|||+||..||........ ...+.
T Consensus 162 fg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~-- 230 (326)
T 2y0a_A 162 FGLAHKIDFGN--------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-LANVS-- 230 (326)
T ss_dssp CTTCEECCTTS--------CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHHHH--
T ss_pred CCCCeECCCCC--------ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-HHHHH--
Confidence 99998653221 12345799999999999999999999999999999999999999865432221 11111
Q ss_pred HhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 743 EARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 743 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
....... + ...... .. .+..++.+||+.||++|||+.++++
T Consensus 231 -~~~~~~~---~-~~~~~~-~~---~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 231 -AVNYEFE---D-EYFSNT-SA---LAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp -HTCCCCC---H-HHHTTS-CH---HHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -hcCCCcC---c-cccccC-CH---HHHHHHHHHccCChhhCCCHHHHhc
Confidence 1111110 0 000111 12 3445666999999999999999986
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=379.36 Aligned_cols=257 Identities=21% Similarity=0.340 Sum_probs=198.8
Q ss_pred hCcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEecc
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYS 592 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~ 592 (834)
++|...+.||+|+||.||+|...++..||||.+..... ..+.|.+|+.+|++++|||||+++|++.+ +..++||||+
T Consensus 184 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~ 260 (452)
T 1fmk_A 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 260 (452)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence 34566678999999999999998888899999875432 24679999999999999999999999977 6689999999
Q ss_pred CCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccC
Q 003278 593 ATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRN 672 (834)
Q Consensus 593 ~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~ 672 (834)
++|+|.+++..... ..+++..++.++.|+|.||+|||+ .+|+||||||+|||+++++.+||+|||+++.....
T Consensus 261 ~~gsL~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 261 SKGSLLDFLKGETG----KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp TTCBHHHHHSHHHH----TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred cCCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 99999999964321 247899999999999999999997 68999999999999999999999999999865432
Q ss_pred CCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCcccc
Q 003278 673 DHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRPLAE 751 (834)
Q Consensus 673 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
.. .......||+.|+|||++..+.++.++|||||||+||||+| |+.|+...... .....+ ....+.
T Consensus 334 ~~------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~-~~~~~i---~~~~~~--- 400 (452)
T 1fmk_A 334 EY------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQV---ERGYRM--- 400 (452)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHHH---HTTCCC---
T ss_pred ce------ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH-HHHHHH---HcCCCC---
Confidence 11 11123457889999999999999999999999999999999 88888644322 222211 111110
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCcc
Q 003278 752 LVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDKR 800 (834)
Q Consensus 752 ~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~~ 800 (834)
...... ++ .+.+++.+||+.||++||||.+|++.|+.+...
T Consensus 401 ----~~~~~~-~~---~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 401 ----PCPPEC-PE---SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp ----CCCTTS-CH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred ----CCCCCC-CH---HHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 111112 22 355666799999999999999999999887553
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=365.22 Aligned_cols=252 Identities=15% Similarity=0.189 Sum_probs=199.4
Q ss_pred hhCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCCh-----hHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeE
Q 003278 512 TNNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKCP-----ALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEM 585 (834)
Q Consensus 512 t~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~ 585 (834)
.+.|...+.||+|+||.||+|... ++..||||.+...... ...+.+.+|+.+|.+++|||||++++++.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 356777889999999999999964 5889999998754322 2356799999999999999999999999999999
Q ss_pred EEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCC----CceEe
Q 003278 586 LVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDM----NPRLG 661 (834)
Q Consensus 586 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~----~~ki~ 661 (834)
++||||+++|+|.+++.... .+++.....++.|++.||+|||+ .+|+||||||+|||++.++ .+||+
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~ 161 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKE------SLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLI 161 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCS------CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred EEEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEE
Confidence 99999999999999986432 48899999999999999999997 6999999999999998877 79999
Q ss_pred eeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHH
Q 003278 662 SFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHE 741 (834)
Q Consensus 662 DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~ 741 (834)
|||++..+.... .....+||+.|+|||++.+..++.++|||||||++|||+||..||........ ...+.
T Consensus 162 DFG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~-~~~i~- 231 (361)
T 2yab_A 162 DFGLAHEIEDGV--------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-LANIT- 231 (361)
T ss_dssp CCSSCEECCTTC--------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHHHH-
T ss_pred ecCCceEcCCCC--------ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHH-
Confidence 999998654321 12346799999999999999999999999999999999999999975432221 11111
Q ss_pred HHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 742 FEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 742 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
.....+ ++......+ .+ +..++.+||..||++|||+.|+++
T Consensus 232 --~~~~~~----~~~~~~~~s-~~---~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 232 --AVSYDF----DEEFFSQTS-EL---AKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp --TTCCCC----CHHHHTTSC-HH---HHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --hcCCCC----CchhccCCC-HH---HHHHHHHHCCCChhHCcCHHHHhc
Confidence 111110 000001111 23 445556899999999999999985
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=361.66 Aligned_cols=272 Identities=13% Similarity=0.153 Sum_probs=198.0
Q ss_pred hCcCcCCcccccCCcEEEEEEEC----CCcEEEEEEecCCCChhH----------HHHHHHHHHHHHhccCCCceeEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD----NHQYVLVKRLGMSKCPAL----------RTRFSNELQNLARLRHRNLVQLCGW 578 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~----~~~~vavK~~~~~~~~~~----------~~~f~~E~~~l~~l~HpNiv~l~g~ 578 (834)
++|...+.||+|+||.||+|... ++..||||.+........ ...+.+|+..+..++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 35666788999999999999975 567899999875543211 1346788999999999999999999
Q ss_pred Eee----CCeEEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecC
Q 003278 579 CTE----QGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDP 654 (834)
Q Consensus 579 ~~~----~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~ 654 (834)
+.. ....++||||+ +++|.+++.... .+++..++.|+.|++.||+|||+ .+|+||||||+|||++.
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~ 186 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG------TFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGY 186 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGG------BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEES
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEcc
Confidence 987 67899999999 999999986532 48899999999999999999997 69999999999999998
Q ss_pred CC--CceEeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCc
Q 003278 655 DM--NPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPE 732 (834)
Q Consensus 655 ~~--~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~ 732 (834)
++ .+||+|||+++.+..................||+.|+|||++.+..++.++|||||||++|||+||+.||......
T Consensus 187 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~ 266 (345)
T 2v62_A 187 KNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD 266 (345)
T ss_dssp SSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC
T ss_pred CCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc
Confidence 87 9999999999876433211111111124567999999999999999999999999999999999999999643333
Q ss_pred hhHHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCc
Q 003278 733 GLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDK 799 (834)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~ 799 (834)
............. .+...+.........+. .+.+++.+||..||++|||+.+|++.|+....
T Consensus 267 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 267 PVAVQTAKTNLLD--ELPQSVLKWAPSGSSCC---EIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHHHHHHHH--TTTHHHHHHSCTTSCCH---HHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred cHHHHHHHHhhcc--cccHHHHhhccccccHH---HHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 2222221111111 11111111111111223 34555669999999999999999999987654
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=356.28 Aligned_cols=268 Identities=21% Similarity=0.295 Sum_probs=198.1
Q ss_pred CCCCC-CCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHh-CCCCceeeEeeeEEeCCEEEEEEE
Q 003278 111 NGFDE-DEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAH-LRHRNLVRLRGWCVHEDQLLLVYD 188 (834)
Q Consensus 111 ~~f~~-~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~-l~H~nIv~l~g~~~~~~~~~lV~E 188 (834)
+.|.. .+.||+|+||.||+|....+|+.||||++........+.+.+|+.++.+ ++||||+++++++.+.+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 45666 3789999999999999988999999999976655566789999999998 479999999999999999999999
Q ss_pred ccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCc---eEEeeccch
Q 003278 189 YMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYN---ARLGDFGLA 265 (834)
Q Consensus 189 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~---~kl~DFGla 265 (834)
|+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++. +||+|||++
T Consensus 92 ~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~ 161 (316)
T 2ac3_A 92 KMRGGSILSHIHKR-------RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLG 161 (316)
T ss_dssp CCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCC
T ss_pred cCCCCcHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCc
Confidence 99999999998653 3588999999999999999999996 9999999999999998766 999999999
Q ss_pred hhhhhhhhhhhhcccccccccccccceeeeccccCCCcccccc----CCCCCcccceeehhhHHHHHHhCCccCCCCCCC
Q 003278 266 RWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQK----GSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPD 341 (834)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~----~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~ 341 (834)
+.+........ ..........||+.|+|||.+.. ...++.++|||||||++|||+||+.||......
T Consensus 162 ~~~~~~~~~~~---------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 232 (316)
T 2ac3_A 162 SGIKLNGDCSP---------ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGS 232 (316)
T ss_dssp C----------------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCS
T ss_pred cccccCCcccc---------ccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccc
Confidence 86532211000 00011234569999999998853 124688999999999999999999999754432
Q ss_pred ccch--------HHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 342 DQII--------LLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 342 ~~~~--------l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
+... ....+......+... ..+... ... ...+.+++..||+.||.+||++.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~i~~~~~~-~~~~~~--~~~----~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 233 DCGWDRGEACPACQNMLFESIQEGKYE-FPDKDW--AHI----SCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp CSCC----CCHHHHHHHHHHHHHCCCC-CCHHHH--TTS----CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cccccccccchhHHHHHHHHHhccCcc-cCchhc--ccC----CHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 2100 000011111111110 000000 001 1357899999999999999999999874
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=349.81 Aligned_cols=254 Identities=22% Similarity=0.376 Sum_probs=195.5
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChh---H---HHHHHHHHHHHHhccCCCceeEEEEEeeCCeE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPA---L---RTRFSNELQNLARLRHRNLVQLCGWCTEQGEM 585 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~---~---~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~ 585 (834)
++|...+.||+|+||.||+|.. .++..||||.+....... . .+.|.+|+.++++++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 4567778899999999999997 568899999986543221 1 167899999999999999999999997765
Q ss_pred EEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCC-----ceE
Q 003278 586 LVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMN-----PRL 660 (834)
Q Consensus 586 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~-----~ki 660 (834)
++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+. .++|+||||||+|||++.++. +||
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~-~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKA-----HPIKWSVKLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTT-----SCCCHHHHHHHHHHHHHHHHHHHTS-SSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred eEEEEecCCCCHHHHHhccc-----CCccHHHHHHHHHHHHHHHHHHHhC-CCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 69999999999998886543 2488999999999999999999973 122999999999999988776 999
Q ss_pred eeeeeccccccCCCCCcccccCccccccccCccchhcc--ccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHH
Q 003278 661 GSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYI--ESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKR 738 (834)
Q Consensus 661 ~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~--~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~ 738 (834)
+|||+++.... ......||+.|+|||++ ....++.++|||||||++|||+||+.||............
T Consensus 171 ~Dfg~~~~~~~----------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 240 (287)
T 4f0f_A 171 ADFGLSQQSVH----------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFIN 240 (287)
T ss_dssp CCCTTCBCCSS----------CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHH
T ss_pred CCCCccccccc----------cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHH
Confidence 99999974321 12345799999999998 4556789999999999999999999999754333221111
Q ss_pred HHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHcc
Q 003278 739 VHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDG 796 (834)
Q Consensus 739 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~ 796 (834)
.... ... .+.+....+ . .+.+++.+||+.||++|||+.+|++.|+.
T Consensus 241 --~~~~--~~~----~~~~~~~~~-~---~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 241 --MIRE--EGL----RPTIPEDCP-P---RLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp --HHHH--SCC----CCCCCTTSC-H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred --HHhc--cCC----CCCCCcccC-H---HHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 1111 111 111112222 3 34556668999999999999999999975
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=363.84 Aligned_cols=245 Identities=22% Similarity=0.271 Sum_probs=197.4
Q ss_pred hcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHHHHHhC-CCCceeeEeeeEEeCCEEE
Q 003278 109 GSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVAVAHL-RHRNLVRLRGWCVHEDQLL 184 (834)
Q Consensus 109 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~ 184 (834)
..++|+..+.||+|+||.||+|+.+.+|+.||||++.... ....+.+..|..++..+ +||||+++++++.+.+.+|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3467999999999999999999998889999999986531 23356688899999987 8999999999999999999
Q ss_pred EEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccc
Q 003278 185 LVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGL 264 (834)
Q Consensus 185 lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGl 264 (834)
+||||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 98 lv~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~ 167 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQV-------GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGM 167 (353)
T ss_dssp EEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEeCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCc
Confidence 999999999999998643 3589999999999999999999996 999999999999999999999999999
Q ss_pred hhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccc
Q 003278 265 ARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQI 344 (834)
Q Consensus 265 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~ 344 (834)
++..... .......+||+.|+|||.+... .++.++|||||||++|||++|+.||.... ..
T Consensus 168 a~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~---~~ 227 (353)
T 2i0e_A 168 CKENIWD----------------GVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGED---ED 227 (353)
T ss_dssp CBCCCCT----------------TCCBCCCCSCGGGCCHHHHTTC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSS---HH
T ss_pred ccccccC----------------CcccccccCCccccChhhhcCC-CcCCcccccchHHHHHHHHcCCCCCCCCC---HH
Confidence 9742111 0113456799999999998654 67999999999999999999999986432 11
Q ss_pred hHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCch
Q 003278 345 ILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSM 398 (834)
Q Consensus 345 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm 398 (834)
.+ ...+.. +.. ... ...+ ..+.+++..||+.||.+||++
T Consensus 228 ~~---~~~i~~-~~~------~~p-~~~s----~~~~~li~~lL~~dP~~R~~~ 266 (353)
T 2i0e_A 228 EL---FQSIME-HNV------AYP-KSMS----KEAVAICKGLMTKHPGKRLGC 266 (353)
T ss_dssp HH---HHHHHH-CCC------CCC-TTSC----HHHHHHHHHHTCSCTTSCTTC
T ss_pred HH---HHHHHh-CCC------CCC-CCCC----HHHHHHHHHHhhcCHHHcCCC
Confidence 11 222222 111 111 1111 357889999999999999965
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=362.86 Aligned_cols=266 Identities=25% Similarity=0.377 Sum_probs=207.2
Q ss_pred CCCCCCCeeeccCCeEEEEEEE----CCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEE--eCCEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVL----PSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCV--HEDQLL 184 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~----~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~--~~~~~~ 184 (834)
++|+..+.||+|+||.||+|.+ ..++..||||++........+.+.+|+.++++++||||+++++++. +.+..+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5688889999999999999994 5678999999998776667788999999999999999999999987 456799
Q ss_pred EEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccc
Q 003278 185 LVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGL 264 (834)
Q Consensus 185 lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGl 264 (834)
+||||+++|+|.+++.... ..+++..+..|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 103 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 173 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHR------ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGL 173 (327)
T ss_dssp EEEECCTTCBHHHHHHHHG------GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGG
T ss_pred EEEeecCCCCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEccccc
Confidence 9999999999999996532 3589999999999999999999995 999999999999999999999999999
Q ss_pred hhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCC---
Q 003278 265 ARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPD--- 341 (834)
Q Consensus 265 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~--- 341 (834)
++....... .........||+.|+|||.+... .++.++|||||||++|||+||+.|+......
T Consensus 174 ~~~~~~~~~-------------~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~ 239 (327)
T 3lxl_A 174 AKLLPLDKD-------------YYVVREPGQSPIFWYAPESLSDN-IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR 239 (327)
T ss_dssp CEECCTTCS-------------EEECSSCCCSCGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH
T ss_pred ceecccCCc-------------cceeeccCCccccccCHHHhccC-CCChHHhHHHHHHHHHHHHhCCCCCccccchhhh
Confidence 986532210 00112334589999999998654 5689999999999999999999998532110
Q ss_pred -----ccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcCC
Q 003278 342 -----DQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGSY 409 (834)
Q Consensus 342 -----~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~~ 409 (834)
........+......+..... .......+.+++..||+.||.+||++.++++.|+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 302 (327)
T 3lxl_A 240 MMGCERDVPALSRLLELLEEGQRLPA----------PPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 302 (327)
T ss_dssp HCC----CCHHHHHHHHHHTTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-
T ss_pred hcccccccccHHHHHHHhhcccCCCC----------CCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 000001111111111111110 1111246889999999999999999999999998764
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=378.64 Aligned_cols=252 Identities=24% Similarity=0.292 Sum_probs=194.0
Q ss_pred hcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc---ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEE
Q 003278 109 GSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK---GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLL 185 (834)
Q Consensus 109 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 185 (834)
..++|+..+.||+|+||.||+|....+|+.||||++... .......+.+|+.++++++||||++++++|...+.+++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 346799999999999999999999999999999998653 23344567889999999999999999999999999999
Q ss_pred EEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccch
Q 003278 186 VYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLA 265 (834)
Q Consensus 186 V~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla 265 (834)
||||+++|+|..++... ..+++..+..++.|++.||+|||+. .+|+||||||+|||++.++.+||+|||++
T Consensus 226 v~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~--~giiHrDlkp~NIll~~~~~~kl~DFG~a 296 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRE-------RVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLC 296 (446)
T ss_dssp EECCCSSCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHH--TCCCCCCCCGGGEEECSSSCEEECCCCCC
T ss_pred EEeeCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHhhc--CCEEECCCCHHHEEECCCCCEEEccCCCc
Confidence 99999999999998643 3689999999999999999999972 38999999999999999999999999999
Q ss_pred hhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccch
Q 003278 266 RWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQII 345 (834)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~ 345 (834)
+...... ...+..+||+.|+|||++... .++.++|||||||++|||+||+.||.... ...
T Consensus 297 ~~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~ 356 (446)
T 4ejn_A 297 KEGIKDG----------------ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HEK 356 (446)
T ss_dssp CTTCC---------------------CCSSSCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHH
T ss_pred eeccCCC----------------cccccccCCccccCHhhcCCC-CCCCccchhhhHHHHHHHhhCCCCCCCCC---HHH
Confidence 7532110 113456799999999998654 67999999999999999999999986432 111
Q ss_pred HHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----chhhHHHH
Q 003278 346 LLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRP-----SMKWVIEA 404 (834)
Q Consensus 346 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~~V~~~ 404 (834)
+. ....... . +.. ... ...+.+|+..||+.||.+|| ++.++++.
T Consensus 357 ~~---~~i~~~~-~------~~p-~~~----~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 357 LF---ELILMEE-I------RFP-RTL----GPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp HH---HHHHHCC-C------CCC-TTS----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HH---HHHHhCC-C------CCC-ccC----CHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 11 1111111 0 111 111 14578899999999999999 88888763
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=354.91 Aligned_cols=261 Identities=23% Similarity=0.353 Sum_probs=210.7
Q ss_pred HHhhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEE
Q 003278 106 LYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLL 185 (834)
Q Consensus 106 l~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 185 (834)
.....++|+..+.||+|+||.||+|.+..++..||||.+... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 86 (288)
T 3kfa_A 8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86 (288)
T ss_dssp TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence 344567899999999999999999999888999999998754 3345779999999999999999999999999999999
Q ss_pred EEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccch
Q 003278 186 VYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLA 265 (834)
Q Consensus 186 V~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla 265 (834)
||||+++|+|.+++.... ...+++..+..|+.|++.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 87 v~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~ 158 (288)
T 3kfa_A 87 ITEFMTYGNLLDYLRECN-----RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLS 158 (288)
T ss_dssp EEECCTTEEHHHHHHHCC-----TTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGG
T ss_pred EEEcCCCCcHHHHHHhcc-----cCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccc
Confidence 999999999999997542 24689999999999999999999996 9999999999999999999999999999
Q ss_pred hhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccc
Q 003278 266 RWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQI 344 (834)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~ 344 (834)
+...... ........||+.|+|||.+... .++.++|||||||++|||+| |+.|+......
T Consensus 159 ~~~~~~~---------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~--- 219 (288)
T 3kfa_A 159 RLMTGDT---------------YTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--- 219 (288)
T ss_dssp GTSCSSS---------------SEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---
T ss_pred eeccCCc---------------cccccCCccccCcCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---
Confidence 8643211 0112334578999999998655 57999999999999999999 99888653222
Q ss_pred hHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 345 ILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 345 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
.+...+. ...... .. ... ...+.+++..||+.||.+||++.++++.|+..
T Consensus 220 ~~~~~~~----~~~~~~-----~~-~~~----~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 220 QVYELLE----KDYRME-----RP-EGC----PEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp GHHHHHH----TTCCCC-----CC-TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHh----ccCCCC-----CC-CCC----CHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 1211111 111000 00 111 24688999999999999999999999998764
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=366.14 Aligned_cols=258 Identities=18% Similarity=0.272 Sum_probs=197.0
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCc----EEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQ----YVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLV 587 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~----~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~l 587 (834)
++|...+.||+|+||.||+|... ++. .||+|.+...........+.+|+.++++++|||||+++++|.+ +..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CccEE
Confidence 35667788999999999999964 344 3888887654433334567889999999999999999999874 56889
Q ss_pred EEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecc
Q 003278 588 IYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAE 667 (834)
Q Consensus 588 v~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~ 667 (834)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 92 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 163 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHR-----GALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVAD 163 (325)
T ss_dssp EEECCTTCBSHHHHHSSG-----GGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred EEEeCCCCCHHHHHHHcc-----ccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCccc
Confidence 999999999999987542 247888999999999999999997 689999999999999999999999999998
Q ss_pred ccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhc
Q 003278 668 FLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARK 746 (834)
Q Consensus 668 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~ 746 (834)
....... ........||+.|+|||++.++.++.++|||||||++|||+| |+.||....... ....+. ...
T Consensus 164 ~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~~~---~~~ 234 (325)
T 3kex_A 164 LLPPDDK-----QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE-VPDLLE---KGE 234 (325)
T ss_dssp GSCCCTT-----CCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH-HHHHHH---TTC
T ss_pred ccCcccc-----cccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH-HHHHHH---cCC
Confidence 7643321 111234578889999999999999999999999999999999 999987543322 111111 111
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCc
Q 003278 747 RPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDK 799 (834)
Q Consensus 747 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~ 799 (834)
.. ..+ ... .. .+..++.+||+.||++|||+.+|++.|+...+
T Consensus 235 ~~----~~~---~~~-~~---~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 235 RL----AQP---QIC-TI---DVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp BC----CCC---TTB-CT---TTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred CC----CCC---CcC-cH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 10 000 011 11 24456668999999999999999999976543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=351.85 Aligned_cols=254 Identities=19% Similarity=0.331 Sum_probs=200.3
Q ss_pred hCcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEecc
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYS 592 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~ 592 (834)
++|...+.||+|+||.||+|...++..||||.+...... .++|.+|++++.+++||||+++++++.+.+..++||||+
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC--HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 456667889999999999999998889999998754333 367899999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccC
Q 003278 593 ATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRN 672 (834)
Q Consensus 593 ~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~ 672 (834)
++|+|.+++..... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 102 ~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 102 ANGCLLNYLREMRH-----RFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173 (283)
T ss_dssp TTCBHHHHHHCGGG-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred CCCcHHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence 99999999875322 38899999999999999999997 69999999999999999999999999999765322
Q ss_pred CCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCcccc
Q 003278 673 DHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRPLAE 751 (834)
Q Consensus 673 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
. ........||+.|+|||++.+..++.++|||||||++|||+| |+.||....... ....+ ......
T Consensus 174 ~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~-~~~~~---~~~~~~--- 240 (283)
T 3gen_A 174 E------YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-TAEHI---AQGLRL--- 240 (283)
T ss_dssp H------HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-HHHHH---HTTCCC---
T ss_pred c------cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH-HHHHH---hcccCC---
Confidence 1 111223457888999999999999999999999999999999 999986543221 11111 111111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccC
Q 003278 752 LVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGN 797 (834)
Q Consensus 752 ~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~ 797 (834)
... ....+ .+.+++.+||+.||++|||+.+|++.|+.+
T Consensus 241 ----~~~-~~~~~---~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 241 ----YRP-HLASE---KVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp ----CCC-TTCCH---HHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCC-CcCCH---HHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 011 11123 345566699999999999999999998754
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=362.20 Aligned_cols=270 Identities=27% Similarity=0.396 Sum_probs=210.5
Q ss_pred HHHhhcCCCCCCCeeeccCCeEEEEEEECCCCe-----EEEEEEecccC-hhhHHHHHHHHHHHHhC-CCCceeeEeeeE
Q 003278 105 ELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGT-----VVAVKCLAEKG-ERFEKTFAAELVAVAHL-RHRNLVRLRGWC 177 (834)
Q Consensus 105 el~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~-----~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~ 177 (834)
++....++|...+.||+|+||.||+|....++. .||||.+.... ....+.+.+|+.+++++ +||||++++++|
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 345567889999999999999999999866554 79999987543 34557799999999999 899999999999
Q ss_pred EeCCEEEEEEEccCCCCHhHHHhcCCCccc-------cCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceE
Q 003278 178 VHEDQLLLVYDYMPNRSLDRVLFRRPENLE-------AAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVM 250 (834)
Q Consensus 178 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NIL 250 (834)
...+..++||||+++|+|.+++........ ....+++..+..++.|++.||.|||+. +|+||||||+|||
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEE
Confidence 999999999999999999999865321100 124689999999999999999999996 9999999999999
Q ss_pred ECCCCceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh
Q 003278 251 LDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS 330 (834)
Q Consensus 251 ld~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt 330 (834)
++.++.+||+|||+++.+..... ........||+.|+|||.+... .++.++|||||||++|||+|
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~--------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t 261 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSN--------------YIVKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFS 261 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTT--------------SEECSSCEECGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTT
T ss_pred ECCCCeEEECccccccccccccc--------------eeecCCCCCCccccCHHHhccC-CCChHHHHHHHHHHHHHHHc
Confidence 99999999999999986432210 0112344588999999988755 57999999999999999999
Q ss_pred -CCccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 331 -GRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 331 -G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
|+.|+....... .+.. ....+... ..+ ... ...+.+++..||+.||.+||++.+|++.|+..
T Consensus 262 ~g~~p~~~~~~~~--~~~~----~~~~~~~~--~~~----~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 262 LGLNPYPGILVNS--KFYK----LVKDGYQM--AQP----AFA----PKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp TSCCSSTTCCSSH--HHHH----HHHHTCCC--CCC----TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCcccchhH--HHHH----HHhcCCCC--CCC----CCC----CHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 988886543221 1111 11111111 001 111 24678899999999999999999999988653
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=361.63 Aligned_cols=264 Identities=22% Similarity=0.266 Sum_probs=195.1
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChh-hHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEc
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGER-FEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDY 189 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 189 (834)
++|...+.||+|+||.||+|....+|+.||||++...... ....+.+|+.++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 4688889999999999999999889999999998643221 122456799999999999999999999999999999999
Q ss_pred cCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhh
Q 003278 190 MPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLE 269 (834)
Q Consensus 190 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~ 269 (834)
++ |+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 82 ~~-~~l~~~~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 151 (324)
T 3mtl_A 82 LD-KDLKQYLDDC------GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKS 151 (324)
T ss_dssp CS-EEHHHHHHHT------TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC-
T ss_pred cc-cCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCccccccc
Confidence 97 5898888654 24689999999999999999999996 99999999999999999999999999997543
Q ss_pred hhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHH
Q 003278 270 HELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDW 349 (834)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~ 349 (834)
... .......||+.|+|||.+.....++.++|||||||++|||+||+.||...... .....
T Consensus 152 ~~~----------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~ 212 (324)
T 3mtl_A 152 IPT----------------KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE---EQLHF 212 (324)
T ss_dssp ---------------------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHH
T ss_pred CCc----------------cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH
Confidence 211 01233468999999999876567899999999999999999999998653221 12222
Q ss_pred HHHHhhcCc---cccccc---------cccCCCCC---CHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 350 IRRLSDEGK---VLQAGD---------NRLSDGSY---KLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 350 ~~~~~~~~~---~~~~~d---------~~l~~~~~---~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
+........ ...... +....... .......+.+++..||+.||.+|||+.|+++
T Consensus 213 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 213 IFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 222221100 000000 00000000 0001135778999999999999999999986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=377.89 Aligned_cols=249 Identities=13% Similarity=0.071 Sum_probs=191.3
Q ss_pred hcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc---ChhhHHHHHHHH---HHHHhCCCCceeeEe-------e
Q 003278 109 GSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK---GERFEKTFAAEL---VAVAHLRHRNLVRLR-------G 175 (834)
Q Consensus 109 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~---~~~~~~~~~~E~---~~l~~l~H~nIv~l~-------g 175 (834)
..++|...+.||+|+||.||+|++..+|+.||||++... .....+.|.+|+ .+|++++|||||+++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 346788899999999999999999888999999998632 344567899999 566677899999998 6
Q ss_pred eEEeCC-----------------EEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCC
Q 003278 176 WCVHED-----------------QLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQ 238 (834)
Q Consensus 176 ~~~~~~-----------------~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 238 (834)
++...+ ..||||||+ +|+|.+++.......+....++|..+..|+.|++.||+|||+. +
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ 226 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---G 226 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence 665543 289999999 6899999975422111223466789999999999999999996 9
Q ss_pred eecCCCCCCceEECCCCceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccC---------
Q 003278 239 IIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKG--------- 309 (834)
Q Consensus 239 iiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--------- 309 (834)
|+||||||+|||++.++.+||+|||+++.... ..+...| +.|+|||.+...
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-------------------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~ 286 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-------------------RVVSSVS-RGFEPPELEARRATISYHRDR 286 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTC-------------------EEECCCC-TTCCCHHHHHHHTSTHHHHCC
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCC-------------------cccCCCC-cCccChhhhcccccccccccc
Confidence 99999999999999999999999999974211 1344568 999999998654
Q ss_pred -CCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhc
Q 003278 310 -SVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCT 388 (834)
Q Consensus 310 -~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl 388 (834)
..++.++|||||||++|||+||+.||......... .... ... ...+ ..+.+++..||
T Consensus 287 ~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~---------------~~~~-~~~--~~~~----~~~~~li~~~L 344 (377)
T 3byv_A 287 RTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGS---------------EWIF-RSC--KNIP----QPVRALLEGFL 344 (377)
T ss_dssp EEECCHHHHHHHHHHHHHHHHHSSCCC------CCS---------------GGGG-SSC--CCCC----HHHHHHHHHHT
T ss_pred cccCChhhhHHHHHHHHHHHHHCCCCCcccccccch---------------hhhh-hhc--cCCC----HHHHHHHHHHc
Confidence 25799999999999999999999998643221110 0010 000 1111 45788999999
Q ss_pred ccCCCCCCchhhHHH
Q 003278 389 LHNPHLRPSMKWVIE 403 (834)
Q Consensus 389 ~~~p~~RPsm~~V~~ 403 (834)
+.||.+||++.++++
T Consensus 345 ~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 345 RYPKEDRLLPLQAME 359 (377)
T ss_dssp CSSGGGCCCHHHHHT
T ss_pred CCCchhCCCHHHHhh
Confidence 999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=352.68 Aligned_cols=253 Identities=25% Similarity=0.407 Sum_probs=198.5
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEcc
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYM 190 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 190 (834)
+.|+..+.||+|+||.||+|.+..+|..||+|.+........+.+.+|+.++.+++||||+++++++...+..++||||+
T Consensus 19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (302)
T 2j7t_A 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFC 98 (302)
T ss_dssp GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECC
T ss_pred cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeC
Confidence 56888999999999999999998899999999987665556778999999999999999999999999999999999999
Q ss_pred CCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhh
Q 003278 191 PNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEH 270 (834)
Q Consensus 191 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~ 270 (834)
++|+|..++... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 99 ~~~~l~~~~~~~------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (302)
T 2j7t_A 99 PGGAVDAIMLEL------DRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK 169 (302)
T ss_dssp TTEEHHHHHHHH------TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred CCCcHHHHHHhh------ccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence 999999988643 24589999999999999999999996 999999999999999999999999999864322
Q ss_pred hhhhhhhcccccccccccccceeeeccccCCCccccc----cCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchH
Q 003278 271 ELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQ----KGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIIL 346 (834)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~----~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l 346 (834)
... ......||+.|+|||.+. .+..++.++|||||||++|||+||+.|+.....
T Consensus 170 ~~~----------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------ 227 (302)
T 2j7t_A 170 TLQ----------------KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------ 227 (302)
T ss_dssp HHH----------------C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH------
T ss_pred ccc----------------ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH------
Confidence 210 123346999999999884 344678999999999999999999999864321
Q ss_pred HHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 347 LDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 347 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
........... ......+ ..+ ...+.+++..||+.||.+||++.++++
T Consensus 228 ~~~~~~~~~~~-~~~~~~~----~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 228 MRVLLKIAKSD-PPTLLTP----SKW----SVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp HHHHHHHHHSC-CCCCSSG----GGS----CHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred HHHHHHHhccC-CcccCCc----ccc----CHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 11112221111 1111000 111 245788999999999999999999876
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=351.45 Aligned_cols=257 Identities=23% Similarity=0.368 Sum_probs=202.9
Q ss_pred hhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEE
Q 003278 108 IGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 108 ~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 187 (834)
...++|+..+.||+|+||.||+|.+. ++..||||++.... ...+.+.+|+.++.+++||||++++++|.+.+..++||
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 98 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence 34567888999999999999999984 78899999987543 23467899999999999999999999999999999999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
||+++|+|.+++... ...+++..+..|+.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 99 e~~~~~~L~~~l~~~------~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 169 (283)
T 3gen_A 99 EYMANGCLLNYLREM------RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRY 169 (283)
T ss_dssp CCCTTCBHHHHHHCG------GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGG
T ss_pred eccCCCcHHHHHHHh------ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccc
Confidence 999999999999653 23589999999999999999999996 999999999999999999999999999986
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccchH
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQIIL 346 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l 346 (834)
....... ......||+.|+|||.+... .++.++|||||||++|||+| |+.||......
T Consensus 170 ~~~~~~~---------------~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~----- 228 (283)
T 3gen_A 170 VLDDEYT---------------SSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS----- 228 (283)
T ss_dssp BCCHHHH---------------STTSTTSCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-----
T ss_pred ccccccc---------------cccCCccCcccCCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccChh-----
Confidence 5432211 01223478899999998755 57999999999999999999 99998643211
Q ss_pred HHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 347 LDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 347 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
.....+. .+.. ...+ ... ...+.+++..||+.||.+||++.++++.|...
T Consensus 229 -~~~~~~~-~~~~--~~~~----~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 229 -ETAEHIA-QGLR--LYRP----HLA----SEKVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp -HHHHHHH-TTCC--CCCC----TTC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHHHHHh-cccC--CCCC----CcC----CHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 1111111 1110 0001 111 24688999999999999999999999998754
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=354.58 Aligned_cols=261 Identities=26% Similarity=0.422 Sum_probs=192.7
Q ss_pred hCcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCC-ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSK-CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~-~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
+.|...++||+|+||.||+|...+ .||||.+.... .....+.|.+|+.++++++||||+++++++.. +..++||||
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~lv~e~ 100 (289)
T 3og7_A 24 GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQW 100 (289)
T ss_dssp TSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred cceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccC-CccEEEEEe
Confidence 457777899999999999998644 59999987554 34456789999999999999999999997654 568899999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccccc
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTR 671 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~ 671 (834)
+++++|.+++.... ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++.....
T Consensus 101 ~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 101 CEGSSLYHHLHASE-----TKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp CCEEEHHHHHTTC--------CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred cCCCcHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceecccccc
Confidence 99999999986433 248899999999999999999997 6899999999999999999999999999976432
Q ss_pred CCCCCcccccCccccccccCccchhccc---cCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCc
Q 003278 672 NDHGHRKATSGNRSVRGIFGYMSPEYIE---SGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRP 748 (834)
Q Consensus 672 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~---~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
... ........||+.|+|||++. +..++.++|||||||++|||+||+.||........+...+... .
T Consensus 173 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-----~ 242 (289)
T 3og7_A 173 WSG-----SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRG-----S 242 (289)
T ss_dssp ----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHT-----S
T ss_pred ccc-----cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhccc-----c
Confidence 211 11123457999999999986 6678899999999999999999999997544433332222211 1
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCc
Q 003278 749 LAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDK 799 (834)
Q Consensus 749 ~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~ 799 (834)
...... .+...+ ++ .+.+++.+||+.||++|||+.+|++.|+.+.+
T Consensus 243 ~~~~~~-~~~~~~-~~---~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 243 LSPDLS-KVRSNC-PK---RMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp CCCCTT-SSCTTS-CH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred cCcchh-hccccC-CH---HHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 100000 011112 23 45566669999999999999999999987653
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=351.07 Aligned_cols=253 Identities=23% Similarity=0.328 Sum_probs=188.9
Q ss_pred hCcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCCCh---hHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCP---ALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIY 589 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~---~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~ 589 (834)
++|...+.||+|+||.||+|... +..||||.+...... ...+.|.+|+.++++++||||+++++++.+.+..++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 46677788999999999999975 778999998654322 23467899999999999999999999999999999999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecC--------CCCceEe
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDP--------DMNPRLG 661 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~--------~~~~ki~ 661 (834)
||+++++|.+++... .+++..+..++.|++.||+|||+....+|+||||||+|||++. ++.+||+
T Consensus 86 e~~~~~~L~~~~~~~-------~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 86 EFARGGPLNRVLSGK-------RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp ECCTTEEHHHHHTSS-------CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred EcCCCCCHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 999999999988532 3788999999999999999999842223999999999999986 6789999
Q ss_pred eeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHH
Q 003278 662 SFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHE 741 (834)
Q Consensus 662 DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~ 741 (834)
|||++....... .....||+.|+|||.+.+..++.++||||||+++|||+||+.||......... . .
T Consensus 159 Dfg~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-~---~ 225 (271)
T 3dtc_A 159 DFGLAREWHRTT---------KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA-Y---G 225 (271)
T ss_dssp CCCC----------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHH-H---H
T ss_pred cCCccccccccc---------ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-H---h
Confidence 999997543221 12357999999999999999999999999999999999999998643322111 1 1
Q ss_pred HHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHcc
Q 003278 742 FEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDG 796 (834)
Q Consensus 742 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~ 796 (834)
... ... ........ ++ .+.+++.+||+.||++|||+.+|++.|+.
T Consensus 226 ~~~-~~~-----~~~~~~~~-~~---~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 226 VAM-NKL-----ALPIPSTC-PE---PFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp HHT-SCC-----CCCCCTTC-CH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred hhc-CCC-----CCCCCccc-CH---HHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 111 110 01111122 23 35556669999999999999999999975
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=359.80 Aligned_cols=250 Identities=14% Similarity=0.195 Sum_probs=199.0
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
++|...+.||+|+||.||+|... ++..||+|.+.... .....+.+|+.+|++++|||||++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc--ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 56777788999999999999965 57889999986442 3346788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecC--CCCceEeeeeecccc
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDP--DMNPRLGSFALAEFL 669 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~--~~~~ki~DfGla~~~ 669 (834)
+++|+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++..
T Consensus 83 ~~g~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~ 154 (321)
T 1tki_A 83 ISGLDIFERINTSA-----FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp CCCCBHHHHHTSSS-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred CCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence 99999999986432 248899999999999999999997 69999999999999997 789999999999865
Q ss_pred ccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcc
Q 003278 670 TRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPL 749 (834)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
.... ......||+.|+|||++.+..++.++|||||||++|||+||..||....... ....+.. .....
T Consensus 155 ~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~---~~~~~ 222 (321)
T 1tki_A 155 KPGD--------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-IIENIMN---AEYTF 222 (321)
T ss_dssp CTTC--------EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHH---TCCCC
T ss_pred CCCC--------ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH-HHHHHHc---CCCCC
Confidence 4321 1234579999999999998889999999999999999999999997543322 1221111 11111
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 750 AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 750 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
. .......+ . .+..++.+||..||++|||+.|+++
T Consensus 223 ~----~~~~~~~s-~---~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 223 D----EEAFKEIS-I---EAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp C----HHHHTTSC-H---HHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C----hhhhccCC-H---HHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 00001111 2 3455666999999999999999987
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=350.04 Aligned_cols=255 Identities=17% Similarity=0.260 Sum_probs=199.7
Q ss_pred hCcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCC-ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeC--CeEEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSK-CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQ--GEMLVIY 589 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~-~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~--~~~~lv~ 589 (834)
++|...+.||+|+||.||+|... +..||||.+.... .....+.|.+|+.++++++|||||++++++.+. +..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 45667788999999999999985 7789999987654 344557899999999999999999999999876 7789999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccc
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFL 669 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~ 669 (834)
||+++|+|.+++..... ..+++..+..|+.|++.||+|||+. ..+|+||||||+|||++.++.+||+|||++...
T Consensus 89 e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTN----FVVDQSQAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp ECCTTCBHHHHHHSCSS----CCCCHHHHHHHHHHHHHHHHHHTTS-SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred cccCCCcHHHHHhhccc----CCCCHHHHHHHHHHHHHHHHHHhcC-CCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 99999999999975432 2489999999999999999999973 123999999999999999999999999987532
Q ss_pred ccCCCCCcccccCccccccccCccchhccccCCCCc---cCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhc
Q 003278 670 TRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATS---MADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARK 746 (834)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~---k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~ 746 (834)
. .....||+.|+|||.+.+..++. ++|||||||++|||+||+.||........... ....
T Consensus 164 ~------------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~- 226 (271)
T 3kmu_A 164 Q------------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMK----VALE- 226 (271)
T ss_dssp S------------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHH----HHHS-
T ss_pred c------------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHH----HHhc-
Confidence 1 12346899999999998766554 79999999999999999999865432221111 1111
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCc
Q 003278 747 RPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDK 799 (834)
Q Consensus 747 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~ 799 (834)
.. .+.+....+ .+ +.+++..||+.||++|||+.+|++.|+.+.+
T Consensus 227 ~~-----~~~~~~~~~-~~---~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 227 GL-----RPTIPPGIS-PH---VSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp CC-----CCCCCTTCC-HH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred CC-----CCCCCCCCC-HH---HHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 10 111112222 33 4556668999999999999999999987643
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=354.34 Aligned_cols=265 Identities=20% Similarity=0.276 Sum_probs=201.8
Q ss_pred CcCcCCcccccCCcEEEEEEECC----CcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEe-eCCeEEEE
Q 003278 514 NFSESQRVAEMDFGTAYQGFLDN----HQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCT-EQGEMLVI 588 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~~~----~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~-~~~~~~lv 588 (834)
.|...+.||+|+||+||+|...+ ...||||.+.........+.|.+|+.++++++|||||+++++|. ..+..++|
T Consensus 26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 105 (298)
T 3f66_A 26 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 105 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred ehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEE
Confidence 35556789999999999998643 23689999887666666788999999999999999999999865 45678999
Q ss_pred EeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccc
Q 003278 589 YDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEF 668 (834)
Q Consensus 589 ~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~ 668 (834)
|||+++|+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++.
T Consensus 106 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 106 LPYMKHGDLRNFIRNET-----HNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp EECCTTCBHHHHHHCTT-----CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred EeCCCCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECccccccc
Confidence 99999999999997533 247888999999999999999997 6999999999999999999999999999986
Q ss_pred cccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCc
Q 003278 669 LTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRP 748 (834)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
....... .........||+.|+|||.+.+..++.++|||||||++|||+||..|+.............. .....
T Consensus 178 ~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~---~~~~~ 251 (298)
T 3f66_A 178 MYDKEYY---SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL---QGRRL 251 (298)
T ss_dssp CSCGGGC---BC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHH---TTCCC
T ss_pred ccccchh---ccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh---cCCCC
Confidence 5432211 11122345688999999999999999999999999999999996555433332222222111 11111
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCccccc
Q 003278 749 LAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDKRFME 803 (834)
Q Consensus 749 ~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~~~~~ 803 (834)
. . ....+. .+.+++.+||+.||++|||+.+|++.|+.+...+.+
T Consensus 252 ----~---~-~~~~~~---~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 295 (298)
T 3f66_A 252 ----L---Q-PEYCPD---PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295 (298)
T ss_dssp ----C---C-CTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred ----C---C-CccCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 0 0 111223 345566699999999999999999999887665543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=363.86 Aligned_cols=252 Identities=17% Similarity=0.231 Sum_probs=199.1
Q ss_pred hhCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCC-ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEE
Q 003278 512 TNNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSK-CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIY 589 (834)
Q Consensus 512 t~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~ 589 (834)
.++|...+.||+|+||.||+|... ++..||||.+.... .....+.|.+|+.++++++|||||++++++.+.+..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 467888899999999999999864 58899999987543 3344577999999999999999999999999999999999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCC---CCceEeeeeec
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPD---MNPRLGSFALA 666 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~---~~~ki~DfGla 666 (834)
||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.+ +.+||+|||++
T Consensus 108 e~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a 178 (362)
T 2bdw_A 108 DLVTGGELFEDIVARE------FYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLA 178 (362)
T ss_dssp CCCCSCBHHHHHTTCS------CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred ecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcc
Confidence 9999999998886432 47889999999999999999997 699999999999999865 45999999999
Q ss_pred cccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhc
Q 003278 667 EFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARK 746 (834)
Q Consensus 667 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~ 746 (834)
....... ......||+.|+|||++.+..++.++|||||||++|||+||..||...... .+...+. ...
T Consensus 179 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-~~~~~i~---~~~ 246 (362)
T 2bdw_A 179 IEVNDSE--------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-RLYAQIK---AGA 246 (362)
T ss_dssp BCCTTCC--------SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHH---HTC
T ss_pred eEecCCc--------ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHH---hCC
Confidence 7654221 123467999999999999999999999999999999999999998643322 1222111 111
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 747 RPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 747 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
.... .+.. ... ..+ +..++.+||+.||++|||+.++++
T Consensus 247 ~~~~---~~~~-~~~-~~~---~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 247 YDYP---SPEW-DTV-TPE---AKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp CCCC---TTGG-GGS-CHH---HHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCCC---cccc-cCC-CHH---HHHHHHHHcCCChhhCcCHHHHhc
Confidence 1100 0000 011 123 445566899999999999999975
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=355.81 Aligned_cols=266 Identities=25% Similarity=0.339 Sum_probs=196.8
Q ss_pred hcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC-----hhhHHHHHHHHHHHHhC---CCCceeeEeeeEEeC
Q 003278 109 GSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG-----ERFEKTFAAELVAVAHL---RHRNLVRLRGWCVHE 180 (834)
Q Consensus 109 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~-----~~~~~~~~~E~~~l~~l---~H~nIv~l~g~~~~~ 180 (834)
.+++|+..+.||+|+||.||+|++..+|+.||||++.... ......+.+|+.+++++ +||||++++++|...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 4678999999999999999999998899999999986432 12234566777776666 499999999999876
Q ss_pred C-----EEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCC
Q 003278 181 D-----QLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQY 255 (834)
Q Consensus 181 ~-----~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~ 255 (834)
+ ..++||||+. |+|.+++.... ...+++..+..|+.|++.||+|||+. +|+||||||+|||++.++
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~-----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~ 157 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAP-----PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGG 157 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCC-----TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTS
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhcc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCC
Confidence 5 5899999997 69999987542 23489999999999999999999996 899999999999999999
Q ss_pred ceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccC
Q 003278 256 NARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAV 335 (834)
Q Consensus 256 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~ 335 (834)
.+||+|||+++..... ...+...||+.|+|||.+... .++.++|||||||++|||+||+.||
T Consensus 158 ~~kl~Dfg~a~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf 219 (308)
T 3g33_A 158 TVKLADFGLARIYSYQ-----------------MALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLF 219 (308)
T ss_dssp CEEECSCSCTTTSTTC-----------------CCSGGGGCCCSSCCHHHHHTS-CCCSTHHHHHHHHHHHHTTTSSCSC
T ss_pred CEEEeeCccccccCCC-----------------cccCCccccccccCchHHcCC-CCCchHHHHHHHHHHHHHHhCCCCC
Confidence 9999999999754321 012345699999999998655 5799999999999999999999998
Q ss_pred CCCCCCccchHHHHHHHHhhcC---cccc---ccccccCC-CCCCH-----HHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 336 DLTYPDDQIILLDWIRRLSDEG---KVLQ---AGDNRLSD-GSYKL-----CDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 336 ~~~~~~~~~~l~~~~~~~~~~~---~~~~---~~d~~l~~-~~~~~-----~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
...... .....+....... .... ........ ..... ...+.+.+++..||+.||.+|||+.++++
T Consensus 220 ~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 220 CGNSEA---DQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CCSSHH---HHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCHH---HHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 643211 1112121111100 0000 00000000 00000 11246788999999999999999999986
Q ss_pred H
Q 003278 404 A 404 (834)
Q Consensus 404 ~ 404 (834)
.
T Consensus 297 h 297 (308)
T 3g33_A 297 H 297 (308)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=352.02 Aligned_cols=261 Identities=23% Similarity=0.390 Sum_probs=197.8
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc---ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK---GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 187 (834)
++|...+.||+|+||.||+|....+|+.||||++... .....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 5688999999999999999999889999999998642 3445677899999999999999999999999999999999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
||+++|+|.+++..... ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 112 e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~ 185 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKK---QKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRF 185 (310)
T ss_dssp ECCCSCBHHHHHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-----
T ss_pred ecCCCCCHHHHHHHhcc---cccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceee
Confidence 99999999999864211 235689999999999999999999996 999999999999999999999999999976
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHH
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILL 347 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~ 347 (834)
...... ......||+.|+|||.+... .++.++|||||||++|||+||+.||...... ..
T Consensus 186 ~~~~~~----------------~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~ 244 (310)
T 2wqm_A 186 FSSKTT----------------AAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LY 244 (310)
T ss_dssp -----------------------------CCSSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HH
T ss_pred ecCCCc----------------cccccCCCeeEeChHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCCcccchh----HH
Confidence 432210 12334689999999988654 6799999999999999999999998643211 22
Q ss_pred HHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 348 DWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 348 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
.+.... ..+.... +....+ ...+.+++..||+.||.+||++.+|++.|+..
T Consensus 245 ~~~~~~-~~~~~~~-----~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l 295 (310)
T 2wqm_A 245 SLCKKI-EQCDYPP-----LPSDHY----SEELRQLVNMCINPDPEKRPDVTYVYDVAKRM 295 (310)
T ss_dssp HHHHHH-HTTCSCC-----CCTTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHh-hcccCCC-----Cccccc----CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 222222 1121111 111111 14578899999999999999999999998765
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=366.98 Aligned_cols=244 Identities=23% Similarity=0.300 Sum_probs=200.1
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC--------hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCC
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG--------ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHED 181 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~--------~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~ 181 (834)
.++|...+.||+|+||.||+|++..+|+.||||++.... ....+.+.+|+.++++++||||++++++|.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 357899999999999999999999999999999986542 112345778999999999999999999999999
Q ss_pred EEEEEEEccCCC-CHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEe
Q 003278 182 QLLLVYDYMPNR-SLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLG 260 (834)
Q Consensus 182 ~~~lV~Ey~~~g-sL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~ 260 (834)
..++||||+.+| +|.+++... ..+++..+..|+.|++.||.|||+. +|+||||||+|||++.++.+||+
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~ 172 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRH-------PRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLI 172 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEEC
T ss_pred EEEEEEEeCCCCccHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEe
Confidence 999999999877 999988643 3589999999999999999999996 99999999999999999999999
Q ss_pred eccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCC
Q 003278 261 DFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYP 340 (834)
Q Consensus 261 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~ 340 (834)
|||+++.+... .......||+.|+|||.+......+.++|||||||++|||+||+.||.....
T Consensus 173 Dfg~a~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 235 (335)
T 3dls_A 173 DFGSAAYLERG-----------------KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE 235 (335)
T ss_dssp CCTTCEECCTT-----------------CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG
T ss_pred ecccceECCCC-----------------CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH
Confidence 99999754321 0124467999999999987664458899999999999999999999853110
Q ss_pred CccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 341 DDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 341 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
. ........ ... ...+.+++..||+.||.+||++.++++.
T Consensus 236 ~-----------------~~~~~~~~---~~~----~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 236 T-----------------VEAAIHPP---YLV----SKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp G-----------------TTTCCCCS---SCC----CHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred H-----------------HhhccCCC---ccc----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 00000000 111 1357889999999999999999999874
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=364.41 Aligned_cols=250 Identities=16% Similarity=0.237 Sum_probs=184.8
Q ss_pred hhCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEe
Q 003278 512 TNNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYD 590 (834)
Q Consensus 512 t~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~E 590 (834)
.+.|...+.||+|+||.||+|... ++..||||.+.... ..+.+.+|+.+|++++|||||++++++.+.+..++|||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 456777889999999999999975 47889999987543 23568899999999999999999999999999999999
Q ss_pred ccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecC---CCCceEeeeeecc
Q 003278 591 YSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDP---DMNPRLGSFALAE 667 (834)
Q Consensus 591 y~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~---~~~~ki~DfGla~ 667 (834)
|+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++
T Consensus 129 ~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~ 199 (349)
T 2w4o_A 129 LVTGGELFDRIVEKG------YYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSK 199 (349)
T ss_dssp CCCSCBHHHHHTTCS------SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC---
T ss_pred eCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCcccc
Confidence 999999999886532 37899999999999999999997 68999999999999975 8899999999997
Q ss_pred ccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcC
Q 003278 668 FLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKR 747 (834)
Q Consensus 668 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||............+.. ...
T Consensus 200 ~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~---~~~ 268 (349)
T 2w4o_A 200 IVEHQV--------LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILN---CEY 268 (349)
T ss_dssp ---------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHT---TCC
T ss_pred ccCccc--------ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHh---CCC
Confidence 653221 123467999999999999999999999999999999999999998654433322222211 111
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 748 PLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 748 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
. ...+ .....+ . .+..++.+||+.||++|||+.++++
T Consensus 269 ~---~~~~-~~~~~~-~---~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 269 Y---FISP-WWDEVS-L---NAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp C---CCTT-TTTTSC-H---HHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred c---cCCc-hhhhCC-H---HHHHHHHHHccCChhhCcCHHHHhc
Confidence 1 0111 111122 2 3445666999999999999999987
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=358.22 Aligned_cols=260 Identities=22% Similarity=0.345 Sum_probs=197.9
Q ss_pred CcCcCCcccccCCcEEEEEEECC-----CcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEE
Q 003278 514 NFSESQRVAEMDFGTAYQGFLDN-----HQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVI 588 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~~~-----~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv 588 (834)
.|...+.||+|+||.||+|.... +..||||.+...........|.+|+.++++++|||||++++++.+.+..++|
T Consensus 45 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 124 (333)
T 1mqb_A 45 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMII 124 (333)
T ss_dssp TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEE
Confidence 34446789999999999998643 2459999998666666667899999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccc
Q 003278 589 YDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEF 668 (834)
Q Consensus 589 ~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~ 668 (834)
|||+++|+|.+++.... ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 125 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 125 TEYMENGALDKFLREKD-----GEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EECCTTEEHHHHHHHTT-----TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EeCCCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 99999999999987543 248899999999999999999997 6899999999999999999999999999987
Q ss_pred cccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcC
Q 003278 669 LTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKR 747 (834)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
....... ........||+.|+|||++.+..++.++|||||||++|||+| |+.||...... .+...+ ....+
T Consensus 197 ~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-~~~~~~---~~~~~ 268 (333)
T 1mqb_A 197 LEDDPEA----TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-EVMKAI---NDGFR 268 (333)
T ss_dssp ------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHHHH---HTTCC
T ss_pred hcccccc----ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH-HHHHHH---HCCCc
Confidence 5432111 111122356889999999999999999999999999999999 99998643322 221111 11111
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCcc
Q 003278 748 PLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDKR 800 (834)
Q Consensus 748 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~~ 800 (834)
. ...... +. .+.+++.+||+.||++|||+.+|++.|+.+.+.
T Consensus 269 ~-------~~~~~~-~~---~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 269 L-------PTPMDC-PS---AIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp C-------CCCTTC-BH---HHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred C-------CCcccC-CH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0 011111 22 355666799999999999999999999765543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=378.62 Aligned_cols=261 Identities=25% Similarity=0.380 Sum_probs=202.7
Q ss_pred HHhhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEE
Q 003278 106 LYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLL 185 (834)
Q Consensus 106 l~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 185 (834)
..+..++|...+.||+|+||.||+|.+. .+..||||++.... ...+.|.+|+.+|++++|||||++++++.+ +..++
T Consensus 179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~i 255 (452)
T 1fmk_A 179 WEIPRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 255 (452)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred cccChhHceeeeeecCCCCeEEEEEEEC-CCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEE
Confidence 3455677888999999999999999995 56789999987543 235679999999999999999999999876 67899
Q ss_pred EEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccch
Q 003278 186 VYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLA 265 (834)
Q Consensus 186 V~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla 265 (834)
||||+++|+|.++|.... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 256 v~e~~~~gsL~~~l~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a 327 (452)
T 1fmk_A 256 VTEYMSKGSLLDFLKGET-----GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLA 327 (452)
T ss_dssp EECCCTTCBHHHHHSHHH-----HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred EehhhcCCCHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccc
Confidence 999999999999996421 24589999999999999999999996 9999999999999999999999999999
Q ss_pred hhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccc
Q 003278 266 RWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQI 344 (834)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~ 344 (834)
+.+..... .......||+.|+|||.+..+ .++.++|||||||++|||+| |+.|+......
T Consensus 328 ~~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--- 388 (452)
T 1fmk_A 328 RLIEDNEY---------------TARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--- 388 (452)
T ss_dssp C-----------------------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---
T ss_pred eecCCCce---------------ecccCCcccccccCHhHHhcC-CCCccccHHhHHHHHHHHHhCCCCCCCCCCHH---
Confidence 86543210 012233478899999998765 67999999999999999999 99988643211
Q ss_pred hHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcCCC
Q 003278 345 ILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGSYS 410 (834)
Q Consensus 345 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~~~ 410 (834)
.+ ... ...+..... . .. ....+.+++..||+.||++||++.++++.|+..+.
T Consensus 389 ~~---~~~-i~~~~~~~~-----~-~~----~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 389 EV---LDQ-VERGYRMPC-----P-PE----CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp HH---HHH-HHTTCCCCC-----C-TT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred HH---HHH-HHcCCCCCC-----C-CC----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 11 111 112211110 0 11 12468899999999999999999999999988654
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=360.77 Aligned_cols=269 Identities=20% Similarity=0.224 Sum_probs=201.6
Q ss_pred HhhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc-----ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCC
Q 003278 107 YIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK-----GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHED 181 (834)
Q Consensus 107 ~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~ 181 (834)
....++|...+.||+|+||.||+|....++..||||++... .....+.+.+|+.++++++|||||+++++|.+.+
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 34457799999999999999999999999999999998643 2345678999999999999999999999999999
Q ss_pred EEEEEEEccCCCCHhHHHhcCCCcc---------------------------------ccCCCCCHHHHHHHHHHHHHHH
Q 003278 182 QLLLVYDYMPNRSLDRVLFRRPENL---------------------------------EAAAPLNWEQRKKIIRGLAAAL 228 (834)
Q Consensus 182 ~~~lV~Ey~~~gsL~~~l~~~~~~~---------------------------------~~~~~l~~~~~~~i~~~ia~gL 228 (834)
..++||||+++|+|.+++....... .....+++..+..|+.|++.||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 9999999999999999985211000 0012246777889999999999
Q ss_pred HHHHhccCCCeecCCCCCCceEECCCC--ceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCcccc
Q 003278 229 HYLHEQLETQIIHRDVKTSNVMLDSQY--NARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESF 306 (834)
Q Consensus 229 ~yLH~~~~~~iiHrDlKp~NILld~~~--~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~ 306 (834)
+|||+. +|+||||||+|||++.++ .+||+|||+++.+...... .........||+.|+|||.+
T Consensus 182 ~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~------------~~~~~~~~~gt~~y~aPE~~ 246 (345)
T 3hko_A 182 HYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNG------------EYYGMTTKAGTPYFVAPEVL 246 (345)
T ss_dssp HHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------------------CCCGGGCCHHHH
T ss_pred HHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCcc------------ccccccccCCCccccCchhh
Confidence 999996 999999999999998766 8999999999864321100 00112445699999999998
Q ss_pred cc-CCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHH
Q 003278 307 QK-GSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLAL 385 (834)
Q Consensus 307 ~~-~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~ 385 (834)
.. ...++.++|||||||++|||+||+.||...... .............. .+.. ... ...+.+++.
T Consensus 247 ~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~~~~~~~~~~--~~~~--~~~----~~~~~~li~ 312 (345)
T 3hko_A 247 NTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDA------DTISQVLNKKLCFE--NPNY--NVL----SPLARDLLS 312 (345)
T ss_dssp TCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCCTT--SGGG--GGS----CHHHHHHHH
T ss_pred ccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChH------HHHHHHHhcccccC--Cccc--ccC----CHHHHHHHH
Confidence 64 246789999999999999999999998643211 11222222111110 0100 001 145788999
Q ss_pred HhcccCCCCCCchhhHHHH
Q 003278 386 LCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 386 ~Cl~~~p~~RPsm~~V~~~ 404 (834)
.||+.||.+||++.++++.
T Consensus 313 ~~l~~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 313 NLLNRNVDERFDAMRALQH 331 (345)
T ss_dssp HHSCSCTTTSCCHHHHHHS
T ss_pred HHcCCChhHCCCHHHHhcC
Confidence 9999999999999999874
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=347.29 Aligned_cols=250 Identities=19% Similarity=0.261 Sum_probs=201.4
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEcc
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYM 190 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 190 (834)
++|...+.||+|+||.||+|....++..||+|++........+.+.+|+.++++++||||++++++|.+.+..++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC 88 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence 46888899999999999999999899999999987654555678999999999999999999999999999999999999
Q ss_pred CCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEE---CCCCceEEeeccchhh
Q 003278 191 PNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVML---DSQYNARLGDFGLARW 267 (834)
Q Consensus 191 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILl---d~~~~~kl~DFGla~~ 267 (834)
++++|.+++... ..+++..+..|+.|++.||.|||+. +|+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 ~~~~L~~~~~~~-------~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~ 158 (277)
T 3f3z_A 89 TGGELFERVVHK-------RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR 158 (277)
T ss_dssp CSCBHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred CCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEeccccee
Confidence 999999988643 3589999999999999999999996 99999999999999 7888999999999975
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHH
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILL 347 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~ 347 (834)
+.... ......||+.|+|||.+.. .++.++|||||||++|||+||+.||...... ..
T Consensus 159 ~~~~~-----------------~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~- 215 (277)
T 3f3z_A 159 FKPGK-----------------MMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDS---EV- 215 (277)
T ss_dssp CCTTS-----------------CBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HH-
T ss_pred ccCcc-----------------chhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHH---HH-
Confidence 43210 1234469999999998753 4799999999999999999999998643211 11
Q ss_pred HHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 348 DWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 348 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
..... .+.... ..... ... ...+.+++..||+.||.+||++.++++
T Consensus 216 --~~~~~-~~~~~~-~~~~~--~~~----~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 216 --MLKIR-EGTFTF-PEKDW--LNV----SPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp --HHHHH-HCCCCC-CHHHH--TTS----CHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred --HHHHH-hCCCCC-Cchhh--hcC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11111 111100 00000 001 146788999999999999999999876
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=375.70 Aligned_cols=249 Identities=22% Similarity=0.366 Sum_probs=203.1
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 187 (834)
++|...+.||+|+||.||+|.+..+|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 56888999999999999999998899999999986532 223567899999999999999999999999999999999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 96 E~~~gg~L~~~l~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~ 165 (476)
T 2y94_A 96 EYVSGGELFDYICKN-------GRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNM 165 (476)
T ss_dssp ECCSSEEHHHHTTSS-------SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred eCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhh
Confidence 999999999998542 4689999999999999999999985 999999999999999999999999999975
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHH
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILL 347 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~ 347 (834)
.... ......+||+.|+|||.+......+.++|||||||++|||+||+.||+.... ..+
T Consensus 166 ~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~---~~~- 224 (476)
T 2y94_A 166 MSDG-----------------EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV---PTL- 224 (476)
T ss_dssp CCTT-----------------CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS---HHH-
T ss_pred cccc-----------------ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH---HHH-
Confidence 4321 0123457999999999987654557899999999999999999999964321 111
Q ss_pred HHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 348 DWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 348 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
...+. .+... .. ...+ ..+.+|+..||+.||.+||++.++++.
T Consensus 225 --~~~i~-~~~~~------~p-~~~s----~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 225 --FKKIC-DGIFY------TP-QYLN----PSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp --HHHHH-TTCCC------CC-TTCC----HHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred --HHHHh-cCCcC------CC-ccCC----HHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 11211 11110 00 1111 357889999999999999999999873
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=371.16 Aligned_cols=253 Identities=18% Similarity=0.196 Sum_probs=198.9
Q ss_pred hhCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCCh-hHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEE
Q 003278 512 TNNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCP-ALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIY 589 (834)
Q Consensus 512 t~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~-~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~ 589 (834)
+++|...+.||+|+||.||+|.. .++..+|+|.+...... ...+.+.+|+.+|++++|||||++++++.+.+..++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 46788889999999999999985 56889999998765433 34567899999999999999999999999999999999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeec---CCCCceEeeeeec
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLD---PDMNPRLGSFALA 666 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld---~~~~~ki~DfGla 666 (834)
||+.+|+|.+++.... .+++.....++.|++.||+|||+ .+|+||||||+|||++ +++.+||+|||++
T Consensus 90 E~~~gg~L~~~i~~~~------~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a 160 (444)
T 3soa_A 90 DLVTGGELFEDIVARE------YYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLA 160 (444)
T ss_dssp CCCBCCBHHHHHHHCS------CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSC
T ss_pred EeCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCcee
Confidence 9999999999887543 38889999999999999999997 6999999999999998 4678999999999
Q ss_pred cccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhc
Q 003278 667 EFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARK 746 (834)
Q Consensus 667 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~ 746 (834)
....... .......||+.|||||++.+..++.++|||||||++|||++|..||...... .+...+.. ..
T Consensus 161 ~~~~~~~-------~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~-~~~~~i~~---~~ 229 (444)
T 3soa_A 161 IEVEGEQ-------QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH-RLYQQIKA---GA 229 (444)
T ss_dssp BCCCTTC-------CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHH---TC
T ss_pred EEecCCC-------ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHh---CC
Confidence 7654321 1123468999999999999999999999999999999999999998654322 22222111 11
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 747 RPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 747 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
.. ...+.. ... .++ +..++.+||+.||++|||+.|+++
T Consensus 230 ~~---~~~~~~-~~~-s~~---~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 230 YD---FPSPEW-DTV-TPE---AKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp CC---CCTTTT-TTS-CHH---HHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CC---CCcccc-ccC-CHH---HHHHHHHHcCCChhHCCCHHHHhc
Confidence 11 111100 111 233 445556899999999999999986
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=362.66 Aligned_cols=200 Identities=26% Similarity=0.420 Sum_probs=174.9
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc-ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEc
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDY 189 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 189 (834)
++|+..+.||+|+||.||+|.+..+|..||+|++... .....+.+.+|+.++.+++||||+++++++...+..++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 5688899999999999999999889999999998654 344567899999999999999999999999999999999999
Q ss_pred cCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhh
Q 003278 190 MPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLE 269 (834)
Q Consensus 190 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~ 269 (834)
+++|+|.+++... ..+++..+..|+.|++.||.|||+. .+|+||||||+|||++.++.+||+|||+++.+.
T Consensus 113 ~~~~~L~~~l~~~-------~~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 113 MDGGSLDQVLKKA-------GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183 (360)
T ss_dssp CTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred CCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence 9999999999653 3588999999999999999999984 279999999999999999999999999997553
Q ss_pred hhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCC
Q 003278 270 HELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLT 338 (834)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~ 338 (834)
... .....||+.|+|||.+... .++.++|||||||++|||+||+.||...
T Consensus 184 ~~~------------------~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 184 DSM------------------ANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp HHC----------------------CCCCTTCCHHHHTTC-CCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred ccc------------------ccCCCCCCCeECHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 221 2345699999999998654 6799999999999999999999998653
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=352.25 Aligned_cols=265 Identities=18% Similarity=0.228 Sum_probs=204.8
Q ss_pred cCcCCcccccCCcEEEEEEEC-CC---cEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeE-EEEE
Q 003278 515 FSESQRVAEMDFGTAYQGFLD-NH---QYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEM-LVIY 589 (834)
Q Consensus 515 f~~~~~ig~g~~g~vy~~~~~-~~---~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~-~lv~ 589 (834)
|...+.||+|+||+||+|... ++ ..||+|.+.........+.|.+|+.++++++|||||++++++.+.+.. ++||
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 102 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL 102 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence 334577999999999999853 33 379999998666666678899999999999999999999999766554 9999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccc
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFL 669 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~ 669 (834)
||+.+|+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++..
T Consensus 103 e~~~~~~L~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 174 (298)
T 3pls_A 103 PYMCHGDLLQFIRSPQ-----RNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDI 174 (298)
T ss_dssp CCCTTCBHHHHHHCTT-----CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTT
T ss_pred ecccCCCHHHHHhccc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCcccc
Confidence 9999999999997533 247889999999999999999997 68999999999999999999999999999765
Q ss_pred ccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcc
Q 003278 670 TRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPL 749 (834)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
..... ..........||+.|+|||.+.+..++.++|||||||++|||+||..|+............... ....
T Consensus 175 ~~~~~---~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~---~~~~- 247 (298)
T 3pls_A 175 LDREY---YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ---GRRL- 247 (298)
T ss_dssp TTGGG---GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHT---TCCC-
T ss_pred cCCcc---cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhc---CCCC-
Confidence 43221 1112233457899999999999999999999999999999999977776444333332222211 1100
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCcccccc
Q 003278 750 AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDKRFMED 804 (834)
Q Consensus 750 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~~~~~~ 804 (834)
..... .++ .+.+++.+||+.||++|||+.++++.|+.+.+.+.+.
T Consensus 248 ------~~~~~-~~~---~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~ 292 (298)
T 3pls_A 248 ------PQPEY-CPD---SLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD 292 (298)
T ss_dssp ------CCCTT-CCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSC
T ss_pred ------CCCcc-chH---HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhcc
Confidence 01111 123 3455666999999999999999999998776655443
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=350.56 Aligned_cols=257 Identities=22% Similarity=0.300 Sum_probs=199.0
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc---ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK---GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 187 (834)
++|...+.||+|+||.||+|....+++.||||++... .....+.+.+|+.++.+++||||+++++++...+..++||
T Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 2h34_A 34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDM 113 (309)
T ss_dssp CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEE
Confidence 6799999999999999999999889999999998654 2334577999999999999999999999999999999999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
||+++++|.+++... .++++..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 114 e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~ 183 (309)
T 2h34_A 114 RLINGVDLAAMLRRQ-------GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASA 183 (309)
T ss_dssp ECCCCEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC---
T ss_pred EecCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcc
Confidence 999999999998643 3589999999999999999999996 999999999999999999999999999976
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHH
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILL 347 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~ 347 (834)
...... .......||+.|+|||.+... .++.++|||||||++|||+||+.||.... ..
T Consensus 184 ~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~----~~-- 241 (309)
T 2h34_A 184 TTDEKL---------------TQLGNTVGTLYYMAPERFSES-HATYRADIYALTCVLYECLTGSPPYQGDQ----LS-- 241 (309)
T ss_dssp ----------------------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCH----HH--
T ss_pred cccccc---------------ccccccCCCcCccCHHHHcCC-CCCchHhHHHHHHHHHHHHHCCCCCCCch----HH--
Confidence 432210 012344699999999988654 67899999999999999999999986421 11
Q ss_pred HHHHHHhhcC-ccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCC-chhhHHHHhhcCC
Q 003278 348 DWIRRLSDEG-KVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRP-SMKWVIEAVSGSY 409 (834)
Q Consensus 348 ~~~~~~~~~~-~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-sm~~V~~~l~~~~ 409 (834)
......... .......+. .+ ..+.+++..||+.||.+|| ++.++++.|....
T Consensus 242 -~~~~~~~~~~~~~~~~~~~-----~~----~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l 295 (309)
T 2h34_A 242 -VMGAHINQAIPRPSTVRPG-----IP----VAFDAVIARGMAKNPEDRYVTCGDLSAAAHAAL 295 (309)
T ss_dssp -HHHHHHHSCCCCGGGTSTT-----CC----THHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred -HHHHHhccCCCCccccCCC-----CC----HHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHH
Confidence 111111111 111111111 11 3578899999999999999 9999999998754
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=360.69 Aligned_cols=275 Identities=25% Similarity=0.392 Sum_probs=214.3
Q ss_pred cccHHHHHhhcCCCCCCCeeeccCCeEEEEEEEC-----CCCeEEEEEEecccC-hhhHHHHHHHHHHHHhCCCCceeeE
Q 003278 100 IFSYAELYIGSNGFDEDEVLGSGGFGKVYRAVLP-----SDGTVVAVKCLAEKG-ERFEKTFAAELVAVAHLRHRNLVRL 173 (834)
Q Consensus 100 ~f~~~el~~~t~~f~~~~~LG~G~fG~Vy~~~~~-----~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l 173 (834)
.+..+++....++|...+.||+|+||.||+|.+. .+++.||||.+.... ......|.+|+.++++++||||+++
T Consensus 14 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 93 (322)
T 1p4o_A 14 VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRL 93 (322)
T ss_dssp CCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCE
T ss_pred ccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeee
Confidence 3455566677788999999999999999999875 357889999987543 3445679999999999999999999
Q ss_pred eeeEEeCCEEEEEEEccCCCCHhHHHhcCCCc---cccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceE
Q 003278 174 RGWCVHEDQLLLVYDYMPNRSLDRVLFRRPEN---LEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVM 250 (834)
Q Consensus 174 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~---~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NIL 250 (834)
++++.+.+..++||||+++|+|.+++...... .....++++..+..++.|++.||.|||+. +|+||||||+|||
T Consensus 94 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIl 170 (322)
T 1p4o_A 94 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCM 170 (322)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEE
T ss_pred EEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEE
Confidence 99999999999999999999999998653211 01124679999999999999999999996 9999999999999
Q ss_pred ECCCCceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh
Q 003278 251 LDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS 330 (834)
Q Consensus 251 ld~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt 330 (834)
++.++.+||+|||+++........ .......||+.|+|||.+... .++.++|||||||++|||+|
T Consensus 171 i~~~~~~kl~Dfg~~~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~ 235 (322)
T 1p4o_A 171 VAEDFTVKIGDFGMTRDIYETDYY--------------RKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIAT 235 (322)
T ss_dssp ECTTCCEEECCTTCCCGGGGGGCE--------------EGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHH
T ss_pred EcCCCeEEECcCcccccccccccc--------------ccccCCCCCCCccChhhhccC-CCCchhhHHHHHHHHHHHHh
Confidence 999999999999999865332110 112334579999999998655 57999999999999999999
Q ss_pred -CCccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcCC
Q 003278 331 -GRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGSY 409 (834)
Q Consensus 331 -G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~~ 409 (834)
|+.|+..... . ...... ..+...... ... ...+.+++..||+.||.+||++.++++.|+...
T Consensus 236 ~g~~p~~~~~~---~---~~~~~~-~~~~~~~~~------~~~----~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 236 LAEQPYQGLSN---E---QVLRFV-MEGGLLDKP------DNC----PDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp TSCCTTTTSCH---H---HHHHHH-HTTCCCCCC------TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred cCCCccccCCH---H---HHHHHH-HcCCcCCCC------CCC----CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 8888754321 1 111111 122211110 111 245788999999999999999999999998754
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=347.03 Aligned_cols=253 Identities=19% Similarity=0.303 Sum_probs=200.2
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeC--CEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHE--DQLLLV 186 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lV 186 (834)
++|...+.||+|+||.||+|++ +|+.||||++... .....+.|.+|+.++++++||||++++++|.+. +..++|
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 4688889999999999999998 4899999998654 334557799999999999999999999999887 778999
Q ss_pred EEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchh
Q 003278 187 YDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLAR 266 (834)
Q Consensus 187 ~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~ 266 (834)
|||+++|+|.+++.... ...+++..+..|+.|++.||.|||+. .++|+||||||+|||++.++.++|+|||++.
T Consensus 88 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~ 161 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGT-----NFVVDQSQAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVKF 161 (271)
T ss_dssp EECCTTCBHHHHHHSCS-----SCCCCHHHHHHHHHHHHHHHHHHTTS-SSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred ecccCCCcHHHHHhhcc-----cCCCCHHHHHHHHHHHHHHHHHHhcC-CCceecCCCccceEEEcCCcceeEEecccee
Confidence 99999999999997542 23689999999999999999999985 1239999999999999999999999998875
Q ss_pred hhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCC--CCCcccceeehhhHHHHHHhCCccCCCCCCCccc
Q 003278 267 WLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGS--VATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQI 344 (834)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~--~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~ 344 (834)
... .....||+.|+|||.+.... .++.++|||||||++|||+||+.||.....
T Consensus 162 ~~~---------------------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---- 216 (271)
T 3kmu_A 162 SFQ---------------------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN---- 216 (271)
T ss_dssp TTS---------------------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH----
T ss_pred eec---------------------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh----
Confidence 311 12235899999999986532 223379999999999999999999864321
Q ss_pred hHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 345 ILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 345 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
..........+... .+. ... ...+.+++..||+.||.+||++.++++.|+..
T Consensus 217 --~~~~~~~~~~~~~~-----~~~-~~~----~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 217 --MEIGMKVALEGLRP-----TIP-PGI----SPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp --HHHHHHHHHSCCCC-----CCC-TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHHHHHHHhcCCCC-----CCC-CCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 11112222222111 111 111 24588999999999999999999999998764
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=358.57 Aligned_cols=264 Identities=22% Similarity=0.304 Sum_probs=206.3
Q ss_pred hCcCcCCcccccCCcEEEEEEEC--------CCcEEEEEEecCCCChhHHHHHHHHHHHHHhc-cCCCceeEEEEEeeCC
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD--------NHQYVLVKRLGMSKCPALRTRFSNELQNLARL-RHRNLVQLCGWCTEQG 583 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~--------~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l-~HpNiv~l~g~~~~~~ 583 (834)
++|...+.||+|+||.||+|... ++..||||++.........+.|.+|+.+++++ +||||++++++|.+.+
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 114 (334)
T 2pvf_A 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 114 (334)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCC
Confidence 46677788999999999999863 46789999998666666667899999999999 9999999999999999
Q ss_pred eEEEEEeccCCCchhhhhhcCCCC----------CCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeec
Q 003278 584 EMLVIYDYSATRILSHLLFHNNHR----------IGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLD 653 (834)
Q Consensus 584 ~~~lv~Ey~~~g~L~~~l~~~~~~----------~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld 653 (834)
..++||||+++|+|.+++...... .....+++..++.++.|++.||+|||+ .+|+||||||+|||++
T Consensus 115 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~ 191 (334)
T 2pvf_A 115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVT 191 (334)
T ss_dssp CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC
T ss_pred ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEEEc
Confidence 999999999999999999764321 012248899999999999999999997 6999999999999999
Q ss_pred CCCCceEeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCc
Q 003278 654 PDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPE 732 (834)
Q Consensus 654 ~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~ 732 (834)
.++.+||+|||+++....... ........||+.|+|||++.+..++.++|||||||++|||+| |+.|+......
T Consensus 192 ~~~~~kL~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 266 (334)
T 2pvf_A 192 ENNVMKIADFGLARDINNIDY-----YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266 (334)
T ss_dssp TTCCEEECCCTTCEECTTTSS-----EECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred CCCCEEEcccccccccccccc-----ccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH
Confidence 999999999999986543221 111223467889999999999999999999999999999999 98888643322
Q ss_pred hhHHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCc
Q 003278 733 GLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDK 799 (834)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~ 799 (834)
.+...+.. .... ......+ . .+.+++.+||+.||++|||+.+|++.|+.+..
T Consensus 267 -~~~~~~~~---~~~~-------~~~~~~~-~---~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 267 -ELFKLLKE---GHRM-------DKPANCT-N---ELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp -HHHHHHHH---TCCC-------CCCTTCC-H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHHHHhc---CCCC-------CCCccCC-H---HHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 22221111 1110 1111222 2 34556669999999999999999999987644
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=366.35 Aligned_cols=254 Identities=20% Similarity=0.368 Sum_probs=195.0
Q ss_pred hcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCCC--CceeeEeeeEEeCCEEE
Q 003278 109 GSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRH--RNLVRLRGWCVHEDQLL 184 (834)
Q Consensus 109 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H--~nIv~l~g~~~~~~~~~ 184 (834)
..+.|+..+.||+|+||.||+|.. .+++.||||++... .....+.|.+|+.+|.+++| |||+++++++...+..+
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 85 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 85 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence 346688999999999999999998 57899999998643 34455789999999999987 99999999999999999
Q ss_pred EEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccc
Q 003278 185 LVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGL 264 (834)
Q Consensus 185 lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGl 264 (834)
+||| +.+|+|.+++... ..+++..+..|+.|++.||.|||+. +|+||||||+|||++ ++.+||+|||+
T Consensus 86 lv~e-~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~ 153 (343)
T 3dbq_A 86 MVME-CGNIDLNSWLKKK-------KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGI 153 (343)
T ss_dssp EEEC-CCSEEHHHHHHHS-------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSS
T ss_pred EEEe-CCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeeccc
Confidence 9999 5688999999653 4689999999999999999999996 999999999999997 56899999999
Q ss_pred hhhhhhhhhhhhhcccccccccccccceeeeccccCCCcccccc----------CCCCCcccceeehhhHHHHHHhCCcc
Q 003278 265 ARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQK----------GSVATAKSDVFSFGIVVLEVVSGRRA 334 (834)
Q Consensus 265 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~----------~~~~~~ksDV~SfGvvl~ElltG~~p 334 (834)
++.+...... ...+...||+.|+|||++.. ...++.++|||||||++|||+||+.|
T Consensus 154 a~~~~~~~~~--------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p 219 (343)
T 3dbq_A 154 ANQMQPDTTS--------------VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219 (343)
T ss_dssp SCCC--------------------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCT
T ss_pred ccccCccccc--------------ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCc
Confidence 9865432110 01234579999999999853 24678999999999999999999999
Q ss_pred CCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 335 VDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 335 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
|...... .............. .++......+.+++..||+.||.+||++.++++.
T Consensus 220 f~~~~~~-----~~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 220 FQQIINQ-----ISKLHAIIDPNHEI----------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp TTTCCSH-----HHHHHHHHCTTSCC----------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred chhhhhH-----HHHHHHHhcCCccc----------CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 8643211 11111111111100 0111112457889999999999999999999875
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=358.57 Aligned_cols=248 Identities=19% Similarity=0.230 Sum_probs=197.3
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCC--ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSK--CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIY 589 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~ 589 (834)
++|...+.||+|+||.||+|... +++.||||.+.... .......+.+|+.+|++++|||||++++++.+.+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 46777889999999999999964 58899999986421 1122456889999999999999999999999999999999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccc
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFL 669 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~ 669 (834)
||+++|+|..++.... .+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 85 E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 155 (337)
T 1o6l_A 85 EYANGGELFFHLSRER------VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEG 155 (337)
T ss_dssp ECCTTCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred eCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhc
Confidence 9999999999886532 37888889999999999999997 69999999999999999999999999999753
Q ss_pred ccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcc
Q 003278 670 TRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPL 749 (834)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
.... ....+.+||+.|||||++.+..++.++|||||||++|||+||+.||....... +...+. ....
T Consensus 156 ~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~i~---~~~~-- 222 (337)
T 1o6l_A 156 ISDG-------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-LFELIL---MEEI-- 222 (337)
T ss_dssp CCTT-------CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHH---HCCC--
T ss_pred ccCC-------CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH-HHHHHH---cCCC--
Confidence 2211 12335689999999999999999999999999999999999999986543221 111111 1111
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----ChhHHHH
Q 003278 750 AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRP-----SMRQILS 792 (834)
Q Consensus 750 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RP-----tm~~v~~ 792 (834)
.++...+ .+ +..++.+||+.||++|| ++.+|++
T Consensus 223 ------~~p~~~s-~~---~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 223 ------RFPRTLS-PE---AKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ------CCCTTSC-HH---HHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ------CCCCCCC-HH---HHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 1111222 33 34455589999999999 8888875
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=369.84 Aligned_cols=255 Identities=22% Similarity=0.293 Sum_probs=192.1
Q ss_pred hcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC--------hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeC
Q 003278 109 GSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG--------ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHE 180 (834)
Q Consensus 109 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~--------~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~ 180 (834)
..++|...+.||+|+||.||+|....+++.||||++.... ......+.+|+.+|++++|||||++++++. .
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~ 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 3578999999999999999999999999999999986431 112235889999999999999999999975 5
Q ss_pred CEEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCC---Cce
Q 003278 181 DQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQ---YNA 257 (834)
Q Consensus 181 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~---~~~ 257 (834)
+..++||||+++|+|.+++... ..+++..+..|+.|++.||+|||+. +|+||||||+|||++.+ ..+
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~ 281 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGN-------KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLI 281 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSS-------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCE
T ss_pred CceEEEEEcCCCCcHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceE
Confidence 5689999999999999887542 4689999999999999999999986 99999999999999754 459
Q ss_pred EEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCcccccc--CCCCCcccceeehhhHHHHHHhCCccC
Q 003278 258 RLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQK--GSVATAKSDVFSFGIVVLEVVSGRRAV 335 (834)
Q Consensus 258 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~~ksDV~SfGvvl~ElltG~~p~ 335 (834)
||+|||+++.+.... ......||+.|+|||++.. ...++.++|||||||++|||+||+.||
T Consensus 282 kl~DFG~a~~~~~~~-----------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf 344 (419)
T 3i6u_A 282 KITDFGHSKILGETS-----------------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 344 (419)
T ss_dssp EECCSSTTTSCC----------------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSS
T ss_pred EEeecccceecCCCc-----------------cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCC
Confidence 999999998653211 1345679999999998853 345788999999999999999999999
Q ss_pred CCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 336 DLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 336 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
....... .+...+. .+..... +... .. ....+.+++..||+.||.+||++.++++.
T Consensus 345 ~~~~~~~--~~~~~i~----~~~~~~~--~~~~-~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 345 SEHRTQV--SLKDQIT----SGKYNFI--PEVW-AE----VSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp CCCSSSC--CHHHHHH----TTCCCCC--HHHH-TT----SCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCcchH--HHHHHHh----cCCCCCC--chhh-cc----cCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 7533221 2222111 1111100 0000 00 12467889999999999999999999874
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=365.88 Aligned_cols=212 Identities=17% Similarity=0.228 Sum_probs=177.0
Q ss_pred hCcCcCCccccc--CCcEEEEEEEC-CCcEEEEEEecCCC-ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEE
Q 003278 513 NNFSESQRVAEM--DFGTAYQGFLD-NHQYVLVKRLGMSK-CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVI 588 (834)
Q Consensus 513 ~~f~~~~~ig~g--~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv 588 (834)
++|...+.||+| +||.||+|... +++.||||++.... .....+.+.+|+.++++++|||||++++++.+.+..++|
T Consensus 25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 104 (389)
T 3gni_B 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV 104 (389)
T ss_dssp GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEE
Confidence 457777889999 99999999975 68999999987543 234557788999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccc
Q 003278 589 YDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEF 668 (834)
Q Consensus 589 ~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~ 668 (834)
|||+++|+|.+++..... ..+++..+..|+.|++.||+|||+ .+|+||||||+||||+.++.+||+|||++..
T Consensus 105 ~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 105 TSFMAYGSAKDLICTHFM----DGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EECCTTCBHHHHHHHTCT----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEccCCCCHHHHHhhhcc----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEccccccee
Confidence 999999999999876421 248899999999999999999997 6899999999999999999999999999865
Q ss_pred cccCCCCCcccccCccccccccCccchhcccc--CCCCccCcchhhHHHHHHHHhCCCccCCCCC
Q 003278 669 LTRNDHGHRKATSGNRSVRGIFGYMSPEYIES--GEATSMADVYSFGVVVLEVVTGQMAVDFRLP 731 (834)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~ 731 (834)
...................||+.|+|||++.+ ..++.++|||||||++|||+||+.||.....
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 242 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA 242 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 43322111111111233579999999999987 5799999999999999999999999975433
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=362.29 Aligned_cols=268 Identities=19% Similarity=0.238 Sum_probs=191.4
Q ss_pred hhCcCcCCcccccCCcEEEEEEECCC----cEEEEEEecCCC-ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeE-
Q 003278 512 TNNFSESQRVAEMDFGTAYQGFLDNH----QYVLVKRLGMSK-CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEM- 585 (834)
Q Consensus 512 t~~f~~~~~ig~g~~g~vy~~~~~~~----~~vavK~~~~~~-~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~- 585 (834)
.++|...+.||+|+||.||+|..... ..||||.+.... .....++|.+|++++++++|||||++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 35688888999999999999986543 279999987543 234467899999999999999999999999876655
Q ss_pred -----EEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceE
Q 003278 586 -----LVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRL 660 (834)
Q Consensus 586 -----~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki 660 (834)
++||||+.+|+|.+++...........+++..+..|+.|++.||+|||+ .+|+||||||+|||+++++.+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEE
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCCEEE
Confidence 9999999999999998754322222358899999999999999999997 68999999999999999999999
Q ss_pred eeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHH
Q 003278 661 GSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRV 739 (834)
Q Consensus 661 ~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~ 739 (834)
+|||+++....... ........||+.|+|||.+.+..++.++|||||||++|||+| |+.|+........ ....
T Consensus 179 ~Dfg~a~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~-~~~~ 252 (323)
T 3qup_A 179 ADFGLSRKIYSGDY-----YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI-YNYL 252 (323)
T ss_dssp CCCCC----------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-HHHH
T ss_pred eecccccccccccc-----ccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH-HHHH
Confidence 99999986543221 111223457889999999999999999999999999999999 8888865433221 1111
Q ss_pred HHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCcccc
Q 003278 740 HEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDKRFM 802 (834)
Q Consensus 740 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~~~~ 802 (834)
. ..... ......+ . .+.+++.+||+.||++|||+.++++.|+.+-...+
T Consensus 253 ~---~~~~~-------~~~~~~~-~---~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~ 301 (323)
T 3qup_A 253 I---GGNRL-------KQPPECM-E---EVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301 (323)
T ss_dssp H---TTCCC-------CCCTTCC-H---HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred h---cCCCC-------CCCCccC-H---HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence 1 11110 0111122 2 45566679999999999999999999987655444
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=360.49 Aligned_cols=266 Identities=22% Similarity=0.289 Sum_probs=193.9
Q ss_pred hcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC--hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEE
Q 003278 109 GSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG--ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLV 186 (834)
Q Consensus 109 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 186 (834)
..++|...+.||+|+||.||+|....+|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 4467999999999999999999999999999999986442 23346688999999999999999999999999999999
Q ss_pred EEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEE-----CCCCceEEee
Q 003278 187 YDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVML-----DSQYNARLGD 261 (834)
Q Consensus 187 ~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILl-----d~~~~~kl~D 261 (834)
|||++ |+|.+++... ..+++..+..|+.|++.||.|||+. +|+||||||+|||+ +.++.+||+|
T Consensus 112 ~e~~~-~~L~~~~~~~-------~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~D 180 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDKN-------PDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGD 180 (329)
T ss_dssp EECCS-EEHHHHHHHC-------TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECC
T ss_pred EecCC-CCHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECc
Confidence 99998 5999998653 3589999999999999999999996 99999999999999 4455699999
Q ss_pred ccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCC
Q 003278 262 FGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPD 341 (834)
Q Consensus 262 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~ 341 (834)
||+++.+.... ...+...||+.|+|||.+.....++.++|||||||++|||+||+.||......
T Consensus 181 fg~a~~~~~~~----------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 244 (329)
T 3gbz_A 181 FGLARAFGIPI----------------RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI 244 (329)
T ss_dssp TTHHHHHC---------------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred CCCccccCCcc----------------cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH
Confidence 99998653221 01234568999999999876556899999999999999999999998643211
Q ss_pred ccchHHHHHHHHhh--cCccc---cccc--cccCC-CCCCHH------HHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 342 DQIILLDWIRRLSD--EGKVL---QAGD--NRLSD-GSYKLC------DMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 342 ~~~~l~~~~~~~~~--~~~~~---~~~d--~~l~~-~~~~~~------~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
..+......... ..... ...+ ..... ...... ....+.+|+..||+.||.+||++.|+++
T Consensus 245 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 245 --DQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp --HHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --HHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 111111111100 00000 0000 00000 000000 1245789999999999999999999986
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=365.29 Aligned_cols=252 Identities=21% Similarity=0.233 Sum_probs=189.7
Q ss_pred CCCCCC-CeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHH-HhCCCCceeeEeeeEEe----CCEEE
Q 003278 111 NGFDED-EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAV-AHLRHRNLVRLRGWCVH----EDQLL 184 (834)
Q Consensus 111 ~~f~~~-~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l-~~l~H~nIv~l~g~~~~----~~~~~ 184 (834)
++|... ++||+|+||.||+|.+..+|+.||||++... ..+.+|+.++ +..+||||++++++|.. .+.+|
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 456555 6899999999999999999999999998643 3466788876 45689999999999876 56789
Q ss_pred EEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECC---CCceEEee
Q 003278 185 LVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDS---QYNARLGD 261 (834)
Q Consensus 185 lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~---~~~~kl~D 261 (834)
||||||++|+|.+++.... ...+++..+..|+.||+.||.|||+. +|+||||||+|||++. ++.+||+|
T Consensus 136 lv~E~~~gg~L~~~l~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~D 207 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRG-----DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD 207 (400)
T ss_dssp EEEECCCSEEHHHHHHCC--------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECC
T ss_pred EEEEeCCCCcHHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEe
Confidence 9999999999999997542 24689999999999999999999995 9999999999999997 78899999
Q ss_pred ccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCC
Q 003278 262 FGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPD 341 (834)
Q Consensus 262 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~ 341 (834)
||+++...... ..+..+||+.|+|||++... .++.++|||||||++|||+||+.||......
T Consensus 208 FG~a~~~~~~~-----------------~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 269 (400)
T 1nxk_A 208 FGFAKETTSHN-----------------SLTTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 269 (400)
T ss_dssp CTTCEECC----------------------------CTTCCGGGSCCC-CSSSHHHHHHHHHHHHHHHHSSCSCCCCTTC
T ss_pred cccccccCCCC-----------------ccccCCCCCCccCHhhcCCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCccc
Confidence 99998543210 12456799999999998644 6799999999999999999999999754332
Q ss_pred cc-chHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 342 DQ-IILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 342 ~~-~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
.. ......+. .+... ...+.. ... ...+.+|+..||+.||.+||++.++++.
T Consensus 270 ~~~~~~~~~i~----~~~~~-~~~~~~--~~~----s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 270 AISPGMKTRIR----MGQYE-FPNPEW--SEV----SEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp SSCCSHHHHHH----HTCCC-CCTTTT--TTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cccHHHHHHHH----cCccc-CCCccc--ccC----CHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 21 11111111 11110 000000 111 1457889999999999999999999874
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=346.54 Aligned_cols=249 Identities=23% Similarity=0.344 Sum_probs=197.4
Q ss_pred CCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEe----CCEEEEE
Q 003278 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCVH----EDQLLLV 186 (834)
Q Consensus 113 f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~lV 186 (834)
|...+.||+|+||.||+|.+..++..||+|.+... .....+.+.+|+.++++++||||+++++++.. .+.+++|
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 107 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence 66777899999999999999999999999998643 34456779999999999999999999999876 3568999
Q ss_pred EEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEEC-CCCceEEeeccch
Q 003278 187 YDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLD-SQYNARLGDFGLA 265 (834)
Q Consensus 187 ~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld-~~~~~kl~DFGla 265 (834)
|||+++|+|.+++... ..+++..+..|+.|++.||.|||+. .++|+||||||+|||++ .++.+||+|||++
T Consensus 108 ~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 108 TELMTSGTLKTYLKRF-------KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEecCCCCHHHHHHHc-------cCCCHHHHHHHHHHHHHHHHHHHcC-CCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 9999999999999643 3588999999999999999999986 12399999999999998 7889999999999
Q ss_pred hhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccch
Q 003278 266 RWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQII 345 (834)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~ 345 (834)
+..... ......||+.|+|||.+. + .++.++|||||||++|||+||+.||......
T Consensus 180 ~~~~~~------------------~~~~~~~t~~y~aPE~~~-~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---- 235 (290)
T 1t4h_A 180 TLKRAS------------------FAKAVIGTPEFMAPEMYE-E-KYDESVDVYAFGMCMLEMATSEYPYSECQNA---- 235 (290)
T ss_dssp GGCCTT------------------SBEESCSSCCCCCGGGGG-T-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH----
T ss_pred cccccc------------------ccccccCCcCcCCHHHHh-c-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcH----
Confidence 643211 123456999999999875 3 4799999999999999999999998643221
Q ss_pred HHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 346 LLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 346 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
....... ..+......+.. ....+.+++..||+.||.+||++.++++.
T Consensus 236 -~~~~~~~-~~~~~~~~~~~~---------~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 236 -AQIYRRV-TSGVKPASFDKV---------AIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp -HHHHHHH-TTTCCCGGGGGC---------CCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -HHHHHHH-hccCCccccCCC---------CCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1111111 111111111111 11458899999999999999999999863
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=380.73 Aligned_cols=256 Identities=24% Similarity=0.318 Sum_probs=204.4
Q ss_pred hhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEE
Q 003278 108 IGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLL 184 (834)
Q Consensus 108 ~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 184 (834)
...++|+..++||+|+||.||+|....+|+.||||++.... ......+.+|+.+|.+++|||||++++++.+.+.+|
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 34567999999999999999999999999999999986531 233466889999999999999999999999999999
Q ss_pred EEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccc
Q 003278 185 LVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGL 264 (834)
Q Consensus 185 lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGl 264 (834)
+||||+++|+|..++.... ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 261 lVmEy~~gg~L~~~l~~~~-----~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGl 332 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMG-----QAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGL 332 (576)
T ss_dssp EEECCCCSCBHHHHHHSSS-----SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEcCCCCcHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEeccc
Confidence 9999999999999987542 23589999999999999999999996 999999999999999999999999999
Q ss_pred hhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccc
Q 003278 265 ARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQI 344 (834)
Q Consensus 265 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~ 344 (834)
++.+... ...+..+||+.|+|||.+... .++.++|||||||++|||+||+.||.........
T Consensus 333 a~~~~~~-----------------~~~~~~~GT~~Y~APEvl~~~-~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~ 394 (576)
T 2acx_A 333 AVHVPEG-----------------QTIKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR 394 (576)
T ss_dssp CEECCTT-----------------CCEECCCSCGGGCCHHHHTTC-EESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH
T ss_pred ceecccC-----------------ccccccCCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCcccccchhH
Confidence 9754321 012345799999999998654 5799999999999999999999999754322211
Q ss_pred hHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----chhhHHH
Q 003278 345 ILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRP-----SMKWVIE 403 (834)
Q Consensus 345 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~~V~~ 403 (834)
....... .... .... ..++ ..+.+|+..||+.||.+|| ++.+|++
T Consensus 395 --~~i~~~i-~~~~------~~~p-~~~s----~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 395 --EEVERLV-KEVP------EEYS-ERFS----PQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp --HHHHHHH-HHCC------CCCC-TTSC----HHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred --HHHHHHh-hccc------ccCC-ccCC----HHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 1111111 1111 0011 1111 4578899999999999999 6677765
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=347.19 Aligned_cols=254 Identities=24% Similarity=0.331 Sum_probs=203.2
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc-ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEc
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDY 189 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 189 (834)
++|+..+.||+|+||.||+|....+|+.||||++... .....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 4688889999999999999999889999999998643 334567899999999999999999999999999999999999
Q ss_pred cCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhh
Q 003278 190 MPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLE 269 (834)
Q Consensus 190 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~ 269 (834)
+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+.
T Consensus 87 ~~~~~L~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 156 (276)
T 2yex_A 87 CSGGELFDRIEPD-------IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR 156 (276)
T ss_dssp CTTEEGGGGSBTT-------TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred cCCCcHHHHHhhc-------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccC
Confidence 9999999888532 3589999999999999999999996 99999999999999999999999999997543
Q ss_pred hhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHH
Q 003278 270 HELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDW 349 (834)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~ 349 (834)
.... ........||+.|+|||.+......+.++|||||||++|||+||+.||........ ....|
T Consensus 157 ~~~~--------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~ 221 (276)
T 2yex_A 157 YNNR--------------ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDW 221 (276)
T ss_dssp ETTE--------------ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHH
T ss_pred CCcc--------------hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHh
Confidence 2110 01123456999999999987654457889999999999999999999976433221 12222
Q ss_pred HHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 350 IRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 350 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
.. ...... ... .. ...+.+++..||+.||.+||++.++++
T Consensus 222 ~~----~~~~~~-~~~-----~~----~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 222 KE----KKTYLN-PWK-----KI----DSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp HT----TCTTST-TGG-----GS----CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hh----cccccC-chh-----hc----CHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 11 110000 000 11 135778999999999999999999876
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=361.08 Aligned_cols=263 Identities=24% Similarity=0.333 Sum_probs=206.2
Q ss_pred hCcCcCCcccccCCcEEEEEEECC-C-----cEEEEEEecCCCChhHHHHHHHHHHHHHhc-cCCCceeEEEEEeeCCeE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDN-H-----QYVLVKRLGMSKCPALRTRFSNELQNLARL-RHRNLVQLCGWCTEQGEM 585 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~-~-----~~vavK~~~~~~~~~~~~~f~~E~~~l~~l-~HpNiv~l~g~~~~~~~~ 585 (834)
++|...+.||+|+||.||+|.... + ..||||.+.........+.|.+|+.+|+++ +|||||+++++|.+.+..
T Consensus 46 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 125 (333)
T 2i1m_A 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPV 125 (333)
T ss_dssp TSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCce
Confidence 567777889999999999998643 2 479999998766666678899999999999 899999999999999999
Q ss_pred EEEEeccCCCchhhhhhcCCCC--------CCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCC
Q 003278 586 LVIYDYSATRILSHLLFHNNHR--------IGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMN 657 (834)
Q Consensus 586 ~lv~Ey~~~g~L~~~l~~~~~~--------~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~ 657 (834)
++||||+++|+|.+++...... .....+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.
T Consensus 126 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~ 202 (333)
T 2i1m_A 126 LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHV 202 (333)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEEGGGE
T ss_pred EEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEECCCCe
Confidence 9999999999999998753210 012347899999999999999999997 69999999999999999999
Q ss_pred ceEeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHH
Q 003278 658 PRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLV 736 (834)
Q Consensus 658 ~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~ 736 (834)
+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||+| |..|+..........
T Consensus 203 ~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 277 (333)
T 2i1m_A 203 AKIGDFGLARDIMNDSNY-----IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY 277 (333)
T ss_dssp EEBCCCGGGCCGGGCTTS-----EECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH
T ss_pred EEECccccccccccccce-----eecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH
Confidence 999999999865432211 11223567889999999999999999999999999999999 888886544433322
Q ss_pred HHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccC
Q 003278 737 KRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGN 797 (834)
Q Consensus 737 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~ 797 (834)
..... .... ... ...+. .+..++.+||+.||.+|||+.+|++.|+..
T Consensus 278 ~~~~~---~~~~-------~~~-~~~~~---~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 278 KLVKD---GYQM-------AQP-AFAPK---NIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp HHHHH---TCCC-------CCC-TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhc---CCCC-------CCC-CCCCH---HHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 22111 1010 011 11123 345566699999999999999999999754
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=348.64 Aligned_cols=249 Identities=25% Similarity=0.425 Sum_probs=183.3
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 187 (834)
++|...+.||+|+||.||+|....+|+.||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 56888999999999999999998899999999986432 223467899999999999999999999999999999999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
||+++++|.+++... ..++++..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 91 e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 161 (278)
T 3cok_A 91 EMCHNGEMNRYLKNR------VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQ 161 (278)
T ss_dssp ECCTTEEHHHHHHTC------SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEE
T ss_pred ecCCCCcHHHHHhhc------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceee
Confidence 999999999998653 24689999999999999999999996 999999999999999999999999999975
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHH
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILL 347 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~ 347 (834)
..... .......||+.|+|||.+... .++.++|||||||++|||+||+.|+.........
T Consensus 162 ~~~~~----------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--- 221 (278)
T 3cok_A 162 LKMPH----------------EKHYTLCGTPNYISPEIATRS-AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL--- 221 (278)
T ss_dssp CC---------------------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------
T ss_pred ccCCC----------------CcceeccCCCCcCCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH---
Confidence 43211 012235699999999988654 5788999999999999999999998754322110
Q ss_pred HHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 348 DWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 348 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
.. +. ..+..+. ... ...+.+++..||+.||.+||++.++++
T Consensus 222 ---~~------~~-~~~~~~~-~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 222 ---NK------VV-LADYEMP-SFL----SIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp -----------CC-SSCCCCC-TTS----CHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ---HH------Hh-hcccCCc-ccc----CHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 00 00 0011111 111 235788999999999999999999986
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=348.73 Aligned_cols=263 Identities=16% Similarity=0.198 Sum_probs=195.2
Q ss_pred CcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCC-ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 514 NFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSK-CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
+|...+.||+|+||+||+|... +++.||||++.... .......+.+|+.++++++|||||++++++.+.+..++||||
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 82 (292)
T 3o0g_A 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEec
Confidence 5667788999999999999974 58899999987543 334457789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccccc
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTR 671 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~ 671 (834)
++++.+.. +.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 83 ~~~~l~~~-~~~~~-----~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 153 (292)
T 3o0g_A 83 CDQDLKKY-FDSCN-----GDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp CSEEHHHH-HHHTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred CCCCHHHH-HHhCC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence 98755544 43322 248899999999999999999997 6999999999999999999999999999976532
Q ss_pred CCCCCcccccCccccccccCccchhccccCC-CCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcC--c
Q 003278 672 NDHGHRKATSGNRSVRGIFGYMSPEYIESGE-ATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKR--P 748 (834)
Q Consensus 672 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~--~ 748 (834)
.. .......||+.|+|||++.+.. ++.++|||||||++|||+||..|+............+........ .
T Consensus 154 ~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~ 226 (292)
T 3o0g_A 154 PV-------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQ 226 (292)
T ss_dssp CC-------SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred cc-------ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhh
Confidence 21 1123457899999999997766 799999999999999999999986544333333333322211100 0
Q ss_pred cc---cccccc---------cCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 749 LA---ELVDLS---------LNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 749 ~~---~~~d~~---------l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
+. ...+.. .........-..+.+++.+|++.||++|||+.|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00 000000 000000001123445666899999999999999985
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=356.38 Aligned_cols=249 Identities=24% Similarity=0.302 Sum_probs=190.2
Q ss_pred cCCCCCCCeeeccCCeEEEEEEEC---CCCeEEEEEEecccC----hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLP---SDGTVVAVKCLAEKG----ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQ 182 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~---~~g~~vAvK~l~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~ 182 (834)
.++|+..+.||+|+||.||+|+.. .+|+.||||++.... ......+.+|+.++++++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 356889999999999999999985 578999999987542 2334567889999999999999999999999999
Q ss_pred EEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeec
Q 003278 183 LLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDF 262 (834)
Q Consensus 183 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DF 262 (834)
.++||||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Df 165 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE-------GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDF 165 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCC
T ss_pred EEEEEeCCCCCcHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeC
Confidence 99999999999999998643 3588999999999999999999996 9999999999999999999999999
Q ss_pred cchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCc
Q 003278 263 GLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDD 342 (834)
Q Consensus 263 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~ 342 (834)
|+++...... .......||+.|+|||.+... .++.++|||||||++|||+||+.||.....
T Consensus 166 g~~~~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~-- 226 (327)
T 3a62_A 166 GLCKESIHDG----------------TVTHTFCGTIEYMAPEILMRS-GHNRAVDWWSLGALMYDMLTGAPPFTGENR-- 226 (327)
T ss_dssp SCC--------------------------CTTSSCCTTSCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--
T ss_pred CcccccccCC----------------ccccccCCCcCccCHhhCcCC-CCCCcccchhHHHHHHHHHHCCCCCCCCCH--
Confidence 9997532211 012345699999999998654 579999999999999999999999864321
Q ss_pred cchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----chhhHHH
Q 003278 343 QIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRP-----SMKWVIE 403 (834)
Q Consensus 343 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~~V~~ 403 (834)
. .....+... .. .+. ... ...+.+++..||+.||.+|| ++.++++
T Consensus 227 -~---~~~~~i~~~-~~------~~p-~~~----~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 227 -K---KTIDKILKC-KL------NLP-PYL----TQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp -H---HHHHHHHHT-CC------CCC-TTS----CHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred -H---HHHHHHHhC-CC------CCC-CCC----CHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 1 111222211 10 011 111 14578899999999999999 5556665
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=356.80 Aligned_cols=269 Identities=23% Similarity=0.320 Sum_probs=196.7
Q ss_pred hhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHh--CCCCceeeEeeeEEeC----C
Q 003278 108 IGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAH--LRHRNLVRLRGWCVHE----D 181 (834)
Q Consensus 108 ~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~g~~~~~----~ 181 (834)
...++|+..+.||+|+||.||+|.+. |+.||||++.... ...+..|..++.. ++||||+++++++... +
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 34467999999999999999999984 8999999986432 2344455555554 5999999999999988 7
Q ss_pred EEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhcc-----CCCeecCCCCCCceEECCCCc
Q 003278 182 QLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQL-----ETQIIHRDVKTSNVMLDSQYN 256 (834)
Q Consensus 182 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~iiHrDlKp~NILld~~~~ 256 (834)
..++||||+++|+|.+++.. ..+++..+..++.|++.||.|||+.+ .++|+||||||+|||++.++.
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~--------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 180 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKS--------TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT 180 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHH--------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred ceEEEEeccCCCcHHHHhhc--------cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC
Confidence 89999999999999999954 25889999999999999999999741 238999999999999999999
Q ss_pred eEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcc------cceeehhhHHHHHHh
Q 003278 257 ARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAK------SDVFSFGIVVLEVVS 330 (834)
Q Consensus 257 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~k------sDV~SfGvvl~Ellt 330 (834)
+||+|||+++.+....... ........||+.|+|||.+... ..+.+ +|||||||++|||+|
T Consensus 181 ~kl~Dfg~a~~~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~~~~DiwslG~il~el~t 247 (337)
T 3mdy_A 181 CCIADLGLAVKFISDTNEV------------DIPPNTRVGTKRYMPPEVLDES-LNRNHFQSYIMADMYSFGLILWEVAR 247 (337)
T ss_dssp EEECCCTTCEECC---------------------CCSSCSCGGGCCHHHHTTC-CCTTCTHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEEeCCCceeeccccccc------------cCCCCCCccCcceeChhhcccc-cCCccccCccccchHHHHHHHHHHHh
Confidence 9999999997653321100 0012345699999999998654 33443 999999999999999
Q ss_pred C----------CccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhh
Q 003278 331 G----------RRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKW 400 (834)
Q Consensus 331 G----------~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~ 400 (834)
| +.|+........ .... .......... .+..............+.+++..||+.||.+||++.+
T Consensus 248 g~~~~~~~~~~~~p~~~~~~~~~-~~~~-~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e 321 (337)
T 3mdy_A 248 RCVSGGIVEEYQLPYHDLVPSDP-SYED-MREIVCIKKL----RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALR 321 (337)
T ss_dssp TBCBTTBCCCCCCTTTTTSCSSC-CHHH-HHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred ccCcccccccccccHhhhcCCCC-chhh-hHHHHhhhcc----CccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHH
Confidence 9 555543222221 1111 1111111111 1111100011134567899999999999999999999
Q ss_pred HHHHhhcC
Q 003278 401 VIEAVSGS 408 (834)
Q Consensus 401 V~~~l~~~ 408 (834)
|++.|+..
T Consensus 322 ll~~L~~l 329 (337)
T 3mdy_A 322 VKKTLAKM 329 (337)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 99999764
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=356.00 Aligned_cols=274 Identities=23% Similarity=0.355 Sum_probs=212.7
Q ss_pred ccHHHHHhhcCCCCCCCeeeccCCeEEEEEEE-----CCCCeEEEEEEecccC-hhhHHHHHHHHHHHHhC-CCCceeeE
Q 003278 101 FSYAELYIGSNGFDEDEVLGSGGFGKVYRAVL-----PSDGTVVAVKCLAEKG-ERFEKTFAAELVAVAHL-RHRNLVRL 173 (834)
Q Consensus 101 f~~~el~~~t~~f~~~~~LG~G~fG~Vy~~~~-----~~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l 173 (834)
+...+.....++|...+.||+|+||.||+|.+ ..+++.||||++.... ....+.+.+|+.++.++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 45566667778999999999999999999985 3567899999987543 33456799999999999 79999999
Q ss_pred eeeEEeCC-EEEEEEEccCCCCHhHHHhcCCCccc---------cCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCC
Q 003278 174 RGWCVHED-QLLLVYDYMPNRSLDRVLFRRPENLE---------AAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRD 243 (834)
Q Consensus 174 ~g~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~~~~---------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrD 243 (834)
+++|...+ ..++||||+++|+|.+++........ ....+++..+..++.|+++||.|||+. +|+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cccccc
Confidence 99998765 48999999999999999976532110 012388999999999999999999996 999999
Q ss_pred CCCCceEECCCCceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhh
Q 003278 244 VKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGI 323 (834)
Q Consensus 244 lKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGv 323 (834)
|||+|||++.++.+||+|||+++.+..... ........||+.|+|||.+... .++.++|||||||
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--------------~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~ 238 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPD--------------YVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGV 238 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTT--------------SEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHH
T ss_pred CccceEEECCCCCEEECCCccccccccCcc--------------ceeccCCCcceeecCchhhccc-cccchhHHHHHHH
Confidence 999999999999999999999985432210 0112345689999999998655 6799999999999
Q ss_pred HHHHHHh-CCccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHH
Q 003278 324 VVLEVVS-GRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVI 402 (834)
Q Consensus 324 vl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~ 402 (834)
++|||+| |+.||....... .+.. ....+..... . ... ...+.+++..||+.||.+||++.+|+
T Consensus 239 il~~l~t~g~~p~~~~~~~~--~~~~----~~~~~~~~~~-----~-~~~----~~~l~~li~~~l~~dp~~Rps~~ell 302 (316)
T 2xir_A 239 LLWEIFSLGASPYPGVKIDE--EFCR----RLKEGTRMRA-----P-DYT----TPEMYQTMLDCWHGEPSQRPTFSELV 302 (316)
T ss_dssp HHHHHHTTSCCSSTTCCCSH--HHHH----HHHHTCCCCC-----C-TTC----CHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHhCCCCCCcccchhH--HHHH----HhccCccCCC-----C-CCC----CHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 9999999 999986543221 1111 1111211111 0 111 24578899999999999999999999
Q ss_pred HHhhcC
Q 003278 403 EAVSGS 408 (834)
Q Consensus 403 ~~l~~~ 408 (834)
+.|+..
T Consensus 303 ~~L~~~ 308 (316)
T 2xir_A 303 EHLGNL 308 (316)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 998764
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=362.55 Aligned_cols=270 Identities=17% Similarity=0.224 Sum_probs=198.4
Q ss_pred CCCCCCCeeeccCCeEEEEEEECC---CCeEEEEEEecccChh-----------hHHHHHHHHHHHHhCCCCceeeEeee
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPS---DGTVVAVKCLAEKGER-----------FEKTFAAELVAVAHLRHRNLVRLRGW 176 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~---~g~~vAvK~l~~~~~~-----------~~~~~~~E~~~l~~l~H~nIv~l~g~ 176 (834)
++|...+.||+|+||.||+|.+.. ++..||||++...... ....+.+|+..+..++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 578899999999999999999976 7889999998654321 11346788899999999999999999
Q ss_pred EEe----CCEEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEEC
Q 003278 177 CVH----EDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLD 252 (834)
Q Consensus 177 ~~~----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld 252 (834)
+.. .+..++||||+ +++|.+++... ..+++..+..|+.|++.||+|||+. +|+||||||+|||++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~ 185 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQN-------GTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLG 185 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGG-------GBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEE
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEc
Confidence 998 67899999999 99999998643 2689999999999999999999996 999999999999998
Q ss_pred CCC--ceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh
Q 003278 253 SQY--NARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS 330 (834)
Q Consensus 253 ~~~--~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt 330 (834)
.++ .+||+|||+++.+...... ............||+.|+|||.+... .++.++|||||||++|||+|
T Consensus 186 ~~~~~~~kL~Dfg~a~~~~~~~~~---------~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~ 255 (345)
T 2v62_A 186 YKNPDQVYLADYGLSYRYCPNGNH---------KQYQENPRKGHNGTIEFTSLDAHKGV-ALSRRSDVEILGYCMLRWLC 255 (345)
T ss_dssp SSSTTSEEECCCTTCEESSGGGCC---------CCCCCCGGGCSCSCTTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHH
T ss_pred cCCCCcEEEEeCCCceeccccccc---------ccchhccccccCCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHh
Confidence 877 9999999999866432110 00011112455799999999998654 67999999999999999999
Q ss_pred CCccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 331 GRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 331 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
|+.||........ .+......... ............... ...+.+++..||+.||.+||++.+|++.|+..
T Consensus 256 g~~pf~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 256 GKLPWEQNLKDPV-AVQTAKTNLLD--ELPQSVLKWAPSGSS----CCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp SSCTTGGGTTCHH-HHHHHHHHHHH--TTTHHHHHHSCTTSC----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred CCCCccccccccH-HHHHHHHhhcc--cccHHHHhhcccccc----HHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 9999964322211 11111111111 111111111100111 14688999999999999999999999999864
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=356.74 Aligned_cols=251 Identities=19% Similarity=0.233 Sum_probs=188.4
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
+.|...+.||+|+||+||++... +++.||||.+...... .+.+.+|+.++++++|||||++++++.+.+..++||||
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS--CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc--cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 45677788999999999999975 6889999998654322 35688999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCC--ceEeeeeecccc
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMN--PRLGSFALAEFL 669 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~--~ki~DfGla~~~ 669 (834)
+++|+|.+++...+ .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++. +||+|||+++..
T Consensus 98 ~~~~~L~~~l~~~~------~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~ 168 (361)
T 3uc3_A 98 ASGGELYERICNAG------RFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168 (361)
T ss_dssp CCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred CCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence 99999999986532 38889999999999999999997 68999999999999987765 999999999743
Q ss_pred ccCCCCCcccccCccccccccCccchhccccCCCCcc-CcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCc
Q 003278 670 TRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSM-ADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRP 748 (834)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k-~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
... .......||+.|+|||++.+..++.+ +|||||||++|||+||+.||......................
T Consensus 169 ~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 240 (361)
T 3uc3_A 169 VLH--------SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYS 240 (361)
T ss_dssp --------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCC
T ss_pred ccc--------CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCC
Confidence 211 11234579999999999988888766 899999999999999999997544333322222222111111
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 749 LAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 749 ~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
.. + .... .. .+..++.+||+.||++|||+.++++
T Consensus 241 ~~---~---~~~~-s~---~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 241 IP---D---DIRI-SP---ECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp CC---T---TSCC-CH---HHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CC---C---cCCC-CH---HHHHHHHHHccCChhHCcCHHHHHh
Confidence 10 0 0011 12 3445666999999999999999986
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=351.33 Aligned_cols=261 Identities=25% Similarity=0.403 Sum_probs=193.6
Q ss_pred hcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEE
Q 003278 109 GSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLV 186 (834)
Q Consensus 109 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 186 (834)
..++|+..+.||+|+||.||+|.+. ..||||++... .....+.|.+|+.++++++||||+++++++ ..+..++|
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv 97 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV 97 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence 4467999999999999999999873 35999998643 344557899999999999999999999965 45568999
Q ss_pred EEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchh
Q 003278 187 YDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLAR 266 (834)
Q Consensus 187 ~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~ 266 (834)
|||+++++|.+++... ...+++..+..|+.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 98 ~e~~~~~~L~~~l~~~------~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~ 168 (289)
T 3og7_A 98 TQWCEGSSLYHHLHAS------ETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLAT 168 (289)
T ss_dssp EECCCEEEHHHHHTTC---------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC---
T ss_pred EEecCCCcHHHHHhhc------cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecc
Confidence 9999999999998643 24689999999999999999999996 99999999999999999999999999997
Q ss_pred hhhhhhhhhhhcccccccccccccceeeeccccCCCccccc--cCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccc
Q 003278 267 WLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQ--KGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQI 344 (834)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~--~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~ 344 (834)
....... ........||+.|+|||.+. .+..++.++|||||||++|||+||+.||......+
T Consensus 169 ~~~~~~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-- 232 (289)
T 3og7_A 169 EKSRWSG--------------SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-- 232 (289)
T ss_dssp -----------------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--
T ss_pred ccccccc--------------cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH--
Confidence 5432110 01123456999999999885 24457889999999999999999999986533221
Q ss_pred hHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 345 ILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 345 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
.+. .....+........ +. .. ....+.+++..||+.||.+||++.++++.|+..
T Consensus 233 ~~~----~~~~~~~~~~~~~~-~~-~~----~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l 286 (289)
T 3og7_A 233 QII----EMVGRGSLSPDLSK-VR-SN----CPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286 (289)
T ss_dssp HHH----HHHHHTSCCCCTTS-SC-TT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred HHH----HHhcccccCcchhh-cc-cc----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 111 22222222111111 00 11 124688999999999999999999999999764
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=361.29 Aligned_cols=262 Identities=18% Similarity=0.271 Sum_probs=198.3
Q ss_pred CcCcCCcccccCCcEEEEEEE-----CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeC--CeEE
Q 003278 514 NFSESQRVAEMDFGTAYQGFL-----DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQ--GEML 586 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~-----~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~--~~~~ 586 (834)
.|...+.||+|+||.||+|.+ .++..||||++.........+.+.+|+.++++++||||+++++++.+. ...+
T Consensus 22 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 101 (302)
T 4e5w_A 22 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 101 (302)
T ss_dssp GEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEE
T ss_pred hhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEE
Confidence 356678899999999999984 457899999997655444557899999999999999999999999876 6689
Q ss_pred EEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeec
Q 003278 587 VIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALA 666 (834)
Q Consensus 587 lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla 666 (834)
+||||+++|+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 102 lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 102 LIMEFLPSGSLKEYLPKNK-----NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp EEEECCTTCBHHHHHHHHT-----TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred EEEEeCCCCcHHHHHHhcc-----ccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECccccc
Confidence 9999999999999986532 238899999999999999999997 69999999999999999999999999999
Q ss_pred cccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCC----------chhHH
Q 003278 667 EFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLP----------EGLLV 736 (834)
Q Consensus 667 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~----------~~~~~ 736 (834)
........ .........||..|+|||++.+..++.++|||||||++|||+||..|+..... .....
T Consensus 174 ~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (302)
T 4e5w_A 174 KAIETDKE----YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTV 249 (302)
T ss_dssp EECCTTCC----EEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHH
T ss_pred ccccCCCc----ceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCH
Confidence 87543321 11122345688999999999999999999999999999999999988642110 00001
Q ss_pred HHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccC
Q 003278 737 KRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGN 797 (834)
Q Consensus 737 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~ 797 (834)
........... .......++ + .+.+++.+||+.||++|||+.+|++.|+.+
T Consensus 250 ~~~~~~~~~~~------~~~~~~~~~-~---~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 250 TRLVNTLKEGK------RLPCPPNCP-D---EVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HHHHHHHHTTC------CCCCCTTCC-H---HHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHhccC------CCCCCCCCC-H---HHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 11111100000 001111222 2 455666699999999999999999999754
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=345.11 Aligned_cols=253 Identities=25% Similarity=0.330 Sum_probs=201.4
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 187 (834)
.++|+..+.||+|+||.||+|.+..+|+.||||++... .....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 46799999999999999999999999999999998653 3344567889999999999999999999999999999999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCc---eEEeeccc
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYN---ARLGDFGL 264 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~---~kl~DFGl 264 (834)
||+++|+|.+.+... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++. +||+|||+
T Consensus 85 e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~ 154 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR-------EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGL 154 (284)
T ss_dssp CCCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred ecCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeecee
Confidence 999999998888643 3589999999999999999999996 9999999999999986655 99999999
Q ss_pred hhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccc
Q 003278 265 ARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQI 344 (834)
Q Consensus 265 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~ 344 (834)
+...... .......||+.|+|||.+... .++.++|||||||++|||++|+.||.... ..
T Consensus 155 ~~~~~~~-----------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~---~~ 213 (284)
T 3kk8_A 155 AIEVNDS-----------------EAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDED---QH 213 (284)
T ss_dssp CEECCSS-----------------CBCCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HH
T ss_pred eEEcccC-----------------ccccCCCCCcCCcCchhhcCC-CCCcccchHHHHHHHHHHHHCCCCCCCCc---hh
Confidence 9753211 012345699999999998654 67999999999999999999999986421 11
Q ss_pred hHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 345 ILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 345 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
.+. ..... +... ...+.. ... ...+.+++..||+.||.+||++.++++.
T Consensus 214 ~~~---~~~~~-~~~~-~~~~~~--~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 214 RLY---AQIKA-GAYD-YPSPEW--DTV----TPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp HHH---HHHHH-TCCC-CCTTTT--TTS----CHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHH---HHHHh-cccc-CCchhh--ccc----CHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 111 11111 1110 010000 111 1457889999999999999999999863
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=356.05 Aligned_cols=265 Identities=23% Similarity=0.334 Sum_probs=200.0
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYD 188 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 188 (834)
++|+..+.||+|+||.||+|....+|+.||||++... .....+.+.+|+.++++++||||++++++|.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 5688889999999999999999889999999988543 23445678899999999999999999999999999999999
Q ss_pred ccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhh
Q 003278 189 YMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWL 268 (834)
Q Consensus 189 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~ 268 (834)
|+++++|..++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+
T Consensus 105 ~~~~~~l~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 174 (331)
T 4aaa_A 105 FVDHTILDDLELFP-------NGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL 174 (331)
T ss_dssp CCSEEHHHHHHHST-------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred cCCcchHHHHHhhc-------cCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceee
Confidence 99999998876432 3589999999999999999999996 9999999999999999999999999999764
Q ss_pred hhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHH
Q 003278 269 EHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLD 348 (834)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~ 348 (834)
..... ......||+.|+|||.+.....++.++|||||||++|||+||+.||......+ .+..
T Consensus 175 ~~~~~----------------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~ 236 (331)
T 4aaa_A 175 AAPGE----------------VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID--QLYH 236 (331)
T ss_dssp -------------------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHH
T ss_pred cCCcc----------------ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH--HHHH
Confidence 32210 12334689999999998765567999999999999999999999986532211 1111
Q ss_pred HHH----------HHhhcCccc-cccccccCCCCCCH-----HHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 349 WIR----------RLSDEGKVL-QAGDNRLSDGSYKL-----CDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 349 ~~~----------~~~~~~~~~-~~~d~~l~~~~~~~-----~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
... ......... ....+.+.. .... .....+.+++..||+.||.+||++.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 237 IMMCLGNLIPRHQELFNKNPVFAGVRLPEIKE-REPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp HHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSS-CCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred HHHHhCCCChhhhhHhhhccccccccCccccc-cchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 110 000100000 000111100 0000 112468899999999999999999998863
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=368.75 Aligned_cols=252 Identities=20% Similarity=0.369 Sum_probs=195.0
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCC--CCceeeEeeeEEeCCEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLR--HRNLVRLRGWCVHEDQLLLV 186 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~--H~nIv~l~g~~~~~~~~~lV 186 (834)
++|+..+.||+|+||.||+|... +++.||||++... .....+.|.+|+.+|.+++ |||||++++++...+.+++|
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcC-CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 45899999999999999999985 5999999998643 3445678999999999996 59999999999999999999
Q ss_pred EEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchh
Q 003278 187 YDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLAR 266 (834)
Q Consensus 187 ~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~ 266 (834)
|| +.+|+|.+++... ..+++..+..|+.||+.||.|||+. +|+||||||+|||++ ++.+||+|||+++
T Consensus 135 ~E-~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~ 202 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKK-------KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIAN 202 (390)
T ss_dssp EE-CCSEEHHHHHHHC-------SSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSC
T ss_pred Ee-cCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccc
Confidence 99 6789999999653 3588899999999999999999985 999999999999996 5789999999998
Q ss_pred hhhhhhhhhhhcccccccccccccceeeeccccCCCcccccc----------CCCCCcccceeehhhHHHHHHhCCccCC
Q 003278 267 WLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQK----------GSVATAKSDVFSFGIVVLEVVSGRRAVD 336 (834)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~----------~~~~~~ksDV~SfGvvl~ElltG~~p~~ 336 (834)
.+...... .......||+.|+|||++.. ...++.++|||||||++|||+||+.||.
T Consensus 203 ~~~~~~~~--------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~ 268 (390)
T 2zmd_A 203 QMQPDTTS--------------VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 268 (390)
T ss_dssp CC-----------------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred cccCCCcc--------------ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcch
Confidence 65432110 01234569999999999854 1357899999999999999999999996
Q ss_pred CCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 337 LTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 337 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
..... ...+........... ++......+.+|+..||+.||.+||++.+|++.
T Consensus 269 ~~~~~-----~~~~~~~~~~~~~~~----------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 269 QIINQ-----ISKLHAIIDPNHEIE----------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp TCCCH-----HHHHHHHHCTTSCCC----------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhHH-----HHHHHHHhCccccCC----------CCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 43211 111222211111000 000112457889999999999999999999874
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=352.87 Aligned_cols=264 Identities=25% Similarity=0.393 Sum_probs=201.6
Q ss_pred CCCCCCCeeeccCCeEEEEEE----ECCCCeEEEEEEeccc-ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeC--CEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAV----LPSDGTVVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHE--DQL 183 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~----~~~~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~ 183 (834)
+.|+..+.||+|+||.||+|+ ...+++.||||++... .....+.+.+|+.++++++||||+++++++... +..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 347888999999999999999 4567999999998743 233457789999999999999999999999877 568
Q ss_pred EEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeecc
Q 003278 184 LLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFG 263 (834)
Q Consensus 184 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFG 263 (834)
++||||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 101 ~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg 171 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKN------KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFG 171 (302)
T ss_dssp EEEEECCTTCBHHHHHHHH------TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCT
T ss_pred EEEEEeCCCCcHHHHHHhc------cccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccc
Confidence 9999999999999999543 24589999999999999999999996 99999999999999999999999999
Q ss_pred chhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCC----
Q 003278 264 LARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTY---- 339 (834)
Q Consensus 264 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~---- 339 (834)
+++....... .........||..|+|||.+... .++.++|||||||++|||+||+.|+....
T Consensus 172 ~~~~~~~~~~-------------~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 237 (302)
T 4e5w_A 172 LTKAIETDKE-------------YYTVKDDRDSPVFWYAPECLMQS-KFYIASDVWSFGVTLHELLTYCDSDSSPMALFL 237 (302)
T ss_dssp TCEECCTTCC-------------EEECCCCTTCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH
T ss_pred ccccccCCCc-------------ceeccCCCCCCccccCCeeecCC-CCCcchhHHHHHHHHHHHHHccCCCcchhhHHh
Confidence 9986532210 00112334588999999988655 56889999999999999999998864321
Q ss_pred -----CCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 340 -----PDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 340 -----~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
.......... ......+.... .. ... ...+.+++..||+.||.+||++.++++.|+..
T Consensus 238 ~~~~~~~~~~~~~~~-~~~~~~~~~~~-----~~-~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 238 KMIGPTHGQMTVTRL-VNTLKEGKRLP-----CP-PNC----PDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HHHCSCCGGGHHHHH-HHHHHTTCCCC-----CC-TTC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred hccCCcccccCHHHH-HHHHhccCCCC-----CC-CCC----CHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 0111111111 11111111111 00 111 24688999999999999999999999998753
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=350.37 Aligned_cols=249 Identities=22% Similarity=0.373 Sum_probs=199.3
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhC-CCCceeeEeeeEEeCCEEEEE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHL-RHRNLVRLRGWCVHEDQLLLV 186 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV 186 (834)
+++|+..+.||+|+||.||+|....+++.||||++... .......+.+|+..+.++ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 35688899999999999999999889999999998653 234566788999999999 999999999999999999999
Q ss_pred EEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECC-------------
Q 003278 187 YDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDS------------- 253 (834)
Q Consensus 187 ~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~------------- 253 (834)
|||+++|+|.+++..... ....+++..+..|+.|++.||.|||+. +|+||||||+|||++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~ 163 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYR---IMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDE 163 (289)
T ss_dssp EECCTTCBHHHHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC--------------
T ss_pred EEecCCCcHHHHHHhhcc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccc
Confidence 999999999999965321 125689999999999999999999996 9999999999999984
Q ss_pred ------CCceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHH
Q 003278 254 ------QYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLE 327 (834)
Q Consensus 254 ------~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~E 327 (834)
...+||+|||+++.... .....||+.|+|||.+.....++.++|||||||++||
T Consensus 164 ~~~~~~~~~~kl~Dfg~~~~~~~--------------------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~ 223 (289)
T 1x8b_A 164 DDWASNKVMFKIGDLGHVTRISS--------------------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVC 223 (289)
T ss_dssp ------CCCEEECCCTTCEETTC--------------------SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHH
T ss_pred ccccCCceEEEEcccccccccCC--------------------ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHH
Confidence 44799999999875321 1223499999999998765566789999999999999
Q ss_pred HHhCCccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 328 VVSGRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 328 lltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
|++|++++... .. + .. ...+.... +. ...+ ..+.+++..||+.||.+||++.++++.
T Consensus 224 l~~~~~~~~~~-----~~---~-~~-~~~~~~~~-----~~-~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 224 AAGAEPLPRNG-----DQ---W-HE-IRQGRLPR-----IP-QVLS----QEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp HTTCCCCCSSS-----HH---H-HH-HHTTCCCC-----CS-SCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred HhcCCCCCcch-----hH---H-HH-HHcCCCCC-----CC-cccC----HHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 99998765321 11 1 11 11222111 11 1111 457889999999999999999999863
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=365.04 Aligned_cols=252 Identities=27% Similarity=0.310 Sum_probs=193.1
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHHH-HHhCCCCceeeEeeeEEeCCEEEE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVA-VAHLRHRNLVRLRGWCVHEDQLLL 185 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~~-l~~l~H~nIv~l~g~~~~~~~~~l 185 (834)
.++|+..+.||+|+||.||+|+.+.+++.||||++.+.. ....+.+..|..+ ++.++|||||++++++.+.+.+|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 357999999999999999999999999999999986542 2234456677776 577999999999999999999999
Q ss_pred EEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccch
Q 003278 186 VYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLA 265 (834)
Q Consensus 186 V~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla 265 (834)
||||+++|+|..++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++++||+|||++
T Consensus 117 v~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a 186 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRE-------RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLC 186 (373)
T ss_dssp EEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBC
T ss_pred EEeCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccc
Confidence 99999999999998653 3578899999999999999999996 9999999999999999999999999999
Q ss_pred hhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccch
Q 003278 266 RWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQII 345 (834)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~ 345 (834)
+..... .......+||+.|+|||.+... .++.++|||||||++|||+||+.||.... ..
T Consensus 187 ~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~---~~- 245 (373)
T 2r5t_A 187 KENIEH----------------NSTTSTFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRN---TA- 245 (373)
T ss_dssp GGGBCC----------------CCCCCSBSCCCCCCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSB---HH-
T ss_pred cccccC----------------CCccccccCCccccCHHHhCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCC---HH-
Confidence 742111 0124556799999999998654 67999999999999999999999986421 11
Q ss_pred HHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhh
Q 003278 346 LLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVS 406 (834)
Q Consensus 346 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~ 406 (834)
.....+... .. .+. ...+ ..+.+|+..||+.||.+||++.+.++.+.
T Consensus 246 --~~~~~i~~~-~~------~~~-~~~~----~~~~~li~~lL~~dp~~R~~~~~~~~~i~ 292 (373)
T 2r5t_A 246 --EMYDNILNK-PL------QLK-PNIT----NSARHLLEGLLQKDRTKRLGAKDDFMEIK 292 (373)
T ss_dssp --HHHHHHHHS-CC------CCC-SSSC----HHHHHHHHHHTCSSGGGSTTTTTTHHHHH
T ss_pred --HHHHHHHhc-cc------CCC-CCCC----HHHHHHHHHHcccCHHhCCCCCCCHHHHh
Confidence 111222211 11 011 1111 35788999999999999999976555443
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=360.88 Aligned_cols=246 Identities=22% Similarity=0.309 Sum_probs=194.6
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCC--hhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKC--PALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIY 589 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~--~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~ 589 (834)
+.|...+.||+|+||+||+|.. .+++.||||++..... ....+.|.+|+.+|++++|||||++++++.+.+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4577788999999999999995 6788999999875432 334567999999999999999999999999999999999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccc
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFL 669 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~ 669 (834)
||+. |+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++...
T Consensus 134 e~~~-g~l~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 204 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM 204 (348)
T ss_dssp ECCS-EEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred ecCC-CCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceec
Confidence 9998 57777765332 248899999999999999999997 68999999999999999999999999999754
Q ss_pred ccCCCCCcccccCccccccccCccchhccc---cCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhc
Q 003278 670 TRNDHGHRKATSGNRSVRGIFGYMSPEYIE---SGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARK 746 (834)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~---~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~ 746 (834)
.. .....||+.|+|||++. .+.++.++|||||||++|||+||+.|+........+ .......
T Consensus 205 ~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~----~~~~~~~ 269 (348)
T 1u5q_A 205 AP-----------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL----YHIAQNE 269 (348)
T ss_dssp SS-----------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH----HHHHHSC
T ss_pred CC-----------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH----HHHHhcC
Confidence 32 12357999999999984 578999999999999999999999998643322211 1111111
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 747 RPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 747 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
.+ .+......+. +..++.+||+.||++|||+.+|++
T Consensus 270 ~~-------~~~~~~~~~~---l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 270 SP-------ALQSGHWSEY---FRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp CC-------CCCCTTSCHH---HHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CC-------CCCCCCCCHH---HHHHHHHHcccChhhCcCHHHHhh
Confidence 11 1111112233 445556899999999999999985
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=358.89 Aligned_cols=274 Identities=20% Similarity=0.272 Sum_probs=206.8
Q ss_pred HhhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEe----CCE
Q 003278 107 YIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVH----EDQ 182 (834)
Q Consensus 107 ~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~----~~~ 182 (834)
....++|+..+.||+|+||.||+|....+|+.||||++........+.+.+|+.++++++||||+++++++.. .+.
T Consensus 25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp EETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred EECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 3455679999999999999999999988999999999876666667889999999999999999999999973 347
Q ss_pred EEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeec
Q 003278 183 LLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDF 262 (834)
Q Consensus 183 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DF 262 (834)
.++||||+++|+|.+++..... ....+++..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~df 178 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKD---KGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDL 178 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred eEEEEEeCCCCcHHHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEec
Confidence 8999999999999999865321 235789999999999999999999996 9999999999999999999999999
Q ss_pred cchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCC--CCCcccceeehhhHHHHHHhCCccCCCCCC
Q 003278 263 GLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGS--VATAKSDVFSFGIVVLEVVSGRRAVDLTYP 340 (834)
Q Consensus 263 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~--~~~~ksDV~SfGvvl~ElltG~~p~~~~~~ 340 (834)
|+++........... ...........||+.|+|||.+.... .++.++|||||||++|||+||+.||.....
T Consensus 179 g~~~~~~~~~~~~~~-------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 251 (317)
T 2buj_A 179 GSMNQACIHVEGSRQ-------ALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQ 251 (317)
T ss_dssp SSCEESCEEEESHHH-------HHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHH
T ss_pred Ccchhcccccccccc-------cccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhc
Confidence 998754211000000 00000122345899999999875432 257899999999999999999999853211
Q ss_pred CccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 341 DDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 341 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
.... +... ... ... ... .... ...+.+++..||+.||.+||++.+|++.|+..
T Consensus 252 ~~~~-~~~~----~~~-~~~-~~~----~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 304 (317)
T 2buj_A 252 KGDS-VALA----VQN-QLS-IPQ----SPRH----SSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304 (317)
T ss_dssp TTSC-HHHH----HHC-C---CCC----CTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred ccch-hhHH----hhc-cCC-CCc----cccC----CHHHHHHHHHHhhcChhhCCCHHHHHHHhhhc
Confidence 1111 1110 011 000 000 0111 24688999999999999999999999999875
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=353.50 Aligned_cols=269 Identities=20% Similarity=0.264 Sum_probs=197.2
Q ss_pred HhhCcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCCChhHHHHHHHHHHHHHh--ccCCCceeEEEEEeeC----Ce
Q 003278 511 ATNNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLAR--LRHRNLVQLCGWCTEQ----GE 584 (834)
Q Consensus 511 at~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~--l~HpNiv~l~g~~~~~----~~ 584 (834)
..++|...+.||+|+||.||+|... +..||||++... ....+..|.+++.. ++|||||++++++... ..
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT----EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred cccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 3467888899999999999999876 788999998532 12344555555554 4999999999999887 78
Q ss_pred EEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhcc-----CCceeecccccCceeecCCCCce
Q 003278 585 MLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEW-----NEQVIHRNITSSAITLDPDMNPR 659 (834)
Q Consensus 585 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~-----~~~iiHrDlK~~NILld~~~~~k 659 (834)
.++||||+++|+|.+++... .+++..+..++.|++.||+|||+.. .++|+||||||+|||++.++.+|
T Consensus 110 ~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 182 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKST-------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC 182 (337)
T ss_dssp EEEEECCCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred eEEEEeccCCCcHHHHhhcc-------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence 99999999999999999643 3889999999999999999999631 12899999999999999999999
Q ss_pred EeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCcc------CcchhhHHHHHHHHhC----------C
Q 003278 660 LGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSM------ADVYSFGVVVLEVVTG----------Q 723 (834)
Q Consensus 660 i~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k------~DV~SfGvvl~E~~tG----------~ 723 (834)
|+|||+++........ .........||+.|+|||++.+..++.+ +|||||||++|||+|| +
T Consensus 183 l~Dfg~a~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~ 259 (337)
T 3mdy_A 183 IADLGLAVKFISDTNE---VDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259 (337)
T ss_dssp ECCCTTCEECC------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred EEeCCCceeecccccc---ccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence 9999999765433211 0111224579999999999987776665 9999999999999999 5
Q ss_pred CccCCCCCchhHHHHHHHHHhhcCccccccccccCCCC-CHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCc
Q 003278 724 MAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEY-NHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDK 799 (834)
Q Consensus 724 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~ 799 (834)
.|+....+............... .. .+...... .......+.+++.+||+.||++|||+.+|++.|+.+.+
T Consensus 260 ~p~~~~~~~~~~~~~~~~~~~~~-~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 331 (337)
T 3mdy_A 260 LPYHDLVPSDPSYEDMREIVCIK-KL----RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331 (337)
T ss_dssp CTTTTTSCSSCCHHHHHHHHTTS-CC----CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccHhhhcCCCCchhhhHHHHhhh-cc----CccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence 56544333222222222211111 11 11111111 11344557777889999999999999999999976543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=353.46 Aligned_cols=252 Identities=21% Similarity=0.297 Sum_probs=201.5
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccCh------hhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGE------RFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLL 184 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 184 (834)
++|+..+.||+|+||.||+|....+|+.||||.+..... ...+.+.+|+.++.+++||||+++++++.+.+..+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 468889999999999999999988999999999865321 13577999999999999999999999999999999
Q ss_pred EEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCC----ceEEe
Q 003278 185 LVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQY----NARLG 260 (834)
Q Consensus 185 lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~----~~kl~ 260 (834)
+||||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++ .+||+
T Consensus 92 lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~ 161 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQK-------ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLI 161 (321)
T ss_dssp EEECCCCSCBHHHHHHTC-------SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred EEEEcCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEc
Confidence 999999999999999643 3588999999999999999999996 999999999999999887 79999
Q ss_pred eccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCC
Q 003278 261 DFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYP 340 (834)
Q Consensus 261 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~ 340 (834)
|||+++...... ......||+.|+|||.+... .++.++|||||||++|||+||+.||.....
T Consensus 162 Dfg~~~~~~~~~-----------------~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 223 (321)
T 2a2a_A 162 DFGLAHEIEDGV-----------------EFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTK 223 (321)
T ss_dssp CCTTCEECCTTC-----------------CCCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred cCccceecCccc-----------------cccccCCCCCccCcccccCC-CCCCccccHHHHHHHHHHHHCCCCCCCCCH
Confidence 999997543210 12345699999999988654 679999999999999999999999864321
Q ss_pred CccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 341 DDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 341 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
. .....+.. ... ..++... ... ...+.+++..||+.||.+||++.++++.
T Consensus 224 ---~---~~~~~i~~-~~~--~~~~~~~-~~~----~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 224 ---Q---ETLANITS-VSY--DFDEEFF-SHT----SELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp ---H---HHHHHHHT-TCC--CCCHHHH-TTC----CHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred ---H---HHHHHHHh-ccc--ccChhhh-ccc----CHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1 11111111 100 0000000 011 1357889999999999999999999873
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=350.48 Aligned_cols=248 Identities=21% Similarity=0.367 Sum_probs=201.3
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
+.|...+.||+|+||.||+|.. .+++.||||.+.........+.|.+|+.++++++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 4577778899999999999986 468899999987665555567899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccccc
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTR 671 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~ 671 (834)
+++++|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++.....
T Consensus 102 ~~~~~L~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 171 (303)
T 3a7i_A 102 LGGGSALDLLEPG-------PLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 171 (303)
T ss_dssp CTTEEHHHHHTTS-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred CCCCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCc
Confidence 9999999998532 38899999999999999999997 6899999999999999999999999999976543
Q ss_pred CCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcccc
Q 003278 672 NDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAE 751 (834)
Q Consensus 672 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
.. .......||+.|+|||++.+..++.++|||||||++|||+||+.|+....+... .... .....
T Consensus 172 ~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~---~~~~~---- 236 (303)
T 3a7i_A 172 TQ-------IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKV-LFLI---PKNNP---- 236 (303)
T ss_dssp TB-------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHH---HHSCC----
T ss_pred cc-------cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHH-HHHh---hcCCC----
Confidence 21 112345799999999999999999999999999999999999999864332211 1111 11111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 752 LVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 752 ~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
+.+...++ . .+..++.+||+.||++|||+.+|++
T Consensus 237 ---~~~~~~~~-~---~l~~li~~~l~~dp~~Rps~~~ll~ 270 (303)
T 3a7i_A 237 ---PTLEGNYS-K---PLKEFVEACLNKEPSFRPTAKELLK 270 (303)
T ss_dssp ---CCCCSSCC-H---HHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ---CCCccccC-H---HHHHHHHHHcCCChhhCcCHHHHhh
Confidence 11222222 2 3455666899999999999999986
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=350.01 Aligned_cols=258 Identities=16% Similarity=0.249 Sum_probs=193.4
Q ss_pred CcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCCC-hhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEecc
Q 003278 514 NFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKC-PALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYS 592 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~-~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~ 592 (834)
+|...+.||+|+||+||+|...+++.||||++..... ....+.+.+|+.++++++|||||++++++.+.+..++||||+
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (288)
T 1ob3_A 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL 82 (288)
T ss_dssp SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred cchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEec
Confidence 5666788999999999999998899999999875432 223467889999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccC
Q 003278 593 ATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRN 672 (834)
Q Consensus 593 ~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~ 672 (834)
++ +|.+++.... ..+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~-~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (288)
T 1ob3_A 83 DQ-DLKKLLDVCE-----GGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (288)
T ss_dssp SE-EHHHHHHTST-----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred CC-CHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence 86 8888876532 237888899999999999999997 69999999999999999999999999999764321
Q ss_pred CCCCcccccCccccccccCccchhcccc-CCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhc--Ccc
Q 003278 673 DHGHRKATSGNRSVRGIFGYMSPEYIES-GEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARK--RPL 749 (834)
Q Consensus 673 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~--~~~ 749 (834)
. .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||........+.. ........ ..+
T Consensus 154 ~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~ 225 (288)
T 1ob3_A 154 V-------RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR-IFRILGTPNSKNW 225 (288)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-HHHHHCCCCTTTS
T ss_pred c-------cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHHHCCCChhhc
Confidence 1 11223578999999999875 4589999999999999999999999875433222222 21111000 000
Q ss_pred cc-----cccccc-----------CCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 750 AE-----LVDLSL-----------NGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 750 ~~-----~~d~~l-----------~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
.. ..++.. .... .+ .+..++.+||+.||++|||+.|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~---~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 226 PNVTELPKYDPNFTVYEPLPWESFLKGL-DE---SGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TTGGGSTTCCTTCCCCCCCCGGGTCCSC-CH---HHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhhcccccccccccccCccHHHHhhhc-CH---HHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00 001000 0111 22 3455666999999999999999975
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=346.81 Aligned_cols=252 Identities=19% Similarity=0.281 Sum_probs=200.1
Q ss_pred cccccCCcEEEEEEEC---CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEeccCCCc
Q 003278 520 RVAEMDFGTAYQGFLD---NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRI 596 (834)
Q Consensus 520 ~ig~g~~g~vy~~~~~---~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~~~g~ 596 (834)
.||+|+||.||+|... ++..||||.+.........+.|.+|++++++++||||+++++++ ..+..++||||+++++
T Consensus 17 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~ 95 (287)
T 1u59_A 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGP 95 (287)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEE
T ss_pred cccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCC
Confidence 7999999999999853 57789999998766666678899999999999999999999999 5567899999999999
Q ss_pred hhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCCCCC
Q 003278 597 LSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGH 676 (834)
Q Consensus 597 L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~~~~ 676 (834)
|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++.........
T Consensus 96 L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~- 166 (287)
T 1u59_A 96 LHKFLVGKR-----EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY- 166 (287)
T ss_dssp HHHHHTTCT-----TTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE-
T ss_pred HHHHHHhCC-----ccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeeccCcce-
Confidence 999986432 248899999999999999999997 69999999999999999999999999999875432211
Q ss_pred cccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCcccccccc
Q 003278 677 RKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDL 755 (834)
Q Consensus 677 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 755 (834)
........||+.|+|||++.+..++.++|||||||++|||+| |+.||....... ....+ .....+
T Consensus 167 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-~~~~i---~~~~~~------- 232 (287)
T 1u59_A 167 ---YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-VMAFI---EQGKRM------- 232 (287)
T ss_dssp ---ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-HHHHH---HTTCCC-------
T ss_pred ---eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH-HHHHH---hcCCcC-------
Confidence 111223467899999999998899999999999999999999 999986543322 11111 111111
Q ss_pred ccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCc
Q 003278 756 SLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDK 799 (834)
Q Consensus 756 ~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~ 799 (834)
...... +. .+.+++.+||+.||++|||+.+|++.|+....
T Consensus 233 ~~~~~~-~~---~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 272 (287)
T 1u59_A 233 ECPPEC-PP---ELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 272 (287)
T ss_dssp CCCTTC-CH---HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCc-CH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111122 23 34556669999999999999999999976644
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=348.32 Aligned_cols=267 Identities=15% Similarity=0.178 Sum_probs=200.0
Q ss_pred HhhCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEE-eeCCeEEEE
Q 003278 511 ATNNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWC-TEQGEMLVI 588 (834)
Q Consensus 511 at~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~-~~~~~~~lv 588 (834)
..++|...+.||+|+||.||+|.. .++..||||.+...... +.+.+|+.++.+++|+|++..+++| .+.+..++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C---CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc---hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 346788889999999999999996 66889999986543322 3578899999999999988877766 567788999
Q ss_pred EeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceee---cCCCCceEeeeee
Q 003278 589 YDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITL---DPDMNPRLGSFAL 665 (834)
Q Consensus 589 ~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILl---d~~~~~ki~DfGl 665 (834)
|||+ +++|.+++..... .+++..+..++.|++.||+|||+ .+|+||||||+|||+ ++++.+||+|||+
T Consensus 84 ~e~~-~~~L~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~ 154 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCSR-----KFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGL 154 (296)
T ss_dssp EECC-CCBHHHHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTT
T ss_pred EEcc-CCCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCcc
Confidence 9999 9999999875432 38899999999999999999997 689999999999999 7889999999999
Q ss_pred ccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCch--hHHHHHHHHH
Q 003278 666 AEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEG--LLVKRVHEFE 743 (834)
Q Consensus 666 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~--~~~~~~~~~~ 743 (834)
++....................||+.|+|||.+.+..++.++|||||||++|||+||+.||....... ..........
T Consensus 155 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 234 (296)
T 4hgt_A 155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 234 (296)
T ss_dssp CEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH
T ss_pred ceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccc
Confidence 98765432211111122335689999999999999999999999999999999999999997533221 1111111111
Q ss_pred hhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCc
Q 003278 744 ARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDK 799 (834)
Q Consensus 744 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~ 799 (834)
. ..+... +...++ + .+.+++.+||+.||++|||+.+|++.|+.+..
T Consensus 235 ~-~~~~~~-----~~~~~~-~---~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~ 280 (296)
T 4hgt_A 235 M-STPIEV-----LCKGYP-S---EFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp H-HSCHHH-----HTTTSC-H---HHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred c-cchhhh-----hhccCC-H---HHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence 1 111100 111122 2 35566669999999999999999999976554
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=348.85 Aligned_cols=268 Identities=17% Similarity=0.247 Sum_probs=201.9
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeE-EeCCEEEEEEE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWC-VHEDQLLLVYD 188 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~-~~~~~~~lV~E 188 (834)
.++|+..+.||+|+||.||+|....+++.||||++..... .+.+.+|+.++..++|+|++..+++| ...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 4679999999999999999999989999999998654322 23578899999999998877766665 66778999999
Q ss_pred ccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEE---CCCCceEEeeccch
Q 003278 189 YMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVML---DSQYNARLGDFGLA 265 (834)
Q Consensus 189 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILl---d~~~~~kl~DFGla 265 (834)
|+ +|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 86 ~~-~~~L~~~~~~~------~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a 155 (296)
T 4hgt_A 86 LL-GPSLEDLFNFC------SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155 (296)
T ss_dssp CC-CCBHHHHHHHT------TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTC
T ss_pred cc-CCCHHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccc
Confidence 99 99999998643 24589999999999999999999996 99999999999999 78899999999999
Q ss_pred hhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccch
Q 003278 266 RWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQII 345 (834)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~ 345 (834)
+.+...... ............||+.|+|||.+... .++.++|||||||++|||+||+.||..........
T Consensus 156 ~~~~~~~~~---------~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 225 (296)
T 4hgt_A 156 KKYRDARTH---------QHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ 225 (296)
T ss_dssp EECBCTTTC---------CBCCCCCSCCCCSCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSS
T ss_pred eeccCcccC---------ccCCCCcccccCCCccccchHHhcCC-CCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhh
Confidence 865332110 00001123456799999999998654 67999999999999999999999997654433222
Q ss_pred HHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcCC
Q 003278 346 LLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGSY 409 (834)
Q Consensus 346 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~~ 409 (834)
....+........ ..... ..+ ...+.+++..||+.||++||++.+|++.|....
T Consensus 226 ~~~~~~~~~~~~~-~~~~~-----~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~ 279 (296)
T 4hgt_A 226 KYERISEKKMSTP-IEVLC-----KGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp HHHHHHHHHHHSC-HHHHT-----TTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred hhhhhhcccccch-hhhhh-----ccC----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence 2221111110000 00000 111 146889999999999999999999999987643
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=363.66 Aligned_cols=247 Identities=15% Similarity=0.168 Sum_probs=190.6
Q ss_pred cCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEeccCCC
Q 003278 517 ESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATR 595 (834)
Q Consensus 517 ~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~~~g 595 (834)
..+.||+|+||.||+|.. .++..||||++.... ....+.|.+|+.+|++++|||||++++++.+.+..++||||+++|
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG-MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc-cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 346799999999999986 568899999987543 234578999999999999999999999999999999999999999
Q ss_pred chhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceee--cCCCCceEeeeeeccccccCC
Q 003278 596 ILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITL--DPDMNPRLGSFALAEFLTRND 673 (834)
Q Consensus 596 ~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILl--d~~~~~ki~DfGla~~~~~~~ 673 (834)
+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++......
T Consensus 172 ~L~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~ 243 (373)
T 2x4f_A 172 ELFDRIIDES-----YNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243 (373)
T ss_dssp EEHHHHHHTG-----GGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred cHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence 9998886542 248899999999999999999997 689999999999999 567889999999998654321
Q ss_pred CCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcccccc
Q 003278 674 HGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELV 753 (834)
Q Consensus 674 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (834)
......||+.|+|||++.++.++.++|||||||++|||+||+.||........ ...+. .......
T Consensus 244 --------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~i~---~~~~~~~--- 308 (373)
T 2x4f_A 244 --------KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET-LNNIL---ACRWDLE--- 308 (373)
T ss_dssp --------BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHH---HTCCCSC---
T ss_pred --------ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHH---hccCCCC---
Confidence 12234799999999999999999999999999999999999999865433221 11111 1111110
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 754 DLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 754 d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
+. .....+ + .+..++.+||+.||++|||+.|+++
T Consensus 309 ~~-~~~~~~-~---~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 309 DE-EFQDIS-E---EAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp SG-GGTTSC-H---HHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hh-hhccCC-H---HHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 001122 2 3455666999999999999999986
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=355.78 Aligned_cols=269 Identities=21% Similarity=0.286 Sum_probs=208.9
Q ss_pred HHHHHhhCcCcCCcccccCCcEEEEEEE------CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhc-cCCCceeEEEEE
Q 003278 507 EIISATNNFSESQRVAEMDFGTAYQGFL------DNHQYVLVKRLGMSKCPALRTRFSNELQNLARL-RHRNLVQLCGWC 579 (834)
Q Consensus 507 el~~at~~f~~~~~ig~g~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l-~HpNiv~l~g~~ 579 (834)
+..-..++|...+.||+|+||.||+|.. .++..||||.+.........+.|.+|+.++.++ +|||||++++++
T Consensus 21 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 100 (316)
T 2xir_A 21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 100 (316)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence 3333456788889999999999999984 346789999998766655667899999999999 799999999998
Q ss_pred eeCC-eEEEEEeccCCCchhhhhhcCCCCC----------CCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccC
Q 003278 580 TEQG-EMLVIYDYSATRILSHLLFHNNHRI----------GHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSS 648 (834)
Q Consensus 580 ~~~~-~~~lv~Ey~~~g~L~~~l~~~~~~~----------~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~ 648 (834)
...+ ..++||||+++|+|.+++....... ....+++..+..++.|++.||+|||+ .+|+||||||+
T Consensus 101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~ 177 (316)
T 2xir_A 101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAAR 177 (316)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGG
T ss_pred ecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccccCccc
Confidence 8754 5899999999999999997643210 01237889999999999999999997 69999999999
Q ss_pred ceeecCCCCceEeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccC
Q 003278 649 AITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVD 727 (834)
Q Consensus 649 NILld~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~ 727 (834)
|||++.++.+||+|||+++....... ........||+.|+|||++.+..++.++|||||||++|||+| |..|+.
T Consensus 178 Nil~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 252 (316)
T 2xir_A 178 NILLSEKNVVKICDFGLARDIYKDPD-----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252 (316)
T ss_dssp GEEECGGGCEEECCCGGGSCTTTCTT-----SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred eEEECCCCCEEECCCccccccccCcc-----ceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence 99999999999999999976543211 111224568999999999999999999999999999999999 999986
Q ss_pred CCCCchhHHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccC
Q 003278 728 FRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGN 797 (834)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~ 797 (834)
.......+...+.. .... ...... .. .+.+++.+||+.||++|||+.+|++.|+.+
T Consensus 253 ~~~~~~~~~~~~~~---~~~~-------~~~~~~-~~---~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 253 GVKIDEEFCRRLKE---GTRM-------RAPDYT-TP---EMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp TCCCSHHHHHHHHH---TCCC-------CCCTTC-CH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccchhHHHHHHhcc---CccC-------CCCCCC-CH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 54433332222211 1110 111112 22 355666799999999999999999999765
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=351.40 Aligned_cols=249 Identities=18% Similarity=0.257 Sum_probs=188.6
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCCh-------------------------hHHHHHHHHHHHHHh
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCP-------------------------ALRTRFSNELQNLAR 566 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~-------------------------~~~~~f~~E~~~l~~ 566 (834)
++|...+.||+|+||.||+|.. .+++.||||.+...... ...+.|.+|+++|++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 4677778899999999999986 45789999998643211 123568999999999
Q ss_pred ccCCCceeEEEEEee--CCeEEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecc
Q 003278 567 LRHRNLVQLCGWCTE--QGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRN 644 (834)
Q Consensus 567 l~HpNiv~l~g~~~~--~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrD 644 (834)
++|||||++++++.+ .+..++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+ .+|+|||
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~D 162 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-------KPLSEDQARFYFQDLIKGIEYLHY---QKIIHRD 162 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCC
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccC
Confidence 999999999999986 5689999999999999886532 248899999999999999999997 6899999
Q ss_pred cccCceeecCCCCceEeeeeeccccccCCCCCcccccCccccccccCccchhccccCC---CCccCcchhhHHHHHHHHh
Q 003278 645 ITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGE---ATSMADVYSFGVVVLEVVT 721 (834)
Q Consensus 645 lK~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~---~~~k~DV~SfGvvl~E~~t 721 (834)
|||+|||++.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++|||||||++|||+|
T Consensus 163 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~ 235 (298)
T 2zv2_A 163 IKPSNLLVGEDGHIKIADFGVSNEFKGSDA-------LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF 235 (298)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECSSSSC-------EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHH
T ss_pred CCHHHEEECCCCCEEEecCCCccccccccc-------cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHH
Confidence 999999999999999999999976543211 112357999999999997655 4778999999999999999
Q ss_pred CCCccCCCCCchhHHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 722 GQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 722 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
|+.||....... ... ......... . ..... .++ +.+++.+||+.||++|||+.||++
T Consensus 236 g~~pf~~~~~~~-~~~---~~~~~~~~~---~---~~~~~-~~~---l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 236 GQCPFMDERIMC-LHS---KIKSQALEF---P---DQPDI-AED---LKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SSCSSCCSSHHH-HHH---HHHHCCCCC---C---SSSCC-CHH---HHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCCCCCccHHH-HHH---HHhcccCCC---C---Ccccc-CHH---HHHHHHHHhhcChhhCCCHHHHhc
Confidence 999986432211 111 111111000 0 01112 233 455666999999999999999864
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=376.43 Aligned_cols=253 Identities=23% Similarity=0.320 Sum_probs=202.2
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLV 186 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 186 (834)
.++|...++||+|+||.||+|+.+.+|+.||||++.... ....+.+.+|+.+|.+++|||||++++++.+.+.+|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 467888899999999999999998899999999986532 22346788999999999999999999999999999999
Q ss_pred EEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchh
Q 003278 187 YDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLAR 266 (834)
Q Consensus 187 ~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~ 266 (834)
|||+++|+|..++..... ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 264 mE~~~gg~L~~~l~~~~~---~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~ 337 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDE---DNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAV 337 (543)
T ss_dssp ECCCTTCBHHHHHHTSST---TSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEeccCCCHHHHHHHhhc---ccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceee
Confidence 999999999999875432 134689999999999999999999996 99999999999999999999999999998
Q ss_pred hhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchH
Q 003278 267 WLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIIL 346 (834)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l 346 (834)
.+.... ......+||+.|+|||.+... .++.++|||||||++|||+||+.||........ .
T Consensus 338 ~~~~~~----------------~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~--~ 398 (543)
T 3c4z_A 338 ELKAGQ----------------TKTKGYAGTPGFMAPELLLGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--N 398 (543)
T ss_dssp ECCTTC----------------CCBCCCCSCTTTSCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC--H
T ss_pred eccCCC----------------cccccccCCccccChhhhcCC-CCChHHhcCcchHHHHHHHhCCCCCCCCccchh--H
Confidence 543210 113445799999999998654 679999999999999999999999975432211 1
Q ss_pred HHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchh
Q 003278 347 LDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMK 399 (834)
Q Consensus 347 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~ 399 (834)
.......... .. ... ..++ ..+..++..||+.||.+||++.
T Consensus 399 ~~~~~~i~~~-~~------~~p-~~~s----~~~~~li~~lL~~dP~~R~~~~ 439 (543)
T 3c4z_A 399 KELKQRVLEQ-AV------TYP-DKFS----PASKDFCEALLQKDPEKRLGFR 439 (543)
T ss_dssp HHHHHHHHHC-CC------CCC-TTSC----HHHHHHHHHHSCSSGGGSCCCB
T ss_pred HHHHHHHhhc-cc------CCC-cccC----HHHHHHHHHhccCCHhHCCCCc
Confidence 1222222211 10 010 1111 3577899999999999999874
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=347.26 Aligned_cols=256 Identities=23% Similarity=0.364 Sum_probs=199.8
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEcc
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYM 190 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 190 (834)
+.|....+||+|+||.||+|.+..++..||||.+........+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 34666679999999999999998999999999997766666778999999999999999999999999999999999999
Q ss_pred CCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECC-CCceEEeeccchhhhh
Q 003278 191 PNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDS-QYNARLGDFGLARWLE 269 (834)
Q Consensus 191 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~-~~~~kl~DFGla~~~~ 269 (834)
++++|.+++..... ...+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++...
T Consensus 102 ~~~~L~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~ 174 (295)
T 2clq_A 102 PGGSLSALLRSKWG----PLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA 174 (295)
T ss_dssp SEEEHHHHHHHTTC----CCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESC
T ss_pred CCCCHHHHHHhhcc----CCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccC
Confidence 99999999976422 24567899999999999999999996 9999999999999987 8899999999997543
Q ss_pred hhhhhhhhcccccccccccccceeeeccccCCCccccccCC-CCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHH
Q 003278 270 HELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGS-VATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLD 348 (834)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~ 348 (834)
... .......||+.|+|||.+..+. .++.++|||||||++|||+||+.||....... ...
T Consensus 175 ~~~----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~-- 235 (295)
T 2clq_A 175 GIN----------------PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ-AAM-- 235 (295)
T ss_dssp C---------------------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH-HHH--
T ss_pred CCC----------------CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh-HHH--
Confidence 210 0123456999999999986532 36889999999999999999999985321111 100
Q ss_pred HHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 349 WIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 349 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
+..... . ..+.+. ... ...+.+++..||+.||++||++.++++.
T Consensus 236 ~~~~~~--~-----~~~~~~-~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 236 FKVGMF--K-----VHPEIP-ESM----SAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp HHHHHH--C-----CCCCCC-TTS----CHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred Hhhccc--c-----cccccc-ccC----CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000000 0 111111 111 2457889999999999999999999863
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=346.63 Aligned_cols=259 Identities=26% Similarity=0.397 Sum_probs=202.0
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEe--CCEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCVH--EDQLLLV 186 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~lV 186 (834)
++|+..+.||+|+||.||+|....+|+.||+|.+... .....+.+.+|+.++++++||||+++++++.. .+..++|
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 85 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 85 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence 5788899999999999999999889999999998643 33456779999999999999999999998865 5689999
Q ss_pred EEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhcc--CCCeecCCCCCCceEECCCCceEEeeccc
Q 003278 187 YDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQL--ETQIIHRDVKTSNVMLDSQYNARLGDFGL 264 (834)
Q Consensus 187 ~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiHrDlKp~NILld~~~~~kl~DFGl 264 (834)
|||+++|+|.+++..... ....+++..+..|+.|++.||.|||+.. ..+|+||||||+|||++.++.+||+|||+
T Consensus 86 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 86 MEYCEGGDLASVITKGTK---ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EECCTTEEHHHHHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EeCCCCCCHHHHHHhhcc---cCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 999999999999965321 2346899999999999999999999961 01299999999999999999999999999
Q ss_pred hhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccc
Q 003278 265 ARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQI 344 (834)
Q Consensus 265 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~ 344 (834)
++........ .....||+.|+|||.+... .++.++|||||||++|||+||+.||.... ..
T Consensus 163 ~~~~~~~~~~----------------~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~ 222 (279)
T 2w5a_A 163 ARILNHDTSF----------------AKTFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFS---QK 222 (279)
T ss_dssp HHHC---CHH----------------HHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSS---HH
T ss_pred heeecccccc----------------ccccCCCccccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCcccC---HH
Confidence 9865332110 1234589999999998654 67899999999999999999999986432 11
Q ss_pred hHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhh
Q 003278 345 ILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVS 406 (834)
Q Consensus 345 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~ 406 (834)
.+.. . ...+.... +. ..+ ...+.+++..||+.||.+||++.+|++.+.
T Consensus 223 ~~~~---~-i~~~~~~~-----~~-~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 223 ELAG---K-IREGKFRR-----IP-YRY----SDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp HHHH---H-HHHTCCCC-----CC-TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred HHHH---H-Hhhccccc-----CC-ccc----CHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 1111 1 11222211 11 111 246889999999999999999999998654
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=356.91 Aligned_cols=264 Identities=25% Similarity=0.416 Sum_probs=202.6
Q ss_pred cCCCCCCCeeeccCCeEEEEEE-----ECCCCeEEEEEEeccc-ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAV-----LPSDGTVVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQL 183 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~-----~~~~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 183 (834)
.++|...+.||+|+||.||+|. ...++..||||.+... .......|.+|+.++++++||||+++++++...+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 4678999999999999999998 4456789999998643 344566799999999999999999999999999999
Q ss_pred EEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECC---CCceEEe
Q 003278 184 LLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDS---QYNARLG 260 (834)
Q Consensus 184 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~---~~~~kl~ 260 (834)
++||||+++|+|.+++............+++..+..++.|++.||.|||+. +|+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999987543333335689999999999999999999996 9999999999999984 4569999
Q ss_pred eccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCC
Q 003278 261 DFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTY 339 (834)
Q Consensus 261 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~ 339 (834)
|||+++........ .......||+.|+|||.+..+ .++.++|||||||++|||+| |+.||....
T Consensus 186 Dfg~~~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~ 250 (327)
T 2yfx_A 186 DFGMARDIYRASYY--------------RKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 250 (327)
T ss_dssp CCHHHHHHHC--------------------CCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cccccccccccccc--------------ccCCCcCCCcceeCHhHhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCcC
Confidence 99999864322110 012334589999999998655 57999999999999999999 888886432
Q ss_pred CCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 340 PDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 340 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
...+..++ ..+..... . ... ...+.+++..||+.||.+||++.+|++.|...
T Consensus 251 ---~~~~~~~~----~~~~~~~~-----~-~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 251 ---NQEVLEFV----TSGGRMDP-----P-KNC----PGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp ---HHHHHHHH----HTTCCCCC-----C-TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHHHHH----hcCCCCCC-----C-CCC----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 11111111 11111110 0 111 24678899999999999999999999998754
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=356.47 Aligned_cols=258 Identities=24% Similarity=0.376 Sum_probs=198.0
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEE----EEEEeccc-ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVV----AVKCLAEK-GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLL 184 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~v----AvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 184 (834)
.++|+..+.||+|+||.||+|.+..++..| |+|.+... .....+.+.+|+.++++++||||++++++|...+ .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 357899999999999999999998777654 66766432 3345678999999999999999999999998765 88
Q ss_pred EEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccc
Q 003278 185 LVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGL 264 (834)
Q Consensus 185 lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGl 264 (834)
+|+||+++|+|.+++.... ..+++..++.|+.|++.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 93 ~v~~~~~~g~L~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~ 163 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHK------DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGL 163 (327)
T ss_dssp EEECCCSSCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC
T ss_pred EEEEecCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcc
Confidence 9999999999999997542 4589999999999999999999996 999999999999999999999999999
Q ss_pred hhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCcc
Q 003278 265 ARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQ 343 (834)
Q Consensus 265 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~ 343 (834)
++.+...... .......||+.|+|||.+... .++.++|||||||++|||+| |+.||......
T Consensus 164 a~~~~~~~~~--------------~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-- 226 (327)
T 3lzb_A 164 AKLLGAEEKE--------------YHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-- 226 (327)
T ss_dssp ------------------------------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--
T ss_pred eeEccCcccc--------------ccccCCCccccccCHHHHcCC-CCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH--
Confidence 9865432110 012234578899999998754 67999999999999999999 99998754322
Q ss_pred chHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcCC
Q 003278 344 IILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGSY 409 (834)
Q Consensus 344 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~~ 409 (834)
.+...+ ..+..... + .. ....+..++..||+.||.+||++.++++.|....
T Consensus 227 -~~~~~~----~~~~~~~~--~----~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 227 -EISSIL----EKGERLPQ--P----PI----CTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp -GHHHHH----HTTCCCCC--C----TT----BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HHHHHH----HcCCCCCC--C----cc----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 122111 11111110 0 11 1235788999999999999999999999998753
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=386.69 Aligned_cols=250 Identities=22% Similarity=0.367 Sum_probs=195.7
Q ss_pred eeeccCCeEEEEEEEC--CCCeEEEEEEecccC-hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEccCCCC
Q 003278 118 VLGSGGFGKVYRAVLP--SDGTVVAVKCLAEKG-ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNRS 194 (834)
Q Consensus 118 ~LG~G~fG~Vy~~~~~--~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 194 (834)
.||+|+||.||+|.+. .++..||||+++... ....+.|.+|+.+|++++|||||+++++|.. +..++|||||++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999875 356789999997542 3456789999999999999999999999976 56999999999999
Q ss_pred HhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhhhhhh
Q 003278 195 LDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQY 274 (834)
Q Consensus 195 L~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~ 274 (834)
|.++|... ...+++..+..|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+......
T Consensus 422 L~~~l~~~------~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 492 (613)
T 2ozo_A 422 LHKFLVGK------REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY 492 (613)
T ss_dssp HHHHHTTC------TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----
T ss_pred HHHHHhhc------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCce
Confidence 99999643 24689999999999999999999996 9999999999999999999999999999865432110
Q ss_pred hhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccchHHHHHHHH
Q 003278 275 QMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQIILLDWIRRL 353 (834)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~ 353 (834)
........||+.|+|||++..+ .++.++|||||||++|||+| |+.||...... .+...
T Consensus 493 -------------~~~~~~~~~~~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~~~---- 551 (613)
T 2ozo_A 493 -------------YTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAF---- 551 (613)
T ss_dssp ----------------------CCTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH---HHHHH----
T ss_pred -------------eeeccCCCCccceeCHhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHHHH----
Confidence 0011233467899999998755 67999999999999999998 99998753321 12221
Q ss_pred hhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 354 SDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 354 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
...+...... .. ....+.+|+..||+.||.+||+|.+|++.|+..
T Consensus 552 i~~~~~~~~p------~~----~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 552 IEQGKRMECP------PE----CPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp HHTTCCCCCC------TT----CCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHcCCCCCCC------Cc----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 2222221111 11 124688999999999999999999999998764
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=367.37 Aligned_cols=217 Identities=25% Similarity=0.387 Sum_probs=165.4
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCC-CCceeeEeeeEEeCC--EEE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLR-HRNLVRLRGWCVHED--QLL 184 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~--~~~ 184 (834)
.++|+..+.||+|+||.||+|.+..+|+.||||++... .....+.+.+|+.++.++. |||||++++++...+ .+|
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 46799999999999999999999999999999998543 3345567889999999997 999999999998655 689
Q ss_pred EEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccc
Q 003278 185 LVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGL 264 (834)
Q Consensus 185 lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGl 264 (834)
+|||||+ |+|..++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 88 lv~e~~~-~~L~~~~~~--------~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~ 155 (388)
T 3oz6_A 88 LVFDYME-TDLHAVIRA--------NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGL 155 (388)
T ss_dssp EEEECCS-EEHHHHHHH--------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEecccC-cCHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcc
Confidence 9999998 689888854 3588999999999999999999996 999999999999999999999999999
Q ss_pred hhhhhhhhhhhhh-c-cc---ccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCC
Q 003278 265 ARWLEHELQYQMR-T-SS---ARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLT 338 (834)
Q Consensus 265 a~~~~~~~~~~~~-~-~~---~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~ 338 (834)
|+.+......... + .. ...........+..+||++|+|||.+.....++.++|||||||++|||+||+.||...
T Consensus 156 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 156 SRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp CEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9865321000000 0 00 0000000112345679999999999876567899999999999999999999999653
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=347.07 Aligned_cols=268 Identities=17% Similarity=0.250 Sum_probs=204.6
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeE-EeCCEEEEEEE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWC-VHEDQLLLVYD 188 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~-~~~~~~~lV~E 188 (834)
.++|+..+.||+|+||.||+|+...+|+.||||++..... .+.+.+|+.++..++|+|++..++++ ...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 4679999999999999999999988999999999865432 24588999999999998877666655 56778899999
Q ss_pred ccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEE---CCCCceEEeeccch
Q 003278 189 YMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVML---DSQYNARLGDFGLA 265 (834)
Q Consensus 189 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILl---d~~~~~kl~DFGla 265 (834)
|+ +|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 86 ~~-~~~L~~~~~~~------~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 155 (296)
T 3uzp_A 86 LL-GPSLEDLFNFC------SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155 (296)
T ss_dssp CC-CCBHHHHHHHT------TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred ec-CCCHHHHHHhh------ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCc
Confidence 99 99999999643 24689999999999999999999996 99999999999999 47889999999999
Q ss_pred hhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccch
Q 003278 266 RWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQII 345 (834)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~ 345 (834)
+.+...... ............||+.|+|||.+... .++.++|||||||++|||+||+.||..........
T Consensus 156 ~~~~~~~~~---------~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 225 (296)
T 3uzp_A 156 KKYRDARTH---------QHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ 225 (296)
T ss_dssp EECBCTTTC---------CBCCCCCSCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSS
T ss_pred ccccccccc---------cccccccccccccccccCChhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhh
Confidence 865432110 00001123456799999999998654 57999999999999999999999997644333222
Q ss_pred HHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcCC
Q 003278 346 LLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGSY 409 (834)
Q Consensus 346 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~~ 409 (834)
....+......... .... ..++ ..+.+++..||+.||.+||++.+|++.|+...
T Consensus 226 ~~~~~~~~~~~~~~-~~~~-----~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 279 (296)
T 3uzp_A 226 KYERISEKKMSTPI-EVLC-----KGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp HHHHHHHHHHHSCH-HHHT-----TTSC----HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred hhhhhcccccCCch-HHHH-----hhCC----HHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHH
Confidence 22222111000000 0000 1111 45889999999999999999999999987653
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=374.88 Aligned_cols=264 Identities=18% Similarity=0.187 Sum_probs=201.9
Q ss_pred cHHHHHHHhhCcCcCCcccccCCcEEEEEEECC-CcEEEEEEecCCCC--hhHHHHHHHHHHHHHhccCCCceeEEEEEe
Q 003278 504 SFKEIISATNNFSESQRVAEMDFGTAYQGFLDN-HQYVLVKRLGMSKC--PALRTRFSNELQNLARLRHRNLVQLCGWCT 580 (834)
Q Consensus 504 ~~~el~~at~~f~~~~~ig~g~~g~vy~~~~~~-~~~vavK~~~~~~~--~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~ 580 (834)
.+.++...+++|...+.||+|+||+||+|...+ ++.||||++..... ......|.+|+.++.+++|||||+++++|.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 445555667899999999999999999999765 78899999863211 111234888999999999999999999999
Q ss_pred eCCeEEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceE
Q 003278 581 EQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRL 660 (834)
Q Consensus 581 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki 660 (834)
+.+..++||||+++|+|.+++.... ..+++.....++.|++.||+|||+ .+||||||||+|||||.++.+||
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~~-----~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL 216 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKFE-----DRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRL 216 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEE
T ss_pred eCCEEEEEEecCCCCcHHHHHHHcc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEE
Confidence 9999999999999999999997532 238889999999999999999997 68999999999999999999999
Q ss_pred eeeeeccccccCCCCCcccccCccccccccCccchhccc-----cCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhH
Q 003278 661 GSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIE-----SGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLL 735 (834)
Q Consensus 661 ~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-----~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~ 735 (834)
+|||+++.+..... ......+||+.|||||++. .+.|+.++|||||||++|||+||+.||.........
T Consensus 217 ~DFGla~~~~~~~~------~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~ 290 (437)
T 4aw2_A 217 ADFGSCLKLMEDGT------VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY 290 (437)
T ss_dssp CCCTTCEECCTTSC------EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred cchhhhhhcccCCC------cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHH
Confidence 99999976543211 1123468999999999997 567899999999999999999999999754433222
Q ss_pred HHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCC--CCChhHHHH
Q 003278 736 VKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPEL--RPSMRQILS 792 (834)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~--RPtm~~v~~ 792 (834)
..+...... ..+.. ..... .+++..++ .+|+..+|++ ||++.||++
T Consensus 291 -~~i~~~~~~-~~~p~-----~~~~~-s~~~~dLi---~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 291 -GKIMNHKER-FQFPT-----QVTDV-SENAKDLI---RRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp -HHHHTHHHH-CCCCS-----SCCCS-CHHHHHHH---HTTSSCGGGCTTTTTTHHHHT
T ss_pred -Hhhhhcccc-ccCCc-----ccccC-CHHHHHHH---HHHhcccccccCCCCHHHHhC
Confidence 222111111 11111 10112 23444444 4677777776 999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=352.35 Aligned_cols=252 Identities=21% Similarity=0.307 Sum_probs=197.2
Q ss_pred hCcCcCCcccccCCcEEEEEEECC-C-------cEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCe
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDN-H-------QYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGE 584 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~ 584 (834)
++|...+.||+|+||+||+|.... + ..||+|.+.... ....+.|.+|+.++++++|||||++++++.+.+.
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-RNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG-GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 456667889999999999998643 2 469999986432 3345789999999999999999999999999999
Q ss_pred EEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCC-------
Q 003278 585 MLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMN------- 657 (834)
Q Consensus 585 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~------- 657 (834)
.++||||+++|+|.+++.... ..+++..+..|+.|++.||+|||+ .+|+||||||+|||++.++.
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~ 158 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNK-----NCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPP 158 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTG-----GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred CEEEEECCCCCCHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCcccccccc
Confidence 999999999999999997643 237888999999999999999997 68999999999999998887
Q ss_pred -ceEeeeeeccccccCCCCCcccccCccccccccCccchhcccc-CCCCccCcchhhHHHHHHHHhCCCccCCCCCchhH
Q 003278 658 -PRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIES-GEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLL 735 (834)
Q Consensus 658 -~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~ 735 (834)
+||+|||++..... .....||+.|+|||++.+ ..++.++|||||||++|||+||..|+.........
T Consensus 159 ~~kl~Dfg~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~ 227 (289)
T 4fvq_A 159 FIKLSDPGISITVLP-----------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK 227 (289)
T ss_dssp EEEECCCCSCTTTSC-----------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred eeeeccCcccccccC-----------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH
Confidence 99999999864321 123568999999999987 67899999999999999999976665433332221
Q ss_pred HHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCcc
Q 003278 736 VKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDKR 800 (834)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~~ 800 (834)
.. .......... .. .. .+.+++.+||+.||++|||+.+|++.|+.+-..
T Consensus 228 ~~----~~~~~~~~~~--------~~-~~---~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 228 LQ----FYEDRHQLPA--------PK-AA---ELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp HH----HHHTTCCCCC--------CS-SC---TTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred HH----HhhccCCCCC--------CC-CH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 11 1111111111 11 11 244566699999999999999999999877553
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=360.17 Aligned_cols=252 Identities=21% Similarity=0.333 Sum_probs=196.6
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhC-CCCceeeEeeeEEeCCEEEEEEEc
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHL-RHRNLVRLRGWCVHEDQLLLVYDY 189 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey 189 (834)
++|+..+.||+|+||.||+|..+.+|+.||||++..... .+.+|+.++.++ +|||||++++++.+.+..|+||||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 97 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 97 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence 568889999999999999999999999999999975432 234688888887 799999999999999999999999
Q ss_pred cCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCC----CceEEeeccch
Q 003278 190 MPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQ----YNARLGDFGLA 265 (834)
Q Consensus 190 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~----~~~kl~DFGla 265 (834)
+++|+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||+.++ +.+||+|||++
T Consensus 98 ~~gg~L~~~i~~~-------~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a 167 (342)
T 2qr7_A 98 MKGGELLDKILRQ-------KFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFA 167 (342)
T ss_dssp CCSCBHHHHHHTC-------TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred CCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence 9999999998643 3589999999999999999999996 99999999999998543 34999999999
Q ss_pred hhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccch
Q 003278 266 RWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQII 345 (834)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~ 345 (834)
+.+.... ......+||+.|+|||.+... .++.++|||||||++|||+||+.||..........
T Consensus 168 ~~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~ 230 (342)
T 2qr7_A 168 KQLRAEN----------------GLLMTPCYTANFVAPEVLERQ-GYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEE 230 (342)
T ss_dssp EECBCTT----------------CCBCCSSCCSSCCCHHHHHHH-HHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHH
T ss_pred ccCcCCC----------------CceeccCCCccccCHHHhcCC-CCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHH
Confidence 8543210 113345799999999988653 46889999999999999999999997533222222
Q ss_pred HHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 346 LLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 346 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
+. ..+ ..+..... .. .. ... ...+.+|+..||+.||.+||++.++++.
T Consensus 231 ~~---~~i-~~~~~~~~-~~-~~-~~~----s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 231 IL---ARI-GSGKFSLS-GG-YW-NSV----SDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp HH---HHH-HHCCCCCC-ST-TT-TTS----CHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HH---HHH-ccCCcccC-cc-cc-ccC----CHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 22 221 12221100 00 00 011 1457889999999999999999998763
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=353.70 Aligned_cols=250 Identities=22% Similarity=0.391 Sum_probs=202.9
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc---ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK---GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLV 186 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 186 (834)
.++|...+.||+|+||.||+|.+..+++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 35688899999999999999999989999999998653 234567789999999999999999999999999999999
Q ss_pred EEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchh
Q 003278 187 YDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLAR 266 (834)
Q Consensus 187 ~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~ 266 (834)
|||+++++|.+++... ..+++..+..|+.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 120 ~e~~~~~~L~~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 189 (335)
T 2owb_A 120 LELCRRRSLLELHKRR-------KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLAT 189 (335)
T ss_dssp ECCCTTCBHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EecCCCCCHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCce
Confidence 9999999999988542 3589999999999999999999996 99999999999999999999999999997
Q ss_pred hhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchH
Q 003278 267 WLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIIL 346 (834)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l 346 (834)
.+.... .......||+.|+|||.+... .++.++|||||||++|||+||+.||.....
T Consensus 190 ~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~------ 246 (335)
T 2owb_A 190 KVEYDG----------------ERKKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCL------ 246 (335)
T ss_dssp ECCSTT----------------CCBCCCCSCCSSCCHHHHHTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSH------
T ss_pred ecccCc----------------ccccccCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHHHCcCCCCCCCH------
Confidence 542110 012345699999999998654 578999999999999999999999864321
Q ss_pred HHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 347 LDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 347 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
......... +.. .+. ...+ ..+.+++..||+.||.+||++.++++.
T Consensus 247 ~~~~~~~~~-~~~------~~~-~~~~----~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 247 KETYLRIKK-NEY------SIP-KHIN----PVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp HHHHHHHHH-TCC------CCC-TTSC----HHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred HHHHHHHhc-CCC------CCC-ccCC----HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111111111 110 111 1111 357789999999999999999999874
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=370.16 Aligned_cols=259 Identities=16% Similarity=0.175 Sum_probs=199.6
Q ss_pred HHHHHHhhCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCC--hhHHHHHHHHHHHHHhccCCCceeEEEEEeeC
Q 003278 506 KEIISATNNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKC--PALRTRFSNELQNLARLRHRNLVQLCGWCTEQ 582 (834)
Q Consensus 506 ~el~~at~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~ 582 (834)
.++....++|...+.||+|+||.||+|... ++..||+|++..... ....+.+.+|+.+++.++|||||++++++.+.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 344455688999999999999999999975 478999999853110 01123478899999999999999999999999
Q ss_pred CeEEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEee
Q 003278 583 GEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGS 662 (834)
Q Consensus 583 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~D 662 (834)
+..++||||+++|+|.+++... .+++.....++.|++.||+|||+ .+||||||||+||||+.++.+||+|
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~~-------~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~D 211 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSNY-------DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLAD 211 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECC
T ss_pred CEEEEEEeCCCCCcHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEec
Confidence 9999999999999999998643 27788888999999999999997 6999999999999999999999999
Q ss_pred eeeccccccCCCCCcccccCccccccccCccchhccccCC----CCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHH
Q 003278 663 FALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGE----ATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKR 738 (834)
Q Consensus 663 fGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~----~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~ 738 (834)
||+++.+.... .....+.+||+.|||||++.+.. ++.++|||||||++|||+||+.||......... ..
T Consensus 212 FG~a~~~~~~~------~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~-~~ 284 (410)
T 3v8s_A 212 FGTCMKMNKEG------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY-SK 284 (410)
T ss_dssp CTTCEECCTTS------EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-HH
T ss_pred cceeEeeccCC------cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHH-HH
Confidence 99997654321 11123568999999999997655 889999999999999999999999754433222 22
Q ss_pred HHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCC--CCChhHHHH
Q 003278 739 VHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPEL--RPSMRQILS 792 (834)
Q Consensus 739 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~--RPtm~~v~~ 792 (834)
+...... .... + .... ..++. .++.+|+..+|.+ ||++.||.+
T Consensus 285 i~~~~~~-~~~p---~---~~~~-s~~~~---~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 285 IMNHKNS-LTFP---D---DNDI-SKEAK---NLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp HHTHHHH-CCCC---T---TCCC-CHHHH---HHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred HHhcccc-ccCC---C---cccc-cHHHH---HHHHHHccChhhhCCCCCHHHHhc
Confidence 2111100 0000 0 0111 23444 4455899988988 999999986
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=346.25 Aligned_cols=266 Identities=15% Similarity=0.180 Sum_probs=202.6
Q ss_pred hhCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEE-eeCCeEEEEE
Q 003278 512 TNNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWC-TEQGEMLVIY 589 (834)
Q Consensus 512 t~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~-~~~~~~~lv~ 589 (834)
.++|...+.||+|+||.||+|.. .+++.||||.+...... +.+.+|+.++.+++|+|++..++++ .+.+..++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC---CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch---hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 45788888999999999999996 67889999998654332 3588999999999999988777665 5677889999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceee---cCCCCceEeeeeec
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITL---DPDMNPRLGSFALA 666 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILl---d~~~~~ki~DfGla 666 (834)
||+ +++|.+++..... .+++..+..++.|++.||+|||+ .+|+||||||+|||+ ++++.+||+|||++
T Consensus 85 e~~-~~~L~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 155 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFCSR-----KFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155 (296)
T ss_dssp ECC-CCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred Eec-CCCHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCc
Confidence 999 9999999874332 48899999999999999999997 699999999999999 48899999999999
Q ss_pred cccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCc--hhHHHHHHHHHh
Q 003278 667 EFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPE--GLLVKRVHEFEA 744 (834)
Q Consensus 667 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~--~~~~~~~~~~~~ 744 (834)
+....................||+.|+|||++.+..++.++|||||||++|||+||+.||...... ......+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (296)
T 3uzp_A 156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 235 (296)
T ss_dssp EECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc
Confidence 876543221111111234568999999999999999999999999999999999999999753221 112222221111
Q ss_pred hcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCc
Q 003278 745 RKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDK 799 (834)
Q Consensus 745 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~ 799 (834)
. .+.. .+...++ + .+.+++.+||+.||++|||+.+|++.|+.+..
T Consensus 236 ~-~~~~-----~~~~~~~-~---~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 280 (296)
T 3uzp_A 236 S-TPIE-----VLCKGYP-S---EFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp H-SCHH-----HHTTTSC-H---HHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred C-CchH-----HHHhhCC-H---HHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHH
Confidence 1 1110 0111222 2 35556669999999999999999999976543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=350.34 Aligned_cols=257 Identities=21% Similarity=0.334 Sum_probs=188.7
Q ss_pred hcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC-hh-hHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEE
Q 003278 109 GSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG-ER-FEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLV 186 (834)
Q Consensus 109 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~-~~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 186 (834)
..++|+..+.||+|+||.||+|....+|+.||||++.... .. ..+.+.++...++.++||||+++++++.+.+..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 3467899999999999999999998999999999986542 22 233444555668889999999999999999999999
Q ss_pred EEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchh
Q 003278 187 YDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLAR 266 (834)
Q Consensus 187 ~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~ 266 (834)
|||++ |+|.+++.... .....+++..+..|+.|++.||.|||+. .+|+||||||+|||++.++.+||+|||+++
T Consensus 85 ~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVI---DKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISG 158 (290)
T ss_dssp EECCS-EEHHHHHHHHH---HTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC----
T ss_pred Eehhc-cchHHHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCcc
Confidence 99997 58887775421 1235799999999999999999999984 389999999999999999999999999998
Q ss_pred hhhhhhhhhhhcccccccccccccceeeeccccCCCcccc---ccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCcc
Q 003278 267 WLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESF---QKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQ 343 (834)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~---~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~ 343 (834)
...... ......||+.|+|||.+ ..+..++.++|||||||++|||+||+.||......
T Consensus 159 ~~~~~~-----------------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-- 219 (290)
T 3fme_A 159 YLVDDV-----------------AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP-- 219 (290)
T ss_dssp ----------------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH--
T ss_pred cccccc-----------------cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch--
Confidence 653321 12233599999999997 24456789999999999999999999998642211
Q ss_pred chHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 344 IILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 344 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
. ........... +......+ ...+.+++..||+.||.+||++.++++
T Consensus 220 --~-~~~~~~~~~~~------~~~~~~~~----~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 220 --F-QQLKQVVEEPS------PQLPADKF----SAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp --H-HHHHHHHHSCC------CCCCTTTS----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --H-HHHHHHhccCC------CCcccccC----CHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 1 11111111111 11111111 145788999999999999999999976
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=361.60 Aligned_cols=264 Identities=20% Similarity=0.253 Sum_probs=201.9
Q ss_pred hCcCcCCcccccCCcEEEEEEE-----CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEe--eCCeE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-----DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCT--EQGEM 585 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-----~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~--~~~~~ 585 (834)
++|...+.||+|+||.||+|.+ .++..||||++... .....+.|.+|++++++++||||+++++++. +....
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC-CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 4566778899999999999984 45789999998754 3444577999999999999999999999886 45678
Q ss_pred EEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeee
Q 003278 586 LVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFAL 665 (834)
Q Consensus 586 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGl 665 (834)
++||||+++|+|.+++.... ..+++..++.|+.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 173 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHR-----ARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGL 173 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHG-----GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGG
T ss_pred EEEEeecCCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEccccc
Confidence 99999999999999987532 248899999999999999999997 6999999999999999999999999999
Q ss_pred ccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchh----------H
Q 003278 666 AEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGL----------L 735 (834)
Q Consensus 666 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~----------~ 735 (834)
+........ .........||+.|+|||++.+..++.++|||||||++|||+||+.|+........ .
T Consensus 174 ~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 249 (327)
T 3lxl_A 174 AKLLPLDKD----YYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPA 249 (327)
T ss_dssp CEECCTTCS----EEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCH
T ss_pred ceecccCCc----cceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhccccccccc
Confidence 987543221 11112335688999999999999999999999999999999999999753221100 0
Q ss_pred HHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCc
Q 003278 736 VKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDK 799 (834)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~ 799 (834)
............ .......+ ++ .+.+++.+||+.||++|||+.+|++.|+.+..
T Consensus 250 ~~~~~~~~~~~~------~~~~~~~~-~~---~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 250 LSRLLELLEEGQ------RLPAPPAC-PA---EVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp HHHHHHHHHTTC------CCCCCTTC-CH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred HHHHHHHhhccc------CCCCCCcc-cH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 000111000000 00111111 23 35556668999999999999999999987643
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=360.36 Aligned_cols=251 Identities=16% Similarity=0.289 Sum_probs=191.0
Q ss_pred hCcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCC-ChhHHHHHHHHHHHHHhccC--CCceeEEEEEeeCCeEEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSK-CPALRTRFSNELQNLARLRH--RNLVQLCGWCTEQGEMLVIY 589 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~-~~~~~~~f~~E~~~l~~l~H--pNiv~l~g~~~~~~~~~lv~ 589 (834)
+.|...+.||+|+||.||++...+++.||||++.... .....+.|.+|+.+|.+++| ||||++++++.+.+..++||
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 88 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 88 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence 3466778899999999999998889999999987543 33455789999999999987 99999999999999999999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccc
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFL 669 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~ 669 (834)
| +.+|+|.+++.... .+++..+..|+.|++.||+|||+ .+|+||||||+|||++ ++.+||+|||+++..
T Consensus 89 e-~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 89 E-CGNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp C-CCSEEHHHHHHHSC------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred e-CCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 9 57889999987542 47888999999999999999997 6899999999999997 577999999999865
Q ss_pred ccCCCCCcccccCccccccccCccchhcccc-----------CCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHH
Q 003278 670 TRNDHGHRKATSGNRSVRGIFGYMSPEYIES-----------GEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKR 738 (834)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-----------~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~ 738 (834)
..... ........||+.|+|||++.+ +.++.++|||||||++|||+||+.||........ .
T Consensus 158 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~ 229 (343)
T 3dbq_A 158 QPDTT-----SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS---K 229 (343)
T ss_dssp -----------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH---H
T ss_pred Ccccc-----cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHH---H
Confidence 43211 111234579999999999865 6789999999999999999999999864332211 1
Q ss_pred HHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 739 VHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 739 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
......... .. ... ..... .+..++.+||+.||++|||+.++++
T Consensus 230 ~~~~~~~~~---~~---~~~-~~~~~---~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 230 LHAIIDPNH---EI---EFP-DIPEK---DLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp HHHHHCTTS---CC---CCC-CCSCH---HHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHhcCCc---cc---CCc-ccCCH---HHHHHHHHHcCCChhHCCCHHHHHh
Confidence 111111000 00 011 11123 3445666899999999999999985
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=372.64 Aligned_cols=211 Identities=21% Similarity=0.309 Sum_probs=157.0
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeC-----CE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHE-----DQ 182 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-----~~ 182 (834)
.++|+..+.||+|+||.||+|++..+|+.||||++... .....+.+.+|+.+|++++|||||+++++|... +.
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 36799999999999999999999999999999998653 334557799999999999999999999999544 46
Q ss_pred EEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeec
Q 003278 183 LLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDF 262 (834)
Q Consensus 183 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DF 262 (834)
+|+||||+ +|+|.+++... ..+++..+..|+.||+.||.|||+. +||||||||+||||+.++.+||+||
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DF 200 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTP-------VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDF 200 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSS-------CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCC
T ss_pred EEEEEecc-ccchhhhcccC-------CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeeccc
Confidence 99999998 57898888542 4689999999999999999999996 9999999999999999999999999
Q ss_pred cchhhhhhhhhhhhhc----c-------cccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhC
Q 003278 263 GLARWLEHELQYQMRT----S-------SARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSG 331 (834)
Q Consensus 263 Gla~~~~~~~~~~~~~----~-------~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG 331 (834)
|+|+.+.......... . ............+..+||++|+|||++..+..++.++|||||||+||||+||
T Consensus 201 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 201 GLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 9998754221000000 0 0000000001235567999999999876666789999999999999999994
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=355.33 Aligned_cols=259 Identities=26% Similarity=0.436 Sum_probs=197.9
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCC----CeEEEEEEeccc-ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSD----GTVVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLL 184 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~----g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 184 (834)
.++|...+.||+|+||.||+|.+..+ +..||||.+... .......|.+|+.++.+++||||+++++++...+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 35677788999999999999987544 346999998754 3345567999999999999999999999999999999
Q ss_pred EEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccc
Q 003278 185 LVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGL 264 (834)
Q Consensus 185 lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGl 264 (834)
+||||+++|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 123 lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 193 (333)
T 1mqb_A 123 IITEYMENGALDKFLREK------DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGL 193 (333)
T ss_dssp EEEECCTTEEHHHHHHHT------TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred EEEeCCCCCcHHHHHHhC------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCc
Confidence 999999999999999653 24689999999999999999999996 999999999999999999999999999
Q ss_pred hhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCcc
Q 003278 265 ARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQ 343 (834)
Q Consensus 265 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~ 343 (834)
++.+....... .......||+.|+|||.+... .++.++|||||||++|||+| |+.||.....
T Consensus 194 ~~~~~~~~~~~-------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~--- 256 (333)
T 1mqb_A 194 SRVLEDDPEAT-------------YTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSN--- 256 (333)
T ss_dssp ------------------------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---
T ss_pred chhhccccccc-------------cccCCCCccccccCchhcccC-CCCchhhhHHHHHHHHHHHcCCCCCcccCCH---
Confidence 98654321100 012233468899999998654 67999999999999999999 9999854321
Q ss_pred chHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 344 IILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 344 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
..+ ...+ ..+.... .. .. ....+.+++..||+.||.+||++.+|++.|+..
T Consensus 257 ~~~---~~~~-~~~~~~~-----~~-~~----~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 257 HEV---MKAI-NDGFRLP-----TP-MD----CPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307 (333)
T ss_dssp HHH---HHHH-HTTCCCC-----CC-TT----CBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHH---HHHH-HCCCcCC-----Cc-cc----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111 1111 1121110 00 11 124688999999999999999999999998764
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=360.64 Aligned_cols=250 Identities=22% Similarity=0.288 Sum_probs=195.8
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCC--ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSK--CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIY 589 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~ 589 (834)
++|...+.||+|+||.||++... ++..||+|.+.... .....+.+.+|+.+|++++|||||++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 46777889999999999999964 47889999986322 1122467889999999999999999999999999999999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccc
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFL 669 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~ 669 (834)
||+.+|+|..++.... .+++..+..++.|++.||+|||+ .+|+||||||+||||+.++.+||+|||+++.+
T Consensus 95 e~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 165 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNV------HFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAML 165 (384)
T ss_dssp CCCTTEEHHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeec
Confidence 9999999999987532 38888999999999999999997 69999999999999999999999999999865
Q ss_pred ccCCCCCcccccCccccccccCccchhcccc---CCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhc
Q 003278 670 TRNDHGHRKATSGNRSVRGIFGYMSPEYIES---GEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARK 746 (834)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~---~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~ 746 (834)
... ....+.+||+.|||||++.. ..++.++|||||||++|||+||+.||........ ...........
T Consensus 166 ~~~--------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~-~~~~~~~~~~~ 236 (384)
T 4fr4_A 166 PRE--------TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS-KEIVHTFETTV 236 (384)
T ss_dssp CTT--------CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCH-HHHHHHHHHCC
T ss_pred cCC--------CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccH-HHHHHHHhhcc
Confidence 432 12345689999999999863 4589999999999999999999999964332211 11111111111
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCC-hhHHHH
Q 003278 747 RPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPS-MRQILS 792 (834)
Q Consensus 747 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPt-m~~v~~ 792 (834)
.. .+..++ . .+..++.+||+.||++||+ +.+|.+
T Consensus 237 ~~--------~p~~~s-~---~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 237 VT--------YPSAWS-Q---EMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp CC--------CCTTSC-H---HHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred cC--------CCCcCC-H---HHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 11 111222 2 3455566899999999998 676654
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=365.87 Aligned_cols=274 Identities=20% Similarity=0.250 Sum_probs=209.8
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC-hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCC--EEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG-ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHED--QLLLVY 187 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~--~~~lV~ 187 (834)
++|...++||+|+||.||+|.+..+|+.||||++.... ....+.+.+|+.++++++|||||++++++...+ ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 46888899999999999999999899999999987532 234567889999999999999999999998765 789999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEE----CCCCceEEeecc
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVML----DSQYNARLGDFG 263 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILl----d~~~~~kl~DFG 263 (834)
||+++|+|.+++..... ...+++..+..|+.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||
T Consensus 89 e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG 161 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSN----AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (396)
T ss_dssp CCCTTEEHHHHTTSGGG----TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred ecCCCCCHHHHHHhhhc----ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCC
Confidence 99999999999865421 23489999999999999999999996 99999999999999 778889999999
Q ss_pred chhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccC-------CCCCcccceeehhhHHHHHHhCCccCC
Q 003278 264 LARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKG-------SVATAKSDVFSFGIVVLEVVSGRRAVD 336 (834)
Q Consensus 264 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-------~~~~~ksDV~SfGvvl~ElltG~~p~~ 336 (834)
+++.+.... ......||+.|+|||.+... ..++.++|||||||++|||+||+.||.
T Consensus 162 ~a~~~~~~~-----------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~ 224 (396)
T 4eut_A 162 AARELEDDE-----------------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFR 224 (396)
T ss_dssp GCEECCCGG-----------------GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEE
T ss_pred CceEccCCC-----------------ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 998643221 12345699999999987531 246789999999999999999999996
Q ss_pred CCCCCccchHHHHHHHHhhcC---ccccc---c------cccc-CCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 337 LTYPDDQIILLDWIRRLSDEG---KVLQA---G------DNRL-SDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 337 ~~~~~~~~~l~~~~~~~~~~~---~~~~~---~------d~~l-~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
........ ...+....... ..... . ...+ ............+..+...||+.||++||++.++++
T Consensus 225 ~~~~~~~~--~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 225 PFEGPRRN--KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp CTTCTTTC--HHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred CCCcccch--HHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 43322211 11122222111 00000 0 0000 011223445567889999999999999999999999
Q ss_pred HhhcCCC
Q 003278 404 AVSGSYS 410 (834)
Q Consensus 404 ~l~~~~~ 410 (834)
.+.....
T Consensus 303 ~l~~il~ 309 (396)
T 4eut_A 303 ETSDILH 309 (396)
T ss_dssp HHHHHHT
T ss_pred HHHHHhh
Confidence 8876543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=361.34 Aligned_cols=257 Identities=24% Similarity=0.341 Sum_probs=201.2
Q ss_pred hcCCCCCCCeeeccCCeEEEEEEEC---CCCeEEEEEEecccC----hhhHHHHHHHHHHHHhC-CCCceeeEeeeEEeC
Q 003278 109 GSNGFDEDEVLGSGGFGKVYRAVLP---SDGTVVAVKCLAEKG----ERFEKTFAAELVAVAHL-RHRNLVRLRGWCVHE 180 (834)
Q Consensus 109 ~t~~f~~~~~LG~G~fG~Vy~~~~~---~~g~~vAvK~l~~~~----~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~ 180 (834)
..++|+..+.||+|+||.||+|+.. .+|+.||||++.... ....+.+.+|+.++.++ +||||+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 131 (355)
T 1vzo_A 52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 131 (355)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence 3467999999999999999999984 478999999986431 22345677899999999 699999999999999
Q ss_pred CEEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEe
Q 003278 181 DQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLG 260 (834)
Q Consensus 181 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~ 260 (834)
+..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+
T Consensus 132 ~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~ 201 (355)
T 1vzo_A 132 TKLHLILDYINGGELFTHLSQR-------ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLT 201 (355)
T ss_dssp TEEEEEECCCCSCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEES
T ss_pred ceEEEEeecCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEe
Confidence 9999999999999999999653 3589999999999999999999986 99999999999999999999999
Q ss_pred eccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccC-CCCCcccceeehhhHHHHHHhCCccCCCCC
Q 003278 261 DFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKG-SVATAKSDVFSFGIVVLEVVSGRRAVDLTY 339 (834)
Q Consensus 261 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~ksDV~SfGvvl~ElltG~~p~~~~~ 339 (834)
|||+++.+..... .......||+.|+|||.+..+ ..++.++|||||||++|||+||+.||....
T Consensus 202 DfG~a~~~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 266 (355)
T 1vzo_A 202 DFGLSKEFVADET---------------ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG 266 (355)
T ss_dssp CSSEEEECCGGGG---------------GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT
T ss_pred eCCCCeecccCCC---------------CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCC
Confidence 9999986432211 012345699999999998743 346889999999999999999999997543
Q ss_pred CCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----chhhHHHH
Q 003278 340 PDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRP-----SMKWVIEA 404 (834)
Q Consensus 340 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~~V~~~ 404 (834)
.... ............ +... ... ...+.+|+..||+.||.+|| ++.++++.
T Consensus 267 ~~~~--~~~~~~~~~~~~-------~~~~-~~~----~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 267 EKNS--QAEISRRILKSE-------PPYP-QEM----SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp SCCC--HHHHHHHHHHCC-------CCCC-TTS----CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred ccch--HHHHHHHHhccC-------CCCC-ccc----CHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 3221 222222222110 1111 111 24577899999999999999 88888765
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=344.75 Aligned_cols=255 Identities=21% Similarity=0.344 Sum_probs=203.2
Q ss_pred hCcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEecc
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYS 592 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~ 592 (834)
++|...+.||+|+||.||+|...++..||||.+...... .+.|.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC--HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 356667889999999999999988889999998754432 367899999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccC
Q 003278 593 ATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRN 672 (834)
Q Consensus 593 ~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~ 672 (834)
++++|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 86 ~~~~L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 86 EHGCLSDYLRTQR-----GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp TTCBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred CCCcHHHHHhhCc-----ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 9999999997543 247889999999999999999997 68999999999999999999999999999765321
Q ss_pred CCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCcccc
Q 003278 673 DHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRPLAE 751 (834)
Q Consensus 673 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
. ........||+.|+|||++.+..++.++||||||+++|||+| |+.|+....... ....+ ......
T Consensus 158 ~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-~~~~i---~~~~~~--- 224 (267)
T 3t9t_A 158 Q------YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-VVEDI---STGFRL--- 224 (267)
T ss_dssp H------HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHHHH---HTTCCC---
T ss_pred c------ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH-HHHHH---hcCCcC---
Confidence 1 111223467889999999999999999999999999999999 888886433221 11111 111110
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCC
Q 003278 752 LVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGND 798 (834)
Q Consensus 752 ~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~ 798 (834)
...... .. .+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 225 ----~~~~~~-~~---~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 225 ----YKPRLA-ST---HVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp ----CCCTTS-CH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCccC-cH---HHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 011111 23 3455666999999999999999999997654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=362.24 Aligned_cols=251 Identities=14% Similarity=0.197 Sum_probs=198.7
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
+.|...+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.+|++++|||||++++++.+.+..++||||
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc-hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 56778889999999999999974 58899999986543 33446789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecC--CCCceEeeeeecccc
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDP--DMNPRLGSFALAEFL 669 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~--~~~~ki~DfGla~~~ 669 (834)
+++|+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++.+
T Consensus 130 ~~gg~L~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~ 201 (387)
T 1kob_A 130 LSGGELFDRIAAED-----YKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 201 (387)
T ss_dssp CCCCBHHHHTTCTT-----CCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred CCCCcHHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceec
Confidence 99999999886532 248899999999999999999997 69999999999999984 577999999999865
Q ss_pred ccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcc
Q 003278 670 TRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPL 749 (834)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
.... ......||+.|+|||++.+..++.++|||||||++|||+||..||....... ....+ .......
T Consensus 202 ~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-~~~~i---~~~~~~~ 269 (387)
T 1kob_A 202 NPDE--------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-TLQNV---KRCDWEF 269 (387)
T ss_dssp CTTS--------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHH---HHCCCCC
T ss_pred CCCc--------ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH-HHHHH---HhCCCCC
Confidence 4321 1223579999999999999999999999999999999999999987533221 11111 1111111
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 750 AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 750 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
+.......+ . .+..++.+||+.||++|||+.++++
T Consensus 270 ----~~~~~~~~s-~---~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 270 ----DEDAFSSVS-P---EAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp ----CSSTTTTSC-H---HHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ----CccccccCC-H---HHHHHHHHHcCCChhHCcCHHHHhh
Confidence 111111122 2 3445666999999999999999986
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=362.42 Aligned_cols=258 Identities=25% Similarity=0.385 Sum_probs=190.8
Q ss_pred CCCCCeeeccCCeEEEEEEECCC---CeEEEEEEeccc-ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEe-CCEEEEEE
Q 003278 113 FDEDEVLGSGGFGKVYRAVLPSD---GTVVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNLVRLRGWCVH-EDQLLLVY 187 (834)
Q Consensus 113 f~~~~~LG~G~fG~Vy~~~~~~~---g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-~~~~~lV~ 187 (834)
|...+.||+|+||.||+|.+..+ +..||||.+... .....+.|.+|+.++++++|||||+++++|.. .+..++||
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~ 170 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 170 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence 56678999999999999987433 246899998653 33456789999999999999999999999765 45789999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
||+++|+|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 171 e~~~~g~L~~~l~~~------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 241 (373)
T 3c1x_A 171 PYMKHGDLRNFIRNE------THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARD 241 (373)
T ss_dssp ECCTTCBHHHHHHCT------TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred ECCCCCCHHHHHhhc------ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccc
Confidence 999999999999653 24578999999999999999999996 999999999999999999999999999986
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccchH
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQIIL 346 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l 346 (834)
+....... ....+...||+.|+|||.+... .++.++|||||||++|||+| |..|+......+ +
T Consensus 242 ~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~ 305 (373)
T 3c1x_A 242 MYDKEFDS------------VHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---I 305 (373)
T ss_dssp ----------------------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---H
T ss_pred cccccccc------------ccccCCCCCcccccChHHhcCC-CCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---H
Confidence 53321100 0112345688999999998755 67999999999999999999 566665432221 1
Q ss_pred HHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcCC
Q 003278 347 LDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGSY 409 (834)
Q Consensus 347 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~~ 409 (834)
...+ ..+.... .+ ... ...+.+++..||+.||.+||++.++++.|+...
T Consensus 306 ~~~~----~~~~~~~--~p----~~~----~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~ 354 (373)
T 3c1x_A 306 TVYL----LQGRRLL--QP----EYC----PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 354 (373)
T ss_dssp HHHH----HTTCCCC--CC----TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHH----HcCCCCC--CC----CCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1111 1121111 01 111 246889999999999999999999999987653
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=361.68 Aligned_cols=267 Identities=16% Similarity=0.163 Sum_probs=202.6
Q ss_pred hCcCcCCcccccCCcEEEEEEECC---------CcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCcee---------
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDN---------HQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQ--------- 574 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~---------~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~--------- 574 (834)
++|...+.||+|+||.||+|.... ++.||||.+... +.+.+|+.++.+++|||||+
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 456677889999999999999764 788999998643 35788999999999999998
Q ss_pred ------EEEEEee-CCeEEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeeccccc
Q 003278 575 ------LCGWCTE-QGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITS 647 (834)
Q Consensus 575 ------l~g~~~~-~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~ 647 (834)
+++++.. .+..++||||+ +++|.+++.... ...+++..++.|+.|++.||+|||+ .+|+||||||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp 187 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP----KHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTA 187 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG----GGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCG
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC----cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCH
Confidence 6788776 67899999999 999999997642 1348999999999999999999997 6999999999
Q ss_pred CceeecCCC--CceEeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCc
Q 003278 648 SAITLDPDM--NPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMA 725 (834)
Q Consensus 648 ~NILld~~~--~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p 725 (834)
+|||++.++ .+||+|||+++.+..................||+.|+|||++.+..++.++|||||||+||||+||+.|
T Consensus 188 ~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 267 (352)
T 2jii_A 188 ENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267 (352)
T ss_dssp GGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred HHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 999999998 899999999987644321111111122345899999999999999999999999999999999999999
Q ss_pred cCCCCCchh-HHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCc
Q 003278 726 VDFRLPEGL-LVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDK 799 (834)
Q Consensus 726 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~ 799 (834)
|....+... +......+... ...+.+........+.+ +.+++.+||+.||++|||+.+|++.|+.+.+
T Consensus 268 f~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~---l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 336 (352)
T 2jii_A 268 WTNCLPNTEDIMKQKQKFVDK---PGPFVGPCGHWIRPSET---LQKYLKVVMALTYEEKPPYAMLRNNLEALLQ 336 (352)
T ss_dssp TGGGTTCHHHHHHHHHHHHHS---CCCEECTTSCEECCCHH---HHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred cccCCcCHHHHHHHHHhccCC---hhhhhhhccccCCCcHH---HHHHHHHHHhCChhhCCCHHHHHHHHHHHHH
Confidence 976543322 22222222111 11222211111111233 4455568999999999999999999976544
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=365.42 Aligned_cols=250 Identities=16% Similarity=0.277 Sum_probs=191.9
Q ss_pred CcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCC-ChhHHHHHHHHHHHHHhcc--CCCceeEEEEEeeCCeEEEEEe
Q 003278 514 NFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSK-CPALRTRFSNELQNLARLR--HRNLVQLCGWCTEQGEMLVIYD 590 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~-~~~~~~~f~~E~~~l~~l~--HpNiv~l~g~~~~~~~~~lv~E 590 (834)
.|...+.||+|+||.||+|...+++.||||.+.... .....+.|.+|+.+|.+++ |||||++++++...+..++|||
T Consensus 57 ~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E 136 (390)
T 2zmd_A 57 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME 136 (390)
T ss_dssp EEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred ceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe
Confidence 467778899999999999998889999999987543 3445678999999999997 5999999999999999999999
Q ss_pred ccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccc
Q 003278 591 YSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLT 670 (834)
Q Consensus 591 y~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~ 670 (834)
+.+++|.+++.... .+++..+..|+.||+.||+|||+ .+|+||||||+|||++ ++.+||+|||+++.+.
T Consensus 137 -~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 137 -CGNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp -CCSEEHHHHHHHCS------SCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred -cCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 67889999987543 37888899999999999999996 6899999999999996 5789999999998654
Q ss_pred cCCCCCcccccCccccccccCccchhcccc-----------CCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHH
Q 003278 671 RNDHGHRKATSGNRSVRGIFGYMSPEYIES-----------GEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRV 739 (834)
Q Consensus 671 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-----------~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~ 739 (834)
.... .......+||+.|||||++.+ ..++.++|||||||+||||+||+.||......... .
T Consensus 206 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~---~ 277 (390)
T 2zmd_A 206 PDTT-----SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK---L 277 (390)
T ss_dssp -------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH---H
T ss_pred CCCc-----cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHH---H
Confidence 3211 111234579999999999865 46899999999999999999999999654322111 1
Q ss_pred HHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 740 HEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 740 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
........ . ..... .... .+..++.+||+.||++|||+.+|++
T Consensus 278 ~~~~~~~~---~---~~~~~-~~~~---~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 278 HAIIDPNH---E---IEFPD-IPEK---DLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp HHHHCTTS---C---CCCCC-CSCH---HHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhCccc---c---CCCCc-cchH---HHHHHHHHHcccChhhCCCHHHHhh
Confidence 11111100 0 00111 1123 3455666899999999999999985
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=357.87 Aligned_cols=255 Identities=20% Similarity=0.286 Sum_probs=190.3
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCC--ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCC----eE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSK--CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQG----EM 585 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~--~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~----~~ 585 (834)
+.|...+.||+|+||.||+|.. .+++.||||++.... .+.....|.+|+.++++++|||||++++++.... ..
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 4677778999999999999995 668899999987543 3445578999999999999999999999987643 34
Q ss_pred EEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeee
Q 003278 586 LVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFAL 665 (834)
Q Consensus 586 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGl 665 (834)
++||||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 92 ~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 162 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHTEG------PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGI 162 (311)
T ss_dssp EEEEECCCEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSC
T ss_pred EEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccC
Confidence 99999999999999987532 48899999999999999999997 6899999999999999999999999999
Q ss_pred ccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhh
Q 003278 666 AEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEAR 745 (834)
Q Consensus 666 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~ 745 (834)
++.+...... ........||+.|+|||++.+..++.++|||||||++|||+||+.||....+........ .
T Consensus 163 a~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~----~- 233 (311)
T 3ork_A 163 ARAIADSGNS----VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV----R- 233 (311)
T ss_dssp C----------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH----H-
T ss_pred cccccccccc----cccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh----c-
Confidence 9865432211 112234679999999999999999999999999999999999999997544332211111 1
Q ss_pred cCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 746 KRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 746 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
..... ........ .. .+..++.+||+.||++||+..+++.
T Consensus 234 ~~~~~---~~~~~~~~-~~---~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 234 EDPIP---PSARHEGL-SA---DLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp CCCCC---HHHHSTTC-CH---HHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred CCCCC---cccccCCC-CH---HHHHHHHHHHhcCHhhChhhHHHHH
Confidence 11110 00001111 12 3455666999999999998777653
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=344.75 Aligned_cols=249 Identities=22% Similarity=0.392 Sum_probs=202.1
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc---ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK---GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 187 (834)
++|...+.||+|+||.||+|....+++.||+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 4688889999999999999999989999999998653 2345677899999999999999999999999999999999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
||+++++|.+++... ..+++..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 95 e~~~~~~L~~~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 164 (294)
T 2rku_A 95 ELCRRRSLLELHKRR-------KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATK 164 (294)
T ss_dssp ECCTTCBHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCcee
Confidence 999999999988542 3589999999999999999999996 999999999999999999999999999975
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHH
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILL 347 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~ 347 (834)
..... .......||+.|+|||.+... .++.++|||||||++|||+||+.||......
T Consensus 165 ~~~~~----------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------ 221 (294)
T 2rku_A 165 VEYDG----------------ERKKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------ 221 (294)
T ss_dssp CCSTT----------------CCBCCCCSCCSSCCHHHHTTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------
T ss_pred cccCc----------------cccccccCCCCcCCcchhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------
Confidence 42110 012345699999999988654 5788999999999999999999998643211
Q ss_pred HHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 348 DWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 348 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
........ +.. .+. ... ...+.+++..||+.||.+||++.++++.
T Consensus 222 ~~~~~~~~-~~~------~~~-~~~----~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 222 ETYLRIKK-NEY------SIP-KHI----NPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp HHHHHHHT-TCC------CCC-TTS----CHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred HHHHHHhh-ccC------CCc-ccc----CHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11111111 110 111 111 1357889999999999999999999874
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=350.52 Aligned_cols=245 Identities=17% Similarity=0.229 Sum_probs=196.4
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCC--hhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKC--PALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIY 589 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~ 589 (834)
++|...+.||+|+||.||++... +++.||+|.+..... ....+.+.+|+.+++.++|||||++++++.+.+..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 46777889999999999999974 688999999864211 122456788999999999999999999999999999999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccc
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFL 669 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~ 669 (834)
||+++|+|.+++.... .+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 86 e~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~ 156 (318)
T 1fot_A 86 DYIEGGELFSLLRKSQ------RFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYV 156 (318)
T ss_dssp CCCCSCBHHHHHHHTS------SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred eCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceec
Confidence 9999999999997542 37888889999999999999996 69999999999999999999999999999764
Q ss_pred ccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcc
Q 003278 670 TRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPL 749 (834)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
... ..+.+||+.|||||++.+..++.++|||||||++|||+||+.||........ ...+. ....
T Consensus 157 ~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~i~---~~~~-- 220 (318)
T 1fot_A 157 PDV----------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-YEKIL---NAEL-- 220 (318)
T ss_dssp SSC----------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHH---HCCC--
T ss_pred CCc----------cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH-HHHHH---hCCC--
Confidence 321 2346899999999999999999999999999999999999999965432211 11111 1111
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----ChhHHHH
Q 003278 750 AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRP-----SMRQILS 792 (834)
Q Consensus 750 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RP-----tm~~v~~ 792 (834)
..+...+ .+ +..++.+|+..||++|| ++.+|++
T Consensus 221 ------~~p~~~~-~~---~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 221 ------RFPPFFN-ED---VKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp ------CCCTTSC-HH---HHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ------CCCCCCC-HH---HHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 1111222 33 44455589999999999 8888874
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=343.01 Aligned_cols=255 Identities=24% Similarity=0.366 Sum_probs=204.3
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEc
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDY 189 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 189 (834)
.++|...+.||+|+||.||+|.+. ++..||||.+..... ..+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 356888899999999999999994 788999999876432 346789999999999999999999999999999999999
Q ss_pred cCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhh
Q 003278 190 MPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLE 269 (834)
Q Consensus 190 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~ 269 (834)
+++|+|.+++.... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 85 ~~~~~L~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 155 (267)
T 3t9t_A 85 MEHGCLSDYLRTQR------GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVL 155 (267)
T ss_dssp CTTCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred CCCCcHHHHHhhCc------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccc
Confidence 99999999996542 4589999999999999999999996 99999999999999999999999999998653
Q ss_pred hhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccchHHH
Q 003278 270 HELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQIILLD 348 (834)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~ 348 (834)
..... ......||+.|+|||.+... .++.++|||||||++|||+| |+.|+..... . .
T Consensus 156 ~~~~~---------------~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~---~ 213 (267)
T 3t9t_A 156 DDQYT---------------SSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---S---E 213 (267)
T ss_dssp CHHHH---------------STTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---H---H
T ss_pred ccccc---------------ccccccccccccChhhhcCC-CccchhchhhhHHHHHHHhccCCCCCCCCCH---H---H
Confidence 32110 01223478899999998654 57899999999999999999 8988864321 1 1
Q ss_pred HHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 349 WIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 349 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
....+.. +... ..+ ... ...+.+++..||+.||.+||++.++++.|...
T Consensus 214 ~~~~i~~-~~~~--~~~----~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 214 VVEDIST-GFRL--YKP----RLA----STHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp HHHHHHT-TCCC--CCC----TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHhc-CCcC--CCC----ccC----cHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1111111 1110 001 111 24678899999999999999999999998764
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=342.50 Aligned_cols=254 Identities=19% Similarity=0.271 Sum_probs=200.5
Q ss_pred hhCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEe
Q 003278 512 TNNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYD 590 (834)
Q Consensus 512 t~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~E 590 (834)
.++|...+.||+|+||.||+|... +++.||||.+.........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 356777889999999999999975 6889999998755444556789999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccc
Q 003278 591 YSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLT 670 (834)
Q Consensus 591 y~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~ 670 (834)
|+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++....
T Consensus 86 ~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 156 (276)
T 2yex_A 86 YCSGGELFDRIEPD------IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFR 156 (276)
T ss_dssp CCTTEEGGGGSBTT------TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred ecCCCcHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccC
Confidence 99999999988543 248889999999999999999997 699999999999999999999999999997653
Q ss_pred cCCCCCcccccCccccccccCccchhccccCCC-CccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcc
Q 003278 671 RNDHGHRKATSGNRSVRGIFGYMSPEYIESGEA-TSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPL 749 (834)
Q Consensus 671 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
.... ........||+.|+|||++.+..+ +.++|||||||++|||+||+.||............ +.......
T Consensus 157 ~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~ 228 (276)
T 2yex_A 157 YNNR-----ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD---WKEKKTYL 228 (276)
T ss_dssp ETTE-----ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHH---HHTTCTTS
T ss_pred CCcc-----hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHH---hhhccccc
Confidence 3211 111234579999999999987775 77899999999999999999999754432222111 11111110
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 750 AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 750 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
.. ....+ . .+.+++.+||+.||++|||+.+|++
T Consensus 229 ~~------~~~~~-~---~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 229 NP------WKKID-S---APLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp TT------GGGSC-H---HHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred Cc------hhhcC-H---HHHHHHHHHCCCCchhCCCHHHHhc
Confidence 00 00111 2 3445666999999999999999975
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=364.50 Aligned_cols=270 Identities=17% Similarity=0.169 Sum_probs=205.6
Q ss_pred CcCcCCcccccCCcEEEEEEECC-CcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCC--eEEEEEe
Q 003278 514 NFSESQRVAEMDFGTAYQGFLDN-HQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQG--EMLVIYD 590 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~~~-~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~--~~~lv~E 590 (834)
.|...+.||+|+||+||+|.... +..||||++.........+.+.+|+++|++++|||||++++++.+.+ ..++|||
T Consensus 10 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e 89 (396)
T 4eut_A 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME 89 (396)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEC
T ss_pred ceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEe
Confidence 46667889999999999999754 88999999875443344577889999999999999999999998755 7899999
Q ss_pred ccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceee----cCCCCceEeeeeec
Q 003278 591 YSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITL----DPDMNPRLGSFALA 666 (834)
Q Consensus 591 y~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILl----d~~~~~ki~DfGla 666 (834)
|+++|+|.+++...... ..+++..+..|+.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||++
T Consensus 90 ~~~~g~L~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 90 FCPCGSLYTVLEEPSNA---YGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp CCTTEEHHHHTTSGGGT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred cCCCCCHHHHHHhhhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 99999999998754322 238899999999999999999997 689999999999999 78888999999999
Q ss_pred cccccCCCCCcccccCccccccccCccchhcccc--------CCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHH
Q 003278 667 EFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIES--------GEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKR 738 (834)
Q Consensus 667 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--------~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~ 738 (834)
+...... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||............
T Consensus 164 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~ 235 (396)
T 4eut_A 164 RELEDDE--------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235 (396)
T ss_dssp EECCCGG--------GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHH
T ss_pred eEccCCC--------ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHH
Confidence 8654321 1224579999999999865 56788999999999999999999999643322222222
Q ss_pred HHHHHhhcCccccc--c------------ccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCC
Q 003278 739 VHEFEARKRPLAEL--V------------DLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGND 798 (834)
Q Consensus 739 ~~~~~~~~~~~~~~--~------------d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~ 798 (834)
........ +...+ + +...........-..+..++.+||+.||++|||+.++++.|+.+-
T Consensus 236 ~~~~~~~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il 308 (396)
T 4eut_A 236 MYKIITGK-PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (396)
T ss_dssp HHHHHHSC-CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHH
T ss_pred HHHHhcCC-CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHh
Confidence 22222111 11000 0 001111223444455667778999999999999999999886543
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=360.28 Aligned_cols=275 Identities=23% Similarity=0.287 Sum_probs=190.8
Q ss_pred HHHHhhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCC-CCceeeEeeeEE----
Q 003278 104 AELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLR-HRNLVRLRGWCV---- 178 (834)
Q Consensus 104 ~el~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~---- 178 (834)
..+.....+|...++||+|+||.||+|.+..+|+.||||++........+.+.+|+.++.++. ||||+++++++.
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 100 (337)
T 3ll6_A 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKE 100 (337)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTT
T ss_pred ceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccc
Confidence 334455567999999999999999999998899999999987666666778999999999996 999999999994
Q ss_pred ----eCCEEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCC
Q 003278 179 ----HEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQ 254 (834)
Q Consensus 179 ----~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~ 254 (834)
.....++||||+. |+|.+++.... ...++++..+..|+.|++.||.|||+. .++|+||||||+|||++.+
T Consensus 101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~ivH~Dikp~NIl~~~~ 174 (337)
T 3ll6_A 101 ESDTGQAEFLLLTELCK-GQLVEFLKKME----SRGPLSCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQ 174 (337)
T ss_dssp TSTTSSEEEEEEEECCS-EEHHHHHHHHH----TTCSCCHHHHHHHHHHHHHHHHHHHTS-SSCCBCCCCCGGGCEECTT
T ss_pred ccccCCceEEEEEEecC-CCHHHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEEccCCcccEEECCC
Confidence 3345899999996 79988886421 234699999999999999999999986 1139999999999999999
Q ss_pred CceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccc--cCCCCCcccceeehhhHHHHHHhCC
Q 003278 255 YNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQ--KGSVATAKSDVFSFGIVVLEVVSGR 332 (834)
Q Consensus 255 ~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~--~~~~~~~ksDV~SfGvvl~ElltG~ 332 (834)
+.+||+|||+++.+........... ............||+.|+|||.+. .+..++.++|||||||++|||+||+
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~ 250 (337)
T 3ll6_A 175 GTIKLCDFGSATTISHYPDYSWSAQ----RRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250 (337)
T ss_dssp SCEEBCCCTTCBCCSSCC-----------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSS
T ss_pred CCEEEecCccceeccccCccccccc----ccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCC
Confidence 9999999999986543211100000 000001123456999999999873 3446788999999999999999999
Q ss_pred ccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 333 RAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 333 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
.||....... .. . +....... ... ...+..++..||+.||.+||++.++++.|...
T Consensus 251 ~p~~~~~~~~------~~----~-~~~~~~~~-----~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~ 306 (337)
T 3ll6_A 251 HPFEDGAKLR------IV----N-GKYSIPPH-----DTQ----YTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI 306 (337)
T ss_dssp CCC-----------------------CCCCTT-----CCS----SGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcchhHHH------hh----c-CcccCCcc-----ccc----chHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 9986421110 00 0 00000000 111 12367899999999999999999999998764
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=351.32 Aligned_cols=269 Identities=22% Similarity=0.374 Sum_probs=199.0
Q ss_pred HHHHhhcCCCCCCCeeeccCCeEEEEEEECC---CCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEE
Q 003278 104 AELYIGSNGFDEDEVLGSGGFGKVYRAVLPS---DGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCV 178 (834)
Q Consensus 104 ~el~~~t~~f~~~~~LG~G~fG~Vy~~~~~~---~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~ 178 (834)
.++....++|...+.||+|+||.||+|.+.. ++..||||.+... .....+.|.+|+.++++++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 3444566789999999999999999998754 4568999998643 3344577999999999999999999999998
Q ss_pred eCCE-----EEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECC
Q 003278 179 HEDQ-----LLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDS 253 (834)
Q Consensus 179 ~~~~-----~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~ 253 (834)
+.+. .++||||+++|+|.+++...... .....+++..+..|+.|+++||.|||+. +|+||||||+|||++.
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~ 182 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLE-TGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRD 182 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBT-TSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECT
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhh-cCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcC
Confidence 7653 59999999999999998543211 1235699999999999999999999985 9999999999999999
Q ss_pred CCceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CC
Q 003278 254 QYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GR 332 (834)
Q Consensus 254 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~ 332 (834)
++.+||+|||+++.+...... .......||+.|+|||.+... .++.++|||||||++|||+| |+
T Consensus 183 ~~~~kl~Dfg~~~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~ 247 (313)
T 3brb_A 183 DMTVCVADFGLSKKIYSGDYY--------------RQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGM 247 (313)
T ss_dssp TSCEEECSCSCC------------------------------CCGGGSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CCcEEEeecCcceeccccccc--------------CcccccCCCccccCchhhcCC-CccchhhhHHHHHHHHHHHhcCC
Confidence 999999999999865332110 012334578999999998654 67999999999999999999 88
Q ss_pred ccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 333 RAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 333 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
.|+...... .+...+ . .+..... . ... ...+.+++..||+.||.+||++.++++.|+..
T Consensus 248 ~p~~~~~~~---~~~~~~---~-~~~~~~~-----~-~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l 306 (313)
T 3brb_A 248 TPYPGVQNH---EMYDYL---L-HGHRLKQ-----P-EDC----LDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306 (313)
T ss_dssp CSSTTCCGG---GHHHHH---H-TTCCCCC-----B-TTC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCccCCHH---HHHHHH---H-cCCCCCC-----C-ccc----cHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 888643221 122211 1 1111110 0 111 24688999999999999999999999998764
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=366.96 Aligned_cols=215 Identities=23% Similarity=0.314 Sum_probs=169.9
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeC-----CE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHE-----DQ 182 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-----~~ 182 (834)
.++|...+.||+|+||.||+|++..+|+.||||++... .....+.+.+|+.+|++++|||||++++++... +.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 36799999999999999999999999999999998653 334557899999999999999999999999876 57
Q ss_pred EEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeec
Q 003278 183 LLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDF 262 (834)
Q Consensus 183 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DF 262 (834)
.|+||||+. |+|.+++... ..+++..+..|+.||++||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~-------~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DF 173 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP-------IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDF 173 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred EEEEEecCC-cCHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccC
Confidence 999999986 6999998542 4689999999999999999999996 9999999999999999999999999
Q ss_pred cchhhhhhhhhhhhhccc------ccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccC
Q 003278 263 GLARWLEHELQYQMRTSS------ARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAV 335 (834)
Q Consensus 263 Gla~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~ 335 (834)
|+|+.............. ...........+..+||++|+|||.+..+..++.++|||||||++|||+||..|+
T Consensus 174 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 174 GLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp TTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred CCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 999876433211000000 0000000012356789999999998766667899999999999999999865554
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=354.67 Aligned_cols=266 Identities=25% Similarity=0.383 Sum_probs=206.0
Q ss_pred hcCCCCCCCeeeccCCeEEEEEEEC-------CCCeEEEEEEeccc-ChhhHHHHHHHHHHHHhC-CCCceeeEeeeEEe
Q 003278 109 GSNGFDEDEVLGSGGFGKVYRAVLP-------SDGTVVAVKCLAEK-GERFEKTFAAELVAVAHL-RHRNLVRLRGWCVH 179 (834)
Q Consensus 109 ~t~~f~~~~~LG~G~fG~Vy~~~~~-------~~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~ 179 (834)
..++|...+.||+|+||.||+|.+. .++..||||++... .....+.+.+|+.+++++ +||||++++++|..
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 4567899999999999999999975 35778999998754 334557799999999999 99999999999999
Q ss_pred CCEEEEEEEccCCCCHhHHHhcCCCcc---------ccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceE
Q 003278 180 EDQLLLVYDYMPNRSLDRVLFRRPENL---------EAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVM 250 (834)
Q Consensus 180 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~---------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NIL 250 (834)
.+..++||||+++|+|.+++....... .....+++..+..++.|++.||.|||+. +|+||||||+|||
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEE
Confidence 999999999999999999997643210 0123589999999999999999999996 9999999999999
Q ss_pred ECCCCceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh
Q 003278 251 LDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS 330 (834)
Q Consensus 251 ld~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt 330 (834)
++.++.+||+|||+++.+..... ........||+.|+|||.+... .++.++|||||||++|||+|
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~--------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt 254 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDY--------------YKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFT 254 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSS--------------EECCSCCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHT
T ss_pred EcCCCCEEEcccccccccccccc--------------ccccCCCCcccceeChHHhcCC-CcChHHHHHHHHHHHHHHHh
Confidence 99999999999999975432210 0112334578999999988654 57899999999999999999
Q ss_pred -CCccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcCC
Q 003278 331 -GRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGSY 409 (834)
Q Consensus 331 -G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~~ 409 (834)
|+.|+..... ..+. ..+ ..+.... .. ... ...+.+++..||+.||.+||++.++++.|+...
T Consensus 255 ~g~~p~~~~~~---~~~~---~~~-~~~~~~~-----~~-~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~ 317 (334)
T 2pvf_A 255 LGGSPYPGIPV---EELF---KLL-KEGHRMD-----KP-ANC----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317 (334)
T ss_dssp TSCCSSTTCCH---HHHH---HHH-HHTCCCC-----CC-TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCcCcCCH---HHHH---HHH-hcCCCCC-----CC-ccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 9999864321 1111 111 1121111 10 111 245788999999999999999999999988753
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=370.18 Aligned_cols=261 Identities=22% Similarity=0.218 Sum_probs=193.7
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeC------C
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHE------D 181 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------~ 181 (834)
.++|+..+.||+|+||.||+|....+|+.||||++... .....+.+.+|+.+|+.++|||||++++++... +
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 46799999999999999999999999999999998653 344567789999999999999999999999754 4
Q ss_pred EEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEee
Q 003278 182 QLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGD 261 (834)
Q Consensus 182 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~D 261 (834)
..||||||++++ |.+.+. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|
T Consensus 141 ~~~lv~E~~~~~-l~~~~~---------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~D 207 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ---------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD 207 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT---------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECC
T ss_pred eEEEEEeCCCCC-HHHHHh---------hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEE
Confidence 679999999865 555553 2488999999999999999999996 999999999999999999999999
Q ss_pred ccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCC
Q 003278 262 FGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPD 341 (834)
Q Consensus 262 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~ 341 (834)
||+|+..... ...+...||++|+|||.+... .++.++|||||||++|||++|+.||......
T Consensus 208 FG~a~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pF~g~~~~ 269 (464)
T 3ttj_A 208 FGLARTAGTS-----------------FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYI 269 (464)
T ss_dssp CCCC-----C-----------------CCC----CCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EEeeeecCCC-----------------cccCCCcccccccCHHHHcCC-CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999854221 113456799999999998754 6899999999999999999999999643211
Q ss_pred ccchHHHHHHHHhhc--------------------Cccc-----cccccccCCCCC--CHHHHHHHHHHHHHhcccCCCC
Q 003278 342 DQIILLDWIRRLSDE--------------------GKVL-----QAGDNRLSDGSY--KLCDMEHLTHLALLCTLHNPHL 394 (834)
Q Consensus 342 ~~~~l~~~~~~~~~~--------------------~~~~-----~~~d~~l~~~~~--~~~~~~~l~~l~~~Cl~~~p~~ 394 (834)
+ ...-+...... .... ......+..... .......+.+|...||+.||.+
T Consensus 270 ~---~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~ 346 (464)
T 3ttj_A 270 D---QWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 346 (464)
T ss_dssp H---HHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTT
T ss_pred H---HHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhh
Confidence 1 11111110000 0000 000000000000 0011346789999999999999
Q ss_pred CCchhhHHHH
Q 003278 395 RPSMKWVIEA 404 (834)
Q Consensus 395 RPsm~~V~~~ 404 (834)
|||+.|+++.
T Consensus 347 R~ta~e~L~H 356 (464)
T 3ttj_A 347 RISVDDALQH 356 (464)
T ss_dssp SCCHHHHHTS
T ss_pred CCCHHHHhcC
Confidence 9999999874
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=360.75 Aligned_cols=248 Identities=14% Similarity=0.188 Sum_probs=191.4
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCC--ChhHHHHHHHHHHHHHhc-cCCCceeEEEEEeeCCeEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSK--CPALRTRFSNELQNLARL-RHRNLVQLCGWCTEQGEMLVI 588 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~E~~~l~~l-~HpNiv~l~g~~~~~~~~~lv 588 (834)
++|...+.||+|+||.||+|... +++.||||+++... .....+.+.+|..+|.++ +|||||++++++.+.+..++|
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV 131 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence 46777889999999999999975 47889999987432 122234578899999887 899999999999999999999
Q ss_pred EeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccc
Q 003278 589 YDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEF 668 (834)
Q Consensus 589 ~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~ 668 (834)
|||+++|+|..++.... .+++..+..++.|++.||+|||+ .+||||||||+||||+.++.+||+|||+++.
T Consensus 132 ~E~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~ 202 (396)
T 4dc2_A 132 IEYVNGGDLMFHMQRQR------KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 202 (396)
T ss_dssp EECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEcCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeee
Confidence 99999999999887532 38899999999999999999997 6999999999999999999999999999975
Q ss_pred cccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCch----hHHHHHHHHHh
Q 003278 669 LTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEG----LLVKRVHEFEA 744 (834)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~----~~~~~~~~~~~ 744 (834)
..... ....+.+||+.|||||++.+..++.++|||||||++|||+||+.||....... ...........
T Consensus 203 ~~~~~-------~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~ 275 (396)
T 4dc2_A 203 GLRPG-------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL 275 (396)
T ss_dssp CCCTT-------CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHH
T ss_pred cccCC-------CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHh
Confidence 32211 12345789999999999999999999999999999999999999996432111 00111111111
Q ss_pred hcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCh
Q 003278 745 RKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSM 787 (834)
Q Consensus 745 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm 787 (834)
... ..++...+ .+ +..++.+||+.||++||++
T Consensus 276 ~~~-------~~~p~~~s-~~---~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 276 EKQ-------IRIPRSLS-VK---AASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp HCC-------CCCCTTSC-HH---HHHHHHHHTCSCTTTSTTC
T ss_pred ccc-------cCCCCcCC-HH---HHHHHHHHhcCCHhHcCCC
Confidence 111 01111222 23 4455568999999999996
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=382.15 Aligned_cols=258 Identities=21% Similarity=0.335 Sum_probs=203.4
Q ss_pred hCcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEecc
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYS 592 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~ 592 (834)
++|...+.||+|+||.||+|...++..||||.++.... ..+.|.+|+++|++++|||||+++++|.+ +..+|||||+
T Consensus 267 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 34556678999999999999998888899999975432 24679999999999999999999999977 6789999999
Q ss_pred CCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccC
Q 003278 593 ATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRN 672 (834)
Q Consensus 593 ~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~ 672 (834)
.+|+|.++|..... ..+++..++.|+.||+.||+|||+ .+||||||||+||||++++.+||+|||+++.+...
T Consensus 344 ~~gsL~~~l~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 416 (535)
T 2h8h_A 344 SKGSLLDFLKGETG----KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 416 (535)
T ss_dssp TTEEHHHHHSHHHH----TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred cCCcHHHHHhhcCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence 99999999964321 247899999999999999999997 68999999999999999999999999999865322
Q ss_pred CCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCcccc
Q 003278 673 DHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRPLAE 751 (834)
Q Consensus 673 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
. ........||..|||||++..+.++.++|||||||+||||+| |+.||...... .+...+ ....+.
T Consensus 417 ~------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~-~~~~~i---~~~~~~--- 483 (535)
T 2h8h_A 417 E------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQV---ERGYRM--- 483 (535)
T ss_dssp H------HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH-HHHHHH---HTTCCC---
T ss_pred c------eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHH---HcCCCC---
Confidence 1 011123457889999999999999999999999999999999 88888643322 222211 111110
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCccc
Q 003278 752 LVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDKRF 801 (834)
Q Consensus 752 ~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~~~ 801 (834)
..... ... .+.+++.+||+.||++||||.+|++.|+.+....
T Consensus 484 ----~~~~~-~~~---~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 484 ----PCPPE-CPE---SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp ----CCCTT-CCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred ----CCCCC-CCH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 01111 223 3556667999999999999999999998876543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=344.40 Aligned_cols=255 Identities=22% Similarity=0.295 Sum_probs=199.3
Q ss_pred hCcCcCCcccccCCcEEEEEEECC----CcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDN----HQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVI 588 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~----~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv 588 (834)
++|...+.||+|+||.||+|...+ +..||||.+.........+.|.+|+.++++++||||+++++++.+. ..++|
T Consensus 12 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v 90 (281)
T 3cc6_A 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWII 90 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEE
T ss_pred cceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEE
Confidence 567777889999999999998643 2369999988765566678899999999999999999999998754 56899
Q ss_pred EeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccc
Q 003278 589 YDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEF 668 (834)
Q Consensus 589 ~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~ 668 (834)
|||+++++|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++..
T Consensus 91 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 91 MELYPYGELGHYLERNK-----NSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp EECCTTCBHHHHHHHHT-----TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred EecCCCCCHHHHHHhcc-----ccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 99999999999997543 237889999999999999999997 6999999999999999999999999999976
Q ss_pred cccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcC
Q 003278 669 LTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKR 747 (834)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
...... .......||+.|+|||++.+..++.++|||||||++|||+| |+.|+....... ....... ...
T Consensus 163 ~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~-~~~~~~~---~~~ 232 (281)
T 3cc6_A 163 IEDEDY------YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD-VIGVLEK---GDR 232 (281)
T ss_dssp C---------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG-HHHHHHH---TCC
T ss_pred cccccc------cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH-HHHHHhc---CCC
Confidence 543211 11223467889999999999999999999999999999999 999986443332 2221111 111
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccC
Q 003278 748 PLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGN 797 (834)
Q Consensus 748 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~ 797 (834)
. ...... ++. +..++.+||+.||++|||+.+|++.|+.+
T Consensus 233 ~-------~~~~~~-~~~---l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 233 L-------PKPDLC-PPV---LYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp C-------CCCTTC-CHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C-------CCCCCC-CHH---HHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 0 011111 233 45566699999999999999999999764
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=357.34 Aligned_cols=246 Identities=18% Similarity=0.308 Sum_probs=193.7
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCC--ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSK--CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIY 589 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~--~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~ 589 (834)
++|...+.||+|+||.||+|.. .+++.||||.+.... .......+.+|+.+|+.++|||||++++++...+..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4677778899999999999996 668899999986321 1112357889999999999999999999999999999999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccc
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFL 669 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~ 669 (834)
||+ +|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||++...
T Consensus 89 E~~-~g~l~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~ 158 (336)
T 3h4j_B 89 EYA-GGELFDYIVEKK------RMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIM 158 (336)
T ss_dssp CCC-CEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTT
T ss_pred ECC-CCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceec
Confidence 999 678888876532 38899999999999999999997 58999999999999999999999999999765
Q ss_pred ccCCCCCcccccCccccccccCccchhccccCCC-CccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCc
Q 003278 670 TRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEA-TSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRP 748 (834)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
.... .....+||+.|+|||++.+..+ +.++|||||||++|||+||+.||......... ..
T Consensus 159 ~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~-----------~~ 219 (336)
T 3h4j_B 159 TDGN--------FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF-----------KK 219 (336)
T ss_dssp TTSB--------TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB-----------CC
T ss_pred cCCc--------ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH-----------HH
Confidence 4321 1234579999999999988776 67899999999999999999999754322110 00
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 749 LAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 749 ~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
.... ...++... ..+ +..++.+||+.||.+|||+.||++
T Consensus 220 i~~~-~~~~p~~~-s~~---~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 220 VNSC-VYVMPDFL-SPG---AQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp CCSS-CCCCCTTS-CHH---HHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred HHcC-CCCCcccC-CHH---HHHHHHHHcCCChhHCcCHHHHHh
Confidence 0000 00111112 233 445556899999999999999975
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=356.15 Aligned_cols=258 Identities=24% Similarity=0.366 Sum_probs=203.6
Q ss_pred HHhhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC--------hhhHHHHHHHHHHHHhC-CCCceeeEeee
Q 003278 106 LYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG--------ERFEKTFAAELVAVAHL-RHRNLVRLRGW 176 (834)
Q Consensus 106 l~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~--------~~~~~~~~~E~~~l~~l-~H~nIv~l~g~ 176 (834)
.....++|+..+.||+|+||.||+|++..+|+.||||++.... ....+.+.+|+.++.++ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 3444567999999999999999999998899999999986432 12346788999999999 79999999999
Q ss_pred EEeCCEEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCc
Q 003278 177 CVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYN 256 (834)
Q Consensus 177 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~ 256 (834)
+...+..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ 238 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTEK-------VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQ 238 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCC
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCC
Confidence 99999999999999999999998642 3589999999999999999999996 9999999999999999999
Q ss_pred eEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCcccccc-----CCCCCcccceeehhhHHHHHHhC
Q 003278 257 ARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQK-----GSVATAKSDVFSFGIVVLEVVSG 331 (834)
Q Consensus 257 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-----~~~~~~ksDV~SfGvvl~ElltG 331 (834)
+||+|||+++.+... .......||+.|+|||++.. ...++.++|||||||++|||+||
T Consensus 239 ikl~DfG~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g 301 (365)
T 2y7j_A 239 IRLSDFGFSCHLEPG-----------------EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301 (365)
T ss_dssp EEECCCTTCEECCTT-----------------CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHS
T ss_pred EEEEecCcccccCCC-----------------cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHC
Confidence 999999998754321 01234579999999998853 22468899999999999999999
Q ss_pred CccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 332 RRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 332 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
+.||.... .......+ . .+... ...+.. ... ...+.+++..||+.||.+||++.++++.
T Consensus 302 ~~pf~~~~---~~~~~~~i---~-~~~~~-~~~~~~--~~~----~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 302 SPPFWHRR---QILMLRMI---M-EGQYQ-FSSPEW--DDR----SSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp SCSSCCSS---HHHHHHHH---H-HTCCC-CCHHHH--SSS----CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCCCCC---HHHHHHHH---H-hCCCC-CCCccc--ccC----CHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 99986421 11111111 1 11110 000000 001 1357889999999999999999999873
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=346.16 Aligned_cols=257 Identities=25% Similarity=0.369 Sum_probs=200.7
Q ss_pred hcCCCCCCCeeeccCCeEEEEEEECC---CCeEEEEEEeccc-ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEE
Q 003278 109 GSNGFDEDEVLGSGGFGKVYRAVLPS---DGTVVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLL 184 (834)
Q Consensus 109 ~t~~f~~~~~LG~G~fG~Vy~~~~~~---~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 184 (834)
..++|...+.||+|+||.||+|.+.. ++..||||.+... .....+.|.+|+.++++++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 45678899999999999999998643 3457999998754 33456789999999999999999999999865 4578
Q ss_pred EEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccc
Q 003278 185 LVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGL 264 (834)
Q Consensus 185 lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGl 264 (834)
+||||+++|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 89 ~v~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 159 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERN------KNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGL 159 (281)
T ss_dssp EEEECCTTCBHHHHHHHH------TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCG
T ss_pred EEEecCCCCCHHHHHHhc------cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCC
Confidence 999999999999999653 24589999999999999999999996 999999999999999999999999999
Q ss_pred hhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCcc
Q 003278 265 ARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQ 343 (834)
Q Consensus 265 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~ 343 (834)
++........ ......||+.|+|||.+... .++.++|||||||++|||+| |+.||......
T Consensus 160 ~~~~~~~~~~---------------~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~llt~g~~p~~~~~~~-- 221 (281)
T 3cc6_A 160 SRYIEDEDYY---------------KASVTRLPIKWMSPESINFR-RFTTASDVWMFAVCMWEILSFGKQPFFWLENK-- 221 (281)
T ss_dssp GGCC------------------------CCCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG--
T ss_pred Cccccccccc---------------ccccCCCCcceeCchhhccC-CCCchhccHHHHHHHHHHHhCCCCCcccCChH--
Confidence 9865332110 12334578999999988654 67999999999999999999 99998643222
Q ss_pred chHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 344 IILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 344 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
.+...+. .+..... . ... ...+.+++..||+.||.+||++.++++.|+..
T Consensus 222 -~~~~~~~----~~~~~~~-----~-~~~----~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 222 -DVIGVLE----KGDRLPK-----P-DLC----PPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp -GHHHHHH----HTCCCCC-----C-TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHHHHHh----cCCCCCC-----C-CCC----CHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 1222111 1111110 0 111 14588999999999999999999999998754
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=360.36 Aligned_cols=243 Identities=16% Similarity=0.202 Sum_probs=190.6
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCC--ChhHHHHHHHHHHHHHhc-cCCCceeEEEEEeeCCeEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSK--CPALRTRFSNELQNLARL-RHRNLVQLCGWCTEQGEMLVI 588 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~E~~~l~~l-~HpNiv~l~g~~~~~~~~~lv 588 (834)
++|...+.||+|+||.||+|... +++.||||.+.... .....+.+.+|..+|..+ +|||||++++++.+.+..++|
T Consensus 23 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv 102 (353)
T 3txo_A 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFV 102 (353)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEE
Confidence 57888899999999999999964 58899999986431 122345678899999988 799999999999999999999
Q ss_pred EeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccc
Q 003278 589 YDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEF 668 (834)
Q Consensus 589 ~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~ 668 (834)
|||+++|+|..++.... .+++.....++.|++.||+|||+ .+|+||||||+||||+.++.+||+|||+++.
T Consensus 103 ~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 103 MEFVNGGDLMFHIQKSR------RFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp EECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceee
Confidence 99999999999987542 38888999999999999999997 6999999999999999999999999999975
Q ss_pred cccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCc
Q 003278 669 LTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRP 748 (834)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
.... .....+.+||+.|||||++.+..++.++|||||||++|||+||+.||....... +...+.. ....
T Consensus 174 ~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-~~~~i~~---~~~~ 242 (353)
T 3txo_A 174 GICN-------GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD-LFEAILN---DEVV 242 (353)
T ss_dssp SCC----------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHH---CCCC
T ss_pred cccC-------CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH-HHHHHHc---CCCC
Confidence 3221 112345689999999999999899999999999999999999999997543322 2222211 1111
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCh
Q 003278 749 LAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSM 787 (834)
Q Consensus 749 ~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm 787 (834)
.+... ..+ +..++.+||+.||++||++
T Consensus 243 --------~p~~~-~~~---~~~li~~lL~~dP~~R~~~ 269 (353)
T 3txo_A 243 --------YPTWL-HED---ATGILKSFMTKNPTMRLGS 269 (353)
T ss_dssp --------CCTTS-CHH---HHHHHHHHTCSSGGGSTTS
T ss_pred --------CCCCC-CHH---HHHHHHHHhhhCHHHccCC
Confidence 11112 233 3445558999999999998
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=357.27 Aligned_cols=266 Identities=15% Similarity=0.182 Sum_probs=196.2
Q ss_pred HHHhhCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCC----ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCC
Q 003278 509 ISATNNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSK----CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQG 583 (834)
Q Consensus 509 ~~at~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~----~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~ 583 (834)
....++|...+.||+|+||.||+|.. .++..||||.+.... .+...+.|.+|+.++++++|||||++++++.+.+
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 34567788889999999999999986 457889999986321 2344578999999999999999999999999999
Q ss_pred eEEEEEeccCCCchhhhhhcCCCC----------------------------------CCCcccCHHHHHHHHHHHHHHH
Q 003278 584 EMLVIYDYSATRILSHLLFHNNHR----------------------------------IGHSILQWHHRYNIIKSLASAI 629 (834)
Q Consensus 584 ~~~lv~Ey~~~g~L~~~l~~~~~~----------------------------------~~~~~l~~~~r~~i~~~ia~gl 629 (834)
..++||||+++|+|.+++...... .....+++.....|+.|++.||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 999999999999999988521100 0011245667788999999999
Q ss_pred HHhhhccCCceeecccccCceeecCCC--CceEeeeeeccccccCCCCCcccccCccccccccCccchhcccc--CCCCc
Q 003278 630 LYLHEEWNEQVIHRNITSSAITLDPDM--NPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIES--GEATS 705 (834)
Q Consensus 630 ~yLH~~~~~~iiHrDlK~~NILld~~~--~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~ 705 (834)
+|||+ .+|+||||||+|||++.++ .+||+|||+++.+....... ........||+.|+|||++.+ ..++.
T Consensus 182 ~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 255 (345)
T 3hko_A 182 HYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGE---YYGMTTKAGTPYFVAPEVLNTTNESYGP 255 (345)
T ss_dssp HHHHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC-----------CCCGGGCCHHHHTCSSSCCCT
T ss_pred HHHHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccc---cccccccCCCccccCchhhccCCCCCCc
Confidence 99997 6899999999999998766 89999999998654322111 111234579999999999965 67899
Q ss_pred cCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCC
Q 003278 706 MADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRP 785 (834)
Q Consensus 706 k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RP 785 (834)
++|||||||++|||+||+.||......... .. ........ ..+.. ... .. .+.+++.+||+.||++||
T Consensus 256 ~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~---~~~~~~~~---~~~~~-~~~-~~---~~~~li~~~l~~~p~~Rp 323 (345)
T 3hko_A 256 KCDAWSAGVLLHLLLMGAVPFPGVNDADTI-SQ---VLNKKLCF---ENPNY-NVL-SP---LARDLLSNLLNRNVDERF 323 (345)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HH---HHHCCCCT---TSGGG-GGS-CH---HHHHHHHHHSCSCTTTSC
T ss_pred HHHHHHHHHHHHHHHHCCCCCCCCChHHHH-HH---HHhccccc---CCccc-ccC-CH---HHHHHHHHHcCCChhHCC
Confidence 999999999999999999998654332221 11 11111111 00100 011 12 344556699999999999
Q ss_pred ChhHHHH
Q 003278 786 SMRQILS 792 (834)
Q Consensus 786 tm~~v~~ 792 (834)
|+.++++
T Consensus 324 s~~~~l~ 330 (345)
T 3hko_A 324 DAMRALQ 330 (345)
T ss_dssp CHHHHHH
T ss_pred CHHHHhc
Confidence 9999986
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=381.68 Aligned_cols=261 Identities=25% Similarity=0.375 Sum_probs=206.8
Q ss_pred HHhhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEE
Q 003278 106 LYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLL 185 (834)
Q Consensus 106 l~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 185 (834)
.++..++|...+.||+|+||.||+|.+. .+..||||++.... ...+.|.+|+.+|++++|||||+++++|.+ +..+|
T Consensus 262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~l 338 (535)
T 2h8h_A 262 WEIPRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 338 (535)
T ss_dssp SBCCGGGEEEEEEEEECSSEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred eecchhhhhhheecccCCCeEEEEEEEC-CCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceE
Confidence 3445677888999999999999999995 56789999997543 335679999999999999999999999876 67899
Q ss_pred EEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccch
Q 003278 186 VYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLA 265 (834)
Q Consensus 186 V~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla 265 (834)
||||+++|+|.++|.... ...+++..++.|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 339 v~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a 410 (535)
T 2h8h_A 339 VTEYMSKGSLLDFLKGET-----GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLA 410 (535)
T ss_dssp EECCCTTEEHHHHHSHHH-----HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTST
T ss_pred eeehhcCCcHHHHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccc
Confidence 999999999999996421 23589999999999999999999996 9999999999999999999999999999
Q ss_pred hhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccc
Q 003278 266 RWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQI 344 (834)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~ 344 (834)
+.+...... ......||+.|+|||.+..+ .++.++|||||||+||||+| |+.||..... .
T Consensus 411 ~~~~~~~~~---------------~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~---~ 471 (535)
T 2h8h_A 411 RLIEDNEYT---------------ARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVN---R 471 (535)
T ss_dssp TTCCCHHHH---------------TTCSTTSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH---H
T ss_pred eecCCCcee---------------cccCCcCcccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---H
Confidence 865432110 01223478899999998765 67999999999999999999 8988864321 1
Q ss_pred hHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcCCC
Q 003278 345 ILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGSYS 410 (834)
Q Consensus 345 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~~~ 410 (834)
.+ ... ...+...... ... ...+.+|+..||+.||++||++.+|++.|+..+.
T Consensus 472 ~~---~~~-i~~~~~~~~~------~~~----~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 472 EV---LDQ-VERGYRMPCP------PEC----PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp HH---HHH-HHTTCCCCCC------TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred HH---HHH-HHcCCCCCCC------CCC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 11 111 1222111110 111 2468899999999999999999999999988654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=355.74 Aligned_cols=255 Identities=16% Similarity=0.232 Sum_probs=196.7
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCC----ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSK----CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLV 587 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~----~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~l 587 (834)
+.|...+.||+|+||.||+|.. .+++.||||.+.... .....+.|.+|+.++++++|||||++++++.+.+..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 4577788999999999999986 468899999985321 11234679999999999999999999999999999999
Q ss_pred EEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCC---ceEeeee
Q 003278 588 IYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMN---PRLGSFA 664 (834)
Q Consensus 588 v~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~---~ki~DfG 664 (834)
||||+++|+|.+++..... ....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++. +||+|||
T Consensus 104 v~e~~~g~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRAD--AGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEECCSSCBHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEeCCCCCCHHHHHHHhcc--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCc
Confidence 9999999999887764321 11247888999999999999999997 69999999999999986654 9999999
Q ss_pred eccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHh
Q 003278 665 LAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEA 744 (834)
Q Consensus 665 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~ 744 (834)
+++...... .......||+.|+|||++.+..++.++|||||||++|||+||+.||... ...+...+. .
T Consensus 179 ~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~~~~i~---~ 246 (351)
T 3c0i_A 179 VAIQLGESG-------LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT--KERLFEGII---K 246 (351)
T ss_dssp TCEECCTTS-------CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS--HHHHHHHHH---H
T ss_pred ceeEecCCC-------eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc--HHHHHHHHH---c
Confidence 997654321 1122457999999999999999999999999999999999999998642 111111111 1
Q ss_pred hcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 745 RKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 745 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
..... ++......+ . .+..++.+||+.||++|||+.++++
T Consensus 247 ~~~~~----~~~~~~~~s-~---~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 247 GKYKM----NPRQWSHIS-E---SAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp TCCCC----CHHHHTTSC-H---HHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCC----CccccccCC-H---HHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11110 000001111 2 3455666999999999999999985
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=351.34 Aligned_cols=255 Identities=21% Similarity=0.330 Sum_probs=197.3
Q ss_pred cCCCCCC-CeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCC-CCceeeEeeeEEeCCEEEE
Q 003278 110 SNGFDED-EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLR-HRNLVRLRGWCVHEDQLLL 185 (834)
Q Consensus 110 t~~f~~~-~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~l 185 (834)
.+.|... +.||+|+||.||+|....+|+.||||++... .......+.+|+.++.++. ||||+++++++...+..++
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l 106 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL 106 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence 3445555 7899999999999999989999999998653 2334677899999999994 6999999999999999999
Q ss_pred EEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECC---CCceEEeec
Q 003278 186 VYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDS---QYNARLGDF 262 (834)
Q Consensus 186 V~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~---~~~~kl~DF 262 (834)
||||+++|+|.+++.... ...+++..+..|+.|++.||+|||+. +|+||||||+|||++. ++.+||+||
T Consensus 107 v~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Df 178 (327)
T 3lm5_A 107 ILEYAAGGEIFSLCLPEL-----AEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDF 178 (327)
T ss_dssp EEECCTTEEGGGGGSSCC------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred EEEecCCCcHHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeC
Confidence 999999999999885432 24689999999999999999999996 9999999999999997 789999999
Q ss_pred cchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCc
Q 003278 263 GLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDD 342 (834)
Q Consensus 263 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~ 342 (834)
|+++.+.... ......||+.|+|||.+... .++.++|||||||++|||+||+.||......
T Consensus 179 g~a~~~~~~~-----------------~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~- 239 (327)
T 3lm5_A 179 GMSRKIGHAC-----------------ELREIMGTPEYLAPEILNYD-PITTATDMWNIGIIAYMLLTHTSPFVGEDNQ- 239 (327)
T ss_dssp GGCEEC--------------------------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-
T ss_pred ccccccCCcc-----------------ccccccCCcCccCCeeecCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCch-
Confidence 9998653221 12345699999999998654 6799999999999999999999998643211
Q ss_pred cchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 343 QIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 343 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
.. ...... ... ....+.. .. ....+.+++..||+.||.+||++.++++.
T Consensus 240 --~~---~~~i~~-~~~-~~~~~~~--~~----~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 240 --ET---YLNISQ-VNV-DYSEETF--SS----VSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp --HH---HHHHHH-TCC-CCCTTTT--TT----SCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred --HH---HHHHHh-ccc-ccCchhh--cc----cCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 11 111111 000 0000000 01 12457889999999999999999999864
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=359.09 Aligned_cols=267 Identities=23% Similarity=0.305 Sum_probs=200.4
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC--hhhHHHHHHHHHHHHhCCCCceeeEeeeEEe--------C
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG--ERFEKTFAAELVAVAHLRHRNLVRLRGWCVH--------E 180 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--------~ 180 (834)
++|+..+.||+|+||.||+|+...+|+.||||++.... ......+.+|+.++++++||||++++++|.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 56888999999999999999999999999999985432 2334578899999999999999999999987 4
Q ss_pred CEEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEe
Q 003278 181 DQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLG 260 (834)
Q Consensus 181 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~ 260 (834)
+..++||||+++ +|...+... ...+++..+..|+.|++.||+|||+. +|+||||||+|||++.++.+||+
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~------~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~ 166 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNV------LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLA 166 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCT------TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred ceEEEEEeccCC-CHHHHHhhc------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEc
Confidence 468999999985 777776543 24589999999999999999999996 99999999999999999999999
Q ss_pred eccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCC
Q 003278 261 DFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYP 340 (834)
Q Consensus 261 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~ 340 (834)
|||+++.+..... ......+...||+.|+|||.+.....++.++|||||||++|||+||+.||.....
T Consensus 167 Dfg~a~~~~~~~~------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 234 (351)
T 3mi9_A 167 DFGLARAFSLAKN------------SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 234 (351)
T ss_dssp CCTTCEECCCCSS------------SSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cchhccccccccc------------ccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 9999975432100 0011134456899999999987655679999999999999999999999875322
Q ss_pred CccchHHHHHHHHhhcCcccccccccc------------CCCCCCHHH-------HHHHHHHHHHhcccCCCCCCchhhH
Q 003278 341 DDQIILLDWIRRLSDEGKVLQAGDNRL------------SDGSYKLCD-------MEHLTHLALLCTLHNPHLRPSMKWV 401 (834)
Q Consensus 341 ~~~~~l~~~~~~~~~~~~~~~~~d~~l------------~~~~~~~~~-------~~~l~~l~~~Cl~~~p~~RPsm~~V 401 (834)
. .....+..... ......-+.. ......... ...+.+|+..||+.||.+||++.|+
T Consensus 235 ~---~~~~~i~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~ 309 (351)
T 3mi9_A 235 Q---HQLALISQLCG--SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 309 (351)
T ss_dssp H---HHHHHHHHHHC--CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred H---HHHHHHHHHhC--CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHH
Confidence 1 12222222211 1100000000 000001110 1347789999999999999999999
Q ss_pred HHH
Q 003278 402 IEA 404 (834)
Q Consensus 402 ~~~ 404 (834)
++.
T Consensus 310 l~h 312 (351)
T 3mi9_A 310 LNH 312 (351)
T ss_dssp HTS
T ss_pred hCC
Confidence 863
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=342.67 Aligned_cols=252 Identities=21% Similarity=0.317 Sum_probs=198.7
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC------hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG------ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLL 184 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~------~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 184 (834)
++|+..+.||+|+||.||+|....+|+.||||.+.... ....+.|.+|+.++++++||||+++++++.+.+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 45888899999999999999998899999999986432 123678999999999999999999999999999999
Q ss_pred EEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCC----ceEEe
Q 003278 185 LVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQY----NARLG 260 (834)
Q Consensus 185 lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~----~~kl~ 260 (834)
+||||+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++ .+||+
T Consensus 85 lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~ 154 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK-------ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLI 154 (283)
T ss_dssp EEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEEC
T ss_pred EEEeecCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEE
Confidence 999999999999998642 3589999999999999999999996 999999999999998876 79999
Q ss_pred eccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCC
Q 003278 261 DFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYP 340 (834)
Q Consensus 261 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~ 340 (834)
|||+++...... ......||+.|+|||.+... .++.++|||||||++|||+||+.||.....
T Consensus 155 dfg~~~~~~~~~-----------------~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 216 (283)
T 3bhy_A 155 DFGIAHKIEAGN-----------------EFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGETK 216 (283)
T ss_dssp CCTTCEECC-------------------------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred ecccceeccCCC-----------------cccccCCCcCccCcceecCC-CCCcchhhhhHHHHHHHHHHCCCCCCCcch
Confidence 999997543211 12334689999999988654 678999999999999999999999864321
Q ss_pred CccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 341 DDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 341 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
. ........ ... ..+.... ... ...+.+++..||+.||.+||++.++++.
T Consensus 217 ---~---~~~~~~~~-~~~--~~~~~~~-~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 217 ---Q---ETLTNISA-VNY--DFDEEYF-SNT----SELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp ---H---HHHHHHHT-TCC--CCCHHHH-TTC----CHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred ---H---HHHHHhHh-ccc--CCcchhc-ccC----CHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 1 11111111 100 0000000 011 2457889999999999999999999873
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=356.88 Aligned_cols=268 Identities=23% Similarity=0.271 Sum_probs=196.7
Q ss_pred hcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccCh-----hhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEE
Q 003278 109 GSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGE-----RFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQL 183 (834)
Q Consensus 109 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~-----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 183 (834)
..++|...+.||+|+||.||+|.+..+|+.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 34679999999999999999999988999999999864321 1234688999999999999999999999999999
Q ss_pred EEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeecc
Q 003278 184 LLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFG 263 (834)
Q Consensus 184 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFG 263 (834)
++||||+++ +|..++... ...+++..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 88 ~lv~e~~~~-~l~~~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg 157 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDN------SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFG 157 (346)
T ss_dssp EEEEECCSE-EHHHHHTTC------CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCG
T ss_pred EEEEEcCCC-CHHHHHHhc------CcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecc
Confidence 999999986 888888543 24588889999999999999999996 99999999999999999999999999
Q ss_pred chhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCcc
Q 003278 264 LARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQ 343 (834)
Q Consensus 264 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~ 343 (834)
+++.+.... ...+...||+.|+|||.+.....++.++|||||||++|||++|..|+......
T Consensus 158 ~a~~~~~~~----------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~-- 219 (346)
T 1ua2_A 158 LAKSFGSPN----------------RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-- 219 (346)
T ss_dssp GGSTTTSCC----------------CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--
T ss_pred cceeccCCc----------------ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH--
Confidence 998543210 11234568999999999876556799999999999999999999988643211
Q ss_pred chHHHHHHHHhh--cCcccc---ccccccCC--CCCCH-----HHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 344 IILLDWIRRLSD--EGKVLQ---AGDNRLSD--GSYKL-----CDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 344 ~~l~~~~~~~~~--~~~~~~---~~d~~l~~--~~~~~-----~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
..+......... ...... ..+..... ..... .....+.+++..||+.||.+||++.|+++.
T Consensus 220 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 220 DQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp HHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 111111111100 000000 00000000 00000 112468899999999999999999999874
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=384.41 Aligned_cols=250 Identities=24% Similarity=0.371 Sum_probs=195.1
Q ss_pred CeeeccCCeEEEEEEE--CCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEccCC
Q 003278 117 EVLGSGGFGKVYRAVL--PSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPN 192 (834)
Q Consensus 117 ~~LG~G~fG~Vy~~~~--~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 192 (834)
+.||+|+||.||+|.+ ..+++.||||+++.. .....+.|.+|+.+|.+++|||||+++++|.. +..++|||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4799999999999965 345789999998753 23446789999999999999999999999964 558999999999
Q ss_pred CCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhhhh
Q 003278 193 RSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHEL 272 (834)
Q Consensus 193 gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~ 272 (834)
|+|.++|... ..+++..+..|+.||+.||+|||+. +||||||||+|||++.++.+||+|||+++.+....
T Consensus 454 g~L~~~l~~~-------~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 523 (635)
T 4fl3_A 454 GPLNKYLQQN-------RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 523 (635)
T ss_dssp EEHHHHHHHC-------TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--
T ss_pred CCHHHHHhhC-------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCc
Confidence 9999999643 4589999999999999999999996 99999999999999999999999999998764321
Q ss_pred hhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccchHHHHHH
Q 003278 273 QYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQIILLDWIR 351 (834)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~ 351 (834)
.. ....+...||+.|+|||++... .++.++|||||||++|||+| |+.||...... .+ .
T Consensus 524 ~~-------------~~~~~~~~~t~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~----~ 582 (635)
T 4fl3_A 524 NY-------------YKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EV----T 582 (635)
T ss_dssp ------------------------CGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HH----H
T ss_pred cc-------------cccccCCCCceeeeChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HH----H
Confidence 11 0112334578999999998655 67999999999999999999 99998643211 11 1
Q ss_pred HHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 352 RLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 352 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
.....+...... ... ...+.+|+..||+.||++||++.+|++.|+..
T Consensus 583 ~~i~~~~~~~~p------~~~----~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 583 AMLEKGERMGCP------AGC----PREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp HHHHTTCCCCCC------TTC----CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHcCCCCCCC------CCC----CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 222222221111 111 24688999999999999999999999998764
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=345.79 Aligned_cols=258 Identities=24% Similarity=0.355 Sum_probs=200.2
Q ss_pred CCCCCeeeccCCeEEEEEEECCCC---eEEEEEEecccC-hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEE-EEEE
Q 003278 113 FDEDEVLGSGGFGKVYRAVLPSDG---TVVAVKCLAEKG-ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQL-LLVY 187 (834)
Q Consensus 113 f~~~~~LG~G~fG~Vy~~~~~~~g---~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~-~lV~ 187 (834)
|...++||+|+||.||+|.+..++ ..||+|.+.... ....+.|.+|+.++++++||||+++++++.+.+.. ++||
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 102 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL 102 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence 556689999999999999875444 379999987543 34567899999999999999999999999877665 9999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
||+.+|+|.+++... ...+++..+..|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 103 e~~~~~~L~~~~~~~------~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 173 (298)
T 3pls_A 103 PYMCHGDLLQFIRSP------QRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARD 173 (298)
T ss_dssp CCCTTCBHHHHHHCT------TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCT
T ss_pred ecccCCCHHHHHhcc------ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccc
Confidence 999999999999653 24689999999999999999999996 999999999999999999999999999986
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHH
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILL 347 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~ 347 (834)
+...... .........||+.|+|||.+... .++.++|||||||++|||+||..|+...... ..+.
T Consensus 174 ~~~~~~~------------~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~~~~~~~~~--~~~~ 238 (298)
T 3pls_A 174 ILDREYY------------SVQQHRHARLPVKWTALESLQTY-RFTTKSDVWSFGVLLWELLTRGAPPYRHIDP--FDLT 238 (298)
T ss_dssp TTTGGGG------------CSCCSSCTTCGGGGSCHHHHTTC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG--GGHH
T ss_pred ccCCccc------------ccccCcCCCCCccccChhhhccC-CCChhhchhhHHHHHHHHhhCCCCCCccCCH--HHHH
Confidence 5432211 01113345689999999998654 6799999999999999999966664322211 1222
Q ss_pred HHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 348 DWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 348 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
..+. .+..... .... ...+.+++..||+.||.+||++.++++.|+..
T Consensus 239 ~~~~----~~~~~~~------~~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~ 285 (298)
T 3pls_A 239 HFLA----QGRRLPQ------PEYC----PDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285 (298)
T ss_dssp HHHH----TTCCCCC------CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhh----cCCCCCC------Cccc----hHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 2111 1111100 0111 24688999999999999999999999998764
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=352.12 Aligned_cols=270 Identities=18% Similarity=0.245 Sum_probs=204.3
Q ss_pred HHhhCcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCCChhHHHHHHHHHHHHHh--ccCCCceeEEEEEeeCC----
Q 003278 510 SATNNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLAR--LRHRNLVQLCGWCTEQG---- 583 (834)
Q Consensus 510 ~at~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~--l~HpNiv~l~g~~~~~~---- 583 (834)
...++|...+.||+|+||.||+|.. +++.||||.+... ....+.+|++++.. ++||||+++++++....
T Consensus 39 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 39 TIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred cccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 3456788889999999999999998 4788999998532 24567889999987 79999999999998765
Q ss_pred eEEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhcc-----CCceeecccccCceeecCCCCc
Q 003278 584 EMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEW-----NEQVIHRNITSSAITLDPDMNP 658 (834)
Q Consensus 584 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~-----~~~iiHrDlK~~NILld~~~~~ 658 (834)
..++||||+++|+|.+++... .+++..++.++.|++.||+|||... ..+|+||||||+|||++.++.+
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~ 186 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 186 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCE
T ss_pred eeEEEEeecCCCcHHHHHhcc-------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCE
Confidence 799999999999999999643 3889999999999999999999311 2689999999999999999999
Q ss_pred eEeeeeeccccccCCCCCcccccCccccccccCccchhccccC------CCCccCcchhhHHHHHHHHhC----------
Q 003278 659 RLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESG------EATSMADVYSFGVVVLEVVTG---------- 722 (834)
Q Consensus 659 ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~------~~~~k~DV~SfGvvl~E~~tG---------- 722 (834)
||+|||++......... .........||+.|+|||++.+. .++.++|||||||++|||+||
T Consensus 187 kL~Dfg~~~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~ 263 (342)
T 1b6c_B 187 CIADLGLAVRHDSATDT---IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 263 (342)
T ss_dssp EECCCTTCEEEETTTTE---EEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred EEEECCCceeccccccc---cccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccc
Confidence 99999999765433211 00112345799999999999765 344789999999999999999
Q ss_pred CCccCCCCCchhHHHHHHHHHhhcCccccccccccCCCC-CHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCc
Q 003278 723 QMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEY-NHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDK 799 (834)
Q Consensus 723 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~ 799 (834)
+.|+....+.......+...... . ...+.+...+ .......+.+++.+||+.||++|||+.+|++.|+.+.+
T Consensus 264 ~~p~~~~~~~~~~~~~~~~~~~~-~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~ 336 (342)
T 1b6c_B 264 QLPYYDLVPSDPSVEEMRKVVCE-Q----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336 (342)
T ss_dssp CCTTTTTSCSSCCHHHHHHHHTT-S----CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCccccCcCcccHHHHHHHHHH-H----HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 67775443322111222111111 1 1111111111 12444567788889999999999999999999987643
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=355.36 Aligned_cols=273 Identities=23% Similarity=0.361 Sum_probs=186.6
Q ss_pred hhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC-hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEE
Q 003278 108 IGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG-ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLV 186 (834)
Q Consensus 108 ~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 186 (834)
...++|...+.||+|+||.||+|....+++.||||++.... ....+.+.+|+.++.+++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 45578999999999999999999988889999999886432 33456788999999999999999999999999999999
Q ss_pred EEccCCCCHhHHHhcCCCc-cccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccch
Q 003278 187 YDYMPNRSLDRVLFRRPEN-LEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLA 265 (834)
Q Consensus 187 ~Ey~~~gsL~~~l~~~~~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla 265 (834)
|||+++|+|.+++...... ......+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccch
Confidence 9999999999998642110 01235689999999999999999999996 9999999999999999999999999999
Q ss_pred hhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccch
Q 003278 266 RWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQII 345 (834)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~ 345 (834)
+.+....... .........||+.|+|||.+.....++.++|||||||++|||+||+.||....... .
T Consensus 169 ~~~~~~~~~~-----------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~ 235 (303)
T 2vwi_A 169 AFLATGGDIT-----------RNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK--V 235 (303)
T ss_dssp HHCC--------------------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG--H
T ss_pred heeccCCCcc-----------chhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh--H
Confidence 8654321100 00112345699999999988653457899999999999999999999987533221 1
Q ss_pred HHHHHHHHhhcC-cccc-ccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 346 LLDWIRRLSDEG-KVLQ-AGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 346 l~~~~~~~~~~~-~~~~-~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
+. ....... .... ..++... ..+ ...+.+++..||+.||.+||++.++++.
T Consensus 236 ~~---~~~~~~~~~~~~~~~~~~~~-~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 236 LM---LTLQNDPPSLETGVQDKEML-KKY----GKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp HH---HHHTSSCCCTTC-----CCC-CCC----CHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HH---HHhccCCCccccccccchhh-hhh----hHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 11 1111100 0000 0011110 111 2457889999999999999999999863
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=351.99 Aligned_cols=248 Identities=15% Similarity=0.189 Sum_probs=193.3
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCC--ChhHHHHHHHHHHHHHhc-cCCCceeEEEEEeeCCeEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSK--CPALRTRFSNELQNLARL-RHRNLVQLCGWCTEQGEMLVI 588 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~E~~~l~~l-~HpNiv~l~g~~~~~~~~~lv 588 (834)
++|...+.||+|+||.||+|... +++.||||.+.... .....+.+.+|+.++.++ +|||||++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 46777889999999999999975 57899999987542 334456788999999988 899999999999999999999
Q ss_pred EeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccc
Q 003278 589 YDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEF 668 (834)
Q Consensus 589 ~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~ 668 (834)
|||+++|+|..++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~e~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~ 159 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQR------KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 159 (345)
T ss_dssp ECCCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBC
T ss_pred EeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEecccccc
Confidence 99999999999986532 37888999999999999999997 6999999999999999999999999999975
Q ss_pred cccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCch----hHHHHHHHHHh
Q 003278 669 LTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEG----LLVKRVHEFEA 744 (834)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~----~~~~~~~~~~~ 744 (834)
..... ....+.+||+.|+|||++.+..++.++|||||||++|||+||+.||....... ...........
T Consensus 160 ~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~ 232 (345)
T 3a8x_A 160 GLRPG-------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL 232 (345)
T ss_dssp SCCTT-------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHH
T ss_pred ccCCC-------CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHH
Confidence 32211 12335689999999999999999999999999999999999999996421110 00011111101
Q ss_pred hcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCh
Q 003278 745 RKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSM 787 (834)
Q Consensus 745 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm 787 (834)
... ..++...+ .+ +..++.+||+.||++||++
T Consensus 233 ~~~-------~~~p~~~s-~~---~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 233 EKQ-------IRIPRSLS-VK---AASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp HCC-------CCCCTTSC-HH---HHHHHHHHTCSSTTTSTTC
T ss_pred cCC-------CCCCCCCC-HH---HHHHHHHHhcCCHhHCCCC
Confidence 111 01111222 23 4455568999999999996
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=353.79 Aligned_cols=265 Identities=24% Similarity=0.386 Sum_probs=201.4
Q ss_pred ccccHHHHHhhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhC-CCCceeeEeeeE
Q 003278 99 RIFSYAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHL-RHRNLVRLRGWC 177 (834)
Q Consensus 99 ~~f~~~el~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~ 177 (834)
..+++.++....++|+..+.||+|+||.||+|.+..+|+.||||++.... ...+.+.+|+.++.++ +||||+++++++
T Consensus 12 ~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 90 (326)
T 2x7f_A 12 DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAF 90 (326)
T ss_dssp ----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred hhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence 33555566667789999999999999999999998899999999986543 2346788999999999 899999999999
Q ss_pred Ee------CCEEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEE
Q 003278 178 VH------EDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVML 251 (834)
Q Consensus 178 ~~------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILl 251 (834)
.. .+..++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+|||+
T Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~ 162 (326)
T 2x7f_A 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK-----GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLL 162 (326)
T ss_dssp EECC--CCCCEEEEEEECCTTEEHHHHHHHSG-----GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEE
T ss_pred eeccCccccceEEEEEEcCCCCcHHHHHHhcc-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEE
Confidence 87 468999999999999999997542 24688999999999999999999996 99999999999999
Q ss_pred CCCCceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCcccccc----CCCCCcccceeehhhHHHH
Q 003278 252 DSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQK----GSVATAKSDVFSFGIVVLE 327 (834)
Q Consensus 252 d~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~----~~~~~~ksDV~SfGvvl~E 327 (834)
+.++.+||+|||+++.+.... .......||+.|+|||.+.. +..++.++|||||||++||
T Consensus 163 ~~~~~~kl~Dfg~~~~~~~~~----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~ 226 (326)
T 2x7f_A 163 TENAEVKLVDFGVSAQLDRTV----------------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226 (326)
T ss_dssp CTTCCEEECCCTTTC-----------------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHH
T ss_pred cCCCCEEEeeCcCceecCcCc----------------cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHH
Confidence 999999999999997643211 01234469999999998852 3457899999999999999
Q ss_pred HHhCCccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 328 VVSGRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 328 lltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
|+||+.||...... ... ..... ... +.+....++ ..+.+++..||..||.+||++.++++.
T Consensus 227 l~~g~~p~~~~~~~---~~~---~~~~~-~~~-----~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 227 MAEGAPPLCDMHPM---RAL---FLIPR-NPA-----PRLKSKKWS----KKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp HHHSSCTTTTSCHH---HHH---HHHHH-SCC-----CCCSCSCSC----HHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHhCCCCCCCCcHH---HHH---HHhhc-Ccc-----ccCCccccC----HHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 99999998543211 111 11111 111 111111122 467889999999999999999999863
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=363.88 Aligned_cols=261 Identities=15% Similarity=0.121 Sum_probs=203.1
Q ss_pred HHHHHhhcCCCCCCCeeeccCCeEEEEEE-----ECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCC---CCceeeEe
Q 003278 103 YAELYIGSNGFDEDEVLGSGGFGKVYRAV-----LPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLR---HRNLVRLR 174 (834)
Q Consensus 103 ~~el~~~t~~f~~~~~LG~G~fG~Vy~~~-----~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~ 174 (834)
..++....++|...+.||+|+||.||+|. ...+++.||||++.... ...+..|+.++..++ |+||++++
T Consensus 57 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~ 133 (365)
T 3e7e_A 57 KTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFY 133 (365)
T ss_dssp SCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEE
T ss_pred ceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhh
Confidence 34455677889999999999999999994 55678999999987543 456778888888887 99999999
Q ss_pred eeEEeCCEEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECC-
Q 003278 175 GWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDS- 253 (834)
Q Consensus 175 g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~- 253 (834)
+++...+..+||||||++|+|.+++...... ....++|..++.|+.|++.||+|||+. +||||||||+|||++.
T Consensus 134 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~ 208 (365)
T 3e7e_A 134 SAHLFQNGSVLVGELYSYGTLLNAINLYKNT--PEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNG 208 (365)
T ss_dssp EEEECSSCEEEEECCCCSCBHHHHHHHHHTS--TTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGG
T ss_pred eeeecCCCcEEEEeccCCCcHHHHHHHhhcc--cccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEeccc
Confidence 9999999999999999999999999753211 135699999999999999999999985 9999999999999998
Q ss_pred ----------CCceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhh
Q 003278 254 ----------QYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGI 323 (834)
Q Consensus 254 ----------~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGv 323 (834)
++.+||+|||+|+.+..... ....+...||++|+|||++... .++.++|||||||
T Consensus 209 ~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~--------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~ 273 (365)
T 3e7e_A 209 FLEQDDEDDLSAGLALIDLGQSIDMKLFPK--------------GTIFTAKCETSGFQCVEMLSNK-PWNYQIDYFGVAA 273 (365)
T ss_dssp GTCC------CTTEEECCCTTCEEGGGSCT--------------TEEECCSSCTTSCCCHHHHTTC-CBSTHHHHHHHHH
T ss_pred ccCccccccccCCEEEeeCchhhhhhccCC--------------CceeeeecCCCCCCChHHhcCC-CCCccccHHHHHH
Confidence 89999999999975432100 0113456799999999998654 5799999999999
Q ss_pred HHHHHHhCCccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCC-CchhhHH
Q 003278 324 VVLEVVSGRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLR-PSMKWVI 402 (834)
Q Consensus 324 vl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~R-Psm~~V~ 402 (834)
++|||+||+.||........ . ....+. ... ..+.+.++...|++.+|.+| |++.++.
T Consensus 274 il~elltg~~pf~~~~~~~~--------------~----~~~~~~-~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~ 331 (365)
T 3e7e_A 274 TVYCMLFGTYMKVKNEGGEC--------------K----PEGLFR-RLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLR 331 (365)
T ss_dssp HHHHHHHSSCCCEEEETTEE--------------E----ECSCCT-TCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred HHHHHHhCCCccccCCCCce--------------e----echhcc-ccC---cHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence 99999999999853221110 0 111111 111 13456678889999999998 6788888
Q ss_pred HHhhcC
Q 003278 403 EAVSGS 408 (834)
Q Consensus 403 ~~l~~~ 408 (834)
+.|...
T Consensus 332 ~~l~~~ 337 (365)
T 3e7e_A 332 QKLKKV 337 (365)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 777654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=357.40 Aligned_cols=258 Identities=18% Similarity=0.276 Sum_probs=195.9
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCc----EEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQ----YVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLV 587 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~----~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~l 587 (834)
++|...+.||+|+||.||+|... ++. .||+|.+.........+.|.+|+.++++++|||||+++++|.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 46777889999999999999963 343 368888765555555678999999999999999999999998765 788
Q ss_pred EEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecc
Q 003278 588 IYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAE 667 (834)
Q Consensus 588 v~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~ 667 (834)
|+||+.+|+|.+++..... .+++..++.|+.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 94 v~~~~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EECCCSSCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred EEEecCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence 9999999999999876432 38889999999999999999997 699999999999999999999999999998
Q ss_pred ccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhc
Q 003278 668 FLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARK 746 (834)
Q Consensus 668 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~ 746 (834)
....... ........||+.|+|||++.+..++.++|||||||++|||+| |+.||....... +...+. ...
T Consensus 166 ~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-~~~~~~---~~~ 236 (327)
T 3lzb_A 166 LLGAEEK-----EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILE---KGE 236 (327)
T ss_dssp -------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-HHHHHH---TTC
T ss_pred EccCccc-----cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-HHHHHH---cCC
Confidence 7543221 111223457889999999999999999999999999999999 999987543322 222111 111
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCc
Q 003278 747 RPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDK 799 (834)
Q Consensus 747 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~ 799 (834)
.. ......+ . .+.+++.+||+.||++|||+.+|++.|+.+.+
T Consensus 237 ~~-------~~~~~~~-~---~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 237 RL-------PQPPICT-I---DVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp CC-------CCCTTBC-H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred CC-------CCCccCC-H---HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 00 0111122 2 35556669999999999999999999976543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=357.11 Aligned_cols=249 Identities=17% Similarity=0.224 Sum_probs=197.2
Q ss_pred HhhCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCC--ChhHHHHHHHHHHHHHhc-cCCCceeEEEEEeeCCeEE
Q 003278 511 ATNNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSK--CPALRTRFSNELQNLARL-RHRNLVQLCGWCTEQGEML 586 (834)
Q Consensus 511 at~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~E~~~l~~l-~HpNiv~l~g~~~~~~~~~ 586 (834)
..++|...+.||+|+||.||+|... +++.||||.+.... .....+.+..|..++..+ +|||||++++++.+.+..+
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 3467888899999999999999975 58899999986431 112235678899999887 9999999999999999999
Q ss_pred EEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeec
Q 003278 587 VIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALA 666 (834)
Q Consensus 587 lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla 666 (834)
+||||+++|+|..++.... .+++..+..++.|++.||+|||+ .+|+||||||+||||+.++.+||+|||++
T Consensus 95 lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a 165 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSCH------KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMC 165 (345)
T ss_dssp EEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhh
Confidence 9999999999999987532 37888999999999999999997 69999999999999999999999999999
Q ss_pred cccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhc
Q 003278 667 EFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARK 746 (834)
Q Consensus 667 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~ 746 (834)
+...... ....+.+||+.|+|||++.+..++.++|||||||++|||+||+.||....... +...+. ...
T Consensus 166 ~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~i~---~~~ 234 (345)
T 1xjd_A 166 KENMLGD-------AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-LFHSIR---MDN 234 (345)
T ss_dssp BCCCCTT-------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHH---HCC
T ss_pred hhcccCC-------CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH-HHHHHH---hCC
Confidence 7532211 12345789999999999999999999999999999999999999997543322 222111 111
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChh-HHH
Q 003278 747 RPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMR-QIL 791 (834)
Q Consensus 747 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~-~v~ 791 (834)
. ..+... ..+ +..++.+||..||++||++. +|.
T Consensus 235 ~--------~~p~~~-s~~---~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 235 P--------FYPRWL-EKE---AKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp C--------CCCTTS-CHH---HHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred C--------CCCccc-CHH---HHHHHHHHhcCCHhHcCCChHHHH
Confidence 1 111112 233 44555689999999999998 664
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=349.94 Aligned_cols=260 Identities=23% Similarity=0.358 Sum_probs=201.1
Q ss_pred hhcCCCCCCC-eeeccCCeEEEEEEE--CCCCeEEEEEEecccC--hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCE
Q 003278 108 IGSNGFDEDE-VLGSGGFGKVYRAVL--PSDGTVVAVKCLAEKG--ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQ 182 (834)
Q Consensus 108 ~~t~~f~~~~-~LG~G~fG~Vy~~~~--~~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~ 182 (834)
...++|...+ .||+|+||.||+|.+ ..++..||||++.... ....+.|.+|+.++++++||||+++++++ ..+.
T Consensus 13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~ 91 (291)
T 1xbb_A 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAES 91 (291)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSS
T ss_pred ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCC
Confidence 3445677777 999999999999954 4567899999986542 33467899999999999999999999999 5677
Q ss_pred EEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeec
Q 003278 183 LLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDF 262 (834)
Q Consensus 183 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DF 262 (834)
.++||||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 92 ~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Df 161 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQN-------RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDF 161 (291)
T ss_dssp EEEEEECCTTEEHHHHHHHC-------TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCC
T ss_pred cEEEEEeCCCCCHHHHHHhC-------cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccC
Confidence 89999999999999999653 3589999999999999999999996 9999999999999999999999999
Q ss_pred cchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCC
Q 003278 263 GLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPD 341 (834)
Q Consensus 263 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~ 341 (834)
|+++.+..... .........||+.|+|||.+... .++.++|||||||++|||+| |+.||.....
T Consensus 162 g~~~~~~~~~~-------------~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~- 226 (291)
T 1xbb_A 162 GLSKALRADEN-------------YYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG- 226 (291)
T ss_dssp TTCEECCTTCS-------------EEEC----CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-
T ss_pred CcceeeccCCC-------------cccccccCCCCceeeChHHhccC-CCChhhhHHHHHHHHHHHHhcCCCCCCCCCH-
Confidence 99976432210 00112234478999999998654 56889999999999999999 9999864321
Q ss_pred ccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcCC
Q 003278 342 DQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGSY 409 (834)
Q Consensus 342 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~~ 409 (834)
..+.. ....+.... .. ... ...+.+++..||+.||.+||++.+|++.|+..+
T Consensus 227 --~~~~~----~~~~~~~~~-----~~-~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 227 --SEVTA----MLEKGERMG-----CP-AGC----PREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp --HHHHH----HHHTTCCCC-----CC-TTC----CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred --HHHHH----HHHcCCCCC-----CC-CCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11111 112222111 10 111 246889999999999999999999999998654
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=353.25 Aligned_cols=265 Identities=21% Similarity=0.304 Sum_probs=206.6
Q ss_pred hhCcCcCCcccccCCcEEEEEEEC------CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeE
Q 003278 512 TNNFSESQRVAEMDFGTAYQGFLD------NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEM 585 (834)
Q Consensus 512 t~~f~~~~~ig~g~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~ 585 (834)
.++|...+.||+|+||.||+|... ++..||||.+...........|.+|+.++++++||||+++++++.+.+..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 103 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 103 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCcc
Confidence 456777889999999999999854 36789999997665555667899999999999999999999999999999
Q ss_pred EEEEeccCCCchhhhhhcCCC----CCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEe
Q 003278 586 LVIYDYSATRILSHLLFHNNH----RIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLG 661 (834)
Q Consensus 586 ~lv~Ey~~~g~L~~~l~~~~~----~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~ 661 (834)
++||||+++|+|.+++..... ......+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+
T Consensus 104 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~~~~~kl~ 180 (322)
T 1p4o_A 104 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIG 180 (322)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEEC
T ss_pred EEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcCCCeEEEC
Confidence 999999999999999875321 0111346889999999999999999997 699999999999999999999999
Q ss_pred eeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHH
Q 003278 662 SFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVH 740 (834)
Q Consensus 662 DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~ 740 (834)
|||+++....... ........||+.|+|||++.++.++.++|||||||++|||+| |..|+...... .....+.
T Consensus 181 Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-~~~~~~~ 254 (322)
T 1p4o_A 181 DFGMTRDIYETDY-----YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-QVLRFVM 254 (322)
T ss_dssp CTTCCCGGGGGGC-----EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH-HHHHHHH
T ss_pred cCccccccccccc-----cccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH-HHHHHHH
Confidence 9999976543221 111223467899999999999999999999999999999999 78887643222 1111111
Q ss_pred HHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCc
Q 003278 741 EFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDK 799 (834)
Q Consensus 741 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~ 799 (834)
. ..... ..... +.+ +.+++.+||+.||++|||+.+|++.|+....
T Consensus 255 ---~--~~~~~-----~~~~~-~~~---l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 255 ---E--GGLLD-----KPDNC-PDM---LFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp ---T--TCCCC-----CCTTC-CHH---HHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ---c--CCcCC-----CCCCC-CHH---HHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 1 11100 11112 233 4456668999999999999999999987644
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=353.84 Aligned_cols=265 Identities=24% Similarity=0.387 Sum_probs=204.5
Q ss_pred CCCCCCCeeeccCCeEEEEEEE----CCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCC--EEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVL----PSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHED--QLL 184 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~----~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~--~~~ 184 (834)
++|+..+.||+|+||.||+|.+ ..+|+.||||++........+.|.+|+.++++++||||+++++++...+ ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 4588889999999999999984 4679999999998766666788999999999999999999999987654 689
Q ss_pred EEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccc
Q 003278 185 LVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGL 264 (834)
Q Consensus 185 lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGl 264 (834)
+||||+++|+|.+++.... ..+++..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 121 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~ 191 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKHK------ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL 191 (326)
T ss_dssp EEECCCTTCBHHHHHHHST------TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred EEEECCCCCCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcc
Confidence 9999999999999997542 3589999999999999999999995 999999999999999999999999999
Q ss_pred hhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCC-----
Q 003278 265 ARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTY----- 339 (834)
Q Consensus 265 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~----- 339 (834)
++........ ........||..|+|||.+... .++.++|||||||++|||+||+.|+....
T Consensus 192 ~~~~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~ 257 (326)
T 2w1i_A 192 TKVLPQDKEY-------------YKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMR 257 (326)
T ss_dssp CEECCSSCSE-------------EECSSCCSCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHH
T ss_pred hhhccccccc-------------cccccCCCCceeEECchhhcCC-CCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 9864322100 0012234578899999988654 56899999999999999999998875321
Q ss_pred ----CCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 340 ----PDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 340 ----~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
..........+......+.... .. ... ...+.+++..||+.||.+||++.+|++.|+..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~-~~~----~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 258 MIGNDKQGQMIVFHLIELLKNNGRLP-----RP-DGC----PDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp HHCTTCCTHHHHHHHHHHHHTTCCCC-----CC-TTC----CHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hhccccchhhhHHHHHHHhhcCCCCC-----CC-Ccc----cHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0000111111112222111111 00 111 24688999999999999999999999998753
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=346.18 Aligned_cols=246 Identities=24% Similarity=0.415 Sum_probs=199.6
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEe-----------
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVH----------- 179 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~----------- 179 (834)
++|+..+.||+|+||.||+|.+..+|+.||||.+.... +.+.+|+.++.+++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 86 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN 86 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence 45888999999999999999998899999999987553 346789999999999999999999865
Q ss_pred -----CCEEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCC
Q 003278 180 -----EDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQ 254 (834)
Q Consensus 180 -----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~ 254 (834)
.+..++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRR-----GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDT 158 (284)
T ss_dssp --CCEEEEEEEEECCCCSCBHHHHHHHGG-----GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEET
T ss_pred ccccCcceEEEEEeccCCCCHHHHHhhcc-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCC
Confidence 445899999999999999996542 24689999999999999999999996 99999999999999999
Q ss_pred CceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCcc
Q 003278 255 YNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRA 334 (834)
Q Consensus 255 ~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p 334 (834)
+.+||+|||+++.+.... ......||+.|+|||.+... .++.++|||||||++|||+||..|
T Consensus 159 ~~~kl~Dfg~~~~~~~~~-----------------~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~ 220 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKNDG-----------------KRTRSKGTLRYMSPEQISSQ-DYGKEVDLYALGLILAELLHVCDT 220 (284)
T ss_dssp TEEEECCCTTCEESSCCS-----------------CCCCCCSCCTTSCHHHHHCS-CCCTHHHHHHHHHHHHHHHSCCSS
T ss_pred CCEEECcchhheeccccc-----------------cccccCCcccccChhhhccC-CCcchhhhHHHHHHHHHHHhcCCc
Confidence 999999999987542210 12344699999999998654 679999999999999999999987
Q ss_pred CCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 335 VDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 335 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
+... ..+...+ ..+.+. ..++ ..+.+++..||+.||.+||++.++++.|...
T Consensus 221 ~~~~--------~~~~~~~-~~~~~~---------~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~ 272 (284)
T 2a19_B 221 AFET--------SKFFTDL-RDGIIS---------DIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272 (284)
T ss_dssp HHHH--------HHHHHHH-HTTCCC---------TTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred chhH--------HHHHHHh-hccccc---------ccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 6310 1111111 111111 1122 3577899999999999999999999998764
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=359.30 Aligned_cols=268 Identities=16% Similarity=0.158 Sum_probs=203.9
Q ss_pred CCCCCCCeeeccCCeEEEEEEECC--------CCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceee----------
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPS--------DGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVR---------- 172 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~--------~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~---------- 172 (834)
++|...+.||+|+||.||+|.... +++.||||++... +.+.+|+.++.+++|||||+
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 679999999999999999999976 4889999998654 45789999999999999998
Q ss_pred -----EeeeEEe-CCEEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCC
Q 003278 173 -----LRGWCVH-EDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKT 246 (834)
Q Consensus 173 -----l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp 246 (834)
+++++.. .+..++||||+ +|+|.+++.... ...+++..+..|+.|++.||.|||+. +|+||||||
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp 187 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-----KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTA 187 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-----GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCG
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCH
Confidence 6778876 67899999999 999999997542 24689999999999999999999996 999999999
Q ss_pred CceEECCCC--ceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhH
Q 003278 247 SNVMLDSQY--NARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIV 324 (834)
Q Consensus 247 ~NILld~~~--~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvv 324 (834)
+|||++.++ .+||+|||+++.+....... .......+...||+.|+|||.+... .++.++|||||||+
T Consensus 188 ~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~---------~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~i 257 (352)
T 2jii_A 188 ENIFVDPEDQSQVTLAGYGFAFRYCPSGKHV---------AYVEGSRSPHEGDLEFISMDLHKGC-GPSRRSDLQSLGYC 257 (352)
T ss_dssp GGEEEETTEEEEEEECCGGGCBCSSGGGCCC---------CCCTTSSCTTCSCTTTCCHHHHTTC-CCCHHHHHHHHHHH
T ss_pred HHEEEcCCCCceEEEecCcceeeccCCCccc---------cccccccccccCCccccCHHHHccC-CCCchhhHHHHHHH
Confidence 999999988 89999999998654321100 0000112345799999999988654 67999999999999
Q ss_pred HHHHHhCCccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 325 VLEVVSGRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 325 l~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
+|||+||+.||....... ..+.......... .....+.......+ ...+.+++..||+.||.+||++.+|++.
T Consensus 258 l~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~--~~~~~~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~ 330 (352)
T 2jii_A 258 MLKWLYGFLPWTNCLPNT-EDIMKQKQKFVDK--PGPFVGPCGHWIRP----SETLQKYLKVVMALTYEEKPPYAMLRNN 330 (352)
T ss_dssp HHHHHHSCCTTGGGTTCH-HHHHHHHHHHHHS--CCCEECTTSCEECC----CHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHHHHhCCCCcccCCcCH-HHHHHHHHhccCC--hhhhhhhccccCCC----cHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence 999999999997543222 1222222222211 11111111000011 1468899999999999999999999999
Q ss_pred hhcCC
Q 003278 405 VSGSY 409 (834)
Q Consensus 405 l~~~~ 409 (834)
|....
T Consensus 331 L~~~~ 335 (352)
T 2jii_A 331 LEALL 335 (352)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 87653
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=347.71 Aligned_cols=253 Identities=19% Similarity=0.285 Sum_probs=193.6
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
+.|...++||+|+||.||++.. .++..||+|.+.........+.+.+|+++|++++|||||++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 4577788999999999999996 457899999987654444457899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceee---cCCCCceEeeeeeccc
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITL---DPDMNPRLGSFALAEF 668 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILl---d~~~~~ki~DfGla~~ 668 (834)
+++|+|.+++...... ...+++..+..|+.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||++..
T Consensus 102 ~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 102 CEGGELLERIVSAQAR--GKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp CSCCBHHHHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred CCCCcHHHHHHhhhhc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 9999999988653211 1348899999999999999999997 689999999999999 4568899999999976
Q ss_pred cccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCc
Q 003278 669 LTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRP 748 (834)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
..... ......||+.|+|||++. +.++.++|||||||++|||+||+.||........ ... .......
T Consensus 177 ~~~~~--------~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~-~~~---~~~~~~~ 243 (285)
T 3is5_A 177 FKSDE--------HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV-QQK---ATYKEPN 243 (285)
T ss_dssp ------------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHH---HHHCCCC
T ss_pred cCCcc--------cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHH-Hhh---hccCCcc
Confidence 53321 123457999999999985 5789999999999999999999999865432211 111 1111111
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 749 LAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 749 ~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
. ... .... .+ .+.+++.+||+.||++|||+.||++
T Consensus 244 ~-~~~----~~~~-~~---~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 244 Y-AVE----CRPL-TP---QAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp C-CC------CCC-CH---HHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred c-ccc----cCcC-CH---HHHHHHHHHccCChhhCcCHHHHhc
Confidence 1 000 0111 22 3445666899999999999999984
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=358.92 Aligned_cols=259 Identities=23% Similarity=0.304 Sum_probs=194.4
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCC------
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHED------ 181 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~------ 181 (834)
.++|...+.||+|+||.||+|.+..+|+.||||++... .....+.+.+|+.++++++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46788999999999999999999999999999998543 3445677899999999999999999999998763
Q ss_pred EEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEee
Q 003278 182 QLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGD 261 (834)
Q Consensus 182 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~D 261 (834)
..|+||||+ +++|.+++.. ..+++..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+|
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~--------~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~D 171 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH--------EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILD 171 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECC
T ss_pred eEEEEEecC-CCCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEe
Confidence 469999999 8899999864 2588999999999999999999996 999999999999999999999999
Q ss_pred ccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCC
Q 003278 262 FGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPD 341 (834)
Q Consensus 262 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~ 341 (834)
||+++.... ..+...||+.|+|||.+.....++.++|||||||+++||+||+.||......
T Consensus 172 fg~a~~~~~-------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 232 (367)
T 1cm8_A 172 FGLARQADS-------------------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL 232 (367)
T ss_dssp CTTCEECCS-------------------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred eeccccccc-------------------ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999975321 1234568999999999876557899999999999999999999998643211
Q ss_pred ccchHHHHHHHHhhcC------------------ccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 342 DQIILLDWIRRLSDEG------------------KVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 342 ~~~~l~~~~~~~~~~~------------------~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
.....+....... .+.......+. .........+.+|...||+.||.+||++.++++
T Consensus 233 ---~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 233 ---DQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFA--SILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp ---HHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGG--GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---HHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHH--HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 1111111110000 00000000000 000011245788999999999999999999987
Q ss_pred H
Q 003278 404 A 404 (834)
Q Consensus 404 ~ 404 (834)
.
T Consensus 308 h 308 (367)
T 1cm8_A 308 H 308 (367)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=350.64 Aligned_cols=248 Identities=17% Similarity=0.198 Sum_probs=187.7
Q ss_pred hCcCcCCcccccCCcEEEEEEE----CCCcEEEEEEecCCC---ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL----DNHQYVLVKRLGMSK---CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEM 585 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~----~~~~~vavK~~~~~~---~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~ 585 (834)
++|...+.||+|+||.||++.. .++..||||.+.... .......+.+|+.+|++++|||||++++++.+.+..
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 4677788999999999999987 468899999987542 122345688999999999999999999999999999
Q ss_pred EEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeee
Q 003278 586 LVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFAL 665 (834)
Q Consensus 586 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGl 665 (834)
++||||+++|+|.+++.... .+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 167 (327)
T 3a62_A 97 YLILEYLSGGELFMQLEREG------IFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGL 167 (327)
T ss_dssp EEEEECCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred EEEEeCCCCCcHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCc
Confidence 99999999999999986532 37788889999999999999997 6999999999999999999999999999
Q ss_pred ccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhh
Q 003278 666 AEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEAR 745 (834)
Q Consensus 666 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~ 745 (834)
++...... ......+||+.|||||++.+..++.++|||||||++|||+||+.||........ ...+. ..
T Consensus 168 ~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~---~~ 236 (327)
T 3a62_A 168 CKESIHDG-------TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT-IDKIL---KC 236 (327)
T ss_dssp C-----------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHH---HT
T ss_pred ccccccCC-------ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH-HHHHH---hC
Confidence 97532211 112346799999999999999999999999999999999999999975432221 11111 11
Q ss_pred cCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----ChhHHHH
Q 003278 746 KRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRP-----SMRQILS 792 (834)
Q Consensus 746 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RP-----tm~~v~~ 792 (834)
... +.... ..+ +..++.+||..||++|| ++.++++
T Consensus 237 ~~~--------~p~~~-~~~---~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 237 KLN--------LPPYL-TQE---ARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp CCC--------CCTTS-CHH---HHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred CCC--------CCCCC-CHH---HHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 111 11112 233 44555689999999999 5666654
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=340.84 Aligned_cols=250 Identities=22% Similarity=0.359 Sum_probs=195.3
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLV 186 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 186 (834)
.++|...+.||+|+||.||+|.+..+|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 367888999999999999999998899999999986432 23356789999999999999999999999999999999
Q ss_pred EEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchh
Q 003278 187 YDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLAR 266 (834)
Q Consensus 187 ~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~ 266 (834)
|||+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 90 ~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~ 159 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH-------GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSN 159 (276)
T ss_dssp EECCCSCBHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGG
T ss_pred EeccCCCcHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeeccccc
Confidence 9999999999998643 3588999999999999999999996 99999999999999999999999999997
Q ss_pred hhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchH
Q 003278 267 WLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIIL 346 (834)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l 346 (834)
...... ......||+.|+|||.+......+.++||||||+++|||+||+.||.... ...+
T Consensus 160 ~~~~~~-----------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~ 219 (276)
T 2h6d_A 160 MMSDGE-----------------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH---VPTL 219 (276)
T ss_dssp CCCC------------------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHH
T ss_pred ccCCCc-----------------ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc---HHHH
Confidence 543211 02234689999999998765444689999999999999999999986421 1111
Q ss_pred HHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 347 LDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 347 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
. .... .+.. .+. ... ...+.+++..||+.||.+||++.++++.
T Consensus 220 ~---~~~~-~~~~------~~~-~~~----~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 220 F---KKIR-GGVF------YIP-EYL----NRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp H---HHHH-HCCC------CCC-TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred H---HHhh-cCcc------cCc-hhc----CHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1 1111 1110 010 111 1457889999999999999999999974
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=342.85 Aligned_cols=256 Identities=22% Similarity=0.377 Sum_probs=201.3
Q ss_pred hCcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEecc
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYS 592 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~ 592 (834)
++|...+.||+|+||.||+|...++..||||.+..... ..+.|.+|++++++++||||+++++++.+ +..++||||+
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 89 (279)
T 1qpc_A 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (279)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc--cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecC
Confidence 45667788999999999999998888999999875432 24679999999999999999999999875 4588999999
Q ss_pred CCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccC
Q 003278 593 ATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRN 672 (834)
Q Consensus 593 ~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~ 672 (834)
++++|.+++.... ...+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||++......
T Consensus 90 ~~~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 90 ENGSLVDFLKTPS----GIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp TTCBHHHHTTSHH----HHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred CCCCHHHHHhcCC----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 9999999986432 1248899999999999999999997 69999999999999999999999999999865432
Q ss_pred CCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCcccc
Q 003278 673 DHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRPLAE 751 (834)
Q Consensus 673 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
.. .......||+.|+|||++.++.++.++|||||||++|||+| |+.|+....... ....+ .....
T Consensus 163 ~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-~~~~~---~~~~~---- 228 (279)
T 1qpc_A 163 EY------TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNL---ERGYR---- 228 (279)
T ss_dssp CE------ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-HHHHH---HTTCC----
T ss_pred cc------ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH-HHHHH---hcccC----
Confidence 11 11223457889999999998999999999999999999999 888886433221 11111 11101
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCc
Q 003278 752 LVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDK 799 (834)
Q Consensus 752 ~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~ 799 (834)
....... ++ .+.+++.+||+.||++|||+.+|++.|+.+..
T Consensus 229 ---~~~~~~~-~~---~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 269 (279)
T 1qpc_A 229 ---MVRPDNC-PE---ELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (279)
T ss_dssp ---CCCCTTC-CH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCCcccc-cH---HHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 0111112 23 34556668999999999999999999976543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=357.35 Aligned_cols=273 Identities=19% Similarity=0.263 Sum_probs=193.1
Q ss_pred hCcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCCChhHHHHHHHHHHH--HHhccCCCceeEEEEEee-----CCeE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQN--LARLRHRNLVQLCGWCTE-----QGEM 585 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~E~~~--l~~l~HpNiv~l~g~~~~-----~~~~ 585 (834)
++|...+.||+|+||.||+|.. +++.||||++.... ...+..|.++ +..++||||+++++++.. ....
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred HHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc----hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 4677788999999999999987 57889999986432 2344444444 556899999999986542 2367
Q ss_pred EEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhcc------CCceeecccccCceeecCCCCce
Q 003278 586 LVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEW------NEQVIHRNITSSAITLDPDMNPR 659 (834)
Q Consensus 586 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~------~~~iiHrDlK~~NILld~~~~~k 659 (834)
++||||+++|+|.+++.... .+|..+..|+.|++.||+|||+.. .++|+||||||+|||++.++.+|
T Consensus 88 ~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLHT-------SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEECCCTTCBHHHHHHHCC-------BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred EEEEecCCCCcHHHHHhhcc-------cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence 89999999999999996532 578889999999999999999631 12999999999999999999999
Q ss_pred EeeeeeccccccCCCCCc-ccccCccccccccCccchhcccc-------CCCCccCcchhhHHHHHHHHhCCCccCCCCC
Q 003278 660 LGSFALAEFLTRNDHGHR-KATSGNRSVRGIFGYMSPEYIES-------GEATSMADVYSFGVVVLEVVTGQMAVDFRLP 731 (834)
Q Consensus 660 i~DfGla~~~~~~~~~~~-~~~~~~~~~~Gt~~Y~aPE~~~~-------~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~ 731 (834)
|+|||+++.+........ ..........||+.|+|||++.+ ..++.++|||||||++|||+||..|+.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 999999987643321100 01112234579999999999976 4567899999999999999999887643222
Q ss_pred chhH-------------HHHHHHHHhhcCccccccccccCCC--CCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHcc
Q 003278 732 EGLL-------------VKRVHEFEARKRPLAELVDLSLNGE--YNHKELMRLIKLGIACTLSNPELRPSMRQILSILDG 796 (834)
Q Consensus 732 ~~~~-------------~~~~~~~~~~~~~~~~~~d~~l~~~--~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~ 796 (834)
.... ............. .+.+... ........+.+++.+||+.||++|||+.||++.|+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ 315 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQ-----RPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE 315 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCC-----CCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhccccc-----CCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence 1100 0000000000000 1111111 111233456777779999999999999999999987
Q ss_pred CCcccc
Q 003278 797 NDKRFM 802 (834)
Q Consensus 797 ~~~~~~ 802 (834)
+-..+.
T Consensus 316 ll~~~~ 321 (336)
T 3g2f_A 316 LMMIWE 321 (336)
T ss_dssp HHHCCC
T ss_pred HHHHHH
Confidence 654433
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=355.05 Aligned_cols=245 Identities=16% Similarity=0.172 Sum_probs=197.2
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCC--hhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKC--PALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIY 589 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~ 589 (834)
++|...+.||+|+||.||++... ++..||||.+..... ....+.+.+|+.+|++++|||||++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 46777889999999999999974 688999999864221 122467889999999999999999999999999999999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccc
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFL 669 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~ 669 (834)
||+++|+|.+++...+ .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 121 e~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~ 191 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIG------RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191 (350)
T ss_dssp ECCTTCBHHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred cCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceec
Confidence 9999999999987532 37888899999999999999997 69999999999999999999999999999764
Q ss_pred ccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcc
Q 003278 670 TRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPL 749 (834)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
... ..+.+||+.|+|||++.+..++.++|||||||++|||+||+.||....+.. ....+. .....
T Consensus 192 ~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~i~---~~~~~- 256 (350)
T 1rdq_E 192 KGR----------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-IYEKIV---SGKVR- 256 (350)
T ss_dssp SSC----------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHH---HCCCC-
T ss_pred cCC----------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH-HHHHHH---cCCCC-
Confidence 321 234689999999999999999999999999999999999999997543222 112111 11111
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCC-----hhHHHH
Q 003278 750 AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPS-----MRQILS 792 (834)
Q Consensus 750 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPt-----m~~v~~ 792 (834)
++..++ .+ +..++.+||+.||++||+ +.+|.+
T Consensus 257 -------~p~~~~-~~---~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 257 -------FPSHFS-SD---LKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -------CCTTCC-HH---HHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -------CCCCCC-HH---HHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 111222 33 445556899999999998 777764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=343.21 Aligned_cols=252 Identities=17% Similarity=0.228 Sum_probs=198.5
Q ss_pred hhCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCC-ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEE
Q 003278 512 TNNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSK-CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIY 589 (834)
Q Consensus 512 t~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~ 589 (834)
.++|...+.||+|+||.||+|... ++..||||.+.... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 367777889999999999999864 58899999986543 3344577899999999999999999999999999999999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCC---ceEeeeeec
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMN---PRLGSFALA 666 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~---~ki~DfGla 666 (834)
||+++++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++. +||+|||++
T Consensus 85 e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~ 155 (284)
T 3kk8_A 85 DLVTGGELFEDIVARE------FYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLA 155 (284)
T ss_dssp CCCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred ecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceee
Confidence 9999999988886532 37889999999999999999997 68999999999999986655 999999999
Q ss_pred cccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhc
Q 003278 667 EFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARK 746 (834)
Q Consensus 667 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~ 746 (834)
....... ......||+.|+|||++.+..++.++|||||||++|||+||+.||....... ...... ...
T Consensus 156 ~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~---~~~ 223 (284)
T 3kk8_A 156 IEVNDSE--------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-LYAQIK---AGA 223 (284)
T ss_dssp EECCSSC--------BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHH---HTC
T ss_pred EEcccCc--------cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH-HHHHHH---hcc
Confidence 7643221 1224579999999999999999999999999999999999999986543221 111111 111
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 747 RPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 747 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
.. ...+. .... ..+ +.+++.+||+.||++|||+.|+++
T Consensus 224 ~~---~~~~~-~~~~-~~~---~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 224 YD---YPSPE-WDTV-TPE---AKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp CC---CCTTT-TTTS-CHH---HHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cc---CCchh-hccc-CHH---HHHHHHHHcccChhhCCCHHHHhc
Confidence 10 00000 0111 233 445666899999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=347.41 Aligned_cols=249 Identities=26% Similarity=0.447 Sum_probs=202.4
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC-hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEc
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG-ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDY 189 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 189 (834)
+.|+..+.||+|+||.||+|....+++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 45888899999999999999998899999999986542 34467899999999999999999999999999999999999
Q ss_pred cCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhh
Q 003278 190 MPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLE 269 (834)
Q Consensus 190 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~ 269 (834)
+++++|.+++.. .++++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+.
T Consensus 102 ~~~~~L~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 170 (303)
T 3a7i_A 102 LGGGSALDLLEP--------GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT 170 (303)
T ss_dssp CTTEEHHHHHTT--------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECB
T ss_pred CCCCcHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecC
Confidence 999999999853 3589999999999999999999996 99999999999999999999999999997543
Q ss_pred hhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHH
Q 003278 270 HELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDW 349 (834)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~ 349 (834)
... .......||+.|+|||.+... .++.++|||||||++|||+||+.|+..... ......
T Consensus 171 ~~~----------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~ 230 (303)
T 3a7i_A 171 DTQ----------------IKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELARGEPPHSELHP---MKVLFL 230 (303)
T ss_dssp TTB----------------CCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHH
T ss_pred ccc----------------cccCccCCCcCccCHHHHhcC-CCCchhhhHHHHHHHHHHccCCCCCCCcCH---HHHHHH
Confidence 210 012345699999999998654 678899999999999999999999864321 111111
Q ss_pred HHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 350 IRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 350 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
+ ..+.. +.+. ..++ ..+..++..||+.||.+||++.++++.
T Consensus 231 ~----~~~~~-----~~~~-~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 231 I----PKNNP-----PTLE-GNYS----KPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp H----HHSCC-----CCCC-SSCC----HHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred h----hcCCC-----CCCc-cccC----HHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 1 11111 1111 1122 357899999999999999999999864
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=386.02 Aligned_cols=250 Identities=20% Similarity=0.303 Sum_probs=193.1
Q ss_pred CcccccCCcEEEEEEEC---CCcEEEEEEecCCC-ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEeccCC
Q 003278 519 QRVAEMDFGTAYQGFLD---NHQYVLVKRLGMSK-CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSAT 594 (834)
Q Consensus 519 ~~ig~g~~g~vy~~~~~---~~~~vavK~~~~~~-~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~~~ 594 (834)
+.||+|+||.||+|.+. .+..||||+++... .....++|.+|+++|.+++|||||+++|+|.+ +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 46999999999999753 45789999987543 23446789999999999999999999999965 558899999999
Q ss_pred CchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCCC
Q 003278 595 RILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDH 674 (834)
Q Consensus 595 g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~~ 674 (834)
|+|.+++.... .+++..++.|+.||+.||+|||+ .+||||||||+||||+.++.+||+|||+++.+.....
T Consensus 454 g~L~~~l~~~~------~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 524 (635)
T 4fl3_A 454 GPLNKYLQQNR------HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 524 (635)
T ss_dssp EEHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---
T ss_pred CCHHHHHhhCC------CCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc
Confidence 99999996532 38899999999999999999997 6899999999999999999999999999987643321
Q ss_pred CCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCcccccc
Q 003278 675 GHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRPLAELV 753 (834)
Q Consensus 675 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (834)
. ........||+.|||||++.+..++.++|||||||+||||+| |+.||...... .+...+ ......
T Consensus 525 ~----~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-~~~~~i---~~~~~~----- 591 (635)
T 4fl3_A 525 Y----YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-EVTAML---EKGERM----- 591 (635)
T ss_dssp --------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHHH---HTTCCC-----
T ss_pred c----cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHH---HcCCCC-----
Confidence 1 111223457889999999999999999999999999999999 99998654322 111111 111110
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccC
Q 003278 754 DLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGN 797 (834)
Q Consensus 754 d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~ 797 (834)
..... .+. .+.+++..||+.||++||||.+|++.|+.+
T Consensus 592 --~~p~~-~~~---~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 592 --GCPAG-CPR---EMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp --CCCTT-CCH---HHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred --CCCCC-CCH---HHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11111 223 355566689999999999999999999754
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=344.60 Aligned_cols=247 Identities=26% Similarity=0.434 Sum_probs=201.0
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 187 (834)
++|...+.||+|+||.||+|....++..||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 56888999999999999999998899999999986431 223567899999999999999999999999999999999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
||+++|+|.+++... ..+++..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+|||++..
T Consensus 94 e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~ 163 (284)
T 2vgo_A 94 EFAPRGELYKELQKH-------GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVH 163 (284)
T ss_dssp CCCTTEEHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EeCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEeccccccc
Confidence 999999999998643 3588999999999999999999985 999999999999999999999999999864
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHH
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILL 347 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~ 347 (834)
.... ......||+.|+|||.+... .++.++|||||||++|||+||+.||......
T Consensus 164 ~~~~------------------~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------ 218 (284)
T 2vgo_A 164 APSL------------------RRRTMCGTLDYLPPEMIEGK-THDEKVDLWCAGVLCYEFLVGMPPFDSPSHT------ 218 (284)
T ss_dssp CSSS------------------CBCCCCSCGGGCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------
T ss_pred Cccc------------------ccccccCCCCcCCHHHhccC-CCCcccchhhHHHHHHHHHHCCCCCCCCCHh------
Confidence 3210 12345699999999988654 6789999999999999999999998643211
Q ss_pred HHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 348 DWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 348 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
........ .. ..+. ... ...+.+++..||+.||.+||++.++++.
T Consensus 219 ~~~~~~~~-~~------~~~~-~~~----~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 219 ETHRRIVN-VD------LKFP-PFL----SDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp HHHHHHHT-TC------CCCC-TTS----CHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred HHHHHHhc-cc------cCCC-CcC----CHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 11111111 11 1111 111 1457889999999999999999999863
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=367.88 Aligned_cols=264 Identities=17% Similarity=0.169 Sum_probs=201.9
Q ss_pred ccHHHHHHHhhCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCC--hhHHHHHHHHHHHHHhccCCCceeEEEEE
Q 003278 503 ISFKEIISATNNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKC--PALRTRFSNELQNLARLRHRNLVQLCGWC 579 (834)
Q Consensus 503 ~~~~el~~at~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~E~~~l~~l~HpNiv~l~g~~ 579 (834)
+.+.++....++|...+.||+|+||.||++... +++.||||++..... ....+.+.+|..+|.+++|||||++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 345555566789999999999999999999974 689999999863211 11224578899999999999999999999
Q ss_pred eeCCeEEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCce
Q 003278 580 TEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPR 659 (834)
Q Consensus 580 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~k 659 (834)
.+.+..++||||+++|+|.+++...+. .+++..+..++.|++.||+|||+ .+||||||||+|||||.++.+|
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vk 202 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKFGE-----RIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIR 202 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHSS-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEE
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEE
Confidence 999999999999999999999975421 37888889999999999999997 6999999999999999999999
Q ss_pred EeeeeeccccccCCCCCcccccCccccccccCccchhccc-------cCCCCccCcchhhHHHHHHHHhCCCccCCCCCc
Q 003278 660 LGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIE-------SGEATSMADVYSFGVVVLEVVTGQMAVDFRLPE 732 (834)
Q Consensus 660 i~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-------~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~ 732 (834)
|+|||+++.+..... ......+||+.|||||++. .+.|+.++|||||||++|||+||+.||......
T Consensus 203 L~DFGla~~~~~~~~------~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~ 276 (412)
T 2vd5_A 203 LADFGSCLKLRADGT------VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA 276 (412)
T ss_dssp ECCCTTCEECCTTSC------EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred EeechhheeccCCCc------cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH
Confidence 999999986543211 1123468999999999997 467899999999999999999999999754433
Q ss_pred hhHHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCC---CChhHHHH
Q 003278 733 GLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELR---PSMRQILS 792 (834)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~R---Ptm~~v~~ 792 (834)
.. ...+...... ..+ +...... ..++. .++.+||. +|++| |++.||.+
T Consensus 277 ~~-~~~i~~~~~~-~~~-----p~~~~~~-s~~~~---dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 277 ET-YGKIVHYKEH-LSL-----PLVDEGV-PEEAR---DFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HH-HHHHHTHHHH-CCC-----C----CC-CHHHH---HHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred HH-HHHHHhcccC-cCC-----CccccCC-CHHHH---HHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 22 2222111110 001 1111112 23444 44558998 99998 68888864
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=346.40 Aligned_cols=251 Identities=22% Similarity=0.351 Sum_probs=198.7
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEcc
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYM 190 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 190 (834)
++|...+.||+|+||.||+|....+|+.||||++........+.+.+|+.++.+++||||+++++++.+.+..++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV 88 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence 46888899999999999999998899999999997654444567889999999999999999999999999999999999
Q ss_pred CCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEE---CCCCceEEeeccchhh
Q 003278 191 PNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVML---DSQYNARLGDFGLARW 267 (834)
Q Consensus 191 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILl---d~~~~~kl~DFGla~~ 267 (834)
++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 ~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~ 158 (304)
T 2jam_A 89 SGGELFDRILER-------GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM 158 (304)
T ss_dssp CSCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred CCccHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence 999999988643 3588999999999999999999996 99999999999999 7888999999999874
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHH
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILL 347 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~ 347 (834)
.... ......||+.|+|||.+... .++.++|||||||++|||+||+.||.... ...+.
T Consensus 159 ~~~~------------------~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~ 216 (304)
T 2jam_A 159 EQNG------------------IMSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVITYILLCGYPPFYEET---ESKLF 216 (304)
T ss_dssp CCCB------------------TTHHHHSCCCBCCTTTBSSC-SCCHHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHH
T ss_pred cCCC------------------ccccccCCCCccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCC---HHHHH
Confidence 3211 02234589999999988654 67999999999999999999999986432 11111
Q ss_pred HHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 348 DWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 348 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
..+. ++... .. .... ... ...+.+++..||+.||.+||++.++++.
T Consensus 217 ---~~i~-~~~~~-~~-~~~~-~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 217 ---EKIK-EGYYE-FE-SPFW-DDI----SESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp ---HHHH-HCCCC-CC-TTTT-TTS----CHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ---HHHH-cCCCC-CC-cccc-ccC----CHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1111 11110 00 0000 111 2467889999999999999999999863
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=344.96 Aligned_cols=260 Identities=25% Similarity=0.378 Sum_probs=198.0
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCC---CeEEEEEEeccc-ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEe-CCEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSD---GTVVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNLVRLRGWCVH-EDQLLL 185 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~---g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-~~~~~l 185 (834)
..|...+.||+|+||.||+|.+..+ +..||||.+... .....+.|.+|+.++++++||||++++++|.. ++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 4577889999999999999997533 346899998753 33455779999999999999999999999764 457899
Q ss_pred EEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccch
Q 003278 186 VYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLA 265 (834)
Q Consensus 186 V~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla 265 (834)
||||+++|+|.+++... ...+++..+..|+.|++.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 105 v~e~~~~~~L~~~l~~~------~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a 175 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNE------THNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLA 175 (298)
T ss_dssp EEECCTTCBHHHHHHCT------TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGG
T ss_pred EEeCCCCCCHHHHHHhc------ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccc
Confidence 99999999999999653 24578999999999999999999996 9999999999999999999999999999
Q ss_pred hhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCC-ccCCCCCCCccc
Q 003278 266 RWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR-RAVDLTYPDDQI 344 (834)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~-~p~~~~~~~~~~ 344 (834)
+.+...... .....+...||+.|+|||.+... .++.++|||||||++|||+||. +|+......+
T Consensus 176 ~~~~~~~~~------------~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~-- 240 (298)
T 3f66_A 176 RDMYDKEYY------------SVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-- 240 (298)
T ss_dssp CCCSCGGGC------------BC-----CCBCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT--
T ss_pred ccccccchh------------ccccccCCCCCccccChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH--
Confidence 865332110 11123445689999999998655 6799999999999999999954 4544322211
Q ss_pred hHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcCC
Q 003278 345 ILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGSY 409 (834)
Q Consensus 345 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~~ 409 (834)
+...+ . .+... ..+ ... ...+.+++..||+.||.+||++.++++.|+...
T Consensus 241 -~~~~~---~-~~~~~--~~~----~~~----~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 290 (298)
T 3f66_A 241 -ITVYL---L-QGRRL--LQP----EYC----PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 290 (298)
T ss_dssp -HHHHH---H-TTCCC--CCC----TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HHHHH---h-cCCCC--CCC----ccC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11111 1 11110 000 111 145889999999999999999999999998754
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=345.78 Aligned_cols=257 Identities=22% Similarity=0.364 Sum_probs=201.7
Q ss_pred CCCCCCC-eeeccCCeEEEEEEEC--CCCeEEEEEEeccc-ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEE
Q 003278 111 NGFDEDE-VLGSGGFGKVYRAVLP--SDGTVVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLV 186 (834)
Q Consensus 111 ~~f~~~~-~LG~G~fG~Vy~~~~~--~~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 186 (834)
++|...+ .||+|+||.||+|.+. .++..||||++... .....+.+.+|+.++++++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4455555 8999999999999864 46788999998764 334567899999999999999999999999 55679999
Q ss_pred EEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchh
Q 003278 187 YDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLAR 266 (834)
Q Consensus 187 ~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~ 266 (834)
|||+++|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~ 158 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGK------REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSK 158 (287)
T ss_dssp EECCTTEEHHHHHTTC------TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEeCCCCCHHHHHHhC------CccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECccccee
Confidence 9999999999998643 24689999999999999999999996 99999999999999999999999999998
Q ss_pred hhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccch
Q 003278 267 WLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQII 345 (834)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~ 345 (834)
.+..... .........||+.|+|||.+... .++.++|||||||++|||+| |+.||...... .
T Consensus 159 ~~~~~~~-------------~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~ 221 (287)
T 1u59_A 159 ALGADDS-------------YYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---E 221 (287)
T ss_dssp ECTTCSC-------------EECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---H
T ss_pred eeccCcc-------------eeeccccccccccccCHHHhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCCHH---H
Confidence 6532210 00112334578999999988654 57899999999999999999 99998653221 1
Q ss_pred HHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 346 LLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 346 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
+...+ ..+.... .. ... ...+.+++..||+.||.+||++.++++.|...
T Consensus 222 ~~~~i----~~~~~~~-----~~-~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 222 VMAFI----EQGKRME-----CP-PEC----PPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp HHHHH----HTTCCCC-----CC-TTC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHH----hcCCcCC-----CC-CCc----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 21111 1221111 11 111 24688999999999999999999999998765
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=345.87 Aligned_cols=262 Identities=20% Similarity=0.303 Sum_probs=192.9
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCC--ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSK--CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIY 589 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~--~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~ 589 (834)
++|...+.||+|+||.||+|.. .++..||||.+.... .......|.+|+.++++++||||+++++++.+.+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 3567778899999999999996 568899999987532 3445678999999999999999999999999999999999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccc
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFL 669 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~ 669 (834)
||+.+|+|.+++..... ....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++...
T Consensus 112 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKK--QKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp ECCCSCBHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred ecCCCCCHHHHHHHhcc--cccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 99999999999865321 12347889999999999999999997 69999999999999999999999999999765
Q ss_pred ccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcc
Q 003278 670 TRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPL 749 (834)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
.... .......||+.|+|||++.+..++.++|||||||++|||+||+.|+........ ......... ..
T Consensus 187 ~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~--~~ 255 (310)
T 2wqm_A 187 SSKT-------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY--SLCKKIEQC--DY 255 (310)
T ss_dssp -------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHH--HHHHHHHTT--CS
T ss_pred cCCC-------ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHH--HHHHHhhcc--cC
Confidence 3321 112235789999999999999999999999999999999999999864322211 111111111 11
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCC
Q 003278 750 AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGND 798 (834)
Q Consensus 750 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~ 798 (834)
. .+.......+ +.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 256 ~-----~~~~~~~~~~---l~~li~~~l~~dp~~Rps~~~il~~l~~l~ 296 (310)
T 2wqm_A 256 P-----PLPSDHYSEE---LRQLVNMCINPDPEKRPDVTYVYDVAKRMH 296 (310)
T ss_dssp C-----CCCTTTSCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C-----CCcccccCHH---HHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 1 1111111233 445666899999999999999999986653
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=350.50 Aligned_cols=263 Identities=22% Similarity=0.277 Sum_probs=201.0
Q ss_pred hCcCcCCcccccCCcEEEEEEE------CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL------DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEML 586 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~ 586 (834)
++|...+.||+|+||.||+|.. .++..||||.+..........+|.+|+.++++++|||||++++++.+.+..+
T Consensus 30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (327)
T 2yfx_A 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 109 (327)
T ss_dssp GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcE
Confidence 4567778899999999999984 3467899999976555566678999999999999999999999999999999
Q ss_pred EEEeccCCCchhhhhhcCCCCC-CCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecC---CCCceEee
Q 003278 587 VIYDYSATRILSHLLFHNNHRI-GHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDP---DMNPRLGS 662 (834)
Q Consensus 587 lv~Ey~~~g~L~~~l~~~~~~~-~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~---~~~~ki~D 662 (834)
+||||+++|+|.+++....... ....+++..++.++.|++.||+|||+ .+|+||||||+|||++. +..+||+|
T Consensus 110 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl~D 186 (327)
T 2yfx_A 110 ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGD 186 (327)
T ss_dssp EEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEECc
Confidence 9999999999999998654321 12358899999999999999999997 69999999999999994 45699999
Q ss_pred eeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHH
Q 003278 663 FALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHE 741 (834)
Q Consensus 663 fGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~ 741 (834)
||++........ ........||+.|+|||++.++.++.++|||||||++|||+| |..|+...... .....+
T Consensus 187 fg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~~~~~-- 258 (327)
T 2yfx_A 187 FGMARDIYRASY-----YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-EVLEFV-- 258 (327)
T ss_dssp CHHHHHHHC-----------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-HHHHHH--
T ss_pred cccccccccccc-----cccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH-HHHHHH--
Confidence 999976533221 111224568999999999999999999999999999999999 88888643322 111111
Q ss_pred HHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCC
Q 003278 742 FEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGND 798 (834)
Q Consensus 742 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~ 798 (834)
.....+ ...... +. .+.+++.+||+.||++|||+.+|++.|+...
T Consensus 259 -~~~~~~-------~~~~~~-~~---~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 259 -TSGGRM-------DPPKNC-PG---PVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp -HTTCCC-------CCCTTC-CH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -hcCCCC-------CCCCCC-CH---HHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 111110 111122 23 3455666999999999999999999987543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=360.80 Aligned_cols=268 Identities=21% Similarity=0.237 Sum_probs=195.6
Q ss_pred HHhhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeC-----
Q 003278 106 LYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHE----- 180 (834)
Q Consensus 106 l~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~----- 180 (834)
+....++|...+.||+|+||.||+|.+..+|+.||||++..... .+.+|+.+++.++|||||+++++|...
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 34566789999999999999999999999999999999865422 234699999999999999999999543
Q ss_pred ---------------------------------CEEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHH
Q 003278 181 ---------------------------------DQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAA 227 (834)
Q Consensus 181 ---------------------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~g 227 (834)
...++||||++ |+|.+.+.... .....+++..+..|+.|+++|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~l~~~~~~~i~~qi~~a 153 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFI---RSGRSIPMNLISIYIYQLFRA 153 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHH---HTTCCCCHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHH---hcCCCCCHHHHHHHHHHHHHH
Confidence 34899999998 58887775421 123578999999999999999
Q ss_pred HHHHHhccCCCeecCCCCCCceEEC-CCCceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCcccc
Q 003278 228 LHYLHEQLETQIIHRDVKTSNVMLD-SQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESF 306 (834)
Q Consensus 228 L~yLH~~~~~~iiHrDlKp~NILld-~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~ 306 (834)
|.|||+. +|+||||||+|||++ .++.+||+|||+|+.+.... ......||+.|+|||.+
T Consensus 154 L~~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-----------------~~~~~~~t~~y~aPE~~ 213 (383)
T 3eb0_A 154 VGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-----------------PSVAYICSRFYRAPELM 213 (383)
T ss_dssp HHHHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-----------------CCCCCCCCSSCCCHHHH
T ss_pred HHHHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-----------------CCcCcccCCCccCHHHh
Confidence 9999985 999999999999998 68899999999998542210 12345689999999998
Q ss_pred ccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHHHHHHhh---------cCccccccccccCCCC----CC
Q 003278 307 QKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIRRLSD---------EGKVLQAGDNRLSDGS----YK 373 (834)
Q Consensus 307 ~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~---------~~~~~~~~d~~l~~~~----~~ 373 (834)
.....++.++|||||||++|||++|+.||......+ .+...+..+.. ........-+.+.... ..
T Consensus 214 ~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (383)
T 3eb0_A 214 LGATEYTPSIDLWSIGCVFGELILGKPLFSGETSID--QLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILP 291 (383)
T ss_dssp TTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSC
T ss_pred cCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCC
Confidence 765568999999999999999999999997532211 11111111000 0000000000000000 00
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 374 LCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 374 ~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
......+.+|+..||+.||.+|||+.|+++
T Consensus 292 ~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 292 EGTPSLAIDLLEQILRYEPDLRINPYEAMA 321 (383)
T ss_dssp TTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111245789999999999999999999986
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=355.34 Aligned_cols=243 Identities=20% Similarity=0.267 Sum_probs=195.6
Q ss_pred hhCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCCh-------hHHHHHHHHHHHHHhccCCCceeEEEEEeeCC
Q 003278 512 TNNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCP-------ALRTRFSNELQNLARLRHRNLVQLCGWCTEQG 583 (834)
Q Consensus 512 t~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~ 583 (834)
.++|...+.||+|+||.||+|.. .++..||||.+...... ...+.|.+|+.+|++++|||||++++++.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 46788889999999999999985 56889999998754321 12345778999999999999999999999999
Q ss_pred eEEEEEeccCCC-chhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEee
Q 003278 584 EMLVIYDYSATR-ILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGS 662 (834)
Q Consensus 584 ~~~lv~Ey~~~g-~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~D 662 (834)
..++||||+.+| +|..++.... .+++..+..|+.|++.||+|||+ .+|+||||||+|||++.++.+||+|
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~~------~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~D 173 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRHP------RLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLID 173 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTCC------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECC
T ss_pred EEEEEEEeCCCCccHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEee
Confidence 999999999877 9999886532 38899999999999999999997 6899999999999999999999999
Q ss_pred eeeccccccCCCCCcccccCccccccccCccchhccccCCC-CccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHH
Q 003278 663 FALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEA-TSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHE 741 (834)
Q Consensus 663 fGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~ 741 (834)
||+++.+.... ......||+.|+|||++.+..+ +.++|||||||++|||+||+.||......
T Consensus 174 fg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------- 236 (335)
T 3dls_A 174 FGSAAYLERGK--------LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------- 236 (335)
T ss_dssp CTTCEECCTTC--------CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---------
T ss_pred cccceECCCCC--------ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---------
Confidence 99998654321 1234679999999999988877 78899999999999999999998531100
Q ss_pred HHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHH
Q 003278 742 FEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSI 793 (834)
Q Consensus 742 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~ 793 (834)
......+ .....++ +..++.+||+.||++|||+.+|++.
T Consensus 237 -------~~~~~~~---~~~~~~~---l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 -------VEAAIHP---PYLVSKE---LMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -------TTTCCCC---SSCCCHH---HHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -------HhhccCC---CcccCHH---HHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000 0111233 4455568999999999999999873
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=369.41 Aligned_cols=249 Identities=19% Similarity=0.227 Sum_probs=188.9
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCC--CChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMS--KCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIY 589 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~--~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~ 589 (834)
++|...+.||+|+||.||+|.. .++..||||.+... ........+.+|+.+|++++|||||+++++|.+.+..++||
T Consensus 148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 227 (446)
T 4ejn_A 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM 227 (446)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence 4577788999999999999986 56889999998642 12233456889999999999999999999999999999999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccc
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFL 669 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~ 669 (834)
||+++|+|..++.... .+++..+..++.|++.||+|||+. .+||||||||+||||+.++.+||+|||+++..
T Consensus 228 e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~--~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 228 EYANGGELFFHLSRER------VFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp CCCSSCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHH--TCCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred eeCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHhhc--CCEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 9999999999886532 488999999999999999999962 58999999999999999999999999999753
Q ss_pred ccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcc
Q 003278 670 TRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPL 749 (834)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
.... ......+||+.|||||++.+..++.++|||||||+||||+||+.||....... +...+. .....
T Consensus 300 ~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~i~---~~~~~- 367 (446)
T 4ejn_A 300 IKDG-------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-LFELIL---MEEIR- 367 (446)
T ss_dssp CC------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHH---HCCCC-
T ss_pred cCCC-------cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH-HHHHHH---hCCCC-
Confidence 3221 11235689999999999999999999999999999999999999996543222 111111 11111
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----ChhHHHH
Q 003278 750 AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRP-----SMRQILS 792 (834)
Q Consensus 750 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RP-----tm~~v~~ 792 (834)
.+...+ .+ +..++.+||+.||++|| |+.|+++
T Consensus 368 -------~p~~~~-~~---~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 368 -------FPRTLG-PE---AKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp -------CCTTSC-HH---HHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -------CCccCC-HH---HHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 111222 33 44555689999999999 9999875
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=354.82 Aligned_cols=276 Identities=22% Similarity=0.301 Sum_probs=194.8
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHH--HHhCCCCceeeEeeeEEe-----CCE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVA--VAHLRHRNLVRLRGWCVH-----EDQ 182 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~--l~~l~H~nIv~l~g~~~~-----~~~ 182 (834)
.++|...+.||+|+||.||+|.. +++.||||++.... ...+..|..+ +..++||||+++++++.. ...
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 46788999999999999999987 68999999986442 2334444444 556899999999986653 236
Q ss_pred EEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhcc------CCCeecCCCCCCceEECCCCc
Q 003278 183 LLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQL------ETQIIHRDVKTSNVMLDSQYN 256 (834)
Q Consensus 183 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------~~~iiHrDlKp~NILld~~~~ 256 (834)
.++||||+++|+|.+++... ..+|..+..|+.|+++||.|||+.+ .++|+||||||+|||++.++.
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~--------~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 158 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLH--------TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT 158 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHC--------CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC
T ss_pred EEEEEecCCCCcHHHHHhhc--------ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc
Confidence 79999999999999999643 3588999999999999999999852 228999999999999999999
Q ss_pred eEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccC------CCCCcccceeehhhHHHHHHh
Q 003278 257 ARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKG------SVATAKSDVFSFGIVVLEVVS 330 (834)
Q Consensus 257 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~------~~~~~ksDV~SfGvvl~Ellt 330 (834)
+||+|||+++.+........ ...........||+.|+|||.+... ..++.++|||||||++|||+|
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~--------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~ 230 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRP--------GEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM 230 (336)
T ss_dssp EEECCCTTCEECSSSSCC-----------------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEeeccceeecccccccCc--------cccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHh
Confidence 99999999986533210000 0000112345699999999988642 234678999999999999999
Q ss_pred CCccCCCCCCCccc--hH---------HHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchh
Q 003278 331 GRRAVDLTYPDDQI--IL---------LDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMK 399 (834)
Q Consensus 331 G~~p~~~~~~~~~~--~l---------~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~ 399 (834)
|+.|+......... .+ ..................... .........+.+|+..||+.||.+|||+.
T Consensus 231 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 307 (336)
T 3g2f_A 231 RCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAW---KENSLAVRSLKETIEDCWDQDAEARLTAQ 307 (336)
T ss_dssp TBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTC---CCCSHHHHHHHHHHHHHSCSSGGGSCCHH
T ss_pred cCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCccc---ccccchHHHHHHHHHHHhcCChhhCcchH
Confidence 98876432221110 00 011111111111111111111 11122345689999999999999999999
Q ss_pred hHHHHhhcCC
Q 003278 400 WVIEAVSGSY 409 (834)
Q Consensus 400 ~V~~~l~~~~ 409 (834)
+|++.|+...
T Consensus 308 e~l~~L~~ll 317 (336)
T 3g2f_A 308 XAEERMAELM 317 (336)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 9999987753
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=346.86 Aligned_cols=256 Identities=20% Similarity=0.311 Sum_probs=203.8
Q ss_pred hhCcCcCCcccccCCcEEEEEEECC-CcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEe
Q 003278 512 TNNFSESQRVAEMDFGTAYQGFLDN-HQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYD 590 (834)
Q Consensus 512 t~~f~~~~~ig~g~~g~vy~~~~~~-~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~E 590 (834)
.++|...+.||+|+||.||+|...+ +..||||.+.... ...+.|.+|+.++++++||||+++++++.+.+..++|||
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS--THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 3567777889999999999999754 7889999986543 345679999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccc
Q 003278 591 YSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLT 670 (834)
Q Consensus 591 y~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~ 670 (834)
|+++++|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++....
T Consensus 90 ~~~~~~L~~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp CCTTEEHHHHHHHCCT----TTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred cCCCCcHHHHHHhccc----CCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 9999999999976432 348899999999999999999997 589999999999999999999999999998654
Q ss_pred cCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCcc
Q 003278 671 RNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRPL 749 (834)
Q Consensus 671 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
.... .......||+.|+|||++.+..++.++|||||||++|||+| |..|+....... ...... ....
T Consensus 163 ~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~-~~~~~~---~~~~-- 230 (288)
T 3kfa_A 163 GDTY------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLE---KDYR-- 230 (288)
T ss_dssp SSSS------EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-HHHHHH---TTCC--
T ss_pred CCcc------ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHh---ccCC--
Confidence 3211 11223467889999999999999999999999999999999 888886433222 111111 1100
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccC
Q 003278 750 AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGN 797 (834)
Q Consensus 750 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~ 797 (834)
....... ++ .+.+++.+||+.||++|||+.+|++.|+..
T Consensus 231 -----~~~~~~~-~~---~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 231 -----MERPEGC-PE---KVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp -----CCCCTTC-CH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCCCC-CH---HHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 0111112 23 345566699999999999999999999754
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=345.67 Aligned_cols=256 Identities=17% Similarity=0.200 Sum_probs=187.2
Q ss_pred CcccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhc-cCCCceeEEEEEeeCCeEEEEEeccCCCc
Q 003278 519 QRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARL-RHRNLVQLCGWCTEQGEMLVIYDYSATRI 596 (834)
Q Consensus 519 ~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l-~HpNiv~l~g~~~~~~~~~lv~Ey~~~g~ 596 (834)
+.||+|+||.||+|.. .++..||||++.... ....+.+.+|+++|.++ +|||||++++++.+.+..++||||+++|+
T Consensus 19 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 97 (316)
T 2ac3_A 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQP-GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGS 97 (316)
T ss_dssp CCCCCCSSEEEEEEECSSSCCEEEEEEEECCS-SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred ceecCCceEEEEEEEEcCCCcEEEEEEEeeCc-chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCc
Confidence 6799999999999984 568899999987543 23356789999999985 79999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCC---ceEeeeeeccccccCC
Q 003278 597 LSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMN---PRLGSFALAEFLTRND 673 (834)
Q Consensus 597 L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~---~ki~DfGla~~~~~~~ 673 (834)
|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++. +||+|||++.......
T Consensus 98 L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~ 168 (316)
T 2ac3_A 98 ILSHIHKRR------HFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG 168 (316)
T ss_dssp HHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC------
T ss_pred HHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCC
Confidence 999987532 37888999999999999999997 69999999999999998776 9999999997654322
Q ss_pred CCCcccccCccccccccCccchhcccc-----CCCCccCcchhhHHHHHHHHhCCCccCCCCCchh-----------HHH
Q 003278 674 HGHRKATSGNRSVRGIFGYMSPEYIES-----GEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGL-----------LVK 737 (834)
Q Consensus 674 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-----~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~-----------~~~ 737 (834)
..............||+.|+|||++.. ..++.++|||||||++|||+||+.||........ ...
T Consensus 169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 248 (316)
T 2ac3_A 169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM 248 (316)
T ss_dssp -------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHH
T ss_pred ccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHH
Confidence 111111112234569999999999875 5689999999999999999999999965432110 000
Q ss_pred HHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 738 RVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 738 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
........... ..+... ...+ . .+..++.+||+.||++|||+.|+++
T Consensus 249 ~~~~i~~~~~~---~~~~~~-~~~~-~---~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 249 LFESIQEGKYE---FPDKDW-AHIS-C---AAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHCCCC---CCHHHH-TTSC-H---HHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHhccCcc---cCchhc-ccCC-H---HHHHHHHHHhhCChhhCCCHHHHhc
Confidence 00111111100 000000 0111 2 3556666999999999999999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=356.04 Aligned_cols=253 Identities=11% Similarity=0.029 Sum_probs=196.2
Q ss_pred hhCcCcCCcccccCCcEEEEEE------ECCCcEEEEEEecCCCChhHHHHHHHHHHHHHhcc---CCCceeEEEEEeeC
Q 003278 512 TNNFSESQRVAEMDFGTAYQGF------LDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLR---HRNLVQLCGWCTEQ 582 (834)
Q Consensus 512 t~~f~~~~~ig~g~~g~vy~~~------~~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~---HpNiv~l~g~~~~~ 582 (834)
.+.|...+.||+|+||+||+|. ..++..||||++.... ..+|..|++++.+++ |+||+++++++...
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN----PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC----HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC----hhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 3567777899999999999994 4567889999986532 346788888888887 99999999999999
Q ss_pred CeEEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecC--------
Q 003278 583 GEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDP-------- 654 (834)
Q Consensus 583 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~-------- 654 (834)
+..++||||+++|+|.+++...... ....++|..+..|+.|++.||+|||+ .+||||||||+||||+.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNT-PEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTS-TTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC---
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcc-cccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCcccc
Confidence 9999999999999999999753221 12358999999999999999999996 68999999999999998
Q ss_pred ---CCCceEeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCC
Q 003278 655 ---DMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLP 731 (834)
Q Consensus 655 ---~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~ 731 (834)
++.+||+|||+|+.+..... .......+||+.|||||++.+..++.++|||||||++|||+||+.||.....
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 290 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPK-----GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG 290 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCT-----TEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred ccccCCEEEeeCchhhhhhccCC-----CceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence 89999999999976532211 1112346799999999999999999999999999999999999999853221
Q ss_pred chhHHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCC-CChhHHHHHHccC
Q 003278 732 EGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELR-PSMRQILSILDGN 797 (834)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~R-Ptm~~v~~~L~~~ 797 (834)
.. ..++..+......+.+.++++ .|+..+|.+| |++.++.+.|+..
T Consensus 291 ~~-----------------~~~~~~~~~~~~~~~~~~~~~---~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 291 GE-----------------CKPEGLFRRLPHLDMWNEFFH---VMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp TE-----------------EEECSCCTTCSSHHHHHHHHH---HHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred Cc-----------------eeechhccccCcHHHHHHHHH---HHcCCCCCCcchHHHHHHHHHHHH
Confidence 10 001111112223445555544 7899999988 5788887777543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=345.56 Aligned_cols=259 Identities=27% Similarity=0.434 Sum_probs=202.9
Q ss_pred HhhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEE
Q 003278 107 YIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLV 186 (834)
Q Consensus 107 ~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 186 (834)
....++|+..+.||+|+||.||+|.. .++..||||.+.... ...+.|.+|+.++++++||||+++++++. .+..++|
T Consensus 9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 85 (279)
T 1qpc_A 9 EVPRETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYII 85 (279)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEE-TTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred ccCHHhhhheeeecCCCCeEEEEEEE-cCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEE
Confidence 34456788899999999999999998 467889999986543 33567999999999999999999999986 4568999
Q ss_pred EEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchh
Q 003278 187 YDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLAR 266 (834)
Q Consensus 187 ~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~ 266 (834)
|||+++|+|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 86 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 157 (279)
T 1qpc_A 86 TEYMENGSLVDFLKTPS-----GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLAR 157 (279)
T ss_dssp EECCTTCBHHHHTTSHH-----HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EecCCCCCHHHHHhcCC-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccc
Confidence 99999999999985421 13689999999999999999999996 99999999999999999999999999997
Q ss_pred hhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccch
Q 003278 267 WLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQII 345 (834)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~ 345 (834)
...... ........||+.|+|||.+..+ .++.++|||||||++|||+| |+.|+..... ..
T Consensus 158 ~~~~~~---------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~ 218 (279)
T 1qpc_A 158 LIEDNE---------------YTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTN---PE 218 (279)
T ss_dssp ECSSSC---------------EECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HH
T ss_pred cccCcc---------------cccccCCCCccCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCcccCH---HH
Confidence 543210 0011233478899999998654 57899999999999999999 8988864321 11
Q ss_pred HHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcCC
Q 003278 346 LLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGSY 409 (834)
Q Consensus 346 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~~ 409 (834)
+ ...+ ..+... .. .... ...+.+++..||+.||.+||++.++++.|+..+
T Consensus 219 ~---~~~~-~~~~~~-----~~-~~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 268 (279)
T 1qpc_A 219 V---IQNL-ERGYRM-----VR-PDNC----PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (279)
T ss_dssp H---HHHH-HTTCCC-----CC-CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H---HHHH-hcccCC-----CC-cccc----cHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 1 1111 111110 00 0111 246889999999999999999999999987653
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=351.58 Aligned_cols=264 Identities=20% Similarity=0.277 Sum_probs=193.9
Q ss_pred hhCcCcCCcccccCCcEEEEEEEC----CCcEEEEEEecCCC-ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCC---
Q 003278 512 TNNFSESQRVAEMDFGTAYQGFLD----NHQYVLVKRLGMSK-CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQG--- 583 (834)
Q Consensus 512 t~~f~~~~~ig~g~~g~vy~~~~~----~~~~vavK~~~~~~-~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~--- 583 (834)
.++|...+.||+|+||.||+|... .+..||||.+.... .....+.|.+|+.++++++||||+++++++.+.+
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 112 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence 356677788999999999999863 24579999987543 3344577999999999999999999999998754
Q ss_pred --eEEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEe
Q 003278 584 --EMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLG 661 (834)
Q Consensus 584 --~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~ 661 (834)
..++||||+++|+|.+++...........+++..+..|+.|++.||.|||+ .+|+||||||+|||++.++.+||+
T Consensus 113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kl~ 189 (313)
T 3brb_A 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMTVCVA 189 (313)
T ss_dssp --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTSCEEEC
T ss_pred CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEEe
Confidence 359999999999999998654322233468999999999999999999996 699999999999999999999999
Q ss_pred eeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHH
Q 003278 662 SFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVH 740 (834)
Q Consensus 662 DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~ 740 (834)
|||+++....... ........||+.|+|||.+.+..++.++|||||||++|||+| |..|+....... ......
T Consensus 190 Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-~~~~~~ 263 (313)
T 3brb_A 190 DFGLSKKIYSGDY-----YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE-MYDYLL 263 (313)
T ss_dssp SCSCC---------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-HHHHHH
T ss_pred ecCcceecccccc-----cCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH-HHHHHH
Confidence 9999976543221 111223467889999999999999999999999999999999 778876443322 211111
Q ss_pred HHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCC
Q 003278 741 EFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGND 798 (834)
Q Consensus 741 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~ 798 (834)
....+ .....++ . .+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 264 ---~~~~~-------~~~~~~~-~---~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 264 ---HGHRL-------KQPEDCL-D---ELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp ---TTCCC-------CCBTTCC-H---HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---cCCCC-------CCCcccc-H---HHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11110 1111122 2 3556666999999999999999999997654
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=352.60 Aligned_cols=247 Identities=15% Similarity=0.196 Sum_probs=173.4
Q ss_pred CCcccccCCcEEEEEEEC-CCcEEEEEEecCCCChhHHHHHHHHHHHHHhcc-CCCceeEEEEEeeCCeEEEEEeccCCC
Q 003278 518 SQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKCPALRTRFSNELQNLARLR-HRNLVQLCGWCTEQGEMLVIYDYSATR 595 (834)
Q Consensus 518 ~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~-HpNiv~l~g~~~~~~~~~lv~Ey~~~g 595 (834)
.+.||+|+||.||+|... +++.||||++.. .....+.+|+.++.++. |||||++++++.+....++||||+++|
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~ 91 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK----RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG 91 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEG----GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEECh----hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence 478999999999999974 588999999853 23456789999999997 999999999999999999999999999
Q ss_pred chhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCC---CceEeeeeeccccccC
Q 003278 596 ILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDM---NPRLGSFALAEFLTRN 672 (834)
Q Consensus 596 ~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~---~~ki~DfGla~~~~~~ 672 (834)
+|.+++.... .+++..+..|+.|++.||+|||+ .+|+||||||+|||++.++ .+||+|||+++.....
T Consensus 92 ~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 162 (325)
T 3kn6_A 92 ELFERIKKKK------HFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162 (325)
T ss_dssp BHHHHHHHCS------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred cHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence 9999987642 48899999999999999999997 6999999999999998665 7999999999764332
Q ss_pred CCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCch---hHHHHHHHHHhhcCcc
Q 003278 673 DHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEG---LLVKRVHEFEARKRPL 749 (834)
Q Consensus 673 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~---~~~~~~~~~~~~~~~~ 749 (834)
. ......+||+.|+|||++.+..++.++|||||||++|||+||+.||....... ................
T Consensus 163 ~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~ 235 (325)
T 3kn6_A 163 N-------QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF 235 (325)
T ss_dssp ----------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC
T ss_pred C-------CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC
Confidence 1 11234578999999999999999999999999999999999999986432210 0111111111110000
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 750 AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 750 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
. .. ..... . ..+..++.+||+.||++|||+.+|++
T Consensus 236 ~---~~-~~~~~-s---~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 236 E---GE-AWKNV-S---QEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp C---SH-HHHTS-C---HHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred C---cc-cccCC-C---HHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 0 00 00001 1 23556666999999999999999874
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=345.17 Aligned_cols=263 Identities=19% Similarity=0.237 Sum_probs=194.5
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCC-hhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEe
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKC-PALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYD 590 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~-~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~E 590 (834)
++|...+.||+|+||+||+|... +++.||||++..... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 45777788999999999999975 488999998865443 3446778999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccc
Q 003278 591 YSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLT 670 (834)
Q Consensus 591 y~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~ 670 (834)
|+++++|..++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++....
T Consensus 83 ~~~~~~l~~~~~~~~------~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 153 (311)
T 4agu_A 83 YCDHTVLHELDRYQR------GVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLT 153 (311)
T ss_dssp CCSEEHHHHHHHTSS------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred eCCCchHHHHHhhhc------CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhcc
Confidence 999999998876432 37889999999999999999997 699999999999999999999999999997654
Q ss_pred cCCCCCcccccCccccccccCccchhcccc-CCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHh-----
Q 003278 671 RNDHGHRKATSGNRSVRGIFGYMSPEYIES-GEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEA----- 744 (834)
Q Consensus 671 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~----- 744 (834)
... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||.......... .......
T Consensus 154 ~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~ 225 (311)
T 4agu_A 154 GPS-------DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLY-LIRKTLGDLIPR 225 (311)
T ss_dssp -------------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-HHHHHHCSCCHH
T ss_pred Ccc-------cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHHhcccccc
Confidence 221 11224578999999999876 668999999999999999999999987544332221 1111100
Q ss_pred ------hcCcc--ccccccccCCCCC---HHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 745 ------RKRPL--AELVDLSLNGEYN---HKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 745 ------~~~~~--~~~~d~~l~~~~~---~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
..... ..+.++....... ...-..+.+++.+||+.||++|||+.|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 226 HQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp HHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00000 0001110000000 001123556777999999999999999985
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=350.73 Aligned_cols=270 Identities=22% Similarity=0.292 Sum_probs=203.9
Q ss_pred hhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHh--CCCCceeeEeeeEEeCC----
Q 003278 108 IGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAH--LRHRNLVRLRGWCVHED---- 181 (834)
Q Consensus 108 ~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~g~~~~~~---- 181 (834)
...++|...+.||+|+||.||+|.+ +|+.||||++... ..+.+.+|+.++.. ++||||+++++++...+
T Consensus 39 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 39 TIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred cccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 3456799999999999999999998 5899999998643 34567888888887 79999999999999876
Q ss_pred EEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhcc-----CCCeecCCCCCCceEECCCCc
Q 003278 182 QLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQL-----ETQIIHRDVKTSNVMLDSQYN 256 (834)
Q Consensus 182 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~iiHrDlKp~NILld~~~~ 256 (834)
..++||||+++|+|.+++... .+++..+..++.|++.||.|||... ..+|+||||||+|||++.++.
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~~--------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~ 185 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNRY--------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 185 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHHC--------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSC
T ss_pred eeEEEEeecCCCcHHHHHhcc--------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCC
Confidence 799999999999999999642 5889999999999999999999210 149999999999999999999
Q ss_pred eEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCC-----CCcccceeehhhHHHHHHhC
Q 003278 257 ARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSV-----ATAKSDVFSFGIVVLEVVSG 331 (834)
Q Consensus 257 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-----~~~ksDV~SfGvvl~ElltG 331 (834)
+||+|||+++........ .........||+.|+|||.+..... ++.++|||||||++|||+||
T Consensus 186 ~kL~Dfg~~~~~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg 253 (342)
T 1b6c_B 186 CCIADLGLAVRHDSATDT------------IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253 (342)
T ss_dssp EEECCCTTCEEEETTTTE------------EEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEECCCceeccccccc------------cccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhc
Confidence 999999999754322100 0001234569999999999865422 22689999999999999999
Q ss_pred ----------CccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhH
Q 003278 332 ----------RRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWV 401 (834)
Q Consensus 332 ----------~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V 401 (834)
+.||....... .....+........ . .+.+............+.+|+..||+.||.+||++.+|
T Consensus 254 ~~~~~~~~~~~~p~~~~~~~~-~~~~~~~~~~~~~~-~----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i 327 (342)
T 1b6c_B 254 CSIGGIHEDYQLPYYDLVPSD-PSVEEMRKVVCEQK-L----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 327 (342)
T ss_dssp BCBTTBCCCCCCTTTTTSCSS-CCHHHHHHHHTTSC-C----CCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred cCcCCcccccccCccccCcCc-ccHHHHHHHHHHHH-h----CCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHH
Confidence 56665432222 11222222222111 1 11111111122445678999999999999999999999
Q ss_pred HHHhhcC
Q 003278 402 IEAVSGS 408 (834)
Q Consensus 402 ~~~l~~~ 408 (834)
++.|+..
T Consensus 328 ~~~L~~i 334 (342)
T 1b6c_B 328 KKTLSQL 334 (342)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999765
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=356.13 Aligned_cols=200 Identities=19% Similarity=0.299 Sum_probs=175.7
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
++|...+.||+|+||.||+|... ++..||+|.+.........+.|.+|+.+|++++|||||++++++.+.+..++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 56777889999999999999975 68899999998766666778899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccccc
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTR 671 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~ 671 (834)
+++|+|.+++.... .+++..+..|+.|++.||+|||+. .+|+||||||+|||++.++.+||+|||++.....
T Consensus 113 ~~~~~L~~~l~~~~------~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 113 MDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp CTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred CCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 99999999987542 378889999999999999999972 3799999999999999999999999999975432
Q ss_pred CCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCC
Q 003278 672 NDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFR 729 (834)
Q Consensus 672 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~ 729 (834)
. ......||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 185 ~---------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 185 S---------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp H---------C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred c---------cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 1 123457999999999999999999999999999999999999998643
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=352.87 Aligned_cols=267 Identities=21% Similarity=0.254 Sum_probs=202.3
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc-ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCC-----EE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHED-----QL 183 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-----~~ 183 (834)
.++|+..+.||+|+||.||+|....++..||||++... .....+.+.+|+.++.+++||||+++++++...+ ..
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 35799999999999999999999889999999998753 3344577999999999999999999999997653 68
Q ss_pred EEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeecc
Q 003278 184 LLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFG 263 (834)
Q Consensus 184 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFG 263 (834)
++||||+. |+|.+++.. ..+++..+..|+.|++.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 106 ~iv~e~~~-~~L~~~l~~--------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg 173 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT--------QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFG 173 (364)
T ss_dssp EEEEECCS-EEHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEcccC-cCHHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCc
Confidence 99999997 599988854 3589999999999999999999996 99999999999999999999999999
Q ss_pred chhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCcc
Q 003278 264 LARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQ 343 (834)
Q Consensus 264 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~ 343 (834)
+++....... .....+...||+.|+|||.+..+..++.++|||||||++|||+||+.||......+.
T Consensus 174 ~a~~~~~~~~-------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~ 240 (364)
T 3qyz_A 174 LARVADPDHD-------------HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ 240 (364)
T ss_dssp TCEECCGGGC-------------BCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH
T ss_pred ceEecCCCCC-------------ccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH
Confidence 9986432210 001124457999999999887666689999999999999999999999975432221
Q ss_pred chHHHHHHHHhhcCccc---c--------ccccccCCCCCCH-----HHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 344 IILLDWIRRLSDEGKVL---Q--------AGDNRLSDGSYKL-----CDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 344 ~~l~~~~~~~~~~~~~~---~--------~~d~~l~~~~~~~-----~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
...+.......... . ............. .....+.+|+..||+.||.+||++.++++.
T Consensus 241 ---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 241 ---LNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp ---HHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---HHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 11111111000000 0 0000000000000 011357899999999999999999999863
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=341.23 Aligned_cols=247 Identities=20% Similarity=0.331 Sum_probs=194.9
Q ss_pred hhCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCC--hhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEE
Q 003278 512 TNNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKC--PALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVI 588 (834)
Q Consensus 512 t~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv 588 (834)
.++|...+.||+|+||.||+|... ++..||||.+..... ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 356778889999999999999864 467899999853221 12246789999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccc
Q 003278 589 YDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEF 668 (834)
Q Consensus 589 ~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~ 668 (834)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++..
T Consensus 88 ~e~~~~~~l~~~l~~~~------~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~ 158 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLS------KFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVH 158 (279)
T ss_dssp ECCCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESC
T ss_pred EecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEecccccc
Confidence 99999999999986542 37889999999999999999996 6999999999999999999999999999864
Q ss_pred cccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCc
Q 003278 669 LTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRP 748 (834)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
.... ......||+.|+|||.+.+..++.++||||||+++|||+||+.||........ .... ......
T Consensus 159 ~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~---~~~~~~ 225 (279)
T 3fdn_A 159 APSS---------RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET-YKRI---SRVEFT 225 (279)
T ss_dssp C-----------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHH---HHTCCC
T ss_pred CCcc---------cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH-HHHH---HhCCCC
Confidence 3221 12345799999999999999999999999999999999999999874432221 1111 111111
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 749 LAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 749 ~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
..... .++ +..++.+||+.||++|||+.||++
T Consensus 226 --------~~~~~-~~~---~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 226 --------FPDFV-TEG---ARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp --------CCTTS-CHH---HHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred --------CCCcC-CHH---HHHHHHHHhccChhhCCCHHHHhh
Confidence 11111 233 445556899999999999999996
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=355.01 Aligned_cols=199 Identities=22% Similarity=0.266 Sum_probs=173.0
Q ss_pred HhhCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhcc-----CCCceeEEEEEeeCCe
Q 003278 511 ATNNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLR-----HRNLVQLCGWCTEQGE 584 (834)
Q Consensus 511 at~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~-----HpNiv~l~g~~~~~~~ 584 (834)
..++|...+.||+|+||.||+|.. .++..||||++.. .....+.+..|+.++.+++ |||||++++++...+.
T Consensus 33 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~ 110 (360)
T 3llt_A 33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN--IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDH 110 (360)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS--CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTE
T ss_pred ecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc--chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCe
Confidence 356788889999999999999997 5688999999863 2344567888999999997 9999999999999999
Q ss_pred EEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecC----------
Q 003278 585 MLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDP---------- 654 (834)
Q Consensus 585 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~---------- 654 (834)
.++||||+ +++|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.
T Consensus 111 ~~lv~e~~-~~~L~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~~~~ 182 (360)
T 3llt_A 111 MCLIFEPL-GPSLYEIITRNNY----NGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITV 182 (360)
T ss_dssp EEEEECCC-CCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCCEEEEEE
T ss_pred eEEEEcCC-CCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccccccccccch
Confidence 99999999 9999999876432 248888999999999999999997 69999999999999985
Q ss_pred ---------------CCCceEeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHH
Q 003278 655 ---------------DMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEV 719 (834)
Q Consensus 655 ---------------~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~ 719 (834)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||
T Consensus 183 ~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 252 (360)
T 3llt_A 183 RRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----------HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL 252 (360)
T ss_dssp ECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----------CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred hcccccccccccccCCCCEEEEeccCceecCCC----------CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence 789999999999753321 2246799999999999999999999999999999999
Q ss_pred HhCCCccCCC
Q 003278 720 VTGQMAVDFR 729 (834)
Q Consensus 720 ~tG~~p~~~~ 729 (834)
+||+.||...
T Consensus 253 l~g~~pf~~~ 262 (360)
T 3llt_A 253 YTGSLLFRTH 262 (360)
T ss_dssp HHSSCSCCCS
T ss_pred HHCCCCCCCC
Confidence 9999999654
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=361.87 Aligned_cols=199 Identities=21% Similarity=0.332 Sum_probs=171.8
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhC------CCCceeeEeeeEEeCCEE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHL------RHRNLVRLRGWCVHEDQL 183 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l------~H~nIv~l~g~~~~~~~~ 183 (834)
.++|+..+.||+|+||.||+|....+++.||||++... ....+.+.+|+.++..+ +|+||+++++++...+..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 45699999999999999999999989999999998653 34456788899888877 677999999999999999
Q ss_pred EEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCc--eEEee
Q 003278 184 LLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYN--ARLGD 261 (834)
Q Consensus 184 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~--~kl~D 261 (834)
++||||+. |+|.+++.... ...+++..+..|+.||+.||+|||+. +|+||||||+|||++.++. +||+|
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~D 245 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNK-----FQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVID 245 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTT-----TCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECC
T ss_pred EEEEeccC-CCHHHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEee
Confidence 99999996 68998887543 23589999999999999999999996 9999999999999999887 99999
Q ss_pred ccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCC
Q 003278 262 FGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLT 338 (834)
Q Consensus 262 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~ 338 (834)
||+++.... ......||+.|+|||++... .++.++|||||||++|||+||+.||...
T Consensus 246 FG~a~~~~~-------------------~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 246 FGSSCYEHQ-------------------RVYTYIQSRFYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp CTTCEETTC-------------------CCCSSCSCGGGCCHHHHHTB-CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccceecCC-------------------cccccCCCCCccChHHHhCC-CCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 999964321 12345699999999998754 5799999999999999999999998654
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=344.01 Aligned_cols=249 Identities=20% Similarity=0.331 Sum_probs=198.3
Q ss_pred hhCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEee---------
Q 003278 512 TNNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTE--------- 581 (834)
Q Consensus 512 t~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~--------- 581 (834)
.++|...+.||+|+||.||+|... +++.||||.+.... +.+.+|++++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 356888889999999999999975 68899999987543 346789999999999999999998854
Q ss_pred -------CCeEEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecC
Q 003278 582 -------QGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDP 654 (834)
Q Consensus 582 -------~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~ 654 (834)
....++||||+++|+|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+|||+++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~ 157 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG----EKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVD 157 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcC
Confidence 4458999999999999999975321 248899999999999999999997 69999999999999999
Q ss_pred CCCceEeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchh
Q 003278 655 DMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGL 734 (834)
Q Consensus 655 ~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~ 734 (834)
++.+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|||+||..|+...
T Consensus 158 ~~~~kl~Dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----- 224 (284)
T 2a19_B 158 TKQVKIGDFGLVTSLKNDG--------KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET----- 224 (284)
T ss_dssp TTEEEECCCTTCEESSCCS--------CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-----
T ss_pred CCCEEECcchhheeccccc--------cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-----
Confidence 9999999999997654321 122357999999999999999999999999999999999998876311
Q ss_pred HHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCcc
Q 003278 735 LVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDKR 800 (834)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~~ 800 (834)
....... .... +...++ .+ +..++.+||+.||++|||+.++++.|+.+.+.
T Consensus 225 -~~~~~~~--~~~~--------~~~~~~-~~---~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 225 -SKFFTDL--RDGI--------ISDIFD-KK---EKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp -HHHHHHH--HTTC--------CCTTSC-HH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred -HHHHHHh--hccc--------ccccCC-HH---HHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 0111111 1111 111222 23 44556689999999999999999999776553
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=365.30 Aligned_cols=247 Identities=20% Similarity=0.317 Sum_probs=197.6
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCC--hhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKC--PALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIY 589 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~ 589 (834)
++|...+.||+|+||.||+|... +|+.||||.+..... ......+.+|+.+|+.++|||||++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 45667788999999999999975 689999999864321 123467899999999999999999999999999999999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccc
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFL 669 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~ 669 (834)
||+++|+|.+++...+ .+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 96 E~~~gg~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~ 166 (476)
T 2y94_A 96 EYVSGGELFDYICKNG------RLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 166 (476)
T ss_dssp ECCSSEEHHHHTTSSS------SCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred eCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhc
Confidence 9999999999986432 38899999999999999999996 69999999999999999999999999999865
Q ss_pred ccCCCCCcccccCccccccccCccchhccccCCC-CccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCc
Q 003278 670 TRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEA-TSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRP 748 (834)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
.... ...+.+||+.|+|||++.+..+ +.++|||||||++|||+||+.||........ ...+. .....
T Consensus 167 ~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~-~~~i~---~~~~~ 234 (476)
T 2y94_A 167 SDGE--------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL-FKKIC---DGIFY 234 (476)
T ss_dssp CTTC--------CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHH-HHHHH---TTCCC
T ss_pred cccc--------cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHH-HHHHh---cCCcC
Confidence 4321 1234579999999999988776 6789999999999999999999975443222 11111 11100
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 749 LAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 749 ~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
.+... ..+ +..++.+||+.||++|||+.+|++
T Consensus 235 --------~p~~~-s~~---~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 235 --------TPQYL-NPS---VISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp --------CCTTC-CHH---HHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --------CCccC-CHH---HHHHHHHHcCCCchhCcCHHHHHh
Confidence 11111 233 445566899999999999999986
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=349.41 Aligned_cols=251 Identities=14% Similarity=0.185 Sum_probs=199.3
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCCh-----hHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKCP-----ALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEML 586 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~ 586 (834)
+.|...+.||+|+||.||+|... ++..||||.+...... ...+.|.+|+.++.+++||||+++++++.+.+..+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 45777889999999999999975 5889999998754322 13577999999999999999999999999999999
Q ss_pred EEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCC----CceEee
Q 003278 587 VIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDM----NPRLGS 662 (834)
Q Consensus 587 lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~----~~ki~D 662 (834)
+||||+++++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++ .+||+|
T Consensus 92 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~D 162 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQKE------SLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLID 162 (321)
T ss_dssp EEECCCCSCBHHHHHHTCS------CEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEcc
Confidence 9999999999999986532 48899999999999999999997 6999999999999999887 799999
Q ss_pred eeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHH
Q 003278 663 FALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEF 742 (834)
Q Consensus 663 fGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~ 742 (834)
||++....... ......||+.|+|||++.+..++.++|||||||++|||+||+.||........ ... .
T Consensus 163 fg~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~---i 230 (321)
T 2a2a_A 163 FGLAHEIEDGV--------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-LAN---I 230 (321)
T ss_dssp CTTCEECCTTC--------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHH---H
T ss_pred CccceecCccc--------cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHH-HHH---H
Confidence 99997654321 12345799999999999999999999999999999999999999865432221 111 1
Q ss_pred HhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 743 EARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 743 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
....... ++......+ . .+..++.+||+.||++|||+.++++
T Consensus 231 ~~~~~~~----~~~~~~~~~-~---~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 231 TSVSYDF----DEEFFSHTS-E---LAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp HTTCCCC----CHHHHTTCC-H---HHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred Hhccccc----ChhhhcccC-H---HHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1111110 111111111 2 3455666999999999999999986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=354.81 Aligned_cols=275 Identities=21% Similarity=0.226 Sum_probs=190.6
Q ss_pred HHHHhhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCE-
Q 003278 104 AELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQ- 182 (834)
Q Consensus 104 ~el~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~- 182 (834)
.+.....++|...+.||+|+||.||+|.+..+|+.||||++.... .....+.+|+..+..++|||||+++++|...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 345567789999999999999999999998899999999885432 233456778888999999999999999976543
Q ss_pred ------EEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECC-CC
Q 003278 183 ------LLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDS-QY 255 (834)
Q Consensus 183 ------~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~-~~ 255 (834)
.++||||+++ +|...+... ......+++..+..++.|++.||.|||.+ ..+|+||||||+|||++. ++
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~ 169 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNY---YRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADG 169 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHH---HTTTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTT
T ss_pred cccceeEEEEeecccc-cHHHHHHHH---hhcccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCC
Confidence 8999999986 444444321 11235688999999999999999999921 249999999999999996 89
Q ss_pred ceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccC
Q 003278 256 NARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAV 335 (834)
Q Consensus 256 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~ 335 (834)
.+||+|||+++.+.... ......||+.|+|||.+.....++.++|||||||++|||+||+.||
T Consensus 170 ~~kl~Dfg~a~~~~~~~-----------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf 232 (360)
T 3e3p_A 170 TLKLCDFGSAKKLSPSE-----------------PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIF 232 (360)
T ss_dssp EEEECCCTTCBCCCTTS-----------------CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred cEEEeeCCCceecCCCC-----------------CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCc
Confidence 99999999998543210 1234468999999999866656899999999999999999999998
Q ss_pred CCCCCCccchHHHHHHH-----------HhhcCccccccccc-cC----CCCCCHHHHHHHHHHHHHhcccCCCCCCchh
Q 003278 336 DLTYPDDQIILLDWIRR-----------LSDEGKVLQAGDNR-LS----DGSYKLCDMEHLTHLALLCTLHNPHLRPSMK 399 (834)
Q Consensus 336 ~~~~~~~~~~l~~~~~~-----------~~~~~~~~~~~d~~-l~----~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~ 399 (834)
...... ..+...+.. +..........+.. .. -..........+.+|+..||+.||.+||++.
T Consensus 233 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 310 (360)
T 3e3p_A 233 RGDNSA--GQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPY 310 (360)
T ss_dssp CCSSHH--HHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCChH--HHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHH
Confidence 653221 111111111 10000000000000 00 0001111245788999999999999999999
Q ss_pred hHHH
Q 003278 400 WVIE 403 (834)
Q Consensus 400 ~V~~ 403 (834)
|+++
T Consensus 311 e~l~ 314 (360)
T 3e3p_A 311 EALC 314 (360)
T ss_dssp HHTT
T ss_pred HHhc
Confidence 9986
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=351.72 Aligned_cols=260 Identities=25% Similarity=0.398 Sum_probs=200.2
Q ss_pred CCCCCeeeccCCeEEEEEEE----CCCCeEEEEEEecccC-hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeC--CEEEE
Q 003278 113 FDEDEVLGSGGFGKVYRAVL----PSDGTVVAVKCLAEKG-ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHE--DQLLL 185 (834)
Q Consensus 113 f~~~~~LG~G~fG~Vy~~~~----~~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~l 185 (834)
|...+.||+|+||.||+|.+ ..+|+.||||++.... ....+.|.+|+.++++++||||+++++++.+. +.+++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 58889999999999988865 3478999999987543 34567799999999999999999999999984 67999
Q ss_pred EEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccch
Q 003278 186 VYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLA 265 (834)
Q Consensus 186 V~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla 265 (834)
||||+++|+|.+++... .+++..+..|+.|++.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 113 v~e~~~~~~L~~~l~~~--------~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a 181 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH--------SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLA 181 (318)
T ss_dssp EECCCTTCBHHHHGGGS--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred EEecccCCcHHHHHhhC--------CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccc
Confidence 99999999999998542 489999999999999999999996 9999999999999999999999999999
Q ss_pred hhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCC----
Q 003278 266 RWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPD---- 341 (834)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~---- 341 (834)
+....... .........||+.|+|||.+... .++.++|||||||++|||+||+.|+......
T Consensus 182 ~~~~~~~~-------------~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~ 247 (318)
T 3lxp_A 182 KAVPEGHE-------------YYRVREDGDSPVFWYAPECLKEY-KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLEL 247 (318)
T ss_dssp EECCTTCS-------------EEEC---CCCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH
T ss_pred cccccccc-------------ccccccCCCCCceeeChHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhh
Confidence 86532210 00112344588999999998654 5688999999999999999999998642111
Q ss_pred -----ccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 342 -----DQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 342 -----~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
..... ..+......+..... . ... ...+.+|+..||+.||.+||++.++++.|+..
T Consensus 248 ~~~~~~~~~~-~~~~~~~~~~~~~~~-----~-~~~----~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 308 (318)
T 3lxp_A 248 IGIAQGQMTV-LRLTELLERGERLPR-----P-DKC----PAEVYHLMKNCWETEASFRPTFENLIPILKTV 308 (318)
T ss_dssp HCSCCHHHHH-HHHHHHHHTTCCCCC-----C-TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hcccccchhH-HHHHHHHhcccCCCC-----C-ccc----cHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 00000 111111121111110 0 111 24688999999999999999999999998764
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=348.90 Aligned_cols=253 Identities=24% Similarity=0.312 Sum_probs=195.7
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC--------hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG--------ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQ 182 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~--------~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~ 182 (834)
++|...+.||+|+||.||+|....+|+.||||++.... ......+.+|+.++++++||||+++++++...+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 56888999999999999999999999999999986432 122345889999999999999999999987665
Q ss_pred EEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCc---eEE
Q 003278 183 LLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYN---ARL 259 (834)
Q Consensus 183 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~---~kl 259 (834)
.++||||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++. +||
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl 158 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGN-------KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKI 158 (322)
T ss_dssp EEEEEECCTTEETHHHHSTT-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEE
T ss_pred eEEEEecCCCCcHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEE
Confidence 89999999999999988542 4689999999999999999999996 9999999999999987654 999
Q ss_pred eeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccc--cCCCCCcccceeehhhHHHHHHhCCccCCC
Q 003278 260 GDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQ--KGSVATAKSDVFSFGIVVLEVVSGRRAVDL 337 (834)
Q Consensus 260 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~--~~~~~~~ksDV~SfGvvl~ElltG~~p~~~ 337 (834)
+|||+++....... .....||+.|+|||.+. ....++.++|||||||++|||+||+.||..
T Consensus 159 ~Dfg~~~~~~~~~~-----------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 221 (322)
T 2ycf_A 159 TDFGHSKILGETSL-----------------MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 221 (322)
T ss_dssp CCCTTCEECCCCHH-----------------HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred ccCccceecccccc-----------------cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 99999976432110 12345899999999874 244678999999999999999999999975
Q ss_pred CCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 338 TYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 338 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
..... .+...+. .+..... +... ... ...+.+++..||+.||.+||++.++++.
T Consensus 222 ~~~~~--~~~~~~~----~~~~~~~--~~~~-~~~----~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 222 HRTQV--SLKDQIT----SGKYNFI--PEVW-AEV----SEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp TTCSS--CHHHHHH----HTCCCCC--HHHH-TTS----CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cchHH--HHHHHHH----hCccccC--chhh-hhc----CHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 43222 2222221 1111100 0000 011 2467899999999999999999999863
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=346.63 Aligned_cols=264 Identities=17% Similarity=0.226 Sum_probs=194.6
Q ss_pred hhCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCC----ChhHHHHHHHHHHHHHhcc---CCCceeEEEEEeeCC
Q 003278 512 TNNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSK----CPALRTRFSNELQNLARLR---HRNLVQLCGWCTEQG 583 (834)
Q Consensus 512 t~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~----~~~~~~~f~~E~~~l~~l~---HpNiv~l~g~~~~~~ 583 (834)
+++|...+.||+|+||+||+|.. .+++.||||++.... .......+.+|+.++++++ |||||+++++|....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 56888889999999999999995 568899999986322 1112245677888877775 999999999998755
Q ss_pred -----eEEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCc
Q 003278 584 -----EMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNP 658 (834)
Q Consensus 584 -----~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ 658 (834)
..++||||+. |+|.+++..... ..+++..+..|+.|++.||+|||+ .+|+||||||+|||++.++.+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~ 159 (308)
T 3g33_A 88 TDREIKVTLVFEHVD-QDLRTYLDKAPP----PGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTV 159 (308)
T ss_dssp SSSEEEEEEEEECCC-CBHHHHHHTCCT----TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCE
T ss_pred CCCceeEEEEehhhh-cCHHHHHhhccC----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCE
Confidence 5899999998 599998875432 238899999999999999999997 689999999999999999999
Q ss_pred eEeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHH
Q 003278 659 RLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKR 738 (834)
Q Consensus 659 ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~ 738 (834)
||+|||+++..... .......||+.|||||++.+..++.++|||||||++|||+||+.||........+ ..
T Consensus 160 kl~Dfg~a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-~~ 230 (308)
T 3g33_A 160 KLADFGLARIYSYQ--------MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL-GK 230 (308)
T ss_dssp EECSCSCTTTSTTC--------CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHH-HH
T ss_pred EEeeCccccccCCC--------cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HH
Confidence 99999999764322 1123468999999999999999999999999999999999999999754433322 22
Q ss_pred HHHHHhhc--Ccccc---ccccccC--CCCCHH-----HHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 739 VHEFEARK--RPLAE---LVDLSLN--GEYNHK-----ELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 739 ~~~~~~~~--~~~~~---~~d~~l~--~~~~~~-----~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
+....... ..+.. +...... ...... ....+.+++.+||+.||++|||+.|+++
T Consensus 231 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 231 IFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 22211100 00000 0000000 000000 0124556667999999999999999985
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=345.99 Aligned_cols=256 Identities=20% Similarity=0.304 Sum_probs=196.2
Q ss_pred CcCcCC-cccccCCcEEEEEEE---CCCcEEEEEEecCCC-ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEE
Q 003278 514 NFSESQ-RVAEMDFGTAYQGFL---DNHQYVLVKRLGMSK-CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVI 588 (834)
Q Consensus 514 ~f~~~~-~ig~g~~g~vy~~~~---~~~~~vavK~~~~~~-~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv 588 (834)
.|.... .||+|+||.||+|.. .++..||||.+.... .....++|.+|+.++++++||||+++++++ +.+..++|
T Consensus 17 ~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv 95 (291)
T 1xbb_A 17 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLV 95 (291)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEE
T ss_pred hhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEE
Confidence 444445 799999999999964 336789999987543 234467899999999999999999999999 56778999
Q ss_pred EeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccc
Q 003278 589 YDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEF 668 (834)
Q Consensus 589 ~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~ 668 (834)
|||+++++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++..
T Consensus 96 ~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 96 MEMAELGPLNKYLQQNR------HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EECCTTEEHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEeCCCCCHHHHHHhCc------CCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 99999999999997542 37889999999999999999997 6999999999999999999999999999986
Q ss_pred cccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcC
Q 003278 669 LTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKR 747 (834)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
....... ........||+.|+|||++.+..++.++|||||||++|||+| |+.|+....... ....+ .....
T Consensus 167 ~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-~~~~~---~~~~~ 238 (291)
T 1xbb_A 167 LRADENY----YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-VTAML---EKGER 238 (291)
T ss_dssp CCTTCSE----EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-HHHHH---HTTCC
T ss_pred eccCCCc----ccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-HHHHH---HcCCC
Confidence 5432211 111223457889999999999899999999999999999999 999986543221 11111 11111
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCC
Q 003278 748 PLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGND 798 (834)
Q Consensus 748 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~ 798 (834)
+.....+ +. .+.+++.+||+.||++|||+.+|++.|+.+-
T Consensus 239 -------~~~~~~~-~~---~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 239 -------MGCPAGC-PR---EMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp -------CCCCTTC-CH---HHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -------CCCCCCC-CH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1111122 23 3455666999999999999999999997653
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=356.88 Aligned_cols=254 Identities=19% Similarity=0.208 Sum_probs=195.3
Q ss_pred hCcCcCCcccccCCcEEEEEEE----CCCcEEEEEEecCCC---ChhHHHHHHHHHHHHHhc-cCCCceeEEEEEeeCCe
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL----DNHQYVLVKRLGMSK---CPALRTRFSNELQNLARL-RHRNLVQLCGWCTEQGE 584 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~----~~~~~vavK~~~~~~---~~~~~~~f~~E~~~l~~l-~HpNiv~l~g~~~~~~~ 584 (834)
++|...+.||+|+||.||++.. .++..||||++.... .....+.+.+|+++|.++ +||||+++++++.+.+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5677888999999999999997 468899999986432 112234577899999999 59999999999999999
Q ss_pred EEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeee
Q 003278 585 MLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFA 664 (834)
Q Consensus 585 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfG 664 (834)
.++||||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||||+.++.+||+|||
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG 204 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRE------RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFG 204 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSS
T ss_pred EEEEeecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCC
Confidence 999999999999999987532 37888999999999999999997 689999999999999999999999999
Q ss_pred eccccccCCCCCcccccCccccccccCccchhcccc--CCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHH
Q 003278 665 LAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIES--GEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEF 742 (834)
Q Consensus 665 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~ 742 (834)
+++...... .......+||+.|+|||++.+ ..++.++|||||||+||||+||+.||................
T Consensus 205 ~a~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 278 (355)
T 1vzo_A 205 LSKEFVADE------TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI 278 (355)
T ss_dssp EEEECCGGG------GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH
T ss_pred CCeecccCC------CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHH
Confidence 997653221 111234679999999999985 347889999999999999999999986443222221111111
Q ss_pred HhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----ChhHHHHH
Q 003278 743 EARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRP-----SMRQILSI 793 (834)
Q Consensus 743 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RP-----tm~~v~~~ 793 (834)
.....+ .....+ . .+..++.+||+.||++|| |+.++++.
T Consensus 279 ~~~~~~--------~~~~~~-~---~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 279 LKSEPP--------YPQEMS-A---LAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp HHCCCC--------CCTTSC-H---HHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred hccCCC--------CCcccC-H---HHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 111111 111222 2 344566699999999999 88888764
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=341.00 Aligned_cols=253 Identities=23% Similarity=0.372 Sum_probs=201.5
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC---------hhhHHHHHHHHHHHHhCC-CCceeeEeeeEEe
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---------ERFEKTFAAELVAVAHLR-HRNLVRLRGWCVH 179 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---------~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~ 179 (834)
.++|+..+.||+|+||.||+|....+|+.||||.+.... ....+.+.+|+.++.++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 367889999999999999999999899999999986432 233567889999999996 9999999999999
Q ss_pred CCEEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEE
Q 003278 180 EDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARL 259 (834)
Q Consensus 180 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl 259 (834)
.+..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl 165 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK-------VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKL 165 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEE
T ss_pred CCeEEEEEeccCCCcHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEE
Confidence 99999999999999999998643 3589999999999999999999996 9999999999999999999999
Q ss_pred eeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccc-----cCCCCCcccceeehhhHHHHHHhCCcc
Q 003278 260 GDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQ-----KGSVATAKSDVFSFGIVVLEVVSGRRA 334 (834)
Q Consensus 260 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-----~~~~~~~ksDV~SfGvvl~ElltG~~p 334 (834)
+|||+++.+... .......||+.|+|||.+. ....++.++|||||||++|||+||+.|
T Consensus 166 ~dfg~~~~~~~~-----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p 228 (298)
T 1phk_A 166 TDFGFSCQLDPG-----------------EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228 (298)
T ss_dssp CCCTTCEECCTT-----------------CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ecccchhhcCCC-----------------cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCC
Confidence 999999754221 0123456999999999875 234578899999999999999999999
Q ss_pred CCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 335 VDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 335 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
+.... .... ...+.. +... ...+.. ......+.+++..||+.||.+||++.++++
T Consensus 229 ~~~~~---~~~~---~~~~~~-~~~~-~~~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 229 FWHRK---QMLM---LRMIMS-GNYQ-FGSPEW------DDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp SCCSS---HHHH---HHHHHH-TCCC-CCTTTG------GGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CcCcc---HHHH---HHHHhc-CCcc-cCcccc------cccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 86421 1111 111111 1111 000000 011246889999999999999999999876
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=358.11 Aligned_cols=247 Identities=16% Similarity=0.201 Sum_probs=184.2
Q ss_pred CcCcC-CcccccCCcEEEEEEEC-CCcEEEEEEecCCCChhHHHHHHHHHHHHHh-ccCCCceeEEEEEee----CCeEE
Q 003278 514 NFSES-QRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKCPALRTRFSNELQNLAR-LRHRNLVQLCGWCTE----QGEML 586 (834)
Q Consensus 514 ~f~~~-~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~-l~HpNiv~l~g~~~~----~~~~~ 586 (834)
+|... +.||+|+||+||+|... ++..||||++... ..+.+|+.++.+ .+|||||++++++.. .+..+
T Consensus 62 ~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 44443 57999999999999964 5889999998532 356788988754 589999999998865 56789
Q ss_pred EEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecC---CCCceEeee
Q 003278 587 VIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDP---DMNPRLGSF 663 (834)
Q Consensus 587 lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~---~~~~ki~Df 663 (834)
|||||+++|+|.+++..... ..+++..+..|+.|++.||+|||+ .+|+||||||+||||+. ++.+||+||
T Consensus 136 lv~E~~~gg~L~~~l~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DF 208 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGD----QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDF 208 (400)
T ss_dssp EEEECCCSEEHHHHHHCC-------CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred EEEEeCCCCcHHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEec
Confidence 99999999999999975432 248999999999999999999997 69999999999999997 789999999
Q ss_pred eeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchh---HHHHHH
Q 003278 664 ALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGL---LVKRVH 740 (834)
Q Consensus 664 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~---~~~~~~ 740 (834)
|+++...... .....+||+.|||||++.+..++.++|||||||++|||+||+.||........ ....+.
T Consensus 209 G~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~ 280 (400)
T 1nxk_A 209 GFAKETTSHN--------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 280 (400)
T ss_dssp TTCEECC-------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH
T ss_pred ccccccCCCC--------ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH
Confidence 9998643211 12346899999999999999999999999999999999999999965432211 111111
Q ss_pred HHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 741 EFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 741 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
..... ...+.. ... ..+ +..++.+||+.||++|||+.+|++
T Consensus 281 ---~~~~~---~~~~~~-~~~-s~~---~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 281 ---MGQYE---FPNPEW-SEV-SEE---VKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp ---HTCCC---CCTTTT-TTS-CHH---HHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---cCccc---CCCccc-ccC-CHH---HHHHHHHHCCCChhHCcCHHHHhc
Confidence 11110 000000 111 233 445666999999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=364.37 Aligned_cols=255 Identities=13% Similarity=0.058 Sum_probs=179.8
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHH---HHHhCCCCceeeEe-------ee
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELV---AVAHLRHRNLVRLR-------GW 176 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~---~l~~l~H~nIv~l~-------g~ 176 (834)
..+|...+.||+|+||.||+|.+..+|+.||||++.... ....+.+.+|+. +|+. +|||||+++ ++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence 345888899999999999999998899999999987643 234556778854 5555 799988755 44
Q ss_pred EEeC-----------------CEEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHH------HHHHHHHHHHHHHHHh
Q 003278 177 CVHE-----------------DQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQR------KKIIRGLAAALHYLHE 233 (834)
Q Consensus 177 ~~~~-----------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~ 233 (834)
+... +..+||||||+ |+|.+++.... ..+++..+ ..++.|+++||+|||+
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~------~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~ 212 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD------FVYVFRGDEGILALHILTAQLIRLAANLQS 212 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH------HSCCCCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc------cccchhhhhhhhhHHHHHHHHHHHHHHHHH
Confidence 4433 34899999999 89999997542 23455566 7888999999999999
Q ss_pred ccCCCeecCCCCCCceEECCCCceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccC-CCC
Q 003278 234 QLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKG-SVA 312 (834)
Q Consensus 234 ~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~ 312 (834)
+ +|+||||||+|||++.++.+||+|||+|+..... .....||+.|+|||.+..+ ..+
T Consensus 213 ~---~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-------------------~~~~~~t~~y~aPE~~~~~~~~~ 270 (371)
T 3q60_A 213 K---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-------------------GPASSVPVTYAPREFLNASTATF 270 (371)
T ss_dssp T---TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE-------------------EEGGGSCGGGCCHHHHTCSEEEC
T ss_pred C---CCccCcCCHHHEEECCCCCEEEEecceeeecCCC-------------------ccCccCCcCCcChhhccCCCCCc
Confidence 6 9999999999999999999999999999754211 1133477999999998641 367
Q ss_pred CcccceeehhhHHHHHHhCCccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCC
Q 003278 313 TAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNP 392 (834)
Q Consensus 313 ~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p 392 (834)
+.++|||||||++|||+||+.||....+..... .................... .....+.+|+..||+.||
T Consensus 271 ~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~dP 341 (371)
T 3q60_A 271 THALNAWQLGLSIYRVWCLFLPFGLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCT-PLPDFVKTLIGRFLNFDR 341 (371)
T ss_dssp CHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSS-CCCHHHHHHHHHHTCSST
T ss_pred CccccHHHHHHHHHHHHhCCCCCCCcCcccccc--------hhhhhhhhccccccchhhcc-CCCHHHHHHHHHHcCCCh
Confidence 999999999999999999999997553321110 00000000001111000000 112468889999999999
Q ss_pred CCCCchhhHHH
Q 003278 393 HLRPSMKWVIE 403 (834)
Q Consensus 393 ~~RPsm~~V~~ 403 (834)
.+||++.++++
T Consensus 342 ~~Rpt~~e~l~ 352 (371)
T 3q60_A 342 RRRLLPLEAME 352 (371)
T ss_dssp TTCCCHHHHTT
T ss_pred hhCCCHHHHhc
Confidence 99999999875
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=350.19 Aligned_cols=260 Identities=19% Similarity=0.219 Sum_probs=198.6
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCC-CCceeeEeeeEEe--CCEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLR-HRNLVRLRGWCVH--EDQLLLVY 187 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~--~~~~~lV~ 187 (834)
++|+..+.||+|+||.||+|+...+++.||||++.... .+.+.+|+.++.+++ ||||+++++++.. ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 57889999999999999999998999999999986432 467889999999997 9999999999998 56799999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCC-ceEEeeccchh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQY-NARLGDFGLAR 266 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~-~~kl~DFGla~ 266 (834)
||+++++|.+++. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+++
T Consensus 113 e~~~~~~l~~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~ 179 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ----------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 179 (330)
T ss_dssp ECCCCCCHHHHGG----------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eccCchhHHHHHH----------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence 9999999998873 278889999999999999999996 999999999999999766 89999999997
Q ss_pred hhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchH
Q 003278 267 WLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIIL 346 (834)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l 346 (834)
...... ......||+.|+|||.+.....++.++|||||||++|||+||+.||....... ..+
T Consensus 180 ~~~~~~-----------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~-~~l 241 (330)
T 3nsz_A 180 FYHPGQ-----------------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY-DQL 241 (330)
T ss_dssp ECCTTC-----------------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH-HHH
T ss_pred EcCCCC-----------------ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchH-HHH
Confidence 543210 12334689999999998765678999999999999999999999985432221 111
Q ss_pred HHHHHH--------HhhcCccc------ccccc-------ccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 347 LDWIRR--------LSDEGKVL------QAGDN-------RLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 347 ~~~~~~--------~~~~~~~~------~~~d~-------~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
...... ........ +.... ..............+.+++..||+.||.+|||+.++++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 242 VRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 111110 00000000 00000 000000001112468899999999999999999999873
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=353.19 Aligned_cols=273 Identities=23% Similarity=0.245 Sum_probs=199.3
Q ss_pred ccHHHHHhhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC-----------hhhHHHHHHHHHHHHhCCCCc
Q 003278 101 FSYAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG-----------ERFEKTFAAELVAVAHLRHRN 169 (834)
Q Consensus 101 f~~~el~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~-----------~~~~~~~~~E~~~l~~l~H~n 169 (834)
....++....++|...+.||+|+||.||+|... +|..||||++.... ....+.+.+|+.++++++|||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 90 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPN 90 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTT
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcC
Confidence 456788889999999999999999999999984 59999999985421 223478999999999999999
Q ss_pred eeeEeeeEEeC-----CEEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCC
Q 003278 170 LVRLRGWCVHE-----DQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDV 244 (834)
Q Consensus 170 Iv~l~g~~~~~-----~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDl 244 (834)
|+++++++... ...++||||++ |+|.+++... ...+++..+..|+.|++.||.|||+. +|+||||
T Consensus 91 iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dl 160 (362)
T 3pg1_A 91 ILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ------RIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDL 160 (362)
T ss_dssp BCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT------TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCC
T ss_pred ccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc------ccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCC
Confidence 99999999653 36899999998 6888887643 24689999999999999999999996 9999999
Q ss_pred CCCceEECCCCceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhH
Q 003278 245 KTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIV 324 (834)
Q Consensus 245 Kp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvv 324 (834)
||+|||++.++.+||+|||+++...... ..+...||+.|+|||.+.....++.++|||||||+
T Consensus 161 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~-----------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 223 (362)
T 3pg1_A 161 HPGNILLADNNDITICDFNLAREDTADA-----------------NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCV 223 (362)
T ss_dssp CGGGEEECTTCCEEECCTTC--------------------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHH
T ss_pred ChHHEEEcCCCCEEEEecCccccccccc-----------------ccceecccceecCcHHhcCCCCCCcHhHHHhHHHH
Confidence 9999999999999999999997432211 12345699999999998765578999999999999
Q ss_pred HHHHHhCCccCCCCCCCccchHHHHHHHHhhcCccc-----------cccccccCC-CCCC-----HHHHHHHHHHHHHh
Q 003278 325 VLEVVSGRRAVDLTYPDDQIILLDWIRRLSDEGKVL-----------QAGDNRLSD-GSYK-----LCDMEHLTHLALLC 387 (834)
Q Consensus 325 l~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~-----------~~~d~~l~~-~~~~-----~~~~~~l~~l~~~C 387 (834)
+|||+||+.||......+ ....+.......... +.....+.. .... ......+.+|+..|
T Consensus 224 l~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 300 (362)
T 3pg1_A 224 MAEMFNRKALFRGSTFYN---QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKM 300 (362)
T ss_dssp HHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHH
T ss_pred HHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHH
Confidence 999999999986532111 111111111000000 000000000 0000 00124578999999
Q ss_pred cccCCCCCCchhhHHHH
Q 003278 388 TLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 388 l~~~p~~RPsm~~V~~~ 404 (834)
|+.||.+||++.++++.
T Consensus 301 L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 301 LEFNPQRRISTEQALRH 317 (362)
T ss_dssp TCSSGGGSCCHHHHHTS
T ss_pred hcCChhhCCCHHHHHcC
Confidence 99999999999999863
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=357.22 Aligned_cols=261 Identities=24% Similarity=0.297 Sum_probs=184.6
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeC------C
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHE------D 181 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------~ 181 (834)
.++|...+.||+|+||.||+|....+|+.||||++... .....+.+.+|+.++++++||||+++++++... +
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 36799999999999999999999999999999998653 334567788999999999999999999998754 5
Q ss_pred EEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEee
Q 003278 182 QLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGD 261 (834)
Q Consensus 182 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~D 261 (834)
..++||||+ +++|.+++.. ..+++..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+|
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~D 175 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC--------QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILD 175 (367)
T ss_dssp CCEEEEECC-CEECC-------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred eEEEEeccc-CCCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEee
Confidence 689999999 7899888743 3589999999999999999999995 999999999999999999999999
Q ss_pred ccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCC
Q 003278 262 FGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPD 341 (834)
Q Consensus 262 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~ 341 (834)
||+++..... .+...||+.|+|||.+.....++.++|||||||++|||+||+.||......
T Consensus 176 FG~a~~~~~~-------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 236 (367)
T 2fst_X 176 FGLARHTADE-------------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 236 (367)
T ss_dssp ----------------------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccccc-------------------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999753221 234569999999999876557899999999999999999999998643221
Q ss_pred ccchHHHHHHHHhhcCc--cccccc--------cccCC-CCCCHH-----HHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 342 DQIILLDWIRRLSDEGK--VLQAGD--------NRLSD-GSYKLC-----DMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 342 ~~~~l~~~~~~~~~~~~--~~~~~d--------~~l~~-~~~~~~-----~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
.....+........ ....+. ..+.. ...... ....+.+|...||+.||.+||++.++++.
T Consensus 237 ---~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 237 ---DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp ---HHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ---HHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 11111111111000 000000 00000 000110 12357889999999999999999999863
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=339.88 Aligned_cols=252 Identities=19% Similarity=0.275 Sum_probs=193.6
Q ss_pred CcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEecc
Q 003278 514 NFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYS 592 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~ 592 (834)
+|.....||+|+||.||+|.. .++..||||.+.... ....+.|.+|+.++++++|||||++++++.+.+..++||||+
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC-C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc-hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 455566899999999999996 567899999987543 334567999999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecC-CCCceEeeeeecccccc
Q 003278 593 ATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDP-DMNPRLGSFALAEFLTR 671 (834)
Q Consensus 593 ~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~-~~~~ki~DfGla~~~~~ 671 (834)
++++|.+++..... ...+++..+..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||++.....
T Consensus 102 ~~~~L~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 102 PGGSLSALLRSKWG---PLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp SEEEHHHHHHHTTC---CCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred CCCCHHHHHHhhcc---CCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 99999999976432 2246788888999999999999997 69999999999999997 89999999999976532
Q ss_pred CCCCCcccccCccccccccCccchhccccCC--CCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcc
Q 003278 672 NDHGHRKATSGNRSVRGIFGYMSPEYIESGE--ATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPL 749 (834)
Q Consensus 672 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~--~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
.. .......||+.|+|||++.++. ++.++|||||||++|||+||+.||............. .....
T Consensus 176 ~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~~~~~--- 243 (295)
T 2clq_A 176 IN-------PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKV--GMFKV--- 243 (295)
T ss_dssp ------------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHH--HHHCC---
T ss_pred CC-------CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhh--ccccc---
Confidence 21 1123457999999999997654 7899999999999999999999986432221111111 00110
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 750 AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 750 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
.+.+....+ . .+..++.+||+.||++|||+.++++
T Consensus 244 ----~~~~~~~~~-~---~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 244 ----HPEIPESMS-A---EAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp ----CCCCCTTSC-H---HHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ----cccccccCC-H---HHHHHHHHHccCChhhCCCHHHHhc
Confidence 111222222 2 3445666899999999999999984
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=346.12 Aligned_cols=264 Identities=19% Similarity=0.252 Sum_probs=195.9
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCC-hhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEe
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKC-PALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYD 590 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~-~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~E 590 (834)
++|...+.||+|+||.||+|... ++..||||++..... ....+.+.+|+.++++++|||||+++++|.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 45677788999999999999975 488999999865443 3445678899999999999999999999999999999999
Q ss_pred ccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccc
Q 003278 591 YSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLT 670 (834)
Q Consensus 591 y~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~ 670 (834)
|+++++|..++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+.
T Consensus 105 ~~~~~~l~~~~~~~~------~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 175 (331)
T 4aaa_A 105 FVDHTILDDLELFPN------GLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLA 175 (331)
T ss_dssp CCSEEHHHHHHHSTT------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred cCCcchHHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence 999999998765432 38899999999999999999997 699999999999999999999999999997653
Q ss_pred cCCCCCcccccCccccccccCccchhccccC-CCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHH-------
Q 003278 671 RNDHGHRKATSGNRSVRGIFGYMSPEYIESG-EATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEF------- 742 (834)
Q Consensus 671 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~------- 742 (834)
.... ......||+.|+|||++.+. .++.++|||||||++|||+||+.||........+.......
T Consensus 176 ~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (331)
T 4aaa_A 176 APGE-------VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRH 248 (331)
T ss_dssp ---------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred CCcc-------ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Confidence 3211 12235789999999999775 68999999999999999999999987544332221111100
Q ss_pred ---HhhcCccccccccccCCCCCHH-----HHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 743 ---EARKRPLAELVDLSLNGEYNHK-----ELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 743 ---~~~~~~~~~~~d~~l~~~~~~~-----~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
............+.+....... ....+.+++.+||+.||++|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 249 QELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000000111111111111110 1134566777999999999999999985
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=357.25 Aligned_cols=264 Identities=20% Similarity=0.260 Sum_probs=199.8
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCC--------CCceeeEeeeEE----
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLR--------HRNLVRLRGWCV---- 178 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~--------H~nIv~l~g~~~---- 178 (834)
++|...+.||+|+||.||+|+...+|+.||||++... ....+.+.+|+.++++++ |+||+++++++.
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 6799999999999999999999899999999998643 445677899999999886 788999999998
Q ss_pred eCCEEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCC---
Q 003278 179 HEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQY--- 255 (834)
Q Consensus 179 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~--- 255 (834)
.....++||||+ +|+|.+.+.... ...+++..+..|+.|++.||.|||++ .+|+||||||+|||++.++
T Consensus 116 ~~~~~~lv~e~~-~~~l~~~~~~~~-----~~~~~~~~~~~i~~qi~~aL~~lH~~--~givHrDikp~NIll~~~~~~~ 187 (397)
T 1wak_A 116 NGTHICMVFEVL-GHHLLKWIIKSN-----YQGLPLPCVKKIIQQVLQGLDYLHTK--CRIIHTDIKPENILLSVNEQYI 187 (397)
T ss_dssp TEEEEEEEECCC-CCBHHHHHHHTT-----TSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECCCCSGGGEEECCCHHHH
T ss_pred CCceEEEEEecc-CccHHHHHHhcc-----cCCCCHHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHeeEeccchhh
Confidence 456799999999 566666664432 24689999999999999999999984 2899999999999999775
Q ss_pred ----------------------------------------------ceEEeeccchhhhhhhhhhhhhcccccccccccc
Q 003278 256 ----------------------------------------------NARLGDFGLARWLEHELQYQMRTSSARNHQFHLA 289 (834)
Q Consensus 256 ----------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~ 289 (834)
.+||+|||+++.....
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~------------------ 249 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------------------ 249 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC------------------
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc------------------
Confidence 7999999999754211
Q ss_pred cceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccch---HHHHHHHHhhc--------Cc
Q 003278 290 ETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQII---LLDWIRRLSDE--------GK 358 (834)
Q Consensus 290 ~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~---l~~~~~~~~~~--------~~ 358 (834)
.+...||+.|+|||.+... .++.++|||||||++|||+||+.||.......... ....+...... +.
T Consensus 250 -~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 327 (397)
T 1wak_A 250 -FTEDIQTRQYRSLEVLIGS-GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGK 327 (397)
T ss_dssp -SCSCCSCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCT
T ss_pred -CccCCCCCcccCChhhcCC-CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhccc
Confidence 2334699999999998754 57999999999999999999999997544332111 11111111100 00
Q ss_pred cc-----------ccccccc--------CCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 359 VL-----------QAGDNRL--------SDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 359 ~~-----------~~~d~~l--------~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
.. ...+... ............+.+|+..||+.||.+||++.|+++
T Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 328 YSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp TGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00 0000000 001123444567889999999999999999999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=353.53 Aligned_cols=261 Identities=28% Similarity=0.427 Sum_probs=202.0
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEE--EEEEeccc-ChhhHHHHHHHHHHHHhC-CCCceeeEeeeEEeCCEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVV--AVKCLAEK-GERFEKTFAAELVAVAHL-RHRNLVRLRGWCVHEDQLLLV 186 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~v--AvK~l~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV 186 (834)
++|...+.||+|+||.||+|.+..+|..+ |||.+... .....+.+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 56888999999999999999998888765 99988643 233456789999999999 999999999999999999999
Q ss_pred EEccCCCCHhHHHhcCCCc---------cccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCce
Q 003278 187 YDYMPNRSLDRVLFRRPEN---------LEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNA 257 (834)
Q Consensus 187 ~Ey~~~gsL~~~l~~~~~~---------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~ 257 (834)
|||+++|+|.+++...... ......+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence 9999999999999754310 01134689999999999999999999996 99999999999999999999
Q ss_pred EEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCC
Q 003278 258 RLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVD 336 (834)
Q Consensus 258 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~ 336 (834)
||+|||+++..... .......||+.|+|||.+... .++.++|||||||++|||+| |+.||.
T Consensus 182 kL~Dfg~~~~~~~~-----------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~ 243 (327)
T 1fvr_A 182 KIADFGLSRGQEVY-----------------VKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYC 243 (327)
T ss_dssp EECCTTCEESSCEE-----------------CCC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred EEcccCcCcccccc-----------------ccccCCCCCccccChhhhccc-cCCchhcchHHHHHHHHHHcCCCCCCC
Confidence 99999998732110 012334578999999988654 57899999999999999998 999986
Q ss_pred CCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcCC
Q 003278 337 LTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGSY 409 (834)
Q Consensus 337 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~~ 409 (834)
.... ......+ ..+... ... ... ...+.+++..||+.||.+||++.++++.|....
T Consensus 244 ~~~~------~~~~~~~-~~~~~~-----~~~-~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 299 (327)
T 1fvr_A 244 GMTC------AELYEKL-PQGYRL-----EKP-LNC----DDEVYDLMRQCWREKPYERPSFAQILVSLNRML 299 (327)
T ss_dssp TCCH------HHHHHHG-GGTCCC-----CCC-TTB----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCcH------HHHHHHh-hcCCCC-----CCC-CCC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 4321 1111111 111111 000 111 246889999999999999999999999987653
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=371.16 Aligned_cols=254 Identities=17% Similarity=0.217 Sum_probs=198.8
Q ss_pred hhCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCC--ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEE
Q 003278 512 TNNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSK--CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVI 588 (834)
Q Consensus 512 t~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv 588 (834)
.++|...+.||+|+||.||+|... +++.||||.+.... .......+.+|+.+|++++|||||++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 356888889999999999999974 68999999986421 112235688999999999999999999999999999999
Q ss_pred EeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccc
Q 003278 589 YDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEF 668 (834)
Q Consensus 589 ~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~ 668 (834)
|||+++|+|..++...+. ..+++..+..++.||+.||+|||+ .+||||||||+||||+.++.+||+|||+++.
T Consensus 263 mEy~~gg~L~~~l~~~~~----~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~ 335 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQ----AGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVH 335 (576)
T ss_dssp ECCCCSCBHHHHHHSSSS----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEcCCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEeccccee
Confidence 999999999999875432 248899999999999999999997 6999999999999999999999999999986
Q ss_pred cccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCc
Q 003278 669 LTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRP 748 (834)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
+.... .....+||+.|||||++.+..++.++|||||||++|||+||+.||.....................
T Consensus 336 ~~~~~--------~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~- 406 (576)
T 2acx_A 336 VPEGQ--------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPE- 406 (576)
T ss_dssp CCTTC--------CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCC-
T ss_pred cccCc--------cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccc-
Confidence 54321 122458999999999999999999999999999999999999999754322111111111111111
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----ChhHHHH
Q 003278 749 LAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRP-----SMRQILS 792 (834)
Q Consensus 749 ~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RP-----tm~~v~~ 792 (834)
.....++ .+ +..++.+||+.||++|| ++.||++
T Consensus 407 -------~~p~~~s-~~---~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 407 -------EYSERFS-PQ---ARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp -------CCCTTSC-HH---HHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred -------cCCccCC-HH---HHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 1111222 33 44555589999999999 6778764
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=340.46 Aligned_cols=249 Identities=19% Similarity=0.305 Sum_probs=177.7
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCC--hhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKC--PALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIY 589 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~--~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~ 589 (834)
++|...+.||+|+||.||+|.. .+++.||||.+..... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 4677788999999999999996 5688999999853211 122467899999999999999999999999999999999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccc
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFL 669 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~ 669 (834)
||+++++|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++...
T Consensus 91 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 162 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRV-----KPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQL 162 (278)
T ss_dssp ECCTTEEHHHHHHTCS-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeec
Confidence 9999999999987542 248899999999999999999997 69999999999999999999999999999765
Q ss_pred ccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcc
Q 003278 670 TRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPL 749 (834)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
.... .......||+.|+|||.+.+..++.++|||||||++|||+||+.|+........... ...
T Consensus 163 ~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---------~~~ 226 (278)
T 3cok_A 163 KMPH-------EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK---------VVL 226 (278)
T ss_dssp C-----------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------CCS
T ss_pred cCCC-------CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHH---------Hhh
Confidence 3221 112245799999999999988999999999999999999999999865432211100 000
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 750 AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 750 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
.+.......+ . .+.+++.+||+.||++|||+.+|++
T Consensus 227 ---~~~~~~~~~~-~---~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 227 ---ADYEMPSFLS-I---EAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp ---SCCCCCTTSC-H---HHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ---cccCCccccC-H---HHHHHHHHHcccCHhhCCCHHHHhc
Confidence 0111112222 2 3445666999999999999999985
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=367.97 Aligned_cols=251 Identities=22% Similarity=0.334 Sum_probs=195.9
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC--hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG--ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYD 188 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 188 (834)
+.|...+.||+|+||.||+|+...++..||||++.... ......+.+|+.+++.++|||||+++++|.+.+..++|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 45888999999999999999999899999999986532 2335678999999999999999999999999999999999
Q ss_pred ccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECC---CCceEEeeccch
Q 003278 189 YMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDS---QYNARLGDFGLA 265 (834)
Q Consensus 189 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~---~~~~kl~DFGla 265 (834)
||++|+|.+.+... ..+++..+..|+.|++.||.|||+. +|+||||||+|||++. ++.+||+|||++
T Consensus 117 ~~~~g~L~~~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a 186 (494)
T 3lij_A 117 CYKGGELFDEIIHR-------MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLS 186 (494)
T ss_dssp CCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred cCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCC
Confidence 99999999888643 3589999999999999999999996 9999999999999976 445999999999
Q ss_pred hhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccch
Q 003278 266 RWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQII 345 (834)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~ 345 (834)
+..... .......||+.|+|||.+. + .++.++|||||||++|||+||+.||..... ..
T Consensus 187 ~~~~~~-----------------~~~~~~~gt~~y~aPE~l~-~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~ 244 (494)
T 3lij_A 187 AVFENQ-----------------KKMKERLGTAYYIAPEVLR-K-KYDEKCDVWSIGVILFILLAGYPPFGGQTD---QE 244 (494)
T ss_dssp EECBTT-----------------BCBCCCCSCTTTCCHHHHT-T-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HH
T ss_pred eECCCC-----------------ccccccCCCcCeeCHHHHc-c-cCCCchhHHHHHHHHHHHHhCCCCCCCCCH---HH
Confidence 754321 0123456999999999885 3 579999999999999999999999864321 11
Q ss_pred HHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 346 LLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 346 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
+ ...... +... ...+.. ... ...+.+++..||+.||.+|||+.++++.
T Consensus 245 ~---~~~i~~-~~~~-~~~~~~--~~~----s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 245 I---LRKVEK-GKYT-FDSPEW--KNV----SEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp H---HHHHHH-TCCC-CCSGGG--TTS----CHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred H---HHHHHh-CCCC-CCchhc--ccC----CHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 1 111111 1111 001111 011 1357889999999999999999999863
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=343.37 Aligned_cols=252 Identities=24% Similarity=0.389 Sum_probs=196.6
Q ss_pred hcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEE
Q 003278 109 GSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYD 188 (834)
Q Consensus 109 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 188 (834)
..++|+..+.||+|+||.||+|....+|+.||||.+.... ..+.+.+|+.++.+++||||+++++++...+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 3467889999999999999999998889999999986543 24668899999999999999999999999999999999
Q ss_pred ccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhh
Q 003278 189 YMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWL 268 (834)
Q Consensus 189 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~ 268 (834)
|+++|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+
T Consensus 105 ~~~~~~L~~~~~~~------~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 175 (314)
T 3com_A 105 YCGAGSVSDIIRLR------NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQL 175 (314)
T ss_dssp CCTTEEHHHHHHHH------TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred cCCCCCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhh
Confidence 99999999998632 24689999999999999999999996 9999999999999999999999999999754
Q ss_pred hhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHH
Q 003278 269 EHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLD 348 (834)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~ 348 (834)
.... .......||+.|+|||.+... .++.++|||||||++|||+||+.||...... .
T Consensus 176 ~~~~----------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~ 232 (314)
T 3com_A 176 TDTM----------------AKRNTVIGTPFWMAPEVIQEI-GYNCVADIWSLGITAIEMAEGKPPYADIHPM------R 232 (314)
T ss_dssp BTTB----------------SCBCCCCSCGGGCCHHHHSSS-CBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------H
T ss_pred hhhc----------------cccCccCCCCCccChhhcCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChH------H
Confidence 3210 112345699999999998654 5789999999999999999999998643211 1
Q ss_pred HHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 349 WIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 349 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
....... ........+ ..+ ...+.+++..||+.||.+||++.++++
T Consensus 233 ~~~~~~~-~~~~~~~~~----~~~----~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 233 AIFMIPT-NPPPTFRKP----ELW----SDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp HHHHHHH-SCCCCCSSG----GGS----CHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHHhc-CCCcccCCc----ccC----CHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 1111111 110000000 011 246789999999999999999999976
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=367.49 Aligned_cols=252 Identities=21% Similarity=0.359 Sum_probs=198.8
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC-------------hhhHHHHHHHHHHHHhCCCCceeeEeee
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG-------------ERFEKTFAAELVAVAHLRHRNLVRLRGW 176 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~-------------~~~~~~~~~E~~~l~~l~H~nIv~l~g~ 176 (834)
.++|...+.||+|+||.||+|....++..||||++.... ....+.+.+|+.++++++|||||+++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 467999999999999999999999999999999986432 1345678999999999999999999999
Q ss_pred EEeCCEEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCC-
Q 003278 177 CVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQY- 255 (834)
Q Consensus 177 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~- 255 (834)
|.+.+..++|||||++|+|.+++... ..+++..+..|+.|++.||.|||+. +|+||||||+|||++.++
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~ 184 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINR-------HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNS 184 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTC
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCC
Confidence 99999999999999999999988643 3589999999999999999999996 999999999999998765
Q ss_pred --ceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCc
Q 003278 256 --NARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRR 333 (834)
Q Consensus 256 --~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~ 333 (834)
.+||+|||+++...... ......||+.|+|||.+. + .++.++|||||||++|||++|+.
T Consensus 185 ~~~~kl~Dfg~a~~~~~~~-----------------~~~~~~gt~~y~aPE~~~-~-~~~~~~DiwslG~il~~ll~g~~ 245 (504)
T 3q5i_A 185 LLNIKIVDFGLSSFFSKDY-----------------KLRDRLGTAYYIAPEVLK-K-KYNEKCDVWSCGVIMYILLCGYP 245 (504)
T ss_dssp CSSEEECCCTTCEECCTTS-----------------CBCCCCSCTTTCCHHHHT-T-CBCTHHHHHHHHHHHHHHHHSSC
T ss_pred CccEEEEECCCCEEcCCCC-----------------ccccccCCcCCCCHHHhc-c-CCCchHHHHHHHHHHHHHHhCCC
Confidence 69999999997543210 123456999999999885 3 57999999999999999999999
Q ss_pred cCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 334 AVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 334 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
||..... ..+ ...+. .+...... +.. ... ...+.+++..||+.||.+|||+.++++.
T Consensus 246 pf~~~~~---~~~---~~~i~-~~~~~~~~-~~~--~~~----s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 246 PFGGQND---QDI---IKKVE-KGKYYFDF-NDW--KNI----SDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp SSCCSSH---HHH---HHHHH-HCCCCCCH-HHH--TTS----CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCCCH---HHH---HHHHH-cCCCCCCc-ccc--CCC----CHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 9964321 111 11111 12111000 000 001 1457889999999999999999999863
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=368.00 Aligned_cols=251 Identities=24% Similarity=0.355 Sum_probs=201.2
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 187 (834)
+.|...+.||+|+||.||+|....+|+.||||++.... ....+.+.+|+.++++++|||||+++++|.+.+..++||
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 105 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG 105 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 46888999999999999999999899999999985432 334678999999999999999999999999999999999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEE---CCCCceEEeeccc
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVML---DSQYNARLGDFGL 264 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILl---d~~~~~kl~DFGl 264 (834)
||+.+|+|.+++... ..+++..+..|+.|++.||.|||+. +|+||||||+|||+ +.++.+||+|||+
T Consensus 106 e~~~~~~L~~~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 175 (484)
T 3nyv_A 106 EVYTGGELFDEIISR-------KRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGL 175 (484)
T ss_dssp CCCCSCBHHHHHHTC-------SCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTH
T ss_pred ecCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeee
Confidence 999999999988643 4589999999999999999999996 99999999999999 4678899999999
Q ss_pred hhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccc
Q 003278 265 ARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQI 344 (834)
Q Consensus 265 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~ 344 (834)
++.+.... ......||+.|+|||.+.. .++.++|||||||++|||+||+.||.... ..
T Consensus 176 a~~~~~~~-----------------~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~ 233 (484)
T 3nyv_A 176 STHFEASK-----------------KMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGAN---EY 233 (484)
T ss_dssp HHHBCCCC-----------------SHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HH
T ss_pred eEEccccc-----------------ccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCC---HH
Confidence 97543210 1233469999999998854 57999999999999999999999986432 11
Q ss_pred hHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 345 ILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 345 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
.+...+ . .+...... +... . ....+.+++..||+.||.+|||+.++++.
T Consensus 234 ~~~~~i---~-~~~~~~~~-~~~~--~----~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 234 DILKKV---E-KGKYTFEL-PQWK--K----VSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp HHHHHH---H-HCCCCCCS-GGGG--G----SCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHH---H-cCCCCCCC-cccc--c----CCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 122111 1 12111000 0000 0 12457889999999999999999999863
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=351.87 Aligned_cols=243 Identities=16% Similarity=0.196 Sum_probs=193.3
Q ss_pred hCcCcCCcccccCCcEEEEEEECC-CcEEEEEEecCCC--ChhHHHHHHHHHHHHHhc-cCCCceeEEEEEeeCCeEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDN-HQYVLVKRLGMSK--CPALRTRFSNELQNLARL-RHRNLVQLCGWCTEQGEMLVI 588 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~-~~~vavK~~~~~~--~~~~~~~f~~E~~~l~~l-~HpNiv~l~g~~~~~~~~~lv 588 (834)
++|...+.||+|+||.||+|.... ++.||||.+.... .....+.+.+|..+|..+ +||||+++++++.+.+..++|
T Consensus 20 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 99 (353)
T 2i0e_A 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 99 (353)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEE
Confidence 578888899999999999999764 7889999986431 112245688899999988 899999999999999999999
Q ss_pred EeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccc
Q 003278 589 YDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEF 668 (834)
Q Consensus 589 ~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~ 668 (834)
|||+++|+|.+++...+ .+++..+..++.|++.||+|||+ .+|+||||||+||||+.++.+||+|||+++.
T Consensus 100 ~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 100 MEYVNGGDLMYHIQQVG------RFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp EECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 99999999999987532 37888999999999999999997 6999999999999999999999999999975
Q ss_pred cccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCc
Q 003278 669 LTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRP 748 (834)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
..... ....+.+||+.|||||++.+..++.++|||||||++|||+||+.||....... +...+.. ....
T Consensus 171 ~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-~~~~i~~---~~~~ 239 (353)
T 2i0e_A 171 NIWDG-------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-LFQSIME---HNVA 239 (353)
T ss_dssp CCCTT-------CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHH---CCCC
T ss_pred cccCC-------cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH-HHHHHHh---CCCC
Confidence 32211 12335689999999999999999999999999999999999999997543322 2222111 1111
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCh
Q 003278 749 LAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSM 787 (834)
Q Consensus 749 ~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm 787 (834)
.+...+ .+ +..++.+||..||++||++
T Consensus 240 --------~p~~~s-~~---~~~li~~lL~~dP~~R~~~ 266 (353)
T 2i0e_A 240 --------YPKSMS-KE---AVAICKGLMTKHPGKRLGC 266 (353)
T ss_dssp --------CCTTSC-HH---HHHHHHHHTCSCTTSCTTC
T ss_pred --------CCCCCC-HH---HHHHHHHHhhcCHHHcCCC
Confidence 111222 33 4455568999999999964
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=365.87 Aligned_cols=251 Identities=21% Similarity=0.343 Sum_probs=199.1
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYD 188 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 188 (834)
++|+..+.||+|+||.||+|....+|+.||||++... .......+.+|+.++++++|||||++++++.+.+..++|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 4588899999999999999999889999999998542 22345778999999999999999999999999999999999
Q ss_pred ccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEEC---CCCceEEeeccch
Q 003278 189 YMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLD---SQYNARLGDFGLA 265 (834)
Q Consensus 189 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld---~~~~~kl~DFGla 265 (834)
|+++|+|.+.+... ..+++..+..|+.|++.||.|||+. +|+||||||+|||++ .++.+||+|||++
T Consensus 102 ~~~~~~L~~~~~~~-------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 171 (486)
T 3mwu_A 102 LYTGGELFDEIIKR-------KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (486)
T ss_dssp CCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCT
T ss_pred cCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcC
Confidence 99999999888643 3589999999999999999999996 999999999999995 4567999999999
Q ss_pred hhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccch
Q 003278 266 RWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQII 345 (834)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~ 345 (834)
+.+.... ......||+.|+|||.+.. .++.++|||||||++|||+||+.||.... ...
T Consensus 172 ~~~~~~~-----------------~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~ 229 (486)
T 3mwu_A 172 TCFQQNT-----------------KMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKN---EYD 229 (486)
T ss_dssp TTBCCC---------------------CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHH
T ss_pred eECCCCC-----------------ccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHH
Confidence 7543211 1234469999999998863 47999999999999999999999986432 111
Q ss_pred HHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 346 LLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 346 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
+ ..... .+...... +.. ... ...+.+++..||+.||.+||++.++++.
T Consensus 230 ~---~~~i~-~~~~~~~~-~~~--~~~----s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 230 I---LKRVE-TGKYAFDL-PQW--RTI----SDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp H---HHHHH-HTCCCSCS-GGG--GGS----CHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred H---HHHHH-hCCCCCCC-ccc--CCC----CHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1 11111 11111000 000 001 1457889999999999999999999874
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=363.41 Aligned_cols=267 Identities=18% Similarity=0.233 Sum_probs=205.5
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCC-CceeeEeeeEEeCCEEEEEEE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRH-RNLVRLRGWCVHEDQLLLVYD 188 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H-~nIv~l~g~~~~~~~~~lV~E 188 (834)
.++|...++||+|+||.||+|.+..+|+.||||++..... ...+..|+.++..++| ++|+.+..++...+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 3679999999999999999999988999999998764422 2357889999999987 566677777788889999999
Q ss_pred ccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEE---CCCCceEEeeccch
Q 003278 189 YMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVML---DSQYNARLGDFGLA 265 (834)
Q Consensus 189 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILl---d~~~~~kl~DFGla 265 (834)
|+ +++|.+++... ...++|..++.|+.||+.||.|||+. +||||||||+|||| +.++.+||+|||++
T Consensus 84 ~~-g~sL~~ll~~~------~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla 153 (483)
T 3sv0_A 84 LL-GPSLEDLFNFC------SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (483)
T ss_dssp CC-CCBHHHHHHHT------TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred CC-CCCHHHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcc
Confidence 99 99999999643 24689999999999999999999996 99999999999999 68889999999999
Q ss_pred hhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccch
Q 003278 266 RWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQII 345 (834)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~ 345 (834)
+.+...... ............||+.|+|||.+... .++.++|||||||+||||+||+.||..........
T Consensus 154 ~~~~~~~~~---------~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~ 223 (483)
T 3sv0_A 154 KKYRDTSTH---------QHIPYRENKNLTGTARYASVNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ 223 (483)
T ss_dssp EECBCTTTC---------CBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHH
T ss_pred eeccCCccc---------cccccccccccCCCccccCHHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccchhHHH
Confidence 865432110 00001123456799999999998654 67999999999999999999999997654443322
Q ss_pred HHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 346 LLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 346 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
....+........+.... . .+ ...+.+++..||+.+|++||++.+|++.|...
T Consensus 224 ~~~~i~~~~~~~~~~~l~-~-----~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 224 KYEKISEKKVATSIEALC-R-----GY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HHHHHHHHHHHSCHHHHH-T-----TS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HHHHHhhccccccHHHHh-c-----CC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 222222111111111000 0 11 14688999999999999999999999988664
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=352.50 Aligned_cols=274 Identities=22% Similarity=0.269 Sum_probs=200.6
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc-ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeC-----CEE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHE-----DQL 183 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-----~~~ 183 (834)
.++|...+.||+|+||.||+|.+..+|+.||||++... .......+.+|+.++++++||||+++++++... +..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 46799999999999999999999889999999998643 334556788999999999999999999988764 679
Q ss_pred EEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeecc
Q 003278 184 LLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFG 263 (834)
Q Consensus 184 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFG 263 (834)
++||||+. |+|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 90 ~lv~e~~~-~~L~~~~~~--------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg 157 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST--------QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFG 157 (353)
T ss_dssp EEEECCCS-EEHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEeccC-ccHHHHHhh--------cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecc
Confidence 99999997 689988854 3589999999999999999999996 99999999999999999999999999
Q ss_pred chhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCcc
Q 003278 264 LARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQ 343 (834)
Q Consensus 264 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~ 343 (834)
+++.+.......... ...........||+.|+|||.+..+..++.++|||||||++|||++|+.||.......
T Consensus 158 ~a~~~~~~~~~~~~~------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~- 230 (353)
T 2b9h_A 158 LARIIDESAADNSEP------TGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH- 230 (353)
T ss_dssp TCEECC----------------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-
T ss_pred cccccccccccccCc------cccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH-
Confidence 998654322110000 0000112345799999999988765678999999999999999999999986432111
Q ss_pred chHHHHHHHHhhcCc---ccccc-cc-------ccCC-CCCCH-----HHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 344 IILLDWIRRLSDEGK---VLQAG-DN-------RLSD-GSYKL-----CDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 344 ~~l~~~~~~~~~~~~---~~~~~-d~-------~l~~-~~~~~-----~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
....+........ ..... .. .+.. ..... .....+.+++..||+.||.+||++.++++.
T Consensus 231 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 231 --QLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp --HHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred --HHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 1111111111000 00000 00 0000 00000 012457789999999999999999999863
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=347.19 Aligned_cols=268 Identities=19% Similarity=0.343 Sum_probs=182.1
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
++|...+.||+|+||.||+|.. .++..||||.+.........++|.+|+.++.+++||||+++++++...+..++||||
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 94 (303)
T 2vwi_A 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKL 94 (303)
T ss_dssp CCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEEC
T ss_pred hhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehh
Confidence 5677788999999999999985 468899999987654444557789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCC--CCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccc
Q 003278 592 SATRILSHLLFHNNH--RIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFL 669 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~--~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~ 669 (834)
+++++|.+++..... ......+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++...
T Consensus 95 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 171 (303)
T 2vwi_A 95 LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFL 171 (303)
T ss_dssp CTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHHHHC
T ss_pred ccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccchhee
Confidence 999999999864211 1112358899999999999999999997 69999999999999999999999999999765
Q ss_pred ccCCCCCcccccCccccccccCccchhcccc-CCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCc
Q 003278 670 TRNDHGHRKATSGNRSVRGIFGYMSPEYIES-GEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRP 748 (834)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
...... ..........||+.|+|||++.+ ..++.++|||||||++|||+||+.||....+....... .......
T Consensus 172 ~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~ 246 (303)
T 2vwi_A 172 ATGGDI--TRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT---LQNDPPS 246 (303)
T ss_dssp C-----------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH---HTSSCCC
T ss_pred ccCCCc--cchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHH---hccCCCc
Confidence 432111 01111234579999999999875 56899999999999999999999998754433222111 1110011
Q ss_pred c-ccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 749 L-AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 749 ~-~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
. ....++.....++ . .+.+++.+||+.||++|||+.+|++
T Consensus 247 ~~~~~~~~~~~~~~~-~---~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 247 LETGVQDKEMLKKYG-K---SFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp TTC-----CCCCCCC-H---HHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cccccccchhhhhhh-H---HHHHHHHHHccCChhhCcCHHHHhh
Confidence 1 1111111222222 2 3455666899999999999999985
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=343.73 Aligned_cols=251 Identities=27% Similarity=0.397 Sum_probs=194.6
Q ss_pred hcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCC-EEEEEE
Q 003278 109 GSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHED-QLLLVY 187 (834)
Q Consensus 109 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-~~~lV~ 187 (834)
..++|+..+.||+|+||.||+|.. +|+.||||++.... ..+.|.+|+.++++++||||+++++++.+.+ ..++||
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred ChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 346788999999999999999988 48999999987542 4567999999999999999999999976554 689999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
||+++|+|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 95 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~ 166 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRG-----RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKE 166 (278)
T ss_dssp CCCTTEEHHHHHHHHH-----HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---
T ss_pred ecCCCCCHHHHHHhcc-----cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccc
Confidence 9999999999996532 12478899999999999999999996 999999999999999999999999999875
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccchH
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQIIL 346 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l 346 (834)
.... .....||+.|+|||.+... .++.++|||||||++|||+| |+.|+...... .+
T Consensus 167 ~~~~-------------------~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~ 223 (278)
T 1byg_A 167 ASST-------------------QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DV 223 (278)
T ss_dssp ----------------------------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GH
T ss_pred cccc-------------------ccCCCccccccCHHHhCCC-CCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HH
Confidence 3221 1223578999999998654 67999999999999999999 99998643221 11
Q ss_pred HHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 347 LDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 347 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
.. .. ..+... ... ... ...+.+++..||+.||.+||++.++++.|+..
T Consensus 224 ~~---~~-~~~~~~-----~~~-~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 224 VP---RV-EKGYKM-----DAP-DGC----PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp HH---HH-TTTCCC-----CCC-TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH---HH-hcCCCC-----CCc-ccC----CHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 11 11 111111 111 111 24688899999999999999999999998764
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=381.95 Aligned_cols=245 Identities=22% Similarity=0.273 Sum_probs=198.3
Q ss_pred hcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc---ChhhHHHHHHHHHHHHhC-CCCceeeEeeeEEeCCEEE
Q 003278 109 GSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK---GERFEKTFAAELVAVAHL-RHRNLVRLRGWCVHEDQLL 184 (834)
Q Consensus 109 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~ 184 (834)
..++|+..++||+|+||.||+|....+++.||||++... .....+.+..|..++..+ +||||+++++++.+.+.+|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 456799999999999999999999999999999998653 123345678899999987 7999999999999999999
Q ss_pred EEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccc
Q 003278 185 LVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGL 264 (834)
Q Consensus 185 lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGl 264 (834)
|||||+++|+|..+|... ..+++..+..|+.||+.||+|||+. +||||||||+||||+.++++||+|||+
T Consensus 419 lV~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGl 488 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV-------GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGM 488 (674)
T ss_dssp EEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTT
T ss_pred EEEeCcCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecce
Confidence 999999999999999653 3589999999999999999999996 999999999999999999999999999
Q ss_pred hhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccc
Q 003278 265 ARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQI 344 (834)
Q Consensus 265 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~ 344 (834)
|+..... .......+||+.|+|||++... .++.++|||||||++|||+||+.||.... ..
T Consensus 489 a~~~~~~----------------~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~---~~ 548 (674)
T 3pfq_A 489 CKENIWD----------------GVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGED---ED 548 (674)
T ss_dssp CEECCCT----------------TCCBCCCCSCSSSCCHHHHTCC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSS---HH
T ss_pred eeccccC----------------CcccccccCCCcccCHhhhcCC-CCCccceEechHHHHHHHHcCCCCCCCCC---HH
Confidence 9742111 0124567899999999998654 67999999999999999999999996432 11
Q ss_pred hHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCch
Q 003278 345 ILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSM 398 (834)
Q Consensus 345 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm 398 (834)
.+ ...+.. +.. ... ... ...+.+|+..||+.||.+||++
T Consensus 549 ~~---~~~i~~-~~~------~~p-~~~----s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 549 EL---FQSIME-HNV------AYP-KSM----SKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp HH---HHHHHS-SCC------CCC-TTS----CHHHHHHHHHHSCSSSTTCTTC
T ss_pred HH---HHHHHh-CCC------CCC-ccC----CHHHHHHHHHHccCCHHHCCCC
Confidence 11 222221 111 111 111 2457889999999999999998
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=341.70 Aligned_cols=257 Identities=19% Similarity=0.220 Sum_probs=193.6
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCC--ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSK--CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIY 589 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~ 589 (834)
++|...+.||+|+||.||+|... +++.||||.+.... .+...+.|.+|+.++.+++||||+++++++.+.+..++||
T Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 2h34_A 34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDM 113 (309)
T ss_dssp CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEE
Confidence 56777889999999999999964 68899999986542 2344578999999999999999999999999999999999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccc
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFL 669 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~ 669 (834)
||+++++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++...
T Consensus 114 e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 184 (309)
T 2h34_A 114 RLINGVDLAAMLRRQG------PLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASAT 184 (309)
T ss_dssp ECCCCEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred EecCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence 9999999999987532 38899999999999999999997 68999999999999999999999999999765
Q ss_pred ccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcc
Q 003278 670 TRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPL 749 (834)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
..... .......||+.|+|||++.+..++.++|||||||++|||+||+.||...... ..........+.
T Consensus 185 ~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~ 253 (309)
T 2h34_A 185 TDEKL------TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-----VMGAHINQAIPR 253 (309)
T ss_dssp ------------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-----HHHHHHHSCCCC
T ss_pred ccccc------ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-----HHHHHhccCCCC
Confidence 33211 1122457999999999999999999999999999999999999998643221 111111111111
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCC-ChhHHHHHHccC
Q 003278 750 AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRP-SMRQILSILDGN 797 (834)
Q Consensus 750 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RP-tm~~v~~~L~~~ 797 (834)
.. ...... +.+ +.+++.+||+.||++|| |+.++++.|+..
T Consensus 254 ~~----~~~~~~-~~~---l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~ 294 (309)
T 2h34_A 254 PS----TVRPGI-PVA---FDAVIARGMAKNPEDRYVTCGDLSAAAHAA 294 (309)
T ss_dssp GG----GTSTTC-CTH---HHHHHHHHTCSSGGGSCSSHHHHHHHHHHT
T ss_pred cc----ccCCCC-CHH---HHHHHHHhccCCHHHHHHhHHHHHHHHHHH
Confidence 00 111111 123 44556689999999999 999999999754
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=367.06 Aligned_cols=252 Identities=16% Similarity=0.203 Sum_probs=196.3
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCC--hhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKC--PALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIY 589 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~ 589 (834)
++|...+.||+|+||.||+|... +++.||||++..... ....+.+.+|+.+|++++|||||++++++.+.+..++||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 56777888999999999999974 589999999864321 122356889999999999999999999999999999999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccc
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFL 669 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~ 669 (834)
||+++|+|..++...... ...+++.....++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+++.+
T Consensus 265 E~~~gg~L~~~l~~~~~~--~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDED--NPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp CCCTTCBHHHHHHTSSTT--SCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EeccCCCHHHHHHHhhcc--cccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 999999999998754321 2348899999999999999999997 69999999999999999999999999999865
Q ss_pred ccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcc
Q 003278 670 TRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPL 749 (834)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
.... ......+||+.|||||++.+..|+.++|||||||++|||+||+.||.....................
T Consensus 340 ~~~~-------~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~-- 410 (543)
T 3c4z_A 340 KAGQ-------TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV-- 410 (543)
T ss_dssp CTTC-------CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCC--
T ss_pred cCCC-------cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhccc--
Confidence 4321 1123468999999999999999999999999999999999999999754321111111111111111
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChh
Q 003278 750 AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMR 788 (834)
Q Consensus 750 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~ 788 (834)
..+...+ .+ +..++.+||+.||++||++.
T Consensus 411 ------~~p~~~s-~~---~~~li~~lL~~dP~~R~~~~ 439 (543)
T 3c4z_A 411 ------TYPDKFS-PA---SKDFCEALLQKDPEKRLGFR 439 (543)
T ss_dssp ------CCCTTSC-HH---HHHHHHHHSCSSGGGSCCCB
T ss_pred ------CCCcccC-HH---HHHHHHHhccCCHhHCCCCc
Confidence 1111222 33 34455589999999999863
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=340.14 Aligned_cols=245 Identities=20% Similarity=0.332 Sum_probs=190.1
Q ss_pred CCcccccCCcEEEEEEE-CCCcEEEEEEecCCC-ChhHHHHHHHHHHHHHhccCCCceeEEEEEee----CCeEEEEEec
Q 003278 518 SQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSK-CPALRTRFSNELQNLARLRHRNLVQLCGWCTE----QGEMLVIYDY 591 (834)
Q Consensus 518 ~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~-~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~----~~~~~lv~Ey 591 (834)
...||+|+||.||+|.. .++..||+|.+.... .....+.|.+|+.++++++|||||++++++.. ....++||||
T Consensus 31 ~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~ 110 (290)
T 1t4h_A 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTEL 110 (290)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEEC
T ss_pred eeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEe
Confidence 45699999999999986 457789999986433 34456789999999999999999999998865 3568999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeec-CCCCceEeeeeeccccc
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLD-PDMNPRLGSFALAEFLT 670 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld-~~~~~ki~DfGla~~~~ 670 (834)
+++|+|.+++.... .+++..+..++.|++.||+|||+. ..+|+||||||+|||++ +++.+||+|||++....
T Consensus 111 ~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 111 MTSGTLKTYLKRFK------VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp CCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred cCCCCHHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHHcC-CCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 99999999996532 378899999999999999999973 12399999999999998 78999999999996532
Q ss_pred cCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCccc
Q 003278 671 RNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLA 750 (834)
Q Consensus 671 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (834)
.. ......||+.|+|||++. +.++.++|||||||++|||+||+.||............. .....+
T Consensus 184 ~~---------~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~---~~~~~~-- 248 (290)
T 1t4h_A 184 AS---------FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV---TSGVKP-- 248 (290)
T ss_dssp TT---------SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHH---TTTCCC--
T ss_pred cc---------ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHH---hccCCc--
Confidence 21 123457999999999886 569999999999999999999999986543332222111 111011
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 751 ELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 751 ~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
.. ..... .. .+.+++.+||+.||++|||+.+|++
T Consensus 249 ~~----~~~~~-~~---~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 249 AS----FDKVA-IP---EVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GG----GGGCC-CH---HHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cc----cCCCC-CH---HHHHHHHHHccCChhhCCCHHHHhh
Confidence 11 11111 12 3556666999999999999999985
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=348.12 Aligned_cols=265 Identities=20% Similarity=0.306 Sum_probs=201.0
Q ss_pred hCcCcCCcccccCCcEEEEEEE-----CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCC--eE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-----DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQG--EM 585 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-----~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~--~~ 585 (834)
++|...+.||+|+||.||+|.. .++..||||++.... ....+.|.+|+.++++++||||+++++++...+ ..
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC-SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 3456678899999999999984 357899999987543 344578999999999999999999999987654 68
Q ss_pred EEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeee
Q 003278 586 LVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFAL 665 (834)
Q Consensus 586 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGl 665 (834)
++||||+++++|.+++..... .+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~ 191 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHKE-----RIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGL 191 (326)
T ss_dssp EEEECCCTTCBHHHHHHHSTT-----SSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred EEEEECCCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcc
Confidence 999999999999999976432 38899999999999999999997 6999999999999999999999999999
Q ss_pred ccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCc-----------hh
Q 003278 666 AEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPE-----------GL 734 (834)
Q Consensus 666 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~-----------~~ 734 (834)
+......... ........||..|+|||.+.+..++.++|||||||++|||+||..|+...... ..
T Consensus 192 ~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 267 (326)
T 2w1i_A 192 TKVLPQDKEY----YKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 267 (326)
T ss_dssp CEECCSSCSE----EECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHH
T ss_pred hhhccccccc----cccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhh
Confidence 9875433210 01122346788899999999999999999999999999999999887531100 00
Q ss_pred HHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCcc
Q 003278 735 LVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDKR 800 (834)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~~ 800 (834)
....+......... ....... +. .+.+++.+||+.||++|||+.+|++.|+.+.++
T Consensus 268 ~~~~~~~~~~~~~~------~~~~~~~-~~---~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 268 IVFHLIELLKNNGR------LPRPDGC-PD---EIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHHHHHHHTTCC------CCCCTTC-CH---HHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hHHHHHHHhhcCCC------CCCCCcc-cH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 00011111000000 0111112 23 355566699999999999999999999876553
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=339.96 Aligned_cols=253 Identities=21% Similarity=0.308 Sum_probs=196.8
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC----hhhHHHHHHHHHHHHhCCCCceeeEeeeEE--eCCEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG----ERFEKTFAAELVAVAHLRHRNLVRLRGWCV--HEDQLL 184 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~--~~~~~~ 184 (834)
++|...+.||+|+||.||+|....++..||||++.... ....+.+.+|+.++++++||||+++++++. +.+..+
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY 84 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence 67999999999999999999998899999999986532 234577999999999999999999999985 445789
Q ss_pred EEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccc
Q 003278 185 LVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGL 264 (834)
Q Consensus 185 lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGl 264 (834)
+||||+++| |.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 85 lv~e~~~~~-l~~~~~~~~-----~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~ 155 (305)
T 2wtk_C 85 MVMEYCVCG-MQEMLDSVP-----EKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGV 155 (305)
T ss_dssp EEEECCSEE-HHHHHHHST-----TCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EEehhccCC-HHHHHHhCc-----ccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccc
Confidence 999999977 767765432 24689999999999999999999996 999999999999999999999999999
Q ss_pred hhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCC-CCCcccceeehhhHHHHHHhCCccCCCCCCCcc
Q 003278 265 ARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGS-VATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQ 343 (834)
Q Consensus 265 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~ 343 (834)
++....... ........||+.|+|||.+.... ..+.++|||||||++|||+||+.||....
T Consensus 156 ~~~~~~~~~--------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---- 217 (305)
T 2wtk_C 156 AEALHPFAA--------------DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN---- 217 (305)
T ss_dssp CEECCTTCS--------------SCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS----
T ss_pred ccccCcccc--------------ccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch----
Confidence 975422100 01123456999999999886432 23779999999999999999999986421
Q ss_pred chHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 344 IILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 344 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
.......+.. +.. .+. ... ...+.+++..||+.||.+||++.++++.
T Consensus 218 --~~~~~~~i~~-~~~------~~~-~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 218 --IYKLFENIGK-GSY------AIP-GDC----GPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp --HHHHHHHHHH-CCC------CCC-SSS----CHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred --HHHHHHHHhc-CCC------CCC-Ccc----CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111222111 111 111 111 2457889999999999999999999974
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=339.31 Aligned_cols=248 Identities=18% Similarity=0.301 Sum_probs=198.9
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCC--CChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMS--KCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIY 589 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~--~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~ 589 (834)
+.|...+.||+|+||.||++... ++..||+|.+... ......+.|.+|+.++++++|||||++++++.+.+..++||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 45666788999999999999975 4788999988643 23445678999999999999999999999999999999999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccc
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFL 669 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~ 669 (834)
||+++++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++...
T Consensus 95 e~~~~~~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 165 (294)
T 2rku_A 95 ELCRRRSLLELHKRRK------ALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 165 (294)
T ss_dssp ECCTTCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceec
Confidence 9999999999886532 48899999999999999999997 69999999999999999999999999999765
Q ss_pred ccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcc
Q 003278 670 TRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPL 749 (834)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
.... .......||+.|+|||++.+..++.++||||||+++|||+||+.|+........ .........
T Consensus 166 ~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~-- 232 (294)
T 2rku_A 166 EYDG-------ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET----YLRIKKNEY-- 232 (294)
T ss_dssp CSTT-------CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH----HHHHHTTCC--
T ss_pred ccCc-------cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHhhccC--
Confidence 3221 112245799999999999988899999999999999999999999865432211 111111111
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 750 AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 750 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
.+....+ . .+.+++.+||+.||++|||+.++++
T Consensus 233 ------~~~~~~~-~---~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 233 ------SIPKHIN-P---VAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp ------CCCTTSC-H---HHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ------CCccccC-H---HHHHHHHHHcccChhhCcCHHHHhh
Confidence 1111222 2 3445666899999999999999986
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=351.40 Aligned_cols=256 Identities=18% Similarity=0.267 Sum_probs=200.5
Q ss_pred HHHHhhCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCC-------hhHHHHHHHHHHHHHhc-cCCCceeEEEE
Q 003278 508 IISATNNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKC-------PALRTRFSNELQNLARL-RHRNLVQLCGW 578 (834)
Q Consensus 508 l~~at~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~f~~E~~~l~~l-~HpNiv~l~g~ 578 (834)
.....++|...+.||+|+||.||+|... +|+.||||++..... ....+.|.+|+.++.++ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 3445677888899999999999999985 689999999865431 12356788999999999 79999999999
Q ss_pred EeeCCeEEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCc
Q 003278 579 CTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNP 658 (834)
Q Consensus 579 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ 658 (834)
+...+..++||||+++++|.+++.... .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~~~------~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~i 239 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTEKV------ALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQI 239 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCE
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCE
Confidence 999999999999999999999987432 48899999999999999999997 699999999999999999999
Q ss_pred eEeeeeeccccccCCCCCcccccCccccccccCccchhcccc------CCCCccCcchhhHHHHHHHHhCCCccCCCCCc
Q 003278 659 RLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIES------GEATSMADVYSFGVVVLEVVTGQMAVDFRLPE 732 (834)
Q Consensus 659 ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~------~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~ 732 (834)
||+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||......
T Consensus 240 kl~DfG~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~ 311 (365)
T 2y7j_A 240 RLSDFGFSCHLEPGE--------KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI 311 (365)
T ss_dssp EECCCTTCEECCTTC--------CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EEEecCcccccCCCc--------ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH
Confidence 999999997654321 1234679999999999864 35888999999999999999999998643321
Q ss_pred hhHHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 733 GLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
.....+. ...... ..+.. ... .. .+..++.+||+.||++|||+.++++
T Consensus 312 -~~~~~i~---~~~~~~---~~~~~-~~~-~~---~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 312 -LMLRMIM---EGQYQF---SSPEW-DDR-SS---TVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp -HHHHHHH---HTCCCC---CHHHH-SSS-CH---HHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -HHHHHHH---hCCCCC---CCccc-ccC-CH---HHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111111 111100 00000 011 12 3455666999999999999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=345.41 Aligned_cols=266 Identities=21% Similarity=0.251 Sum_probs=194.2
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEE------------
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCV------------ 178 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~------------ 178 (834)
++|...+.||+|+||.||+|....+|+.||||++........+.+.+|+.++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 56888999999999999999998889999999987766666788999999999999999999999873
Q ss_pred --eCCEEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEEC-CCC
Q 003278 179 --HEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLD-SQY 255 (834)
Q Consensus 179 --~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld-~~~ 255 (834)
+.+..++||||++ |+|.+++.. .++++..+..++.|++.||+|||+. +|+||||||+|||++ +++
T Consensus 91 ~~~~~~~~lv~e~~~-~~L~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~ 158 (320)
T 2i6l_A 91 LTELNSVYIVQEYME-TDLANVLEQ--------GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDL 158 (320)
T ss_dssp CCSCSEEEEEEECCS-EEHHHHHTT--------CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTT
T ss_pred ccccCceeEEeeccC-CCHHHHhhc--------CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCC
Confidence 4467999999998 699998843 3588999999999999999999996 999999999999997 567
Q ss_pred ceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccC
Q 003278 256 NARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAV 335 (834)
Q Consensus 256 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~ 335 (834)
.+||+|||+++........ ........||+.|+|||.+.....++.++|||||||++|||+||+.||
T Consensus 159 ~~kl~Dfg~~~~~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf 225 (320)
T 2i6l_A 159 VLKIGDFGLARIMDPHYSH-------------KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLF 225 (320)
T ss_dssp EEEECCCTTCBCC---------------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred eEEEccCccccccCCCccc-------------ccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCC
Confidence 9999999999865322110 011233457999999998876567899999999999999999999998
Q ss_pred CCCCCCccchHHHHHHHHhhc----------CccccccccccCCCCCCH-----HHHHHHHHHHHHhcccCCCCCCchhh
Q 003278 336 DLTYPDDQIILLDWIRRLSDE----------GKVLQAGDNRLSDGSYKL-----CDMEHLTHLALLCTLHNPHLRPSMKW 400 (834)
Q Consensus 336 ~~~~~~~~~~l~~~~~~~~~~----------~~~~~~~d~~l~~~~~~~-----~~~~~l~~l~~~Cl~~~p~~RPsm~~ 400 (834)
...... .....+...... ..+............... .....+.+++..||+.||.+||++.+
T Consensus 226 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 302 (320)
T 2i6l_A 226 AGAHEL---EQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEE 302 (320)
T ss_dssp CCSSHH---HHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred CCCCHH---HHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHH
Confidence 743211 111111000000 000000000000000000 01246789999999999999999999
Q ss_pred HHHH
Q 003278 401 VIEA 404 (834)
Q Consensus 401 V~~~ 404 (834)
+++.
T Consensus 303 ll~h 306 (320)
T 2i6l_A 303 ALSH 306 (320)
T ss_dssp HHTS
T ss_pred HhCC
Confidence 9863
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=353.10 Aligned_cols=260 Identities=22% Similarity=0.307 Sum_probs=196.3
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEE----
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQL---- 183 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~---- 183 (834)
.++|...+.||+|+||.||+|.+..+|+.||||++... .....+.+.+|+.++++++||||++++++|...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 36788999999999999999999999999999998653 344567889999999999999999999999887654
Q ss_pred --EEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEee
Q 003278 184 --LLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGD 261 (834)
Q Consensus 184 --~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~D 261 (834)
++||||+. |+|.+++. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|
T Consensus 121 ~~~lv~e~~~-~~l~~~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~D 187 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG---------MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILD 187 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT---------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECS
T ss_pred eEEEEEcccc-ccHHHHhh---------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEe
Confidence 99999997 68887762 2489999999999999999999996 999999999999999999999999
Q ss_pred ccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCC
Q 003278 262 FGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPD 341 (834)
Q Consensus 262 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~ 341 (834)
||+++..... .+...||+.|+|||.+.....++.++|||||||++|||+||+.||......
T Consensus 188 fg~a~~~~~~-------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 248 (371)
T 4exu_A 188 FGLARHADAE-------------------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL 248 (371)
T ss_dssp TTCC---------------------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cCcccccccC-------------------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH
Confidence 9999754221 233468999999999876557899999999999999999999999643211
Q ss_pred ccchHHHHHHHHhhcC--ccccccc--------cccC-CCCCCH-----HHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 342 DQIILLDWIRRLSDEG--KVLQAGD--------NRLS-DGSYKL-----CDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 342 ~~~~l~~~~~~~~~~~--~~~~~~d--------~~l~-~~~~~~-----~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
+ ....+....... ....... ..+. ...... .....+.+|+..||+.||.+||++.++++.
T Consensus 249 ~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 249 D---QLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp H---HHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred H---HHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 1 111111100000 0000000 0000 000000 012467899999999999999999999863
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=340.81 Aligned_cols=251 Identities=21% Similarity=0.323 Sum_probs=192.4
Q ss_pred hCcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeC-CeEEEEEec
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQ-GEMLVIYDY 591 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~-~~~~lv~Ey 591 (834)
++|...+.||+|+||.||+|... +..||||.+.... ..+.|.+|+.++++++|||||++++++.+. +..++||||
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 21 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 45677788999999999999875 7789999986433 346799999999999999999999997654 468999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccccc
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTR 671 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~ 671 (834)
+++|+|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++.....
T Consensus 97 ~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 97 MAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CTTEEHHHHHHHHHH----HHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred CCCCCHHHHHHhccc----ccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 999999999875421 237888899999999999999997 6899999999999999999999999999875432
Q ss_pred CCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCccc
Q 003278 672 NDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRPLA 750 (834)
Q Consensus 672 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (834)
. .....||+.|+|||.+.+..++.++||||||+++|||+| |+.|+....... ....+ ....
T Consensus 170 ~----------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-~~~~~---~~~~---- 231 (278)
T 1byg_A 170 T----------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-VVPRV---EKGY---- 231 (278)
T ss_dssp ----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG-HHHHH---TTTC----
T ss_pred c----------ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHH---hcCC----
Confidence 1 112367889999999999999999999999999999999 998886443222 11111 1110
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCc
Q 003278 751 ELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDK 799 (834)
Q Consensus 751 ~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~ 799 (834)
........ +.+ +.+++.+||+.||++|||+.+|++.|+.+..
T Consensus 232 ---~~~~~~~~-~~~---l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 232 ---KMDAPDGC-PPA---VYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp ---CCCCCTTC-CHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCCCcccC-CHH---HHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 01111122 233 4455568999999999999999999987643
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=351.02 Aligned_cols=259 Identities=15% Similarity=0.227 Sum_probs=189.2
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
++|...+.||+|+||+||+|... ++..||||++...........+.+|+.+|++++|||||++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 35667788999999999999975 68899999987544333333466799999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccccc
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTR 671 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~ 671 (834)
++ |+|.+++..... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~-~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 152 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGN-----IINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSI 152 (324)
T ss_dssp CS-EEHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC--
T ss_pred cc-cCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccC
Confidence 98 588888765432 47888899999999999999997 6999999999999999999999999999975432
Q ss_pred CCCCCcccccCccccccccCccchhcccc-CCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhc--Cc
Q 003278 672 NDHGHRKATSGNRSVRGIFGYMSPEYIES-GEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARK--RP 748 (834)
Q Consensus 672 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~--~~ 748 (834)
.. .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||........+ ..+....... ..
T Consensus 153 ~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-~~i~~~~~~~~~~~ 224 (324)
T 3mtl_A 153 PT-------KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQL-HFIFRILGTPTEET 224 (324)
T ss_dssp -----------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHHHCCCCTTT
T ss_pred Cc-------cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhCCCChHh
Confidence 11 11223578999999999876 56899999999999999999999999754433222 2222211100 00
Q ss_pred ccccccc---------c--------cCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 749 LAELVDL---------S--------LNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 749 ~~~~~d~---------~--------l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
+...... . .....+ ..+..++.+||+.||++|||+.|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 225 WPGILSNEEFKTYNYPKYRAEALLSHAPRLD----SDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp STTGGGCHHHHHTCCCCCCCCCHHHHCTTSC----HHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred chhhhcchhhcccccccccchhhhhhcCCCC----HHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0010000 0 000111 23456667999999999999999986
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=340.53 Aligned_cols=251 Identities=15% Similarity=0.223 Sum_probs=196.1
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCCh-----hHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKCP-----ALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEML 586 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~ 586 (834)
++|...+.||+|+||.||+|... +++.||||.+...... ...+.|.+|+.++++++||||+++++++.+.+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 45777789999999999999975 5889999998654321 23578999999999999999999999999999999
Q ss_pred EEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCC----CceEee
Q 003278 587 VIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDM----NPRLGS 662 (834)
Q Consensus 587 lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~----~~ki~D 662 (834)
+||||+++++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++ .+||+|
T Consensus 85 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~d 155 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKE------SLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLID 155 (283)
T ss_dssp EEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECC
T ss_pred EEEeecCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEe
Confidence 9999999999999986532 48899999999999999999997 6999999999999999877 799999
Q ss_pred eeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHH
Q 003278 663 FALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEF 742 (834)
Q Consensus 663 fGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~ 742 (834)
||++....... ......||+.|+|||++.+..++.++||||||+++|||+||+.|+........ .. ..
T Consensus 156 fg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~---~~ 223 (283)
T 3bhy_A 156 FGIAHKIEAGN--------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET-LT---NI 223 (283)
T ss_dssp CTTCEECC----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HH---HH
T ss_pred cccceeccCCC--------cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH-HH---Hh
Confidence 99997653221 12245699999999999999999999999999999999999999865432211 11 11
Q ss_pred HhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 743 EARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 743 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
....... +....... .. .+.+++.+||+.||++|||+.++++
T Consensus 224 ~~~~~~~----~~~~~~~~-~~---~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 224 SAVNYDF----DEEYFSNT-SE---LAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp HTTCCCC----CHHHHTTC-CH---HHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HhcccCC----cchhcccC-CH---HHHHHHHHHccCCHhHCcCHHHHHh
Confidence 1111110 00000111 12 3456666999999999999999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=346.69 Aligned_cols=259 Identities=22% Similarity=0.304 Sum_probs=196.8
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCcE--EEEEEecCCCChhHHHHHHHHHHHHHhc-cCCCceeEEEEEeeCCeEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQY--VLVKRLGMSKCPALRTRFSNELQNLARL-RHRNLVQLCGWCTEQGEMLVI 588 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~--vavK~~~~~~~~~~~~~f~~E~~~l~~l-~HpNiv~l~g~~~~~~~~~lv 588 (834)
++|...+.||+|+||.||+|... ++.. ||||.+.........+.|.+|+.++.++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 45677788999999999999864 4554 5999887554455556799999999999 999999999999999999999
Q ss_pred EeccCCCchhhhhhcCCC----------CCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCc
Q 003278 589 YDYSATRILSHLLFHNNH----------RIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNP 658 (834)
Q Consensus 589 ~Ey~~~g~L~~~l~~~~~----------~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ 658 (834)
|||+++|+|.+++..... ......+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCeE
Confidence 999999999999976431 0112358899999999999999999997 699999999999999999999
Q ss_pred eEeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHH
Q 003278 659 RLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVK 737 (834)
Q Consensus 659 ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~ 737 (834)
||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||....... +..
T Consensus 182 kL~Dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-~~~ 252 (327)
T 1fvr_A 182 KIADFGLSRGQEVY--------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-LYE 252 (327)
T ss_dssp EECCTTCEESSCEE--------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHH
T ss_pred EEcccCcCcccccc--------ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH-HHH
Confidence 99999999743211 11223457889999999998899999999999999999999 999986443221 111
Q ss_pred HHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccC
Q 003278 738 RVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGN 797 (834)
Q Consensus 738 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~ 797 (834)
. ... . .........+ . .+.+++.+||+.||++|||+.++++.|+.+
T Consensus 253 ~---~~~--~-----~~~~~~~~~~-~---~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 298 (327)
T 1fvr_A 253 K---LPQ--G-----YRLEKPLNCD-D---EVYDLMRQCWREKPYERPSFAQILVSLNRM 298 (327)
T ss_dssp H---GGG--T-----CCCCCCTTBC-H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H---hhc--C-----CCCCCCCCCC-H---HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1 100 0 0011111222 2 345566699999999999999999988754
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=338.55 Aligned_cols=250 Identities=17% Similarity=0.227 Sum_probs=195.5
Q ss_pred hhCcCcCCcccccCCcEEEEEEECC-CcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEe
Q 003278 512 TNNFSESQRVAEMDFGTAYQGFLDN-HQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYD 590 (834)
Q Consensus 512 t~~f~~~~~ig~g~~g~vy~~~~~~-~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~E 590 (834)
.+.|...+.||+|+||.||+|.... +..||+|.+...... ..+.|.+|++++++++||||+++++++.+.+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE-DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc-hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 3567778899999999999999754 678999998654322 24679999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceee---cCCCCceEeeeeecc
Q 003278 591 YSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITL---DPDMNPRLGSFALAE 667 (834)
Q Consensus 591 y~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILl---d~~~~~ki~DfGla~ 667 (834)
|+++++|.+++.... .+++..+..|+.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||++.
T Consensus 87 ~~~~~~L~~~~~~~~------~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~ 157 (277)
T 3f3z_A 87 LCTGGELFERVVHKR------VFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA 157 (277)
T ss_dssp CCCSCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred ccCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccce
Confidence 999999999886532 37899999999999999999997 689999999999999 788999999999997
Q ss_pred ccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcC
Q 003278 668 FLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKR 747 (834)
Q Consensus 668 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
...... ......||+.|+|||++.+ .++.++|||||||++|||+||+.||....... ..... .....
T Consensus 158 ~~~~~~--------~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~---~~~~~ 224 (277)
T 3f3z_A 158 RFKPGK--------MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSE-VMLKI---REGTF 224 (277)
T ss_dssp ECCTTS--------CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHH---HHCCC
T ss_pred eccCcc--------chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHH-HHHHH---HhCCC
Confidence 654321 1234579999999999865 59999999999999999999999987543222 11111 11111
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 748 PLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 748 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
.... ... ... .. .+..++.+||+.||++|||+.++++
T Consensus 225 ~~~~---~~~-~~~-~~---~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 225 TFPE---KDW-LNV-SP---QAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp CCCH---HHH-TTS-CH---HHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCc---hhh-hcC-CH---HHHHHHHHHccCChhhCcCHHHHhc
Confidence 1100 000 011 12 3455666999999999999999874
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=340.71 Aligned_cols=260 Identities=19% Similarity=0.268 Sum_probs=199.1
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCC-ChhHHHHHHHHHHHHHhccCCCceeEEEEEee--CCeEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSK-CPALRTRFSNELQNLARLRHRNLVQLCGWCTE--QGEMLVI 588 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~--~~~~~lv 588 (834)
++|...+.||+|+||.||+|... +++.||+|.+.... .....+.|.+|+.++++++||||+++++++.+ ....++|
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 85 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 85 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence 46777788999999999999974 68899999987543 34556789999999999999999999998854 5789999
Q ss_pred EeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhcc--CCceeecccccCceeecCCCCceEeeeeec
Q 003278 589 YDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEW--NEQVIHRNITSSAITLDPDMNPRLGSFALA 666 (834)
Q Consensus 589 ~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~--~~~iiHrDlK~~NILld~~~~~ki~DfGla 666 (834)
|||+++|+|.+++..... ....+++..+..|+.|++.||+|||+.. ..+|+||||||+|||++.++.+||+|||++
T Consensus 86 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 86 MEYCEGGDLASVITKGTK--ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp EECCTTEEHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred EeCCCCCCHHHHHHhhcc--cCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 999999999999875322 1234889999999999999999999742 123999999999999999999999999999
Q ss_pred cccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhc
Q 003278 667 EFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARK 746 (834)
Q Consensus 667 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~ 746 (834)
+...... .......||+.|+|||.+.+..++.++|||||||++|||+||+.|+...... .+...+.. ..
T Consensus 164 ~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~i~~---~~ 232 (279)
T 2w5a_A 164 RILNHDT-------SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK-ELAGKIRE---GK 232 (279)
T ss_dssp HHC---C-------HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHH---TC
T ss_pred eeecccc-------ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH-HHHHHHhh---cc
Confidence 7643221 0112357899999999999999999999999999999999999998654321 12221111 11
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHcc
Q 003278 747 RPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDG 796 (834)
Q Consensus 747 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~ 796 (834)
.. .+...++ . .+.+++.+||+.||++|||+.+|++.+..
T Consensus 233 --~~-----~~~~~~~-~---~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 233 --FR-----RIPYRYS-D---ELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp --CC-----CCCTTSC-H---HHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred --cc-----cCCcccC-H---HHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 11 1111222 3 34556669999999999999999987643
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=363.42 Aligned_cols=253 Identities=16% Similarity=0.246 Sum_probs=187.0
Q ss_pred HhhCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCC-------ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeC
Q 003278 511 ATNNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSK-------CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQ 582 (834)
Q Consensus 511 at~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~-------~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~ 582 (834)
..++|...+.||+|+||.||+|.. .++..||||.+.... .......|.+|+.+|++++|||||++++++. .
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~ 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 357888889999999999999986 457899999986432 1112235889999999999999999999975 4
Q ss_pred CeEEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCC---CCce
Q 003278 583 GEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPD---MNPR 659 (834)
Q Consensus 583 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~---~~~k 659 (834)
+..++||||+++|+|.+++.... .+++.....|+.|++.||+|||+ .+|+||||||+|||++.+ +.+|
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~k 282 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGNK------RLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIK 282 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSSC------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEE
T ss_pred CceEEEEEcCCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEE
Confidence 56899999999999998886432 48899999999999999999997 689999999999999754 4599
Q ss_pred EeeeeeccccccCCCCCcccccCccccccccCccchhccc---cCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHH
Q 003278 660 LGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIE---SGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLV 736 (834)
Q Consensus 660 i~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~---~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~ 736 (834)
|+|||+++..... ......+||+.|||||++. ...++.++|||||||++|||+||+.||........+.
T Consensus 283 l~DFG~a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~ 354 (419)
T 3i6u_A 283 ITDFGHSKILGET--------SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK 354 (419)
T ss_dssp ECCSSTTTSCC-------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHH
T ss_pred EeecccceecCCC--------ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHH
Confidence 9999999865322 1123468999999999985 3678899999999999999999999997543332222
Q ss_pred HHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 737 KRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 737 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
..+.. ..... . +......+ ..+.+++.+||+.||++|||+.++++
T Consensus 355 ~~i~~---~~~~~---~-~~~~~~~~----~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 355 DQITS---GKYNF---I-PEVWAEVS----EKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HHHHT---TCCCC---C-HHHHTTSC----HHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHhc---CCCCC---C-chhhcccC----HHHHHHHHHHccCChhHCcCHHHHhC
Confidence 22111 11000 0 00001111 23556667999999999999999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=355.75 Aligned_cols=204 Identities=22% Similarity=0.325 Sum_probs=172.6
Q ss_pred HhhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCC-CC-----ceeeEeeeEEeC
Q 003278 107 YIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLR-HR-----NLVRLRGWCVHE 180 (834)
Q Consensus 107 ~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-H~-----nIv~l~g~~~~~ 180 (834)
....++|+..+.||+|+||.||+|....+|+.||||++... ......+..|+.++..++ |+ +|+++++++...
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 34567899999999999999999999889999999999743 344567788999988875 44 499999999999
Q ss_pred CEEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEEC--CCCceE
Q 003278 181 DQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLD--SQYNAR 258 (834)
Q Consensus 181 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld--~~~~~k 258 (834)
+..++||||++ |+|.+++.... ...+++..+..|+.|++.||.|||++ ..+|+||||||+|||++ .++.+|
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~~-----~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~k 201 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNTN-----FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIK 201 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHTT-----TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEE
T ss_pred CceEEEEecCC-CCHHHHHhhcC-----cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEE
Confidence 99999999996 59999987542 24589999999999999999999953 35899999999999995 477899
Q ss_pred EeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCC
Q 003278 259 LGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLT 338 (834)
Q Consensus 259 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~ 338 (834)
|+|||+++..... .....||+.|+|||.+... .++.++|||||||++|||+||+.||...
T Consensus 202 L~DFG~a~~~~~~-------------------~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 202 IVDFGSSCQLGQR-------------------IYQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp ECCCTTCEETTCC-------------------CCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEeccCceecccc-------------------cccccCCccccChHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999754211 2345699999999998755 6799999999999999999999999753
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=346.04 Aligned_cols=248 Identities=18% Similarity=0.301 Sum_probs=198.8
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCC--CChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMS--KCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIY 589 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~--~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~ 589 (834)
+.|...+.||+|+||.||++... ++..||+|.+... .....++.|.+|+.++++++|||||++++++.+.+..++||
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 34666788999999999999975 4788999998643 23445678999999999999999999999999999999999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccc
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFL 669 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~ 669 (834)
||+.+++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++...
T Consensus 121 e~~~~~~L~~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 191 (335)
T 2owb_A 121 ELCRRRSLLELHKRRK------ALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 191 (335)
T ss_dssp CCCTTCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceec
Confidence 9999999999886532 48899999999999999999997 69999999999999999999999999999765
Q ss_pred ccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcc
Q 003278 670 TRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPL 749 (834)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
.... .......||+.|+|||++.+..++.++|||||||++|||+||+.||......... .........
T Consensus 192 ~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~----~~~~~~~~~- 259 (335)
T 2owb_A 192 EYDG-------ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY----LRIKKNEYS- 259 (335)
T ss_dssp CSTT-------CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH----HHHHHTCCC-
T ss_pred ccCc-------ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHH----HHHhcCCCC-
Confidence 3221 1123457999999999999989999999999999999999999998654322211 111111111
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 750 AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 750 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
+....+ .+ +..++.+||+.||++|||+.++++
T Consensus 260 -------~~~~~~-~~---~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 260 -------IPKHIN-PV---AASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp -------CCTTSC-HH---HHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred -------CCccCC-HH---HHHHHHHHccCChhHCcCHHHHhc
Confidence 111222 23 445666899999999999999986
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=350.32 Aligned_cols=262 Identities=23% Similarity=0.233 Sum_probs=190.8
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCC------
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHED------ 181 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~------ 181 (834)
.++|...+.||+|+||.||+|....+|+.||||++... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 36799999999999999999999889999999998653 3345567889999999999999999999998765
Q ss_pred EEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEee
Q 003278 182 QLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGD 261 (834)
Q Consensus 182 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~D 261 (834)
..++||||++ |+|.+.+. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|
T Consensus 104 ~~~lv~e~~~-~~l~~~~~---------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~D 170 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQ---------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD 170 (371)
T ss_dssp EEEEEEECCS-EEHHHHHH---------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECC
T ss_pred ceEEEEEcCC-CCHHHHHh---------hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEE
Confidence 7899999997 47877774 2478999999999999999999996 999999999999999999999999
Q ss_pred ccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCC
Q 003278 262 FGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPD 341 (834)
Q Consensus 262 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~ 341 (834)
||+++...... ..+...||+.|+|||.+... .++.++|||||||++|||+||+.||......
T Consensus 171 fg~a~~~~~~~-----------------~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 232 (371)
T 2xrw_A 171 FGLARTAGTSF-----------------MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHI 232 (371)
T ss_dssp CCC---------------------------------CTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred eeccccccccc-----------------ccCCceecCCccCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99997543210 12345699999999998654 6799999999999999999999998643211
Q ss_pred ccchHHHHH------------------HHHhhc-Cccc-----cccccccCCCCC--CHHHHHHHHHHHHHhcccCCCCC
Q 003278 342 DQIILLDWI------------------RRLSDE-GKVL-----QAGDNRLSDGSY--KLCDMEHLTHLALLCTLHNPHLR 395 (834)
Q Consensus 342 ~~~~l~~~~------------------~~~~~~-~~~~-----~~~d~~l~~~~~--~~~~~~~l~~l~~~Cl~~~p~~R 395 (834)
+ .+...+ ...... .... ........+... .......+.+|+..||+.||.+|
T Consensus 233 ~--~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R 310 (371)
T 2xrw_A 233 D--QWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 310 (371)
T ss_dssp H--HHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGS
T ss_pred H--HHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhC
Confidence 1 000000 000000 0000 000000000000 01123568899999999999999
Q ss_pred CchhhHHHH
Q 003278 396 PSMKWVIEA 404 (834)
Q Consensus 396 Psm~~V~~~ 404 (834)
||+.++++.
T Consensus 311 ~t~~e~l~h 319 (371)
T 2xrw_A 311 ISVDEALQH 319 (371)
T ss_dssp CCHHHHHHS
T ss_pred CCHHHHhCC
Confidence 999999874
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=351.28 Aligned_cols=208 Identities=19% Similarity=0.293 Sum_probs=161.8
Q ss_pred hhCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCC-CChhHHHHHHHHHHHHHhcc-CCCceeEEEEEeeCC--eEE
Q 003278 512 TNNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMS-KCPALRTRFSNELQNLARLR-HRNLVQLCGWCTEQG--EML 586 (834)
Q Consensus 512 t~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~-~~~~~~~~f~~E~~~l~~l~-HpNiv~l~g~~~~~~--~~~ 586 (834)
.++|...+.||+|+||.||+|.. .+++.||||++... .......++.+|+.+|.++. |||||++++++...+ ..+
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 46788889999999999999986 56889999998643 23344567889999999997 999999999987543 789
Q ss_pred EEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeec
Q 003278 587 VIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALA 666 (834)
Q Consensus 587 lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla 666 (834)
+||||++ |+|..++... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+|
T Consensus 88 lv~e~~~-~~L~~~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a 156 (388)
T 3oz6_A 88 LVFDYME-TDLHAVIRAN-------ILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLS 156 (388)
T ss_dssp EEEECCS-EEHHHHHHHT-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEecccC-cCHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCccc
Confidence 9999998 5888888642 37888889999999999999997 68999999999999999999999999999
Q ss_pred cccccCCCCC--------------cccccCccccccccCccchhcccc-CCCCccCcchhhHHHHHHHHhCCCccCCCC
Q 003278 667 EFLTRNDHGH--------------RKATSGNRSVRGIFGYMSPEYIES-GEATSMADVYSFGVVVLEVVTGQMAVDFRL 730 (834)
Q Consensus 667 ~~~~~~~~~~--------------~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~ 730 (834)
+.+....... ..........+||+.|+|||++.+ ..++.++|||||||++|||+||+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 235 (388)
T 3oz6_A 157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235 (388)
T ss_dssp EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 8653211000 000111234689999999999976 678999999999999999999999996543
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=357.99 Aligned_cols=264 Identities=14% Similarity=0.170 Sum_probs=201.0
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCC-CceeEEEEEeeCCeEEEEEe
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHR-NLVQLCGWCTEQGEMLVIYD 590 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~Hp-Niv~l~g~~~~~~~~~lv~E 590 (834)
++|...+.||+|+||.||+|.. .++..||||.+...... .++.+|++++..++|+ +|..+..++.+.+..+||||
T Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS---CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc---HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 5788889999999999999996 66889999987654332 3478899999999885 55556667778889999999
Q ss_pred ccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceee---cCCCCceEeeeeecc
Q 003278 591 YSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITL---DPDMNPRLGSFALAE 667 (834)
Q Consensus 591 y~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILl---d~~~~~ki~DfGla~ 667 (834)
|+ +++|.+++..... .+++..++.|+.||+.||+|||+ .+||||||||+|||| +.++.+||+|||+++
T Consensus 84 ~~-g~sL~~ll~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCSR-----KLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (483)
T ss_dssp CC-CCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred CC-CCCHHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence 99 9999999875432 48999999999999999999997 699999999999999 688999999999998
Q ss_pred ccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchh--HHHHHHHHHhh
Q 003278 668 FLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGL--LVKRVHEFEAR 745 (834)
Q Consensus 668 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~--~~~~~~~~~~~ 745 (834)
....................||+.|+|||++.+..++.++||||||||||||+||+.||........ ....+.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~- 233 (483)
T 3sv0_A 155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV- 233 (483)
T ss_dssp ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH-
T ss_pred eccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc-
Confidence 7654322111111123356899999999999999999999999999999999999999975433221 1111111110
Q ss_pred cCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCC
Q 003278 746 KRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGND 798 (834)
Q Consensus 746 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~ 798 (834)
......+. ..++ . ++.+++..||+.+|++||++.+|++.|+.+-
T Consensus 234 ~~~~~~l~-----~~~p-~---~l~~li~~cl~~dP~~RPs~~el~~~L~~l~ 277 (483)
T 3sv0_A 234 ATSIEALC-----RGYP-T---EFASYFHYCRSLRFDDKPDYSYLKRLFRDLF 277 (483)
T ss_dssp HSCHHHHH-----TTSC-H---HHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred cccHHHHh-----cCCc-H---HHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 01111111 1111 2 4556667999999999999999999987653
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=347.63 Aligned_cols=260 Identities=20% Similarity=0.323 Sum_probs=199.4
Q ss_pred CCCCCCCeeeccCCeEEEEEEE-CCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCc------eeeEeeeEEeCCEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVL-PSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRN------LVRLRGWCVHEDQL 183 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~-~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~n------Iv~l~g~~~~~~~~ 183 (834)
++|+..+.||+|+||.||+|.. ..+|+.||||++... ....+.+.+|+.++..++|+| |+++++++...+..
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 5788999999999999999998 567899999998643 345677889999999887665 99999999999999
Q ss_pred EEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECC----------
Q 003278 184 LLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDS---------- 253 (834)
Q Consensus 184 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~---------- 253 (834)
++||||+ +++|.+++.... ..++++..+..++.|+++||+|||+. +|+||||||+|||++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~ 163 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKENG-----FLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPK 163 (339)
T ss_dssp EEEEECC-CCBHHHHHHHTT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC--
T ss_pred EEEEcCC-CCCHHHHHHhcC-----CCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCc
Confidence 9999999 899999986542 24689999999999999999999996 9999999999999987
Q ss_pred ---------CCceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhH
Q 003278 254 ---------QYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIV 324 (834)
Q Consensus 254 ---------~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvv 324 (834)
++.+||+|||+++.... ......||+.|+|||.+... .++.++|||||||+
T Consensus 164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~-------------------~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~i 223 (339)
T 1z57_A 164 IKRDERTLINPDIKVVDFGSATYDDE-------------------HHSTLVSTRHYRAPEVILAL-GWSQPCDVWSIGCI 223 (339)
T ss_dssp --CEEEEESCCCEEECCCSSCEETTS-------------------CCCSSCSCGGGCCHHHHTTS-CCCTHHHHHHHHHH
T ss_pred cccccccccCCCceEeeCcccccCcc-------------------ccccccCCccccChHHhhCC-CCCcchhhHHHHHH
Confidence 66799999999974321 12345699999999998654 67999999999999
Q ss_pred HHHHHhCCccCCCCCCCccchHHHHHHHHhhc--------C---ccc------------------cccccccCCCCCCHH
Q 003278 325 VLEVVSGRRAVDLTYPDDQIILLDWIRRLSDE--------G---KVL------------------QAGDNRLSDGSYKLC 375 (834)
Q Consensus 325 l~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~--------~---~~~------------------~~~d~~l~~~~~~~~ 375 (834)
+|||+||+.||......+ ....+...... . ... ....+..........
T Consensus 224 l~el~~g~~pf~~~~~~~---~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (339)
T 1z57_A 224 LIEYYLGFTVFPTHDSKE---HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDV 300 (339)
T ss_dssp HHHHHHSSCSCCCSCHHH---HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSH
T ss_pred HHHHHhCCCCCCCCChHH---HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchh
Confidence 999999999986532221 11111111100 0 000 000000000011223
Q ss_pred HHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 376 DMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 376 ~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
....+.+++..||+.||.+||++.|+++
T Consensus 301 ~~~~l~~li~~~L~~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 301 EHERLFDLIQKMLEYDPAKRITLREALK 328 (339)
T ss_dssp HHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hHHHHHHHHHHHhCcCcccccCHHHHhc
Confidence 3467889999999999999999999975
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=362.50 Aligned_cols=245 Identities=13% Similarity=0.054 Sum_probs=186.2
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCC--CChhHHHHHHHHH---HHHHhccCCCceeEE-------EEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMS--KCPALRTRFSNEL---QNLARLRHRNLVQLC-------GWC 579 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~--~~~~~~~~f~~E~---~~l~~l~HpNiv~l~-------g~~ 579 (834)
++|...+.||+|+||.||+|.. .+++.||||++... ......+.|.+|+ ++|++++|||||+++ +++
T Consensus 73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~ 152 (377)
T 3byv_A 73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 152 (377)
T ss_dssp EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence 4566678899999999999995 66899999998743 2334557899999 566677899999998 666
Q ss_pred eeCC-----------------eEEEEEeccCCCchhhhhhcCCCC-CCCcccCHHHHHHHHHHHHHHHHHhhhccCCcee
Q 003278 580 TEQG-----------------EMLVIYDYSATRILSHLLFHNNHR-IGHSILQWHHRYNIIKSLASAILYLHEEWNEQVI 641 (834)
Q Consensus 580 ~~~~-----------------~~~lv~Ey~~~g~L~~~l~~~~~~-~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~ii 641 (834)
.+.+ ..++||||+ +|+|.+++...... .....++|..++.|+.|++.||+|||+ .+|+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~iv 228 (377)
T 3byv_A 153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLV 228 (377)
T ss_dssp ECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTEE
T ss_pred hccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCee
Confidence 5543 278999999 68999998754211 112346678899999999999999997 6899
Q ss_pred ecccccCceeecCCCCceEeeeeeccccccCCCCCcccccCccccccccCccchhccccC-----------CCCccCcch
Q 003278 642 HRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESG-----------EATSMADVY 710 (834)
Q Consensus 642 HrDlK~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-----------~~~~k~DV~ 710 (834)
||||||+||||+.++.+||+|||+++.... ......| +.|||||++.+. .++.++|||
T Consensus 229 HrDikp~NIll~~~~~~kL~DFG~a~~~~~----------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dvw 297 (377)
T 3byv_A 229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAW 297 (377)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTC----------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHH
T ss_pred cCCCCHHHEEEcCCCCEEEEechhheecCC----------cccCCCC-cCccChhhhcccccccccccccccCChhhhHH
Confidence 999999999999999999999999975221 1234578 999999999887 899999999
Q ss_pred hhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHH
Q 003278 711 SFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQI 790 (834)
Q Consensus 711 SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v 790 (834)
||||+||||+||+.||........ ...+... .... +++ +.+++.+||+.||++|||+.++
T Consensus 298 SlG~il~elltg~~Pf~~~~~~~~--------------~~~~~~~--~~~~-~~~---~~~li~~~L~~dp~~Rpt~~e~ 357 (377)
T 3byv_A 298 ALGLVIYWIWCADLPITKDAALGG--------------SEWIFRS--CKNI-PQP---VRALLEGFLRYPKEDRLLPLQA 357 (377)
T ss_dssp HHHHHHHHHHHSSCCC------CC--------------SGGGGSS--CCCC-CHH---HHHHHHHHTCSSGGGCCCHHHH
T ss_pred HHHHHHHHHHHCCCCCcccccccc--------------hhhhhhh--ccCC-CHH---HHHHHHHHcCCCchhCCCHHHH
Confidence 999999999999999854321110 1111110 0112 233 4456669999999999999999
Q ss_pred HH
Q 003278 791 LS 792 (834)
Q Consensus 791 ~~ 792 (834)
++
T Consensus 358 l~ 359 (377)
T 3byv_A 358 ME 359 (377)
T ss_dssp HT
T ss_pred hh
Confidence 85
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=361.00 Aligned_cols=264 Identities=26% Similarity=0.293 Sum_probs=193.0
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeC----C--EEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHE----D--QLL 184 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~----~--~~~ 184 (834)
.+|+..+.||+|+||.||+|++..+|+.||||++..... .+.+|+.+|++++|||||+++++|... + .++
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 358888999999999999999988999999999864322 234699999999999999999998642 2 367
Q ss_pred EEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCC-CceEEeecc
Q 003278 185 LVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQ-YNARLGDFG 263 (834)
Q Consensus 185 lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~-~~~kl~DFG 263 (834)
+||||+++ +|.+.+.... .....+++..+..++.||++||.|||+. +|+||||||+|||++.+ +.+||+|||
T Consensus 130 lv~e~~~~-~l~~~~~~~~---~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG 202 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYS---RAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFG 202 (420)
T ss_dssp EEEECCCE-EHHHHHHHHH---HTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eehhcccc-cHHHHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccch
Confidence 99999986 5655554211 1235689999999999999999999985 99999999999999965 568999999
Q ss_pred chhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCcc
Q 003278 264 LARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQ 343 (834)
Q Consensus 264 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~ 343 (834)
+++.+.... ......||+.|+|||++.....++.++|||||||++|||+||+.||......
T Consensus 203 ~a~~~~~~~-----------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~-- 263 (420)
T 1j1b_A 203 SAKQLVRGE-----------------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-- 263 (420)
T ss_dssp TCEECCTTC-----------------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--
T ss_pred hhhhcccCC-----------------CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH--
Confidence 998542210 1234568999999999876556899999999999999999999998753211
Q ss_pred chHHHHHHHHhh---------cCccccccccccCCCC----CCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 344 IILLDWIRRLSD---------EGKVLQAGDNRLSDGS----YKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 344 ~~l~~~~~~~~~---------~~~~~~~~d~~l~~~~----~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
..+...+..+.. ........-+.+.... +.......+.+|+..||+.||.+||++.|+++.
T Consensus 264 ~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 264 DQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 122222221100 0000010011110000 000112467899999999999999999999864
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=348.60 Aligned_cols=251 Identities=16% Similarity=0.211 Sum_probs=192.3
Q ss_pred hhCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCChhHHHHHHHHHHHHHhc-cCCCceeEEEEEeeCCeEEEEE
Q 003278 512 TNNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKCPALRTRFSNELQNLARL-RHRNLVQLCGWCTEQGEMLVIY 589 (834)
Q Consensus 512 t~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l-~HpNiv~l~g~~~~~~~~~lv~ 589 (834)
.++|...+.||+|+||.||+|... +++.||||.+..... .+.+|+++|.++ +|||||++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 456888889999999999999975 588999999875432 234688899888 7999999999999999999999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCC-C---CceEeeeee
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPD-M---NPRLGSFAL 665 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~-~---~~ki~DfGl 665 (834)
||+++|+|.+++.... .+++.....++.|++.||+|||+ .+|+||||||+|||+.++ + .+||+|||+
T Consensus 96 E~~~gg~L~~~i~~~~------~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~ 166 (342)
T 2qr7_A 96 ELMKGGELLDKILRQK------FFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGF 166 (342)
T ss_dssp CCCCSCBHHHHHHTCT------TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTT
T ss_pred eCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCC
Confidence 9999999999886532 38899999999999999999997 699999999999998543 3 499999999
Q ss_pred ccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhh
Q 003278 666 AEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEAR 745 (834)
Q Consensus 666 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~ 745 (834)
++...... ....+.+||+.|+|||++.+..++.++|||||||++|||+||..||....... ...........
T Consensus 167 a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~~~~i~~~ 238 (342)
T 2qr7_A 167 AKQLRAEN-------GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT-PEEILARIGSG 238 (342)
T ss_dssp CEECBCTT-------CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC-HHHHHHHHHHC
T ss_pred cccCcCCC-------CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC-HHHHHHHHccC
Confidence 98654321 11234689999999999988889999999999999999999999996432111 11111111111
Q ss_pred cCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 746 KRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 746 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
...+. ....... .++ +..++.+||..||++|||+.+|++
T Consensus 239 ~~~~~----~~~~~~~-s~~---~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 239 KFSLS----GGYWNSV-SDT---AKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp CCCCC----STTTTTS-CHH---HHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CcccC----ccccccC-CHH---HHHHHHHHCCCChhHCcCHHHHhc
Confidence 11110 0000111 233 445556899999999999999875
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=354.07 Aligned_cols=248 Identities=18% Similarity=0.199 Sum_probs=186.8
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCC--hhHHHHHHHHHHH-HHhccCCCceeEEEEEeeCCeEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKC--PALRTRFSNELQN-LARLRHRNLVQLCGWCTEQGEMLVI 588 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~E~~~-l~~l~HpNiv~l~g~~~~~~~~~lv 588 (834)
++|...+.||+|+||.||+|... ++..||||.+..... ......+.+|..+ ++.++|||||++++++.+.+..++|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 46777889999999999999975 478899999864322 2223456677776 5789999999999999999999999
Q ss_pred EeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccc
Q 003278 589 YDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEF 668 (834)
Q Consensus 589 ~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~ 668 (834)
|||+++|+|..++.... .+++.....++.|++.||+|||+ .+|+||||||+||||+.++.+||+|||+++.
T Consensus 118 ~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~ 188 (373)
T 2r5t_A 118 LDYINGGELFYHLQRER------CFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKE 188 (373)
T ss_dssp EECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred EeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCccccc
Confidence 99999999999987532 37788888899999999999997 6999999999999999999999999999975
Q ss_pred cccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCc
Q 003278 669 LTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRP 748 (834)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
..... ....+.+||+.|||||++.+..++.++|||||||++|||+||..||....... +...+. . .+
T Consensus 189 ~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-~~~~i~---~--~~ 255 (373)
T 2r5t_A 189 NIEHN-------STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-MYDNIL---N--KP 255 (373)
T ss_dssp GBCCC-------CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH-HHHHHH---H--SC
T ss_pred cccCC-------CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHH---h--cc
Confidence 32211 12345789999999999999999999999999999999999999997543222 112111 1 11
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 749 LAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 749 ~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
. .+....+ .+ +..++.+||+.||++||++.+.+.
T Consensus 256 ~------~~~~~~~-~~---~~~li~~lL~~dp~~R~~~~~~~~ 289 (373)
T 2r5t_A 256 L------QLKPNIT-NS---ARHLLEGLLQKDRTKRLGAKDDFM 289 (373)
T ss_dssp C------CCCSSSC-HH---HHHHHHHHTCSSGGGSTTTTTTHH
T ss_pred c------CCCCCCC-HH---HHHHHHHHcccCHHhCCCCCCCHH
Confidence 1 1111222 33 344555899999999999865443
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=360.10 Aligned_cols=259 Identities=19% Similarity=0.183 Sum_probs=189.2
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCC-ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeC------Ce
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSK-CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQ------GE 584 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~-~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~------~~ 584 (834)
++|...+.||+|+||.||+|.. .+++.||||++.... .....+++.+|+.+|++++|||||++++++... ..
T Consensus 62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 141 (464)
T 3ttj_A 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 141 (464)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCe
Confidence 5677788999999999999985 458899999986432 334457889999999999999999999998654 46
Q ss_pred EEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeee
Q 003278 585 MLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFA 664 (834)
Q Consensus 585 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfG 664 (834)
.++||||+.++.+ +.+.. .+++..+..++.|++.||+|||+ .+|+||||||+||||+.++.+||+|||
T Consensus 142 ~~lv~E~~~~~l~-~~~~~--------~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG 209 (464)
T 3ttj_A 142 VYLVMELMDANLC-QVIQM--------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG 209 (464)
T ss_dssp EEEEEECCSEEHH-HHHTS--------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred EEEEEeCCCCCHH-HHHhh--------cCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEE
Confidence 7999999987644 44421 27888889999999999999997 689999999999999999999999999
Q ss_pred eccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHh
Q 003278 665 LAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEA 744 (834)
Q Consensus 665 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~ 744 (834)
+|+..... ......+||+.|+|||++.+..|+.++|||||||+||||++|+.||........+.. +.....
T Consensus 210 ~a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~-i~~~lg 280 (464)
T 3ttj_A 210 LARTAGTS--------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK-VIEQLG 280 (464)
T ss_dssp CC-----C--------CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-HHHHHC
T ss_pred eeeecCCC--------cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHhcC
Confidence 99764321 112346899999999999999999999999999999999999999975432222111 111100
Q ss_pred h------------------cCc-c-----ccccccccCCCCC---HHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 745 R------------------KRP-L-----AELVDLSLNGEYN---HKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 745 ~------------------~~~-~-----~~~~d~~l~~~~~---~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
. ..+ . .......+..... ...-..+..+..+||..||++|||+.|+++
T Consensus 281 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 281 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp SCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 000 0 0000000000000 011234667777999999999999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=338.68 Aligned_cols=266 Identities=25% Similarity=0.389 Sum_probs=193.2
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEe-----------
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVH----------- 179 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~----------- 179 (834)
++|+..+.||+|+||.||+|+...+|+.||||++... ....+.+.+|+.++++++||||++++++|.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 4688899999999999999999889999999998643 3445778999999999999999999999875
Q ss_pred --CCEEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCce
Q 003278 180 --EDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNA 257 (834)
Q Consensus 180 --~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~ 257 (834)
.+..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~ 155 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSEN------LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNV 155 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHSC------GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCE
T ss_pred ccCCceEEEEecCCCCCHHHhhhccc------cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCE
Confidence 356899999999999999997532 3467889999999999999999996 99999999999999999999
Q ss_pred EEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCC
Q 003278 258 RLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDL 337 (834)
Q Consensus 258 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~ 337 (834)
||+|||+++............... ............||+.|+|||.+.....++.++|||||||++|||+| |+..
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~ 230 (303)
T 1zy4_A 156 KIGDFGLAKNVHRSLDILKLDSQN--LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFST 230 (303)
T ss_dssp EECCCCCCSCTTC---------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred EEeeCcchhhcccccchhcccccc--ccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCC
Confidence 999999998654321100000000 00000113455799999999998755467999999999999999998 3321
Q ss_pred CCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 338 TYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 338 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
. .........+.. .. ..+. ..+.......+.+++..||+.||.+||++.++++.
T Consensus 231 ~-----~~~~~~~~~~~~-~~------~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 231 G-----MERVNILKKLRS-VS------IEFP-PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp H-----HHHHHHHHHHHS-TT------CCCC-TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred c-----hhHHHHHHhccc-cc------cccC-ccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 1 111111222111 10 0111 11122223457889999999999999999999874
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=345.80 Aligned_cols=261 Identities=25% Similarity=0.334 Sum_probs=180.4
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC-hhhHHHHHHHHH-HHHhCCCCceeeEeeeEEeCCEEEEEE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG-ERFEKTFAAELV-AVAHLRHRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~-~~~~~~~~~E~~-~l~~l~H~nIv~l~g~~~~~~~~~lV~ 187 (834)
.++|...+.||+|+||.||+|....+|+.||||++.... ......+..|+. +++.++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 467889999999999999999998899999999986542 334455666666 777889999999999999999999999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
||+++ +|.+++..... .....+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||+++.
T Consensus 101 e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYS--VLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp CCCSE-EHHHHHHHHHH--TTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred eecCC-ChHHHHHHHHh--hhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 99985 88777653111 0135689999999999999999999984 3899999999999999999999999999976
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCccccc---cCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccc
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQ---KGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQI 344 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~---~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~ 344 (834)
+.... ..+...||+.|+|||.+. .+..++.++|||||||++|||+||+.||........
T Consensus 176 ~~~~~-----------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~- 237 (327)
T 3aln_A 176 LVDSI-----------------AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD- 237 (327)
T ss_dssp -----------------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------
T ss_pred ccccc-----------------ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-
Confidence 53221 122346999999999884 234578999999999999999999999864321100
Q ss_pred hHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 345 ILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 345 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
.. ..+.....+.+... ........+.+++..||+.||.+||++.++++.
T Consensus 238 ----~~------~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 238 ----QL------TQVVKGDPPQLSNS-EEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp ------------CCCCCSCCCCCCCC-SSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred ----HH------HHHhcCCCCCCCCc-ccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 00 01111111111110 000112468899999999999999999999763
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=346.70 Aligned_cols=262 Identities=16% Similarity=0.204 Sum_probs=188.2
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCC-hhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEe
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKC-PALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYD 590 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~-~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~E 590 (834)
++|...+.||+|+||+||+|.. .+++.||||++..... ....+.+.+|+.+|++++|||||++++++.+.+..++|||
T Consensus 34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 113 (329)
T 3gbz_A 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFE 113 (329)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEe
Confidence 5677788999999999999985 4688999999875443 2334678899999999999999999999999999999999
Q ss_pred ccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeec-----CCCCceEeeeee
Q 003278 591 YSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLD-----PDMNPRLGSFAL 665 (834)
Q Consensus 591 y~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld-----~~~~~ki~DfGl 665 (834)
|+++ +|.+++.... .+++..+..|+.|++.||+|||+ .+|+||||||+|||++ +++.+||+|||+
T Consensus 114 ~~~~-~L~~~~~~~~------~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 114 YAEN-DLKKYMDKNP------DVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp CCSE-EHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred cCCC-CHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 9985 8988886543 37889999999999999999997 6999999999999994 555699999999
Q ss_pred ccccccCCCCCcccccCccccccccCccchhccccC-CCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHh
Q 003278 666 AEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESG-EATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEA 744 (834)
Q Consensus 666 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~ 744 (834)
++...... .......||+.|+|||++.+. .++.++|||||||++|||+||+.||........+.........
T Consensus 184 a~~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 256 (329)
T 3gbz_A 184 ARAFGIPI-------RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGL 256 (329)
T ss_dssp HHHHC------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred ccccCCcc-------cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCC
Confidence 97653221 112335789999999999774 4899999999999999999999998754433322222111100
Q ss_pred hcCc-ccccc--------ccccCCCCCHH------HHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 745 RKRP-LAELV--------DLSLNGEYNHK------ELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 745 ~~~~-~~~~~--------d~~l~~~~~~~------~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
.... +.... .+..... ... .-..+..++.+||+.||++|||+.|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 257 PDDTTWPGVTALPDWKQSFPKFRGK-TLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp CCTTTSTTGGGSTTCCTTCCCCCCC-CHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred Cchhhhhhhhhhhhhhhhhhhhccc-cHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0000 00000 0000000 000 0124556677999999999999999985
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=339.97 Aligned_cols=254 Identities=15% Similarity=0.210 Sum_probs=182.0
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHH-HHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEe
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALR-TRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYD 590 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~-~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~E 590 (834)
++|...+.||+|+||.||+|.. .+++.||||++......... +.+.++...++.++||||+++++++.+.+..++|||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e 86 (290)
T 3fme_A 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICME 86 (290)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEE
T ss_pred HhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEe
Confidence 5677788999999999999996 56889999999765444333 344555666888999999999999999999999999
Q ss_pred ccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccc
Q 003278 591 YSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLT 670 (834)
Q Consensus 591 y~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~ 670 (834)
|+++ +|.+++..... ....+++..+..|+.|++.||+|||+. .+|+||||||+|||++.++.+||+|||+++...
T Consensus 87 ~~~~-~l~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 87 LMDT-SLDKFYKQVID--KGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp CCSE-EHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred hhcc-chHHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9984 77776654211 113488999999999999999999972 389999999999999999999999999997654
Q ss_pred cCCCCCcccccCccccccccCccchhcc----ccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhc
Q 003278 671 RNDHGHRKATSGNRSVRGIFGYMSPEYI----ESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARK 746 (834)
Q Consensus 671 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~----~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~ 746 (834)
... ......||+.|+|||++ .+..++.++|||||||++|||+||+.|+............ .....
T Consensus 162 ~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~ 230 (290)
T 3fme_A 162 DDV--------AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQ---VVEEP 230 (290)
T ss_dssp ----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHH---HHHSC
T ss_pred ccc--------cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHH---HhccC
Confidence 321 12234699999999996 5667899999999999999999999998643322211111 11111
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 747 RPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 747 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
. .. ........ .+.+++.+||+.||++|||+.+|++
T Consensus 231 ~--~~-----~~~~~~~~---~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 231 S--PQ-----LPADKFSA---EFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp C--CC-----CCTTTSCH---HHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred C--CC-----cccccCCH---HHHHHHHHHhhcChhhCcCHHHHHh
Confidence 1 11 11111123 3455666999999999999999975
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=345.99 Aligned_cols=266 Identities=18% Similarity=0.224 Sum_probs=191.5
Q ss_pred HhhCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCCh----hHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeE
Q 003278 511 ATNNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKCP----ALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEM 585 (834)
Q Consensus 511 at~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~----~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~ 585 (834)
..++|...+.||+|+||.||+|... +++.||||.+...... ...+.+.+|+.++++++|||||++++++.+.+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 3467888899999999999999964 5889999998753321 1224688999999999999999999999999999
Q ss_pred EEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeee
Q 003278 586 LVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFAL 665 (834)
Q Consensus 586 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGl 665 (834)
++||||+++ +|..++.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 158 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGL 158 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCC-----SSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGG
T ss_pred EEEEEcCCC-CHHHHHHhcC-----cCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEeccc
Confidence 999999996 7877775432 247788889999999999999997 6899999999999999999999999999
Q ss_pred ccccccCCCCCcccccCccccccccCccchhccccC-CCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHh
Q 003278 666 AEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESG-EATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEA 744 (834)
Q Consensus 666 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~ 744 (834)
++.+.... .......||+.|+|||++.+. .++.++|||||||++|||++|..|+........+ ..+.....
T Consensus 159 a~~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~-~~i~~~~~ 230 (346)
T 1ua2_A 159 AKSFGSPN-------RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL-TRIFETLG 230 (346)
T ss_dssp GSTTTSCC-------CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHHHC
T ss_pred ceeccCCc-------ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHH-HHHHHHcC
Confidence 97653221 112345799999999999754 4889999999999999999999888654333222 22221111
Q ss_pred hc--Cccccc---cccccC---CCCCHH-----HHHHHHHHHHHhccCCCCCCCChhHHHHH
Q 003278 745 RK--RPLAEL---VDLSLN---GEYNHK-----ELMRLIKLGIACTLSNPELRPSMRQILSI 793 (834)
Q Consensus 745 ~~--~~~~~~---~d~~l~---~~~~~~-----~~~~l~~l~~~C~~~~P~~RPtm~~v~~~ 793 (834)
.. ..+... .+.... ...... .-..+.+++.+||+.||++|||+.|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 231 TPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp CCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00 000000 000000 000000 01245566669999999999999999863
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=347.67 Aligned_cols=270 Identities=16% Similarity=0.204 Sum_probs=199.1
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEee----CCeEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTE----QGEMLV 587 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~----~~~~~l 587 (834)
++|...+.||+|+||.||++.. .+++.||||++... .....+.|.+|+.++++++|||||++++++.. ....++
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH-EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC-CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 4577778999999999999996 66889999988643 34456789999999999999999999999873 347899
Q ss_pred EEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecc
Q 003278 588 IYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAE 667 (834)
Q Consensus 588 v~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~ 667 (834)
||||+++|+|.+++..... ....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++.
T Consensus 108 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKD--KGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEECCTTCBHHHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EEEeCCCCcHHHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 9999999999998875321 12358899999999999999999997 699999999999999999999999999987
Q ss_pred ccccCCCCCcc--cccCccccccccCccchhccccCC---CCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHH
Q 003278 668 FLTRNDHGHRK--ATSGNRSVRGIFGYMSPEYIESGE---ATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEF 742 (834)
Q Consensus 668 ~~~~~~~~~~~--~~~~~~~~~Gt~~Y~aPE~~~~~~---~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~ 742 (834)
........... .........||+.|+|||++.... ++.++|||||||++|||+||+.||..............
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-- 260 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV-- 260 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHH--
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHh--
Confidence 54321100000 000112346899999999987554 68899999999999999999999853211111111000
Q ss_pred HhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCccc
Q 003278 743 EARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDKRF 801 (834)
Q Consensus 743 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~~~ 801 (834)
...... .....++ . .+.+++.+||+.||.+|||+.+|++.|+.+....
T Consensus 261 -~~~~~~------~~~~~~~-~---~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 308 (317)
T 2buj_A 261 -QNQLSI------PQSPRHS-S---ALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA 308 (317)
T ss_dssp -HCC--C------CCCTTSC-H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred -hccCCC------CccccCC-H---HHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence 000000 0011122 2 3555666999999999999999999998876543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=336.53 Aligned_cols=247 Identities=16% Similarity=0.237 Sum_probs=193.7
Q ss_pred hhCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCC-hhHHHHHHHHHHHHHhc-cCCCceeEEEEEeeCCeEEEE
Q 003278 512 TNNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKC-PALRTRFSNELQNLARL-RHRNLVQLCGWCTEQGEMLVI 588 (834)
Q Consensus 512 t~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~-~~~~~~f~~E~~~l~~l-~HpNiv~l~g~~~~~~~~~lv 588 (834)
+++|...+.||+|+||.||+|... ++..||||.+..... .....++.+|+..+.++ +|||||++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 467888899999999999999975 688999999875432 33456788999999999 999999999999999999999
Q ss_pred EeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecC--------------
Q 003278 589 YDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDP-------------- 654 (834)
Q Consensus 589 ~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~-------------- 654 (834)
|||+++|+|.+++...... ...+++..+..|+.|++.||+|||+ .+|+||||||+|||++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRI--MSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EECCTTCBHHHHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC---------------
T ss_pred EEecCCCcHHHHHHhhccc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence 9999999999998754211 1248899999999999999999997 69999999999999984
Q ss_pred -----CCCceEeeeeeccccccCCCCCcccccCccccccccCccchhccccC-CCCccCcchhhHHHHHHHHhCCCccCC
Q 003278 655 -----DMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESG-EATSMADVYSFGVVVLEVVTGQMAVDF 728 (834)
Q Consensus 655 -----~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~k~DV~SfGvvl~E~~tG~~p~~~ 728 (834)
...+||+|||++...... ....||+.|+|||++.+. .++.++|||||||++|||++|..++..
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~ 233 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSP-----------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN 233 (289)
T ss_dssp -----CCCEEECCCTTCEETTCS-----------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSS
T ss_pred cccCCceEEEEcccccccccCCc-----------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence 447899999999764321 123599999999999766 567899999999999999999876532
Q ss_pred CCCchhHHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 729 RLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
. .... .... ... +.+....+ .+ +.+++.+||+.||++|||+.++++
T Consensus 234 ~----~~~~---~~~~--~~~-----~~~~~~~~-~~---~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 234 G----DQWH---EIRQ--GRL-----PRIPQVLS-QE---FTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp S----HHHH---HHHT--TCC-----CCCSSCCC-HH---HHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred h----hHHH---HHHc--CCC-----CCCCcccC-HH---HHHHHHHHhCCCcccCCCHHHHhh
Confidence 1 1111 1111 111 11111222 33 445556899999999999999985
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=348.33 Aligned_cols=261 Identities=22% Similarity=0.329 Sum_probs=200.7
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChh-----------------hHHHHHHHHHHHHhCCCCceee
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGER-----------------FEKTFAAELVAVAHLRHRNLVR 172 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~-----------------~~~~~~~E~~~l~~l~H~nIv~ 172 (834)
.++|...+.||+|+||.||+|.. +|+.||||++...... ..+.|.+|+.++.+++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 46799999999999999999998 8999999998643211 1278999999999999999999
Q ss_pred EeeeEEeCCEEEEEEEccCCCCHhHH------HhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHh-ccCCCeecCCCC
Q 003278 173 LRGWCVHEDQLLLVYDYMPNRSLDRV------LFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHE-QLETQIIHRDVK 245 (834)
Q Consensus 173 l~g~~~~~~~~~lV~Ey~~~gsL~~~------l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDlK 245 (834)
+++++.+.+..++||||+++|+|.++ +... ....+++..+..++.|++.||.|||+ . +|+|||||
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~-----~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~ 179 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN-----YTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVK 179 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS-----SCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCC
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc-----cccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCC
Confidence 99999999999999999999999988 4321 13579999999999999999999998 5 99999999
Q ss_pred CCceEECCCCceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCc-ccceeehhhH
Q 003278 246 TSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATA-KSDVFSFGIV 324 (834)
Q Consensus 246 p~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~-ksDV~SfGvv 324 (834)
|+|||++.++.+||+|||+++..... ......||+.|+|||.+.....++. ++|||||||+
T Consensus 180 p~Nil~~~~~~~kl~dfg~~~~~~~~------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~i 241 (348)
T 2pml_X 180 PSNILMDKNGRVKLSDFGESEYMVDK------------------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGIC 241 (348)
T ss_dssp GGGEEECTTSCEEECCCTTCEECBTT------------------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHH
T ss_pred hHhEEEcCCCcEEEeccccccccccc------------------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHH
Confidence 99999999999999999999754221 1234569999999999876534555 9999999999
Q ss_pred HHHHHhCCccCCCCCCCccchHHHHHHHHhhcCcccccccc-----ccCCC---CCCHHHHHHHHHHHHHhcccCCCCCC
Q 003278 325 VLEVVSGRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDN-----RLSDG---SYKLCDMEHLTHLALLCTLHNPHLRP 396 (834)
Q Consensus 325 l~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~-----~l~~~---~~~~~~~~~l~~l~~~Cl~~~p~~RP 396 (834)
+|||+||+.||...... ..+.. .+ ..+......+. ..... .........+.+++..||+.||.+||
T Consensus 242 l~~l~~g~~pf~~~~~~--~~~~~---~i-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 315 (348)
T 2pml_X 242 LYVMFYNVVPFSLKISL--VELFN---NI-RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERI 315 (348)
T ss_dssp HHHHHHSSCSSCCSSCS--HHHHH---HH-TSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSC
T ss_pred HHHHHhCCCCCCCCCcH--HHHHH---HH-hccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCC
Confidence 99999999999754332 11111 11 11111100000 00000 00011124678999999999999999
Q ss_pred chhhHHHH
Q 003278 397 SMKWVIEA 404 (834)
Q Consensus 397 sm~~V~~~ 404 (834)
++.++++.
T Consensus 316 s~~e~l~h 323 (348)
T 2pml_X 316 TSEDALKH 323 (348)
T ss_dssp CHHHHHTS
T ss_pred CHHHHhcC
Confidence 99999863
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=348.24 Aligned_cols=265 Identities=18% Similarity=0.274 Sum_probs=197.6
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCC-----------CCceeeEeeeEEe
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLR-----------HRNLVRLRGWCVH 179 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-----------H~nIv~l~g~~~~ 179 (834)
++|...+.||+|+||.||+|....+|+.||||++... ....+.+.+|+.++.+++ ||||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 5688999999999999999999899999999998643 344567889999999886 8999999999987
Q ss_pred CC----EEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEEC---
Q 003278 180 ED----QLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLD--- 252 (834)
Q Consensus 180 ~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld--- 252 (834)
.+ ..++||||+ +++|.+++.... ...+++..+..|+.|++.||+|||++ .+|+||||||+|||++
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~-----~~~~~~~~~~~i~~qi~~aL~~lH~~--~~ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYE-----HRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVD 169 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTT-----TSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEE
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhh-----ccCCcHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChHHeEEeccC
Confidence 54 789999999 899999987542 24589999999999999999999983 2899999999999994
Q ss_pred ---CCCceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHH
Q 003278 253 ---SQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVV 329 (834)
Q Consensus 253 ---~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ell 329 (834)
..+.+||+|||+++..... .+...||+.|+|||.+... .++.++|||||||++|||+
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~~-------------------~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~ 229 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDEH-------------------YTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELI 229 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTBC-------------------CCSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHH
T ss_pred CCcCcceEEEcccccccccCCC-------------------CCCCCCCccccCcHHHhCC-CCCchHhHHHHHHHHHHHH
Confidence 4457999999999754211 2334689999999998754 5799999999999999999
Q ss_pred hCCccCCCCCCCcc----chHHHHHHHH-------hhcCc----------cccccccc---------cCCCCCCHHHHHH
Q 003278 330 SGRRAVDLTYPDDQ----IILLDWIRRL-------SDEGK----------VLQAGDNR---------LSDGSYKLCDMEH 379 (834)
Q Consensus 330 tG~~p~~~~~~~~~----~~l~~~~~~~-------~~~~~----------~~~~~d~~---------l~~~~~~~~~~~~ 379 (834)
||+.||........ ..+...+..+ ...++ ....+... .....+.......
T Consensus 230 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (373)
T 1q8y_A 230 TGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKE 309 (373)
T ss_dssp HSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHH
T ss_pred hCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHH
Confidence 99999975432211 1111111100 00000 00000000 0001223344567
Q ss_pred HHHHHHHhcccCCCCCCchhhHHHH
Q 003278 380 LTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 380 l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
+.+|+..||+.||.+||++.++++.
T Consensus 310 ~~~li~~~L~~dP~~Rpt~~ell~h 334 (373)
T 1q8y_A 310 ISDFLSPMLQLDPRKRADAGGLVNH 334 (373)
T ss_dssp HHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred HHHHHHHHhccCccccCCHHHHhhC
Confidence 8899999999999999999999873
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=350.52 Aligned_cols=256 Identities=21% Similarity=0.289 Sum_probs=195.4
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCE------
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQ------ 182 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~------ 182 (834)
++|...+.||+|+||.||+|.+..+|+.||||++... .....+.+.+|+.++++++||||+++++++...+.
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 5688899999999999999999999999999998653 33456778999999999999999999999987654
Q ss_pred EEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeec
Q 003278 183 LLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDF 262 (834)
Q Consensus 183 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DF 262 (834)
.++||||+. |+|.+++. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 104 ~~lv~e~~~-~~l~~~~~---------~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Df 170 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMG---------LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDF 170 (353)
T ss_dssp CEEEEECCS-EEGGGTTT---------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECST
T ss_pred EEEEecccc-CCHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeec
Confidence 499999997 68877662 2489999999999999999999996 9999999999999999999999999
Q ss_pred cchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCc
Q 003278 263 GLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDD 342 (834)
Q Consensus 263 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~ 342 (834)
|+++..... .+...||+.|+|||.+.....++.++|||||||++|||+||+.||......
T Consensus 171 g~~~~~~~~-------------------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~- 230 (353)
T 3coi_A 171 GLARHADAE-------------------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL- 230 (353)
T ss_dssp TCTTC---------------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH-
T ss_pred ccccCCCCC-------------------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-
Confidence 999753221 233468999999999876557899999999999999999999999753211
Q ss_pred cchHHHHHHHHhhcC------------------ccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 343 QIILLDWIRRLSDEG------------------KVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 343 ~~~l~~~~~~~~~~~------------------~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
.....+....... .+.....+.+. .........+.+++..||+.||.+||++.++++
T Consensus 231 --~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 231 --DQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFT--QLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp --HHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTT--TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred --HHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHH--HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1111111110000 00000000000 000111246789999999999999999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=344.59 Aligned_cols=267 Identities=16% Similarity=0.271 Sum_probs=195.3
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCC-hhHHHHHHHHHHHHHhccCCCceeEEEEEee--------C
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKC-PALRTRFSNELQNLARLRHRNLVQLCGWCTE--------Q 582 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~-~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~--------~ 582 (834)
++|...+.||+|+||.||+|.. .+++.||||++..... ......+.+|+.+|++++|||||++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 4677788999999999999997 5688999999865432 2234568899999999999999999999977 4
Q ss_pred CeEEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEee
Q 003278 583 GEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGS 662 (834)
Q Consensus 583 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~D 662 (834)
+..++||||+.+ +|...+.... ..+++..+..|+.|++.||+|||+ .+|+||||||+|||++.++.+||+|
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~D 167 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVL-----VKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLAD 167 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECC
T ss_pred ceEEEEEeccCC-CHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEcc
Confidence 468999999986 5666655432 238899999999999999999997 6999999999999999999999999
Q ss_pred eeeccccccCCCCCcccccCccccccccCccchhcccc-CCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHH
Q 003278 663 FALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIES-GEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHE 741 (834)
Q Consensus 663 fGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~ 741 (834)
||+++.+...... .........||+.|+|||++.+ ..++.++|||||||++|||+||+.||........ ...+..
T Consensus 168 fg~a~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~i~~ 243 (351)
T 3mi9_A 168 FGLARAFSLAKNS---QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ-LALISQ 243 (351)
T ss_dssp CTTCEECCCCSSS---SCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHH
T ss_pred chhcccccccccc---cccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHH
Confidence 9999875432211 1112234678999999999876 4589999999999999999999999875443322 222222
Q ss_pred HHhhcCc--ccccccccc--------CCCCCH-HHH------HHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 742 FEARKRP--LAELVDLSL--------NGEYNH-KEL------MRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 742 ~~~~~~~--~~~~~d~~l--------~~~~~~-~~~------~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
......+ +...-+... ...... ..+ ..+..++.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 244 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp HHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 1111000 000000000 000001 111 13566777999999999999999986
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=345.75 Aligned_cols=259 Identities=19% Similarity=0.246 Sum_probs=197.6
Q ss_pred hhCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeC-----CeE
Q 003278 512 TNNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQ-----GEM 585 (834)
Q Consensus 512 t~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~-----~~~ 585 (834)
.+.|...+.||+|+||.||+|... ++..||||++.........+.|.+|+++|.+++|||||++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 356778889999999999999864 67889999997655555667899999999999999999999998654 468
Q ss_pred EEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeee
Q 003278 586 LVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFAL 665 (834)
Q Consensus 586 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGl 665 (834)
++||||+. |+|.+++... .+++..+..|+.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 106 ~iv~e~~~-~~L~~~l~~~-------~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 174 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ-------HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGL 174 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEcccC-cCHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcc
Confidence 99999998 4888888642 37889999999999999999997 6999999999999999999999999999
Q ss_pred ccccccCCCCCcccccCccccccccCccchhcccc-CCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHh
Q 003278 666 AEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIES-GEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEA 744 (834)
Q Consensus 666 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~ 744 (834)
++....... .........||+.|+|||++.+ ..++.++|||||||++|||+||+.||........+.. +.....
T Consensus 175 a~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-i~~~~~ 249 (364)
T 3qyz_A 175 ARVADPDHD----HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNH-ILGILG 249 (364)
T ss_dssp CEECCGGGC----BCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHH-HHHHHC
T ss_pred eEecCCCCC----ccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHH-HHHHhC
Confidence 986543211 1111234689999999998754 4589999999999999999999999975543332221 111100
Q ss_pred hcCcccc----------------ccc------cccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 745 RKRPLAE----------------LVD------LSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 745 ~~~~~~~----------------~~d------~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
.+..+ ... ..+....+ ..+..++.+||+.||++|||+.|+++
T Consensus 250 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 250 --SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNAD----SKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp --SCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSC----HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --CCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCC----HHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000 000 00001111 23556667999999999999999986
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=340.33 Aligned_cols=249 Identities=15% Similarity=0.230 Sum_probs=195.1
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
++|...+.||+|+||.||++... +++.||||.+..... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA-FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 46777788999999999999964 688999999875432 2235688999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceee---cCCCCceEeeeeeccc
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITL---DPDMNPRLGSFALAEF 668 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILl---d~~~~~ki~DfGla~~ 668 (834)
+++++|.+++...+ .+++.....++.|++.||+|||+ .+|+||||||+|||+ ++++.+||+|||++..
T Consensus 88 ~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~ 158 (304)
T 2jam_A 88 VSGGELFDRILERG------VYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM 158 (304)
T ss_dssp CCSCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred CCCccHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence 99999999886532 37888999999999999999997 699999999999999 7889999999999865
Q ss_pred cccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCc
Q 003278 669 LTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRP 748 (834)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
.... ......||+.|+|||++.+..++.++|||||||++|||+||+.||....... ....+. .....
T Consensus 159 ~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~i~---~~~~~ 225 (304)
T 2jam_A 159 EQNG---------IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK-LFEKIK---EGYYE 225 (304)
T ss_dssp CCCB---------TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHH---HCCCC
T ss_pred cCCC---------ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHH---cCCCC
Confidence 3211 1224579999999999999999999999999999999999999986543221 111111 11111
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 749 LAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 749 ~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
.. .......+ . .+.+++.+||+.||++|||+.++++
T Consensus 226 ~~----~~~~~~~~-~---~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 226 FE----SPFWDDIS-E---SAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp CC----TTTTTTSC-H---HHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CC----ccccccCC-H---HHHHHHHHHcCCChhHCcCHHHHhc
Confidence 10 01111122 2 3455666899999999999999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=352.51 Aligned_cols=207 Identities=22% Similarity=0.401 Sum_probs=155.6
Q ss_pred CCC-CCeeeccCCeEEEEEEEC--CCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEe--CCEEEEEE
Q 003278 113 FDE-DEVLGSGGFGKVYRAVLP--SDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVH--EDQLLLVY 187 (834)
Q Consensus 113 f~~-~~~LG~G~fG~Vy~~~~~--~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~lV~ 187 (834)
|+. .++||+|+||.||+|.++ .++..||||++.... ....+.+|+.+|++++|||||+++++|.. .+..++||
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~ 99 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 99 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence 444 468999999999999975 468899999987543 23568899999999999999999999965 66899999
Q ss_pred EccCCCCHhHHHhcCCCc--cccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEE----CCCCceEEee
Q 003278 188 DYMPNRSLDRVLFRRPEN--LEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVML----DSQYNARLGD 261 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILl----d~~~~~kl~D 261 (834)
||+. |+|.+++...... ......+++..+..|+.||+.||.|||+. +|+||||||+|||+ +.++.+||+|
T Consensus 100 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 100 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp ECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred eCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 9997 5777777532110 11123589999999999999999999996 99999999999999 6788999999
Q ss_pred ccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCC
Q 003278 262 FGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLT 338 (834)
Q Consensus 262 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~ 338 (834)
||+|+.+...... ........||+.|+|||.+.....++.++|||||||++|||+||+.||...
T Consensus 176 fg~a~~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 176 MGFARLFNSPLKP-------------LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp TTCCC-----------------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred CCCceecCCCCcc-------------cccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 9999865432110 011345679999999999876556899999999999999999999999654
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=356.10 Aligned_cols=250 Identities=12% Similarity=0.036 Sum_probs=175.3
Q ss_pred CcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCC--hhHHHHHHHHHHHHHhc--cCCCceeEE-------EEEee
Q 003278 514 NFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKC--PALRTRFSNELQNLARL--RHRNLVQLC-------GWCTE 581 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~E~~~l~~l--~HpNiv~l~-------g~~~~ 581 (834)
+|...+.||+|+||.||+|... +++.||||++..... ....+.+.+|+.++..| +|||||+++ +++..
T Consensus 63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~ 142 (371)
T 3q60_A 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV 142 (371)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEE
T ss_pred eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheec
Confidence 3566788999999999999964 688999999886543 23456788886555555 599988855 44433
Q ss_pred C-----------------CeEEEEEeccCCCchhhhhhcCCCCCCCcccCHHHH------HHHHHHHHHHHHHhhhccCC
Q 003278 582 Q-----------------GEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHR------YNIIKSLASAILYLHEEWNE 638 (834)
Q Consensus 582 ~-----------------~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r------~~i~~~ia~gl~yLH~~~~~ 638 (834)
. ...++||||++ |+|.+++...+. .+.+..+ +.++.|++.||+|||+ .
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-----~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~ 213 (371)
T 3q60_A 143 QSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-----VYVFRGDEGILALHILTAQLIRLAANLQS---K 213 (371)
T ss_dssp TTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-----SCCCCHHHHHHHHHHHHHHHHHHHHHHHH---T
T ss_pred CCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-----ccchhhhhhhhhHHHHHHHHHHHHHHHHH---C
Confidence 2 34899999999 899999976432 2455666 7888999999999997 6
Q ss_pred ceeecccccCceeecCCCCceEeeeeeccccccCCCCCcccccCccccccccCccchhcccc--CCCCccCcchhhHHHH
Q 003278 639 QVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIES--GEATSMADVYSFGVVV 716 (834)
Q Consensus 639 ~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~k~DV~SfGvvl 716 (834)
+||||||||+||||+.++.+||+|||+++..... .....||+.|||||++.+ ..++.++|||||||+|
T Consensus 214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il 283 (371)
T 3q60_A 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----------GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSI 283 (371)
T ss_dssp TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE----------EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHH
T ss_pred CCccCcCCHHHEEECCCCCEEEEecceeeecCCC----------ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHH
Confidence 8999999999999999999999999999754211 113457799999999987 6799999999999999
Q ss_pred HHHHhCCCccCCCCCchhHHHHHHHHHhhcCccccccccc--cCC-CCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 717 LEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLS--LNG-EYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 717 ~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~--l~~-~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
|||+||+.||....+..... + ............ ... ...+++ +..++.+||+.||++|||+.++++
T Consensus 284 ~elltg~~Pf~~~~~~~~~~-----~--~~~~~~~~~~~~~~~~~~~~~~~~---~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 284 YRVWCLFLPFGLVTPGIKGS-----W--KRPSLRVPGTDSLAFGSCTPLPDF---VKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp HHHHHSSCSTTBCCTTCTTC-----C--CBCCTTSCCCCSCCCTTSSCCCHH---HHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred HHHHhCCCCCCCcCcccccc-----h--hhhhhhhccccccchhhccCCCHH---HHHHHHHHcCCChhhCCCHHHHhc
Confidence 99999999997543321100 0 000000000000 000 011233 445566999999999999999874
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=336.39 Aligned_cols=246 Identities=18% Similarity=0.296 Sum_probs=196.6
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCC--ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSK--CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIY 589 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~ 589 (834)
++|...+.||+|+||.||+|... ++..||||.+.... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46777889999999999999975 57789999985321 1122467899999999999999999999999999999999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccc
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFL 669 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~ 669 (834)
||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++...
T Consensus 94 e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~ 164 (284)
T 2vgo_A 94 EFAPRGELYKELQKHG------RFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHA 164 (284)
T ss_dssp CCCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EeCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccC
Confidence 9999999999987542 37889999999999999999996 69999999999999999999999999998654
Q ss_pred ccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcc
Q 003278 670 TRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPL 749 (834)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
... ......||+.|+|||++.+..++.++||||||+++|||+||+.||........ .. ......
T Consensus 165 ~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~---~~~~~~--- 228 (284)
T 2vgo_A 165 PSL---------RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET-HR---RIVNVD--- 228 (284)
T ss_dssp SSS---------CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HH---HHHTTC---
T ss_pred ccc---------ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH-HH---HHhccc---
Confidence 321 12245799999999999999999999999999999999999999864332211 11 111110
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 750 AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 750 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
..+....+ .+ +..++.+||+.||++|||+.+|++
T Consensus 229 -----~~~~~~~~-~~---~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 229 -----LKFPPFLS-DG---SKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp -----CCCCTTSC-HH---HHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----cCCCCcCC-HH---HHHHHHHHhhcCHhhCCCHHHHhh
Confidence 11111222 33 445566899999999999999985
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=346.83 Aligned_cols=268 Identities=22% Similarity=0.326 Sum_probs=201.6
Q ss_pred cHHHHHhhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEe
Q 003278 102 SYAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCVH 179 (834)
Q Consensus 102 ~~~el~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~ 179 (834)
...+..+..++|+..+.||+|+||.||+|.+.. .||||.+... .....+.|.+|+.++++++||||+++++++.+
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 100 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS 100 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence 344455566889999999999999999999843 4999998643 22234567889999999999999999999999
Q ss_pred CCEEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEE
Q 003278 180 EDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARL 259 (834)
Q Consensus 180 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl 259 (834)
.+..++||||+++++|.+++... ...+++..+..|+.|++.||+|||+. +|+||||||+|||++ ++.+||
T Consensus 101 ~~~~~iv~e~~~~~~L~~~l~~~------~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l 170 (319)
T 2y4i_B 101 PPHLAIITSLCKGRTLYSVVRDA------KIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVI 170 (319)
T ss_dssp SSCEEEECBCCCSEEHHHHTTSS------CCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEE
T ss_pred CCceEEEeecccCCcHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEE
Confidence 99999999999999999998643 23688999999999999999999996 999999999999998 679999
Q ss_pred eeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCcccccc--------CCCCCcccceeehhhHHHHHHhC
Q 003278 260 GDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQK--------GSVATAKSDVFSFGIVVLEVVSG 331 (834)
Q Consensus 260 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--------~~~~~~ksDV~SfGvvl~ElltG 331 (834)
+|||+++........ ..........||+.|+|||.+.. ...++.++|||||||++|||+||
T Consensus 171 ~Dfg~~~~~~~~~~~-----------~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g 239 (319)
T 2y4i_B 171 TDFGLFSISGVLQAG-----------RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAR 239 (319)
T ss_dssp CCCSCCC---------------------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHS
T ss_pred eecCCcccccccccc-----------ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhC
Confidence 999998754321110 00011234459999999998864 23568899999999999999999
Q ss_pred CccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcCC
Q 003278 332 RRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGSY 409 (834)
Q Consensus 332 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~~ 409 (834)
+.||...... .....+ ..+........ ..+ ..+.+++..||+.||.+||++.++++.|+...
T Consensus 240 ~~p~~~~~~~------~~~~~~-~~~~~~~~~~~-----~~~----~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~ 301 (319)
T 2y4i_B 240 EWPFKTQPAE------AIIWQM-GTGMKPNLSQI-----GMG----KEISDILLFCWAFEQEERPTFTKLMDMLEKLP 301 (319)
T ss_dssp SCSSSSCCHH------HHHHHH-HTTCCCCCCCS-----SCC----TTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-
T ss_pred CCCCCCCCHH------HHHHHh-ccCCCCCCCcC-----CCC----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 9998643211 111111 11211111111 111 24778999999999999999999999998754
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=351.38 Aligned_cols=268 Identities=17% Similarity=0.193 Sum_probs=196.3
Q ss_pred ccHHHHHHHhhCcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCCC----------hhHHHHHHHHHHHHHhccCCCc
Q 003278 503 ISFKEIISATNNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKC----------PALRTRFSNELQNLARLRHRNL 572 (834)
Q Consensus 503 ~~~~el~~at~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~----------~~~~~~f~~E~~~l~~l~HpNi 572 (834)
....++...+++|...+.||+|+||.||+|...++..||||++..... ....+.|.+|+.++++++||||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 346778888999999999999999999999988899999999864221 2234789999999999999999
Q ss_pred eeEEEEEee-----CCeEEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeeccccc
Q 003278 573 VQLCGWCTE-----QGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITS 647 (834)
Q Consensus 573 v~l~g~~~~-----~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~ 647 (834)
|++++++.. ....++||||+. |+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp 162 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR-----IVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHP 162 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCG
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCCh
Confidence 999999854 346899999999 57777776432 248899999999999999999997 6899999999
Q ss_pred CceeecCCCCceEeeeeeccccccCCCCCcccccCccccccccCccchhcccc-CCCCccCcchhhHHHHHHHHhCCCcc
Q 003278 648 SAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIES-GEATSMADVYSFGVVVLEVVTGQMAV 726 (834)
Q Consensus 648 ~NILld~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~k~DV~SfGvvl~E~~tG~~p~ 726 (834)
+|||++.++.+||+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||
T Consensus 163 ~NIl~~~~~~~kl~Dfg~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf 234 (362)
T 3pg1_A 163 GNILLADNNDITICDFNLAREDTAD--------ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF 234 (362)
T ss_dssp GGEEECTTCCEEECCTTC-----------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred HHEEEcCCCCEEEEecCcccccccc--------cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCC
Confidence 9999999999999999999753322 11234578999999999876 67899999999999999999999999
Q ss_pred CCCCCchhHHHHHHHHHhhc------------------Ccccccccc---ccCCCCCHHHHHHHHHHHHHhccCCCCCCC
Q 003278 727 DFRLPEGLLVKRVHEFEARK------------------RPLAELVDL---SLNGEYNHKELMRLIKLGIACTLSNPELRP 785 (834)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~d~---~l~~~~~~~~~~~l~~l~~~C~~~~P~~RP 785 (834)
........+. .+....... ......... ......+ ..+..++.+||+.||++||
T Consensus 235 ~~~~~~~~~~-~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~li~~~L~~dP~~Rp 309 (362)
T 3pg1_A 235 RGSTFYNQLN-KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTAD----PVALDLIAKMLEFNPQRRI 309 (362)
T ss_dssp CCSSHHHHHH-HHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSC----HHHHHHHHHHTCSSGGGSC
T ss_pred CCCCHHHHHH-HHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCC----HHHHHHHHHHhcCChhhCC
Confidence 7544322221 111110000 000000000 0001111 2355666799999999999
Q ss_pred ChhHHHH
Q 003278 786 SMRQILS 792 (834)
Q Consensus 786 tm~~v~~ 792 (834)
|+.++++
T Consensus 310 t~~ell~ 316 (362)
T 3pg1_A 310 STEQALR 316 (362)
T ss_dssp CHHHHHT
T ss_pred CHHHHHc
Confidence 9999986
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=344.91 Aligned_cols=252 Identities=20% Similarity=0.250 Sum_probs=188.2
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCC-ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeC------Ce
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSK-CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQ------GE 584 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~-~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~------~~ 584 (834)
+.|...+.||+|+||.||+|.. .+++.||||++.... .....+++.+|+.+|++++|||||++++++... ..
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 104 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 104 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence 4577778899999999999996 568899999986433 344567899999999999999999999998765 34
Q ss_pred EEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeee
Q 003278 585 MLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFA 664 (834)
Q Consensus 585 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfG 664 (834)
.++||||+ +++|.+++... .+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 105 ~~lv~e~~-~~~L~~~~~~~-------~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg 173 (367)
T 1cm8_A 105 FYLVMPFM-GTDLGKLMKHE-------KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFG 173 (367)
T ss_dssp CEEEEECC-SEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEecC-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeee
Confidence 69999999 88999988652 37888889999999999999997 699999999999999999999999999
Q ss_pred eccccccCCCCCcccccCccccccccCccchhcccc-CCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHH
Q 003278 665 LAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIES-GEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFE 743 (834)
Q Consensus 665 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~ 743 (834)
+++..... .....||+.|+|||++.+ ..++.++|||||||++|||+||+.||........+ ..+....
T Consensus 174 ~a~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l-~~i~~~~ 242 (367)
T 1cm8_A 174 LARQADSE----------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQL-KEIMKVT 242 (367)
T ss_dssp TCEECCSS----------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHHH
T ss_pred cccccccc----------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHhc
Confidence 99764321 234578999999999877 67999999999999999999999998654332221 1111110
Q ss_pred hhcCccc-------------------ccccc---ccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 744 ARKRPLA-------------------ELVDL---SLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 744 ~~~~~~~-------------------~~~d~---~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
. .+.. ..... .+.... .. .+..+..+|++.||++|||+.++++
T Consensus 243 g--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~---~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 243 G--TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNA-SP---LAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp C--CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTC-CH---HHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred C--CCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCC-CH---HHHHHHHHHccCChhHCCCHHHHhc
Confidence 0 0000 00000 001111 22 3445556899999999999999987
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=360.11 Aligned_cols=258 Identities=22% Similarity=0.297 Sum_probs=183.0
Q ss_pred CCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhC-CCCceeeEeeeEEeCCEEEEEEEccC
Q 003278 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHL-RHRNLVRLRGWCVHEDQLLLVYDYMP 191 (834)
Q Consensus 113 f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~ 191 (834)
|...++||+|+||+||.+.. .+|+.||||++... ..+.+.+|+.+|.++ +|||||++++++.+.+..++|||||.
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~-~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGS-FQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEE-SSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeccCeEeeCCCeEEEEEEE-ECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 34467899999999987655 57999999998643 245678899999876 89999999999999999999999995
Q ss_pred CCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCC-------------CceE
Q 003278 192 NRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQ-------------YNAR 258 (834)
Q Consensus 192 ~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~-------------~~~k 258 (834)
|+|.+++.............++..+..|+.||+.||+|||+. +|+||||||+|||++.+ +.+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 699999976532211111224445678999999999999996 99999999999999654 4899
Q ss_pred EeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCcccccc------CCCCCcccceeehhhHHHHHHh-C
Q 003278 259 LGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQK------GSVATAKSDVFSFGIVVLEVVS-G 331 (834)
Q Consensus 259 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~------~~~~~~ksDV~SfGvvl~Ellt-G 331 (834)
|+|||+++.+...... .........||++|+|||.+.. ...++.++|||||||++|||+| |
T Consensus 169 L~DFG~a~~~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g 236 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSS------------FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKG 236 (434)
T ss_dssp ECCCTTCEECCC--------------------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTS
T ss_pred EcccccceecCCCCcc------------ceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCC
Confidence 9999999865432110 0001234579999999999854 2467899999999999999999 9
Q ss_pred CccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 332 RRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 332 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
+.||....... ..... +... . +.+. ..........+.+++..||+.||.+||++.+|++
T Consensus 237 ~~Pf~~~~~~~----~~i~~-----~~~~-~--~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 237 KHPFGDKYSRE----SNIIR-----GIFS-L--DEMK-CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp CCTTCSTTTHH----HHHHH-----TCCC-C--CCCT-TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCCchhhH----HHHhc-----CCCC-c--cccc-ccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 99986432211 11111 1100 0 0000 1112233456889999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=341.80 Aligned_cols=260 Identities=20% Similarity=0.292 Sum_probs=191.4
Q ss_pred hCcCcCCcccccCCcEEEEEEEC--CCc--EEEEEEecCCC--ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD--NHQ--YVLVKRLGMSK--CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEML 586 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~--~~~--~vavK~~~~~~--~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~ 586 (834)
++|...+.||+|+||.||+|... ++. .||||.+.... .....+.|.+|+.++.+++||||+++++++.+.. .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 45677788999999999999853 333 68999886542 3345678999999999999999999999998765 88
Q ss_pred EEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeec
Q 003278 587 VIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALA 666 (834)
Q Consensus 587 lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla 666 (834)
+||||+++|+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 97 ~v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~ 168 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQ-----GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLM 168 (291)
T ss_dssp EEEECCTTCBHHHHHHHHG-----GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred eeEecccCCCHHHHHHhcc-----CCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEcccccc
Confidence 9999999999999987542 247889999999999999999997 69999999999999999999999999999
Q ss_pred cccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhh
Q 003278 667 EFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEAR 745 (834)
Q Consensus 667 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~ 745 (834)
......... ........||+.|+|||++.+..++.++|||||||++|||+| |+.|+........ .. .....
T Consensus 169 ~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-~~---~~~~~ 240 (291)
T 1u46_A 169 RALPQNDDH----YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI-LH---KIDKE 240 (291)
T ss_dssp EECCC-CCE----EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-HH---HHHTS
T ss_pred ccccccccc----hhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHH-HH---HHHcc
Confidence 875433211 111223468889999999999899999999999999999999 9999865432221 11 11111
Q ss_pred cCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCc
Q 003278 746 KRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDK 799 (834)
Q Consensus 746 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~ 799 (834)
... ....... +. .+.+++.+||+.||++|||+.+|++.|+....
T Consensus 241 ~~~------~~~~~~~-~~---~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 241 GER------LPRPEDC-PQ---DIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp CCC------CCCCTTC-CH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred CCC------CCCCcCc-CH---HHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 100 0111112 22 35556669999999999999999999976544
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=343.65 Aligned_cols=265 Identities=18% Similarity=0.244 Sum_probs=196.4
Q ss_pred hhCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeC-----CeE
Q 003278 512 TNNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQ-----GEM 585 (834)
Q Consensus 512 t~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~-----~~~ 585 (834)
.++|...+.||+|+||.||+|... +++.||||.+..........++.+|+.++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 357788889999999999999975 58899999997655566667889999999999999999999998764 678
Q ss_pred EEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeee
Q 003278 586 LVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFAL 665 (834)
Q Consensus 586 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGl 665 (834)
++||||+. |+|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 90 ~lv~e~~~-~~L~~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 158 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ-------MLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGL 158 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEeccC-ccHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEeccc
Confidence 99999998 5888887642 38899999999999999999997 6999999999999999999999999999
Q ss_pred ccccccCCCCCcc---cccCccccccccCccchhcccc-CCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHH
Q 003278 666 AEFLTRNDHGHRK---ATSGNRSVRGIFGYMSPEYIES-GEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHE 741 (834)
Q Consensus 666 a~~~~~~~~~~~~---~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~ 741 (834)
++........... .........||+.|+|||++.+ ..++.++|||||||++|||+||+.||........+.. ...
T Consensus 159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~ 237 (353)
T 2b9h_A 159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL-IFG 237 (353)
T ss_dssp CEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-HHH
T ss_pred ccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH-HHH
Confidence 9875432211000 0111234679999999998764 6789999999999999999999999875432222111 111
Q ss_pred HHhhcCc---cccc---------------ccc---ccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 742 FEARKRP---LAEL---------------VDL---SLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 742 ~~~~~~~---~~~~---------------~d~---~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
....... ...+ ... ......+ ..+.+++.+||+.||++|||+.+|++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVN----PKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCC----HHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 1000000 0000 000 0001111 23456667999999999999999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=333.19 Aligned_cols=247 Identities=20% Similarity=0.327 Sum_probs=188.9
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCC--ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSK--CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIY 589 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~ 589 (834)
++|...+.||+|+||.||+|... +++.||||.+.... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 45677788999999999999975 68899999986422 1223467899999999999999999999999999999999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccc
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFL 669 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~ 669 (834)
||+++++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++...
T Consensus 91 e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 91 EYVSGGELFDYICKHG------RVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 161 (276)
T ss_dssp ECCCSCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred eccCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeeccccccc
Confidence 9999999999986532 37888999999999999999997 58999999999999999999999999999765
Q ss_pred ccCCCCCcccccCccccccccCccchhccccCCC-CccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCc
Q 003278 670 TRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEA-TSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRP 748 (834)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
.... ......||+.|+|||.+.+..+ +.++||||||+++|||+||+.|+....... ....+ ......
T Consensus 162 ~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~---~~~~~~ 229 (276)
T 2h6d_A 162 SDGE--------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT-LFKKI---RGGVFY 229 (276)
T ss_dssp CC---------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHH---HHCCCC
T ss_pred CCCc--------ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH-HHHHh---hcCccc
Confidence 3321 1123478999999999987765 689999999999999999999986533221 11111 111111
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 749 LAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 749 ~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
+....+ .+ +..++.+||+.||++|||+.+|++
T Consensus 230 --------~~~~~~-~~---l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 230 --------IPEYLN-RS---VATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp --------CCTTSC-HH---HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------CchhcC-HH---HHHHHHHHccCChhhCCCHHHHHh
Confidence 111122 23 445666899999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=339.91 Aligned_cols=251 Identities=18% Similarity=0.287 Sum_probs=191.7
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
+.|...+.||+|+||.||+|... ++..||+|.+..... ...+.|.+|+.++++++||||+++++++.+.+..++||||
T Consensus 19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE-EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH-HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 56777888999999999999975 488999999865432 3346799999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccccc
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTR 671 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~ 671 (834)
+++++|..++..... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++.....
T Consensus 98 ~~~~~l~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (302)
T 2j7t_A 98 CPGGAVDAIMLELDR-----GLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK 169 (302)
T ss_dssp CTTEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred CCCCcHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence 999999998865322 38899999999999999999997 6999999999999999999999999999854321
Q ss_pred CCCCCcccccCccccccccCccchhcc-----ccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhc
Q 003278 672 NDHGHRKATSGNRSVRGIFGYMSPEYI-----ESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARK 746 (834)
Q Consensus 672 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~-----~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~ 746 (834)
. ........||+.|+|||++ ....++.++|||||||++|||+||+.|+....+..... ......
T Consensus 170 ~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~ 238 (302)
T 2j7t_A 170 T-------LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL----KIAKSD 238 (302)
T ss_dssp H-------HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH----HHHHSC
T ss_pred c-------ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH----HHhccC
Confidence 1 0112235799999999998 36778999999999999999999999986543322111 111111
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 747 RPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 747 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
.+ .... ...+ .. .+..++.+||+.||++|||+.+|++
T Consensus 239 ~~--~~~~---~~~~-~~---~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 239 PP--TLLT---PSKW-SV---EFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp CC--CCSS---GGGS-CH---HHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred Cc--ccCC---cccc-CH---HHHHHHHHHcccChhhCCCHHHHhc
Confidence 11 1110 0111 12 3455666899999999999999975
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=362.35 Aligned_cols=250 Identities=16% Similarity=0.256 Sum_probs=191.2
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCC-hhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEe
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKC-PALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYD 590 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~-~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~E 590 (834)
+.|...+.||+|+||+||+|... ++..||||.+..... ......+.+|+.+|++++|||||+++++|.+.+..++|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 45777889999999999999974 678999999875432 2234678999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecC---CCCceEeeeeecc
Q 003278 591 YSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDP---DMNPRLGSFALAE 667 (834)
Q Consensus 591 y~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~---~~~~ki~DfGla~ 667 (834)
|+++|+|.+++.... .+++..+..|+.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||++.
T Consensus 117 ~~~~g~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~ 187 (494)
T 3lij_A 117 CYKGGELFDEIIHRM------KFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSA 187 (494)
T ss_dssp CCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred cCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence 999999998886542 37888999999999999999997 68999999999999976 4559999999997
Q ss_pred ccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcC
Q 003278 668 FLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKR 747 (834)
Q Consensus 668 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
...... ......||+.|+|||++. +.++.++|||||||++|||+||..||....... +...+. ....
T Consensus 188 ~~~~~~--------~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~---~~~~ 254 (494)
T 3lij_A 188 VFENQK--------KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE-ILRKVE---KGKY 254 (494)
T ss_dssp ECBTTB--------CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHH---HTCC
T ss_pred ECCCCc--------cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH---hCCC
Confidence 654321 123457999999999986 579999999999999999999999997544322 222221 1111
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 748 PLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 748 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
.. ..+.. ... ..+ +..++.+||+.||++|||+.++++
T Consensus 255 ~~---~~~~~-~~~-s~~---~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 255 TF---DSPEW-KNV-SEG---AKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp CC---CSGGG-TTS-CHH---HHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CC---Cchhc-ccC-CHH---HHHHHHHHCCCChhhCccHHHHhc
Confidence 11 01111 111 233 445556899999999999999874
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=340.84 Aligned_cols=256 Identities=14% Similarity=0.200 Sum_probs=192.8
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhcc-CCCceeEEEEEee--CCeEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLR-HRNLVQLCGWCTE--QGEMLVI 588 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~-HpNiv~l~g~~~~--~~~~~lv 588 (834)
++|...+.||+|+||.||+|.. .+++.||||.+.... .+.+.+|+.+|.+++ ||||+++++++.+ ....++|
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 4577778999999999999985 568899999986432 467899999999997 9999999999987 6678999
Q ss_pred EeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCC-CceEeeeeecc
Q 003278 589 YDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDM-NPRLGSFALAE 667 (834)
Q Consensus 589 ~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~-~~ki~DfGla~ 667 (834)
|||+.+++|.+++. .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++ .+||+|||+++
T Consensus 112 ~e~~~~~~l~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~ 179 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ---------TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 179 (330)
T ss_dssp EECCCCCCHHHHGG---------GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EeccCchhHHHHHH---------hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence 99999999998874 26788889999999999999997 6899999999999999776 89999999998
Q ss_pred ccccCCCCCcccccCccccccccCccchhcccc-CCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhh-
Q 003278 668 FLTRNDHGHRKATSGNRSVRGIFGYMSPEYIES-GEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEAR- 745 (834)
Q Consensus 668 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~- 745 (834)
...... ......||..|+|||++.+ ..++.++|||||||++|||+||+.|+.........+.........
T Consensus 180 ~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~ 251 (330)
T 3nsz_A 180 FYHPGQ--------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 251 (330)
T ss_dssp ECCTTC--------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHH
T ss_pred EcCCCC--------ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCc
Confidence 654321 1223578999999999876 678999999999999999999999986544332222211111000
Q ss_pred ---------cCccc----cc--------cccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 746 ---------KRPLA----EL--------VDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 746 ---------~~~~~----~~--------~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
..... ++ .............-..+..++.+||+.||++|||+.|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 252 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000 00 0000000000001124556667999999999999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=337.83 Aligned_cols=250 Identities=20% Similarity=0.335 Sum_probs=193.5
Q ss_pred hhCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEe
Q 003278 512 TNNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYD 590 (834)
Q Consensus 512 t~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~E 590 (834)
.+.|...+.||+|+||.||+|... ++..||||.+..... .+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD---LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC---CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH---HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 456788889999999999999975 488999999875432 3568899999999999999999999999999999999
Q ss_pred ccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccc
Q 003278 591 YSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLT 670 (834)
Q Consensus 591 y~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~ 670 (834)
|+++|+|.+++.... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++....
T Consensus 105 ~~~~~~L~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (314)
T 3com_A 105 YCGAGSVSDIIRLRN-----KTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLT 176 (314)
T ss_dssp CCTTEEHHHHHHHHT-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECB
T ss_pred cCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhh
Confidence 999999999986432 248899999999999999999997 689999999999999999999999999997653
Q ss_pred cCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCccc
Q 003278 671 RNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLA 750 (834)
Q Consensus 671 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (834)
... .......||+.|+|||++.+..++.++|||||||++|||+||+.|+....+... .........+
T Consensus 177 ~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~~~-- 243 (314)
T 3com_A 177 DTM-------AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA----IFMIPTNPPP-- 243 (314)
T ss_dssp TTB-------SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH----HHHHHHSCCC--
T ss_pred hhc-------cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH----HHHHhcCCCc--
Confidence 321 112345799999999999999999999999999999999999999864332211 1111111111
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 751 ELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 751 ~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
....+ ..+ .. .+.+++.+||+.||++|||+.++++
T Consensus 244 ~~~~~---~~~-~~---~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 244 TFRKP---ELW-SD---NFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp CCSSG---GGS-CH---HHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccCCc---ccC-CH---HHHHHHHHHccCChhhCcCHHHHHh
Confidence 11001 111 12 3455666999999999999999975
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=345.54 Aligned_cols=262 Identities=18% Similarity=0.311 Sum_probs=194.3
Q ss_pred hCcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCCC-hhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKC-PALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~-~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
++|...+.||+|+||.||+|...+ .||||.+..... ....+.|.+|+.++++++||||+++++++.+.+..++||||
T Consensus 33 ~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~ 110 (319)
T 2y4i_B 33 EQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSL 110 (319)
T ss_dssp SCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBC
T ss_pred HHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeec
Confidence 467778899999999999998765 389998875432 22335678899999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccccc
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTR 671 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~ 671 (834)
+++++|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++ ++.+||+|||+++....
T Consensus 111 ~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 111 CKGRTLYSVVRDAK-----IVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181 (319)
T ss_dssp CCSEEHHHHTTSSC-----CCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred ccCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence 99999999986532 247889999999999999999997 6999999999999998 67999999999876432
Q ss_pred CCCCCcccccCccccccccCccchhcccc---------CCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHH
Q 003278 672 NDHGHRKATSGNRSVRGIFGYMSPEYIES---------GEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEF 742 (834)
Q Consensus 672 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~---------~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~ 742 (834)
.... ..........||+.|+|||++.. ..++.++|||||||++|||+||+.||........ ... .
T Consensus 182 ~~~~--~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~---~ 255 (319)
T 2y4i_B 182 LQAG--RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI-IWQ---M 255 (319)
T ss_dssp --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH-HHH---H
T ss_pred cccc--ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHH---h
Confidence 1111 01111233469999999999864 4578899999999999999999999875433221 111 1
Q ss_pred HhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCccc
Q 003278 743 EARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDKRF 801 (834)
Q Consensus 743 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~~~ 801 (834)
.....+ ... ....+. .+.+++.+||+.||++|||+.+|++.|+.+.++.
T Consensus 256 ~~~~~~--~~~-----~~~~~~---~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 256 GTGMKP--NLS-----QIGMGK---EISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp HTTCCC--CCC-----CSSCCT---THHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred ccCCCC--CCC-----cCCCCH---HHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 111111 111 111112 3455666999999999999999999999887643
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=374.20 Aligned_cols=255 Identities=21% Similarity=0.312 Sum_probs=199.5
Q ss_pred hCcCcCCcccccCCcEEEEEEECC----CcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDN----HQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVI 588 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~----~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv 588 (834)
++|...+.||+|+||.||+|.... +..||||.+.........+.|.+|+.+|++++|||||+++|++.+ +..++|
T Consensus 390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~lv 468 (656)
T 2j0j_A 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWII 468 (656)
T ss_dssp GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceEEE
Confidence 456667889999999999998743 457999998766666667889999999999999999999999865 568999
Q ss_pred EeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccc
Q 003278 589 YDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEF 668 (834)
Q Consensus 589 ~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~ 668 (834)
|||+++|+|.+++.... ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 469 ~E~~~~g~L~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 469 MELCTLGELRSFLQVRK-----FSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp EECCTTCBHHHHHHHTT-----TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred EEcCCCCcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCee
Confidence 99999999999997543 248899999999999999999997 6999999999999999999999999999986
Q ss_pred cccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcC
Q 003278 669 LTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKR 747 (834)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
...... .......||+.|||||++.+..++.++|||||||++|||+| |..||...... .....+. ....
T Consensus 541 ~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~-~~~~~i~---~~~~ 610 (656)
T 2j0j_A 541 MEDSTY------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-DVIGRIE---NGER 610 (656)
T ss_dssp CCC----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHHHHH---HTCC
T ss_pred cCCCcc------eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHH---cCCC
Confidence 543211 11123467889999999999999999999999999999997 88888643322 2222221 1111
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccC
Q 003278 748 PLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGN 797 (834)
Q Consensus 748 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~ 797 (834)
. .+.... +. .+..++.+||+.||++|||+.+|++.|+.+
T Consensus 611 ~-------~~~~~~-~~---~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 611 L-------PMPPNC-PP---TLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp C-------CCCTTC-CH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C-------CCCccc-cH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1 111122 23 345566799999999999999999999764
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=363.70 Aligned_cols=251 Identities=19% Similarity=0.283 Sum_probs=194.1
Q ss_pred hhCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCCh------------hHHHHHHHHHHHHHhccCCCceeEEEE
Q 003278 512 TNNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKCP------------ALRTRFSNELQNLARLRHRNLVQLCGW 578 (834)
Q Consensus 512 t~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~------------~~~~~f~~E~~~l~~l~HpNiv~l~g~ 578 (834)
.+.|...+.||+|+||+||+|... ++..||||.+...... ...+.+.+|+.+|++++|||||+++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 356777889999999999999974 5789999998653311 235678999999999999999999999
Q ss_pred EeeCCeEEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCC--
Q 003278 579 CTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDM-- 656 (834)
Q Consensus 579 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~-- 656 (834)
|.+.+..++||||+++|+|.+++.... .+++..+..|+.|++.||+|||+ .+|+||||||+|||++.++
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~ 185 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRH------KFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSL 185 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCC
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCC
Confidence 999999999999999999998886532 38899999999999999999997 6999999999999999775
Q ss_pred -CceEeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhH
Q 003278 657 -NPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLL 735 (834)
Q Consensus 657 -~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~ 735 (834)
.+||+|||+++...... ......||+.|+|||++. +.++.++|||||||++|||+||..||....... +
T Consensus 186 ~~~kl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~ 255 (504)
T 3q5i_A 186 LNIKIVDFGLSSFFSKDY--------KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD-I 255 (504)
T ss_dssp SSEEECCCTTCEECCTTS--------CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-H
T ss_pred ccEEEEECCCCEEcCCCC--------ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-H
Confidence 69999999998654321 123457999999999986 579999999999999999999999997543322 2
Q ss_pred HHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 736 VKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
...+.. ..... +.......+ . .+..++.+||+.||.+|||+.|+++
T Consensus 256 ~~~i~~---~~~~~----~~~~~~~~s-~---~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 256 IKKVEK---GKYYF----DFNDWKNIS-D---EAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHHHHH---CCCCC----CHHHHTTSC-H---HHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHc---CCCCC----CccccCCCC-H---HHHHHHHHHcCCChhHCCCHHHHhc
Confidence 222211 11100 000001111 2 3455666899999999999999985
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=344.53 Aligned_cols=259 Identities=19% Similarity=0.314 Sum_probs=193.9
Q ss_pred cHHHHHHHhhCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhc-cCCCceeEEEEEee
Q 003278 504 SFKEIISATNNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARL-RHRNLVQLCGWCTE 581 (834)
Q Consensus 504 ~~~el~~at~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l-~HpNiv~l~g~~~~ 581 (834)
++.++....+.|...+.||+|+||.||+|.. .+++.||||.+...... .+.+.+|+.++.++ +||||+++++++..
T Consensus 15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE--EEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST--THHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred cchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc--HHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 3334444567888889999999999999997 56889999998654322 35788999999999 89999999999976
Q ss_pred ------CCeEEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCC
Q 003278 582 ------QGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPD 655 (834)
Q Consensus 582 ------~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~ 655 (834)
.+..++||||+++|+|.+++.... ...+++.....++.|++.||+|||+ .+|+||||||+|||++.+
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~ 165 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTK----GNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTEN 165 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHSG----GGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTT
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhcc----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCC
Confidence 467899999999999999987542 1247888899999999999999997 689999999999999999
Q ss_pred CCceEeeeeeccccccCCCCCcccccCccccccccCccchhccc-----cCCCCccCcchhhHHHHHHHHhCCCccCCCC
Q 003278 656 MNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIE-----SGEATSMADVYSFGVVVLEVVTGQMAVDFRL 730 (834)
Q Consensus 656 ~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-----~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~ 730 (834)
+.+||+|||++....... .......||+.|+|||++. +..++.++|||||||++|||+||+.|+....
T Consensus 166 ~~~kl~Dfg~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 238 (326)
T 2x7f_A 166 AEVKLVDFGVSAQLDRTV-------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 238 (326)
T ss_dssp CCEEECCCTTTC--------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CCEEEeeCcCceecCcCc-------cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence 999999999997643211 1123457999999999986 5678999999999999999999999986433
Q ss_pred CchhHHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 731 PEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
+.... . .... .+..... ....... +..++.+||..||++|||+.++++
T Consensus 239 ~~~~~-~---~~~~--~~~~~~~-----~~~~~~~---l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 239 PMRAL-F---LIPR--NPAPRLK-----SKKWSKK---FQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHHHH-H---HHHH--SCCCCCS-----CSCSCHH---HHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHH-H---Hhhc--CccccCC-----ccccCHH---HHHHHHHHhccChhhCCCHHHHhh
Confidence 22211 1 1111 1111111 1111233 445556899999999999999986
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=355.19 Aligned_cols=200 Identities=18% Similarity=0.271 Sum_probs=152.6
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCC-ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeC-----CeE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSK-CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQ-----GEM 585 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~-----~~~ 585 (834)
++|...+.||+|+||+||+|... ++..||||++.... .....++|.+|+.+|++++|||||++++++... ...
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 56888899999999999999854 68899999986543 334457899999999999999999999999543 568
Q ss_pred EEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeee
Q 003278 586 LVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFAL 665 (834)
Q Consensus 586 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGl 665 (834)
++||||+. |+|.+++.... .+++..+..|+.||+.||+|||+ .+||||||||+||||+.++.+||+|||+
T Consensus 133 ~lv~e~~~-~~L~~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGl 202 (458)
T 3rp9_A 133 YVVLEIAD-SDFKKLFRTPV------YLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGL 202 (458)
T ss_dssp EEEECCCS-EEHHHHHHSSC------CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEeccc-cchhhhcccCC------CCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeeccccc
Confidence 99999975 68888886432 48899999999999999999997 6999999999999999999999999999
Q ss_pred ccccccCCCCCcc--------------------cccCccccccccCccchhcc-ccCCCCccCcchhhHHHHHHHHhC
Q 003278 666 AEFLTRNDHGHRK--------------------ATSGNRSVRGIFGYMSPEYI-ESGEATSMADVYSFGVVVLEVVTG 722 (834)
Q Consensus 666 a~~~~~~~~~~~~--------------------~~~~~~~~~Gt~~Y~aPE~~-~~~~~~~k~DV~SfGvvl~E~~tG 722 (834)
|+........... ........+||+.|||||++ ....|+.++|||||||+||||+||
T Consensus 203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 9875432111000 00112456799999999986 456799999999999999999994
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=341.04 Aligned_cols=263 Identities=19% Similarity=0.362 Sum_probs=198.6
Q ss_pred cccHHHHHhhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCC--CCceeeEee
Q 003278 100 IFSYAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLR--HRNLVRLRG 175 (834)
Q Consensus 100 ~f~~~el~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~--H~nIv~l~g 175 (834)
.+.+..+....++|+..+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+.++.+++ ||||+++++
T Consensus 17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~ 95 (313)
T 3cek_A 17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95 (313)
T ss_dssp ---CCEEEETTEEEEEEEEEECCSSEEEEEEEC-TTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred CCCeeeeeeccceEEEEEEecCCCCEEEEEEEc-CCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEE
Confidence 455555666677899999999999999999998 46899999998643 3445678999999999997 599999999
Q ss_pred eEEeCCEEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCC
Q 003278 176 WCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQY 255 (834)
Q Consensus 176 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~ 255 (834)
++...+..++||| +.+++|.+++... ..+++..+..|+.|+++||.|||+. +|+||||||+|||+++ +
T Consensus 96 ~~~~~~~~~lv~e-~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~ 163 (313)
T 3cek_A 96 YEITDQYIYMVME-CGNIDLNSWLKKK-------KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-G 163 (313)
T ss_dssp EEECSSEEEEEEC-CCSEEHHHHHHHC-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-T
T ss_pred EeecCCEEEEEEe-cCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-C
Confidence 9999999999999 6789999998653 3588999999999999999999996 9999999999999975 7
Q ss_pred ceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCcccccc----------CCCCCcccceeehhhHH
Q 003278 256 NARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQK----------GSVATAKSDVFSFGIVV 325 (834)
Q Consensus 256 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~----------~~~~~~ksDV~SfGvvl 325 (834)
.+||+|||+++.+...... .......||+.|+|||.+.. ...++.++|||||||++
T Consensus 164 ~~kL~Dfg~~~~~~~~~~~--------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il 229 (313)
T 3cek_A 164 MLKLIDFGIANQMQPDTTS--------------VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 229 (313)
T ss_dssp EEEECCCSSSCC----------------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHH
T ss_pred eEEEeeccccccccCcccc--------------ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHH
Confidence 8999999999865332110 01234469999999998854 13578899999999999
Q ss_pred HHHHhCCccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 326 LEVVSGRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 326 ~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
|||+||+.||...... ............... .. ... ...+.+++..||+.||.+||++.++++.
T Consensus 230 ~el~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~-----~~-~~~----~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 230 YYMTYGKTPFQQIINQ-----ISKLHAIIDPNHEIE-----FP-DIP----EKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HHHHHSSCTTTTCCSH-----HHHHHHHHCTTSCCC-----CC-CCS----CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHhCCCchhhHHHH-----HHHHHHHHhcccccC-----Cc-ccc----hHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 9999999998643211 111122111111100 00 111 2467889999999999999999999874
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=340.15 Aligned_cols=259 Identities=25% Similarity=0.386 Sum_probs=193.4
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECC-CC--eEEEEEEeccc---ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPS-DG--TVVAVKCLAEK---GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQL 183 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~-~g--~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 183 (834)
.++|+..+.||+|+||.||+|.+.. ++ ..||||++... .....+.|.+|+.++.+++||||+++++++...+ .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 4578899999999999999998632 33 36999988643 2345678999999999999999999999998765 8
Q ss_pred EEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeecc
Q 003278 184 LLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFG 263 (834)
Q Consensus 184 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFG 263 (834)
++||||+++|+|.+++.... ..+++..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg 166 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQ------GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFG 166 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHG------GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCT
T ss_pred eeeEecccCCCHHHHHHhcc------CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccc
Confidence 99999999999999986532 3588999999999999999999996 99999999999999999999999999
Q ss_pred chhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCc
Q 003278 264 LARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDD 342 (834)
Q Consensus 264 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~ 342 (834)
+++.+..... .........||+.|+|||.+... .++.++|||||||++|||+| |+.||.....
T Consensus 167 ~~~~~~~~~~-------------~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-- 230 (291)
T 1u46_A 167 LMRALPQNDD-------------HYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-- 230 (291)
T ss_dssp TCEECCC-CC-------------EEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH--
T ss_pred cccccccccc-------------chhhhccCCCCceeeCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcccCCH--
Confidence 9976432210 00112344588899999988654 56889999999999999999 9999864321
Q ss_pred cchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 343 QIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 343 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
..........+.... .. ... ...+.+++..||+.||.+||++.++++.|...
T Consensus 231 ----~~~~~~~~~~~~~~~-----~~-~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 282 (291)
T 1u46_A 231 ----SQILHKIDKEGERLP-----RP-EDC----PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 282 (291)
T ss_dssp ----HHHHHHHHTSCCCCC-----CC-TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----HHHHHHHHccCCCCC-----CC-cCc----CHHHHHHHHHHccCCcccCcCHHHHHHHHHHh
Confidence 112222222211110 00 111 24688999999999999999999999998764
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=356.63 Aligned_cols=263 Identities=22% Similarity=0.253 Sum_probs=190.2
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCE------EE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQ------LL 184 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~------~~ 184 (834)
.+|...++||+|+||.||+|.+..++. ||+|++..... ...+|+.+++.++|||||+++++|...+. ++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 458889999999999999999965554 88888754322 12369999999999999999999976543 88
Q ss_pred EEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEEC-CCCceEEeecc
Q 003278 185 LVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLD-SQYNARLGDFG 263 (834)
Q Consensus 185 lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld-~~~~~kl~DFG 263 (834)
+||||++++.+....... .....+++..+..++.|+++||+|||+. +|+||||||+|||++ .++.+||+|||
T Consensus 115 lv~e~~~~~l~~~~~~~~----~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG 187 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYA----KLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFG 187 (394)
T ss_dssp EEEECCSEEHHHHHHHHH----HTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEeeccCccHHHHHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence 999999876554433211 1135689999999999999999999996 999999999999999 79999999999
Q ss_pred chhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCcc
Q 003278 264 LARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQ 343 (834)
Q Consensus 264 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~ 343 (834)
+|+.+.... ......||+.|+|||.+.....++.++|||||||++|||++|+.||......
T Consensus 188 ~a~~~~~~~-----------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-- 248 (394)
T 4e7w_A 188 SAKILIAGE-----------------PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI-- 248 (394)
T ss_dssp TCEECCTTC-----------------CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--
T ss_pred CcccccCCC-----------------CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--
Confidence 998642210 1234568999999999876556899999999999999999999999653221
Q ss_pred chHHHHHHHHhh---------cCccccccccccCCCC----CCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 344 IILLDWIRRLSD---------EGKVLQAGDNRLSDGS----YKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 344 ~~l~~~~~~~~~---------~~~~~~~~d~~l~~~~----~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
..+...+..+.. ........-+...... +.......+.+|+..||+.||.+||++.++++.
T Consensus 249 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 249 DQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 112221111000 0000000000000000 000112468899999999999999999999863
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=342.25 Aligned_cols=252 Identities=15% Similarity=0.219 Sum_probs=193.1
Q ss_pred CcCcC-CcccccCCcEEEEEEEC-CCcEEEEEEecCCC-ChhHHHHHHHHHHHHHhcc-CCCceeEEEEEeeCCeEEEEE
Q 003278 514 NFSES-QRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSK-CPALRTRFSNELQNLARLR-HRNLVQLCGWCTEQGEMLVIY 589 (834)
Q Consensus 514 ~f~~~-~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~f~~E~~~l~~l~-HpNiv~l~g~~~~~~~~~lv~ 589 (834)
.|... +.||+|+||.||+|... +++.||||.+.... .......+.+|+.++.+++ ||||+++++++.+.+..++||
T Consensus 29 ~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~ 108 (327)
T 3lm5_A 29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILIL 108 (327)
T ss_dssp HEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred EEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEE
Confidence 34443 67999999999999865 58899999987533 2334577899999999995 699999999999999999999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecC---CCCceEeeeeec
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDP---DMNPRLGSFALA 666 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~---~~~~ki~DfGla 666 (834)
||+++|+|.+++.... ...+++..+..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||++
T Consensus 109 e~~~~~~L~~~~~~~~----~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a 181 (327)
T 3lm5_A 109 EYAAGGEIFSLCLPEL----AEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMS 181 (327)
T ss_dssp ECCTTEEGGGGGSSCC-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCEEECCGGGC
T ss_pred EecCCCcHHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcEEEeeCccc
Confidence 9999999999985432 1348899999999999999999997 68999999999999998 789999999999
Q ss_pred cccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhc
Q 003278 667 EFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARK 746 (834)
Q Consensus 667 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~ 746 (834)
+...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||......... ..+. ...
T Consensus 182 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~i~---~~~ 249 (327)
T 3lm5_A 182 RKIGHAC--------ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETY-LNIS---QVN 249 (327)
T ss_dssp EEC-----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHH---HTC
T ss_pred cccCCcc--------ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH-HHHH---hcc
Confidence 8653221 123457999999999999999999999999999999999999998654322211 1111 111
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 747 RPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 747 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
.... ....... .. .+..++.+||+.||++|||+.++++
T Consensus 250 ~~~~----~~~~~~~-~~---~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 250 VDYS----EETFSSV-SQ---LATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp CCCC----TTTTTTS-CH---HHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccC----chhhccc-CH---HHHHHHHHHcCCChhhCcCHHHHhC
Confidence 1100 0000111 22 3445666899999999999999975
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=341.13 Aligned_cols=267 Identities=24% Similarity=0.340 Sum_probs=197.2
Q ss_pred hhcCCCCCCCeeeccCCeEEEEEEEC-CCCeEEEEEEecccC--hhhHHHHHHHHHHHHhC---CCCceeeEeeeEE---
Q 003278 108 IGSNGFDEDEVLGSGGFGKVYRAVLP-SDGTVVAVKCLAEKG--ERFEKTFAAELVAVAHL---RHRNLVRLRGWCV--- 178 (834)
Q Consensus 108 ~~t~~f~~~~~LG~G~fG~Vy~~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l---~H~nIv~l~g~~~--- 178 (834)
.+.++|+..+.||+|+||.||+|... .+|+.||||++.... ......+.+|+.+++.+ +||||++++++|.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 34578999999999999999999985 678999999986432 11223466777776665 8999999999997
Q ss_pred --eCCEEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCc
Q 003278 179 --HEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYN 256 (834)
Q Consensus 179 --~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~ 256 (834)
..+..++||||++ |+|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~ 158 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVP-----EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQ 158 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSC-----TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCC
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcc-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCC
Confidence 4567899999998 69999987643 23589999999999999999999996 9999999999999999999
Q ss_pred eEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCC
Q 003278 257 ARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVD 336 (834)
Q Consensus 257 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~ 336 (834)
+||+|||+++...... ......||+.|+|||.+... .++.++|||||||++|||+||+.||.
T Consensus 159 ~kl~Dfg~~~~~~~~~-----------------~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~ 220 (326)
T 1blx_A 159 IKLADFGLARIYSFQM-----------------ALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFR 220 (326)
T ss_dssp EEECSCCSCCCCCGGG-----------------GGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred EEEecCcccccccCCC-----------------CccccccccceeCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCC
Confidence 9999999997643211 12345689999999998655 57999999999999999999999986
Q ss_pred CCCCCccchHHHHHHHHhhcC---ccccc---cccccCC------CCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 337 LTYPDDQIILLDWIRRLSDEG---KVLQA---GDNRLSD------GSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 337 ~~~~~~~~~l~~~~~~~~~~~---~~~~~---~d~~l~~------~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
.... ......+....... ..... ....... ..........+.+++..||+.||.+||++.++++.
T Consensus 221 ~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 221 GSSD---VDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp CSSH---HHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCH---HHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 4321 11111111111100 00000 0000000 00000112457889999999999999999999863
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=363.21 Aligned_cols=250 Identities=19% Similarity=0.275 Sum_probs=197.0
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCC--hhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKC--PALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIY 589 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~--~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~ 589 (834)
+.|...+.||+|+||.||+|... +++.||||++..... ....+.+.+|+.+|++++|||||++++++.+.+..++||
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 105 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG 105 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 45777788999999999999975 688999999864432 234577999999999999999999999999999999999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceee---cCCCCceEeeeeec
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITL---DPDMNPRLGSFALA 666 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILl---d~~~~~ki~DfGla 666 (834)
||+.+|+|.+++.... .+++..+..|+.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||++
T Consensus 106 e~~~~~~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 176 (484)
T 3nyv_A 106 EVYTGGELFDEIISRK------RFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLS 176 (484)
T ss_dssp CCCCSCBHHHHHHTCS------CCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred ecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence 9999999999886542 38899999999999999999997 689999999999999 56789999999999
Q ss_pred cccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhc
Q 003278 667 EFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARK 746 (834)
Q Consensus 667 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~ 746 (834)
+...... ......||+.|+|||++.+ .++.++|||||||++|||+||..||....... ....+. ...
T Consensus 177 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~---~~~ 243 (484)
T 3nyv_A 177 THFEASK--------KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD-ILKKVE---KGK 243 (484)
T ss_dssp HHBCCCC--------SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHH---HCC
T ss_pred EEccccc--------ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHH---cCC
Confidence 7654321 1234579999999999865 79999999999999999999999997543322 222221 111
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 747 RPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 747 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
.... . +.. ... .++ +..++.+||+.||++|||+.++++
T Consensus 244 ~~~~-~--~~~-~~~-s~~---~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 244 YTFE-L--PQW-KKV-SES---AKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp CCCC-S--GGG-GGS-CHH---HHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCC-C--ccc-ccC-CHH---HHHHHHHHCCCChhHCcCHHHHhh
Confidence 1100 0 000 011 123 445566899999999999999985
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=332.05 Aligned_cols=251 Identities=22% Similarity=0.354 Sum_probs=199.3
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYD 188 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 188 (834)
++|+..+.||+|+||.||+|....+++.||||++... .....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence 5689999999999999999999889999999998643 23346779999999999999999999999999999999999
Q ss_pred ccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCC---CceEEeeccch
Q 003278 189 YMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQ---YNARLGDFGLA 265 (834)
Q Consensus 189 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~---~~~kl~DFGla 265 (834)
|+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++
T Consensus 102 ~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 102 LYTGGELFDEIIKR-------KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp CCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred ccCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 99999999888643 3589999999999999999999996 99999999999999754 46999999998
Q ss_pred hhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccch
Q 003278 266 RWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQII 345 (834)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~ 345 (834)
+..... .......||+.|+|||.+.. .++.++|||||||++|||+||+.||.... ..
T Consensus 172 ~~~~~~-----------------~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~- 228 (287)
T 2wei_A 172 TCFQQN-----------------TKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKN---EY- 228 (287)
T ss_dssp GTBCCC-----------------SSCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HH-
T ss_pred eeecCC-----------------CccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCC---HH-
Confidence 754221 01223458999999998753 47899999999999999999999986432 11
Q ss_pred HHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 346 LLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 346 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
.....+. .+...... +.. ... ...+.+++..||+.||.+||++.++++.
T Consensus 229 --~~~~~~~-~~~~~~~~-~~~--~~~----~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 229 --DILKRVE-TGKYAFDL-PQW--RTI----SDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp --HHHHHHH-HCCCCCCS-GGG--TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred --HHHHHHH-cCCCCCCc-hhh--hhc----CHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 1112211 12111100 000 111 1457889999999999999999999873
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=341.80 Aligned_cols=272 Identities=22% Similarity=0.199 Sum_probs=184.5
Q ss_pred HHHHHhhCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCe-
Q 003278 507 EIISATNNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGE- 584 (834)
Q Consensus 507 el~~at~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~- 584 (834)
+.....++|...+.||+|+||.||+|.. .++..||||++..... ...++.+|++.++.++|||||++++++...+.
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR--FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT--CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc--ccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 3455668899999999999999999997 4588999998854322 22456788999999999999999999876443
Q ss_pred ------EEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecC-CCC
Q 003278 585 ------MLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDP-DMN 657 (834)
Q Consensus 585 ------~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~-~~~ 657 (834)
.++||||++++.+..+..... ....+++.....++.|++.||.|||.. ..+|+||||||+|||++. ++.
T Consensus 95 ~~~~~~~~lv~e~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPDTLHRCCRNYYR---RQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CTTCEEEEEEEECCSCBHHHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTTE
T ss_pred cccceeEEEEeecccccHHHHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCCc
Confidence 789999999764433221111 123478888889999999999999932 269999999999999996 899
Q ss_pred ceEeeeeeccccccCCCCCcccccCccccccccCccchhccccCC-CCccCcchhhHHHHHHHHhCCCccCCCCCchhHH
Q 003278 658 PRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGE-ATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLV 736 (834)
Q Consensus 658 ~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~ 736 (834)
+||+|||+++...... ......||+.|+|||++.+.. ++.++|||||||++|||+||+.||........+.
T Consensus 171 ~kl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~ 242 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSE--------PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH 242 (360)
T ss_dssp EEECCCTTCBCCCTTS--------CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred EEEeeCCCceecCCCC--------CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHH
Confidence 9999999998654321 123457899999999986554 8999999999999999999999997644333222
Q ss_pred HHHHHHHhh-------cCccccccccccC---------CCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 737 KRVHEFEAR-------KRPLAELVDLSLN---------GEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 737 ~~~~~~~~~-------~~~~~~~~d~~l~---------~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
......... ..+.....+.... ..........+..++.+||+.||++|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 243 EIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 221111000 0000000000000 0000112234666777999999999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=360.28 Aligned_cols=250 Identities=20% Similarity=0.269 Sum_probs=194.4
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCC-ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEe
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSK-CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYD 590 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~E 590 (834)
+.|...+.||+|+||+||+|... +++.||||++.... .......+.+|+.+|++++|||||++++++.+.+..++|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 46777889999999999999974 68899999985321 11234678999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeec---CCCCceEeeeeecc
Q 003278 591 YSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLD---PDMNPRLGSFALAE 667 (834)
Q Consensus 591 y~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld---~~~~~ki~DfGla~ 667 (834)
|+.+|+|.+++.... .+++..+..|+.|++.||+|||+ .+|+||||||+|||++ .++.+||+|||+++
T Consensus 102 ~~~~~~L~~~~~~~~------~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 102 LYTGGELFDEIIKRK------RFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp CCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred cCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 999999998886542 37889999999999999999997 6899999999999995 45679999999997
Q ss_pred ccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcC
Q 003278 668 FLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKR 747 (834)
Q Consensus 668 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
...... ......||+.|+|||++.+ .++.++|||||||++|||+||..||....... ....+.. ...
T Consensus 173 ~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~---~~~ 239 (486)
T 3mwu_A 173 CFQQNT--------KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-ILKRVET---GKY 239 (486)
T ss_dssp TBCCC------------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHH---TCC
T ss_pred ECCCCC--------ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHh---CCC
Confidence 653321 1234579999999999875 69999999999999999999999997543322 2222211 111
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 748 PLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 748 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
... . +.. ... ..+ +..++.+||+.||++|||+.++++
T Consensus 240 ~~~-~--~~~-~~~-s~~---~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 240 AFD-L--PQW-RTI-SDD---AKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp CSC-S--GGG-GGS-CHH---HHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCC-C--ccc-CCC-CHH---HHHHHHHHcCCChhhCcCHHHHhc
Confidence 110 0 000 011 123 445666899999999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=349.26 Aligned_cols=261 Identities=18% Similarity=0.195 Sum_probs=189.7
Q ss_pred HHHhhCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeC-----
Q 003278 509 ISATNNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQ----- 582 (834)
Q Consensus 509 ~~at~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~----- 582 (834)
....++|...+.||+|+||.||+|.. .++..||||++..... .+.+|+++|++++|||||++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-----hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 34567788889999999999999986 5689999999865432 234699999999999999999998543
Q ss_pred ---------------------------------CeEEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHH
Q 003278 583 ---------------------------------GEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAI 629 (834)
Q Consensus 583 ---------------------------------~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl 629 (834)
...++||||++ |+|.+.+...... ...+++..+..++.|+++||
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~--~~~l~~~~~~~i~~qi~~aL 154 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRS--GRSIPMNLISIYIYQLFRAV 154 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhc--CCCCCHHHHHHHHHHHHHHH
Confidence 34889999999 4777666532111 12488999999999999999
Q ss_pred HHhhhccCCceeecccccCceeec-CCCCceEeeeeeccccccCCCCCcccccCccccccccCccchhccccC-CCCccC
Q 003278 630 LYLHEEWNEQVIHRNITSSAITLD-PDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESG-EATSMA 707 (834)
Q Consensus 630 ~yLH~~~~~~iiHrDlK~~NILld-~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~k~ 707 (834)
+|||+ .+|+||||||+|||++ .++.+||+|||+++.+.... ......||+.|+|||.+.+. .++.++
T Consensus 155 ~~LH~---~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~ 223 (383)
T 3eb0_A 155 GFIHS---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--------PSVAYICSRFYRAPELMLGATEYTPSI 223 (383)
T ss_dssp HHHHT---TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--------CCCCCCCCSSCCCHHHHTTCSSCCTHH
T ss_pred HHHHH---CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--------CCcCcccCCCccCHHHhcCCCCCCcch
Confidence 99996 6999999999999998 68899999999998653321 12345789999999998765 489999
Q ss_pred cchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHH--------hhcCccccccccc---------cCCCCCHHHHHHHH
Q 003278 708 DVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFE--------ARKRPLAELVDLS---------LNGEYNHKELMRLI 770 (834)
Q Consensus 708 DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~d~~---------l~~~~~~~~~~~l~ 770 (834)
|||||||++|||+||+.||........+...+.... .......+..-+. +.... +. .+.
T Consensus 224 DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~---~~~ 299 (383)
T 3eb0_A 224 DLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGT-PS---LAI 299 (383)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTC-CH---HHH
T ss_pred hhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCC-CH---HHH
Confidence 999999999999999999976544333222221100 0000000000000 11111 12 355
Q ss_pred HHHHHhccCCCCCCCChhHHHH
Q 003278 771 KLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 771 ~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
.++.+||+.||++|||+.|+++
T Consensus 300 ~li~~~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 300 DLLEQILRYEPDLRINPYEAMA 321 (383)
T ss_dssp HHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHHccCChhhCCCHHHHhc
Confidence 6666999999999999999984
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=348.62 Aligned_cols=260 Identities=16% Similarity=0.223 Sum_probs=194.3
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhcc--------CCCceeEEEEEe---
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLR--------HRNLVQLCGWCT--- 580 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~--------HpNiv~l~g~~~--- 580 (834)
++|...+.||+|+||+||+|.. .+++.||||++... ....+.+.+|+.+|++++ |||||++++++.
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 5677788999999999999985 55789999998643 344577899999999996 788999999987
Q ss_pred -eCCeEEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCC-ceeecccccCceeecCCC--
Q 003278 581 -EQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNE-QVIHRNITSSAITLDPDM-- 656 (834)
Q Consensus 581 -~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~-~iiHrDlK~~NILld~~~-- 656 (834)
+....++||||+.++++ +++..... ..+++..+..|+.|++.||+|||+ . +|+||||||+||||+.++
T Consensus 115 ~~~~~~~lv~e~~~~~l~-~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~~ 186 (397)
T 1wak_A 115 VNGTHICMVFEVLGHHLL-KWIIKSNY----QGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQY 186 (397)
T ss_dssp TTEEEEEEEECCCCCBHH-HHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHHH
T ss_pred CCCceEEEEEeccCccHH-HHHHhccc----CCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccchh
Confidence 45678999999955544 44443321 248899999999999999999997 5 899999999999999775
Q ss_pred -----------------------------------------------CceEeeeeeccccccCCCCCcccccCccccccc
Q 003278 657 -----------------------------------------------NPRLGSFALAEFLTRNDHGHRKATSGNRSVRGI 689 (834)
Q Consensus 657 -----------------------------------------------~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt 689 (834)
.+||+|||++...... .....||
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----------~~~~~gt 256 (397)
T 1wak_A 187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----------FTEDIQT 256 (397)
T ss_dssp HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----------SCSCCSC
T ss_pred hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----------CccCCCC
Confidence 8999999999765321 2235799
Q ss_pred cCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchh-----HHHHHHHHHhh--------cCcccccccc-
Q 003278 690 FGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGL-----LVKRVHEFEAR--------KRPLAELVDL- 755 (834)
Q Consensus 690 ~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~-----~~~~~~~~~~~--------~~~~~~~~d~- 755 (834)
+.|||||++.+..++.++|||||||+||||+||+.||........ ........... .....+....
T Consensus 257 ~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 336 (397)
T 1wak_A 257 RQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKK 336 (397)
T ss_dssp GGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTT
T ss_pred CcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCc
Confidence 999999999999999999999999999999999999965432211 11111111000 0000000000
Q ss_pred ---------c---------cCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 756 ---------S---------LNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 756 ---------~---------l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
. -...........+..++.+||+.||++|||+.||++
T Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 337 GDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp SSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0 000123444556778888999999999999999985
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=333.52 Aligned_cols=251 Identities=20% Similarity=0.274 Sum_probs=197.0
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCC--------hhHHHHHHHHHHHHHhcc-CCCceeEEEEEeeC
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKC--------PALRTRFSNELQNLARLR-HRNLVQLCGWCTEQ 582 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~f~~E~~~l~~l~-HpNiv~l~g~~~~~ 582 (834)
++|...+.||+|+||.||+|... +++.||||.+..... ...++.+.+|+.++.+++ ||||+++++++.+.
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (298)
T 1phk_A 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 96 (298)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred hccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccC
Confidence 56777889999999999999974 578999999875431 123567889999999996 99999999999999
Q ss_pred CeEEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEee
Q 003278 583 GEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGS 662 (834)
Q Consensus 583 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~D 662 (834)
+..++||||+++++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|
T Consensus 97 ~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 97 TFFFLVFDLMKKGELFDYLTEKV------TLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECC
T ss_pred CeEEEEEeccCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEec
Confidence 99999999999999999987532 47889999999999999999997 6899999999999999999999999
Q ss_pred eeeccccccCCCCCcccccCccccccccCccchhccc------cCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHH
Q 003278 663 FALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIE------SGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLV 736 (834)
Q Consensus 663 fGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~------~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~ 736 (834)
||++....... ......||+.|+|||++. ...++.++|||||||++|||+||+.|+....... ..
T Consensus 168 fg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~ 238 (298)
T 1phk_A 168 FGFSCQLDPGE--------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-ML 238 (298)
T ss_dssp CTTCEECCTTC--------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HH
T ss_pred ccchhhcCCCc--------ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH-HH
Confidence 99997654321 123457999999999985 4568899999999999999999999986433221 11
Q ss_pred HHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 737 KRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 737 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
..+. ...... ..+.. ..+ +. .+.+++.+||+.||++|||+.++++
T Consensus 239 ~~~~---~~~~~~---~~~~~-~~~-~~---~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 239 RMIM---SGNYQF---GSPEW-DDY-SD---TVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHH---HTCCCC---CTTTG-GGS-CH---HHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHh---cCCccc---Ccccc-ccc-CH---HHHHHHHHHccCCcccCCCHHHHHh
Confidence 1111 111110 00000 011 12 3556666999999999999999975
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=350.73 Aligned_cols=199 Identities=16% Similarity=0.200 Sum_probs=168.9
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCChhHHHHHHHHHHHHHhc------cCCCceeEEEEEeeCCeE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKCPALRTRFSNELQNLARL------RHRNLVQLCGWCTEQGEM 585 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l------~HpNiv~l~g~~~~~~~~ 585 (834)
..|...+.||+|+||.||+|... +++.||||++... ....+.+.+|+.++..+ +||||+++++++...+..
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE--KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc--cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 35667788999999999999864 5889999998643 33456788899999888 567999999999999999
Q ss_pred EEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCC--ceEeee
Q 003278 586 LVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMN--PRLGSF 663 (834)
Q Consensus 586 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~--~ki~Df 663 (834)
++||||+. ++|.+++..... ..+++..+..|+.|++.||+|||+ .+||||||||+||||+.++. +||+||
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DF 246 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKF----QGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDF 246 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred EEEEeccC-CCHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeec
Confidence 99999997 588888865432 238899999999999999999997 58999999999999999887 999999
Q ss_pred eeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCC
Q 003278 664 ALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLP 731 (834)
Q Consensus 664 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~ 731 (834)
|++...... ..+..||+.|||||++.+..++.++|||||||+||||+||..||.....
T Consensus 247 G~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~ 304 (429)
T 3kvw_A 247 GSSCYEHQR----------VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE 304 (429)
T ss_dssp TTCEETTCC----------CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccceecCCc----------ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 999653221 2245799999999999999999999999999999999999999875443
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=343.06 Aligned_cols=254 Identities=20% Similarity=0.255 Sum_probs=171.9
Q ss_pred cCCCCCC-CeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEe----CCEEE
Q 003278 110 SNGFDED-EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVH----EDQLL 184 (834)
Q Consensus 110 t~~f~~~-~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~ 184 (834)
.++|... ++||+|+||.||+|.+..+|+.||||++... ... ..+....+..++||||+++++++.. .+..+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~---~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-PKA---RQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-HHH---HHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-HHH---HHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 3578874 4699999999999999989999999998653 111 1222344667899999999999986 44589
Q ss_pred EEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECC---CCceEEee
Q 003278 185 LVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDS---QYNARLGD 261 (834)
Q Consensus 185 lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~---~~~~kl~D 261 (834)
+||||+++|+|.+++.... ...+++..+..|+.|++.||.|||+. +|+||||||+|||++. ++.+||+|
T Consensus 103 lv~e~~~gg~L~~~l~~~~-----~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~D 174 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERG-----DQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTD 174 (336)
T ss_dssp EEEECCTTEEHHHHHHTC------CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred EEEeccCCCCHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEec
Confidence 9999999999999997542 24689999999999999999999996 9999999999999976 45599999
Q ss_pred ccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCC
Q 003278 262 FGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPD 341 (834)
Q Consensus 262 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~ 341 (834)
||+++..... ......||+.|+|||.+... .++.++|||||||++|||+||+.||......
T Consensus 175 fg~~~~~~~~------------------~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 235 (336)
T 3fhr_A 175 FGFAKETTQN------------------ALQTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQ 235 (336)
T ss_dssp CTTCEEC----------------------------------------C-HHHHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred cccceecccc------------------ccccCCCCcCccChhhhCCC-CCCchhhHHHHHHHHHHHHHCCCCCCCccch
Confidence 9999754321 12344689999999988544 5788999999999999999999998643322
Q ss_pred ccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 342 DQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 342 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
... ....... ..+. ........ ......+.+++..||+.||.+||++.++++.
T Consensus 236 ~~~--~~~~~~~-~~~~------~~~~~~~~-~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 236 AIS--PGMKRRI-RLGQ------YGFPNPEW-SEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp ------------------------CCCTTTS-TTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hhh--hhHHHhh-hccc------cccCchhh-ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 110 0000000 0000 00000000 0112457889999999999999999999974
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=345.24 Aligned_cols=263 Identities=17% Similarity=0.189 Sum_probs=180.4
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhcc-CCCceeEEEEEe--------eC
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLR-HRNLVQLCGWCT--------EQ 582 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~-HpNiv~l~g~~~--------~~ 582 (834)
.+|...+.||+|+||.||+|.. .++..||||++... .....+.+.+|+.++.++. |||||++++++. ..
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN-EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES-SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC-chHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 3566678899999999999996 46889999988543 3344567899999999996 999999999983 34
Q ss_pred CeEEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEee
Q 003278 583 GEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGS 662 (834)
Q Consensus 583 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~D 662 (834)
...++||||+. |+|.+++..... ...+++..+..|+.|++.||+|||+. .++|+||||||+|||++.++.+||+|
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMES---RGPLSCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHT---TCSCCHHHHHHHHHHHHHHHHHHHTS-SSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred ceEEEEEEecC-CCHHHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEEccCCcccEEECCCCCEEEec
Confidence 56899999996 788888764221 12489999999999999999999973 12399999999999999999999999
Q ss_pred eeeccccccCCCCCcc-----cccCccccccccCccchhcc---ccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchh
Q 003278 663 FALAEFLTRNDHGHRK-----ATSGNRSVRGIFGYMSPEYI---ESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGL 734 (834)
Q Consensus 663 fGla~~~~~~~~~~~~-----~~~~~~~~~Gt~~Y~aPE~~---~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~ 734 (834)
||+++........... .........||+.|+|||++ .+..++.++|||||||++|||+||+.||........
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~ 261 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI 261 (337)
T ss_dssp CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh
Confidence 9999875432211000 00111245699999999998 567789999999999999999999999864221110
Q ss_pred HHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCc
Q 003278 735 LVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDK 799 (834)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~ 799 (834)
. ..... ...... .... +..++.+||+.||++|||+.++++.|+.+..
T Consensus 262 -----~---~~~~~------~~~~~~-~~~~---~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 262 -----V---NGKYS------IPPHDT-QYTV---FHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp ------------CC------CCTTCC-SSGG---GHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----h---cCccc------CCcccc-cchH---HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0 00000 000011 1122 4456668999999999999999999976654
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=373.16 Aligned_cols=262 Identities=24% Similarity=0.380 Sum_probs=203.4
Q ss_pred HHHHhhcCCCCCCCeeeccCCeEEEEEEECCC---CeEEEEEEeccc-ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEe
Q 003278 104 AELYIGSNGFDEDEVLGSGGFGKVYRAVLPSD---GTVVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNLVRLRGWCVH 179 (834)
Q Consensus 104 ~el~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~---g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~ 179 (834)
.+.....++|+..+.||+|+||.||+|.+..+ +..||||.+... .....+.|.+|+.++++++|||||+++|++.
T Consensus 383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 461 (656)
T 2j0j_A 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 461 (656)
T ss_dssp GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-
Confidence 34445567788889999999999999998543 568999998653 3445578999999999999999999999985
Q ss_pred CCEEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEE
Q 003278 180 EDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARL 259 (834)
Q Consensus 180 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl 259 (834)
.+..++||||+++|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||
T Consensus 462 ~~~~~lv~E~~~~g~L~~~l~~~------~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL 532 (656)
T 2j0j_A 462 ENPVWIIMELCTLGELRSFLQVR------KFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKL 532 (656)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHT------TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEE
T ss_pred cCceEEEEEcCCCCcHHHHHHhc------cCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEE
Confidence 45689999999999999999653 24589999999999999999999996 9999999999999999999999
Q ss_pred eeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCC
Q 003278 260 GDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLT 338 (834)
Q Consensus 260 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~ 338 (834)
+|||+++.+..... ...+...||+.|+|||.+... .++.++|||||||++|||+| |+.||...
T Consensus 533 ~DFG~a~~~~~~~~---------------~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 596 (656)
T 2j0j_A 533 GDFGLSRYMEDSTY---------------YKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGV 596 (656)
T ss_dssp CCCCCCCSCCC-------------------------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred EecCCCeecCCCcc---------------eeccCCCCCcceeCHHHhcCC-CCCchhhHHHHHHHHHHHHHcCCCCCCCC
Confidence 99999986532211 012334578999999998655 67999999999999999997 99898643
Q ss_pred CCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 339 YPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 339 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
.. ..+.. .+.. +.... +. ... ...+.+++..||+.||.+||++.+|++.|...
T Consensus 597 ~~---~~~~~---~i~~-~~~~~-----~~-~~~----~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 597 KN---NDVIG---RIEN-GERLP-----MP-PNC----PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp CH---HHHHH---HHHH-TCCCC-----CC-TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CH---HHHHH---HHHc-CCCCC-----CC-ccc----cHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 21 11111 1111 11111 11 111 24678899999999999999999999998754
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=336.32 Aligned_cols=255 Identities=23% Similarity=0.383 Sum_probs=181.1
Q ss_pred hcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccCh-h-hHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEE
Q 003278 109 GSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGE-R-FEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLV 186 (834)
Q Consensus 109 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~-~-~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 186 (834)
..++|+..+.||+|+||.||+|.+..+|+.||||++..... . ..+.+.++..++..++||||+++++++...+..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 34678888999999999999999988999999999865422 2 233444555678889999999999999999999999
Q ss_pred EEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchh
Q 003278 187 YDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLAR 266 (834)
Q Consensus 187 ~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~ 266 (834)
|||+ ++.+..++... ...+++..+..++.|+++||.|||+. .+|+||||||+|||++.++.+||+|||+++
T Consensus 103 ~e~~-~~~~~~l~~~~------~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 173 (318)
T 2dyl_A 103 MELM-GTCAEKLKKRM------QGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISG 173 (318)
T ss_dssp ECCC-SEEHHHHHHHH------TSCCCHHHHHHHHHHHHHHHHHHHHH--HCCCCCCCCGGGEEECTTSCEEECCCTTC-
T ss_pred Eecc-CCcHHHHHHHh------ccCCCHHHHHHHHHHHHHHHHHHHhh--CCEEeCCCCHHHEEECCCCCEEEEECCCch
Confidence 9999 45555554321 24689999999999999999999983 289999999999999999999999999997
Q ss_pred hhhhhhhhhhhcccccccccccccceeeeccccCCCccccc----cCCCCCcccceeehhhHHHHHHhCCccCCCCCCCc
Q 003278 267 WLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQ----KGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDD 342 (834)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~----~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~ 342 (834)
.+.... ......||+.|+|||.+. .+..++.++|||||||++|||+||+.||......
T Consensus 174 ~~~~~~-----------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~- 235 (318)
T 2dyl_A 174 RLVDDK-----------------AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD- 235 (318)
T ss_dssp ------------------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-
T ss_pred hccCCc-----------------cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-
Confidence 543221 123346999999999985 2345788999999999999999999998642211
Q ss_pred cchHHHHHHHHhhcCccccccccccCC-CCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 343 QIILLDWIRRLSDEGKVLQAGDNRLSD-GSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 343 ~~~l~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
. ........... +.+.. ...+ ..+.+++..||+.||.+||++.++++.
T Consensus 236 -~---~~~~~~~~~~~------~~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 236 -F---EVLTKVLQEEP------PLLPGHMGFS----GDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp -H---HHHHHHHHSCC------CCCCSSSCCC----HHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred -H---HHHHHHhccCC------CCCCccCCCC----HHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1 11122221111 11100 0111 357889999999999999999999863
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=344.54 Aligned_cols=197 Identities=18% Similarity=0.220 Sum_probs=160.3
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCC-ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCC------e
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSK-CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQG------E 584 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~-~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~------~ 584 (834)
++|...+.||+|+||.||+|.. .++..||||++.... .....+.+.+|+.++++++|||||++++++...+ .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 5677788999999999999986 458889999987543 3445577899999999999999999999997654 7
Q ss_pred EEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeee
Q 003278 585 MLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFA 664 (834)
Q Consensus 585 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfG 664 (834)
.++||||+.+ +|.+++.. .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 105 ~~lv~e~~~~-~l~~~~~~--------~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 172 (371)
T 2xrw_A 105 VYIVMELMDA-NLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG 172 (371)
T ss_dssp EEEEEECCSE-EHHHHHHS--------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred eEEEEEcCCC-CHHHHHhh--------ccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEee
Confidence 8999999985 67666642 27888889999999999999997 699999999999999999999999999
Q ss_pred eccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCC
Q 003278 665 LAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFR 729 (834)
Q Consensus 665 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~ 729 (834)
+++..... .......||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 173 ~a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 229 (371)
T 2xrw_A 173 LARTAGTS--------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 229 (371)
T ss_dssp C------------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccccccc--------cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 99764321 1123457999999999999999999999999999999999999998654
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=343.28 Aligned_cols=252 Identities=16% Similarity=0.248 Sum_probs=191.0
Q ss_pred hhCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCC-------hhHHHHHHHHHHHHHhccCCCceeEEEEEeeCC
Q 003278 512 TNNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKC-------PALRTRFSNELQNLARLRHRNLVQLCGWCTEQG 583 (834)
Q Consensus 512 t~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~ 583 (834)
.++|...+.||+|+||.||+|... ++..||||.+..... ......|.+|+.+|++++||||+++++++....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 356788889999999999999864 578999999864321 122345889999999999999999999987655
Q ss_pred eEEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCC---ceE
Q 003278 584 EMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMN---PRL 660 (834)
Q Consensus 584 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~---~ki 660 (834)
.++||||+++|+|.+++.... .+++.....++.|++.||+|||+ .+|+||||||+|||++.++. +||
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl 158 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGNK------RLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKI 158 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTTC------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEE
T ss_pred -eEEEEecCCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEE
Confidence 899999999999999886432 47888999999999999999997 69999999999999987654 999
Q ss_pred eeeeeccccccCCCCCcccccCccccccccCccchhccc---cCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHH
Q 003278 661 GSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIE---SGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVK 737 (834)
Q Consensus 661 ~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~---~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~ 737 (834)
+|||+++...... ......||+.|+|||++. ...++.++|||||||++|||+||..||........+..
T Consensus 159 ~Dfg~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 230 (322)
T 2ycf_A 159 TDFGHSKILGETS--------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD 230 (322)
T ss_dssp CCCTTCEECCCCH--------HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHH
T ss_pred ccCccceeccccc--------ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHH
Confidence 9999997653211 112457999999999974 56789999999999999999999999875443322222
Q ss_pred HHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 738 RVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 738 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
.+.. ...... +......+ ..+.+++.+||+.||++|||+.++++
T Consensus 231 ~~~~---~~~~~~----~~~~~~~~----~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 231 QITS---GKYNFI----PEVWAEVS----EKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHHH---TCCCCC----HHHHTTSC----HHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHh---CccccC----chhhhhcC----HHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 2211 111100 00001111 24556667999999999999999985
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=345.72 Aligned_cols=246 Identities=24% Similarity=0.385 Sum_probs=198.6
Q ss_pred HhhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccCh------hhHHHHHHHHHHHHhCC--CCceeeEeeeEE
Q 003278 107 YIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGE------RFEKTFAAELVAVAHLR--HRNLVRLRGWCV 178 (834)
Q Consensus 107 ~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~------~~~~~~~~E~~~l~~l~--H~nIv~l~g~~~ 178 (834)
....++|...+.||+|+||.||+|....+|+.||||++..... ...+.+.+|+.++.+++ ||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 3445679999999999999999999989999999999865321 12245678999999996 599999999999
Q ss_pred eCCEEEEEEEccCC-CCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEEC-CCCc
Q 003278 179 HEDQLLLVYDYMPN-RSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLD-SQYN 256 (834)
Q Consensus 179 ~~~~~~lV~Ey~~~-gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld-~~~~ 256 (834)
..+..++||||+.+ ++|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+|||++ +++.
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~ 188 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITER-------GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGE 188 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTE
T ss_pred cCCcEEEEEEcCCCCccHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCC
Confidence 99999999999976 8999998642 3589999999999999999999996 999999999999999 7889
Q ss_pred eEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCC
Q 003278 257 ARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVD 336 (834)
Q Consensus 257 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~ 336 (834)
+||+|||+++.+... ......||+.|+|||.+......+.++|||||||++|||+||+.||.
T Consensus 189 ~kL~Dfg~~~~~~~~------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 250 (320)
T 3a99_A 189 LKLIDFGSGALLKDT------------------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 250 (320)
T ss_dssp EEECCCTTCEECCSS------------------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred EEEeeCccccccccc------------------cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCC
Confidence 999999999754221 12345699999999998766555788999999999999999999985
Q ss_pred CCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 337 LTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 337 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
.. . .... +... .. ...+ ..+.+++..||+.||.+||++.++++.
T Consensus 251 ~~----~--------~~~~-~~~~--~~-----~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 251 HD----E--------EIIR-GQVF--FR-----QRVS----SECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp SH----H--------HHHH-CCCC--CS-----SCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred Ch----h--------hhhc-cccc--cc-----ccCC----HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 31 0 0011 1110 11 1111 457889999999999999999999873
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=350.17 Aligned_cols=204 Identities=19% Similarity=0.256 Sum_probs=164.5
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCC-ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeC-----CeE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSK-CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQ-----GEM 585 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~-~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~-----~~~ 585 (834)
++|...+.||+|+||.||+|.. .++..||||++.... .....+++.+|+.+|++++|||||++++++... ...
T Consensus 26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 105 (432)
T 3n9x_A 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL 105 (432)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence 5677788999999999999986 457889999987542 334457899999999999999999999999776 579
Q ss_pred EEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeee
Q 003278 586 LVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFAL 665 (834)
Q Consensus 586 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGl 665 (834)
++||||+. |+|.+++.... .+++..+..++.|++.||.|||+ .+|+||||||+||||+.++.+||+|||+
T Consensus 106 ~lv~e~~~-~~L~~~~~~~~------~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGl 175 (432)
T 3n9x_A 106 YIVLEIAD-SDLKKLFKTPI------FLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGL 175 (432)
T ss_dssp EEEEECCS-EEHHHHHHSSC------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEecCC-cCHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCC
Confidence 99999987 59998886432 48899999999999999999997 6899999999999999999999999999
Q ss_pred ccccccCCCCCcc---------------cccCccccccccCccchhcc-ccCCCCccCcchhhHHHHHHHHhCCCcc
Q 003278 666 AEFLTRNDHGHRK---------------ATSGNRSVRGIFGYMSPEYI-ESGEATSMADVYSFGVVVLEVVTGQMAV 726 (834)
Q Consensus 666 a~~~~~~~~~~~~---------------~~~~~~~~~Gt~~Y~aPE~~-~~~~~~~k~DV~SfGvvl~E~~tG~~p~ 726 (834)
++........... ........+||+.|+|||++ ....++.++|||||||++|||+||..|+
T Consensus 176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp CEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 9875432211000 00112457899999999986 5566999999999999999999876554
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=341.11 Aligned_cols=260 Identities=20% Similarity=0.289 Sum_probs=197.0
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCC-eEEEEEEecccChhhHHHHHHHHHHHHhCCCCc------eeeEeeeEEeCCEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDG-TVVAVKCLAEKGERFEKTFAAELVAVAHLRHRN------LVRLRGWCVHEDQL 183 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g-~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~n------Iv~l~g~~~~~~~~ 183 (834)
++|+..+.||+|+||.||+|....++ ..||||++... ....+.+.+|+.++++++|+| ++.+++++...+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 67999999999999999999997766 79999998643 345677889999999998776 99999999999999
Q ss_pred EEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEE------------
Q 003278 184 LLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVML------------ 251 (834)
Q Consensus 184 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILl------------ 251 (834)
++||||+ +|+|.+++.... ..++++..+..|+.|++.||.|||+. +|+||||||+|||+
T Consensus 98 ~lv~e~~-~~~l~~~l~~~~-----~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKENN-----FQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp EEEEECC-CCBHHHHHHHTT-----TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC
T ss_pred EEEEecc-CCChHHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccc
Confidence 9999999 667767765432 24689999999999999999999985 99999999999999
Q ss_pred -------CCCCceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhH
Q 003278 252 -------DSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIV 324 (834)
Q Consensus 252 -------d~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvv 324 (834)
+.++.+||+|||+++.... ..+...||+.|+|||.+... .++.++|||||||+
T Consensus 169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~-------------------~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~i 228 (355)
T 2eu9_A 169 KSCEEKSVKNTSIRVADFGSATFDHE-------------------HHTTIVATRHYRPPEVILEL-GWAQPCDVWSIGCI 228 (355)
T ss_dssp -CCCEEEESCCCEEECCCTTCEETTS-------------------CCCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHH
T ss_pred ccccccccCCCcEEEeecCccccccc-------------------cccCCcCCCcccCCeeeecC-CCCCccchHHHHHH
Confidence 5678899999999974321 12345699999999998654 67999999999999
Q ss_pred HHHHHhCCccCCCCCCCccchHHHHHHHHhhc--------Cccccc---------------------cccccCCCCCCHH
Q 003278 325 VLEVVSGRRAVDLTYPDDQIILLDWIRRLSDE--------GKVLQA---------------------GDNRLSDGSYKLC 375 (834)
Q Consensus 325 l~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~--------~~~~~~---------------------~d~~l~~~~~~~~ 375 (834)
+|||+||+.||......+ ....+...... ...... ..+..........
T Consensus 229 l~el~~g~~pf~~~~~~~---~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (355)
T 2eu9_A 229 LFEYYRGFTLFQTHENRE---HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSL 305 (355)
T ss_dssp HHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSH
T ss_pred HHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccch
Confidence 999999999997432211 11111111100 000000 0000000001112
Q ss_pred HHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 376 DMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 376 ~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
....+.+|+..||+.||.+||++.++++
T Consensus 306 ~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 306 EHVQLFDLMRRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp HHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hHHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 2346889999999999999999999975
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=345.83 Aligned_cols=245 Identities=24% Similarity=0.406 Sum_probs=190.5
Q ss_pred hhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccCh------hhHHHHHHHHHHHHhC----CCCceeeEeeeE
Q 003278 108 IGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGE------RFEKTFAAELVAVAHL----RHRNLVRLRGWC 177 (834)
Q Consensus 108 ~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~------~~~~~~~~E~~~l~~l----~H~nIv~l~g~~ 177 (834)
.-.++|...+.||+|+||.||+|....+|+.||||++..... .....+.+|+.++.++ +||||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 345789999999999999999999988999999999865422 1223466799999988 899999999999
Q ss_pred EeCCEEEEEEEc-cCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEEC-CCC
Q 003278 178 VHEDQLLLVYDY-MPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLD-SQY 255 (834)
Q Consensus 178 ~~~~~~~lV~Ey-~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld-~~~ 255 (834)
...+..++|||| +.+++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++ .++
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~ 177 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITEK-------GPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRG 177 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTT
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCC
Confidence 999999999999 7999999998653 3589999999999999999999996 999999999999999 889
Q ss_pred ceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccC
Q 003278 256 NARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAV 335 (834)
Q Consensus 256 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~ 335 (834)
.+||+|||+++..... ......||+.|+|||.+......+.++|||||||++|||+||+.||
T Consensus 178 ~~kl~dfg~~~~~~~~------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf 239 (312)
T 2iwi_A 178 CAKLIDFGSGALLHDE------------------PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPF 239 (312)
T ss_dssp EEEECCCSSCEECCSS------------------CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSC
T ss_pred eEEEEEcchhhhcccC------------------cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCC
Confidence 9999999999754221 1234569999999999876655456899999999999999999998
Q ss_pred CCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 336 DLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 336 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
... . . ... ... .+. ... ...+.+++..||+.||.+||++.++++.
T Consensus 240 ~~~----~-~-------~~~-~~~------~~~-~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 240 ERD----Q-E-------ILE-AEL------HFP-AHV----SPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp CSH----H-H-------HHH-TCC------CCC-TTS----CHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred CCh----H-H-------Hhh-hcc------CCc-ccC----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 531 0 0 011 100 010 111 1357889999999999999999999974
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=343.77 Aligned_cols=256 Identities=20% Similarity=0.251 Sum_probs=178.1
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCC-ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeC------Ce
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSK-CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQ------GE 584 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~-~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~------~~ 584 (834)
+.|...+.||+|+||.||+|.. .+++.||||++.... .....+++.+|+.+|++++|||||++++++... ..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 5677788999999999999985 568899999986543 334557889999999999999999999998654 56
Q ss_pred EEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeee
Q 003278 585 MLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFA 664 (834)
Q Consensus 585 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfG 664 (834)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 109 ~~lv~e~~-~~~L~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG 177 (367)
T 2fst_X 109 VYLVTHLM-GADLNNIVKC-------QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFG 177 (367)
T ss_dssp CEEEEECC-CEECC------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC--
T ss_pred EEEEeccc-CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeecc
Confidence 79999999 6899888753 138899999999999999999997 699999999999999999999999999
Q ss_pred eccccccCCCCCcccccCccccccccCccchhcccc-CCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHH
Q 003278 665 LAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIES-GEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFE 743 (834)
Q Consensus 665 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~ 743 (834)
+++..... .....||+.|+|||++.+ ..++.++|||||||++|||+||+.||........+ ..+....
T Consensus 178 ~a~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l-~~i~~~~ 246 (367)
T 2fst_X 178 LARHTADE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL-KLILRLV 246 (367)
T ss_dssp -----------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHHH
T ss_pred cccccccc----------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHh
Confidence 99764321 234579999999999876 67899999999999999999999998654332221 1111111
Q ss_pred hhcCcccccccc-----------ccC--CCCCHHH-----HHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 744 ARKRPLAELVDL-----------SLN--GEYNHKE-----LMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 744 ~~~~~~~~~~d~-----------~l~--~~~~~~~-----~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
. .+..+.... .+. ....... -..+..++.+||..||++|||+.++++
T Consensus 247 g--~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 247 G--TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp C--SCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred C--CCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 0 000000000 000 0000000 123456666999999999999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=335.13 Aligned_cols=257 Identities=18% Similarity=0.324 Sum_probs=186.4
Q ss_pred hhCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEee---------
Q 003278 512 TNNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTE--------- 581 (834)
Q Consensus 512 t~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~--------- 581 (834)
.++|...+.||+|+||.||+|.. .++..||||.+.. .....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH--TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE--EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec--cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 45788888999999999999996 4688999999853 23445779999999999999999999998865
Q ss_pred ----CCeEEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCC
Q 003278 582 ----QGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMN 657 (834)
Q Consensus 582 ----~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~ 657 (834)
.+..++||||+++|+|.+++.... ..+++.....++.|++.||+|||+ .+|+||||||+|||++.++.
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~ 154 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSEN-----LNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRN 154 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSC-----GGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccc-----cccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCC
Confidence 356899999999999999997543 246788889999999999999997 68999999999999999999
Q ss_pred ceEeeeeeccccccCCCCCc-------ccccCccccccccCccchhccccC-CCCccCcchhhHHHHHHHHhCCCccCCC
Q 003278 658 PRLGSFALAEFLTRNDHGHR-------KATSGNRSVRGIFGYMSPEYIESG-EATSMADVYSFGVVVLEVVTGQMAVDFR 729 (834)
Q Consensus 658 ~ki~DfGla~~~~~~~~~~~-------~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~k~DV~SfGvvl~E~~tG~~p~~~~ 729 (834)
+||+|||++........... ..........||+.|+|||++.+. .++.++|||||||++|||+| |+...
T Consensus 155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~ 231 (303)
T 1zy4_A 155 VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG 231 (303)
T ss_dssp EEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred EEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc
Confidence 99999999976542210000 001112345799999999999754 78999999999999999998 43321
Q ss_pred CCchhHHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 730 LPEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
....... ......... ............+.+++.+||+.||++|||+.++++
T Consensus 232 ~~~~~~~---~~~~~~~~~--------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 232 MERVNIL---KKLRSVSIE--------FPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHHHHH---HHHHSTTCC--------CCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhHHHHH---Hhccccccc--------cCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 1111111 111111011 111111111223455666999999999999999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=345.57 Aligned_cols=258 Identities=18% Similarity=0.309 Sum_probs=197.9
Q ss_pred hCcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCCCh----------------hHHHHHHHHHHHHHhccCCCceeEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCP----------------ALRTRFSNELQNLARLRHRNLVQLC 576 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~----------------~~~~~f~~E~~~l~~l~HpNiv~l~ 576 (834)
++|...+.||+|+||.||+|.. ++..||||.+...... ...+.|.+|+.++++++||||++++
T Consensus 31 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 109 (348)
T 2pml_X 31 NDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109 (348)
T ss_dssp TTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred CceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 5677788999999999999999 8899999998632111 1126799999999999999999999
Q ss_pred EEEeeCCeEEEEEeccCCCchhhh------hhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCce
Q 003278 577 GWCTEQGEMLVIYDYSATRILSHL------LFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAI 650 (834)
Q Consensus 577 g~~~~~~~~~lv~Ey~~~g~L~~~------l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NI 650 (834)
+++.+.+..++||||+++|+|.++ +.... ...+++..+..++.|++.||+|||+ ..+|+||||||+||
T Consensus 110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Ni 183 (348)
T 2pml_X 110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY----TCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNI 183 (348)
T ss_dssp EEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS----CCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGE
T ss_pred EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc----ccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhE
Confidence 999999999999999999999998 43311 2358999999999999999999996 26999999999999
Q ss_pred eecCCCCceEeeeeeccccccCCCCCcccccCccccccccCccchhccccC-CCCc-cCcchhhHHHHHHHHhCCCccCC
Q 003278 651 TLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESG-EATS-MADVYSFGVVVLEVVTGQMAVDF 728 (834)
Q Consensus 651 Lld~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~-k~DV~SfGvvl~E~~tG~~p~~~ 728 (834)
|++.++.+||+|||++...... ......||+.|+|||++.+. .++. ++|||||||++|||+||+.||..
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 254 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK---------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL 254 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT---------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EEcCCCcEEEeccccccccccc---------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999764322 12245799999999999877 6776 99999999999999999999975
Q ss_pred CCCchhHHHHHHHHHhhcCcccc----ccccccC------CCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 729 RLPEGLLVKRVHEFEARKRPLAE----LVDLSLN------GEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~~~----~~d~~l~------~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
..........+. ........ ...+... ...... .+..++.+||+.||++|||+.++++
T Consensus 255 ~~~~~~~~~~i~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 255 KISLVELFNNIR---TKNIEYPLDRNHFLYPLTNKKSTCSNNFLSN---EDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp SSCSHHHHHHHT---SCCCCCCCSSSSSTTTTCC--------CCCH---HHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCcHHHHHHHHh---ccCcCCccchhhhhccccccccccchhhcCH---HHHHHHHHHccCChhhCCCHHHHhc
Confidence 544222222211 11111000 0000000 011122 3455666999999999999999986
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=351.60 Aligned_cols=260 Identities=22% Similarity=0.253 Sum_probs=185.7
Q ss_pred CcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeC------CeEE
Q 003278 514 NFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQ------GEML 586 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~------~~~~ 586 (834)
.|...+.||+|+||.||+|... +++.||||++..... .+.+|+++|++++|||||+++++|... ...+
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 4666788999999999999975 589999999864321 234699999999999999999988542 2367
Q ss_pred EEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCC-CCceEeeeee
Q 003278 587 VIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPD-MNPRLGSFAL 665 (834)
Q Consensus 587 lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~-~~~ki~DfGl 665 (834)
+||||+++ +|...+..... ....+++..+..++.|+++||+|||+ .+|+||||||+||||+.+ +.+||+|||+
T Consensus 130 lv~e~~~~-~l~~~~~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSR--AKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred eehhcccc-cHHHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchh
Confidence 89999997 44444432111 11248889999999999999999996 699999999999999965 5689999999
Q ss_pred ccccccCCCCCcccccCccccccccCccchhccccC-CCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHH--
Q 003278 666 AEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESG-EATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEF-- 742 (834)
Q Consensus 666 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~-- 742 (834)
++.+.... ......||+.|+|||++.+. .++.++|||||||+||||+||+.||........+...+...
T Consensus 204 a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~ 275 (420)
T 1j1b_A 204 AKQLVRGE--------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 275 (420)
T ss_dssp CEECCTTC--------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred hhhcccCC--------CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 98654321 12346799999999998764 78999999999999999999999997544333222222110
Q ss_pred ------HhhcCccccccccccCCC-----CCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 743 ------EARKRPLAELVDLSLNGE-----YNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 743 ------~~~~~~~~~~~d~~l~~~-----~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
........+...+.+... +....-..+..|+.+||+.||++|||+.|+++
T Consensus 276 p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 276 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp CCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 000000111111111100 00000124556667999999999999999985
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=371.00 Aligned_cols=248 Identities=17% Similarity=0.197 Sum_probs=196.5
Q ss_pred hhCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCC--ChhHHHHHHHHHHHHHhc-cCCCceeEEEEEeeCCeEEE
Q 003278 512 TNNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSK--CPALRTRFSNELQNLARL-RHRNLVQLCGWCTEQGEMLV 587 (834)
Q Consensus 512 t~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~--~~~~~~~f~~E~~~l~~l-~HpNiv~l~g~~~~~~~~~l 587 (834)
.++|...+.||+|+||.||+|... +++.||||++.... .....+.+..|..+|..+ +||||+++++++.+.+.++|
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 367888889999999999999964 57889999986421 112235678899999987 79999999999999999999
Q ss_pred EEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecc
Q 003278 588 IYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAE 667 (834)
Q Consensus 588 v~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~ 667 (834)
||||+++|+|..++...+ .+++..+..|+.||+.||+|||+ .+||||||||+|||||.++.+||+|||+++
T Consensus 420 V~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~ 490 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQVG------RFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK 490 (674)
T ss_dssp EEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred EEeCcCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceee
Confidence 999999999999987543 38899999999999999999997 699999999999999999999999999997
Q ss_pred ccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcC
Q 003278 668 FLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKR 747 (834)
Q Consensus 668 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
...... ....+.+||+.|||||++.+..|+.++|||||||+||||+||+.||....... +...+. ....
T Consensus 491 ~~~~~~-------~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~-~~~~i~---~~~~ 559 (674)
T 3pfq_A 491 ENIWDG-------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-LFQSIM---EHNV 559 (674)
T ss_dssp ECCCTT-------CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHH---SSCC
T ss_pred ccccCC-------cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH-HHHHHH---hCCC
Confidence 532221 12345789999999999999999999999999999999999999997543322 222111 1110
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCCh-----hHHH
Q 003278 748 PLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSM-----RQIL 791 (834)
Q Consensus 748 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm-----~~v~ 791 (834)
..+...+ .+ +..++..||+.||++||++ .+|.
T Consensus 560 --------~~p~~~s-~~---~~~li~~lL~~dP~~R~~~~~~~~~ei~ 596 (674)
T 3pfq_A 560 --------AYPKSMS-KE---AVAICKGLMTKHPGKRLGCGPEGERDIK 596 (674)
T ss_dssp --------CCCTTSC-HH---HHHHHHHHSCSSSTTCTTCSTTHHHHHH
T ss_pred --------CCCccCC-HH---HHHHHHHHccCCHHHCCCCCCCcHHHHh
Confidence 1111222 33 4445558999999999998 5655
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=340.26 Aligned_cols=258 Identities=18% Similarity=0.217 Sum_probs=173.9
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCChhHHHHHHHHHH-HHHhccCCCceeEEEEEeeCCeEEEEEe
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKCPALRTRFSNELQ-NLARLRHRNLVQLCGWCTEQGEMLVIYD 590 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~E~~-~l~~l~HpNiv~l~g~~~~~~~~~lv~E 590 (834)
++|...+.||+|+||.||+|... +++.||||++..........++..|+. +++.++|||||+++|++.+.+..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 46777889999999999999974 688999999976655555556666766 7778899999999999999999999999
Q ss_pred ccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccc
Q 003278 591 YSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLT 670 (834)
Q Consensus 591 y~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~ 670 (834)
|+++ +|.+++...... ....+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||+++...
T Consensus 102 ~~~~-~l~~~~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSV-LDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCSE-EHHHHHHHHHHT-TCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred ecCC-ChHHHHHHHHhh-hcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 9996 776666531110 123488899999999999999999972 389999999999999999999999999997653
Q ss_pred cCCCCCcccccCccccccccCccchhcc----ccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhc
Q 003278 671 RNDHGHRKATSGNRSVRGIFGYMSPEYI----ESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARK 746 (834)
Q Consensus 671 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~----~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~ 746 (834)
... ......||+.|+|||++ .+..++.++|||||||++|||+||+.||......... .....
T Consensus 178 ~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~~~~ 243 (327)
T 3aln_A 178 DSI--------AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ------LTQVV 243 (327)
T ss_dssp ------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CCCC
T ss_pred ccc--------ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH------HHHHh
Confidence 321 11234699999999998 4667899999999999999999999998642211000 00000
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 747 RPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 747 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
......+.......+ .. .+.+++.+||+.||++|||+.+|++
T Consensus 244 ~~~~~~~~~~~~~~~-~~---~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 244 KGDPPQLSNSEEREF-SP---SFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CSCCCCCCCCSSCCC-CH---HHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cCCCCCCCCcccccC-CH---HHHHHHHHHhhCChhhCcCHHHHHh
Confidence 000000000001112 22 4556666999999999999999975
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=352.16 Aligned_cols=260 Identities=20% Similarity=0.216 Sum_probs=186.9
Q ss_pred CcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCC------eEEE
Q 003278 514 NFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQG------EMLV 587 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~------~~~l 587 (834)
.|...+.||+|+||.||+|...++..||+|++..... ...+|+++|+.++|||||++++++...+ ..++
T Consensus 41 ~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~-----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 41 AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR-----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc-----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 4666788999999999999987777799998754322 1236999999999999999999986543 3789
Q ss_pred EEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeec-CCCCceEeeeeec
Q 003278 588 IYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLD-PDMNPRLGSFALA 666 (834)
Q Consensus 588 v~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld-~~~~~ki~DfGla 666 (834)
||||++++.+......... ...+++.....++.|++.||+|||+ .+|+||||||+||||+ .++.+||+|||++
T Consensus 116 v~e~~~~~l~~~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKL---KQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp EEECCSEEHHHHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EeeccCccHHHHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 9999998766544321111 1247888899999999999999997 6999999999999999 7999999999999
Q ss_pred cccccCCCCCcccccCccccccccCccchhccccC-CCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHH--
Q 003278 667 EFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESG-EATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFE-- 743 (834)
Q Consensus 667 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~-- 743 (834)
+.+.... ......||+.|+|||++.+. .++.++|||||||++|||+||+.||........+........
T Consensus 190 ~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p 261 (394)
T 4e7w_A 190 KILIAGE--------PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTP 261 (394)
T ss_dssp EECCTTC--------CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred ccccCCC--------CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 8653321 12345789999999998765 589999999999999999999999975443332222111100
Q ss_pred ------hhcCccccccccccCCC-----CCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 744 ------ARKRPLAELVDLSLNGE-----YNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 744 ------~~~~~~~~~~d~~l~~~-----~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
.......+..-+..... +....-..+..++.+||+.||++|||+.|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 262 SREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp CHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 00000000000000000 00001124556667999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=350.49 Aligned_cols=254 Identities=17% Similarity=0.203 Sum_probs=181.6
Q ss_pred cCCcccccCCcEEEEEEECCCcEEEEEEecCCCChhHHHHHHHHHHHHHhc-cCCCceeEEEEEeeCCeEEEEEeccCCC
Q 003278 517 ESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARL-RHRNLVQLCGWCTEQGEMLVIYDYSATR 595 (834)
Q Consensus 517 ~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l-~HpNiv~l~g~~~~~~~~~lv~Ey~~~g 595 (834)
..+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.+|.++ +|||||++++++.+.+..++||||+. |
T Consensus 19 ~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-g 93 (434)
T 2rio_A 19 SEKILGYGSSGTVVFQGSFQGRPVAVKRMLID----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-L 93 (434)
T ss_dssp EEEEEEECSTTCEEEEEESSSSEEEEEEEEGG----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-E
T ss_pred ccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-C
Confidence 34679999999998777778999999998542 235678899999987 89999999999999999999999996 6
Q ss_pred chhhhhhcCCCCCCC-cccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCC-------------CCceEe
Q 003278 596 ILSHLLFHNNHRIGH-SILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPD-------------MNPRLG 661 (834)
Q Consensus 596 ~L~~~l~~~~~~~~~-~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~-------------~~~ki~ 661 (834)
+|.+++......... ...++..++.|+.|++.||+|||+ .+|+||||||+||||+.+ +.+||+
T Consensus 94 sL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~ 170 (434)
T 2rio_A 94 NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS 170 (434)
T ss_dssp EHHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEEC
T ss_pred CHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEEEEc
Confidence 999999765422111 112344567899999999999997 699999999999999754 479999
Q ss_pred eeeeccccccCCCCCcccccCccccccccCccchhcccc-------CCCCccCcchhhHHHHHHHHh-CCCccCCCCCch
Q 003278 662 SFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIES-------GEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEG 733 (834)
Q Consensus 662 DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-------~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~ 733 (834)
|||+++.+....... ........||+.|||||++.+ ..++.++|||||||++|||+| |+.|+.......
T Consensus 171 DFG~a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 171 DFGLCKKLDSGQSSF---RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp CCTTCEECCC-----------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred ccccceecCCCCccc---eeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 999998764332110 111234679999999999975 678999999999999999999 899986443221
Q ss_pred hHHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 734 LLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
. ........... +...........+..++.+||+.||++|||+.+|++
T Consensus 248 ~------~i~~~~~~~~~-----~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 S------NIIRGIFSLDE-----MKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp H------HHHHTCCCCCC-----CTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H------HHhcCCCCccc-----ccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1 11111111111 111112233345667777999999999999999985
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-37 Score=341.37 Aligned_cols=202 Identities=16% Similarity=0.218 Sum_probs=170.1
Q ss_pred hhCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCChhHHHHHHHHHHHHHhcc-CCC-----ceeEEEEEeeCCe
Q 003278 512 TNNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKCPALRTRFSNELQNLARLR-HRN-----LVQLCGWCTEQGE 584 (834)
Q Consensus 512 t~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~-HpN-----iv~l~g~~~~~~~ 584 (834)
.++|...+.||+|+||+||+|... +++.||||++... .....++.+|+.++..++ |+| ||++++++...+.
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK--KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc--HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 467888889999999999999864 5788999998642 344567888999999886 553 9999999999999
Q ss_pred EEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeec--CCCCceEee
Q 003278 585 MLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLD--PDMNPRLGS 662 (834)
Q Consensus 585 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld--~~~~~ki~D 662 (834)
.++||||++ |+|.+++..... ..+++..+..++.|++.||+|||+. ..+||||||||+||||+ .++.+||+|
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNTNF----RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred eEEEEecCC-CCHHHHHhhcCc----CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 999999997 489888876432 2388999999999999999999953 36899999999999994 578899999
Q ss_pred eeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCC
Q 003278 663 FALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLP 731 (834)
Q Consensus 663 fGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~ 731 (834)
||+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus 205 FG~a~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 263 (382)
T 2vx3_A 205 FGSSCQLGQR----------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263 (382)
T ss_dssp CTTCEETTCC----------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccCceecccc----------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999765321 2245799999999999999999999999999999999999999975443
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=334.45 Aligned_cols=252 Identities=16% Similarity=0.271 Sum_probs=190.9
Q ss_pred hhCcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCC-ChhHHHHHHHHHHHHHhccC--CCceeEEEEEeeCCeEEEE
Q 003278 512 TNNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSK-CPALRTRFSNELQNLARLRH--RNLVQLCGWCTEQGEMLVI 588 (834)
Q Consensus 512 t~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~-~~~~~~~f~~E~~~l~~l~H--pNiv~l~g~~~~~~~~~lv 588 (834)
.++|...+.||+|+||.||++...+++.||||.+.... .....+.|.+|+.++.+++| |||+++++++.+.+..++|
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 106 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 106 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEE
T ss_pred cceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEE
Confidence 34577778999999999999998889999999987543 34456789999999999984 9999999999999999999
Q ss_pred EeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccc
Q 003278 589 YDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEF 668 (834)
Q Consensus 589 ~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~ 668 (834)
|| +.+++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||+++ +.+||+|||+++.
T Consensus 107 ~e-~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~ 175 (313)
T 3cek_A 107 ME-CGNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLIDFGIANQ 175 (313)
T ss_dssp EC-CCSEEHHHHHHHCS------SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEECCCSSSCC
T ss_pred Ee-cCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEEeecccccc
Confidence 99 67889999987542 47888999999999999999997 69999999999999975 7899999999976
Q ss_pred cccCCCCCcccccCccccccccCccchhcccc-----------CCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHH
Q 003278 669 LTRNDHGHRKATSGNRSVRGIFGYMSPEYIES-----------GEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVK 737 (834)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-----------~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~ 737 (834)
...... ........||+.|+|||++.+ ..++.++|||||||++|||+||+.||.........
T Consensus 176 ~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-- 248 (313)
T 3cek_A 176 MQPDTT-----SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK-- 248 (313)
T ss_dssp -------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH--
T ss_pred ccCccc-----cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHH--
Confidence 543211 111224579999999999865 47888999999999999999999998654332111
Q ss_pred HHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 738 RVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 738 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
......... . ...... ...+ +.+++.+||+.||++|||+.+|++
T Consensus 249 -~~~~~~~~~---~---~~~~~~-~~~~---l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 249 -LHAIIDPNH---E---IEFPDI-PEKD---LQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp -HHHHHCTTS---C---CCCCCC-SCHH---HHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -HHHHHhccc---c---cCCccc-chHH---HHHHHHHHccCCcccCcCHHHHhc
Confidence 111111000 0 011111 1233 445566899999999999999985
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=328.54 Aligned_cols=251 Identities=20% Similarity=0.271 Sum_probs=190.9
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCC---ChhHHHHHHHHHHHHHhccCCCceeEEEEEe--eCCeEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSK---CPALRTRFSNELQNLARLRHRNLVQLCGWCT--EQGEML 586 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~---~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~--~~~~~~ 586 (834)
++|...+.||+|+||.||++.. .++..||||.+.... .....+.|.+|+.++++++||||+++++++. +....+
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY 84 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence 5788889999999999999996 457899999986432 1234577999999999999999999999984 456789
Q ss_pred EEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeec
Q 003278 587 VIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALA 666 (834)
Q Consensus 587 lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla 666 (834)
+||||+.++ |.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 85 lv~e~~~~~-l~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~ 156 (305)
T 2wtk_C 85 MVMEYCVCG-MQEMLDSVPE----KRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVA 156 (305)
T ss_dssp EEEECCSEE-HHHHHHHSTT----CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEehhccCC-HHHHHHhCcc----cccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeeccccc
Confidence 999999988 5566654321 248899999999999999999997 69999999999999999999999999999
Q ss_pred cccccCCCCCcccccCccccccccCccchhccccCC--CCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHh
Q 003278 667 EFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGE--ATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEA 744 (834)
Q Consensus 667 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~--~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~ 744 (834)
......... .......||+.|+|||++.+.. ++.++|||||||++|||+||+.|+....... .... ...
T Consensus 157 ~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~---i~~ 227 (305)
T 2wtk_C 157 EALHPFAAD-----DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK-LFEN---IGK 227 (305)
T ss_dssp EECCTTCSS-----CEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHH---HHH
T ss_pred cccCccccc-----cccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH-HHHH---Hhc
Confidence 765422111 1112456999999999997644 3779999999999999999999987533221 1111 111
Q ss_pred hcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 745 RKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 745 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
... .+...++ .+ +.+++.+||+.||++|||+.++++
T Consensus 228 ~~~--------~~~~~~~-~~---l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 228 GSY--------AIPGDCG-PP---LSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp CCC--------CCCSSSC-HH---HHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCC--------CCCCccC-HH---HHHHHHHHccCChhhCCCHHHHhc
Confidence 111 1112222 33 445566899999999999999986
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=334.82 Aligned_cols=258 Identities=16% Similarity=0.221 Sum_probs=196.7
Q ss_pred hCcCcCCcccccCCcEEEEEEE--CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCC------ceeEEEEEeeCCe
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL--DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRN------LVQLCGWCTEQGE 584 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~--~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpN------iv~l~g~~~~~~~ 584 (834)
+.|...+.||+|+||.||+|.. .++..||||.+... ....+.+.+|+.++.+++|+| |+++++++.+.+.
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV--DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC--CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 4677778899999999999986 36789999998642 344577899999999998876 9999999999999
Q ss_pred EEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecC----------
Q 003278 585 MLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDP---------- 654 (834)
Q Consensus 585 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~---------- 654 (834)
.++||||+ +++|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~ 163 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGF----LPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPK 163 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC--
T ss_pred EEEEEcCC-CCCHHHHHHhcCC----CCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCc
Confidence 99999999 8899988876432 247888999999999999999997 69999999999999987
Q ss_pred ---------CCCceEeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCc
Q 003278 655 ---------DMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMA 725 (834)
Q Consensus 655 ---------~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p 725 (834)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.|
T Consensus 164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 233 (339)
T 1z57_A 164 IKRDERTLINPDIKVVDFGSATYDDEH----------HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTV 233 (339)
T ss_dssp --CEEEEESCCCEEECCCSSCEETTSC----------CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cccccccccCCCceEeeCcccccCccc----------cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCC
Confidence 678999999999753221 2245799999999999999999999999999999999999999
Q ss_pred cCCCCCchhHHHHHHHHHhhcCcc--------cccc-ccccC---------------------CCCCHHHHHHHHHHHHH
Q 003278 726 VDFRLPEGLLVKRVHEFEARKRPL--------AELV-DLSLN---------------------GEYNHKELMRLIKLGIA 775 (834)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~-d~~l~---------------------~~~~~~~~~~l~~l~~~ 775 (834)
|........ ......... ..+. .... ..... .......-..+.+++.+
T Consensus 234 f~~~~~~~~-~~~~~~~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 311 (339)
T 1z57_A 234 FPTHDSKEH-LAMMERILG-PLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQK 311 (339)
T ss_dssp CCCSCHHHH-HHHHHHHHC-SCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHH
T ss_pred CCCCChHHH-HHHHHHHhC-CCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHH
Confidence 865433221 111111100 0000 0000 00000 00111233456677789
Q ss_pred hccCCCCCCCChhHHHH
Q 003278 776 CTLSNPELRPSMRQILS 792 (834)
Q Consensus 776 C~~~~P~~RPtm~~v~~ 792 (834)
||+.||++|||+.||++
T Consensus 312 ~L~~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 312 MLEYDPAKRITLREALK 328 (339)
T ss_dssp HTCSSTTTSCCHHHHTT
T ss_pred HhCcCcccccCHHHHhc
Confidence 99999999999999974
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=336.52 Aligned_cols=261 Identities=18% Similarity=0.243 Sum_probs=194.7
Q ss_pred HhhCcCcCCcccccCCcEEEEEEE--CCCcEEEEEEecCCCC-hhHHHHHHHHHHHHHhc---cCCCceeEEEEEe----
Q 003278 511 ATNNFSESQRVAEMDFGTAYQGFL--DNHQYVLVKRLGMSKC-PALRTRFSNELQNLARL---RHRNLVQLCGWCT---- 580 (834)
Q Consensus 511 at~~f~~~~~ig~g~~g~vy~~~~--~~~~~vavK~~~~~~~-~~~~~~f~~E~~~l~~l---~HpNiv~l~g~~~---- 580 (834)
+.++|...+.||+|+||.||+|.. .++..||||++..... ......+.+|+.+++++ +||||++++++|.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457788889999999999999997 4678999998864321 11123466788777776 8999999999987
Q ss_pred -eCCeEEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCce
Q 003278 581 -EQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPR 659 (834)
Q Consensus 581 -~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~k 659 (834)
.....++||||+. |+|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~k 160 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPE----PGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIK 160 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCT----TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEE
T ss_pred CCCceEEEEEecCC-CCHHHHHHhccc----CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEE
Confidence 4567899999998 699998875432 238899999999999999999997 6999999999999999999999
Q ss_pred EeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHH
Q 003278 660 LGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRV 739 (834)
Q Consensus 660 i~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~ 739 (834)
|+|||+++...... ......||+.|+|||++.++.++.++|||||||++|||+||+.||........+ ..+
T Consensus 161 l~Dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~i 231 (326)
T 1blx_A 161 LADFGLARIYSFQM--------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL-GKI 231 (326)
T ss_dssp ECSCCSCCCCCGGG--------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHH
T ss_pred EecCcccccccCCC--------CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHH-HHH
Confidence 99999997643211 123457999999999999999999999999999999999999998754332222 222
Q ss_pred HHHHhhc--Ccccccc---c-----------cccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 740 HEFEARK--RPLAELV---D-----------LSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 740 ~~~~~~~--~~~~~~~---d-----------~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
....... ..+.... . ..+.... +. .+..++.+||+.||++|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~---~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 232 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDI-DE---LGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp HHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSC-CH---HHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHcCCCCcccCccccccchhhhcccCcchhhhccccC-CH---HHHHHHHHHcCCCcccCCCHHHHhc
Confidence 2111000 0000000 0 0001111 22 3445666999999999999999984
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=346.13 Aligned_cols=201 Identities=17% Similarity=0.290 Sum_probs=150.4
Q ss_pred CCcccccCCcEEEEEEEC---CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEee--CCeEEEEEecc
Q 003278 518 SQRVAEMDFGTAYQGFLD---NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTE--QGEMLVIYDYS 592 (834)
Q Consensus 518 ~~~ig~g~~g~vy~~~~~---~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~--~~~~~lv~Ey~ 592 (834)
.++||+|+||+||+|... ++..||||++...... ..+.+|+.+|++++|||||++++++.. ....++||||+
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~ 102 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS---MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 102 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC---HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECC
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC---HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCC
Confidence 468999999999999975 4678999998754322 467899999999999999999999954 67899999999
Q ss_pred CCCchhhhhhcCCC---CCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceee----cCCCCceEeeeee
Q 003278 593 ATRILSHLLFHNNH---RIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITL----DPDMNPRLGSFAL 665 (834)
Q Consensus 593 ~~g~L~~~l~~~~~---~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILl----d~~~~~ki~DfGl 665 (834)
.+ +|.+++..... ......+++..+..|+.|++.||+|||+ .+|+||||||+|||| +.++.+||+|||+
T Consensus 103 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 178 (405)
T 3rgf_A 103 EH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGF 178 (405)
T ss_dssp SE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEECCTTC
T ss_pred CC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEEEECCC
Confidence 85 66666543211 1112248899999999999999999997 689999999999999 7789999999999
Q ss_pred ccccccCCCCCcccccCccccccccCccchhccccC-CCCccCcchhhHHHHHHHHhCCCccCCC
Q 003278 666 AEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESG-EATSMADVYSFGVVVLEVVTGQMAVDFR 729 (834)
Q Consensus 666 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~k~DV~SfGvvl~E~~tG~~p~~~~ 729 (834)
++....... ........+||+.|+|||++.+. .++.++|||||||+||||+||+.||...
T Consensus 179 a~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 179 ARLFNSPLK----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp CC--------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred ceecCCCCc----ccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 986543211 01122346899999999999874 5899999999999999999999999643
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=330.96 Aligned_cols=259 Identities=17% Similarity=0.218 Sum_probs=185.8
Q ss_pred hCcCcCCcccccCCcEEEEEEECC-CcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEe-----------
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDN-HQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCT----------- 580 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~-~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~----------- 580 (834)
+.|...+.||+|+||.||+|.... ++.||||++... .....+.+.+|+.++++++|||||++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT-DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 456777889999999999999764 889999998654 3445678999999999999999999999873
Q ss_pred ---eCCeEEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeec-CCC
Q 003278 581 ---EQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLD-PDM 656 (834)
Q Consensus 581 ---~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld-~~~ 656 (834)
+....++||||+. |+|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+|||++ +++
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~ 158 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQG-------PLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDL 158 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTTC-------CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTT
T ss_pred cccccCceeEEeeccC-CCHHHHhhcC-------CccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCC
Confidence 4467899999998 6999888532 37888899999999999999997 6999999999999997 567
Q ss_pred CceEeeeeeccccccCCCCCcccccCccccccccCccchhcccc-CCCCccCcchhhHHHHHHHHhCCCccCCCCCchhH
Q 003278 657 NPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIES-GEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLL 735 (834)
Q Consensus 657 ~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~ 735 (834)
.+||+|||+++....... .........||..|+|||.+.+ ..++.++|||||||++|||+||+.||.........
T Consensus 159 ~~kl~Dfg~~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 234 (320)
T 2i6l_A 159 VLKIGDFGLARIMDPHYS----HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM 234 (320)
T ss_dssp EEEECCCTTCBCC------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred eEEEccCccccccCCCcc----cccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 999999999986532211 0111234568999999998865 67899999999999999999999998754332221
Q ss_pred HHHHHHHH---------hhcCcccccccc----------ccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 736 VKRVHEFE---------ARKRPLAELVDL----------SLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 736 ~~~~~~~~---------~~~~~~~~~~d~----------~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
..+.... .....+...+.. .+....+ ..+.+++.+||+.||++|||+.++++
T Consensus 235 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 235 -QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGIS----REAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp -HHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCC----HHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred -HHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhh----HHHHHHHHHHcCCCccccCCHHHHhC
Confidence 1111100 000000000000 0001111 24556667999999999999999985
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=332.51 Aligned_cols=252 Identities=19% Similarity=0.267 Sum_probs=176.3
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCChhH-HHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEe
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKCPAL-RTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYD 590 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~-~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~E 590 (834)
++|...+.||+|+||.||+|... ++..||||.+........ .+.+.++..+++.++||||+++++++.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e 104 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME 104 (318)
T ss_dssp GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence 46777788999999999999975 688999999876554433 3445555667888999999999999999999999999
Q ss_pred ccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccc
Q 003278 591 YSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLT 670 (834)
Q Consensus 591 y~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~ 670 (834)
|+ ++++..+..... ..+++..+..++.|++.||+|||+. .+|+||||||+|||++.++.+||+|||++....
T Consensus 105 ~~-~~~~~~l~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 105 LM-GTCAEKLKKRMQ-----GPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp CC-SEEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHH--HCCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred cc-CCcHHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHhh--CCEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 99 455555543321 2478899999999999999999972 389999999999999999999999999997643
Q ss_pred cCCCCCcccccCccccccccCccchhccc-----cCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhh
Q 003278 671 RNDHGHRKATSGNRSVRGIFGYMSPEYIE-----SGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEAR 745 (834)
Q Consensus 671 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-----~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~ 745 (834)
... ......||+.|+|||++. ...++.++|||||||++|||+||+.||.............. ..
T Consensus 177 ~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~---~~ 245 (318)
T 2dyl_A 177 DDK--------AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVL---QE 245 (318)
T ss_dssp ------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH---HS
T ss_pred CCc--------cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHh---cc
Confidence 221 122357999999999984 56788999999999999999999999875333322222111 11
Q ss_pred cCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 746 KRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 746 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
..+. +.. .... +.+ +..++.+||+.||.+|||+.+|++
T Consensus 246 ~~~~--~~~---~~~~-~~~---l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 246 EPPL--LPG---HMGF-SGD---FQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CCCC--CCS---SSCC-CHH---HHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCC--CCc---cCCC-CHH---HHHHHHHHccCChhHCcCHHHHhh
Confidence 1110 000 0111 233 445666999999999999999985
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=350.41 Aligned_cols=255 Identities=22% Similarity=0.270 Sum_probs=185.7
Q ss_pred HhhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhC-CCCceeeEeeeEEeCCEEEE
Q 003278 107 YIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHL-RHRNLVRLRGWCVHEDQLLL 185 (834)
Q Consensus 107 ~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~l 185 (834)
..+..+|+..++||+|+||+||.... .+|+.||||++..... ..+.+|+.+|+++ +|||||++++++.+.+..|+
T Consensus 20 ~i~~~~y~~~~~LG~G~~G~V~~~~~-~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l 95 (432)
T 3p23_A 20 IVGKISFCPKDVLGHGAEGTIVYRGM-FDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYI 95 (432)
T ss_dssp EETTEEEEEEEEEEECGGGCEEEEEE-SSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEE
T ss_pred EEccEEEecCCeeecCcCEEEEEEEE-eCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEE
Confidence 34556799999999999998654333 5789999999865322 2356799999999 79999999999999999999
Q ss_pred EEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECC-----CCceEEe
Q 003278 186 VYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDS-----QYNARLG 260 (834)
Q Consensus 186 V~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~-----~~~~kl~ 260 (834)
|||||+ |+|.+++.... ..+.+..+..|+.||++||.|||+. +|+||||||+|||++. ...+||+
T Consensus 96 v~E~~~-g~L~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~ 165 (432)
T 3p23_A 96 AIELCA-ATLQEYVEQKD------FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMIS 165 (432)
T ss_dssp EEECCS-EEHHHHHHSSS------CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEEC
T ss_pred EEECCC-CCHHHHHHhcC------CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEe
Confidence 999996 69999987543 2344446678999999999999996 9999999999999943 3458899
Q ss_pred eccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCcccccc--CCCCCcccceeehhhHHHHHHh-CCccCCC
Q 003278 261 DFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQK--GSVATAKSDVFSFGIVVLEVVS-GRRAVDL 337 (834)
Q Consensus 261 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~ 337 (834)
|||+++.+...... ....+...||++|+|||.+.. ...++.++|||||||++|||+| |+.||..
T Consensus 166 DFG~a~~~~~~~~~-------------~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~ 232 (432)
T 3p23_A 166 DFGLCKKLAVGRHS-------------FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGK 232 (432)
T ss_dssp CTTEEECC-------------------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBS
T ss_pred cccceeeccCCCcc-------------eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcch
Confidence 99999865432110 011345679999999999864 3356789999999999999999 8888853
Q ss_pred CCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 338 TYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 338 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
..... ........ ..... .........+.+|+..||+.||.+||++.+|++
T Consensus 233 ~~~~~-------~~~~~~~~-~~~~~-------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 233 SLQRQ-------ANILLGAC-SLDCL-------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TTTHH-------HHHHTTCC-CCTTS-------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhHHH-------HHHHhccC-Ccccc-------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 32110 11111110 00000 111122344678999999999999999999986
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=340.71 Aligned_cols=251 Identities=17% Similarity=0.218 Sum_probs=190.0
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCC-ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeE-----
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSK-CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEM----- 585 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~-~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~----- 585 (834)
++|...+.||+|+||.||+|.. .+++.||||++.... .....+++.+|+.++++++|||||++++++...+..
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 4677778899999999999986 458899999987543 334467899999999999999999999999876654
Q ss_pred -EEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeee
Q 003278 586 -LVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFA 664 (834)
Q Consensus 586 -~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfG 664 (834)
++||||+. ++|.+++.. .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 122 ~~lv~e~~~-~~l~~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg 189 (371)
T 4exu_A 122 FYLVMPFMQ-TDLQKIMGM--------EFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFG 189 (371)
T ss_dssp CEEEEECCC-EEHHHHTTS--------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTT
T ss_pred EEEEEcccc-ccHHHHhhc--------CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecC
Confidence 99999998 577776621 27899999999999999999997 699999999999999999999999999
Q ss_pred eccccccCCCCCcccccCccccccccCccchhcccc-CCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHH
Q 003278 665 LAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIES-GEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFE 743 (834)
Q Consensus 665 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~ 743 (834)
+++..... .....||+.|+|||++.+ ..++.++|||||||++|||+||+.||........+.... ...
T Consensus 190 ~a~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~-~~~ 258 (371)
T 4exu_A 190 LARHADAE----------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL-KVT 258 (371)
T ss_dssp CC------------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH-HHH
T ss_pred cccccccC----------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH-HHh
Confidence 99754221 234578999999999977 678999999999999999999999997543322221111 100
Q ss_pred hhcCccccccc----------------c------ccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 744 ARKRPLAELVD----------------L------SLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 744 ~~~~~~~~~~d----------------~------~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
..+..+..+ . .+.... . ..+..++.+||+.||++|||+.|+++
T Consensus 259 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~---~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 259 --GVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRA-S---PQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp --CCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTS-C---HHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred --CCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhcccc-C---hHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 000000000 0 000011 1 24556667999999999999999986
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=328.00 Aligned_cols=251 Identities=20% Similarity=0.265 Sum_probs=195.7
Q ss_pred hhCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCC-ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEE
Q 003278 512 TNNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSK-CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIY 589 (834)
Q Consensus 512 t~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~ 589 (834)
.+.|...+.||+|+||.||+|... +++.||||.+.... .....+.|.+|+.++++++||||+++++++.+.+..++||
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 467888899999999999999975 68899999986432 2234567999999999999999999999999999999999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCC---CCceEeeeeec
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPD---MNPRLGSFALA 666 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~---~~~ki~DfGla 666 (834)
||+++++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.+ +.+||+|||++
T Consensus 101 e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 101 ELYTGGELFDEIIKRK------RFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp CCCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EccCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 9999999998886532 37899999999999999999997 699999999999999754 46999999999
Q ss_pred cccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhc
Q 003278 667 EFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARK 746 (834)
Q Consensus 667 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~ 746 (834)
....... ......||+.|+|||.+.+ .++.++||||||+++|||+||+.|+...... .....+ ....
T Consensus 172 ~~~~~~~--------~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~---~~~~ 238 (287)
T 2wei_A 172 TCFQQNT--------KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY-DILKRV---ETGK 238 (287)
T ss_dssp GTBCCCS--------SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHH---HHCC
T ss_pred eeecCCC--------ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH-HHHHHH---HcCC
Confidence 7653321 1223468999999999865 5899999999999999999999998654322 111211 1111
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 747 RPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 747 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
... +.......+ . .+.+++.+||+.||++|||+.++++
T Consensus 239 ~~~----~~~~~~~~~-~---~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 239 YAF----DLPQWRTIS-D---DAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CCC----CSGGGTTSC-H---HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCC----CchhhhhcC-H---HHHHHHHHHcccChhhCcCHHHHhc
Confidence 110 000001122 2 3455666999999999999999986
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=333.65 Aligned_cols=253 Identities=16% Similarity=0.209 Sum_probs=189.7
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCC-ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCe------
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSK-CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGE------ 584 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~-~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~------ 584 (834)
++|...+.||+|+||.||+|.. .++..||||.+.... .....+++.+|+.++++++|||||++++++...+.
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 4677778899999999999996 458899999987543 33446789999999999999999999999987653
Q ss_pred EEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeee
Q 003278 585 MLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFA 664 (834)
Q Consensus 585 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfG 664 (834)
.++||||+. |+|.+++.. .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 104 ~~lv~e~~~-~~l~~~~~~--------~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg 171 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMGL--------KFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFG 171 (353)
T ss_dssp CEEEEECCS-EEGGGTTTS--------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTT
T ss_pred EEEEecccc-CCHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeecc
Confidence 499999998 588777631 27889999999999999999997 699999999999999999999999999
Q ss_pred eccccccCCCCCcccccCccccccccCccchhcccc-CCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHH
Q 003278 665 LAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIES-GEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFE 743 (834)
Q Consensus 665 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~ 743 (834)
+++..... .....||+.|+|||++.+ ..++.++|||||||++|||+||+.||........+ .......
T Consensus 172 ~~~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-~~i~~~~ 240 (353)
T 3coi_A 172 LARHADAE----------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL-TQILKVT 240 (353)
T ss_dssp CTTC------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHH-HHHHHHH
T ss_pred cccCCCCC----------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHh
Confidence 99754221 224578999999999876 67899999999999999999999999754332221 1111110
Q ss_pred hhc-----------------Cccccccccc---cCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 744 ARK-----------------RPLAELVDLS---LNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 744 ~~~-----------------~~~~~~~d~~---l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
... ..+....... +.... .. .+..++.+||+.||++|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~---~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 241 GVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRA-SP---QAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp CBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTS-CH---HHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCc-CH---HHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000 0000000000 01111 22 3455666999999999999999985
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=333.83 Aligned_cols=252 Identities=16% Similarity=0.180 Sum_probs=166.3
Q ss_pred hhCcCcCC-cccccCCcEEEEEEEC-CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEee----CCeE
Q 003278 512 TNNFSESQ-RVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTE----QGEM 585 (834)
Q Consensus 512 t~~f~~~~-~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~----~~~~ 585 (834)
+++|...+ .||+|+||.||+|... +++.||||++... ....+ +....+..++||||+++++++.. ....
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~---e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS--PKARQ---EVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS--HHHHH---HHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc--HHHHH---HHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 35676644 5999999999999975 6889999998542 22222 22334667799999999999876 4558
Q ss_pred EEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecC---CCCceEee
Q 003278 586 LVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDP---DMNPRLGS 662 (834)
Q Consensus 586 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~---~~~~ki~D 662 (834)
++||||+++|+|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~----~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~D 174 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGD----QAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTD 174 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-C----CCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred EEEEeccCCCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEec
Confidence 999999999999999975432 248899999999999999999997 69999999999999986 45599999
Q ss_pred eeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHH
Q 003278 663 FALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEF 742 (834)
Q Consensus 663 fGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~ 742 (834)
||+++..... ......||+.|+|||++.+..++.++|||||||++|||+||+.||................
T Consensus 175 fg~~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 245 (336)
T 3fhr_A 175 FGFAKETTQN---------ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRI 245 (336)
T ss_dssp CTTCEEC-------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------
T ss_pred cccceecccc---------ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhh
Confidence 9999754321 1224578999999999998899999999999999999999999986433221100000000
Q ss_pred HhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 743 EARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 743 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
..... ....+. .... .. .+.+++.+||+.||++|||+.++++
T Consensus 246 ~~~~~---~~~~~~-~~~~-~~---~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 246 RLGQY---GFPNPE-WSEV-SE---DAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp --------CCCTTT-STTC-CH---HHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hcccc---ccCchh-hccC-CH---HHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00000 000000 0111 23 3455666899999999999999997
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=344.86 Aligned_cols=250 Identities=19% Similarity=0.234 Sum_probs=180.4
Q ss_pred hCcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCCChhHHHHHHHHHHHHHhc-cCCCceeEEEEEeeCCeEEEEEec
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARL-RHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l-~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
.+|...+.||+|+||+||.....+++.||||++...... .+.+|+++|+++ +|||||++++++.+....++||||
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~----~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS----FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE----ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH----HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 357777889999999976555677889999998654322 356799999999 899999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecC-----CCCceEeeeeec
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDP-----DMNPRLGSFALA 666 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~-----~~~~ki~DfGla 666 (834)
+. |+|.+++..... .+.+..+..++.|++.||+|||+ .+|+||||||+||||+. ...+||+|||++
T Consensus 100 ~~-g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 100 CA-ATLQEYVEQKDF-----AHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp CS-EEHHHHHHSSSC-----CCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred CC-CCHHHHHHhcCC-----CccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 97 599998875432 23344567899999999999997 68999999999999953 346789999999
Q ss_pred cccccCCCCCcccccCccccccccCccchhccc---cCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHH
Q 003278 667 EFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIE---SGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEF 742 (834)
Q Consensus 667 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~---~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~ 742 (834)
+.+...... ........||+.|||||++. ...++.++|||||||++|||+| |..|+........ ..
T Consensus 171 ~~~~~~~~~----~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~------~~ 240 (432)
T 3p23_A 171 KKLAVGRHS----FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA------NI 240 (432)
T ss_dssp ECC----------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH------HH
T ss_pred eeccCCCcc----eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH------HH
Confidence 876432211 11223467999999999997 4567889999999999999999 8888754322111 01
Q ss_pred HhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 743 EARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 743 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
....... .... .. ...-..+..++.+||+.||++|||+.+|++
T Consensus 241 ~~~~~~~-~~~~----~~--~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 241 LLGACSL-DCLH----PE--KHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp HTTCCCC-TTSC----TT--CHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhccCCc-cccC----cc--ccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 1111111 0000 00 111223456667999999999999999984
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-36 Score=328.75 Aligned_cols=198 Identities=19% Similarity=0.294 Sum_probs=166.7
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-C-CcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCC------ceeEEEEEeeCCe
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-N-HQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRN------LVQLCGWCTEQGE 584 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~-~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpN------iv~l~g~~~~~~~ 584 (834)
++|...+.||+|+||.||+|... + +..||||.+... ....+.+.+|+.++++++|+| ++.+++++...+.
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV--GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc--ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 46777889999999999999864 3 368999998642 344577899999999999887 9999999999999
Q ss_pred EEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceee------------
Q 003278 585 MLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITL------------ 652 (834)
Q Consensus 585 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILl------------ 652 (834)
.++||||+. ++|.+++..... ..+++..+..|+.|++.||+|||+ .+|+||||||+|||+
T Consensus 97 ~~lv~e~~~-~~l~~~l~~~~~----~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 97 MCIAFELLG-KNTFEFLKENNF----QPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp EEEEEECCC-CBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC
T ss_pred EEEEEeccC-CChHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeccccccccccc
Confidence 999999994 555555554321 248899999999999999999996 699999999999999
Q ss_pred -------cCCCCceEeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCc
Q 003278 653 -------DPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMA 725 (834)
Q Consensus 653 -------d~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p 725 (834)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.|
T Consensus 169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 238 (355)
T 2eu9_A 169 KSCEEKSVKNTSIRVADFGSATFDHEH----------HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTL 238 (355)
T ss_dssp -CCCEEEESCCCEEECCCTTCEETTSC----------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ccccccccCCCcEEEeecCcccccccc----------ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCC
Confidence 67889999999999753221 2345799999999999999999999999999999999999999
Q ss_pred cCCCC
Q 003278 726 VDFRL 730 (834)
Q Consensus 726 ~~~~~ 730 (834)
|....
T Consensus 239 f~~~~ 243 (355)
T 2eu9_A 239 FQTHE 243 (355)
T ss_dssp CCCSS
T ss_pred CCCCC
Confidence 97543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=335.26 Aligned_cols=241 Identities=19% Similarity=0.292 Sum_probs=191.4
Q ss_pred hhCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCCh-----hHHHHHHHHHHHHHhcc--CCCceeEEEEEeeCC
Q 003278 512 TNNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCP-----ALRTRFSNELQNLARLR--HRNLVQLCGWCTEQG 583 (834)
Q Consensus 512 t~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~f~~E~~~l~~l~--HpNiv~l~g~~~~~~ 583 (834)
.++|...+.||+|+||.||+|.. .+++.||||.+...... ...++|.+|+.++.+++ ||||+++++++.+.+
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~ 121 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 121 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCC
Confidence 35677788999999999999985 56889999998643211 11245678999999996 599999999999999
Q ss_pred eEEEEEeccCC-CchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeec-CCCCceEe
Q 003278 584 EMLVIYDYSAT-RILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLD-PDMNPRLG 661 (834)
Q Consensus 584 ~~~lv~Ey~~~-g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld-~~~~~ki~ 661 (834)
..++||||+.+ ++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++ +++.+||+
T Consensus 122 ~~~lv~e~~~~~~~L~~~l~~~~------~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 122 SFVLILERPEPVQDLFDFITERG------ALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEEC
T ss_pred cEEEEEEcCCCCccHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEEe
Confidence 99999999976 89999987532 47888999999999999999997 6999999999999999 78999999
Q ss_pred eeeeccccccCCCCCcccccCccccccccCccchhccccCCC-CccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHH
Q 003278 662 SFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEA-TSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVH 740 (834)
Q Consensus 662 DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~ 740 (834)
|||+++...... .....||+.|+|||++.+..+ +.++|||||||++|||+||+.||....
T Consensus 193 Dfg~~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~---------- 253 (320)
T 3a99_A 193 DFGSGALLKDTV---------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------- 253 (320)
T ss_dssp CCTTCEECCSSC---------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------
T ss_pred eCcccccccccc---------ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh----------
Confidence 999997654221 223579999999999987776 678999999999999999999985310
Q ss_pred HHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 741 EFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 741 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
........ .....+ . .+.+++.+||+.||++|||+.+|++
T Consensus 254 ~~~~~~~~--------~~~~~~-~---~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 254 EIIRGQVF--------FRQRVS-S---ECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp HHHHCCCC--------CSSCCC-H---HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhccccc--------ccccCC-H---HHHHHHHHHccCChhhCcCHHHHhc
Confidence 01111111 111122 2 3455666999999999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=334.90 Aligned_cols=260 Identities=15% Similarity=0.205 Sum_probs=193.6
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhcc-----------CCCceeEEEEEe
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLR-----------HRNLVQLCGWCT 580 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~-----------HpNiv~l~g~~~ 580 (834)
++|...+.||+|+||.||+|.. .+++.||||.+... ....+.+.+|+.++.+++ ||||+++++++.
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC--ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 4677778899999999999996 56889999998642 334567889999999987 899999999987
Q ss_pred eCC----eEEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCC-ceeecccccCceeec--
Q 003278 581 EQG----EMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNE-QVIHRNITSSAITLD-- 653 (834)
Q Consensus 581 ~~~----~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~-~iiHrDlK~~NILld-- 653 (834)
..+ ..++||||+ +++|.+++..... ..+++..+..|+.|++.||+|||+ . +|+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~ 168 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEH----RGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIV 168 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEE
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhc----cCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEecc
Confidence 654 789999999 8999999876432 237888999999999999999997 5 899999999999994
Q ss_pred ----CCCCceEeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCC
Q 003278 654 ----PDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFR 729 (834)
Q Consensus 654 ----~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~ 729 (834)
..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 169 ~~~~~~~~~kl~Dfg~a~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 238 (373)
T 1q8y_A 169 DSPENLIQIKIADLGNACWYDEH----------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 238 (373)
T ss_dssp ETTTTEEEEEECCCTTCEETTBC----------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred CCCcCcceEEEcccccccccCCC----------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 4457999999999764321 12347899999999999999999999999999999999999999643
Q ss_pred CCc-----hhHHHHHHHHHhhc------------------Cccccccccc---------cCCCCCHHHHHHHHHHHHHhc
Q 003278 730 LPE-----GLLVKRVHEFEARK------------------RPLAELVDLS---------LNGEYNHKELMRLIKLGIACT 777 (834)
Q Consensus 730 ~~~-----~~~~~~~~~~~~~~------------------~~~~~~~d~~---------l~~~~~~~~~~~l~~l~~~C~ 777 (834)
... ......+....... ..+..+.... -...........+..++.+||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 318 (373)
T 1q8y_A 239 EGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 318 (373)
T ss_dssp ------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGG
T ss_pred cccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHh
Confidence 321 11111111110000 0000000000 001123344556778888999
Q ss_pred cCCCCCCCChhHHHH
Q 003278 778 LSNPELRPSMRQILS 792 (834)
Q Consensus 778 ~~~P~~RPtm~~v~~ 792 (834)
+.||++|||+.||++
T Consensus 319 ~~dP~~Rpt~~ell~ 333 (373)
T 1q8y_A 319 QLDPRKRADAGGLVN 333 (373)
T ss_dssp CSSTTTCBCHHHHHT
T ss_pred ccCccccCCHHHHhh
Confidence 999999999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=329.27 Aligned_cols=241 Identities=19% Similarity=0.292 Sum_probs=185.9
Q ss_pred hhCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCCh-----hHHHHHHHHHHHHHhc----cCCCceeEEEEEee
Q 003278 512 TNNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCP-----ALRTRFSNELQNLARL----RHRNLVQLCGWCTE 581 (834)
Q Consensus 512 t~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~f~~E~~~l~~l----~HpNiv~l~g~~~~ 581 (834)
.++|...+.||+|+||.||+|.. .+++.||||.+...... .....+.+|+.++.++ +||||+++++++.+
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~ 109 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET 109 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence 46788889999999999999985 56889999998654321 1223466799999999 89999999999999
Q ss_pred CCeEEEEEec-cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeec-CCCCce
Q 003278 582 QGEMLVIYDY-SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLD-PDMNPR 659 (834)
Q Consensus 582 ~~~~~lv~Ey-~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld-~~~~~k 659 (834)
.+..++|||| +.+++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++ +++.+|
T Consensus 110 ~~~~~~v~e~~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 110 QEGFMLVLERPLPAQDLFDYITEKG------PLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp ---CEEEEECCSSEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEEE
T ss_pred CCeEEEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeEE
Confidence 8999999999 78999999987532 38899999999999999999997 5899999999999999 889999
Q ss_pred EeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCC-ccCcchhhHHHHHHHHhCCCccCCCCCchhHHHH
Q 003278 660 LGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEAT-SMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKR 738 (834)
Q Consensus 660 i~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~ 738 (834)
|+|||++....... .....||..|+|||++.+..+. .++|||||||++|||+||+.||....
T Consensus 181 l~dfg~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------- 243 (312)
T 2iwi_A 181 LIDFGSGALLHDEP---------YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-------- 243 (312)
T ss_dssp ECCCSSCEECCSSC---------BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------
T ss_pred EEEcchhhhcccCc---------ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--------
Confidence 99999997654321 2245799999999999877765 58999999999999999999985310
Q ss_pred HHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 739 VHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 739 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
....... .+....+ . .+.+++.+||+.||++|||+.+|++
T Consensus 244 --~~~~~~~--------~~~~~~~-~---~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 244 --EILEAEL--------HFPAHVS-P---DCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp --HHHHTCC--------CCCTTSC-H---HHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred --HHhhhcc--------CCcccCC-H---HHHHHHHHHccCChhhCcCHHHHhc
Confidence 0111111 0111222 2 3455666999999999999999986
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=365.93 Aligned_cols=239 Identities=21% Similarity=0.326 Sum_probs=191.0
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECC-CCeEEEEEEeccc-ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCE-----
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPS-DGTVVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQ----- 182 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~-~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~----- 182 (834)
.++|...+.||+|+||.||+|.+.. +|+.||||++... .....+.|.+|+.++.+++|||||+++++|...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 3679999999999999999999865 7899999998643 33456678999999999999999999999998765
Q ss_pred EEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeec
Q 003278 183 LLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDF 262 (834)
Q Consensus 183 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DF 262 (834)
.||||||+++++|.+++. ..++|..++.|+.||++||.|||+. +||||||||+|||++.+ .+||+||
T Consensus 159 ~~lv~E~~~g~~L~~~~~---------~~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DF 225 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKG---------QKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDL 225 (681)
T ss_dssp EEEEEECCCCEECC-------------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCC
T ss_pred eEEEEEeCCCCcHHHHHh---------CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEec
Confidence 799999999999987763 2589999999999999999999996 99999999999999986 8999999
Q ss_pred cchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCc
Q 003278 263 GLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDD 342 (834)
Q Consensus 263 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~ 342 (834)
|+++.+.. .+...||++|+|||.+..+ .+.++|||||||++|||++|..|+.......
T Consensus 226 G~a~~~~~--------------------~~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~ 283 (681)
T 2pzi_A 226 GAVSRINS--------------------FGYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVDG 283 (681)
T ss_dssp TTCEETTC--------------------CSCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECSS
T ss_pred ccchhccc--------------------CCccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCccccccc
Confidence 99975321 2345699999999998654 3889999999999999999998875321110
Q ss_pred cchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCc-hhhHHHHhhc
Q 003278 343 QIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPS-MKWVIEAVSG 407 (834)
Q Consensus 343 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-m~~V~~~l~~ 407 (834)
+. ...........+.+++..||+.||.+||+ +.++.+.|.+
T Consensus 284 ----------------~~--------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 284 ----------------LP--------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp ----------------CC--------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ----------------cc--------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 00 00000111246788999999999999995 5555555544
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=357.18 Aligned_cols=262 Identities=24% Similarity=0.366 Sum_probs=195.9
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc-ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEe------CCEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNLVRLRGWCVH------EDQL 183 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~------~~~~ 183 (834)
++|...+.||+|+||.||+|.+..+|+.||||++... .....+.|.+|+.++.+++|||||++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 6799999999999999999999889999999998653 34456779999999999999999999998765 6678
Q ss_pred EEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCc---eEEe
Q 003278 184 LLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYN---ARLG 260 (834)
Q Consensus 184 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~---~kl~ 260 (834)
++||||+++|+|.+++..... ...+++..+..|+.|++.||+|||+. +|+||||||+|||++.++. +||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~----~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~ 166 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFEN----CCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKII 166 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSC----TTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred EEEEEeCCCCCHHHHHHhccc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEc
Confidence 999999999999999976432 24688899999999999999999995 9999999999999987654 9999
Q ss_pred eccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCC
Q 003278 261 DFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYP 340 (834)
Q Consensus 261 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~ 340 (834)
|||+++..... .......||+.|+|||.+... .++.++|||||||++|||+||+.||.....
T Consensus 167 DFG~a~~~~~~-----------------~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSLGviLyeLltG~~Pf~~~~~ 228 (676)
T 3qa8_A 167 DLGYAKELDQG-----------------ELCTEFVGTLQYLAPELLEQK-KYTVTVDYWSFGTLAFECITGFRPFLPNWQ 228 (676)
T ss_dssp SCCCCCBTTSC-----------------CCCCCCCSCCTTCSSCSSCCS-CCSTTHHHHHHHHHHHHHHSSCSSCCSSCH
T ss_pred ccccccccccc-----------------cccccccCCcccCChHHhccC-CCCchhHHHHHHHHHHHHHHCCCCCCcccc
Confidence 99999854221 012345799999999988644 679999999999999999999999864211
Q ss_pred CccchHHHHHHHHhhcCc----cccccc------cccC-CCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHH
Q 003278 341 DDQIILLDWIRRLSDEGK----VLQAGD------NRLS-DGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVI 402 (834)
Q Consensus 341 ~~~~~l~~~~~~~~~~~~----~~~~~d------~~l~-~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~ 402 (834)
...|......... ..+... ..+. ...........+.+++..||..||.+||++.+++
T Consensus 229 -----~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL 296 (676)
T 3qa8_A 229 -----PVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP 296 (676)
T ss_dssp -----HHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred -----hhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence 1111111100000 000000 0000 0112233456789999999999999999998743
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=356.80 Aligned_cols=264 Identities=20% Similarity=0.230 Sum_probs=193.7
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEee------CCeE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTE------QGEM 585 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~------~~~~ 585 (834)
++|...+.||+|+||.||+|.. .++..||||++.........+.|.+|+.+|++++|||||++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 5788899999999999999986 45889999998766666667889999999999999999999999765 6678
Q ss_pred EEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCC---ceEee
Q 003278 586 LVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMN---PRLGS 662 (834)
Q Consensus 586 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~---~ki~D 662 (834)
++||||+++|+|.+++...... ..+++..+..|+.|++.||+|||+ .+|+||||||+|||++.++. +||+|
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~---~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~D 167 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENC---CGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIID 167 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCT---TCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred EEEEEeCCCCCHHHHHHhcccC---CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEcc
Confidence 9999999999999999764322 247888899999999999999997 68999999999999997665 89999
Q ss_pred eeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHH
Q 003278 663 FALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEF 742 (834)
Q Consensus 663 fGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~ 742 (834)
||++....... ......||+.|+|||++.++.++.++|||||||++|||+||..||................
T Consensus 168 FG~a~~~~~~~--------~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~ 239 (676)
T 3qa8_A 168 LGYAKELDQGE--------LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREK 239 (676)
T ss_dssp CCCCCBTTSCC--------CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC--
T ss_pred ccccccccccc--------ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcc
Confidence 99998654321 1234679999999999999999999999999999999999999986432111000000000
Q ss_pred HhhcCccccccc------cc--cCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHH
Q 003278 743 EARKRPLAELVD------LS--LNGEYNHKELMRLIKLGIACTLSNPELRPSMRQI 790 (834)
Q Consensus 743 ~~~~~~~~~~~d------~~--l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v 790 (834)
........+... .. ............+..++.+||..||++|||+.++
T Consensus 240 ~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 240 SNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp ----CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred cchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 000000000000 00 0111122223455666679999999999999773
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-36 Score=321.00 Aligned_cols=230 Identities=13% Similarity=0.091 Sum_probs=181.4
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 187 (834)
++|...+.||+|+||.||+|.+..+|+.||||++.... ....+.|.+|+.++.+++||||+++++++.+.+..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 56999999999999999999998889999999987542 344578999999999999999999999999999999999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
||+++++|.+++... ....+...|+.|++.||+|||+. +|+||||||+|||++.++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~~---------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~---- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS---------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA---- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC---------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC----
T ss_pred EecCCCCHHHHHhcC---------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc----
Confidence 999999999998431 23446788999999999999996 99999999999999999999987543
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHH
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILL 347 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~ 347 (834)
|++| ++.++|||||||++|||+||+.||............
T Consensus 175 --------------------------------~~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~ 214 (286)
T 3uqc_A 175 --------------------------------TMPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA 214 (286)
T ss_dssp --------------------------------CCTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC
T ss_pred --------------------------------ccCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH
Confidence 4443 578999999999999999999999754332211000
Q ss_pred HHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 348 DWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 348 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
.... .+.. ..+....... ...+.+++..||+.||.+| |+.++++.|...
T Consensus 215 ---~~~~-~~~~---~~~~~~~~~~----~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~ 263 (286)
T 3uqc_A 215 ---ERDT-AGQP---IEPADIDRDI----PFQISAVAARSVQGDGGIR-SASTLLNLMQQA 263 (286)
T ss_dssp ---CBCT-TSCB---CCHHHHCTTS----CHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHH
T ss_pred ---HHHh-ccCC---CChhhcccCC----CHHHHHHHHHHcccCCccC-CHHHHHHHHHHH
Confidence 0000 0000 0000000111 2458899999999999999 999999999764
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=359.43 Aligned_cols=237 Identities=18% Similarity=0.223 Sum_probs=187.8
Q ss_pred hCcCcCCcccccCCcEEEEEEEC--CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCe-----E
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD--NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGE-----M 585 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~--~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~-----~ 585 (834)
++|...+.||+|+||.||+|... +++.||||.+...........|.+|+.+|++++|||||++++++...+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 56778889999999999999975 5789999998766556666789999999999999999999999987655 7
Q ss_pred EEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeee
Q 003278 586 LVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFAL 665 (834)
Q Consensus 586 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGl 665 (834)
+|||||+++++|.+++.. .++|..++.|+.|++.||+|||+ .+||||||||+|||++.+ .+||+|||+
T Consensus 160 ~lv~E~~~g~~L~~~~~~--------~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~ 227 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ--------KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGA 227 (681)
T ss_dssp EEEEECCCCEECC----C--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTT
T ss_pred EEEEEeCCCCcHHHHHhC--------CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEeccc
Confidence 999999999999887642 38899999999999999999997 689999999999999986 899999999
Q ss_pred ccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhh
Q 003278 666 AEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEAR 745 (834)
Q Consensus 666 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~ 745 (834)
++..... ....||++|||||++.++. +.++|||||||+||||++|..|+........
T Consensus 228 a~~~~~~-----------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----------- 284 (681)
T 2pzi_A 228 VSRINSF-----------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL----------- 284 (681)
T ss_dssp CEETTCC-----------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC-----------
T ss_pred chhcccC-----------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc-----------
Confidence 9764321 2457999999999997654 8899999999999999999887653211100
Q ss_pred cCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCC-hhHHHHHHc
Q 003278 746 KRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPS-MRQILSILD 795 (834)
Q Consensus 746 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPt-m~~v~~~L~ 795 (834)
. . ..........+..++.+||+.||++||+ +.++...|.
T Consensus 285 ----~---~----~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 285 ----P---E----DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp ----C---T----TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred ----c---c----cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence 0 0 0000011124556777999999999996 555555554
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=344.16 Aligned_cols=252 Identities=14% Similarity=0.053 Sum_probs=182.8
Q ss_pred HHhhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHHHHHhCCC-Ccee----------
Q 003278 106 LYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVAVAHLRH-RNLV---------- 171 (834)
Q Consensus 106 l~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H-~nIv---------- 171 (834)
+...+.+|...++||+|+||.||+|.+..+|+.||||++.... ....+.|.+|+.++..++| +|+.
T Consensus 73 ~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~ 152 (413)
T 3dzo_A 73 LGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF 152 (413)
T ss_dssp SSSCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCC
T ss_pred CCCCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhccccc
Confidence 3345566888899999999999999998999999999987332 2235678999999999987 3221
Q ss_pred -----eE------eeeEEe-----CCEEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhcc
Q 003278 172 -----RL------RGWCVH-----EDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQL 235 (834)
Q Consensus 172 -----~l------~g~~~~-----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 235 (834)
.+ ..++.. ....+++|+++ +|+|.+++............++|..++.|+.|+++||+|||+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~- 230 (413)
T 3dzo_A 153 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY- 230 (413)
T ss_dssp CCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT-
T ss_pred chhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 11 111111 12367777765 6899988842111011234688999999999999999999986
Q ss_pred CCCeecCCCCCCceEECCCCceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccc--------
Q 003278 236 ETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQ-------- 307 (834)
Q Consensus 236 ~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-------- 307 (834)
+||||||||+|||++.++.+||+|||+++..... .+...| +.|+|||.+.
T Consensus 231 --~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-------------------~~~~~g-~~y~aPE~~~~~~~~~~~ 288 (413)
T 3dzo_A 231 --GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-------------------AVSPIG-RGFAPPETTAERMLPFGQ 288 (413)
T ss_dssp --TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE-------------------ECCCCC-TTTCCHHHHHHHTSTTGG
T ss_pred --CcccCCcccceEEEecCCeEEEEeccceeecCCc-------------------cccCCC-CceeCchhhhcccccccc
Confidence 9999999999999999999999999998753211 234568 9999999983
Q ss_pred -cCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHH
Q 003278 308 -KGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALL 386 (834)
Q Consensus 308 -~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~ 386 (834)
.+..++.++|||||||++|||+||+.||........ ........ ...+ ..+.+|+..
T Consensus 289 ~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~---------------~~~~~~~~---~~~~----~~~~~li~~ 346 (413)
T 3dzo_A 289 HHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGG---------------SEWIFRSC---KNIP----QPVRALLEG 346 (413)
T ss_dssp GCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSC---------------SGGGGSSC---CCCC----HHHHHHHHH
T ss_pred ccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhh---------------HHHHHhhc---ccCC----HHHHHHHHH
Confidence 334578899999999999999999999864322111 00111100 1111 468899999
Q ss_pred hcccCCCCCCchhhHHH
Q 003278 387 CTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 387 Cl~~~p~~RPsm~~V~~ 403 (834)
||+.||.+||++.++++
T Consensus 347 ~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 347 FLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HTCSSGGGSCCHHHHTT
T ss_pred HccCChhhCcCHHHHHh
Confidence 99999999999887754
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=317.29 Aligned_cols=228 Identities=20% Similarity=0.233 Sum_probs=177.1
Q ss_pred CCCCCC-CeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHH-HhCCCCceeeEeeeEEe----CCEEE
Q 003278 111 NGFDED-EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAV-AHLRHRNLVRLRGWCVH----EDQLL 184 (834)
Q Consensus 111 ~~f~~~-~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l-~~l~H~nIv~l~g~~~~----~~~~~ 184 (834)
++|... +.||+|+||.||+|....+|+.||||++... ..+.+|+.++ +.++||||+++++++.. .+..+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 456665 7899999999999999999999999998643 4567788887 66799999999999987 67799
Q ss_pred EEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECC---CCceEEee
Q 003278 185 LVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDS---QYNARLGD 261 (834)
Q Consensus 185 lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~---~~~~kl~D 261 (834)
+||||+++|+|.+++.... ...+++..+..|+.|++.||.|||+. +|+||||||+|||++. ++.+||+|
T Consensus 92 lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~D 163 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRG-----DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD 163 (299)
T ss_dssp EEECCCCSCBHHHHHHHCT-----TCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred EEEeecCCCcHHHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEec
Confidence 9999999999999997642 24689999999999999999999996 9999999999999998 78899999
Q ss_pred ccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCC
Q 003278 262 FGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPD 341 (834)
Q Consensus 262 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~ 341 (834)
||+++... +..++.++|||||||++|||+||+.||......
T Consensus 164 fg~a~~~~---------------------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~ 204 (299)
T 3m2w_A 164 FGFAKETT---------------------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 204 (299)
T ss_dssp CTTCEECT---------------------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC----
T ss_pred cccccccc---------------------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcch
Confidence 99886321 123577899999999999999999998643211
Q ss_pred ccchHHHHHHHHhhcCccccccccccCCCCCCH----HHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 342 DQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKL----CDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 342 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~----~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
.. . .......... ...... .....+.+++..||+.||.+||++.++++.
T Consensus 205 ~~-----------~-~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 205 AI-----------S-PGMKTRIRMG--QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp ---------------CCSCCSSCTT--CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hh-----------h-HHHHHHHhhc--cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 10 0 0000000000 000010 012467889999999999999999999863
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=309.90 Aligned_cols=231 Identities=10% Similarity=0.067 Sum_probs=176.6
Q ss_pred hCcCcCCcccccCCcEEEEEEECC-CcEEEEEEecCCCC--hhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDN-HQYVLVKRLGMSKC--PALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIY 589 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~-~~~vavK~~~~~~~--~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~ 589 (834)
+.|...+.||+|+||.||+|.... ++.||||.+..... ....+.|.+|+.++++++|||||++++++.+.+..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 346667889999999999999754 88999999876533 445578999999999999999999999999999999999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccc
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFL 669 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~ 669 (834)
||+++++|.+++... ......++|+.|++.||+|||+ .+|+||||||+|||++.++.+||+++
T Consensus 111 e~~~g~~L~~~l~~~--------~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~------ 173 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS--------PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYP------ 173 (286)
T ss_dssp ECCCEEEHHHHHTTC--------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSC------
T ss_pred EecCCCCHHHHHhcC--------CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEec------
Confidence 999999999998431 2334578899999999999997 69999999999999999999988632
Q ss_pred ccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcc
Q 003278 670 TRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPL 749 (834)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
+|++| ++.++|||||||++|||+||+.||........+... .....
T Consensus 174 ---------------------~~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~------~~~~~ 219 (286)
T 3uqc_A 174 ---------------------ATMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA------ERDTA 219 (286)
T ss_dssp ---------------------CCCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC------CBCTT
T ss_pred ---------------------cccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH------HHHhc
Confidence 35544 688999999999999999999998754332110000 00000
Q ss_pred cccccc-ccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCc
Q 003278 750 AELVDL-SLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDK 799 (834)
Q Consensus 750 ~~~~d~-~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~ 799 (834)
.....+ .+.... +. .+..++.+||+.||++| |+.++++.|+....
T Consensus 220 ~~~~~~~~~~~~~-~~---~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 220 GQPIEPADIDRDI-PF---QISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp SCBCCHHHHCTTS-CH---HHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred cCCCChhhcccCC-CH---HHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 000000 011111 12 34556669999999999 99999999976543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-35 Score=329.08 Aligned_cols=245 Identities=14% Similarity=0.059 Sum_probs=174.0
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChh--HHHHHHHHHHHHHhccC-CCce----------eE---
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPA--LRTRFSNELQNLARLRH-RNLV----------QL--- 575 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~--~~~~f~~E~~~l~~l~H-pNiv----------~l--- 575 (834)
.+|...+.||+|+||.||+|.. .+++.||||++....... ..+.|.+|+.++..++| +|.. .+
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 3455667899999999999994 568999999987433222 24679999999999988 3221 11
Q ss_pred --------EEEEee-----CCeEEEEEeccCCCchhhhhhcCCC-CCCCcccCHHHHHHHHHHHHHHHHHhhhccCCcee
Q 003278 576 --------CGWCTE-----QGEMLVIYDYSATRILSHLLFHNNH-RIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVI 641 (834)
Q Consensus 576 --------~g~~~~-----~~~~~lv~Ey~~~g~L~~~l~~~~~-~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~ii 641 (834)
..++.. ....+++|++ .+++|.+++..... ......++|..++.|+.|+++||+|||+ .+||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPR-MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEEC-CSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEE
T ss_pred ccCCCCccccccCCCccccccceEEEeeh-hcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcc
Confidence 111111 1234566665 46889888742110 1112358899999999999999999997 6999
Q ss_pred ecccccCceeecCCCCceEeeeeeccccccCCCCCcccccCccccccccCccchhcc----------ccCCCCccCcchh
Q 003278 642 HRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYI----------ESGEATSMADVYS 711 (834)
Q Consensus 642 HrDlK~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~----------~~~~~~~k~DV~S 711 (834)
||||||+||||+.++.+||+|||+++..... ....+| +.|||||++ .+..++.++||||
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwS 302 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWT 302 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE----------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc----------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHH
Confidence 9999999999999999999999998753221 234578 999999999 5556889999999
Q ss_pred hHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHH
Q 003278 712 FGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQIL 791 (834)
Q Consensus 712 fGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~ 791 (834)
|||++|||+||+.||....+... ...++... ...+ + .+..++.+||+.||++|||+.+++
T Consensus 303 lGvil~elltg~~Pf~~~~~~~~--------------~~~~~~~~--~~~~-~---~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 303 LGLAIYWIWCADLPNTDDAALGG--------------SEWIFRSC--KNIP-Q---PVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHHHHHHHHSSCCCCTTGGGSC--------------SGGGGSSC--CCCC-H---HHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHHHHHHHCCCCCCCcchhhh--------------HHHHHhhc--ccCC-H---HHHHHHHHHccCChhhCcCHHHHH
Confidence 99999999999999864322111 11111100 1122 3 355566699999999999988775
Q ss_pred H
Q 003278 792 S 792 (834)
Q Consensus 792 ~ 792 (834)
+
T Consensus 363 ~ 363 (413)
T 3dzo_A 363 E 363 (413)
T ss_dssp T
T ss_pred h
Confidence 4
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=323.80 Aligned_cols=238 Identities=16% Similarity=0.180 Sum_probs=178.2
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC--------hhhHHHHHHHHHHHHhCC---------CCceee
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG--------ERFEKTFAAELVAVAHLR---------HRNLVR 172 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~--------~~~~~~~~~E~~~l~~l~---------H~nIv~ 172 (834)
.++|...+.||+|+||+||+|++ +|+.||||++.... ....+.+.+|+.+++.++ |||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 35688899999999999999998 68999999986542 223477889999998886 777777
Q ss_pred EeeeEE-----------------e-------------CCEEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHH
Q 003278 173 LRGWCV-----------------H-------------EDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIR 222 (834)
Q Consensus 173 l~g~~~-----------------~-------------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~ 222 (834)
+.+.+. + .+..+||||||++|++.+.+.+ ..+++..+..|+.
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--------~~~~~~~~~~i~~ 168 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--------KLSSLATAKSILH 168 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--------TCCCHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--------cCCCHHHHHHHHH
Confidence 766543 2 6789999999999976666532 3578999999999
Q ss_pred HHHHHHHHHH-hccCCCeecCCCCCCceEECCCC--------------------ceEEeeccchhhhhhhhhhhhhcccc
Q 003278 223 GLAAALHYLH-EQLETQIIHRDVKTSNVMLDSQY--------------------NARLGDFGLARWLEHELQYQMRTSSA 281 (834)
Q Consensus 223 ~ia~gL~yLH-~~~~~~iiHrDlKp~NILld~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~~ 281 (834)
||+.||+||| +. +|+||||||+|||++.++ .+||+|||+|+....
T Consensus 169 qi~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~----------- 234 (336)
T 2vuw_A 169 QLTASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD----------- 234 (336)
T ss_dssp HHHHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-----------
T ss_pred HHHHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-----------
Confidence 9999999999 75 999999999999999886 899999999985421
Q ss_pred cccccccccceeeeccccCCCccccccCCCCCcccceeehhhH-HHHHHhCCccCCCCCCCccchHHHHHHHH----hhc
Q 003278 282 RNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIV-VLEVVSGRRAVDLTYPDDQIILLDWIRRL----SDE 356 (834)
Q Consensus 282 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvv-l~ElltG~~p~~~~~~~~~~~l~~~~~~~----~~~ 356 (834)
....||+.|||||.+... . +.++||||||++ .+++++|..|+.. ..|.... ...
T Consensus 235 ----------~~~~gt~~y~aPE~~~g~-~-~~~~Diwsl~~~~~~~~~~g~~p~~~---------~~~~~~~~~~~~~~ 293 (336)
T 2vuw_A 235 ----------GIVVFCDVSMDEDLFTGD-G-DYQFDIYRLMKKENNNRWGEYHPYSN---------VLWLHYLTDKMLKQ 293 (336)
T ss_dssp ----------TEEECCCCTTCSGGGCCC-S-SHHHHHHHHHHHHHTTCTTSCCTHHH---------HHHHHHHHHHHHHT
T ss_pred ----------CcEEEeecccChhhhcCC-C-ccceehhhhhCCCCcccccccCCCcc---------hhhhhHHHHhhhhh
Confidence 234699999999998643 3 889999998777 7889999988731 1222211 111
Q ss_pred CccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHH
Q 003278 357 GKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVI 402 (834)
Q Consensus 357 ~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~ 402 (834)
..... ... ..........+.+|+..||+.| |+.|++
T Consensus 294 ~~~~~----~~~-~~~~~~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 294 MTFKT----KCN-TPAMKQIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp CCCSS----CCC-SHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred hccCc----ccc-hhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence 00000 000 0001123356889999999965 888887
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-34 Score=305.57 Aligned_cols=226 Identities=15% Similarity=0.170 Sum_probs=171.0
Q ss_pred hCcCcC-CcccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHHHHHHHHHHHH-HhccCCCceeEEEEEee----CCeE
Q 003278 513 NNFSES-QRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNL-ARLRHRNLVQLCGWCTE----QGEM 585 (834)
Q Consensus 513 ~~f~~~-~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~E~~~l-~~l~HpNiv~l~g~~~~----~~~~ 585 (834)
++|... +.||+|+||.||+|.. .++..||||.+... ..+.+|+.++ +.++||||+++++++.. ....
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 345544 5699999999999986 56889999998532 3567899888 56699999999999876 6778
Q ss_pred EEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecC---CCCceEee
Q 003278 586 LVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDP---DMNPRLGS 662 (834)
Q Consensus 586 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~---~~~~ki~D 662 (834)
++||||+++|+|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~D 163 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGD----QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTD 163 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred EEEEeecCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEec
Confidence 999999999999999976432 248899999999999999999997 68999999999999998 78899999
Q ss_pred eeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHH
Q 003278 663 FALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEF 742 (834)
Q Consensus 663 fGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~ 742 (834)
||++.... +..++.++|||||||++|||+||+.||.........
T Consensus 164 fg~a~~~~-----------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~------- 207 (299)
T 3m2w_A 164 FGFAKETT-----------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS------- 207 (299)
T ss_dssp CTTCEECT-----------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------------
T ss_pred cccccccc-----------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-------
Confidence 99986421 135678999999999999999999998643211100
Q ss_pred HhhcCccccccccccCCCCCHH----HHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 743 EARKRPLAELVDLSLNGEYNHK----ELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 743 ~~~~~~~~~~~d~~l~~~~~~~----~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
......+..... ..... .-..+..++.+||+.||++|||+.++++
T Consensus 208 ---~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 208 ---PGMKTRIRMGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp ---CCSCCSSCTTCC--SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ---HHHHHHHhhccc--cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 000000000000 00100 0124556666999999999999999986
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=316.53 Aligned_cols=191 Identities=11% Similarity=0.127 Sum_probs=158.3
Q ss_pred hCcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCC-------ChhHHHHHHHHHHHHHhcc---------CCCceeEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSK-------CPALRTRFSNELQNLARLR---------HRNLVQLC 576 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~-------~~~~~~~f~~E~~~l~~l~---------HpNiv~l~ 576 (834)
++|...+.||+|+||.||+|.. +++.||||++.... .....+.+.+|+.+|++++ |||||++.
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred ccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 4577788999999999999987 67899999987543 2233467899999999996 88888888
Q ss_pred EEEe------------------------------eCCeEEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHH
Q 003278 577 GWCT------------------------------EQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLA 626 (834)
Q Consensus 577 g~~~------------------------------~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia 626 (834)
+++. +.+..+|||||+++|++.+.+.. ..+++.....|+.|++
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-------~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-------KLSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-------TCCCHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-------cCCCHHHHHHHHHHHH
Confidence 8643 26789999999999976666532 1378899999999999
Q ss_pred HHHHHhh-hccCCceeecccccCceeecCCC--------------------CceEeeeeeccccccCCCCCcccccCccc
Q 003278 627 SAILYLH-EEWNEQVIHRNITSSAITLDPDM--------------------NPRLGSFALAEFLTRNDHGHRKATSGNRS 685 (834)
Q Consensus 627 ~gl~yLH-~~~~~~iiHrDlK~~NILld~~~--------------------~~ki~DfGla~~~~~~~~~~~~~~~~~~~ 685 (834)
.||+||| + .+||||||||+||||+.++ .+||+|||+|+.... ..
T Consensus 172 ~aL~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------------~~ 236 (336)
T 2vuw_A 172 ASLAVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------------GI 236 (336)
T ss_dssp HHHHHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------------TE
T ss_pred HHHHHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC------------Cc
Confidence 9999999 6 5899999999999999887 899999999986432 13
Q ss_pred cccccCccchhccccCCCCccCcchhhHHH-HHHHHhCCCccC
Q 003278 686 VRGIFGYMSPEYIESGEATSMADVYSFGVV-VLEVVTGQMAVD 727 (834)
Q Consensus 686 ~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvv-l~E~~tG~~p~~ 727 (834)
..||+.|||||++.+.. +.++||||+|++ .+++++|..|+.
T Consensus 237 ~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~ 278 (336)
T 2vuw_A 237 VVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS 278 (336)
T ss_dssp EECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred EEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence 47999999999998655 889999998777 778889988873
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 834 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-57 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 8e-42 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-55 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-38 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-53 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-36 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-52 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-33 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-52 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-36 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-52 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-41 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-52 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-40 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-52 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-34 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-51 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-37 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-51 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-39 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-50 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-35 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-50 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-32 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 8e-50 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-38 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-49 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-38 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-49 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-33 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-49 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-36 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-48 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-34 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 7e-48 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-34 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 8e-48 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-35 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-47 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-36 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-47 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 8e-38 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-47 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-33 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-47 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-38 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-47 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-33 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-47 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 9e-38 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-47 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-33 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-47 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-31 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-46 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-31 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-45 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-23 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-43 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-34 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-43 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-29 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-43 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-29 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-43 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-31 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-42 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-27 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-42 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-27 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 8e-42 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-30 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-41 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-24 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-41 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-25 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-40 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-29 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-39 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 9e-26 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-39 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-21 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-38 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 9e-26 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-38 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-24 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-38 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-28 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-38 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-28 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-38 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-22 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-37 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-21 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-37 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-23 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-37 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-24 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-36 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-25 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-35 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-24 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-35 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-25 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-34 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-19 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-33 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-25 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-33 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-21 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-33 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-21 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-32 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-21 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-30 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 9e-19 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 9e-30 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-14 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-27 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 8e-17 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-27 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-15 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-22 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-15 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-20 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-09 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 1e-57
Identities = 70/301 (23%), Positives = 113/301 (37%), Gaps = 43/301 (14%)
Query: 108 IGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCL--AEKGERFEKTFAAELVAVAHL 165
I + +GSG FG VY+ D VAVK L + + F E+ +
Sbjct: 5 IPDGQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61
Query: 166 RHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLA 225
RH N++ G+ QL +V + SL L + I R A
Sbjct: 62 RHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIET------KFEMIKLIDIARQTA 114
Query: 226 AALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQ 285
+ YLH + IIHRD+K++N+ L ++GDFGLA
Sbjct: 115 QGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQ--------- 162
Query: 286 FHLAETTRIGGTIGYLPPESF--QKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQ 343
++ G+I ++ PE Q + + +SDV++FGIV+ E+++G+ P
Sbjct: 163 -----FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQL------PYSN 211
Query: 344 IILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403
I D I + G + S+ + L C RP ++
Sbjct: 212 INNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKR------LMAECLKKKRDERPLFPQILA 265
Query: 404 A 404
+
Sbjct: 266 S 266
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 8e-42
Identities = 68/287 (23%), Positives = 119/287 (41%), Gaps = 30/287 (10%)
Query: 513 NNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKC-PALRTRFSNELQNLARLRHRN 571
+ QR+ FGT Y+G H V VK L ++ P F NE+ L + RH N
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 572 LVQLCGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILY 631
++ G+ T ++ ++ + L H L + + +I + A + Y
Sbjct: 66 ILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIETK-----FEMIKLIDIARQTAQGMDY 119
Query: 632 LHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFG 691
LH + +IHR++ S+ I L D+ ++G F LA +R H+ + G
Sbjct: 120 LH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ-----LSGSIL 171
Query: 692 YMSPEYI---ESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRP 748
+M+PE I + + +DVY+FG+V+ E++TGQ+ ++ V
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDL 231
Query: 749 LAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795
+ K + RL+ C + RP QIL+ ++
Sbjct: 232 SKVRSNCP-------KAMKRLMA---ECLKKKRDERPLFPQILASIE 268
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 2e-55
Identities = 61/299 (20%), Positives = 115/299 (38%), Gaps = 31/299 (10%)
Query: 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCL-AEKGERFEKTFAAELVAVAHLRHRN 169
+ F++ LG+G G V++ G V+A K + E EL +
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 170 LVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALH 229
+V G + ++ + ++M SLD+VL + + + K+ + L
Sbjct: 66 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-------GRIPEQILGKVSIAVIKGLT 118
Query: 230 YLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLA 289
YL E+ +I+HRDVK SN++++S+ +L DFG++ L +
Sbjct: 119 YLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----------------- 159
Query: 290 ETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDW 349
GT Y+ PE Q G+ + +SD++S G+ ++E+ GR + + ++
Sbjct: 160 -ANSFVGTRSYMSPERLQ-GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGC 217
Query: 350 IRR--LSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVS 406
++ + LS + L P PS + +E
Sbjct: 218 QVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQD 276
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 2e-38
Identities = 50/314 (15%), Positives = 107/314 (34%), Gaps = 52/314 (16%)
Query: 511 ATNNFSESQRVAEMDFGTAYQGF-LDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRH 569
++F + + + G ++ + + K + + PA+R + ELQ L
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 570 RNLVQLCGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAI 629
+V G GE+ + ++ L +L + + ++ +
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR------IPEQILGKVSIAVIKGL 117
Query: 630 LYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGI 689
YL E+ ++HR++ S I ++ +L F ++ L S S G
Sbjct: 118 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---------DSMANSFVGT 166
Query: 690 FGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQ---------------------MAVDF 728
YMSPE ++ + +D++S G+ ++E+ G+ A +
Sbjct: 167 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAET 226
Query: 729 RLPEGLLVKRVHEFEARKRPLAELVDL----------SLNGEYNHKELMRLIKLGIACTL 778
+ + + RP + +L L E + C +
Sbjct: 227 PPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVN---KCLI 283
Query: 779 SNPELRPSMRQILS 792
NP R ++Q++
Sbjct: 284 KNPAERADLKQLMV 297
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 7e-53
Identities = 63/306 (20%), Positives = 108/306 (35%), Gaps = 41/306 (13%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGW 176
E +G G FG+V+R G VAVK + + ER AE+ LRH N++
Sbjct: 9 ESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAA 65
Query: 177 CVHED----QLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLH 232
++ QL LV DY + SL L R + E K+ A+ L +LH
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--------VTVEGMIKLALSTASGLAHLH 117
Query: 233 EQL-----ETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFH 287
++ + I HRD+K+ N+++ + D GLA +
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA--------- 168
Query: 288 LAETTRIGGTIGYLPPESFQ-----KGSVATAKSDVFSFGIVVLEVVSGRR----AVDLT 338
GT Y+ PE K + ++D+++ G+V E+ D
Sbjct: 169 ---PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 225
Query: 339 YPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSM 398
P ++ D + Q + + + + + C N R +
Sbjct: 226 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA 285
Query: 399 KWVIEA 404
+ +
Sbjct: 286 LRIKKT 291
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 2e-36
Identities = 57/291 (19%), Positives = 100/291 (34%), Gaps = 34/291 (11%)
Query: 526 FGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQG-- 583
FG ++G + V VK S E+ LRH N++ +
Sbjct: 16 FGEVWRGKWRG-EEVAVKIF--SSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGT 72
Query: 584 --EMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEE-----W 636
++ ++ DY L L + + S AS + +LH E
Sbjct: 73 WTQLWLVSDYHEHGSLFDYLNRYT-------VTVEGMIKLALSTASGLAHLHMEIVGTQG 125
Query: 637 NEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPE 696
+ HR++ S I + + + LA A + G YM+PE
Sbjct: 126 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN---HRVGTKRYMAPE 182
Query: 697 YIES------GEATSMADVYSFGVVVLEVVTGQM----AVDFRLPEGLLVKRVHEFEA-R 745
++ E+ AD+Y+ G+V E+ D++LP LV E R
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 746 KRPLAELVDLSLNGEYNHKELMR-LIKLGIACTLSNPELRPSMRQILSILD 795
K + + ++ + E +R + K+ C +N R + +I L
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 3e-52
Identities = 62/291 (21%), Positives = 113/291 (38%), Gaps = 44/291 (15%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGW 176
LG G FGKVY+A + A K + K E + + E+ +A H N+V+L
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 177 CVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLE 236
+E+ L ++ ++ ++D V+ PL Q + + + AL+YLH+
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLELER------PLTESQIQVVCKQTLDALNYLHDN-- 129
Query: 237 TQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGG 296
+IIHRD+K N++ + +L DFG++ +Q G
Sbjct: 130 -KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR----------------RDSFIG 172
Query: 297 TIGYLPPESFQ----KGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIRR 352
T ++ PE K K+DV+S GI ++E+ P ++ + + +
Sbjct: 173 TPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEP------PHHELNPMRVLLK 226
Query: 353 LSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403
++ A +R S C N R + +++
Sbjct: 227 IAKSEPPTLAQPSRWSSNFKDFLKK---------CLEKNVDARWTTSQLLQ 268
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (324), Expect = 1e-33
Identities = 51/273 (18%), Positives = 96/273 (35%), Gaps = 35/273 (12%)
Query: 526 FGTAYQGF-LDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGE 584
FG Y+ + K + L + E+ LA H N+V+L +
Sbjct: 25 FGKVYKAQNKETSVLAAAKVIDTKSEEELE-DYMVEIDILASCDHPNIVKLLDAFYYENN 83
Query: 585 MLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRN 644
+ ++ ++ A + ++ L + K A+ YLH+ ++IHR+
Sbjct: 84 LWILIEFCAGGAVDAVMLELERP-----LTESQIQVVCKQTLDALNYLHD---NKIIHRD 135
Query: 645 ITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYI-----E 699
+ + I D + +L F ++ TR S G +M+PE + +
Sbjct: 136 LKAGNILFTLDGDIKLADFGVSAKNTRTIQRR-------DSFIGTPYWMAPEVVMCETSK 188
Query: 700 SGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNG 759
ADV+S G+ ++E+ + P +L+K LA+ S
Sbjct: 189 DRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS---EPPTLAQPSRWS--- 242
Query: 760 EYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792
+K C N + R + Q+L
Sbjct: 243 ----SNFKDFLK---KCLEKNVDARWTTSQLLQ 268
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 182 bits (462), Expect = 4e-52
Identities = 65/296 (21%), Positives = 106/296 (35%), Gaps = 51/296 (17%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCL---AEKGERFEKTFAAELVAVAHLRHRN 169
F + +G G FG VY A + VVA+K + ++ + E+ + LRH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 170 LVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALH 229
++ RG + E LV +Y + D + + PL + + G L
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK-------PLQEVEIAAVTHGALQGLA 129
Query: 230 YLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLA 289
YLH +IHRDVK N++L +LGDFG A +A
Sbjct: 130 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSAS--------------------IMA 166
Query: 290 ETTRIGGTIGYLPPESFQKGSV--ATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILL 347
GT ++ PE K DV+S GI +E+ + + +
Sbjct: 167 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-- 224
Query: 348 DWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403
+ Q L G + E+ + C P RP+ + +++
Sbjct: 225 ----------HIAQNESPALQSGHWS----EYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 135 bits (342), Expect = 7e-36
Identities = 62/334 (18%), Positives = 116/334 (34%), Gaps = 48/334 (14%)
Query: 502 EISFKEIISATNNFSESQRVAEMDFGTAYQGF-LDNHQYVLVKRLGMSKC--PALRTRFS 558
E+ FK+ FS+ + + FG Y + N + V +K++ S
Sbjct: 6 ELFFKD--DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDII 63
Query: 559 NELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHR 618
E++ L +LRH N +Q G + ++ +Y L H LQ
Sbjct: 64 KEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP------LQEVEI 117
Query: 619 YNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRK 678
+ + YLH +IHR++ + I L +LG F A + +
Sbjct: 118 AAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN----- 169
Query: 679 ATSGNRSVRGIFGYMSPEYIES---GEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLL 735
S G +M+PE I + G+ DV+S G+ +E+ + + L
Sbjct: 170 ------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 223
Query: 736 VKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795
+ P + S + + +C P+ RP+ +L
Sbjct: 224 YHIAQN----ESPALQSGHWS-------EYFRNFVD---SCLQKIPQDRPTSEVLLK--- 266
Query: 796 GNDKRFMEDGQMTENLEEWKQRNECSLSLIKRIQ 829
RF+ + + + QR + ++ + +Q
Sbjct: 267 ---HRFVLRERPPTVIMDLIQRTKDAVRELDNLQ 297
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 4e-52
Identities = 71/298 (23%), Positives = 119/298 (39%), Gaps = 45/298 (15%)
Query: 108 IGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRH 167
+ E LG+G FG+V+ T VAVK L ++G F AE + L+H
Sbjct: 10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQH 67
Query: 168 RNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAA 227
+ LVRL ++ + ++ +YM N SL L L + + +A
Sbjct: 68 QRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGI-----KLTINKLLDMAAQIAEG 121
Query: 228 LHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFH 287
+ ++ E+ IHRD++ +N+++ + ++ DFGLAR +E
Sbjct: 122 MAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA------------ 166
Query: 288 LAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQII-L 346
I + PE+ G+ T KSDV+SFGI++ E+V+ R + ++I
Sbjct: 167 ---REGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN 222
Query: 347 LDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404
L+ R+ E L L LC P RP+ ++
Sbjct: 223 LERGYRMVRPDNC-----------------PEELYQLMRLCWKERPEDRPTFDYLRSV 263
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 3e-41
Identities = 59/283 (20%), Positives = 117/283 (41%), Gaps = 30/283 (10%)
Query: 513 NNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNL 572
+R+ FG + G+ + H V VK L + F E + +L+H+ L
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL--KQGSMSPDAFLAEANLMKQLQHQRL 70
Query: 573 VQLCGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYL 632
V+L T+ + +I +Y L L L + ++ +A + ++
Sbjct: 71 VRLYAVVTQ-EPIYIITEYMENGSLVDFL----KTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 633 HEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGY 692
E IHR++ ++ I + ++ ++ F LA + N++ R+ + +
Sbjct: 126 EER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE------GAKFPIKW 176
Query: 693 MSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAEL 752
+PE I G T +DV+SFG+++ E+VT + +++ + RP
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP---- 232
Query: 753 VDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795
+ +EL +L++L C PE RP+ + S+L+
Sbjct: 233 -------DNCPEELYQLMRL---CWKERPEDRPTFDYLRSVLE 265
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 181 bits (459), Expect = 7e-52
Identities = 74/318 (23%), Positives = 128/318 (40%), Gaps = 52/318 (16%)
Query: 101 FSYAELYIGSNGFDE---------DEVLGSGGFGKVYRAVLPSDG---TVVAVKCL-AEK 147
F++ + F + ++V+G+G FG+V L G VA+K L +
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 148 GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLE 207
E+ + F +E + H N++ L G ++++ ++M N SLD L +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG--- 123
Query: 208 AAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267
Q ++RG+AA + YL + +HRD+ N++++S ++ DFGL+R+
Sbjct: 124 ---QFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRF 177
Query: 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLE 327
LE + TS+ I + PE+ Q + SDV+S+GIV+ E
Sbjct: 178 LEDDTSDPTYTSALGGK-----------IPIRWTAPEAIQYRKFTS-ASDVWSYGIVMWE 225
Query: 328 VVS-GRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALL 386
V+S G R D I ++ RL L L L
Sbjct: 226 VMSYGERPYWDMTNQDVINAIEQDYRLPPPMDC-----------------PSALHQLMLD 268
Query: 387 CTLHNPHLRPSMKWVIEA 404
C + + RP ++
Sbjct: 269 CWQKDRNHRPKFGQIVNT 286
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 147 bits (372), Expect = 5e-40
Identities = 55/305 (18%), Positives = 121/305 (39%), Gaps = 37/305 (12%)
Query: 504 SFKEIISATNNFSESQRVAEMD---------FGTAYQGFL----DNHQYVLVKRLGMSKC 550
+F++ A F++ ++ + FG G L +V +K L
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 551 PALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGH 610
R F +E + + H N++ L G T+ +++I ++ L L N+ +
Sbjct: 68 EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF-- 125
Query: 611 SILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLT 670
+++ +A+ + YL + +HR++ + I ++ ++ ++ F L+ FL
Sbjct: 126 ---TVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFL- 178
Query: 671 RNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRL 730
D + + + +PE I+ + TS +DV+S+G+V+ EV++ + +
Sbjct: 179 -EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 237
Query: 731 PEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQI 790
++ + + P+ L +L + C + RP QI
Sbjct: 238 TNQDVINAIEQDYRLPPPM--------------DCPSALHQLMLDCWQKDRNHRPKFGQI 283
Query: 791 LSILD 795
++ LD
Sbjct: 284 VNTLD 288
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 9e-52
Identities = 66/297 (22%), Positives = 121/297 (40%), Gaps = 43/297 (14%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCL--AEKGERFEKTFAAELVAVAHLRHRNL 170
++ +G+G +G+ + SDG ++ K L E ++ +E+ + L+H N+
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 171 VRLRGWCVHE--DQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAAL 228
VR + L +V +Y L V+ + + + L+ E +++ L AL
Sbjct: 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQ---YLDEEFVLRVMTQLTLAL 122
Query: 229 HYLHEQLET--QIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQF 286
H + + ++HRD+K +NV LD + N +LGDFGLAR L H+ +
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF------------ 170
Query: 287 HLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIIL 346
GT Y+ PE + S KSD++S G ++ E+ + +
Sbjct: 171 ----AKAFVGTPYYMSPEQMNRMSY-NEKSDIWSLGCLLYELCALMPPFTAFSQKELA-- 223
Query: 347 LDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403
GK+ + R+ E L + + RPS++ ++E
Sbjct: 224 ----------GKIREGKFRRIPYR----YSDE-LNEIITRMLNLKDYHRPSVEEILE 265
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 2e-34
Identities = 51/288 (17%), Positives = 104/288 (36%), Gaps = 30/288 (10%)
Query: 510 SATNNFSESQRVAEMDFGTAYQGF-LDNHQYVLVKRLGMSKC-PALRTRFSNELQNLARL 567
S ++ + +G + + + ++ K L A + +E+ L L
Sbjct: 1 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 60
Query: 568 RHRNLVQLCGWCTEQ--GEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSL 625
+H N+V+ ++ + ++ +Y L+ ++ + L ++ L
Sbjct: 61 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQY--LDEEFVLRVMTQL 118
Query: 626 ASAILYLHE--EWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGN 683
A+ H + V+HR++ + + LD N +LG F LA L +
Sbjct: 119 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA------- 171
Query: 684 RSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFE 743
++ G YMSPE + +D++S G ++ E+ + L ++ E +
Sbjct: 172 KAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA-GKIREGK 230
Query: 744 ARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQIL 791
R+ P EL +I RPS+ +IL
Sbjct: 231 FRRIP-----------YRYSDELNEIIT---RMLNLKDYHRPSVEEIL 264
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 1e-51
Identities = 62/292 (21%), Positives = 108/292 (36%), Gaps = 40/292 (13%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCL-AEKGERFEKTFAAELVAVAHLRHRNLV 171
+D + LG G +G+V AV VAVK + ++ + E+ L H N+V
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 172 RLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYL 231
+ G + L +Y L + + ++ L A + YL
Sbjct: 67 KFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-------GMPEPDAQRFFHQLMAGVVYL 119
Query: 232 HEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAET 291
H I HRD+K N++LD + N ++ DFGLA + + ++
Sbjct: 120 HGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL--------------L 162
Query: 292 TRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIR 351
++ GT+ Y+ PE ++ DV+S GIV+ +++G D Q DW
Sbjct: 163 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-SDWK- 220
Query: 352 RLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403
E K ++ L + NP R ++ + +
Sbjct: 221 ----EKKTYLNPWKKIDSAPLALLHK---------ILVENPSARITIPDIKK 259
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 2e-37
Identities = 47/269 (17%), Positives = 90/269 (33%), Gaps = 29/269 (10%)
Query: 526 FGTAYQGF-LDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGE 584
+G + V VK + M + E+ L H N+V+ G E
Sbjct: 18 YGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNI 77
Query: 585 MLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRN 644
+ +Y + L + + + L + ++YLH + HR+
Sbjct: 78 QYLFLEYCSGGELFDRIEPDIG------MPEPDAQRFFHQLMAGVVYLHGIG---ITHRD 128
Query: 645 ITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEAT 704
I + LD N ++ F LA N+ + G Y++PE ++ E
Sbjct: 129 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-----MCGTLPYVAPELLKRREFH 183
Query: 705 SMA-DVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYNH 763
+ DV+S G+V+ ++ G++ D E + P ++
Sbjct: 184 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI----------D 233
Query: 764 KELMRLIKLGIACTLSNPELRPSMRQILS 792
+ L+ + NP R ++ I
Sbjct: 234 SAPLALLH---KILVENPSARITIPDIKK 259
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 6e-51
Identities = 61/296 (20%), Positives = 113/296 (38%), Gaps = 43/296 (14%)
Query: 108 IGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRH 167
I + + +GSG FG V+ + VA+K + +G E+ F E + L H
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSH 59
Query: 168 RNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAA 227
LV+L G C+ + + LV+++M + L L + E + +
Sbjct: 60 PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG------LFAAETLLGMCLDVCEG 113
Query: 228 LHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFH 287
+ YL E +IHRD+ N ++ ++ DFG+ R++ +
Sbjct: 114 MAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG--------- 161
Query: 288 LAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILL 347
+ + PE F ++KSDV+SFG+++ EV S + + ++ +
Sbjct: 162 ------TKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV--V 212
Query: 348 DWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403
+ I RL +L H+ + C P RP+ ++
Sbjct: 213 EDIST-----------GFRLYKP--RLAS-THVYQIMNHCWKERPEDRPAFSRLLR 254
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 3e-39
Identities = 49/283 (17%), Positives = 100/283 (35%), Gaps = 30/283 (10%)
Query: 513 NNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNL 572
+ + Q + FG + G+ N V +K + + F E + + +L H L
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI--REGAMSEEDFIEEAEVMMKLSHPKL 62
Query: 573 VQLCGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYL 632
VQL G C EQ + +++++ LS L + + +
Sbjct: 63 VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF-----AAETLLGMCLDVCEG---M 114
Query: 633 HEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGY 692
VIHR++ + + + ++ F + F+ + + + + +
Sbjct: 115 AYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS------STGTKFPVKW 168
Query: 693 MSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAEL 752
SPE +S +DV+SFGV++ EV + +V+ + +P
Sbjct: 169 ASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP---- 224
Query: 753 VDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795
+ +++ C PE RP+ ++L L
Sbjct: 225 -------RLASTHVYQIMNH---CWKERPEDRPAFSRLLRQLA 257
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 178 bits (451), Expect = 1e-50
Identities = 79/330 (23%), Positives = 135/330 (40%), Gaps = 60/330 (18%)
Query: 97 NPRIFSYAELYIGSNGFDEDEVLGSGGFGKVYRAVLPS-----DGTVVAVKCL-AEKGER 150
NP++ L N + +G G FG+V++A P T+VAVK L E
Sbjct: 2 NPKL---LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD 58
Query: 151 FEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENL---- 206
+ F E +A + N+V+L G C + L+++YM L+ L +
Sbjct: 59 MQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSL 118
Query: 207 -------------EAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDS 253
PL+ ++ I R +AA + YL E+ + +HRD+ T N ++
Sbjct: 119 SHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGE 175
Query: 254 QYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVAT 313
++ DFGL+R + Y+ I ++PPES + T
Sbjct: 176 NMVVKIADFGLSRNIYSADYYKA--------------DGNDAIPIRWMPPESIF-YNRYT 220
Query: 314 AKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYK 373
+SDV+++G+V+ E+ S +++I ++R +G +L +N
Sbjct: 221 TESDVWAYGVVLWEIFSYGLQPYYGMAHEEVI--YYVR----DGNILACPEN-------- 266
Query: 374 LCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403
C +E L +L LC P RPS +
Sbjct: 267 -CPLE-LYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 133 bits (336), Expect = 3e-35
Identities = 59/307 (19%), Positives = 108/307 (35%), Gaps = 46/307 (14%)
Query: 513 NNFSESQRVAEMDFGTAYQGFL------DNHQYVLVKRLGMSKCPALRTRFSNELQNLAR 566
NN + + E FG +Q + V VK L ++ F E +A
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 567 LRHRNLVQLCGWCTEQGEMLVIYDYSATRILSHLLFHNNHRI------------------ 608
+ N+V+L G C M ++++Y A L+ L +
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 609 GHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEF 668
G L + I + +A+ + YL E + +HR++ + + +M ++ F L+
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 669 LTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDF 728
+ D+ +M PE I T+ +DV+++GVV+ E+ + + +
Sbjct: 190 IYSADYYKADGN-----DAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 244
Query: 729 RLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMR 788
+ ++ V + P + L L C P RPS
Sbjct: 245 GMAHEEVIYYVRDGNILACP--------------ENCPLELYNLMRLCWSKLPADRPSFC 290
Query: 789 QILSILD 795
I IL
Sbjct: 291 SIHRILQ 297
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (446), Expect = 2e-50
Identities = 72/296 (24%), Positives = 118/296 (39%), Gaps = 54/296 (18%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK---GERFEKTFAAELVAVAHLRHRN 169
F+ LG G FG VY A ++A+K L + E E+ +HLRH N
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67
Query: 170 LVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALH 229
++RL G+ ++ L+ +Y P ++ R L + + ++ I LA AL
Sbjct: 68 ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-------KFDEQRTATYITELANALS 120
Query: 230 YLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLA 289
Y H + ++IHRD+K N++L S ++ DFG +
Sbjct: 121 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS------------------ 159
Query: 290 ETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDW 349
T + GT+ YLPPE + G + K D++S G++ E + G+ + +
Sbjct: 160 RRTTLCGTLDYLPPEMIE-GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY----- 213
Query: 350 IRRLSDEGKVLQAGDNRLSDGSYKLCDM--EHLTHLALLCTLHNPHLRPSMKWVIE 403
R+S + D E L HNP RP ++ V+E
Sbjct: 214 ---------------KRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 2e-32
Identities = 50/283 (17%), Positives = 102/283 (36%), Gaps = 37/283 (13%)
Query: 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKC--PALRTRFSNELQNLARLRH 569
+F + + + FG Y + + +K L ++ + + E++ + LRH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 570 RNLVQLCGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAI 629
N+++L G+ + + +I +Y+ + L + I LA+A+
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK------FDEQRTATYITELANAL 119
Query: 630 LYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGI 689
Y H + +VIHR+I + L ++ F + + ++ G
Sbjct: 120 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---------TTLCGT 167
Query: 690 FGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPL 749
Y+ PE IE D++S GV+ E + G+ + + + +
Sbjct: 168 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV----EFTF 223
Query: 750 AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792
+ V + LI NP RP +R++L
Sbjct: 224 PDFVT---------EGARDLIS---RLLKHNPSQRPMLREVLE 254
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 8e-50
Identities = 60/297 (20%), Positives = 113/297 (38%), Gaps = 45/297 (15%)
Query: 108 IGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRH 167
I + LG+G FG V VA+K + ++G E F E + +L H
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSH 58
Query: 168 RNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAA 227
LV+L G C + + ++ +YM N L L +Q ++ + + A
Sbjct: 59 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH------RFQTQQLLEMCKDVCEA 112
Query: 228 LHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFH 287
+ YL + Q +HRD+ N +++ Q ++ DFGL+R++ +
Sbjct: 113 MEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS------------ 157
Query: 288 LAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQIIL 346
+ + + PPE S ++KSD+++FG+++ E+ S G+ + +
Sbjct: 158 ---SVGSKFPVRWSPPE-VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH 213
Query: 347 LDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403
+ RL E + + C RP+ K ++
Sbjct: 214 IAQGLRLYRPHLA-----------------SEKVYTIMYSCWHEKADERPTFKILLS 253
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 2e-38
Identities = 51/282 (18%), Positives = 111/282 (39%), Gaps = 30/282 (10%)
Query: 513 NNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNL 572
+ + + + FG G V +K + + F E + + L H L
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI--KEGSMSEDEFIEEAKVMMNLSHEKL 61
Query: 573 VQLCGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYL 632
VQL G CT+Q + +I +Y A L + L HR Q + K + A+ YL
Sbjct: 62 VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-----FQTQQLLEMCKDVCEAMEYL 116
Query: 633 HEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGY 692
++Q +HR++ + ++ ++ F L+ ++ +++ + + + +
Sbjct: 117 E---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY------TSSVGSKFPVRW 167
Query: 693 MSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAEL 752
PE + + +S +D+++FGV++ E+ + R + + + RP
Sbjct: 168 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP---- 223
Query: 753 VDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSIL 794
H ++ + +C + RP+ + +LS +
Sbjct: 224 ----------HLASEKVYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 174 bits (443), Expect = 1e-49
Identities = 63/308 (20%), Positives = 117/308 (37%), Gaps = 41/308 (13%)
Query: 97 NPRIFSYAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFA 156
+P +Y + + LG G +G+VY V VAVK L ++ + F
Sbjct: 3 DPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFL 61
Query: 157 AELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQ 216
E + ++H NLV+L G C E ++ ++M +L L ++
Sbjct: 62 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-----EVSAVV 116
Query: 217 RKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQM 276
+ +++A+ YL ++ IHRD+ N ++ + ++ DFGL+R + +
Sbjct: 117 LLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA- 172
Query: 277 RTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVD 336
I + PES + KSDV++FG+++ E+ +
Sbjct: 173 --------------HAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGM--- 214
Query: 337 LTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRP 396
I L + L ++ ++ + E + L C NP RP
Sbjct: 215 ---SPYPGIDLSQVYELLEKDYRMERPEG----------CPEKVYELMRACWQWNPSDRP 261
Query: 397 SMKWVIEA 404
S + +A
Sbjct: 262 SFAEIHQA 269
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 141 bits (357), Expect = 4e-38
Identities = 56/315 (17%), Positives = 123/315 (39%), Gaps = 34/315 (10%)
Query: 500 PREISFKEIISATNNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFS 558
P ++ + + + ++ +G Y+G V VK L + F
Sbjct: 4 PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFL 61
Query: 559 NELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHR 618
E + ++H NLVQL G CT + +I ++ L L N + +
Sbjct: 62 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ----EVSAVVL 117
Query: 619 YNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRK 678
+ ++SA+ YL + + IHR++ + + + ++ F L+ +T + +
Sbjct: 118 LYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY---- 170
Query: 679 ATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKR 738
+ + + + +PE + + + +DV++FGV++ E+ T M+ + +
Sbjct: 171 --TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-- 226
Query: 739 VHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGND 798
EL++ E ++ +L AC NP RPS +I
Sbjct: 227 ------------ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF---- 270
Query: 799 KRFMEDGQMTENLEE 813
+ ++ +++ +E+
Sbjct: 271 ETMFQESSISDEVEK 285
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 2e-49
Identities = 58/295 (19%), Positives = 105/295 (35%), Gaps = 50/295 (16%)
Query: 116 DEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG--ERFEKTFAAELVAVAHLRHRNLVRL 173
D +G G F VY+ + VA L ++ + + F E + L+H N+VR
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 174 RGWCV----HEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALH 229
+ ++LV + M + +L L R + + + R + L
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-------VMKIKVLRSWCRQILKGLQ 126
Query: 230 YLHEQLETQIIHRDVKTSNVMLDSQ-YNARLGDFGLARWLEHELQYQMRTSSARNHQFHL 288
+LH + IIHRD+K N+ + + ++GD GLA
Sbjct: 127 FLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF---------------- 169
Query: 289 AETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLD 348
+ GT ++ PE +++ DV++FG+ +LE+ + P +
Sbjct: 170 --AKAVIGTPEFMAPEMYEEK--YDESVDVYAFGMCMLEMATSEY------PYSECQNAA 219
Query: 349 WIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403
I R G + D + + C N R S+K ++
Sbjct: 220 QIYRRVTSGVKPASFDKVAI---------PEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 2e-33
Identities = 52/274 (18%), Positives = 101/274 (36%), Gaps = 37/274 (13%)
Query: 526 FGTAYQGFL-DNHQYVLVKRLGMSKC-PALRTRFSNELQNLARLRHRNLVQLCGWC---- 579
F T Y+G + V L K + R RF E + L L+H N+V+
Sbjct: 22 FKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 81
Query: 580 TEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQ 639
+ ++++ + + L L ++ + + + + +LH
Sbjct: 82 KGKKCIVLVTELMTSGTLKTYLKRFKV------MKIKVLRSWCRQILKGLQFLHTR-TPP 134
Query: 640 VIHRNITSSAITL-DPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYI 698
+IHR++ I + P + ++G LA S ++V G +M+PE
Sbjct: 135 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKR---------ASFAKAVIGTPEFMAPEMY 185
Query: 699 ESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLN 758
E + DVY+FG+ +LE+ T + + +RV +
Sbjct: 186 E-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP---- 240
Query: 759 GEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792
E+ +I+ C N + R S++ +L+
Sbjct: 241 ------EVKEIIE---GCIRQNKDERYSIKDLLN 265
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 3e-49
Identities = 74/297 (24%), Positives = 116/297 (39%), Gaps = 49/297 (16%)
Query: 108 IGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRH 167
+ + +G G FG V G VAVKC+ K + + F AE + LRH
Sbjct: 4 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCI--KNDATAQAFLAEASVMTQLRH 59
Query: 168 RNLVRLRGWCVHED-QLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAA 226
NLV+L G V E L +V +YM SL L R + L + K +
Sbjct: 60 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-----VLGGDCLLKFSLDVCE 114
Query: 227 ALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQF 286
A+ YL +HRD+ NV++ A++ DFGL +
Sbjct: 115 AMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS---------------- 155
Query: 287 HLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIIL 346
+ + PE+ ++ + KSDV+SFGI++ E+ S R P +I L
Sbjct: 156 ---TQDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGR-----VPYPRIPL 206
Query: 347 LDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403
D + R+ ++G + A D + + C + +RPS + E
Sbjct: 207 KDVVPRV-EKGYKMDAPDGC----------PPAVYEVMKNCWHLDAAMRPSFLQLRE 252
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 3e-36
Identities = 58/271 (21%), Positives = 108/271 (39%), Gaps = 36/271 (13%)
Query: 526 FGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQ-GE 584
FG G ++ VK + K A F E + +LRH NLVQL G E+ G
Sbjct: 20 FGDVMLGDYRGNKVA-VKCI---KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 75
Query: 585 MLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRN 644
+ ++ +Y A L L G S+L + A+ YL +HR+
Sbjct: 76 LYIVTEYMAKGSLVDYL----RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRD 128
Query: 645 ITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEAT 704
+ + + + D ++ F L ++A+S + + + +PE + + +
Sbjct: 129 LAARNVLVSEDNVAKVSDFGLT----------KEASSTQDTGKLPVKWTAPEALREKKFS 178
Query: 705 SMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHK 764
+ +DV+SFG+++ E+ + R+P +V RV + P +
Sbjct: 179 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAP-----------DGCPP 227
Query: 765 ELMRLIKLGIACTLSNPELRPSMRQILSILD 795
+ ++K C + +RPS Q+ L+
Sbjct: 228 AVYEVMK---NCWHLDAAMRPSFLQLREQLE 255
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 3e-48
Identities = 66/315 (20%), Positives = 120/315 (38%), Gaps = 51/315 (16%)
Query: 108 IGSNGFDEDEVLGSGGFGKVYRAVLP-----SDGTVVAVKCL-AEKGERFEKTFAAELVA 161
N + LG+G FGKV A VAVK L + +EL
Sbjct: 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKV 79
Query: 162 VAHL-RHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENL-----------EAA 209
+++L H N+V L G C L++ +Y L L R+ ++ +
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 210 APLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLE 269
L+ E +A + +L + IHRD+ N++L ++ DFGLAR ++
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIK 196
Query: 270 HELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVV 329
++ Y + + ++ PE V T +SDV+S+GI + E+
Sbjct: 197 NDSNYVV--------------KGNARLPVKWMAPE-SIFNCVYTFESDVWSYGIFLWELF 241
Query: 330 SGRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTL 389
S + P D ++ EG + + ++ ++ + + C
Sbjct: 242 SLGSSPYPGMPVDS-----KFYKMIKEGFRMLSPEHAPAE----------MYDIMKTCWD 286
Query: 390 HNPHLRPSMKWVIEA 404
+P RP+ K +++
Sbjct: 287 ADPLKRPTFKQIVQL 301
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 1e-34
Identities = 58/290 (20%), Positives = 104/290 (35%), Gaps = 40/290 (13%)
Query: 526 FGTAYQGFL------DNHQYVLVKRLGMSKCPALRTRFSNELQNLARL-RHRNLVQLCGW 578
FG + D V VK L S R +EL+ L+ L H N+V L G
Sbjct: 36 FGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGA 95
Query: 579 CTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSI------------LQWHHRYNIIKSLA 626
CT G LVI +Y L + L S L + +A
Sbjct: 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVA 155
Query: 627 SAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSV 686
+ +L + IHR++ + I L ++ F LA + + + K +
Sbjct: 156 KGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK-----GNA 207
Query: 687 RGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARK 746
R +M+PE I + T +DV+S+G+ + E+ + + +P
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV-------------D 254
Query: 747 RPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDG 796
+++ + + C ++P RP+ +QI+ +++
Sbjct: 255 SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 7e-48
Identities = 76/348 (21%), Positives = 124/348 (35%), Gaps = 64/348 (18%)
Query: 87 VQMSEKVGGDN-------PRIFSYAELY-IGSNGFDEDEVLGSGGFGKVYRAVLPSDG-- 136
+QM + G + R + Y + + +VLGSG FGKV A
Sbjct: 5 LQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKT 64
Query: 137 ---TVVAVKCLAEKG-ERFEKTFAAELVAVAHL-RHRNLVRLRGWCVHEDQLLLVYDYMP 191
VAVK L EK + +EL + L H N+V L G C + L+++Y
Sbjct: 65 GVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCC 124
Query: 192 NRSLDRVLFRRPENL----------------EAAAPLNWEQRKKIIRGLAAALHYLHEQL 235
L L + E E L +E +A + +L +
Sbjct: 125 YGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK- 183
Query: 236 ETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIG 295
+HRD+ NV++ ++ DFGLAR + + Y +R +
Sbjct: 184 --SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGN--------------AR 227
Query: 296 GTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIRRLSD 355
+ ++ PES +G T KSDV+S+GI++ E+ S P I + +L
Sbjct: 228 LPVKWMAPESLFEGIY-TIKSDVWSYGILLWEIFSLGVN-----PYPGIPVDANFYKLIQ 281
Query: 356 EGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403
G + + + + C + RPS +
Sbjct: 282 NGFKMDQPFYATEE----------IYIIMQSCWAFDSRKRPSFPNLTS 319
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 3e-34
Identities = 52/295 (17%), Positives = 105/295 (35%), Gaps = 47/295 (15%)
Query: 526 FGTAYQGFL------DNHQYVLVKRLGMSKCPALRTRFSNELQNLARL-RHRNLVQLCGW 578
FG V VK L + R +EL+ + +L H N+V L G
Sbjct: 50 FGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGA 109
Query: 579 CTEQGEMLVIYDYSATRILSHLLFHNNHRI-----------------GHSILQWHHRYNI 621
CT G + +I++Y L + L + ++L +
Sbjct: 110 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCF 169
Query: 622 IKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATS 681
+A + +L + +HR++ + + + ++ F LA + + + +
Sbjct: 170 AYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGN- 225
Query: 682 GNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVH 740
R +M+PE + G T +DV+S+G+++ E+ + G + K +
Sbjct: 226 ----ARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQ 281
Query: 741 EFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795
+P Y +E+ +++ +C + RPS + S L
Sbjct: 282 NGFKMDQP-----------FYATEEIYIIMQ---SCWAFDSRKRPSFPNLTSFLG 322
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 8e-48
Identities = 62/304 (20%), Positives = 120/304 (39%), Gaps = 44/304 (14%)
Query: 105 ELYIGSNGFD-EDEVLGSGGFGKVYRAVLPS--DGTVVAVKCL-AEKGERFEKTFAAELV 160
+L++ + D LG G FG V + V VA+K L + + E
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61
Query: 161 AVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKI 220
+ L + +VRL G C + L+LV + L + L + E + ++
Sbjct: 62 IMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKRE------EIPVSNVAEL 114
Query: 221 IRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSS 280
+ ++ + YL E+ +HRD+ NV+L +++ A++ DFGL++ L + Y S+
Sbjct: 115 LHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 171
Query: 281 ARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYP 340
+ + + PE +++SDV+S+G+ + E +S +
Sbjct: 172 GK-------------WPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMK 217
Query: 341 DDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKW 400
+++ ++GK ++ C E L L C ++ RP
Sbjct: 218 GPEVM------AFIEQGKRMECPPE---------CPPE-LYALMSDCWIYKWEDRPDFLT 261
Query: 401 VIEA 404
V +
Sbjct: 262 VEQR 265
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 2e-35
Identities = 48/272 (17%), Positives = 102/272 (37%), Gaps = 30/272 (11%)
Query: 526 FGTAYQGFL---DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQ 582
FG+ QG V +K L A E Q + +L + +V+L G C +
Sbjct: 22 FGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE 81
Query: 583 GEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIH 642
MLV + + L L + + ++ ++ + YL + +H
Sbjct: 82 ALMLV-MEMAGGGPLHKFLVGKREE-----IPVSNVAELLHQVSMGMKYLE---EKNFVH 132
Query: 643 RNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGE 702
R++ + + L ++ F L++ L +D + ++G + + +PE I +
Sbjct: 133 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG----KWPLKWYAPECINFRK 188
Query: 703 ATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYN 762
+S +DV+S+GV + E ++ ++ ++ + + + + P
Sbjct: 189 FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECP-----------PEC 237
Query: 763 HKELMRLIKLGIACTLSNPELRPSMRQILSIL 794
EL L+ C + E RP + +
Sbjct: 238 PPELYALMSD---CWIYKWEDRPDFLTVEQRM 266
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 1e-47
Identities = 63/295 (21%), Positives = 112/295 (37%), Gaps = 47/295 (15%)
Query: 115 EDEVLGSGGFGKVYRAVLPSDGT--VVAVKCLAEKG--ERFEKTFAAELVAVAHLRHRNL 170
ED+ LGSG FG V + VAVK L + + AE + L + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 171 VRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHY 230
VR+ G C + +LV + L++ L + + + +++ ++ + Y
Sbjct: 71 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR-------HVKDKNIIELVHQVSMGMKY 122
Query: 231 LHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAE 290
L E +HRD+ NV+L +Q+ A++ DFGL++ L + Y
Sbjct: 123 LEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA------------- 166
Query: 291 TTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQIILLDW 349
T + + PE ++KSDV+SFG+++ E S G++ + +L+
Sbjct: 167 QTHGKWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 225
Query: 350 IRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404
R+ + L LC ++ RP V
Sbjct: 226 GERMGCPAGCP-----------------REMYDLMNLCWTYDVENRPGFAAVELR 263
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 6e-36
Identities = 53/273 (19%), Positives = 108/273 (39%), Gaps = 32/273 (11%)
Query: 526 FGTAYQGFLDNH---QYVLVKRLGMSKC-PALRTRFSNELQNLARLRHRNLVQLCGWCTE 581
FGT +G+ + V VK L PAL+ E + +L + +V++ G C
Sbjct: 20 FGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA 79
Query: 582 QGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVI 641
+ MLV + + L+ L N H ++ + ++ ++ + YL +
Sbjct: 80 ESWMLV-MEMAELGPLNKYLQQNRH------VKDKNIIELVHQVSMGMKYLE---ESNFV 129
Query: 642 HRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESG 701
HR++ + + L ++ F L++ L +++ ++ T + + +PE I
Sbjct: 130 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH----GKWPVKWYAPECINYY 185
Query: 702 EATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEY 761
+ +S +DV+SFGV++ E + + + + + E P
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP-----------AG 234
Query: 762 NHKELMRLIKLGIACTLSNPELRPSMRQILSIL 794
+E+ L+ L C + E RP + L
Sbjct: 235 CPREMYDLMNL---CWTYDVENRPGFAAVELRL 264
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 2e-47
Identities = 67/315 (21%), Positives = 117/315 (37%), Gaps = 45/315 (14%)
Query: 101 FSYAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELV 160
+ I + LG G FG+V+ T VA+K L + G + F E
Sbjct: 7 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTL-KPGTMSPEAFLQEAQ 64
Query: 161 AVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKI 220
+ LRH LV+L E+ + +V +YM SL L L Q +
Sbjct: 65 VMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGK-----YLRLPQLVDM 118
Query: 221 IRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSS 280
+A+ + Y+ +HRD++ +N+++ ++ DFGLAR +E
Sbjct: 119 AAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA----- 170
Query: 281 ARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYP 340
I + PE+ G T KSDV+SFGI++ E+ + R
Sbjct: 171 ----------RQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMV 219
Query: 341 DDQII-LLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMK 399
+ +++ ++ R+ + E L L C P RP+ +
Sbjct: 220 NREVLDQVERGYRMPCPPEC-----------------PESLHDLMCQCWRKEPEERPTFE 262
Query: 400 WVIEAVSGSYSGKLP 414
++ + ++ P
Sbjct: 263 YLQAFLEDYFTSTEP 277
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 8e-38
Identities = 59/299 (19%), Positives = 108/299 (36%), Gaps = 30/299 (10%)
Query: 513 NNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNL 572
+ ++ + FG + G + V +K L F E Q + +LRH L
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKL 74
Query: 573 VQLCGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYL 632
VQL +E+ +V S L L+ ++ +AS + Y+
Sbjct: 75 VQLYAVVSEEPIYIVTEYMS-----KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 129
Query: 633 HEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGY 692
+HR++ ++ I + ++ ++ F LA + N++ R+ + +
Sbjct: 130 ERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ------GAKFPIKW 180
Query: 693 MSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAEL 752
+PE G T +DV+SFG+++ E+ T RV R + +
Sbjct: 181 TAPEAALYGRFTIKSDVWSFGILLTELTTK--------------GRVPYPGMVNREVLDQ 226
Query: 753 VDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDKRFMEDGQMTENL 811
V+ + L L C PE RP+ + + L+ Q ENL
Sbjct: 227 VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL 285
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 2e-47
Identities = 59/291 (20%), Positives = 113/291 (38%), Gaps = 43/291 (14%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVR 172
+ E +G G G VY A+ + G VA++ + + + ++ E++ + ++ N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 173 LRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLH 232
+ D+L +V +Y+ SL V+ + Q + R AL +LH
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVVTETCM--------DEGQIAAVCRECLQALEFLH 133
Query: 233 EQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETT 292
Q+IHRD+K+ N++L + +L DFG + E +
Sbjct: 134 SN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK----------------RS 174
Query: 293 RIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIRR 352
+ GT ++ PE + + K D++S GI+ +E++ G P L +
Sbjct: 175 TMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEP------PYLNENPLRALYL 227
Query: 353 LSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403
++ G +LS C + R S K +++
Sbjct: 228 IATNGTPELQNPEKLS---------AIFRDFLNRCLDMDVEKRGSAKELLQ 269
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 2e-33
Identities = 48/268 (17%), Positives = 95/268 (35%), Gaps = 32/268 (11%)
Query: 526 FGTAYQGF-LDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGE 584
GT Y + Q V ++++ + + P + NE+ + ++ N+V E
Sbjct: 33 SGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDSYLVGDE 91
Query: 585 MLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRN 644
+ V+ +Y A L+ ++ + + A+ +LH QVIHR+
Sbjct: 92 LWVVMEYLAGGSLTDVVTETCM-------DEGQIAAVCRECLQALEFLHSN---QVIHRD 141
Query: 645 ITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEAT 704
I S I L D + +L F +T ++ G +M+PE +
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS-------TMVGTPYWMAPEVVTRKAYG 194
Query: 705 SMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHK 764
D++S G++ +E++ G+ P L + +L
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL----------SA 244
Query: 765 ELMRLIKLGIACTLSNPELRPSMRQILS 792
+ C + E R S +++L
Sbjct: 245 IFRDFLN---RCLDMDVEKRGSAKELLQ 269
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 2e-47
Identities = 67/302 (22%), Positives = 124/302 (41%), Gaps = 44/302 (14%)
Query: 108 IGSNGFDEDEVLGSGGFGKVYRAVLPSDG----TVVAVKCL-AEKGERFEKTFAAELVAV 162
I + +V+G+G FG+VY+ +L + VA+K L A E+ F E +
Sbjct: 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIM 63
Query: 163 AHLRHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIR 222
H N++RL G ++++ +YM N +LD+ L + + Q ++R
Sbjct: 64 GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEF------SVLQLVGMLR 117
Query: 223 GLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSAR 282
G+AA + YL +HRD+ N++++S ++ DFGL+R LE + +
Sbjct: 118 GIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT----- 169
Query: 283 NHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDD 342
T+ I + PE+ + SDV+SFGIV+ EV++ +
Sbjct: 170 --------TSGGKIPIRWTAPEAISYRKFTS-ASDVWSFGIVMWEVMTYGERPYWELSNH 220
Query: 343 QIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVI 402
+++ + ++G L + + L + C RP ++
Sbjct: 221 EVM------KAINDGFRLPTPMD----------CPSAIYQLMMQCWQQERARRPKFADIV 264
Query: 403 EA 404
Sbjct: 265 SI 266
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 1e-38
Identities = 55/289 (19%), Positives = 111/289 (38%), Gaps = 31/289 (10%)
Query: 513 NNFSESQRVAEMDFGTAYQGFLDN-----HQYVLVKRLGMSKCPALRTRFSNELQNLARL 567
+ + + + +FG Y+G L V +K L R F E + +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 568 RHRNLVQLCGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLAS 627
H N+++L G ++ M++I +Y + R +++ +A+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYM-----ENGALDKFLREKDGEFSVLQLVGMLRGIAA 121
Query: 628 AILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVR 687
+ YL N +HR++ + I ++ ++ ++ F L+ L + + G +
Sbjct: 122 GMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGG----K 174
Query: 688 GIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKR 747
+ +PE I + TS +DV+SFG+V+ EV+T + L ++K +++
Sbjct: 175 IPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND------ 228
Query: 748 PLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDG 796
+ +L + C RP I+SILD
Sbjct: 229 --------GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 2e-47
Identities = 77/309 (24%), Positives = 128/309 (41%), Gaps = 50/309 (16%)
Query: 108 IGSNGFDEDEVLGSGGFGKVYRAVLPSDGT--VVAVKCLAEKGER-FEKTFAAELVAVAH 164
+ N +V+G G FG+V +A + DG A+K + E + + FA EL +
Sbjct: 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCK 66
Query: 165 L-RHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRP---------ENLEAAAPLNW 214
L H N++ L G C H L L +Y P+ +L L + A+ L+
Sbjct: 67 LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 126
Query: 215 EQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQY 274
+Q +A + YL ++ Q IHRD+ N+++ Y A++ DFGL+R E ++
Sbjct: 127 QQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK- 182
Query: 275 QMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRA 334
T + ++ ES V T SDV+S+G+++ E+VS
Sbjct: 183 ----------------KTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGT 225
Query: 335 VDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHL 394
P + + +L +G L+ N CD E + L C P+
Sbjct: 226 -----PYCGMTCAELYEKL-PQGYRLEKPLN---------CDDE-VYDLMRQCWREKPYE 269
Query: 395 RPSMKWVIE 403
RPS ++
Sbjct: 270 RPSFAQILV 278
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 1e-33
Identities = 59/318 (18%), Positives = 117/318 (36%), Gaps = 43/318 (13%)
Query: 513 NNFSESQRVAEMDFGTAYQGFLDN---HQYVLVKRLGMSKCPALRTRFSNELQNLARL-R 568
N+ + E +FG + + +KR+ F+ EL+ L +L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 569 HRNLVQLCGWCTEQGEMLVIYDYSATRILSHLLFHNNH----------RIGHSILQWHHR 618
H N++ L G C +G + + +Y+ L L + S L
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 619 YNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRK 678
+ +A + YL +Q IHR++ + I + + ++ F L+
Sbjct: 130 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT-- 184
Query: 679 ATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKR 738
R +M+ E + T+ +DV+S+GV++ E+V+ + L ++
Sbjct: 185 ------MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 238
Query: 739 VHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGND 798
+ + ++P E+ L++ C P RPS QIL L+
Sbjct: 239 LPQGYRLEKP-----------LNCDDEVYDLMRQ---CWREKPYERPSFAQILVSLN--- 281
Query: 799 KRFMEDGQMTENLEEWKQ 816
R +E+ + N +++
Sbjct: 282 -RMLEERKTYVNTTLYEK 298
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 4e-47
Identities = 68/296 (22%), Positives = 111/296 (37%), Gaps = 43/296 (14%)
Query: 116 DEVLGSGGFGKVYRAVLPSD---GTVVAVKCL-AEKGERFEKTFAAELVAVAHLRHRNLV 171
+EV+G G FG VY L + AVK L F E + + H N++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 172 RLRGWCVH-EDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHY 230
L G C+ E L+V YM + L + N + +A + +
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPT------VKDLIGFGLQVAKGMKF 145
Query: 231 LHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAE 290
L + + +HRD+ N MLD ++ ++ DFGLAR + + +
Sbjct: 146 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN------------ 190
Query: 291 TTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWI 350
T + ++ ES Q T KSDV+SFG+++ E+++ P + D
Sbjct: 191 KTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGA-----PPYPDVNTFDIT 244
Query: 351 RRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVS 406
L RL Y + L + L C +RPS ++ +S
Sbjct: 245 VYLLQ--------GRRLLQPEY---CPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 9e-38
Identities = 52/284 (18%), Positives = 107/284 (37%), Gaps = 30/284 (10%)
Query: 526 FGTAYQGFLDNH----QYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTE 581
FG Y G L ++ + VK L ++F E + H N++ L G C
Sbjct: 40 FGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR 99
Query: 582 -QGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQV 640
+G LV+ Y L + + + H +A + +++
Sbjct: 100 SEGSPLVVLPYMKHGDLRNFIRNETHN-----PTVKDLIGFGLQVAKG---MKFLASKKF 151
Query: 641 IHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIES 700
+HR++ + LD ++ F LA + + +G + +M+ E +++
Sbjct: 152 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTG---AKLPVKWMALESLQT 208
Query: 701 GEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGE 760
+ T+ +DV+SFGV++ E++T + + + + +P E
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP-----------E 257
Query: 761 YNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDKRFMED 804
Y L ++ C E+RPS +++S + F+ +
Sbjct: 258 YCPDPLYEVMLK---CWHPKAEMRPSFSELVSRISAIFSTFIGE 298
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 6e-47
Identities = 78/345 (22%), Positives = 129/345 (37%), Gaps = 55/345 (15%)
Query: 98 PRIFSYAELY------IGSNGFDEDEVLGSGGFGKVYRAVLPS-----DGTVVAVKCL-A 145
P FS A++Y + LG G FG VY V T VA+K +
Sbjct: 1 PEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE 60
Query: 146 EKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLF---RR 202
R F E + ++VRL G L++ + M L L
Sbjct: 61 AASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPA 120
Query: 203 PENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDF 262
N AP + + ++ +A + YL+ + +HRD+ N M+ + ++GDF
Sbjct: 121 MANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDF 177
Query: 263 GLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFG 322
G+ R + Y+ + + ++ PES + G T SDV+SFG
Sbjct: 178 GMTRDIYETDYYRK--------------GGKGLLPVRWMSPESLKDGVF-TTYSDVWSFG 222
Query: 323 IVVLEVVSGRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTH 382
+V+ E+ + ++Q++ R EG +L DN + L
Sbjct: 223 VVLWEIATLAEQPYQGLSNEQVL------RFVMEGGLLDKPDNCP----------DMLFE 266
Query: 383 LALLCTLHNPHLRPSMKWVIEAVSGSYSGKLPALPSFQSHPLYIS 427
L +C +NP +RPS +I ++ P F+ Y S
Sbjct: 267 LMRMCWQYNPKMRPSFLEIISSIKEEME------PGFREVSFYYS 305
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 2e-33
Identities = 55/302 (18%), Positives = 112/302 (37%), Gaps = 32/302 (10%)
Query: 513 NNFSESQRVAEMDFGTAYQGFL------DNHQYVLVKRLGMSKCPALRTRFSNELQNLAR 566
+ S+ + + FG Y+G + V +K + + R F NE +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 567 LRHRNLVQLCGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGH----SILQWHHRYNII 622
++V+L G ++ LVI + L L + + + +
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 623 KSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSG 682
+A + + +HR++ + + D ++G F + + D+ +
Sbjct: 140 GEIADG---MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK-- 194
Query: 683 NRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEF 742
+MSPE ++ G T+ +DV+SFGVV+ E+ T L +++ V E
Sbjct: 195 ---GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG 251
Query: 743 EARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDKRFM 802
+P + L L+++ C NP++RPS +I+S + +
Sbjct: 252 GLLDKP-----------DNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIKEEMEPGF 297
Query: 803 ED 804
+
Sbjct: 298 RE 299
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 168 bits (427), Expect = 7e-47
Identities = 63/348 (18%), Positives = 136/348 (39%), Gaps = 52/348 (14%)
Query: 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNL 170
+ +D E LG+G FG V+R + G A K + E ++T E+ ++ LRH L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 171 VRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHY 230
V L +++++++Y++M L + ++ ++ + +R + L +
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN------KMSEDEAVEYMRQVCKGLCH 139
Query: 231 LHEQLETQIIHRDVKTSNVMLDSQYNAR--LGDFGLARWLEHELQYQMRTSSARNHQFHL 288
+HE +H D+K N+M ++ + L DFGL L+ + ++ T
Sbjct: 140 MHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---------- 186
Query: 289 AETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLD 348
GT + PE + G +D++S G++ ++SG D+ + +
Sbjct: 187 -------GTAEFAAPEVAE-GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV- 237
Query: 349 WIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMK------WVI 402
S + + + + +S+ L +P+ R ++ W+
Sbjct: 238 ----KSCDWNMDDSAFSGISEDGKDFIRK---------LLLADPNTRMTIHQALEHPWLT 284
Query: 403 EAVSGSYSGKLPALPSFQSHPLYISLSSPTNTSTSNTETTRSTNTTAS 450
G+ G+ +PS + + S+ + + + +S
Sbjct: 285 P---GNAPGRDSQIPSSRYTKIRDSIKTKYDAWPEPLPPLGRISNYSS 329
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 124 bits (312), Expect = 2e-31
Identities = 44/296 (14%), Positives = 98/296 (33%), Gaps = 35/296 (11%)
Query: 500 PREISFKEIISATNNFSESQRVAEMDFGTAYQGF-LDNHQYVLVKRLGMSKCPALRTRFS 558
P EI ++ +++ + + FG ++ K + M+ + +
Sbjct: 16 PVEIKHDHVL---DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFV-MTPHESDKETVR 71
Query: 559 NELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHR 618
E+Q ++ LRH LV L + EM++IY++ + L + +++ +
Sbjct: 72 KEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-----MSEDEA 126
Query: 619 YNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPR--LGSFALAEFLTRNDHGH 676
++ + + ++HE +H ++ I + L F L L
Sbjct: 127 VEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 183
Query: 677 RKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLV 736
G + +PE E D++S GV+ +++G + L
Sbjct: 184 --------VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLR 235
Query: 737 KRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792
+ ++ I+ L++P R ++ Q L
Sbjct: 236 NVKSCDWNMDDSAFSGIS---------EDGKDFIR---KLLLADPNTRMTIHQALE 279
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 1e-46
Identities = 66/303 (21%), Positives = 113/303 (37%), Gaps = 45/303 (14%)
Query: 107 YIGSNGFDEDEVLGSGGFGKVYRAVLPSD---GTVVAVKCL---AEKGERFEKTFAAELV 160
IG E LG G FG V R + VAVKCL F E+
Sbjct: 4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN 63
Query: 161 AVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKI 220
A+ L HRNL+RL G + +V + P SL L + +
Sbjct: 64 AMHSLDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQG------HFLLGTLSRY 116
Query: 221 IRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSS 280
+A + YL + + IHRD+ N++L ++ ++GDFGL R L + +
Sbjct: 117 AVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM--- 170
Query: 281 ARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYP 340
+ PES + + + SD + FG+ + E+ + + P
Sbjct: 171 ----------QEHRKVPFAWCAPESLKTRTF-SHASDTWMFGVTLWEMFTYGQ-----EP 214
Query: 341 DDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKW 400
+ + ++ EG+ L ++ C + + ++ + C H P RP+
Sbjct: 215 WIGLNGSQILHKIDKEGERLPRPED---------CPQD-IYNVMVQCWAHKPEDRPTFVA 264
Query: 401 VIE 403
+ +
Sbjct: 265 LRD 267
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 7e-31
Identities = 54/275 (19%), Positives = 93/275 (33%), Gaps = 32/275 (11%)
Query: 526 FGTAYQGFLD----NHQYVLVKRLGMSKC--PALRTRFSNELQNLARLRHRNLVQLCGWC 579
FG +G D V VK L P F E+ + L HRNL++L G
Sbjct: 21 FGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVV 80
Query: 580 TEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQ 639
+V L LL GH +A + YL +
Sbjct: 81 LTPPMKMVTELAP----LGSLLDRLRKHQGH--FLLGTLSRYAVQVAEGMGYLESKR--- 131
Query: 640 VIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIE 699
IHR++ + + L ++G F L L +ND + + F + +PE ++
Sbjct: 132 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE----HRKVPFAWCAPESLK 187
Query: 700 SGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNG 759
+ + +D + FGV + E+ T L ++ ++ + R +
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQ----- 242
Query: 760 EYNHKELMRLIKLGIACTLSNPELRPSMRQILSIL 794
+ + + C PE RP+ + L
Sbjct: 243 --------DIYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 163 bits (414), Expect = 5e-45
Identities = 54/252 (21%), Positives = 96/252 (38%), Gaps = 34/252 (13%)
Query: 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCL------AEKGERFEKTFAAELVAVAH 164
N F ++G GGFG+VY G + A+KCL ++GE L V+
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 165 LRHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGL 224
+V + D+L + D M L L + + + +
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG-------VFSEADMRFYAAEI 116
Query: 225 AAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNH 284
L ++H + +++RD+K +N++LD + R+ D GLA +
Sbjct: 117 ILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK------------- 160
Query: 285 QFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQI 344
+ GT GY+ PE QKG + +D FS G ++ +++ G D+
Sbjct: 161 -----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 215
Query: 345 ILLDWIRRLSDE 356
+ ++ E
Sbjct: 216 EIDRMTLTMAVE 227
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 99.4 bits (247), Expect = 5e-23
Identities = 44/284 (15%), Positives = 85/284 (29%), Gaps = 38/284 (13%)
Query: 513 NNFSESQRVAEMDFGTAYQGF-LDNHQYVLVKRL-----GMSKCPALRTRFSNELQNLAR 566
N+FS + + FG Y D + +K L M + L L ++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 567 LRHRNLVQLCGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLA 626
+V + ++ I D L + L + +
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF------SEADMRFYAAEII 117
Query: 627 SAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSV 686
+ ++H + V++R++ + I LD + R+ LA ++
Sbjct: 118 LGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA---------S 165
Query: 687 RGIFGYMSPEYIESGEA-TSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEAR 745
G GYM+PE ++ G A S AD +S G ++ +++ G +
Sbjct: 166 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA 225
Query: 746 KRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQ 789
EL L++ + R
Sbjct: 226 VELPDSF----------SPELRSLLE---GLLQRDVNRRLGCLG 256
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 1e-43
Identities = 69/328 (21%), Positives = 132/328 (40%), Gaps = 48/328 (14%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTV----VAVKCLAE-KGERFEKTFAAELVAVAHLRH 167
F + +VLGSG FG VY+ + +G VA+K L E + K E +A + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 168 RNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAA 227
++ RL G C + L+ MP L + +N+ + +A
Sbjct: 71 PHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNI------GSQYLLNWCVQIAKG 123
Query: 228 LHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFH 287
++YL ++ +++HRD+ NV++ + + ++ DFGLA+ L E +
Sbjct: 124 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH----------- 169
Query: 288 LAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILL 347
I ++ ES T +SDV+S+G+ V E+++ P +I
Sbjct: 170 ---AEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-- 223
Query: 348 DWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSG 407
+ ++G+ L C ++ + + + C + + RP + +I
Sbjct: 224 ----SILEKGERLPQPPI---------CTID-VYMIMVKCWMIDADSRPKFRELIIEF-- 267
Query: 408 SYSGKLPALPSFQSHPLYISLSSPTNTS 435
S + P + L SPT+++
Sbjct: 268 SKMARDPQRYLVIQGDERMHLPSPTDSN 295
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 2e-34
Identities = 49/297 (16%), Positives = 111/297 (37%), Gaps = 34/297 (11%)
Query: 504 SFKEIISATNNFSESQRVAEMDFGTAYQGFLDNH-----QYVLVKRLGMSKCPALRTRFS 558
+ I+ T F + + + FGT Y+G V +K L + P
Sbjct: 1 ALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL 59
Query: 559 NELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHR 618
+E +A + + ++ +L G C L+ +L ++ H ++ +
Sbjct: 60 DEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNI------GSQYL 113
Query: 619 YNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRK 678
N +A + YL + +++HR++ + + + + ++ F LA+ L + +
Sbjct: 114 LNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 170
Query: 679 ATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKR 738
+ +M+ E I T +DV+S+GV V E++T +P +
Sbjct: 171 -----EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 225
Query: 739 VHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795
+ + E +P ++ ++ C + + + RP R+++
Sbjct: 226 LEKGERLPQP-----------PICTIDVYMIMVK---CWMIDADSRPKFRELIIEFS 268
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 2e-43
Identities = 50/224 (22%), Positives = 88/224 (39%), Gaps = 28/224 (12%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVAVAHLRHRN 169
F ++LG G F V A + A+K L ++ E E ++ L H
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 170 LVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALH 229
V+L +++L Y N L + + + + + + +AL
Sbjct: 70 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-------SFDETCTRFYTAEIVSALE 122
Query: 230 YLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLA 289
YLH + IIHRD+K N++L+ + ++ DFG A+ L E +
Sbjct: 123 YLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR------------- 166
Query: 290 ETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRR 333
GT Y+ PE A SD+++ G ++ ++V+G
Sbjct: 167 -ANSFVGTAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLP 208
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 1e-29
Identities = 48/287 (16%), Positives = 92/287 (32%), Gaps = 43/287 (14%)
Query: 526 FGTAYQGF-LDNHQYVLVKRLGMSKC--PALRTRFSNELQNLARLRHRNLVQLCGWCTEQ 582
F T L + +K L + E ++RL H V+L +
Sbjct: 21 FSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD 80
Query: 583 GEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIH 642
++ Y+ L + + SA+ YLH + +IH
Sbjct: 81 EKLYFGLSYAKNGELLKYIRKIGS------FDETCTRFYTAEIVSALEYLHGKG---IIH 131
Query: 643 RNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGE 702
R++ I L+ DM+ ++ F A+ L+ R + G Y+SPE +
Sbjct: 132 RDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS-----FVGTAQYVSPELLTEKS 186
Query: 703 ATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYN 762
A +D+++ G ++ ++V G P F A + + EY+
Sbjct: 187 ACKSSDLWALGCIIYQLVAG------LPP----------FRAGNE--YLIFQKIIKLEYD 228
Query: 763 H-----KELMRLIKLGIACTLSNPELRPSMRQILSILDGNDKRFMED 804
+ L++ + + R ++ F E
Sbjct: 229 FPEKFFPKARDLVE---KLLVLDATKRLGCEEMEGYGPLKAHPFFES 272
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 158 bits (400), Expect = 3e-43
Identities = 60/342 (17%), Positives = 123/342 (35%), Gaps = 45/342 (13%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVR 172
+D E LGSG FG V+R V + G V K + + T E+ + L H L+
Sbjct: 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 90
Query: 173 LRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLH 232
L + +++L+ +++ L + ++ + +R L ++H
Sbjct: 91 LHDAFEDKYEMVLILEFLSGGELFDRIAAEDY------KMSEAEVINYMRQACEGLKHMH 144
Query: 233 EQLETQIIHRDVKTSNVMLDSQYNAR--LGDFGLARWLEHELQYQMRTSSARNHQFHLAE 290
E I+H D+K N+M +++ + + DFGLA L + ++ T
Sbjct: 145 EH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT------------ 189
Query: 291 TTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWI 350
T + PE + V +D+++ G++ ++SG +D + L +
Sbjct: 190 -----ATAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLS---PFAGEDDLETLQNV 240
Query: 351 RRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA--VSGS 408
+R D + ++ E P R ++ +E + G
Sbjct: 241 KR----------CDWEFDEDAFSSVSPE-AKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289
Query: 409 YSGKLPALPSFQSHPLYISLSSPTNTSTSNTETTRSTNTTAS 450
+S +PS + + + + + +S
Sbjct: 290 HSNLTSRIPSSRYNKIRQKIKEKYADWPAPQPAIGRIANFSS 331
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 118 bits (296), Expect = 2e-29
Identities = 38/270 (14%), Positives = 85/270 (31%), Gaps = 32/270 (11%)
Query: 526 FGTAYQGF-LDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGE 584
FG ++ + + K + P + NE+ + +L H L+ L ++ E
Sbjct: 42 FGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE 100
Query: 585 MLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRN 644
M++I ++ + L + +++ + N ++ + ++HE ++H +
Sbjct: 101 MVLILEFLSGGELFDRIAAEDYK-----MSEAEVINYMRQACEGLKHMHE---HSIVHLD 152
Query: 645 ITSSAITLDPDMNPR--LGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGE 702
I I + + F LA L ++ + +PE ++
Sbjct: 153 IKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV--------TTATAEFAAPEIVDREP 204
Query: 703 ATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYN 762
D+++ GV+ +++G L V
Sbjct: 205 VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVS-------- 256
Query: 763 HKELMRLIKLGIACTLSNPELRPSMRQILS 792
E IK P R ++ L
Sbjct: 257 -PEAKDFIK---NLLQKEPRKRLTVHDALE 282
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 4e-43
Identities = 60/298 (20%), Positives = 111/298 (37%), Gaps = 46/298 (15%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSD---GTVVAVKCLAE-KGERFEKTFAAELVAVAHLRHR 168
+ +G G FG V++ + S VA+K + + F E + + H
Sbjct: 9 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 68
Query: 169 NLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAAL 228
++V+L G E+ + ++ + L L R L+ L+ AL
Sbjct: 69 HIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKY------SLDLASLILYAYQLSTAL 121
Query: 229 HYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHL 288
YL + + +HRD+ NV++ S +LGDFGL+R++E Y+
Sbjct: 122 AYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK------------- 165
Query: 289 AETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLD 348
++ I ++ PES + SDV+ FG+ + E++ ++ +I
Sbjct: 166 --ASKGKLPIKWMAPESINFRRFTS-ASDVWMFGVCMWEILMHGVKPFQGVKNNDVI--- 219
Query: 349 WIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVS 406
G++ + C L L C ++P RP + +S
Sbjct: 220 --------GRIENGERLPMPPN----CPPT-LYSLMTKCWAYDPSRRPRFTELKAQLS 264
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 5e-31
Identities = 52/274 (18%), Positives = 102/274 (37%), Gaps = 33/274 (12%)
Query: 526 FGTAYQGFL----DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTE 581
FG +QG + V +K ++R +F E + + H ++V+L G TE
Sbjct: 20 FGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE 79
Query: 582 QGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVI 641
+ +I + L L + L L++A+ YL ++ +
Sbjct: 80 -NPVWIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTALAYLES---KRFV 130
Query: 642 HRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESG 701
HR+I + + + + +LG F L+ ++ + + + +M+PE I
Sbjct: 131 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK------ASKGKLPIKWMAPESINFR 184
Query: 702 EATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEY 761
TS +DV+ FGV + E++ + + ++ R+ E P
Sbjct: 185 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP-----------PN 233
Query: 762 NHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795
L L+ C +P RP ++ + L
Sbjct: 234 CPPTLYSLMT---KCWAYDPSRRPRFTELKAQLS 264
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 6e-42
Identities = 56/352 (15%), Positives = 122/352 (34%), Gaps = 54/352 (15%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGW 176
E LG G FG V+R V S K + KG + E+ + RHRN++ L
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHES 69
Query: 177 CVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLE 236
++L+++++++ + + LN + + + AL +LH
Sbjct: 70 FESMEELVMIFEFISGLDIFERINTSAF------ELNEREIVSYVHQVCEALQFLHSH-- 121
Query: 237 TQIIHRDVKTSNVMLDSQYNAR--LGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRI 294
I H D++ N++ ++ ++ + +FG AR L+ +++ +
Sbjct: 122 -NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL-----------------L 163
Query: 295 GGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWIRRLS 354
Y PE Q V + +D++S G +V ++SG + +++ I
Sbjct: 164 FTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGIN---PFLAETNQQIIENIMN-- 217
Query: 355 DEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMK------WVIEAVSGS 408
+ + ++K +E + R + W+ + +
Sbjct: 218 --------AEYTFDEEAFKEISIE-AMDFVDRLLVKERKSRMTASEALQHPWLKQKIERV 268
Query: 409 YSGKLPALPSFQSHPLYISLSSPTNTS----TSNTETTRSTNTTASNTTIAS 456
+ + L + + I S + + + +AS
Sbjct: 269 STKVIRTLKHRRYYHTLIKKDLNMVVSAARISCGGAIRSQKGVSVAKVKVAS 320
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 3e-27
Identities = 37/269 (13%), Positives = 91/269 (33%), Gaps = 33/269 (12%)
Query: 526 FGTAYQGF-LDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGE 584
FG ++ + + + K + + + E+ L RHRN++ L E
Sbjct: 18 FGIVHRCVETSSKKTYMAKFVKVKGTD--QVLVKKEISILNIARHRNILHLHESFESMEE 75
Query: 585 MLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRN 644
+++I+++ + + + + L + + + A+ +LH + H +
Sbjct: 76 LVMIFEFISGLDIFERINTSAFE-----LNEREIVSYVHQVCEALQFLHSHN---IGHFD 127
Query: 645 ITSSAITLDPDMNPR--LGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGE 702
I I + + F A L D+ R + Y +PE +
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--------FRLLFTAPEYYAPEVHQHDV 179
Query: 703 ATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYN 762
++ D++S G +V +++G + ++ ++ ++S
Sbjct: 180 VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN--AEYTFDEEAFKEIS------ 231
Query: 763 HKELMRLIKLGIACTLSNPELRPSMRQIL 791
E M + + + R + + L
Sbjct: 232 -IEAMDFVD---RLLVKERKSRMTASEAL 256
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 152 bits (384), Expect = 6e-42
Identities = 71/295 (24%), Positives = 117/295 (39%), Gaps = 45/295 (15%)
Query: 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCL---AEKGERFEKTFAAELVAVAHLR 166
S+ ++ E+LG GG +V+ A VAVK L + F F E A L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 167 HRNLVRLRGWCVHED----QLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIR 222
H +V + E +V +Y+ +L ++ P+ ++ ++I
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-------PMTPKRAIEVIA 118
Query: 223 GLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSAR 282
AL++ H+ IIHRDVK +N+M+ + ++ DFG+AR + +T++
Sbjct: 119 DACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA-- 173
Query: 283 NHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDD 342
+ GT YL PE + SV A+SDV+S G V+ EV++G P
Sbjct: 174 -----------VIGTAQYLSPEQARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSPVS 221
Query: 343 QIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPS 397
+ + ++ A LS L + L NP R
Sbjct: 222 VA-----YQHVREDPIPPSARHEGLS---------ADLDAVVLKALAKNPENRYQ 262
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 110 bits (275), Expect = 2e-27
Identities = 59/304 (19%), Positives = 111/304 (36%), Gaps = 41/304 (13%)
Query: 499 TPREISFKEIISATNNFSESQRVAEMDFGTAYQGF-LDNHQYVLVKRL--GMSKCPALRT 555
TP +S + + + + + L H+ V VK L +++ P+
Sbjct: 1 TPSHLS--------DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYL 52
Query: 556 RFSNELQNLARLRHRNLVQLCGWCTEQGE----MLVIYDYSATRILSHLLFHNNHRIGHS 611
RF E QN A L H +V + + ++ +Y L ++
Sbjct: 53 RFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----- 107
Query: 612 ILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTR 671
+ +I A+ + H+ +IHR++ + I + ++ F +A +
Sbjct: 108 -MTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIAD 163
Query: 672 NDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLP 731
+ + + + V G Y+SPE + +DVYS G V+ EV+TG+ P
Sbjct: 164 SGNSVTQTAA----VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 219
Query: 732 EGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRP-SMRQI 790
+ + V E P A LS +L ++ NPE R + ++
Sbjct: 220 VSVAYQHVR--EDPIPPSARHEGLS-------ADLDAVVL---KALAKNPENRYQTAAEM 267
Query: 791 LSIL 794
+ L
Sbjct: 268 RADL 271
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 8e-42
Identities = 69/314 (21%), Positives = 124/314 (39%), Gaps = 52/314 (16%)
Query: 108 IGSNGFDEDEVLGSGGFGKVYRAVL-------PSDGTVVAVKCL-AEKGERFEKTFAAEL 159
+ + + LG G FG+V A P+ T VAVK L ++ E+ +E+
Sbjct: 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEM 69
Query: 160 VAVAHL-RHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRR---------PENLEAA 209
+ + +H+N++ L G C + L ++ +Y +L L R +
Sbjct: 70 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129
Query: 210 APLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLE 269
L+ + +A + YL + + IHRD+ NV++ ++ DFGLAR +
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIH 186
Query: 270 HELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVV 329
H Y+ TT + ++ PE+ T +SDV+SFG+++ E+
Sbjct: 187 HIDYYKK--------------TTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIF 231
Query: 330 SGRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTL 389
+ YP + + + +L EG + N L + C
Sbjct: 232 TLGG---SPYPGVPV---EELFKLLKEGHRMDKPSN----------CTNELYMMMRDCWH 275
Query: 390 HNPHLRPSMKWVIE 403
P RP+ K ++E
Sbjct: 276 AVPSQRPTFKQLVE 289
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 3e-30
Identities = 59/289 (20%), Positives = 111/289 (38%), Gaps = 41/289 (14%)
Query: 526 FGTAYQGFL--------DNHQYVLVKRLGMSKCPALRTRFSNELQNLARL-RHRNLVQLC 576
FG + V VK L + +E++ + + +H+N++ L
Sbjct: 26 FGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLL 85
Query: 577 GWCTEQGEMLVIYDYSATRILSHLLFH----------NNHRIGHSILQWHHRYNIIKSLA 626
G CT+ G + VI +Y++ L L N L + +A
Sbjct: 86 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVA 145
Query: 627 SAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSV 686
+ YL + + IHR++ + + + D ++ F LA + D+ + +
Sbjct: 146 RGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK-----TTNG 197
Query: 687 RGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARK 746
R +M+PE + T +DV+SFGV++ E+ T + +P L K + E
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMD 257
Query: 747 RPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795
+P EL +++ C + P RP+ +Q++ LD
Sbjct: 258 KP-----------SNCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLD 292
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 2e-41
Identities = 61/298 (20%), Positives = 103/298 (34%), Gaps = 41/298 (13%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCL-----AEKGERFEKTFAAELVAVAHLRHRNLV 171
+ LG G F VY+A + +VA+K + +E + +T E+ + L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 172 RLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYL 231
L H+ + LV+D+M + L K + L YL
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSL-------VLTPSHIKAYMLMTLQGLEYL 116
Query: 232 HEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAET 291
H+ I+HRD+K +N++LD +L DFGLA+ +
Sbjct: 117 HQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY---------------- 157
Query: 292 TRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILL---- 347
T T Y PE + D+++ G ++ E++ + DQ+ +
Sbjct: 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETL 217
Query: 348 ------DWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMK 399
W S V + + L L L NP R +
Sbjct: 218 GTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITAT 275
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 4e-24
Identities = 45/287 (15%), Positives = 96/287 (33%), Gaps = 40/287 (13%)
Query: 526 FGTAYQGF-LDNHQYVLVKRLGMSKC----PALRTRFSNELQNLARLRHRNLVQLCGWCT 580
F T Y+ + +Q V +K++ + + E++ L L H N++ L
Sbjct: 11 FATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG 70
Query: 581 EQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQV 640
+ + +++D+ T + + ++ L H + + YLH+ W +
Sbjct: 71 HKSNISLVFDFMETDLEVIIKDNSLV------LTPSHIKAYMLMTLQGLEYLHQHW---I 121
Query: 641 IHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIES 700
+HR++ + + LD + +L F LA+ + + Y +PE +
Sbjct: 122 LHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH-------QVVTRWYRAPELLFG 174
Query: 701 GEA-TSMADVYSFGVVVLEVVTGQ---------------MAVDFRLPEGLLVKRVHEFEA 744
D+++ G ++ E++ E +
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234
Query: 745 RKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQIL 791
+ L +L+ LI+ L NP R + Q L
Sbjct: 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQ---GLFLFNPCARITATQAL 278
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 150 bits (380), Expect = 3e-41
Identities = 59/302 (19%), Positives = 114/302 (37%), Gaps = 56/302 (18%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCL---------AEKGERFEKTFAAELVAVA 163
++ E+LG G V R + AVK + AE+ + + E+ +
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 164 HLR-HRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIR 222
+ H N+++L+ LV+D M L L + L+ ++ +KI+R
Sbjct: 65 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-------TLSEKETRKIMR 117
Query: 223 GLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSAR 282
L + LH+ I+HRD+K N++LD N +L DFG + L+
Sbjct: 118 ALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG----------- 163
Query: 283 NHQFHLAETTRIGGTIGYLPPESFQKGSVA-----TAKSDVFSFGIVVLEVVSGRRAVDL 337
+ + GT YL PE + + D++S G+++ +++G
Sbjct: 164 ------EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP---P 214
Query: 338 TYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPS 397
+ Q+++L I G+ + + + + L + P R +
Sbjct: 215 FWHRKQMLMLRMIMS----------GNYQFGSPEWDDYS-DTVKDLVSRFLVVQPQKRYT 263
Query: 398 MK 399
+
Sbjct: 264 AE 265
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 105 bits (262), Expect = 1e-25
Identities = 53/283 (18%), Positives = 95/283 (33%), Gaps = 45/283 (15%)
Query: 526 FGTAYQGF-LDNHQYVLVKRLGMSKCPA--------LRTRFSNELQNLARLR-HRNLVQL 575
+ + VK + ++ + LR E+ L ++ H N++QL
Sbjct: 16 SSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQL 75
Query: 576 CGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEE 635
+++D L L L I+++L I LH+
Sbjct: 76 KDTYETNTFFFLVFDLMKKGELFDYLTEKVT------LSEKETRKIMRALLEVICALHKL 129
Query: 636 WNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSP 695
++HR++ I LD DMN +L F + L + R V G Y++P
Sbjct: 130 N---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--------LREVCGTPSYLAP 178
Query: 696 EYIESGEA------TSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPL 749
E IE D++S GV++ ++ G R +L + P
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP- 237
Query: 750 AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792
E D S + L+ + P+ R + + L+
Sbjct: 238 -EWDDYS-------DTVKDLVS---RFLVVQPQKRYTAEEALA 269
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 1e-40
Identities = 63/308 (20%), Positives = 109/308 (35%), Gaps = 50/308 (16%)
Query: 113 FDEDEVLGSGGFGKVYRAVLP-----SDGTVVAVKCLAEKG--ERFEKTFAAELVAVAHL 165
+ LG G FG+V A + VAVK L E + + +
Sbjct: 15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 74
Query: 166 RHRNLVRLRGWCVHEDQ-LLLVYDYMPNRSLDRVLFRR---------PENLEAAAPLNWE 215
H N+V L G C L+++ ++ +L L + L E
Sbjct: 75 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 134
Query: 216 QRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQ 275
+A + +L + + IHRD+ N++L + ++ DFGLAR + + Y
Sbjct: 135 HLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191
Query: 276 MRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAV 335
+ ++ PE+ V T +SDV+SFG+++ E+ S
Sbjct: 192 R--------------KGDARLPLKWMAPETIF-DRVYTIQSDVWSFGVLLWEIFSLGA-- 234
Query: 336 DLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLR 395
P + + + R EG ++A D + L C P R
Sbjct: 235 ---SPYPGVKIDEEFCRRLKEGTRMRAPDY----------TTPEMYQTMLDCWHGEPSQR 281
Query: 396 PSMKWVIE 403
P+ ++E
Sbjct: 282 PTFSELVE 289
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 1e-29
Identities = 59/289 (20%), Positives = 106/289 (36%), Gaps = 41/289 (14%)
Query: 526 FGTAYQGF------LDNHQYVLVKRLGMSKCPALRTRFSNELQNLAR-LRHRNLVQLCGW 578
FG + + V VK L + +EL+ L H N+V L G
Sbjct: 26 FGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85
Query: 579 CTEQGE-MLVIYDYSATRILSHLLFHNNHR----------IGHSILQWHHRYNIIKSLAS 627
CT+ G ++VI ++ LS L + + L H +A
Sbjct: 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAK 145
Query: 628 AILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVR 687
+ +L + IHR++ + I L ++ F LA + ++ RK R
Sbjct: 146 GMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD-----AR 197
Query: 688 GIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRL-PEGLLVKRVHEFEARK 746
+M+PE I T +DV+SFGV++ E+ + + + + +R+ E +
Sbjct: 198 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 257
Query: 747 RPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795
P +Y E+ + + C P RP+ +++ L
Sbjct: 258 AP-----------DYTTPEMYQTMLD---CWHGEPSQRPTFSELVEHLG 292
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 4e-39
Identities = 52/303 (17%), Positives = 107/303 (35%), Gaps = 34/303 (11%)
Query: 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCL-AEKGERFEKTFAAELVAVAHLRHRN 169
+ +G G +G V A + VA+K + + + + + E+ + RH N
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 67
Query: 170 LVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALH 229
++ + + Y+ + L++ + L+ + + + L
Sbjct: 68 IIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLK 123
Query: 230 YLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLA 289
Y+H ++HRD+K SN++L++ + ++ DFGLAR + + +
Sbjct: 124 YIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF------------ 168
Query: 290 ETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDW 349
T T Y PE T D++S G ++ E++S R + DQ+ +
Sbjct: 169 -LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 227
Query: 350 IRRLSDEGKVLQAGDNRLSDGSYKLCDM-------------EHLTHLALLCTLHNPHLRP 396
I + + + + + L L NPH R
Sbjct: 228 ILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI 287
Query: 397 SMK 399
++
Sbjct: 288 EVE 290
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 9e-26
Identities = 43/287 (14%), Positives = 95/287 (33%), Gaps = 33/287 (11%)
Query: 526 FGTAYQGF-LDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGE 584
+G + N V +K++ + R E++ L R RH N++ +
Sbjct: 21 YGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI 80
Query: 585 MLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRN 644
+ Y T ++ L+ + L H + + + Y+H V+HR+
Sbjct: 81 EQMKDVYLVTHLMGADLY---KLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRD 134
Query: 645 ITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEAT 704
+ S + L+ + ++ F LA + T Y +PE + + +
Sbjct: 135 LKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT----EYVATRWYRAPEIMLNSKGY 190
Query: 705 SMA-DVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEA------------------R 745
+ + D++S G ++ E+++ + + L + +
Sbjct: 191 TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 250
Query: 746 KRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792
P V + + + L+ NP R + Q L+
Sbjct: 251 SLPHKNKVPWNRLFPNADSKALDLLD---KMLTFNPHKRIEVEQALA 294
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 5e-39
Identities = 50/244 (20%), Positives = 87/244 (35%), Gaps = 34/244 (13%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCL----AEKGERFEKTFAAELVAVAHLRHR 168
F ++LG G FGKV+ A A+K L + E T + V H
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 169 NLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAAL 228
L + ++ L V +Y+ L + + + + L
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-------KFDLSRATFYAAEIILGL 116
Query: 229 HYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHL 288
+LH + I++RD+K N++LD + ++ DFG+ +
Sbjct: 117 QFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT------------- 160
Query: 289 AETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLD 348
GT Y+ PE G D +SFG+++ E++ G+ + D+ L
Sbjct: 161 ---NTFCGTPDYIAPEILL-GQKYNHSVDWWSFGVLLYEMLIGQS---PFHGQDEEELFH 213
Query: 349 WIRR 352
IR
Sbjct: 214 SIRM 217
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.8 bits (235), Expect = 1e-21
Identities = 41/283 (14%), Positives = 91/283 (32%), Gaps = 36/283 (12%)
Query: 513 NNFSESQRVAEMDFGTAYQGF-LDNHQYVLVKRLGMSKC--PALRTRFSNELQNLAR-LR 568
+F + + + FG + +Q+ +K L E + L+
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 569 HRNLVQLCGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASA 628
H L + + + + +Y L + + + +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK------FDLSRATFYAAEIILG 115
Query: 629 ILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRG 688
+ +L ++ +++R++ I LD D + ++ F + + D + G
Sbjct: 116 LQFL---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN-------TFCG 165
Query: 689 IFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRP 748
Y++PE + + D +SFGV++ E++ GQ G + + P
Sbjct: 166 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ-----SPFHGQDEEELFHSIRMDNP 220
Query: 749 LAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQIL 791
+ KE L+ + PE R +R +
Sbjct: 221 FYP--------RWLEKEAKDLLV---KLFVREPEKRLGVRGDI 252
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 2e-38
Identities = 66/302 (21%), Positives = 118/302 (39%), Gaps = 42/302 (13%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCL--AEKGERFEKTFAAELVAVAHLRHRNL 170
F + E +G G +G VY+A G VVA+K + + E T E+ + L H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 171 VRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHY 230
V+L E++L LV++++ ++ L + + + K + L L +
Sbjct: 64 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALT-----GIPLPLIKSYLFQLLQGLAF 117
Query: 231 LHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAE 290
H +++HRD+K N++++++ +L DFGLAR ++
Sbjct: 118 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--------------- 159
Query: 291 TTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWI 350
T T+ Y PE + D++S G + E+V+ R DQ+ +
Sbjct: 160 -THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--F 216
Query: 351 RRLSDEGKVLQAGDNRLSDGSYKLCDM-------------EHLTHLALLCTLHNPHLRPS 397
R L +V+ G + D E L ++P+ R S
Sbjct: 217 RTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRIS 276
Query: 398 MK 399
K
Sbjct: 277 AK 278
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (264), Expect = 9e-26
Identities = 41/298 (13%), Positives = 97/298 (32%), Gaps = 37/298 (12%)
Query: 514 NFSESQRVAEMDFGTAYQGF-LDNHQYVLVKRLGMSKC-PALRTRFSNELQNLARLRHRN 571
NF + +++ E +G Y+ + V +K++ + + + E+ L L H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 572 LVQLCGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILY 631
+V+L + ++ +++++ + + + + + L + +
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-----IPLPLIKSYLFQLLQGLAF 117
Query: 632 LHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFG 691
H V+HR++ + ++ + +L F LA +
Sbjct: 118 CHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-------THEVVTLW 167
Query: 692 YMSPE-YIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKR--- 747
Y +PE + ++ D++S G + E+VT + L +
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 227
Query: 748 -------------PLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792
P D S ++ L+ +P R S + L+
Sbjct: 228 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLS---QMLHYDPNKRISAKAALA 282
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 142 bits (359), Expect = 4e-38
Identities = 51/224 (22%), Positives = 93/224 (41%), Gaps = 33/224 (14%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK---GERFEKTFAAELVAVAHLRHRN 169
F LG+G FG+V+ +G A+K L ++ + + E + ++ + H
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 170 LVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALH 229
++R+ G Q+ ++ DY+ L +L + K + AL
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ-------RFPNPVAKFYAAEVCLALE 118
Query: 230 YLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLA 289
YLH + II+RD+K N++LD + ++ DFG A+++
Sbjct: 119 YLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD------------------- 156
Query: 290 ETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRR 333
T + GT Y+ PE D +SFGI++ E+++G
Sbjct: 157 VTYTLCGTPDYIAPEVVSTKPY-NKSIDWWSFGILIYEMLAGYT 199
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 101 bits (253), Expect = 4e-24
Identities = 42/280 (15%), Positives = 96/280 (34%), Gaps = 38/280 (13%)
Query: 513 NNFSESQRVAEMDFGTAYQGF-LDNHQYVLVKRLGMSKC--PALRTRFSNELQNLARLRH 569
+F + + FG + N +Y +K L ++E L+ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 570 RNLVQLCGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAI 629
++++ G + ++ +I DY L LL + Q A
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS---------QRFPNPVAKFYAAEVC 114
Query: 630 LYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGI 689
L L ++ +I+R++ I LD + + ++ F A+++ + ++ G
Sbjct: 115 LALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY----------TLCGT 164
Query: 690 FGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPL 749
Y++PE + + D +SFG+++ E++ G K ++ +
Sbjct: 165 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA----ELRF 220
Query: 750 AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQ 789
+ +++ L+ + R Q
Sbjct: 221 PPFFN---------EDVKDLLS---RLITRDLSQRLGNLQ 248
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 141 bits (357), Expect = 5e-38
Identities = 52/304 (17%), Positives = 95/304 (31%), Gaps = 39/304 (12%)
Query: 105 ELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAH 164
EL +G N + +GSG FG +Y + G VA+K K + E
Sbjct: 2 ELRVG-NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKM 58
Query: 165 LRHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGL 224
++ + WC E ++ + SL+ + + + + +
Sbjct: 59 MQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR------KFSLKTVLLLADQM 112
Query: 225 AAALHYLHEQLETQIIHRDVKTSNVM---LDSQYNARLGDFGLARWLEHELQYQMRTSSA 281
+ + Y+H + IHRDVK N + + DFGLA+ +Q
Sbjct: 113 ISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH----- 164
Query: 282 RNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPD 341
E + GT Y + G + + D+ S G V++ G
Sbjct: 165 ----IPYRENKNLTGTARYASINTHL-GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA 219
Query: 342 DQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDM--EHLTHLALLCTLHNPHLRPSMK 399
+ K + + ++S LC C +P
Sbjct: 220 TKRQ------------KYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYS 267
Query: 400 WVIE 403
++ +
Sbjct: 268 YLRQ 271
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 114 bits (285), Expect = 1e-28
Identities = 42/293 (14%), Positives = 82/293 (27%), Gaps = 26/293 (8%)
Query: 526 FGTAYQGF-LDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGE 584
FG Y G + + V +K + E + ++ + WC +G+
Sbjct: 20 FGDIYLGTDIAAGEEVAIKLE---CVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGD 76
Query: 585 MLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRN 644
V+ L L + + + + S I Y+H + IHR+
Sbjct: 77 YNVMVMELLGPSLEDLFNFCSRK-----FSLKTVLLLADQMISRIEYIHSK---NFIHRD 128
Query: 645 ITSSAI---TLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESG 701
+ + F LA+ N+++ G Y S
Sbjct: 129 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI 188
Query: 702 EATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEY 761
E + D+ S G V++ G + K E + E++
Sbjct: 189 EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYP--- 245
Query: 762 NHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDKRFMEDGQMTENLEEW 814
E + C + +P + + F G + + +W
Sbjct: 246 --SEFATYLN---FCRSLRFDDKPDYSYLRQLF---RNLFHRQGFSYDYVFDW 290
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 142 bits (358), Expect = 5e-38
Identities = 54/291 (18%), Positives = 102/291 (35%), Gaps = 40/291 (13%)
Query: 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG-ERFEKTFAAELVAVAHLRHR 168
+ +D +VLG+G F +V A +VA+KC+A+K E E + E+ + ++H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 169 NLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAAL 228
N+V L L L+ + L + + ++I + A+
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-------FYTERDASRLIFQVLDAV 120
Query: 229 HYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHL 288
YLH+ + LD + DFGL++ +
Sbjct: 121 KYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG----------------- 163
Query: 289 AETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLD 348
+ + GT GY+ PE + D +S G++ ++ G Y ++ L +
Sbjct: 164 SVLSTACGTPGYVAPE-VLAQKPYSKAVDCWSIGVIAYILLCGYP---PFYDENDAKLFE 219
Query: 349 WIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMK 399
I L E + + +SD + +P R + +
Sbjct: 220 QI--LKAEYEFDSPYWDDISDSAKDFIRH---------LMEKDPEKRFTCE 259
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 115 bits (288), Expect = 1e-28
Identities = 43/271 (15%), Positives = 84/271 (30%), Gaps = 33/271 (12%)
Query: 526 FGTAYQGF-LDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGE 584
F + V +K + NE+ L +++H N+V L G
Sbjct: 22 FSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGH 81
Query: 585 MLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRN 644
+ +I + L + +I + A+ YLH+ ++HR+
Sbjct: 82 LYLIMQLVSGGELFDRIVEKGF------YTERDASRLIFQVLDAVKYLHDLG---IVHRD 132
Query: 645 ITSSAI---TLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESG 701
+ + +LD D + F L++ + G GY++PE +
Sbjct: 133 LKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV--------LSTACGTPGYVAPEVLAQK 184
Query: 702 EATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEY 761
+ D +S GV+ ++ G L + + P + +
Sbjct: 185 PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDIS------- 237
Query: 762 NHKELMRLIKLGIACTLSNPELRPSMRQILS 792
I+ +PE R + Q L
Sbjct: 238 --DSAKDFIR---HLMEKDPEKRFTCEQALQ 263
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 6e-38
Identities = 59/311 (18%), Positives = 115/311 (36%), Gaps = 46/311 (14%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCL--AEKGERFEKTFAAELVAVAHLRHRNL 170
+++ +G G FG+V++A G VA+K + + E F T E+ + L+H N+
Sbjct: 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71
Query: 171 VRLRGWC--------VHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIR 222
V L C + + LV+D+ + + + K++++
Sbjct: 72 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV-------KFTLSEIKRVMQ 124
Query: 223 GLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSAR 282
L L+Y+H +I+HRD+K +NV++ +L DFGLAR Q
Sbjct: 125 MLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR---- 177
Query: 283 NHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDD 342
T T+ Y PPE D++ G ++ E+ + +
Sbjct: 178 --------YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH 229
Query: 343 QIILLDWI--------------RRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCT 388
Q+ L+ + L ++ ++++ ++ D + L
Sbjct: 230 QLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLL 289
Query: 389 LHNPHLRPSMK 399
+ +P R
Sbjct: 290 VLDPAQRIDSD 300
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.3 bits (241), Expect = 1e-22
Identities = 42/289 (14%), Positives = 91/289 (31%), Gaps = 29/289 (10%)
Query: 526 FGTAYQGF-LDNHQYVLVKRLGMSKC-PALRTRFSNELQNLARLRHRNLVQLCGWCTEQG 583
FG ++ Q V +K++ M E++ L L+H N+V L C +
Sbjct: 23 FGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKA 82
Query: 584 EMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHR 643
S ++ H+ + ++L I + + + L+ +++HR
Sbjct: 83 SPYNRCKGS-IYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHR 141
Query: 644 NITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEA 703
++ ++ + + D +L F LA + + + + Y PE +
Sbjct: 142 DMKAANVLITRDGVLKLADFGLARAFSLAKNSQP---NRYTNRVVTLWYRPPELLLGERD 198
Query: 704 -TSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVK-------------------RVHEFE 743
D++ G ++ E+ T + + L ++E
Sbjct: 199 YGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKL 258
Query: 744 ARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792
+ V L + LI + +P R L+
Sbjct: 259 ELVKGQKRKVKDRLKAYVRDPYALDLID---KLLVLDPAQRIDSDDALN 304
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 1e-37
Identities = 56/322 (17%), Positives = 106/322 (32%), Gaps = 59/322 (18%)
Query: 116 DEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRG 175
+VLG G GKV + A+K L + + + + ++VR+
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKML-QDCPKARREVELHW---RASQCPHIVRIVD 72
Query: 176 WC----VHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYL 231
LL+V + + L + R + + +I++ + A+ YL
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-----AFTEREASEIMKSIGEAIQYL 127
Query: 232 HEQLETQIIHRDVKTSNVMLDSQYN---ARLGDFGLARWLEHELQYQMRTSSARNHQFHL 288
H I HRDVK N++ S+ +L DFG A+
Sbjct: 128 HSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--------- 175
Query: 289 AETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLD 348
T Y+ PE D++S G+++ ++ G Y + + +
Sbjct: 176 --------TPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGYP---PFYSNHGLAISP 223
Query: 349 WIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMK------WVI 402
++ ++ G + + E + L P R ++ W++
Sbjct: 224 GMKTR------IRMGQYEFPNPEWSEVS-EEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 276
Query: 403 EAVSGSYSGKLPALPSFQSHPL 424
+ S K+P P S L
Sbjct: 277 Q------STKVPQTPLHTSRVL 292
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.6 bits (232), Expect = 3e-21
Identities = 42/278 (15%), Positives = 93/278 (33%), Gaps = 42/278 (15%)
Query: 526 FGTAYQGF-LDNHQYVLVKRLGMSKCPALRTRFSNELQNLARL-RHRNLVQLCGWC---- 579
G Q F + +K L + E++ R + ++V++
Sbjct: 25 NGKVLQIFNKRTQEKFALKMLQDCP------KARREVELHWRASQCPHIVRIVDVYENLY 78
Query: 580 TEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQ 639
+ +L++ + L + G I+KS+ AI YLH
Sbjct: 79 AGRKCLLIVMECLDGGELFSRI----QDRGDQAFTEREASEIMKSIGEAIQYLHSI---N 131
Query: 640 VIHRNITSSAITLDPDMNP---RLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPE 696
+ HR++ + +L F A+ T ++ + Y++PE
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT--------PYYVAPE 183
Query: 697 YIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLL--VKRVHEFEARKRPLAELVD 754
+ + D++S GV++ ++ G + +K + P E +
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 243
Query: 755 LSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792
+S +E+ LI+ + P R ++ + ++
Sbjct: 244 VS-------EEVKMLIR---NLLKTEPTQRMTITEFMN 271
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 2e-37
Identities = 60/299 (20%), Positives = 104/299 (34%), Gaps = 66/299 (22%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCL------AEKGERFEKTFAAELVAVAHLR--HR 168
+LGSGGFG VY + SD VA+K + E+V + +
Sbjct: 10 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 169 NLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAAL 228
++RL W D +L+ + L E + + A+
Sbjct: 70 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG------ALQEELARSFFWQVLEAV 123
Query: 229 HYLHEQLETQIIHRDVKTSNVMLD-SQYNARLGDFGLARWLEHELQYQMRTSSARNHQFH 287
+ H ++HRD+K N+++D ++ +L DFG L+
Sbjct: 124 RHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---------------- 164
Query: 288 LAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIIL- 346
T GT Y PPE + + V+S GI++ ++V G + D+ I+
Sbjct: 165 --VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP----FEHDEEIIR 218
Query: 347 --LDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403
+ + +R+S E + HL C P RP+ + +
Sbjct: 219 GQVFFRQRVSSECQ-----------------------HLIRWCLALRPSDRPTFEEIQN 254
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.5 bits (242), Expect = 5e-23
Identities = 48/277 (17%), Positives = 89/277 (32%), Gaps = 49/277 (17%)
Query: 526 FGTAYQGF-LDNHQYVLVKRLGMSKC-----PALRTRFSNELQNLARLR--HRNLVQLCG 577
FG+ Y G + ++ V +K + + TR E+ L ++ +++L
Sbjct: 17 FGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 76
Query: 578 WCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWN 637
W ++I + LQ + + A+ + N
Sbjct: 77 WFERPDSFVLILERPEPVQDLFDFITERGA-----LQEELARSFFWQVLEAVRHC---HN 128
Query: 638 EQVIHRNITSSAITLDPD-MNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPE 696
V+HR+I I +D + +L F L + T Y PE
Sbjct: 129 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTR---------VYSPPE 179
Query: 697 YIESGEATSM-ADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDL 755
+I A V+S G+++ ++V G + FE + + V
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIP----------------FEHDEEIIRGQVFF 223
Query: 756 SLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792
+ E LI+ C P RP+ +I +
Sbjct: 224 R---QRVSSECQHLIR---WCLALRPSDRPTFEEIQN 254
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 3e-37
Identities = 70/306 (22%), Positives = 112/306 (36%), Gaps = 48/306 (15%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVR 172
+ + +V+G+G FG VY+A L G +VA+K + + + EL + L H N+VR
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 77
Query: 173 LRGWCVHEDQ------LLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAA 226
LR + + L LV DY+P L K + L
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK----QTLPVIYVKLYMYQLFR 133
Query: 227 ALHYLHEQLETQIIHRDVKTSNVMLDSQ-YNARLGDFGLARWLEHELQYQMRTSSARNHQ 285
+L Y+H I HRD+K N++LD +L DFG A+ L
Sbjct: 134 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC------ 184
Query: 286 FHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQII 345
+ Y PE + T+ DV+S G V+ E++ G+ DQ++
Sbjct: 185 -----------SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233
Query: 346 LL---------DWIRRLS---DEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPH 393
+ + IR ++ E K Q + + E L + P
Sbjct: 234 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPE-AIALCSRLLEYTPT 292
Query: 394 LRPSMK 399
R +
Sbjct: 293 ARLTPL 298
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 2e-24
Identities = 60/317 (18%), Positives = 112/317 (35%), Gaps = 51/317 (16%)
Query: 498 ETPREISFKEIISATNNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTR 556
+ P+E+S+ + + + FG YQ L D+ + V +K++ K
Sbjct: 15 DRPQEVSYTDT----------KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RF 59
Query: 557 FSNELQNLARLRHRNLVQLCGWCTEQGE------MLVIYDYSATRILSHLLFHNNHRIGH 610
+ ELQ + +L H N+V+L + GE + ++ DY + ++ +
Sbjct: 60 KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK--- 116
Query: 611 SILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPD-MNPRLGSFALAEFL 669
L + + L ++ Y+H + HR+I + LDPD +L F A+ L
Sbjct: 117 QTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173
Query: 670 TRNDHGHRKATSGNRSVRGIFGYMSP-EYIESGEATSMADVYSFGVVVLEVVTGQMAVDF 728
R + S Y +P + + TS DV+S G V+ E++ GQ
Sbjct: 174 VRGEPNV--------SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 225
Query: 729 RLPEGLLVK-------------RVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIA 775
LV+ R + ++ + + I L
Sbjct: 226 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSR 285
Query: 776 CTLSNPELRPSMRQILS 792
P R + + +
Sbjct: 286 LLEYTPTARLTPLEACA 302
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 137 bits (345), Expect = 1e-36
Identities = 55/300 (18%), Positives = 113/300 (37%), Gaps = 40/300 (13%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCL--AEKGERFEKTFAAELVAVAHLRHRNL 170
+ E +G G +G VY+A G A+K + ++ E T E+ + L+H N+
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 171 VRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHY 230
V+L + +L+LV++++ + L K + L + Y
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG-------GLESVTAKSFLLQLLNGIAY 115
Query: 231 LHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAE 290
H++ +++HRD+K N++++ + ++ DFGLAR ++
Sbjct: 116 CHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV---------- 162
Query: 291 TTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWI 350
T+ Y P+ + D++S G + E+V+G DQ++ + I
Sbjct: 163 ------TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRI 216
Query: 351 RRLSDEGKVLQAGDNRLSDGSYKLCDM-----------EHLTHLALLCTLHNPHLRPSMK 399
+ + D ++ + + E L +P+ R + K
Sbjct: 217 LGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAK 276
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 104 bits (261), Expect = 2e-25
Identities = 41/282 (14%), Positives = 95/282 (33%), Gaps = 31/282 (10%)
Query: 526 FGTAYQGFLDNHQYVLVKRLGMSKC-PALRTRFSNELQNLARLRHRNLVQLCGWCTEQGE 584
+G Y+ + + +K++ + K + + E+ L L+H N+V+L +
Sbjct: 15 YGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR 74
Query: 585 MLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRN 644
+++++++ + L L+ + + L + I Y H+ V+HR+
Sbjct: 75 LVLVFEHLDQDLKKLLDVCEGG------LESVTAKSFLLQLLNGIAYCHDRR---VLHRD 125
Query: 645 ITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIE-SGEA 703
+ + ++ + ++ F LA + Y +P+ + S +
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKY-------THEIVTLWYRAPDVLMGSKKY 178
Query: 704 TSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYNH 763
++ D++S G + E+V G L++ V + N
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238
Query: 764 KELMRLIKLGIACTLS-------------NPELRPSMRQILS 792
L L +P R + +Q L
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 133 bits (336), Expect = 2e-35
Identities = 35/293 (11%), Positives = 80/293 (27%), Gaps = 38/293 (12%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHR-NLVRLRG 175
+G G FG ++ + VA+K + + E L + +
Sbjct: 11 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYY 68
Query: 176 WCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQL 235
+ +LV D + D + + + + + A + +HE+
Sbjct: 69 FGQEGLHNVLVIDLLGPSLEDLLDLCGR-------KFSVKTVAMAAKQMLARVQSIHEK- 120
Query: 236 ETQIIHRDVKTSNVMLDSQY-----NARLGDFGLARWLEHELQYQMRTSSARNHQFHLAE 290
+++RD+K N ++ + DFG+ ++ + Q E
Sbjct: 121 --SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQH---------IPYRE 169
Query: 291 TTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWI 350
+ GT Y+ + + + D+ + G V + + G + I
Sbjct: 170 KKNLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 228
Query: 351 RRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403
+ + E P ++
Sbjct: 229 GEKKQSTPLRELCAG---------FPEE-FYKYMHYARNLAFDATPDYDYLQG 271
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 102 bits (256), Expect = 1e-24
Identities = 35/276 (12%), Positives = 81/276 (29%), Gaps = 25/276 (9%)
Query: 526 FGTAYQGF-LDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGE 584
FG ++G L N+Q V +K + + +E + L + + ++G
Sbjct: 18 FGVIFEGTNLLNNQQVAIKFE---PRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGL 74
Query: 585 MLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRN 644
V+ L LL + K + + + +HE+ +++R+
Sbjct: 75 HNVLVIDLLGPSLEDLLDLCGRK-----FSVKTVAMAAKQMLARVQSIHEKS---LVYRD 126
Query: 645 ITSSAITLDPDMNP-----RLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIE 699
I + + + F + +F +++ G YMS
Sbjct: 127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL 186
Query: 700 SGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNG 759
E + D+ + G V + + G + K E ++ +
Sbjct: 187 GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFP- 245
Query: 760 EYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795
+E + + + P + +
Sbjct: 246 ----EEFYKYMHY---ARNLAFDATPDYDYLQGLFS 274
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 3e-35
Identities = 52/304 (17%), Positives = 110/304 (36%), Gaps = 52/304 (17%)
Query: 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCL------AEKGERFEKTFAAELVAVA 163
+ +D E LGSG F V + S G A K + + + + E+ +
Sbjct: 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 68
Query: 164 HLRHRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRG 223
++H N++ L ++ ++L+ + + L L + L E+ + ++
Sbjct: 69 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-------SLTEEEATEFLKQ 121
Query: 224 LAAALHYLHEQLETQIIHRDVKTSNVMLDSQ----YNARLGDFGLARWLEHELQYQMRTS 279
+ ++YLH QI H D+K N+ML + ++ DFGLA ++
Sbjct: 122 ILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-------- 170
Query: 280 SARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTY 339
E I GT ++ PE + ++D++S G++ ++SG
Sbjct: 171 ---------NEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDT 220
Query: 340 PDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMK 399
+ + + A + D + + +P R +++
Sbjct: 221 KQETL-------------ANVSAVNYEFEDEYFSNTS-ALAKDFIRRLLVKDPKKRMTIQ 266
Query: 400 WVIE 403
++
Sbjct: 267 DSLQ 270
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (264), Expect = 1e-25
Identities = 40/277 (14%), Positives = 84/277 (30%), Gaps = 39/277 (14%)
Query: 526 FGTAYQGF-LDNHQYVLVK-----RLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWC 579
F + K R S+ R E+ L ++H N++ L
Sbjct: 23 FAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY 82
Query: 580 TEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQ 639
+ ++++I + A L L L +K + + + YLH
Sbjct: 83 ENKTDVILILELVAGGELFDFLAEKES------LTEEEATEFLKQILNGVYYLHSLQ--- 133
Query: 640 VIHRNITSSAITLDPDMNPR----LGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSP 695
+ H ++ I L P+ + F LA + + + G +++P
Sbjct: 134 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--------IFGTPEFVAP 185
Query: 696 EYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDL 755
E + AD++S GV+ +++G + L +
Sbjct: 186 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS- 244
Query: 756 SLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792
I+ + +P+ R +++ L
Sbjct: 245 --------ALAKDFIR---RLLVKDPKKRMTIQDSLQ 270
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 5e-34
Identities = 63/258 (24%), Positives = 99/258 (38%), Gaps = 35/258 (13%)
Query: 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCL---AEKGERFEKTFAAELVAVAHLRH 167
N FD ++LG G FGKV + G A+K L + E + + RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 168 RNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAA 227
L L+ D+L V +Y L L R E+ + + +A
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER-------VFTEERARFYGAEIVSA 117
Query: 228 LHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFH 287
L YLH + +++RD+K N+MLD + ++ DFGL + +
Sbjct: 118 LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT------------- 161
Query: 288 LAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDD--QII 345
GT YL PE + D + G+V+ E++ GR + ++I
Sbjct: 162 ---MKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217
Query: 346 L---LDWIRRLSDEGKVL 360
L + + R LS E K L
Sbjct: 218 LMEEIRFPRTLSPEAKSL 235
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.1 bits (220), Expect = 1e-19
Identities = 50/285 (17%), Positives = 86/285 (30%), Gaps = 45/285 (15%)
Query: 513 NNFSESQRVAEMDFGTAYQGF-LDNHQYVLVKRLGMSKC--PALRTRFSNELQNLARLRH 569
N+F + + + FG +Y +K L E + L RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 570 RNLVQLCGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAI 629
L L + + +Y+ L L + SA
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV------FTEERARFYGAEIVSA- 117
Query: 630 LYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGI 689
L + V++R+I + LD D + ++ F L + + + G
Sbjct: 118 --LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-------FCGT 168
Query: 690 FGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPL 749
Y++PE +E + D + GVV+ E++ G RLP F +
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG------RLP----------FYN--QDH 210
Query: 750 AELVDLSLNGEYN-----HKELMRLIKLGIACTLSNPELRPSMRQ 789
L +L L E E L+ +P+ R
Sbjct: 211 ERLFELILMEEIRFPRTLSPEAKSLLA---GLLKKDPKQRLGGGP 252
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 1e-33
Identities = 65/303 (21%), Positives = 112/303 (36%), Gaps = 39/303 (12%)
Query: 113 FDEDEVLGSGGFGKVYRAV-LPSDGTVVAVKCL-----AEKGERFEKTFAAELVAVAHLR 166
++ +G G +GKV++A L + G VA+K + E A L +
Sbjct: 9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68
Query: 167 HRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAA 226
H N+VRL C + +D+ L + + + E K ++ L
Sbjct: 69 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP-GVPTETIKDMMFQLLR 127
Query: 227 ALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQF 286
L +LH +++HRD+K N+++ S +L DFGLAR ++
Sbjct: 128 GLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL------------ 172
Query: 287 HLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIIL 346
T + T+ Y PE + S D++S G + E+ + + DQ+
Sbjct: 173 -----TSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK 226
Query: 347 L----------DWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRP 396
+ DW R ++ + + + + D E L L C NP R
Sbjct: 227 ILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDID-ELGKDLLLKCLTFNPAKRI 285
Query: 397 SMK 399
S
Sbjct: 286 SAY 288
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 1e-25
Identities = 47/287 (16%), Positives = 86/287 (29%), Gaps = 34/287 (11%)
Query: 526 FGTAYQGF--LDNHQYVLVKRL----GMSKCPALRTRFSNELQNLARLRHRNLVQLCGWC 579
+G ++ + ++V +KR+ G P R L++L H N+V+L C
Sbjct: 20 YGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVC 79
Query: 580 TEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQ 639
T + L ++ + +++ L + +LH
Sbjct: 80 TVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--- 136
Query: 640 VIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIE 699
V+HR++ I + +L F LA + SV Y +PE +
Sbjct: 137 VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT--------SVVVTLWYRAPEVLL 188
Query: 700 SGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVK--------------RVHEFEAR 745
+ D++S G + E+ + L K R +
Sbjct: 189 QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQ 248
Query: 746 KRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792
+ + L+ C NP R S LS
Sbjct: 249 AFHSKSAQPIEKFVTDIDELGKDLLL---KCLTFNPAKRISAYSALS 292
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 1e-33
Identities = 45/219 (20%), Positives = 90/219 (41%), Gaps = 28/219 (12%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCL--AEKGERFEKTFAAELVAVAHLRHRNLVRLR 174
E +G G +G V++A +VA+K + + E + E+ + L+H+N+VRL
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 175 GWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQ 234
+ +L LV+++ + + E K + L L + H +
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-------DPEIVKSFLFQLLKGLGFCHSR 120
Query: 235 LETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRI 294
++HRD+K N++++ +L +FGLAR ++ +
Sbjct: 121 ---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC----------------YSAE 161
Query: 295 GGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRR 333
T+ Y PP+ + + D++S G + E+ + R
Sbjct: 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.9 bits (227), Expect = 5e-21
Identities = 37/286 (12%), Positives = 93/286 (32%), Gaps = 37/286 (12%)
Query: 526 FGTAYQGF-LDNHQYVLVKRLGMSKC-PALRTRFSNELQNLARLRHRNLVQLCGWCTEQG 583
+GT ++ + H+ V +KR+ + + + E+ L L+H+N+V+L
Sbjct: 15 YGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK 74
Query: 584 EMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHR 643
++ +++++ + + N + L + L + V+HR
Sbjct: 75 KLTLVFEFCDQDLKKYFDSCNG---------DLDPEIVKSFLFQLLKGLGFCHSRNVLHR 125
Query: 644 NITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEA 703
++ + ++ + +L +F LA + + V ++ +
Sbjct: 126 DLKPQNLLINRNGELKLANFGLARAFGIPVRCY------SAEVVTLWYRPPDVLFGAKLY 179
Query: 704 TSMADVYSFGVVVLEVVTGQ----------------MAVDFRLPEGLLVKRVHEFEARKR 747
++ D++S G + E+ + E + +
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239
Query: 748 PLAELVDLSLNGEYN-HKELMRLIKLGIACTLSNPELRPSMRQILS 792
P+ +N + L++ NP R S + L
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQ---NLLKCNPVQRISAEEALQ 282
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 127 bits (321), Expect = 8e-33
Identities = 48/245 (19%), Positives = 87/245 (35%), Gaps = 36/245 (14%)
Query: 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK---GERFEKTFAAELVAVAHLRH 167
+ FD + LG+G FG+V G A+K L ++ + + E + +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 168 RNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAA 227
LV+L L +V +Y+ + L R + + +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-------RFSEPHARFYAAQIVLT 153
Query: 228 LHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFH 287
YLH +I+RD+K N+++D Q ++ DFG A+
Sbjct: 154 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKR-------------------V 191
Query: 288 LAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILL 347
T + GT L PE D ++ G+++ E+ +G + D I +
Sbjct: 192 KGRTWTLCGTPEALAPEIILSKGY-NKAVDWWALGVLIYEMAAGYP---PFFADQPIQIY 247
Query: 348 DWIRR 352
+ I
Sbjct: 248 EKIVS 252
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 93.7 bits (232), Expect = 4e-21
Identities = 42/256 (16%), Positives = 84/256 (32%), Gaps = 27/256 (10%)
Query: 471 ATAECGGNTESKSNNSRSQRRNSFFMVETPREISFKEIISATNNFSESQRVAEMDFGTAY 530
A A+ G ES + + ETP + + + + F + + FG
Sbjct: 4 AAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQ-----LDQFDRIKTLGTGSFGRVM 58
Query: 531 QGF-LDNHQYVLVKRLGMSKC--PALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLV 587
++ + +K L K NE + L + LV+L + + +
Sbjct: 59 LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118
Query: 588 IYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITS 647
+ +Y A + L H + YLH +I+R++
Sbjct: 119 VMEYVAGGEMFSHLRRIGR------FSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKP 169
Query: 648 SAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMA 707
+ +D ++ F A ++ ++ G ++PE I S
Sbjct: 170 ENLLIDQQGYIQVTDFGFA----------KRVKGRTWTLCGTPEALAPEIILSKGYNKAV 219
Query: 708 DVYSFGVVVLEVVTGQ 723
D ++ GV++ E+ G
Sbjct: 220 DWWALGVLIYEMAAGY 235
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 6e-32
Identities = 61/302 (20%), Positives = 112/302 (37%), Gaps = 40/302 (13%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCL--AEKGERFEKTFAAELVAVAHLRHRNL 170
+ + + +GSG +G V AV G VA+K L + E F K EL + H+RH N+
Sbjct: 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79
Query: 171 VRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHY 230
+ L ++ L D+ + L L ++ + ++ + L Y
Sbjct: 80 IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGK---LMKHEKLGEDRIQFLVYQMLKGLRY 136
Query: 231 LHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAE 290
+H IIHRD+K N+ ++ ++ DFGLAR + E+
Sbjct: 137 IHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM------------------ 175
Query: 291 TTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWI 350
T T Y PE T D++S G ++ E+++G+ + DQ+ + +
Sbjct: 176 -TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKV 234
Query: 351 RRLSDEGKVLQAGDNRLSDGSYKLCDME-------------HLTHLALLCTLHNPHLRPS 397
V + + + L ++E +L + + R +
Sbjct: 235 TGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVT 294
Query: 398 MK 399
Sbjct: 295 AG 296
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.3 bits (236), Expect = 1e-21
Identities = 55/323 (17%), Positives = 106/323 (32%), Gaps = 50/323 (15%)
Query: 526 FGTAYQGF-LDNHQYVLVKRLGMSKC-PALRTRFSNELQNLARLRHRNLVQLCGWCTEQG 583
+G V +K+L R EL+ L +RH N++ L T
Sbjct: 31 YGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE 90
Query: 584 EMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHR 643
+ D+ ++ + + H L ++ + + Y+H IHR
Sbjct: 91 TLDDFTDFYL--VMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGI---IHR 145
Query: 644 NITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYI-ESGE 702
++ + ++ D ++ F LA G+ Y +PE I
Sbjct: 146 DLKPGNLAVNEDCELKILDFGLARQADSEMTGY----------VVTRWYRAPEVILNWMR 195
Query: 703 ATSMADVYSFGVVVLEVVTGQ---------------MAVDFRLPEGL---LVKRVHEFEA 744
T D++S G ++ E++TG+ M V P L +
Sbjct: 196 YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYM 255
Query: 745 RKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQIL------SILDGND 798
+ P E D + + L++ + + E R + + L S+ D D
Sbjct: 256 KGLPELEKKDFASILTNASPLAVNLLE---KMLVLDAEQRVTAGEALAHPYFESLHDTED 312
Query: 799 KRFMED-----GQMTENLEEWKQ 816
+ ++ + L+EWK+
Sbjct: 313 EPQVQKYDDSFDDVDRTLDEWKR 335
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 4e-30
Identities = 57/249 (22%), Positives = 100/249 (40%), Gaps = 34/249 (13%)
Query: 108 IGSNGFDEDEVLGSGGFGKVYRAVLPSD---GTVVAVKCL----AEKGERFEKTFAAELV 160
+G F+ +VLG+G +GKV+ S G + A+K L + + + E
Sbjct: 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ 80
Query: 161 AVAHLRHR-NLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKK 219
+ H+R LV L E +L L+ DY+ L L +R + +
Sbjct: 81 VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE-------RFTEHEVQI 133
Query: 220 IIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTS 279
+ + AL +LH+ II+RD+K N++LDS + L DFGL++
Sbjct: 134 YVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF----------- 179
Query: 280 SARNHQFHLAETTRIGGTIGYLPPESFQKGSVA-TAKSDVFSFGIVVLEVVSGRRAVDLT 338
GTI Y+ P+ + G D +S G+++ E+++G +
Sbjct: 180 ----VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD 235
Query: 339 YPDDQIILL 347
+ +
Sbjct: 236 GEKNSQAEI 244
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.0 bits (212), Expect = 9e-19
Identities = 47/274 (17%), Positives = 91/274 (33%), Gaps = 37/274 (13%)
Query: 526 FGTAYQGFL----DNHQYVLVKRL---GMSKCPALRTRFSNELQNLARLRHR-NLVQLCG 577
+G + D + +K L + + E Q L +R LV L
Sbjct: 37 YGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHY 96
Query: 578 WCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWN 637
+ ++ +I DY L L H + + A+ +LH+
Sbjct: 97 AFQTETKLHLILDYINGGELFTHLSQRER------FTEHEVQIYVGEIVLALEHLHKL-- 148
Query: 638 EQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEY 697
+I+R+I I LD + + L F L++ ++ T G YM+P+
Sbjct: 149 -GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE------TERAYDFCGTIEYMAPDI 201
Query: 698 IESGEA--TSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDL 755
+ G++ D +S GV++ E++TG + + + P + +
Sbjct: 202 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS- 260
Query: 756 SLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQ 789
LI+ + +P+ R
Sbjct: 261 --------ALAKDLIQ---RLLMKDPKKRLGCGP 283
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 118 bits (297), Expect = 9e-30
Identities = 48/243 (19%), Positives = 89/243 (36%), Gaps = 40/243 (16%)
Query: 98 PRIFSYAELYIGSNGFDE---DEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKT 154
+ Y + D+ LG G + +V+ A+ ++ V VK L +K
Sbjct: 19 REYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKK 75
Query: 155 FAAELVAVAHLR-HRNLVRLRGWCVHED--QLLLVYDYMPNRSLDRVLFRRPENLEAAAP 211
E+ + +LR N++ L LV++++ N ++
Sbjct: 76 IKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----------QT 125
Query: 212 LNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQ-YNARLGDFGLARWLEH 270
L + + + AL Y H I+HRDVK NVM+D + RL D+GLA +
Sbjct: 126 LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182
Query: 271 ELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS 330
+Y +R + + PE + D++S G ++ ++
Sbjct: 183 GQEYNVRV-----------------ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 225
Query: 331 GRR 333
+
Sbjct: 226 RKE 228
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 72.2 bits (176), Expect = 4e-14
Identities = 38/293 (12%), Positives = 102/293 (34%), Gaps = 48/293 (16%)
Query: 526 FGTAYQGF-LDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLR-HRNLVQLCGWCTEQG 583
+ ++ + N++ V+VK L K + + E++ L LR N++ L +
Sbjct: 48 YSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPV 103
Query: 584 EMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHR 643
++ + + + + + L + + + A+ Y H ++HR
Sbjct: 104 SRTPA-------LVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMG---IMHR 153
Query: 644 NITSSAITLDPD-MNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGE 702
++ + +D + RL + LAEF + + + PE + +
Sbjct: 154 DVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV--------ASRYFKGPELLVDYQ 205
Query: 703 A-TSMADVYSFGVVVLEVVTGQ---------MAVDFRLPEGLLVKRVHEFEARKRPLAEL 752
D++S G ++ ++ + R+ + L + ++++ + +
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 265
Query: 753 VDLSLNGEYNHKELMRLIKLGIACTLS-------------NPELRPSMRQILS 792
+ G ++ K R + +S + + R + R+ +
Sbjct: 266 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (282), Expect = 1e-27
Identities = 51/227 (22%), Positives = 89/227 (39%), Gaps = 37/227 (16%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCL--AEKGERFEKTFAAELVAVAHLRHRNL 170
+ +GSG +G V A G VAVK L + K EL + H++H N+
Sbjct: 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79
Query: 171 VRLRGWCV-----HEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLA 225
+ L E + + ++ L+ ++ + L + + +I +
Sbjct: 80 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--------KLTDDHVQFLIYQIL 131
Query: 226 AALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQ 285
L Y+H IIHRD+K SN+ ++ ++ DFGLAR + E+ +
Sbjct: 132 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-------- 180
Query: 286 FHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332
T Y PE D++S G ++ E+++GR
Sbjct: 181 -----------TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.3 bits (197), Expect = 8e-17
Identities = 45/287 (15%), Positives = 93/287 (32%), Gaps = 37/287 (12%)
Query: 526 FGTAYQGF-LDNHQYVLVKRLGMS-KCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQG 583
+G+ F V VK+L + R EL+ L ++H N++ L T
Sbjct: 31 YGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 90
Query: 584 EMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHR 643
+ D L +N + L H +I + + Y+H IHR
Sbjct: 91 SLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSADI---IHR 145
Query: 644 NITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEA 703
++ S + ++ D ++ F LA G+ + +
Sbjct: 146 DLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR---------WYRAPEIMLNWMHY 196
Query: 704 TSMADVYSFGVVVLEVVTGQ---------------MAVDFRLPEGLLVKRVHEFEA---R 745
D++S G ++ E++TG+ + + LL K E +
Sbjct: 197 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 256
Query: 746 KRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792
++ + + + L++ + + + R + Q L+
Sbjct: 257 SLTQMPKMNFANVFIGANPLAVDLLE---KMLVLDSDKRITAAQALA 300
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 2e-27
Identities = 51/240 (21%), Positives = 84/240 (35%), Gaps = 39/240 (16%)
Query: 113 FDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCL--AEKGERFEKTFAAELVAVAHLRHRNL 170
+ + +GSG G V A VA+K L + + K ELV + + H+N+
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 171 VRLRGWCVHED------QLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGL 224
+ L + + LV + M + E+ ++ +
Sbjct: 79 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD----------HERMSYLLYQM 128
Query: 225 AAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNH 284
+ +LH IIHRD+K SN+++ S ++ DFGLAR
Sbjct: 129 LCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---------- 175
Query: 285 QFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQI 344
T T Y PE G D++S G ++ E+V + DQ
Sbjct: 176 -------TPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW 227
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.9 bits (188), Expect = 1e-15
Identities = 45/298 (15%), Positives = 91/298 (30%), Gaps = 48/298 (16%)
Query: 526 FGTAYQGF-LDNHQYVLVKRLGMSKC-PALRTRFSNELQNLARLRHRNLVQLCGWCTEQG 583
G + + V +K+L R EL + + H+N++ L T Q
Sbjct: 30 QGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK 89
Query: 584 EMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHR 643
+ ++ ++ L+ N ++ L ++ + I +LH IHR
Sbjct: 90 TL---EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGI---IHR 143
Query: 644 NITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEA 703
++ S I + D ++ F LA + Y +PE I
Sbjct: 144 DLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP--------YVVTRYYRAPEVILGMGY 195
Query: 704 TSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEA------------------- 744
D++S G ++ E+V ++ R K + +
Sbjct: 196 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 255
Query: 745 ----------RKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792
+ P + S + + + L+ + +P R S+ L
Sbjct: 256 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLS---KMLVIDPAKRISVDDALQ 310
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 96.6 bits (239), Expect = 4e-22
Identities = 42/247 (17%), Positives = 83/247 (33%), Gaps = 28/247 (11%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGW 176
LG G F V+ A + T VA+K + + + + E+ + + + +
Sbjct: 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 77
Query: 177 CV-HEDQLLLVYDYMPNRSLDRVLFRRPE--------NLEAAAPLNWEQRKKIIRGLAAA 227
H +LL +++ + V+ + K+I + L
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 228 LHYLHEQLETQIIHRDVKTSNVMLDSQ-YNARLGDFGLARWLEHELQYQMRTSSARNHQF 286
L Y+H + IIH D+K NV+++ L +A +
Sbjct: 138 LDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY--------- 186
Query: 287 HLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIIL 346
T T Y PE G+ +D++S ++ E+++G +
Sbjct: 187 -----TNSIQTREYRSPEVLL-GAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 240
Query: 347 LDWIRRL 353
D I ++
Sbjct: 241 DDHIAQI 247
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 75.5 bits (184), Expect = 4e-15
Identities = 32/210 (15%), Positives = 69/210 (32%), Gaps = 21/210 (10%)
Query: 526 FGTAYQGF-LDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGE 584
F T + + N+ +V +K + +E++ L R+ + +
Sbjct: 26 FSTVWLAKDMVNNTHVAMKI--VRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHIL 83
Query: 585 MLVIYDYSATRILSHLLFHN----------NHRIGHSILQWHHRYNIIKSLASAILYLHE 634
L+ + H++ + H + + I K L + Y+H
Sbjct: 84 KLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR 143
Query: 635 EWNEQVIHRNITSSAITLDP-DMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYM 693
+IH +I + ++ D L +A+ + + Y
Sbjct: 144 RCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYR 196
Query: 694 SPEYIESGEATSMADVYSFGVVVLEVVTGQ 723
SPE + AD++S ++ E++TG
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 87.5 bits (216), Expect = 3e-20
Identities = 25/165 (15%), Positives = 55/165 (33%), Gaps = 25/165 (15%)
Query: 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKT----------FAAELVAVAHLR 166
+++G G V+ VK F+K F+ + A
Sbjct: 6 KLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 167 HRNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAA 226
R L +L+G V + Y + N + + + + E +++ +
Sbjct: 65 FRALQKLQGLAVPKV-----YAWEGN-----AVLMELIDAKELYRVRVENPDEVLDMILE 114
Query: 227 ALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHE 271
+ + + I+H D+ NV++ + + DF + + E
Sbjct: 115 EVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEE 155
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 56.7 bits (136), Expect = 1e-09
Identities = 26/203 (12%), Positives = 58/203 (28%), Gaps = 34/203 (16%)
Query: 526 FGTAYQGFLDNHQYVLVKRLGMSKC---------PALRTRFSNELQNLARLRHRNLVQLC 576
+ + + +VK + FS AR R L +L
Sbjct: 13 ESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 72
Query: 577 GWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEW 636
G + +Y + +L L+ + ++ + + +
Sbjct: 73 GLAVPK-----VYAWEGNAVLMELIDAKELYRVR----VENPDEVLDMILEEVAKFYHRG 123
Query: 637 NEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSG-NRSVRGIFGYMSP 695
++H +++ + + + + F + + G R VR I Y S
Sbjct: 124 ---IVHGDLSQYNVLVS-EEGIWIIDFPQS-----VEVGEEGWREILERDVRNIITYFSR 174
Query: 696 EYIESGEATSMADVYSFGVVVLE 718
Y + D+ S +L+
Sbjct: 175 TY------RTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 834 | |||
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.22 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.7 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.56 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.48 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.99 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.64 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.25 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.3 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.12 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 94.23 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 93.3 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 91.1 |
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.5e-52 Score=447.62 Aligned_cols=270 Identities=21% Similarity=0.352 Sum_probs=203.5
Q ss_pred ccHHHHHHHhhCcCc---------CCcccccCCcEEEEEEECC-C---cEEEEEEecCCCChhHHHHHHHHHHHHHhccC
Q 003278 503 ISFKEIISATNNFSE---------SQRVAEMDFGTAYQGFLDN-H---QYVLVKRLGMSKCPALRTRFSNELQNLARLRH 569 (834)
Q Consensus 503 ~~~~el~~at~~f~~---------~~~ig~g~~g~vy~~~~~~-~---~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~H 569 (834)
++++++.+||.+|+. .+.||+|+||+||+|.... + ..||||.+........+++|.+|+++|++++|
T Consensus 7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H 86 (299)
T d1jpaa_ 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86 (299)
T ss_dssp GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC
T ss_pred CCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC
Confidence 567777888877764 3579999999999999743 2 36899998776667777889999999999999
Q ss_pred CCceeEEEEEeeCCeEEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCc
Q 003278 570 RNLVQLCGWCTEQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSA 649 (834)
Q Consensus 570 pNiv~l~g~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~N 649 (834)
||||+++|+|.+.+..++|||||++|+|.+++.... ..++|..++.|+.|||+||+|||+ .+||||||||+|
T Consensus 87 pnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~-----~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~N 158 (299)
T d1jpaa_ 87 PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND-----GQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARN 158 (299)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTT-----TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGG
T ss_pred CCCccEEEEEeeCCEEEEEEEecCCCcceeeecccc-----CCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccce
Confidence 999999999999999999999999999999887543 248999999999999999999997 699999999999
Q ss_pred eeecCCCCceEeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCC
Q 003278 650 ITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDF 728 (834)
Q Consensus 650 ILld~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~ 728 (834)
||||+++.+||+|||+|+.+...... ..........||+.|||||++.++.|+.++|||||||+||||+| |+.||..
T Consensus 159 ILl~~~~~~Kl~DFGla~~~~~~~~~--~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~ 236 (299)
T d1jpaa_ 159 ILVNSNLVCKVSDFGLSRFLEDDTSD--PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD 236 (299)
T ss_dssp EEECTTCCEEECCC-------------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred EEECCCCcEEECCcccceEccCCCCc--ceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCC
Confidence 99999999999999999876543211 11112223568999999999999999999999999999999998 8888865
Q ss_pred CCCchhHHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccC
Q 003278 729 RLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGN 797 (834)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~ 797 (834)
..+. .+...+. ...++ ..... .++ .+.+++.+||+.||++||||.||++.|+.+
T Consensus 237 ~~~~-~~~~~i~---~~~~~-------~~~~~-~~~---~l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 237 MTNQ-DVINAIE---QDYRL-------PPPMD-CPS---ALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp CCHH-HHHHHHH---TTCCC-------CCCTT-CCH---HHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCHH-HHHHHHH---cCCCC-------CCCcc-chH---HHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 4332 2222221 11111 01111 223 355666799999999999999999999754
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-52 Score=437.60 Aligned_cols=255 Identities=20% Similarity=0.325 Sum_probs=197.3
Q ss_pred hCcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEecc
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYS 592 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~ 592 (834)
++|.-.+.||+|+||+||+|.+.+++.||||++..... ..++|.+|+++|++++|||||+++|+|.+.+..++||||+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC--cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 35666678999999999999999888999999875432 3467999999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccC
Q 003278 593 ATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRN 672 (834)
Q Consensus 593 ~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~ 672 (834)
++|+|.+++.... ..++|..++.|+.|+|.||+|||+ .+|+||||||+|||||+++.+||+|||+|+.....
T Consensus 83 ~~g~L~~~l~~~~-----~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 154 (263)
T d1sm2a_ 83 EHGCLSDYLRTQR-----GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 154 (263)
T ss_dssp TTCBHHHHHHTTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC--------
T ss_pred CCCcHHHHhhccc-----cCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCC
Confidence 9999999987543 248899999999999999999997 68999999999999999999999999999876432
Q ss_pred CCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCccccc
Q 003278 673 DHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAEL 752 (834)
Q Consensus 673 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (834)
.. .......||+.|||||++.++.|+.++|||||||+||||+||..|+........+...+.. ..++
T Consensus 155 ~~------~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~---~~~~---- 221 (263)
T d1sm2a_ 155 QY------TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST---GFRL---- 221 (263)
T ss_dssp ----------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHH---TCCC----
T ss_pred Cc------eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHh---cCCC----
Confidence 21 1122357999999999999999999999999999999999976665444443333333222 1111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccC
Q 003278 753 VDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGN 797 (834)
Q Consensus 753 ~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~ 797 (834)
..+ ...++ ++.+++.+||+.||++||||++|++.|+.+
T Consensus 222 ~~p----~~~~~---~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 222 YKP----RLAST---HVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp CCC----TTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCc----cccCH---HHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 111 11223 355666799999999999999999999765
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-52 Score=439.38 Aligned_cols=260 Identities=26% Similarity=0.395 Sum_probs=200.1
Q ss_pred hCcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCC-ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSK-CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~-~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
++|.-.+.||+|+||+||+|.+++ .||||+++... .+...+.|.+|+.+|++++|||||+++|++.+ +..++||||
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey 84 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQW 84 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred ccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEec
Confidence 467778899999999999998654 59999987543 34556789999999999999999999999875 457999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccccc
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTR 671 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~ 671 (834)
|++|+|.+++.... ..++|..++.|+.|||+||+|||+ ++||||||||+|||||.++.+||+|||+|+....
T Consensus 85 ~~~g~L~~~l~~~~-----~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 85 CEGSSLYHHLHIIE-----TKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp CCEEEHHHHHHTSC-----CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred CCCCCHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 99999999997543 248999999999999999999997 6999999999999999999999999999987543
Q ss_pred CCCCCcccccCccccccccCccchhcccc---CCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCc
Q 003278 672 NDHGHRKATSGNRSVRGIFGYMSPEYIES---GEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRP 748 (834)
Q Consensus 672 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~---~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
... .....+..||+.|||||++.+ +.|+.++|||||||+||||+||+.||....+...+...+... ...+
T Consensus 157 ~~~-----~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~--~~~p 229 (276)
T d1uwha_ 157 WSG-----SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRG--YLSP 229 (276)
T ss_dssp --------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHT--SCCC
T ss_pred cCC-----cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcC--CCCC
Confidence 221 112345689999999999864 458999999999999999999999997554443332222211 1111
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCC
Q 003278 749 LAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGND 798 (834)
Q Consensus 749 ~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~ 798 (834)
. + ..+.... ++ .+.+++.+||+.||++||||.+|++.|+.+.
T Consensus 230 ~--~--~~~~~~~-~~---~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 230 D--L--SKVRSNC-PK---AMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp C--G--GGSCTTC-CH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred c--c--hhccccc-hH---HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 0 0 0111122 23 3455666999999999999999999997654
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.9e-52 Score=443.74 Aligned_cols=270 Identities=26% Similarity=0.436 Sum_probs=199.9
Q ss_pred ccHHHHHhhcCCC---------CCCCeeeccCCeEEEEEEECCCCe---EEEEEEeccc-ChhhHHHHHHHHHHHHhCCC
Q 003278 101 FSYAELYIGSNGF---------DEDEVLGSGGFGKVYRAVLPSDGT---VVAVKCLAEK-GERFEKTFAAELVAVAHLRH 167 (834)
Q Consensus 101 f~~~el~~~t~~f---------~~~~~LG~G~fG~Vy~~~~~~~g~---~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H 167 (834)
|+|+++..++.+| +..++||+|+||+||+|.++.+|. .||||.+... .....+.|.+|+.+|++++|
T Consensus 7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H 86 (299)
T d1jpaa_ 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86 (299)
T ss_dssp GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC
T ss_pred CCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC
Confidence 4555665555444 445799999999999999976654 6999998653 44556789999999999999
Q ss_pred CceeeEeeeEEeCCEEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCC
Q 003278 168 RNLVRLRGWCVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTS 247 (834)
Q Consensus 168 ~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~ 247 (834)
||||+++|+|.+.+..++|||||++|+|.+++... ...++|.+++.|+.|||+||.|||+. +||||||||+
T Consensus 87 pnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~------~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~ 157 (299)
T d1jpaa_ 87 PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN------DGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAAR 157 (299)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTT------TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGG
T ss_pred CCCccEEEEEeeCCEEEEEEEecCCCcceeeeccc------cCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccc
Confidence 99999999999999999999999999999988653 24689999999999999999999995 9999999999
Q ss_pred ceEECCCCceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHH
Q 003278 248 NVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLE 327 (834)
Q Consensus 248 NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~E 327 (834)
||||+.++.+||+|||+|+.+....... .........||+.|||||.+..+ .++.++|||||||+|||
T Consensus 158 NILl~~~~~~Kl~DFGla~~~~~~~~~~-----------~~~~~~~~~~t~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~e 225 (299)
T d1jpaa_ 158 NILVNSNLVCKVSDFGLSRFLEDDTSDP-----------TYTSALGGKIPIRWTAPEAIQYR-KFTSASDVWSYGIVMWE 225 (299)
T ss_dssp GEEECTTCCEEECCC----------------------------------CGGGSCHHHHHSC-CCCHHHHHHHHHHHHHH
T ss_pred eEEECCCCcEEECCcccceEccCCCCcc-----------eeeecccccCCccccCHHHHhcC-CCCcccccccchHHHHH
Confidence 9999999999999999998765432110 01112334689999999998765 67999999999999999
Q ss_pred HHh-CCccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhh
Q 003278 328 VVS-GRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVS 406 (834)
Q Consensus 328 llt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~ 406 (834)
|+| |+.||..... ..+...+ ..+..... +......+.+|+..||+.||++||+|.+|++.|+
T Consensus 226 l~t~g~~Pf~~~~~---~~~~~~i----~~~~~~~~----------~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~ 288 (299)
T d1jpaa_ 226 VMSYGERPYWDMTN---QDVINAI----EQDYRLPP----------PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD 288 (299)
T ss_dssp HHTTSCCTTTTCCH---HHHHHHH----HTTCCCCC----------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred HHhCCCCCCCCCCH---HHHHHHH----HcCCCCCC----------CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 998 8999864321 1122221 11211110 1111246889999999999999999999999987
Q ss_pred cC
Q 003278 407 GS 408 (834)
Q Consensus 407 ~~ 408 (834)
..
T Consensus 289 ~~ 290 (299)
T d1jpaa_ 289 KM 290 (299)
T ss_dssp HH
T ss_pred HH
Confidence 64
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-51 Score=435.03 Aligned_cols=261 Identities=21% Similarity=0.352 Sum_probs=203.4
Q ss_pred hCcCcCCcccccCCcEEEEEEECCC-----cEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDNH-----QYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLV 587 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~~-----~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~l 587 (834)
+.|+..+.||+|+||.||+|.+++. ..||||++.....+....+|.+|+++|++++|||||+++|+|.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 3466778899999999999987542 47999999877667667789999999999999999999999999999999
Q ss_pred EEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecc
Q 003278 588 IYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAE 667 (834)
Q Consensus 588 v~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~ 667 (834)
||||+.+|++.+++.... ..++|..+++|+.|+|.||+|||+ .+||||||||+|||||.++.+||+|||+|+
T Consensus 87 v~e~~~~~~l~~~~~~~~-----~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~ 158 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKD-----GEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSR 158 (283)
T ss_dssp EEECCTTEEHHHHHHHTT-----TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred EEEecccCcchhhhhccc-----ccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhh
Confidence 999999999998876543 248999999999999999999997 689999999999999999999999999998
Q ss_pred ccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcC
Q 003278 668 FLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKR 747 (834)
Q Consensus 668 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
.+...... ........||+.|||||++.++.++.++|||||||+||||+||..|+....+...+...+.. ..+
T Consensus 159 ~~~~~~~~----~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~---~~~ 231 (283)
T d1mqba_ 159 VLEDDPEA----TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND---GFR 231 (283)
T ss_dssp -------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT---TCC
T ss_pred cccCCCcc----ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhc---cCC
Confidence 76543211 11123457899999999999999999999999999999999988777655554443333221 111
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCc
Q 003278 748 PLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDK 799 (834)
Q Consensus 748 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~ 799 (834)
+ ..... .+. .+.+++.+||+.||++||||.+|++.|+.+-+
T Consensus 232 ~-------~~~~~-~~~---~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 232 L-------PTPMD-CPS---AIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp C-------CCCTT-CBH---HHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred C-------CCchh-hHH---HHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 1 11111 223 45566779999999999999999999976543
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-51 Score=433.24 Aligned_cols=254 Identities=24% Similarity=0.318 Sum_probs=202.1
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC-hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEc
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG-ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDY 189 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 189 (834)
++|+..+.||+|+||+||+|+++.+|+.||||++.... ....+.|.+|+.+|++++|||||++++++.+++..||||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 56888999999999999999999999999999986542 23446789999999999999999999999999999999999
Q ss_pred cCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhh
Q 003278 190 MPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLE 269 (834)
Q Consensus 190 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~ 269 (834)
|++|+|.++|... ..+++..+..|+.|+++||+|||++ +|+||||||+|||+++++.+||+|||+|+.+.
T Consensus 85 ~~gg~L~~~l~~~-------~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~ 154 (271)
T d1nvra_ 85 CSGGELFDRIEPD-------IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR 154 (271)
T ss_dssp CTTEEGGGGSBTT-------TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECE
T ss_pred cCCCcHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeec
Confidence 9999999988532 4689999999999999999999996 99999999999999999999999999998653
Q ss_pred hhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHH
Q 003278 270 HELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDW 349 (834)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~ 349 (834)
.... ....+..+||+.|||||.+.....++.++|||||||++|||+||+.||........ ....
T Consensus 155 ~~~~--------------~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-~~~~- 218 (271)
T d1nvra_ 155 YNNR--------------ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSD- 218 (271)
T ss_dssp ETTE--------------ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH-HHHH-
T ss_pred cCCc--------------cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH-HHHH-
Confidence 2210 01134567999999999987665557889999999999999999999975433221 1111
Q ss_pred HHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 350 IRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 350 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
... ........+.+ ...+.+|...||+.||++|||+.|+++
T Consensus 219 ---~~~-~~~~~~~~~~~---------s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 219 ---WKE-KKTYLNPWKKI---------DSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp ---HHT-TCTTSTTGGGS---------CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---Hhc-CCCCCCccccC---------CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111 11111001111 135678999999999999999999865
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-51 Score=433.15 Aligned_cols=255 Identities=22% Similarity=0.355 Sum_probs=204.1
Q ss_pred hCcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEecc
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYS 592 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~ 592 (834)
++|...+.||+|+||+||+|.+++++.||||+++.... ..+.|.+|+++|++++|||||+++|+|.+ +..++||||+
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC--CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 35666788999999999999999888999999975432 34679999999999999999999999876 4578999999
Q ss_pred CCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccC
Q 003278 593 ATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRN 672 (834)
Q Consensus 593 ~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~ 672 (834)
++|+|.+++.... ...++|..+++|+.|||+||+|||+ .+|+||||||+|||||+++.+||+|||+|+.+...
T Consensus 90 ~~g~L~~~~~~~~----~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~ 162 (272)
T d1qpca_ 90 ENGSLVDFLKTPS----GIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (272)
T ss_dssp TTCBHHHHTTSHH----HHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred CCCcHHHHHhhcC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCC
Confidence 9999998775432 1248999999999999999999997 68999999999999999999999999999876543
Q ss_pred CCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCccccc
Q 003278 673 DHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAEL 752 (834)
Q Consensus 673 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (834)
.. .......||+.|||||++.++.++.++|||||||+||||+||..|+........+...+. ...++
T Consensus 163 ~~------~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~---~~~~~---- 229 (272)
T d1qpca_ 163 EY------TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE---RGYRM---- 229 (272)
T ss_dssp CE------ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH---TTCCC----
T ss_pred cc------ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHH---hcCCC----
Confidence 21 112345799999999999999999999999999999999998777654444333333221 11111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccC
Q 003278 753 VDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGN 797 (834)
Q Consensus 753 ~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~ 797 (834)
..+... ++ ++.+++.+||+.||++||||.+|++.|+.+
T Consensus 230 ---~~p~~~-~~---~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 230 ---VRPDNC-PE---ELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp ---CCCTTC-CH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCcccC-hH---HHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 111122 23 355666799999999999999999999754
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-51 Score=432.01 Aligned_cols=261 Identities=24% Similarity=0.372 Sum_probs=201.1
Q ss_pred hcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEE
Q 003278 109 GSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLV 186 (834)
Q Consensus 109 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 186 (834)
..++|+..+.||+|+||+||+|++. ..||||+++.. .....+.|.+|+.+|++++|||||+++|++.+ +.++||
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv 81 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIV 81 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred ccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEE
Confidence 4567899999999999999999863 35999998643 34556789999999999999999999998865 568999
Q ss_pred EEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchh
Q 003278 187 YDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLAR 266 (834)
Q Consensus 187 ~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~ 266 (834)
||||++|+|.++|.... ..++|..++.|+.|||+||+|||+. +||||||||+||||+.++.+||+|||+|+
T Consensus 82 ~Ey~~~g~L~~~l~~~~------~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~ 152 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHIIE------TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLAT 152 (276)
T ss_dssp EECCCEEEHHHHHHTSC------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSC
T ss_pred EecCCCCCHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEcccccee
Confidence 99999999999997542 4689999999999999999999985 99999999999999999999999999998
Q ss_pred hhhhhhhhhhhcccccccccccccceeeeccccCCCccccccC--CCCCcccceeehhhHHHHHHhCCccCCCCCCCccc
Q 003278 267 WLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKG--SVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQI 344 (834)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~ 344 (834)
........ ...++..||+.|||||.+... ..++.++|||||||+||||+||+.||.......
T Consensus 153 ~~~~~~~~--------------~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~-- 216 (276)
T d1uwha_ 153 VKSRWSGS--------------HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-- 216 (276)
T ss_dssp C--------------------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--
T ss_pred eccccCCc--------------ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH--
Confidence 65432110 113456799999999998632 347899999999999999999999986432211
Q ss_pred hHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 345 ILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 345 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
.+ ......+....... .+. ... .+.+.+|+..||+.||++||||.+|++.|+..
T Consensus 217 ~~----~~~~~~~~~~p~~~-~~~-~~~----~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l 270 (276)
T d1uwha_ 217 QI----IFMVGRGYLSPDLS-KVR-SNC----PKAMKRLMAECLKKKRDERPLFPQILASIELL 270 (276)
T ss_dssp HH----HHHHHHTSCCCCGG-GSC-TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH----HHHHhcCCCCCcch-hcc-ccc----hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11 11122221111110 010 111 24688999999999999999999999998754
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-51 Score=439.46 Aligned_cols=267 Identities=23% Similarity=0.344 Sum_probs=214.4
Q ss_pred cHHHHHhhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCC
Q 003278 102 SYAELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHED 181 (834)
Q Consensus 102 ~~~el~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~ 181 (834)
+|++.++..++|+..+.||+|+||+||+|+++.+|+.||||+++... ...++|.+|+.+|++++|||||+++|+|.+++
T Consensus 8 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 86 (287)
T d1opja_ 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 86 (287)
T ss_dssp TCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCC
Confidence 34445556678999999999999999999998889999999987543 34567999999999999999999999999999
Q ss_pred EEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEee
Q 003278 182 QLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGD 261 (834)
Q Consensus 182 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~D 261 (834)
..++|||||++|+|..+|.... ...++|..++.|+.|||+||+|||+. +||||||||+||||++++.+||+|
T Consensus 87 ~~~iv~E~~~~g~l~~~l~~~~-----~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~D 158 (287)
T d1opja_ 87 PFYIITEFMTYGNLLDYLRECN-----RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVAD 158 (287)
T ss_dssp SCEEEEECCTTCBHHHHHHHSC-----TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECC
T ss_pred eeEEEeecccCcchHHHhhhcc-----ccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEcc
Confidence 9999999999999999997542 35789999999999999999999995 999999999999999999999999
Q ss_pred ccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCC
Q 003278 262 FGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPD 341 (834)
Q Consensus 262 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~ 341 (834)
||+|+....+. ....+...||+.|||||++..+ .++.|+|||||||++|||+||..|+......
T Consensus 159 FG~a~~~~~~~---------------~~~~~~~~g~~~y~aPE~~~~~-~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~ 222 (287)
T d1opja_ 159 FGLSRLMTGDT---------------YTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 222 (287)
T ss_dssp CCCTTTCCSSS---------------SEEETTEEECGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred ccceeecCCCC---------------ceeeccccccccccChHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCcchH
Confidence 99998653221 0112345689999999998766 6799999999999999999987776432211
Q ss_pred ccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcCC
Q 003278 342 DQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGSY 409 (834)
Q Consensus 342 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~~ 409 (834)
..+. .....+.... .. ... ...+.+|+..||+.||++||||.+|++.|+..+
T Consensus 223 --~~~~----~~i~~~~~~~-----~~-~~~----~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 223 --SQVY----ELLEKDYRME-----RP-EGC----PEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp --HHHH----HHHHTTCCCC-----CC-TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred --HHHH----HHHhcCCCCC-----CC-ccc----hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1111 1222221111 11 111 246889999999999999999999999987653
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=430.45 Aligned_cols=253 Identities=24% Similarity=0.352 Sum_probs=206.1
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEcc
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYM 190 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 190 (834)
+.|+..+.||+|+||+||+|+++.+|+.||||++........+.|.+|+.+|++++|||||++++++.+.+..+||||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 45788899999999999999999999999999997766666678999999999999999999999999999999999999
Q ss_pred CCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhh
Q 003278 191 PNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEH 270 (834)
Q Consensus 191 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~ 270 (834)
++|+|.+++.+. ..++++..+..|+.||++||.|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 92 ~~g~L~~~~~~~------~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~ 162 (288)
T d2jfla1 92 AGGAVDAVMLEL------ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 162 (288)
T ss_dssp TTEEHHHHHHHH------TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred CCCcHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCC
Confidence 999999987643 24689999999999999999999996 999999999999999999999999999986543
Q ss_pred hhhhhhhcccccccccccccceeeeccccCCCccccc----cCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchH
Q 003278 271 ELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQ----KGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIIL 346 (834)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~----~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l 346 (834)
... ..++..||+.|||||++. .+..++.++|||||||++|||+||+.||......+ +
T Consensus 163 ~~~----------------~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~---~ 223 (288)
T d2jfla1 163 TIQ----------------RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR---V 223 (288)
T ss_dssp HHH----------------HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---H
T ss_pred Ccc----------------cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH---H
Confidence 321 123457999999999884 23457899999999999999999999986532221 1
Q ss_pred HHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 347 LDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 347 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
.. .... +.......+ ..-...+.+|+..||+.||.+|||+.|+++
T Consensus 224 ~~---~i~~-~~~~~~~~~--------~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 224 LL---KIAK-SEPPTLAQP--------SRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp HH---HHHH-SCCCCCSSG--------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HH---HHHc-CCCCCCCcc--------ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11 1111 111111000 011245788999999999999999999875
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=426.50 Aligned_cols=255 Identities=24% Similarity=0.375 Sum_probs=196.1
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEcc
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYM 190 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 190 (834)
++|+..+.||+|+||+||+|.+. ++..||||+++... ...++|.+|+.++++++|||||+++|+|..++..++|||||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 56888899999999999999994 67899999997543 34578999999999999999999999999999999999999
Q ss_pred CCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhh
Q 003278 191 PNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEH 270 (834)
Q Consensus 191 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~ 270 (834)
++|+|.+++... ...++|..++.|+.|+|+||.|||+. +|+||||||+|||+|+++.+||+|||+|+.+..
T Consensus 83 ~~g~L~~~l~~~------~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 153 (263)
T d1sm2a_ 83 EHGCLSDYLRTQ------RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 153 (263)
T ss_dssp TTCBHHHHHHTT------TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-------
T ss_pred CCCcHHHHhhcc------ccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccC
Confidence 999999998654 24689999999999999999999995 999999999999999999999999999986543
Q ss_pred hhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHHH
Q 003278 271 ELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWI 350 (834)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~ 350 (834)
... .......||+.|||||.+..+ .++.|+|||||||++|||+||..|+..... ...+...+
T Consensus 154 ~~~---------------~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvil~el~t~~~~~~~~~~--~~~~~~~i 215 (263)
T d1sm2a_ 154 DQY---------------TSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRS--NSEVVEDI 215 (263)
T ss_dssp --------------------------CTTSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSCC--HHHHHHHH
T ss_pred CCc---------------eeecceecCcccCChHHhcCC-CCCchhhhcchHHHHHHHHHCCCCCCCCCC--HHHHHHHH
Confidence 211 012345699999999998755 689999999999999999996555432211 11122221
Q ss_pred HHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 351 RRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 351 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
. .+... ..+.. ....+.+|+..||+.||++||||++|++.|+.+
T Consensus 216 ~----~~~~~--~~p~~--------~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 216 S----TGFRL--YKPRL--------ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp H----HTCCC--CCCTT--------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H----hcCCC--CCccc--------cCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 1 12111 11111 124688999999999999999999999998754
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-50 Score=428.49 Aligned_cols=250 Identities=20% Similarity=0.286 Sum_probs=201.0
Q ss_pred cccccCCcEEEEEEEC---CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEeccCCCc
Q 003278 520 RVAEMDFGTAYQGFLD---NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSATRI 596 (834)
Q Consensus 520 ~ig~g~~g~vy~~~~~---~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~~~g~ 596 (834)
+||+|+||+||+|... ++..||||.++........++|.+|+++|++++|||||+++|+|.+ +..++||||+++|+
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~ 94 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 94 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEE
T ss_pred EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCc
Confidence 4999999999999864 3557999999876666667889999999999999999999999965 46899999999999
Q ss_pred hhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCCCCC
Q 003278 597 LSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDHGH 676 (834)
Q Consensus 597 L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~~~~ 676 (834)
|.+++.... ..++|..+++|+.|+|+||+|||+ ++||||||||+||||+.++.+||+|||+|+.+.....
T Consensus 95 L~~~l~~~~-----~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-- 164 (285)
T d1u59a_ 95 LHKFLVGKR-----EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS-- 164 (285)
T ss_dssp HHHHHTTCT-----TTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC--
T ss_pred HHHHhhccc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhccccccc--
Confidence 999876433 248999999999999999999997 6999999999999999999999999999987654321
Q ss_pred cccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCcccccccc
Q 003278 677 RKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRPLAELVDL 755 (834)
Q Consensus 677 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 755 (834)
.........||+.|||||++.++.++.++|||||||++|||+| |+.||...... .+...+. ...++
T Consensus 165 --~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~-~~~~~i~---~~~~~------- 231 (285)
T d1u59a_ 165 --YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-EVMAFIE---QGKRM------- 231 (285)
T ss_dssp --EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-HHHHHHH---TTCCC-------
T ss_pred --ccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH-HHHHHHH---cCCCC-------
Confidence 1122334579999999999999999999999999999999998 89998754332 2222221 11111
Q ss_pred ccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccC
Q 003278 756 SLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGN 797 (834)
Q Consensus 756 ~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~ 797 (834)
..+.. .+++ +.+++.+||+.||++||||.+|++.|+..
T Consensus 232 ~~p~~-~~~~---l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 232 ECPPE-CPPE---LYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp CCCTT-CCHH---HHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCc-CCHH---HHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11112 2233 45566799999999999999999998754
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-50 Score=431.95 Aligned_cols=257 Identities=20% Similarity=0.303 Sum_probs=206.7
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
++|.-.+.||+|+||+||+|... +++.||||+++.+.. ..++|.+|+++|++++|||||+++|+|.+.+..+|||||
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc--hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 35666778999999999999975 478899999875433 346799999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccccc
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTR 671 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~ 671 (834)
|++|+|..++..... ..++|..++.|+.|||+||+|||+ .+||||||||+|||||+++.+||+|||+|+....
T Consensus 95 ~~~g~l~~~l~~~~~----~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 95 MTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167 (287)
T ss_dssp CTTCBHHHHHHHSCT----TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred ccCcchHHHhhhccc----cchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecCC
Confidence 999999999875432 358999999999999999999997 6899999999999999999999999999987643
Q ss_pred CCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcccc
Q 003278 672 NDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAE 751 (834)
Q Consensus 672 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
... .......||+.|||||++.++.|+.++|||||||+||||+||..|+........+...+. ...+
T Consensus 168 ~~~------~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~---~~~~---- 234 (287)
T d1opja_ 168 DTY------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE---KDYR---- 234 (287)
T ss_dssp SSS------EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH---TTCC----
T ss_pred CCc------eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHh---cCCC----
Confidence 321 112235689999999999999999999999999999999998888765444333222211 1111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCC
Q 003278 752 LVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGND 798 (834)
Q Consensus 752 ~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~ 798 (834)
+...... ++ ++.+++.+||+.||++||||.+|++.|+.+.
T Consensus 235 ---~~~~~~~-~~---~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 235 ---MERPEGC-PE---KVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp ---CCCCTTC-CH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ---CCCCccc-hH---HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1111122 23 3556667999999999999999999997653
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-50 Score=426.41 Aligned_cols=250 Identities=23% Similarity=0.367 Sum_probs=204.2
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEcc
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYM 190 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 190 (834)
++|+..+.||+|+||+||+|+.+.+|+.||||++........+.+.+|+.+|++++|||||++++++.+.+.+|||||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 46899999999999999999999999999999987655555678999999999999999999999999999999999999
Q ss_pred CCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhh
Q 003278 191 PNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEH 270 (834)
Q Consensus 191 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~ 270 (834)
++|+|.+++.+ ..+++..+..|+.||+.||+|||++ +||||||||+|||++.++++||+|||+|+.+..
T Consensus 100 ~gg~L~~~~~~--------~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~ 168 (293)
T d1yhwa1 100 AGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (293)
T ss_dssp TTCBHHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred CCCcHHHHhhc--------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence 99999988754 2589999999999999999999996 999999999999999999999999999986532
Q ss_pred hhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHHH
Q 003278 271 ELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWI 350 (834)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~ 350 (834)
+. ......+||+.|||||.+... .++.++|||||||++|||+||+.||..... . ...
T Consensus 169 ~~----------------~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~---~---~~~ 225 (293)
T d1yhwa1 169 EQ----------------SKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENP---L---RAL 225 (293)
T ss_dssp TT----------------CCBCCCCSCGGGCCHHHHSSS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---H---HHH
T ss_pred cc----------------ccccccccCCCccChhhhcCC-CCCchhceehHhHHHHHHhhCCCCCCCCCH---H---HHH
Confidence 21 113455799999999998754 679999999999999999999999864221 1 111
Q ss_pred HHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 351 RRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 351 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
......+.......+.+ ...+.++...||+.||.+|||+.|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~---------s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 226 YLIATNGTPELQNPEKL---------SAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp HHHHHHCSCCCSSGGGS---------CHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHhCCCCCCCCcccC---------CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111111100000111 145788999999999999999999875
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=423.88 Aligned_cols=246 Identities=28% Similarity=0.464 Sum_probs=203.0
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc---ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK---GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 187 (834)
++|+..+.||+|+||+||+|+++.+|+.||||++.+. .....+.+.+|+.++++++|||||++++++.+++.+|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 4588899999999999999999999999999998643 2334577899999999999999999999999999999999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
|||++|+|.+++... .++++..+..|+.||++||+|||++ +||||||||+|||++.++.+||+|||+|+.
T Consensus 86 Ey~~~g~L~~~l~~~-------~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~ 155 (263)
T d2j4za1 86 EYAPLGTVYRELQKL-------SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVH 155 (263)
T ss_dssp ECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSC
T ss_pred eecCCCcHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeee
Confidence 999999999998643 4689999999999999999999996 999999999999999999999999999975
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHH
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILL 347 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~ 347 (834)
.... ......||+.|||||.+... .++.++|||||||+||||+||+.||..... ..+
T Consensus 156 ~~~~------------------~~~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~---~~~- 212 (263)
T d2j4za1 156 APSS------------------RRTTLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTY---QET- 212 (263)
T ss_dssp CCCC------------------CCEETTEEGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHH-
T ss_pred cCCC------------------cccccCCCCcccCHHHHcCC-CCCchhhhhhHhHHHHHHhcCCCCCCCCCH---HHH-
Confidence 4221 13456799999999998754 679999999999999999999999964321 111
Q ss_pred HHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 348 DWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 348 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
..... .+. ..+. ... .+.+.+|...||+.||++|||+.|+++
T Consensus 213 --~~~i~-~~~------~~~p-~~~----s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 213 --YKRIS-RVE------FTFP-DFV----TEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp --HHHHH-TTC------CCCC-TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --HHHHH-cCC------CCCC-ccC----CHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 11111 111 1111 111 145778999999999999999999986
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-50 Score=425.35 Aligned_cols=253 Identities=19% Similarity=0.254 Sum_probs=197.8
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
++|...+.||+|+||+||+|.. .+++.||||++.........+.|.+|+++|++++|||||++++++.+.+..+|||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 4677788999999999999996 568999999997665555556799999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccccc
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTR 671 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~ 671 (834)
+++|+|.+++.... .+++.....|+.|++.||+|||+ .+||||||||+||||++++.+||+|||+|+.+..
T Consensus 85 ~~gg~L~~~l~~~~------~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~ 155 (271)
T d1nvra_ 85 CSGGELFDRIEPDI------GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRY 155 (271)
T ss_dssp CTTEEGGGGSBTTT------BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEE
T ss_pred cCCCcHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeecc
Confidence 99999999986432 48899999999999999999997 6899999999999999999999999999987643
Q ss_pred CCCCCcccccCccccccccCccchhccccCCC-CccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCccc
Q 003278 672 NDHGHRKATSGNRSVRGIFGYMSPEYIESGEA-TSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLA 750 (834)
Q Consensus 672 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (834)
... .....+.+||+.|||||++.+..+ +.++|||||||+||||+||+.||............. ... ....
T Consensus 156 ~~~-----~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~---~~~-~~~~ 226 (271)
T d1nvra_ 156 NNR-----ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW---KEK-KTYL 226 (271)
T ss_dssp TTE-----ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHH---HTT-CTTS
T ss_pred CCc-----cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHH---hcC-CCCC
Confidence 321 112345789999999999988876 577999999999999999999997543322221111 111 1110
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 751 ELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 751 ~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
.. . ...+ ++ +.+++.+||+.||++|||+.||++
T Consensus 227 ~~-~----~~~s-~~---~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 227 NP-W----KKID-SA---PLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TT-G----GGSC-HH---HHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred Cc-c----ccCC-HH---HHHHHHHHcCCChhHCcCHHHHhc
Confidence 00 0 0111 33 345556899999999999999864
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-50 Score=438.08 Aligned_cols=204 Identities=25% Similarity=0.410 Sum_probs=179.5
Q ss_pred hhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc-ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEE
Q 003278 108 IGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLV 186 (834)
Q Consensus 108 ~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 186 (834)
+..++|+..+.||+|+||+||+|++..+|+.||||+++.. .....+.+.+|+.+|++++|||||+++++|.+++.+|||
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 3467899999999999999999999999999999998654 344567899999999999999999999999999999999
Q ss_pred EEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchh
Q 003278 187 YDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLAR 266 (834)
Q Consensus 187 ~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~ 266 (834)
||||++|+|.+++.+. ..+++..+..++.|+++||.|||++ .+|+||||||+|||++.++++||+|||+|+
T Consensus 83 mEy~~gg~L~~~l~~~-------~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~ 153 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKA-------GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSG 153 (322)
T ss_dssp EECCTTEEHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCH
T ss_pred EEcCCCCcHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCcc
Confidence 9999999999999653 3589999999999999999999973 289999999999999999999999999998
Q ss_pred hhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCC
Q 003278 267 WLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTY 339 (834)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~ 339 (834)
.+.... .++.+||+.|||||++... .++.++|||||||++|||+||+.||....
T Consensus 154 ~~~~~~------------------~~~~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 154 QLIDSM------------------ANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp HHHHHT------------------C---CCSSCCCCHHHHHCS-CCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred ccCCCc------------------cccccCCccccCchHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 654321 3456799999999999754 68999999999999999999999997543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=426.12 Aligned_cols=256 Identities=26% Similarity=0.393 Sum_probs=194.1
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEe--CCEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCVH--EDQLLLV 186 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~lV 186 (834)
++|+..+.||+|+||+||+|+.+.+|+.||||.+... .+...+.|.+|+.+|++++|||||++++++.+ .+.+|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 5688999999999999999999999999999998654 33445679999999999999999999999975 4568999
Q ss_pred EEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhcc--CCCeecCCCCCCceEECCCCceEEeeccc
Q 003278 187 YDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQL--ETQIIHRDVKTSNVMLDSQYNARLGDFGL 264 (834)
Q Consensus 187 ~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiHrDlKp~NILld~~~~~kl~DFGl 264 (834)
||||++|+|.+++.... .....+++..+..|+.|++.||.|||++. ..+||||||||+||||+.++.+||+|||+
T Consensus 84 mEy~~~g~L~~~i~~~~---~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~ 160 (269)
T d2java1 84 MEYCEGGDLASVITKGT---KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 160 (269)
T ss_dssp EECCTTEEHHHHHHHHH---HHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred EecCCCCcHHHHHHhcc---ccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence 99999999999986432 12357999999999999999999999862 13599999999999999999999999999
Q ss_pred hhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccc
Q 003278 265 ARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQI 344 (834)
Q Consensus 265 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~ 344 (834)
|+.+..+.. ..+...||+.|||||.+... .++.++|||||||++|||+||+.||..... .
T Consensus 161 a~~~~~~~~----------------~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyel~tg~~Pf~~~~~---~ 220 (269)
T d2java1 161 ARILNHDTS----------------FAKAFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQ---K 220 (269)
T ss_dssp HHHC---------------------------CCCSCCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---H
T ss_pred eeecccCCC----------------ccccCCCCcccCCHHHHcCC-CCChHHHHHhhCHHHHHHhhCCCCCCCCCH---H
Confidence 987643211 13456799999999998654 679999999999999999999999864321 1
Q ss_pred hHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 345 ILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 345 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
.+. ... ..+..... . ..++ +.+.+|+..||+.||.+|||+.|+++
T Consensus 221 ~~~---~~i-~~~~~~~~-----~-~~~s----~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 221 ELA---GKI-REGKFRRI-----P-YRYS----DELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HHH---HHH-HHTCCCCC-----C-TTSC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHH---HHH-HcCCCCCC-----C-cccC----HHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 111 111 12222111 1 1122 35788999999999999999999986
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-51 Score=429.61 Aligned_cols=258 Identities=26% Similarity=0.422 Sum_probs=203.5
Q ss_pred hhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEE
Q 003278 108 IGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 108 ~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 187 (834)
+..++|+..+.||+|+||+||+|.+ .+++.||||+++... ...+.|.+|+.+|++++|||||+++|+|.+ +..++||
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~ 86 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT 86 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEE-TTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEE-CCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEE
Confidence 3446788889999999999999999 478899999997543 345679999999999999999999998864 5679999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
|||++|+|.+++.... ..+++|..++.|+.|||+||.|||+. +|+||||||+||||++++.+||+|||+|+.
T Consensus 87 Ey~~~g~L~~~~~~~~-----~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~ 158 (272)
T d1qpca_ 87 EYMENGSLVDFLKTPS-----GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARL 158 (272)
T ss_dssp ECCTTCBHHHHTTSHH-----HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EeCCCCcHHHHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEE
Confidence 9999999999875432 24689999999999999999999995 999999999999999999999999999986
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHH
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILL 347 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~ 347 (834)
+.... ....+...||+.|||||++..+ .++.++|||||||++|||+||..|+...... ..+.
T Consensus 159 ~~~~~---------------~~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~--~~~~ 220 (272)
T d1qpca_ 159 IEDNE---------------YTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--PEVI 220 (272)
T ss_dssp CSSSC---------------EECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHH
T ss_pred ccCCc---------------cccccccCCcccccChHHHhCC-CCCchhhhhhhHHHHHHHHhCCCCCCCCCCH--HHHH
Confidence 53221 0112345699999999998765 5799999999999999999976665432211 1121
Q ss_pred HHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 348 DWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 348 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
..+ ..+..... . ... .+.+.+|+..||+.||++||||.+|++.|+..
T Consensus 221 ~~i----~~~~~~~~-----p-~~~----~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 221 QNL----ERGYRMVR-----P-DNC----PEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp HHH----HTTCCCCC-----C-TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHH----HhcCCCCC-----c-ccC----hHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 111 12211111 1 111 24578999999999999999999999998764
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=416.98 Aligned_cols=253 Identities=20% Similarity=0.339 Sum_probs=206.2
Q ss_pred hCcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEecc
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYS 592 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~ 592 (834)
++|.-.+.||+|+||+||+|..+++..||||.++.... ..+.|.+|+.++++++|||||+++|+|.+.+.+++||||+
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~--~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS--CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC--CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 57777889999999999999999888999999875433 3467999999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccC
Q 003278 593 ATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRN 672 (834)
Q Consensus 593 ~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~ 672 (834)
++|+|..++..... .++|..+.+|+.|+|+||+|||+ .+|+||||||+|||+|+++.+||+|||+++.+...
T Consensus 82 ~~g~l~~~~~~~~~-----~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 153 (258)
T d1k2pa_ 82 ANGCLLNYLREMRH-----RFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 153 (258)
T ss_dssp TTEEHHHHHHSGGG-----CCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS
T ss_pred CCCcHHHhhhcccc-----CCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCC
Confidence 99999998765432 47899999999999999999997 69999999999999999999999999999876543
Q ss_pred CCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCcccc
Q 003278 673 DHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRPLAE 751 (834)
Q Consensus 673 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
.. .......||+.|||||.+.++.++.++|||||||++|||+| |+.||..... ..+...+.. ..+
T Consensus 154 ~~------~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~-~~~~~~i~~---~~~---- 219 (258)
T d1k2pa_ 154 EY------TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-SETAEHIAQ---GLR---- 219 (258)
T ss_dssp SC------CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH-HHHHHHHHT---TCC----
T ss_pred Cc------eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH-HHHHHHHHh---CCC----
Confidence 21 11223579999999999999999999999999999999998 7888865432 222222211 111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHcc
Q 003278 752 LVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDG 796 (834)
Q Consensus 752 ~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~ 796 (834)
...+ ...+++ +.+++.+||+.||++||||++|++.|..
T Consensus 220 ~~~p----~~~~~~---l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 220 LYRP----HLASEK---VYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCCC----TTCCHH---HHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCc----ccccHH---HHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 1111 122233 4556669999999999999999998853
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-50 Score=425.10 Aligned_cols=260 Identities=25% Similarity=0.423 Sum_probs=199.2
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCC----eEEEEEEeccc-ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDG----TVVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLL 184 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g----~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 184 (834)
.+.|+..++||+|+||+||+|.++.++ ..||||++... .....+.|.+|+.+|++++|||||+++|+|.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 456888899999999999999986554 47999998653 3444567999999999999999999999999999999
Q ss_pred EEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccc
Q 003278 185 LVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGL 264 (834)
Q Consensus 185 lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGl 264 (834)
+|||||.+|++.+++... ...++|..++.|+.|||.||+|||+. +||||||||+||||+.++.+||+|||+
T Consensus 86 ~v~e~~~~~~l~~~~~~~------~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGl 156 (283)
T d1mqba_ 86 IITEYMENGALDKFLREK------DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGL 156 (283)
T ss_dssp EEEECCTTEEHHHHHHHT------TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred EEEEecccCcchhhhhcc------cccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccch
Confidence 999999999999887653 24699999999999999999999995 999999999999999999999999999
Q ss_pred hhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccc
Q 003278 265 ARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQI 344 (834)
Q Consensus 265 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~ 344 (834)
|+.+....... ...+...||+.|||||++..+ .++.++|||||||++|||+||..|+.......
T Consensus 157 a~~~~~~~~~~-------------~~~~~~~gt~~Y~APE~l~~~-~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~-- 220 (283)
T d1mqba_ 157 SRVLEDDPEAT-------------YTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNH-- 220 (283)
T ss_dssp ------------------------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--
T ss_pred hhcccCCCccc-------------eEeccCCCCccccCHHHHccC-CCCCcccccccHHHHHHHHhCCCCccccCCHH--
Confidence 98764432110 112345689999999998765 68999999999999999999777654322211
Q ss_pred hHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 345 ILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 345 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
.+... ...+..... +......+.+|+..||+.||++||+|.+|++.|+..
T Consensus 221 ~~~~~----i~~~~~~~~----------~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l 270 (283)
T d1mqba_ 221 EVMKA----INDGFRLPT----------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270 (283)
T ss_dssp HHHHH----HHTTCCCCC----------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHH----HhccCCCCC----------chhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence 12111 122221111 111224688999999999999999999999998764
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-50 Score=427.18 Aligned_cols=259 Identities=22% Similarity=0.350 Sum_probs=204.4
Q ss_pred hcCCCCCCCe-eeccCCeEEEEEEECC--CCeEEEEEEeccc-ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEE
Q 003278 109 GSNGFDEDEV-LGSGGFGKVYRAVLPS--DGTVVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLL 184 (834)
Q Consensus 109 ~t~~f~~~~~-LG~G~fG~Vy~~~~~~--~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 184 (834)
..++|...+. ||+|+||+||+|.++. ++..||||+++.. .....+.|.+|+.+|++++|||||+++|+|.. +.+|
T Consensus 6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~ 84 (285)
T d1u59a_ 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM 84 (285)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEE
Confidence 3456666664 9999999999998753 4568999998754 34456789999999999999999999999865 5689
Q ss_pred EEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccc
Q 003278 185 LVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGL 264 (834)
Q Consensus 185 lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGl 264 (834)
||||||++|+|.+++... ...++|..+..|+.|||+||+|||+. +||||||||+|||++.++.+||+|||+
T Consensus 85 lvmE~~~~g~L~~~l~~~------~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGl 155 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVGK------REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGL 155 (285)
T ss_dssp EEEECCTTEEHHHHHTTC------TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTT
T ss_pred EEEEeCCCCcHHHHhhcc------ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchh
Confidence 999999999999988543 24689999999999999999999995 999999999999999999999999999
Q ss_pred hhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCcc
Q 003278 265 ARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQ 343 (834)
Q Consensus 265 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~ 343 (834)
|+.+..... .....+...||+.|||||++..+ .++.++|||||||++|||+| |+.||......
T Consensus 156 a~~~~~~~~-------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~-- 219 (285)
T d1u59a_ 156 SKALGADDS-------------YYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-- 219 (285)
T ss_dssp CEECTTCSC-------------EECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--
T ss_pred hhccccccc-------------ccccccccccCccccChHHHhCC-CCCccchhhcchHHHHHHHhCCCCCCCCCCHH--
Confidence 986543210 01113445699999999998766 67999999999999999998 89998653221
Q ss_pred chHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 344 IILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 344 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
.+.. ....+...... ... ...+.+|+..||+.||++||+|.+|++.|+..
T Consensus 220 -~~~~----~i~~~~~~~~p------~~~----~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 220 -EVMA----FIEQGKRMECP------PEC----PPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp -HHHH----HHHTTCCCCCC------TTC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHHH----HHHcCCCCCCC------CcC----CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1222 12233322211 111 14678999999999999999999999988753
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-49 Score=416.70 Aligned_cols=247 Identities=23% Similarity=0.348 Sum_probs=195.9
Q ss_pred CCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEe----CCEEEEEE
Q 003278 114 DEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCVH----EDQLLLVY 187 (834)
Q Consensus 114 ~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~lV~ 187 (834)
+..++||+|+||+||+|++..++..||||.+... .....+.|.+|+.+|++++|||||+++++|.+ .+.+|+||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 4456899999999999999999999999998653 33445679999999999999999999999875 34689999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEEC-CCCceEEeeccchh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLD-SQYNARLGDFGLAR 266 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld-~~~~~kl~DFGla~ 266 (834)
|||++|+|.+++.+. ..+++..+..|+.||++||+|||++ .++||||||||+|||++ +++.+||+|||+|+
T Consensus 92 E~~~~g~L~~~l~~~-------~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~ 163 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF-------KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163 (270)
T ss_dssp ECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred eCCCCCcHHHHHhcc-------ccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence 999999999999653 4689999999999999999999986 23499999999999996 57899999999997
Q ss_pred hhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchH
Q 003278 267 WLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIIL 346 (834)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l 346 (834)
..... .....+||+.|||||.+.. .++.++|||||||++|||+||+.||...... ..+
T Consensus 164 ~~~~~------------------~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~--~~~ 221 (270)
T d1t4ha_ 164 LKRAS------------------FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQI 221 (270)
T ss_dssp GCCTT------------------SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHH
T ss_pred eccCC------------------ccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccH--HHH
Confidence 53211 1345679999999998853 4799999999999999999999998643211 111
Q ss_pred HHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 347 LDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 347 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
...+ ..+......+.. . ...+.+|+..||+.||++|||+.|+++
T Consensus 222 ---~~~i-~~~~~~~~~~~~-----~----~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 222 ---YRRV-TSGVKPASFDKV-----A----IPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ---HHHH-TTTCCCGGGGGC-----C----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---HHHH-HcCCCCcccCcc-----C----CHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 1111 112111111111 1 135788999999999999999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=422.22 Aligned_cols=250 Identities=20% Similarity=0.305 Sum_probs=195.2
Q ss_pred CcccccCCcEEEEEEECC---CcEEEEEEecCCC-ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEeccCC
Q 003278 519 QRVAEMDFGTAYQGFLDN---HQYVLVKRLGMSK-CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYSAT 594 (834)
Q Consensus 519 ~~ig~g~~g~vy~~~~~~---~~~vavK~~~~~~-~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~~~ 594 (834)
++||+|+||+||+|.+.+ ++.||||+++... .+..+++|.+|+.+|++++|||||+++|+|.+ +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 469999999999998643 4679999987543 34456789999999999999999999999965 457899999999
Q ss_pred CchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCCC
Q 003278 595 RILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRNDH 674 (834)
Q Consensus 595 g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~~ 674 (834)
|+|.+++.... .++|..+++|+.|||.||+|||+ .+||||||||+||||+.++.+||+|||+|+.+.....
T Consensus 92 g~L~~~l~~~~------~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~ 162 (277)
T d1xbba_ 92 GPLNKYLQQNR------HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162 (277)
T ss_dssp EEHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred CcHHHHHhhcc------CCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhcccccc
Confidence 99999987543 48999999999999999999997 6899999999999999999999999999987643321
Q ss_pred CCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCcccccc
Q 003278 675 GHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRPLAELV 753 (834)
Q Consensus 675 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (834)
.........||+.|||||.+.++.++.++|||||||++|||+| |+.||..... ..+...+. ...++
T Consensus 163 ----~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~-~~~~~~i~---~~~~~----- 229 (277)
T d1xbba_ 163 ----YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-SEVTAMLE---KGERM----- 229 (277)
T ss_dssp ----EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHHHHH---TTCCC-----
T ss_pred ----ccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH-HHHHHHHH---cCCCC-----
Confidence 1122234679999999999999999999999999999999998 8999865332 22222221 11111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccC
Q 003278 754 DLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGN 797 (834)
Q Consensus 754 d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~ 797 (834)
..+.. .+++ +.+++.+||+.||++||||++|++.|+..
T Consensus 230 --~~p~~-~~~~---~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 230 --GCPAG-CPRE---MYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp --CCCTT-CCHH---HHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred --CCCcc-cCHH---HHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 11112 2233 45566799999999999999999988653
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.9e-50 Score=429.64 Aligned_cols=269 Identities=22% Similarity=0.305 Sum_probs=212.8
Q ss_pred HHHHhhCcCcCCcccccCCcEEEEEEEC------CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEee
Q 003278 508 IISATNNFSESQRVAEMDFGTAYQGFLD------NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTE 581 (834)
Q Consensus 508 l~~at~~f~~~~~ig~g~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~ 581 (834)
++-..++|...+.||+|+||+||+|... +++.||||+++........++|.+|+++|++++|||||+++|+|.+
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 87 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 87 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence 3334578888899999999999999864 3578999999877666677889999999999999999999999999
Q ss_pred CCeEEEEEeccCCCchhhhhhcCCCC------------------CCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeec
Q 003278 582 QGEMLVIYDYSATRILSHLLFHNNHR------------------IGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHR 643 (834)
Q Consensus 582 ~~~~~lv~Ey~~~g~L~~~l~~~~~~------------------~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHr 643 (834)
.+..+++|||+++|+|.+++...... .....++|..++.|+.|+|.||+|||+ .+||||
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivHr 164 (301)
T d1lufa_ 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHR 164 (301)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCS
T ss_pred CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEee
Confidence 99999999999999999998753211 112348999999999999999999996 699999
Q ss_pred ccccCceeecCCCCceEeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCC
Q 003278 644 NITSSAITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQ 723 (834)
Q Consensus 644 DlK~~NILld~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~ 723 (834)
||||+|||||.++.+||+|||+|+.+..... .....+..||+.|||||++.+..||.++|||||||++|||+||.
T Consensus 165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~ 239 (301)
T d1lufa_ 165 DLATRNCLVGENMVVKIADFGLSRNIYSADY-----YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239 (301)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGC-----BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred EEcccceEECCCCcEEEccchhheeccCCcc-----ccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccC
Confidence 9999999999999999999999987644321 11223567899999999999999999999999999999999997
Q ss_pred CccCCCCCchhHHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCC
Q 003278 724 MAVDFRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGND 798 (834)
Q Consensus 724 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~ 798 (834)
.|+....+...+...+.. ... .. .+...+ . ++.+++.+||+.||++||||.||++.|+.+.
T Consensus 240 ~~p~~~~~~~e~~~~v~~---~~~--~~-----~p~~~~-~---~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 240 LQPYYGMAHEEVIYYVRD---GNI--LA-----CPENCP-L---ELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp CCTTTTSCHHHHHHHHHT---TCC--CC-----CCTTCC-H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCCCCHHHHHHHHHc---CCC--CC-----CCccch-H---HHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 654434444333333221 111 11 111222 2 4566777999999999999999999998653
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-50 Score=432.95 Aligned_cols=261 Identities=20% Similarity=0.292 Sum_probs=201.6
Q ss_pred hCcCcCCcccccCCcEEEEEEECC-C-----cEEEEEEecCCCChhHHHHHHHHHHHHHhc-cCCCceeEEEEEeeCCeE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDN-H-----QYVLVKRLGMSKCPALRTRFSNELQNLARL-RHRNLVQLCGWCTEQGEM 585 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~-~-----~~vavK~~~~~~~~~~~~~f~~E~~~l~~l-~HpNiv~l~g~~~~~~~~ 585 (834)
++|.-.+.||+|+||+||+|.... + ..||||.+...........|.+|+.+|.++ +|||||+++|+|.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 456667889999999999998633 2 369999987655555567899999999998 899999999999999999
Q ss_pred EEEEeccCCCchhhhhhcCCCC-----------------CCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccC
Q 003278 586 LVIYDYSATRILSHLLFHNNHR-----------------IGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSS 648 (834)
Q Consensus 586 ~lv~Ey~~~g~L~~~l~~~~~~-----------------~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~ 648 (834)
++|||||++|+|.++|...... .....++|..++.|+.|||.||+|||+ .+||||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCchh
Confidence 9999999999999999764321 112358999999999999999999997 69999999999
Q ss_pred ceeecCCCCceEeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccC
Q 003278 649 AITLDPDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVD 727 (834)
Q Consensus 649 NILld~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~ 727 (834)
|||++.++.+||+|||+|+........ ....+..||+.|||||++.++.|+.++|||||||+||||+| |+.||.
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNY-----VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTS-----EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred ccccccCCeEEEeeccccccccCCCce-----eeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence 999999999999999999875443211 11234678999999999999999999999999999999998 899986
Q ss_pred CCCCchhHHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHc
Q 003278 728 FRLPEGLLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795 (834)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~ 795 (834)
.......+...+.. ..+ +..+. ..+++ +.+++.+||+.||++||||+||++.|.
T Consensus 269 ~~~~~~~~~~~~~~---~~~-------~~~p~-~~~~~---l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 269 GIPVDANFYKLIQN---GFK-------MDQPF-YATEE---IYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp TCCCSHHHHHHHHT---TCC-------CCCCT-TCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCHHHHHHHHHhc---CCC-------CCCCC-cCCHH---HHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 54443333222211 111 11111 12233 455666999999999999999999984
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.2e-49 Score=426.03 Aligned_cols=246 Identities=26% Similarity=0.413 Sum_probs=200.5
Q ss_pred CCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEE
Q 003278 112 GFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYD 188 (834)
Q Consensus 112 ~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 188 (834)
.|+..+.||+|+||+||+|+...+|+.||||++.... ....+.|.+|+.+|++++|||||+++++|.+++..|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 3888899999999999999999999999999986543 2344678999999999999999999999999999999999
Q ss_pred ccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhh
Q 003278 189 YMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWL 268 (834)
Q Consensus 189 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~ 268 (834)
||++|+|..++... .++++..+..|+.||+.||.|||++ +||||||||+|||++.++.+||+|||+|+..
T Consensus 96 ~~~~g~l~~~~~~~-------~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~ 165 (309)
T d1u5ra_ 96 YCLGSASDLLEVHK-------KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM 165 (309)
T ss_dssp CCSEEHHHHHHHHT-------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred ecCCCchHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeeccccccc
Confidence 99999998766432 4689999999999999999999996 9999999999999999999999999999753
Q ss_pred hhhhhhhhhcccccccccccccceeeeccccCCCcccccc--CCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchH
Q 003278 269 EHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQK--GSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIIL 346 (834)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l 346 (834)
.. .....||+.|||||++.. ...++.++|||||||++|||+||+.||.....
T Consensus 166 ~~--------------------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~------ 219 (309)
T d1u5ra_ 166 AP--------------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------ 219 (309)
T ss_dssp SS--------------------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------
T ss_pred CC--------------------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH------
Confidence 21 234569999999999853 23578999999999999999999999864221
Q ss_pred HHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 347 LDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 347 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
...+..... +.. +.+....++ +.+.+|+..||+.||.+|||+.|+++
T Consensus 220 ~~~~~~i~~-~~~-----~~~~~~~~s----~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 220 MSALYHIAQ-NES-----PALQSGHWS----EYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp HHHHHHHHH-SCC-----CCCSCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHh-CCC-----CCCCCCCCC----HHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 111112111 111 111111222 45788999999999999999999875
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-49 Score=430.13 Aligned_cols=265 Identities=26% Similarity=0.376 Sum_probs=205.4
Q ss_pred hhcCCCCCCCeeeccCCeEEEEEEECCCC-----eEEEEEEeccc-ChhhHHHHHHHHHHHHhC-CCCceeeEeeeEEeC
Q 003278 108 IGSNGFDEDEVLGSGGFGKVYRAVLPSDG-----TVVAVKCLAEK-GERFEKTFAAELVAVAHL-RHRNLVRLRGWCVHE 180 (834)
Q Consensus 108 ~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g-----~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~ 180 (834)
+..++|+..++||+|+||+||+|++..++ ..||||.+... .......|.+|+.+|.++ +|||||+++|+|.+.
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 34567889999999999999999985443 37999998653 333456789999999998 899999999999999
Q ss_pred CEEEEEEEccCCCCHhHHHhcCCCcc----------------ccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCC
Q 003278 181 DQLLLVYDYMPNRSLDRVLFRRPENL----------------EAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDV 244 (834)
Q Consensus 181 ~~~~lV~Ey~~~gsL~~~l~~~~~~~----------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDl 244 (834)
+.++||||||++|+|.++|..+.... .....++|..++.|+.||++||+|||++ +||||||
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDl 190 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDL 190 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTC
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccC
Confidence 99999999999999999997653211 1234689999999999999999999996 9999999
Q ss_pred CCCceEECCCCceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhH
Q 003278 245 KTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIV 324 (834)
Q Consensus 245 Kp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvv 324 (834)
||+|||++.++.+||+|||+|+....... ....++..||+.|||||.+..+ .++.++|||||||+
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~--------------~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwS~Gvi 255 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSN--------------YVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGIL 255 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTT--------------SEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHH
T ss_pred chhccccccCCeEEEeeccccccccCCCc--------------eeeeccccCCCccCChHHHcCC-CCCcceeccchhHH
Confidence 99999999999999999999986533210 0112356789999999998765 67999999999999
Q ss_pred HHHHHh-CCccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 325 VLEVVS-GRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 325 l~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
||||+| |+.||....... .+. .....+...+. . ... .+.+.+|+..||+.||++||||.||++
T Consensus 256 l~emlt~g~~Pf~~~~~~~--~~~----~~~~~~~~~~~-----p-~~~----~~~l~~li~~cl~~dP~~RPt~~ei~~ 319 (325)
T d1rjba_ 256 LWEIFSLGVNPYPGIPVDA--NFY----KLIQNGFKMDQ-----P-FYA----TEEIYIIMQSCWAFDSRKRPSFPNLTS 319 (325)
T ss_dssp HHHHTTTSCCSSTTCCCSH--HHH----HHHHTTCCCCC-----C-TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhCCCCCCCCCCHHH--HHH----HHHhcCCCCCC-----C-CcC----CHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999998 899986543321 122 12222211111 0 111 246889999999999999999999999
Q ss_pred Hhh
Q 003278 404 AVS 406 (834)
Q Consensus 404 ~l~ 406 (834)
.|.
T Consensus 320 ~L~ 322 (325)
T d1rjba_ 320 FLG 322 (325)
T ss_dssp HHH
T ss_pred HHh
Confidence 885
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-49 Score=423.95 Aligned_cols=263 Identities=20% Similarity=0.296 Sum_probs=208.2
Q ss_pred CcccccCCcEEEEEEECCC----cEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEee-CCeEEEEEeccC
Q 003278 519 QRVAEMDFGTAYQGFLDNH----QYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTE-QGEMLVIYDYSA 593 (834)
Q Consensus 519 ~~ig~g~~g~vy~~~~~~~----~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~-~~~~~lv~Ey~~ 593 (834)
+.||+|+||+||+|.+.++ ..||||+++........++|.+|+++|++++|||||+++|+|.+ .+..++|||||+
T Consensus 33 ~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~ 112 (311)
T d1r0pa_ 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMK 112 (311)
T ss_dssp EEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCT
T ss_pred eEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEee
Confidence 5699999999999997542 36899999866666667889999999999999999999999876 468999999999
Q ss_pred CCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccCC
Q 003278 594 TRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRND 673 (834)
Q Consensus 594 ~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~~ 673 (834)
+|+|.+++.... ..++|..++.++.|+|.||.|||+ .+|+||||||+|||||+++.+||+|||+++.+....
T Consensus 113 ~g~l~~~~~~~~-----~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 113 HGDLRNFIRNET-----HNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp TCBHHHHHHCTT-----CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred cCchhhhhcccc-----ccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 999999887543 247788899999999999999997 689999999999999999999999999998765432
Q ss_pred CCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcccccc
Q 003278 674 HGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAELV 753 (834)
Q Consensus 674 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (834)
.. .........||+.|+|||++.++.++.++|||||||++|||+||+.|+............+. ...++.
T Consensus 185 ~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~---~g~~~~---- 254 (311)
T d1r0pa_ 185 FD---SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL---QGRRLL---- 254 (311)
T ss_dssp CC---CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHH---TTCCCC----
T ss_pred cc---cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHH---cCCCCC----
Confidence 21 11223346799999999999999999999999999999999999888765433322222221 112211
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCccccccCc
Q 003278 754 DLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDKRFMEDGQ 806 (834)
Q Consensus 754 d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~~~~~~~~ 806 (834)
.+ ...++ .+.+++.+||+.||++||||.||++.|+.+.++|..+..
T Consensus 255 ~p----~~~~~---~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~~~ 300 (311)
T d1r0pa_ 255 QP----EYCPD---PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHY 300 (311)
T ss_dssp CC----TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCCB
T ss_pred Cc----ccCcH---HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhhhc
Confidence 11 12223 355666799999999999999999999999888777643
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-49 Score=418.19 Aligned_cols=249 Identities=24% Similarity=0.356 Sum_probs=195.2
Q ss_pred CeeeccCCeEEEEEEECC--CCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEccCC
Q 003278 117 EVLGSGGFGKVYRAVLPS--DGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYMPN 192 (834)
Q Consensus 117 ~~LG~G~fG~Vy~~~~~~--~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 192 (834)
++||+|+||+||+|.++. +++.||||+++.. .....+.|.+|+.+|++++|||||+++|+|.. +..+||||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999998643 4578999998643 33446789999999999999999999999965 457899999999
Q ss_pred CCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhhhh
Q 003278 193 RSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEHEL 272 (834)
Q Consensus 193 gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~~~ 272 (834)
|+|.+++... .+++|..++.|+.|||.||+|||+. +||||||||+||||+.++.+||+|||+|+.+....
T Consensus 92 g~L~~~l~~~-------~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~ 161 (277)
T d1xbba_ 92 GPLNKYLQQN-------RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 161 (277)
T ss_dssp EEHHHHHHHC-------TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred CcHHHHHhhc-------cCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhccccc
Confidence 9999998653 4689999999999999999999985 99999999999999999999999999998653221
Q ss_pred hhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccchHHHHHH
Q 003278 273 QYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQIILLDWIR 351 (834)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~ 351 (834)
. .........||+.|||||.+..+ .++.++|||||||++|||+| |+.||..... ..+.
T Consensus 162 ~-------------~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~---~~~~---- 220 (277)
T d1xbba_ 162 N-------------YYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVT---- 220 (277)
T ss_dssp S-------------EEEC----CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHH----
T ss_pred c-------------ccccccccCCCceecCchhhcCC-CCCchhhhccchhhhhHHhhCCCCCCCCCCH---HHHH----
Confidence 0 01113445799999999998765 57999999999999999998 8999864321 1111
Q ss_pred HHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhc
Q 003278 352 RLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSG 407 (834)
Q Consensus 352 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~ 407 (834)
.....+...... ... ...+.+|+..||+.||++||||.+|++.|+.
T Consensus 221 ~~i~~~~~~~~p------~~~----~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 221 AMLEKGERMGCP------AGC----PREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp HHHHTTCCCCCC------TTC----CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred HHHHcCCCCCCC------ccc----CHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 122223222111 111 2467899999999999999999999988864
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-49 Score=413.94 Aligned_cols=246 Identities=20% Similarity=0.335 Sum_probs=200.0
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCC--ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSK--CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIY 589 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~--~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~ 589 (834)
++|...+.||+|+||+||+|.. .+++.||||++.... .....+.|.+|+++|++++|||||++++++.+.+..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 4677788999999999999997 468899999986322 1223567899999999999999999999999999999999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccc
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFL 669 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~ 669 (834)
|||++|+|.+++...+ .+++.....|+.|++.||+|||+ .+||||||||+||||++++.+||+|||+|+..
T Consensus 86 Ey~~~g~L~~~l~~~~------~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~ 156 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS------KFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHA 156 (263)
T ss_dssp ECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCC
T ss_pred eecCCCcHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeec
Confidence 9999999999987542 38899999999999999999997 69999999999999999999999999999765
Q ss_pred ccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcc
Q 003278 670 TRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPL 749 (834)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
... .....+||+.|||||++.+..|+.++|||||||+||||+||+.||....+... ...+ ......
T Consensus 157 ~~~---------~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-~~~i---~~~~~~- 222 (263)
T d2j4za1 157 PSS---------RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET-YKRI---SRVEFT- 222 (263)
T ss_dssp CCC---------CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHH---HTTCCC-
T ss_pred CCC---------cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHH-HHHH---HcCCCC-
Confidence 322 12346899999999999999999999999999999999999999975443222 1211 111111
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 750 AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 750 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
++... ++++ ..+..+||+.||++|||+.||++
T Consensus 223 -------~p~~~-s~~~---~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 223 -------FPDFV-TEGA---RDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp -------CCTTS-CHHH---HHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------CCccC-CHHH---HHHHHHHccCCHhHCcCHHHHHc
Confidence 11112 2344 44556899999999999999975
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-49 Score=410.92 Aligned_cols=252 Identities=23% Similarity=0.381 Sum_probs=205.7
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEcc
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYM 190 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 190 (834)
++|+..+.||+|+||+||+|++ .+++.||||.++... ...++|.+|+.++++++|||||+++|+|.+.+.+++||||+
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred HHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 6899999999999999999999 578899999987543 34568999999999999999999999999999999999999
Q ss_pred CCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhh
Q 003278 191 PNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEH 270 (834)
Q Consensus 191 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~ 270 (834)
++|+|..++... ...++|..+.+|+.|+|+||+|||+. +|+||||||+|||+++++.+||+|||+|+.+..
T Consensus 82 ~~g~l~~~~~~~------~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~ 152 (258)
T d1k2pa_ 82 ANGCLLNYLREM------RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 152 (258)
T ss_dssp TTEEHHHHHHSG------GGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSS
T ss_pred CCCcHHHhhhcc------ccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccC
Confidence 999999997653 24689999999999999999999985 999999999999999999999999999986432
Q ss_pred hhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccchHHHH
Q 003278 271 ELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQIILLDW 349 (834)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~ 349 (834)
.. ....+...||+.|+|||.+... .++.|+|||||||++|||+| |+.||...... ..
T Consensus 153 ~~---------------~~~~~~~~~t~~y~aPE~~~~~-~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~------~~ 210 (258)
T d1k2pa_ 153 DE---------------YTSSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS------ET 210 (258)
T ss_dssp SS---------------CCCCCCSCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH------HH
T ss_pred CC---------------ceeecccCCCCCcCCcHHhcCC-CCCcceeecccchhhHhHHhcCCCCCCCCCHH------HH
Confidence 11 0113345699999999998765 57999999999999999998 78888643211 11
Q ss_pred HHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhh
Q 003278 350 IRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVS 406 (834)
Q Consensus 350 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~ 406 (834)
... ..++.... .+ .. ..+.+.+|+..||+.||++||||.++++.|.
T Consensus 211 ~~~-i~~~~~~~--~p----~~----~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 256 (258)
T d1k2pa_ 211 AEH-IAQGLRLY--RP----HL----ASEKVYTIMYSCWHEKADERPTFKILLSNIL 256 (258)
T ss_dssp HHH-HHTTCCCC--CC----TT----CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HHH-HHhCCCCC--Cc----cc----ccHHHHHHHHHHccCCHhHCcCHHHHHHHhh
Confidence 111 12222111 11 11 1246889999999999999999999999875
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=415.91 Aligned_cols=249 Identities=20% Similarity=0.300 Sum_probs=199.7
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
+.|...+.||+|+||+||+|.. .+|+.||||++...... ..+.|.+|+.+|++++|||||++++++.+.+..++||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh-HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 3588888999999999999985 56899999998754333 246799999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccccc
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTR 671 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~ 671 (834)
|++|+|.+++.+. .+++.....|+.|++.||+|||+ .+||||||||+||||+.++.+||+|||+|+.+..
T Consensus 99 ~~gg~L~~~~~~~-------~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~ 168 (293)
T d1yhwa1 99 LAGGSLTDVVTET-------CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (293)
T ss_dssp CTTCBHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred cCCCcHHHHhhcc-------CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence 9999999887542 37888899999999999999997 6999999999999999999999999999987643
Q ss_pred CCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcccc
Q 003278 672 NDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAE 751 (834)
Q Consensus 672 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
.. ......+||+.|||||++.++.|+.++|||||||++|||+||+.||....+...+.. .. ....+.
T Consensus 169 ~~-------~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~-~~---~~~~~~-- 235 (293)
T d1yhwa1 169 EQ-------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL-IA---TNGTPE-- 235 (293)
T ss_dssp TT-------CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-HH---HHCSCC--
T ss_pred cc-------ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHH-HH---hCCCCC--
Confidence 22 112346799999999999999999999999999999999999999965433222211 11 111110
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 752 LVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 752 ~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
+. ..... .++ +..++.+||+.||++|||+.|+++
T Consensus 236 ~~---~~~~~-s~~---~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 236 LQ---NPEKL-SAI---FRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp CS---SGGGS-CHH---HHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CC---CcccC-CHH---HHHHHHHHccCChhHCcCHHHHhc
Confidence 10 01111 233 445556899999999999999863
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-49 Score=428.46 Aligned_cols=201 Identities=19% Similarity=0.295 Sum_probs=178.7
Q ss_pred hhCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEe
Q 003278 512 TNNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYD 590 (834)
Q Consensus 512 t~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~E 590 (834)
.++|...+.||+|+||+||+|.. .+++.||||+++....+..++++.+|+.+|++++|||||+++++|.+.+..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 46788889999999999999996 56899999999876666677889999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccc
Q 003278 591 YSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLT 670 (834)
Q Consensus 591 y~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~ 670 (834)
|+++|+|.+++...+ .+++..+..++.|++.||.|||+. .+||||||||+||||++++.+||+|||+|+.+.
T Consensus 85 y~~gg~L~~~l~~~~------~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp CCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred cCCCCcHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 999999999997543 388999999999999999999962 379999999999999999999999999998653
Q ss_pred cCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCC
Q 003278 671 RNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFR 729 (834)
Q Consensus 671 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~ 729 (834)
.. ...+.+||+.|||||++.+..|+.++||||+||++|||+||+.||...
T Consensus 157 ~~---------~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~ 206 (322)
T d1s9ja_ 157 DS---------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206 (322)
T ss_dssp HH---------TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred CC---------ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 22 123568999999999999999999999999999999999999999654
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-49 Score=417.87 Aligned_cols=256 Identities=19% Similarity=0.291 Sum_probs=191.5
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCC-ChhHHHHHHHHHHHHHhccCCCceeEEEEEee--CCeEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSK-CPALRTRFSNELQNLARLRHRNLVQLCGWCTE--QGEMLVI 588 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~-~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~--~~~~~lv 588 (834)
++|...+.||+|+||+||+|.. .+|+.||||.+.... .+...+.|.+|+++|++++|||||++++++.+ .+.+++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 5677788999999999999986 568899999987654 34456789999999999999999999999865 4568999
Q ss_pred EeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhcc--CCceeecccccCceeecCCCCceEeeeeec
Q 003278 589 YDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEW--NEQVIHRNITSSAITLDPDMNPRLGSFALA 666 (834)
Q Consensus 589 ~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~--~~~iiHrDlK~~NILld~~~~~ki~DfGla 666 (834)
||||++|+|.+++...... ...+++..+..++.|++.||+|||+.. ..+||||||||+||||+.++.+||+|||+|
T Consensus 84 mEy~~~g~L~~~i~~~~~~--~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 84 MEYCEGGDLASVITKGTKE--RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EECCTTEEHHHHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EecCCCCcHHHHHHhcccc--CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 9999999999998653221 134899999999999999999999742 135999999999999999999999999999
Q ss_pred cccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhc
Q 003278 667 EFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARK 746 (834)
Q Consensus 667 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~ 746 (834)
+.+.... ....+..||+.|||||++.+..|+.++|||||||+||||+||+.||...... .+...+..
T Consensus 162 ~~~~~~~-------~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~-~~~~~i~~----- 228 (269)
T d2java1 162 RILNHDT-------SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK-ELAGKIRE----- 228 (269)
T ss_dssp HHC------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHH-----
T ss_pred eecccCC-------CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH-HHHHHHHc-----
Confidence 8764321 1123568999999999999999999999999999999999999999754332 22222211
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 747 RPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 747 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
..... ++..++ ++ +.+++.+||+.||++|||+.||++
T Consensus 229 ~~~~~-----~~~~~s-~~---l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 229 GKFRR-----IPYRYS-DE---LNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp TCCCC-----CCTTSC-HH---HHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCC-----CCcccC-HH---HHHHHHHHcCCChhHCcCHHHHHh
Confidence 11111 112222 33 445556999999999999999874
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-49 Score=418.56 Aligned_cols=257 Identities=21% Similarity=0.325 Sum_probs=200.6
Q ss_pred hCcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEecc
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYS 592 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~ 592 (834)
++|...+.||+|+||.||+|..++++.||||+++.... ..+.|.+|+.+|++++|||||+++|+|.+ +..++||||+
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC--CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 45777788999999999999999888999999875433 24679999999999999999999999965 5578999999
Q ss_pred CCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccC
Q 003278 593 ATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRN 672 (834)
Q Consensus 593 ~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~ 672 (834)
++|+|..++..... ..++|..++.|+.|||.||+|||+ .+|+||||||+|||||+++.+||+|||+|+.....
T Consensus 94 ~~g~l~~~~~~~~~----~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~ 166 (285)
T d1fmka3 94 SKGSLLDFLKGETG----KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 166 (285)
T ss_dssp TTCBHHHHHSHHHH----TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred CCCchhhhhhhccc----ccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCC
Confidence 99999988865321 248999999999999999999997 68999999999999999999999999999875432
Q ss_pred CCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCccccc
Q 003278 673 DHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAEL 752 (834)
Q Consensus 673 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (834)
.. .......||+.|||||++..+.++.++|||||||+||||+||..|+........+...+.. ..+
T Consensus 167 ~~------~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~---~~~----- 232 (285)
T d1fmka3 167 EY------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER---GYR----- 232 (285)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT---TCC-----
T ss_pred Cc------eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHh---cCC-----
Confidence 21 1123457999999999999999999999999999999999987776554443333332221 111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCCc
Q 003278 753 VDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGNDK 799 (834)
Q Consensus 753 ~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~~ 799 (834)
+...... ++ ++.+++.+||+.||++||||.+|+++|+....
T Consensus 233 --~~~~~~~-~~---~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 233 --MPCPPEC-PE---SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp --CCCCTTS-CH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred --CCCCccc-CH---HHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 1111122 23 45566779999999999999999999987543
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6e-49 Score=422.29 Aligned_cols=271 Identities=26% Similarity=0.395 Sum_probs=212.8
Q ss_pred HHHHHhhcCCCCCCCeeeccCCeEEEEEEEC-----CCCeEEEEEEecccC-hhhHHHHHHHHHHHHhCCCCceeeEeee
Q 003278 103 YAELYIGSNGFDEDEVLGSGGFGKVYRAVLP-----SDGTVVAVKCLAEKG-ERFEKTFAAELVAVAHLRHRNLVRLRGW 176 (834)
Q Consensus 103 ~~el~~~t~~f~~~~~LG~G~fG~Vy~~~~~-----~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~ 176 (834)
+.+++...++|+..+.||+|+||+||+|+++ .+++.||||++.... ....+.|.+|+.+|++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 4556677889999999999999999999874 356899999987543 3456789999999999999999999999
Q ss_pred EEeCCEEEEEEEccCCCCHhHHHhcCCCc-----------------cccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCe
Q 003278 177 CVHEDQLLLVYDYMPNRSLDRVLFRRPEN-----------------LEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQI 239 (834)
Q Consensus 177 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~-----------------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 239 (834)
|...+..++||||+++|+|.++|...... ......++|..++.|+.|+|.||+|||+. +|
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---Ce
Confidence 99999999999999999999999754211 11234589999999999999999999985 99
Q ss_pred ecCCCCCCceEECCCCceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCccccee
Q 003278 240 IHRDVKTSNVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVF 319 (834)
Q Consensus 240 iHrDlKp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~ 319 (834)
|||||||+|||+|.++++||+|||+|+.+..... ....++..||+.|+|||.+... .++.|+|||
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~--------------~~~~~~~~~~~~y~aPE~~~~~-~~t~ksDVw 226 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADY--------------YKADGNDAIPIRWMPPESIFYN-RYTTESDVW 226 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGC--------------BC----CCBCGGGCCHHHHHHC-CCCHHHHHH
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCcc--------------ccccCCCCcCcCcCCHHHHccC-CCChhhhhc
Confidence 9999999999999999999999999986543211 1123456799999999998765 689999999
Q ss_pred ehhhHHHHHHhCCc-cCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCch
Q 003278 320 SFGIVVLEVVSGRR-AVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSM 398 (834)
Q Consensus 320 SfGvvl~ElltG~~-p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm 398 (834)
||||++|||+||.. |+.... ...+... ..++...... ... ...+.+|+..||+.||++||||
T Consensus 227 S~Gvvl~ell~~~~~p~~~~~---~~e~~~~----v~~~~~~~~p------~~~----~~~~~~li~~cl~~~P~~RPt~ 289 (301)
T d1lufa_ 227 AYGVVLWEIFSYGLQPYYGMA---HEEVIYY----VRDGNILACP------ENC----PLELYNLMRLCWSKLPADRPSF 289 (301)
T ss_dssp HHHHHHHHHHTTTCCTTTTSC---HHHHHHH----HHTTCCCCCC------TTC----CHHHHHHHHHHTCSSGGGSCCH
T ss_pred cchhhHHHHHccCCCCCCCCC---HHHHHHH----HHcCCCCCCC------ccc----hHHHHHHHHHHcCCChhHCcCH
Confidence 99999999999964 554321 1112222 2233322211 111 2468899999999999999999
Q ss_pred hhHHHHhhcC
Q 003278 399 KWVIEAVSGS 408 (834)
Q Consensus 399 ~~V~~~l~~~ 408 (834)
.||++.|+..
T Consensus 290 ~ev~~~L~~i 299 (301)
T d1lufa_ 290 CSIHRILQRM 299 (301)
T ss_dssp HHHHHHHHHT
T ss_pred HHHHHHHHHh
Confidence 9999998764
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-49 Score=418.59 Aligned_cols=257 Identities=25% Similarity=0.379 Sum_probs=200.3
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEcc
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYM 190 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 190 (834)
++|+..+.||+|+||+||+|+++ ++..||||++.... ...+.|.+|+.++++++|||||+++|+|.+ +..++|||||
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~-~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHEEEeeEEeeCCCeEEEEEEEC-CCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 56888999999999999999995 56789999996543 345779999999999999999999999854 5689999999
Q ss_pred CCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhh
Q 003278 191 PNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEH 270 (834)
Q Consensus 191 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~ 270 (834)
++|+|..++.... ...++|..++.|+.|||.||+|||+. +|+||||||+|||||.++.+||+|||+|+.+..
T Consensus 94 ~~g~l~~~~~~~~-----~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~ 165 (285)
T d1fmka3 94 SKGSLLDFLKGET-----GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED 165 (285)
T ss_dssp TTCBHHHHHSHHH-----HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred CCCchhhhhhhcc-----cccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccC
Confidence 9999999886532 24699999999999999999999995 999999999999999999999999999986543
Q ss_pred hhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHHH
Q 003278 271 ELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWI 350 (834)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~ 350 (834)
... ...+...||+.|+|||++..+ .++.++|||||||++|||+||..|+...... ..+..++
T Consensus 166 ~~~---------------~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--~~~~~~i 227 (285)
T d1fmka3 166 NEY---------------TARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQV 227 (285)
T ss_dssp -------------------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHH
T ss_pred CCc---------------eeeccccccccccChHHHhCC-CCCcHHhhhcchHHHHHHHhCCCCCCCCCCH--HHHHHHH
Confidence 211 113345699999999999766 5799999999999999999987776443222 1122222
Q ss_pred HHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcCCC
Q 003278 351 RRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGSYS 410 (834)
Q Consensus 351 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~~~ 410 (834)
. .+.... .. .. ..+.+.+++..||+.||++||+|.+|++.|+..+.
T Consensus 228 ~----~~~~~~-----~~-~~----~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 228 E----RGYRMP-----CP-PE----CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp H----TTCCCC-----CC-TT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred H----hcCCCC-----CC-cc----cCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 2 121111 11 11 12468899999999999999999999999987654
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-49 Score=418.45 Aligned_cols=250 Identities=21% Similarity=0.315 Sum_probs=201.2
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc---ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK---GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 187 (834)
++|+..+.||+|+||+||+|+.+.+|+.||||++... .....+.+.+|+.+|++++|||||++++++.+++.+|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 4688999999999999999999999999999998643 2234567999999999999999999999999999999999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
|||++|+|.+++... ..+++..+..++.|++.||+|||+. +||||||||+|||+++++.+||+|||+|+.
T Consensus 88 Ey~~gg~L~~~~~~~-------~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~ 157 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI-------GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKV 157 (288)
T ss_dssp CCCTTEEHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EccCCCCHHHhhhcc-------CCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEeccccccee
Confidence 999999999988643 4689999999999999999999996 999999999999999999999999999987
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHH
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILL 347 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~ 347 (834)
+...... ...+..+||+.|||||.+... .++.++|||||||++|||+||+.||.... ...+.
T Consensus 158 ~~~~~~~--------------~~~~~~~GT~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~---~~~~~ 219 (288)
T d1uu3a_ 158 LSPESKQ--------------ARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGN---EYLIF 219 (288)
T ss_dssp CC------------------------CCCCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHH
T ss_pred cccCCcc--------------cccccccCCccccCceeeccC-CCCcccceehhhHHHHHHhhCCCCCCCcC---HHHHH
Confidence 5432110 113456799999999998654 67999999999999999999999996431 11111
Q ss_pred HHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 348 DWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 348 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
.... .+.. .+. ...+ ..+.+|+..||+.||.+|||+.|++.
T Consensus 220 ---~~i~-~~~~------~~p-~~~s----~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 220 ---QKII-KLEY------DFP-EKFF----PKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp ---HHHH-TTCC------CCC-TTCC----HHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred ---HHHH-cCCC------CCC-ccCC----HHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 1111 1111 111 1111 35788999999999999999998754
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-48 Score=419.94 Aligned_cols=253 Identities=21% Similarity=0.333 Sum_probs=188.6
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC-hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG-ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYD 188 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 188 (834)
.+.|+..+.||+|+||+||+|+.+.+|+.||||++.... ....+.+.+|+.+|++++|||||++++++.+++.+|||||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 356888999999999999999999999999999986543 2334668899999999999999999999999999999999
Q ss_pred ccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEEC---CCCceEEeeccch
Q 003278 189 YMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLD---SQYNARLGDFGLA 265 (834)
Q Consensus 189 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld---~~~~~kl~DFGla 265 (834)
||++|+|.++|... ..+++..+..|+.|++.||+|||+. +|+||||||+|||+. +++.+||+|||+|
T Consensus 88 ~~~gg~L~~~l~~~-------~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a 157 (307)
T d1a06a_ 88 LVSGGELFDRIVEK-------GFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLS 157 (307)
T ss_dssp CCCSCBHHHHHHTC-------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC---
T ss_pred ccCCCcHHHhhhcc-------cCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEecccee
Confidence 99999999999643 4689999999999999999999986 999999999999994 5788999999999
Q ss_pred hhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccch
Q 003278 266 RWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQII 345 (834)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~ 345 (834)
+...... ...+.+||+.|||||.+... .++.++|||||||++|||+||+.||.... ...
T Consensus 158 ~~~~~~~-----------------~~~~~~GT~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~---~~~ 216 (307)
T d1a06a_ 158 KMEDPGS-----------------VLSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVIAYILLCGYPPFYDEN---DAK 216 (307)
T ss_dssp --------------------------------CTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHH
T ss_pred EEccCCC-----------------eeeeeeeCccccCcHHHcCC-CCCcHHHhhhhhHHHHHHHhCCCCCCCCC---HHH
Confidence 8643221 12346799999999998754 67999999999999999999999996422 111
Q ss_pred HHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 346 LLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 346 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
+.. .... +... .+.... ...+ ..+.+|...||+.||.+|||+.|+++.
T Consensus 217 ~~~---~i~~-~~~~--~~~~~~-~~~s----~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 217 LFE---QILK-AEYE--FDSPYW-DDIS----DSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp HHH---HHHT-TCCC--CCTTTT-TTSC----HHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHH---HHhc-cCCC--CCCccc-cCCC----HHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 211 1111 1110 000000 1111 357889999999999999999999873
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=416.69 Aligned_cols=251 Identities=19% Similarity=0.276 Sum_probs=198.8
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
+.|...+.||+|+||+||+|.. .++..||||++.... ....+.|.+|+++|++++|||||++++++.+.+..++||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS-SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 3466678899999999999996 468899999987543 33346789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccccc
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTR 671 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~ 671 (834)
|++|+|..++.+... .+++..+..|+.|++.||.|||+ .+||||||||+||||+.++.+||+|||+|+....
T Consensus 91 ~~~g~L~~~~~~~~~-----~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~ 162 (288)
T d2jfla1 91 CAGGAVDAVMLELER-----PLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 162 (288)
T ss_dssp CTTEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred CCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCC
Confidence 999999998765332 48899999999999999999997 6899999999999999999999999999976432
Q ss_pred CCCCCcccccCccccccccCccchhccc-----cCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhc
Q 003278 672 NDHGHRKATSGNRSVRGIFGYMSPEYIE-----SGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARK 746 (834)
Q Consensus 672 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-----~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~ 746 (834)
.. ....+.+||+.|||||++. +..|+.++|||||||+||||+||+.||....+...+. .+. ...
T Consensus 163 ~~-------~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~-~i~---~~~ 231 (288)
T d2jfla1 163 TI-------QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL-KIA---KSE 231 (288)
T ss_dssp HH-------HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH-HHH---HSC
T ss_pred Cc-------ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHH-HHH---cCC
Confidence 11 1123468999999999983 5668999999999999999999999997654433222 211 111
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 747 RPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 747 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
.+. +..+ ... .++ +..++.+||+.||++|||+.|+++
T Consensus 232 ~~~--~~~~---~~~-s~~---~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 232 PPT--LAQP---SRW-SSN---FKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp CCC--CSSG---GGS-CHH---HHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCC--CCcc---ccC-CHH---HHHHHHHHccCChhHCcCHHHHhc
Confidence 111 1101 111 233 445556899999999999999864
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-48 Score=409.04 Aligned_cols=244 Identities=21% Similarity=0.339 Sum_probs=191.2
Q ss_pred CcccccCCcEEEEEEEC-CCcEEEEEEecCCC-ChhHHHHHHHHHHHHHhccCCCceeEEEEEee----CCeEEEEEecc
Q 003278 519 QRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSK-CPALRTRFSNELQNLARLRHRNLVQLCGWCTE----QGEMLVIYDYS 592 (834)
Q Consensus 519 ~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~-~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~----~~~~~lv~Ey~ 592 (834)
..||+|+||+||+|... ++..||||.+.... ....++.|.+|+++|++++|||||++++++.+ ...+++||||+
T Consensus 15 ~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~ 94 (270)
T d1t4ha_ 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM 94 (270)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECC
T ss_pred eEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCC
Confidence 46999999999999964 57899999986543 34456789999999999999999999999865 34689999999
Q ss_pred CCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeec-CCCCceEeeeeecccccc
Q 003278 593 ATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLD-PDMNPRLGSFALAEFLTR 671 (834)
Q Consensus 593 ~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld-~~~~~ki~DfGla~~~~~ 671 (834)
++|+|.+++.... .+++..+..++.||++||+|||+. .++||||||||+||||+ +++.+||+|||+|+....
T Consensus 95 ~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 95 TSGTLKTYLKRFK------VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp CSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred CCCcHHHHHhccc------cccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 9999999987542 488999999999999999999974 23499999999999997 578999999999975322
Q ss_pred CCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcccc
Q 003278 672 NDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPLAE 751 (834)
Q Consensus 672 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
. ...+.+||+.|||||++.+ .|+.++|||||||+||||+||+.||........+...+. ....+
T Consensus 168 ~---------~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~---~~~~~--- 231 (270)
T d1t4ha_ 168 S---------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT---SGVKP--- 231 (270)
T ss_dssp T---------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHT---TTCCC---
T ss_pred C---------ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHH---cCCCC---
Confidence 1 1235689999999999864 699999999999999999999999965443333222221 11111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 752 LVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 752 ~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
+.+.... .++ +.+++.+||+.||++|||+.|+++
T Consensus 232 ---~~~~~~~-~~~---~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 232 ---ASFDKVA-IPE---VKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ---GGGGGCC-CHH---HHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---cccCccC-CHH---HHHHHHHHccCCHhHCcCHHHHhC
Confidence 1111112 233 445566999999999999999975
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=8.5e-48 Score=420.57 Aligned_cols=252 Identities=21% Similarity=0.339 Sum_probs=206.2
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEcc
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYM 190 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 190 (834)
++|++.+.||+|+||+||+|+.+.+|+.||||++........+.+.+|+.+|++++|||||++++++.+.+.+|||||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 57999999999999999999999999999999998766666778999999999999999999999999999999999999
Q ss_pred CCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECC--CCceEEeeccchhhh
Q 003278 191 PNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDS--QYNARLGDFGLARWL 268 (834)
Q Consensus 191 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~--~~~~kl~DFGla~~~ 268 (834)
++|+|.+++... ...+++..+..|+.||+.||.|||++ +||||||||+|||++. ++.+||+|||+|+.+
T Consensus 106 ~gg~L~~~l~~~------~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~ 176 (350)
T d1koaa2 106 SGGELFEKVADE------HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176 (350)
T ss_dssp CSCBHHHHHTCT------TSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred CCCCHHHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence 999999998543 24689999999999999999999996 9999999999999964 678999999999865
Q ss_pred hhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHH
Q 003278 269 EHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLD 348 (834)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~ 348 (834)
... .......||+.|||||++... .++.++|||||||++|||+||+.||.... .. +
T Consensus 177 ~~~-----------------~~~~~~~gT~~Y~aPEv~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~---~~---~ 232 (350)
T d1koaa2 177 DPK-----------------QSVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGEN---DD---E 232 (350)
T ss_dssp CTT-----------------SCEEEECSCTTTCCHHHHHTC-CBCHHHHHHHHHHHHHHHHHSSCSSCCSS---HH---H
T ss_pred ccc-----------------cccceecCcccccCHHHHcCC-CCChhHhhhhhhHHHHHHHhCCCCCCCCC---HH---H
Confidence 321 113456799999999998654 67999999999999999999999986432 11 1
Q ss_pred HHHHHhh-cCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 349 WIRRLSD-EGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 349 ~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
....... ........-+.+ .+.+.+|+..||+.||.+|||+.|+++.
T Consensus 233 ~~~~i~~~~~~~~~~~~~~~---------s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 233 TLRNVKSCDWNMDDSAFSGI---------SEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HHHHHHHTCCCSCCGGGGGC---------CHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred HHHHHHhCCCCCCcccccCC---------CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1222211 111111111111 1357889999999999999999999874
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.4e-47 Score=419.10 Aligned_cols=253 Identities=20% Similarity=0.260 Sum_probs=205.3
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEcc
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYM 190 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 190 (834)
++|+..+.||+|+||+||+|+...+|+.||||++........+.+.+|+.+|++++|||||++++++.+++.+|||||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 46899999999999999999999999999999997765556678899999999999999999999999999999999999
Q ss_pred CCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEEC--CCCceEEeeccchhhh
Q 003278 191 PNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLD--SQYNARLGDFGLARWL 268 (834)
Q Consensus 191 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld--~~~~~kl~DFGla~~~ 268 (834)
++|+|.+++... ..++++..+..|+.||+.||.|||+. +||||||||+||||+ .++.+||+|||+|+.+
T Consensus 109 ~gg~L~~~~~~~------~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~ 179 (352)
T d1koba_ 109 SGGELFDRIAAE------DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL 179 (352)
T ss_dssp CCCBHHHHTTCT------TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred CCChHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceec
Confidence 999998877543 24689999999999999999999985 999999999999998 5789999999999865
Q ss_pred hhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHH
Q 003278 269 EHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLD 348 (834)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~ 348 (834)
..+ .......||+.|||||++... .++.++|||||||++|||+||+.||.... ...+..
T Consensus 180 ~~~-----------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~---~~~~~~ 238 (352)
T d1koba_ 180 NPD-----------------EIVKVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGED---DLETLQ 238 (352)
T ss_dssp CTT-----------------SCEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHH
T ss_pred CCC-----------------CceeeccCcccccCHHHHcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCC---HHHHHH
Confidence 321 113456799999999988654 68999999999999999999999996432 111111
Q ss_pred HHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 349 WIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 349 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
.+.. +... ...... ... ...+.+|+..||+.||.+|||+.|+++.
T Consensus 239 ---~i~~-~~~~--~~~~~~-~~~----s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 239 ---NVKR-CDWE--FDEDAF-SSV----SPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp ---HHHH-CCCC--CCSSTT-TTS----CHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ---HHHh-CCCC--CCcccc-cCC----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111 1110 000000 111 1357889999999999999999999874
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.5e-48 Score=416.60 Aligned_cols=245 Identities=22% Similarity=0.311 Sum_probs=196.8
Q ss_pred CcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCC--hhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEe
Q 003278 514 NFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKC--PALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYD 590 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~--~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~E 590 (834)
.|+..+.||+|+||+||+|.. .++..||||.+..... ....+.|.+|+.+|++++|||||+++|++.+.+..++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 478888999999999999985 5688999999875543 3345679999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccc
Q 003278 591 YSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLT 670 (834)
Q Consensus 591 y~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~ 670 (834)
||.+|+|..++.... .+++..+..|+.||+.||.|||+ .+||||||||+||||++++.+||+|||+|+...
T Consensus 96 ~~~~g~l~~~~~~~~------~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKK------PLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (309)
T ss_dssp CCSEEHHHHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred ecCCCchHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccC
Confidence 999999987665432 48999999999999999999997 699999999999999999999999999997543
Q ss_pred cCCCCCcccccCccccccccCccchhcccc---CCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcC
Q 003278 671 RNDHGHRKATSGNRSVRGIFGYMSPEYIES---GEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKR 747 (834)
Q Consensus 671 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~---~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
. .....||+.|||||++.+ +.|+.++|||||||++|||+||+.||....+...+ . .......
T Consensus 167 ~-----------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~-~---~i~~~~~ 231 (309)
T d1u5ra_ 167 P-----------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-Y---HIAQNES 231 (309)
T ss_dssp S-----------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-H---HHHHSCC
T ss_pred C-----------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHH-H---HHHhCCC
Confidence 2 224579999999999853 56899999999999999999999998654332221 1 1111111
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 748 PLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 748 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
+ .+......++ +..++.+||+.||++|||+.|+++
T Consensus 232 ~-------~~~~~~~s~~---~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 232 P-------ALQSGHWSEY---FRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp C-------CCSCTTSCHH---HHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred C-------CCCCCCCCHH---HHHHHHHHCcCChhHCcCHHHHHh
Confidence 1 1111112234 445556999999999999999975
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-48 Score=417.03 Aligned_cols=257 Identities=18% Similarity=0.292 Sum_probs=197.6
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCc----EEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQ----YVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLV 587 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~----~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~l 587 (834)
++|...+.||+|+||+||+|... +|+ .||||++.........++|.+|+.+|++++|||||+++|+|.+. ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 35888899999999999999864 343 58999987665555667899999999999999999999999875 5678
Q ss_pred EEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecc
Q 003278 588 IYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAE 667 (834)
Q Consensus 588 v~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~ 667 (834)
++||+.+|+|.+++.... ..++|..+++|+.|||.||+|||+ ++||||||||+||||+.++.+||+|||+|+
T Consensus 88 v~e~~~~~~l~~~~~~~~-----~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~ 159 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHK-----DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAK 159 (317)
T ss_dssp EEECCTTCBHHHHHHHTS-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHH
T ss_pred EEEeccCCcccccccccc-----cCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccce
Confidence 899999999998877543 248899999999999999999997 689999999999999999999999999998
Q ss_pred ccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhc
Q 003278 668 FLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARK 746 (834)
Q Consensus 668 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~ 746 (834)
.+..... ........||+.|||||++.++.|+.++|||||||+||||+| |+.|+... +...+...+.. ..
T Consensus 160 ~~~~~~~-----~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~-~~~~~~~~i~~---~~ 230 (317)
T d1xkka_ 160 LLGAEEK-----EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEK---GE 230 (317)
T ss_dssp HTTTTCC-------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS-CGGGHHHHHHH---TC
T ss_pred ecccccc-----cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCC-CHHHHHHHHHc---CC
Confidence 7654321 111234579999999999999999999999999999999999 67776543 33333332221 11
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCC
Q 003278 747 RPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGND 798 (834)
Q Consensus 747 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~ 798 (834)
++ ..+.. .+. .+.+++.+||+.||++||||.||++.|+.+.
T Consensus 231 ~~-------~~p~~-~~~---~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 231 RL-------PQPPI-CTI---DVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp CC-------CCCTT-BCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CC-------CCCcc-cCH---HHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 11 01111 122 3556667999999999999999999887553
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=415.17 Aligned_cols=256 Identities=24% Similarity=0.386 Sum_probs=198.5
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCe----EEEEEEeccc-ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGT----VVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLL 185 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~----~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 185 (834)
++|+..++||+|+||+||+|.+..+|+ .||||++... .....+.|.+|+.+|++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 458999999999999999999977775 5888888643 344567899999999999999999999999865 5678
Q ss_pred EEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccch
Q 003278 186 VYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLA 265 (834)
Q Consensus 186 V~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla 265 (834)
+|||+.+|+|.+++... ...++|..+++|+.|||+||+|||++ +||||||||+|||++.++.+||+|||+|
T Consensus 88 v~e~~~~~~l~~~~~~~------~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla 158 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH------KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA 158 (317)
T ss_dssp EEECCTTCBHHHHHHHT------SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHH
T ss_pred EEEeccCCccccccccc------ccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccc
Confidence 89999999999988654 34689999999999999999999996 9999999999999999999999999999
Q ss_pred hhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccc
Q 003278 266 RWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQI 344 (834)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~ 344 (834)
+.+...... ...+...||+.|||||.+..+ .++.++|||||||+||||+| |+.|++.....
T Consensus 159 ~~~~~~~~~--------------~~~~~~~gt~~y~APE~l~~~-~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~--- 220 (317)
T d1xkka_ 159 KLLGAEEKE--------------YHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--- 220 (317)
T ss_dssp HHTTTTCC----------------------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG---
T ss_pred eeccccccc--------------ccccccccCccccChHHHhcC-CCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH---
Confidence 875432110 113345699999999998766 67999999999999999999 78887643221
Q ss_pred hHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 345 ILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 345 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
.+...+ ..+...... .. ....+.+|+..||+.||.+||||.+|++.|...
T Consensus 221 ~~~~~i----~~~~~~~~p------~~----~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 221 EISSIL----EKGERLPQP------PI----CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp GHHHHH----HHTCCCCCC------TT----BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHH----HcCCCCCCC------cc----cCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 122211 222211110 11 124678999999999999999999999987653
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-48 Score=407.70 Aligned_cols=249 Identities=21% Similarity=0.328 Sum_probs=191.4
Q ss_pred CcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEee-CCeEEEEEecc
Q 003278 514 NFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTE-QGEMLVIYDYS 592 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~-~~~~~lv~Ey~ 592 (834)
+|.-.+.||+|+||.||+|.+. |..||||+++.+. ..+.|.+|+++|++++|||||+++|+|.+ .+.+++||||+
T Consensus 8 ~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 8 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 3455677999999999999985 6789999996533 34679999999999999999999999965 45689999999
Q ss_pred CCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccC
Q 003278 593 ATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRN 672 (834)
Q Consensus 593 ~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~ 672 (834)
++|+|.++|.... ...++|..+++|+.|||.||+|||+ .+||||||||+|||++.++.+|++|||+++.....
T Consensus 84 ~~g~L~~~l~~~~----~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~ 156 (262)
T d1byga_ 84 AKGSLVDYLRSRG----RSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 156 (262)
T ss_dssp TTEEHHHHHHHHH----HHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred CCCCHHHHHHhcC----CCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCC
Confidence 9999999997542 2358999999999999999999997 69999999999999999999999999999864322
Q ss_pred CCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcCcccc
Q 003278 673 DHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKRPLAE 751 (834)
Q Consensus 673 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
.....||+.|||||++.++.+|.++|||||||++|||+| |+.|+.. .+...+...+.. ..++
T Consensus 157 ----------~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~-~~~~~~~~~i~~---~~~~--- 219 (262)
T d1byga_ 157 ----------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPRVEK---GYKM--- 219 (262)
T ss_dssp ---------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT-SCGGGHHHHHTT---TCCC---
T ss_pred ----------CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHc---CCCC---
Confidence 223578999999999999999999999999999999999 5655543 333333333211 1111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCC
Q 003278 752 LVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGND 798 (834)
Q Consensus 752 ~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~ 798 (834)
.+.... +++ +.+++.+||+.||++||||.+|++.|+.++
T Consensus 220 ----~~~~~~-~~~---~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 220 ----DAPDGC-PPA---VYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp ----CCCTTC-CHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCccC-CHH---HHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 111122 233 445666999999999999999999997653
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.9e-48 Score=414.66 Aligned_cols=251 Identities=16% Similarity=0.221 Sum_probs=184.4
Q ss_pred hCcCcCCcccccCCcEEEEEEEC-CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD-NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
+.|.-.+.||+|+||+||+|... +++.||||.+...........|.+|+.+|++++|||||++++++.+.+..+|||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~ 88 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 45677788999999999999964 58899999987655444456788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeec---CCCCceEeeeeeccc
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLD---PDMNPRLGSFALAEF 668 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld---~~~~~ki~DfGla~~ 668 (834)
|++|+|.+++...+ .+++.....++.|++.||+|||+ .+||||||||+|||++ +++.+||+|||+|+.
T Consensus 89 ~~gg~L~~~l~~~~------~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~ 159 (307)
T d1a06a_ 89 VSGGELFDRIVEKG------FYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159 (307)
T ss_dssp CCSCBHHHHHHTCS------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred cCCCcHHHhhhccc------CCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEE
Confidence 99999999997532 48899999999999999999997 6999999999999994 578999999999986
Q ss_pred cccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCc
Q 003278 669 LTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRP 748 (834)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
..... ...+.+||+.|||||++.++.|+.++|||||||+||||+||+.||....... +...+. .....
T Consensus 160 ~~~~~--------~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-~~~~i~---~~~~~ 227 (307)
T d1a06a_ 160 EDPGS--------VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK-LFEQIL---KAEYE 227 (307)
T ss_dssp ---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHH---TTCCC
T ss_pred ccCCC--------eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH-HHHHHh---ccCCC
Confidence 53321 1234689999999999999999999999999999999999999997543322 111111 11111
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 749 LAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 749 ~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
. +.......+ ++ +..++.+||+.||++|||+.|+++
T Consensus 228 ~----~~~~~~~~s-~~---~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 228 F----DSPYWDDIS-DS---AKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp C----CTTTTTTSC-HH---HHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred C----CCccccCCC-HH---HHHHHHHHccCCHhHCcCHHHHhc
Confidence 1 011111222 33 445556999999999999999987
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-47 Score=407.61 Aligned_cols=249 Identities=20% Similarity=0.288 Sum_probs=201.7
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC------hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG------ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLL 184 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~------~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 184 (834)
+.|+..+.||+|+||+||+|+.+.+|+.||||++.+.. ....+.|.+|+.+|++++|||||+++++|.+.+.+|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 56899999999999999999999999999999986431 223578999999999999999999999999999999
Q ss_pred EEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCC----ceEEe
Q 003278 185 LVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQY----NARLG 260 (834)
Q Consensus 185 lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~----~~kl~ 260 (834)
||||||++|+|.++|... ..+++..+..|+.|++.||+|||+. +|+||||||+|||++.++ .+||+
T Consensus 90 iv~E~~~gg~L~~~i~~~-------~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~ 159 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEK-------ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKII 159 (293)
T ss_dssp EEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEEC
T ss_pred EEEEcCCCccccchhccc-------cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEec
Confidence 999999999999998653 3689999999999999999999996 999999999999998766 49999
Q ss_pred eccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCC
Q 003278 261 DFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYP 340 (834)
Q Consensus 261 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~ 340 (834)
|||+|+.+... .......||+.|||||.+... .++.++|||||||++|||+||+.||....
T Consensus 160 DfG~a~~~~~~-----------------~~~~~~~~t~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~- 220 (293)
T d1jksa_ 160 DFGLAHKIDFG-----------------NEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDT- 220 (293)
T ss_dssp CCTTCEECTTS-----------------CBCSCCCCCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSS-
T ss_pred chhhhhhcCCC-----------------ccccccCCCCcccCHHHHcCC-CCCCcccchhhhHHHHHHHcCCCCCCCCC-
Confidence 99999864321 113445799999999998654 67999999999999999999999996432
Q ss_pred CccchHHHHHHHHhhcCcc--ccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 341 DDQIILLDWIRRLSDEGKV--LQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 341 ~~~~~l~~~~~~~~~~~~~--~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
.... ...... +.. .....+.+ ...+.+|...||+.||.+|||+.|+++
T Consensus 221 --~~~~---~~~i~~-~~~~~~~~~~~~~---------s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 221 --KQET---LANVSA-VNYEFEDEYFSNT---------SALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp --HHHH---HHHHHT-TCCCCCHHHHTTS---------CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --HHHH---HHHHHh-cCCCCCchhcCCC---------CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111 111111 111 11011111 135778999999999999999999986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-48 Score=405.88 Aligned_cols=250 Identities=27% Similarity=0.387 Sum_probs=195.4
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeC-CEEEEEEE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHE-DQLLLVYD 188 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-~~~~lV~E 188 (834)
.++|+..+.||+|+||.||+|.+ .|+.||||+++.. ...+.|.+|+.++++++|||||+++|+|.+. +.+++|||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 34677889999999999999998 4789999999654 3457799999999999999999999999754 56899999
Q ss_pred ccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhh
Q 003278 189 YMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWL 268 (834)
Q Consensus 189 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~ 268 (834)
|+++|+|.++|..+. ...++|..+++|+.|||.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 82 y~~~g~L~~~l~~~~-----~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~ 153 (262)
T d1byga_ 82 YMAKGSLVDYLRSRG-----RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 153 (262)
T ss_dssp CCTTEEHHHHHHHHH-----HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred ccCCCCHHHHHHhcC-----CCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceec
Confidence 999999999997542 23589999999999999999999985 9999999999999999999999999999854
Q ss_pred hhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCccchHH
Q 003278 269 EHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQIILL 347 (834)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~ 347 (834)
... .....||+.|+|||++..+ .++.++|||||||++|||+| |+.|+.... ...+.
T Consensus 154 ~~~-------------------~~~~~~~~~y~aPE~l~~~-~~t~~sDIwSfG~il~el~t~~~~p~~~~~---~~~~~ 210 (262)
T d1byga_ 154 SST-------------------QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIP---LKDVV 210 (262)
T ss_dssp ---------------------------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSC---GGGHH
T ss_pred CCC-------------------CccccccccCCChHHHhCC-CCChHHHHHhHHHHHHHHHHCCCCCCCCCC---HHHHH
Confidence 321 2334589999999999766 67999999999999999999 676665432 12233
Q ss_pred HHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 348 DWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 348 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
.++. .+...+.. ... ...+.+|+..||+.||.+||||.+|++.|+..
T Consensus 211 ~~i~----~~~~~~~~------~~~----~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 211 PRVE----KGYKMDAP------DGC----PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp HHHT----TTCCCCCC------TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHH----cCCCCCCC------ccC----CHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 3321 22222111 111 24678999999999999999999999998754
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-47 Score=406.77 Aligned_cols=257 Identities=24% Similarity=0.379 Sum_probs=195.6
Q ss_pred hcCCCCCCCeeeccCCeEEEEEEECCC---CeEEEEEEeccc-ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEE
Q 003278 109 GSNGFDEDEVLGSGGFGKVYRAVLPSD---GTVVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLL 184 (834)
Q Consensus 109 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~---g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 184 (834)
..++|+..+.||+|+||+||+|++..+ +..||||.++.. .....+.|.+|+.+|++++|||||+++|+|. .+.++
T Consensus 5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 83 (273)
T d1mp8a_ 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 83 (273)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence 346788899999999999999998644 457999998653 3445678999999999999999999999986 46789
Q ss_pred EEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccc
Q 003278 185 LVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGL 264 (834)
Q Consensus 185 lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGl 264 (834)
+||||+++|+|..++... ...++|..++.++.||++||.|||+. +||||||||+|||+++++.+||+|||+
T Consensus 84 iv~E~~~~g~l~~~~~~~------~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~ 154 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQVR------KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGL 154 (273)
T ss_dssp EEEECCTTEEHHHHHHHT------TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---
T ss_pred EEEEeccCCcHHhhhhcc------CCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchh
Confidence 999999999999987653 24689999999999999999999996 999999999999999999999999999
Q ss_pred hhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCcc
Q 003278 265 ARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQ 343 (834)
Q Consensus 265 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~ 343 (834)
|+.+..... ...+...||+.|+|||.+..+ .++.++|||||||++|||+| |+.|+......
T Consensus 155 a~~~~~~~~---------------~~~~~~~gt~~y~apE~l~~~-~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~-- 216 (273)
T d1mp8a_ 155 SRYMEDSTY---------------YKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-- 216 (273)
T ss_dssp -------------------------------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--
T ss_pred heeccCCcc---------------eeccceecCcccchhhHhccC-CCCCccccccchHHHHHHHhcCCCCCCCCCHH--
Confidence 986543211 113456689999999999765 67999999999999999998 88888654322
Q ss_pred chHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 344 IILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 344 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
.+...+ ..+..... . ... ...+.+|+..||+.||++|||+.+|++.|+..
T Consensus 217 -~~~~~i----~~~~~~~~-----~-~~~----~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 217 -DVIGRI----ENGERLPM-----P-PNC----PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp -GHHHHH----HTTCCCCC-----C-TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHHHHH----HcCCCCCC-----C-CCC----CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 222222 12222111 1 111 24688999999999999999999999988653
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=406.55 Aligned_cols=255 Identities=21% Similarity=0.314 Sum_probs=193.4
Q ss_pred hCcCcCCcccccCCcEEEEEEECC----CcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDN----HQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVI 588 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~----~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv 588 (834)
++|.-.+.||+|+||.||+|.... +..||||.++.......++.|.+|+.+|++++|||||+++|+|.+ +..++|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEEE
Confidence 356667889999999999998643 356899998766666777889999999999999999999999965 578999
Q ss_pred EeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccc
Q 003278 589 YDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEF 668 (834)
Q Consensus 589 ~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~ 668 (834)
|||+++|+|..++.... ..+++..++.++.|+|+||+|||+ .+||||||||+|||+++++.+||+|||+|+.
T Consensus 86 ~E~~~~g~l~~~~~~~~-----~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVRK-----YSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp EECCTTEEHHHHHHHTT-----TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEeccCCcHHhhhhccC-----CCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhhee
Confidence 99999999999876543 248999999999999999999997 6999999999999999999999999999987
Q ss_pred cccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhhcC
Q 003278 669 LTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEARKR 747 (834)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
+..... .......||+.|||||++.++.|+.++|||||||++|||+| |..|+....+. .+...+.. ..+
T Consensus 158 ~~~~~~------~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~-~~~~~i~~---~~~ 227 (273)
T d1mp8a_ 158 MEDSTY------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-DVIGRIEN---GER 227 (273)
T ss_dssp -------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-GHHHHHHT---TCC
T ss_pred ccCCcc------eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH-HHHHHHHc---CCC
Confidence 543221 12234578999999999999999999999999999999998 77787654333 23332221 111
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccC
Q 003278 748 PLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGN 797 (834)
Q Consensus 748 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~ 797 (834)
+ .+.... +++ +.+++.+||+.||++||||.||++.|+.+
T Consensus 228 ~-------~~~~~~-~~~---~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 228 L-------PMPPNC-PPT---LYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp C-------CCCTTC-CHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C-------CCCCCC-CHH---HHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1 111122 233 45566699999999999999999998654
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-48 Score=417.24 Aligned_cols=261 Identities=21% Similarity=0.290 Sum_probs=199.0
Q ss_pred hCcCcCCcccccCCcEEEEEEECC-Cc--EEEEEEecCCCChhHHHHHHHHHHHHHhc-cCCCceeEEEEEeeCCeEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDN-HQ--YVLVKRLGMSKCPALRTRFSNELQNLARL-RHRNLVQLCGWCTEQGEMLVI 588 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~-~~--~vavK~~~~~~~~~~~~~f~~E~~~l~~l-~HpNiv~l~g~~~~~~~~~lv 588 (834)
++|.-.+.||+|+||+||+|...+ +. .||||++.........+.|.+|+++|+++ +|||||+++|+|.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 456666789999999999999744 33 57889886555555567899999999999 799999999999999999999
Q ss_pred EeccCCCchhhhhhcCCC----------CCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCc
Q 003278 589 YDYSATRILSHLLFHNNH----------RIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNP 658 (834)
Q Consensus 589 ~Ey~~~g~L~~~l~~~~~----------~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ 658 (834)
|||+++|+|.++|+.... ......++|..++.++.|||.||.|||+ .+||||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCce
Confidence 999999999999975421 1123458999999999999999999997 699999999999999999999
Q ss_pred eEeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHH
Q 003278 659 RLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKR 738 (834)
Q Consensus 659 ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~ 738 (834)
||+|||+|+..... .......||..|+|||.+.++.|+.++|||||||++|||+||..|+........+...
T Consensus 167 kl~DfG~a~~~~~~--------~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~ 238 (309)
T d1fvra_ 167 KIADFGLSRGQEVY--------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 238 (309)
T ss_dssp EECCTTCEESSCEE--------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH
T ss_pred EEcccccccccccc--------ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 99999999764321 1123457999999999999999999999999999999999987654333333332222
Q ss_pred HHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccCC
Q 003278 739 VHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGND 798 (834)
Q Consensus 739 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~~ 798 (834)
+.. ..+ +...... ++ ++.+++.+||+.||++||||.+|++.|+.+.
T Consensus 239 i~~---~~~-------~~~~~~~-~~---~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 239 LPQ---GYR-------LEKPLNC-DD---EVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp GGG---TCC-------CCCCTTB-CH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHh---cCC-------CCCCccC-CH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 211 111 1111112 23 4556667999999999999999999887653
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-48 Score=415.33 Aligned_cols=270 Identities=23% Similarity=0.274 Sum_probs=198.6
Q ss_pred CCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCC----EEEEEE
Q 003278 112 GFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHED----QLLLVY 187 (834)
Q Consensus 112 ~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~----~~~lV~ 187 (834)
.|...+.||+|+||.||+|++ +|+.||||++..... ....+..|+..+.+++|||||+++|+|.+.+ .+++||
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 355678899999999999997 689999999865422 2222344566667899999999999998765 689999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhcc-----CCCeecCCCCCCceEECCCCceEEeec
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQL-----ETQIIHRDVKTSNVMLDSQYNARLGDF 262 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~iiHrDlKp~NILld~~~~~kl~DF 262 (834)
|||++|+|.++|++. .++|..+++++.|+|.||+|||+.. .++||||||||+||||+.++.+||+||
T Consensus 81 Ey~~~g~L~~~l~~~--------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF 152 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRY--------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp ECCTTCBHHHHHHHC--------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred ecccCCCHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence 999999999999653 5899999999999999999999732 369999999999999999999999999
Q ss_pred cchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCC-----CCCcccceeehhhHHHHHHhCCccCCC
Q 003278 263 GLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGS-----VATAKSDVFSFGIVVLEVVSGRRAVDL 337 (834)
Q Consensus 263 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-----~~~~ksDV~SfGvvl~ElltG~~p~~~ 337 (834)
|+++....... ..........||++|||||++.... .++.|+|||||||+||||+||..|+..
T Consensus 153 Gl~~~~~~~~~------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~ 220 (303)
T d1vjya_ 153 GLAVRHDSATD------------TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp TTCEEEETTTT------------EECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred CccccccCCCc------------ceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCc
Confidence 99986533210 0011234567999999999986432 246789999999999999999988743
Q ss_pred CCCCccc--------hHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 338 TYPDDQI--------ILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 338 ~~~~~~~--------~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
....... ............+. .++.+............+.+|+..||+.||.+||||.||++.|+..
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 221 HEDYQLPYYDLVPSDPSVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CCCCCCTTTTTSCSSCCHHHHHHHHTTSC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccccchhhcccccchHHHHHHHHhccc----cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 2211110 01122222222211 1222211111233456788999999999999999999999998754
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-47 Score=407.49 Aligned_cols=256 Identities=24% Similarity=0.369 Sum_probs=200.7
Q ss_pred CCeeeccCCeEEEEEEECCCC---eEEEEEEecc-cChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeC-CEEEEEEEcc
Q 003278 116 DEVLGSGGFGKVYRAVLPSDG---TVVAVKCLAE-KGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHE-DQLLLVYDYM 190 (834)
Q Consensus 116 ~~~LG~G~fG~Vy~~~~~~~g---~~vAvK~l~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-~~~~lV~Ey~ 190 (834)
.++||+|+||+||+|++..++ ..||||+++. ......+.|.+|+.+|++++|||||+++|+|... +..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 468999999999999986543 3699999874 3455567899999999999999999999998864 5899999999
Q ss_pred CCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhh
Q 003278 191 PNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEH 270 (834)
Q Consensus 191 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~ 270 (834)
++|+|.+++... ...++|..+++++.|+|+||.|||+. +|+||||||+|||||+++.+||+|||+++.+..
T Consensus 112 ~~g~l~~~~~~~------~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~ 182 (311)
T d1r0pa_ 112 KHGDLRNFIRNE------THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 182 (311)
T ss_dssp TTCBHHHHHHCT------TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTT
T ss_pred ecCchhhhhccc------cccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccc
Confidence 999999998754 24578899999999999999999985 999999999999999999999999999987643
Q ss_pred hhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHHH
Q 003278 271 ELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWI 350 (834)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~ 350 (834)
.... .....+...||+.|+|||.+..+ .++.++|||||||++|||+||+.|+.......+ +..++
T Consensus 183 ~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~--~~~~i 247 (311)
T d1r0pa_ 183 KEFD------------SVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVYL 247 (311)
T ss_dssp TTCC------------CTTCTTCSSCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHH
T ss_pred cccc------------cceecccccccccccChHHHhcC-CCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH--HHHHH
Confidence 2110 01113345699999999998766 679999999999999999998888754322211 11221
Q ss_pred HHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcCC
Q 003278 351 RRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGSY 409 (834)
Q Consensus 351 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~~ 409 (834)
..+..... + .. ..+.+.+|+..||+.||++||+|.||++.|+...
T Consensus 248 ----~~g~~~~~--p----~~----~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~ 292 (311)
T d1r0pa_ 248 ----LQGRRLLQ--P----EY----CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 292 (311)
T ss_dssp ----HTTCCCCC--C----TT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----HcCCCCCC--c----cc----CcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 12222111 1 11 1246889999999999999999999999998764
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=407.50 Aligned_cols=250 Identities=17% Similarity=0.215 Sum_probs=198.1
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCC--ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSK--CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIY 589 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~--~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~ 589 (834)
++|...+.||+|+||+||+|.. .+++.||||.+.... .....+.|.+|+++|++++|||||++++++.+.+..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 4677788999999999999996 568899999986321 1223467899999999999999999999999999999999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccc
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFL 669 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~ 669 (834)
||+++|+|.+++...+ .+++.....++.|++.||+|||+ .+||||||||+||||++++.+||+|||+|+.+
T Consensus 88 Ey~~gg~L~~~~~~~~------~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~ 158 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG------SFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVL 158 (288)
T ss_dssp CCCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EccCCCCHHHhhhccC------CCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceec
Confidence 9999999999887543 48899999999999999999997 69999999999999999999999999999876
Q ss_pred ccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcc
Q 003278 670 TRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPL 749 (834)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
..... .....+.+||+.|||||++.+..|+.++|||||||+||||+||+.||....+.. +...+. ....
T Consensus 159 ~~~~~-----~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-~~~~i~---~~~~-- 227 (288)
T d1uu3a_ 159 SPESK-----QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-IFQKII---KLEY-- 227 (288)
T ss_dssp C---------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHH---TTCC--
T ss_pred ccCCc-----ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH-HHHHHH---cCCC--
Confidence 43221 112235689999999999999999999999999999999999999997543322 112111 1111
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 750 AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 750 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
.++...+ ++ +.+++.+||+.||++|||++|+.+
T Consensus 228 ------~~p~~~s-~~---~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 228 ------DFPEKFF-PK---ARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp ------CCCTTCC-HH---HHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred ------CCCccCC-HH---HHHHHHHHccCCHhHCcCHHHHcC
Confidence 1112222 33 345556999999999999999754
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-47 Score=408.06 Aligned_cols=263 Identities=21% Similarity=0.286 Sum_probs=195.1
Q ss_pred hCcCcCCcccccCCcEEEEEEEC------CCcEEEEEEecCCCChhHHHHHHHHHHHHHhc-cCCCceeEEEEEeeC-Ce
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD------NHQYVLVKRLGMSKCPALRTRFSNELQNLARL-RHRNLVQLCGWCTEQ-GE 584 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l-~HpNiv~l~g~~~~~-~~ 584 (834)
++|.-.+.||+|+||.||+|... +++.||||+++........+.|.+|+..+.++ +|||||++++++.+. ..
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 45667788999999999999853 24689999998666666667888999988887 689999999998764 46
Q ss_pred EEEEEeccCCCchhhhhhcCCCC----------CCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecC
Q 003278 585 MLVIYDYSATRILSHLLFHNNHR----------IGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDP 654 (834)
Q Consensus 585 ~~lv~Ey~~~g~L~~~l~~~~~~----------~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~ 654 (834)
.++|||||++|+|.+++...... .....++|..++.++.|||+||+|||+ .+||||||||+||||++
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSE 169 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECG
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCccceeECC
Confidence 89999999999999999764321 112358999999999999999999997 69999999999999999
Q ss_pred CCCceEeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCC-ccCCCCCch
Q 003278 655 DMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQM-AVDFRLPEG 733 (834)
Q Consensus 655 ~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~-p~~~~~~~~ 733 (834)
++.+||+|||+|+....... ........||+.|||||++.++.++.++|||||||++|||+||.. |+.......
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~ 244 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPD-----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244 (299)
T ss_dssp GGCEEECC------CCSCTT-----SCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred CCcEEEccCcchhhcccccc-----ccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999987543321 112335689999999999999999999999999999999999865 554333333
Q ss_pred hHHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccC
Q 003278 734 LLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGN 797 (834)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~ 797 (834)
.+...+.. ..++ ..... .++ ++.+++.+||+.||++||||.||++.|+.+
T Consensus 245 ~~~~~~~~---~~~~-------~~~~~-~~~---~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 245 EFCRRLKE---GTRM-------RAPDY-TTP---EMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp HHHHHHHH---TCCC-------CCCTT-CCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHhc---CCCC-------CCCcc-CCH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 22222221 1111 11111 223 355667799999999999999999998754
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.3e-47 Score=416.77 Aligned_cols=250 Identities=25% Similarity=0.346 Sum_probs=198.7
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHH---HHHHHHHhCCCCceeeEeeeEEeCCEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFA---AELVAVAHLRHRNLVRLRGWCVHEDQLL 184 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~---~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 184 (834)
++|+..++||+|+||.||+|+.+.+|+.||||++.... ......+. .|+.+++.++|||||+++++|.+.+.+|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 67999999999999999999999999999999986431 11223333 4467788889999999999999999999
Q ss_pred EEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccc
Q 003278 185 LVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGL 264 (834)
Q Consensus 185 lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGl 264 (834)
+|||||++|+|.++|... ..+++..+..|+.||+.||.|||+. +||||||||+|||++.++.+||+|||+
T Consensus 84 ivmE~~~gg~L~~~l~~~-------~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGl 153 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH-------GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGL 153 (364)
T ss_dssp EEECCCCSCBHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTT
T ss_pred EEEEecCCCcHHHHHHhc-------ccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeece
Confidence 999999999999999653 4578899999999999999999996 999999999999999999999999999
Q ss_pred hhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccc
Q 003278 265 ARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQI 344 (834)
Q Consensus 265 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~ 344 (834)
|+.+... ......||+.|||||.+..+..++.++|||||||+||||+||+.||......+..
T Consensus 154 a~~~~~~------------------~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~ 215 (364)
T d1omwa3 154 ACDFSKK------------------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 215 (364)
T ss_dssp CEECSSS------------------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH
T ss_pred eeecCCC------------------cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9854321 1344579999999999977767899999999999999999999999754433221
Q ss_pred hHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCch-----hhHHH
Q 003278 345 ILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSM-----KWVIE 403 (834)
Q Consensus 345 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm-----~~V~~ 403 (834)
. +....... ..... ...+ ..+.+|+..||+.||.+||++ .++++
T Consensus 216 ~----~~~~~~~~------~~~~~-~~~s----~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 216 E----IDRMTLTM------AVELP-DSFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp H----HHHHSSSC------CCCCC-SSSC----HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred H----HHHhcccC------CCCCC-CCCC----HHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 1 11111000 00111 1112 357889999999999999994 56654
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-47 Score=407.90 Aligned_cols=270 Identities=24% Similarity=0.337 Sum_probs=199.3
Q ss_pred HHHhhcCCCCCCCeeeccCCeEEEEEEECC-----CCeEEEEEEeccc-ChhhHHHHHHHHHHHHhC-CCCceeeEeeeE
Q 003278 105 ELYIGSNGFDEDEVLGSGGFGKVYRAVLPS-----DGTVVAVKCLAEK-GERFEKTFAAELVAVAHL-RHRNLVRLRGWC 177 (834)
Q Consensus 105 el~~~t~~f~~~~~LG~G~fG~Vy~~~~~~-----~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~ 177 (834)
+.++..++|+..+.||+|+||+||+|.+.. +++.||||+++.. .....+.|.+|+..+.++ +|+|||.+++++
T Consensus 7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~ 86 (299)
T d1ywna1 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 86 (299)
T ss_dssp HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence 334455779999999999999999998743 4578999998653 334456788888888776 689999999998
Q ss_pred EeCC-EEEEEEEccCCCCHhHHHhcCCCcc---------ccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCC
Q 003278 178 VHED-QLLLVYDYMPNRSLDRVLFRRPENL---------EAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTS 247 (834)
Q Consensus 178 ~~~~-~~~lV~Ey~~~gsL~~~l~~~~~~~---------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~ 247 (834)
...+ .+++|||||++|+|.++|....... .....++|..++.|+.|||+||.|||++ +||||||||+
T Consensus 87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~ 163 (299)
T d1ywna1 87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAAR 163 (299)
T ss_dssp CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGG
T ss_pred ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCcc
Confidence 7654 6899999999999999997653211 1134689999999999999999999996 9999999999
Q ss_pred ceEECCCCceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHH
Q 003278 248 NVMLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLE 327 (834)
Q Consensus 248 NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~E 327 (834)
||||++++++||+|||+|+....... ....+...||+.|||||.+..+ .++.++|||||||++||
T Consensus 164 NILl~~~~~~Kl~DFGla~~~~~~~~--------------~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gvil~e 228 (299)
T d1ywna1 164 NILLSEKNVVKICDFGLARDIYKDPD--------------YVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWE 228 (299)
T ss_dssp GEEECGGGCEEECC------CCSCTT--------------SCCTTSCCCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHH
T ss_pred ceeECCCCcEEEccCcchhhcccccc--------------ccccCceeeCccccchhHhhcC-CCCcccceeehHHHHHH
Confidence 99999999999999999986432210 1123456799999999999765 67999999999999999
Q ss_pred HHhCCc-cCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhh
Q 003278 328 VVSGRR-AVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVS 406 (834)
Q Consensus 328 lltG~~-p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~ 406 (834)
|+||.. |+....... .+......+......+ .. ...+.+++..||+.||++||||.||+++|+
T Consensus 229 llt~~~~p~~~~~~~~------~~~~~~~~~~~~~~~~------~~----~~~l~~li~~cl~~dP~~Rpt~~eil~~L~ 292 (299)
T d1ywna1 229 IFSLGASPYPGVKIDE------EFCRRLKEGTRMRAPD------YT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLG 292 (299)
T ss_dssp HHTTSCCSSTTCCCSH------HHHHHHHHTCCCCCCT------TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHhCCCCCCCCCCHHH------HHHHHHhcCCCCCCCc------cC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 999754 564332221 1222222332222111 11 235789999999999999999999999987
Q ss_pred cC
Q 003278 407 GS 408 (834)
Q Consensus 407 ~~ 408 (834)
.+
T Consensus 293 ~i 294 (299)
T d1ywna1 293 NL 294 (299)
T ss_dssp HH
T ss_pred HH
Confidence 54
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=7.6e-47 Score=401.03 Aligned_cols=259 Identities=26% Similarity=0.366 Sum_probs=200.0
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc---ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCC----EE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK---GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHED----QL 183 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~----~~ 183 (834)
++|+..+.||+|+||+||+|++..+|+.||||+++.. +....+.|.+|+.+|++++|||||++++++...+ .+
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 5699999999999999999999999999999998653 2344567999999999999999999999998754 38
Q ss_pred EEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeecc
Q 003278 184 LLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFG 263 (834)
Q Consensus 184 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFG 263 (834)
|||||||++|+|..++... .++++.++..|+.||+.||+|||+. +||||||||+|||++.++..+|+|||
T Consensus 87 ~lvmE~~~g~~L~~~~~~~-------~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~ 156 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTE-------GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFG 156 (277)
T ss_dssp EEEEECCCEEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCT
T ss_pred EEEEECCCCCEehhhhccc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhh
Confidence 9999999999999888543 4689999999999999999999985 99999999999999999999999999
Q ss_pred chhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCcc
Q 003278 264 LARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQ 343 (834)
Q Consensus 264 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~ 343 (834)
+++....... ........+||+.|||||.+... .++.++|||||||++|||+||+.||.....
T Consensus 157 ~~~~~~~~~~-------------~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~--- 219 (277)
T d1o6ya_ 157 IARAIADSGN-------------SVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSP--- 219 (277)
T ss_dssp TCEECC-----------------------------TTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---
T ss_pred hhhhhccccc-------------cccccccccCcccccCHHHHcCC-CCCcceecccchHHHHHHHhCCCCCCCcCH---
Confidence 9875432211 01123556799999999998654 679999999999999999999999864321
Q ss_pred chHHHHHHHHhhcCccc-cccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCC-chhhHHHHhhcC
Q 003278 344 IILLDWIRRLSDEGKVL-QAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRP-SMKWVIEAVSGS 408 (834)
Q Consensus 344 ~~l~~~~~~~~~~~~~~-~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-sm~~V~~~l~~~ 408 (834)
..........+... ....+.+ + ..+.++...||+.||.+|| ++.++.+.|..+
T Consensus 220 ---~~~~~~~~~~~~~~~~~~~~~~-----s----~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 220 ---VSVAYQHVREDPIPPSARHEGL-----S----ADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp ---HHHHHHHHHCCCCCGGGTSSSC-----C----HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ---HHHHHHHHhcCCCCCchhccCC-----C----HHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 11122222222111 1111111 1 4578899999999999999 899999888654
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-47 Score=410.95 Aligned_cols=263 Identities=21% Similarity=0.300 Sum_probs=207.4
Q ss_pred hCcCcCCcccccCCcEEEEEEEC------CCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLD------NHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEML 586 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~ 586 (834)
++|.-.++||+|+||+||+|.+. +++.||||+++..........|.+|++++++++|||||+++|+|...+..+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 45666788999999999999863 257899999986666666678999999999999999999999999999999
Q ss_pred EEEeccCCCchhhhhhcCCC----CCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEee
Q 003278 587 VIYDYSATRILSHLLFHNNH----RIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGS 662 (834)
Q Consensus 587 lv~Ey~~~g~L~~~l~~~~~----~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~D 662 (834)
+||||+++|+|.+++..... ......++|..++.|+.|+|+||.|||+ .+|+||||||+|||||+++.+||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEEee
Confidence 99999999999998865321 1112347899999999999999999997 6899999999999999999999999
Q ss_pred eeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHH
Q 003278 663 FALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEF 742 (834)
Q Consensus 663 fGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~ 742 (834)
||+|+.+..... ........||+.|||||.+.++.++.++|||||||+||||+||..|+............+..
T Consensus 177 FGla~~~~~~~~-----~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~- 250 (308)
T d1p4oa_ 177 FGMTRDIYETDY-----YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME- 250 (308)
T ss_dssp TTCCCGGGGGGC-----EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT-
T ss_pred cccceeccCCcc-----eeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh-
Confidence 999987644321 11123457899999999999999999999999999999999996544333333332222211
Q ss_pred HhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccC
Q 003278 743 EARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGN 797 (834)
Q Consensus 743 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~ 797 (834)
... .. ..... ++ .+.+++.+||+.||++||||.+|++.|+..
T Consensus 251 --~~~--~~-----~p~~~-~~---~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 251 --GGL--LD-----KPDNC-PD---MLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp --TCC--CC-----CCTTC-CH---HHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred --CCC--CC-----Ccccc-hH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 111 11 11112 22 456677799999999999999999999765
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.2e-46 Score=398.39 Aligned_cols=252 Identities=23% Similarity=0.393 Sum_probs=202.8
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC---------hhhHHHHHHHHHHHHhCC-CCceeeEeeeEEeC
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---------ERFEKTFAAELVAVAHLR-HRNLVRLRGWCVHE 180 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---------~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~ 180 (834)
++|+..+.||+|+||+||+|+...+|+.||||++.... ....+.+.+|+.+|++++ |||||++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 57888999999999999999999999999999986532 123456889999999997 99999999999999
Q ss_pred CEEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEe
Q 003278 181 DQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLG 260 (834)
Q Consensus 181 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~ 260 (834)
+.+|||||||++|+|.++|... .++++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~-------~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~ 152 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK-------VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLT 152 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred cceEEEEEcCCCchHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEc
Confidence 9999999999999999999643 4689999999999999999999985 99999999999999999999999
Q ss_pred eccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCcccccc-----CCCCCcccceeehhhHHHHHHhCCccC
Q 003278 261 DFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQK-----GSVATAKSDVFSFGIVVLEVVSGRRAV 335 (834)
Q Consensus 261 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-----~~~~~~ksDV~SfGvvl~ElltG~~p~ 335 (834)
|||+++.+... ...+...||+.|+|||.+.. ...++.++||||+||+||||+||+.||
T Consensus 153 DFG~a~~~~~~-----------------~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf 215 (277)
T d1phka_ 153 DFGFSCQLDPG-----------------EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 215 (277)
T ss_dssp CCTTCEECCTT-----------------CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred cchheeEccCC-----------------CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCC
Confidence 99999865321 01344679999999998852 334688999999999999999999999
Q ss_pred CCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 336 DLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 336 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
..... .... .... .+... ...+.. ... .+.+.+++..||+.||.+||++.||++
T Consensus 216 ~~~~~---~~~~---~~i~-~~~~~-~~~~~~--~~~----s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 216 WHRKQ---MLML---RMIM-SGNYQ-FGSPEW--DDY----SDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp CCSSH---HHHH---HHHH-HTCCC-CCTTTG--GGS----CHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCCCH---HHHH---HHHH-hCCCC-CCCccc--ccC----CHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 74321 1111 1111 12111 011110 011 146789999999999999999999875
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.9e-47 Score=407.49 Aligned_cols=245 Identities=23% Similarity=0.356 Sum_probs=200.6
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc---ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK---GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 187 (834)
++|+..+.||+|+||+||+|+.+.+|+.||||++... .....+.+.+|+.+|++++|||||++++++.+.+.+|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 4688999999999999999999999999999998643 2234577999999999999999999999999999999999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
|||++|+|..++... ..+++.....++.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+.
T Consensus 84 E~~~gg~l~~~~~~~-------~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~ 153 (316)
T d1fota_ 84 DYIEGGELFSLLRKS-------QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKY 153 (316)
T ss_dssp CCCCSCBHHHHHHHT-------SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred eecCCcccccccccc-------ccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceE
Confidence 999999999988654 4578889999999999999999986 999999999999999999999999999986
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHH
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILL 347 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~ 347 (834)
+.. ..++.+||+.|||||.+... .++.++|||||||++|||+||+.||.... ..
T Consensus 154 ~~~-------------------~~~~~~Gt~~Y~APE~l~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~---~~--- 207 (316)
T d1fota_ 154 VPD-------------------VTYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSN---TM--- 207 (316)
T ss_dssp CSS-------------------CBCCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSS---HH---
T ss_pred ecc-------------------ccccccCcccccCHHHHcCC-CCCchhhccccchhHHHHHhCCCCCCCcC---HH---
Confidence 421 13456799999999998644 67999999999999999999999996422 11
Q ss_pred HHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----chhhHHH
Q 003278 348 DWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRP-----SMKWVIE 403 (834)
Q Consensus 348 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~~V~~ 403 (834)
........ +.. .+. ...+ ..+.++...||+.||.+|| ++.++++
T Consensus 208 ~~~~~i~~-~~~------~~p-~~~s----~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 208 KTYEKILN-AEL------RFP-PFFN----EDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp HHHHHHHH-CCC------CCC-TTSC----HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHHHHHc-CCC------CCC-CCCC----HHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 11122211 111 110 1111 3577899999999999996 7777765
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-47 Score=409.77 Aligned_cols=249 Identities=26% Similarity=0.310 Sum_probs=202.3
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc---ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK---GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLV 186 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 186 (834)
.++|+..+.||+|+||+||+|+.+.+|+.||||++.+. .....+.+.+|+.+|++++|||||++++++.+.+.+|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 46799999999999999999999999999999998653 223456789999999999999999999999999999999
Q ss_pred EEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchh
Q 003278 187 YDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLAR 266 (834)
Q Consensus 187 ~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~ 266 (834)
||||++|+|..++... ..+++.....++.|++.||+|||++ +||||||||+|||++.++.+||+|||+|+
T Consensus 84 ~ey~~gg~L~~~~~~~-------~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~ 153 (337)
T d1o6la_ 84 MEYANGGELFFHLSRE-------RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK 153 (337)
T ss_dssp EECCTTCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred eeccCCCchhhhhhcc-------cCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccccc
Confidence 9999999999998653 4688899999999999999999996 99999999999999999999999999998
Q ss_pred hhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchH
Q 003278 267 WLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIIL 346 (834)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l 346 (834)
...... ......+||+.|||||++... .++.++|||||||++|||+||+.||..... ..+
T Consensus 154 ~~~~~~----------------~~~~~~~GT~~Y~aPE~~~~~-~y~~~~DiwSlGvilyeml~G~~pf~~~~~---~~~ 213 (337)
T d1o6la_ 154 EGISDG----------------ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERL 213 (337)
T ss_dssp CSCCTT----------------CCBCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHH
T ss_pred ccccCC----------------cccccceeCHHHhhhhhccCC-CCChhhcccchhhHHHHHHHCCCCCCCcCH---HHH
Confidence 542210 113457899999999988654 679999999999999999999999864321 112
Q ss_pred HHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCc-----hhhHHH
Q 003278 347 LDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPS-----MKWVIE 403 (834)
Q Consensus 347 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----m~~V~~ 403 (834)
. .... .+.. .+. ...+ ..+.+|+..||+.||.+||+ ..++++
T Consensus 214 ~---~~i~-~~~~------~~p-~~~s----~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 214 F---ELIL-MEEI------RFP-RTLS----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp H---HHHH-HCCC------CCC-TTSC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred H---HHHh-cCCC------CCC-ccCC----HHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 1 1111 1111 111 1122 34678999999999999996 555554
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-47 Score=407.44 Aligned_cols=264 Identities=23% Similarity=0.290 Sum_probs=207.3
Q ss_pred hCcCcCCcccccCCcEEEEEEE------CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhc-cCCCceeEEEEEeeCCeE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL------DNHQYVLVKRLGMSKCPALRTRFSNELQNLARL-RHRNLVQLCGWCTEQGEM 585 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l-~HpNiv~l~g~~~~~~~~ 585 (834)
++|.-.+.||+|+||.||+|.+ .++..||||+++..........|.+|+.+++++ +|||||+++|+|.+.+..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 3455567899999999999986 345689999998777667777899999999999 699999999999999999
Q ss_pred EEEEeccCCCchhhhhhcCCCC------------CCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeec
Q 003278 586 LVIYDYSATRILSHLLFHNNHR------------IGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLD 653 (834)
Q Consensus 586 ~lv~Ey~~~g~L~~~l~~~~~~------------~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld 653 (834)
++|||||++|+|..++...... .....+++..++.++.|||.||+|||+ ++||||||||+|||++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccccccccccc
Confidence 9999999999999998764321 112358999999999999999999997 6899999999999999
Q ss_pred CCCCceEeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCch
Q 003278 654 PDMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEG 733 (834)
Q Consensus 654 ~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~ 733 (834)
.++.+|++|||+++....... ........||+.|||||++.++.++.++|||||||++|||+|++.|+....+..
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~ 254 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSN-----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTT-----SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred ccCcccccccchheeccCCCc-----ceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999987643321 111234689999999999999999999999999999999999655554333332
Q ss_pred hHHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccC
Q 003278 734 LLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGN 797 (834)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~ 797 (834)
..+..... ...++. .. ...++ .+.+|+.+||+.||++||||.+|+++|+..
T Consensus 255 ~~~~~~i~--~~~~~~-------~~-~~~~~---~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 255 SKFYKMIK--EGFRML-------SP-EHAPA---EMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp HHHHHHHH--HTCCCC-------CC-TTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHh--cCCCCC-------Cc-ccccH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 22222211 111111 11 11223 355666799999999999999999999753
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=405.49 Aligned_cols=256 Identities=20% Similarity=0.294 Sum_probs=189.9
Q ss_pred hCcCcCCcccccCCcEEEEEEECC--C--cEEEEEEecCCC--ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDN--H--QYVLVKRLGMSK--CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEML 586 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~--~--~~vavK~~~~~~--~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~ 586 (834)
++|.-.+.||+|+||.||+|.+.. + ..||||.++... .....++|.+|+.+|++++|||||+++|+|.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 356667889999999999998632 2 368999886542 34455789999999999999999999999976 4678
Q ss_pred EEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeec
Q 003278 587 VIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALA 666 (834)
Q Consensus 587 lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla 666 (834)
+||||+++|++.+++.... ..++|..+++++.|+|.||.|||+ ++|+||||||+||||+.++.+||+|||++
T Consensus 87 lv~e~~~~~~l~~~~~~~~-----~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~ 158 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ-----GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLM 158 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG-----GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred eeeeeecCcchhhhhhccc-----CCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhh
Confidence 9999999999998876542 248999999999999999999997 68999999999999999999999999999
Q ss_pred cccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCchhHHHHHHHHHhh
Q 003278 667 EFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEGLLVKRVHEFEAR 745 (834)
Q Consensus 667 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~~~~~~~~~~~~~ 745 (834)
+.+..... .........||..|||||++.+..++.++|||||||++|||+| |+.||....... ....+. ..
T Consensus 159 ~~~~~~~~----~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~-~~~~i~---~~ 230 (273)
T d1u46a_ 159 RALPQNDD----HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ-ILHKID---KE 230 (273)
T ss_dssp EECCC-CC----EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHHHHH---TS
T ss_pred hhcccCCC----cceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH-HHHHHH---hC
Confidence 87644321 1122334578899999999999999999999999999999998 898886433222 222211 11
Q ss_pred cCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHc
Q 003278 746 KRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILD 795 (834)
Q Consensus 746 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~ 795 (834)
... +......+ .+ +.+++.+||+.||++||||.+|++.|.
T Consensus 231 --~~~----~~~~~~~~-~~---l~~li~~cl~~dp~~RPt~~ei~~~L~ 270 (273)
T d1u46a_ 231 --GER----LPRPEDCP-QD---IYNVMVQCWAHKPEDRPTFVALRDFLL 270 (273)
T ss_dssp --CCC----CCCCTTCC-HH---HHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred --CCC----CCCccccc-HH---HHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 100 01111222 33 456666999999999999999999885
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-46 Score=402.83 Aligned_cols=262 Identities=18% Similarity=0.220 Sum_probs=193.8
Q ss_pred CCcccccCCcEEEEEEECCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCC----eEEEEEeccC
Q 003278 518 SQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQG----EMLVIYDYSA 593 (834)
Q Consensus 518 ~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~----~~~lv~Ey~~ 593 (834)
.++||+|+||.||+|.+ +|+.||||.++... .....+..|+..+.+++|||||+++|+|.+.+ .+++|||||+
T Consensus 8 ~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~--~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~ 84 (303)
T d1vjya_ 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE 84 (303)
T ss_dssp EEEEECCSSSEEEEEEE-TTEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCT
T ss_pred EEEEeeCCCeEEEEEEE-CCEEEEEEEECccc--hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEeccc
Confidence 45799999999999997 46789999986432 22222345666667899999999999998654 6899999999
Q ss_pred CCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhcc-----CCceeecccccCceeecCCCCceEeeeeeccc
Q 003278 594 TRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEW-----NEQVIHRNITSSAITLDPDMNPRLGSFALAEF 668 (834)
Q Consensus 594 ~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~-----~~~iiHrDlK~~NILld~~~~~ki~DfGla~~ 668 (834)
+|+|..+|... .++|..+++++.|+|.||+|||+.. .++||||||||+|||||+++.+||+|||+++.
T Consensus 85 ~g~L~~~l~~~-------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 85 HGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp TCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 99999999753 3889999999999999999999631 36999999999999999999999999999987
Q ss_pred cccCCCCCcccccCccccccccCccchhccccC------CCCccCcchhhHHHHHHHHhCCCccCCCCCc----------
Q 003278 669 LTRNDHGHRKATSGNRSVRGIFGYMSPEYIESG------EATSMADVYSFGVVVLEVVTGQMAVDFRLPE---------- 732 (834)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~------~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~---------- 732 (834)
...... ..........||+.|||||++.+. .++.++|||||||+||||+||..|+......
T Consensus 158 ~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 158 HDSATD---TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp EETTTT---EECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred ccCCCc---ceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 654321 111123356899999999998754 3678999999999999999998776432111
Q ss_pred hhHHHHHHHHHhhcCccccccccccCCCC-CHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccC
Q 003278 733 GLLVKRVHEFEARKRPLAELVDLSLNGEY-NHKELMRLIKLGIACTLSNPELRPSMRQILSILDGN 797 (834)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~ 797 (834)
............ ....++.+.... ..+....+.+++.+||+.||++||||.||++.|+.+
T Consensus 235 ~~~~~~~~~~~~-----~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 235 DPSVEEMRKVVC-----EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp SCCHHHHHHHHT-----TSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred cchHHHHHHHHh-----ccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 011111111111 111122222221 223445677888999999999999999999998754
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-47 Score=410.19 Aligned_cols=266 Identities=25% Similarity=0.396 Sum_probs=209.6
Q ss_pred hhcCCCCCCCeeeccCCeEEEEEEEC-----CCCeEEEEEEeccc-ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCC
Q 003278 108 IGSNGFDEDEVLGSGGFGKVYRAVLP-----SDGTVVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHED 181 (834)
Q Consensus 108 ~~t~~f~~~~~LG~G~fG~Vy~~~~~-----~~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~ 181 (834)
+..++|...+.||+|+||+||+|.+. .+++.||||+++.. .......|.+|+.++++++|||||+++|+|..++
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 96 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 96 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence 34467888899999999999999874 23678999999754 3444567999999999999999999999999999
Q ss_pred EEEEEEEccCCCCHhHHHhcCCCcc---ccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceE
Q 003278 182 QLLLVYDYMPNRSLDRVLFRRPENL---EAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNAR 258 (834)
Q Consensus 182 ~~~lV~Ey~~~gsL~~~l~~~~~~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~k 258 (834)
..++|||||++|+|.+++....... .....++|..+.+|+.|+|+||.|||+. +|+||||||+|||+|+++++|
T Consensus 97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~K 173 (308)
T d1p4oa_ 97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK 173 (308)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEE
T ss_pred ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEE
Confidence 9999999999999999986542111 1234679999999999999999999995 999999999999999999999
Q ss_pred EeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCC-ccCCC
Q 003278 259 LGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR-RAVDL 337 (834)
Q Consensus 259 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~-~p~~~ 337 (834)
|+|||+|+.+..... ....+...||+.|+|||.+..+ .++.++|||||||++|||+||+ .|+..
T Consensus 174 l~DFGla~~~~~~~~--------------~~~~~~~~~t~~y~aPe~l~~~-~~~~~~Dv~S~G~il~El~t~~~~p~~~ 238 (308)
T d1p4oa_ 174 IGDFGMTRDIYETDY--------------YRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQG 238 (308)
T ss_dssp ECCTTCCCGGGGGGC--------------EEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTTTT
T ss_pred EeecccceeccCCcc--------------eeeccceecccccCCHHHHccC-CCCcccccccHHHHHHHHHhCCCCCCCC
Confidence 999999987643311 0113445699999999998766 6789999999999999999996 44432
Q ss_pred CCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 338 TYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 338 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
. ....+...+. .+......+ .. ...+.+|+..||+.||++||||.+|++.|+..
T Consensus 239 ~------~~~~~~~~i~-~~~~~~~p~------~~----~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 239 L------SNEQVLRFVM-EGGLLDKPD------NC----PDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp S------CHHHHHHHHH-TTCCCCCCT------TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred C------CHHHHHHHHH-hCCCCCCcc------cc----hHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 1 1112222222 233222211 11 14688999999999999999999999999875
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-47 Score=409.00 Aligned_cols=261 Identities=28% Similarity=0.409 Sum_probs=202.3
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCe--EEEEEEeccc-ChhhHHHHHHHHHHHHhC-CCCceeeEeeeEEeCCEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGT--VVAVKCLAEK-GERFEKTFAAELVAVAHL-RHRNLVRLRGWCVHEDQLLLV 186 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~--~vAvK~l~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV 186 (834)
++|+..++||+|+||+||+|+++.+|. .||||++... .....+.|.+|+.+|+++ +|||||+++|+|.+.+.+++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 568888999999999999999987776 4778887543 333456799999999998 799999999999999999999
Q ss_pred EEccCCCCHhHHHhcCCCc---------cccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCce
Q 003278 187 YDYMPNRSLDRVLFRRPEN---------LEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNA 257 (834)
Q Consensus 187 ~Ey~~~gsL~~~l~~~~~~---------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~ 257 (834)
|||+++|+|.++|+..... ......++|..+..++.|||.||.|||+. +||||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 9999999999999764210 12246799999999999999999999995 99999999999999999999
Q ss_pred EEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCc-cCC
Q 003278 258 RLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRR-AVD 336 (834)
Q Consensus 258 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~-p~~ 336 (834)
||+|||+|+..... .......||+.|+|||.+..+ .++.++|||||||++|||+||.. |+.
T Consensus 167 kl~DfG~a~~~~~~-----------------~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSfGvil~ell~~~~~p~~ 228 (309)
T d1fvra_ 167 KIADFGLSRGQEVY-----------------VKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYC 228 (309)
T ss_dssp EECCTTCEESSCEE-----------------CCC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred EEcccccccccccc-----------------ccccceecCCcccchHHhccC-CCCccceeehhHHHHHHHHhcCCCCCC
Confidence 99999999753211 112345699999999999766 67999999999999999999865 453
Q ss_pred CCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcCC
Q 003278 337 LTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGSY 409 (834)
Q Consensus 337 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~~ 409 (834)
.. ....+. .. ..++.... . +....+.+.+|+..||+.||++||||.+|++.|+...
T Consensus 229 ~~---~~~~~~---~~-i~~~~~~~-----~-----~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 229 GM---TCAELY---EK-LPQGYRLE-----K-----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp TC---CHHHHH---HH-GGGTCCCC-----C-----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CC---CHHHHH---HH-HHhcCCCC-----C-----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 22 111111 11 12222111 1 1111246889999999999999999999999987754
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-47 Score=407.47 Aligned_cols=268 Identities=25% Similarity=0.359 Sum_probs=209.1
Q ss_pred hhcCCCCCCCeeeccCCeEEEEEEEC-----CCCeEEEEEEeccc-ChhhHHHHHHHHHHHHhC-CCCceeeEeeeEEeC
Q 003278 108 IGSNGFDEDEVLGSGGFGKVYRAVLP-----SDGTVVAVKCLAEK-GERFEKTFAAELVAVAHL-RHRNLVRLRGWCVHE 180 (834)
Q Consensus 108 ~~t~~f~~~~~LG~G~fG~Vy~~~~~-----~~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~ 180 (834)
+..++|+..++||+|+||.||+|++. .+++.||||+++.. .......|.+|+.+++++ +|||||+++|+|.+.
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 44567888999999999999999863 46789999999754 334556799999999999 699999999999999
Q ss_pred CEEEEEEEccCCCCHhHHHhcCCCc-----------cccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCce
Q 003278 181 DQLLLVYDYMPNRSLDRVLFRRPEN-----------LEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNV 249 (834)
Q Consensus 181 ~~~~lV~Ey~~~gsL~~~l~~~~~~-----------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NI 249 (834)
+..++|||||++|+|..+|+..... ......++|..++.|+.|||+||+|||++ +||||||||+||
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NI 176 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNI 176 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccc
Confidence 9999999999999999999765321 12234699999999999999999999996 999999999999
Q ss_pred EECCCCceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHH
Q 003278 250 MLDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVV 329 (834)
Q Consensus 250 Lld~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ell 329 (834)
|++.++.+|++|||+++........ ...+...||+.|+|||.+..+ .++.++|||||||++|||+
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~--------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwS~G~~l~ell 241 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNY--------------VVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELF 241 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTS--------------EECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHH
T ss_pred cccccCcccccccchheeccCCCcc--------------eEeeecccChHHcCHHHhcCC-CCCCcccccchHHHHHHHH
Confidence 9999999999999999865432110 113456799999999999765 6799999999999999999
Q ss_pred hCCccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 330 SGRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 330 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
|++.|+........ .+.. +...+...... .. ....+.+|+..||+.||.+||||.+|+++|+..
T Consensus 242 t~g~p~~~~~~~~~-~~~~----~i~~~~~~~~~------~~----~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 242 SLGSSPYPGMPVDS-KFYK----MIKEGFRMLSP------EH----APAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp TTTCCSSTTCCSSH-HHHH----HHHHTCCCCCC------TT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hCCCCCCCCCCHHH-HHHH----HHhcCCCCCCc------cc----ccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 95555433222211 1222 22222211110 11 124688999999999999999999999999753
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-47 Score=401.37 Aligned_cols=257 Identities=26% Similarity=0.393 Sum_probs=193.2
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCC-C--eEEEEEEeccc---ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSD-G--TVVAVKCLAEK---GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLL 184 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~-g--~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 184 (834)
++|+..+.||+|+||+||+|++..+ + ..||||++... .....+.|.+|+.+|++++|||||+++|+|.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 5688899999999999999986432 2 47999998643 33456789999999999999999999999975 4678
Q ss_pred EEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccc
Q 003278 185 LVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGL 264 (834)
Q Consensus 185 lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGl 264 (834)
+|||||++|+|.+++... ..+++|..++.++.|+|+||.|||+. +|+||||||+||||+.++.+||+|||+
T Consensus 87 lv~e~~~~~~l~~~~~~~------~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl 157 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH------QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGL 157 (273)
T ss_dssp EEEECCTTCBHHHHHHHH------GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred eeeeeecCcchhhhhhcc------cCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchh
Confidence 999999999999887653 24589999999999999999999995 999999999999999999999999999
Q ss_pred hhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh-CCccCCCCCCCcc
Q 003278 265 ARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS-GRRAVDLTYPDDQ 343 (834)
Q Consensus 265 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~ 343 (834)
++.+..... .....+...||+.|+|||.+... .++.++|||||||++|||+| |+.||.... .
T Consensus 158 ~~~~~~~~~-------------~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~---~ 220 (273)
T d1u46a_ 158 MRALPQNDD-------------HYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLN---G 220 (273)
T ss_dssp CEECCC-CC-------------EEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCC---H
T ss_pred hhhcccCCC-------------cceecCccccCcccCCHHHHhCC-CCCcchhhhhhHHHHHHHHhCCCCCCCCcC---H
Confidence 986533211 01123445689999999999765 67999999999999999998 899986321 1
Q ss_pred chHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhc
Q 003278 344 IILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSG 407 (834)
Q Consensus 344 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~ 407 (834)
..+. ..+...+...... ...+ ..+.+|+..||+.||++||||.+|++.|..
T Consensus 221 ~~~~---~~i~~~~~~~~~~------~~~~----~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 221 SQIL---HKIDKEGERLPRP------EDCP----QDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp HHHH---HHHHTSCCCCCCC------TTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHH---HHHHhCCCCCCCc------cccc----HHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 1122 2222332222111 1111 358899999999999999999999998864
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2e-46 Score=409.60 Aligned_cols=251 Identities=16% Similarity=0.246 Sum_probs=200.8
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
++|...+.||+|+||.||+|.. .+|+.||||++.... ....+.|.+|+.+|++++|||||++++++.+.+..++||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc-hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4677788999999999999996 568899999987543 33457799999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeec--CCCCceEeeeeecccc
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLD--PDMNPRLGSFALAEFL 669 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld--~~~~~ki~DfGla~~~ 669 (834)
|++|+|.+++.... ..+++.....|+.||+.||+|||+ .+||||||||+||||+ .++.+||+|||+|+.+
T Consensus 105 ~~gg~L~~~l~~~~-----~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~ 176 (350)
T d1koaa2 105 MSGGELFEKVADEH-----NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176 (350)
T ss_dssp CCSCBHHHHHTCTT-----SCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred CCCCCHHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence 99999999886432 248999999999999999999997 6999999999999996 4678999999999875
Q ss_pred ccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcc
Q 003278 670 TRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPL 749 (834)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
.... ...+..||+.|||||++.+..|+.++|||||||++|||+||+.||....... ....+.. .....
T Consensus 177 ~~~~--------~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~~~~i~~---~~~~~ 244 (350)
T d1koaa2 177 DPKQ--------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-TLRNVKS---CDWNM 244 (350)
T ss_dssp CTTS--------CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHH---TCCCS
T ss_pred cccc--------ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH-HHHHHHh---CCCCC
Confidence 4321 1235689999999999999999999999999999999999999997543322 2222211 11111
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 750 AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 750 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
.. ...... .++ +..++.+||+.||++|||++|+++
T Consensus 245 ~~----~~~~~~-s~~---~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 245 DD----SAFSGI-SED---GKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp CC----GGGGGC-CHH---HHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred Cc----ccccCC-CHH---HHHHHHHHccCChhHCcCHHHHhc
Confidence 11 000111 133 445556999999999999999987
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=401.57 Aligned_cols=251 Identities=15% Similarity=0.200 Sum_probs=199.6
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCC-----hhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKC-----PALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEML 586 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~ 586 (834)
+.|...+.||+|+||+||+|.. .+|+.||||++..... ....+.|.+|+.+|++++|||||++++++.+.+..+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 4577778899999999999996 5689999999864321 224678999999999999999999999999999999
Q ss_pred EEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCC----CceEee
Q 003278 587 VIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDM----NPRLGS 662 (834)
Q Consensus 587 lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~----~~ki~D 662 (834)
||||||++|+|.+++...+ .+++.....++.|++.||+|||+ .+||||||||+|||++.++ .+|++|
T Consensus 90 iv~E~~~gg~L~~~i~~~~------~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~D 160 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKE------SLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIID 160 (293)
T ss_dssp EEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECC
T ss_pred EEEEcCCCccccchhcccc------ccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecc
Confidence 9999999999999987542 48899999999999999999997 6999999999999999776 489999
Q ss_pred eeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHH
Q 003278 663 FALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEF 742 (834)
Q Consensus 663 fGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~ 742 (834)
||+|+.+.... ...+..||+.|||||++.+..++.++|||||||+||||+||+.||....... ....+.
T Consensus 161 fG~a~~~~~~~--------~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-~~~~i~-- 229 (293)
T d1jksa_ 161 FGLAHKIDFGN--------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TLANVS-- 229 (293)
T ss_dssp CTTCEECTTSC--------BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHH--
T ss_pred hhhhhhcCCCc--------cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH-HHHHHH--
Confidence 99998754321 1234679999999999999999999999999999999999999997543322 112111
Q ss_pred HhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 743 EARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 743 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
.......... .... +.+ +.+++.+||+.||++|||++||++
T Consensus 230 -~~~~~~~~~~----~~~~-s~~---~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 230 -AVNYEFEDEY----FSNT-SAL---AKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp -TTCCCCCHHH----HTTS-CHH---HHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -hcCCCCCchh----cCCC-CHH---HHHHHHHHccCChhHCcCHHHHhc
Confidence 1111111100 0111 123 445556999999999999999975
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-46 Score=402.36 Aligned_cols=261 Identities=22% Similarity=0.290 Sum_probs=201.2
Q ss_pred CcCcCCcccccCCcEEEEEEECC--------CcEEEEEEecCCCChhHHHHHHHHHHHHHhc-cCCCceeEEEEEeeCCe
Q 003278 514 NFSESQRVAEMDFGTAYQGFLDN--------HQYVLVKRLGMSKCPALRTRFSNELQNLARL-RHRNLVQLCGWCTEQGE 584 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~~~--------~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l-~HpNiv~l~g~~~~~~~ 584 (834)
+|.-.+.||+|+||.||+|.... +..||||+++.+.......+|.+|+..+.++ +|||||+++|+|.+.+.
T Consensus 14 ~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~ 93 (299)
T d1fgka_ 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP 93 (299)
T ss_dssp GEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCe
Confidence 45556789999999999998522 3579999998777666677899999999999 89999999999999999
Q ss_pred EEEEEeccCCCchhhhhhcCCCC----------CCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecC
Q 003278 585 MLVIYDYSATRILSHLLFHNNHR----------IGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDP 654 (834)
Q Consensus 585 ~~lv~Ey~~~g~L~~~l~~~~~~----------~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~ 654 (834)
.++||||+.+|+|.+++...... .....++|..++.++.|+|.||+|||+ .+||||||||+|||++.
T Consensus 94 ~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl~~ 170 (299)
T d1fgka_ 94 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTE 170 (299)
T ss_dssp CEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECT
T ss_pred EEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceeecC
Confidence 99999999999999999765321 112358999999999999999999997 69999999999999999
Q ss_pred CCCceEeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHh-CCCccCCCCCch
Q 003278 655 DMNPRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVT-GQMAVDFRLPEG 733 (834)
Q Consensus 655 ~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~t-G~~p~~~~~~~~ 733 (834)
++.+||+|||+++....... ........||+.|||||++.++.|+.++||||||||+|||+| |..|+... +..
T Consensus 171 ~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~-~~~ 244 (299)
T d1fgka_ 171 DNVMKIADFGLARDIHHIDY-----YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVE 244 (299)
T ss_dssp TCCEEECSTTCCCCGGGCCT-----TCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-CHH
T ss_pred CCCeEeccchhhcccccccc-----ccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCC-CHH
Confidence 99999999999987654321 112334679999999999999999999999999999999999 56666433 222
Q ss_pred hHHHHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccC
Q 003278 734 LLVKRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGN 797 (834)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~ 797 (834)
.+...+. ...++ ..+... ++ .+.+++.+||+.||++||||.||++.|+.+
T Consensus 245 ~~~~~i~---~~~~~-------~~p~~~-~~---~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 245 ELFKLLK---EGHRM-------DKPSNC-TN---ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp HHHHHHH---TTCCC-------CCCSSC-CH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHH---cCCCC-------CCCccc-hH---HHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 2222221 11111 111122 23 355667799999999999999999999754
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-46 Score=401.21 Aligned_cols=259 Identities=23% Similarity=0.236 Sum_probs=195.0
Q ss_pred CCeeeccCCeEEEEEEECCCCeEEEEEEecccCh-----hhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEcc
Q 003278 116 DEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGE-----RFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYM 190 (834)
Q Consensus 116 ~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~-----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 190 (834)
.++||+|+||+||+|+++.+|+.||||+++.... ...+.+.+|+.+|++++|||||++++++.+++..||||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 4689999999999999999999999999864321 12356889999999999999999999999999999999999
Q ss_pred CCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhhhh
Q 003278 191 PNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWLEH 270 (834)
Q Consensus 191 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~~~ 270 (834)
.++++..++.. ...+++..+..|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|+....
T Consensus 83 ~~~~~~~~~~~-------~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~ 152 (299)
T d1ua2a_ 83 ETDLEVIIKDN-------SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 152 (299)
T ss_dssp SEEHHHHHTTC-------CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred cchHHhhhhhc-------ccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCC
Confidence 99887766532 24578889999999999999999996 999999999999999999999999999975432
Q ss_pred hhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHHHH
Q 003278 271 ELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLDWI 350 (834)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~ 350 (834)
.. ......+||+.|||||.+..+..++.++|||||||++|||+||+.||..... ......+
T Consensus 153 ~~----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~---~~~l~~i 213 (299)
T d1ua2a_ 153 PN----------------RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD---LDQLTRI 213 (299)
T ss_dssp CC----------------CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHH
T ss_pred Cc----------------ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH---HHHHHHH
Confidence 11 1123456999999999987776789999999999999999999999864322 1122222
Q ss_pred HHHhhcCcccccccc-------ccC-CCCCCHH-----HHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 351 RRLSDEGKVLQAGDN-------RLS-DGSYKLC-----DMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 351 ~~~~~~~~~~~~~d~-------~l~-~~~~~~~-----~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
.............+. ... ....+.. ..+.+.+|...||+.||++|||+.|+++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 214 FETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp HHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred HHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 222111000000000 000 0000111 1245788999999999999999999986
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.5e-46 Score=405.84 Aligned_cols=245 Identities=22% Similarity=0.298 Sum_probs=201.0
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc---ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK---GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVY 187 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 187 (834)
++|+..+.||+|+||+||+|+++.+|+.||||++... .....+.+.+|+.+|++++|||||++++++.+.+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 4688999999999999999999999999999998643 2234567899999999999999999999999999999999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARW 267 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~ 267 (834)
||+.+|+|..++... ..+++..+..|+.||+.||.|||+. +||||||||+|||++.++.+||+|||+|+.
T Consensus 121 e~~~~g~l~~~l~~~-------~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~ 190 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI-------GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKR 190 (350)
T ss_dssp ECCTTCBHHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred ccccccchhhhHhhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeee
Confidence 999999999998653 3589999999999999999999986 999999999999999999999999999985
Q ss_pred hhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHH
Q 003278 268 LEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILL 347 (834)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~ 347 (834)
+.. ...+..||+.|||||.+.. ..++.++|||||||++|||+||+.||.... ...+
T Consensus 191 ~~~-------------------~~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~---~~~~- 246 (350)
T d1rdqe_ 191 VKG-------------------RTWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQ---PIQI- 246 (350)
T ss_dssp CSS-------------------CBCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHH-
T ss_pred ccc-------------------ccccccCccccCCHHHHcC-CCCCccccccchhHHHHHHHhCCCCCCCcC---HHHH-
Confidence 421 1345679999999999865 467999999999999999999999996421 1111
Q ss_pred HHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----chhhHHH
Q 003278 348 DWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRP-----SMKWVIE 403 (834)
Q Consensus 348 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~~V~~ 403 (834)
...... +.. ... ...+ ..+.+++..||+.||.+|| ++.++++
T Consensus 247 --~~~i~~-~~~------~~p-~~~s----~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 247 --YEKIVS-GKV------RFP-SHFS----SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --HHHHHH-CCC------CCC-TTCC----HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --HHHHhc-CCC------CCC-ccCC----HHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 122211 111 010 1111 3577899999999999994 7788765
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.5e-46 Score=407.22 Aligned_cols=251 Identities=14% Similarity=0.192 Sum_probs=200.7
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
+.|...+.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|+.+|++++|||||++++++.+.+.++|||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4677788999999999999996 568999999987543 33456789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeec--CCCCceEeeeeecccc
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLD--PDMNPRLGSFALAEFL 669 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld--~~~~~ki~DfGla~~~ 669 (834)
|++|+|.+++...+ ..+++.....|+.||+.||+|||+ .+||||||||+||||+ .++.+||+|||+|+.+
T Consensus 108 ~~gg~L~~~~~~~~-----~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~ 179 (352)
T d1koba_ 108 LSGGELFDRIAAED-----YKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 179 (352)
T ss_dssp CCCCBHHHHTTCTT-----CCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred CCCChHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceec
Confidence 99999988775433 248899999999999999999996 6999999999999998 6789999999999876
Q ss_pred ccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcc
Q 003278 670 TRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPL 749 (834)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
.... ...+..||+.|||||++.+..|+.++|||||||+||||+||+.||....... ....+. ......
T Consensus 180 ~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~i~---~~~~~~ 247 (352)
T d1koba_ 180 NPDE--------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-TLQNVK---RCDWEF 247 (352)
T ss_dssp CTTS--------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHH---HCCCCC
T ss_pred CCCC--------ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH---hCCCCC
Confidence 4321 1234679999999999999999999999999999999999999996543322 222211 111111
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 750 AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 750 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
. .......+ .+ +..++.+||+.||++|||+.|+++
T Consensus 248 ~----~~~~~~~s-~~---~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 248 D----EDAFSSVS-PE---AKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp C----SSTTTTSC-HH---HHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred C----cccccCCC-HH---HHHHHHHHccCChhHCcCHHHHhc
Confidence 1 11111122 33 445566999999999999999986
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=398.07 Aligned_cols=251 Identities=20% Similarity=0.274 Sum_probs=202.2
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEEcc
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYDYM 190 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 190 (834)
++|++.+.||+|+||+||+|+++.+|+.||||.++.... ....+.+|+.+|++++|||||++++++.+.+.+|||||||
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 568889999999999999999999999999999976543 3456889999999999999999999999999999999999
Q ss_pred CCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECC--CCceEEeeccchhhh
Q 003278 191 PNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDS--QYNARLGDFGLARWL 268 (834)
Q Consensus 191 ~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~--~~~~kl~DFGla~~~ 268 (834)
++|+|.++|... ...+++.++..|+.||++||+|||+. +|+||||||+|||++. ...+||+|||+++..
T Consensus 84 ~gg~L~~~i~~~------~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~ 154 (321)
T d1tkia_ 84 SGLDIFERINTS------AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp CCCBHHHHHTSS------SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred CCCcHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhcc
Confidence 999999999643 24689999999999999999999985 9999999999999985 457999999999754
Q ss_pred hhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHH
Q 003278 269 EHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLD 348 (834)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~ 348 (834)
... .......||+.|+|||.+... .++.++|||||||++|||+||+.||..... ..+
T Consensus 155 ~~~-----------------~~~~~~~~t~~y~ape~~~~~-~~~~~~DiWSlGvily~ll~G~~Pf~~~~~---~~~-- 211 (321)
T d1tkia_ 155 KPG-----------------DNFRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETN---QQI-- 211 (321)
T ss_dssp CTT-----------------CEEEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSH---HHH--
T ss_pred ccC-----------------CcccccccccccccchhccCC-CCCchhhcccHHHHHHHHHhCCCCCCCCCH---HHH--
Confidence 221 113456799999999988654 679999999999999999999999964321 111
Q ss_pred HHHHHhhcC-ccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 349 WIRRLSDEG-KVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 349 ~~~~~~~~~-~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
........ .......+.+ ...+.++...||+.||.+|||+.|+++.
T Consensus 212 -~~~i~~~~~~~~~~~~~~~---------s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 212 -IENIMNAEYTFDEEAFKEI---------SIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp -HHHHHHTCCCCCHHHHTTS---------CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -HHHHHhCCCCCChhhccCC---------CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 12221111 1111111111 1347789999999999999999999873
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-46 Score=398.93 Aligned_cols=265 Identities=25% Similarity=0.368 Sum_probs=203.2
Q ss_pred hcCCCCCCCeeeccCCeEEEEEEECCC-------CeEEEEEEecccC-hhhHHHHHHHHHHHHhC-CCCceeeEeeeEEe
Q 003278 109 GSNGFDEDEVLGSGGFGKVYRAVLPSD-------GTVVAVKCLAEKG-ERFEKTFAAELVAVAHL-RHRNLVRLRGWCVH 179 (834)
Q Consensus 109 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~-------g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~ 179 (834)
..++|+..+.||+|+||.||+|+...+ +..||||+++... .....++.+|+..+.++ +|||||+++|+|.+
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 345788889999999999999987443 3579999987643 34557889999999888 89999999999999
Q ss_pred CCEEEEEEEccCCCCHhHHHhcCCCc---------cccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceE
Q 003278 180 EDQLLLVYDYMPNRSLDRVLFRRPEN---------LEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVM 250 (834)
Q Consensus 180 ~~~~~lV~Ey~~~gsL~~~l~~~~~~---------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NIL 250 (834)
++..++|||||++|+|.++|..+... ......++|.+++.++.|+|.||+|||+. +||||||||+|||
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiL 167 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL 167 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeeccccee
Confidence 99999999999999999999765321 11235689999999999999999999996 9999999999999
Q ss_pred ECCCCceEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHh
Q 003278 251 LDSQYNARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVS 330 (834)
Q Consensus 251 ld~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~Ellt 330 (834)
++.++.+||+|||+++....... ........||+.|+|||.+..+ .++.|+|||||||++|||+|
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~--------------~~~~~~~~~~~~y~aPE~l~~~-~y~~k~DiwS~Gvvl~ell~ 232 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDY--------------YKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFT 232 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCT--------------TCCCTTSCCGGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHT
T ss_pred ecCCCCeEeccchhhcccccccc--------------ccccccCCCChhhhhhhHhcCC-CCCchhhhHHhHHHHHHhcc
Confidence 99999999999999986543211 0113445699999999999765 68999999999999999998
Q ss_pred -CCccCCCCCCCccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhcC
Q 003278 331 -GRRAVDLTYPDDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSGS 408 (834)
Q Consensus 331 -G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~~ 408 (834)
|+.|+..... ..+. .....+...... ... ...+.+|+.+||+.||.+||||.||++.|+.+
T Consensus 233 ~g~~p~~~~~~---~~~~----~~i~~~~~~~~p------~~~----~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 233 LGGSPYPGVPV---EELF----KLLKEGHRMDKP------SNC----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp TSCCSSTTCCH---HHHH----HHHHTTCCCCCC------SSC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCCH---HHHH----HHHHcCCCCCCC------ccc----hHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 6777653221 1111 222223222111 111 24688999999999999999999999999764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=6.6e-46 Score=393.76 Aligned_cols=259 Identities=20% Similarity=0.279 Sum_probs=195.7
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCC--ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCC----eE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSK--CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQG----EM 585 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~--~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~----~~ 585 (834)
+.|...+.||+|+||+||+|.. .+++.||||.+.... .+....+|.+|+++|++++|||||++++++...+ ..
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 4577778899999999999985 568899999997543 3445678999999999999999999999987643 48
Q ss_pred EEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeee
Q 003278 586 LVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFAL 665 (834)
Q Consensus 586 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGl 665 (834)
+|||||+++|+|..++...+ .+++.....|+.|++.||+|||+ .+||||||||+||||+.++..+++|||+
T Consensus 87 ~lvmE~~~g~~L~~~~~~~~------~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~ 157 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTEG------PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGI 157 (277)
T ss_dssp EEEEECCCEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTT
T ss_pred EEEEECCCCCEehhhhcccC------CCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhh
Confidence 89999999999998886543 48899999999999999999997 6999999999999999999999999999
Q ss_pred ccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhh
Q 003278 666 AEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEAR 745 (834)
Q Consensus 666 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~ 745 (834)
+........ ......+.+||+.|||||++.+..|+.++|||||||+||||+||+.||....+...+...+ .
T Consensus 158 ~~~~~~~~~----~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~----~- 228 (277)
T d1o6ya_ 158 ARAIADSGN----SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV----R- 228 (277)
T ss_dssp CEECC--------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH----H-
T ss_pred hhhhccccc----cccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHH----h-
Confidence 876543221 1122345689999999999999999999999999999999999999997544332222111 1
Q ss_pred cCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCC-ChhHHHHHHcc
Q 003278 746 KRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRP-SMRQILSILDG 796 (834)
Q Consensus 746 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RP-tm~~v~~~L~~ 796 (834)
..+.. +.......+++ +.++..+||+.||++|| |++++.+.|..
T Consensus 229 ~~~~~----~~~~~~~~s~~---l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 229 EDPIP----PSARHEGLSAD---LDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp CCCCC----GGGTSSSCCHH---HHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred cCCCC----CchhccCCCHH---HHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 11110 11111111234 44555699999999999 89999887754
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.4e-45 Score=397.62 Aligned_cols=245 Identities=17% Similarity=0.226 Sum_probs=197.7
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCC--ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSK--CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIY 589 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~--~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~ 589 (834)
++|...+.||+|+||+||+|.. .+|+.||||++.... .....+.|.+|+.+|++++|||||++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 4677788999999999999996 568999999986422 1223467899999999999999999999999999999999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccc
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFL 669 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~ 669 (834)
||+.+|+|..++.... .+++.....++.|++.||+|||+ .+||||||||+||||+.++.+||+|||+|+.+
T Consensus 84 E~~~gg~l~~~~~~~~------~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~ 154 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ------RFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYV 154 (316)
T ss_dssp CCCCSCBHHHHHHHTS------SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred eecCCccccccccccc------cccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEe
Confidence 9999999999887643 36777788899999999999996 69999999999999999999999999999875
Q ss_pred ccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcc
Q 003278 670 TRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPL 749 (834)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
... ..+.+||+.|||||++.+..|+.++|||||||+||||+||+.||....+.. +...+. .....
T Consensus 155 ~~~----------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~i~---~~~~~- 219 (316)
T d1fota_ 155 PDV----------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK-TYEKIL---NAELR- 219 (316)
T ss_dssp SSC----------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHH---HCCCC-
T ss_pred ccc----------cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH-HHHHHH---cCCCC-
Confidence 321 235789999999999999999999999999999999999999997543322 222211 11111
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----ChhHHHH
Q 003278 750 AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRP-----SMRQILS 792 (834)
Q Consensus 750 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RP-----tm~~v~~ 792 (834)
.+...+ ++ +..++.+||+.||.+|| |+++|++
T Consensus 220 -------~p~~~s-~~---~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 220 -------FPPFFN-ED---VKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp -------CCTTSC-HH---HHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -------CCCCCC-HH---HHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 111122 33 34455589999999996 8888875
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-46 Score=403.19 Aligned_cols=248 Identities=20% Similarity=0.287 Sum_probs=198.8
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC---hhhHHHHHHHHHHHH-hCCCCceeeEeeeEEeCCEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG---ERFEKTFAAELVAVA-HLRHRNLVRLRGWCVHEDQLLLV 186 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~-~l~H~nIv~l~g~~~~~~~~~lV 186 (834)
++|+..+.||+|+||+||+|+.+.+|+.||||++.+.. ....+.+..|+.++. .++|||||++++++.+++.+|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57889999999999999999999999999999986431 233455667777665 68999999999999999999999
Q ss_pred EEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchh
Q 003278 187 YDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLAR 266 (834)
Q Consensus 187 ~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~ 266 (834)
||||++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||+++++++||+|||+|+
T Consensus 82 mEy~~~g~L~~~i~~~-------~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~ 151 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC-------HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK 151 (320)
T ss_dssp EECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EeecCCCcHHHHhhcc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhh
Confidence 9999999999999653 3578899999999999999999996 99999999999999999999999999998
Q ss_pred hhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchH
Q 003278 267 WLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIIL 346 (834)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l 346 (834)
...... ...+...||+.|+|||.+... .++.++|||||||++|||+||+.||..... ..+
T Consensus 152 ~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~PF~~~~~---~~~ 211 (320)
T d1xjda_ 152 ENMLGD----------------AKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDE---EEL 211 (320)
T ss_dssp CCCCTT----------------CCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHH
T ss_pred hccccc----------------ccccccCCCCCcCCHHHHcCC-CCCchhhhhhhhHHHHHHHhCCCCCCCCCH---HHH
Confidence 542210 113456799999999999755 679999999999999999999999964321 111
Q ss_pred HHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchh-hHHH
Q 003278 347 LDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMK-WVIE 403 (834)
Q Consensus 347 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~-~V~~ 403 (834)
.. ... .+. +... ...+ ..+.+|...||+.||.+||++. ++++
T Consensus 212 ~~---~i~-~~~------~~~p-~~~s----~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 212 FH---SIR-MDN------PFYP-RWLE----KEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp HH---HHH-HCC------CCCC-TTSC----HHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred HH---HHH-cCC------CCCC-ccCC----HHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 11 111 111 1111 1111 3578899999999999999986 6654
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-46 Score=397.08 Aligned_cols=267 Identities=24% Similarity=0.308 Sum_probs=199.3
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC--hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG--ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYD 188 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 188 (834)
++|+..+.||+|+||+||+|++..+|+.||||++.... +...+.+.+|+.+|++++|||||++++++.+++..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 57999999999999999999999999999999986432 2335678999999999999999999999999999999999
Q ss_pred ccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhh
Q 003278 189 YMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWL 268 (834)
Q Consensus 189 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~ 268 (834)
|+.++.+ .++.... ...+++..+..++.|++.||+|||++ +||||||||+|||++.++.+||+|||+|+..
T Consensus 82 ~~~~~~~-~~~~~~~-----~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~ 152 (298)
T d1gz8a_ 82 FLHQDLK-KFMDASA-----LTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 152 (298)
T ss_dssp CCSEEHH-HHHHHTT-----TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHH
T ss_pred ecCCchh-hhhhhhc-----ccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceec
Confidence 9976544 4443321 34699999999999999999999996 9999999999999999999999999999854
Q ss_pred hhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHH
Q 003278 269 EHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLD 348 (834)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~ 348 (834)
.... .......||+.|+|||.+.....++.++|||||||++|||+||+.||...... ..+..
T Consensus 153 ~~~~----------------~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~--~~~~~ 214 (298)
T d1gz8a_ 153 GVPV----------------RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--DQLFR 214 (298)
T ss_dssp CCCS----------------BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHH
T ss_pred cCCc----------------ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH--HHHHH
Confidence 2210 11334569999999998877767789999999999999999999999643211 11111
Q ss_pred HHHHHhh-cCc----cccccccc--cCC-CCCCHH-----HHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 349 WIRRLSD-EGK----VLQAGDNR--LSD-GSYKLC-----DMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 349 ~~~~~~~-~~~----~~~~~d~~--l~~-~~~~~~-----~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
-...... ... .....+.. ... ...... ....+.++...||+.||.+|||+.|+++.
T Consensus 215 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 215 IFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp HHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 1111100 000 00000000 000 000000 01356789999999999999999999864
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=401.41 Aligned_cols=253 Identities=20% Similarity=0.224 Sum_probs=193.7
Q ss_pred CCCCCC-CeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHh-CCCCceeeEeeeEEe----CCEEE
Q 003278 111 NGFDED-EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAH-LRHRNLVRLRGWCVH----EDQLL 184 (834)
Q Consensus 111 ~~f~~~-~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~-l~H~nIv~l~g~~~~----~~~~~ 184 (834)
++|.+. ++||+|+||+||+|++..+|+.||||+++.. +.+.+|+.++.+ ++|||||+++++|.+ .+.+|
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 568776 4699999999999999999999999998643 456789988665 589999999999876 35689
Q ss_pred EEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECC---CCceEEee
Q 003278 185 LVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDS---QYNARLGD 261 (834)
Q Consensus 185 lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~---~~~~kl~D 261 (834)
||||||+||+|.++|..+. ...+++..+..|+.||+.||+|||+. +|+||||||+|||++. ++.+||+|
T Consensus 86 ivmEy~~gg~L~~~i~~~~-----~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~D 157 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRG-----DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD 157 (335)
T ss_dssp EEEECCCSEEHHHHHHSCS-----CCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred EEEECCCCCcHHHHHHhcC-----CCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccc
Confidence 9999999999999997542 24689999999999999999999996 9999999999999985 45799999
Q ss_pred ccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCC
Q 003278 262 FGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPD 341 (834)
Q Consensus 262 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~ 341 (834)
||+|+..... .......||+.|||||++... .++.++|||||||+||||+||+.||......
T Consensus 158 FG~a~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~-~y~~~~DiwSlGvily~lltg~~Pf~~~~~~ 219 (335)
T d2ozaa1 158 FGFAKETTSH-----------------NSLTTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 219 (335)
T ss_dssp CTTCEECCCC-----------------CCCCCCSCCCSSCCCCCCCGG-GGSHHHHHHHHHHHHHHHTTSSCSCEETTCC
T ss_pred cceeeeccCC-----------------CccccccCCcccCCcHHHcCC-CCCHHHHHHhhchhHHHHhhCCCCCCCCCHH
Confidence 9999854221 113455799999999988654 6799999999999999999999999643322
Q ss_pred ccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 342 DQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 342 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
. ....+......+. ...... ....-...+.+|+..||+.||.+|||+.|+++.
T Consensus 220 ~---~~~~~~~~i~~~~------~~~~~~-~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 220 A---ISPGMKTRIRMGQ------YEFPNP-EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp -----------CCCSCS------SSCCTT-HHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred H---HHHHHHHHHhcCC------CCCCCc-ccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1 1111111000000 000000 000112457889999999999999999999873
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.5e-45 Score=387.04 Aligned_cols=251 Identities=20% Similarity=0.270 Sum_probs=198.8
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCC--------hhHHHHHHHHHHHHHhcc-CCCceeEEEEEeeC
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKC--------PALRTRFSNELQNLARLR-HRNLVQLCGWCTEQ 582 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~--------~~~~~~f~~E~~~l~~l~-HpNiv~l~g~~~~~ 582 (834)
++|...+.||+|+||+||+|.. .+++.||||++..... ...++++.+|+.+|++++ |||||++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 4677788999999999999986 5688999999875432 123457899999999997 99999999999999
Q ss_pred CeEEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEee
Q 003278 583 GEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGS 662 (834)
Q Consensus 583 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~D 662 (834)
+..+|||||+++|+|.+++...+ .+++.....++.||+.||+|||+ .+||||||||+||||+.++.+||+|
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~------~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~D 153 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV------TLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTD 153 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECC
T ss_pred cceEEEEEcCCCchHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEcc
Confidence 99999999999999999997543 48999999999999999999997 6999999999999999999999999
Q ss_pred eeeccccccCCCCCcccccCccccccccCccchhcccc------CCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHH
Q 003278 663 FALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIES------GEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLV 736 (834)
Q Consensus 663 fGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~------~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~ 736 (834)
||+++.+.... ......||+.|+|||++.+ ..++.++||||+||+||||+||+.||....+.. ..
T Consensus 154 FG~a~~~~~~~--------~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-~~ 224 (277)
T d1phka_ 154 FGFSCQLDPGE--------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-ML 224 (277)
T ss_dssp CTTCEECCTTC--------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HH
T ss_pred chheeEccCCC--------ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH-HH
Confidence 99998764321 1234679999999999863 346889999999999999999999997554322 22
Q ss_pred HHHHHHHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 737 KRVHEFEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 737 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
..+.. ...... .+ .....+ + ++.+++.+||+.||++|||+.||++
T Consensus 225 ~~i~~---~~~~~~---~~-~~~~~s-~---~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 225 RMIMS---GNYQFG---SP-EWDDYS-D---TVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHHHH---TCCCCC---TT-TGGGSC-H---HHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHh---CCCCCC---Cc-ccccCC-H---HHHHHHHHHccCChhHCcCHHHHHc
Confidence 22211 111100 00 001122 3 3445666999999999999999864
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-45 Score=397.52 Aligned_cols=248 Identities=19% Similarity=0.228 Sum_probs=198.7
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCC--ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSK--CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIY 589 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~--~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~ 589 (834)
++|...+.||+|+||.||+|.. .+++.||||++.... .....+.+.+|+.+|++++|||||++++++.+.+.+++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 4688888999999999999996 568999999986431 1223467889999999999999999999999999999999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccc
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFL 669 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~ 669 (834)
|||++|+|..++.... .++......++.|++.||+|||+ .+||||||||+|||||+++.+||+|||+|+.+
T Consensus 85 ey~~gg~L~~~~~~~~------~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~ 155 (337)
T d1o6la_ 85 EYANGGELFFHLSRER------VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEG 155 (337)
T ss_dssp ECCTTCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred eccCCCchhhhhhccc------CCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeeccccccc
Confidence 9999999999987643 37777788899999999999997 69999999999999999999999999999865
Q ss_pred ccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcc
Q 003278 670 TRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPL 749 (834)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
.... ....+.+||+.|||||++.+..|+.++||||+||+||||+||+.||........ ..... ....
T Consensus 156 ~~~~-------~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-~~~i~---~~~~-- 222 (337)
T d1o6la_ 156 ISDG-------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-FELIL---MEEI-- 222 (337)
T ss_dssp CCTT-------CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHH---HCCC--
T ss_pred ccCC-------cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHH-HHHHh---cCCC--
Confidence 3321 123357899999999999999999999999999999999999999975543322 22111 1111
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCC-----hhHHHH
Q 003278 750 AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPS-----MRQILS 792 (834)
Q Consensus 750 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPt-----m~~v~~ 792 (834)
.++...+ .+ +..++.+||+.||++||+ +.||++
T Consensus 223 ------~~p~~~s-~~---~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 223 ------RFPRTLS-PE---AKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ------CCCTTSC-HH---HHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ------CCCccCC-HH---HHHHHHhhccCCchhhcccccccHHHHHc
Confidence 1112223 33 344556899999999995 667664
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-46 Score=392.59 Aligned_cols=241 Identities=25% Similarity=0.402 Sum_probs=194.8
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccCh------hhHHHHHHHHHHHHhCC--CCceeeEeeeEEeCCE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGE------RFEKTFAAELVAVAHLR--HRNLVRLRGWCVHEDQ 182 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~------~~~~~~~~E~~~l~~l~--H~nIv~l~g~~~~~~~ 182 (834)
++|+..+.||+|+||+||+|+...+|+.||||++..... .....+.+|+.+|++++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 468889999999999999999999999999999864311 11234678999999987 8999999999999999
Q ss_pred EEEEEEccCC-CCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECC-CCceEEe
Q 003278 183 LLLVYDYMPN-RSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDS-QYNARLG 260 (834)
Q Consensus 183 ~~lV~Ey~~~-gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~-~~~~kl~ 260 (834)
.++||||+.+ +++.+++... ..+++..+..|+.|+++||+|||+. +|+||||||+|||++. ++.+||+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~-------~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~ 153 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER-------GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLI 153 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEEC
T ss_pred EEEEEEeccCcchHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEEC
Confidence 9999999976 6777777542 4689999999999999999999995 9999999999999985 4789999
Q ss_pred eccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCC
Q 003278 261 DFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYP 340 (834)
Q Consensus 261 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~ 340 (834)
|||+|+..... ..++..||+.|||||++.....++.++|||||||++|||+||+.||...
T Consensus 154 DFG~a~~~~~~------------------~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~-- 213 (273)
T d1xwsa_ 154 DFGSGALLKDT------------------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-- 213 (273)
T ss_dssp CCTTCEECCSS------------------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH--
T ss_pred ccccceecccc------------------cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc--
Confidence 99999753211 1345679999999999876655677899999999999999999998531
Q ss_pred CccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 341 DDQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 341 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
+ . ... +.. ...+. .+ ..+.+++..||+.||.+|||+.|+++
T Consensus 214 --~-~-------i~~-~~~--~~~~~-----~s----~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 214 --E-E-------IIR-GQV--FFRQR-----VS----SECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp --H-H-------HHH-CCC--CCSSC-----CC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --h-H-------Hhh-ccc--CCCCC-----CC----HHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 1 0 111 111 11111 12 35788999999999999999999986
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.5e-44 Score=397.16 Aligned_cols=249 Identities=17% Similarity=0.196 Sum_probs=191.3
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCC--hhHHHHH---HHHHHHHHhccCCCceeEEEEEeeCCeEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKC--PALRTRF---SNELQNLARLRHRNLVQLCGWCTEQGEML 586 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~--~~~~~~f---~~E~~~l~~l~HpNiv~l~g~~~~~~~~~ 586 (834)
++|...+.||+|+||.||+|.. .+|+.||||++..... ......+ .+|+.+++.++|||||++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 5677888999999999999996 4689999999853211 1112223 34577788889999999999999999999
Q ss_pred EEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeec
Q 003278 587 VIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALA 666 (834)
Q Consensus 587 lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla 666 (834)
+||||+++|+|.+++.... .+++.....++.||+.||+|||+ .+||||||||+||||+.++.+||+|||+|
T Consensus 84 ivmE~~~gg~L~~~l~~~~------~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla 154 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG------VFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLA 154 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTC
T ss_pred EEEEecCCCcHHHHHHhcc------cccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeecee
Confidence 9999999999999987543 37788889999999999999997 69999999999999999999999999999
Q ss_pred cccccCCCCCcccccCccccccccCccchhcccc-CCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhh
Q 003278 667 EFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIES-GEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEAR 745 (834)
Q Consensus 667 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~ 745 (834)
+.+.... ....+||+.|||||++.. ..|+.++|||||||+||||+||+.||......... .+...
T Consensus 155 ~~~~~~~---------~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~--~~~~~--- 220 (364)
T d1omwa3 155 CDFSKKK---------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--EIDRM--- 220 (364)
T ss_dssp EECSSSC---------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH--HHHHH---
T ss_pred eecCCCc---------ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHh---
Confidence 8654321 234589999999999975 46899999999999999999999999754332211 11111
Q ss_pred cCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCC-----hhHHHH
Q 003278 746 KRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPS-----MRQILS 792 (834)
Q Consensus 746 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPt-----m~~v~~ 792 (834)
.... ...+....+ +++ ..++.+||+.||++||| ++||++
T Consensus 221 ~~~~----~~~~~~~~s-~~~---~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 221 TLTM----AVELPDSFS-PEL---RSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp SSSC----CCCCCSSSC-HHH---HHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred cccC----CCCCCCCCC-HHH---HHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 0000 011111222 344 44555899999999999 477753
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.2e-45 Score=396.67 Aligned_cols=245 Identities=16% Similarity=0.171 Sum_probs=198.1
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCC--ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSK--CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIY 589 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~--~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~ 589 (834)
++|...+.||+|+||.||+|.. .+|+.||||++.... .....+.+.+|+.+|++++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 4677888999999999999996 568999999986322 1223467899999999999999999999999999999999
Q ss_pred eccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccc
Q 003278 590 DYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFL 669 (834)
Q Consensus 590 Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~ 669 (834)
||+.+|+|..++...+ .+++.....|+.|++.||.|||+ .+||||||||+||||+.++.+||+|||+|+.+
T Consensus 121 e~~~~g~l~~~l~~~~------~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~ 191 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG------RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191 (350)
T ss_dssp ECCTTCBHHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred ccccccchhhhHhhcC------CCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeec
Confidence 9999999999987543 38888999999999999999997 68999999999999999999999999999865
Q ss_pred ccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcc
Q 003278 670 TRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPL 749 (834)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
... ..+..||+.|||||++.+..|+.++|||||||+||||+||+.||....+.. +...+. .....
T Consensus 192 ~~~----------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~i~---~~~~~- 256 (350)
T d1rdqe_ 192 KGR----------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-IYEKIV---SGKVR- 256 (350)
T ss_dssp SSC----------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHH---HCCCC-
T ss_pred ccc----------cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH-HHHHHh---cCCCC-
Confidence 321 234689999999999999999999999999999999999999997543222 122111 11111
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----ChhHHHH
Q 003278 750 AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRP-----SMRQILS 792 (834)
Q Consensus 750 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RP-----tm~~v~~ 792 (834)
.....+ +++ ..++.+||+.||++|+ |+++|++
T Consensus 257 -------~p~~~s-~~~---~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 257 -------FPSHFS-SDL---KDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -------CCTTCC-HHH---HHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -------CCccCC-HHH---HHHHHHHhhhCHHhccccccccHHHHHc
Confidence 111222 333 4455589999999994 8888875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-44 Score=392.80 Aligned_cols=251 Identities=14% Similarity=0.163 Sum_probs=190.6
Q ss_pred hCcCcCC-cccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhc-cCCCceeEEEEEee----CCeE
Q 003278 513 NNFSESQ-RVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARL-RHRNLVQLCGWCTE----QGEM 585 (834)
Q Consensus 513 ~~f~~~~-~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l-~HpNiv~l~g~~~~----~~~~ 585 (834)
++|.... .||+|+||+||+|.. .+++.||||.++.. ..+.+|+.++.++ +|||||++++++.+ ...+
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 5676554 499999999999986 56899999998532 4577899997765 89999999998865 4568
Q ss_pred EEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecC---CCCceEee
Q 003278 586 LVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDP---DMNPRLGS 662 (834)
Q Consensus 586 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~---~~~~ki~D 662 (834)
++|||||++|+|.+++...+. ..+++.....|+.|++.||+|||+ .+|+||||||+|||+++ ++.+||+|
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~----~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~D 157 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGD----QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTD 157 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSC----CCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred EEEEECCCCCcHHHHHHhcCC----CCcCHHHHHHHHHHHHHHHHHHHH---cCCccccccccccccccccccccccccc
Confidence 999999999999999975432 248999999999999999999997 69999999999999985 46799999
Q ss_pred eeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHH
Q 003278 663 FALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEF 742 (834)
Q Consensus 663 fGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~ 742 (834)
||+|+...... .....+||+.|||||++.+..|+.++|||||||+||||+||+.||......... ..+..
T Consensus 158 FG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~-~~~~~- 227 (335)
T d2ozaa1 158 FGFAKETTSHN--------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-PGMKT- 227 (335)
T ss_dssp CTTCEECCCCC--------CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------
T ss_pred cceeeeccCCC--------ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH-HHHHH-
Confidence 99998654322 123468999999999999999999999999999999999999999643322111 00000
Q ss_pred HhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 743 EARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 743 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
..... ....+.......-.++..++.+||+.||++|||+.|+++
T Consensus 228 ----~i~~~--~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 228 ----RIRMG--QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp ----CCCSC--SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ----HHhcC--CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 00000 000000000111124556667999999999999999987
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-44 Score=385.66 Aligned_cols=258 Identities=17% Similarity=0.210 Sum_probs=189.8
Q ss_pred CCcccccCCcEEEEEEE-CCCcEEEEEEecCCCCh----hHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEecc
Q 003278 518 SQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCP----ALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDYS 592 (834)
Q Consensus 518 ~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~----~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey~ 592 (834)
.+.||+|+||+||+|.. .+++.||||+++..... ...+.+.+|+.+|++++|||||++++++.+.+..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 35799999999999996 56899999998754322 12356889999999999999999999999999999999999
Q ss_pred CCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccccC
Q 003278 593 ATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTRN 672 (834)
Q Consensus 593 ~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~~ 672 (834)
.++++..+.... ..+++.....++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|+.....
T Consensus 83 ~~~~~~~~~~~~------~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~ 153 (299)
T d1ua2a_ 83 ETDLEVIIKDNS------LVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 153 (299)
T ss_dssp SEEHHHHHTTCC------SSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred cchHHhhhhhcc------cCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCC
Confidence 999887665432 237778888999999999999997 69999999999999999999999999999765432
Q ss_pred CCCCcccccCccccccccCccchhccccC-CCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhc--Ccc
Q 003278 673 DHGHRKATSGNRSVRGIFGYMSPEYIESG-EATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARK--RPL 749 (834)
Q Consensus 673 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~--~~~ 749 (834)
. ....+.+||+.|||||++..+ .|+.++|||||||++|||+||..||........ +..+....... ..+
T Consensus 154 ~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~-l~~i~~~~~~~~~~~~ 225 (299)
T d1ua2a_ 154 N-------RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ-LTRIFETLGTPTEEQW 225 (299)
T ss_dssp C-------CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCTTTS
T ss_pred c-------ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH-HHHHHHhcCCCChhhc
Confidence 1 112345799999999998654 579999999999999999999999875443332 22222211100 000
Q ss_pred cccc---ccc-c--CCCCCHHH-----HHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 750 AELV---DLS-L--NGEYNHKE-----LMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 750 ~~~~---d~~-l--~~~~~~~~-----~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
.... +.. . ........ -..+.+++.+|++.||++|||+.|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 226 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0000 000 0 00001111 124556667999999999999999975
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.5e-44 Score=385.09 Aligned_cols=263 Identities=23% Similarity=0.303 Sum_probs=198.4
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccC--hhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG--ERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYD 188 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 188 (834)
++|+..++||+|+||+||+|+++ +|+.||||++.... +...+.|.+|+.+|++++|||||+++++|...+..++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 57888999999999999999994 88999999986532 3345789999999999999999999999999999999999
Q ss_pred ccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhh
Q 003278 189 YMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWL 268 (834)
Q Consensus 189 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~ 268 (834)
|+.++.+..+... ...+++..+..|+.||+.||+|||+. +||||||||+|||++.++.+||+|||+|...
T Consensus 81 ~~~~~~~~~~~~~-------~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~ 150 (286)
T d1ob3a_ 81 HLDQDLKKLLDVC-------EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF 150 (286)
T ss_dssp CCSEEHHHHHHTS-------TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHH
T ss_pred eehhhhHHHHHhh-------cCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceec
Confidence 9988877766543 24689999999999999999999986 9999999999999999999999999999864
Q ss_pred hhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHH
Q 003278 269 EHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLD 348 (834)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~ 348 (834)
.... .......||+.|+|||.+.....++.++|||||||++|||+||+.||......+ .+..
T Consensus 151 ~~~~----------------~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~--~~~~ 212 (286)
T d1ob3a_ 151 GIPV----------------RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD--QLMR 212 (286)
T ss_dssp CC-------------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHH
T ss_pred ccCc----------------cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH--HHHH
Confidence 3221 012344689999999999777678999999999999999999999996432211 1111
Q ss_pred HHHHHhhcCc------cccc--cccccCC--C----CCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 349 WIRRLSDEGK------VLQA--GDNRLSD--G----SYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 349 ~~~~~~~~~~------~~~~--~d~~l~~--~----~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
+........ .... .+..... . .........+.+++..||+.||++|||++|+++
T Consensus 213 -i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 213 -IFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp -HHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -HHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111111000 0000 0000000 0 000001235778999999999999999999975
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-44 Score=389.80 Aligned_cols=247 Identities=18% Similarity=0.241 Sum_probs=194.7
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCC--ChhHHHHHHHHHHHHH-hccCCCceeEEEEEeeCCeEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSK--CPALRTRFSNELQNLA-RLRHRNLVQLCGWCTEQGEMLVI 588 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~--~~~~~~~f~~E~~~l~-~l~HpNiv~l~g~~~~~~~~~lv 588 (834)
++|.-.+.||+|+||+||+|.. .+++.||||++.... .....+.+..|..++. .++|||||++++++.+.+..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 4677778999999999999996 468899999986421 1122345677777765 68999999999999999999999
Q ss_pred EeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccc
Q 003278 589 YDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEF 668 (834)
Q Consensus 589 ~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~ 668 (834)
|||+++|+|.+++.... .++......++.||+.||+|||+ .+||||||||+|||+++++.+||+|||+++.
T Consensus 82 mEy~~~g~L~~~i~~~~------~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~ 152 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH------KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKE 152 (320)
T ss_dssp EECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EeecCCCcHHHHhhccC------CCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhh
Confidence 99999999999987543 37788889999999999999997 6899999999999999999999999999986
Q ss_pred cccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCc
Q 003278 669 LTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRP 748 (834)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
..... .......||+.|||||++.++.|+.++|||||||++|||+||+.||....+.. +...+. .. .+
T Consensus 153 ~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~-~~~~i~---~~-~~ 220 (320)
T d1xjda_ 153 NMLGD-------AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-LFHSIR---MD-NP 220 (320)
T ss_dssp CCCTT-------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHH---HC-CC
T ss_pred ccccc-------ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH-HHHHHH---cC-CC
Confidence 43221 12234689999999999999999999999999999999999999997544332 222221 11 11
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChh-HHH
Q 003278 749 LAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMR-QIL 791 (834)
Q Consensus 749 ~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~-~v~ 791 (834)
..+... ++++ ..+..+||+.||++|||+. +|.
T Consensus 221 -------~~p~~~-s~~~---~dli~~~L~~dP~~R~s~~~~l~ 253 (320)
T d1xjda_ 221 -------FYPRWL-EKEA---KDLLVKLFVREPEKRLGVRGDIR 253 (320)
T ss_dssp -------CCCTTS-CHHH---HHHHHHHSCSSGGGSBTTBSCGG
T ss_pred -------CCCccC-CHHH---HHHHHHhcccCCCCCcCHHHHHH
Confidence 111122 2344 4555589999999999996 664
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-44 Score=385.92 Aligned_cols=250 Identities=15% Similarity=0.205 Sum_probs=198.0
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
+.|...+.||+|+||+||+|.. .+++.||||.++... .....+.+|+++|++++|||||++++++.+.+.++|||||
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 4566678899999999999996 468899999997543 2335688999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecC--CCCceEeeeeecccc
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDP--DMNPRLGSFALAEFL 669 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~--~~~~ki~DfGla~~~ 669 (834)
|++|+|.+++...+ ..+++.....|+.|++.||+|||+ .+|+||||||+|||++. ...+||+|||+++..
T Consensus 83 ~~gg~L~~~i~~~~-----~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~ 154 (321)
T d1tkia_ 83 ISGLDIFERINTSA-----FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp CCCCBHHHHHTSSS-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred CCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhcc
Confidence 99999999986543 238899999999999999999996 69999999999999985 457999999999865
Q ss_pred ccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcCcc
Q 003278 670 TRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKRPL 749 (834)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
.... ......||+.|||||.+.+..|+.++||||+||++|||+||+.||........ ...+.. ....+
T Consensus 155 ~~~~--------~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~-~~~i~~---~~~~~ 222 (321)
T d1tkia_ 155 KPGD--------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI-IENIMN---AEYTF 222 (321)
T ss_dssp CTTC--------EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHH---TCCCC
T ss_pred ccCC--------cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHH-HHHHHh---CCCCC
Confidence 3321 12345799999999999999999999999999999999999999975543322 222211 11111
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 750 AELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 750 ~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
..... ...+ ++ +..+..+|++.||++|||+.|+++
T Consensus 223 ~~~~~----~~~s-~~---~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 223 DEEAF----KEIS-IE---AMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp CHHHH----TTSC-HH---HHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred Chhhc----cCCC-HH---HHHHHHHHccCChhHCcCHHHHhc
Confidence 11000 1111 23 445556999999999999999986
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-44 Score=380.96 Aligned_cols=265 Identities=15% Similarity=0.209 Sum_probs=195.1
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCC-hhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEe
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKC-PALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYD 590 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~-~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~E 590 (834)
++|...+.||+|+||+||+|.. .+++.||||++..... ....++|.+|+++|++++|||||++++++.+.+..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5788889999999999999996 6689999999865432 2235689999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeeccccc
Q 003278 591 YSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLT 670 (834)
Q Consensus 591 y~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~ 670 (834)
|+.++++........ ..+++.....++.|++.||+|||+ .+||||||||+|||++.++.+||+|||+|+...
T Consensus 82 ~~~~~~~~~~~~~~~-----~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~ 153 (298)
T d1gz8a_ 82 FLHQDLKKFMDASAL-----TGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFG 153 (298)
T ss_dssp CCSEEHHHHHHHTTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHC
T ss_pred ecCCchhhhhhhhcc-----cCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceecc
Confidence 998766554433222 248999999999999999999997 689999999999999999999999999998754
Q ss_pred cCCCCCcccccCccccccccCccchhccccCCC-CccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhc-Cc
Q 003278 671 RNDHGHRKATSGNRSVRGIFGYMSPEYIESGEA-TSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARK-RP 748 (834)
Q Consensus 671 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~-~~ 748 (834)
... .......||+.|+|||.+....+ +.++|||||||++|||+||+.||........+........... ..
T Consensus 154 ~~~-------~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 226 (298)
T d1gz8a_ 154 VPV-------RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVV 226 (298)
T ss_dssp CCS-------BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred CCc-------ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhh
Confidence 321 11234579999999998876664 7889999999999999999999975443332222111110000 00
Q ss_pred ccccc---cc--ccC--CCCCHH-----HHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 749 LAELV---DL--SLN--GEYNHK-----ELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 749 ~~~~~---d~--~l~--~~~~~~-----~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
..... +. ... ...... .-..+..++.+|++.||++|||+.|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 227 WPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp STTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 00000 00 000 000000 0124556667999999999999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-44 Score=385.03 Aligned_cols=267 Identities=22% Similarity=0.286 Sum_probs=197.1
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeC--------
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHE-------- 180 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-------- 180 (834)
++|+..+.||+|+||+||+|++..+|+.||||++... .+...+.+.+|+.+|++++||||+++++++...
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 5788999999999999999999999999999998543 334457789999999999999999999998653
Q ss_pred CEEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEe
Q 003278 181 DQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLG 260 (834)
Q Consensus 181 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~ 260 (834)
+..++||||+.++++...... ...++...+..|+.|++.||.|||+. +|+||||||+|||++.++.+||+
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~-------~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~ 159 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNV-------LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLA 159 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCT-------TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEEC
T ss_pred ceEEEEEeccCCCccchhhhc-------ccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEee
Confidence 458999999998877655432 24578889999999999999999986 99999999999999999999999
Q ss_pred eccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCC
Q 003278 261 DFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYP 340 (834)
Q Consensus 261 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~ 340 (834)
|||+++.+....... .......+||+.|+|||.+.....++.++|||||||++|||+||+.||....
T Consensus 160 dfg~~~~~~~~~~~~------------~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~- 226 (318)
T d3blha1 160 DFGLARAFSLAKNSQ------------PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT- 226 (318)
T ss_dssp CCTTCEECCC-----------------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-
T ss_pred ecceeeecccccccc------------cccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCC-
Confidence 999998654321110 0112345699999999998766578999999999999999999999986432
Q ss_pred CccchHHHHHHHHhhcCcccccccccc------------CCCCCCHHH-------HHHHHHHHHHhcccCCCCCCchhhH
Q 003278 341 DDQIILLDWIRRLSDEGKVLQAGDNRL------------SDGSYKLCD-------MEHLTHLALLCTLHNPHLRPSMKWV 401 (834)
Q Consensus 341 ~~~~~l~~~~~~~~~~~~~~~~~d~~l------------~~~~~~~~~-------~~~l~~l~~~Cl~~~p~~RPsm~~V 401 (834)
......-+..... .......... ......... ...+.+|...||+.||++|||+.|+
T Consensus 227 --~~~~~~~i~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~el 302 (318)
T d3blha1 227 --EQHQLALISQLCG--SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302 (318)
T ss_dssp --HHHHHHHHHHHHC--CCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred --HHHHHHHHHHhcC--CCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHH
Confidence 1111111222111 1000000000 000011111 1245678999999999999999999
Q ss_pred HHH
Q 003278 402 IEA 404 (834)
Q Consensus 402 ~~~ 404 (834)
++.
T Consensus 303 L~H 305 (318)
T d3blha1 303 LNH 305 (318)
T ss_dssp HHS
T ss_pred HcC
Confidence 874
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-44 Score=384.05 Aligned_cols=264 Identities=23% Similarity=0.304 Sum_probs=192.3
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCC-CeEEEEEEeccc--ChhhHHHHHHHHHHHHhC---CCCceeeEeeeEEe----
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSD-GTVVAVKCLAEK--GERFEKTFAAELVAVAHL---RHRNLVRLRGWCVH---- 179 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~-g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l---~H~nIv~l~g~~~~---- 179 (834)
.++|+..+.||+|+||+||+|++..+ ++.||||++... .+.....+.+|+.+|+.| +|||||+++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 36799999999999999999998654 788999998543 222233456777776655 89999999999864
Q ss_pred -CCEEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceE
Q 003278 180 -EDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNAR 258 (834)
Q Consensus 180 -~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~k 258 (834)
....+++|||+.+|++....... ...+++.....|+.|++.||+|||++ +||||||||+|||+++++.+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~------~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~k 156 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVP------EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIK 156 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSC------TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred cCceEEEEEEeccCCchhhhhhcc------CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCee
Confidence 24689999999988876554332 34689999999999999999999996 999999999999999999999
Q ss_pred EeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCC
Q 003278 259 LGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLT 338 (834)
Q Consensus 259 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~ 338 (834)
|+|||+++...... ......||+.|||||.+... .++.++||||+||++|||+||+.||...
T Consensus 157 l~dfg~~~~~~~~~-----------------~~~~~~gT~~Y~APE~~~~~-~y~~~~DiwSlG~il~ell~g~~pf~~~ 218 (305)
T d1blxa_ 157 LADFGLARIYSFQM-----------------ALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGS 218 (305)
T ss_dssp ECSCCSCCCCCGGG-----------------GGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ecchhhhhhhcccc-----------------cCCCcccChhhcCcchhcCC-CCChhehhhchHHHHHHHHHCCCCCCCC
Confidence 99999987543221 13456799999999998654 6899999999999999999999999643
Q ss_pred CCCccchHHHHHHHHhhcCcccc------ccccccC-CC-----CCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 339 YPDDQIILLDWIRRLSDEGKVLQ------AGDNRLS-DG-----SYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 339 ~~~~~~~l~~~~~~~~~~~~~~~------~~d~~l~-~~-----~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
... ....-+........... ....... .. .+.....+.+.+|...||+.||.+|||+.|+++
T Consensus 219 ~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 219 SDV---DQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp SHH---HHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CHH---HHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 211 11111111111000000 0000000 00 000011235678999999999999999999886
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-43 Score=385.05 Aligned_cols=262 Identities=26% Similarity=0.296 Sum_probs=192.4
Q ss_pred CCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCC------EEEE
Q 003278 112 GFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLVRLRGWCVHED------QLLL 185 (834)
Q Consensus 112 ~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~------~~~l 185 (834)
.|+..++||+|+||+||+|++..+|+.||||++..... .+.+|+.+|++++|||||+++++|.... .++|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 47777899999999999999999999999999865432 2347999999999999999999996543 4799
Q ss_pred EEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCC-ceEEeeccc
Q 003278 186 VYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQY-NARLGDFGL 264 (834)
Q Consensus 186 V~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~-~~kl~DFGl 264 (834)
|||||++|.+..+.... .....+++..+..|+.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+
T Consensus 97 v~Ey~~~~~~~~l~~~~----~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~ 169 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYS----RAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGS 169 (350)
T ss_dssp EEECCSEEHHHHHHHHH----HTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred EEeccCCccHHHHHhhh----hccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccc
Confidence 99999877555443321 1235799999999999999999999985 999999999999999765 899999999
Q ss_pred hhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccc
Q 003278 265 ARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQI 344 (834)
Q Consensus 265 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~ 344 (834)
++.+.... ...+..||+.|+|||.+.....++.++|||||||++|||+||+.||......+
T Consensus 170 a~~~~~~~-----------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~-- 230 (350)
T d1q5ka_ 170 AKQLVRGE-----------------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-- 230 (350)
T ss_dssp CEECCTTS-----------------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH--
T ss_pred hhhccCCc-----------------ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH--
Confidence 98543210 12345699999999988766678999999999999999999999996532211
Q ss_pred hHHHHH-----------HHHhhc---CccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 345 ILLDWI-----------RRLSDE---GKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 345 ~l~~~~-----------~~~~~~---~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
.+...+ ...... ............ ..........+.+|...||+.||++|||+.|+++.
T Consensus 231 ~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 231 QLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWT-KVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGG-GTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHhCCChHHhhhhhccchhhccccccccCchh-hhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111111 111000 000000000000 00000112357789999999999999999999863
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-44 Score=376.99 Aligned_cols=240 Identities=19% Similarity=0.297 Sum_probs=188.3
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCCh-----hHHHHHHHHHHHHHhcc--CCCceeEEEEEeeCCe
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCP-----ALRTRFSNELQNLARLR--HRNLVQLCGWCTEQGE 584 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~f~~E~~~l~~l~--HpNiv~l~g~~~~~~~ 584 (834)
+.|...+.||+|+||+||+|.. .+++.||||++...... ....++.+|+.+|++++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 3566678899999999999996 56899999998643211 11234678999999997 9999999999999999
Q ss_pred EEEEEeccCC-CchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCC-CCceEee
Q 003278 585 MLVIYDYSAT-RILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPD-MNPRLGS 662 (834)
Q Consensus 585 ~~lv~Ey~~~-g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~-~~~ki~D 662 (834)
.++||||+.+ +++.+++.... .+++.....++.|++.||+|||+ .+||||||||+||||+.+ +.+||+|
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~------~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~D 154 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERG------ALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLID 154 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECC
T ss_pred EEEEEEeccCcchHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECc
Confidence 9999999976 67777775432 48899999999999999999997 699999999999999854 7899999
Q ss_pred eeeccccccCCCCCcccccCccccccccCccchhccccCCC-CccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHH
Q 003278 663 FALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEA-TSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHE 741 (834)
Q Consensus 663 fGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~ 741 (834)
||+|+..... ...+..||+.|||||++.+..+ +.++|||||||+||||+||+.||... . .
T Consensus 155 FG~a~~~~~~---------~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---~----~--- 215 (273)
T d1xwsa_ 155 FGSGALLKDT---------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD---E----E--- 215 (273)
T ss_dssp CTTCEECCSS---------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH---H----H---
T ss_pred cccceecccc---------cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc---h----H---
Confidence 9999764321 1235689999999999988776 56789999999999999999998531 0 0
Q ss_pred HHhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 742 FEARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 742 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
....... +....+ ++ +.+++.+||+.||++|||++|+++
T Consensus 216 i~~~~~~--------~~~~~s-~~---~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 216 IIRGQVF--------FRQRVS-SE---CQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp HHHCCCC--------CSSCCC-HH---HHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HhhcccC--------CCCCCC-HH---HHHHHHHHccCCHhHCcCHHHHhc
Confidence 1111111 111222 34 444556899999999999999975
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-43 Score=385.91 Aligned_cols=260 Identities=23% Similarity=0.305 Sum_probs=193.1
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCC------
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHED------ 181 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~------ 181 (834)
.++|+..+.||+|+||+||+|++..+|+.||||+++.. .+...+.+.+|+.+|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 36788899999999999999999999999999998653 3445678899999999999999999999998765
Q ss_pred EEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEee
Q 003278 182 QLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGD 261 (834)
Q Consensus 182 ~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~D 261 (834)
.+|+||||+ +++|..+... ..+++..+..|+.|++.||.|||+. +|+||||||+|||++.++.+|++|
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~--------~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~D 164 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH--------EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILD 164 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECC
T ss_pred eEEEEEecc-cccHHHHHHh--------ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccccccccccc
Confidence 479999999 5677776643 3589999999999999999999996 999999999999999999999999
Q ss_pred ccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCC
Q 003278 262 FGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPD 341 (834)
Q Consensus 262 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~ 341 (834)
||+|+.... ..+...||+.|+|||.+.....++.++||||+||++|||++|+.||......
T Consensus 165 fg~a~~~~~-------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~ 225 (346)
T d1cm8a_ 165 FGLARQADS-------------------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL 225 (346)
T ss_dssp CTTCEECCS-------------------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ccceeccCC-------------------ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChH
Confidence 999975321 1344569999999999876667799999999999999999999998653211
Q ss_pred ccchHHHHHHHH-------hhcC----------ccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 342 DQIILLDWIRRL-------SDEG----------KVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 342 ~~~~l~~~~~~~-------~~~~----------~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
. .+....... .... .........+. ..... .-..+.+|+..||+.||.+|||+.|+++.
T Consensus 226 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 226 D--QLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFA-SILTN-ASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp H--HHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTT-CCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred H--HHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchH-HhccC-CCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 1 111100000 0000 00000000000 00000 01346789999999999999999999873
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-43 Score=381.92 Aligned_cols=266 Identities=20% Similarity=0.234 Sum_probs=196.8
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc-ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCC----EEE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK-GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHED----QLL 184 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~----~~~ 184 (834)
+++|+..+.||+|+||+||+|+...+|+.||||++... .....+.+.+|+.+|++++|||||++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 35688999999999999999999899999999999654 3445678999999999999999999999997653 234
Q ss_pred EEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccc
Q 003278 185 LVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGL 264 (834)
Q Consensus 185 lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGl 264 (834)
+++||+.+|+|.+++.. ..+++..+..++.|++.||+|||++ +||||||||+|||+++++.+||+|||+
T Consensus 87 ~l~~~~~~g~L~~~l~~--------~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~ 155 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT--------QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGL 155 (345)
T ss_dssp EEEEECCCEEHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEeecCCchhhhhhc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCc
Confidence 44556779999999853 2589999999999999999999996 999999999999999999999999999
Q ss_pred hhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccc
Q 003278 265 ARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQI 344 (834)
Q Consensus 265 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~ 344 (834)
|+....... ........+||+.|+|||.+..+..++.++||||+||++|||+||+.||......+..
T Consensus 156 a~~~~~~~~-------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~ 222 (345)
T d1pmea_ 156 ARVADPDHD-------------HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 222 (345)
T ss_dssp CEECCGGGC-------------BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred eeeccCCCc-------------cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHH
Confidence 986533211 0011345679999999999877667889999999999999999999998654322111
Q ss_pred hHHHHHHHHhhcCccc-------------cccccccCCCCCCHHH-----HHHHHHHHHHhcccCCCCCCchhhHHHH
Q 003278 345 ILLDWIRRLSDEGKVL-------------QAGDNRLSDGSYKLCD-----MEHLTHLALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 345 ~l~~~~~~~~~~~~~~-------------~~~d~~l~~~~~~~~~-----~~~l~~l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
.. ........... ....+.. ....... -..+.+|...||+.||.+|||+.|+++.
T Consensus 223 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 223 NH---ILGILGSPSQEDLNCIINLKARNYLLSLPHK--NKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HH---HHHHHCSCCHHHHHTCCCHHHHHHHHTSCCC--CCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HH---HhhhccCCChhhhhhhhhhhhhcccccCCcc--CCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 10 00000000000 0000000 0000000 1257789999999999999999999863
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6.6e-43 Score=372.40 Aligned_cols=259 Identities=17% Similarity=0.252 Sum_probs=195.1
Q ss_pred hCcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCCC-hhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 513 NNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKC-PALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~-~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
++|...+.||+|+||+||+|...+++.||||++..... ....++|.+|+.+|++++|||||++++++.+.+..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 35677788999999999999999999999999875432 33357899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccccc
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTR 671 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~ 671 (834)
+.++++..+.... ..+++.....|+.||+.||+|||+ .+||||||||+||||+.++.+|++|||+|.....
T Consensus 82 ~~~~~~~~~~~~~------~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~ 152 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE------GGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGI 152 (286)
T ss_dssp CSEEHHHHHHTST------TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred ehhhhHHHHHhhc------CCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceeccc
Confidence 9998887775433 248889999999999999999997 6899999999999999999999999999986543
Q ss_pred CCCCCcccccCccccccccCccchhccccC-CCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcC--c
Q 003278 672 NDHGHRKATSGNRSVRGIFGYMSPEYIESG-EATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKR--P 748 (834)
Q Consensus 672 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~--~ 748 (834)
.. .......||+.|+|||.+.+. .++.++|||||||++|||+||+.||........ ............ .
T Consensus 153 ~~-------~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~-~~~i~~~~~~~~~~~ 224 (286)
T d1ob3a_ 153 PV-------RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ-LMRIFRILGTPNSKN 224 (286)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTTT
T ss_pred Cc-------cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH-HHHHHHhhCCCChhh
Confidence 21 112234689999999998754 568999999999999999999999975433222 222222111100 0
Q ss_pred cc---ccc--cc-----------ccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 749 LA---ELV--DL-----------SLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 749 ~~---~~~--d~-----------~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
.. ... +. ...... .+ .+..++.+|++.||++|||++|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-s~---~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 225 WPNVTELPKYDPNFTVYEPLPWESFLKGL-DE---SGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp STTGGGSTTCCTTCCCCCCCCGGGTCCSC-CH---HHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccchhhhhhcccccccccCcchhhhcccC-CH---HHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 000 00 000011 12 3445566899999999999999974
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-42 Score=373.33 Aligned_cols=265 Identities=18% Similarity=0.230 Sum_probs=194.6
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCcee-eEeeeEEeCCEEEEEEEc
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNLV-RLRGWCVHEDQLLLVYDY 189 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nIv-~l~g~~~~~~~~~lV~Ey 189 (834)
++|+..+.||+|+||+||+|++..+|+.||||++..... .+.+..|+.++++++|+|+| .+.++..+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 458999999999999999999999999999998765422 24578899999999877655 455566778889999999
Q ss_pred cCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECC---CCceEEeeccchh
Q 003278 190 MPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDS---QYNARLGDFGLAR 266 (834)
Q Consensus 190 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~---~~~~kl~DFGla~ 266 (834)
+. |+|...+... ...+++..+..++.|++.||+|||++ +||||||||+|||++. +..+||+|||+|+
T Consensus 85 ~~-~~l~~~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~ 154 (299)
T d1ckia_ 85 LG-PSLEDLFNFC------SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154 (299)
T ss_dssp CC-CBHHHHHHHT------TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCE
T ss_pred cC-Cchhhhhhhc------cCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcce
Confidence 94 5666655432 24689999999999999999999996 9999999999999863 5579999999998
Q ss_pred hhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchH
Q 003278 267 WLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIIL 346 (834)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l 346 (834)
.+....... .......+...||+.|||||.+... .++.++|||||||++|||+||+.||...........
T Consensus 155 ~~~~~~~~~---------~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~ 224 (299)
T d1ckia_ 155 KYRDARTHQ---------HIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK 224 (299)
T ss_dssp ECBCTTTCC---------BCCCCBCCSCCCCSSSCCHHHHTTB-CCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------
T ss_pred ecccccccc---------ceeccccCCcCCCccccCHHHHhCC-CCCChhhEEecCHHHHHHHhCCCcccccchHHHHHH
Confidence 764332110 0111224566799999999988654 679999999999999999999999975443332211
Q ss_pred HHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhc
Q 003278 347 LDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSG 407 (834)
Q Consensus 347 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~ 407 (834)
............ . +.+. ...+ ..+.+++..||+.+|++||++.++.+.|+.
T Consensus 225 ~~~~~~~~~~~~-~----~~~~-~~~p----~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 275 (299)
T d1ckia_ 225 YERISEKKMSTP-I----EVLC-KGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275 (299)
T ss_dssp HHHHHHHHHHSC-H----HHHT-TTSC----HHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred HHHhhcccCCCC-h----hHhc-cCCC----HHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 111111000000 0 0010 1111 457889999999999999999988887764
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.6e-42 Score=370.34 Aligned_cols=265 Identities=15% Similarity=0.219 Sum_probs=203.4
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCC-CceeeEeeeEEeCCEEEEEEEc
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRH-RNLVRLRGWCVHEDQLLLVYDY 189 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H-~nIv~l~g~~~~~~~~~lV~Ey 189 (834)
++|.+.+.||+|+||+||+|++..+|+.||||++..... ...+.+|++.+..++| +||+.+++++...+..++||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 578999999999999999999999999999998865422 2346788899999976 8999999999999999999999
Q ss_pred cCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECC-----CCceEEeeccc
Q 003278 190 MPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDS-----QYNARLGDFGL 264 (834)
Q Consensus 190 ~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~-----~~~~kl~DFGl 264 (834)
+ +|+|.+++... ...+++.++..|+.|++.||+|||+. +||||||||+|||++. ++.+||+|||+
T Consensus 83 ~-~~~l~~~~~~~------~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~ 152 (293)
T d1csna_ 83 L-GPSLEDLLDLC------GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 152 (293)
T ss_dssp C-CCBHHHHHHHT------TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred c-CCCHHHHHHhh------ccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccce
Confidence 8 68999888653 24689999999999999999999986 9999999999999974 56799999999
Q ss_pred hhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccc
Q 003278 265 ARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQI 344 (834)
Q Consensus 265 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~ 344 (834)
|+.+....... .........+.||+.|||||.+.. ..++.++|||||||++|||+||+.||.........
T Consensus 153 a~~~~~~~~~~---------~~~~~~~~~~~GT~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~ 222 (293)
T d1csna_ 153 VKFYRDPVTKQ---------HIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK 222 (293)
T ss_dssp CEESBCTTTCC---------BCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH
T ss_pred eEEcccCcccc---------ceeecccCceEEchhhcCHHHhcC-CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHH
Confidence 98754321110 011122456789999999999865 46899999999999999999999999754443322
Q ss_pred hHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHHHhhc
Q 003278 345 ILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIEAVSG 407 (834)
Q Consensus 345 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~~l~~ 407 (834)
.....+..........+ +. ...+ +.+.++...|+..+|++||+++.+.+.|..
T Consensus 223 ~~~~~i~~~~~~~~~~~-----l~-~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~ 275 (293)
T d1csna_ 223 QKYERIGEKKQSTPLRE-----LC-AGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSK 275 (293)
T ss_dssp HHHHHHHHHHHHSCHHH-----HT-TTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred HHHHHHHhccCCCChHH-----hc-CCCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 22222211111110100 10 1111 457888999999999999998888776654
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=373.82 Aligned_cols=260 Identities=17% Similarity=0.232 Sum_probs=190.9
Q ss_pred hhCcCcCCcccccCCcEEEEEEE-CC-CcEEEEEEecCCCC-hhHHHHHHHHHHHHHhc---cCCCceeEEEEEee----
Q 003278 512 TNNFSESQRVAEMDFGTAYQGFL-DN-HQYVLVKRLGMSKC-PALRTRFSNELQNLARL---RHRNLVQLCGWCTE---- 581 (834)
Q Consensus 512 t~~f~~~~~ig~g~~g~vy~~~~-~~-~~~vavK~~~~~~~-~~~~~~f~~E~~~l~~l---~HpNiv~l~g~~~~---- 581 (834)
.++|...+.||+|+||+||+|.. .+ ++.||||++..... ......+.+|+.+|+.| +|||||+++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 35788888999999999999986 33 66899999864321 12223466788777766 79999999999853
Q ss_pred -CCeEEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceE
Q 003278 582 -QGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRL 660 (834)
Q Consensus 582 -~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki 660 (834)
....+++|||+.++++........ ..+++.....++.|++.||+|||+ .+||||||||+|||+++++.+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl 157 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPE-----PGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKL 157 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCT-----TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEE
T ss_pred cCceEEEEEEeccCCchhhhhhccC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeee
Confidence 346899999999998865544322 247888888999999999999997 68999999999999999999999
Q ss_pred eeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHH
Q 003278 661 GSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVH 740 (834)
Q Consensus 661 ~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~ 740 (834)
+|||+++..... .......||+.|||||++.+..|+.++||||+||++|||+||+.||....+...+ ....
T Consensus 158 ~dfg~~~~~~~~--------~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~-~~i~ 228 (305)
T d1blxa_ 158 ADFGLARIYSFQ--------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL-GKIL 228 (305)
T ss_dssp CSCCSCCCCCGG--------GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHH
T ss_pred cchhhhhhhccc--------ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHH-HHHH
Confidence 999999764322 1233568999999999999999999999999999999999999999755433322 2222
Q ss_pred HHHhhcC--cccc-------cc----c---cccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 741 EFEARKR--PLAE-------LV----D---LSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 741 ~~~~~~~--~~~~-------~~----d---~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
....... .+.. .. . ....... .++ +..++.+||+.||++|||+.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-s~~---~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 229 DVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDI-DEL---GKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp HHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSC-CHH---HHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HhhCCCchhcccccccchhhhhccccccchhhccccC-CHH---HHHHHHHHCcCChhHCcCHHHHhc
Confidence 2111000 0000 00 0 0001111 123 445566899999999999999875
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-42 Score=371.06 Aligned_cols=263 Identities=14% Similarity=0.138 Sum_probs=191.7
Q ss_pred CcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEE-EEEeeCCeEEEEEec
Q 003278 514 NFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLC-GWCTEQGEMLVIYDY 591 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~-g~~~~~~~~~lv~Ey 591 (834)
.|.-.+.||+|+||.||+|.. .+++.||||.+...... .++..|++++++++|+|+|.++ ++..+.+..++||||
T Consensus 8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS---CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC---HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 466678899999999999986 56889999987654322 3578899999999888766655 455777889999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeec---CCCCceEeeeeeccc
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLD---PDMNPRLGSFALAEF 668 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld---~~~~~ki~DfGla~~ 668 (834)
++++ |...+..... .+++..++.++.|++.||+|||+ .+||||||||+|||++ .+..+|++|||+|+.
T Consensus 85 ~~~~-l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~ 155 (299)
T d1ckia_ 85 LGPS-LEDLFNFCSR-----KFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 155 (299)
T ss_dssp CCCB-HHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred cCCc-hhhhhhhccC-----CCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCccee
Confidence 9654 4444443322 48899999999999999999997 6999999999999875 456799999999988
Q ss_pred cccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhh-cC
Q 003278 669 LTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEAR-KR 747 (834)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~-~~ 747 (834)
+...............+..||+.|||||.+.+..++.++|||||||++|||+||+.||................... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ckia_ 156 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 235 (299)
T ss_dssp CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS
T ss_pred ccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC
Confidence 65443222112223346789999999999999999999999999999999999999996544332221111111110 11
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccC
Q 003278 748 PLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGN 797 (834)
Q Consensus 748 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~ 797 (834)
+... +...+ +++ +.+++..||..||++||++++|.+.|+..
T Consensus 236 ~~~~-----~~~~~-p~~---~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 236 PIEV-----LCKGY-PSE---FATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp CHHH-----HTTTS-CHH---HHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred ChhH-----hccCC-CHH---HHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 1111 11122 233 44555689999999999999999888754
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-42 Score=367.85 Aligned_cols=265 Identities=21% Similarity=0.243 Sum_probs=202.8
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeCCEEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHEDQLLLVYD 188 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 188 (834)
++|+..+.||+|+||+||+|++..+|+.||||+++.. .....+.+.+|+.+|++++|||||+++++|.+.+..++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 4688899999999999999999999999999998543 34456789999999999999999999999999999999999
Q ss_pred ccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeeccchhhh
Q 003278 189 YMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDFGLARWL 268 (834)
Q Consensus 189 y~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~~~ 268 (834)
|+.+++|..++... ..+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||.|+..
T Consensus 82 ~~~~~~l~~~~~~~-------~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~ 151 (292)
T d1unla_ 82 FCDQDLKKYFDSCN-------GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF 151 (292)
T ss_dssp CCSEEHHHHHHHTT-------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred eccccccccccccc-------cccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcc
Confidence 99999998877543 4678999999999999999999996 9999999999999999999999999999864
Q ss_pred hhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccchHHH
Q 003278 269 EHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQIILLD 348 (834)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~ 348 (834)
.... .......+++.|+|||.+.....++.++|||||||++|||+||+.|+...... .....
T Consensus 152 ~~~~----------------~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~--~~~~~ 213 (292)
T d1unla_ 152 GIPV----------------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLK 213 (292)
T ss_dssp CSCC----------------SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH--HHHHH
T ss_pred cCCC----------------ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCH--HHHHH
Confidence 3211 01233457899999999877666799999999999999999999997432211 11111
Q ss_pred HHHHHhhcC---c------cccccccccCC-----CCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 349 WIRRLSDEG---K------VLQAGDNRLSD-----GSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 349 ~~~~~~~~~---~------~~~~~d~~l~~-----~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
-+....... . .....+..... .......-..+.+|...|++.||.+|||+.||++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 214 RIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp HHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111111100 0 00000000000 0000111235678899999999999999999875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=7e-42 Score=371.79 Aligned_cols=260 Identities=20% Similarity=0.245 Sum_probs=196.2
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCC-CCceeeEeeeEEeC--CEEEEEE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLR-HRNLVRLRGWCVHE--DQLLLVY 187 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~--~~~~lV~ 187 (834)
++|+..++||+|+||+||+|++..+|+.||||+++... .+.+.+|+.+|.+++ ||||+++++++... +.+++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 57999999999999999999999999999999986532 457889999999995 99999999999854 4699999
Q ss_pred EccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCC-ceEEeeccchh
Q 003278 188 DYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQY-NARLGDFGLAR 266 (834)
Q Consensus 188 Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~-~~kl~DFGla~ 266 (834)
|||++|+|..+. ..+++..+..|+.||+.||.|||++ +|+||||||+|||++.++ .+||+|||+|+
T Consensus 112 e~~~~~~L~~~~----------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~ 178 (328)
T d3bqca1 112 EHVNNTDFKQLY----------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 178 (328)
T ss_dssp ECCCSCBGGGTT----------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred eecCCCcHHHHh----------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccce
Confidence 999999997653 3588999999999999999999996 999999999999998655 68999999998
Q ss_pred hhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCccch-
Q 003278 267 WLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDDQII- 345 (834)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~- 345 (834)
.+.... ..+...||+.|+|||.+.....++.++||||+||+++||++|+.||..........
T Consensus 179 ~~~~~~-----------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~ 241 (328)
T d3bqca1 179 FYHPGQ-----------------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 241 (328)
T ss_dssp ECCTTC-----------------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHH
T ss_pred eccCCC-----------------cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHH
Confidence 643211 13445699999999998776668999999999999999999999986543221110
Q ss_pred ----------HHHHHHHHhhcC--cccccccc-------ccCCCCCCHHHHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 346 ----------LLDWIRRLSDEG--KVLQAGDN-------RLSDGSYKLCDMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 346 ----------l~~~~~~~~~~~--~~~~~~d~-------~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
...|........ ........ ..............+.+|+..||+.||.+|||++|+++
T Consensus 242 ~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 242 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 001111100000 00000000 00000000011135678999999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.6e-41 Score=362.64 Aligned_cols=263 Identities=16% Similarity=0.172 Sum_probs=200.3
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccC-CCceeEEEEEeeCCeEEEEEe
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRH-RNLVQLCGWCTEQGEMLVIYD 590 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~H-pNiv~l~g~~~~~~~~~lv~E 590 (834)
++|.-.+.||+|+||+||+|.. .+++.||||.+...... ..+.+|++.++.|+| +||+.+++++.+....++|||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA---PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS---CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc---HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 4567778899999999999995 46889999987644322 346778899999976 899999999999999999999
Q ss_pred ccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecC-----CCCceEeeeee
Q 003278 591 YSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDP-----DMNPRLGSFAL 665 (834)
Q Consensus 591 y~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~-----~~~~ki~DfGl 665 (834)
|+ +++|.+++...+. .+++..+..++.|++.||+|||+ .+||||||||+|||++. ++.+||+|||+
T Consensus 82 ~~-~~~l~~~~~~~~~-----~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~ 152 (293)
T d1csna_ 82 LL-GPSLEDLLDLCGR-----KFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 152 (293)
T ss_dssp CC-CCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred ec-CCCHHHHHHhhcc-----chhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccce
Confidence 98 6888888765432 37889999999999999999996 79999999999999974 56799999999
Q ss_pred ccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhH--HHHHHHHH
Q 003278 666 AEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLL--VKRVHEFE 743 (834)
Q Consensus 666 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~--~~~~~~~~ 743 (834)
|+.................+++||+.|||||++.+..++.++|||||||++|||+||+.||......... ...+....
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~ 232 (293)
T d1csna_ 153 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK 232 (293)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred eEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhcc
Confidence 9886543322222222344678999999999999999999999999999999999999999754433221 11111111
Q ss_pred hhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHHHHccC
Q 003278 744 ARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILSILDGN 797 (834)
Q Consensus 744 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~~L~~~ 797 (834)
...+..++ ....+ ++ +.+++..||..+|++||+++.+.+.|+..
T Consensus 233 -~~~~~~~l-----~~~~p-~~---l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 233 -QSTPLREL-----CAGFP-EE---FYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp -HHSCHHHH-----TTTSC-HH---HHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred -CCCChHHh-----cCCCC-HH---HHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 11111111 11222 34 44555589999999999999988877643
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-42 Score=374.13 Aligned_cols=254 Identities=24% Similarity=0.348 Sum_probs=198.1
Q ss_pred CCCCCCCeeeccCCeEEEEEEE---CCCCeEEEEEEeccc----ChhhHHHHHHHHHHHHhCCC-CceeeEeeeEEeCCE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVL---PSDGTVVAVKCLAEK----GERFEKTFAAELVAVAHLRH-RNLVRLRGWCVHEDQ 182 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~---~~~g~~vAvK~l~~~----~~~~~~~~~~E~~~l~~l~H-~nIv~l~g~~~~~~~ 182 (834)
++|+..+.||+|+||+||+|+. +.+|+.||||.++.. .....+.+.+|+.+|++++| |||+++++++.+.+.
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 6799999999999999999987 346899999998643 22345668899999999977 899999999999999
Q ss_pred EEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeec
Q 003278 183 LLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDF 262 (834)
Q Consensus 183 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DF 262 (834)
.++||||+.+|+|.+++... ..++......++.|++.||+|||+. +|+||||||+||||+.++.+||+||
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~-------~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DF 173 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR-------ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDF 173 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCS
T ss_pred eeeeeecccccHHHHHHHhc-------ccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeec
Confidence 99999999999999998653 3467788899999999999999996 9999999999999999999999999
Q ss_pred cchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCC-CCCcccceeehhhHHHHHHhCCccCCCCCCC
Q 003278 263 GLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGS-VATAKSDVFSFGIVVLEVVSGRRAVDLTYPD 341 (834)
Q Consensus 263 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~ 341 (834)
|+|+.+..... .......||+.|+|||.+.... .++.++|||||||+||||+||+.||......
T Consensus 174 G~a~~~~~~~~---------------~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~ 238 (322)
T d1vzoa_ 174 GLSKEFVADET---------------ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK 238 (322)
T ss_dssp SEEEECCGGGG---------------GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC
T ss_pred cchhhhccccc---------------ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99986533211 1123456999999999986543 4688999999999999999999999765443
Q ss_pred ccchHHHHHHHHhhcCccccccccccCCCCCCHHHHHHHHHHHHHhcccCCCCCCc-----hhhHHH
Q 003278 342 DQIILLDWIRRLSDEGKVLQAGDNRLSDGSYKLCDMEHLTHLALLCTLHNPHLRPS-----MKWVIE 403 (834)
Q Consensus 342 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----m~~V~~ 403 (834)
+... ........ .. +.+. ... ...+.++...||+.||++||+ ++|+++
T Consensus 239 ~~~~--~i~~~~~~-~~------~~~~-~~~----s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 239 NSQA--EISRRILK-SE------PPYP-QEM----SALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp CCHH--HHHHHHHH-CC------CCCC-TTS----CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred HHHH--HHHHhccc-CC------CCCc-ccC----CHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 3211 11111111 11 1111 111 246788999999999999996 566654
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-41 Score=372.38 Aligned_cols=259 Identities=18% Similarity=0.205 Sum_probs=192.8
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCC----eEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQG----EMLV 587 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~----~~~l 587 (834)
+.|...+.||+|+||+||+|.. .+++.||||++.........+++.+|+++|++++|||||++++++.... ..++
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 4577778999999999999985 5789999999986666666778999999999999999999999987643 2345
Q ss_pred EEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecc
Q 003278 588 IYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAE 667 (834)
Q Consensus 588 v~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~ 667 (834)
++||+.+|+|.+++... .+++.....++.|++.||+|||+ .+||||||||+||||++++.+||+|||+|+
T Consensus 88 l~~~~~~g~L~~~l~~~-------~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~ 157 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKTQ-------HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLAR 157 (345)
T ss_dssp EEEECCCEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEeecCCchhhhhhcC-------CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCcee
Confidence 56677899999998643 37899999999999999999997 699999999999999999999999999998
Q ss_pred ccccCCCCCcccccCccccccccCccchhccc-cCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhc
Q 003278 668 FLTRNDHGHRKATSGNRSVRGIFGYMSPEYIE-SGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARK 746 (834)
Q Consensus 668 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~ 746 (834)
........ .......+||+.|+|||++. ...++.++||||+||++|||+||+.||................ .
T Consensus 158 ~~~~~~~~----~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~---~ 230 (345)
T d1pmea_ 158 VADPDHDH----TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL---G 230 (345)
T ss_dssp ECCGGGCB----CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH---C
T ss_pred eccCCCcc----ceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhc---c
Confidence 75433211 11223467999999999985 4567889999999999999999999986543322211111100 0
Q ss_pred Ccccccc--------------cc--------ccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 747 RPLAELV--------------DL--------SLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 747 ~~~~~~~--------------d~--------~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
.+..... .+ .+....+ .++..+..+|++.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s----~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 231 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNAD----SKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp SCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSC----HHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000 00 0001111 13556777999999999999999986
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-41 Score=369.99 Aligned_cols=254 Identities=19% Similarity=0.246 Sum_probs=186.6
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCC-ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCC------e
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSK-CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQG------E 584 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~-~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~------~ 584 (834)
+.|...+.||+|+||+||+|.. .+|+.||||++.... .....+.+.+|+++|++++|||||+++++|...+ .
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~ 97 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 97 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence 4677778899999999999996 568999999997543 3445678999999999999999999999997654 5
Q ss_pred EEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeee
Q 003278 585 MLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFA 664 (834)
Q Consensus 585 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfG 664 (834)
+++||||+ +.+|..+.... .+++.....++.|++.||+|||+ .+||||||||+|||++.++.+|++|||
T Consensus 98 ~~lv~e~~-~~~l~~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg 166 (346)
T d1cm8a_ 98 FYLVMPFM-GTDLGKLMKHE-------KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFG 166 (346)
T ss_dssp CEEEEECC-SEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEecc-cccHHHHHHhc-------cccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhccccccccccccc
Confidence 79999999 55777766432 38899999999999999999997 699999999999999999999999999
Q ss_pred eccccccCCCCCcccccCccccccccCccchhccccC-CCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHH
Q 003278 665 LAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESG-EATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFE 743 (834)
Q Consensus 665 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~ 743 (834)
+|+..... .+...||+.|||||.+.+. .++.++||||+||++|||+||+.||........+ .......
T Consensus 167 ~a~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~-~~~~~~~ 235 (346)
T d1cm8a_ 167 LARQADSE----------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQL-KEIMKVT 235 (346)
T ss_dssp TCEECCSS----------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHHH
T ss_pred ceeccCCc----------cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHH-HHHHhcc
Confidence 99764321 2346799999999998764 5688999999999999999999998654322211 1111100
Q ss_pred hhc-----------------Cccccccc---cccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 744 ARK-----------------RPLAELVD---LSLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 744 ~~~-----------------~~~~~~~d---~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
... ..+.+... ..+....+ .+ ++.++.+|+..||++|||+.||++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s-~~---~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 236 GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNAS-PL---AVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp CCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCC-HH---HHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCC-HH---HHHHHHHHCcCChhHCcCHHHHhc
Confidence 000 00000000 00111112 23 345566899999999999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-41 Score=366.55 Aligned_cols=267 Identities=15% Similarity=0.247 Sum_probs=191.5
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCC-hhHHHHHHHHHHHHHhccCCCceeEEEEEee--------C
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKC-PALRTRFSNELQNLARLRHRNLVQLCGWCTE--------Q 582 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~-~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~--------~ 582 (834)
++|...+.||+|+||+||+|.. .+++.||||++..... .....++.+|+++|++++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 5677788999999999999996 5789999999865432 2344678999999999999999999998855 3
Q ss_pred CeEEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEee
Q 003278 583 GEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGS 662 (834)
Q Consensus 583 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~D 662 (834)
+..++||||+.++++..+.... ..++......|+.|++.||.|||+ .+|+||||||+||||+.++.+||+|
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~~------~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~d 160 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNVL------VKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLAD 160 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCTT------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECC
T ss_pred ceEEEEEeccCCCccchhhhcc------cccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeee
Confidence 4689999999998887554322 136677778899999999999997 6999999999999999999999999
Q ss_pred eeeccccccCCCCCcccccCccccccccCccchhccccC-CCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHH
Q 003278 663 FALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESG-EATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHE 741 (834)
Q Consensus 663 fGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~ 741 (834)
||+++........ ......+.+||+.|+|||.+.+. .|+.++|||||||++|||+||+.||....+... ......
T Consensus 161 fg~~~~~~~~~~~---~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~-~~~i~~ 236 (318)
T d3blha1 161 FGLARAFSLAKNS---QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ-LALISQ 236 (318)
T ss_dssp CTTCEECCC--------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHH
T ss_pred cceeeeccccccc---ccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHH-HHHHHH
Confidence 9999765433211 11223346799999999998765 689999999999999999999999875433222 222222
Q ss_pred HHhhcC--cccccccc--------ccCCCCCHHH-H------HHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 742 FEARKR--PLAELVDL--------SLNGEYNHKE-L------MRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 742 ~~~~~~--~~~~~~d~--------~l~~~~~~~~-~------~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
...... ........ .........+ + ..++.++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 237 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp HHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 211100 00000000 0000111111 1 13456777999999999999999984
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-42 Score=374.20 Aligned_cols=256 Identities=23% Similarity=0.246 Sum_probs=186.2
Q ss_pred CcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCceeEEEEEeeC------CeEE
Q 003278 514 NFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLVQLCGWCTEQ------GEML 586 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~------~~~~ 586 (834)
+|...+.||+|+||+||+|.. .+++.||||++..... .+.+|+++|++++|||||++++++... ..++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence 456677899999999999997 4689999999875432 234699999999999999999998543 3578
Q ss_pred EEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCC-CceEeeeee
Q 003278 587 VIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDM-NPRLGSFAL 665 (834)
Q Consensus 587 lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~-~~ki~DfGl 665 (834)
+|||||+++++..+...... ...+++..+..|+.|++.||+|||+ .+||||||||+||||+.++ .+||+|||+
T Consensus 96 lv~Ey~~~~~~~~l~~~~~~---~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~ 169 (350)
T d1q5ka_ 96 LVLDYVPETVYRVARHYSRA---KQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGS 169 (350)
T ss_dssp EEEECCSEEHHHHHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred EEEeccCCccHHHHHhhhhc---cCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccc
Confidence 99999998765544322111 1248899999999999999999996 7999999999999999775 899999999
Q ss_pred ccccccCCCCCcccccCccccccccCccchhcccc-CCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHH-
Q 003278 666 AEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIES-GEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFE- 743 (834)
Q Consensus 666 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~- 743 (834)
++.+.... ...+..||+.|+|||.+.+ ..|+.++||||+||++|||+||+.||........+.. +....
T Consensus 170 a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~-i~~~~g 240 (350)
T d1q5ka_ 170 AKQLVRGE--------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE-IIKVLG 240 (350)
T ss_dssp CEECCTTS--------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHH-HHHHHC
T ss_pred hhhccCCc--------ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHH-HHHHhC
Confidence 98754322 1234579999999998765 4689999999999999999999999865433222211 11110
Q ss_pred --------hhcCc-----ccccccc---ccCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 744 --------ARKRP-----LAELVDL---SLNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 744 --------~~~~~-----~~~~~d~---~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
..... +...... .+......++ +..++.+|+..||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~---~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 241 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPE---AIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp CCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHH---HHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CChHHhhhhhccchhhccccccccCchhhhcccCCCHH---HHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 0000000 0000111223 445556899999999999999985
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-41 Score=371.82 Aligned_cols=261 Identities=23% Similarity=0.274 Sum_probs=194.8
Q ss_pred cCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeC-----CE
Q 003278 110 SNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHE-----DQ 182 (834)
Q Consensus 110 t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-----~~ 182 (834)
+++|+..+.||+|+||+||+|++..+|+.||||++... .....+.+.+|+.+|++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 56799999999999999999999999999999998754 234456789999999999999999999998643 34
Q ss_pred EEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeec
Q 003278 183 LLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDF 262 (834)
Q Consensus 183 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DF 262 (834)
.+++|||+.+|+|.+++.. ..+++..+..|+.||+.||+|||+. +|+||||||+|||++.++.+|++||
T Consensus 97 ~~~i~~~~~gg~L~~~~~~--------~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~df 165 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC--------QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDF 165 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT--------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC
T ss_pred eEEEEEeecCCchhhhccc--------ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCcccccccccccccccc
Confidence 5667788899999999853 3589999999999999999999996 9999999999999999999999999
Q ss_pred cchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCc
Q 003278 263 GLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDD 342 (834)
Q Consensus 263 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~ 342 (834)
|++...... .....||+.|+|||.+.....++.++|||||||++|||+||+.||.....
T Consensus 166 g~a~~~~~~-------------------~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~-- 224 (348)
T d2gfsa1 166 GLARHTDDE-------------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH-- 224 (348)
T ss_dssp ----CCTGG-------------------GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH--
T ss_pred chhcccCcc-------------------cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCH--
Confidence 999754221 23456999999999877666678999999999999999999999864321
Q ss_pred cchHHHHHHHHhhcCc--ccc--------ccccccC-CCCCCHH-----HHHHHHHHHHHhcccCCCCCCchhhHHH
Q 003278 343 QIILLDWIRRLSDEGK--VLQ--------AGDNRLS-DGSYKLC-----DMEHLTHLALLCTLHNPHLRPSMKWVIE 403 (834)
Q Consensus 343 ~~~l~~~~~~~~~~~~--~~~--------~~d~~l~-~~~~~~~-----~~~~l~~l~~~Cl~~~p~~RPsm~~V~~ 403 (834)
......+........ ... .....+. ....... ....+.+|...||+.||.+|||+.|+++
T Consensus 225 -~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 225 -IDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp -HHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -HHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 111111111100000 000 0000000 0000000 1134678999999999999999999986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-41 Score=357.02 Aligned_cols=263 Identities=16% Similarity=0.209 Sum_probs=198.2
Q ss_pred CcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCC-ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeCCeEEEEEec
Q 003278 514 NFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSK-CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQGEMLVIYDY 591 (834)
Q Consensus 514 ~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~-~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~~~~~lv~Ey 591 (834)
.|...+.||+|+||+||+|.. .+++.||||+++... ......++.+|+.+|++++|||||+++++|.+....++|+||
T Consensus 3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~ 82 (292)
T d1unla_ 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeee
Confidence 566778999999999999996 578899999987544 334567899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeeeecccccc
Q 003278 592 SATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFALAEFLTR 671 (834)
Q Consensus 592 ~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~~~~~ 671 (834)
+.+++|..++.... .+++..+..++.|++.||+|||+ .+||||||||+|||++.++.+||+|||+|+....
T Consensus 83 ~~~~~l~~~~~~~~------~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~ 153 (292)
T d1unla_ 83 CDQDLKKYFDSCNG------DLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp CSEEHHHHHHHTTT------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred cccccccccccccc------ccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccC
Confidence 99999988776432 36788888999999999999997 6999999999999999999999999999987543
Q ss_pred CCCCCcccccCccccccccCccchhccccCC-CCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHHhhcC--c
Q 003278 672 NDHGHRKATSGNRSVRGIFGYMSPEYIESGE-ATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFEARKR--P 748 (834)
Q Consensus 672 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~~~~~--~ 748 (834)
... ......+++.|+|||.+.... ++.++|||||||++|||+||+.|+............+........ .
T Consensus 154 ~~~-------~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (292)
T d1unla_ 154 PVR-------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQ 226 (292)
T ss_dssp CCS-------CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred CCc-------cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhh
Confidence 221 122345788899999987665 689999999999999999999997544443333333332221100 0
Q ss_pred c---cccccc----ccCC-----CCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 749 L---AELVDL----SLNG-----EYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 749 ~---~~~~d~----~l~~-----~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
. ....+. .... ......-..+.++..+|++.||.+|||++||++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 000000 0000 000000123445556899999999999999874
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-41 Score=365.76 Aligned_cols=253 Identities=19% Similarity=0.226 Sum_probs=193.6
Q ss_pred hCcCcCCcccccCCcEEEEEEE----CCCcEEEEEEecCCC---ChhHHHHHHHHHHHHHhccC-CCceeEEEEEeeCCe
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL----DNHQYVLVKRLGMSK---CPALRTRFSNELQNLARLRH-RNLVQLCGWCTEQGE 584 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~----~~~~~vavK~~~~~~---~~~~~~~f~~E~~~l~~l~H-pNiv~l~g~~~~~~~ 584 (834)
++|...+.||+|+||+||+|.. .+|+.||||.++... .....+.+.+|+++|++++| ||||++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 4688888999999999999985 247899999986432 12234568899999999987 899999999999999
Q ss_pred EEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeee
Q 003278 585 MLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFA 664 (834)
Q Consensus 585 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfG 664 (834)
.+++|||+.+|+|..++..... +.......++.|++.||+|||+ .+||||||||+|||||.++.+||+|||
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~------~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG 174 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRER------FTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFG 174 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSC------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSS
T ss_pred eeeeeecccccHHHHHHHhccc------ccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeecc
Confidence 9999999999999999876532 4566677899999999999997 689999999999999999999999999
Q ss_pred eccccccCCCCCcccccCccccccccCccchhccccC--CCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHH
Q 003278 665 LAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESG--EATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEF 742 (834)
Q Consensus 665 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~ 742 (834)
+|+.+..... ....+..||+.|+|||.+.+. .++.++|||||||+||||+||+.||................
T Consensus 175 ~a~~~~~~~~------~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~ 248 (322)
T d1vzoa_ 175 LSKEFVADET------ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI 248 (322)
T ss_dssp EEEECCGGGG------GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH
T ss_pred chhhhccccc------ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 9986543221 112346799999999999754 46789999999999999999999997654443322222221
Q ss_pred HhhcCccccccccccCCCCCHHHHHHHHHHHHHhccCCCCCCCC-----hhHHHH
Q 003278 743 EARKRPLAELVDLSLNGEYNHKELMRLIKLGIACTLSNPELRPS-----MRQILS 792 (834)
Q Consensus 743 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPt-----m~~v~~ 792 (834)
.....+ +....+ .+ +..++.+||+.||++||| ++|+++
T Consensus 249 ~~~~~~--------~~~~~s-~~---~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 249 LKSEPP--------YPQEMS-AL---AKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp HHCCCC--------CCTTSC-HH---HHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ccCCCC--------CcccCC-HH---HHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 111111 111222 33 444556899999999995 566653
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-40 Score=366.16 Aligned_cols=260 Identities=22% Similarity=0.237 Sum_probs=187.6
Q ss_pred CCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEeccc--ChhhHHHHHHHHHHHHhCCCCceeeEeeeEEeC------CE
Q 003278 111 NGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK--GERFEKTFAAELVAVAHLRHRNLVRLRGWCVHE------DQ 182 (834)
Q Consensus 111 ~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------~~ 182 (834)
++|+..++||+|+||+||+|++..+|+.||||++... .....+.+.+|+.+|++++|||||+++++|... +.
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 5799999999999999999999999999999998653 334456789999999999999999999999643 68
Q ss_pred EEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCceEEeec
Q 003278 183 LLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYNARLGDF 262 (834)
Q Consensus 183 ~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~~kl~DF 262 (834)
+|+|||||.++.+. .+. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+|++||
T Consensus 97 ~~iv~Ey~~~~l~~-~~~---------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df 163 (355)
T d2b1pa1 97 VYLVMELMDANLCQ-VIQ---------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_dssp EEEEEECCSEEHHH-HHT---------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC
T ss_pred eEEEEeccchHHHH-hhh---------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeech
Confidence 99999999766554 442 3478999999999999999999996 9999999999999999999999999
Q ss_pred cchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCCccCCCCCCCc
Q 003278 263 GLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGRRAVDLTYPDD 342 (834)
Q Consensus 263 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~~p~~~~~~~~ 342 (834)
|+++...... ..+...||+.|+|||.+.. ..++.++||||+||+++||++|+.||.......
T Consensus 164 ~~~~~~~~~~-----------------~~~~~~~t~~y~aPE~l~~-~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~ 225 (355)
T d2b1pa1 164 GLARTAGTSF-----------------MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 225 (355)
T ss_dssp CC--------------------------------CCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred hhhhcccccc-----------------ccccccccccccChhhhcC-CCCCCCcccccccchHHHHhhCCCCCCCCCHHH
Confidence 9987543211 1345579999999999865 478999999999999999999999986432111
Q ss_pred cchHHHH------------------HHHHhhcC-ccc-----cccccccCCCCC--CHHHHHHHHHHHHHhcccCCCCCC
Q 003278 343 QIILLDW------------------IRRLSDEG-KVL-----QAGDNRLSDGSY--KLCDMEHLTHLALLCTLHNPHLRP 396 (834)
Q Consensus 343 ~~~l~~~------------------~~~~~~~~-~~~-----~~~d~~l~~~~~--~~~~~~~l~~l~~~Cl~~~p~~RP 396 (834)
.+... ........ ... ............ .......+.+|+..||+.||++||
T Consensus 226 --~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ 303 (355)
T d2b1pa1 226 --QWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 303 (355)
T ss_dssp --HHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSC
T ss_pred --HHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCc
Confidence 00000 01111100 000 000000000000 112234578899999999999999
Q ss_pred chhhHHH
Q 003278 397 SMKWVIE 403 (834)
Q Consensus 397 sm~~V~~ 403 (834)
|++|+++
T Consensus 304 ta~elL~ 310 (355)
T d2b1pa1 304 SVDDALQ 310 (355)
T ss_dssp CHHHHHT
T ss_pred CHHHHhc
Confidence 9999986
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=9.2e-40 Score=354.98 Aligned_cols=195 Identities=16% Similarity=0.248 Sum_probs=165.0
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhcc-CCCceeEEEEEee--CCeEEEE
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLR-HRNLVQLCGWCTE--QGEMLVI 588 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~-HpNiv~l~g~~~~--~~~~~lv 588 (834)
++|...++||+|+||+||+|.. .+++.||||+++... .+++.+|+++|.+++ |||||++++++.. ....++|
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 4677788999999999999996 568999999986432 457889999999996 9999999999874 3568999
Q ss_pred EeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCC-CceEeeeeecc
Q 003278 589 YDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDM-NPRLGSFALAE 667 (834)
Q Consensus 589 ~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~-~~ki~DfGla~ 667 (834)
|||+.+|+|..+.. .+++.....++.||+.||+|||+ .+||||||||+|||++.++ .+||+|||+|+
T Consensus 111 ~e~~~~~~L~~~~~---------~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~ 178 (328)
T d3bqca1 111 FEHVNNTDFKQLYQ---------TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 178 (328)
T ss_dssp EECCCSCBGGGTTT---------SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred EeecCCCcHHHHhc---------CCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccce
Confidence 99999999977642 37788888999999999999997 6999999999999999655 58999999998
Q ss_pred ccccCCCCCcccccCccccccccCccchhccccC-CCCccCcchhhHHHHHHHHhCCCccCCCCC
Q 003278 668 FLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESG-EATSMADVYSFGVVVLEVVTGQMAVDFRLP 731 (834)
Q Consensus 668 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~ 731 (834)
.+.... ......||+.|+|||.+.+. .++.++||||+||++|||++|+.|+.....
T Consensus 179 ~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~ 235 (328)
T d3bqca1 179 FYHPGQ--------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 235 (328)
T ss_dssp ECCTTC--------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred eccCCC--------cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCch
Confidence 754322 12345799999999998765 479999999999999999999999865443
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-39 Score=357.22 Aligned_cols=259 Identities=17% Similarity=0.161 Sum_probs=185.4
Q ss_pred hCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCC-ChhHHHHHHHHHHHHHhccCCCceeEEEEEee------CCe
Q 003278 513 NNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSK-CPALRTRFSNELQNLARLRHRNLVQLCGWCTE------QGE 584 (834)
Q Consensus 513 ~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~-~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~------~~~ 584 (834)
+.|...+.||+|+||+||+|.. .+|+.||||++.... ......++.+|+.+|++++|||||++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 4577778999999999999996 468999999997543 33455678999999999999999999999864 368
Q ss_pred EEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeee
Q 003278 585 MLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFA 664 (834)
Q Consensus 585 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfG 664 (834)
.|+||||+.++++..+. ..+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+|++|||
T Consensus 97 ~~iv~Ey~~~~l~~~~~---------~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~ 164 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQ---------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_dssp EEEEEECCSEEHHHHHT---------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred eEEEEeccchHHHHhhh---------cCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechh
Confidence 89999999887665442 137888889999999999999997 699999999999999999999999999
Q ss_pred eccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHH--
Q 003278 665 LAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEF-- 742 (834)
Q Consensus 665 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~-- 742 (834)
+++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||........ ...+...
T Consensus 165 ~~~~~~~~--------~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~-~~~i~~~~~ 235 (355)
T d2b1pa1 165 LARTAGTS--------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLG 235 (355)
T ss_dssp C-----------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHC
T ss_pred hhhccccc--------cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHH-HHHHHHhcc
Confidence 98764322 122346799999999999999999999999999999999999999864332111 1111110
Q ss_pred -----------------HhhcCccc-----cccccccCCCCC---HHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 743 -----------------EARKRPLA-----ELVDLSLNGEYN---HKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 743 -----------------~~~~~~~~-----~~~d~~l~~~~~---~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
........ ............ ...-..+..++.+|++.||++|||++||++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 236 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp CCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000000 000000001111 112235667778999999999999999984
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-39 Score=352.26 Aligned_cols=256 Identities=17% Similarity=0.202 Sum_probs=188.5
Q ss_pred hhCcCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCC-ChhHHHHHHHHHHHHHhccCCCceeEEEEEeeC-----Ce
Q 003278 512 TNNFSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSK-CPALRTRFSNELQNLARLRHRNLVQLCGWCTEQ-----GE 584 (834)
Q Consensus 512 t~~f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~-~~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~~~-----~~ 584 (834)
++.|...+.||+|+||+||+|.. .+|+.||||++.... .....+++.+|+++|++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 45677788999999999999985 579999999987543 334456789999999999999999999998632 34
Q ss_pred EEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceEeeee
Q 003278 585 MLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRLGSFA 664 (834)
Q Consensus 585 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki~DfG 664 (834)
.+++|||+.+|+|.+++... .+++.....++.||+.||+|||+ .+|+||||||+|||++.++.+|++|||
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~-------~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg 166 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ-------KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFG 166 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC-------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC-
T ss_pred eEEEEEeecCCchhhhcccc-------cccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccc
Confidence 56778888999999998532 38888999999999999999997 699999999999999999999999999
Q ss_pred eccccccCCCCCcccccCccccccccCccchhccccCC-CCccCcchhhHHHHHHHHhCCCccCCCCCchhHHHHHHHHH
Q 003278 665 LAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGE-ATSMADVYSFGVVVLEVVTGQMAVDFRLPEGLLVKRVHEFE 743 (834)
Q Consensus 665 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~~~~~~~~~~ 743 (834)
++...... ..+..||+.|+|||.+.+.. ++.++|||||||++|||+||+.||........ ...+....
T Consensus 167 ~a~~~~~~----------~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~-~~~i~~~~ 235 (348)
T d2gfsa1 167 LARHTDDE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLILRLV 235 (348)
T ss_dssp ---CCTGG----------GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHH
T ss_pred hhcccCcc----------cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHH-HHHHHHhc
Confidence 99654221 23457999999999876654 58899999999999999999999864432211 11111110
Q ss_pred hhcC-----------------ccccccccc---cCCCCCHHHHHHHHHHHHHhccCCCCCCCChhHHHH
Q 003278 744 ARKR-----------------PLAELVDLS---LNGEYNHKELMRLIKLGIACTLSNPELRPSMRQILS 792 (834)
Q Consensus 744 ~~~~-----------------~~~~~~d~~---l~~~~~~~~~~~l~~l~~~C~~~~P~~RPtm~~v~~ 792 (834)
.... ......... ..... .. .+..++.+|++.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-s~---~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 236 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA-NP---LAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp CCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTC-CH---HHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCC-CH---HHHHHHHHHCcCChhhCcCHHHHhc
Confidence 0000 000000000 00011 12 3455666999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.3e-36 Score=332.56 Aligned_cols=266 Identities=18% Similarity=0.247 Sum_probs=188.8
Q ss_pred CCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCC-----------CCceeeEeeeEEe-
Q 003278 112 GFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLR-----------HRNLVRLRGWCVH- 179 (834)
Q Consensus 112 ~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-----------H~nIv~l~g~~~~- 179 (834)
.|++.++||+|+||+||+|+...+|+.||||+++.. ....+.+.+|+.++++++ |+|||++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 388899999999999999999999999999999754 334567888999988875 5789999998865
Q ss_pred -CCEEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCc--
Q 003278 180 -EDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYN-- 256 (834)
Q Consensus 180 -~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~-- 256 (834)
....+++|+++..+.......... ....+++..+..++.|+++||+|||+. .+|+||||||+|||++.++.
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKY----EHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHT----TTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTT
T ss_pred cccceeeeeeecccccccccccccc----cccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCccc
Confidence 356777888776655433332211 235688899999999999999999983 48999999999999986543
Q ss_pred ----eEEeeccchhhhhhhhhhhhhcccccccccccccceeeeccccCCCccccccCCCCCcccceeehhhHHHHHHhCC
Q 003278 257 ----ARLGDFGLARWLEHELQYQMRTSSARNHQFHLAETTRIGGTIGYLPPESFQKGSVATAKSDVFSFGIVVLEVVSGR 332 (834)
Q Consensus 257 ----~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ksDV~SfGvvl~ElltG~ 332 (834)
+|++|||.|+.... ......||+.|+|||.+... .++.++||||+||+++||+||+
T Consensus 167 ~~~~~kl~dfg~s~~~~~-------------------~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~ 226 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDE-------------------HYTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGD 226 (362)
T ss_dssp TEEEEEECCCTTCEETTB-------------------CCCSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSS
T ss_pred ccceeeEeeccccccccc-------------------ccccccccccccChhhcccc-CCCccccccchHHHHHHHHHCC
Confidence 89999999874321 12345699999999988755 5789999999999999999999
Q ss_pred ccCCCCCCCccc----hHHHHHHHHh-------hcC----------cccccccc-cc--------CCCCCCHHHHHHHHH
Q 003278 333 RAVDLTYPDDQI----ILLDWIRRLS-------DEG----------KVLQAGDN-RL--------SDGSYKLCDMEHLTH 382 (834)
Q Consensus 333 ~p~~~~~~~~~~----~l~~~~~~~~-------~~~----------~~~~~~d~-~l--------~~~~~~~~~~~~l~~ 382 (834)
.||......... .+...+..+. ..+ ........ .. ............+.+
T Consensus 227 ~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 306 (362)
T d1q8ya_ 227 FLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD 306 (362)
T ss_dssp CCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHH
T ss_pred CCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHH
Confidence 998643322111 1111111100 000 00000000 00 001122334567889
Q ss_pred HHHHhcccCCCCCCchhhHHHH
Q 003278 383 LALLCTLHNPHLRPSMKWVIEA 404 (834)
Q Consensus 383 l~~~Cl~~~p~~RPsm~~V~~~ 404 (834)
|...|+..||.+|||++|+++.
T Consensus 307 ll~~mL~~dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 307 FLSPMLQLDPRKRADAGGLVNH 328 (362)
T ss_dssp HHGGGGCSSTTTCBCHHHHHTC
T ss_pred HHHHHCCCChhHCcCHHHHhcC
Confidence 9999999999999999999863
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.6e-34 Score=314.96 Aligned_cols=261 Identities=13% Similarity=0.161 Sum_probs=182.3
Q ss_pred cCcCCcccccCCcEEEEEEE-CCCcEEEEEEecCCCChhHHHHHHHHHHHHHhcc-----------CCCceeEEEEEee-
Q 003278 515 FSESQRVAEMDFGTAYQGFL-DNHQYVLVKRLGMSKCPALRTRFSNELQNLARLR-----------HRNLVQLCGWCTE- 581 (834)
Q Consensus 515 f~~~~~ig~g~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~-----------HpNiv~l~g~~~~- 581 (834)
|...+.||+|+||+||+|.. .+|+.||||+++.. ....+.+.+|+.++++++ |||||++++++..
T Consensus 15 Y~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~--~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc--ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 66678899999999999996 57899999998643 234467888999998886 4789999988754
Q ss_pred -CCeEEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCC---
Q 003278 582 -QGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMN--- 657 (834)
Q Consensus 582 -~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~--- 657 (834)
....+++|+++..+.......... ....+++.....++.|++.||+|||+. .+|+||||||+||||+.++.
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKY---EHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTT
T ss_pred cccceeeeeeecccccccccccccc---cccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCcccc
Confidence 355677777766554332222211 122467778889999999999999973 68999999999999986654
Q ss_pred ---ceEeeeeeccccccCCCCCcccccCccccccccCccchhccccCCCCccCcchhhHHHHHHHHhCCCccCCCCCchh
Q 003278 658 ---PRLGSFALAEFLTRNDHGHRKATSGNRSVRGIFGYMSPEYIESGEATSMADVYSFGVVVLEVVTGQMAVDFRLPEGL 734 (834)
Q Consensus 658 ---~ki~DfGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~k~DV~SfGvvl~E~~tG~~p~~~~~~~~~ 734 (834)
+|++|||.|...... .....||+.|+|||++....++.++||||+||+++||+||+.||........
T Consensus 168 ~~~~kl~dfg~s~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~ 237 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDEH----------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY 237 (362)
T ss_dssp EEEEEECCCTTCEETTBC----------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred cceeeEeecccccccccc----------cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccc
Confidence 899999998754321 2245799999999999999999999999999999999999999864321110
Q ss_pred -----HHHHHHHHHh--------hcCccccccc-----cc--------------cCCCCCHHHHHHHHHHHHHhccCCCC
Q 003278 735 -----LVKRVHEFEA--------RKRPLAELVD-----LS--------------LNGEYNHKELMRLIKLGIACTLSNPE 782 (834)
Q Consensus 735 -----~~~~~~~~~~--------~~~~~~~~~d-----~~--------------l~~~~~~~~~~~l~~l~~~C~~~~P~ 782 (834)
.......... .........+ .. ............+..+..+|++.||+
T Consensus 238 ~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~ 317 (362)
T d1q8ya_ 238 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR 317 (362)
T ss_dssp -CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred cchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChh
Confidence 0000000000 0000000000 00 01112334455677888899999999
Q ss_pred CCCChhHHHH
Q 003278 783 LRPSMRQILS 792 (834)
Q Consensus 783 ~RPtm~~v~~ 792 (834)
+|||+.|+++
T Consensus 318 ~Rpta~e~L~ 327 (362)
T d1q8ya_ 318 KRADAGGLVN 327 (362)
T ss_dssp TCBCHHHHHT
T ss_pred HCcCHHHHhc
Confidence 9999999975
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=1.3e-23 Score=208.36 Aligned_cols=132 Identities=14% Similarity=0.195 Sum_probs=104.2
Q ss_pred CCCeeeccCCeEEEEEEECCCCeEEEEEEecccC------------------hhhHHHHHHHHHHHHhCCCCceeeEeee
Q 003278 115 EDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKG------------------ERFEKTFAAELVAVAHLRHRNLVRLRGW 176 (834)
Q Consensus 115 ~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~------------------~~~~~~~~~E~~~l~~l~H~nIv~l~g~ 176 (834)
+.++||+|+||+||+|++ .+|+.||||+++... ......+..|...+.++.|+|++..+++
T Consensus 4 vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 467999999999999998 579999999864210 0112345678889999999999998865
Q ss_pred EEeCCEEEEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhccCCCeecCCCCCCceEECCCCc
Q 003278 177 CVHEDQLLLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQLETQIIHRDVKTSNVMLDSQYN 256 (834)
Q Consensus 177 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlKp~NILld~~~~ 256 (834)
. . .++||||++++.+.. +++.....++.|+++||+|||+. +|+||||||+|||++++ .
T Consensus 83 ~--~--~~lvme~~~~~~~~~--------------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~ 140 (191)
T d1zara2 83 E--G--NAVLMELIDAKELYR--------------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-G 140 (191)
T ss_dssp E--T--TEEEEECCCCEEGGG--------------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-E
T ss_pred c--C--CEEEEEeeccccccc--------------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-C
Confidence 3 2 379999998765532 23334568999999999999996 99999999999999965 5
Q ss_pred eEEeeccchhhhh
Q 003278 257 ARLGDFGLARWLE 269 (834)
Q Consensus 257 ~kl~DFGla~~~~ 269 (834)
++|+|||+|+...
T Consensus 141 ~~liDFG~a~~~~ 153 (191)
T d1zara2 141 IWIIDFPQSVEVG 153 (191)
T ss_dssp EEECCCTTCEETT
T ss_pred EEEEECCCcccCC
Confidence 9999999997543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=2.9e-22 Score=198.56 Aligned_cols=131 Identities=9% Similarity=0.157 Sum_probs=103.8
Q ss_pred CCcccccCCcEEEEEEECCCcEEEEEEecCCCC-----------------hhHHHHHHHHHHHHHhccCCCceeEEEEEe
Q 003278 518 SQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKC-----------------PALRTRFSNELQNLARLRHRNLVQLCGWCT 580 (834)
Q Consensus 518 ~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~-----------------~~~~~~f~~E~~~l~~l~HpNiv~l~g~~~ 580 (834)
.++||+|+||+||+|...+|+.||||.+..... ......+.+|...|.++.|+|++..+++..
T Consensus 5 g~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~~ 84 (191)
T d1zara2 5 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWEG 84 (191)
T ss_dssp EEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEET
T ss_pred CCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEecC
Confidence 578999999999999998999999998653211 011234567899999999999999887642
Q ss_pred eCCeEEEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhccCCceeecccccCceeecCCCCceE
Q 003278 581 EQGEMLVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEWNEQVIHRNITSSAITLDPDMNPRL 660 (834)
Q Consensus 581 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~~~~iiHrDlK~~NILld~~~~~ki 660 (834)
.+++|||++++.+..+ +......++.|++.||+|||+ .+|+||||||+|||+++++ +++
T Consensus 85 ----~~lvme~~~~~~~~~l-------------~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~~-~~l 143 (191)
T d1zara2 85 ----NAVLMELIDAKELYRV-------------RVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEEG-IWI 143 (191)
T ss_dssp ----TEEEEECCCCEEGGGC-------------CCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETTE-EEE
T ss_pred ----CEEEEEeeccccccch-------------hhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCCC-EEE
Confidence 2689999998765432 223345799999999999997 6999999999999999764 899
Q ss_pred eeeeecccc
Q 003278 661 GSFALAEFL 669 (834)
Q Consensus 661 ~DfGla~~~ 669 (834)
+|||+|...
T Consensus 144 iDFG~a~~~ 152 (191)
T d1zara2 144 IDFPQSVEV 152 (191)
T ss_dssp CCCTTCEET
T ss_pred EECCCcccC
Confidence 999999653
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.22 E-value=2e-06 Score=86.96 Aligned_cols=148 Identities=16% Similarity=0.082 Sum_probs=94.6
Q ss_pred HHHhhcCCCCCCCeeeccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCC-CCceeeEeeeEEeCCEE
Q 003278 105 ELYIGSNGFDEDEVLGSGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLR-HRNLVRLRGWCVHEDQL 183 (834)
Q Consensus 105 el~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~ 183 (834)
||..--..|...+..+-++.+.||+... ++..+.||+...........+.+|...+..+. +--+.+++.++..++..
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 3333334555443333344568998764 55667788775443333334677888877664 33356788888889999
Q ss_pred EEEEEccCCCCHhHHHhcCCCccccCCCCCHHHHHHHHHHHHHHHHHHHhcc----------------------------
Q 003278 184 LLVYDYMPNRSLDRVLFRRPENLEAAAPLNWEQRKKIIRGLAAALHYLHEQL---------------------------- 235 (834)
Q Consensus 184 ~lV~Ey~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------- 235 (834)
++||+++++.++....... .....++.++++.|+.||+..
T Consensus 86 ~lv~~~l~G~~~~~~~~~~------------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE------------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADV 153 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC------------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCC
T ss_pred EEEEEeccccccccccccc------------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhh
Confidence 9999999998875543210 012234455555555555321
Q ss_pred ----------------------------CCCeecCCCCCCceEECCCCceEEeeccchh
Q 003278 236 ----------------------------ETQIIHRDVKTSNVMLDSQYNARLGDFGLAR 266 (834)
Q Consensus 236 ----------------------------~~~iiHrDlKp~NILld~~~~~kl~DFGla~ 266 (834)
...++|+|+.|.|||++++...-|.||+.+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 154 DCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1237999999999999987666799998775
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.70 E-value=8.8e-05 Score=74.38 Aligned_cols=148 Identities=11% Similarity=0.049 Sum_probs=89.8
Q ss_pred HHHHHhhCcCcCCcccccCCcEEEEEEECCCcEEEEEEecCCCChhHHHHHHHHHHHHHhcc-CCCceeEEEEEeeCCeE
Q 003278 507 EIISATNNFSESQRVAEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLR-HRNLVQLCGWCTEQGEM 585 (834)
Q Consensus 507 el~~at~~f~~~~~ig~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~-HpNiv~l~g~~~~~~~~ 585 (834)
||.+--.+|......+.++-..||+...+++ .+.||+....... ....+.+|...+..+. |--+-++++++.+.+..
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~~~~-~~vlk~~~~~~~~-~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGENE-NLYLKMTDSRYKG-TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEECSSC-EEEEEEECGGGTT-STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEeCCC-eEEEEEcCCCccc-chhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 3333334444332222223468998765444 4567876432211 1124567888887764 32345678888888899
Q ss_pred EEEEeccCCCchhhhhhcCCCCCCCcccCHHHHHHHHHHHHHHHHHhhhcc-----------------------------
Q 003278 586 LVIYDYSATRILSHLLFHNNHRIGHSILQWHHRYNIIKSLASAILYLHEEW----------------------------- 636 (834)
Q Consensus 586 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~l~~~~r~~i~~~ia~gl~yLH~~~----------------------------- 636 (834)
++||++.++..+........ ....++.++++.++-||+..
T Consensus 86 ~lv~~~l~G~~~~~~~~~~~-----------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDEQ-----------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVD 154 (263)
T ss_dssp EEEEECCSSEEHHHHTTTCS-----------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCC
T ss_pred EEEEEecccccccccccccc-----------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhh
Confidence 99999999988865432110 11234455555555555310
Q ss_pred ---------------------------CCceeecccccCceeecCCCCceEeeeeecc
Q 003278 637 ---------------------------NEQVIHRNITSSAITLDPDMNPRLGSFALAE 667 (834)
Q Consensus 637 ---------------------------~~~iiHrDlK~~NILld~~~~~ki~DfGla~ 667 (834)
...++|+|+.|.|||++++...-|.||+.+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 155 CENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1237999999999999987666688887764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.56 E-value=9.8e-05 Score=73.65 Aligned_cols=74 Identities=15% Similarity=0.107 Sum_probs=50.8
Q ss_pred eeeccCC-eEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCC--CceeeEeeeEEeCCEEEEEEEccCCCC
Q 003278 118 VLGSGGF-GKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRH--RNLVRLRGWCVHEDQLLLVYDYMPNRS 194 (834)
Q Consensus 118 ~LG~G~f-G~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~g~~~~~~~~~lV~Ey~~~gs 194 (834)
.+..|.. +.||+... .++..+.+|.-..... ..+..|...++.+.. --+.++++++.+++..++||||++|.+
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 92 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence 3444543 67999876 5677788887654322 235567777665543 335678888888889999999998866
Q ss_pred H
Q 003278 195 L 195 (834)
Q Consensus 195 L 195 (834)
+
T Consensus 93 ~ 93 (255)
T d1nd4a_ 93 L 93 (255)
T ss_dssp T
T ss_pred c
Confidence 5
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.48 E-value=0.00025 Score=70.59 Aligned_cols=75 Identities=12% Similarity=0.026 Sum_probs=53.2
Q ss_pred ccccCC-cEEEEEEECCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCC--ceeEEEEEeeCCeEEEEEeccCCCch
Q 003278 521 VAEMDF-GTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRN--LVQLCGWCTEQGEMLVIYDYSATRIL 597 (834)
Q Consensus 521 ig~g~~-g~vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpN--iv~l~g~~~~~~~~~lv~Ey~~~g~L 597 (834)
+..|.. +.||+...+++..+.+|....... ..+..|+.+|+.+.... +-++++++.+.+..++||+|+++.++
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTT----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCH----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 444443 678998888887788887654322 23567888887775433 45678888888889999999988776
Q ss_pred hh
Q 003278 598 SH 599 (834)
Q Consensus 598 ~~ 599 (834)
..
T Consensus 94 ~~ 95 (255)
T d1nd4a_ 94 LS 95 (255)
T ss_dssp TT
T ss_pred cc
Confidence 43
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.99 E-value=0.00059 Score=72.75 Aligned_cols=76 Identities=12% Similarity=0.083 Sum_probs=46.8
Q ss_pred CeeeccCCeEEEEEEECCCCeEEEEEEeccc----C---hhhHHHHHHHHHHHHhCC---CCceeeEeeeEEeCCEEEEE
Q 003278 117 EVLGSGGFGKVYRAVLPSDGTVVAVKCLAEK----G---ERFEKTFAAELVAVAHLR---HRNLVRLRGWCVHEDQLLLV 186 (834)
Q Consensus 117 ~~LG~G~fG~Vy~~~~~~~g~~vAvK~l~~~----~---~~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~lV 186 (834)
+.||.|....||+.....+|+.|.||.-... . .....+...|...|..+. ...+.+++.+ +++..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 4689999999999988666788999964321 1 111223445777666542 2346667655 44556899
Q ss_pred EEccCCCC
Q 003278 187 YDYMPNRS 194 (834)
Q Consensus 187 ~Ey~~~gs 194 (834)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99998754
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.64 E-value=0.0015 Score=69.42 Aligned_cols=76 Identities=12% Similarity=0.091 Sum_probs=46.5
Q ss_pred CcccccCCcEEEEEEECC-CcEEEEEEecC------CCChhHHHHHHHHHHHHHhcc-C--CCceeEEEEEeeCCeEEEE
Q 003278 519 QRVAEMDFGTAYQGFLDN-HQYVLVKRLGM------SKCPALRTRFSNELQNLARLR-H--RNLVQLCGWCTEQGEMLVI 588 (834)
Q Consensus 519 ~~ig~g~~g~vy~~~~~~-~~~vavK~~~~------~~~~~~~~~f~~E~~~l~~l~-H--pNiv~l~g~~~~~~~~~lv 588 (834)
+.||.|....||+....+ +..++||.-.. ...+...++...|.++|..+. + ..+.+++++.. +..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~--~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT--EMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET--TTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcC--CCCEEE
Confidence 458999999999988654 56788886431 111212234456887777663 2 34556666544 445789
Q ss_pred EeccCCCc
Q 003278 589 YDYSATRI 596 (834)
Q Consensus 589 ~Ey~~~g~ 596 (834)
|||+++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.25 E-value=0.0045 Score=63.73 Aligned_cols=138 Identities=13% Similarity=0.189 Sum_probs=77.2
Q ss_pred eEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCce-----eeEe--eeEEeCCEEEEEEEccCCCCHh-
Q 003278 125 GKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNL-----VRLR--GWCVHEDQLLLVYDYMPNRSLD- 196 (834)
Q Consensus 125 G~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nI-----v~l~--g~~~~~~~~~lV~Ey~~~gsL~- 196 (834)
-.||++.. .+|..|++|+.... ....+++..|...+..|....| +..- ......+..+.+++|++|..+.
T Consensus 36 N~vy~v~~-~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 36 NRVYQFQD-EDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SEEEEECC-TTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred ceeEEEEc-CCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 47999988 68899999987543 2234567778887776643222 2221 1334567789999999864321
Q ss_pred ----------HH---HhcC--CCccccCCCCCH-------------------HHHHHHHHHHHHHHHHHHh----ccCCC
Q 003278 197 ----------RV---LFRR--PENLEAAAPLNW-------------------EQRKKIIRGLAAALHYLHE----QLETQ 238 (834)
Q Consensus 197 ----------~~---l~~~--~~~~~~~~~l~~-------------------~~~~~i~~~ia~gL~yLH~----~~~~~ 238 (834)
.. +|.. .........+++ ..+..+...+...++.+.. ..+.+
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 00 1110 000000011111 1111222223333333332 23457
Q ss_pred eecCCCCCCceEECCCCceEEeeccchh
Q 003278 239 IIHRDVKTSNVMLDSQYNARLGDFGLAR 266 (834)
Q Consensus 239 iiHrDlKp~NILld~~~~~kl~DFGla~ 266 (834)
+||+|+.+.|||++++ ..+.||+-++
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred eecCCCCcccEEEeCC--ceEEechhcc
Confidence 8999999999999754 4589999775
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.30 E-value=0.028 Score=57.45 Aligned_cols=70 Identities=17% Similarity=0.191 Sum_probs=47.0
Q ss_pred cEEEEEEECCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCc-----eeEEE--EEeeCCeEEEEEeccCCCchh
Q 003278 527 GTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNL-----VQLCG--WCTEQGEMLVIYDYSATRILS 598 (834)
Q Consensus 527 g~vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNi-----v~l~g--~~~~~~~~~lv~Ey~~~g~L~ 598 (834)
-.||+...++|+.+++|........ .+++..|...|..|...+| +..-| .....+..+.+++|++|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~s--~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~ 112 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERWT--ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE 112 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTSC--HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCCC--HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence 5899999999999999987654332 3567788888888754333 11111 123456678899999876543
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.12 E-value=0.016 Score=61.27 Aligned_cols=73 Identities=22% Similarity=0.274 Sum_probs=46.3
Q ss_pred CeeeccCCeEEEEEEECC-------CCeEEEEEEecccChhhHHHHHHHHHHHHhCCCCce-eeEeeeEEeCCEEEEEEE
Q 003278 117 EVLGSGGFGKVYRAVLPS-------DGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHRNL-VRLRGWCVHEDQLLLVYD 188 (834)
Q Consensus 117 ~~LG~G~fG~Vy~~~~~~-------~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~lV~E 188 (834)
+.|+.|-.-.+|++.... .+..|.+++... .... -...+|..+++.+.-.++ .+++++|.+ .+|||
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~-idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETE-SHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCH-HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cchh-hHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 467777778899988743 234566666542 2222 234578888777753444 477877643 68999
Q ss_pred ccCCCCH
Q 003278 189 YMPNRSL 195 (834)
Q Consensus 189 y~~~gsL 195 (834)
|+++.+|
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987544
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=94.23 E-value=0.085 Score=55.26 Aligned_cols=73 Identities=19% Similarity=0.137 Sum_probs=47.2
Q ss_pred CcccccCCcEEEEEEECCC--------cEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCce-eEEEEEeeCCeEEEEE
Q 003278 519 QRVAEMDFGTAYQGFLDNH--------QYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNLV-QLCGWCTEQGEMLVIY 589 (834)
Q Consensus 519 ~~ig~g~~g~vy~~~~~~~--------~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNiv-~l~g~~~~~~~~~lv~ 589 (834)
++|+.|---.+|+....++ ..|.++... ... .. ..-.+|..+++.+.-.+++ ++++++.+ .+||
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~-~~-idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPE-TE-SHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCC-CH-HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccc-hh-hHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 4566667788999887543 345555544 222 22 2234788898888655665 68888754 4789
Q ss_pred eccCCCchh
Q 003278 590 DYSATRILS 598 (834)
Q Consensus 590 Ey~~~g~L~ 598 (834)
||+++..|.
T Consensus 121 efi~g~~l~ 129 (395)
T d1nw1a_ 121 EYIPSRPLS 129 (395)
T ss_dssp CCCCEEECC
T ss_pred EEeccccCC
Confidence 999876554
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=93.30 E-value=0.28 Score=49.11 Aligned_cols=162 Identities=15% Similarity=0.112 Sum_probs=82.4
Q ss_pred ccHHHHHhhcCCCCCCCeee-----ccCCeEEEEEEECCCCeEEEEEEecccChhhHHHHHHHHHHHHhCCCC-----ce
Q 003278 101 FSYAELYIGSNGFDEDEVLG-----SGGFGKVYRAVLPSDGTVVAVKCLAEKGERFEKTFAAELVAVAHLRHR-----NL 170 (834)
Q Consensus 101 f~~~el~~~t~~f~~~~~LG-----~G~fG~Vy~~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~H~-----nI 170 (834)
.+-+|+.....+|...+... .|---+.|+... .+|+ +++|+...... .+....|+.++..|... ..
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t-~~g~-yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~p 78 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHT-TKDP-LILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLP 78 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEE-SSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEE-CCCc-EEEEEcCCCCC--HHHHHHHHHHHHhhhhcccccccc
Confidence 45677777777887765543 444467899887 3454 78898754311 22334456666655332 22
Q ss_pred eeEe-e--eEEeCCEEEEEEEccCCCCHhH--------------HHhcCCCcc--c-cCCCC-----------------C
Q 003278 171 VRLR-G--WCVHEDQLLLVYDYMPNRSLDR--------------VLFRRPENL--E-AAAPL-----------------N 213 (834)
Q Consensus 171 v~l~-g--~~~~~~~~~lV~Ey~~~gsL~~--------------~l~~~~~~~--~-~~~~l-----------------~ 213 (834)
+... | +....+....++.++.+..... .++...... . ..... .
T Consensus 79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (316)
T d2ppqa1 79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 158 (316)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence 2211 1 1223456777787776643210 011000000 0 00000 0
Q ss_pred HHHHHHHHHHHHHHHHHHH-hccCCCeecCCCCCCceEECCCCceEEeeccchh
Q 003278 214 WEQRKKIIRGLAAALHYLH-EQLETQIIHRDVKTSNVMLDSQYNARLGDFGLAR 266 (834)
Q Consensus 214 ~~~~~~i~~~ia~gL~yLH-~~~~~~iiHrDlKp~NILld~~~~~kl~DFGla~ 266 (834)
.......+......+.-.+ ...+.++||+|+.+.|||++.+...-|.||+.+.
T Consensus 159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 0111122222222222222 2234579999999999999988777899999875
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=91.10 E-value=0.86 Score=45.29 Aligned_cols=162 Identities=11% Similarity=0.019 Sum_probs=83.1
Q ss_pred cccHHHHHHHhhCcCcCCcc-----cccCCcEEEEEEECCCcEEEEEEecCCCChhHHHHHHHHHHHHHhccCCCc----
Q 003278 502 EISFKEIISATNNFSESQRV-----AEMDFGTAYQGFLDNHQYVLVKRLGMSKCPALRTRFSNELQNLARLRHRNL---- 572 (834)
Q Consensus 502 ~~~~~el~~at~~f~~~~~i-----g~g~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~f~~E~~~l~~l~HpNi---- 572 (834)
++|.+||.....+|.-++.. ..|---+.|+-..++|. .++|+....... +....|+.+|..|...++
T Consensus 2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~~---~~l~~~~~~l~~L~~~g~pvp~ 77 (316)
T d2ppqa1 2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVEK---NDLPFFLGLMQHLAAKGLSCPL 77 (316)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC---C---CHHHHHHHHHHHHHHTTCCCCC
T ss_pred CCCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCCH---HHHHHHHHHHHhhhhccccccc
Confidence 35778888888888654332 23444677998888776 557876533222 234456777777754333
Q ss_pred -eeEE-E--EEeeCCeEEEEEeccCCCchhhhhh--------------c----CCCCCC-CcccCH--------------
Q 003278 573 -VQLC-G--WCTEQGEMLVIYDYSATRILSHLLF--------------H----NNHRIG-HSILQW-------------- 615 (834)
Q Consensus 573 -v~l~-g--~~~~~~~~~lv~Ey~~~g~L~~~l~--------------~----~~~~~~-~~~l~~-------------- 615 (834)
+... | +..-.+....++.+..+......-. . ...... .....|
T Consensus 78 pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (316)
T d2ppqa1 78 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 157 (316)
T ss_dssp BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred cceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhh
Confidence 1110 1 1122345666777766644432100 0 000000 000000
Q ss_pred --HHHHHHHHHHHHHHHHhh-hccCCceeecccccCceeecCCCCceEeeeeecc
Q 003278 616 --HHRYNIIKSLASAILYLH-EEWNEQVIHRNITSSAITLDPDMNPRLGSFALAE 667 (834)
Q Consensus 616 --~~r~~i~~~ia~gl~yLH-~~~~~~iiHrDlK~~NILld~~~~~ki~DfGla~ 667 (834)
......+......+.-.+ ...+.++||+|+.+.|||++++...-|.||+.+.
T Consensus 158 ~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 158 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 011122222222222222 1234679999999999999988777788998873
|